Citrus Sinensis ID: 014174
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 429 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZD5 | 410 | Shaggy-related protein ki | yes | no | 0.941 | 0.985 | 0.882 | 0.0 | |
| P43288 | 405 | Shaggy-related protein ki | no | no | 0.913 | 0.967 | 0.883 | 0.0 | |
| P51137 | 411 | Glycogen synthase kinase- | N/A | no | 0.958 | 1.0 | 0.825 | 0.0 | |
| P43289 | 409 | Shaggy-related protein ki | no | no | 0.953 | 1.0 | 0.804 | 0.0 | |
| Q40518 | 409 | Shaggy-related protein ki | N/A | no | 0.923 | 0.968 | 0.859 | 0.0 | |
| P51139 | 411 | Glycogen synthase kinase- | N/A | no | 0.920 | 0.961 | 0.852 | 0.0 | |
| P51138 | 411 | Glycogen synthase kinase- | N/A | no | 0.953 | 0.995 | 0.799 | 0.0 | |
| Q96287 | 472 | Shaggy-related protein ki | no | no | 0.890 | 0.809 | 0.800 | 0.0 | |
| O04160 | 468 | Shaggy-related protein ki | N/A | no | 0.892 | 0.818 | 0.783 | 0.0 | |
| Q39012 | 407 | Shaggy-related protein ki | no | no | 0.853 | 0.899 | 0.825 | 0.0 |
| >sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 753 bits (1944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/410 (88%), Positives = 378/410 (92%), Gaps = 6/410 (1%)
Query: 23 VDKLPAKP---DDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTT 79
V LPA + ++ +KLPE INEMKIK + KEMEA VVDGNGTETGHIIVTT
Sbjct: 4 VGTLPASSMATKQSNASICAEKLPEGINEMKIKDD---KEMEAAVVDGNGTETGHIIVTT 60
Query: 80 IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 139
IGG+NGQPKQTISYMAER+VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61 IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
LLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETVYRV+KHYSRA+QRMP+IYVKLYTY
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
QICRALAYIHGG+GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
RAPELIFGATEYTT IDIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300
Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379
CMNPNYTEFKFPQIKAHPWHKIFHKR PPEAVDLVSRLLQYSPNLR TA+EA +HPFF E
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDE 360
Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 429
LRDPN RLPNGR PPLFNFKPQELKGAS ELLSKLIP+HARKQC FL
Sbjct: 361 LRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 410
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 729 bits (1881), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/395 (88%), Positives = 370/395 (93%), Gaps = 3/395 (0%)
Query: 35 DAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYM 94
D+ VDKLPEE+N+MKI R +KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYM
Sbjct: 14 DSTGVDKLPEEMNDMKI---RDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYM 70
Query: 95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
AERVVG GSFG+VFQAKCLETGETVAIKKVLQD+RYKNRELQTMRLLDHPNVVSLKHCFF
Sbjct: 71 AERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFF 130
Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
STT+KDELYLNLVLE+VPETV+RV KHY++ +QRMPLIYVKLYTYQI RAL+YIH IGV
Sbjct: 131 STTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGV 190
Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 274
CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA
Sbjct: 191 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 250
Query: 275 IDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 334
ID+WS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK
Sbjct: 251 IDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 310
Query: 335 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFP 394
AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR AL+ +HPFF ELRDPNARLPNGR P
Sbjct: 311 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLP 370
Query: 395 PLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 429
PLFNFKP ELKG E+++KL+PEHARKQCP+LG
Sbjct: 371 PLFNFKPHELKGVPLEMVAKLVPEHARKQCPWLGL 405
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 719 bits (1855), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/429 (82%), Positives = 373/429 (86%), Gaps = 18/429 (4%)
Query: 1 MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
M S G+AP + D + VD D LPEE+++MKI+ +R EM
Sbjct: 1 MASVGVAPTSGFREVLGDGEIGVD---------------DILPEEMSDMKIRDDR---EM 42
Query: 61 EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVG GSFG+VFQAKCLETGETVA
Sbjct: 43 EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVA 102
Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETV+RV K
Sbjct: 103 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIK 162
Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
HYS+ +QRMP+IYVKLYTYQI RAL+YIH IGVCHRDIKPQNLLVNPHTHQVKLCDFGS
Sbjct: 163 HYSKLNQRMPMIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 222
Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID+WSVGCVLAELLLGQPLFPGE GV
Sbjct: 223 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGV 282
Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP EAVDLVSRLLQY
Sbjct: 283 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQY 342
Query: 361 SPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
SPNLRC AL+ HPFF ELRDPNARLP GR PPLFNFKP ELKG E L KL+PEHA
Sbjct: 343 SPNLRCQALDCLTHPFFDELRDPNARLPTGRFLPPLFNFKPHELKGVPVETLMKLVPEHA 402
Query: 421 RKQCPFLGF 429
RKQCPFLG
Sbjct: 403 RKQCPFLGL 411
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 718 bits (1853), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/429 (80%), Positives = 376/429 (87%), Gaps = 20/429 (4%)
Query: 1 MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
M S G+ P+ AV + + D+LPEE+ +MKI+ + KEM
Sbjct: 1 MASVGIEPSAAVR-----------------ESTGNVTDADRLPEEMKDMKIQDD---KEM 40
Query: 61 EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
EAT+V+GN TETGHIIVTTIGGRNGQPKQTISYMAERVVG GSFG+VFQAKCLETGETVA
Sbjct: 41 EATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVA 100
Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
IKKVLQD+RYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETV+RV K
Sbjct: 101 IKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIK 160
Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
HY++ +QRMPL+YVKLYTYQI R+L+YIH IGVCHRDIKPQNLLVNPHTHQVKLCDFGS
Sbjct: 161 HYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 220
Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID+WS GCVLAELLLGQPLFPGESGV
Sbjct: 221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGV 280
Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY
Sbjct: 281 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 340
Query: 361 SPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
SPNLRC AL++ +HPFF ELRDPNARLPNGR PPLFNFKP ELKG E+++KL+PEHA
Sbjct: 341 SPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHELKGVPVEMVAKLVPEHA 400
Query: 421 RKQCPFLGF 429
RKQCP+L
Sbjct: 401 RKQCPWLSL 409
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 717 bits (1852), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/399 (85%), Positives = 365/399 (91%), Gaps = 3/399 (0%)
Query: 31 DDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQT 90
+ ++ VD+LPEE+N+M+I R +KE+EA +VDGNGTETGHIIVTTIGGR+GQPKQT
Sbjct: 14 ESSSHSVGVDRLPEEMNDMRI---RDDKEIEAAIVDGNGTETGHIIVTTIGGRHGQPKQT 70
Query: 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK 150
ISYMAER+VGQGSFG+VFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVV LK
Sbjct: 71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVCLK 130
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
HCFFSTT+KDE+YLNLVLE+VPETV+RV KHY++ +QRMPLI VKLYTYQI RAL+YIH
Sbjct: 131 HCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQIFRALSYIHH 190
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE
Sbjct: 191 TIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
YTTAIDIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY EFKF
Sbjct: 251 YTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYNEFKF 310
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNG 390
PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA H FF ELRDPN RLPNG
Sbjct: 311 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAVTHAFFDELRDPNTRLPNG 370
Query: 391 RPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 429
R PPLFNFK ELKG S E L KL+PEHARKQCP LG
Sbjct: 371 RVLPPLFNFKAHELKGVSAENLLKLVPEHARKQCPSLGL 409
|
May mediate extracellular signals to regulate transcription in differentiating cells. Nicotiana tabacum (taxid: 4097) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 714 bits (1844), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 340/399 (85%), Positives = 366/399 (91%), Gaps = 4/399 (1%)
Query: 31 DDDDDAMPVDKLPEEINEMKIKGERVEKEMEA-TVVDGNGTETGHIIVTTIGGRNGQPKQ 89
D + ++ V+KLPEE+N+MKI R +KEMEA T+VDGNGTETGHIIVTTIGG+NGQPKQ
Sbjct: 14 DKNASSVGVEKLPEEMNDMKI---RDDKEMEAATIVDGNGTETGHIIVTTIGGKNGQPKQ 70
Query: 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL 149
TISYMAERVVG GSFG+VFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL
Sbjct: 71 TISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL 130
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
KHCFFSTT+KDELYLNLVLE+VPETV RV +HY++ +QRMP+IYVKLY+YQICRALAYIH
Sbjct: 131 KHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSYQICRALAYIH 190
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
IGVCHRDIKPQNLLVNPHTHQ+K+CDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT
Sbjct: 191 NSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 250
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
EYTTAIDIWS GCVL ELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK
Sbjct: 251 EYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 310
Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPN 389
FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR TALEA +HPF+ ++RDPN RLPN
Sbjct: 311 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEALVHPFYDDVRDPNTRLPN 370
Query: 390 GRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLG 428
GR PPLFNFK ELKG E+L KL+P HARKQC G
Sbjct: 371 GRFLPPLFNFKVNELKGVPAEMLVKLVPPHARKQCALFG 409
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 706 bits (1823), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/428 (79%), Positives = 367/428 (85%), Gaps = 19/428 (4%)
Query: 1 MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
M + G+APA + DV + A+ VDKLP+EI M+IK + KEM
Sbjct: 1 MATAGVAPASGIV-----DV-----------NASSAIAVDKLPDEILGMRIKDD---KEM 41
Query: 61 EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
EA VVDGN TE GH+IVTTIGG+NGQPKQTISYMAER VGQGSFG+VFQAKCLETGETVA
Sbjct: 42 EAHVVDGNSTEAGHVIVTTIGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVA 101
Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
IKKVLQDKRYKNRELQTMRLLDHPNVV+LKHCFFSTT+KDELYLNLVLEFVPETV+RV +
Sbjct: 102 IKKVLQDKRYKNRELQTMRLLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIR 161
Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
HYS+ +QRMPLIYVKLY+YQICR+LAYIH +GV HRDIKPQNLLVNPHTHQ+KLCDFGS
Sbjct: 162 HYSKMNQRMPLIYVKLYSYQICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGS 221
Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
AKVLVKGEPNISYICSRYYRAPELIFGATEYT+AIDIWS GCVL ELLLGQPLFPG SGV
Sbjct: 222 AKVLVKGEPNISYICSRYYRAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGV 281
Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQY
Sbjct: 282 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQY 341
Query: 361 SPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
SPNLR TALEA +HPFF ELRDPN RLPNGR PPLFNFK ELKG E+L KL+P HA
Sbjct: 342 SPNLRSTALEALVHPFFDELRDPNTRLPNGRHLPPLFNFKANELKGVPAEMLVKLVPSHA 401
Query: 421 RKQCPFLG 428
RKQC
Sbjct: 402 RKQCSLFA 409
|
Medicago sativa (taxid: 3879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 666 bits (1719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 309/386 (80%), Positives = 345/386 (89%), Gaps = 4/386 (1%)
Query: 40 DKLPEEINEMKIKGERV----EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMA 95
D+LP+ + EMKI+ ER +K+ME TVV+G+GTETG +I TT+GGR+G+PKQTISYMA
Sbjct: 81 DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMA 140
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 155
+RVVG GSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQ MRL DHPNVV L+H FFS
Sbjct: 141 QRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFS 200
Query: 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 215
TTDKDELYLNLVLE+VPETVYR +KHY++ +Q MP+I+V+LYTYQICRAL Y+H +GVC
Sbjct: 201 TTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVC 260
Query: 216 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI 275
HRDIKPQNLLVNP THQ+K+CDFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT AI
Sbjct: 261 HRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAI 320
Query: 276 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 335
D+WS GCV+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIKA
Sbjct: 321 DMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKA 380
Query: 336 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPP 395
HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC HPFF +LRDPN LPNGR PP
Sbjct: 381 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPP 440
Query: 396 LFNFKPQELKGASKELLSKLIPEHAR 421
LFNF QEL GAS EL +LIP H +
Sbjct: 441 LFNFTAQELAGASTELRQRLIPAHCQ 466
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O04160|KSGT_BRANA Shaggy-related protein kinase theta OS=Brassica napus PE=2 SV=2 | Back alignment and function description |
|---|
Score = 653 bits (1684), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 307/392 (78%), Positives = 342/392 (87%), Gaps = 9/392 (2%)
Query: 38 PVDKLPEEINEMKIK--------GERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQ 89
P D+LPE +N+M+++ GE +K+ME +V+G GTETG +I TT+GGR+G+PKQ
Sbjct: 72 PPDQLPEVMNDMRLREDEPHANRGEE-DKDMEPPIVNGCGTETGQVITTTVGGRDGKPKQ 130
Query: 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL 149
TISYMA+RVVG GSFG+VFQAKCLETGE VAIKKVLQDKRYKNRELQ MRL DHPNVV L
Sbjct: 131 TISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRL 190
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+H FFSTTDKDELYLNLVLEFVPETVYR KHY++ +Q MP+I V+LYTYQICRAL Y+H
Sbjct: 191 RHSFFSTTDKDELYLNLVLEFVPETVYRALKHYTKMNQHMPIILVQLYTYQICRALNYLH 250
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
+GVCHRDIKPQNLLVN HTHQ+K+CDFGSAK+LV GEPNISYICSRYYRAPELIFGAT
Sbjct: 251 RVVGVCHRDIKPQNLLVNTHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGAT 310
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
EYT AID+WS GCV+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFK
Sbjct: 311 EYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFK 370
Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPN 389
FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC HPFF +LR PN LPN
Sbjct: 371 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRAPNVSLPN 430
Query: 390 GRPFPPLFNFKPQELKGASKELLSKLIPEHAR 421
GR PPLFNF QEL GAS EL +LIP H +
Sbjct: 431 GRALPPLFNFTAQELAGASTELRQRLIPAHCQ 462
|
May mediate extracellular signals to regulate transcription in differentiating cells. Brassica napus (taxid: 3708) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39012|KSG9_ARATH Shaggy-related protein kinase iota OS=Arabidopsis thaliana GN=ASK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 653 bits (1684), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 303/367 (82%), Positives = 337/367 (91%), Gaps = 1/367 (0%)
Query: 57 EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG 116
+KEM A V++GN TGHII TTIGG+NG+PKQTISYMAERVVG GSFGIVFQAKCLETG
Sbjct: 34 DKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 93
Query: 117 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVY 176
E+VAIKKVLQD+RYKNRELQ MR +DHPNV+SLKHCFFSTT +DEL+LNLV+E+VPET+Y
Sbjct: 94 ESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLY 153
Query: 177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236
RV +HY+ ++QRMP+ YVKLYTYQI R LAYIH GVCHRD+KPQNLLV+P THQVKLC
Sbjct: 154 RVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 213
Query: 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT +IDIWS GCVLAELLLGQPLFPG
Sbjct: 214 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPG 273
Query: 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 356
E+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SR
Sbjct: 274 ENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 333
Query: 357 LLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
LLQYSP+LRCTALEAC HPFF ELR+PNARLPNGRP PPLFNFK QEL GAS EL+++LI
Sbjct: 334 LLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK-QELGGASMELINRLI 392
Query: 417 PEHARKQ 423
PEH R+Q
Sbjct: 393 PEHVRRQ 399
|
May mediate extracellular signals to regulate transcription in differentiating cells. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 429 | ||||||
| 296087644 | 412 | unnamed protein product [Vitis vinifera] | 0.960 | 1.0 | 0.892 | 0.0 | |
| 359488836 | 416 | PREDICTED: shaggy-related protein kinase | 0.946 | 0.975 | 0.891 | 0.0 | |
| 449515565 | 410 | PREDICTED: shaggy-related protein kinase | 0.955 | 1.0 | 0.881 | 0.0 | |
| 449446680 | 410 | PREDICTED: shaggy-related protein kinase | 0.955 | 1.0 | 0.876 | 0.0 | |
| 297811597 | 410 | kinase family protein [Arabidopsis lyrat | 0.955 | 1.0 | 0.850 | 0.0 | |
| 22326813 | 410 | Shaggy-related protein kinase epsilon [A | 0.941 | 0.985 | 0.882 | 0.0 | |
| 7573313 | 408 | protein kinase MSK-3-like [Arabidopsis t | 0.937 | 0.985 | 0.880 | 0.0 | |
| 619894 | 409 | Petunia Shaggy kinase 4 [Petunia x hybri | 0.916 | 0.960 | 0.901 | 0.0 | |
| 116787052 | 370 | unknown [Picea sitchensis] | 0.862 | 1.0 | 0.951 | 0.0 | |
| 302812402 | 423 | GSK3/shaggy-like protein kinase [Selagin | 0.911 | 0.924 | 0.878 | 0.0 |
| >gi|296087644|emb|CBI34900.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/429 (89%), Positives = 396/429 (92%), Gaps = 17/429 (3%)
Query: 1 MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
M S G+ PA AV KP + M VDKLPEEINEMKI+ ++VEKEM
Sbjct: 1 MASAGIPPASAVGKP-----------------SGNTMFVDKLPEEINEMKIRDDKVEKEM 43
Query: 61 EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA
Sbjct: 44 EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 103
Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
IKKVLQDKRYKNRELQTMRLLDHPN+VSLKHCFFSTTDKDELYLNLVLE+VPETVYRVAK
Sbjct: 104 IKKVLQDKRYKNRELQTMRLLDHPNIVSLKHCFFSTTDKDELYLNLVLEYVPETVYRVAK 163
Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
HYSRA+QRMPLIYVKLYTYQICRALAYIHG +GVCHRDIKPQNLLVNPH HQ+KLCDFGS
Sbjct: 164 HYSRANQRMPLIYVKLYTYQICRALAYIHGVVGVCHRDIKPQNLLVNPHIHQLKLCDFGS 223
Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID+WSVGCVLAELLLGQPLFPGESGV
Sbjct: 224 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDMWSVGCVLAELLLGQPLFPGESGV 283
Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY
Sbjct: 284 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 343
Query: 361 SPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
SPNLRCTALEACIHPFF ELRD N+RLPNGRP PPLFNFKPQELKGAS ELL+KLIPEHA
Sbjct: 344 SPNLRCTALEACIHPFFDELRDQNSRLPNGRPLPPLFNFKPQELKGASLELLAKLIPEHA 403
Query: 421 RKQCPFLGF 429
RKQCPFLGF
Sbjct: 404 RKQCPFLGF 412
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488836|ref|XP_002276754.2| PREDICTED: shaggy-related protein kinase epsilon [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 777 bits (2006), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/423 (89%), Positives = 390/423 (92%), Gaps = 17/423 (4%)
Query: 1 MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
M S G+ PA AV KP + M VDKLPEEINEMKI+ ++VEKEM
Sbjct: 1 MASAGIPPASAVGKP-----------------SGNTMFVDKLPEEINEMKIRDDKVEKEM 43
Query: 61 EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA
Sbjct: 44 EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 103
Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
IKKVLQDKRYKNRELQTMRLLDHPN+VSLKHCFFSTTDKDELYLNLVLE+VPETVYRVAK
Sbjct: 104 IKKVLQDKRYKNRELQTMRLLDHPNIVSLKHCFFSTTDKDELYLNLVLEYVPETVYRVAK 163
Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
HYSRA+QRMPLIYVKLYTYQICRALAYIHG +GVCHRDIKPQNLLVNPH HQ+KLCDFGS
Sbjct: 164 HYSRANQRMPLIYVKLYTYQICRALAYIHGVVGVCHRDIKPQNLLVNPHIHQLKLCDFGS 223
Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID+WSVGCVLAELLLGQPLFPGESGV
Sbjct: 224 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDMWSVGCVLAELLLGQPLFPGESGV 283
Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY
Sbjct: 284 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 343
Query: 361 SPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
SPNLRCTALEACIHPFF ELRD N+RLPNGRP PPLFNFKPQELKGAS ELL+KLIPEHA
Sbjct: 344 SPNLRCTALEACIHPFFDELRDQNSRLPNGRPLPPLFNFKPQELKGASLELLAKLIPEHA 403
Query: 421 RKQ 423
RKQ
Sbjct: 404 RKQ 406
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449515565|ref|XP_004164819.1| PREDICTED: shaggy-related protein kinase epsilon-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 772 bits (1993), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 378/429 (88%), Positives = 388/429 (90%), Gaps = 19/429 (4%)
Query: 1 MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
M S+GM P V KP A+ DKLPE INEMKI+ E+VEKEM
Sbjct: 1 MASSGMGP---VGKP----------------GSGVALFADKLPEGINEMKIRDEKVEKEM 41
Query: 61 EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
EATVVDGNGTETGHIIVTTIGGRNGQ +QTISYMAER VGQGSFGIVFQAKCLETGETVA
Sbjct: 42 EATVVDGNGTETGHIIVTTIGGRNGQSRQTISYMAERPVGQGSFGIVFQAKCLETGETVA 101
Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETVYRV K
Sbjct: 102 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVIK 161
Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
HY++ASQRMPLIYVKLY YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS
Sbjct: 162 HYTKASQRMPLIYVKLYAYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 221
Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWS GCVLAELLLGQPLFPGESGV
Sbjct: 222 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGV 281
Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY
Sbjct: 282 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 341
Query: 361 SPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
SPNLRCTALEACIHPFF ELRDPN RLPNGRP PPLFNFKPQELKGA+ ELLSKLIPEHA
Sbjct: 342 SPNLRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELKGATLELLSKLIPEHA 401
Query: 421 RKQCPFLGF 429
RKQC FL F
Sbjct: 402 RKQCSFLDF 410
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446680|ref|XP_004141099.1| PREDICTED: shaggy-related protein kinase epsilon-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 766 bits (1979), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 376/429 (87%), Positives = 387/429 (90%), Gaps = 19/429 (4%)
Query: 1 MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
M S+GM P V KP A+ DKLPE INEMKI+ E+VEKEM
Sbjct: 1 MASSGMGP---VGKP----------------GSGVALFADKLPEGINEMKIRDEKVEKEM 41
Query: 61 EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
EATVVDGNGTETGHIIVTTIGGRNGQ +QTISYMAER VGQGSFGIVFQAKCLETGETVA
Sbjct: 42 EATVVDGNGTETGHIIVTTIGGRNGQSRQTISYMAERPVGQGSFGIVFQAKCLETGETVA 101
Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETVYRV K
Sbjct: 102 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVIK 161
Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
HY++A+QRMPLIYVKLY YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS
Sbjct: 162 HYTKANQRMPLIYVKLYAYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 221
Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWS GCVLAELLLGQPLFPGESGV
Sbjct: 222 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGV 281
Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY
Sbjct: 282 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 341
Query: 361 SPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
SPNLRCTALEA IHPFF ELRDPN RLPNGRP PPLFNFKPQELKGA+ ELLSKLIPEHA
Sbjct: 342 SPNLRCTALEAFIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELKGATLELLSKLIPEHA 401
Query: 421 RKQCPFLGF 429
RKQC FL F
Sbjct: 402 RKQCSFLDF 410
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297811597|ref|XP_002873682.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297319519|gb|EFH49941.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 755 bits (1950), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 365/429 (85%), Positives = 384/429 (89%), Gaps = 19/429 (4%)
Query: 1 MYSTGMAPALAVAKPEDDDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEM 60
M S G PA +VA + + ++ +KLPE INEMKIK + KEM
Sbjct: 1 MASVGTLPASSVATKQSNA----------------SICAEKLPEGINEMKIKDD---KEM 41
Query: 61 EATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVA 120
EA VVDGNGTETGHIIVTTIGG+NGQPKQTISYMAER+VGQGSFGIVFQAKCLETGETVA
Sbjct: 42 EAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVA 101
Query: 121 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAK 180
IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETVYRV+K
Sbjct: 102 IKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSK 161
Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
HYSRA+QRMP+IYVKLYTYQICRALAYIHGG+GVCHRDIKPQNLLVNPHTHQVKLCDFGS
Sbjct: 162 HYSRANQRMPMIYVKLYTYQICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGS 221
Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWS GCVLAELLLGQPLFPGESGV
Sbjct: 222 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGV 281
Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR PPEAVDLVSRLLQY
Sbjct: 282 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQY 341
Query: 361 SPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA 420
SP+LR TA+EA +HPFF ELRDPN RLPNGRP PPLFNFKPQEL GAS ELLSKLIP+HA
Sbjct: 342 SPSLRSTAMEAIVHPFFDELRDPNTRLPNGRPLPPLFNFKPQELNGASSELLSKLIPDHA 401
Query: 421 RKQCPFLGF 429
RKQC FL
Sbjct: 402 RKQCSFLAL 410
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|22326813|ref|NP_196968.2| Shaggy-related protein kinase epsilon [Arabidopsis thaliana] gi|46576619|sp|Q8VZD5.1|KSG5_ARATH RecName: Full=Shaggy-related protein kinase epsilon; AltName: Full=ASK-epsilon gi|18086450|gb|AAL57679.1| AT5g14640/T15N1_130 [Arabidopsis thaliana] gi|34365555|gb|AAQ65089.1| At5g14640/T15N1_130 [Arabidopsis thaliana] gi|332004674|gb|AED92057.1| Shaggy-related protein kinase epsilon [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/410 (88%), Positives = 378/410 (92%), Gaps = 6/410 (1%)
Query: 23 VDKLPAKP---DDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTT 79
V LPA + ++ +KLPE INEMKIK + KEMEA VVDGNGTETGHIIVTT
Sbjct: 4 VGTLPASSMATKQSNASICAEKLPEGINEMKIKDD---KEMEAAVVDGNGTETGHIIVTT 60
Query: 80 IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 139
IGG+NGQPKQTISYMAER+VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61 IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
LLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETVYRV+KHYSRA+QRMP+IYVKLYTY
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
QICRALAYIHGG+GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
RAPELIFGATEYTT IDIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300
Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379
CMNPNYTEFKFPQIKAHPWHKIFHKR PPEAVDLVSRLLQYSPNLR TA+EA +HPFF E
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDE 360
Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 429
LRDPN RLPNGR PPLFNFKPQELKGAS ELLSKLIP+HARKQC FL
Sbjct: 361 LRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 410
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7573313|emb|CAB87631.1| protein kinase MSK-3-like [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 745 bits (1924), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 361/410 (88%), Positives = 376/410 (91%), Gaps = 8/410 (1%)
Query: 23 VDKLPAKP---DDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTT 79
V LPA + ++ +KLPE INEMKIK + KEMEA VVDGNGTETGHIIVTT
Sbjct: 4 VGTLPASSMATKQSNASICAEKLPEGINEMKIKDD---KEMEAAVVDGNGTETGHIIVTT 60
Query: 80 IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 139
IGG+NGQPKQTISYMAER+VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61 IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
LLDHPNVVSLKHCFFSTT+KDELYLNLVLE+VPETVYRV+KHYSRA+QRMP+IYVKLYTY
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
QICRALAYIHGG+GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
RAPELIFGATEYTT IDIWS GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300
Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379
CMNPNYTEFKFPQIKAHPWHKIFHKR PPEAVDLVSRLLQYSPNLR TA A +HPFF E
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTA--AIVHPFFDE 358
Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 429
LRDPN RLPNGR PPLFNFKPQELKGAS ELLSKLIP+HARKQC FL
Sbjct: 359 LRDPNTRLPNGRALPPLFNFKPQELKGASLELLSKLIPDHARKQCSFLAL 408
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|619894|emb|CAA58594.1| Petunia Shaggy kinase 4 [Petunia x hybrida] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1920), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/394 (90%), Positives = 375/394 (95%), Gaps = 1/394 (0%)
Query: 35 DAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYM 94
DAM VDKLPEEINEMKI+ ++ EKEMEA VVDGNGTE GHIIVTTIGG+NG+PKQTISYM
Sbjct: 16 DAMLVDKLPEEINEMKIRDDKAEKEMEAAVVDGNGTEKGHIIVTTIGGKNGEPKQTISYM 75
Query: 95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT+RLLDHPNVV+L+HCFF
Sbjct: 76 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTIRLLDHPNVVALRHCFF 135
Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
STT+KDELYLNLVLE+VPETVYRV +HYS+A+Q+MP+IYVKLYTYQI RALAYIHG IGV
Sbjct: 136 STTEKDELYLNLVLEYVPETVYRVLRHYSKANQQMPMIYVKLYTYQIFRALAYIHG-IGV 194
Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 274
CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT A
Sbjct: 195 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTFA 254
Query: 275 IDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 334
IDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK MNPNYTEFKFPQIK
Sbjct: 255 IDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKSMNPNYTEFKFPQIK 314
Query: 335 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFP 394
AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR TALEAC H FF ELRDP RLPNGRP P
Sbjct: 315 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTALEACTHTFFDELRDPKTRLPNGRPLP 374
Query: 395 PLFNFKPQELKGASKELLSKLIPEHARKQCPFLG 428
PLFNF+PQELKGAS +LL+KLIPEHA+KQC FLG
Sbjct: 375 PLFNFRPQELKGASADLLNKLIPEHAKKQCTFLG 408
|
Source: Petunia x hybrida Species: Petunia x hybrida Genus: Petunia Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116787052|gb|ABK24355.1| unknown [Picea sitchensis] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1909), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/370 (95%), Positives = 360/370 (97%)
Query: 60 MEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETV 119
MEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVG GSFGIVFQAKCLETGETV
Sbjct: 1 MEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGTGSFGIVFQAKCLETGETV 60
Query: 120 AIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVA 179
AIKKVLQDKRYKNRELQTMRLLDHPN+V LKHCFFSTTDKDELYLNLVLE+VPETVYRVA
Sbjct: 61 AIKKVLQDKRYKNRELQTMRLLDHPNIVCLKHCFFSTTDKDELYLNLVLEYVPETVYRVA 120
Query: 180 KHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239
KHYSR +QRMPL+YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ+KLCDFG
Sbjct: 121 KHYSRMNQRMPLLYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQLKLCDFG 180
Query: 240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG 299
SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWS+GCVLAELLLGQPLFPGESG
Sbjct: 181 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSMGCVLAELLLGQPLFPGESG 240
Query: 300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 359
VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ
Sbjct: 241 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 300
Query: 360 YSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEH 419
YSPNLRCTALEACIHPFF ELRDPN RLPNGRP PPLFNFKPQELKGA+ +LL KLIPEH
Sbjct: 301 YSPNLRCTALEACIHPFFDELRDPNTRLPNGRPLPPLFNFKPQELKGATPDLLIKLIPEH 360
Query: 420 ARKQCPFLGF 429
ARKQCPFL
Sbjct: 361 ARKQCPFLNL 370
|
Source: Picea sitchensis Species: Picea sitchensis Genus: Picea Family: Pinaceae Order: Coniferales Class: Coniferopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302812402|ref|XP_002987888.1| GSK3/shaggy-like protein kinase [Selaginella moellendorffii] gi|302824786|ref|XP_002994033.1| hypothetical protein SELMODRAFT_163279 [Selaginella moellendorffii] gi|300138136|gb|EFJ04915.1| hypothetical protein SELMODRAFT_163279 [Selaginella moellendorffii] gi|300144277|gb|EFJ10962.1| GSK3/shaggy-like protein kinase [Selaginella moellendorffii] | Back alignment and taxonomy information |
|---|
Score = 737 bits (1903), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/395 (87%), Positives = 374/395 (94%), Gaps = 4/395 (1%)
Query: 39 VDKLPEEINEMKIKGERVE----KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYM 94
VD+LPEE++EMKI+ ++ + KE+EATVVDGNGTETGHII TTIGGRNGQPKQTISY+
Sbjct: 29 VDQLPEEMHEMKIRDDKTDHSDDKELEATVVDGNGTETGHIIATTIGGRNGQPKQTISYV 88
Query: 95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
AERVVG GSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ MRLLDHPN+V+LKHCFF
Sbjct: 89 AERVVGTGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQIMRLLDHPNIVALKHCFF 148
Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
STTDKDELYLNLVLE+VPETVYR+AKH++R +QRMPL+YVKLYTYQICR+LAYIHGGIGV
Sbjct: 149 STTDKDELYLNLVLEYVPETVYRIAKHHNRMNQRMPLLYVKLYTYQICRSLAYIHGGIGV 208
Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 274
CHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA
Sbjct: 209 CHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 268
Query: 275 IDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 334
IDIWS+GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK
Sbjct: 269 IDIWSMGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 328
Query: 335 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFP 394
AHPWHK+FHKRMPPEAVDLVSRLLQYSPNLRC++LEA HPFF ELRDPN RLPNGRP P
Sbjct: 329 AHPWHKVFHKRMPPEAVDLVSRLLQYSPNLRCSSLEALAHPFFDELRDPNTRLPNGRPLP 388
Query: 395 PLFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 429
PL+NFK ELKGAS ELL++L+PEHARKQ PFL
Sbjct: 389 PLYNFKQLELKGASPELLNRLVPEHARKQVPFLAL 423
|
Source: Selaginella moellendorffii Species: Selaginella moellendorffii Genus: Selaginella Family: Selaginellaceae Order: Selaginellales Class: Isoetopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 429 | ||||||
| TAIR|locus:2222642 | 410 | SK13 "shaggy-like kinase 13" [ | 0.888 | 0.929 | 0.924 | 6.3e-195 | |
| TAIR|locus:2832141 | 405 | SK 11 "AT5G26751" [Arabidopsis | 0.890 | 0.943 | 0.890 | 8.8e-189 | |
| TAIR|locus:2074464 | 409 | ATSK12 [Arabidopsis thaliana ( | 0.888 | 0.931 | 0.875 | 1.9e-186 | |
| TAIR|locus:2052861 | 412 | SKdZeta "SHAGGY-related protei | 0.853 | 0.888 | 0.828 | 9.1e-171 | |
| TAIR|locus:2126993 | 472 | SK32 "shaggy-like protein kina | 0.871 | 0.792 | 0.809 | 9.1e-171 | |
| TAIR|locus:2202255 | 407 | GSK1 "GSK3/SHAGGY-like protein | 0.853 | 0.899 | 0.825 | 1.9e-170 | |
| TAIR|locus:2124082 | 380 | BIN2 "BRASSINOSTEROID-INSENSIT | 0.853 | 0.963 | 0.822 | 9.4e-169 | |
| TAIR|locus:2024341 | 421 | SK41 "shaggy-like protein kina | 0.864 | 0.881 | 0.800 | 2.5e-168 | |
| TAIR|locus:2098896 | 438 | AT3G61160 [Arabidopsis thalian | 0.876 | 0.858 | 0.730 | 7.4e-153 | |
| UNIPROTKB|Q91757 | 420 | gsk3b "Glycogen synthase kinas | 0.825 | 0.842 | 0.674 | 3.1e-131 |
| TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1888 (669.7 bits), Expect = 6.3e-195, P = 6.3e-195
Identities = 355/384 (92%), Positives = 367/384 (95%)
Query: 44 EEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGS 103
E INEMKIK + KEMEA VVDGNGTETGHIIVTTIGG+NGQPKQTISYMAER+VGQGS
Sbjct: 28 EGINEMKIKDD---KEMEAAVVDGNGTETGHIIVTTIGGKNGQPKQTISYMAERIVGQGS 84
Query: 104 FGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163
FGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELY
Sbjct: 85 FGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY 144
Query: 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223
LNLVLE+VPETVYRV+KHYSRA+QRMP+IYVKLYTYQICRALAYIHGG+GVCHRDIKPQN
Sbjct: 145 LNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTYQICRALAYIHGGVGVCHRDIKPQN 204
Query: 224 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCV 283
LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT IDIWS GCV
Sbjct: 205 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTTIDIWSAGCV 264
Query: 284 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 343
LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH
Sbjct: 265 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 324
Query: 344 KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQE 403
KR PPEAVDLVSRLLQYSPNLR TA+EA +HPFF ELRDPN RLPNGR PPLFNFKPQE
Sbjct: 325 KRTPPEAVDLVSRLLQYSPNLRSTAMEAIVHPFFDELRDPNTRLPNGRALPPLFNFKPQE 384
Query: 404 LKGASKELLSKLIPEHARKQCPFL 427
LKGAS ELLSKLIP+HARKQC FL
Sbjct: 385 LKGASLELLSKLIPDHARKQCSFL 408
|
|
| TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1830 (649.3 bits), Expect = 8.8e-189, P = 8.8e-189
Identities = 343/385 (89%), Positives = 363/385 (94%)
Query: 44 EEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGS 103
EE+N+MKI R +KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVG GS
Sbjct: 23 EEMNDMKI---RDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGS 79
Query: 104 FGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163
FG+VFQAKCLETGETVAIKKVLQD+RYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELY
Sbjct: 80 FGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY 139
Query: 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223
LNLVLE+VPETV+RV KHY++ +QRMPLIYVKLYTYQI RAL+YIH IGVCHRDIKPQN
Sbjct: 140 LNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQIFRALSYIHRCIGVCHRDIKPQN 199
Query: 224 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCV 283
LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID+WS GCV
Sbjct: 200 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCV 259
Query: 284 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 343
LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH
Sbjct: 260 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 319
Query: 344 KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQE 403
KRMPPEAVDLVSRLLQYSPNLR AL+ +HPFF ELRDPNARLPNGR PPLFNFKP E
Sbjct: 320 KRMPPEAVDLVSRLLQYSPNLRSAALDTLVHPFFDELRDPNARLPNGRFLPPLFNFKPHE 379
Query: 404 LKGASKELLSKLIPEHARKQCPFLG 428
LKG E+++KL+PEHARKQCP+LG
Sbjct: 380 LKGVPLEMVAKLVPEHARKQCPWLG 404
|
|
| TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1808 (641.5 bits), Expect = 1.9e-186, P = 1.9e-186
Identities = 336/384 (87%), Positives = 362/384 (94%)
Query: 44 EEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGS 103
EE+ +MKI+ + KEMEAT+V+GN TETGHIIVTTIGGRNGQPKQTISYMAERVVG GS
Sbjct: 27 EEMKDMKIQDD---KEMEATIVNGNVTETGHIIVTTIGGRNGQPKQTISYMAERVVGHGS 83
Query: 104 FGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163
FG+VFQAKCLETGETVAIKKVLQD+RYKNRELQTMRLLDHPNVVSLKHCFFSTT+KDELY
Sbjct: 84 FGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRLLDHPNVVSLKHCFFSTTEKDELY 143
Query: 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223
LNLVLE+VPETV+RV KHY++ +QRMPL+YVKLYTYQI R+L+YIH IGVCHRDIKPQN
Sbjct: 144 LNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQIFRSLSYIHRCIGVCHRDIKPQN 203
Query: 224 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCV 283
LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID+WS GCV
Sbjct: 204 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDVWSAGCV 263
Query: 284 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 343
LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH
Sbjct: 264 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 323
Query: 344 KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQE 403
KRMPPEAVDLVSRLLQYSPNLRC AL++ +HPFF ELRDPNARLPNGR PPLFNFKP E
Sbjct: 324 KRMPPEAVDLVSRLLQYSPNLRCAALDSLVHPFFDELRDPNARLPNGRFLPPLFNFKPHE 383
Query: 404 LKGASKELLSKLIPEHARKQCPFL 427
LKG E+++KL+PEHARKQCP+L
Sbjct: 384 LKGVPVEMVAKLVPEHARKQCPWL 407
|
|
| TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1660 (589.4 bits), Expect = 9.1e-171, P = 9.1e-171
Identities = 304/367 (82%), Positives = 337/367 (91%)
Query: 57 EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG 116
+KEM A V++GN TGHII TTIGG+NG+PKQTISYMAERVVG GSFGIVFQAKCLETG
Sbjct: 36 DKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 95
Query: 117 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVY 176
E+VAIKKVLQD+RYKNRELQ MRL+DHPNVVSLKHCFFSTT +DEL+LNLV+E+VPET+Y
Sbjct: 96 ESVAIKKVLQDRRYKNRELQLMRLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLY 155
Query: 177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236
RV KHY+ ++QRMP+ YVKLYTYQI R LAYIH GVCHRD+KPQNLLV+P THQ KLC
Sbjct: 156 RVLKHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLC 215
Query: 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
DFGSAKVLVKGE NISYICSRYYRAPELIFGATEYT++IDIWS GCVLAELLLGQPLFPG
Sbjct: 216 DFGSAKVLVKGEANISYICSRYYRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPG 275
Query: 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 356
E+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SR
Sbjct: 276 ENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 335
Query: 357 LLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
LLQYSP+LRCTALEAC HPFF ELR+PNARLPNGRP PPLFNFK QEL GAS EL+++LI
Sbjct: 336 LLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK-QELSGASPELINRLI 394
Query: 417 PEHARKQ 423
PEH R+Q
Sbjct: 395 PEHVRRQ 401
|
|
| TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1660 (589.4 bits), Expect = 9.1e-171, P = 9.1e-171
Identities = 306/378 (80%), Positives = 339/378 (89%)
Query: 48 EMKIKGER----VEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGS 103
EMKI+ ER +K+ME TVV+G+GTETG +I TT+GGR+G+PKQTISYMA+RVVG GS
Sbjct: 89 EMKIRDERNANREDKDMETTVVNGSGTETGQVITTTVGGRDGKPKQTISYMAQRVVGTGS 148
Query: 104 FGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163
FG+VFQAKCLETGE VAIKKVLQDKRYKNRELQ MRL DHPNVV L+H FFSTTDKDELY
Sbjct: 149 FGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHSFFSTTDKDELY 208
Query: 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223
LNLVLE+VPETVYR +KHY++ +Q MP+I+V+LYTYQICRAL Y+H +GVCHRDIKPQN
Sbjct: 209 LNLVLEYVPETVYRASKHYTKMNQHMPIIFVQLYTYQICRALNYLHRVVGVCHRDIKPQN 268
Query: 224 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCV 283
LLVNP THQ+K+CDFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT AID+WS GCV
Sbjct: 269 LLVNPQTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYTNAIDMWSGGCV 328
Query: 284 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 343
+AELLLGQPLFPGESG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQIKAHPWHKIFH
Sbjct: 329 MAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQIKAHPWHKIFH 388
Query: 344 KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQE 403
KRMPPEAVDLVSRLLQYSPNLRCTALEAC HPFF +LRDPN LPNGR PPLFNF QE
Sbjct: 389 KRMPPEAVDLVSRLLQYSPNLRCTALEACAHPFFDDLRDPNVSLPNGRALPPLFNFTAQE 448
Query: 404 LKGASKELLSKLIPEHAR 421
L GAS EL +LIP H +
Sbjct: 449 LAGASTELRQRLIPAHCQ 466
|
|
| TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1657 (588.4 bits), Expect = 1.9e-170, P = 1.9e-170
Identities = 303/367 (82%), Positives = 337/367 (91%)
Query: 57 EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG 116
+KEM A V++GN TGHII TTIGG+NG+PKQTISYMAERVVG GSFGIVFQAKCLETG
Sbjct: 34 DKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 93
Query: 117 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVY 176
E+VAIKKVLQD+RYKNRELQ MR +DHPNV+SLKHCFFSTT +DEL+LNLV+E+VPET+Y
Sbjct: 94 ESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVPETLY 153
Query: 177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236
RV +HY+ ++QRMP+ YVKLYTYQI R LAYIH GVCHRD+KPQNLLV+P THQVKLC
Sbjct: 154 RVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQVKLC 213
Query: 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT +IDIWS GCVLAELLLGQPLFPG
Sbjct: 214 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQPLFPG 273
Query: 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 356
E+ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+FHKRMPPEA+DL SR
Sbjct: 274 ENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASR 333
Query: 357 LLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
LLQYSP+LRCTALEAC HPFF ELR+PNARLPNGRP PPLFNFK QEL GAS EL+++LI
Sbjct: 334 LLQYSPSLRCTALEACAHPFFNELREPNARLPNGRPLPPLFNFK-QELGGASMELINRLI 392
Query: 417 PEHARKQ 423
PEH R+Q
Sbjct: 393 PEHVRRQ 399
|
|
| TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1641 (582.7 bits), Expect = 9.4e-169, P = 9.4e-169
Identities = 302/367 (82%), Positives = 336/367 (91%)
Query: 57 EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG 116
+KEM A VVDG+ TGHII TTIGG+NG+PKQTISYMAERVVG GSFGIVFQAKCLETG
Sbjct: 4 DKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETG 63
Query: 117 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVY 176
ETVAIKKVLQD+RYKNRELQ MR++DHPNVV LKHCFFSTT KDEL+LNLV+E+VPE++Y
Sbjct: 64 ETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESLY 123
Query: 177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236
RV KHYS A+QRMPL+YVKLY YQI R LAYIH GVCHRD+KPQNLLV+P THQVK+C
Sbjct: 124 RVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKIC 183
Query: 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
DFGSAK LVKGE NISYICSR+YRAPELIFGATEYTT+IDIWS GCVLAELLLGQPLFPG
Sbjct: 184 DFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFPG 243
Query: 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 356
E+ VDQLVEIIKVLGTPTREEI+CMNP+YT+F+FPQIKAHPWHKIFHKRMPPEA+D SR
Sbjct: 244 ENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFASR 303
Query: 357 LLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
LLQYSP+LRCTALEAC HPFF ELR+PNARLPNGRPFPPLFNFK QE+ G+S EL++KLI
Sbjct: 304 LLQYSPSLRCTALEACAHPFFDELREPNARLPNGRPFPPLFNFK-QEVAGSSPELVNKLI 362
Query: 417 PEHARKQ 423
P+H ++Q
Sbjct: 363 PDHIKRQ 369
|
|
| TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1637 (581.3 bits), Expect = 2.5e-168, P = 2.5e-168
Identities = 297/371 (80%), Positives = 330/371 (88%)
Query: 57 EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG 116
E++ E ++DG G E GH+I TT+ GRNGQ +QT+SY++E VVG GSFG+VFQAKC ETG
Sbjct: 47 ERDSEPDIIDGAGAEPGHVIRTTLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETG 106
Query: 117 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVY 176
E VAIKKVLQDKRYKNRELQ M++LDHPN V+LKH FFS TD +E+YLNLVLEFVPETV
Sbjct: 107 EVVAIKKVLQDKRYKNRELQIMQMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVN 166
Query: 177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236
RVA+ YSR +Q MPLIYVKLYTYQICRALAYIH G+CHRDIKPQNLLVNPHTHQ+K+C
Sbjct: 167 RVARSYSRTNQLMPLIYVKLYTYQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKIC 226
Query: 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
DFGSAKVLVKGEPN+SYICSRYYRAPELIFGA+EYTTAIDIWS GCV+AELLLGQPLFPG
Sbjct: 227 DFGSAKVLVKGEPNVSYICSRYYRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPG 286
Query: 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 356
ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDL+ R
Sbjct: 287 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCR 346
Query: 357 LLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
QYSPNLRCTALEACIHP F ELRDPN RLPNGRP PPLFNFKPQEL G E++++L+
Sbjct: 347 FFQYSPNLRCTALEACIHPLFDELRDPNTRLPNGRPLPPLFNFKPQELSGIPPEIVNRLV 406
Query: 417 PEHARKQCPFL 427
PEHARKQ F+
Sbjct: 407 PEHARKQNLFM 417
|
|
| TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1491 (529.9 bits), Expect = 7.4e-153, P = 7.4e-153
Identities = 277/379 (73%), Positives = 321/379 (84%)
Query: 44 EEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGS 103
+EI E+ + G+ +K+M+ ++ GNGTE+G II T G N Q +TISY AE V+G GS
Sbjct: 63 KEIREVGL-GD--DKDMDCGIIKGNGTESGRIITTKKKGLNDQKDKTISYRAEHVIGTGS 119
Query: 104 FGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163
FG+VFQAKCLET E VAIKKVLQDKRYKNRELQ MR+LDHPNVV LKH FFSTT+KDELY
Sbjct: 120 FGVVFQAKCLETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVELKHSFFSTTEKDELY 179
Query: 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223
LNLVLE+VPET+YR ++ Y++ +Q MPLIY++LYTYQICRA+ Y+H +GVCHRDIKPQN
Sbjct: 180 LNLVLEYVPETIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYLHQVVGVCHRDIKPQN 239
Query: 224 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCV 283
LLVN TH+VK+CDFGSAK+L+ GEPNISYICSRYYRAPELIFGATEYT+AID+WSVGCV
Sbjct: 240 LLVNNVTHEVKICDFGSAKMLIPGEPNISYICSRYYRAPELIFGATEYTSAIDMWSVGCV 299
Query: 284 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 343
+AEL LG PLFPGE+ VDQLVEIIK+LGTP REEIK MNP Y +FKFPQIKA PWHKIF
Sbjct: 300 MAELFLGHPLFPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDFKFPQIKAQPWHKIFR 359
Query: 344 KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQE 403
+++ PEA+DL SRLLQYSPNLRCTALEAC HPFF +LRDP A LPNGR PPLF+F QE
Sbjct: 360 RQVSPEAMDLASRLLQYSPNLRCTALEACAHPFFDDLRDPRASLPNGRALPPLFDFTAQE 419
Query: 404 LKGASKELLSKLIPEHARK 422
L GAS EL +LIPEHARK
Sbjct: 420 LAGASVELRHRLIPEHARK 438
|
|
| UNIPROTKB|Q91757 gsk3b "Glycogen synthase kinase-3 beta" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 1287 (458.1 bits), Expect = 3.1e-131, P = 3.1e-131
Identities = 242/359 (67%), Positives = 293/359 (81%)
Query: 66 DGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL 125
D +G++ ++ T G+ +Q ++Y +V+G GSFG+V+QAK +TGE VAIKKVL
Sbjct: 31 DKDGSKVTTVVATP--GQGPDRQQEVTYTDTKVIGNGSFGVVYQAKLCDTGELVAIKKVL 88
Query: 126 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSR 184
QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSR
Sbjct: 89 QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 148
Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
A Q +P+IYVKLY YQ+ R+LAYIH G+CHRDIKPQNLL++P T +KLCDFGSAK L
Sbjct: 149 AKQALPIIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPETAVLKLCDFGSAKQL 207
Query: 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLV
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F R PPEA+ L SRLL+Y+P
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRARTPPEAIALCSRLLEYTPTS 327
Query: 365 RCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 423
R T L+AC H FF ELRDPN +LPNGR FP LFNF QEL ++ L S LIP HAR Q
Sbjct: 328 RLTPLDACAHSFFDELRDPNLKLPNGREFPALFNFTTQELS-SNPSLSSILIPAHARNQ 385
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P43289 | KSG3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8041 | 0.9533 | 1.0 | no | no |
| P43288 | KSG1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8835 | 0.9137 | 0.9679 | no | no |
| Q96287 | KSG8_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8005 | 0.8904 | 0.8093 | no | no |
| Q10452 | GSK3_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.6011 | 0.8041 | 0.8914 | yes | no |
| Q39012 | KSG9_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8256 | 0.8531 | 0.8992 | no | no |
| Q39010 | KSG6_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8283 | 0.8531 | 0.8883 | no | no |
| Q39011 | KSG7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8228 | 0.8531 | 0.9631 | no | no |
| Q39019 | KSG10_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7664 | 0.9114 | 0.9287 | no | no |
| P38615 | RIM11_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.5195 | 0.7529 | 0.8729 | yes | no |
| Q9U2Q9 | GSK3_CAEEL | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6625 | 0.7482 | 0.8867 | yes | no |
| Q9FVS6 | KSG4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7562 | 0.9300 | 0.95 | no | no |
| O23145 | KSG2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7258 | 0.8694 | 0.8654 | no | no |
| Q40518 | MSK1_TOBAC | 2, ., 7, ., 1, 1, ., 1 | 0.8596 | 0.9230 | 0.9682 | N/A | no |
| Q9WV60 | GSK3B_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.6694 | 0.8275 | 0.8452 | yes | no |
| P51136 | GSK3_DICDI | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6347 | 0.7715 | 0.7087 | yes | no |
| P51137 | MSK1_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.8251 | 0.9580 | 1.0 | N/A | no |
| P51138 | MSK2_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.7990 | 0.9533 | 0.9951 | N/A | no |
| P51139 | MSK3_MEDSA | 2, ., 7, ., 1, 1, ., 1 | 0.8521 | 0.9207 | 0.9610 | N/A | no |
| O04160 | KSGT_BRANA | 2, ., 7, ., 1, 1, ., 1 | 0.7831 | 0.8927 | 0.8183 | N/A | no |
| P18266 | GSK3B_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.6694 | 0.8275 | 0.8452 | yes | no |
| Q8VZD5 | KSG5_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8829 | 0.9417 | 0.9853 | yes | no |
| Q91757 | GSK3B_XENLA | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6768 | 0.8251 | 0.8428 | N/A | no |
| Q5YJC2 | GSK3B_SPECI | 2, ., 7, ., 1, 1, ., 1 | 0.6666 | 0.8275 | 0.8452 | N/A | no |
| P49841 | GSK3B_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.6713 | 0.8251 | 0.8428 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 429 | |||
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-134 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-92 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-86 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-85 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-85 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-78 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-77 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-77 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-76 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-74 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-72 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-70 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-68 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-67 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-67 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-66 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-63 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-63 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-61 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-60 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-59 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-59 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-58 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-58 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-57 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-56 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-55 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-54 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-54 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-54 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-54 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-53 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-53 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-52 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-52 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-51 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-49 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-49 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-49 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-49 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-49 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-47 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-47 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-46 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-46 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-46 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-45 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-45 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-45 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-44 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-43 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-38 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-38 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-38 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-37 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-37 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-36 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-36 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-35 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-34 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-33 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-33 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-33 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-31 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-30 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-30 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-29 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-29 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-26 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-26 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-25 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-25 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-23 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-23 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-22 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-21 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-21 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-20 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-20 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-20 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-20 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-19 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-19 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-19 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-18 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-18 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-18 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-17 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-17 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-17 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-16 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-16 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-16 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-16 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-15 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-15 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-15 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-15 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-15 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-14 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-14 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 3e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 8e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-08 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-05 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-05 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-05 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-04 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-04 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.001 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.002 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.002 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 394 bits (1012), Expect = e-134
Identities = 172/331 (51%), Positives = 241/331 (72%), Gaps = 5/331 (1%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 151
SY ++G GSFG+V++A C++T E VAIKKVLQD +YKNREL M+ L+H N++ LK
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126
Query: 152 CFFSTT---DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
+++ ++ ++LN+V+EF+P+TV++ KHY+R + +PL VKLY+YQ+CRALAYI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
H +CHRD+KPQNLL++P+TH +KLCDFGSAK L+ G+ ++SYICSR+YRAPEL+ GA
Sbjct: 187 HSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
T YTT ID+WS+GC++AE++LG P+F G+S VDQLV II+VLGTPT +++K MNPNY +
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLP 388
KFP +K K+F K P +A++ +S+ L+Y P R +EA PFF +LRDP +LP
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365
Query: 389 NG-RPFPPLFNFKPQELKGASKELLSKLIPE 418
P LFNF E+K S K+IP+
Sbjct: 366 KYIDKLPDLFNFCDAEIKEMSDACRRKIIPK 396
|
Length = 440 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 280 bits (718), Expect = 7e-92
Identities = 123/339 (36%), Positives = 185/339 (54%), Gaps = 28/339 (8%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
Y + +G G++G+V A TG VAIKK+ L D + RE++ +R L H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 147 VSLKHCF--FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
+ L S D +++Y+ V E + +++V K Q + +++ + YQI R
Sbjct: 62 IGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRG 115
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYR 260
L Y+H V HRD+KP N+LVN +K+CDFG A+ + E Y+ +R+YR
Sbjct: 116 LKYLHSA-NVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
APEL+ ++ YT AIDIWSVGC+ AELL +PLFPG +DQL I++VLGTP+ E++K
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233
Query: 321 M-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ + + P+ P K+F PEA+DL+ ++L + P R TA EA HP+
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292
Query: 378 YELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
+L DP P +P F EL ++E L +LI
Sbjct: 293 AQLHDPE-DEPVAKPPFDFDFFDDDEL---TEEELKELI 327
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 263 bits (676), Expect = 4e-86
Identities = 110/295 (37%), Positives = 171/295 (57%), Gaps = 35/295 (11%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHPNVVSLK 150
+G+G++G+V++A+ +TGE VA+KK+ D + RE+ ++ L HPN+V L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
+ + +LYL V E+ + K+ + + +K YQ+ R LAY H
Sbjct: 65 DVIHT---ERKLYL--VFEYCD---MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 267
+ HRD+KPQN+L+N +KL DFG A+ G P +Y + + +YRAPE++ G
Sbjct: 117 -HRILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLG 172
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
+ Y+TA+DIWSVGC+ AE++ G+PLFPG+S +DQL +I ++LGTPT E P T+
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW----PGVTK 228
Query: 328 FK-----FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
FP+ K+ R+ PE +DL+S++LQY+P R +A EA HP+F
Sbjct: 229 LPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 263 bits (673), Expect = 1e-85
Identities = 115/294 (39%), Positives = 170/294 (57%), Gaps = 20/294 (6%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKN---RELQTMRLLDHPNV 146
Y +G+G++G+V++A+ TGE VAIKK+ RE++ ++ L+HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
+ L F K +LYL V EF+ +Y++ K R +P +K Y YQ+ + LA
Sbjct: 61 IKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLLQGLA 112
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 265
+ H G+ HRD+KP+NLL+N +KL DFG A+ P Y+ +R+YRAPEL+
Sbjct: 113 FCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 324
G Y+T +DIWSVGC+ AELL +PLFPG+S +DQL +I + LGTP E
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230
Query: 325 -YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+F FP+ P K+F P+A+DL+S++L Y P+ R TA +A HP+F
Sbjct: 231 RNYKFSFPKKAGMPLPKLF-PNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 262 bits (672), Expect = 1e-85
Identities = 112/293 (38%), Positives = 169/293 (57%), Gaps = 23/293 (7%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 150
+G+G+ GIVF+AK ETGETVA+KKV + RE++ ++ HP VV L
Sbjct: 6 GRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLL 65
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
F + LV+E++P + V + R +P VK Y + + +AY+H
Sbjct: 66 DVFPHGSG-----FVLVMEYMPSDLSEVLRDEERP---LPEAQVKSYMRMLLKGVAYMHA 117
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--ICSRYYRAPELIFGA 268
G+ HRD+KP NLL++ +K+ DFG A++ + EP + + +R+YRAPEL++GA
Sbjct: 118 -NGIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 325
+Y +D+W+VGC+ AELL G PLFPGE+ ++QL + + LGTP E + + P+Y
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL-PDY 234
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378
+ FP+ K P +IF PEA+DL+ LL Y P+ R +A EA HP+F
Sbjct: 235 NKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 248 bits (637), Expect = 1e-80
Identities = 104/290 (35%), Positives = 150/290 (51%), Gaps = 41/290 (14%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 147
Y +G+GSFG V+ A+ +TG+ VAIK + +D+ RE++ ++ L HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
L F D+D+LYL V+E+ + R+ + Y QI AL Y
Sbjct: 61 RLYDVF---EDEDKLYL--VMEYCE---GGDLFDLLKKRGRLSEDEARFYLRQILSALEY 112
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
+H G+ HRD+KP+N+L++ H VKL DFG A+ L GE +++ + Y APE++ G
Sbjct: 113 LHS-KGIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG 170
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
Y A+DIWS+G +L ELL G+P FPG+ DQL+E+ K +G P
Sbjct: 171 -KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPK------------- 213
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
P + PEA DL+ +LL P R TA EA HPFF
Sbjct: 214 ---------PPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 243 bits (622), Expect = 2e-78
Identities = 96/289 (33%), Positives = 141/289 (48%), Gaps = 39/289 (13%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 149
R +G GSFG V++AK TG+ VA+K + + RE++ +R L HPN+V L
Sbjct: 4 LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
F DKD LYL V+E+ Y + K QI R L Y+H
Sbjct: 64 IDAF---EDKDHLYL--VMEYCEGGDL---FDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGA 268
G+ HRD+KP+N+L++ VK+ DFG AK L+K +++ + +Y APE++ G
Sbjct: 116 S-NGIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
Y +D+WS+G +L ELL G+P F GE+ +DQL I ++LG P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL-------------- 219
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ + EA DL+ + L P+ R TA E HP+F
Sbjct: 220 --------EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 241 bits (618), Expect = 2e-77
Identities = 109/291 (37%), Positives = 164/291 (56%), Gaps = 21/291 (7%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKH 151
VVG+G++G+V + + TGE VAIKK + D+ K RE++ +R L H N+V+LK
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
F K LYL V E+V T+ + + +P V+ Y +Q+ +A+AY H
Sbjct: 68 AFRR---KGRLYL--VFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHSH 119
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV--KGEPNISYICSRYYRAPELIFGAT 269
+ HRDIKP+N+LV+ +KLCDFG A+ L P Y+ +R+YRAPEL+ G T
Sbjct: 120 -NIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTE 327
Y +D+W++GC++AELL G+PLFPG+S +DQL I K LG P+ +E+ NP +
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237
Query: 328 FKFPQIKA-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
FP+ + + ++ A+D + L+ P R T E HP+F
Sbjct: 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 6e-77
Identities = 112/293 (38%), Positives = 175/293 (59%), Gaps = 26/293 (8%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVS 148
+ +G G+FG V+ A+ ETGE VAIKK+ + ++ + RE++++R L +HPN+V
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
LK F + DELY V E++ +Y++ K R + ++ YQI + LA+I
Sbjct: 63 LKEVF---RENDELYF--VFEYMEGNLYQLMK--DRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
H G HRD+KP+NLLV+ VK+ DFG A+ + P Y+ +R+YRAPE++ +
Sbjct: 116 HK-HGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKCMNPN 324
T Y++ +DIW++GC++AEL +PLFPG S +DQL +I VLGTPT+++ K +
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK- 232
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
F+FPQ H++ PEA+DL+ +L++ P R TA +A HP+F
Sbjct: 233 -LGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 6e-76
Identities = 112/302 (37%), Positives = 160/302 (52%), Gaps = 35/302 (11%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDH 143
Y + +G+G++ +V++A+ ETG VAIKK+ +R + RE++ ++ L H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVP---ETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
PN++ L F +NLV EF+ E V + S + +K Y
Sbjct: 62 PNIIGLLDVF--GHKS---NINLVFEFMETDLEKVIK------DKSIVLTPADIKSYMLM 110
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC---SR 257
R L Y+H + HRD+KP NLL+ +KL DFG A+ G PN +R
Sbjct: 111 TLRGLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTR 166
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
+YRAPEL+FGA Y +D+WSVGC+ AELLL P PG+S +DQL +I + LGTPT E
Sbjct: 167 WYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN 226
Query: 318 IKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375
+ P+Y EFK P +IF +A+DL+ RLL +PN R TA +A HP
Sbjct: 227 WPGVTSLPDYVEFKP--FPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHP 283
Query: 376 FF 377
+F
Sbjct: 284 YF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 1e-74
Identities = 113/309 (36%), Positives = 177/309 (57%), Gaps = 31/309 (10%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRE---LQTMRLLDH 143
Y + +G+G++GIV++A T E VA+KK+ D + RE LQ + DH
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG--DH 66
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
PN+V L + + DKD +YL V E++ ++ V + + ++ + YQ+ +
Sbjct: 67 PNIVKLLNVIKAENDKD-IYL--VFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLK 118
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS------YICSR 257
AL YIH G V HRD+KP N+L+N VKL DFG A+ L + E N Y+ +R
Sbjct: 119 ALKYIHSG-NVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
+YRAPE++ G+T YT +D+WSVGC+L E+LLG+PLFPG S ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236
Query: 318 IKCMNPNYTEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
I+ + + P P ++ + +A+DL+ +LL ++PN R TA EA H
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH 295
Query: 375 PFFYELRDP 383
P+ + +P
Sbjct: 296 PYVAQFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 2e-72
Identities = 115/339 (33%), Positives = 186/339 (54%), Gaps = 30/339 (8%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 147
Y +G+G++G+V A TG VAIKK+ + + + R L+ +++L H N++
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66
Query: 148 SLKHCFFSTT--DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+ + +++Y+ V E + +Y++ K +Q + +++ + YQI R L
Sbjct: 67 GILDIIRPPSFESFNDVYI--VQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGL 119
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRA 261
YIH V HRD+KP NLL+N +K+CDFG A++ + Y+ +R+YRA
Sbjct: 120 KYIHSA-NVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
PE++ + YT AIDIWSVGC+LAE+L +PLFPG+ + QL I+ VLGTP++E++ C+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237
Query: 322 -NP---NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ NY + P PW+K+F P+A+DL+ ++L ++P+ R T EA HP+
Sbjct: 238 ISLRARNYIK-SLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITVEEALAHPYL 295
Query: 378 YELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
+ DP+ PFP F KE L +LI
Sbjct: 296 EQYHDPSDEPVAEEPFPFDFELFDD----LPKEKLKELI 330
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 223 bits (572), Expect = 1e-70
Identities = 95/291 (32%), Positives = 155/291 (53%), Gaps = 22/291 (7%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 151
+G+G++G V++A+ +TGE VA+KK+ + K RE++ ++ L HPN+V LK
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
S K +Y+ V E++ + + + +K Y Q+ L Y+H
Sbjct: 66 IVTSK-GKGSIYM--VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHS- 118
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGAT 269
G+ HRDIK N+L+N +KL DFG A+ K + + + +YR PEL+ GAT
Sbjct: 119 NGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 326
Y +D+WSVGC+LAEL LG+P+F G + ++QL +I ++ G+PT E + + P +
Sbjct: 178 RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL-PWFE 236
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
K + + F + P A+DL+ +LL P R +A +A H +F
Sbjct: 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 6e-68
Identities = 112/342 (32%), Positives = 182/342 (53%), Gaps = 28/342 (8%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKK------VLQDKRYKNRELQTMRLLDHPN 145
Y +G G++G+V A +G+ VAIKK V + REL+ +R H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+++++ D + +V++ + ++ + + Q + +++ + YQ+ R L
Sbjct: 66 IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHII----HSDQPLTEEHIRYFLYQLLRGL 120
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-----ISYICSRYYR 260
YIH V HRD+KP NLLVN +++ DFG A+ L Y+ +R+YR
Sbjct: 121 KYIHSA-NVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
APEL+ EYTTAID+WSVGC+ AE+L + LFPG++ V QL I+ VLG+P+ E +
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238
Query: 321 MNP----NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
+ Y + P+ + PW KIF K PEA+DL+S++LQ+ P R T +A HPF
Sbjct: 239 IGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITVEQALQHPF 296
Query: 377 FYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPE 418
+ DP+ + PP F+F + ++ + ++L ++ E
Sbjct: 297 LAQYHDPD----DEPTCPPPFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 2e-67
Identities = 120/337 (35%), Positives = 189/337 (56%), Gaps = 28/337 (8%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
Y+ + +G+G++GIV AK ET E VAIKK+ D + RE++ +R LDH NV
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66
Query: 147 VSLKHCFFSTTDKD---ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
+++K ++ ++Y+ V E + ++++ R+SQ + + + + YQ+ R
Sbjct: 67 IAIKDIM-PPPHREAFNDVYI--VYELMDTDLHQII----RSSQTLSDDHCQYFLYQLLR 119
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAP 262
L YIH V HRD+KP NLL+N + +K+CDFG A+ KG+ Y+ +R+YRAP
Sbjct: 120 GLKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 321
EL+ +EYTTAID+WSVGC+ AELL +PLFPG+ V QL I ++LG+P+ E++ +
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237
Query: 322 NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379
N + P + ++F P A+DL+ ++L + P+ R T EA HP+
Sbjct: 238 NEKARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296
Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
L DP+ PF F+F+ L E + +LI
Sbjct: 297 LHDPSDEPVCQTPFS--FDFEEDALTE---EDIKELI 328
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 3e-67
Identities = 103/293 (35%), Positives = 165/293 (56%), Gaps = 30/293 (10%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
+G+G++G+V++A+ TGE VA+KK+ + + RE+ ++ L+HPN+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHY--SRASQRMPLIYVKLYTYQICRALAYIHG 210
S +LYL V EF+ + K Y S + +K Y YQ+ + +AY H
Sbjct: 67 VHSEN---KLYL--VFEFLDLDL----KKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 267
V HRD+KPQNLL++ +KL DFG A+ G P +Y + + +YRAPE++ G
Sbjct: 118 H-RVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 173
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPN 324
+ +Y+T +DIWS+GC+ AE++ +PLFPG+S +DQL I + LGTP + + + P+
Sbjct: 174 SRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PD 232
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
Y FP+ K+ + + +DL+S++L Y P R +A A HP+F
Sbjct: 233 YKP-TFPKWARQDLSKVV-PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 2e-66
Identities = 105/305 (34%), Positives = 163/305 (53%), Gaps = 26/305 (8%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 144
Y VG G++G V A +TG VAIKK+ + KR Y REL+ ++ +DH
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74
Query: 145 NVVSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
NV+ L F + ++ + LV + + + K Q++ +++ YQI R
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILR 129
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
L YIH G+ HRD+KP N+ VN ++K+ DFG A+ + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPE 185
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
++ Y +DIWSVGC++AELL G+ LFPG +DQL I+ ++GTP E ++ ++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245
Query: 324 ----NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379
NY + PQ+ + ++F P A+DL+ ++L P+ R TA EA HP+ E
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303
Query: 380 LRDPN 384
DP
Sbjct: 304 YHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 2e-63
Identities = 104/290 (35%), Positives = 154/290 (53%), Gaps = 27/290 (9%)
Query: 100 GQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVSLKH 151
G+G+F V +A+ +TG+ AIK + K +K+ RE+Q +R L HPN++ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 152 CFFSTTDKDELYLNLVLEFVPETVY---RVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
F D+ L LV E + +Y + K +P VK Y YQ+ ++L ++
Sbjct: 66 VLF---DRKTGRLALVFELMDMNLYELIKGRKRP------LPEKRVKSYMYQLLKSLDHM 116
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
H G+ HRDIKP+N+L+ +KL DFGS + + P YI +R+YRAPE +
Sbjct: 117 HR-NGIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTD 173
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-NYTE 327
Y +DIW+VGCV E+L PLFPG + +DQ+ +I VLGTP E +K +
Sbjct: 174 GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ FP K K+ E +DL+ +LL Y P+ R TA +A HP+F
Sbjct: 234 YNFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 6e-63
Identities = 118/290 (40%), Positives = 169/290 (58%), Gaps = 21/290 (7%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKH 151
+VG+GS+G+V + K ETG+ VAIKK L+ DK K RE++ ++ L H N+V+L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
F K LYL V EFV TV + Y + V+ Y +QI R + + H
Sbjct: 68 VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSH 119
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATE 270
+ HRDIKP+N+LV+ + VKLCDFG A+ L GE Y+ +R+YRAPEL+ G T+
Sbjct: 120 -NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEIKCMNPNYTEF 328
Y A+DIW+VGC++ E+L G+PLFPG+S +DQL IIK LG P +EI NP +
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 329 KFPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ P++K P K F K + +DL + L+ P+ R ++ + H FF
Sbjct: 238 RLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 5e-61
Identities = 104/293 (35%), Positives = 164/293 (55%), Gaps = 30/293 (10%)
Query: 101 QGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHCFF 154
+G++G+V++A+ +TGE VA+KK+ +K + RE+ + L HPN+V++K
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV 74
Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
+ D++Y+ V+E+V + + + Q VK Q+ +A++H +
Sbjct: 75 GSNL-DKIYM--VMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN-WI 127
Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEY 271
HRD+K NLL+N + +K+CDFG A+ G P Y + + +YRAPEL+ GA EY
Sbjct: 128 LHRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKEY 184
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
+TAID+WSVGC+ AELL +PLFPG+S +DQL +I K+LGTPT + P ++E
Sbjct: 185 STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW----PGFSELPGA 240
Query: 332 QIKAHPWH-------KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ K + K + DL++RLL Y P R +A +A HP+F
Sbjct: 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 1e-60
Identities = 127/345 (36%), Positives = 192/345 (55%), Gaps = 28/345 (8%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
Y + V+G+GS+G+V A TGE VAIKK+ + D RE++ +RLL HP++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
V +KH + ++ + +V E + +++V K A+ + + + + YQ+ RAL
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIK----ANDDLTPEHHQFFLYQLLRALK 117
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN----ISYICSRYYRAP 262
YIH V HRD+KP+N+L N ++K+CDFG A+V P Y+ +R+YRAP
Sbjct: 118 YIHTA-NVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175
Query: 263 ELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-K 319
EL G+ ++YT AIDIWS+GC+ AE+L G+PLFPG++ V QL I +LGTP+ E I +
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234
Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMP---PEAVDLVSRLLQYSPNLRCTALEACIHPF 376
N + K P F ++ P P A+ L+ RLL + P R TA EA P+
Sbjct: 235 VRNEKARRYLSSMRKKQP--VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292
Query: 377 FYELRDPNARLPNGRPFPPL-FNFKPQEL-KGASKELLSKLIPEH 419
F L R P+ +P L F F+ + L K +EL+ + I E+
Sbjct: 293 FKGLAKVE-REPSAQPITKLEFEFERRRLTKEDVRELIYREILEY 336
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 3e-59
Identities = 102/289 (35%), Positives = 159/289 (55%), Gaps = 21/289 (7%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 152
+G+GS+G+VF+ + ETG+ VAIKK ++ K+ RE++ ++ L HPN+V+L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
F + + L+LV E+ TV + R +P +K +Q +A+ + H
Sbjct: 69 F-----RRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHKH- 119
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEY 271
HRD+KP+N+L+ Q+KLCDFG A++L + + Y+ +R+YRAPEL+ G T+Y
Sbjct: 120 NCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG--TPTREEIKCMNPNYTEFK 329
+D+W++GCV AELL GQPL+PG+S VDQL I K LG P ++I N +
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238
Query: 330 FPQIKA-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
P+ + P F + A+ + LQ P R + E HP+F
Sbjct: 239 IPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 4e-59
Identities = 112/304 (36%), Positives = 160/304 (52%), Gaps = 27/304 (8%)
Query: 99 VGQGSFGIVFQAKCLET--GETVAIKK---VLQDKRYKNRELQTMRLL----DHPNVVSL 149
+GQG++GIV A+ ET ETVAIKK V K R L+ ++LL H N+ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 150 KHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
+ELYL E + ++++ R+ Q + + + + YQI L YI
Sbjct: 68 YDMDIVFPGNFNELYL--YEELMEADLHQII----RSGQPLTDAHFQSFIYQILCGLKYI 121
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK----VLVKGEPNIS-YICSRYYRAPE 263
H V HRD+KP NLLVN ++K+CDFG A+ + ++ Y+ +R+YRAPE
Sbjct: 122 HSA-NVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKC 320
++ YT AID+WSVGC+LAELL +P+F G+ VDQL +I++VLGTP E I
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
P I P+ IF P A+DL+ +LL + P R + EA HP+
Sbjct: 240 PKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298
Query: 381 RDPN 384
DP+
Sbjct: 299 HDPD 302
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 193 bits (491), Expect = 4e-58
Identities = 107/304 (35%), Positives = 173/304 (56%), Gaps = 25/304 (8%)
Query: 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDH 143
T Y+ + VG G+FG+V A+ TG+ VAIKK+++ + REL+ ++ L H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
N++SL F S +++Y V E + ++R+ S+ + +++ + YQI R
Sbjct: 69 ENIISLSDIFISP--LEDIYF--VTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILR 119
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 262
L Y+H GV HRD+KP N+L+N + +K+CDFG A++ +P ++ Y+ +RYYRAP
Sbjct: 120 GLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVSTRYYRAP 174
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 321
E++ +Y +DIWS GC+ AE+L G+PLFPG+ V+Q I +LGTP + I +
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234
Query: 322 NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379
+ N F P+ + P+ + F K P A+DL+ ++L + P R +A EA HP+
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293
Query: 380 LRDP 383
DP
Sbjct: 294 YHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 4e-58
Identities = 107/295 (36%), Positives = 167/295 (56%), Gaps = 34/295 (11%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
+G+G++G+V++A+ TGE VA+KK+ D + RE+ ++ L+HPN+V L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR--MPLIYVKLYTYQICRALAYIHG 210
+ +++LYL V EF+ + + K + AS +PL +K Y +Q+ + LA+ H
Sbjct: 68 IHT---ENKLYL--VFEFLHQDL----KKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 267
V HRD+KPQNLL+N +KL DFG A+ G P +Y + + +YRAPE++ G
Sbjct: 119 H-RVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
Y+TA+DIWS+GC+ AE++ + LFPG+S +DQL I + LGTP + P T
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTS 230
Query: 328 FK-----FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
FP+ + K+ + + DL+S++L Y PN R +A A HPFF
Sbjct: 231 LPDYKPSFPKWARQDFSKVV-PPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 6e-57
Identities = 99/294 (33%), Positives = 158/294 (53%), Gaps = 23/294 (7%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDH-PNVVSLKH 151
+G+G++G V++A+ TG+ VA+KK + + RE+ +++L +V L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR-MPLIYVKLYTYQICRALAYIHG 210
+ L LV E++ + + R R +P +K + YQ+ + +A+ H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 267
GV HRD+KPQNLLV+ +K+ D G + P SY I + +YRAPE++ G
Sbjct: 129 -HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLLG 185
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
+T Y+T +DIWSVGC+ AE+ QPLFPG+S + QL+ I K+LGTPT + P ++
Sbjct: 186 STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVSK 241
Query: 328 FK----FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ FPQ K + + PE +DL+ ++L+Y P R +A A HP+F
Sbjct: 242 LRDWHEFPQWKPQDLSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 1e-56
Identities = 104/292 (35%), Positives = 169/292 (57%), Gaps = 28/292 (9%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 153
+G+G++ V++ + TGE VA+K++ D RE+ M+ L H N+V L H
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHY--SRASQR-MPLIYVKLYTYQICRALAYIHG 210
T +K L LV E++ + + K Y + + + VK +TYQ+ + +A+ H
Sbjct: 67 IHTENK----LMLVFEYMDKDL----KKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 267
V HRD+KPQNLL+N ++KL DFG A+ G P ++ + + +YRAP+++ G
Sbjct: 119 N-RVLHRDLKPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLG 174
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNY 325
+ Y+T+IDIWSVGC++AE++ G+PLFPG + DQL++I +++GTPT ++ P Y
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ FP+ ++F P +DL+ RLLQ +P LR +A +A HP+F
Sbjct: 235 -KPTFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 5e-55
Identities = 113/317 (35%), Positives = 159/317 (50%), Gaps = 46/317 (14%)
Query: 99 VGQGSFGIVFQAKCLE--TGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
+G+G++G V++AK G+ AIKK DK RE+ +R L H NVVSL
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRM-PLIYVKLYTYQICRALAYI 208
F DK +YL + ++ ++++ K + +A + P VK +QI + Y+
Sbjct: 68 VEVFLEHADK-SVYL--LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124
Query: 209 HGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSA-------KVLVKGEPNISYICSRY 258
H V HRD+KP N+LV P VK+ D G A K L +P + I +
Sbjct: 125 HSNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG---------VDQLVEIIKV 309
YRAPEL+ GA YT AIDIW++GC+ AELL +P+F G DQL I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240
Query: 310 LGTPTREE---IKCMNPNY----TEFKFPQIKAHPWHKIFHKRMP--PEAVDLVSRLLQY 360
LGTPT ++ IK M P Y +FK ++ K K + DL+ +LL+Y
Sbjct: 241 LGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299
Query: 361 SPNLRCTALEACIHPFF 377
P R TA EA HP+F
Sbjct: 300 DPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 1e-54
Identities = 101/298 (33%), Positives = 160/298 (53%), Gaps = 24/298 (8%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 146
+Y +G+GS+ V++ + TG+ VA+K++ L+ + RE ++ L H N+
Sbjct: 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
V+L H T L LV E++ + + + + V+L+ +Q+ R LA
Sbjct: 66 VTL-HDIIHTKKT----LTLVFEYLDTDLKQYMDDCGGG---LSMHNVRLFLFQLLRGLA 117
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 263
Y H V HRD+KPQNLL++ ++KL DFG A+ K P+ +Y + + +YR P+
Sbjct: 118 YCHQR-RVLHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPD 173
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIK--C 320
++ G+TEY+T++D+W VGC+ E+ G+PLFPG + V DQL +I +VLGTPT E
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS 233
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
NP + + FP P + P +L + LQY P R +A EA HP+F
Sbjct: 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 2e-54
Identities = 98/304 (32%), Positives = 155/304 (50%), Gaps = 48/304 (15%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 145
+G+G++G V++A+ L TG VA+KKV R RE+ ++ L+ HPN
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR-MPLIYVKLYTYQICRA 204
+V L EL L LV E V + + A + S+ + +P +K Q+ R
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQDL---ATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
+ ++H + HRD+KPQN+LV QVK+ DFG A++ S + + +YRAPE+
Sbjct: 120 VDFLHSH-RIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEV 177
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
+ ++ Y T +D+WSVGC+ AEL +PLF G S DQL +I V+G P+ EE
Sbjct: 178 LLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE------- 229
Query: 325 YTEFKFPQIKAHPWHKIFHKR-----------MPPEAVDLVSRLLQYSPNLRCTALEACI 373
+P+ + P F + E +DL+ ++L ++P+ R +A EA
Sbjct: 230 -----WPRNVSLPRSS-FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283
Query: 374 HPFF 377
HP+F
Sbjct: 284 HPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 2e-54
Identities = 105/295 (35%), Positives = 155/295 (52%), Gaps = 28/295 (9%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
+G+G++GIV++A+ +GE VA+KKV D RE+ + L HPN+V LK
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
K + LV+E+ + + + + VK Q+ R L Y+H
Sbjct: 75 ---VVGKHLDSIFLVMEYCEQDLASLLDNMPTP---FSESQVKCLMLQLLRGLQYLHENF 128
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
+ HRD+K NLL+ +K+ DFG A+ G P + + +YRAPEL+ G T
Sbjct: 129 -IIHRDLKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLGCT 184
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 327
YTTAID+W+VGC+LAELL +PL PG+S ++QL II++LGTP + P +
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244
Query: 328 FKFPQIKAHPWHKIFHKRMP--PEA-VDLVSRLLQYSPNLRCTALEACIHPFFYE 379
F P+ P++ + HK P EA + L++ LL Y P R TA EA +F E
Sbjct: 245 FTLPK---QPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 4e-54
Identities = 105/306 (34%), Positives = 171/306 (55%), Gaps = 33/306 (10%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
Y +G+G++G+V++A+ T ET+A+KK+ ++ + RE+ ++ + H N+
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRA-----SQRMPLIYVKLYTYQI 201
V L+ S E L LV E++ + KH + + R+ +K Y YQI
Sbjct: 64 VRLQDVVHS-----EKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRL----IKTYLYQI 111
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRY 258
R +AY H V HRD+KPQNLL++ T+ +KL DFG A+ G P ++ + + +
Sbjct: 112 LRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLW 168
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
YRAPE++ G+ Y+T +DIWSVGC+ AE++ +PLFPG+S +D+L +I ++LGTP E
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETW 228
Query: 319 KCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
+ P+Y FP+ + + P VDL+S++L+ P+ R TA A H +
Sbjct: 229 PGVTSLPDYKS-AFPKWPPKDLATVV-PTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286
Query: 377 FYELRD 382
F +L D
Sbjct: 287 FKDLGD 292
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 1e-53
Identities = 102/292 (34%), Positives = 159/292 (54%), Gaps = 28/292 (9%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
+G+G++G VF+AK ET E VA+K+V D + RE+ ++ L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
S + L LV E+ + + K++ + + VK + +Q+ + LA+ H
Sbjct: 68 LHS-----DKKLTLVFEYCDQDL---KKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH- 118
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
V HRD+KPQNLL+N + ++KL DFG A+ G P Y + + +YR P+++FGA
Sbjct: 119 NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 175
Query: 270 EYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN--PNYT 326
Y+T+ID+WS GC+ AEL G+PLFPG DQL I ++LGTPT E ++ P+Y
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235
Query: 327 EF-KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ +P + + ++ DL+ LL +P R +A EA HP+F
Sbjct: 236 PYPMYPATTS--LVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 3e-53
Identities = 93/291 (31%), Positives = 137/291 (47%), Gaps = 46/291 (15%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLK 150
++G+GSFG V+ A +TGE +A+K V L + RE++ + L HPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 151 HCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+ S D+++ LN+ LE+V ++ + K + + + + ++ YT QI LAY+H
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---YYRAPELIF 266
G+ HRDIK N+LV+ VKL DFG AK L E R Y+ APE+I
Sbjct: 119 SN-GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
G EY A DIWS+GC + E+ G+P + + I G P
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------- 222
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
P+I H + EA D + + L+ P R TA E HPF
Sbjct: 223 ----PEIPEH---------LSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 5e-53
Identities = 106/297 (35%), Positives = 159/297 (53%), Gaps = 22/297 (7%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDH---PNVVSLKHC 152
VG G++G V A TG VAIKK+ Q + + R + +RLL H NV+ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 153 FFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
F D + LV+ F+ + ++ KH + R ++ YQ+ + L YIH
Sbjct: 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDR-----IQFLVYQMLKGLKYIHAA 137
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
G+ HRD+KP NL VN ++K+ DFG A+ Y+ +R+YRAPE+I Y
Sbjct: 138 -GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMHY 193
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYTE 327
T +DIWSVGC++AE+L G+PLF G +DQL+EI+KV GTP++E ++ + NY +
Sbjct: 194 TQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK 253
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384
K P+ + + + P AV+++ ++L R TA EA HP+F E DP
Sbjct: 254 -KLPRFRKKDFRSLL-PNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 1e-52
Identities = 92/327 (28%), Positives = 137/327 (41%), Gaps = 48/327 (14%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHP 144
SY R +G+GSFG V+ A+ + VA+K + + K+ RE+Q + L+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 145 -NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
N+V L F +DE L LV+E+V + QI
Sbjct: 58 PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-------SYICS 256
AL Y+H G+ HRDIKP+N+L++ VKL DFG AK+L + + +
Sbjct: 113 ALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 257 RYYRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKVLG 311
Y APE++ G + +++ DIWS+G L ELL G P F GE Q ++II L
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231
Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
TP A P + + A DL+ +LL P R ++
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272
Query: 372 CIHPFFYELRDPNARLPNGRPFPPLFN 398
H L+ + L +
Sbjct: 273 LSHDLLAHLKLKESDLSDLLKPDDSAP 299
|
Length = 384 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 1e-52
Identities = 68/247 (27%), Positives = 118/247 (47%), Gaps = 40/247 (16%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 153
+G+G FG V+ A+ +TG+ VAIK + ++ RE++ ++ L+HPN+V L F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 154 FSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
+DE +L LV+E+ ++ ++ + QI L Y+H
Sbjct: 61 -----EDENHLYLVMEYCEGGSLK---DLLKENEGKLSEDEILRILLQILEGLEYLHS-N 111
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 271
G+ HRD+KP+N+L++ +VKL DFG +K+L + + I + Y APE++ G Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKF 330
+ DIWS+G +L EL +L ++I+ K + + +
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208
Query: 331 PQIKAHP 337
+I H
Sbjct: 209 KEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 5e-52
Identities = 100/297 (33%), Positives = 160/297 (53%), Gaps = 37/297 (12%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLDHPNVVS 148
+G+G++G+V++ + +TG+ VA+KK+ R ++ RE+ ++ L HPN+V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY---SRASQRMPLIYVKLYTYQICRAL 205
L+ E L L+ EF+ + K Y Q M VK Y YQI + +
Sbjct: 64 LQDVLM-----QESRLYLIFEFLSMDL----KKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAP 262
+ H V HRD+KPQNLL++ + +KL DFG A+ G P Y + + +YRAP
Sbjct: 115 LFCHSR-RVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAP 170
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
E++ G+ Y+T +DIWS+G + AE+ +PLF G+S +DQL I ++LGTPT + +
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230
Query: 323 --PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
P+Y FP+ K K + + +DL+ ++L Y P R +A +A HP+F
Sbjct: 231 SLPDYKN-TFPKWKKGSLRSAV-KNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 4e-51
Identities = 97/306 (31%), Positives = 150/306 (49%), Gaps = 39/306 (12%)
Query: 100 GQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKHC 152
G+G+FG V++A+ ++TG VA+KK+L K+ RE++ ++ L HPNVV L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
DK + V P + ++ S ++ +K Y Q+ + Y+H
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN- 134
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY------------ICSRYYR 260
+ HRDIK N+L++ + +K+ DFG A+ PN + +R+YR
Sbjct: 135 HILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYR 193
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
PEL+ G YTTA+DIW +GCV AE+ +P+ G+S +DQL I K+ GTPT E
Sbjct: 194 PPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETW-- 251
Query: 321 MNPNYTEFKFPQIKAHPWH---------KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
P + P H + ++ PE +DL+S+LL P R TA +A
Sbjct: 252 --PGWR--SLP--GCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDA 305
Query: 372 CIHPFF 377
HP+F
Sbjct: 306 LEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-49
Identities = 103/304 (33%), Positives = 161/304 (52%), Gaps = 25/304 (8%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLL---DHPNV 146
Y + + VG G++G V A TGE VAIKK+ Q + + R + + LL H NV
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+ L F S DE LV+ ++ + ++ H + V+ YQ+ L
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK------VQYLVYQMLCGL 130
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPEL 264
YIH G+ HRD+KP NL VN ++K+ DFG A+ + ++ Y+ +R+YRAPE+
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPEV 185
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-- 322
I Y +DIWSVGC++AE+L G+ LF G+ +DQL +I+KV G P E ++ +
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245
Query: 323 --PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
+Y + P+ + +F + P+AVDL+ ++L+ + R TA EA HP+F
Sbjct: 246 AAKSYIK-SLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303
Query: 381 RDPN 384
RD +
Sbjct: 304 RDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 169 bits (429), Expect = 2e-49
Identities = 112/292 (38%), Positives = 163/292 (55%), Gaps = 24/292 (8%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKH 151
VVG+G++G+V + + ET E VAIKK K REL+ +R L N+V LK
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
F + +LYL V E+V + + + + P V+ Y YQ+ +A+ + H
Sbjct: 68 AF---RRRGKLYL--VFEYVEKNMLELLEEMPNGV---PPEKVRSYIYQLIKAIHWCHKN 119
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNIS-YICSRYYRAPELIFGAT 269
+ HRDIKP+NLL++ H +KLCDFG A+ L +G N + Y+ +R+YR+PEL+ GA
Sbjct: 120 -DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTE 327
Y A+D+WSVGC+L EL GQPLFPGES +DQL I KVLG E++K NP +
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236
Query: 328 FKFPQIKAHP--WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+FP + HP + + + +DL+ LL+ +P R + HP F
Sbjct: 237 LRFPAV-NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 3e-49
Identities = 94/329 (28%), Positives = 163/329 (49%), Gaps = 44/329 (13%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKK-VLQDKR---YKNRELQTMRLLDHPNVVS 148
YM R +G GS G+VF A + + VA+KK VL D + + RE++ +R LDH N+V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 149 LKHCFFSTTDKDELYLN---------LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
+ + + +V E++ + V + + + +L+ Y
Sbjct: 67 VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMY 121
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY------ 253
Q+ R L YIH V HRD+KP N+ +N +K+ DFG A+++ +P+ S+
Sbjct: 122 QLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSE 177
Query: 254 -ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQL---VEIIKV 309
+ +++YR+P L+ YT AID+W+ GC+ AE+L G+PLF G ++Q+ +E + V
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237
Query: 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPW--HKIFHKRMP---PEAVDLVSRLLQYSPNL 364
+ R E+ + P++ ++ + +P PEA+D + ++L ++P
Sbjct: 238 VREEDRNELLNVIPSF-------VRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMD 290
Query: 365 RCTALEACIHPFFYELRDPNARLPNGRPF 393
R TA EA +HP+ P + PF
Sbjct: 291 RLTAEEALMHPYMSCYSCPFDEPVSLHPF 319
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 166 bits (424), Expect = 6e-49
Identities = 80/285 (28%), Positives = 129/285 (45%), Gaps = 42/285 (14%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
+G+G FG V++A+ TG+ VAIK + L+ K K E+Q ++ HPN+V
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
+ KDEL+ +V+EF ++ + K +Q + + ++ + L Y+H
Sbjct: 66 YL---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLH-S 116
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
G+ HRDIK N+L+ +VKL DFG + L + + + + Y+ APE+I G Y
Sbjct: 117 NGIIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPY 174
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
DIWS+G EL G+P + E + + I G P + P
Sbjct: 175 DYKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPPG-------------LRNP 220
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
++ E D + + LQ +P R TA + HPF
Sbjct: 221 ------------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 7e-49
Identities = 106/309 (34%), Positives = 162/309 (52%), Gaps = 41/309 (13%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKK---VLQD----KRYKNRELQTMRLLDHPNVVS 148
+R +G G+FG+V+ G+ VA+KK V Q+ KR REL+ + H NV+S
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63
Query: 149 --------LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
F +E+Y+ V E + ++++ + Q + +VK++ YQ
Sbjct: 64 ALDILQPPHIDPF------EEIYV--VTELMQSDLHKIIV----SPQPLSSDHVKVFLYQ 111
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-----IC 255
I R L Y+H G+ HRDIKP NLLVN + +K+CDFG A+V EP+ S +
Sbjct: 112 ILRGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARV---EEPDESKHMTQEVV 166
Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315
++YYRAPE++ G+ YT+A+DIWSVGC+ AELL + LF +S + QL I +LGTP+
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226
Query: 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP---EAVDLVSRLLQYSPNLRCTALEAC 372
E ++ P + + EAV L+ R+L + P+ R +A +A
Sbjct: 227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286
Query: 373 IHPFFYELR 381
HP+ E R
Sbjct: 287 AHPYLDEGR 295
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 164 bits (415), Expect = 3e-47
Identities = 99/308 (32%), Positives = 169/308 (54%), Gaps = 23/308 (7%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
+Y+ +G+G++ V++ + T VA+K++ + RE+ ++ L H N+
Sbjct: 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
V+L H T E L LV E++ + + ++ + + VKL+ +Q+ R L
Sbjct: 67 VTL-HDIIHT----EKSLTLVFEYLDKDL---KQYLDDCGNSINMHNVKLFLFQLLRGLN 118
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 263
Y H V HRD+KPQNLL+N ++KL DFG A+ K P +Y + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 321
++ G+T+Y+T ID+W VGC+ E+ G+PLFPG + +QL I ++LGTPT E +
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381
N + + +P+ +A H R+ + +L+S+LLQ+ R +A EA HP+F+ L
Sbjct: 235 NEEFKSYNYPKYRADCLHN-HAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293
Query: 382 DPNARLPN 389
+ +LP+
Sbjct: 294 ERIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-47
Identities = 103/313 (32%), Positives = 162/313 (51%), Gaps = 25/313 (7%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
Y VG G++G V A + VA+KK+ L R REL+ ++ + H NV
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 147 VSLKHCFFSTT---DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
+ L F T + +E+YL V + + + K Q++ +V+ YQ+ R
Sbjct: 77 IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLR 129
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
L YIH G+ HRD+KP N+ VN ++++ DFG A+ + Y+ +R+YRAPE
Sbjct: 130 GLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
++ Y +DIWSVGC++AELL G+ LFPG +DQL I++V+GTP+ E +K ++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245
Query: 324 NYTEFKF---PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
+ P + KIF + P A+DL+ ++L + R +A EA HP+F +
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304
Query: 381 RDPNARLPNGRPF 393
DP P P+
Sbjct: 305 HDPEDE-PEAEPY 316
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 107/334 (32%), Positives = 169/334 (50%), Gaps = 28/334 (8%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
VG G++G V A +TG VA+KK ++ KR REL+ ++ + H NV+ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83
Query: 152 CFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
F +E + LV + + + K Q++ +V+ YQI R L YIH
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHS 138
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
+ HRD+KP NL VN ++K+ DFG A+ + Y+ +R+YRAPE++
Sbjct: 139 A-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP----NYT 326
Y +DIWSVGC++AELL G+ LFPG +DQL I++++GTP E +K ++ NY
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNAR 386
+ Q+ + +F P AVDL+ ++L + R TA +A H +F + DP+
Sbjct: 255 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 312
Query: 387 LPNGRPFPPLFNFKP---QELKGASKELLSKLIP 417
P P+ F + E K + + + +P
Sbjct: 313 -PVADPYDQSFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 104/332 (31%), Positives = 156/332 (46%), Gaps = 55/332 (16%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------------------RELQTMR 139
+G+G++G V +A TG+ VAIKKV + N REL+ M
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
+ H N++ L + ++NLV++ + + +V R ++ VK
Sbjct: 76 EIKHENIMGLVDVYVE-----GDFINLVMDIMASDLKKVVDRKIRLTES----QVKCILL 126
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-----VLVKGEPNISYI 254
QI L +H + HRD+ P N+ +N K+ DFG A+ +
Sbjct: 127 QILNGLNVLHKWYFM-HRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 255 CSR----------YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
R +YRAPEL+ GA +Y A+D+WSVGC+ AELL G+PLFPGE+ +DQL
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244
Query: 305 EIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 361
I ++LGTP + + K + P YTEF + K K +A+DL+ LL+ +
Sbjct: 245 RIFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD---LKTIFPNASDDAIDLLQSLLKLN 300
Query: 362 PNLRCTALEACIHPFFYELRDPNARLPNGRPF 393
P R +A EA H +F DP P+ PF
Sbjct: 301 PLERISAKEALKHEYFKS--DPLPCDPSQLPF 330
|
Length = 335 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 9e-46
Identities = 90/292 (30%), Positives = 137/292 (46%), Gaps = 55/292 (18%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSLKH 151
+G+GSFG V + +TG+ A+K K+++ K + E + ++HP +V L +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
F + E L LVLE+ P E ++K R + Y +I AL Y+H
Sbjct: 61 AF-----QTEEKLYLVLEYAPGGELFSHLSKE-----GRFSEERARFYAAEIVLALEYLH 110
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 268
+G+ +RD+KP+N+L++ H +KL DFG AK L + C + Y APE++ G
Sbjct: 111 S-LGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
Y A+D WS+G +L E+L G+P F E ++ E I
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL----------------KDPL 210
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA-CI--HPFF 377
+FP + + PEA DL+S LLQ P R + A I HPFF
Sbjct: 211 RFP------------EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-45
Identities = 101/298 (33%), Positives = 162/298 (54%), Gaps = 24/298 (8%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNRELQTMRLLDHPNV 146
SY+ +G+GS+ V++ G+ VA+K + RE ++ L H N+
Sbjct: 6 SYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
V L H T + L V E++ + A++ + + V+L+ +Q+ R LA
Sbjct: 66 VLL-HDIIHTKET----LTFVFEYMHTDL---AQYMIQHPGGLHPYNVRLFMFQLLRGLA 117
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 263
YIHG + HRD+KPQNLL++ + ++KL DFG A+ K P+ +Y + + +YR P+
Sbjct: 118 YIHGQ-HILHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPPD 173
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN 322
++ GAT+Y++A+DIW GC+ E+L GQP FPG S V +QL +I VLG PT + ++
Sbjct: 174 VLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233
Query: 323 --PNYTEFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
PNY F K ++ + PP+A DL S++L P R +A +A +HP+F
Sbjct: 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-45
Identities = 103/300 (34%), Positives = 165/300 (55%), Gaps = 25/300 (8%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
+Y+ +G+G++ VF+ + T VA+K++ + RE+ ++ L H N+
Sbjct: 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
V+L TDK L LV E++ + + ++ M + VK++ YQI R LA
Sbjct: 67 VTLHDIVH--TDKS---LTLVFEYLDKDL---KQYMDDCGNIMSMHNVKIFLYQILRGLA 118
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 263
Y H V HRD+KPQNLL+N ++KL DFG A+ K P +Y + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
++ G++EY+T ID+W VGC+ E+ G+PLFPG + D+L I ++LGTPT E ++
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234
Query: 324 N--YTEFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
N + + FP+ K P I H R+ E ++L+++ LQY R +A EA H +F L
Sbjct: 235 NDEFKNYNFPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 3e-45
Identities = 101/298 (33%), Positives = 161/298 (54%), Gaps = 27/298 (9%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
+Y+ +G+G++ VF+ + T VA+K++ + RE+ ++ L H N+
Sbjct: 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI 65
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY-SRASQRMPLIYVKLYTYQICRAL 205
V+L H T E L LV E++ + K Y M + VK++ +Q+ R L
Sbjct: 66 VTL-HDIIHT----ERCLTLVFEYLDSDL----KQYLDNCGNLMSMHNVKIFMFQLLRGL 116
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAP 262
+Y H + HRD+KPQNLL+N ++KL DFG A+ K P +Y + + +YR P
Sbjct: 117 SYCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPP 172
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK--C 320
+++ G+TEY+T ID+W VGC+L E+ G+P+FPG + ++L I ++LGTPT E
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232
Query: 321 MNPNYTEFKFPQIKAHPWHKIFH-KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
N + + FPQ +A P I H R+ + +DL+S LL Y R +A A H +F
Sbjct: 233 SNEEFRSYLFPQYRAQPL--INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 105/328 (32%), Positives = 165/328 (50%), Gaps = 47/328 (14%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKK-------VLQDKR-YKNRELQTMRLLDHP 144
Y + +G G+ GIV A TG+ VAIKK V KR Y REL M+L++H
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75
Query: 145 NVVSLKHCFFSTTDKD-----ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
N++ L + F T K ++YL V+E + + +V +RM + Y
Sbjct: 76 NIIGLLNVF--TPQKSLEEFQDVYL--VMELMDANLCQVI-QMDLDHERMSYL-----LY 125
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
Q+ + ++H G+ HRD+KP N++V +K+ DFG A+ Y+ +RYY
Sbjct: 126 QMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 183
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
RAPE+I G Y +DIWSVGC++ E++ G LFPG +DQ +II+ LGTP+ E +
Sbjct: 184 RAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242
Query: 320 CMNP---NYTEFKFPQIKAHPWHKIF------------HKRMPPEAVDLVSRLLQYSPNL 364
+ P NY E + P+ + + ++F +K +A DL+S++L P
Sbjct: 243 RLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301
Query: 365 RCTALEACIHPF---FYELRDPNARLPN 389
R + +A HP+ +Y+ + A P
Sbjct: 302 RISVDDALQHPYINVWYDPSEVEAPPPA 329
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 8e-43
Identities = 92/308 (29%), Positives = 151/308 (49%), Gaps = 49/308 (15%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 151
+G+G++G V++A+ +TGE VA+KKV D + RE++ +R L+H N+V+LK
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 152 CFFSTTD-----KDELYLNLVLEFVPETVYRVAK----HYSRASQRMPLIYVKLYTYQIC 202
D KD+ LV E++ + + + H+S ++K + Q+
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED-------HIKSFMKQLL 126
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--PNISYICSRYYR 260
L Y H HRDIK N+L+N + Q+KL DFG A++ E P + + + +YR
Sbjct: 127 EGLNYCHKK-NFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
PEL+ G Y AID+WS GC+L EL +P+F + QL I ++ G+P
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC----PA 240
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRM------------PPEAVDLVSRLLQYSPNLRCTA 368
+ P+ + + ++ + K+ P A+DL+ +L P+ RCTA
Sbjct: 241 VWPDVIKLPY-------FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA 293
Query: 369 LEACIHPF 376
EA P+
Sbjct: 294 EEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 5e-41
Identities = 92/298 (30%), Positives = 142/298 (47%), Gaps = 26/298 (8%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH- 151
+GQG+FG VF+A+ +T + VA+KKVL + + RE++ ++LL H NVV+L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79
Query: 152 CFFSTT----DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
C T K YL V EF + +A S + + L +K + L Y
Sbjct: 80 CRTKATPYNRYKGSFYL--VFEFCE---HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY 134
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 262
IH + HRD+K N+L+ +KL DFG A+ +PN + + + +YR P
Sbjct: 135 IHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP 192
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI-KCM 321
EL+ G +Y ID+W GC++AE+ P+ G + QL I ++ G+ T E
Sbjct: 193 ELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVD 252
Query: 322 N-PNYTEFKFPQ-IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ + + PQ K ++ P A+DL+ +LL P R A A H FF
Sbjct: 253 KLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 78/294 (26%), Positives = 128/294 (43%), Gaps = 60/294 (20%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
Y + +G+GSFG V+ + G+ +K++ +++ E++ ++ L+HPN+
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+ F +++ L +V+E+ + + K + + P + + Q+C AL
Sbjct: 62 IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNISYICS 256
Y+H + HRDIKPQN+ + VKL DFG +KVL V G P
Sbjct: 117 KYLH-SRKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTP------- 167
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
YY +PEL Y DIWS+GCVL EL + F GE+ + +L K+L +
Sbjct: 168 -YYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KG 218
Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 370
+ + Y E +LVS LLQ P R + +
Sbjct: 219 QYPPIPSQY---------------------SSELRNLVSSLLQKDPEERPSIAQ 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 6e-38
Identities = 91/290 (31%), Positives = 137/290 (47%), Gaps = 48/290 (16%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVL---QDKRYK------NRELQTMRLLDHPNVV 147
++G GSFG V++ L+ G+ A+K+V + + +E+ + L HPN+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSR-ASQRMPLIYVKLYTYQICRALA 206
+ T+++E L + LE VP +AK + S P+I +LYT QI L
Sbjct: 66 Q-----YLGTEREEDNLYIFLELVPGG--SLAKLLKKYGSFPEPVI--RLYTRQILLGLE 116
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
Y+H HRDIK N+LV+ VKL DFG AK +V+ S+ S Y+ APE+I
Sbjct: 117 YLHDR-NTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
Y A DIWS+GC + E+ G+P + S ++ + + K+ + I
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRSKELPPI-------- 223
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
P H + EA D + + LQ P+LR TA E HPF
Sbjct: 224 ----------PDH------LSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 7e-38
Identities = 85/321 (26%), Positives = 141/321 (43%), Gaps = 79/321 (24%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTM-RLLDHP 144
+ +++G+GSF V AK ET + AIK +++++K+ Y E + + RL HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
++ L + F D++ LY VLE+ P + + + Y ++ + Y +I
Sbjct: 63 GIIKLYYTF---QDEENLY--FVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEILL 113
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRY- 258
AL Y+H G+ HRD+KP+N+L++ H +K+ DFG+AKVL
Sbjct: 114 ALEYLH-SKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 259 ----------------YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ 302
Y +PEL+ + D+W++GC++ ++L G+P F G + +
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--EY 228
Query: 303 LV--EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
L +I+K E+ FP PP+A DL+ +LL
Sbjct: 229 LTFQKILK-----------------LEYSFPPN------------FPPDAKDLIEKLLVL 259
Query: 361 SPNLRCTALEACI----HPFF 377
P R E HPFF
Sbjct: 260 DPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 9e-38
Identities = 100/304 (32%), Positives = 160/304 (52%), Gaps = 30/304 (9%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 146
SY +G+GS+ V++ K G+ VA+K + LQ++ RE ++ L H N+
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
V L H T + L LV E+V + ++ + + VKL+ +Q+ R L+
Sbjct: 66 VLL-HDIIHTKET----LTLVFEYVHTDL---CQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 263
YIH + HRD+KPQNLL++ T ++KL DFG A+ K P+ +Y + + +YR P+
Sbjct: 118 YIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPD 173
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMN 322
++ G+TEY+T +D+W VGC+ E++ G FPG + DQL I VLGTP + ++
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233
Query: 323 --PNYTEFKFPQIKA----HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
P++ +F W+K+ + A DL S+LLQ P R +A A H +
Sbjct: 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVN---HAEDLASKLLQCFPKNRLSAQAALSHEY 290
Query: 377 FYEL 380
F +L
Sbjct: 291 FSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 7e-37
Identities = 97/312 (31%), Positives = 158/312 (50%), Gaps = 31/312 (9%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
Y + +G G+ GIV A G VA+KK+ Q++ + R EL ++ ++H N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+SL + F +E + LV+E + + +V H +RM + YQ+ +
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGI 136
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
++H G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE+I
Sbjct: 137 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
G Y +DIWSVGC++ EL+ G +F G +DQ ++I+ LGTP+ E + + P
Sbjct: 195 LG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253
Query: 324 -NYTEFKFPQIKAHPWHKIFHKRMPP-----------EAVDLVSRLLQYSPNLRCTALEA 371
NY E + PQ + ++F + P +A DL+S++L P+ R + EA
Sbjct: 254 RNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 372 CIHPFFYELRDP 383
HP+ DP
Sbjct: 313 LRHPYITVWYDP 324
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 8e-37
Identities = 91/290 (31%), Positives = 141/290 (48%), Gaps = 20/290 (6%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR---LL------DHPNVVSL 149
+G G++G V++A+ +G VA+K V L T+R LL DHPN+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 150 KH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRA-SQRMPLIYVKLYTYQICRALAY 207
C S TD+ E + LV E V + + + + +P +K Q R L +
Sbjct: 68 MDVCATSRTDR-ETKVTLVFEHVDQDL---RTYLDKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
+H + HRD+KP+N+LV QVKL DFG A++ + + +YRAPE++
Sbjct: 124 LHANC-IVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
+T Y T +D+WSVGC+ AE+ +PLF G S DQL +I ++G P ++ +
Sbjct: 182 ST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTLPR 239
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
F P + L+ +L ++P+ R +A A HPFF
Sbjct: 240 GAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 20/203 (9%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKH 151
++G+G+FG+V++ LETG+ VAIK++ L+ + + +E+ ++ L HPN+V
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
+ L ++LE+ ++ ++ K + + + V +Y YQ+ + LAY+H
Sbjct: 67 SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 269
GV HRDIK N+L VKL DFG A L + S + + Y+ APE+I +
Sbjct: 118 Q-GVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174
Query: 270 EYTTAIDIWSVGCVLAELLLGQP 292
+TA DIWS+GC + ELL G P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNP 197
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-36
Identities = 89/295 (30%), Positives = 134/295 (45%), Gaps = 60/295 (20%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYK-NRELQTMRLLDHPNVVSLKHC 152
V+GQGS G+V++ + TG+ A+KK+ ++ R + REL+T+R + P VV
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 153 FFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
F+ E +++VLE++ + + +P + QI + L Y+
Sbjct: 68 FYK-----EGEISIVLEYMDGGSLADLLKKVGK-------IPEPVLAYIARQILKGLDYL 115
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 263
H + HRDIKP NLL+N +VK+ DFG +KVL N C+ + Y +PE
Sbjct: 116 HTKRHIIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPE 170
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQ-P-LFPGESGVDQLVEIIKVLGTPTREEIKCM 321
I G + Y+ A DIWS+G L E LG+ P L PG+ +L++ I C
Sbjct: 171 RIQGES-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CD 217
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
P + PE D +S LQ P R +A E HPF
Sbjct: 218 GPPP----SLP----------AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 50/292 (17%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKHC 152
+G G+FG V+ A L+TGE +A+K++ +QD K E++ + LL HPN+V
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64
Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
+ ++++Y+ +E+ T+ + +H + + +++YT Q+ LAY+H
Sbjct: 65 YGVEVHREKVYI--FMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-----GEPNISYICSRYYRAPELIF 266
G+ HRDIKP N+ ++ H +KL DFG A L GE S + Y APE+I
Sbjct: 119 -GIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 267 GAT--EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
G + A DIWS+GCV+ E+ G+ + S +D +I+ +G +
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGA--------GHK- 224
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
P I ++ PE D + R L+ P R TA E HPF
Sbjct: 225 ------PPIPD-------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-35
Identities = 93/301 (30%), Positives = 142/301 (47%), Gaps = 63/301 (20%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNR------ELQTMRLLDHPNVVSLKH 151
+ +G++G VF AK TG+ AIK + D KN+ E + P VV L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58
Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
++S K LYL V+E++P + + ++ + + ++Y +I AL Y+H
Sbjct: 59 -YYSFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLHS 111
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISY--------ICSRYYRA 261
G+ HRD+KP N+L++ + H +KL DFG +KV LV+ + N++ + + Y A
Sbjct: 112 -NGIIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
PE+I G ++ +D WS+GC+L E L+G P F GE T EEI
Sbjct: 170 PEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGE----------------TPEEI--- 209
Query: 322 NPNYTEFKFPQIKAH--PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL---EACIHPF 376
F I W + + EA+DL+S+LL P R A E HPF
Sbjct: 210 --------FQNILNGKIEWPEDVE--VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259
Query: 377 F 377
F
Sbjct: 260 F 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 97/293 (33%), Positives = 151/293 (51%), Gaps = 25/293 (8%)
Query: 99 VGQGSFGIVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 148
+G+G++G VF+A+ L+ G VA+K+V + L T+R +HPNVV
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 149 L-KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR-MPLIYVKLYTYQICRALA 206
L C S TD+ E L LV E V + + + + + +P +K +Q+ R L
Sbjct: 69 LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 124
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
++H V HRD+KPQN+LV + Q+KL DFG A++ S + + +YRAPE++
Sbjct: 125 FLHSH-RVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
++ Y T +D+WSVGC+ AE+ +PLF G S VDQL +I+ V+G P E+ P
Sbjct: 183 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PRDV 237
Query: 327 EFKFPQIKAHPWHKI--FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ I F + DL+ + L ++P R +A A HP+F
Sbjct: 238 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 129 bits (324), Expect = 1e-33
Identities = 98/312 (31%), Positives = 157/312 (50%), Gaps = 31/312 (9%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
Y + +G G+ GIV A VAIKK+ Q++ + R EL M+ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+SL + F +E + LV+E + + +V + +RM + YQ+ +
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 132
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
++H G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE+I
Sbjct: 133 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
G Y +DIWSVGC++ E++ + LFPG +DQ ++I+ LGTP E +K + P
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 324 -NYTEFKFPQIKAHPWHKIFHKRMPP-----------EAVDLVSRLLQYSPNLRCTALEA 371
NY E + P+ + K+F + P +A DL+S++L P R + EA
Sbjct: 250 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308
Query: 372 CIHPFFYELRDP 383
HP+ DP
Sbjct: 309 LQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 5e-33
Identities = 87/321 (27%), Positives = 148/321 (46%), Gaps = 65/321 (20%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 149
+ +G GSFG V + +G+ A+K K+++ K+ + E + ++ + HP +V+L
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
F +D+ L LV+E+VP E + R S R P + Y Q+ AL Y
Sbjct: 67 YGSF-----QDDSNLYLVMEYVPGGELF-----SHLRKSGRFPEPVARFYAAQVVLALEY 116
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 266
+H + + +RD+KP+NLL++ + +K+ DFG AK + + +C + Y APE+I
Sbjct: 117 LH-SLDIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
Y A+D W++G ++ E+L G P F ++ Q+ E I ++
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKI----------LEG------ 213
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-----HPFFYELR 381
+ +FP P+A DL+ LLQ R L+ + HP+F +
Sbjct: 214 KVRFP------------SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI- 260
Query: 382 DPNARLPNGRPFPPLFNFKPQ 402
D A L + P F P+
Sbjct: 261 DWIA-LLQRKIEAP---FIPK 277
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 6e-33
Identities = 95/312 (30%), Positives = 156/312 (50%), Gaps = 31/312 (9%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 146
Y + +G G+ GIV A VAIKK+ Q++ + R EL M+ ++H N+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 147 VSLKHCFFSTTDKDELY-LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+ L + F +E + +V+E + + +V + +RM + YQ+ +
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
++H G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRAPE+I
Sbjct: 140 KHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323
G Y +DIWSVGC++ E++ G LFPG +DQ ++I+ LGTP E +K + P
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 324 -NYTEFKFPQIKAHPWHKIFHKRMPP-----------EAVDLVSRLLQYSPNLRCTALEA 371
Y E + P+ + + K+F + P +A DL+S++L + R + EA
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 372 CIHPFFYELRDP 383
HP+ DP
Sbjct: 316 LQHPYINVWYDP 327
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 102/320 (31%), Positives = 157/320 (49%), Gaps = 52/320 (16%)
Query: 99 VGQGSFGIVFQAKCLETGET--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 154
VG+G++G V++AK + + A+K++ RE+ +R L HPNV+SL+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQ------RMPLIYVKLYTYQICRALAYI 208
S D+ + L+ ++ ++ + K + RAS+ ++P VK YQI + Y+
Sbjct: 69 SHADRK---VWLLFDYAEHDLWHIIK-FHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 209 HGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKV-------LVKGEPNISYICSRY 258
H V HRD+KP N+LV P +VK+ D G A++ L +P + + +
Sbjct: 125 HAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFW 180
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF---------PGESGVDQLVEIIKV 309
YRAPEL+ GA YT AIDIW++GC+ AELL +P+F DQL I V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240
Query: 310 LGTPTR---EEIKCMNPNYTEFK---------FPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
+G P E+IK M + T K IK HK+ + +A L+ +L
Sbjct: 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV---KPDSKAFHLLQKL 297
Query: 358 LQYSPNLRCTALEACIHPFF 377
L P R T+ +A P+F
Sbjct: 298 LTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-31
Identities = 72/291 (24%), Positives = 124/291 (42%), Gaps = 47/291 (16%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVL--QDKRYKN---RELQTMRLLDHPNVVSLKH 151
+G G+ G+V + TG+ +A+K + ++ + REL + + P +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
F++ D +++ +E++ + K R+P + + + L Y+H
Sbjct: 67 AFYNNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
+ HRD+KP N+LVN Q+KLCDFG + LV +++ + Y APE I G +Y
Sbjct: 120 HKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDY 176
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESG-----VDQLVEIIKVLGTPTREEIKCMNPNYT 326
+ DIWS+G L EL G+ +P E+ + L I+ P
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN------------EPP--- 221
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
P++ + + P+ D V+ L P R + E HPF
Sbjct: 222 ----PRLPSGKF--------SPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-31
Identities = 81/286 (28%), Positives = 133/286 (46%), Gaps = 44/286 (15%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 154
+G+G+ G V++A TG+ VAIKK+ L+ + + E+ M+ HPN+V +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 155 STTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
DEL++ V+E++ + +++ R ++ + YV ++ + L Y+H
Sbjct: 86 ---VGDELWV--VMEYMDGGSLTDIITQNFVRMNEPQ-IAYVCR---EVLQGLEYLHSQ- 135
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 271
V HRDIK N+L++ VKL DFG A L K + S + + Y+ APE+I +Y
Sbjct: 136 NVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDY 193
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
+DIWS+G + E+ G+P + E + L I G P +K NP
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIP---PLK--NPE------- 240
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ PE D +++ L P R +A E HPF
Sbjct: 241 -------------KWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 101/318 (31%), Positives = 157/318 (49%), Gaps = 48/318 (15%)
Query: 99 VGQGSFGIVFQAKCLETGET--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 154
VG+G++G V++AK + + A+K++ RE+ +R L HPNV++L+ F
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQ------RMPLIYVKLYTYQICRALAYI 208
S +D+ + L+ ++ ++ + K + RAS+ ++P VK YQI + Y+
Sbjct: 69 SHSDRK---VWLLFDYAEHDLWHIIK-FHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 209 HGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKV-------LVKGEPNISYICSRY 258
H V HRD+KP N+LV P +VK+ D G A++ L +P + + +
Sbjct: 125 HAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFW 180
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF---------PGESGVDQLVEIIKV 309
YRAPEL+ GA YT AIDIW++GC+ AELL +P+F DQL I V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240
Query: 310 LGTPTR---EEIKCMNPNY----TEFKFPQIKAHPWHKIF--HKRMPPEAVD-LVSRLLQ 359
+G P E+I+ M P Y +F+ K HK P V L+ +LL
Sbjct: 241 MGFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLT 299
Query: 360 YSPNLRCTALEACIHPFF 377
P R T+ +A P+F
Sbjct: 300 MDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 4e-30
Identities = 101/380 (26%), Positives = 153/380 (40%), Gaps = 88/380 (23%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-------LDHPNVVSLK 150
V+G+G+FG V+ + +TG+ A+K + + K ++ +R D P +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
+ F +DE +L LV+E++P R P + Y ++ AL +H
Sbjct: 67 YYSF----QDEEHLYLVMEYMPGGDLM--NLLIR-KDVFPEETARFYIAELVLALDSVHK 119
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-----------------------VLVKG 247
+G HRDIKP N+L++ H +KL DFG K VLV+
Sbjct: 120 -LGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 248 EPNISYICSRY-------YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
+ Y APE++ G T Y D WS+G +L E+L G P F ++
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT-- 234
Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 359
L E T +I N+ E +FP + PEA+DL+ RLL
Sbjct: 235 --LQE--------TYNKII----NWKESLRFPP----------DPPVSPEAIDLICRLLC 270
Query: 360 YSPNLRCTALEACIHPFF--YELRDPNARLPNGRPFPPLF-------NF-KPQELKGASK 409
+ + E HPFF + + P PF P NF ++ K S
Sbjct: 271 DPEDRLGSFEEIKSHPFFKGIDWENLRETKP---PFVPELSSPLDTSNFDDFEDDKDLSD 327
Query: 410 ELLSKLIPEHARKQCPFLGF 429
L + KQ F+GF
Sbjct: 328 YLSQNSKKLNKGKQLAFVGF 347
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-30
Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 44/236 (18%)
Query: 96 ERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
+ +G+G+FG V++ VA+K + +D + RE + MR LDHPN+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY--SRASQRMPLIYVKLYTYQICRA 204
V L T+++ L +V+E++P Y + + L + + QI R
Sbjct: 64 VKLLGV---CTEEEPLM--IVMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 260
+ Y+ HRD+ +N LV VK+ DFG ++ L + YY+
Sbjct: 116 MEYLE-SKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVKGG 164
Query: 261 -------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 308
APE + ++T+ D+WS G +L E+ LG+ +PG S +++E +K
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAEVLEYLK 218
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 80/295 (27%), Positives = 126/295 (42%), Gaps = 56/295 (18%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
+G G FG V K T A+K V + + E + + +HP +V L +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59
Query: 152 CFFSTTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
F KD+ Y+ +++E+ T+ R + + R Y + A Y
Sbjct: 60 RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR-------FYIACVVLAFEY 108
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
+H G+ +RD+KP+NLL++ VKL DFG AK L G+ ++ + Y APE+I
Sbjct: 109 LHN-RGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN 166
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
Y ++D WS+G +L ELL G+P F GE D + +I N
Sbjct: 167 KG-YDFSVDYWSLGILLYELLTGRPPF-GEDDEDPME---------IYNDILKGNGKL-- 213
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-----HPFF 377
+FP + A DL+ +LL+ +P R L+ I H +F
Sbjct: 214 -EFPNY------------IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-29
Identities = 66/235 (28%), Positives = 113/235 (48%), Gaps = 43/235 (18%)
Query: 96 ERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
+ +G+G+FG V++ K + VA+K + +D + RE + MR LDHPNV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
V L T+++ LY +V+E++ Y R ++ ++ L + + QI R +
Sbjct: 64 VKLLGV---CTEEEPLY--IVMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
Y+ HRD+ +N LV VK+ DFG ++ L + YYR
Sbjct: 116 EYLE-SKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRGGK 164
Query: 261 ------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIK 308
APE + ++T+ D+WS G +L E+ LG+ +PG S ++++E +K
Sbjct: 165 LPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-NEEVLEYLK 217
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 85/294 (28%), Positives = 131/294 (44%), Gaps = 58/294 (19%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLL---DHPNVVSLK 150
+ +G+FG V+ AK TG+ AIK ++ + N + + ++ + P V L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL- 62
Query: 151 HCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
++S KD YL LV+E++ ++ + +P + K Y ++ +
Sbjct: 63 --YYSFQSKD--YLYLVMEYLNGGDCASLIKTLGG-------LPEDWAKQYIAEVVLGVE 111
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
+H G+ HRDIKP+NLL++ H +KL DFG ++ G N ++ + Y APE I
Sbjct: 112 DLHQR-GIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETIL 166
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
G + D WS+GCV+ E L G P F E+ D + + I I N+
Sbjct: 167 GVGD-DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRI-----NWP 213
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA---LEACIHPFF 377
E PEAVDL++RLL P R A E HPFF
Sbjct: 214 EEVKEFCS-------------PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-28
Identities = 70/214 (32%), Positives = 108/214 (50%), Gaps = 17/214 (7%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNR---ELQTMRLLDHPN 145
+ E+ +G+G F +V++A CL G VA+KKV + D + + E+ ++ LDHPN
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
V+ F + LN+VLE + R+ KH+ + + +P + Y Q+C A
Sbjct: 64 VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-KGEPNISYICSRYYRAPE 263
L ++H + HRDIKP N+ + T VKL D G + K S + + YY +PE
Sbjct: 119 LEHMHSK-RIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297
I Y DIWS+GC+L E+ Q F G+
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 7e-28
Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 22/225 (9%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
+G+GSFG V + + G+ + K++ ++K+ E+ +R L HPN+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
D+ L +V+E+ + ++ + + + + ++ Q+ AL H
Sbjct: 67 RII---DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 211 GIG----VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 263
V HRD+KP N+ ++ + VKL DFG AK+L G + +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
+ + Y DIWS+GC++ EL P F QL IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 43/228 (18%)
Query: 97 RVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
+ +G+G+FG V++ GE VA+K + + + E M+ L HPN+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRAS-QRMPLIYVKLYTYQICRALA 206
L T + LY +V E++P + R +++ L + QI + +
Sbjct: 65 RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLLQMALQIAKGME 116
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
Y+ HRD+ +N LV VK+ DFG ++ + + + YYR
Sbjct: 117 YLE-SKNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGGGK 165
Query: 261 ------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
APE + ++T+ D+WS G +L E+ LG+ +PG S +
Sbjct: 166 LPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE 212
|
Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 76/290 (26%), Positives = 128/290 (44%), Gaps = 46/290 (15%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 149
RV+G+G+FG V + +T + A+K K ++ +N E + ++ L+HP +V+L
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+ F +DE + LV++ + R H S+ + VK + +I AL Y+H
Sbjct: 66 WYSF-----QDEENMYLVVDLLLGGDLRY--HLSQK-VKFSEEQVKFWICEIVLALEYLH 117
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
G+ HRDIKP N+L++ H V + DF A + S + Y APE++
Sbjct: 118 SK-GIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
Y+ A+D WS+G E L G+ + G S R++I+
Sbjct: 176 -YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAKQETADV-L 220
Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR--CTALEACIHPFF 377
+P EA+D +++LL+ P R + HP+F
Sbjct: 221 YP--ATW----------STEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 7e-27
Identities = 75/288 (26%), Positives = 119/288 (41%), Gaps = 49/288 (17%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 155
+G+GS+G V++A ETG+ VAIK V ++ + +E+ ++ D P +V +F
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69
Query: 156 TTDKDELYLNLVLEF-----VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
TD L +V+E+ V + + K + + YQ + L Y+H
Sbjct: 70 NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEE-------IAAILYQTLKGLEYLHS 117
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 269
HRDIK N+L+N Q KL DFG + L + I + ++ APE+I
Sbjct: 118 -NKKIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
Y DIWS+G E+ G+P + + + I P T
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN-------------KPPPT-LS 220
Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
P ++ PE D V + L P R +A++ HPF
Sbjct: 221 DP------------EKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 78/296 (26%), Positives = 121/296 (40%), Gaps = 52/296 (17%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHC 152
V+G G+ +V+ A CL E VAIK++ +K + +E+Q M +HPNVV +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YT 66
Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKH-YSRASQRMPLIYVKLYTYQICRALAYIHG 210
F DEL+ LV+ ++ ++ + K Y R +I L ++ + L Y+H
Sbjct: 67 SF--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHS 120
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----YICSRYYRAPELI 265
G HRDIK N+L+ VK+ DFG + L G ++ + + APE++
Sbjct: 121 N-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQP----LFPGESGVDQLVEIIKVLGTPTREEIKCM 321
Y DIWS G EL G P + L+ ++ P+ E
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV----LMLTLQN-DPPSLETGADY 233
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
F+ ++S LQ P+ R TA E H FF
Sbjct: 234 KKYSKSFR----------------------KMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 87/308 (28%), Positives = 139/308 (45%), Gaps = 67/308 (21%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-------QDKRYKN------RELQTMR 139
++ ++G GSFG V+ +GE +A+K+V R ++ RE+ ++
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYT 198
L H N+V D +LN+ LE+VP +V + +Y + + V+ +
Sbjct: 62 ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI------- 251
QI + L Y+H G+ HRDIK N+LV+ + +K+ DFG +K K E N
Sbjct: 113 RQILKGLNYLHNR-GIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTNG 167
Query: 252 ---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
S S ++ APE++ T YT DIWS+GC++ E+L G+ FP QL I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFK 223
Query: 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368
+ E P+I ++ + EA+D + + + N R TA
Sbjct: 224 I----------------GENASPEIPSN---------ISSEAIDFLEKTFEIDHNKRPTA 258
Query: 369 LEACIHPF 376
E HPF
Sbjct: 259 AELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 44/227 (19%)
Query: 97 RVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 148
+ +G+G+FG V++ K VA+K + +D + R E + M+ L HPNVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKL--YTYQIC 202
L T+++ LY LVLE++ R ++ + ++ L L + QI
Sbjct: 61 LLGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 260
+ + Y+ HRD+ +N LV VK+ DFG ++ + + YYR
Sbjct: 116 KGMEYLA-SKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRKK 164
Query: 261 ----------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
APE + +T+ D+WS G +L E+ LG +PG
Sbjct: 165 TGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 5e-26
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKV--------LQDKRYKNRELQTMRLLDHPNVVSL 149
++G+G++G V++ K + TG VA+K + + D + + L +R PN+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+ L +++E+ R +++ Y+ + ++ AL YIH
Sbjct: 68 YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA 268
+GV HRDIK N+LV +T VKLCDFG A +L + +++ + Y+ APE+I
Sbjct: 119 K-VGVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQL 303
Y T DIWS+G + E+ G P + S VD
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 75/297 (25%), Positives = 135/297 (45%), Gaps = 51/297 (17%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKV--------LQDKRYKN--RELQTMRLLDHPNV 146
+ +G G+F +QA+ ++TG +A+K+V Q++ + +E++ M L+HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+ +T + + NL +E++ +V + Y + + + YT Q+ R L
Sbjct: 66 I---RMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEA---VIIN-YTEQLLRGL 116
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-----GEPNISYICSRYYR 260
+Y+H + HRD+K NLL++ ++++ DFG+A L GE + + +
Sbjct: 117 SYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
APE++ G +Y + D+WSVGCV+ E+ +P + E + L I K I
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---------IAS 225
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
P I H + P D+ R L+ P R + E HP F
Sbjct: 226 ATTA------PSIPEH---------LSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 87/304 (28%), Positives = 145/304 (47%), Gaps = 55/304 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--------LQDKRYK------NRELQTM 138
++ ++G+G++G V+ A + TGE +A+K+V D R K E++T+
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLY 197
+ LDH N+V + E YL++ LE+VP ++ + Y R +++ V+ +
Sbjct: 63 KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV---LVKGEPNISYI 254
T Q+ LAY+H G+ HRD+K NLLV+ K+ DFG +K + + N+S
Sbjct: 114 TEQVLEGLAYLHSK-GILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 255 CSRYYRAPELIFGATE-YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
S ++ APE+I ++ Y+ +DIWS+GCV+ E+ G+ + E
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE---------------- 215
Query: 314 TREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
E I M FK + A P + P A+D ++ +P+ R TA E
Sbjct: 216 --EAIAAM------FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELL 267
Query: 373 IHPF 376
HPF
Sbjct: 268 QHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 88/298 (29%), Positives = 139/298 (46%), Gaps = 49/298 (16%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 152
+G+GS GIV A TG VA+KK+ D R + R E+ MR HPN+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81
Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
+ S DEL++ V+EF+ + + H RM + + +AL+++H
Sbjct: 82 YSSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATE 270
GV HRDIK ++L+ +VKL DFG + K P S + + Y+ APE+I
Sbjct: 135 -GVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLP 191
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
Y T +DIWS+G ++ E++ G+P + E + + + I+ P
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM------------KRIRDNLP------- 232
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLP 388
P++K HK+ P + R+L P R TA E HPF + P++ +P
Sbjct: 233 PKLKNL--HKV-----SPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 78/295 (26%), Positives = 133/295 (45%), Gaps = 53/295 (17%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNR------ELQTMRLLDHPNVV 147
+++GQG+FG V+ ++TG +A+K+V K E+Q ++ L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
C +D+ L++ +E++P +V K Y ++ + + YT QI +
Sbjct: 68 QYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRYYRAP 262
Y+H + + HRDIK N+L + VKL DFG++K L G S + Y+ +P
Sbjct: 119 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
E+I G Y D+WSVGC + E+L +P + + + + I K+ PT
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTN------- 225
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
PQ+ +H + P+A + + R + R +A E H F
Sbjct: 226 --------PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 6e-24
Identities = 80/291 (27%), Positives = 128/291 (43%), Gaps = 52/291 (17%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKV-LQDK---RYKNRELQTMRLLDHPNVVSLKHCFF 154
+G G++G V++A+ + TGE VAIK + L+ +E+ ++ HPN+V+ +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI-YVKLYTYQICRALAYIHGGIG 213
+D+L+ +V+E+ + +R I YV T + LAY+H G
Sbjct: 71 R---RDKLW--IVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLK---GLAYLH-ETG 121
Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIFGATE- 270
HRDIK N+L+ VKL DFG + L + S+I + Y+ APE+ A E
Sbjct: 122 KIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEVA--AVER 177
Query: 271 ---YTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
Y DIW++G EL Q P+F + ++ L ++
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS---------- 219
Query: 327 EFKFPQIKA-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
F P++K W +FH D + + L P R TA + HPF
Sbjct: 220 NFPPPKLKDKEKWSPVFH--------DFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 86/300 (28%), Positives = 124/300 (41%), Gaps = 62/300 (20%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNR-----ELQTMRLLDHPNV 146
Y+ RV+G+G+FG + E V K+V L K R E+ + LL HPN+
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
++ + F D+ L + +E+ T+Y + Q V Y +QI A+
Sbjct: 62 IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAV 114
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNISYICS 256
+YIH G+ HRDIK N+ + +KL DFG +K+L V G P
Sbjct: 115 SYIHK-AGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP------- 165
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
YY +PEL G +Y DIW++GCVL ELL + F + ++
Sbjct: 166 -YYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDA----TNPLNLV--------- 210
Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
+K + NYT E + LV LLQ P R TA E P
Sbjct: 211 -VKIVQGNYTPVVSVYSS--------------ELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 84/290 (28%), Positives = 130/290 (44%), Gaps = 43/290 (14%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNRELQTMRLL---DHPNVVSLKH 151
VGQG +G VF AK +TGE VA+K +L L +L +V L +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRA-SQRMPLIYVKLYTYQICRALAYIHG 210
F D + LYL +E+VP +R + S+ + + Y ++ A+ +H
Sbjct: 69 AF---QDDEYLYL--AMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFEAVDALHE 119
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
+G HRD+KP+N L++ H +KL DFG +K +V S + S Y APE++ G
Sbjct: 120 -LGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRG-KG 174
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
Y +D WS+GC+L E L G P F G + + + T R P Y + +F
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR-------PVYDDPRF 227
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
+ EA DL+++L+ + + HPFF E+
Sbjct: 228 --------------NLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 7e-23
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
R +G GSFG V+ A+ + T E VAIKK+ + N +E++ ++ L HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
K C+ E LV+E+ + + + + + Q + + + + + LAY+H
Sbjct: 81 KGCYLR-----EHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI---CHGALQGLAYLH 132
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
HRDIK N+L+ VKL DFGSA ++ P S++ + Y+ APE+I
Sbjct: 133 -SHERIHRDIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTPYWMAPEVILAMD 187
Query: 270 E--YTTAIDIWSVGCVLAELLLGQ-PLF 294
E Y +D+WS+G EL + PLF
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-22
Identities = 72/215 (33%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHP 144
++ E+ +G+G F V++A CL G VA+KKV L D + + +E+ ++ L+HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
NV+ F + LN+VLE + R+ KH+ + + +P V Y Q+C
Sbjct: 63 NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAP 262
AL ++H V HRDIKP N+ + T VKL D G + K S + + YY +P
Sbjct: 118 ALEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297
E I Y DIWS+GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 75/297 (25%), Positives = 119/297 (40%), Gaps = 59/297 (19%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 147
+ +G+GSFG V++A T + VAIK + + +E+Q + P +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
F + L +++E+ + + K ++ Y+ ++ L
Sbjct: 63 KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLK-----PGKLDETYIAFILREVLLGLE 112
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-------YY 259
Y+H G HRDIK N+L++ VKL DFG V G+ S + R ++
Sbjct: 113 YLHEE-GKIHRDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRNTFVGTPFW 164
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
APE+I + Y DIWS+G EL G+P P S + + +VL K
Sbjct: 165 MAPEVIKQ-SGYDEKADIWSLGITAIELAKGEP--P-LSDLHPM----RVL----FLIPK 212
Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
NP P ++ + + K F D VS L P R +A E H F
Sbjct: 213 N-NP-------PSLEGNKFSKPFK--------DFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 83/291 (28%), Positives = 127/291 (43%), Gaps = 61/291 (20%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTM-------RLLDHPNVV 147
+V+G+GSFG V AK G+ A+ KVLQ K K + M + + HP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
L H F T DK L VL++V E + H R + P + Y +I AL
Sbjct: 60 GL-HYSFQTADK----LYFVLDYVNGGELFF----HLQR-ERSFPEPRARFYAAEIASAL 109
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 264
Y+H + + +RD+KP+N+L++ H V L DFG K ++ S C + Y APE+
Sbjct: 110 GYLH-SLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEV 167
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
+ Y +D W +G VL E+L G P F ++ + +L P R + PN
Sbjct: 168 LR-KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYD--NILNKPLR-----LKPN 218
Query: 325 YT---------------------EFKFPQIKAHP------WHKIFHKRMPP 348
+ + F +IK H W + +K++ P
Sbjct: 219 ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITP 269
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 4e-22
Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 25/212 (11%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLL-DHPNVVSLKH 151
V+G+G++G V++A+ +TG+ VAIK + D E +R +HPN+ +
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70
Query: 152 CFF---STTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
F + D+L+ LV+E +V + K + +R+ ++ + R LAY
Sbjct: 71 AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 266
+H V HRDIK QN+L+ +VKL DFG SA++ ++I + Y+ APE+I
Sbjct: 129 LHEN-KVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI- 185
Query: 267 GATE------YTTAIDIWSVGCVLAELLLGQP 292
A + Y D+WS+G EL G+P
Sbjct: 186 -ACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 5e-22
Identities = 67/219 (30%), Positives = 110/219 (50%), Gaps = 22/219 (10%)
Query: 100 GQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNRE--LQTMRLL---DHPNVVSLKHCF 153
G+GS+G V++ K L + A+K+V L K RE + +R+L +HPN++S K F
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68
Query: 154 FSTTDKDELYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTY--QICRALAYIHG 210
D ++L + V+E+ P + + R +R + +++ Q+ R L +H
Sbjct: 69 L---DGNKLCI--VMEYAPFGDLSKAIS--KRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121
Query: 211 GIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
+ HRD+K N LLV VK+ D G +KVL K + I + +Y APE ++
Sbjct: 122 -QKILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGR 176
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
Y+ DIWS+GC+L E+ P F S D ++ +
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 8e-22
Identities = 66/213 (30%), Positives = 107/213 (50%), Gaps = 16/213 (7%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNV 146
Y RVVG+G+FGIV + + V IK++ ++ K+ E Q ++LL HPN+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+ F DK L +V+E+ P T+ + R + + + + QI AL
Sbjct: 62 IEYYENFLE--DKA---LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLAL 114
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
++H + + HRD+K QN+L++ H VK+ DFG +K+L + + + Y +PEL
Sbjct: 115 HHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
G Y DIW++GCVL EL + F +
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 1e-21
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHP 144
++ E+ +G+G F V++A CL + VA+KKV + D + + +E+ ++ L+HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
NV+ F + LN+VLE + ++ K++ + + +P V Y Q+C
Sbjct: 63 NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAP 262
A+ ++H V HRDIKP N+ + T VKL D G + K S + + YY +P
Sbjct: 118 AVEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297
E I Y DIWS+GC+L E+ Q F G+
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 88/316 (27%), Positives = 136/316 (43%), Gaps = 53/316 (16%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 150
+G+G FG V + TG+ A KK L KR K R+ + M L + +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
+ F + KD+L L + L + Y + I+ Y QI L ++H
Sbjct: 60 YAFET---KDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIF---YAAQIICGLEHLHQ 113
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
+ +RD+KP+N+L++ H + V++ D G A L G+ + Y APE++ G
Sbjct: 114 -RRIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE-V 170
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
Y ++D +++GC L E++ G+ F Q E ++ +EE+K ++
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRRTLE-MAVEY 217
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDPNA 385
P + PEA DL LLQ P R +A E HP F +L
Sbjct: 218 PD------------KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWR-- 263
Query: 386 RLPNGRPFPPLFNFKP 401
RL G PP F P
Sbjct: 264 RLEAGMLEPP---FIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 83/300 (27%), Positives = 135/300 (45%), Gaps = 58/300 (19%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 148
+V+G+GSFG V A+ T E A+K + +D ++ +++ TM R+L HP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
L H F T KD L+ V+E+V + ++ + + S R + Y +I L
Sbjct: 61 L-HSCFQT--KDRLFF--VMEYVNGGDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQ 110
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
++H G+ +RD+K N+L++ H +K+ DFG K + G S C + Y APE++
Sbjct: 111 FLHER-GIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEIL 168
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
Y A+D W++G +L E+L GQ F G+ D+L
Sbjct: 169 SY-QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDEL---------------------- 204
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL---EACI--HPFFYEL 380
F I + + + EA ++ L +P R L E I HPFF E+
Sbjct: 205 ----FQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 5e-21
Identities = 76/289 (26%), Positives = 125/289 (43%), Gaps = 41/289 (14%)
Query: 100 GQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHCF 153
G+G++G+V + + + TG +A+K++ + KR +MR +D P V+
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
F D + + +E + ++ + K +P + I +AL Y+H +
Sbjct: 70 FREGD-----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124
Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--- 270
V HRD+KP N+L+N QVKLCDFG + LV + Y APE I
Sbjct: 125 VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
Y D+WS+G + EL G+ FP +S TP +++K
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDS-----------WKTPF-QQLK----------- 218
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379
Q+ P ++ ++ PE D V++ L+ + R E HPFF
Sbjct: 219 -QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 87/296 (29%), Positives = 133/296 (44%), Gaps = 55/296 (18%)
Query: 96 ERVV-GQGSFGIVFQAKCLETGETVAIKKV-LQDKRYK---NRELQTMRLLDHPNVVSLK 150
ERVV G+G++GIV+ A+ L T +AIK++ +D RY + E+ L H N+V
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ-- 69
Query: 151 HCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIY----VKLYTYQIC 202
+ +D + + + +E VP + R S+ PL + YT QI
Sbjct: 70 ---YLGSDSENGFFKIFMEQVPGGSLSALLR--------SKWGPLKDNEQTIIFYTKQIL 118
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRA 261
L Y+H + HRDIK N+LVN ++ VK+ DFG++K L P ++ + Y A
Sbjct: 119 EGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177
Query: 262 PELI-FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
PE+I G Y DIWS+GC + E+ G+P F I+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF-----------------------IEL 214
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
P FK K HP + + EA + + R + P+ R +A + PF
Sbjct: 215 GEPQAAMFKVGMFKIHP---EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 62/215 (28%), Positives = 107/215 (49%), Gaps = 36/215 (16%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 151
VG G+FG V + + A+K + L+ +++ + E + ++ + HP ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
F++ D+ LY+ ++E+VP E Y R S R Y +I AL Y+H
Sbjct: 67 -FWTEHDQRFLYM--LMEYVPGGELF-----SYLRNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYYRAPE 263
+ +RD+KP+N+L++ H +KL DFG AK L G P Y APE
Sbjct: 119 S-KEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLAPE 168
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
+I + + A+D W++G ++ E+L+G P F ++
Sbjct: 169 VI-QSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 31/210 (14%)
Query: 97 RVVGQGSFGIVFQAKCLE-----TGETVAIKK-----VLQDKRYKNRELQTMRLLDHPNV 146
+ +G+G FG V + TGE VA+K Q + RE++ +R LDH N+
Sbjct: 10 KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY-SRASQRMPLIYVKLYTYQICRAL 205
V K L L++E++P + Y R ++ L + L++ QIC+ +
Sbjct: 69 VKYKGV---CEKPGGRSLRLIMEYLP---SGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRY 258
Y+ G HRD+ +N+LV VK+ DFG AKVL + EP S I +
Sbjct: 123 DYL-GSQRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--FW 178
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELL 288
Y APE + + +++A D+WS G L EL
Sbjct: 179 Y-APECLRTSK-FSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-20
Identities = 77/294 (26%), Positives = 122/294 (41%), Gaps = 49/294 (16%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 151
+G GSFG V+ A T E VA+KK+ + N +E++ ++ L HPN + K
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
C+ E LV+E+ + + + + + Q + + + T+ + LAY+H
Sbjct: 89 CYLK-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLHSH 140
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 270
+ HRDIK N+L+ QVKL DFGSA P S++ + Y+ APE+I E
Sbjct: 141 NMI-HRDIKAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTPYWMAPEVILAMDEG 195
Query: 271 -YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
Y +D+WS+G EL +P + + L I +
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------------AQND 236
Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383
P ++++ W F V LQ P R + E H F R
Sbjct: 237 SPTLQSNEWTDSFRG--------FVDYCLQKIPQERPASAELLRHDFVRRDRPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 4e-20
Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 31/213 (14%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD--------KRYK--NRELQTMRLLDHPNVV 147
V+G+G++G V+ G+ +A+K+V D K Y+ E+ ++ L H N+V
Sbjct: 7 VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
+ T D+ +++ +EFVP ++ + + +P YT QI +A
Sbjct: 66 Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVA 116
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI-------CSRYY 259
Y+H V HRDIK N+++ P +KL DFG A+ L + ++ + Y+
Sbjct: 117 YLHNN-CVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQP 292
APE+I + Y DIWS+GC + E+ G+P
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-20
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ L HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+ C+ E LV+E+ + + + + + Q + + V T+ + LAY+H
Sbjct: 81 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV---THGALQGLAYLH 132
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
+ HRD+K N+L++ VKL DFGSA ++ P ++ + Y+ APE+I
Sbjct: 133 SH-NMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMD 187
Query: 270 E--YTTAIDIWSVGCVLAELLLGQP 292
E Y +D+WS+G EL +P
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 6e-20
Identities = 90/318 (28%), Positives = 148/318 (46%), Gaps = 59/318 (18%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 148
+V+G+GSFG V A+ T E AIK + +D ++ +++ TM R+L +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
L C F T + +L V+E++ + ++ + ++S R + Y +I L
Sbjct: 61 L-FCTFQTKE----HLFFVMEYLNGGDLMFHI-----QSSGRFDEARARFYAAEIICGLQ 110
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
++H G+ +RD+K N+L++ H +K+ DFG K + GE S C + Y APE++
Sbjct: 111 FLHKK-GIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL 168
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
G +Y ++D WS G +L E+L+GQ F GE D+L + I +
Sbjct: 169 KG-QKYNESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR------- 212
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-TALEACIHPFFYELRDPN 384
P F + + EA D +S+L + P R + HPFF R +
Sbjct: 213 -----------PH---FPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF---RGID 255
Query: 385 ARLPNGRPFPPLFNFKPQ 402
R PP FKP+
Sbjct: 256 WERLEKREIPP--PFKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 7e-20
Identities = 84/286 (29%), Positives = 136/286 (47%), Gaps = 49/286 (17%)
Query: 97 RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDKRYKNRELQTMRL-------LDHPNV 146
+V+GQGSFG VF + + + G+ A+K VL+ K R+ ++ ++HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMK-VLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY--VKLYTYQICRA 204
V L H F T K L L+L+F+ R ++R S+ + VK Y ++ A
Sbjct: 61 VKL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALA 110
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 263
L ++H +G+ +RD+KP+N+L++ H +KL DFG +K + E C Y APE
Sbjct: 111 LDHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPT-------- 314
++ +T + D WS G ++ E+L G F G+ + + I+K LG P
Sbjct: 169 VV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227
Query: 315 --REEIKCMNPNYTEFKFPQ----IKAHP------WHKIFHKRMPP 348
R K NP P IK HP W+K++ + + P
Sbjct: 228 LLRALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 9e-20
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
R +G GSFG V+ A+ + T E VAIKK+ + N +E++ ++ + HPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
K C+ E LV+E+ + + + + + Q + + + T+ + LAY+H
Sbjct: 91 KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI---THGALQGLAYLH 142
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
+ HRDIK N+L+ QVKL DFGSA + P S++ + Y+ APE+I
Sbjct: 143 SH-NMIHRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMD 197
Query: 270 E--YTTAIDIWSVGCVLAELLLGQP 292
E Y +D+WS+G EL +P
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 9e-20
Identities = 98/356 (27%), Positives = 162/356 (45%), Gaps = 68/356 (19%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 148
+V+G+GSFG V A+ GE A+K + +D + +++ TM R+L ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
L +C F T + +L V+EF+ + ++ + + R L Y +I L
Sbjct: 61 L-YCTFQTKE----HLFFVMEFLNGGDLMFHI-----QDKGRFDLYRATFYAAEIVCGLQ 110
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
++H G+ +RD+K N++++ H +K+ DFG K V G+ S C + Y APE++
Sbjct: 111 FLHSK-GIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEIL 168
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
G +YT ++D WS G +L E+L+GQ F G+ D+L E I+V TP
Sbjct: 169 QG-LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV-DTP------------ 213
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL-EACIHPFFYELRDPN 384
+P+ W + E+ D++ +L + P R + HPFF + N
Sbjct: 214 ---HYPR-----W-------ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI---N 255
Query: 385 ARLPNGRPFPPLFNFK---PQELKGASKELLS-KLIPEHARK-------QCPFLGF 429
R P F K P + +E LS K ++ K Q F GF
Sbjct: 256 WTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLSYSDKNLIDSMDQSAFAGF 311
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 73/210 (34%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 147
+V+G+GSFG V AK G+ A+K VLQ K NR+ Q ++ + HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
L H F TT+K L VL+FV E + + + S R + Y +I AL
Sbjct: 60 GL-HYSFQTTEK----LYFVLDFVNGGELFFHLQRERSFPEPR-----ARFYAAEIASAL 109
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 264
Y+H I + +RD+KP+N+L++ H V L DFG K + + C + Y APE+
Sbjct: 110 GYLHS-INIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
I Y +D W +G VL E+L G P F
Sbjct: 168 I-RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 92/316 (29%), Positives = 142/316 (44%), Gaps = 60/316 (18%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLKH 151
+G+GSFG V Q + +T A+K + + E+ + ++ P +V LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
FS ++LYL VL F+ E + + + R L + YT ++ AL +H
Sbjct: 60 --FSFQSPEKLYL--VLAFINGGELFHHLQRE-----GRFDLSRARFYTAELLCALENLH 110
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 268
V +RD+KP+N+L++ + + LCDFG K+ +K + + C + Y APEL+ G
Sbjct: 111 K-FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
YT A+D W++G +L E+L G P F E+ V+++ K+L P R
Sbjct: 169 G-YTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYR--KILQEPLR------------- 211
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---TALEACIHPFFYELRDPNA 385
FP +A DL+ LL P R A E HPFF +L
Sbjct: 212 -FPD------------GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS--WK 256
Query: 386 RLPNGRPFPPLFNFKP 401
+L PP FKP
Sbjct: 257 KLLMKGIQPP---FKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 3e-19
Identities = 70/208 (33%), Positives = 102/208 (49%), Gaps = 34/208 (16%)
Query: 99 VGQGSFGIVFQAKCL------ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 148
+G+G+FG V C TGE VA+KK+ R RE++ ++ L H N+V
Sbjct: 12 LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYR--VAKHYSRASQRMPLIYVKLYTYQICRALA 206
K +S ++ L LV+E++P R + KH R R L LY QIC+ +
Sbjct: 70 YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYY 259
Y+ G HRD+ +N+LV VK+ DFG KVL EP S I ++
Sbjct: 123 YL-GSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI---FW 177
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAEL 287
APE + ++++ A D+WS G VL EL
Sbjct: 178 YAPESL-TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 88/306 (28%), Positives = 138/306 (45%), Gaps = 67/306 (21%)
Query: 97 RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDKRYKNRELQTMRLLDH---------- 143
RV+G G++G VF + + + G+ A+K VL+ K +Q + +H
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMK-VLK----KATIVQKAKTAEHTRTERQVLEA 60
Query: 144 ----PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR--MPLIYVKLY 197
P +V+L H F T K L+L+L++V + ++ QR V++Y
Sbjct: 61 VRRCPFLVTL-HYAFQTDTK----LHLILDYV-----NGGELFTHLYQREHFTESEVRVY 110
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC 255
+I AL ++H +G+ +RDIK +N+L++ H V L DFG +K + E S+
Sbjct: 111 IAEIVLALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCG 168
Query: 256 SRYYRAPELIFGATE-YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
+ Y APE+I G + + A+D WS+G + ELL G F + + EI +
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------S 221
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---TALEA 371
R +K P FP K M EA D + +LL+ P R A E
Sbjct: 222 RRILKSKPP------FP------------KTMSAEARDFIQKLLEKDPKKRLGANGADEI 263
Query: 372 CIHPFF 377
HPFF
Sbjct: 264 KNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 86/297 (28%), Positives = 134/297 (45%), Gaps = 47/297 (15%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 152
+G+GS GIV A+ +G VA+K + D R + R E+ MR H NVV +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
+ S +EL++ ++EF+ +R ++ + + +AL Y+H
Sbjct: 84 YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLHSQ- 136
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 271
GV HRDIK ++L+ +VKL DFG + K P S + + Y+ APE+I T Y
Sbjct: 137 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPY 194
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
T +DIWS+G ++ E++ G+P + +S V + + R+ P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------P 233
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLP 388
K HKI P D + R+L P R TA E HPF + P +P
Sbjct: 234 PPKLKNAHKI-----SPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 87/328 (26%), Positives = 146/328 (44%), Gaps = 70/328 (21%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQ---------DKRYKNRELQTMRLLDHPNVV 147
+++ G++G V+ + ET + A+KK+ + + + R++ T ++P VV
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA--ENPFVV 64
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
S+ C F T + +L +V+E+V + K+ +P+ ++Y + AL
Sbjct: 65 SM-FCSFET----KRHLCMVMEYVEGGDCATLLKNIGA----LPVDMARMYFAETVLALE 115
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNI-------------- 251
Y+H G+ HRD+KP NLL+ H +KL DFG +K+ L+ N+
Sbjct: 116 YLHN-YGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 252 SYIC-SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310
+C + Y APE+I Y +D W++G +L E L+G F G++ + ++I
Sbjct: 174 KQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-- 230
Query: 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---T 367
++I P E +P +A DL+SRLL+ +P R
Sbjct: 231 -----DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLERLGTGG 266
Query: 368 ALEACIHPFFYELRDPNARLPNGRPFPP 395
A E H FF L D N L F P
Sbjct: 267 AFEVKQHRFFLGL-DWNGLLRQKAEFIP 293
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 88/293 (30%), Positives = 133/293 (45%), Gaps = 54/293 (18%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSLKH 151
+G GSFG V AK TGE AIK ++L+ K+ + +E + L HP +V++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
F D++ +Y +LEFV V + R + R P K Y ++ A Y+H
Sbjct: 86 SF---QDENRVYF--LLEFV---VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS- 136
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
+ +RD+KP+NLL++ H VK+ DFG AK + + + + Y APE+I + +
Sbjct: 137 KDIIYRDLKPENLLLDNKGH-VKVTDFGFAKKVP--DRTFTLCGTPEYLAPEVI-QSKGH 192
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
A+D W++G +L E + G P F + TP R K + KFP
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPFFDD--------------TPFRIYEKILA---GRLKFP 235
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-----HPFFYE 379
W F R A DLV LLQ R L+ + HP+F+
Sbjct: 236 N-----W---FDGR----ARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276
|
Length = 329 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 5e-19
Identities = 68/242 (28%), Positives = 119/242 (49%), Gaps = 27/242 (11%)
Query: 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLL 141
I++ +++GQG+FG V+ ++TG +A K+V D E+Q ++ L
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 142 DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQ 200
H +V C D+ E L + +E++P +V K Y ++ + + YT Q
Sbjct: 62 QHERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICS 256
I ++Y+H + + HRDIK N+L + VKL DFG++K L + G S +
Sbjct: 115 ILEGMSYLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
Y+ +PE+I G Y D+WS+GC + E+L +P + + + + I K+ PT
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNP 228
Query: 317 EI 318
++
Sbjct: 229 QL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 9e-19
Identities = 75/299 (25%), Positives = 130/299 (43%), Gaps = 48/299 (16%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQTMRLLDHPNVVSLKHCF 153
+G+G++G V++ TG T+A+K++ L + ++ EL + P +V F
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
F E + + +E++ A++ +P ++ TY + + L ++
Sbjct: 69 FI-----EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI-----FGA 268
+ HRD+KP N+LVN + QVKLCDFG + LV + C Y APE I
Sbjct: 124 IIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQN 181
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGTPTREEIKCMNPNY 325
YT D+WS+G + E+ LG+ +P E+ + QL I+ G P + Y
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT-----LPSGY 234
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384
+ +A D V++ L PN R T + HP+ + ++ +
Sbjct: 235 S---------------------DDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 153
+G G+ G V + K + TG +A K V + RELQ M P +VS F
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 154 FSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+ + + + +EF+ + +Y+ +P+ + + L Y++
Sbjct: 73 LNENN-----ICMCMEFMDCGSLDRIYKKGG-------PIPVEILGKIAVAVVEGLTYLY 120
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
+ HRDIKP N+LVN Q+KLCDFG + L+ + +++ + Y +PE I G
Sbjct: 121 NVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG- 177
Query: 270 EYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
+YT D+WS+G + EL LG+ P D + + +L
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL---------------- 221
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
QI P ++ P + D V L P R T + C P F
Sbjct: 222 -LQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 87/297 (29%), Positives = 135/297 (45%), Gaps = 47/297 (15%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 152
+G+GS GIV A +G+ VA+KK+ D R + R E+ MR H NVV + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
+ DEL+ +V+EF+ ++R ++ + + +AL+ +H
Sbjct: 86 YLV---GDELW--VVMEFLEGGALTDIVTHTRMNEEQ----IAAVCLAVLKALSVLHAQ- 135
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEY 271
GV HRDIK ++L+ H +VKL DFG + K P S + + Y+ APELI Y
Sbjct: 136 GVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI-SRLPY 193
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
+DIWS+G ++ E++ G+P + E P + +K + N
Sbjct: 194 GPEVDIWSLGIMVIEMVDGEPPYFNE---------------PPLKAMKMIRDNLP----- 233
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLP 388
P K HK + P + RLL P R TA E HPF + P+ +P
Sbjct: 234 -----PKLKNLHK-VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 64/236 (27%), Positives = 118/236 (50%), Gaps = 27/236 (11%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 147
+++G+G+FG V+ +TG +A+K+V D + E+Q ++ L H +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
C D +E L++ +E++P ++ K Y ++ + + YT QI + ++
Sbjct: 68 QYYGCL---RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK----VLVKGEPNISYICSRYYRAP 262
Y+H + + HRDIK N+L + VKL DFG++K + + G S + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
E+I G Y D+WSV C + E+L +P + + + + I K+ PT+ +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-18
Identities = 68/236 (28%), Positives = 114/236 (48%), Gaps = 27/236 (11%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 147
+++GQG+FG V+ +TG +A+K+V D E+Q ++ L H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
C D E L++ +E +P ++ K Y ++ + + YT QI ++
Sbjct: 68 QYYGCL---RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRYYRAP 262
Y+H + + HRDIK N+L + VKL DFG++K L + G S + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
E+I G Y DIWSVGC + E+L +P + + + + I K+ PT +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVL 230
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 76/283 (26%), Positives = 121/283 (42%), Gaps = 50/283 (17%)
Query: 100 GQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFF 154
G+G+ G V + + TG A+K + D ++ REL+ + P +V F
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF- 68
Query: 155 STTDKDELYLNLVLEFVP----ETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
D+ + + +E+ +++Y +V K R ++ L + + + L+Y+H
Sbjct: 69 --LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKI---AESVLKGLSYLH 122
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELI 265
+ HRDIKP N+L+ QVKLCDFG V GE S + + +Y APE I
Sbjct: 123 SR-KIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERI 175
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGES----GVDQLVEIIKVLGTPT------- 314
G Y+ D+WS+G L E+ + FP E G +L+ I + P
Sbjct: 176 QGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGN 234
Query: 315 ----REEIK-----CMNPNYTEFKFP-QIKAHPWHKIFHKRMP 347
EE K C+ + T P + HPW K K+
Sbjct: 235 GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 86/319 (26%), Positives = 149/319 (46%), Gaps = 61/319 (19%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 148
+++G+GSFG VF A+ T + AIK + +D + +++ TM R+L +HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
L +C F T K+ L+ V+E++ + ++ + ++ + L Y +I L
Sbjct: 61 L-YCTFQT--KENLFF--VMEYLNGGDLMFHI-----QSCHKFDLPRATFYAAEIICGLQ 110
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
++H G+ +RD+K N+L++ H +K+ DFG K + G+ C + Y APE++
Sbjct: 111 FLHSK-GIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL 168
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
G +Y T++D WS G +L E+L+GQ F G + + I+ NP Y
Sbjct: 169 LG-QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF------------QSIRMDNPCY 215
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI--HPFFYELRDP 383
+ + EA D++ +L P R ++ I HPFF E+
Sbjct: 216 PRW-----------------LTREAKDILVKLFVREPERR-LGVKGDIRQHPFFREID-- 255
Query: 384 NARLPNGRPFPPLFNFKPQ 402
+ L PP FKP+
Sbjct: 256 WSALEEREIEPP---FKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 77/299 (25%), Positives = 133/299 (44%), Gaps = 63/299 (21%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 146
+++G+G+FG V + TG+ A+K + ++ ++R LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
+LK+ F T D L V+E+ E + +++ + R + Y +I A
Sbjct: 58 TALKYSF-QTHD----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 263
L Y+H V +RD+K +NL+++ H +K+ DFG K + + C + Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
+ +Y A+D W +G V+ E++ G+ F + ++L E+I + EEI+
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 213
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 377
F + + PEA L++ LL+ P R A E H FF
Sbjct: 214 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 95/337 (28%), Positives = 150/337 (44%), Gaps = 73/337 (21%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 148
RV+G+GSFG V A+ E+G A+K + +D ++ +++ TM R+L +HP +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
L +C F T D+ L V+EFV + ++ + K S+R + Y +I AL
Sbjct: 61 L-YCCFQTPDR----LFFVMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEITSALM 110
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
++H G+ +RD+K N+L++ H KL DFG K + S C + Y APE I
Sbjct: 111 FLHDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-I 167
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
Y ++D W++G +L E+L G F E+ D L E I +E+
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI------LNDEV------- 213
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR--CTAL--EACI--HPFFYE 379
++ + +AVD++ + +P +R L E I HPFF E
Sbjct: 214 ---------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258
Query: 380 LRDPNARLPNGRPFPPLF-----------NFKPQELK 405
L + N R P F NF P +K
Sbjct: 259 L---DWEKLNRRQIEPPFRPRIKSREDVSNFDPDFIK 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 5e-18
Identities = 86/319 (26%), Positives = 137/319 (42%), Gaps = 55/319 (17%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 148
RV+G+G FG V + TG+ A KK L+ KR K R+ + M L ++ VVS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
L + + + KD L L L L + + + Y+ + Y +I L +
Sbjct: 65 LAYAYET---KDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
H + +RD+KP+N+L++ + H +++ D G A + +GE + + Y APE++
Sbjct: 119 HRE-RIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
YT + D W +GC++ E++ G+ F E +K REE++ E
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK------EKVK------REEVERRVKEDQE- 222
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR--C---TALEACIHPFFYELRDP 383
+ ++ A + +LL P R C A E HPFF R
Sbjct: 223 ------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF---RTA 267
Query: 384 N-ARLPNGRPFPPLFNFKP 401
N RL G PP F P
Sbjct: 268 NFKRLEAGMLEPP---FCP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 5e-18
Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 24/221 (10%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKV-LQ--DKRYKNRELQTMRLL---DHPNVVSLKHC 152
+G+GSFG+VF+ A+K++ L ++R + + R+L D ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
F D+ LN+V+E+ ++++ K + +P V + QI LA++H
Sbjct: 68 FL-----DKGKLNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFG 267
+ HRDIK NL ++ + VK+ D G AK+L N ++ + + YY +PEL
Sbjct: 121 -KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC-E 174
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
Y D+W++G VL E G+ F + +++II+
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 79/305 (25%), Positives = 125/305 (40%), Gaps = 47/305 (15%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKV-LQDK-RYKN---RELQTMRLLDHPNVVSLKHC 152
+G G+ G+V + +G +A K + L+ K +N REL+ + + P +V
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 153 FFSTTD-------KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
F+S + D L+ VL + + R+P + + + R L
Sbjct: 68 FYSDGEISICMEHMDGGSLDQVL---------------KKAGRIPENILGKISIAVLRGL 112
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
Y+ + HRD+KP N+LVN ++KLCDFG + L+ N S++ +R Y +PE +
Sbjct: 113 TYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 170
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
G T YT DIWS+G L E+ +G+ P E+ + G P E +
Sbjct: 171 QG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDA----KELEAMFGRPVSEGEAKESHRP 225
Query: 326 TEFKFPQ-------------IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
P I P K+ E D V + L+ +P R E
Sbjct: 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285
Query: 373 IHPFF 377
HPF
Sbjct: 286 KHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 86/338 (25%), Positives = 130/338 (38%), Gaps = 102/338 (30%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 149
+V+G+G+FG V + +TG A+KK+ + + + ++ +R +L D+P VV L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVK---------LYTYQ 200
+ F +DE YL L++E++P M L+ K Y +
Sbjct: 67 YYSF-----QDENYLYLIMEYLP------------GGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG------------SAKVLVKGE 248
A+ IH +G HRDIKP NLL++ H +KL DFG ++L
Sbjct: 110 TILAIDSIHK-LGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHAL 167
Query: 249 PNISYICSR--------------------Y-------YRAPELIFGATEYTTAIDIWSVG 281
P+ Y Y APE +F T Y D WS+G
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLG 226
Query: 282 CVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 341
++ E+L+G P F + P K +N T +FP
Sbjct: 227 VIMYEMLVGYPPFCSD--------------NPQETYRKIINWKET-LQFPD--------- 262
Query: 342 FHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFF 377
+ PEA DL+ RL + E HPFF
Sbjct: 263 -EVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
Y RVVG+GSFG + + + + A+K++ K +E + + HPN+V
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
+ K F + + +L +V+E+ + K + + P + + Q+C + +
Sbjct: 62 AFKESF-----EADGHLYIVMEYCDGGDL-MQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIF 266
IH V HRDIK +N+ + +VKL DFGSA++L G +Y+ + YY PE I+
Sbjct: 116 IHEK-RVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE-IW 172
Query: 267 GATEYTTAIDIWSVGCVLAEL 287
Y DIWS+GC+L EL
Sbjct: 173 ENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 85/299 (28%), Positives = 132/299 (44%), Gaps = 59/299 (19%)
Query: 97 RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQ---------DKRYKNRELQTMRLLDHP 144
+V+G+G +G VFQ + + +TG+ A+K VL+ D + E + + HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
+V L F T K L L+LE++ + H R M Y +I A
Sbjct: 61 FIVDL-IYAFQTGGK----LYLILEYLSGG--ELFMHLEREGIFMEDT-ACFYLSEISLA 112
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 263
L ++H G+ +RD+KP+N+L++ H VKL DFG K + C Y APE
Sbjct: 113 LEHLHQ-QGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
I + + A+D WS+G ++ ++L G P F E+ + +I+K K P
Sbjct: 171 -ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNLP 220
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 377
Y + PEA DL+ +LL+ +P+ R A E HPFF
Sbjct: 221 PY--------------------LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 74/296 (25%), Positives = 125/296 (42%), Gaps = 47/296 (15%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHC 152
++G G+ G V++A L T +A+K + D ++ EL+ + D P ++
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 153 FFSTTDKDELYLNLVLEFVPE---TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
FF E +++ EF+ VYR ++P + + + L Y+
Sbjct: 68 FFV-----ENRISICTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLW 112
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
+ + HRD+KP N+LVN QVKLCDFG + LV +Y+ + Y APE I G
Sbjct: 113 S-LKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-E 168
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
+Y D+WS+G EL LG+ +P + +++L E+
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP----------- 217
Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNA 385
P + + + F V +++ ++ P R HPF + D NA
Sbjct: 218 -PVLPVGQFSEKF--------VHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 41/214 (19%)
Query: 97 RVVGQGSFGIV----FQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
RV+G+G FG V + TGE VA+K + ++ +N E+ ++ L H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYR--VAKHYSRASQRMPLIYVKLYTYQICRAL 205
K C +++ L L++E+VP R + KH +Q + L+ QIC +
Sbjct: 70 KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE-- 263
AY+H + HRD+ +N+L++ + VK+ DFG AK + +G YYR E
Sbjct: 121 AYLHSQHYI-HRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDG 170
Query: 264 ---LIFGATE------YTTAIDIWSVGCVLAELL 288
+ + A E ++ A D+WS G L ELL
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 4e-17
Identities = 89/316 (28%), Positives = 147/316 (46%), Gaps = 49/316 (15%)
Query: 85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTM 138
G P++ + + +G+GS GIV A TG+ VA+KK+ D R + R E+ M
Sbjct: 18 GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIM 73
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
R H NVV + + + DEL++ V+EF+ ++R ++ +
Sbjct: 74 RDYHHENVVDMYNSYLV---GDELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATVC 124
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSR 257
+ RAL+Y+H GV HRDIK ++L+ ++KL DFG + K P S + +
Sbjct: 125 LSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGTP 182
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
Y+ APE+I Y T +DIWS+G ++ E++ G+P + E + + I R+
Sbjct: 183 YWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI--------RDN 233
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ P++K HK+ + +DL +L P+ R TA E HPF
Sbjct: 234 LP-----------PRVKDS--HKV--SSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275
Query: 378 YELRDPNARLPNGRPF 393
P+ +P R +
Sbjct: 276 KLAGPPSCIVPLMRQY 291
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 104/409 (25%), Positives = 161/409 (39%), Gaps = 120/409 (29%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 149
+V+G+G+FG V + +TG+ A+K +L+ + +K +L ++ +L D P VVSL
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
+ F +D YL L++EF+P + + Y S+ + + Y + A+ +
Sbjct: 67 YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECVLAIEAV 117
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG------------SAKVLVKGEPNISYICS 256
H +G HRDIKP N+L++ H +KL DFG + L++G+ N + I +
Sbjct: 118 H-KLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175
Query: 257 RY------------------------------------YRAPELIFGATEYTTAIDIWSV 280
R Y APE IF Y D WS+
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSL 234
Query: 281 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWH 339
G ++ E L+G P F E+ + +II N+ E FP H
Sbjct: 235 GAIMFECLIGWPPFCSENSHETYRKII----------------NWRETLYFPD-DIH--- 274
Query: 340 KIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFY-----ELRDPNARLPNGRP 392
+ EA DL+ RL+ + N R A E HPFF +R A P
Sbjct: 275 ------LSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRA------P 322
Query: 393 FPPLFN-------FKPQELKG-----ASKELLSKLIPEHARKQCPFLGF 429
F P F EL+ A K+ E F+G+
Sbjct: 323 FIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGY 371
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 5e-17
Identities = 71/287 (24%), Positives = 128/287 (44%), Gaps = 50/287 (17%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-----------LDHPNV 146
++G+G FG V+ + +TG+ A+K L KR K ++ +T+ L D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
V + + F T DK L+ +L+ + + Y +++H + M + Y +I
Sbjct: 60 VCMSYAF-HTPDK----LSFILDLMNGGDLHYHLSQHGVFSEAEM-----RFYAAEIILG 109
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
L ++H V +RD+KP N+L++ H H V++ D G A K +P+ S + + Y APE+
Sbjct: 110 LEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEV 166
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLF----------------------PGESGVDQ 302
+ Y ++ D +S+GC+L +LL G F P +
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 226
Query: 303 LVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFHKRMPP 348
+ +L + C+ E K P ++ W +F ++ PP
Sbjct: 227 RSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 94/308 (30%), Positives = 144/308 (46%), Gaps = 64/308 (20%)
Query: 97 RVVGQGSFGIVF---QAKCLETGETVAIKKVLQD----KRYKNRE-LQTMR-LLDH---- 143
+V+G G++G VF + +TG+ A+K VLQ ++ K E +T R +L+H
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQS 64
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKLYTY 199
P +V+L H F T K L+L+L++V T ++S V+ Y+
Sbjct: 65 PFLVTL-HYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDE-------VRFYSG 112
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY 258
+I AL ++H +G+ +RDIK +N+L++ H V L DFG +K + E +Y C
Sbjct: 113 EIILALEHLHK-LGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTI 170
Query: 259 -YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
Y APE+I G + A+D WS+G ++ ELL G F E + E+ +R
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRI 223
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEAC 372
+KC P F + PEA DL+ +LL+ P R A E
Sbjct: 224 LKCDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIK 265
Query: 373 IHPFFYEL 380
HPFF L
Sbjct: 266 EHPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 6e-17
Identities = 79/304 (25%), Positives = 118/304 (38%), Gaps = 68/304 (22%)
Query: 100 GQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKHC 152
G G+FG V++A+ ETG A K + L+D E+ + HPN+V L
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70
Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLI--YVKLYTYQICRALAYIH 209
+F L +++EF + + R L ++ Q+ AL ++H
Sbjct: 71 YFYENK-----LWILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLH 120
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI--- 265
V HRD+K N+L+ VKL DFG SAK + ++I + Y+ APE++
Sbjct: 121 SHK-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACE 178
Query: 266 -FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
F Y DIWS+G L EL +P P E +NP
Sbjct: 179 TFKDNPYDYKADIWSLGITLIELAQMEP--------------------PHHE----LNPM 214
Query: 325 YTEFKFPQ------IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378
K + + W F+ D + L P+ R TA E HPF
Sbjct: 215 RVLLKILKSEPPTLDQPSKWSSSFN--------DFLKSCLVKDPDDRPTAAELLKHPFVS 266
Query: 379 ELRD 382
+ D
Sbjct: 267 DQSD 270
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 9e-17
Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 28/221 (12%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 150
+ +G+GSFG ++ AK E IK++ +++K +E+ + + HPN+V+
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLI---YVKLYTYQICRAL 205
F S + L++ V+E+ + + R+ + QR L + + QI L
Sbjct: 65 --FASFQENGRLFI--VMEYCDGGDLMKRINR------QRGVLFSEDQILSWFVQISLGL 114
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPE 263
+IH + HRDIK QN+ ++ + KL DFG A+ L ++Y C + YY +PE
Sbjct: 115 KHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE 172
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
I Y DIWS+GCVL EL + F G + + QLV
Sbjct: 173 -ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 31/220 (14%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
+V+G+G+FG V + + + A+K + + + K E M + +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108
Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
H F +D+ YL +V+E++P + + +Y +P + + YT ++ AL I
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----IPEKWARFYTAEVVLALDAI 158
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 263
H +G HRD+KP N+L++ H +KL DFG+ +K + N C Y +PE
Sbjct: 159 HS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISPE 213
Query: 264 LIF---GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
++ G Y D WSVG L E+L+G F +S V
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 87/315 (27%), Positives = 134/315 (42%), Gaps = 61/315 (19%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 147
+V+G+GSFG V AK G A+K VLQ K ++ Q ++ L HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
L H F T +K L VL++V E + + + R + Y ++ A+
Sbjct: 60 GL-HYSFQTAEK----LYFVLDYVNGGELFFHLQRERCFLEPR-----ARFYAAEVASAI 109
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 264
Y+H + + +RD+KP+N+L++ H V L DFG K V+ E S C + Y APE
Sbjct: 110 GYLHS-LNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE- 166
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII----------------K 308
+ Y +D W +G VL E+L G P F V Q+ + I
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPLQLPGGKTVAACD 225
Query: 309 VLGTPTREEIKCMNPNYTEFKFPQIKAH------PWHKIFHKRMPPEAVDLVSRLLQYSP 362
+L ++ + +F +IK H W ++HKR+ P Y+P
Sbjct: 226 LLVGLLHKDQRRRLGAKADFL--EIKNHVFFSPINWDDLYHKRITPP----------YNP 273
Query: 363 NLRCTALEACIHPFF 377
N+ A P F
Sbjct: 274 NVAGPADLRHFDPEF 288
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 79/321 (24%), Positives = 136/321 (42%), Gaps = 62/321 (19%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----------LQTMRLLDHPNVVS 148
+G+G+FG V+Q + +T A+K + + + +E L L + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
LK F + +D L LV +++ E + + K + R K Y ++ AL
Sbjct: 61 LKFSFQTDSD-----LYLVTDYMSGGELFWHLQKEGRFSEDR-----AKFYIAELVLALE 110
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELI 265
++H + +RD+KP+N+L++ H + LCDFG +K L + ++ + Y APE++
Sbjct: 111 HLHKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
YT +D WS+G ++ E+ G F E Q+ I +
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED-TQQMYRNIA----------------F 211
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI----HPFFYELR 381
+ +FP+ + E V LL +P R A + HPFF ++
Sbjct: 212 GKVRFPK-----------NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI- 259
Query: 382 DPNARLPNGRPFPPLFNFKPQ 402
D + L + PP FKP
Sbjct: 260 DWDL-LSKKQITPP---FKPI 276
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 86/322 (26%), Positives = 148/322 (45%), Gaps = 60/322 (18%)
Query: 97 RVVGQGSFGIVFQAKCL---ETGETVAIK-----KVLQDKRYKNRELQTMRLLDH----P 144
+V+G G++G VF + + ++G+ A+K ++Q + ++L+H P
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY--VKLYTYQIC 202
+V+L + F + T L+L+L+++ + ++ SQR V++Y+ +I
Sbjct: 66 FLVTLHYAFQTDTK-----LHLILDYI-----NGGELFTHLSQRERFKEQEVQIYSGEIV 115
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-YR 260
AL ++H +G+ +RDIK +N+L++ + H V L DFG +K + E +Y C Y
Sbjct: 116 LALEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 261 APELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
AP+++ G + A+D WS+G ++ ELL G F + + EI +R +K
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILK 226
Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIH 374
P +PQ M A D++ RLL P R A E H
Sbjct: 227 SEPP------YPQ------------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268
Query: 375 PFFYELR-DPNARLPNGRPFPP 395
PFF ++ D A PF P
Sbjct: 269 PFFQKINWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 84/305 (27%), Positives = 136/305 (44%), Gaps = 59/305 (19%)
Query: 85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
G PK+ Y +GQG+ G V+ A + TG+ VAIK++ LQ + K E+ MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
HPN+V+ YL+ L V + ++ V ++ + S + + Q
Sbjct: 73 NKHPNIVN--------------YLDSYL--VGDELWVVMEYLAGGSLTDVVTETCMDEGQ 116
Query: 201 I---CR----ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNIS 252
I CR AL ++H V HRDIK N+L+ VKL DFG A++ + +
Sbjct: 117 IAAVCRECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRST 174
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
+ + Y+ APE++ Y +DIWS+G + E++ G+P + E+ + L +I GT
Sbjct: 175 MVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGT 232
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
P E + P+ ++ D ++R L+ R +A E
Sbjct: 233 P-------------ELQNPE------------KLSAIFRDFLNRCLEMDVEKRGSAKELL 267
Query: 373 IHPFF 377
HPF
Sbjct: 268 QHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 3e-16
Identities = 91/318 (28%), Positives = 141/318 (44%), Gaps = 53/318 (16%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 148
RV+G+G FG V + TG+ A KK L+ KR K R+ ++M L L+ N VVS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
L + + + KD L L L L + + + Y Y +IC L +
Sbjct: 65 LAYAYET---KDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
H + +RD+KP+N+L++ H H +++ D G A + +G+ + + Y APE++
Sbjct: 119 HQE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
YT + D W++GC+L E++ GQ F Q + IK REE++ + E
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEVERLVKEVQE- 222
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDP 383
+ ++ P+A L LL P R A E HP F ++
Sbjct: 223 ------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQIN-- 268
Query: 384 NARLPNGRPFPPLFNFKP 401
RL G PP FKP
Sbjct: 269 FKRLEAGMLEPP---FKP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 94/369 (25%), Positives = 155/369 (42%), Gaps = 86/369 (23%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKK----VLQDKR---YKNRELQTMRLLDHPNVVSLK 150
+VG+G FG V + TG+ A+K VL + + E + + + P + L+
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
+ F DKD LYL V+E+ P + + + ++ + + M + Y ++ A+ +
Sbjct: 68 YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-------KVLVK---GEPNISYICSRY 258
H +G HRDIKP+N+L++ H +KL DFGSA V K G P+
Sbjct: 119 HQ-MGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPD-------- 168
Query: 259 YRAPELI-----FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
Y APE++ G Y D WS+G + E++ G+ F + I+
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM------ 222
Query: 314 TREEIKCMNPNYTEF-KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
N+ F KFP+ ++ + +DL+ LL R C
Sbjct: 223 ----------NFQRFLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261
Query: 373 IHPFFYELRDPNAR--LPNGRPFPPLF-------NF-KPQELKGASKELLSKLIPEH--A 420
HPFF ++ N R LP PF P NF +P++ + + + + +
Sbjct: 262 CHPFFSKIDWNNIRNSLP---PFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGFS 318
Query: 421 RKQCPFLGF 429
K PF+GF
Sbjct: 319 GKDLPFVGF 327
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 76/304 (25%), Positives = 146/304 (48%), Gaps = 54/304 (17%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL-----DHPNVV 147
RV+G+GS+ V + +T A+ KV++ + + E +QT + + +HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAM-KVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
L CF + + L V+EFV + ++ H R +++P + + Y+ +I AL
Sbjct: 60 GLHSCFQTESR-----LFFVIEFVSGGDLMF----HMQR-QRKLPEEHARFYSAEISLAL 109
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPEL 264
++H G+ +RD+K N+L++ H +KL D+G K + G+ ++ + Y APE+
Sbjct: 110 NFLHER-GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEI 167
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLF--------PGESGVDQLVEII--KVLGTPT 314
+ G +Y ++D W++G ++ E++ G+ F P ++ D L ++I K + P
Sbjct: 168 LRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR 226
Query: 315 REEIKC-------MNPNYTE-------FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
+K +N + E F IK+HP F + + + ++ L Y
Sbjct: 227 SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHP----FFRNIDWDLLEQKQVLPPY 282
Query: 361 SPNL 364
PN+
Sbjct: 283 KPNI 286
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 6e-16
Identities = 84/289 (29%), Positives = 128/289 (44%), Gaps = 49/289 (16%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
+G G++G V++A+ + TGE AIK + +D +E+ M+ H N+V+ F
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73
Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
S +D+L++ +EF + H + + YV T Q L Y+H G
Sbjct: 74 SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQ---GLYYLHSK-GK 127
Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE--- 270
HRDIK N+L+ + H VKL DFG SA++ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184
Query: 271 -YTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
Y DIW+VG EL L P+F + ++ L T+ + F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFD--------LHPMRALFLMTK----------SNF 226
Query: 329 KFPQIKAH-PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
+ P++K W FH V L +P R TA + HPF
Sbjct: 227 QPPKLKDKMKWSNSFHH--------FVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 69/222 (31%), Positives = 118/222 (53%), Gaps = 25/222 (11%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 148
+V+G+GSFG V A+ T E AIK + +D ++ ++ TM R+L HP + +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
L HC F T D+ L V+E+V + ++++ + S++ + Y ++ AL
Sbjct: 61 L-HCCFQTKDR----LFFVMEYVNGGDLMFQIQR-----SRKFDEPRSRFYAAEVTLALM 110
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELI 265
++H GV +RD+K N+L++ H KL DFG K ++ G ++ + Y APE I
Sbjct: 111 FLHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPE-I 167
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
EY ++D W++G ++ E++ GQP F ++ D L E I
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 7e-16
Identities = 61/208 (29%), Positives = 107/208 (51%), Gaps = 23/208 (11%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-----------DHPNV 146
++G+G FG V+ + +TG+ A+K L KR K ++ +T+ L D P +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
V + + F + D+L L L + Y +++H + + M + Y +I L
Sbjct: 60 VCMTYAFHT---PDKLCFILDLMNGGDLHYHLSQHGVFSEKEM-----RFYATEIILGLE 111
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
++H V +RD+KP N+L++ H H V++ D G A K +P+ S + + Y APE++
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEVLQ 168
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLF 294
T Y ++ D +S+GC+L +LL G F
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 68/210 (32%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY--KNRELQTM-------RLLDHPNVV 147
+V+G+GSFG V A+ + E KVLQ K K E M + + HP +V
Sbjct: 1 KVIGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
L H F T DK L VL+++ E Y + + R + Y +I AL
Sbjct: 60 GL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASAL 109
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 264
Y+H + + +RD+KP+N+L++ H V L DFG K ++ S C + Y APE+
Sbjct: 110 GYLHS-LNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
+ Y +D W +G VL E+L G P F
Sbjct: 168 LH-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 1e-15
Identities = 74/258 (28%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRL 140
G PK+ Y +GQG+ G VF A + TG+ VAIK++ K+ K E+ M+
Sbjct: 15 GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEF---------VPETVYRVAKHYSRASQRMPL 191
L +PN+V+ F DEL+ +V+E+ V ET A+
Sbjct: 73 LKNPNIVNFLDSFLV---GDELF--VVMEYLAGGSLTDVVTETCMDEAQ----------- 116
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPN 250
+ + +AL ++H V HRDIK N+L+ VKL DFG A++ +
Sbjct: 117 --IAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKR 172
Query: 251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310
+ + + Y+ APE++ Y +DIWS+G + E++ G+P + E+ + L +I
Sbjct: 173 STMVGTPYWMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATN 230
Query: 311 GTPTREEIKCMNPNYTEF 328
GTP + + ++P + +F
Sbjct: 231 GTPELQNPEKLSPIFRDF 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 76/297 (25%), Positives = 126/297 (42%), Gaps = 59/297 (19%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM----RLLD------HPNVV 147
V+G+G FG V A+ +TGE AIK + + E++++ R+ + HP +V
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
+L CF +D + V+E+ + H S+ Y + L Y
Sbjct: 66 NLFACF---QTEDHVCF--VMEYAAGGDLMMHIHTDVFSEPR----AVFYAACVVLGLQY 116
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 266
+H + +RD+K NLL++ VK+ DFG K + S C + + APE++
Sbjct: 117 LHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
T YT A+D W +G ++ E+L+G+ FPG+ EE+
Sbjct: 175 E-TSYTRAVDWWGLGVLIYEMLVGESPFPGD----------------DEEEV-------- 209
Query: 327 EFKFPQIKA-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 377
F I + F + EA+ ++ RLL+ +P R A + PFF
Sbjct: 210 ---FDSIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 81/323 (25%), Positives = 136/323 (42%), Gaps = 79/323 (24%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNR----ELQTMRLLDHPNVVSL 149
+++G+G G VF + TG+ A+K K KR K + E + + LDHP + +L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 150 KHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
F + T YL LV+++ P ++R+ + + + + + Y ++ AL Y+
Sbjct: 67 YASFQTET-----YLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDF-------------------GSAKVLVKGEP 249
H +G+ +RD+KP+N+L++ H + L DF GS + V P
Sbjct: 120 HL-LGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIP 177
Query: 250 NISYICS-----------RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
+ ++ Y APE+I G + +A+D W++G +L E+L G F G +
Sbjct: 178 SETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSN 236
Query: 299 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 358
+ I+K E FP + A DL+ +LL
Sbjct: 237 RDETFSNILK-----------------KEVTFPG----------SPPVSSSARDLIRKLL 269
Query: 359 QYSPNLRC----TALEACIHPFF 377
P+ R A E HPFF
Sbjct: 270 VKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 65/214 (30%), Positives = 96/214 (44%), Gaps = 31/214 (14%)
Query: 97 RVVGQGSFGIVFQAK-CLETGE--TVAIKKVLQDKRYKNREL-----QTMRLLDHPNVVS 148
R +G+G FG V+Q E VA+K RE MR DHP++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
L ++ +++ V+E P R + + L + LY+YQ+ ALAY+
Sbjct: 72 L----IGVITENPVWI--VMELAPLGELR--SYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 209 HGGIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
HRDI +N+LV +P VKL DFG ++ L E Y S+ + AP
Sbjct: 124 E-SKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWMAP 177
Query: 263 ELIFGATEYTTAIDIWSVG-CVLAELLLG-QPLF 294
E I +T+A D+W G C+ L+LG +P
Sbjct: 178 ESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQ 210
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 2e-15
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKN--RELQTMRLLDHPNV 146
Y+ + +G+GSFG K E G+ IK++ + K + +E+ + + HPN+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY----VKLYTYQIC 202
V + F + LY+ V+++ Y + + + +++ + + QIC
Sbjct: 62 VQYQESF---EENGNLYI--VMDYCEG-----GDLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRA 261
AL ++H + HRDIK QN+ + +KL DFG A+VL E + I + YY +
Sbjct: 112 LALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLS 169
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELL 288
PE I Y DIW++GCVL E+
Sbjct: 170 PE-ICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 66/242 (27%), Positives = 98/242 (40%), Gaps = 47/242 (19%)
Query: 99 VGQGSFGIVFQAKCLETGE---TVAIK-----KVLQDKRYKNRELQTMRLLDHPNVVSLK 150
+G G+FG V + L VA+K + K+ RE M LDHP +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKH-YSRASQRMPLIYVKLYTYQICRALAYIH 209
+ L LV+E P Y + + +P+ +K +Q+ +AY+
Sbjct: 62 ---IGVCKGEPLM--LVMELAPLG----PLLKYLKKRREIPVSDLKELAHQVAMGMAYLE 112
Query: 210 GGIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-------- 260
V HRD+ +N LLVN HQ K+ DFG ++ L G S YYR
Sbjct: 113 SKHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161
Query: 261 ----APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVEIIKVLGTP 313
APE I +++ D+WS G L E G + G + ++E + L P
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRP 220
Query: 314 TR 315
Sbjct: 221 EE 222
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 22/229 (9%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQ----TMRLLDHPNVVSLKHC 152
+G+G+FG V + +G +A+K++ D++ + R L MR D P +V
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 153 FFSTTDK---DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
F D EL +++ L+ + VY V K +P + +AL Y+
Sbjct: 72 LFREGDCWICMEL-MDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALNYLK 124
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI--FG 267
+ + HRD+KP N+L++ + + +KLCDFG + LV R Y APE I
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 183
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPG-ESGVDQLVEIIKVLGTPTR 315
Y D+WS+G L E+ G+ +P S DQL +++K G P
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 88/326 (26%), Positives = 142/326 (43%), Gaps = 71/326 (21%)
Query: 97 RVVGQGSFGIVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 146
+++G+G+FG V K TG E + K + +NR LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
+LK+ F T D+ L V+E+ E + +++ + R + Y +I A
Sbjct: 58 TALKYSF-QTHDR----LCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 263
L Y+H V +RD+K +NL+++ H +K+ DFG K +K + C + Y APE
Sbjct: 108 LDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
+ +Y A+D W +G V+ E++ G+ F + ++L E+I + EEI+
Sbjct: 167 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EEIR---- 214
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF- 377
F + + PEA L+S LL+ P R A E H FF
Sbjct: 215 ------------------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA 256
Query: 378 -YELRDPNARLPNGRPFPPLFNFKPQ 402
+D + + PP FKPQ
Sbjct: 257 GIVWQDVYEK----KLVPP---FKPQ 275
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 5e-15
Identities = 56/183 (30%), Positives = 97/183 (53%), Gaps = 19/183 (10%)
Query: 133 RELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPL 191
RELQ + + P +V F+S + +++ +E + ++ +V K ++R+P
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPE 102
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
+ + + R LAY+ + HRD+KP N+LVN ++KLCDFG + L+ N
Sbjct: 103 EILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN- 160
Query: 252 SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVL 310
S++ +R Y +PE + G T Y+ DIWS+G L EL +G+ P+ P ++ E+ +
Sbjct: 161 SFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIF 214
Query: 311 GTP 313
G P
Sbjct: 215 GRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 67/207 (32%), Positives = 102/207 (49%), Gaps = 23/207 (11%)
Query: 97 RVVGQGSFGIVFQAKCL-ETGETVAIKKVLQDKRYKNR-------ELQTMRLLDHPNVVS 148
R +G GSFG V A E VAIK+ + K K + E + + ++HP V+
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
L F KDE YL LVLEFV + + R ++R P Y QI Y+
Sbjct: 96 LYGSF-----KDESYLYLVLEFVIGGEFFT---FLRRNKRFPNDVGCFYAAQIVLIFEYL 147
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 267
+ + +RD+KP+NLL++ +K+ DFG AKV+ + +C + Y APE++
Sbjct: 148 Q-SLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLF 294
+ A D W++G + E+L+G P F
Sbjct: 203 VG-HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 93/347 (26%), Positives = 144/347 (41%), Gaps = 105/347 (30%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 148
+ +G G+FG V A ++T A+K L+ K NR E + D+ VV
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP-----ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
L ++S DKD LY V++++P + R+ + P + + Y ++
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIPGGDMMSLLIRM--------EVFPEVLARFYIAELTL 112
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG---------SAKVLVKG------- 247
A+ +H +G HRDIKP N+L++ H +KL DFG ++K KG
Sbjct: 113 AIESVHK-MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDS 170
Query: 248 -EPNI-------------------------------SYICSRYYRAPELIFGATEYTTAI 275
EP+ S + + Y APE++ YT
Sbjct: 171 MEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLC 229
Query: 276 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 335
D WSVG +L E+L+GQP F + TPT ++K +N T PQ+K
Sbjct: 230 DWWSVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK- 274
Query: 336 HPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFYEL 380
+ PEAVDL+++L + R A + HPFF E+
Sbjct: 275 ----------LSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 69/220 (31%), Positives = 109/220 (49%), Gaps = 23/220 (10%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 150
V+G+GSFG V A+ T E AIK V+QD + E + + L D P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
H F T D+ L V+E+V + +Y H + + V Y +I L ++
Sbjct: 67 HSCFQTVDR----LYFVMEYVNGGDLMY----HIQQVGKFKEPQAV-FYAAEISVGLFFL 117
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 267
H G+ +RD+K N++++ H +K+ DFG K +V G ++ + Y APE+I
Sbjct: 118 HRR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-A 174
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
Y ++D W+ G +L E+L GQP F GE D+L + I
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 41/236 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 145
Y +V+G+G+FG V + + + A+K + + D + E M + P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
VV L C F +D+ YL +V+E++P + + +Y +P + K YT ++ A
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLA 154
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISYI 254
L IH +G+ HRD+KP N+L++ H H +KL DFG+ + + G P+
Sbjct: 155 LDAIHS-MGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPD---- 208
Query: 255 CSRYYRAPELIF---GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
Y +PE++ G Y D WSVG L E+L+G F +S V +I+
Sbjct: 209 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 82/305 (26%), Positives = 130/305 (42%), Gaps = 50/305 (16%)
Query: 83 RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 137
R+ P + + E +G G+FG V++AK ETG +A KV++ K + E++
Sbjct: 6 RDLDPNEVWEIIGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEI 62
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKL 196
+ +HP +V L F+ + L +++EF P V + R P I ++
Sbjct: 63 LATCNHPYIVKLLGAFYW-----DGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQI--QV 114
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYIC 255
Q+ AL Y+H + + HRD+K N+L+ +KL DFG SAK + + S+I
Sbjct: 115 ICRQMLEALQYLH-SMKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIG 172
Query: 256 SRYYRAPELIFGAT----EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
+ Y+ APE++ T Y DIWS+G L E+ +P
Sbjct: 173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP------------------- 213
Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
P E +NP K K+ P + E D + L P R +A +
Sbjct: 214 -PHHE----LNPMRVLLKIA--KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266
Query: 372 CIHPF 376
HPF
Sbjct: 267 LEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 18/208 (8%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 148
RV+G+G FG V + TG+ A K+ L+ KR K R+ ++M L L+ N VV+
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
L + + + KD L L L + + + + Y+ + Y +I L +
Sbjct: 65 LAYAYET---KDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
H +RD+KP+N+L++ + H +++ D G A + +GE + + Y APE++
Sbjct: 119 HRE-NTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPG 296
YT + D W +GC++ E++ GQ F G
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 67/236 (28%), Positives = 110/236 (46%), Gaps = 41/236 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 145
Y +V+G+G+FG V + T + A+K + + D + E M + P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
VV L + F +D+ YL +V+E++P + + +Y +P + + YT ++ A
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLA 154
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISYI 254
L IH +G HRD+KP N+L++ H +KL DFG+ + K G P+
Sbjct: 155 LDAIHS-MGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD---- 208
Query: 255 CSRYYRAPELIF---GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
Y +PE++ G Y D WSVG L E+L+G F +S V +I+
Sbjct: 209 ----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 22/210 (10%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM------RLLDHPNVVSLK 150
V+G+GSFG V A+ T E AIK + +D ++ +++ TM L P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
H F T D+ L V+E+V + +Y + + + P + Y +I L ++
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQ---VGKFKEP--HAVFYAAEIAIGLFFL 117
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 267
H G+ +RD+K N++++ H +K+ DFG K + G C + Y APE+I
Sbjct: 118 HSK-GIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-A 174
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297
Y ++D W+ G +L E+L GQP F GE
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN 145
+Y RVVG+GS+G V + G+ IKK+ ++++ +E Q + L HPN
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
+V+ + + + ++ L +V+ F +Y K + + +P V + QI A
Sbjct: 61 IVAYRESW----EGEDGLLYIVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMA 114
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPE 263
L Y+H + HRD+K QN+ + T+ +K+ D G A+VL S I + YY +PE
Sbjct: 115 LQYLHEK-HILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172
Query: 264 LIFGATEYTTAIDIWSVGCVLAEL 287
L F Y D+W++GC + E+
Sbjct: 173 L-FSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 62/228 (27%), Positives = 116/228 (50%), Gaps = 28/228 (12%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 148
RV+G+GS+ V + +T A+K V ++ + ++ QT + + +HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
L CF + E L V+E+V + H R +++P + + Y+ +I AL Y+
Sbjct: 61 LHSCF-----QTESRLFFVIEYVNGG--DLMFHMQR-QRKLPEEHARFYSAEISLALNYL 112
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 267
H G+ +RD+K N+L++ H +KL D+G K ++ S C + Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLF--------PGESGVDQLVEII 307
+Y ++D W++G ++ E++ G+ F P ++ D L ++I
Sbjct: 171 E-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 4e-14
Identities = 64/229 (27%), Positives = 116/229 (50%), Gaps = 23/229 (10%)
Query: 99 VGQGSFGIVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 151
+G G+ G+VF+ +G +A IK ++++ RELQ + + P +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70
Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
F+S + +++ +E + ++ +V K + R+P + + + + L Y+
Sbjct: 71 AFYSDGE-----ISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
+ HRD+KP N+LVN ++KLCDFG + L+ N S++ +R Y +PE + G T
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178
Query: 271 YTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEI 318
Y+ DIWS+G L E+ +G+ P+ P ++ +L+ V G P E
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 4e-14
Identities = 87/331 (26%), Positives = 150/331 (45%), Gaps = 54/331 (16%)
Query: 85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
G PK+ Y +GQG+ G V+ A + TG+ VAIK++ LQ + K E+ MR
Sbjct: 15 GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTY 199
+PN+V+ + DEL++ V+E++ ++ V ++ +
Sbjct: 73 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 122
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 258
+ +AL ++H V HRDIK N+L+ VKL DFG A++ + + + + Y
Sbjct: 123 ECLQALDFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
+ APE++ Y +DIWS+G + E++ G+P + E+ + L +I GTP
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTP----- 233
Query: 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378
+ NP +R+ D ++R L+ + R +A E HPF
Sbjct: 234 ELQNP--------------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL- 272
Query: 379 ELRDPNARLPNGRPFPPLFNFKPQELKGASK 409
+L P + L PL + +K +S+
Sbjct: 273 KLAKPLSSL------TPLIIAAKEAIKNSSR 297
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-14
Identities = 63/239 (26%), Positives = 113/239 (47%), Gaps = 25/239 (10%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 150
+G+G FG V + TG+ A KK L KR K + + M LL+ P +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
+ F S T +L LV+ + + Y + Y+ + + + V Y+ QI + ++
Sbjct: 60 YAFESKT-----HLCLVMSLMNGGDLKYHI---YNVGERGLEMERVIHYSAQITCGILHL 111
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
H + + +RD+KP+N+L++ +L D G A L G+ + Y APE I
Sbjct: 112 HS-MDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKE 168
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
Y+ +D +++GC + E++ G+ F + V ++ +E+K + N+TE
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEHQNFTE 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 64/234 (27%), Positives = 117/234 (50%), Gaps = 28/234 (11%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVS 148
RV+G+GS+ V + + + A+K V ++ + + ++ ++ H P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
L CF +T+ L LV+E+V + H R +++P + + Y +IC AL ++
Sbjct: 61 LHSCFQTTSR-----LFLVIEYVNGG--DLMFHMQR-QRKLPEEHARFYAAEICIALNFL 112
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 267
H G+ +RD+K N+L++ H +KL D+G K + S C + Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLF------PGESGVDQLVEIIKVLGTPTR 315
EY ++D W++G ++ E++ G+ F P + D L ++I L P R
Sbjct: 171 E-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--LEKPIR 221
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 72/276 (26%), Positives = 125/276 (45%), Gaps = 43/276 (15%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD-------H--PNVVSL 149
+G G+ G V++ + +TG +A+K++ +R N+E L+D H P +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
F + +D + + +E + + ++ K R +P + T I +AL Y+
Sbjct: 80 YGYFITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGA 268
GV HRD+KP N+L++ + VKLCDFG + LV + S C+ Y APE I
Sbjct: 132 EKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPP 189
Query: 269 T---EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT-----PTREE--- 317
+Y D+WS+G L EL GQ FP ++ + + K+L P E
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP 247
Query: 318 ------IKCMNPNYTEF-KFPQIKAHPWHKIFHKRM 346
C+ ++ + K+ ++ HP+ + +
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAE 283
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 57/242 (23%), Positives = 107/242 (44%), Gaps = 34/242 (14%)
Query: 99 VGQGSFGIVFQAKCLETGET-VAIKKVL-------QDKRYKNRELQTM--------RLLD 142
+G G+FG V++ + G+ +A+K++ +DKR +++ + + L
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYR------VAKHYSRASQRMPLIYVKL 196
HPN+V F + D LY+ V++ + K +R+ I+V
Sbjct: 68 HPNIVRYYKTF---LENDRLYI--VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV-- 120
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
Q+ AL Y+H + HRD+ P N+++ +V + DFG AK S + +
Sbjct: 121 ---QMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLTSVVGT 176
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
Y PE++ Y D+W+ GC+L ++ QP F + + +I++ + P E
Sbjct: 177 ILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPE 235
Query: 317 EI 318
+
Sbjct: 236 GM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 84/324 (25%), Positives = 141/324 (43%), Gaps = 68/324 (20%)
Query: 97 RVVGQGSFGIVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 146
+++G+G+FG V + TG E + K + ++R LQ R HP +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 57
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
+LK+ F T D+ L V+E+ E + +++ +R + Y +I A
Sbjct: 58 TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 107
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 263
L Y+H V +RDIK +NL+++ H +K+ DFG K + + C + Y APE
Sbjct: 108 LEYLHSR-DVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
+ +Y A+D W +G V+ E++ G+ F + ++L E+I + EEI+
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILM------EEIR---- 213
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFY 378
F + + PEA L++ LL+ P R A E H FF
Sbjct: 214 ------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255
Query: 379 ELRDPNARLPNGRPFPPLFNFKPQ 402
+ + + + PP FKPQ
Sbjct: 256 SINWQD--VVQKKLLPP---FKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 71/320 (22%), Positives = 116/320 (36%), Gaps = 40/320 (12%)
Query: 97 RVVGQGSFG--IVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVS 148
++G+ IV AK T VA+KK+ D K E+ T R L HPN++
Sbjct: 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRV--AKHYSRASQRMPLIYVKLYTYQICRALA 206
F ELY+ V + H+ +P + + + AL
Sbjct: 64 YVTSF---IVDSELYV--VSPLMAYGSCEDLLKTHFPEG---LPELAIAFILKDVLNALD 115
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--------EPNISYICSRY 258
YIH G HR +K ++L++ V L + ++K + S + +
Sbjct: 116 YIHS-KGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP 173
Query: 259 YRAPELIFGATE-YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR-- 315
+ +PE++ + Y DI+SVG EL G F L+E KV GT
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLL 231
Query: 316 ------EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 369
M+ + + + P + + + V LQ P R +A
Sbjct: 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSV-DHPYTRTFSEHFHQFVELCLQRDPESRPSAS 290
Query: 370 EACIHPFFYELRDPNARLPN 389
+ H FF + + N L +
Sbjct: 291 QLLNHSFFKQCKRRNTSLLD 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (177), Expect = 1e-13
Identities = 71/254 (27%), Positives = 116/254 (45%), Gaps = 49/254 (19%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ---DKRYKNR---ELQTMRLLDHPNV 146
Y + +G G FG VF K T E K + +R K++ E+ MR L H N+
Sbjct: 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL-------YTY 199
V F + ++ +LY+ ++EF A SR Q+ ++ K+ T
Sbjct: 75 VRYIDRFLNKANQ-KLYI--LMEFCD------AGDLSRNIQKCYKMFGKIEEHAIVDITR 125
Query: 200 QICRALAYIHG------GIGVCHRDIKPQNLLVNPHTHQV----------------KLCD 237
Q+ ALAY H G V HRD+KPQN+ ++ + K+ D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185
Query: 238 FGSAKVLVKGEPNISYIC--SRYYRAPELIFGATE-YTTAIDIWSVGCVLAELLLGQPLF 294
FG +K + G ++++ C + YY +PEL+ T+ Y D+W++GC++ EL G+ F
Sbjct: 186 FGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
Query: 295 PGESGVDQLVEIIK 308
+ QL+ +K
Sbjct: 244 HKANNFSQLISELK 257
|
Length = 1021 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 64/271 (23%)
Query: 121 IKKVLQDKRYKNREL---QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP----- 172
++K+++ K + E Q M+ D+PN + L + TT K + L+++++
Sbjct: 45 VQKIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSV--TTLKGHV---LIMDYIKDGDLF 97
Query: 173 ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ 232
+ + + ++ VK Q+ AL +H + H DIK +N+L + +
Sbjct: 98 DLL--------KKEGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDR 148
Query: 233 VKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTTAIDIWSVGCVLAEL 287
+ LCD+G K + G P S Y Y +PE I G Y + D W+VG + EL
Sbjct: 149 IYLCDYGLCK--IIGTP------SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYEL 199
Query: 288 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP 347
L G+ P + D E + +++ + + K P F K +
Sbjct: 200 LTGK--HPFKEDED---EEL---------DLESLLKRQ-QKKLP----------FIKNVS 234
Query: 348 PEAVDLVSRLLQYSPNLRCTALEACI-HPFF 377
A D V +L+Y+ N R T I HPF
Sbjct: 235 KNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 64/203 (31%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
VG G++G V++A+ L TGE A+K + D +E+ ++ H N+V+ F
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73
Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
S +++L+ + +E+ + H + + + YV T Q LAY+H G
Sbjct: 74 SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQ---GLAYLHSK-GK 127
Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE--- 270
HRDIK N+L+ + VKL DFG +AK+ S+I + Y+ APE+ A E
Sbjct: 128 MHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184
Query: 271 -YTTAIDIWSVGCVLAELLLGQP 292
Y DIW+VG EL QP
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 85/321 (26%), Positives = 144/321 (44%), Gaps = 62/321 (19%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNRELQTMRLLD---HPNVVSL 149
+++G+G+FG V + +G+ A+K +V+ K L R+L HP + SL
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
K+ F T D+ L V+E+V E + +++ + R + Y +I AL Y
Sbjct: 61 KYSF-QTKDR----LCFVMEYVNGGELFFHLSRERVFSEDR-----TRFYGAEIVSALDY 110
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 266
+H G + +RD+K +NL+++ H +K+ DFG K + + C + Y APE +
Sbjct: 111 LHSG-KIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VL 167
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
+Y A+D W +G V+ E++ G+ F + ++L E+I + E+IK
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILM------EDIK------- 213
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELR 381
F + + +A L+S LL PN R A E H FF +
Sbjct: 214 ---------------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258
Query: 382 DPNARLPNGRPFPPLFNFKPQ 402
+ + + PP FKPQ
Sbjct: 259 WQDVY--DKKLVPP---FKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 18/206 (8%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-----RLLDHPN---VVS 148
RV+G+G FG V + TG+ A KK L+ KR K R+ + M R+L+ N VVS
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
L + + + KD L L L + + + + Y+ + Y ++C L +
Sbjct: 65 LAYAYET---KDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
+ +RD+KP+N+L++ H +++ D G A + +GE + + Y APE+I
Sbjct: 119 QRE-RIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLF 294
+YT + D W +GC++ E++ GQ F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 4e-13
Identities = 68/250 (27%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 140
G PK+ Y +GQG+ G V+ A + TG+ VAI+++ LQ + K E+ MR
Sbjct: 16 GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTY 199
+PN+V+ + DEL++ V+E++ ++ V ++ +
Sbjct: 74 NKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTETCMDEGQIAAV-----CR 123
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 258
+ +AL ++H V HRDIK N+L+ VKL DFG A++ + + + + Y
Sbjct: 124 ECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
+ APE++ Y +DIWS+G + E++ G+P + E+ + L +I GTP +
Sbjct: 182 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 319 KCMNPNYTEF 328
+ ++ + +F
Sbjct: 240 EKLSAIFRDF 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 8e-13
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 27/208 (12%)
Query: 97 RVVGQGSFGIV----FQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
R +G+G FG V + + TGE VA+K + + + +E++ +R L H N+V
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
K T+ + L++EF+P + ++ R ++ L Y QIC+ + Y
Sbjct: 70 KYKGI---CTEDGGNGIKLIMEFLPSGSLK--EYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-------YYR 260
+ G HRD+ +N+LV HQVK+ DFG K + E + Y + ++
Sbjct: 125 L-GSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDSPVFWY 179
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELL 288
APE + + Y A D+WS G L ELL
Sbjct: 180 APECLIQSKFYI-ASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 9e-13
Identities = 69/228 (30%), Positives = 107/228 (46%), Gaps = 31/228 (13%)
Query: 82 GRNGQPKQTISYMA-ERV--VGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNR 133
P S ERV +G G+ G V++ TG A+K + + +R R
Sbjct: 62 ASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR 121
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIY 193
E++ +R ++HPNVV H F + + ++LEF+ + + + L
Sbjct: 122 EIEILRDVNHPNVVKC-HDMFDHNGE----IQVLLEFMD----GGSLEGTHIADEQFLAD 172
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNIS 252
V QI +AY+H + HRDIKP NLL+N VK+ DFG +++L + +P S
Sbjct: 173 V---ARQILSGIAYLHRR-HIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMDPCNS 227
Query: 253 YICSRYYRAPELI-----FGATEYTTAIDIWSVGCVLAELLLGQPLFP 295
+ + Y +PE I GA + A DIWS+G + E LG+ FP
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYD-GYAGDIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 87/323 (26%), Positives = 135/323 (41%), Gaps = 67/323 (20%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-----LL--DHPNVVSL 149
+V+G+G+FG V K TG+ A+K + + + K E R L+ D + +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY----SRASQRMPLIYVKLYTYQICRAL 205
+ F +DE L LV++ Y V S+ R+P + Y ++ A+
Sbjct: 67 HYAF-----QDENNLYLVMD------YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI 115
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISYIC 255
+H +G HRDIKP N+L++ + H ++L DFGS L+ G P+ YI
Sbjct: 116 DSVHQ-LGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPD--YIS 171
Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315
+A E G Y D WS+G + E+L G+ F ES V+ +I+
Sbjct: 172 PEILQAME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM-------- 221
Query: 316 EEIKCMNPNYTE-FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEAC 372
N+ E F+FP + EA DL+ RL+ R +
Sbjct: 222 --------NHKEHFQFPPDVTD---------VSEEAKDLIRRLICSPETRLGRNGLQDFK 264
Query: 373 IHPFFYELRDPNARLPNGRPFPP 395
HPFF + N R P+ P
Sbjct: 265 DHPFFEGIDWDNIRNSTA-PYVP 286
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 77/306 (25%), Positives = 122/306 (39%), Gaps = 47/306 (15%)
Query: 102 GSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161
G+ G F +T E V IK + E +R ++HP+++ LK F
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF-------- 152
Query: 162 LYLNLVLEFVPETVYRVAKH-YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK 220
Y +P Y+ + Y A + + + + + RA+ Y+H + HRDIK
Sbjct: 153 TYNKFTCLILPR--YKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIK 209
Query: 221 PQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY--------RAPELIFGATEYT 272
+N+ +N H V L DFG+A V N +YY APEL+ Y
Sbjct: 210 AENIFIN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPYG 261
Query: 273 TAIDIWSVGCVLAELLLGQPLFPGESGVD-------QLVEIIKVLGTPTREEIKCMNPNY 325
A+DIWS G VL E+ + G+D Q+ II+ GT E N
Sbjct: 262 PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321
Query: 326 TEFKFPQIK-------AHP-WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
E K + P W ++ +P + L+ ++L + + R +A F
Sbjct: 322 DEIYIGLAKKSSRKPGSRPLWTNLY--ELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF 379
Query: 378 YELRDP 383
++ DP
Sbjct: 380 QDIPDP 385
|
Length = 391 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 69/295 (23%), Positives = 124/295 (42%), Gaps = 30/295 (10%)
Query: 102 GSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161
GS G VF A + V +K + K E ++ ++HP+V+ +K S
Sbjct: 77 GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGA---- 130
Query: 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP 221
+VL +Y + ++ S+ +P+ + QI L Y+H + HRD+K
Sbjct: 131 -ITCMVLPHYSSDLY---TYLTKRSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKT 185
Query: 222 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVG 281
+N+ +N QV + D G+A+ V + + APE + +Y + DIWS G
Sbjct: 186 ENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243
Query: 282 CVLAELLL----------GQPLFPGESGVDQLVEIIKVLGT-----PTREEIKCMNPNYT 326
VL E+L P +S L++II L P + + +
Sbjct: 244 IVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR-LVRGFI 302
Query: 327 EFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
E+ + + + + F + +P + LV ++L + +R +A E +P F +L
Sbjct: 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 77/289 (26%), Positives = 120/289 (41%), Gaps = 48/289 (16%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 153
+G G+FG V++A+ ETG +A KV+ K + E+ + DHPN+V L F
Sbjct: 13 LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 154 FSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
+ + L +++EF V V R + +++ Q AL Y+H
Sbjct: 72 YYENN-----LWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYLHEN- 122
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE- 270
+ HRD+K N+L +KL DFG SAK + S+I + Y+ APE++ T
Sbjct: 123 KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 271 ---YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
Y D+WS+G L E+ +P P E +NP
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEP--------------------PHHE----LNPMRVL 217
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
K K+ P R E D + + L+ + + R T + HPF
Sbjct: 218 LKIA--KSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 65/220 (29%), Positives = 107/220 (48%), Gaps = 23/220 (10%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 150
V+G+GSFG V A+ T E AIK V+QD + E + + L P ++
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
H F T D+ L V+E+V + +Y++ + R + Y +I L ++
Sbjct: 67 HSCFQTMDR----LYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFL 117
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 267
H G+ +RD+K N++++ H +K+ DFG K + G ++ + Y APE+I
Sbjct: 118 HSK-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-A 174
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
Y ++D W+ G +L E+L GQ F GE D+L + I
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSI 213
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 52/244 (21%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 152
+V+G+G+FG V + +TG A+K + + + ++ +R +L + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 153 FFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
F+S DK LYL ++EF+P + + + K + + + + Y + A+ IH
Sbjct: 67 FYSFQDKRNLYL--IMEFLPGGDMMTLLMKKDTLSEEA-----TQFYIAETVLAIDAIHQ 119
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFG------------------------------- 239
+G HRDIKP NLL++ H VKL DFG
Sbjct: 120 -LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 240 ---SAKVLVKGEPNISY--ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
A+ K ++Y + + Y APE +F T Y D WS+G ++ E+L+G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 295 PGES 298
E+
Sbjct: 237 CSET 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 79/385 (20%), Positives = 146/385 (37%), Gaps = 61/385 (15%)
Query: 18 DDVMIVDKLPAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIV 77
D D K DD D+ D + + + + E+ + +
Sbjct: 30 DTSDSKDTTGDKFDDCDELGDSDDVTHATD--------YDADEESLSPQTDVCQEPCETT 81
Query: 78 TTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNRE 134
++ + Q Y + GS G VF C + G+ I K + + RE
Sbjct: 82 SSSDPASVVRMQ---YNILSSLTPGSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGRE 136
Query: 135 LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYV 194
+ ++ + H +++L H + + + V +P+ + + R+ +PL
Sbjct: 137 IDILKTISHRAIINLIHAY--------RWKSTVCMVMPKYKCDLFTYVDRSGP-LPLEQA 187
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
++ ALAY+HG G+ HRD+K +N+ ++ + V L DFG+A L +
Sbjct: 188 ITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQ 243
Query: 255 CSRY-----YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIK 308
C + +PEL+ Y DIWS G VL E+ + LF + +K
Sbjct: 244 CYGWSGTLETNSPELL-ALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ---------VK 293
Query: 309 VLGTPTREEIKCMNPNYTEF-------------KFPQIKAHPWH--KIFHKRMPPEAVD- 352
+ R I+CM + EF ++ + P+ + K V+
Sbjct: 294 SSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEY 353
Query: 353 LVSRLLQYSPNLRCTALEACIHPFF 377
L++++L + R +A + P F
Sbjct: 354 LIAKMLTFDQEFRPSAQDILSLPLF 378
|
Length = 392 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 16/221 (7%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 156
+V+G+G+FG V K T A+K + + + K E R + NV+ C + T
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64
Query: 157 T----DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
T +DE YL LV+++ + S+ R+P + Y ++ A+ IH +
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGG--DLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ-L 121
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF---- 266
HRDIKP N+L++ + H ++L DFGS K+ G S + + Y +PE++
Sbjct: 122 HYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
G +Y D WS+G + E+L G+ F ES V+ +I+
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 83/356 (23%), Positives = 122/356 (34%), Gaps = 133/356 (37%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 148
+ +G G+FG V + ++T A+K L+ R E + D+ VV
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVK 65
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLI---------YVKLYTY 199
L ++S DKD LY V++++P M L+ + Y
Sbjct: 66 L---YYSFQDKDNLYF--VMDYIP------------GGDMMSLLIRLGIFEEDLARFYIA 108
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPH----------------THQVKL-------- 235
++ A+ +H +G HRDIKP N+L++ TH K
Sbjct: 109 ELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167
Query: 236 ---------------CDFGSAKVLVK------------GEPNISYICSRYYRAPELIFGA 268
C + K G PN Y APE++
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIAPEVLL-R 218
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
T YT D WSVG +L E+L+GQP F + TP ++K +N
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVIN------ 258
Query: 329 KFPQIKAHPWHKIFH----KRMPPEAVDLVSRLLQYSPNLRC---TALEACIHPFF 377
W H ++ EA DL+ RL R A E HPFF
Sbjct: 259 ---------WETTLHIPSQAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHC 152
VVG G++G V++ + ++TG+ AIK V +D+ + + M + H N+ +
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 153 FFSTT---DKDELYLNLVLEFV-PETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
F + D+L+ LV+EF +V + K+ + + ++ +I R LA++
Sbjct: 82 FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVKNTKGNALKED--WIAYICREILRGLAHL 137
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF 266
H V HRDIK QN+L+ + +VKL DFG + L + G N ++I + Y+ APE+I
Sbjct: 138 HAH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIA 194
Query: 267 ----GATEYTTAIDIWSVGCVLAELLLGQP 292
Y DIWS+G E+ G P
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 41/234 (17%)
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLL-------VNPHTHQ--------VKLCDFGSAKV 243
+Q AL Y H + + H D+KP+N+L V+P T++ V++CD G
Sbjct: 238 FQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC-- 295
Query: 244 LVKGEPNISYICSRYYRAPELIFG-ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ 302
+ + + +R+YR+PE++ G Y+T D+WS+GC++ EL G+ L+ ++
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEH 353
Query: 303 LVEIIKVLGT-PTREEIKCMNPN----YTEFKFPQIKAHPWH--KIFHKRMPPEAV---- 351
L + K LG P+ +C Y + P H +I R E +
Sbjct: 354 LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDL 413
Query: 352 --DLVSRLLQYSPNLRCTALEACIHPFFYELRDPNAR----LPNGRPF---PPL 396
DL+ LL Y R A + HP+ + P R P+ R P+
Sbjct: 414 LCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY-PECRQHPNYPDNRSMLRPTPI 466
|
Length = 467 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 52/244 (21%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 152
+V+G+G+FG V + +TG A+K + + + ++ +R +L + + +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 153 FFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
F+S DK LYL ++EF+P + + + K + + + Y + A+ IH
Sbjct: 67 FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEE-----TQFYIAETVLAIDSIHQ 119
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------------------- 250
+G HRDIKP NLL++ H VKL DFG L K
Sbjct: 120 -LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 251 ----------------ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF 294
S + + Y APE +F T Y D WS+G ++ E+L+G P F
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 295 PGES 298
E+
Sbjct: 237 CSET 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 37/228 (16%)
Query: 99 VGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLK 150
+G GSFG+V + + +G VA+K + DK +E M LDH N++ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 151 HCFFSTTDKDELYLNLVLEFVP-----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+ L +V E P + + + A + + + Y QI +
Sbjct: 63 GVVLTHP------LMMVTELAPLGSLLDRLRKDALGH------FLISTLCDYAVQIANGM 110
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
Y+ + HRD+ +N+L+ +VK+ DFG + L + E + Y+ + +
Sbjct: 111 RYLESKRFI-HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPFAW 166
Query: 261 -APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEI 306
APE + T ++ A D+W G L E+ G+ + G SG L +I
Sbjct: 167 CAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 30/226 (13%)
Query: 97 RVVGQGSFGIVFQAKCLETGET----VAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
+V+G G+FG V++ + GE VAIK + ++ K E M +DHP+VV
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
L S+ + L+ + +P + V H + L + QI + +
Sbjct: 73 RLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW----CVQIAKGM 122
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 262
+Y+ + HRD+ +N+LV H VK+ DFG AK+L E + + A
Sbjct: 123 SYLEE-KRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
E I YT D+WS G + EL+ G + G V+ L+E
Sbjct: 181 ESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 14/217 (6%)
Query: 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLL 141
P + ++ +G+G++G VF+ + G A+K +L + E++ L
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALS 72
Query: 142 DHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
DHPNVV ++ K+ L LVLE +V + K + + +RM + ++
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYY 259
L ++H + HRD+K N+L+ VKL DFG SA++ + + + ++
Sbjct: 133 ALMGLQHLHVNKTI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFW 190
Query: 260 RAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQP 292
APE+I + Y D+WS+G EL G P
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 69/300 (23%), Positives = 117/300 (39%), Gaps = 71/300 (23%)
Query: 96 ERVVGQGSFGIVFQ--AKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPN 145
R +GQGSFG+V++ AK + GE VAIK V ++ + R E M+ + +
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 146 VVSL-------KHCFFSTTDKDELYLNLVLEFVPETVYR--VAKHYSRASQ---RMPLIY 193
VV L + +V+E + + + + A P
Sbjct: 71 VVRLLGVVSTGQPTL------------VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118
Query: 194 VKLYTY--QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
K +I +AY+ HRD+ +N +V VK+ DFG + +I
Sbjct: 119 QKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVA-EDLTVKIGDFGMTR-------DI 169
Query: 252 SYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGES 298
+ YYR APE + +TT D+WS G VL E+ L + + G S
Sbjct: 170 YE--TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLS 226
Query: 299 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 358
+++++ + G E C + + W ++ +M P +++VS L
Sbjct: 227 N-EEVLKFVIDGGHLDLPE-NCPDKLLELMR------MCWQ--YNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 61/240 (25%), Positives = 97/240 (40%), Gaps = 62/240 (25%)
Query: 87 PKQTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIK--------KVLQDKRYKNR 133
P + ++ E +G+G+FG V++ + + +VAIK KV Q+ R +
Sbjct: 3 PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-----ETVYRVAKH------Y 182
E + M L HPN+V C K++ L E++ E + R + H
Sbjct: 58 EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAES 112
Query: 183 SRASQRMPLIYVKLY--TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
+ + L QI + Y+ HRD+ +N LV VK+ DFG
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVGEG-LTVKISDFGL 170
Query: 241 AKVLVKGEPNISYICSRYYR------------APELI-FGATEYTTAIDIWSVGCVLAEL 287
++ + + YYR PE I +G ++TT DIWS G VL E+
Sbjct: 171 SRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 97 RVVGQGSFGIVFQAKCLETGET-----VAIKKVLQDKRYKNR-----ELQTMRLL-DHPN 145
+ +G G+FG V +A ++ VA+K + R EL+ M L +H N
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICR 203
+V+L + T + + + E+ Y ++ R + L L ++YQ+ +
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYC---CYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YR 260
+A++ + HRD+ +N+L+ H VK+CDFG A+ ++ + +R +
Sbjct: 153 GMAFLASKNCI-HRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
APE IF YT D+WS G +L E+ LG +PG
Sbjct: 211 APESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 21/209 (10%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHCF 153
+VG G++G V++ + ++TG+ AIK V D+ + ++ M + H N+ + F
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 154 FSTTD---KDELYLNLVLEFV-PETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
D+L+ LV+EF +V + K+ + + ++ +I R L+++H
Sbjct: 73 IKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNTLKEE--WIAYICREILRGLSHLH 128
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 266
V HRDIK QN+L+ + +VKL DFG + L + G N ++I + Y+ APE+I
Sbjct: 129 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 185
Query: 267 ---GATEYTTAIDIWSVGCVLAELLLGQP 292
Y D+WS+G E+ G P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 7e-10
Identities = 60/241 (24%), Positives = 101/241 (41%), Gaps = 52/241 (21%)
Query: 97 RVVGQGSFGIVFQAKCLE-----TGET-VAIKK-----VLQDKRYKNRELQTMRLLDHPN 145
+G G+FG V++ + +G VA+K Q+K+ +E M +HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 146 VVS-LKHCFFSTTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKLYTYQ 200
+V L C + Y+ ++E + + R A+ + L +
Sbjct: 61 IVKLLGVCL----LNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD 114
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ----VKLCDFGSAKVLVKGEPNISYICS 256
+ + Y+ + HRD+ +N LV+ + VK+ DFG A+ + K S
Sbjct: 115 VAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK---------S 164
Query: 257 RYYR------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQ 302
YYR APE L+ G +TT D+WS G ++ E+L LGQ +P + +
Sbjct: 165 DYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV 222
Query: 303 L 303
L
Sbjct: 223 L 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 61/224 (27%), Positives = 110/224 (49%), Gaps = 22/224 (9%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-----LLDHPN--VVSL 149
+V+G+G+FG V K + A+K + + + K E R L++ N + +L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+ F D++ LYL V+++ + S+ R+P + Y ++ A+ +H
Sbjct: 67 HYAF---QDENNLYL--VMDYYVGG--DLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF- 266
+ HRDIKP N+L++ + H ++L DFGS K++ G S + + Y +PE++
Sbjct: 120 Q-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 267 ---GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
G +Y D WS+G + E+L G+ F ES V+ +I+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 14/205 (6%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVVSLKHCF 153
+G+G++G V++ + G A+K +L + E++ L +HPNVV F
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 154 FSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
+ L LVLE +V + K QR+ + Y L ++H
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
+ HRD+K N+L+ VKL DFG SA++ + + + ++ APE+I +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206
Query: 272 TTA----IDIWSVGCVLAELLLGQP 292
+ D+WS+G EL G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 7e-10
Identities = 59/206 (28%), Positives = 85/206 (41%), Gaps = 34/206 (16%)
Query: 114 ETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165
TG VAIK + D R++ RE L HPN+V+L + + L
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55
Query: 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL 225
V E+VP R + A +P Q+ ALA H G+ HRD+KPQN++
Sbjct: 56 AVFEYVPG---RTLREVLAADGALPAGETGRLMLQVLDALACAHNQ-GIVHRDLKPQNIM 111
Query: 226 VN-----PHTHQVKLCDFGSAKVLVKGEPNI--------SYICSRYYRAPELIFGATEYT 272
V+ PH K+ DFG +L + + Y APE + G T
Sbjct: 112 VSQTGVRPHA---KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV-T 167
Query: 273 TAIDIWSVGCVLAELLLGQPLFPGES 298
D+++ G + E L GQ + G S
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 30/216 (13%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKK-----VLQDKRYKNRELQTMRLLDHPNVVSLKH 151
+G+G+FG V++ L+ VA+K KR +E + ++ DHPN+V L
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
K +Y +V+E VP + R+ + + + + Y+
Sbjct: 58 -IGVCVQKQPIY--IVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-------APE- 263
HRD+ +N LV + +K+ DFG + + E Y S + APE
Sbjct: 113 -NCIHRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEA 166
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGES 298
L +G YT+ D+WS G +L E LG +PG S
Sbjct: 167 LNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMS 200
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 16/219 (7%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
Y RV+G G+ G V AK + GE A+K V DK E+ + D ++
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 147 VSLKHCFFSTTDKDE---LYLNLVLEFVPETVYRVA-KHYSRASQRMPLIYVKLYTYQIC 202
V F ++ L + LVL++ R K ++ ++ L Q+
Sbjct: 94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 259
A+ ++H + HRDIK N+L+ + VKL DFG +K+ V + ++ + YY
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
APE I+ Y+ D++S+G +L ELL + F GE+
Sbjct: 212 VAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 153
+G+GSFG VF+ T + VAIK + L++ + +E+ + D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY--QICRALAYIHGG 211
T L +++E++ A RA P ++ T +I + L Y+H
Sbjct: 72 LKGTK-----LWIIMEYLGGGS---ALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE 120
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATE 270
+ HRDIK N+L++ VKL DFG A L + +++ + ++ APE+I +
Sbjct: 121 KKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQSA 177
Query: 271 YTTAIDIWSVGCVLAELLLGQP 292
Y + DIWS+G EL G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 65/247 (26%), Positives = 111/247 (44%), Gaps = 55/247 (22%)
Query: 99 VGQGSFGIVFQAKCLETGE-----TVAIKKVLQDKRYKN-----RELQTMRLL-DHPNVV 147
+G+G+FG V +A+ + TVA+K + D K+ E++ M+++ H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYR--------VAKHYSRASQRMPLIYVKLY-- 197
+L T + LY+ V+E+ R ++ S R P +
Sbjct: 80 NLLGV---CTQEGPLYV--VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 198 ---TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
YQ+ R + ++ HRD+ +N+LV H +K+ DFG A+ +I +I
Sbjct: 135 VSFAYQVARGMEFLASK-KCIHRDLAARNVLVT-EDHVMKIADFGLAR-------DIHHI 185
Query: 255 CSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
YYR APE +F YT D+WS G +L E+ LG +PG V+
Sbjct: 186 --DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VE 241
Query: 302 QLVEIIK 308
+L +++K
Sbjct: 242 ELFKLLK 248
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 64/237 (27%), Positives = 94/237 (39%), Gaps = 50/237 (21%)
Query: 87 PKQTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQ 136
P+ I Y R +GQG+FG VFQA+ E VA+K + + RE
Sbjct: 3 PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 137 TMRLLDHPNVVSL--------KHC----FFSTTDKDELYLNLVLEFVPETVYRVAKHYSR 184
M DHPN+V L C + + D +E + + +
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 185 ASQRMPLIYVKLY--TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242
+PL + Q+ +AY+ V HRD+ +N LV + VK+ DFG ++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENM-VVKIADFGLSR 178
Query: 243 VLVKGEPNISYICSRYYRA------------PELIFGATEYTTAIDIWSVGCVLAEL 287
NI + YY+A PE IF YTT D+W+ G VL E+
Sbjct: 179 -------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 16/165 (9%)
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
Y++Q+ + + ++ HRD+ +N+L++ + VK+CDFG A+ + K + +
Sbjct: 184 YSFQVAKGMEFL-ASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 257 RY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 312
R + APE IF YT D+WS G +L E+ LG +PG V+I +
Sbjct: 242 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 293
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
+E + P+YT + Q WH +R P +LV L
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR--PTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 22/202 (10%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 153
+G+GSFG VF+ T + VAIK + L++ + +E+ + D P V +
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY--QICRALAYIHGG 211
T L +++E++ + PL ++ T +I + L Y+H
Sbjct: 72 LKDTK-----LWIIMEYLG------GGSALDLLEPGPLDETQIATILREILKGLDYLHSE 120
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATE 270
+ HRDIK N+L++ H +VKL DFG A L + + ++ + ++ APE+I +
Sbjct: 121 KKI-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSA 177
Query: 271 YTTAIDIWSVGCVLAELLLGQP 292
Y + DIWS+G EL G+P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 44/217 (20%)
Query: 98 VVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 147
+G+G FG VF AK E GET+ + K LQ + +N REL R L H NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYT--YQI 201
L + + Y ++LE+ + R K + PL + QI
Sbjct: 72 RL---LGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR- 260
+ ++ V HRD+ +N LV+ +VK+ S L K N S YY+
Sbjct: 127 ALGMDHLSNARFV-HRDLAARNCLVSS-QREVKV----SLLSLSKDVYN-----SEYYKL 175
Query: 261 ----------APELIFGATEYTTAIDIWSVGCVLAEL 287
APE + +++T D+WS G ++ E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 56/220 (25%), Positives = 106/220 (48%), Gaps = 26/220 (11%)
Query: 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDH 143
P++++ ER +G G FG V+ T + VA+K + +E Q M+ L H
Sbjct: 4 PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMP-LIYVKLYTYQI 201
+V L + ++++ +Y+ V E++ + ++ K R+P L+ + QI
Sbjct: 61 DKLVQL---YAVCSEEEPIYI--VTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---AAQI 112
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--- 258
+AY+ HRD+ +N+LV + K+ DFG A+++ E + +++
Sbjct: 113 AEGMAYLES-RNYIHRDLAARNILVGEN-LVCKIADFGLARLIEDDE-YTAREGAKFPIK 169
Query: 259 YRAPELI-FGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
+ APE +G +T D+WS G +L E++ G+ +PG
Sbjct: 170 WTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 60/229 (26%), Positives = 105/229 (45%), Gaps = 32/229 (13%)
Query: 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVV 147
+++M E +G G FG+V K VAIK + + + E + M L HP +V
Sbjct: 6 LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
L + T + LY+ V EF+ + + + + S+ M L + +C +
Sbjct: 63 QL---YGVCTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGM 113
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YY 259
Y+ HRD+ +N LV+ T VK+ DFG + ++ E Y S +
Sbjct: 114 EYLERN-SFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKW 167
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII 307
PE +F ++Y++ D+WS G ++ E+ G+ F +S ++VE+I
Sbjct: 168 SPPE-VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 61/244 (25%), Positives = 95/244 (38%), Gaps = 56/244 (22%)
Query: 87 PKQTISYMAERVVGQGSFGIVFQAKC--LETGET---VAIKKVLQD------KRYKNREL 135
+ TI R +G+G+FG VF +C LE VA+ K L++ ++ RE
Sbjct: 3 QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59
Query: 136 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-----ETVYRVAKHYSRA----S 186
+ + H N+V T+ D +V E++ + + + S
Sbjct: 60 ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 187 QRMPLIYVKLY--TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
L +L QI + Y+ V HRD+ +N LV + VK+ DFG ++ +
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFV-HRDLATRNCLVG-YDLVVKIGDFGMSRDV 172
Query: 245 VKGEPNISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELLL--G 290
Y YYR PE I +TT D+WS G VL E+
Sbjct: 173 --------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGK 222
Query: 291 QPLF 294
QP +
Sbjct: 223 QPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 45/168 (26%), Positives = 78/168 (46%), Gaps = 15/168 (8%)
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
Y++Q+ R + ++ HRD+ +N+L++ + VK+CDFG A+ + K + +
Sbjct: 179 YSFQVARGMEFL-ASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 257 RY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGT 312
R + APE IF YTT D+WS G +L E+ LG +PG V+I +
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQ 288
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP-PEAVDLVSRLLQ 359
++ + P + +I W +R V+++ LLQ
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 51/195 (26%), Positives = 82/195 (42%), Gaps = 22/195 (11%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR---ELQTMRLLDHPNVVSLKHCFFS 155
+G+G FG V G+ VA+K + D E M L HPN+V L
Sbjct: 14 IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70
Query: 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 215
+ LY+ V E++ + V SR + L + +C + Y+
Sbjct: 71 --QGNPLYI--VTEYMAKGSL-VDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-NFV 124
Query: 216 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 272
HRD+ +N+LV+ K+ DFG AK E + + + APE + +++
Sbjct: 125 HRDLAARNVLVS-EDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL-REKKFS 177
Query: 273 TAIDIWSVGCVLAEL 287
T D+WS G +L E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 72/272 (26%), Positives = 113/272 (41%), Gaps = 60/272 (22%)
Query: 115 TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPET 174
T +T +K + + Y +RE T+ PN+V L S +D ++L VL+
Sbjct: 17 TQQTFILKGLRKSSEY-SRERLTIIPHCVPNMVCLHKYIVS---EDSVFL--VLQHA--- 67
Query: 175 VYRVAKHYSRASQ--RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ 232
K +S S+ +P VK + ++ AL +H VC RD+ P N+L++ H
Sbjct: 68 --EGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNILLDDRGH- 123
Query: 233 VKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ 291
++L F + E + Y APE + G +E T A D WS+G +L ELL G+
Sbjct: 124 IQLTYFSR---WSEVEDSCDGEAVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGK 179
Query: 292 PLFPGE-SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEA 350
L SG++ +T P+ + EA
Sbjct: 180 TLVECHPSGINT----------------------HTTLNIPEW------------VSEEA 205
Query: 351 VDLVSRLLQYSPNLRCTALEACI-----HPFF 377
L+ +LLQ++P R A A + HPFF
Sbjct: 206 RSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 64/295 (21%), Positives = 126/295 (42%), Gaps = 48/295 (16%)
Query: 93 YMAERVVGQGSFGIVF--QAKCLETGETVAIKKVL-------QDKRYKNRELQTMRLLDH 143
Y+ ++ +G+GSFG V+ + K E + + K + + N+E Q + LDH
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
P +V H F D ++ E+ + + + + V + Q+
Sbjct: 62 PAIVKF-HASFLERDA----FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRA 261
+ Y+H + HRD+K +N+ + + +K+ DFG +++L+ + ++ + YY +
Sbjct: 117 LGVHYMHQR-RILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
PE + Y + DIWS+GC+L E+ F G+ + L +++++ PT
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---NFLSVVLRIVEGPT------- 222
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
P+ E + ++ +L P+LR +A E +PF
Sbjct: 223 -PSLPE-----------------TYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 70/218 (32%), Positives = 101/218 (46%), Gaps = 23/218 (10%)
Query: 93 YMAERVVGQGSFGIVFQA-KCLETGETVAIKKV-LQDKR---YKNRELQTMRLLDHPNVV 147
Y+ +VG+ F A + + E V K V L D+R Y EL + DH +V
Sbjct: 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128
Query: 148 SLKHCF-FSTTDKDELYLNLVLEF-VPETVYRVAKHYSRASQRMPL--IYVKLYTYQICR 203
KH F + DK L L++E+ + + K R + +P V L YQI
Sbjct: 129 --KHFDDFKSDDK----LLLIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGLLFYQIVL 180
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYR 260
AL +H + HRD+K N+ + P T +KL DFG +K V + S+ + YY
Sbjct: 181 ALDEVHSR-KMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
APEL + Y+ D+WS+G +L ELL F G S
Sbjct: 239 APEL-WERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275
|
Length = 478 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 8e-09
Identities = 55/238 (23%), Positives = 105/238 (44%), Gaps = 49/238 (20%)
Query: 97 RVVGQGSFGIVFQAKCLETG-----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNV 146
+ +G+G FG V +A TVA+K + ++ R E ++ ++HP+V
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL---------- 196
+ L + +D L L++E+ Y + + R S+++ Y+
Sbjct: 66 IKL----YGACSQDGPLL-LIVEYAK---YGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 197 --------------YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242
+ +QI R + Y+ + + HRD+ +N+LV ++K+ DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYL-AEMKLVHRDLAARNVLV-AEGRKMKISDFGLSR 175
Query: 243 VLVKGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
+ + + + R + A E +F YTT D+WS G +L E++ LG +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-09
Identities = 82/322 (25%), Positives = 128/322 (39%), Gaps = 68/322 (21%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQTMRLLDHPN---VVSLK 150
+G+G FG V + TG+ A KK L KR K R+ + R+L + +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 151 HCFFSTTDKDELYLNLVLEF-----VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+ F + TD L LV+ + +Y V + + YT QI L
Sbjct: 60 YAFQTKTD-----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRAC----FYTAQIISGL 110
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPEL 264
++H + +RD+KP+N+L++ + V++ D G A L G+ Y + + APEL
Sbjct: 111 EHLHQR-RIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPEL 168
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLF--PGESGVDQLVEIIKVLGTPTREEIKCMN 322
+ G EY ++D +++G L E++ + F GE KV ++ I +
Sbjct: 169 LQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE----------KVENKELKQRILNDS 217
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-------CTALEACIHP 375
Y + + P + LL P R C L HP
Sbjct: 218 VTYPD-----------------KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT--HP 258
Query: 376 FFYELRDPNARLPNGRPFPPLF 397
F RD N R PP F
Sbjct: 259 LF---RDLNWRQLEAGMLPPPF 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 77/300 (25%), Positives = 132/300 (44%), Gaps = 55/300 (18%)
Query: 99 VGQGSFGIVFQAKCL-------ETGETVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 145
+G+G FG V A+ L + TVA+K + D K+ E++ M+++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYR--------VAKHYSRASQRMP---LIYV 194
+++L + T LY+ ++E+ + R YS R+P + +
Sbjct: 83 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFK 137
Query: 195 KLY--TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
L TYQ+ R + Y+ + HRD+ +N+LV + +K+ DFG L + NI
Sbjct: 138 DLVSCTYQVARGMEYLASQKCI-HRDLAARNVLVT-ENNVMKIADFG----LARDVNNID 191
Query: 253 YICSRY-------YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLV 304
Y + APE +F YT D+WS G ++ E+ LG +PG V++L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELF 249
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FHKRMPPEAVDLVSRLLQYSPN 363
+++K G + C N Y + WH I H+ + V+ + R+L + N
Sbjct: 250 KLLKE-GHRMDKPANCTNELYMMMR------DCWHAIPSHRPTFKQLVEDLDRILTLTTN 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 60/227 (26%), Positives = 93/227 (40%), Gaps = 49/227 (21%)
Query: 83 RNGQPKQTIS-------YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL 135
R +P ++ + R + GS G VF++ + + V +K E
Sbjct: 154 RGCKPPSEVAKVVAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYAS--SVHEA 211
Query: 136 QTMRLLDHPNVVSLKH--------CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ 187
+ +R L HP V++L C + +LY L +
Sbjct: 212 RLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYL----------------GARLR 255
Query: 188 RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247
+ L V Q+ A+ YIHG G+ HRDIK +N+LVN + L DFG+A +G
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG 312
Query: 248 EPNISYICSRYY--------RAPELIFGATEYTTAIDIWSVGCVLAE 286
S+ +Y APE++ G YT ++DIWS G V+ E
Sbjct: 313 ----SWSTPFHYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 52/231 (22%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRL---LDHPNVVSL 149
R++G+G G V+ A VA+KK+ +D K R L+ ++ L HP +V +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 150 KHCFFSTTDKDELY----------LNLVLEFVPETVYRVAKHYSRASQRMPL-IYVKLYT 198
+ +D D +Y L +L+ V + + + S L I+ K
Sbjct: 68 ---YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK--- 121
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV----------LVKGE 248
IC + Y+H GV HRD+KP N+L+ V L D+G+A + E
Sbjct: 122 --ICATIEYVHSK-GVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLEEEDLLDIDVDE 177
Query: 249 PNISY---------ICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELL 288
NI Y + + Y APE + G A+E T DI+++G +L ++L
Sbjct: 178 RNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 155
+G G +G V++ + TVA+K + +D +E M+ + HPN+V L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL---LGV 70
Query: 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHGGIG 213
T + Y ++ EF+ Y Y R R + V L QI A+ Y+
Sbjct: 71 CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK-N 124
Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATE 270
HRD+ +N LV + H VK+ DFG ++ L+ G+ ++ +++ + APE + +
Sbjct: 125 FIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL-AYNK 181
Query: 271 YTTAIDIWSVGCVLAEL-LLGQPLFPG 296
++ D+W+ G +L E+ G +PG
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 75/289 (25%), Positives = 121/289 (41%), Gaps = 57/289 (19%)
Query: 97 RVVGQGSFGIVFQAKCLETGET---VAIKKV-----LQDKRYKNRELQTMRLLDHPNVVS 148
RV+G+G FG V+ +++ A+K + L++ +E M+ HPNV+S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH-----YSRASQRMP----LIYVKLYTY 199
L L + L E P V KH + R+ P LI L
Sbjct: 61 L------------LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--- 105
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
Q+ + + Y+ V HRD+ +N +++ + VK+ DFG A+ + E Y +
Sbjct: 106 QVAKGMEYLASKKFV-HRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNH 159
Query: 260 RAPEL--IFGATE------YTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVL 310
+L + A E +TT D+WS G +L EL+ G P +P D V +++
Sbjct: 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-- 217
Query: 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 359
G + C +P Y ++ WH R P +LVSR+ Q
Sbjct: 218 GRRLLQPEYCPDPLY------EVMLSCWHPKPEMR--PTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 79/334 (23%), Positives = 124/334 (37%), Gaps = 87/334 (26%)
Query: 96 ERVVGQGSFGIVFQAKCLETG-----ETVAIKKVLQDKRY-KNRELQT-MRLL----DHP 144
+ +G+G+FG V QA TVA+K + + + + L T +++L H
Sbjct: 12 GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHL 71
Query: 145 NVV------------------------------SLKHCFFSTTDKD-ELYLNLVLEFVPE 173
NVV S + CF +K E +
Sbjct: 72 NVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQ 131
Query: 174 TVYRVAKHYSRASQRM---------------------PLIYVKL--YTYQICRALAYIHG 210
+ V+ S AS PL L Y++Q+ R + ++
Sbjct: 132 RLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLAS 191
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 264
+ HRD+ +N+L++ + VK+CDFG A+ + K + Y+ R APE
Sbjct: 192 RKCI-HRDLAARNILLS-ENNVVKICDFGLARDIYK---DPDYVRKGDARLPLKWMAPES 246
Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
IF YTT D+WS G +L E+ LG +PG V+I + +E + P
Sbjct: 247 IFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEEFCRRLKEGTRMRAP 298
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
Y + I WH R P +LV L
Sbjct: 299 EYATPEIYSIMLDCWHNNPEDR--PTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 7/104 (6%)
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---Y 253
+TYQ+ R + ++ HRD+ +N+L+ VK+CDFG A+ ++ +S
Sbjct: 242 FTYQVARGMEFL-ASKNCVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGST 299
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
+ APE IF YTT D+WS G +L E+ LG +PG
Sbjct: 300 FLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 48/164 (29%), Positives = 82/164 (50%), Gaps = 19/164 (11%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYKN--RELQTMR----LLDHPNVVSLKH 151
+ +G+FG V+ + + A+K V + D KN ++Q R L P +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL-- 69
Query: 152 CFFSTTDKDELYLNLVLEF-VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
++S + +YL V+E+ + V + Y + M + Y+ ++ AL Y+H
Sbjct: 70 -YYSLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHR 122
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
G+ HRD+KP N+L++ H +KL DFG +KV + E N+ I
Sbjct: 123 H-GIIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 6e-08
Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 26/199 (13%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVSLKHCFF 154
+G G FG+V+ LE + VAIK + + ++ + E Q M L HP +V L
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69
Query: 155 STTDKDELYLNLVLEFVPE---TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
+ + LV EF+ + Y A+ + + L+ + L +C +AY+
Sbjct: 70 ERSP-----ICLVFEFMEHGCLSDYLRAQRGKFSQE--TLLGMCL---DVCEGMAYLESS 119
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGA 268
V HRD+ +N LV VK+ DFG + ++ + S +++ + +PE +F
Sbjct: 120 -NVIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPE-VFSF 175
Query: 269 TEYTTAIDIWSVGCVLAEL 287
++Y++ D+WS G ++ E+
Sbjct: 176 SKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 35/211 (16%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 147
E+V+G G FG V + + G+ VAIK + DK+ + E M DHPN++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
L+ + + ++ E++ + R Q + ++ I
Sbjct: 69 RLEGVVTKSRP-----VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLR------GIAS 117
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY------ICSR 257
+ Y+ + HRD+ +N+LVN + K+ DFG ++ L + +Y I R
Sbjct: 118 GMKYL-SEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIR 173
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
+ APE I ++T+A D+WS G V+ E++
Sbjct: 174 W-TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 7e-08
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 147
E+V+G G FG V + G+ VAIK + +K+ ++ E M DHPN++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
L+ T K + +V E++ + + + +I + I + Y
Sbjct: 69 HLEGVV--TKSKPVM---IVTEYMENG--SLDAFLRKHDGQFTVIQLVGMLRGIASGMKY 121
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
+ +G HRD+ +N+LVN + K+ DFG ++VL + +P +Y + AP
Sbjct: 122 L-SDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 178
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
E I ++T+A D+WS G V+ E++
Sbjct: 179 EAI-AYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 26/204 (12%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158
+G+GSFG V++ T E VAIK + D E++ ++ + L C
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKII--DLEEAEDEIEDIQ----QEITVLSQC------ 59
Query: 159 KDELYLNLVL-EFVPETVYRVAKHYSRASQRMPLI--------YVKLYTYQICRALAYIH 209
D Y+ ++ T + Y + L+ Y+ +I + L Y+H
Sbjct: 60 -DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLH 118
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA 268
+ HRDIK N+L++ VKL DFG A L + +++ + ++ APE+I
Sbjct: 119 SERKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQ 175
Query: 269 TEYTTAIDIWSVGCVLAELLLGQP 292
+ Y DIWS+G EL G+P
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 97 RVVGQGSFGIVFQAKCLETGET----VAIKKVLQDKRYK-NREL----QTMRLLDHPNVV 147
+V+G G+FG V++ + GE VAIK++ + K N+E+ M +D+P+V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 148 SLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
L C ST + L+ + +P + Y R + + Y+ + QI + +
Sbjct: 73 RLLGICLTST-------VQLITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 262
Y+ V HRD+ +N+LV H VK+ DFG AK+L E + + A
Sbjct: 123 NYLEERRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
E I YT D+WS G + EL+
Sbjct: 181 ESILHRI-YTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 44/221 (19%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRLLDHPNVVSLKH 151
ER +G G FG V++ VAIK + D K + E+Q ++ L H +++SL
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67
Query: 152 CFFSTTDKDELYL--------NLVLEFV--PETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
F + + +Y+ +L L F+ PE + LI + Q+
Sbjct: 68 -FAVCSVGEPVYIITELMEKGSL-LAFLRSPE---------GQVLPVASLIDM---ACQV 113
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-----VKGEPNISYICS 256
+AY+ HRD+ +N+LV K+ DFG A+++ + + I Y
Sbjct: 114 AEGMAYLEEQ-NSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPY--- 168
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPG 296
+ APE ++T D+WS G +L E+ GQ +PG
Sbjct: 169 -KWTAPEAA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 155
++G+G FG V Q + TG+ VA+K + D + E M L H N+V L
Sbjct: 13 IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 215
L +V+E + + V +R + +I + ++ + + Y+ +
Sbjct: 71 NG------LYIVMELMSKGNL-VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK-KLV 122
Query: 216 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI 275
HRD+ +N+LV+ K+ DFG A+V G N + APE + ++++
Sbjct: 123 HRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPEAL-KHKKFSSKS 178
Query: 276 DIWSVGCVLAELL-LGQPLFP 295
D+WS G +L E+ G+ +P
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYP 199
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 147
+V+G G+FG V++ + GETV I K+L + ++ M +DHP++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
L S T + LV + +P + V +H ++ L + QI + +
Sbjct: 73 RLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC----VQIAKGM 122
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 262
Y+ + HRD+ +N+LV H VK+ DFG A++L E + + + A
Sbjct: 123 MYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLL--GQP 292
E I ++T D+WS G + EL+ G+P
Sbjct: 181 ECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 15/108 (13%)
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 249
++ Q+ + + ++ HRD+ +N+L+ K+CDFG A+ +VKG
Sbjct: 217 FSSQVAQGMDFL-ASKNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNA 274
Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
+ + APE IF YT D+WS G +L E+ LG+ +PG
Sbjct: 275 RLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-07
Identities = 56/223 (25%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 97 RVVGQGSFGIVFQAKCLETGET-VAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
R +G G FG V++ L T VA+K + E Q M+ L HP ++ L
Sbjct: 12 RKLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--- 66
Query: 153 FFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMP-LIYVKLYTYQICRALAYI-- 208
+ T ++ +Y+ V E + ++ + + + ++P LI + Q+ +AY+
Sbjct: 67 YAVCTLEEPIYI--VTELMKYGSLLEYLQGGAGRALKLPQLIDM---AAQVASGMAYLEA 121
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 265
I HRD+ +N+LV + + K+ DFG A+V+ + + +++ + APE
Sbjct: 122 QNYI---HRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTAPEAA 176
Query: 266 FGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESG--VDQLVE 305
++ D+WS G +L E++ G+ +PG + V Q V+
Sbjct: 177 L-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 52/226 (23%), Positives = 95/226 (42%), Gaps = 38/226 (16%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNRELQ-------TMRLLDHPNV 146
+++G+G FG V + + L + +K K ++ + E++ M+ DHPNV
Sbjct: 5 KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 147 VSLKHCFFSTTDKDELYLNLV-LEFVPETVYRVAKHYSR---ASQRMPLIYVKLYTYQIC 202
+ L F + ++ +V L F+ YSR +++PL + + I
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
+ Y+ HRD+ +N ++ V + DFG +K + G+ YYR
Sbjct: 124 LGMEYLSNR-NFIHRDLAARNCMLR-EDMTVCVADFGLSKKIYSGD---------YYRQG 172
Query: 263 ELI-----FGATE------YTTAIDIWSVGCVLAELL-LGQPLFPG 296
+ + A E YT+ D+W+ G + E+ GQ +PG
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 148
+V+G G+FG V++ + GE V I ++ R +LD V++
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 149 --LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
L C ST + LV + +P Y Y R ++ R+ + + QI + +
Sbjct: 73 RLLGICLTST-------VQLVTQLMP---YGCLLDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 262
+Y+ + + HRD+ +N+LV H VK+ DFG A++L E + + A
Sbjct: 123 SYLE-EVRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
E I +T D+WS G + EL+
Sbjct: 181 ESIL-HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 30/201 (14%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 155
+G G FG+V K + VAIK + + ++ E + M L HPN+V L +
Sbjct: 12 LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YGV 67
Query: 156 TTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
T + +++ V E++ R K + + +C A+ Y+
Sbjct: 68 CTKQRPIFI--VTEYMANGCLLNYLRERKGKLGTEWLLDM------CSDVCEAMEYLESN 119
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----APELIF 266
G HRD+ +N LV + VK+ DFG A+ ++ + Y S+ + AP +F
Sbjct: 120 -GFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVF 173
Query: 267 GATEYTTAIDIWSVGCVLAEL 287
+ +++ D+WS G ++ E+
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 46/286 (16%)
Query: 97 RVVGQGSFGIVFQAKCLE---TGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 147
R++G+G FG V +A+ + + VA+K + D + RE M+ DHPNV+
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 148 SLKHCFFSTTDKDELYLNLV-LEFVPETVYRVAKHYSRASQR---MPLIYVKLYTYQICR 203
L + K L + +V L F+ SR + +PL + + I
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 260
+ Y+ HRD+ +N ++N + V + DFG +K + G+ YYR
Sbjct: 125 GMEYLSSK-NFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGD---------YYRQGC 173
Query: 261 APELIFG--ATE------YTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLG 311
A +L A E YTT D+W+ G + E++ GQ + G + +IK G
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK--G 231
Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
++ C+ Y ++ W R P L +L
Sbjct: 232 NRLKQPPDCLEDVY------ELMCQCWSPEPKCR--PSFQHLRDQL 269
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 191 LIYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248
L Y+ L ++YQ+ + ++ V HRD+ +N+L+ VK+CDFG A+ +++
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCV-HRDLAARNVLIC-EGKLVKICDFGLARDIMRDS 293
Query: 249 PNIS---YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLV 304
IS + APE IF YTT D+WS G +L E+ LG +P +Q
Sbjct: 294 NYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP-PEAVDLVSRLL 358
IK + P + + +I W + F R + V LV LL
Sbjct: 353 NAIK-------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 15/108 (13%)
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 249
++YQ+ + ++++ HRD+ +N+L+ H K+CDFG A+ +VKG
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
+ + APE IF YT D+WS G +L E+ LG +PG
Sbjct: 277 RLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 26/69 (37%), Positives = 37/69 (53%), Gaps = 9/69 (13%)
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY- 258
QI AL +H G+ HRD+KPQN++ + + K+ D G+A L G I+YI +
Sbjct: 263 QILFALDGLHS-TGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318
Query: 259 ----YRAPE 263
Y APE
Sbjct: 319 LDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 80/352 (22%), Positives = 134/352 (38%), Gaps = 95/352 (26%)
Query: 98 VVGQG--SFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 149
V+G+G V A+ TGE V ++++ + + EL +L +HPN+V
Sbjct: 5 VIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAK-----HYSRASQRMPLIYVKLYTYQICRA 204
+ F + +EL++ Y AK H+ + + Y+ + +A
Sbjct: 65 RATFIA---DNELWV-----VTSFMAYGSAKDLICTHFMDGMSELAIAYILQ---GVLKA 113
Query: 205 LAYIHGGIGVCHRDIKPQNLLVN-----------------PHTHQVKLC-DFG--SAKVL 244
L YIH +G HR +K ++L++ H ++++ DF S KVL
Sbjct: 114 LDYIH-HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL 172
Query: 245 VKGEPNISYICSRYYRAPELIFGATE-YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQL 303
P +S PE++ + Y DI+SVG EL G F L
Sbjct: 173 ----PWLS---------PEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 219
Query: 304 VEIIKVLGT------------------PTR--------EEIKCMNPNYTEFKFPQIKAHP 337
+E K+ GT P+R E P + + +HP
Sbjct: 220 LE--KLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSN---GESSSHP 274
Query: 338 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL-RDPNARLP 388
+++ F P V + LQ +P+ R +A H FF ++ R + LP
Sbjct: 275 YNRTF----SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 322
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHC 152
++G+G+FG VF+ L+ VA+K +D + K + L R+L DHPN+V L
Sbjct: 2 LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
T + +Y +V+E VP + + + + + +AY+
Sbjct: 58 IGVCTQRQPIY--IVMELVPGGDF--LSFLRKKKDELKTKQLVKFALDAAAGMAYLESK- 112
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPE-LI 265
HRD+ +N LV + +K+ DFG + + E + Y S + APE L
Sbjct: 113 NCIHRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAPEALN 167
Query: 266 FGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
+G Y++ D+WS G +L E LG +PG
Sbjct: 168 YG--RYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 36/212 (16%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
++V+G G FG VF+ G VAIK + K R E M H N++
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
L+ +V +F P + + + + +YQ+ L
Sbjct: 70 RLE--------------GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG 115
Query: 208 IHGGI------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---- 257
I G+ HRD+ +N+LVN + K+ DFG ++VL + +P +Y S
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIP 173
Query: 258 -YYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
+ APE I ++T+A D+WS G V+ E++
Sbjct: 174 IRWTAPEAI-AYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 4e-06
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
E V+G G FG V + + G+ VAIK + K R E M DHPN++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
L+ + + ++ EF+ + + + +I + I + Y
Sbjct: 69 HLEGVVTKSRP-----VMIITEFMENGA--LDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 121
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYRA 261
+ + HRD+ +N+LVN + K+ DFG ++ L + +Y S + A
Sbjct: 122 L-SEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELL 288
PE I ++T+A D+WS G V+ E++
Sbjct: 180 PEAI-AYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 25/219 (11%)
Query: 97 RVVGQGSFGIVFQAKCLETGET--VAIK--KVLQDKRYKN----RELQTMRLLDHPNVVS 148
+ +G+G FG V + + + VA+K K+ R + E M+ DHPNV+
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 149 LKHCFFSTTDKDELYLNLV-LEFVPETVYRVAKHYSR---ASQRMPLIYVKLYTYQICRA 204
L T + + +V L F+ YSR Q +P + + I
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
+ Y+ HRD+ +N ++N + + V + DFG +K + G+ Y R + P +
Sbjct: 125 MEYLSSK-SFIHRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKMP-V 178
Query: 265 IFGATE------YTTAIDIWSVGCVLAELLL-GQPLFPG 296
+ A E YTT D+WS G + E+ GQ +PG
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 45/189 (23%), Positives = 73/189 (38%), Gaps = 40/189 (21%)
Query: 120 AIKKVLQDKRYKNRELQTMRLLDHPNVVSL-------KHCFFSTTDKDELYLNLVL-EFV 171
A +D +E++ + L PN+ L + LN L + V
Sbjct: 58 ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114
Query: 172 PETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH 231
ET S++ L+Y+ QI + Y+ + HRD+ +N LV +
Sbjct: 115 AETSG--LACNSKSLSFSTLLYMAT---QIASGMRYLES-LNFVHRDLATRNCLVGK-NY 167
Query: 232 QVKLCDFGSAKVLVKGEPNISYICSRYY----RAP--------ELIFGATEYTTAIDIWS 279
+K+ DFG ++ L Y YY RAP E + ++TT D+W+
Sbjct: 168 TIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWA 217
Query: 280 VGCVLAELL 288
G L E+L
Sbjct: 218 FGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 64/244 (26%), Positives = 113/244 (46%), Gaps = 47/244 (19%)
Query: 99 VGQGSFGIVFQAKCLETGE-------TVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 145
+G+G FG V A+ + + TVA+K + D K+ E++ M+++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYR--------VAKHYSRASQRMP---LIYV 194
+++L + T LY+ ++E+ + R YS + ++P L +
Sbjct: 80 IINL---LGACTQDGPLYV--LVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 195 KLYT--YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
L + YQ+ R + Y+ + HRD+ +N+LV + +K+ DFG L + NI
Sbjct: 135 DLVSCAYQVARGMEYLASQKCI-HRDLAARNVLVT-EDNVMKIADFG----LARDVHNID 188
Query: 253 YICSRY-------YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLV 304
Y + APE +F YT D+WS G +L E+ LG +PG V++L
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP-VEELF 246
Query: 305 EIIK 308
+++K
Sbjct: 247 KLLK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 23/153 (15%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYKNR------ELQTMRLLDHPNVVSL 149
+ +G G+FG V A+ ++T A+K + + D +N+ E + D+ VV L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRM---PLIYVKLYTYQICRALA 206
++S DKD LY V++++P RM P + Y ++ A+
Sbjct: 67 ---YYSFQDKDNLYF--VMDYIP------GGDMMSLLIRMGIFPEDLARFYIAELTCAVE 115
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239
+H +G HRDIKP N+L++ H +KL DFG
Sbjct: 116 SVHK-MGFIHRDIKPDNILIDRDGH-IKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 39/138 (28%), Positives = 56/138 (40%), Gaps = 46/138 (33%)
Query: 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 306
G PN Y APE++ T YT D WSVG +L E+L+GQP F ++ ++ +++
Sbjct: 210 GTPN--------YIAPEVLL-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKV 260
Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH----KRMPPEAVDLVSRLLQYSP 362
I W H ++ PEA DL+ +L + P
Sbjct: 261 IN-----------------------------WQTSLHIPPQAKLSPEASDLIIKLCR-GP 290
Query: 363 NLRC---TALEACIHPFF 377
R A E HPFF
Sbjct: 291 EDRLGKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 80/331 (24%), Positives = 137/331 (41%), Gaps = 85/331 (25%)
Query: 87 PKQTISYMAERVVGQGSFGIVFQ--AKCLETGET---VAIKKVLQDKRYKNR-----ELQ 136
++ I+ + E +GQGSFG+V++ A+ + GE VA+K V + + R E
Sbjct: 4 SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 137 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLI 192
M+ +VV L K + L +V+E + ++ R + + + P
Sbjct: 62 VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116
Query: 193 YVK---LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249
++ +I +AY++ V HRD+ +N +V H VK+ DFG + + + +
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173
Query: 250 NISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAEL--LLGQPLFP 295
YYR APE + +TT+ D+WS G VL E+ L QP +
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQP-YQ 223
Query: 296 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS 355
G S +Q+++ + M+ Y + P P DL+
Sbjct: 224 GLSN-EQVLKFV-------------MDGGYLD--------QP------DNCPERVTDLMR 255
Query: 356 RLLQYSPNLRCTALEAC------IHPFFYEL 380
Q++P +R T LE +HP F E+
Sbjct: 256 MCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 46/199 (23%), Positives = 89/199 (44%), Gaps = 26/199 (13%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 155
+G G FG+V K VAIK + + ++ E + M L H +V L +
Sbjct: 12 LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67
Query: 156 TTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
T + +Y +V E++ R + SQ + + +C +AY+
Sbjct: 68 CTKQRPIY--IVTEYMSNGCLLNYLREHGKRFQPSQLLEM------CKDVCEGMAYLESK 119
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGA 268
HRD+ +N LV+ VK+ DFG ++ ++ E S + S++ + PE +
Sbjct: 120 -QFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLY 175
Query: 269 TEYTTAIDIWSVGCVLAEL 287
+++++ D+W+ G ++ E+
Sbjct: 176 SKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 49/219 (22%), Positives = 88/219 (40%), Gaps = 39/219 (17%)
Query: 98 VVGQGSFGIVFQAKCLETG----ETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 148
++ +G+FG +F ++ E V +K V E + L H N++
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSR--------ASQRMPLIYVKLYTYQ 200
+ H + + P + K + + Q + + Q
Sbjct: 73 ILHVCIEDGEPPFVLY-------PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC----- 255
I ++Y+H GV H+DI +N +++ QVK+ D ++ L + Y C
Sbjct: 126 IACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----YHCLGDNE 179
Query: 256 SRYYR--APELIFGATEYTTAIDIWSVGCVLAELL-LGQ 291
+R + A E + EY++A D+WS G +L EL+ LGQ
Sbjct: 180 NRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 61/247 (24%), Positives = 111/247 (44%), Gaps = 53/247 (21%)
Query: 99 VGQGSFGIVFQAKCL-------ETGETVAIKKVLQDKRYKN-----RELQTMRLLD-HPN 145
+G+G FG V +A+ + TVA+K + + K+ E++ M+L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRA--------------SQRMPL 191
+++L T + LY+ ++E+ + R + RA L
Sbjct: 80 IINL---LGVCTQEGPLYV--IVEYAAKGNLR---EFLRARRPPGPDYTFDITKVPEEQL 131
Query: 192 IYVKLYT--YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249
+ L + YQ+ R + Y+ + HRD+ +N+LV + +K+ DFG L +G
Sbjct: 132 SFKDLVSCAYQVARGMEYLESRRCI-HRDLAARNVLVT-EDNVMKIADFG----LARGVH 185
Query: 250 NISYICSRY-------YRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
+I Y + APE +F YT D+WS G ++ E+ LG +PG V+
Sbjct: 186 DIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVWSFGILMWEIFTLGGSPYPGIP-VE 243
Query: 302 QLVEIIK 308
+L ++++
Sbjct: 244 ELFKLLR 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 27/220 (12%)
Query: 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDH 143
P++T+ + +G G FG V+ VAIK + Q E M+ L H
Sbjct: 4 PRETLKL--VKKLGAGQFGEVWMG-YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
P +V L ++ ++ +Y+ + E++ E V + ++ + + QI
Sbjct: 61 PRLVRL----YAVVTQEPIYI--ITEYM-ENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------ 257
+A+I HRD++ N+LV+ T K+ DFG A+++ E Y
Sbjct: 114 GMAFIER-KNYIHRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGAKFPI 167
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
+ APE I T +T D+WS G +L E++ G+ +PG
Sbjct: 168 KWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 43/221 (19%)
Query: 96 ERVVGQGSFGIVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 147
+ V+G+G+FG V +A+ + G AIK++ + D R EL+ + +L HPN++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 148 SL-KHCFFSTTDKDELYLNLVLEFVP----------------ETVYRVAKHYSRASQRMP 190
+L C + YL L +E+ P + + +A +
Sbjct: 72 NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 191 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK---VLVKG 247
L++ + + R + Y+ + HRD+ +N+LV + K+ DFG ++ V VK
Sbjct: 126 LLH---FAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK- 179
Query: 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
+ + R+ L + YTT D+WS G +L E++
Sbjct: 180 -KTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 52/224 (23%)
Query: 99 VGQGSFGIVFQAKCL----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSL 149
+G+G+FG VF A+C E + + K L++ ++ RE + + +L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71
Query: 150 KHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYSRASQRMPLIYVKL 196
F+ + L +V E++ P+ +A A ++ L +
Sbjct: 72 ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDA-KILAGGEDVAPGQLTLGQMLA 126
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
QI + Y+ + HRD+ +N LV VK+ DFG ++ + +
Sbjct: 127 IASQIASGMVYL-ASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD-------- 176
Query: 257 RYYRA------------PELIFGATEYTTAIDIWSVGCVLAELL 288
YYR PE I ++TT DIWS G VL E+
Sbjct: 177 -YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEIF 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 64/255 (25%), Positives = 105/255 (41%), Gaps = 54/255 (21%)
Query: 96 ERVVGQGSFGIVFQAKCLETGET-----VAIKKV----LQDKRYKNRELQTMRLLDHPNV 146
+R +G+G+FG VF A+C T VA+K + L ++ RE + + L H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYSRASQRMPLIY 193
V + D D L +V E++ P+ + V +A + L
Sbjct: 70 VKF---YGVCGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
+ QI + Y+ V HRD+ +N LV + VK+ DFG ++ +
Sbjct: 125 MLHIASQIASGMVYLASQHFV-HRDLATRNCLVGANL-LVKIGDFGMSRDVYS------- 175
Query: 254 ICSRYYRA------------PELIFGATEYTTAIDIWSVGCVLAELLL--GQPLFP-GES 298
+ YYR PE I ++TT D+WS G +L E+ QP F +
Sbjct: 176 --TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
Query: 299 GVDQLVEIIKVLGTP 313
V + + +VL P
Sbjct: 233 EVIECITQGRVLERP 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 32/206 (15%)
Query: 99 VGQGSFGIVFQA--KCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 150
+G G+FG V + K + VAIK VL+++ K+ RE + M LD+P +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
+ + L LV+E + K S + + V +Q+ + Y+ G
Sbjct: 61 ---IGVCEAEALM--LVMEMASGG--PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 211 GIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-------YRAP 262
V HRD+ +N LLVN H K+ DFG +K L + SY +R + AP
Sbjct: 114 KNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL 288
E I ++++ D+WS G + E
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 72/305 (23%), Positives = 130/305 (42%), Gaps = 65/305 (21%)
Query: 99 VGQGSFGIVFQAKCLETGE-------TVAIKKVLQDKRYKN-----RELQTMRLL-DHPN 145
+G+G FG V A+ + + VA+K + D K+ E++ M+++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYR--------VAKHYSRASQRMPLIYVKLY 197
+++L + T LY+ ++E+ + R Y ++P +
Sbjct: 86 IINL---LGACTQDGPLYV--IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 198 -----TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
YQ+ R + Y+ + HRD+ +N+LV + +K+ DFG A+ +I
Sbjct: 141 DLVSCAYQVARGMEYLASKKCI-HRDLAARNVLVT-EDNVMKIADFGLAR-------DIH 191
Query: 253 YICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESG 299
+I YY+ APE +F YT D+WS G +L E+ LG +PG
Sbjct: 192 HI--DYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP- 247
Query: 300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP-PEAVDLVSRLL 358
V++L +++K G + C N Y + WH + +R + V+ + R+L
Sbjct: 248 VEELFKLLKE-GHRMDKPSNCTNELYMMMR------DCWHAVPSQRPTFKQLVEDLDRIL 300
Query: 359 QYSPN 363
+ N
Sbjct: 301 ALTSN 305
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 8e-05
Identities = 63/294 (21%), Positives = 105/294 (35%), Gaps = 63/294 (21%)
Query: 97 RVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
R +G G+FG V++ VA+K + + ++ E M +H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 147 VSLKHCFFSTTDKDELYLNLVL-------EFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
V + ++ ++ L L F+ E R + S + L++
Sbjct: 72 V---RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKD--LLFCARDVA 126
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSR 257
+ C+ L H HRDI +N L+ K+ DFG A+ + + +
Sbjct: 127 KGCKYLEENH----FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYR---------AS 173
Query: 258 YYR-----------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESG--VDQL 303
YYR P F +T+ D+WS G +L E+ LG +PG + V +
Sbjct: 174 YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
V L P C P Y +I W R P ++ R+
Sbjct: 234 VTGGGRLDPPK----GCPGPVY------RIMTDCWQHTPEDR--PNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 57/228 (25%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 147
E V+G+G+FG V +A + G AIK + + D R EL+ + +L HPN++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 148 SL-KHCFFSTTDKDELYLNLVLEFVP--------------ETVYRVAKHYSRASQRMPLI 192
+L C ++ YL + +E+ P ET AK + AS
Sbjct: 67 NLLGAC------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST----- 115
Query: 193 YVKLYTYQICRALAYIHGGI------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246
L + Q+ + + + G+ HRD+ +N+LV + K+ DFG L +
Sbjct: 116 ---LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL-ASKIADFG----LSR 167
Query: 247 GEPNISYICSRYYRAPELIFGATE------YTTAIDIWSVGCVLAELL 288
GE Y+ R P + + A E YTT D+WS G +L E++
Sbjct: 168 GEE--VYVKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 63/244 (25%), Positives = 106/244 (43%), Gaps = 34/244 (13%)
Query: 90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMR 139
T+ +M E +G+ FG V++ E + VAIK L+DK R + + MR
Sbjct: 6 TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62
Query: 140 L-LDHPNVVSL---------KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRM 189
L HPN+V L FS +L+ LV+ V + S
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 190 PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE- 248
P +V + T QI + ++ V H+D+ +N+LV + VK+ D G + + +
Sbjct: 123 PADFVHIVT-QIAAGMEFLSSH-HVVHKDLATRNVLVFDKLN-VKISDLGLFREVYAADY 179
Query: 249 ---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLV 304
S + R+ +++G +++ DIWS G VL E+ G + G S D ++
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-VI 236
Query: 305 EIIK 308
E+I+
Sbjct: 237 EMIR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 36/121 (29%), Positives = 56/121 (46%), Gaps = 29/121 (23%)
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
QI + Y+ + HRD+ +N LV + +K+ DFG ++ L G+ YY
Sbjct: 146 QIASGMKYL-SSLNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD---------YY 194
Query: 260 R------------APELIFGATEYTTAIDIWSVGCVLAELLL---GQPLFPGESGVDQLV 304
R A E I ++TTA D+W+ G L E+L+ QP GE +Q++
Sbjct: 195 RIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILMLCKEQPY--GELTDEQVI 251
Query: 305 E 305
E
Sbjct: 252 E 252
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 29/75 (38%), Positives = 39/75 (52%), Gaps = 5/75 (6%)
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG---EPN 250
+K Q+ L +H IG+ HRDIKP+NLLV QVK+ DFG+A + G P
Sbjct: 311 IKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPL 368
Query: 251 ISYICSRYYRAPELI 265
+ RY EL+
Sbjct: 369 YGMLDPRYSPPEELV 383
|
Length = 507 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 47/208 (22%), Positives = 89/208 (42%), Gaps = 31/208 (14%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 147
+++G G FG V + + G+++ I K +QD+ + + M LDH +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 148 SLKH-CFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
L C ++ L LV + P + V +H + L + QI +
Sbjct: 73 RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW----CVQIAKG 121
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYR 260
+ Y+ + HR++ +N+L+ + V++ DFG A +L + Y ++
Sbjct: 122 MYYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELL 288
++FG YT D+WS G + E++
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 155
+GQG FG V+ T + VAIK + +E Q M+ L H +V L ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68
Query: 156 TTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
++ +Y+ V EF+ + ++ K ++P + V + QI +AYI +
Sbjct: 69 VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDMAA-QIADGMAYIER-MNY 123
Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYRAPEL-IFG 267
HRD++ N+LV + K+ DFG A+++ E Y + + APE ++G
Sbjct: 124 IHRDLRAANILVGDNL-VCKIADFGLARLIEDNE----YTARQGAKFPIKWTAPEAALYG 178
Query: 268 ATEYTTAIDIWSVGCVLAELLL-GQPLFPG 296
+T D+WS G +L EL+ G+ +PG
Sbjct: 179 --RFTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRLLDHPNVV 147
S + +G G FG V+ G T K L+ E Q M+ L H +V
Sbjct: 7 SLQLIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
L ++ ++ +Y+ V E++ + ++ K + ++P + V + Q+ +A
Sbjct: 65 QL----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMA 116
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 263
YI + HRD++ N+LV K+ DFG A+ L++ + +++ + APE
Sbjct: 117 YIER-MNYIHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPE 173
Query: 264 L-IFGATEYTTAIDIWSVGCVLAELLL-GQPLFPG 296
++G +T D+WS G +L EL+ G+ +PG
Sbjct: 174 AALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 38/116 (32%), Positives = 56/116 (48%), Gaps = 8/116 (6%)
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--ICSR 257
Q+ A+ YIH + HRDIK +N+ +N V L DFG+A K Y + +
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDGKIV-LGDFGTAMPFEKEREAFDYGWVGTV 332
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD---QLVEIIKVL 310
+PE++ G Y DIWS G +L ++L G+ G QL++II L
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387
|
Length = 501 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 72/292 (24%), Positives = 118/292 (40%), Gaps = 55/292 (18%)
Query: 99 VGQGSFGIVFQAKCLETGETVA--IKKVLQDKRYKN------RELQTMRLLDHPNVVS-L 149
+G G FG V + G + A + K L+ + +E+Q R L+HPNV+ L
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRM------PLIYVKLYTYQICR 203
C S YL LVLEF P K+Y R+++ M + ++ ++
Sbjct: 62 GQCIESIP-----YL-LVLEFCP---LGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVAS 111
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YR 260
L ++H H D+ +N + VK+ D+G A + I+ C +
Sbjct: 112 GLLWLH-QADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169
Query: 261 APEL--IFGA----TEYTTAIDIWSVGCVLAEL--LLGQPLFPGESGVDQLVEIIKVLGT 312
APEL I G + T +IWS+G + EL QP +P S L ++++
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP-YPDLSDEQVLKQVVR---- 224
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFH-KRMPPE---AVDLVSRLLQY 360
++IK P + W+++ + PE + V LL Y
Sbjct: 225 --EQDIKLPKPQ-----LDLKYSDRWYEVMQFCWLDPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 51/223 (22%)
Query: 98 VVGQGSFGIVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVVSL 149
V+G+G+FG V +A+ + G AIK++ + D R EL+ + +L HPN+++L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 150 -KHCFFSTTDKDELYLNLVLEFVP--------------ETVYRVAKHYSRASQRMPLIYV 194
C + YL L +E+ P ET A S AS
Sbjct: 62 LGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS-------- 107
Query: 195 KLYTYQICRALAYIHGGIG------VCHRDIKPQNLLVNPHTHQVKLCDFGSAK---VLV 245
L + Q+ A + G+ HRD+ +N+LV + K+ DFG ++ V V
Sbjct: 108 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYV 166
Query: 246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL 288
K + + R+ L + YTT D+WS G +L E++
Sbjct: 167 K--KTMGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 58/234 (24%), Positives = 97/234 (41%), Gaps = 65/234 (27%)
Query: 99 VGQGSFGIVFQ------AKCLETGET--------VAIKKVLQD--KRYKN---RELQTMR 139
+G+G FG V A+ L G VA+K + D K +N +E++ M
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-------------ETVYRVAKHYSRAS 186
L +PN++ L + D L ++ E++ E+ + A + S
Sbjct: 73 RLKNPNIIRLL-GVCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 187 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246
L+Y+ + QI + Y+ + HRD+ +N LV H + +K+ DFG ++ L
Sbjct: 128 -IANLLYMAV---QIASGMKYL-ASLNFVHRDLATRNCLVGNH-YTIKIADFGMSRNLYS 181
Query: 247 GEPNISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL 288
G+ YYR A E I ++TTA D+W+ G L E+
Sbjct: 182 GD---------YYRIQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEMF 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 54/227 (23%)
Query: 96 ERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNV 146
+R +G+G+FG VF A+C E + + K L+D ++ +RE + + L H ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYSRASQRMPLIY 193
V + + D L + V E++ P+ V + + +++
Sbjct: 70 VKF---YGVCVEGDPLIM--VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
+ QI + Y+ V HRD+ +N LV + VK+ DFG ++ + +
Sbjct: 125 I---AQQIAAGMVYLASQHFV-HRDLATRNCLVGENL-LVKIGDFGMSRDVYSTD----- 174
Query: 254 ICSRYYRA------------PELIFGATEYTTAIDIWSVGCVLAELL 288
YYR PE I ++TT D+WS+G VL E+
Sbjct: 175 ----YYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIF 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 429 | |||
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.54 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.51 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.38 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.3 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.26 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.14 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.06 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.01 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.88 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.67 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.62 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.56 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.55 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.38 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.31 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.21 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.16 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.05 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.93 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.93 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.85 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.8 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.65 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.64 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.64 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.63 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.59 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.55 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.52 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.49 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.45 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.4 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.26 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.26 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.18 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.05 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.97 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.87 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.8 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.76 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.69 | |
| PLN02236 | 344 | choline kinase | 96.66 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.58 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.38 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.36 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.15 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.43 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 93.43 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.3 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.39 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 92.18 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.61 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 91.34 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 91.21 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 91.14 |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-72 Score=509.83 Aligned_cols=351 Identities=74% Similarity=1.203 Sum_probs=329.9
Q ss_pred ccEEEEeeCCCCCCCccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceE
Q 014174 73 GHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 152 (429)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 152 (429)
++...+...+..........|+-.+++|+|+||.||.|....+++.||||++..+.+...+|+.+|+.++|||||++..+
T Consensus 6 ~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~ 85 (364)
T KOG0658|consen 6 GHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYF 85 (364)
T ss_pred eeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEE
Confidence 34444555555555666778999999999999999999999999999999999999999999999999999999999999
Q ss_pred eeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCc
Q 014174 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ 232 (429)
Q Consensus 153 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~ 232 (429)
|....+.+..|+.+||||++.+|.+.++++.+.+.+++...++-+.+||++||.||| +.||+||||||.|+|+|.+.+.
T Consensus 86 f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh-~~~IcHRDIKPqNlLvD~~tg~ 164 (364)
T KOG0658|consen 86 FSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH-SHGICHRDIKPQNLLVDPDTGV 164 (364)
T ss_pred EEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH-hcCcccCCCChheEEEcCCCCe
Confidence 987776667889999999999999999999888999999999999999999999999 7999999999999999999889
Q ss_pred EEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014174 233 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312 (429)
Q Consensus 233 vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 312 (429)
+||||||.|+....++...++.||++|+|||.+.+...|+.+.||||.||++.||+-|++.|+|.+..+++..|.+.+|.
T Consensus 165 LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 165 LKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT 244 (364)
T ss_pred EEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCC
Q 014174 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRP 392 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~ 392 (429)
|+.+++.+|++++.+..+|++....|.+.+.+..++++.+|+.++|.++|.+|+++.|+|.||||.++++++.+.+++.+
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~g~~ 324 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPNGRP 324 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcCCCc
Confidence 99999999999999999999999999998999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCChhhhccCCHHHHHhhcHHHHhhhCC
Q 014174 393 FPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425 (429)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (429)
.|++++|+..+ .+..-+.+..++|++.+++..
T Consensus 325 lp~lf~f~~~e-~~~~~~~~~~l~p~~~~~~~~ 356 (364)
T KOG0658|consen 325 LPPLFNFKRAE-LGISPELVNVLIPEHLREQEK 356 (364)
T ss_pred CCCccCchHHH-hccchHHHHhhccHhhhhhcc
Confidence 99999999984 467789999999998887764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-59 Score=424.35 Aligned_cols=320 Identities=38% Similarity=0.652 Sum_probs=273.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.|..++.||+|+||.|+.|.++.+|+.||||++..- .....||+++|+.++|+||+.+.+++.......-.-+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 466689999999999999999999999999988522 23445899999999999999999988663333444588
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+|+|+|+.+|..+++. ++.++..+++.+++||++||.|+| +.+|+||||||.|+|++.++ .+||+|||+|+...
T Consensus 103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiH-SAnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIH-SANVIHRDLKPSNLLLNADC-DLKICDFGLARYLD 176 (359)
T ss_pred EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhh-cccccccccchhheeeccCC-CEEeccccceeecc
Confidence 9999999888887764 455999999999999999999999 99999999999999999999 79999999999875
Q ss_pred c---CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 246 K---GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 246 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
. ....+.++.|++|+|||++.....|+.++||||+||||.||++|++.|+|.+..+++..|+..+|.|..+.+..+.
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 3 4445778889999999999888889999999999999999999999999999999999999999999999887765
Q ss_pred c-Ccccc--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCC
Q 014174 323 P-NYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNF 399 (429)
Q Consensus 323 ~-~~~~~--~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 399 (429)
. +...+ +.|..+..++...++ +.++.+.+|+.+||.+||.+|+|++|+|+||||..+.+|...+.....+..
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~---- 331 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS---- 331 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc----
Confidence 2 22222 678888888888887 789999999999999999999999999999999999999887433332211
Q ss_pred ChhhhccCCHHHHHhhcHHHHhhhCC
Q 014174 400 KPQELKGASKELLSKLIPEHARKQCP 425 (429)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (429)
.+.. ...+.|..+++++..+-.|
T Consensus 332 --~~~~-~~~~~~r~~i~~e~~~~~~ 354 (359)
T KOG0660|consen 332 --FEHE-LTEEELRELIYKEILDFHP 354 (359)
T ss_pred --cccc-ccHHHHHHHHHHHHHhhCc
Confidence 2333 6678888888888766555
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-60 Score=442.54 Aligned_cols=283 Identities=37% Similarity=0.657 Sum_probs=254.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhh-----hHHHHHHHHHcC-CCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-----KNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 163 (429)
..+|.++++||.|.||.||+|+...+|+.||||++++.... .-||++.|++|+ |||||++.+++.+.. ..
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ce
Confidence 45799999999999999999999999999999988765322 238999999999 999999999885432 16
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+++|||||+.+|+++++.. ...|++..++.|++||++||+|+| ++|+.||||||+||||..+. .|||+|||+|+.
T Consensus 85 L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiH-k~GfFHRDlKPENiLi~~~~-~iKiaDFGLARe 159 (538)
T KOG0661|consen 85 LYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIH-KHGFFHRDLKPENILISGND-VIKIADFGLARE 159 (538)
T ss_pred EeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHH-hcCcccccCChhheEecccc-eeEecccccccc
Confidence 8999999999999998863 678999999999999999999999 99999999999999999766 799999999999
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc--
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 321 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 321 (429)
.......+.++.|++|+|||++.....|+.++||||+|||++|+.+-++.|+|.++.+++.+|.+++|.|..+.+..-
T Consensus 160 v~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 160 VRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 988888899999999999999998888999999999999999999999999999999999999999999998877542
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
-.+...+.+|+.....+...++. .+.++.+||.+||.+||.+||||.++|+||||+.-+.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 13345678899888888888877 9999999999999999999999999999999976443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-59 Score=414.14 Aligned_cols=281 Identities=36% Similarity=0.676 Sum_probs=246.9
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
++|+.+.++|+|+||.||+++++.||+.||||++..+. ...-||+++|++|+|+|+|.++.+| .....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 36889999999999999999999999999999996543 2335899999999999999999999 555568
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++|+|||+.++++.+..+ ...++...++.+++|++.|+.|+| ++++|||||||+||||+.++ .+||||||+|+..
T Consensus 77 hLVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cH-k~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L 151 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCH-KNNCIHRDIKPENILITQNG-VVKLCDFGFARTL 151 (396)
T ss_pred EEEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhh-hcCeecccCChhheEEecCC-cEEeccchhhHhh
Confidence 899999999888877664 467999999999999999999999 88999999999999999998 8999999999988
Q ss_pred c-cCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH--hhc
Q 014174 245 V-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI--KCM 321 (429)
Q Consensus 245 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~--~~~ 321 (429)
. .++..+.++.|++|+|||.+.+...|+..+||||+||++.||++|.+.|+|.+..+++..|++.+|....... -..
T Consensus 152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence 7 5666778899999999999999888999999999999999999999999999999999999999998766544 455
Q ss_pred CcCcccccCCCcCCC-CcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 322 NPNYTEFKFPQIKAH-PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~-~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
++-|..+.+|..... ++...++ .++..+.||+.+||..||.+|++.+++|.||||..+..
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred CCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 667777788876533 3444443 47889999999999999999999999999999966443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-58 Score=411.00 Aligned_cols=284 Identities=33% Similarity=0.554 Sum_probs=252.5
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhh------hHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
....|+.+..|++|+||.||+|+++.|++.||+|+++.+... .-||+.+|.+++|||||.+..+.+..+-.
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d--- 150 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD--- 150 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc---
Confidence 445799999999999999999999999999999999765422 24899999999999999998887654422
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+|||||||+.+|..++... .++|...+++.++.|++.||+||| ...|+|||||++|+|++..| .+||+|||+|+
T Consensus 151 ~iy~VMe~~EhDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH-~~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR 225 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLH-DNWILHRDLKTSNLLLSHKG-ILKIADFGLAR 225 (419)
T ss_pred eeeeeHHHHHhhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHh-hceeEecccchhheeeccCC-cEEecccchhh
Confidence 27899999999999988764 378999999999999999999999 88999999999999999888 79999999999
Q ss_pred ecccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 243 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.+.... ..+..+.|.+|+|||++.+...|+.++|+||+|||+.||+++++.|+|.+..+++.+|++.+|.|+...|...
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 987653 3567788999999999999999999999999999999999999999999999999999999999999888654
Q ss_pred C--cCcccccCCCcCCCCcccccCCC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 322 N--PNYTEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 322 ~--~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
. +.+..+.++..+...++..|+.. ++....+|+.++|.+||.+|+||.++|+|+||.+.
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 3 34445677777778888888776 78999999999999999999999999999999883
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-56 Score=446.11 Aligned_cols=332 Identities=52% Similarity=0.972 Sum_probs=291.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecC---CCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT---DKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~~~~l 166 (429)
..+|++.++||+|+||.||+|.+..+++.||||++........+|+.+++.++|+||++++++|.... .....++++
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l 144 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV 144 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence 34799999999999999999999999999999999877767778999999999999999998875432 133457889
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
||||+++++...+..+......+++..++.++.||+.||.||| +.||+||||||+||||+.+++.+||+|||+|+....
T Consensus 145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH-~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~ 223 (440)
T PTZ00036 145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH-SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223 (440)
T ss_pred EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence 9999999988887776666778999999999999999999999 899999999999999997765799999999987765
Q ss_pred CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+.+.+|.|..+.+..+++++.
T Consensus 224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~ 303 (440)
T PTZ00036 224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA 303 (440)
T ss_pred CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence 55555678899999999987766789999999999999999999999999999999999999999999999998888888
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCC-CCCCCCCCCCChhhhc
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPN-GRPFPPLFNFKPQELK 405 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 405 (429)
.+.++.+....+...++...++++++||.+||++||.+|+|+.|+|+||||.+++++....+. ....|.+++|+..+..
T Consensus 304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (440)
T PTZ00036 304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYIDKLPDLFNFCDAEIK 383 (440)
T ss_pred cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCCCCCCCCcCCCHHHHh
Confidence 888888877778778888899999999999999999999999999999999999887655444 3466788999999998
Q ss_pred cCCHHHHHhhcHHHHhh
Q 014174 406 GASKELLSKLIPEHARK 422 (429)
Q Consensus 406 ~~~~~~~~~~~~~~~~~ 422 (429)
....+...++++.....
T Consensus 384 ~~~~~~~~~~~~~~~~~ 400 (440)
T PTZ00036 384 EMSDACRRKIIPKCTYE 400 (440)
T ss_pred hCCHHHHHHHhhHHHHH
Confidence 88888888877764443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-57 Score=396.23 Aligned_cols=277 Identities=39% Similarity=0.709 Sum_probs=241.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.+|...++||+|.||.||+|++..||+.||||+++... ...-||++.|+.++|+||+.++++| .+...+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 36889999999999999999999999999999996442 2234899999999999999999999 444448
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
.||+||++.+|..+++. ....++...++.|+.++++||+||| ++.|+||||||.|+||+++| .+||+|||+|+.+
T Consensus 77 ~lVfEfm~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H-~~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f 151 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCH-SKWILHRDLKPNNLLISSDG-QLKIADFGLARFF 151 (318)
T ss_pred EEEEEeccccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHH-hhhhhcccCCccceEEcCCC-cEEeecccchhcc
Confidence 89999999998888765 4567999999999999999999999 89999999999999999998 8999999999988
Q ss_pred ccCCCc-ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 014174 245 VKGEPN-ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 322 (429)
Q Consensus 245 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 322 (429)
...... +..+.|++|+|||.+.|...|+..+||||.|||+.||+.|.+.|+|.++.+++..|+..+|+|..+.|..+.
T Consensus 152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 655433 334779999999999999999999999999999999999999999999999999999999999999998765
Q ss_pred -cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 323 -PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 323 -~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
++|..++ +++.......+ +..++++.||+.+||.+||.+|+|+.|+|+|+||...
T Consensus 232 lpdY~~~~--~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 232 LPDYVKIQ--QFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred cccHHHHh--cCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 3444443 33333333334 3478899999999999999999999999999999873
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-57 Score=433.00 Aligned_cols=267 Identities=31% Similarity=0.507 Sum_probs=229.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.+|...+.||+|||++||.+++..+|+.||+|++.+. .....+|++|.+.|+|||||+++++| ++..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 4699999999999999999999999999999999652 34556899999999999999999999 77777
Q ss_pred EEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
+|||+|+|..+ +..+++ ..+.++|.+++.+++||+.||.||| +++|+|||||..|+|++.+. .|||+|||+|.
T Consensus 93 VYivLELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH-~~~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt 166 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLH-SLGIIHRDLKLGNLFLNENM-NVKIGDFGLAT 166 (592)
T ss_pred eEEEEEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHH-hcCceecccchhheeecCcC-cEEecccceee
Confidence 99999999954 444433 3578999999999999999999999 89999999999999999988 69999999999
Q ss_pred ecccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 243 VLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 243 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
..... +...+.||||+|+|||++.. ..++..+||||+|||||.|++|++||...+-.+.+.+|..
T Consensus 167 ~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~------------- 232 (592)
T KOG0575|consen 167 QLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL------------- 232 (592)
T ss_pred eecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh-------------
Confidence 88754 66678899999999999975 5699999999999999999999999998888888887766
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFN 398 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~ 398 (429)
.+|.+ |..+|.++++||.+||..||.+|||+.++|.|+||..-..|.....+.....+.+.
T Consensus 233 ----~~Y~~------------P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp~~~l~~~p~~~ 293 (592)
T KOG0575|consen 233 ----NEYSM------------PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLPSSCLTMVPRFG 293 (592)
T ss_pred ----cCccc------------ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCCccccccCCcCC
Confidence 23333 34689999999999999999999999999999999665555554444444444444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-57 Score=414.71 Aligned_cols=258 Identities=32% Similarity=0.496 Sum_probs=222.0
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...+|+++++||+|+||+||+|+.+.|++.||+|++++. ......|..||..++||+||+++..| ++.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccC
Confidence 345799999999999999999999999999999988653 34455799999999999999999988 666
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
..+|+|+||+.|+ ++..+ .+..+.|++..++.|+.+|+.||.||| ++|||||||||+|||+|.+|| ++|+|||+|
T Consensus 98 ~kLylVld~~~GG--eLf~h-L~~eg~F~E~~arfYlaEi~lAL~~LH-~~gIiyRDlKPENILLd~~GH-i~LtDFgL~ 172 (357)
T KOG0598|consen 98 EKLYLVLDYLNGG--ELFYH-LQREGRFSEDRARFYLAEIVLALGYLH-SKGIIYRDLKPENILLDEQGH-IKLTDFGLC 172 (357)
T ss_pred CeEEEEEeccCCc--cHHHH-HHhcCCcchhHHHHHHHHHHHHHHHHH-hCCeeeccCCHHHeeecCCCc-EEEeccccc
Confidence 6799999999975 33323 233688999999999999999999999 999999999999999999995 999999999
Q ss_pred eecccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 242 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 242 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+..... ....+++||+.|||||++.+. .|+.++||||||+++|+|++|.+||.+.+......+|.+...
T Consensus 173 k~~~~~~~~t~tfcGT~eYmAPEil~~~-gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~--------- 242 (357)
T KOG0598|consen 173 KEDLKDGDATRTFCGTPEYMAPEILLGK-GYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKL--------- 242 (357)
T ss_pred hhcccCCCccccccCCccccChHHHhcC-CCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcC---------
Confidence 965544 445567999999999999875 599999999999999999999999999998888888876310
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC----CHHHHhcCCCCcccCCCCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC----TALEACIHPFFYELRDPNA 385 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~----t~~ell~hp~f~~~~~~~~ 385 (429)
...+..++.++++||+++|+.||++|. .+.++-+||||..+.|...
T Consensus 243 -------------------~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l 292 (357)
T KOG0598|consen 243 -------------------PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL 292 (357)
T ss_pred -------------------CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence 012234899999999999999999996 6889999999999888643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-58 Score=421.13 Aligned_cols=256 Identities=34% Similarity=0.500 Sum_probs=211.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----------hhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
..|.+.+.||+|+||.|-+|..+.||+.||||++++.. ....+|+++|++|+|||||+++++| .
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f-----~ 246 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF-----E 246 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----e
Confidence 46999999999999999999999999999999996532 1235899999999999999999998 4
Q ss_pred CceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC---CCcEEEe
Q 014174 160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH---THQVKLC 236 (429)
Q Consensus 160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~---~~~vkl~ 236 (429)
...+.||||||++|+ +++... -.++.+.+...+.+++|++.|+.||| +.||+||||||+|||+..+ . .+||+
T Consensus 247 ~~ds~YmVlE~v~GG--eLfd~v-v~nk~l~ed~~K~~f~Qll~avkYLH-~~GI~HRDiKPeNILl~~~~e~~-llKIt 321 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGG--ELFDKV-VANKYLREDLGKLLFKQLLTAVKYLH-SQGIIHRDIKPENILLSNDAEDC-LLKIT 321 (475)
T ss_pred cCCceEEEEEEecCc--cHHHHH-HhccccccchhHHHHHHHHHHHHHHH-HcCcccccCCcceEEeccCCcce-EEEec
Confidence 444579999999965 333332 23578899999999999999999999 8999999999999999765 4 69999
Q ss_pred ecccceecccCCCcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCC
Q 014174 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD-QLVEIIKVLGTP 313 (429)
Q Consensus 237 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~ 313 (429)
|||+|+..+......+.|||+.|.|||++.+. ..+..++|||||||+||.+++|.+||.+..... ...+|.+.
T Consensus 322 DFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G---- 397 (475)
T KOG0615|consen 322 DFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG---- 397 (475)
T ss_pred ccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC----
Confidence 99999999888788889999999999999653 334568999999999999999999998765544 33333331
Q ss_pred CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
.|.+ ....+.+++.++++||.+||..||++|||+.|+|+||||+...
T Consensus 398 -------------~y~f--------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 398 -------------RYAF--------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred -------------cccc--------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 1111 1112235899999999999999999999999999999998543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-57 Score=422.49 Aligned_cols=285 Identities=36% Similarity=0.600 Sum_probs=241.6
Q ss_pred CCCccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC
Q 014174 85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 85 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 158 (429)
+.+.....|+.+++||+|.||.||+|++..+|+.||+|++..+. ....||+.||++|+||||+++.+.....
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~-- 188 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK-- 188 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec--
Confidence 34556678999999999999999999999999999999996543 3345899999999999999999987654
Q ss_pred CCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 159 KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
....+|||+|||+.+|..++.. ..-.|++.+++.|+.||+.||+||| ++||+|||||.+|||||.+| .+||+||
T Consensus 189 -~~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH-~~gvlHRDIK~SNiLidn~G-~LKiaDF 262 (560)
T KOG0600|consen 189 -LSGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCH-SRGVLHRDIKGSNILIDNNG-VLKIADF 262 (560)
T ss_pred -CCceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHh-hcCeeeccccccceEEcCCC-CEEeccc
Confidence 2345889999999988777653 3457999999999999999999999 89999999999999999888 8999999
Q ss_pred ccceecccCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 239 GSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 239 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
|+|+.+.... ..++.+.|.+|+|||++.|...|+.++|+||.||||.||++|++.|+|.++.+++.+|++.+|.|+..
T Consensus 263 GLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 263 GLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred cceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 9999775543 46778889999999999999999999999999999999999999999999999999999999999998
Q ss_pred HHhhcC-cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCc
Q 014174 317 EIKCMN-PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378 (429)
Q Consensus 317 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~ 378 (429)
.|.... +.+..+.-..--.+.+... -..++..+.+|+..||+.||.+|.||.++|+|+||.
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 887221 1222221111112223333 346899999999999999999999999999999993
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=401.87 Aligned_cols=256 Identities=30% Similarity=0.519 Sum_probs=214.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.+.+.++.||+|+.|+||+|+++.|++.+|+|++... ...+.+|+++++.++|||||++|++|+.... .++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is 154 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS 154 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence 3577788999999999999999999999999999432 3445689999999999999999999976542 388
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
|+||||+++.++.+.. ..+++++.....++.+|++||.|||.+++||||||||+||||++.| .|||||||.++...
T Consensus 155 I~mEYMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lv 230 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILV 230 (364)
T ss_pred eehhhcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhh
Confidence 9999999765554432 2478999999999999999999999659999999999999999998 79999999999887
Q ss_pred cCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHHHHhCCCCHHHHhh
Q 014174 246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE-----SGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-----~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+. ...++.||..|||||.+.+. .|+.++||||||++++||++|+.||... +..+.+..|.. .|+
T Consensus 231 nS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~---~pp------ 299 (364)
T KOG0581|consen 231 NS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVD---EPP------ 299 (364)
T ss_pred hh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhc---CCC------
Confidence 66 66789999999999999875 4999999999999999999999999874 22333333322 111
Q ss_pred cCcCcccccCCCcCCCCcccccCCC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
| .++.. +|+++++|+..||++||.+|+|+.++++|||+.+...++
T Consensus 300 ----------P---------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~ 345 (364)
T KOG0581|consen 300 ----------P---------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN 345 (364)
T ss_pred ----------C---------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc
Confidence 0 12333 899999999999999999999999999999998766543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-54 Score=411.00 Aligned_cols=256 Identities=32% Similarity=0.579 Sum_probs=224.8
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
....+|..++.||+|+|++|++|+++.+++.||||++.+. ..+..+|-.+|.+| .||.|++++..| +
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence 3445899999999999999999999999999999987543 35566899999999 799999999888 5
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
+...+|+|+||++ |.|+.++.++ +.|++..++.++.||+.||+||| ++|||||||||+|||+|.++ .+||+||
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH-~~GIIHRDlKPENILLd~dm-hikITDF 218 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLH-SNGIIHRDLKPENILLDKDG-HIKITDF 218 (604)
T ss_pred cccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHH-hcCceeccCChhheeEcCCC-cEEEeec
Confidence 5556899999998 6777777664 78999999999999999999999 89999999999999999999 5999999
Q ss_pred ccceecccCC--------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 014174 239 GSAKVLVKGE--------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304 (429)
Q Consensus 239 G~a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 304 (429)
|.|+.+.... ...+++||..|.+||++.. ...++.+|||+||||+|.|+.|.+||.+.++--.++
T Consensus 219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq 297 (604)
T KOG0592|consen 219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ 297 (604)
T ss_pred cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence 9998874321 1145899999999999966 448999999999999999999999999999988999
Q ss_pred HHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 305 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
+|++. .| .|++++++.+++||+++|..||++|+|+.+|.+||||..+.|.+
T Consensus 298 kI~~l-----------------~y------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n 348 (604)
T KOG0592|consen 298 KIQAL-----------------DY------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN 348 (604)
T ss_pred HHHHh-----------------cc------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence 98884 22 24557899999999999999999999999999999999988865
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-54 Score=406.72 Aligned_cols=265 Identities=32% Similarity=0.505 Sum_probs=221.8
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
...++|.++++||+|+||.||+|+-+.||..||+|++++.. .....|..+|...++|+||++|..| ++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cC
Confidence 35668999999999999999999999999999999997653 3334688999999999999999999 77
Q ss_pred ceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
..++||||||++|+-...+ ....+.|++.++++|+.+++.|+..|| +.|+|||||||+|+|||..|| +||+|||+
T Consensus 213 ~~~LYLiMEylPGGD~mTL---L~~~~~L~e~~arfYiaE~vlAI~~iH-~~gyIHRDIKPdNlLiD~~GH-iKLSDFGL 287 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTL---LMRKDTLTEDWARFYIAETVLAIESIH-QLGYIHRDIKPDNLLIDAKGH-IKLSDFGL 287 (550)
T ss_pred CCeeEEEEEecCCccHHHH---HHhcCcCchHHHHHHHHHHHHHHHHHH-HcCcccccCChhheeecCCCC-Eeeccccc
Confidence 7789999999997533222 223578999999999999999999999 999999999999999999996 99999999
Q ss_pred ceeccc----------------------C--C-----C-------------------cccccccccccccccccCCCCCC
Q 014174 241 AKVLVK----------------------G--E-----P-------------------NISYICSRYYRAPELIFGATEYT 272 (429)
Q Consensus 241 a~~~~~----------------------~--~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~ 272 (429)
|..... . . . ..+.+|||.|||||++.+.. |+
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~ 366 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG 366 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence 854311 0 0 0 02457999999999998855 99
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHH
Q 014174 273 TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVD 352 (429)
Q Consensus 273 ~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~ 352 (429)
..+|+|||||||||||.|.+||.+.+..+...+|+..... +.+|. ...++++++|
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~---------------l~fP~----------~~~~s~eA~D 421 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET---------------LKFPE----------EVDLSDEAKD 421 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh---------------ccCCC----------cCcccHHHHH
Confidence 9999999999999999999999999999999988874211 11221 1246899999
Q ss_pred HHHhhcCcCCCCCCC---HHHHhcCCCCcccCCCCCCCCC
Q 014174 353 LVSRLLQYSPNLRCT---ALEACIHPFFYELRDPNARLPN 389 (429)
Q Consensus 353 Li~~~L~~dP~~R~t---~~ell~hp~f~~~~~~~~~~~~ 389 (429)
||.+||+ ||++|+. +.||.+||||+.+.|.+.+.-.
T Consensus 422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~ 460 (550)
T KOG0605|consen 422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMP 460 (550)
T ss_pred HHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCC
Confidence 9999999 9999995 8899999999999997755433
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-54 Score=379.50 Aligned_cols=253 Identities=30% Similarity=0.500 Sum_probs=221.6
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
....+|.+++.||.|+||.|.+++.+.+|..||+|++.+.. +....|.++|+.+.||+++++++.| .+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----cc
Confidence 34457999999999999999999999999999999886542 3345799999999999999999888 66
Q ss_pred ceEEEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
..++++||||++|+ ++. +.++.++|++..+++++.||+.||+||| +++|++|||||+|||+|.+|+ +||+|||
T Consensus 116 ~~~lymvmeyv~GGElFS----~Lrk~~rF~e~~arFYAAeivlAleylH-~~~iiYRDLKPENiLlD~~G~-iKitDFG 189 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFS----YLRKSGRFSEPHARFYAAEIVLALEYLH-SLDIIYRDLKPENLLLDQNGH-IKITDFG 189 (355)
T ss_pred CCeEEEEEeccCCccHHH----HHHhcCCCCchhHHHHHHHHHHHHHHHH-hcCeeeccCChHHeeeccCCc-EEEEecc
Confidence 66799999999965 333 3455789999999999999999999999 899999999999999999995 9999999
Q ss_pred cceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
.|+..... ....|||+.|+|||++.. ..|+.++|+|||||++|||+.|.+||...+....+.+|.+.
T Consensus 190 FAK~v~~r--T~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~---------- 256 (355)
T KOG0616|consen 190 FAKRVSGR--TWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEG---------- 256 (355)
T ss_pred ceEEecCc--EEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhC----------
Confidence 99987544 567899999999999976 45999999999999999999999999999998888888873
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDP 383 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~ 383 (429)
.+. +|..+++++++||+++|+.|-.+|. ...++.+||||+.+.|.
T Consensus 257 -------~v~------------fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~ 306 (355)
T KOG0616|consen 257 -------KVK------------FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWE 306 (355)
T ss_pred -------ccc------------CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHH
Confidence 222 4456899999999999999999994 56799999999998774
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-53 Score=385.92 Aligned_cols=291 Identities=34% Similarity=0.679 Sum_probs=243.8
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh------hhHHHHHHHHHcCCCC-eeecceEeeecCC-CCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR------YKNRELQTMRLLDHPN-VVSLKHCFFSTTD-KDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~-~~~~ 162 (429)
..|..+++||+|+||+||+|+.+.+|+.||+|++.-+.. ...||+.+++.|+|+| ||.+++++...+. ....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 358888899999999999999999999999999965433 2358999999999999 9999998865442 2334
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+++|+||++.++...+.........++...++.+++||+.||+||| ++||+||||||.||||+++| .+||+|||+|+
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H-~~~IlHRDLKPQNlLi~~~G-~lKlaDFGlAr 168 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH-SHGILHRDLKPQNLLISSSG-VLKLADFGLAR 168 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH-hCCeecccCCcceEEECCCC-cEeeeccchHH
Confidence 68899999998888877765433356888999999999999999999 89999999999999999988 79999999999
Q ss_pred ecc-cCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 243 VLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 243 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
... .....+..++|.+|+|||++.+...|+..+||||+|||++||+++++.|++.++.+++..|++.+|.|+.+.|...
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 776 3344667788999999999999988999999999999999999999999999999999999999999999888754
Q ss_pred C--cCcccccCCCcC-CCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCC
Q 014174 322 N--PNYTEFKFPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNA 385 (429)
Q Consensus 322 ~--~~~~~~~~~~~~-~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~ 385 (429)
. +.|.. .++... ...+... .+..+++..+|+.+||+++|.+|.|+..+|.||||.++.....
T Consensus 249 ~~~~~~k~-~f~~~~~~~~l~~~-~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~ 313 (323)
T KOG0594|consen 249 SSLPDYKA-PFPKWPGPKDLSSI-LPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSS 313 (323)
T ss_pred cccccccc-cCcCCCCccchHHh-ccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchh
Confidence 3 23332 344433 2222222 2345679999999999999999999999999999998765543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-53 Score=409.61 Aligned_cols=257 Identities=29% Similarity=0.497 Sum_probs=223.4
Q ss_pred CccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcC-CCCeeecceEeeecCC
Q 014174 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTD 158 (429)
Q Consensus 87 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 158 (429)
.....+|+++++||+|+||+|++|..+.+++.||||+++++. +....|.+|+...+ ||++++++.+|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f----- 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF----- 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence 344568999999999999999999999999999999987653 33446888887775 99999999999
Q ss_pred CCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 159 KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
+...++|+||||+.|+. +.+ .+..+.|++..+++|+..|+.||.||| ++||||||||.+|||+|.+|| +||+||
T Consensus 439 QT~~~l~fvmey~~Ggd---m~~-~~~~~~F~e~rarfyaAev~l~L~fLH-~~~IIYRDlKLdNiLLD~eGh-~kiADF 512 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGD---LMH-HIHTDVFSEPRARFYAAEVVLGLQFLH-ENGIIYRDLKLDNLLLDTEGH-VKIADF 512 (694)
T ss_pred ccCCeEEEEEEecCCCc---EEE-EEecccccHHHHHHHHHHHHHHHHHHH-hcCceeeecchhheEEcccCc-EEeccc
Confidence 77778999999999874 222 334578999999999999999999999 999999999999999999995 999999
Q ss_pred ccceecc-cCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 239 GSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 239 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
|+|+... .+....+++||+.|||||++.+.. |+.++|||||||+||||+.|.+||.++++.+....|+.
T Consensus 513 GlcKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~--------- 582 (694)
T KOG0694|consen 513 GLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN--------- 582 (694)
T ss_pred ccccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------
Confidence 9999865 555667889999999999998755 99999999999999999999999999999999888775
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCCCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRDPN 384 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~~~ 384 (429)
.++.+ |..+|.++.++++++|..||++|+. +.+|.+||||+.+.|..
T Consensus 583 --------d~~~y------------P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~ 634 (694)
T KOG0694|consen 583 --------DEVRY------------PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD 634 (694)
T ss_pred --------CCCCC------------CCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence 22333 3358999999999999999999995 57899999999988753
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-52 Score=403.55 Aligned_cols=280 Identities=36% Similarity=0.605 Sum_probs=230.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhH---HHHHHHHHcC-C-----CCeeecceEeeecCCCCce
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLD-H-----PNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~~ 162 (429)
+|.|.++||+|+||.|.+|.+..|++.||||+++....+.. .|+++|..|+ | -|+|+++++| ....
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~ 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence 79999999999999999999999999999999988776654 5888999886 3 4899999999 5555
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC-CCCcEEEeecccc
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~-~~~~vkl~DfG~a 241 (429)
++|||+|.++.+|+++++. +....++...++.++.||+.||.+|| +.||||+||||+||||.. +...|||+|||+|
T Consensus 262 HlciVfELL~~NLYellK~--n~f~Glsl~~ir~~~~Qil~~L~~L~-~l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKN--NKFRGLSLPLVRKFAQQILTALLFLH-ELGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ceeeeehhhhhhHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCChhheeeccCCcCceeEEecccc
Confidence 6999999999999999986 34467999999999999999999999 999999999999999843 3347999999999
Q ss_pred eecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
+..... ...++.+++|+|||++.+.+ |+.+.||||||||++||++|.++|+|.++.+++..|++.+|.|+...+...
T Consensus 339 c~~~q~--vytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 339 CFESQR--VYTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cccCCc--ceeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 876433 33788899999999999865 999999999999999999999999999999999999999999998877643
Q ss_pred CcCcccccC----CC---c---------------------------CCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC
Q 014174 322 NPNYTEFKF----PQ---I---------------------------KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367 (429)
Q Consensus 322 ~~~~~~~~~----~~---~---------------------------~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t 367 (429)
......+.- +. . ....+...+...-...+.|||.+||.+||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 322221111 00 0 0011111111122345799999999999999999
Q ss_pred HHHHhcCCCCcccCC
Q 014174 368 ALEACIHPFFYELRD 382 (429)
Q Consensus 368 ~~ell~hp~f~~~~~ 382 (429)
+.++|+||||.....
T Consensus 496 p~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 496 PAQALNHPFLTGTSL 510 (586)
T ss_pred HHHHhcCcccccccc
Confidence 999999999986444
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-52 Score=401.09 Aligned_cols=254 Identities=31% Similarity=0.497 Sum_probs=225.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
+-|++++.||.|+-|.|-+|++..||+.+|||++.+. ...+++|+-||+.++|||++++|+++ ++..+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCce
Confidence 3499999999999999999999999999999999776 46678999999999999999999999 66667
Q ss_pred EEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
+|+|.||++++ |++.+ ...+++++.+++.++.||+.|+.||| ..+|+||||||+|+|+|.++ .|||+|||+|.
T Consensus 87 lylvlEyv~gGELFdyl----v~kG~l~e~eaa~ff~QIi~gv~yCH-~~~icHRDLKpENlLLd~~~-nIKIADFGMAs 160 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYL----VRKGPLPEREAAHFFRQILDGVSYCH-AFNICHRDLKPENLLLDVKN-NIKIADFGMAS 160 (786)
T ss_pred EEEEEEecCCchhHHHH----HhhCCCCCHHHHHHHHHHHHHHHHHh-hhcceeccCCchhhhhhccc-CEeeeccceee
Confidence 99999999854 44333 33688999999999999999999999 89999999999999999888 59999999999
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
.-..+.-..+.||+++|.|||++.+.++.+.++||||.|||||.|+||+.||.+.+....+.++.+
T Consensus 161 Le~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~-------------- 226 (786)
T KOG0588|consen 161 LEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR-------------- 226 (786)
T ss_pred cccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc--------------
Confidence 887777778899999999999999999889999999999999999999999997777666666654
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
..|.+ |..+|+++++||++||..||++|+|.+||++|||+.......
T Consensus 227 ---G~f~M------------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 227 ---GVFEM------------PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred ---CcccC------------CCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence 22333 346899999999999999999999999999999998766643
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=394.69 Aligned_cols=251 Identities=33% Similarity=0.498 Sum_probs=216.2
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---------hhhhHHHHHHHHHcC-CCCeeecceEeeecCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTD 158 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 158 (429)
..+.|.+.+.||+|+||+|++|++..+|+.||+|++.+. .....+|+.+++.++ ||||++++.++..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t--- 91 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT--- 91 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec---
Confidence 345799999999999999999999999999999976543 223458999999999 9999999999843
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC-CCcEEEe
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-THQVKLC 236 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~-~~~vkl~ 236 (429)
...+++|||||.+ .|++.+. . .+++.+..++.+++||+.|++||| ++||+||||||+|||++.+ + .+||+
T Consensus 92 --~~~~~ivmEy~~gGdL~~~i~---~-~g~l~E~~ar~~F~Qlisav~y~H-~~gi~HRDLK~ENilld~~~~-~~Kl~ 163 (370)
T KOG0583|consen 92 --PTKIYIVMEYCSGGDLFDYIV---N-KGRLKEDEARKYFRQLISAVAYCH-SRGIVHRDLKPENILLDGNEG-NLKLS 163 (370)
T ss_pred --CCeEEEEEEecCCccHHHHHH---H-cCCCChHHHHHHHHHHHHHHHHHH-hCCEeeCCCCHHHEEecCCCC-CEEEe
Confidence 3348899999996 5555443 2 688999999999999999999999 8999999999999999988 6 79999
Q ss_pred ecccceec-ccCCCcccccccccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 237 DFGSAKVL-VKGEPNISYICSRYYRAPELIFGAT-EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 237 DfG~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
|||++... .........+||+.|+|||++.+.. +.+.++||||+||+||.|++|+.||...+.......|.+
T Consensus 164 DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------ 237 (370)
T KOG0583|consen 164 DFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------ 237 (370)
T ss_pred ccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc------
Confidence 99999988 4566677899999999999998866 557899999999999999999999998776666666544
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCC-ChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRM-PPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
..+.+ +..+ |+++++||++||..||.+|+|+.++++||||+.
T Consensus 238 -----------~~~~~------------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 -----------GEFKI------------PSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -----------CCccC------------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 12222 3346 999999999999999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-53 Score=374.19 Aligned_cols=254 Identities=30% Similarity=0.510 Sum_probs=210.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeec------chhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.+|+|+++||+|+||.||+|.+..+|..+|.|.+.- .+...-.|+.+|++|+|||||++++.-+. .+...+
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl 95 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL 95 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence 369999999999999999999999999999998852 23334479999999999999999883322 222337
Q ss_pred EEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC--CC--eeeecCCCCceEecCCCCcEEEeecc
Q 014174 165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG--IG--VCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--~g--ivH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
+||||||+ |+|...++++....+.+++.+++.++.|+|.||.++| + .. |+||||||.||+|+.+| .+||+|||
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH-~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfG 173 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCH-SKIPRGTVMHRDIKPANIFLTANG-VVKLGDFG 173 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHh-ccccccceeeccCcchheEEcCCC-ceeeccch
Confidence 89999998 7888899999888999999999999999999999999 5 33 99999999999999988 89999999
Q ss_pred cceecccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 240 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 240 ~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
+++....... ..+++|||+||+||.+.+.. |+.+|||||+||++|||+.-++||.+.+-.+.-.+|.+.--.|...
T Consensus 174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~-- 250 (375)
T KOG0591|consen 174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD-- 250 (375)
T ss_pred hHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH--
Confidence 9998755433 35789999999999997754 9999999999999999999999999996666656665531111110
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
...|.++..||..|+..||..||+. +|++.++..
T Consensus 251 -------------------------~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~~ 284 (375)
T KOG0591|consen 251 -------------------------EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQS 284 (375)
T ss_pred -------------------------HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHHH
Confidence 2368999999999999999999986 555554443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=378.28 Aligned_cols=254 Identities=30% Similarity=0.517 Sum_probs=215.8
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..++|.+.+.||+|+||+||+|+++.++..||||.+.+.. +....|+.+|+.++|||||++++|+ ....
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence 4557999999999999999999999999999999986542 3345799999999999999999998 4445
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC-C----CcEEEe
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-T----HQVKLC 236 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~-~----~~vkl~ 236 (429)
++|+|||||+| +|...+ +..+.+++..++.++.||+.||++|| +++||||||||+||||+.. + -.+||+
T Consensus 83 ~i~lVMEyC~gGDLs~yi----~~~~~l~e~t~r~Fm~QLA~alq~L~-~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIA 157 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYI----RRRGRLPEATARHFMQQLASALQFLH-ENNIIHRDLKPQNILLSTTARNDTSPVLKIA 157 (429)
T ss_pred eEEEEEEeCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCCcceEEeccCCCCCCCceEEec
Confidence 79999999995 444433 44578999999999999999999999 8999999999999999764 1 269999
Q ss_pred ecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 237 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
|||+|+....+....+.+|++.|||||++... .|+.++|+||+|+++|+|++|+.||...+..+.+..+.+..
T Consensus 158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~------ 230 (429)
T KOG0595|consen 158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN------ 230 (429)
T ss_pred ccchhhhCCchhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc------
Confidence 99999999888878889999999999999654 59999999999999999999999999888777766444321
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.....++..++..+.+|+...|+.+|..|.+..+-+.|++...
T Consensus 231 --------------------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 231 --------------------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred --------------------cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 1111233346788889999999999999999999999999864
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-51 Score=376.46 Aligned_cols=277 Identities=27% Similarity=0.433 Sum_probs=231.2
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
.....|++++.||.|.-|+||+|+...++..+|+|++.++. ...+.|.+||+.++||+++.+|+.| +.
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et 148 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ET 148 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ec
Confidence 44457999999999999999999999999999999996542 2234699999999999999999999 77
Q ss_pred ceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
..|.|+|||||+|+-+..+.+ .+..+.|++..+++|+.+++.||+||| -.|||+|||||+||||-.+|| |.|+||.+
T Consensus 149 ~~~~cl~meyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLH-mlGivYRDLKPENILvredGH-IMLsDFDL 225 (459)
T KOG0610|consen 149 DKYSCLVMEYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLH-MLGIVYRDLKPENILVREDGH-IMLSDFDL 225 (459)
T ss_pred cceeEEEEecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHH-hhceeeccCCcceeEEecCCc-EEeeeccc
Confidence 778999999999655554443 355788999999999999999999999 999999999999999999996 99999998
Q ss_pred ceeccc---------------------------------C-C-----------------------Ccccccccccccccc
Q 014174 241 AKVLVK---------------------------------G-E-----------------------PNISYICSRYYRAPE 263 (429)
Q Consensus 241 a~~~~~---------------------------------~-~-----------------------~~~~~~gt~~y~aPE 263 (429)
+..... . . ...+++||-.|+|||
T Consensus 226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE 305 (459)
T KOG0610|consen 226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE 305 (459)
T ss_pred cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence 643200 0 0 012467899999999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccC
Q 014174 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH 343 (429)
Q Consensus 264 ~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (429)
++.+.. .+.++|||+|||++|||+.|..||.|.+..+.+..|+.. ...+|..
T Consensus 306 vI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-----------------~l~Fp~~---------- 357 (459)
T KOG0610|consen 306 VIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-----------------PLKFPEE---------- 357 (459)
T ss_pred eeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-----------------CCcCCCC----------
Confidence 998754 899999999999999999999999999999999887752 2233332
Q ss_pred CCCChhHHHHHHhhcCcCCCCCCC----HHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCC
Q 014174 344 KRMPPEAVDLVSRLLQYSPNLRCT----ALEACIHPFFYELRDPNARLPNGRPFPPLFNFK 400 (429)
Q Consensus 344 ~~~s~~l~~Li~~~L~~dP~~R~t----~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 400 (429)
+.++..++|||+++|.+||++|+. |.||.+||||..++|.--+-..+..+|.+.+..
T Consensus 358 ~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~ 418 (459)
T KOG0610|consen 358 PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVDGG 418 (459)
T ss_pred CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccccC
Confidence 247899999999999999999998 999999999999999866655555556666554
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=373.77 Aligned_cols=277 Identities=33% Similarity=0.623 Sum_probs=229.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
..+|++.++||.|+||.||+|++..++..||+|++.... ....+|+.+++.++||||+++++++ ....+.
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence 346999999999999999999999999999999885332 2345799999999999999999988 334468
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++||||+++++...+.. ....+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++..
T Consensus 79 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~ 153 (288)
T cd07871 79 TLVFEYLDSDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCH-KRKILHRDLKPQNLLINEKG-ELKLADFGLARAK 153 (288)
T ss_pred EEEEeCCCcCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCC-CEEECcCcceeec
Confidence 89999999887766543 2345889999999999999999999 89999999999999999888 7999999999765
Q ss_pred ccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ......+|+.|+|||++.+...++.++||||+||++|+|+||++||.+.+..+.+..+.+..+.+..+.+.....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 3322 223456789999999987666689999999999999999999999999999999999999999998887765432
Q ss_pred --CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 --NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 --~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.+..+.++......+.. ....++.++++||++||++||.+|+|+.|+|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLIN-HAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred chhhhccccCccCCCchHH-hCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 23333444433333222 234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=387.48 Aligned_cols=286 Identities=29% Similarity=0.451 Sum_probs=232.4
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+.. ....+|++|++.++|||||.+++.| +....+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 46999999999999999999999999999999886542 2356899999999999999999999 666669
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++|+||+.|+|..++.. .+.++++.++.++.+++.||.||| +.+|+|||+||.|||+...+ .+|+||||+|+.+
T Consensus 77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLh-s~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLH-SNRILHRDMKPQNILLEKGG-TLKLCDFGLARAM 150 (808)
T ss_pred EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH-hcCcccccCCcceeeecCCC-ceeechhhhhhhc
Confidence 99999999988887765 688999999999999999999999 89999999999999999888 7999999999988
Q ss_pred ccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
..+.. .++.-||+.|||||.+.+. .|+..+|+|||||++|||++|++||...+..+....|.+. |
T Consensus 151 ~~~t~vltsikGtPlYmAPElv~e~-pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d---~---------- 216 (808)
T KOG0597|consen 151 STNTSVLTSIKGTPLYMAPELVEEQ-PYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKD---P---------- 216 (808)
T ss_pred ccCceeeeeccCcccccCHHHHcCC-CccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC---C----------
Confidence 66543 3566799999999999864 5999999999999999999999999877666555555441 1
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCChhh
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQE 403 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (429)
. ..+..++..++.||..+|.+||.+|+|..+++.|||.+.--...........-.+..|..|.|
T Consensus 217 ----v------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spftn~~Ppe 280 (808)
T KOG0597|consen 217 ----V------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFTNNTPPE 280 (808)
T ss_pred ----C------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCccccCCChH
Confidence 0 122357999999999999999999999999999999976333322222222333444555666
Q ss_pred hccCCHHHHHhhcH
Q 014174 404 LKGASKELLSKLIP 417 (429)
Q Consensus 404 ~~~~~~~~~~~~~~ 417 (429)
.+....+.-++..+
T Consensus 281 ~kek~~kq~srqa~ 294 (808)
T KOG0597|consen 281 YKEKDRKQGSRQAE 294 (808)
T ss_pred HHHhhhcccCcccC
Confidence 66655444444333
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-52 Score=355.98 Aligned_cols=255 Identities=31% Similarity=0.467 Sum_probs=216.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeec------chhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.+.|.+.++||+|.|+.|+++.+..||+.+|+|++.. +.+.+++|++|-+.|+|||||++...+ ....+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence 3469999999999999999999999999999998742 345667999999999999999998887 66778
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC--CCcEEEeecccc
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH--THQVKLCDFGSA 241 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~--~~~vkl~DfG~a 241 (429)
.++|+|++.|+ ++....-. ...+++..+-.+++||+.||.|+| ..||||||+||+|+++-+. +--+||+|||+|
T Consensus 85 ~ylvFe~m~G~--dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH-~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 85 HYLVFDLVTGG--ELFEDIVA-REFYSEADASHCIQQILEALAYCH-SNGIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred eEEEEecccch--HHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHH-hcCceeccCChhheeeeeccCCCceeecccceE
Confidence 99999999964 22222111 245789999999999999999999 8899999999999999532 336999999999
Q ss_pred eecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.....+.....+.|||.|||||++...+ |+..+|||+.|++||-|+.|.+||.+.+....+..|++.
T Consensus 161 i~l~~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g------------ 227 (355)
T KOG0033|consen 161 IEVNDGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG------------ 227 (355)
T ss_pred EEeCCccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc------------
Confidence 9988776677889999999999997654 999999999999999999999999998888888888773
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.+.++. ...+.+++++++|+++||..||.+|+|+.|+|+|||+.+
T Consensus 228 -----~yd~~~--------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 228 -----AYDYPS--------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred -----ccCCCC--------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 222222 123458999999999999999999999999999999976
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=330.79 Aligned_cols=281 Identities=34% Similarity=0.573 Sum_probs=238.5
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|.-.++||+|.||+||+|++..+++.||+|.+.-+. ...-+|+.+++.++|.|||+++++. .....+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 4666789999999999999999999999999986542 3446899999999999999999987 3334488
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+|+|||...+...... .++.+..+.++.++.|+++||.|+| +++++||||||.|+||+.+| .+|++|||+++..+
T Consensus 78 lvfe~cdqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fch-shnvlhrdlkpqnllin~ng-elkladfglarafg 152 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCH-SHNVLHRDLKPQNLLINRNG-ELKLADFGLARAFG 152 (292)
T ss_pred EeHHHhhHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhh-hhhhhhccCCcceEEeccCC-cEEecccchhhhcC
Confidence 9999999876665543 4678999999999999999999999 89999999999999999999 79999999999876
Q ss_pred cCCCc-ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 246 KGEPN-ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 246 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
-.-.+ ...+.|.+|++|.++.+..-|+...|+||.|||+.|+.. |++.|++.+-.+++.+|+..+|.|+.+.|..+..
T Consensus 153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 55433 334569999999999999999999999999999999986 8999999999999999999999999999987764
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
--.-..+|.++....-..+-++++...+||++++|.-+|.+|++++++|+||||.+...
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s~ 291 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFSP 291 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccCC
Confidence 33333455544332222334567888999999999999999999999999999987543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-50 Score=372.30 Aligned_cols=260 Identities=29% Similarity=0.437 Sum_probs=215.6
Q ss_pred CCCccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------------------hhhHHHHHHHHHcCCCCe
Q 014174 85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------------RYKNRELQTMRLLDHPNV 146 (429)
Q Consensus 85 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------~~~~~E~~~l~~l~h~ni 146 (429)
......++|++++.||+|.||+|-+|++..+++.||||++.+.. +...+|+.||++|.||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 34466789999999999999999999999999999999985431 234589999999999999
Q ss_pred eecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceE
Q 014174 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQR-MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL 225 (429)
Q Consensus 147 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nil 225 (429)
|+++.+.-+ .....+|||+|||..+-.. . ...... +++.+++.|++.++.||.||| .+|||||||||+|+|
T Consensus 171 V~LiEvLDD---P~s~~~YlVley~s~G~v~--w--~p~d~~els~~~Ar~ylrDvv~GLEYLH-~QgiiHRDIKPsNLL 242 (576)
T KOG0585|consen 171 VKLIEVLDD---PESDKLYLVLEYCSKGEVK--W--CPPDKPELSEQQARKYLRDVVLGLEYLH-YQGIIHRDIKPSNLL 242 (576)
T ss_pred eEEEEeecC---cccCceEEEEEeccCCccc--c--CCCCcccccHHHHHHHHHHHHHHHHHHH-hcCeeccccchhheE
Confidence 999998743 4445689999999865222 1 223344 999999999999999999999 889999999999999
Q ss_pred ecCCCCcEEEeecccceecccC------CCcccccccccccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 014174 226 VNPHTHQVKLCDFGSAKVLVKG------EPNISYICSRYYRAPELIFG---ATEYTTAIDIWSVGCVLAELLLGQPLFPG 296 (429)
Q Consensus 226 l~~~~~~vkl~DfG~a~~~~~~------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~ 296 (429)
|+++| .+||+|||.+.....+ .......||+.|+|||.+.+ ....+.+.||||+||+||.|+.|+.||-+
T Consensus 243 l~~~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~ 321 (576)
T KOG0585|consen 243 LSSDG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD 321 (576)
T ss_pred EcCCC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc
Confidence 99998 7999999999866222 12234789999999999976 33458899999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014174 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376 (429)
Q Consensus 297 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~ 376 (429)
....+...+|... .+.+|.. +.+.++++|||.+||++||+.|+++.++..|||
T Consensus 322 ~~~~~l~~KIvn~-----------------pL~fP~~----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 322 DFELELFDKIVND-----------------PLEFPEN----------PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred chHHHHHHHHhcC-----------------cccCCCc----------ccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 8888888877652 2233332 246899999999999999999999999999999
Q ss_pred Cccc
Q 014174 377 FYEL 380 (429)
Q Consensus 377 f~~~ 380 (429)
...-
T Consensus 375 vt~~ 378 (576)
T KOG0585|consen 375 VTRD 378 (576)
T ss_pred eccC
Confidence 9653
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=373.08 Aligned_cols=257 Identities=33% Similarity=0.531 Sum_probs=207.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.+|...+.||+|+||.||++.+..+|..+|+|.+... .....+|+.+|+.|+|||||++++......+ ..+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence 3588999999999999999999999999999988665 4446899999999999999999886432221 46889
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC-CCCcEEEeecccceec
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVL 244 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~-~~~~vkl~DfG~a~~~ 244 (429)
.|||+++ ++.+.+..+ ++.+++..++.+.+||++||.||| ++|||||||||+|||++. ++ .+||+|||+++..
T Consensus 94 ~mEy~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylH-s~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLH-SKGIVHCDIKPANILLDPSNG-DVKLADFGLAKKL 168 (313)
T ss_pred eeeccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-hCCEeccCcccceEEEeCCCC-eEEeccCcccccc
Confidence 9999996 444444432 227999999999999999999999 899999999999999998 56 7999999999876
Q ss_pred cc----CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHh
Q 014174 245 VK----GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 245 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
.. ........||+.|||||++........++|||||||++.||+||.+||... ...+.+..+....
T Consensus 169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--------- 239 (313)
T KOG0198|consen 169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--------- 239 (313)
T ss_pred ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC---------
Confidence 53 223446789999999999975333445999999999999999999999873 3222222222100
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
..| .++..+|+++++||++||.+||++||||.++|+|||...-..
T Consensus 240 ---------~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 240 ---------SLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ---------CCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 111 345668999999999999999999999999999999976443
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=375.12 Aligned_cols=318 Identities=37% Similarity=0.647 Sum_probs=238.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.++||+|+||.||+|++..+|..||||++... .....+|+++++.++||||+++++++..........++
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 599999999999999999999999999999988532 12345799999999999999999988655444445688
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||+++++...+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus 81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIH-TANVFHRDLKPKNILANADC-KLKICDFGLARVAF 154 (338)
T ss_pred EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence 9999999887776543 456999999999999999999999 88999999999999999888 79999999997643
Q ss_pred cCCC----cccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 246 KGEP----NISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 246 ~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
.... .....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....|.+....+..
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 1345689999999988542 4588999999999999999999999999888888888888888887765543
Q ss_pred cCcCc-ccc--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCC
Q 014174 321 MNPNY-TEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLF 397 (429)
Q Consensus 321 ~~~~~-~~~--~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 397 (429)
..... ..+ .........+...+ +.+++.+.+||.+||..||++|||+.++++||||..+...... +...+.+..
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~-~~~~~~~~~- 311 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVERE-PSAQPITKL- 311 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccc-cccCccccc-
Confidence 32110 000 00000011111111 2468899999999999999999999999999999987775433 333333221
Q ss_pred CCChhhhccCCHHHHHhhcHHH
Q 014174 398 NFKPQELKGASKELLSKLIPEH 419 (429)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~ 419 (429)
.+. .+....+.+....++..+
T Consensus 312 ~~~-~~~~~~~~~~~~~~~~~~ 332 (338)
T cd07859 312 EFE-FERRRLTKEDVRELIYRE 332 (338)
T ss_pred ccc-HHHHhcCHHHHHHHHHHH
Confidence 221 123344445555554443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-48 Score=368.43 Aligned_cols=281 Identities=32% Similarity=0.528 Sum_probs=218.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++. ...+.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeEE
Confidence 57999999999999999999999999999999886432 23457999999999999999999883 344688
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||+++++...+.. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++....
T Consensus 80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 154 (303)
T cd07869 80 LVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIH-QRYILHRDLKPQNLLISDTG-ELKLADFGLARAKS 154 (303)
T ss_pred EEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEECCCCcceecc
Confidence 9999999888776543 2456899999999999999999999 88999999999999999887 79999999987543
Q ss_pred cC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 246 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 246 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.. .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.. ..+.+..+....+.+....+.....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 22 222345678999999998766668999999999999999999999998754 3456666777777776554432211
Q ss_pred --CcccccCCCcCCCCccccc-CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 324 --NYTEFKFPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 324 --~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
.+....+.......+...+ ....++++.+||++||++||.+|+|+.++|+||||.++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 1110011111111111111 113567899999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=376.88 Aligned_cols=250 Identities=29% Similarity=0.471 Sum_probs=214.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..|....+||+|+-|.||.|+...+++.||||++... ++.+-.|+.+|+.++|+|||.+++.|...++ +++
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eEE
Confidence 3688899999999999999999999999999999644 3455689999999999999999999976644 899
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
||||++|+.+..+-. ...++|..++.++++++.||+||| .+||+|||||.+|||++.+| .+||+|||+|..+..
T Consensus 348 VMEym~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH-~~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLH-ARGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISE 421 (550)
T ss_pred EEeecCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHH-hcceeeeccccceeEeccCC-cEEEeeeeeeecccc
Confidence 999999654433322 355999999999999999999999 88999999999999999998 799999999988765
Q ss_pred CC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 014174 247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325 (429)
Q Consensus 247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 325 (429)
.. .....+||++|||||++.. ..|++++||||||+++.||+-|++||-..+....+..|... |.|..
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~l---------- 489 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKL---------- 489 (550)
T ss_pred ccCccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCc----------
Confidence 54 4567789999999999965 45999999999999999999999999888887777776552 33221
Q ss_pred ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCc
Q 014174 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378 (429)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~ 378 (429)
..+..+|+.+++||.+||+.|+.+|++|.|||+||||.
T Consensus 490 ---------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 490 ---------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred ---------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 12346899999999999999999999999999999994
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=373.10 Aligned_cols=286 Identities=31% Similarity=0.534 Sum_probs=225.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCC-CCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 162 (429)
..+|++.+.||+|+||.||+|.+..+|..||+|++... .....+|+.+++.++||||+++++++..... ....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 45799999999999999999999999999999988542 2234479999999999999999998754332 1223
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+++||||+++++...+. ..+++..+..++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++
T Consensus 100 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH-~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~ 171 (359)
T cd07876 100 DVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLAR 171 (359)
T ss_pred eeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCC-CEEEecCCCcc
Confidence 578999999988766542 35889999999999999999999 88999999999999999888 79999999997
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.+.++.+..+.+....
T Consensus 172 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 172 TACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 65544444556789999999999764 48999999999999999999999999998888888888888888765443221
Q ss_pred cCcccc--cCCCcCCCCc-----------ccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 323 PNYTEF--KFPQIKAHPW-----------HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 323 ~~~~~~--~~~~~~~~~~-----------~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
.....+ ..+......+ ........++.+++||.+||.+||++|||+.|+|+||||..+.++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~ 325 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPA 325 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCcc
Confidence 110000 0000000000 0011223578899999999999999999999999999998776654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-50 Score=349.23 Aligned_cols=259 Identities=27% Similarity=0.456 Sum_probs=220.3
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------------hhhhHHHHHHHHHc-CCCCeeecceEeeecCC
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 158 (429)
.|.-.+.||+|..++|-++.++.+|..+|+|++... .+...+|+.||+++ .||||+++.++|
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y----- 92 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY----- 92 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence 477788999999999999999999999999988321 12223689999998 599999999999
Q ss_pred CCceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEee
Q 014174 159 KDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD 237 (429)
Q Consensus 159 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~D 237 (429)
+...++++|+|.|+ |.|++.+. ..-.+++...+.+++|++.|+.||| ..+||||||||+|||++.+. ++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylH-a~~IVHRDLKpENILlddn~-~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLH-ARNIVHRDLKPENILLDDNM-NIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHH-HhhhhhcccChhheeecccc-ceEEec
Confidence 77778999999998 56666554 3567999999999999999999999 88999999999999999877 799999
Q ss_pred cccceecccCCCcccccccccccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014174 238 FGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312 (429)
Q Consensus 238 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 312 (429)
||.|+....++.....|||+.|+|||.+.+ .+.|+..+|+|++|+|||.|+.|.+||......-++..|++..-.
T Consensus 167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ 246 (411)
T ss_pred cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence 999999999999999999999999999854 356889999999999999999999999888777777777773211
Q ss_pred CCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCC
Q 014174 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNAR 386 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~ 386 (429)
-..+ . ..++|..++|||++||+.||.+|+|++|+|.||||..+.....+
T Consensus 247 F~sp--------------------e-----Wadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~r 295 (411)
T KOG0599|consen 247 FRSP--------------------E-----WADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQAR 295 (411)
T ss_pred cCCc--------------------c-----hhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhccc
Confidence 1111 1 13479999999999999999999999999999999776655443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=358.02 Aligned_cols=272 Identities=27% Similarity=0.442 Sum_probs=222.4
Q ss_pred CCCccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 85 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
..+.....|++..+||.|.-++||+|++..+++.||||++.-+ ...+.+|+..++.++||||++++.+|.....
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~- 98 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE- 98 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce-
Confidence 3455666899999999999999999999999999999999643 2556789999999999999999999965544
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
+|+||.||. |+++++++.+.. ..++|..++.|++++++||.||| ++|.||||||+.||||+.+| .|||+||
T Consensus 99 ----LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH-~~G~IHRdvKAgnILi~~dG-~VkLadF 170 (516)
T KOG0582|consen 99 ----LWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLH-QNGHIHRDVKAGNILIDSDG-TVKLADF 170 (516)
T ss_pred ----eEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHH-hcCceecccccccEEEcCCC-cEEEcCc
Confidence 999999998 678888887654 45999999999999999999999 89999999999999999999 7999999
Q ss_pred ccceecccCCCc-----ccccccccccccccc-cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014174 239 GSAKVLVKGEPN-----ISYICSRYYRAPELI-FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312 (429)
Q Consensus 239 G~a~~~~~~~~~-----~~~~gt~~y~aPE~~-~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 312 (429)
|.+..+...... ..+.||++|||||++ .....|+.++||||||++..||++|..||........+-..++ +.
T Consensus 171 gvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n~ 248 (516)
T KOG0582|consen 171 GVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--ND 248 (516)
T ss_pred eeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--CC
Confidence 987665443221 345789999999994 4456799999999999999999999999998877776644333 34
Q ss_pred CCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
|+..... .....-.+.++..++.+|..||.+||.+||||.++|+|+||+..+...
T Consensus 249 pp~~~t~-----------------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~ 303 (516)
T KOG0582|consen 249 PPTLLTS-----------------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKE 303 (516)
T ss_pred CCCcccc-----------------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchh
Confidence 3311100 000111134678999999999999999999999999999998866544
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=360.15 Aligned_cols=275 Identities=39% Similarity=0.696 Sum_probs=220.8
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++|+||+++++++ ....+++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 76 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY 76 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence 699999999999999999999999999999988643 12345799999999999999999988 3444689
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||++++++..+.. ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 151 (287)
T cd07848 77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCH-KNDIVHRDIKPENLLISHND-VLKLCDFGFARNLS 151 (287)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence 9999999887765532 2457999999999999999999999 88999999999999999887 79999999998754
Q ss_pred cCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 014174 246 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 322 (429)
Q Consensus 246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 322 (429)
... ......||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+....+..+.+.+....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 322 122456899999999997654 8999999999999999999999999988888887777777766655544322
Q ss_pred -cCcccccCCCcC-CCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 323 -PNYTEFKFPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 323 -~~~~~~~~~~~~-~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
+.+.....+... ...+...+...+|.++.+||++||++||++|||+.++|+||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 111111222111 1112222334578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=360.94 Aligned_cols=279 Identities=34% Similarity=0.575 Sum_probs=220.5
Q ss_pred ceEEeeEEccCCceEEEEEEEcC-CCcEEEEEEeecch------hhhHHHHHHHHHc---CCCCeeecceEeeecCCCCc
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~ 161 (429)
+|++.+.||+|+||.||+|++.. ++..||+|.+.... ....+|+.+++.+ +||||+++++++........
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 69999999999999999999864 46889999885321 2234677777765 69999999998865443445
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
..+++||||+++++...+... ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH-~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTSSG-QIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence 568899999998887766542 2345899999999999999999999 88999999999999999888 7999999999
Q ss_pred eecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
+............||+.|+|||.+.+. .++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 158 RIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred EeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 876554444456789999999998664 4899999999999999999999999999999999999988887766554321
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.. .....+......... .+.+.++..+.+||.+||+.||++|||+.++|+||||
T Consensus 237 ~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VA-LPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hc-ccchhccCCCCCCHH-HHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 10 000111111111111 1234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=371.39 Aligned_cols=288 Identities=31% Similarity=0.527 Sum_probs=228.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCC-CCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 162 (429)
..+|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++..... ....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 45799999999999999999999999999999988642 1234479999999999999999988753321 2234
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+++||||+++++...+. ..+++..+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|||+++
T Consensus 103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~ 174 (364)
T cd07875 103 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLAR 174 (364)
T ss_pred eEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHh-hCCeecCCCCHHHEEECCCC-cEEEEeCCCcc
Confidence 578999999988776553 34888999999999999999999 88999999999999999888 79999999998
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
............+|..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....+.|..+.+..+.
T Consensus 175 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 175 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred ccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 76544444556789999999999764 48999999999999999999999999999999999999888888766554433
Q ss_pred cCcccc--cCCCcCC-----------CCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCC
Q 014174 323 PNYTEF--KFPQIKA-----------HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNAR 386 (429)
Q Consensus 323 ~~~~~~--~~~~~~~-----------~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~ 386 (429)
.....+ ..+.... .++........+..+++||.+||+.||.+|||+.++|+||||..+.++...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~ 330 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEA 330 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccC
Confidence 221110 0111100 011111222346789999999999999999999999999999987776544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-47 Score=360.80 Aligned_cols=281 Identities=34% Similarity=0.634 Sum_probs=228.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.+|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++.. ....+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----DKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-----CCeEE
Confidence 46999999999999999999999999999999886432 234579999999999999999998843 33588
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||+++++...+.. ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus 81 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH-~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~ 155 (309)
T cd07872 81 LVFEYLDKDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCH-RRKVLHRDLKPQNLLINERG-ELKLADFGLARAKS 155 (309)
T ss_pred EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEECccccceecC
Confidence 9999999877765543 2356899999999999999999999 88999999999999999887 79999999997643
Q ss_pred cCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
... ......+|..|+|||.+.+...++.++|||||||++|+|+||++||.+.+..+.+..+....+.+....+......
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 322 2233467899999999876666899999999999999999999999999988899999999998888776544321
Q ss_pred --cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 325 --YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 325 --~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
+..+.++......+.. ....++.++++||.+||..||.+|+|+.|+++||||..+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 236 DEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred hhhhhhhcCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 2223333332222222 12357899999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=333.71 Aligned_cols=252 Identities=30% Similarity=0.451 Sum_probs=218.1
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..++|.+.+.||+|-||.||+|+.++++..||+|++.++. ....||++|-..|+||||+++|++| .+.
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HDS 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ecc
Confidence 3457999999999999999999999999999999986542 3445899999999999999999999 455
Q ss_pred eEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
..+|+++||.+ |.++..+.. ....++++..+..++.|++.||.|+| .++++||||||+|+|++.++ .+||+|||.
T Consensus 95 ~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h-~k~VIhRdiKpenlLlg~~~-~lkiAdfGw 170 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCH-LKRVIHRDIKPENLLLGSAG-ELKIADFGW 170 (281)
T ss_pred ceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhc-cCCcccCCCCHHHhccCCCC-CeeccCCCc
Confidence 55899999998 555555542 24577999999999999999999999 89999999999999999998 799999999
Q ss_pred ceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+.... .......|||..|.+||+..+.. ++..+|+|++|++.||++.|.+||...+..+.+++|.+.
T Consensus 171 sV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~----------- 237 (281)
T KOG0580|consen 171 SVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV----------- 237 (281)
T ss_pred eeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-----------
Confidence 87654 44456789999999999997754 899999999999999999999999998888888887774
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
+..++..++.++.|||.+||.++|.+|.+..|++.|||+...
T Consensus 238 ------------------~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 238 ------------------DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ------------------cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 112345689999999999999999999999999999999653
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=355.20 Aligned_cols=279 Identities=30% Similarity=0.533 Sum_probs=221.2
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHc---CCCCeeecceEeeecCCCCce
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 162 (429)
+|++.+.||+|+||+||+|++..+++.||+|.+.... ....+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4899999999999999999999999999999886421 1234677777665 799999999988655444556
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+++||||+++++...+... ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++.
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dikp~Nili~~~~-~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENILVTSGG-QVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccccCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEECccCccc
Confidence 68899999998877766532 2345899999999999999999999 88999999999999999888 79999999998
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
............+|..|+|||++.+. .++.++|||||||++|+|++|.+||.+......+.++....+.+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 157 IYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred cccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 76544444456789999999998764 48999999999999999999999999988888888888888777655443211
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
. .....+.......+. ...+.++..+.+||.+||++||.+|||+.+++.||||
T Consensus 236 ~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 236 T-LPRGAFSPRGPRPVQ-SVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred c-ccccccCCCCCCchH-HhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 000011111111111 1223578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=364.43 Aligned_cols=317 Identities=32% Similarity=0.564 Sum_probs=241.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC-CCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 163 (429)
.+|++.+.||+|+||+||+|.+..+++.||+|.+.... ....+|+++++.++|+||+++++++..... .....
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 46999999999999999999999999999999886432 234479999999999999999988753221 22234
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
.+++++++++++...+. ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus 95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~ 167 (343)
T cd07878 95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQ 167 (343)
T ss_pred EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeecccCChhhEEECCCC-CEEEcCCcccee
Confidence 68999999887766553 356999999999999999999999 88999999999999999888 799999999987
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..+.+.....
T Consensus 168 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd07878 168 ADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245 (343)
T ss_pred cCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence 543 234567899999999987756689999999999999999999999999888888888888888877665543322
Q ss_pred Ccccc---cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCC
Q 014174 324 NYTEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFK 400 (429)
Q Consensus 324 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 400 (429)
..... ..+......+...+ ...++.+.+||.+||..||.+|||+.++|+||||.....+..... ...+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~-----~~~~~~~ 319 (343)
T cd07878 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPE-----AEPYDES 319 (343)
T ss_pred hhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccc-----cCccccc
Confidence 11100 11111111111111 246788999999999999999999999999999998877654321 2223333
Q ss_pred hhhhccCCHHHHHhhcHHHHhhh
Q 014174 401 PQELKGASKELLSKLIPEHARKQ 423 (429)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~ 423 (429)
... +......+..+..++..+.
T Consensus 320 ~~~-~~~~~~~~~~~~~~~~~~~ 341 (343)
T cd07878 320 PEN-KERTIEEWKELTYEEVSSF 341 (343)
T ss_pred hhh-hhccHHHHHHHHHHHHHhc
Confidence 322 2333455666666655543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=366.83 Aligned_cols=285 Identities=32% Similarity=0.539 Sum_probs=226.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC-CCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 162 (429)
..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++..... ....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 457999999999999999999999999999999886421 233479999999999999999998754332 2223
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
..++||||+++++...+. ..+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++
T Consensus 96 ~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDikp~Nill~~~~-~~kl~Dfg~~~ 167 (355)
T cd07874 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLAR 167 (355)
T ss_pred eeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHHEEECCCC-CEEEeeCcccc
Confidence 578999999988766543 35889999999999999999999 88999999999999999888 79999999998
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
............+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...++.+..+.+..+.
T Consensus 168 ~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 168 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred cCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 76554444556789999999998764 48999999999999999999999999999888888888888888766554433
Q ss_pred cCc----------ccccCCCcCC---CCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 323 PNY----------TEFKFPQIKA---HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 323 ~~~----------~~~~~~~~~~---~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
+.. ....++.... ...........+..+++||.+||..||++|||+.|+|+||||..+.++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~ 320 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP 320 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence 221 1111111100 001111223356789999999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=356.71 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=206.0
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++ ....+.+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence 889999999999999999999999999999885432 1234799999999999999998887 3344688
Q ss_pred EEEeccchhHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~~l~-~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||++++.+ ..+.. .....+++..+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|||++...
T Consensus 77 lv~e~~~~g~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~ 152 (285)
T cd05631 77 LVLTIMNGGDLKFHIYN--MGNPGFDEQRAIFYAAELCCGLEDLQ-RERIVYRDLKPENILLDDRG-HIRISDLGLAVQI 152 (285)
T ss_pred EEEEecCCCcHHHHHHh--hCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEc
Confidence 99999986533 33322 12346899999999999999999999 89999999999999999887 7999999999876
Q ss_pred ccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
..........||..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 220 (285)
T cd05631 153 PEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----------- 220 (285)
T ss_pred CCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc-----------
Confidence 544444456789999999999764 48999999999999999999999998765433322222211000
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCCC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRDP 383 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~~ 383 (429)
...++..++.++.+||++||+.||.+|+| ++++++||||..+.+.
T Consensus 221 --------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 221 --------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred --------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 01123457999999999999999999997 8999999999886653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=370.13 Aligned_cols=284 Identities=35% Similarity=0.562 Sum_probs=225.2
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|+||.||+|.+..+|+.||||.+... .....+|+++++.++|+||+++++++..........++
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 378899999999999999999999999999988542 12345799999999999999999988544322223688
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||+.+++...+. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus 81 lv~e~~~~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQSDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLH-SAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEE 154 (372)
T ss_pred EEeeccccCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChHHEEECCCC-CEEeccccceeecc
Confidence 999999987766553 2467999999999999999999999 88999999999999999888 79999999997653
Q ss_pred cCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 246 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... ......+|+.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+..+.+..+...+|.++.+.+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 322 223346789999999997766689999999999999999999999999999999999999999988766543211
Q ss_pred Ccccc--cCCCc-CCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 324 NYTEF--KFPQI-KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 324 ~~~~~--~~~~~-~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
..... ..+.. ........+....++++.+||.+||++||.+|||+.++|+||||...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 11000 00000 000000112345689999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=363.01 Aligned_cols=251 Identities=29% Similarity=0.424 Sum_probs=207.3
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++. ...
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCC
Confidence 457999999999999999999999999999999986432 23457999999999999999999884 344
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
++++||||+.+ +|.+.+. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus 92 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~ 165 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLH-SKDIIYRDLKPENLLLDNKG-HVKVTDFGFA 165 (329)
T ss_pred EEEEEEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHEEECCCC-CEEEeeccCc
Confidence 58899999985 4444443 2467899999999999999999999 89999999999999999888 7999999999
Q ss_pred eecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
+..... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 166 ~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~------------ 230 (329)
T PTZ00263 166 KKVPDR--TFTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG------------ 230 (329)
T ss_pred eEcCCC--cceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Confidence 876332 2346789999999999764 4899999999999999999999999877665544443321
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRDP 383 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~~ 383 (429)
.. .++..++..+++||++||+.||.+|++ +.++++||||.+..+.
T Consensus 231 -----~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 231 -----RL------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred -----Cc------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 00 122346889999999999999999997 7999999999875443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=354.07 Aligned_cols=245 Identities=25% Similarity=0.447 Sum_probs=217.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++.+.||+|.||+|-+|.....|+.||||.++++. -.+.+|++||..|+||||+.+|.+| ++..-+
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkdKI 128 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKDKI 128 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCceE
Confidence 6999999999999999999999999999999886543 2346899999999999999999999 555568
Q ss_pred EEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
.|||||.. |.|++.+.. .+.+++.+++.+++||..|+.|+| +++++|||||.+|||+|.++ .+||+|||++..
T Consensus 129 vivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCH-knrVvHRDLKLENILLD~N~-NiKIADFGLSNl 202 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCH-KNRVVHRDLKLENILLDQNN-NIKIADFGLSNL 202 (668)
T ss_pred EEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHh-hccceecccchhheeecCCC-Ceeeeccchhhh
Confidence 89999998 556665543 578999999999999999999999 89999999999999999998 799999999999
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
+........+||++.|.+||++.+.++-++.+|.||||++||.|+.|..||.|.+....+.+|...
T Consensus 203 y~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G-------------- 268 (668)
T KOG0611|consen 203 YADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG-------------- 268 (668)
T ss_pred hccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc--------------
Confidence 988888889999999999999999887799999999999999999999999999988887776552
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.|.- +.-+.++.-||+.||..||++|.|+.++-.|=|.
T Consensus 269 ---aYrE-------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 269 ---AYRE-------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred ---cccC-------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 1211 2257889999999999999999999999999776
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=357.20 Aligned_cols=249 Identities=26% Similarity=0.398 Sum_probs=207.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++.+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+++.++||||+++++++ .+..++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 76 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL 76 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence 699999999999999999999999999999988542 22345799999999999999998877 444568
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+.+ +|.+.+. ..+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus 77 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~ 150 (291)
T cd05612 77 YMLMEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLH-SKEIVYRDLKPENILLDKEG-HIKLTDFGFAKK 150 (291)
T ss_pred EEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence 999999985 4544443 3467899999999999999999999 89999999999999999888 799999999976
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 151 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 151 LRDR--TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred ccCC--cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 5432 2345789999999998664 4899999999999999999999999887765555544331
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRDP 383 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~~ 383 (429)
. ..++..+++.+++||++||+.||.+|++ +.++++||||..+.+.
T Consensus 214 ---~------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 214 ---K------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred ---C------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 0 0123346899999999999999999995 9999999999876653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=363.54 Aligned_cols=255 Identities=32% Similarity=0.518 Sum_probs=216.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcC-CCCeeecceEeeecCCCCc
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 161 (429)
...|.+.+.||+|.||.||+++.+.||+.+|+|.+.+.. ....+|+.+|+.++ |||||.+++.| +..
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----EDP 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----EcC
Confidence 346999999999999999999999999999999996543 35678999999999 99999999999 444
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC---CcEEEee
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT---HQVKLCD 237 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~---~~vkl~D 237 (429)
..+++|||+|.| .|++.+... .+++..+..++.||+.|+.||| +.||+||||||+|+|+.... ..+|++|
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH-~~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLH-SLGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHH-hCCceeccCCHHHeeeccccCCCCcEEEee
Confidence 468999999995 444444332 3999999999999999999999 89999999999999996442 2799999
Q ss_pred cccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 238 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
||++.....+......+||+.|+|||++.. ..|+..+||||+|+++|.|++|.+||.+.+.......+...-.
T Consensus 183 FGla~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~------ 255 (382)
T KOG0032|consen 183 FGLAKFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF------ 255 (382)
T ss_pred CCCceEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC------
Confidence 999999877666778899999999999965 4599999999999999999999999999988777776655211
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
.+.. .....++..+++||++||..||.+|+|+.++|+|||+....
T Consensus 256 --------------~f~~-----~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 256 --------------DFTS-----EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred --------------CCCC-----CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 1111 12245799999999999999999999999999999987753
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=371.94 Aligned_cols=278 Identities=24% Similarity=0.314 Sum_probs=212.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEe
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
..+|++++.||+|+||.||+|.+..+++.||+|.... ....+|+++++.++||||++++++|.. ..+.++|+|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~e 163 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCLILP 163 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEEEEe
Confidence 3469999999999999999999999999999997543 345689999999999999999998843 345889999
Q ss_pred ccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC--
Q 014174 170 FVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-- 247 (429)
Q Consensus 170 ~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~-- 247 (429)
++.+++...+.. ...+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH-~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLH-ENRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINA 237 (391)
T ss_pred cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHhEEEcCCC-CEEEEeCCcccccccccc
Confidence 999877665543 356899999999999999999999 88999999999999999888 7999999999754322
Q ss_pred CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------hHHHHHHHHHHhCCCCHHHHhh
Q 014174 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES-------GVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+ ....+..+....|.++.+....
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred cccccccCccCCCChhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 222345789999999998664 48999999999999999999998775432 3456666777666554321100
Q ss_pred cCcCcc--------cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 321 MNPNYT--------EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 321 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
...... ...........|.. ...++.++.+||.+||++||.+|||+.|+|+||||.++..+
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTN--LYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHH--HhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 000000 00000000001111 11357789999999999999999999999999999875443
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-48 Score=344.77 Aligned_cols=255 Identities=29% Similarity=0.442 Sum_probs=217.5
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhh-------hHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-------KNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..++|..+++||+|.||+|.+++.+.+|+.||||+++++.-. .-.|-++|+..+||++..+...| +..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence 456899999999999999999999999999999988765322 22478899999999999998877 555
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
..+|+||||.+|+ ++.-+.. ....+++..++++..+|+.||.||| +.+||+||||.+|+|+|.+|| |||+|||+|
T Consensus 241 drlCFVMeyanGG--eLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLH-s~~ivYRDlKLENLlLDkDGH-IKitDFGLC 315 (516)
T KOG0690|consen 241 DRLCFVMEYANGG--ELFFHLS-RERVFSEDRTRFYGAEIVSALGYLH-SRNIVYRDLKLENLLLDKDGH-IKITDFGLC 315 (516)
T ss_pred ceEEEEEEEccCc--eEeeehh-hhhcccchhhhhhhHHHHHHhhhhh-hCCeeeeechhhhheeccCCc-eEeeecccc
Confidence 5699999999975 3332322 3577999999999999999999999 889999999999999999995 999999999
Q ss_pred eeccc-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 242 KVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 242 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+.... +.....+|||+.|+|||++.. ..|+.++|||.+||+||||++|+.||...+.......|+..
T Consensus 316 KE~I~~g~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----------- 383 (516)
T KOG0690|consen 316 KEEIKYGDTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----------- 383 (516)
T ss_pred hhcccccceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----------
Confidence 87543 455667899999999999965 56999999999999999999999999998877776666542
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDP 383 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~ 383 (429)
++ .+|..++++++.|+..+|.+||.+|+ .+.|+.+|+||..+.|.
T Consensus 384 ------d~------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 384 ------DL------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred ------hc------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 12 24456899999999999999999998 57899999999998884
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=342.55 Aligned_cols=284 Identities=36% Similarity=0.616 Sum_probs=228.0
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCc----EEEEEEeecchh------hhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
.|+++..||+|.||.||+|....++. .||||.++.++. ..-||+.+++.++|||++.+..+|... .
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----d 100 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----D 100 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----C
Confidence 59999999999999999996655433 689999876532 234899999999999999999998653 3
Q ss_pred eEEEEEEeccchhHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC----CCcEEEe
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRA-SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH----THQVKLC 236 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~----~~~vkl~ 236 (429)
..+++++||.+.+|+.++++.... ...++...++.++.||+.|+.||| +.-|+||||||.||||..+ | .|||+
T Consensus 101 ~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH-~NWvlHRDLKPaNIlvmgdgperG-~VKIa 178 (438)
T KOG0666|consen 101 KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH-SNWVLHRDLKPANILVMGDGPERG-RVKIA 178 (438)
T ss_pred ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh-hhheeeccCCcceEEEeccCCccC-eeEee
Confidence 458999999999999999876543 356899999999999999999999 8889999999999999877 5 89999
Q ss_pred ecccceecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------hHHHH
Q 014174 237 DFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES---------GVDQL 303 (429)
Q Consensus 237 DfG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---------~~~~~ 303 (429)
|||+++.+...-. ....+.|.+|+|||.+.+...|+.++|+||+|||+.||+|-.+.|.+.. ..+++
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 9999998765432 2245679999999999999999999999999999999999999998743 34688
Q ss_pred HHHHHHhCCCCHHHHhhcC--cCcccccCCCcCCCCccc-----cc--CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 304 VEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKAHPWHK-----IF--HKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 304 ~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-----~~--~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.+|++.+|.|+.+.|..+. +.+.. .+..+....+.. .+ .+.-++...+|+.+||++||.+|+|++++|+|
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~-~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQT-LLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHH-HHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 9999999999998886543 22210 011111111111 01 12235669999999999999999999999999
Q ss_pred CCCcccCC
Q 014174 375 PFFYELRD 382 (429)
Q Consensus 375 p~f~~~~~ 382 (429)
+||.+-.-
T Consensus 338 ~yF~~d~l 345 (438)
T KOG0666|consen 338 PYFTEDPL 345 (438)
T ss_pred cccccCCC
Confidence 99987433
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=352.38 Aligned_cols=282 Identities=32% Similarity=0.598 Sum_probs=227.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
..+|++.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++|+||+++++++. ...+.
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence 346999999999999999999999999999999886432 23457999999999999999999883 34458
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++||||+++++...+.. ....+++..++.++.||+.||.||| +.||+|+||||+||+++.++ .+||+|||++...
T Consensus 80 ~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 154 (301)
T cd07873 80 TLVFEYLDKDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCH-RRKVLHRDLKPQNLLINERG-ELKLADFGLARAK 154 (301)
T ss_pred EEEEeccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCHHHEEECCCC-cEEECcCcchhcc
Confidence 89999999877766543 2456899999999999999999999 88999999999999999887 7999999998764
Q ss_pred ccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ......+++.|+|||.+.+...++.++|||||||++|+|+||++||.+.+..+.+..+...++.+....+..+..
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 3322 222345688999999987666688999999999999999999999999888888888888888887766544322
Q ss_pred --CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 324 --NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 324 --~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
.+.....+....... ......+++++.+||.+||+.||.+|||+.|+|+||||..+..
T Consensus 235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 235 NEEFKSYNYPKYRADCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred cccccccccCccccccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 122223333222111 1233467899999999999999999999999999999987664
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=361.64 Aligned_cols=245 Identities=27% Similarity=0.434 Sum_probs=200.8
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEe
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++ ....++++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999986532 2234689999999999999999888 34446899999
Q ss_pred ccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc-C
Q 014174 170 FVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-G 247 (429)
Q Consensus 170 ~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~-~ 247 (429)
|++++ |...+. ....+++..++.++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.... .
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH-~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~ 149 (323)
T cd05571 76 YANGGELFFHLS----RERVFSEDRARFYGAEIVSALGYLH-SCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence 99864 333332 3467899999999999999999999 88999999999999999888 799999999875432 2
Q ss_pred CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 014174 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327 (429)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 327 (429)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------E 211 (323)
T ss_pred CcccceecCccccChhhhcCC-CCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC-----------------C
Confidence 233456789999999998764 4899999999999999999999999877655444333221 0
Q ss_pred ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCC
Q 014174 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRD 382 (429)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~ 382 (429)
. .++..+++++.+||++||..||++|| ++.++++||||..+.+
T Consensus 212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 212 I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred C------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 0 12345799999999999999999999 8999999999988654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=362.34 Aligned_cols=251 Identities=29% Similarity=0.438 Sum_probs=206.5
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCC-cEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
...+|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ....+|+.+++.++||||+++++++. .
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----D 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----e
Confidence 4457999999999999999999876655 689999885431 23447999999999999999999883 3
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
..++++||||+.+ +|.+.+. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NILl~~~~-~ikL~DFG 176 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQ-SLNIVYRDLKPENLLLDKDG-FIKMTDFG 176 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEccCCCHHHEEECCCC-CEEEecCC
Confidence 4468999999975 4544443 2467999999999999999999999 88999999999999999888 79999999
Q ss_pred cceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--------- 244 (340)
T PTZ00426 177 FAKVVDT--RTYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--------- 244 (340)
T ss_pred CCeecCC--CcceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------
Confidence 9986533 23456789999999999764 48999999999999999999999998877655554443310
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRD 382 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~ 382 (429)
. .++..+++.+.+||++||+.||.+|+ |+.++++||||..+.+
T Consensus 245 --------~------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 245 --------I------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred --------C------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 0 12345789999999999999999996 8999999999987654
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=357.70 Aligned_cols=259 Identities=29% Similarity=0.431 Sum_probs=228.8
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..+-|.+.+.||+|.|..|-+|++..||+.||+|++.+.+ ..+..|++.|+.++|||||++|.+. ....
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccc
Confidence 3445999999999999999999999999999999996542 3445799999999999999999987 4445
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+|+|+|+-++ ++++.+... ...+.+..+++|+.||+.|+.|+| +..+|||||||+||.+-..-+-|||+|||++
T Consensus 91 KlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCH-qLHVVHRDLKPENVVFFEKlGlVKLTDFGFS 166 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCH-QLHVVHRDLKPENVVFFEKLGLVKLTDFGFS 166 (864)
T ss_pred eEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHh-hhhhhcccCCcceeEEeeecCceEeeecccc
Confidence 58899999885 777766543 467999999999999999999999 9999999999999987666668999999999
Q ss_pred eecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
..+..+......||+..|.|||++.+..+..+++||||||||||.|++|++||...+..+.+..|+.+.
T Consensus 167 Nkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCK----------- 235 (864)
T KOG4717|consen 167 NKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCK----------- 235 (864)
T ss_pred ccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhccc-----------
Confidence 999999999999999999999999998877889999999999999999999999999999999988752
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNA 385 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~ 385 (429)
| .+|..++.++++||.+||..||.+|.|.++|..|+|++....+..
T Consensus 236 ------Y------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~s 281 (864)
T KOG4717|consen 236 ------Y------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLS 281 (864)
T ss_pred ------c------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCcc
Confidence 1 234468999999999999999999999999999999988766543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=393.26 Aligned_cols=304 Identities=29% Similarity=0.458 Sum_probs=240.5
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...+|.|+++||+|+||.|.+++.+.|++.||+|++++. ...+..|..+|-.-+.+-|+.++..| ++.
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~ 147 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDE 147 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCc
Confidence 345799999999999999999999999999999988652 35566788999999999999998888 788
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
.|+|+||||++| +++.++..+ .++|+.++++|+..|+.||.-|| +.|+|||||||+|||||..|| |||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH-~mgyVHRDiKPDNvLld~~GH-ikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLH-SMGYVHRDIKPDNVLLDKSGH-IKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHH-hccceeccCCcceeEecccCc-Eeeccchh
Confidence 889999999984 566666543 37999999999999999999999 999999999999999999995 99999999
Q ss_pred ceecccCCC--cccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 241 AKVLVKGEP--NISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 241 a~~~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
|-.+..... ....+|||.|++||++.. ...|+..+||||+||++|||+.|..||+..+-.+.+.+|+...
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk---- 297 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK---- 297 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh----
Confidence 987764443 345689999999999843 2458999999999999999999999999999999999998752
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCCcccCCCCCCCCCCC
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACIHPFFYELRDPNARLPNGR 391 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t---~~ell~hp~f~~~~~~~~~~~~~~ 391 (429)
+.+.||.. ..+|.++++||+++++ +|+.|.. ++++.+||||..+.|.+-+-..++
T Consensus 298 -----------~~l~FP~~----------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP 355 (1317)
T KOG0612|consen 298 -----------ESLSFPDE----------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPP 355 (1317)
T ss_pred -----------hhcCCCcc----------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCC
Confidence 12233321 2489999999999988 5788888 999999999999999765544444
Q ss_pred CCCCC------CCCChhhhccCCHHHHHhhcHHHH-hhhCCCCCC
Q 014174 392 PFPPL------FNFKPQELKGASKELLSKLIPEHA-RKQCPFLGF 429 (429)
Q Consensus 392 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 429 (429)
.+|.. .||+-.+-.....+.+..-++..+ -.+.||-||
T Consensus 356 ~vPevssd~DTsnFd~~~dd~~~~e~~p~~~~~~f~Gn~LPFIGf 400 (1317)
T KOG0612|consen 356 VVPEVSSDDDTSNFDVDEDDLRDAETFPPRIPKAFSGNHLPFIGF 400 (1317)
T ss_pred CCCcCCCCCccccccccccccchhhccCCCCCCCCcCCcCCeeee
Confidence 44433 334222212222333332233333 345688887
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=355.37 Aligned_cols=277 Identities=31% Similarity=0.531 Sum_probs=210.1
Q ss_pred eeEEccCCceEEEEEEEc--CCCcEEEEEEeecch--hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 96 ERVVGQGSFGIVFQAKCL--ETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
.++||+|+||.||+|++. .+++.||+|.+.... ....+|+++++.++||||+++++++... ....+++||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence 358999999999999965 467899999886542 3456899999999999999999887543 234578999999
Q ss_pred chhHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec----CCCCcEEEeecccce
Q 014174 172 PETVYRVAKHYSR-----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN----PHTHQVKLCDFGSAK 242 (429)
Q Consensus 172 ~~~l~~~~~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~----~~~~~vkl~DfG~a~ 242 (429)
++++...+..... ....+++..++.++.||+.||.||| +.||+||||||+|||++ .++ .+||+|||+++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~ivHrDlkp~Nil~~~~~~~~~-~~kl~DfG~a~ 160 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR 160 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH-hCCEEcCCCCHHHEEEecCCCCcC-cEEEeecCcee
Confidence 9988777653221 1235899999999999999999999 88999999999999994 334 79999999998
Q ss_pred ecccCC----CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHH
Q 014174 243 VLVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG---------VDQLVEIIKV 309 (429)
Q Consensus 243 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~~i~~~ 309 (429)
...... ......||+.|+|||++.+...++.++||||+||++|+|++|++||.+... ..++..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 754322 123457799999999997766689999999999999999999999975442 3567778888
Q ss_pred hCCCCHHHHhhcCcCcc------cccCCCcCCC---CcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 310 LGTPTREEIKCMNPNYT------EFKFPQIKAH---PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 310 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~---~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
+|.|....+........ .+........ .+........+..+.+||++||++||.+|+|++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 88887766544321000 0000000000 00001112346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=372.14 Aligned_cols=284 Identities=23% Similarity=0.364 Sum_probs=214.5
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCC------CeeecceEeeecCCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHP------NVVSLKHCFFSTTDK 159 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~ 159 (429)
..++|++.++||+|+||+||+|.+..+++.||||++.... .....|+.+++.++|. ++++++++|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~---- 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN---- 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----
Confidence 3468999999999999999999999999999999986432 2335688888877554 57888777642
Q ss_pred CceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC--------
Q 014174 160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-------- 231 (429)
Q Consensus 160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~-------- 231 (429)
...++|+||++++++++..+.. .+.+++..++.++.||+.||.|||++.|||||||||+|||++.++.
T Consensus 203 ~~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 203 ETGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CCceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccc
Confidence 2335889999999888776643 3679999999999999999999993369999999999999986542
Q ss_pred -------cEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 014174 232 -------QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304 (429)
Q Consensus 232 -------~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 304 (429)
.+||+|||.+.... ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+.
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred ccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 49999999886432 223456889999999999775 48999999999999999999999999999888888
Q ss_pred HHHHHhCCCCHHHHhhcCcC-----cccc--cCCCcCCCCcccc-----c-CCCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 014174 305 EIIKVLGTPTREEIKCMNPN-----YTEF--KFPQIKAHPWHKI-----F-HKRMPPEAVDLVSRLLQYSPNLRCTALEA 371 (429)
Q Consensus 305 ~i~~~~~~~~~~~~~~~~~~-----~~~~--~~~~~~~~~~~~~-----~-~~~~s~~l~~Li~~~L~~dP~~R~t~~el 371 (429)
.+.+.+|.++.......... +... ..+......+... . ....++.+.+||.+||++||.+|||+.|+
T Consensus 356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~ 435 (467)
T PTZ00284 356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM 435 (467)
T ss_pred HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence 88888887765433211100 0000 0000000000000 0 00124678899999999999999999999
Q ss_pred hcCCCCcccCCC
Q 014174 372 CIHPFFYELRDP 383 (429)
Q Consensus 372 l~hp~f~~~~~~ 383 (429)
|+||||......
T Consensus 436 L~Hp~~~~~~~~ 447 (467)
T PTZ00284 436 TTHPYVLKYYPE 447 (467)
T ss_pred hcCccccccCCc
Confidence 999999886553
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=355.59 Aligned_cols=318 Identities=35% Similarity=0.635 Sum_probs=243.1
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
++|++.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+.+++.++|+||+++++++..........++
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 4799999999999999999999999999999988532 12234699999999999999999887554434445688
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+|+||+++++...+. ...+++..++.++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus 85 lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH-~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~ 157 (336)
T cd07849 85 IVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTNC-DLKICDFGLARIAD 157 (336)
T ss_pred EEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEECCCC-CEEECcccceeecc
Confidence 999999987766553 357999999999999999999999 88999999999999999888 79999999987654
Q ss_pred cCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 246 KGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 246 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.... .....+|..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+...++.+..+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 3221 123467899999998766556899999999999999999999999998888888888888888877665433
Q ss_pred CcCccc-c--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCC
Q 014174 322 NPNYTE-F--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFN 398 (429)
Q Consensus 322 ~~~~~~-~--~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~ 398 (429)
...... + ..+......+.. ..+..++++.+||.+||+.||++|||+.++++||||..+.++........+ +-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~----~~ 312 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNK-LFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEP----FP 312 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHH-HhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCC----CC
Confidence 211110 0 011111111111 123468899999999999999999999999999999998876544333222 23
Q ss_pred CChhhhccCCHHHHHhhcHHHH
Q 014174 399 FKPQELKGASKELLSKLIPEHA 420 (429)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~ 420 (429)
|+-.+...+-++-++.++.+++
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~ 334 (336)
T cd07849 313 FDFELFDDLPKEKLKELIFEEI 334 (336)
T ss_pred hhhccccccCHHHHHHHHHHHh
Confidence 4444445555676777666543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=361.66 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=203.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++++.||+|+||+||+|++..+++.||||++.+.. ....+|+.+++.++|+||+++++++ ....++
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~ 76 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL 76 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence 6999999999999999999999999999999986532 2345789999999999999999988 444568
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+++ +|.+.+. ..+.+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH-~~givHrDlKp~NILi~~~~-~vkL~DFGla~~ 150 (363)
T cd05628 77 YLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIH-QLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTG 150 (363)
T ss_pred EEEEcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecCCCHHHeEECCCC-CEEEeeccCccc
Confidence 999999985 4444443 2467999999999999999999999 89999999999999999888 799999999875
Q ss_pred cccCC------------------------------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHH
Q 014174 244 LVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAEL 287 (429)
Q Consensus 244 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 287 (429)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DvwSlGvil~el 229 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-CCCCchhhhhhHHHHHHH
Confidence 42210 01235789999999999764 489999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCC---C
Q 014174 288 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN---L 364 (429)
Q Consensus 288 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~---~ 364 (429)
++|..||.+.+..+...++...... ..+|. ...+++++++||.+|+. +|. .
T Consensus 230 l~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~ 283 (363)
T cd05628 230 LIGYPPFCSETPQETYKKVMNWKET---------------LIFPP----------EVPISEKAKDLILRFCC-EWEHRIG 283 (363)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCcCc---------------ccCCC----------cCCCCHHHHHHHHHHcC-ChhhcCC
Confidence 9999999887776666555432110 01111 01368999999999876 454 4
Q ss_pred CCCHHHHhcCCCCcccCCC
Q 014174 365 RCTALEACIHPFFYELRDP 383 (429)
Q Consensus 365 R~t~~ell~hp~f~~~~~~ 383 (429)
||++.|+++||||....+.
T Consensus 284 r~~~~ei~~hp~f~~~~~~ 302 (363)
T cd05628 284 APGVEEIKTNPFFEGVDWE 302 (363)
T ss_pred CCCHHHHhCCCCCCCCCHH
Confidence 5899999999999887654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=346.17 Aligned_cols=276 Identities=34% Similarity=0.539 Sum_probs=218.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|+||.||+|++..+|+.||+|.+.... ....+|+.+++.++|+||+++++++. +..+.+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence 4899999999999999999999999999999885431 23457999999999999999999883 344588
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+|+||+++++...+.. ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus 76 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH-~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~ 150 (284)
T cd07839 76 LVFEYCDQDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCH-SHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFG 150 (284)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence 9999999887765543 2456999999999999999999999 88999999999999999887 79999999997654
Q ss_pred cCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... ......++..|+|||.+.+...++.++|||||||++|+|+||..| |.+.+....+..+.+..+.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 322 122345688999999987766679999999999999999998877 566666777788888888777665543221
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.-....++............+.+++++.+||.+||..||.+|||+.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 111111111111111112234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-46 Score=361.80 Aligned_cols=256 Identities=28% Similarity=0.457 Sum_probs=206.1
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..+|++.+.||+|+||.||+|++..+++.||+|++.+. .....+|+.+++.++||||+++++++ ....
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~~ 116 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDDK 116 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCC
Confidence 35799999999999999999999999999999988642 22345799999999999999999988 4445
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
++++||||+++ +|.+.+. ...+++.+++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+|
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH-~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a 189 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIH-SMGLIHRDVKPDNMLLDKHG-HLKLADFGTC 189 (370)
T ss_pred EEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEECCCC-CEEEEecccc
Confidence 68999999985 5555443 246899999999999999999999 89999999999999999888 7999999999
Q ss_pred eecccCCC--cccccccccccccccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 242 KVLVKGEP--NISYICSRYYRAPELIFGAT---EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 242 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
........ .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~---- 265 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNS---- 265 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcc----
Confidence 87643322 23457899999999986532 3788999999999999999999999988776666555442110
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCCcccCC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFYELRD 382 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--R~t~~ell~hp~f~~~~~ 382 (429)
..+|. ...++..+++||.+||..++.+ |+|+.++++||||....+
T Consensus 266 -----------~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 266 -----------LNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred -----------cCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 11111 1236899999999999866544 899999999999987443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=360.72 Aligned_cols=253 Identities=31% Similarity=0.496 Sum_probs=204.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++|+||+++++++ ....++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL 76 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence 6999999999999999999999999999999986431 2345799999999999999999988 444568
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+.+ +|.+.+. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH-~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~ 150 (364)
T cd05599 77 YLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIH-KLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTG 150 (364)
T ss_pred EEEECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEECCCC-CEEEeeccccee
Confidence 999999975 4444433 2457999999999999999999999 88999999999999999888 799999999875
Q ss_pred cccCC---------------------------------------CcccccccccccccccccCCCCCCCchhHHHHHHHH
Q 014174 244 LVKGE---------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVL 284 (429)
Q Consensus 244 ~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 284 (429)
..... .....+||+.|+|||++.+. .++.++|||||||++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il 229 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT-GYNKECDWWSLGVIM 229 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC-CCCCeeeeecchhHH
Confidence 43211 01124689999999998654 489999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC
Q 014174 285 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364 (429)
Q Consensus 285 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~ 364 (429)
|+|++|..||.+.+..+....+..... .+.++. ...+++++.+||++||. +|.+
T Consensus 230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~----------~~~~s~~~~~li~~ll~-~p~~ 283 (364)
T cd05599 230 YEMLVGYPPFCSDNPQETYRKIINWKE---------------TLQFPD----------EVPLSPEAKDLIKRLCC-EAER 283 (364)
T ss_pred HHhhcCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCC----------CCCCCHHHHHHHHHHcc-CHhh
Confidence 999999999988776665554433110 001111 11368999999999997 9999
Q ss_pred CCC---HHHHhcCCCCcccCC
Q 014174 365 RCT---ALEACIHPFFYELRD 382 (429)
Q Consensus 365 R~t---~~ell~hp~f~~~~~ 382 (429)
|++ +.++++||||....+
T Consensus 284 R~~~~~~~~ll~h~~~~~~~~ 304 (364)
T cd05599 284 RLGNNGVNEIKSHPFFKGVDW 304 (364)
T ss_pred cCCCCCHHHHhcCCCcCCCCH
Confidence 998 999999999988655
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=355.41 Aligned_cols=256 Identities=30% Similarity=0.463 Sum_probs=208.7
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++ ....+.
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~ 76 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL 76 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence 6999999999999999999999999999999986432 2344689999999999999999888 344468
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+++ +|.+.+. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~ 150 (333)
T cd05600 77 YLAMEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALH-ELGYIHRDLKPENFLIDASG-HIKLTDFGLSKG 150 (333)
T ss_pred EEEEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEECCCC-CEEEEeCcCCcc
Confidence 999999975 4544443 2467899999999999999999999 89999999999999999888 799999999976
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+......
T Consensus 151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~----------- 216 (333)
T cd05600 151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET----------- 216 (333)
T ss_pred ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc-----------
Confidence 543 23456789999999999765 5899999999999999999999999887766655544432100
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
...+.... ....+++++.+||.+||..+|.+|+|+.++++||||..+.+
T Consensus 217 ----~~~~~~~~------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 217 ----LQRPVYDD------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred ----ccCCCCCc------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 00111000 01246899999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=360.13 Aligned_cols=254 Identities=29% Similarity=0.459 Sum_probs=201.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.|++++.||+|+||+||+|++..+++.||||++.... ....+|+.+++.++|+||+++++++. ...++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence 5899999999999999999999999999999986432 23457999999999999999999884 34468
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+++ +|...+. ....+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH-~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~ 150 (381)
T cd05626 77 YFVMDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVH-KMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTG 150 (381)
T ss_pred EEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence 899999985 4444443 2457899999999999999999999 88999999999999999888 799999999753
Q ss_pred cccCC------------------------------------------------CcccccccccccccccccCCCCCCCch
Q 014174 244 LVKGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTTAI 275 (429)
Q Consensus 244 ~~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~ 275 (429)
..... .....+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (381)
T cd05626 151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK-GYTQLC 229 (381)
T ss_pred cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC-CCCCcc
Confidence 21000 01235689999999998764 489999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHH
Q 014174 276 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS 355 (429)
Q Consensus 276 DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~ 355 (429)
|||||||++|+|++|..||...+..+....+...... ...+. ...+++++.+||.
T Consensus 230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~----------~~~~s~~~~dli~ 284 (381)
T cd05626 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------LHIPP----------QVKLSPEAVDLIT 284 (381)
T ss_pred ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------cCCCC----------CCCCCHHHHHHHH
Confidence 9999999999999999999887665554444321000 01111 1247899999999
Q ss_pred hhcCc--CCCCCCCHHHHhcCCCCcccCC
Q 014174 356 RLLQY--SPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 356 ~~L~~--dP~~R~t~~ell~hp~f~~~~~ 382 (429)
+||.. +|..|+|+.++++||||.++.+
T Consensus 285 ~ll~~~~~~~~R~~~~~~l~hp~f~~~~~ 313 (381)
T cd05626 285 KLCCSAEERLGRNGADDIKAHPFFSEVDF 313 (381)
T ss_pred HHccCcccccCCCCHHHHhcCcccCCCCh
Confidence 96654 4455999999999999988655
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=351.46 Aligned_cols=318 Identities=35% Similarity=0.619 Sum_probs=243.0
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.+|.+.+.||+|+||+||+|++..++..||||.+... .....+|+.+++.++|+||+++++++..........+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4699999999999999999999999999999987542 1233469999999999999999998764433333458
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++|+||+++++...+.. ...+++..+..++.||+.||.||| +.|++||||||+||+++.++ .+||+|||++...
T Consensus 85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH-~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~ 158 (337)
T cd07858 85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIH-SANVLHRDLKPSNLLLNANC-DLKICDFGLARTT 158 (337)
T ss_pred EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCC-CEEECcCcccccc
Confidence 89999999877765543 467999999999999999999999 88999999999999999887 7999999999866
Q ss_pred ccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... .......++..|+|||.+.....++.++|||||||++|+|++|++||.+.+.......+....+.+..+.+.....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 443 2223456788999999886544589999999999999999999999999888888888888888877665532211
Q ss_pred -Ccccc--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCC
Q 014174 324 -NYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFK 400 (429)
Q Consensus 324 -~~~~~--~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 400 (429)
....+ ..+......+. ...+.+++++.+||++||+.||++|||+.++++||||..+.++...... ..+..++|+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~--~~~~~~~~~ 315 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVC--QTPFSFDFE 315 (337)
T ss_pred hhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccC--CCccchhhh
Confidence 11100 01111111111 1224579999999999999999999999999999999998887654332 223344444
Q ss_pred hhhhccCCHHHHHhhcHHHH
Q 014174 401 PQELKGASKELLSKLIPEHA 420 (429)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~ 420 (429)
..+ .+++.+++++--++
T Consensus 316 ~~~---~~~~~~~~~~~~~~ 332 (337)
T cd07858 316 EDA---LTEEDIKELIYNEM 332 (337)
T ss_pred hhh---cCHHHHHHHHHHHH
Confidence 433 45556766655443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-45 Score=342.65 Aligned_cols=276 Identities=34% Similarity=0.633 Sum_probs=218.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|++|.||+|++..++..||+|.+... .....+|+.+++.++||||+++++++.. ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence 489999999999999999999999999999988532 1334579999999999999999998843 34588
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||+.+++...+.... ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 152 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCH-SRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG 152 (285)
T ss_pred EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence 999999987776654322 2357899999999999999999999 88999999999999999888 79999999987653
Q ss_pred cCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 014174 246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP- 323 (429)
Q Consensus 246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 323 (429)
... ......++..|+|||.+.+...++.++|+|||||++|+|+||++||.+.........+....+.+....+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence 322 122345688899999987666678999999999999999999999999888888877777777666554432110
Q ss_pred -CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 -NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 -~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
++.. ..+........ .....+++++.+||++||..||.+|||+.++++||||
T Consensus 233 ~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 233 PDYKN-TFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred HHHHh-hccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000 11111111111 1223479999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=344.70 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=206.3
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.|++.++||+|+||.||++.+..+++.||+|++.... ....+|+.+++.++|+||+++++++ ....++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 3899999999999999999999999999999886432 2234699999999999999999887 333468
Q ss_pred EEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+.++ +...+.. .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~ 151 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLH-RERIVYRDLKPENILLDDYG-HIRISDLGLAVE 151 (285)
T ss_pred EEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCHHHEEECCCC-CEEEeeCCCcee
Confidence 9999999864 4333322 22356899999999999999999999 88999999999999999887 799999999987
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
...........|+..|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+.......
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 220 (285)
T cd05605 152 IPEGETIRGRVGTVGYMAPEVVKNE-RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED---------- 220 (285)
T ss_pred cCCCCccccccCCCCccCcHHhcCC-CCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----------
Confidence 6544443455789999999998764 48999999999999999999999998766544333332211000
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDP 383 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~ 383 (429)
...++..++..+.+||.+||..||.+|| ++.++++||||....+.
T Consensus 221 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 221 ---------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred ---------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 0112334789999999999999999999 99999999999875554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=360.89 Aligned_cols=253 Identities=30% Similarity=0.486 Sum_probs=202.2
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++++.||+|+||+||+|.+..+++.||||++.+.. ....+|+++++.++||||++++++| .+..++
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 76 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL 76 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence 6999999999999999999999999999999886432 2345699999999999999999988 444568
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
|+||||+++ +|...+. ....+++..++.++.|++.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH-~~givHrDlkp~NIll~~~~-~~kl~DfGla~~ 150 (377)
T cd05629 77 YLIMEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVH-KLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTG 150 (377)
T ss_pred EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEECCCC-CEEEeecccccc
Confidence 999999975 5544443 2467899999999999999999999 89999999999999999887 799999999863
Q ss_pred cccCC------------------------------------------------CcccccccccccccccccCCCCCCCch
Q 014174 244 LVKGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTTAI 275 (429)
Q Consensus 244 ~~~~~------------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~ 275 (429)
..... .....+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 229 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ-GYGQEC 229 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC-CCCCce
Confidence 31100 00124689999999998664 489999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHH
Q 014174 276 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS 355 (429)
Q Consensus 276 DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~ 355 (429)
|||||||++|+|++|.+||.+.+..+.+..+..... ...+|. ...++.++.+||.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dli~ 284 (377)
T cd05629 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPD----------DIHLSVEAEDLIR 284 (377)
T ss_pred eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCC----------CCCCCHHHHHHHH
Confidence 999999999999999999988776655554443110 011111 1136899999999
Q ss_pred hhcCcCCCCC---CCHHHHhcCCCCcccCC
Q 014174 356 RLLQYSPNLR---CTALEACIHPFFYELRD 382 (429)
Q Consensus 356 ~~L~~dP~~R---~t~~ell~hp~f~~~~~ 382 (429)
+||. +|.+| +|+.++++||||....+
T Consensus 285 ~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 285 RLIT-NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred HHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 9998 77765 59999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=360.92 Aligned_cols=253 Identities=28% Similarity=0.463 Sum_probs=202.6
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.|+++++||+|+||.||+|++..+++.||+|++.+.. ....+|+.+++.++|+||+++++++. ...++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence 5999999999999999999999999999999986532 23457999999999999999999884 34468
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+++ +|...+.. .+.+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+|..
T Consensus 77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH-~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~ 150 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVH-KMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG 150 (382)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence 999999986 44444432 357899999999999999999999 88999999999999999888 799999999753
Q ss_pred cccC------------------------------------------------CCcccccccccccccccccCCCCCCCch
Q 014174 244 LVKG------------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAI 275 (429)
Q Consensus 244 ~~~~------------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 275 (429)
.... ......+||+.|+|||++.+. .++.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~ 229 (382)
T cd05625 151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLC 229 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC-CCCCee
Confidence 2100 001234689999999998764 489999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHH
Q 014174 276 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS 355 (429)
Q Consensus 276 DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~ 355 (429)
|||||||++|+|++|++||.+.+..+....+...... ...| ....+++++.+||.
T Consensus 230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~s~~~~~li~ 284 (382)
T cd05625 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIP----------PQAKLSPEASDLII 284 (382)
T ss_pred eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCC----------CcccCCHHHHHHHH
Confidence 9999999999999999999887766555444331100 0011 11347899999999
Q ss_pred hhcCcCCCCCCC---HHHHhcCCCCcccCC
Q 014174 356 RLLQYSPNLRCT---ALEACIHPFFYELRD 382 (429)
Q Consensus 356 ~~L~~dP~~R~t---~~ell~hp~f~~~~~ 382 (429)
+|+ .+|.+|++ +.++++||||..+.+
T Consensus 285 ~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 285 KLC-RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 986 59999997 999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=352.40 Aligned_cols=245 Identities=30% Similarity=0.499 Sum_probs=199.2
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+.||+|+||.||+|++..+++.||+|++.+.. .....|..+++.+ +||||+++++++ .....+++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 36999999999999999999999999986432 2233577777766 699999999988 3344588999
Q ss_pred eccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||++++ |...+ .....+++..+..++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 76 Ey~~~g~L~~~i----~~~~~l~~~~~~~~~~ql~~~L~~lH-~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~ 149 (320)
T cd05590 76 EFVNGGDLMFHI----QKSRRFDEARARFYAAEITSALMFLH-DKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFN 149 (320)
T ss_pred cCCCCchHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcC
Confidence 999864 33333 23467999999999999999999999 89999999999999999888 7999999998764322
Q ss_pred -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~----------------- 211 (320)
T cd05590 150 GKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND----------------- 211 (320)
T ss_pred CCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC-----------------
Confidence 223345789999999998654 4899999999999999999999999887766655544321
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCCcccCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHPFFYELRD 382 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~------~ell~hp~f~~~~~ 382 (429)
.. .++..++.++.+||++||+.||.+|+++ .++++||||..+.+
T Consensus 212 ~~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~ 261 (320)
T cd05590 212 EV------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDW 261 (320)
T ss_pred CC------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCH
Confidence 00 1223478999999999999999999998 89999999988665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=354.27 Aligned_cols=277 Identities=24% Similarity=0.372 Sum_probs=205.8
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEec
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF 170 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 170 (429)
.+|++++.||+|+||.||+|++..++..||+|+.... ....|+.+++.++|+||+++++++.. ..+.++|||+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~ 138 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLPH 138 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEEc
Confidence 3699999999999999999999999999999975433 33569999999999999999998843 3357899999
Q ss_pred cchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCc
Q 014174 171 VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 250 (429)
Q Consensus 171 ~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~ 250 (429)
+.+++...+.. ....+++..+..++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++........
T Consensus 139 ~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~ 213 (357)
T PHA03209 139 YSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLH-AQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAF 213 (357)
T ss_pred cCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEEecCccccccccCccc
Confidence 99887776543 3467999999999999999999999 88999999999999999888 7999999999765444444
Q ss_pred ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHHHhCCCCHHHHhh
Q 014174 251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESG---------VDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~ 320 (429)
....||..|+|||++.+. .++.++|||||||++|+|+++. .+|..... ...+..+...++..+......
T Consensus 214 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 292 (357)
T PHA03209 214 LGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292 (357)
T ss_pred ccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence 456789999999999764 4899999999999999999865 44443221 223344444444322211100
Q ss_pred cCcCcc-c-ccCCCcCCCCc---ccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 321 MNPNYT-E-FKFPQIKAHPW---HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 321 ~~~~~~-~-~~~~~~~~~~~---~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
...... . .........++ ...-...++.++.+||.+||++||.+|||+.|+|+||||+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 000000 0 00000000000 001112467889999999999999999999999999999863
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=351.94 Aligned_cols=245 Identities=27% Similarity=0.411 Sum_probs=200.0
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEe
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
+.||+|+||.||+|++..+|..||+|++.... ....+|+++++.++||||++++++|. ...++++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence 46999999999999999999999999986532 22346899999999999999998883 3346889999
Q ss_pred ccchhHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC-
Q 014174 170 FVPETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG- 247 (429)
Q Consensus 170 ~~~~~l~-~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~- 247 (429)
|++++.+ ..+ .....+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||++......
T Consensus 76 ~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~ 149 (323)
T cd05595 76 YANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG 149 (323)
T ss_pred CCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC
Confidence 9986533 332 23467899999999999999999999 88999999999999999888 7999999998754322
Q ss_pred CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 014174 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327 (429)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 327 (429)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (323)
T cd05595 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-----------------E 211 (323)
T ss_pred CccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC-----------------C
Confidence 222345789999999998664 4899999999999999999999999877665544443321 0
Q ss_pred ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCC
Q 014174 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRD 382 (429)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~ 382 (429)
. .++..+++++.+||.+||..||.+|+ ++.++++||||....+
T Consensus 212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 212 I------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred C------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 0 12345799999999999999999998 8999999999987554
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=356.77 Aligned_cols=254 Identities=31% Similarity=0.520 Sum_probs=208.3
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.++..++|+||+++++++ ....++
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL 76 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence 6999999999999999999999999999999986432 2345799999999999999999887 444568
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+.+ +|...+.. ...+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH-~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~ 150 (350)
T cd05573 77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVH-KLGFIHRDIKPDNILIDADG-HIKLADFGLCKK 150 (350)
T ss_pred EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence 999999975 55554432 367999999999999999999999 89999999999999999888 799999999976
Q ss_pred cccCC------------------------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 014174 244 LVKGE------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL 293 (429)
Q Consensus 244 ~~~~~------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p 293 (429)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P 229 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP 229 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence 54433 22345689999999999765 589999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-HHHHh
Q 014174 294 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-ALEAC 372 (429)
Q Consensus 294 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-~~ell 372 (429)
|.+.+.......+..... ...+|. ...+++++.+||.+||. ||.+|++ +.+++
T Consensus 230 f~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 230 FYSDTLQETYNKIINWKE---------------SLRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred CCCCCHHHHHHHHhccCC---------------cccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 988876655555443110 001111 11268999999999998 9999999 99999
Q ss_pred cCCCCcccCCC
Q 014174 373 IHPFFYELRDP 383 (429)
Q Consensus 373 ~hp~f~~~~~~ 383 (429)
+||||..+.+.
T Consensus 284 ~hp~~~~~~~~ 294 (350)
T cd05573 284 SHPFFKGIDWE 294 (350)
T ss_pred cCCCcCCCCHH
Confidence 99999886654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=353.06 Aligned_cols=245 Identities=26% Similarity=0.401 Sum_probs=199.0
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEe
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
+.||+|+||.||+|++..+|+.||+|++.... ....+|+++++.++||||+++++++ .....+++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999986532 2334688999999999999998887 34446889999
Q ss_pred ccchhHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC-
Q 014174 170 FVPETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG- 247 (429)
Q Consensus 170 ~~~~~l~-~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~- 247 (429)
|++++.+ ..+ .....+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 76 y~~~g~L~~~l----~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~ 149 (328)
T cd05593 76 YVNGGELFFHL----SRERVFSEDRTRFYGAEIVSALDYLH-SGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA 149 (328)
T ss_pred CCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc
Confidence 9986533 332 23467999999999999999999999 89999999999999999888 7999999998764322
Q ss_pred CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 014174 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327 (429)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 327 (429)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+... .
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-----------------~ 211 (328)
T cd05593 150 ATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------D 211 (328)
T ss_pred cccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC-----------------C
Confidence 222345789999999998664 4899999999999999999999999876654443332210 0
Q ss_pred ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCC
Q 014174 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRD 382 (429)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~ 382 (429)
. .++..+++++.+||++||..||.+|+ ++.++++||||....+
T Consensus 212 ~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 212 I------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred c------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 0 12345799999999999999999997 8999999999977543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=351.02 Aligned_cols=287 Identities=32% Similarity=0.568 Sum_probs=225.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCC-CCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 162 (429)
..+|++.+.||+|+||.||+|.+..+|+.||||.+... .....+|+.+++.++|+||++++++|..... .+..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 35799999999999999999999999999999988542 1233469999999999999999998754322 2223
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
+.++||||+.+++...+.. .+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||+++
T Consensus 95 ~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH-~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~ 166 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLAR 166 (353)
T ss_pred cEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEECCCC-CEEEccCccce
Confidence 5789999999887776532 2889999999999999999999 88999999999999999888 79999999998
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
............+|..|+|||.+.+. .++.++|||||||++|+|++|+.||...+......++...++.|..+......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 167 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred eCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 76544433455678899999999764 48999999999999999999999999998888888888888888766544332
Q ss_pred cCcccc--cCCCcCCCCcccc------------cCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCC
Q 014174 323 PNYTEF--KFPQIKAHPWHKI------------FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNA 385 (429)
Q Consensus 323 ~~~~~~--~~~~~~~~~~~~~------------~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~ 385 (429)
.....+ ..+......+... .....+..+++||.+||+.||++|||+.++|+||||..+-++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~ 322 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSE 322 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCcc
Confidence 211111 0011111111111 12235678999999999999999999999999999987666533
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=351.20 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=201.5
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHH---HHcCCCCeeecceEeeecCCCCce
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTM---RLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|.+++ +.++||||+++++++. ...
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence 788999999999999999999999999999986432 2233455554 4568999999999883 344
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+|+||||+.++.+.... ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+++
T Consensus 76 ~~~lv~E~~~~~~L~~~~----~~~~l~~~~~~~~~~qi~~al~~lH-~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~ 149 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHI----HTDVFSEPRAVFYAACVVLGLQYLH-ENKIVYRDLKLDNLLLDTEG-FVKIADFGLCK 149 (324)
T ss_pred EEEEEEcCCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecCCCHHHeEECCCC-cEEeCcccCCc
Confidence 588999999875433222 1357999999999999999999999 89999999999999999888 79999999987
Q ss_pred ecccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 243 VLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 243 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
..... .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------- 217 (324)
T cd05589 150 EGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------- 217 (324)
T ss_pred cCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 54322 223356789999999998764 48999999999999999999999998877666555443310
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRD 382 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~ 382 (429)
..++..++..+.+||++||..||.+|| ++.++++||||..+.+
T Consensus 218 ------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 218 ------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 012335789999999999999999999 7999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=350.48 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=203.4
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 163 (429)
+|.+.+.||+|+||.||+|++..+++.||+|++.+.. .....|..++..+ .|++|+++++++ .....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 4899999999999999999999999999999986542 1223466777666 588999998887 33445
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
+++||||+++ +|...+. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++
T Consensus 76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~ 149 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLDSEG-HIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCEEecCCCHHHeEECCCC-cEEEccCCCce
Confidence 8899999985 4443332 2467899999999999999999999 88999999999999999888 79999999997
Q ss_pred eccc-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 243 VLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 243 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.... ........||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+.......+....
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------- 217 (323)
T cd05616 150 ENMWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN----------- 217 (323)
T ss_pred ecCCCCCccccCCCChhhcCHHHhcCC-CCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 5432 2223356789999999999764 48999999999999999999999998877666655544310
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRDP 383 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~~ 383 (429)
..++..++.++.+|+.+||+.||.+|++ ..++++||||..+.+.
T Consensus 218 ------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 218 ------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred ------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 0123457899999999999999999998 4899999999886653
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=356.69 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=207.4
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...+|++.+.||+|+||.||+|++..++..||+|++.+. .....+|+.+++.++||||+++++++ ...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 345799999999999999999999999999999998642 12345799999999999999999888 444
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
.++++||||+++ +|..++. ...+++.++..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NILl~~~~-~~kL~DfG~ 188 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSG-HLKLADFGT 188 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEcCCC-CEEEEeccc
Confidence 568999999975 4544443 246899999999999999999999 88999999999999999888 799999999
Q ss_pred ceecccCC--CcccccccccccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 241 AKVLVKGE--PNISYICSRYYRAPELIFGA---TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 241 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---- 264 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN---- 264 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC----
Confidence 98764332 12345789999999998653 2378899999999999999999999998776655555543110
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCCcccC
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFYELR 381 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--R~t~~ell~hp~f~~~~ 381 (429)
...+|. ...+|.++.+||++||..+|.+ |+|+.++++||||....
T Consensus 265 -----------~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~ 311 (370)
T cd05596 265 -----------SLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ 311 (370)
T ss_pred -----------cCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence 011111 1246899999999999999988 99999999999998744
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=349.61 Aligned_cols=242 Identities=32% Similarity=0.514 Sum_probs=197.9
Q ss_pred EccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++. ...+.++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence 699999999999999999999999886431 22346899999999999999988873 344588999999
Q ss_pred chh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC-CC
Q 014174 172 PET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EP 249 (429)
Q Consensus 172 ~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~-~~ 249 (429)
+++ |...+. ..+.+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++..... ..
T Consensus 76 ~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~ 149 (312)
T cd05585 76 NGGELFHHLQ----REGRFDLSRARFYTAELLCALENLH-KFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK 149 (312)
T ss_pred CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence 864 434332 2467999999999999999999999 89999999999999999888 7999999999754322 22
Q ss_pred cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 014174 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329 (429)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
.....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 150 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~-----------------~-- 209 (312)
T cd05585 150 TNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE-----------------P-- 209 (312)
T ss_pred cccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC-----------------C--
Confidence 3345789999999999764 4899999999999999999999999887665554443321 0
Q ss_pred CCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC---CHHHHhcCCCCcccC
Q 014174 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---TALEACIHPFFYELR 381 (429)
Q Consensus 330 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~---t~~ell~hp~f~~~~ 381 (429)
..++..+++++.+||.+||..||.+|+ ++.++++||||.+..
T Consensus 210 ----------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~ 254 (312)
T cd05585 210 ----------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254 (312)
T ss_pred ----------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCC
Confidence 012345789999999999999999997 589999999998764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=356.83 Aligned_cols=278 Identities=22% Similarity=0.330 Sum_probs=211.3
Q ss_pred ccceEEeeEEccCCceEEEEEEEc--CCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCL--ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
..+|.+++.||+|+||.||+|... .++..||+|.+... ....+|+++++.++||||+++++++. ....+|+|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~~~lv 164 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAYR-----WKSTVCMV 164 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeEe-----eCCEEEEE
Confidence 347999999999999999999754 45678999988654 34468999999999999999999883 34458899
Q ss_pred EeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||++.+++...+. ....+++..+..++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 165 ~e~~~~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH-~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 165 MPKYKCDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLH-GRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAH 238 (392)
T ss_pred ehhcCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEcCCC-CEEEccCccccccCcc
Confidence 9999988777653 3467999999999999999999999 88999999999999999888 7999999999765433
Q ss_pred CC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHhhc
Q 014174 248 EP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES---GVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 248 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.. .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ....+..+.+.++....+.....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 22 2345789999999998664 48999999999999999999999997654 34566666666654432211100
Q ss_pred Cc----CcccccCCCcCCCCccccc-CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 322 NP----NYTEFKFPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 322 ~~----~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
.. .+..+.............+ ...++.++.+||++||.+||++|||+.++|+||||.+.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00 0000110000000000011 12467889999999999999999999999999999763
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=353.42 Aligned_cols=255 Identities=30% Similarity=0.457 Sum_probs=200.5
Q ss_pred ceEEeeEEccCCceEEEEEEEc---CCCcEEEEEEeecch--------hhhHHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 92 SYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
+|++.+.||+|+||.||+|++. .+++.||+|++.+.. ....+|+.+++.+ +|+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4899999999999999999864 478999999886421 2234689999999 599999998887 4
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
....+++||||+.+ ++...+. ....+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+||
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivHrDlkp~Nili~~~~-~~kl~Df 149 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLH-KLGIVYRDIKLENILLDSEG-HVVLTDF 149 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCcEecCCCHHHeEECCCC-CEEEeeC
Confidence 44468899999986 4444432 2467999999999999999999999 88999999999999999888 7999999
Q ss_pred ccceecccCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 239 GSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 239 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
|+++...... ......||+.|+|||++.+...++.++|||||||++|+|+||..||...........+.....
T Consensus 150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----- 224 (332)
T cd05614 150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL----- 224 (332)
T ss_pred cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh-----
Confidence 9997654332 223457899999999997655678999999999999999999999975432211111111100
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRD 382 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~ 382 (429)
. ....++..+++.+.+||.+||..||++|+ ++.++++||||.+..+
T Consensus 225 ---~-----------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~ 275 (332)
T cd05614 225 ---K-----------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDW 275 (332)
T ss_pred ---c-----------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 0 00112345789999999999999999999 8889999999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=350.38 Aligned_cols=245 Identities=29% Similarity=0.467 Sum_probs=199.0
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+.||+|+||+||+|++..++..||+|++.+.. ....+|.++++.+ +||||+++++++. ...++++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence 46999999999999999999999999987532 2234678888877 6999999999883 344589999
Q ss_pred eccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+.++ |...+. ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~ 149 (318)
T cd05570 76 EYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLH-ERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILG 149 (318)
T ss_pred cCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcC
Confidence 999864 333332 3457999999999999999999999 88999999999999999888 7999999998754322
Q ss_pred -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
......+||..|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+.......+...
T Consensus 150 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~----------------- 211 (318)
T cd05570 150 GVTTSTFCGTPDYIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED----------------- 211 (318)
T ss_pred CCcccceecCccccCHHHhcCC-CCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 223345689999999999764 4899999999999999999999999877755544443221
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCCcccCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFYELRD 382 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~-----~ell~hp~f~~~~~ 382 (429)
. ..++..++..+.+||++||..||.+|||+ .++++||||....+
T Consensus 212 ~------------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~ 260 (318)
T cd05570 212 E------------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDW 260 (318)
T ss_pred C------------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 0 01233578999999999999999999999 99999999988654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=346.86 Aligned_cols=247 Identities=30% Similarity=0.445 Sum_probs=199.7
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcE-EEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGET-VAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
...+.+.||+|+||+||++.+ .|.. ||+|++... ...+.+|+.+|.+++|||||++++++..... .+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~ 115 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SL 115 (362)
T ss_pred HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ce
Confidence 455667799999999999998 5556 999998653 2356789999999999999999998844331 48
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC-eeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG-VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g-ivH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+|||||++++.+..+.+.. ....++...+..++.||++||.||| +++ ||||||||+||||+.+...+||+|||+++.
T Consensus 116 ~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH-~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLH-SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHh-cCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 8999999965444443321 3578999999999999999999999 889 999999999999998753699999999988
Q ss_pred cccC-CCcccccccccccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 244 LVKG-EPNISYICSRYYRAPELIFG-ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 244 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.... ...+...||+.|||||++.+ ...|+.++||||||++||||+||+.||.+....+....+......|
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp-------- 265 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRP-------- 265 (362)
T ss_pred eccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------
Confidence 7654 34445789999999999974 3569999999999999999999999999888744444443321111
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.++...++.+..|+.+||..||..||+..+++.
T Consensus 266 -------------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 266 -------------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred -------------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 133447899999999999999999999998765
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=345.02 Aligned_cols=277 Identities=30% Similarity=0.535 Sum_probs=207.6
Q ss_pred eeEEccCCceEEEEEEEcC--CCcEEEEEEeecch--hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 96 ERVVGQGSFGIVFQAKCLE--TGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
..+||+|+||.||+|++.. ++..||+|.+.... ....+|+++++.++||||+++++++... ....+++||||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence 3589999999999999654 56899999886542 3456799999999999999999987543 234578999999
Q ss_pred chhHHHHHHHhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec----CCCCcEEEeecccce
Q 014174 172 PETVYRVAKHYSR-----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN----PHTHQVKLCDFGSAK 242 (429)
Q Consensus 172 ~~~l~~~~~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~----~~~~~vkl~DfG~a~ 242 (429)
+++++..+..... ....+++..++.++.||+.||.||| +.||+||||||+|||+. .++ .+||+|||+++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~ 160 (317)
T cd07867 83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERG-RVKIADMGFAR 160 (317)
T ss_pred CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH-hCCEEcCCCCHHHEEEccCCCCCC-cEEEeecccee
Confidence 9988877653211 1235889999999999999999999 88999999999999993 344 79999999998
Q ss_pred ecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHHHHHHH
Q 014174 243 VLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG---------VDQLVEIIKV 309 (429)
Q Consensus 243 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~~i~~~ 309 (429)
....... .....+|..|+|||++.+...++.++|||||||++|+|+||.+||..... ...+..+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 6543321 23456799999999987766689999999999999999999999975432 3456677777
Q ss_pred hCCCCHHHHhhcCc--Ccccc----cCCCcCCCCc---ccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 310 LGTPTREEIKCMNP--NYTEF----KFPQIKAHPW---HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 310 ~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~---~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
++.+..+.+..... .+... .......... ........+..+.+||.+||..||.+|||+.|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 77776655543211 11000 0000000000 011112346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=353.28 Aligned_cols=256 Identities=26% Similarity=0.450 Sum_probs=207.4
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|.+.+.||+|+||+||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++ ....+.
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~ 76 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL 76 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence 5999999999999999999999999999999986532 2345789999999999999999887 334458
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+++ +|.+.+.. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH-~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~ 151 (330)
T cd05601 77 YLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVH-QMGYVHRDIKPENVLIDRTG-HIKLADFGSAAR 151 (330)
T ss_pred EEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEcccCchHheEECCCC-CEEeccCCCCeE
Confidence 899999975 55554433 2357999999999999999999999 89999999999999999888 799999999987
Q ss_pred cccCCCc--ccccccccccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 244 LVKGEPN--ISYICSRYYRAPELIFG-----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 244 ~~~~~~~--~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
....... ....||+.|+|||++.. ...++.++|||||||++|+|++|..||...+....+..+.....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~----- 226 (330)
T cd05601 152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR----- 226 (330)
T ss_pred CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 6443322 23468999999999863 34478899999999999999999999988776665555443200
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
...++. ...++.++.+||++||. +|.+|+|+.++++||||..+.+.
T Consensus 227 ----------~~~~~~----------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 227 ----------FLKFPE----------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred ----------ccCCCC----------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence 001111 12478999999999998 99999999999999999876554
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=352.43 Aligned_cols=248 Identities=27% Similarity=0.413 Sum_probs=206.5
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.|+..+.||+|+||.||+|.+..+++.||||++.-+ ...+++|+.+|..++++||.++|+.|+.... +++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LWI 88 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HHH
Confidence 588889999999999999999999999999998644 3445689999999999999999999965554 899
Q ss_pred EEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||.|+ +.++++ .+..+.+..+..++++++.||.||| ..+.+|||||+.|||+..+| .+||+|||.+....
T Consensus 89 iMey~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH-~~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLH-SEKKIHRDIKAANILLSESG-DVKLADFGVAGQLT 162 (467)
T ss_pred HHHHhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhh-hcceecccccccceeEeccC-cEEEEecceeeeee
Confidence 99999965 334333 2455589999999999999999999 88999999999999999887 79999999998765
Q ss_pred cCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
.... ...++||++|||||++.+ ..|+.++||||||++.+||++|.+|+.....+..+..|-+
T Consensus 163 ~~~~rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk---------------- 225 (467)
T KOG0201|consen 163 NTVKRRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK---------------- 225 (467)
T ss_pred chhhccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC----------------
Confidence 4433 367899999999999985 5599999999999999999999999987655333322211
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
-. ...+...+|+.+++|+..||.+||+.||||.++|+|+|++.
T Consensus 226 --------~~----PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 226 --------SA----PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred --------CC----CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 10 11122357999999999999999999999999999999966
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=347.77 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=202.5
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCC-CeeecceEeeecCCCCceE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHP-NVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 163 (429)
+|++.+.||+|+||.||+|++..+++.||+|++.... .....|.+++..++|+ +|+++++++. ....
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence 4899999999999999999999999999999986432 2234688888888765 5778887773 3345
Q ss_pred EEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
+++||||++++ |...+. ....+++..+..++.||+.||.||| ++||+||||||+|||++.++ .+||+|||++.
T Consensus 76 ~~lv~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~ 149 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLDAEG-HIKIADFGMCK 149 (324)
T ss_pred EEEEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEEcCCC-CEEEeecCcce
Confidence 88999999854 433332 3467899999999999999999999 88999999999999999888 79999999987
Q ss_pred eccc-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 243 VLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 243 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.... ........||+.|+|||++.+.. ++.++||||+||++|+|+||+.||.+.+..+.+..+....
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~----------- 217 (324)
T cd05587 150 ENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN----------- 217 (324)
T ss_pred ecCCCCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 5422 22233457899999999997644 8999999999999999999999998877666655543310
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCCcccCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFYELRD 382 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~-----~ell~hp~f~~~~~ 382 (429)
..++..++.++.+||++||..||.+|++. .++++||||....+
T Consensus 218 ------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 218 ------------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 01233578999999999999999999986 89999999987654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=348.27 Aligned_cols=245 Identities=29% Similarity=0.479 Sum_probs=196.6
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHH-cCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
++||+|+||.||+|++..+|+.||+|.+.... .....|..++.. ++||||+++++++ ....++++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 46999999999999999999999999986532 223456777765 4899999999988 3445689999
Q ss_pred eccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+.++ |...+. ....+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+++.....
T Consensus 76 E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~ 149 (316)
T cd05620 76 EFLNGGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLH-SKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFG 149 (316)
T ss_pred CCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccC
Confidence 999864 433332 2467899999999999999999999 88999999999999999888 7999999998754222
Q ss_pred -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~-------------- 212 (316)
T cd05620 150 DNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--T-------------- 212 (316)
T ss_pred CCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence 223446789999999999764 4899999999999999999999999877665544433221 0
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-HHHhcCCCCcccCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-LEACIHPFFYELRD 382 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~-~ell~hp~f~~~~~ 382 (429)
+ .++..++.++++||++||..||++|+++ .++++||||....+
T Consensus 213 ----~---------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~ 256 (316)
T cd05620 213 ----P---------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINW 256 (316)
T ss_pred ----C---------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCH
Confidence 0 1223478999999999999999999998 58999999988654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=340.72 Aligned_cols=293 Identities=27% Similarity=0.410 Sum_probs=234.7
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh-------hhHHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
....+|..+.+||+|+||+|.+|..+.+.+.||||+++++.- ..-.|-++|... +-|++++++.||.
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ----- 420 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ----- 420 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh-----
Confidence 344579999999999999999999999999999998876532 222466666655 4688999999984
Q ss_pred CceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
.-..+|+||||+.|+ +++-+ .+.-+++.+..+.+++.+|+.||-+|| ++|||+||||.+|||++.+|| |||+|||
T Consensus 421 TmDRLyFVMEyvnGG--DLMyh-iQQ~GkFKEp~AvFYAaEiaigLFFLh-~kgIiYRDLKLDNvmLd~eGH-iKi~DFG 495 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGG--DLMYH-IQQVGKFKEPVAVFYAAEIAIGLFFLH-SKGIIYRDLKLDNVMLDSEGH-IKIADFG 495 (683)
T ss_pred hhhheeeEEEEecCc--hhhhH-HHHhcccCCchhhhhhHHHHHHhhhhh-cCCeeeeeccccceEeccCCc-eEeeecc
Confidence 333488999999976 33333 233578999999999999999999999 899999999999999999995 9999999
Q ss_pred cceecccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 240 SAKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 240 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
+++...-. .....++||+.|+|||++.-+ .|+.++||||+||+||||+.|++||.+.++.+..+.|+..
T Consensus 496 mcKEni~~~~TTkTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh--------- 565 (683)
T KOG0696|consen 496 MCKENIFDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH--------- 565 (683)
T ss_pred cccccccCCcceeeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc---------
Confidence 99876444 345578999999999999664 4999999999999999999999999999999999998874
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCCcccCCCCCCCCCCCCC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFYELRDPNARLPNGRPF 393 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~-----~ell~hp~f~~~~~~~~~~~~~~~~ 393 (429)
...+++.+|.++.+++..+|.+.|.+|+.. .++-.||||+.+.|.... .+.+
T Consensus 566 --------------------nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E---~~ei 622 (683)
T KOG0696|consen 566 --------------------NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLE---RREI 622 (683)
T ss_pred --------------------cCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHh---hccC
Confidence 122556799999999999999999999854 589999999998886433 2344
Q ss_pred CCCCCCChhhhccCCHHHHHhhcHHHHhhhCC
Q 014174 394 PPLFNFKPQELKGASKELLSKLIPEHARKQCP 425 (429)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (429)
+|++.... ..+.+.+-+.+.+..+....-|
T Consensus 623 qPPfkPk~--k~~r~~eNFD~~Ft~~~~~lTP 652 (683)
T KOG0696|consen 623 QPPFKPKI--KCGRDAENFDKFFTREPTDLTP 652 (683)
T ss_pred CCCCCCcc--ccCCchhhhhHHHhcCCCCCCC
Confidence 55544332 2345556677776666655555
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=347.01 Aligned_cols=275 Identities=26% Similarity=0.427 Sum_probs=204.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
++|++.+.||+|+||.||+|++..+|..||+|.+.... ..+.+|+++++.++||||+++++++.. ...++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 79 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS 79 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEEE
Confidence 47999999999999999999999999999999886432 335679999999999999999998843 33488
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+++ +|.+.+. ....+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 154 (331)
T cd06649 80 ICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL 154 (331)
T ss_pred EEeecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCcccccc
Confidence 99999986 4544443 2456899999999999999999999434799999999999999888 7999999998765
Q ss_pred ccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH----Hhh
Q 014174 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE----IKC 320 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~----~~~ 320 (429)
... ......||..|+|||++.+. .++.++|||||||++|+|++|+.||...+..+... + ++.+.... ...
T Consensus 155 ~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~---~~~~~~~~~~~~~~~ 228 (331)
T cd06649 155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA-I---FGRPVVDGEEGEPHS 228 (331)
T ss_pred ccc-ccccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-H---hcccccccccCCccc
Confidence 432 22345789999999999764 48999999999999999999999997766543222 1 12111000 000
Q ss_pred cCcCccc----c------cCC---------CcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 321 MNPNYTE----F------KFP---------QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 321 ~~~~~~~----~------~~~---------~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
..+.... . ..+ .+............+++++++||.+||.+||++|||+.++++||||....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0000000 0 000 00000000001124688999999999999999999999999999997644
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=329.05 Aligned_cols=261 Identities=29% Similarity=0.475 Sum_probs=208.4
Q ss_pred cceEEe-eEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEEEE
Q 014174 91 ISYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 91 ~~y~i~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
.+|++. ++||-|-.|+|..+.++.||+.+|+|++.. .....+|+++--.. .|||||.++++|...- .+..++.+||
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiVm 138 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIVM 138 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEeee
Confidence 356664 589999999999999999999999997654 44456788865544 5999999999885433 4567788999
Q ss_pred eccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC--CcEEEeecccceecc
Q 014174 169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVLV 245 (429)
Q Consensus 169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~--~~vkl~DfG~a~~~~ 245 (429)
|.+.|+ |++.+.. +..+.|++.++..|+.||+.|+.||| +.+|.||||||+|+|....+ -.+||+|||+|+...
T Consensus 139 E~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH-~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 139 ECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLH-SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred ecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHH-hcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 999864 4444432 34567999999999999999999999 99999999999999985432 279999999999877
Q ss_pred cCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHhhc
Q 014174 246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~ 321 (429)
......+.+.|++|.|||++ +...|+..+|+||+||+||.|++|.+||....... +-.+|..
T Consensus 216 ~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~------------- 281 (400)
T KOG0604|consen 216 EPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT------------- 281 (400)
T ss_pred CCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc-------------
Confidence 66667778889999999988 55669999999999999999999999998765422 2222222
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
..|.||. ..| ..+|.+++|+|+++|..+|++|+|+.++++|||+.....
T Consensus 282 ----gqy~FP~---pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 282 ----GQYEFPE---PEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred ----cCccCCC---hhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 1222322 111 237999999999999999999999999999999987554
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=357.27 Aligned_cols=253 Identities=27% Similarity=0.436 Sum_probs=201.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++++.||+|+||.||+|++..+++.||+|++... .....+|+++++.++|+||+++++.+ ....++
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~ 76 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence 599999999999999999999999999999988542 23345799999999999999999888 344468
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+++ +|.+.+.. .+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+|..
T Consensus 77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~ 150 (376)
T cd05598 77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVH-KMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTG 150 (376)
T ss_pred EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence 999999975 45554432 457899999999999999999999 89999999999999999888 799999999753
Q ss_pred cccC--------------------------------------------CCcccccccccccccccccCCCCCCCchhHHH
Q 014174 244 LVKG--------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAIDIWS 279 (429)
Q Consensus 244 ~~~~--------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 279 (429)
.... ......+||+.|+|||++.+. .++.++||||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwS 229 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT-GYTQLCDWWS 229 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC-CCCcceeeee
Confidence 2100 001134689999999999664 4899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcC
Q 014174 280 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQ 359 (429)
Q Consensus 280 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~ 359 (429)
|||++|+|++|+.||.+.+..+....+..... ....+ ....+++++.+||.+|+
T Consensus 230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~----------~~~~~s~~~~~li~~l~- 283 (376)
T cd05598 230 VGVILYEMLVGQPPFLADTPAETQLKVINWET---------------TLHIP----------SQAKLSREASDLILRLC- 283 (376)
T ss_pred ccceeeehhhCCCCCCCCCHHHHHHHHhccCc---------------cccCC----------CCCCCCHHHHHHHHHHh-
Confidence 99999999999999988776554443322100 00011 11247899999999977
Q ss_pred cCCCCCC---CHHHHhcCCCCcccCC
Q 014174 360 YSPNLRC---TALEACIHPFFYELRD 382 (429)
Q Consensus 360 ~dP~~R~---t~~ell~hp~f~~~~~ 382 (429)
.+|.+|+ |+.++++||||..+..
T Consensus 284 ~~p~~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 284 CGAEDRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred cCHhhcCCCCCHHHHhCCCCcCCCCH
Confidence 5999999 9999999999987543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=339.76 Aligned_cols=285 Identities=35% Similarity=0.557 Sum_probs=225.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
..+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++|+||+++++++.... ...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence 457999999999999999999999999999999886432 12347999999999999999999875322 234
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+++||||+++++..++... ...+++..+..++.||+.||.||| +.|++||||||+||+++.++ .+||+|||++..
T Consensus 83 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~ 157 (309)
T cd07845 83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLH-ENFIIHRDLKVSNLLLTDKG-CLKIADFGLART 157 (309)
T ss_pred EEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEECccceeee
Confidence 7899999998777766542 356899999999999999999999 88999999999999999887 799999999987
Q ss_pred cccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 244 LVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 244 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
..... ......++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 65432 22233457889999998776668999999999999999999999999999999999998888877765443221
Q ss_pred --cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 323 --PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 323 --~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
+....+..+......+...+ ...++.+.+||++||.+||++|||+.++++||||.+..-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred cccccccccccCCCCCchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 11111222211111111111 2358899999999999999999999999999999865544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-46 Score=344.12 Aligned_cols=265 Identities=27% Similarity=0.400 Sum_probs=216.0
Q ss_pred CCccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCC
Q 014174 86 QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 86 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 158 (429)
.+...+.|+.-++||+|+||.||-++.+.||+.||+|.+.+.+ .....|-.||..++.++||.+-..|
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf----- 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF----- 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----
Confidence 3445567899999999999999999999999999999774332 2334688999999999999997777
Q ss_pred CCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 159 KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
+....+|+|+..|+|+-+..- -+......|++..+++|+.+|+.||++|| +.+||+|||||+|||+|..|| |+|+|+
T Consensus 255 eTkd~LClVLtlMNGGDLkfH-iyn~g~~gF~e~ra~FYAAEi~cGLehlH-~~~iVYRDLKPeNILLDd~Gh-vRISDL 331 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFH-IYNHGNPGFDEQRARFYAAEIICGLEHLH-RRRIVYRDLKPENILLDDHGH-VRISDL 331 (591)
T ss_pred cCCCceEEEEEeecCCceeEE-eeccCCCCCchHHHHHHHHHHHhhHHHHH-hcceeeccCChhheeeccCCC-eEeecc
Confidence 344459999999997633211 12223358999999999999999999999 889999999999999999995 999999
Q ss_pred ccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 239 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 239 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
|+|..+..+......+||..|||||++.+.. |+...|||||||++|+|+.|+.||........-.++-+..-.
T Consensus 332 GLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~------ 404 (591)
T KOG0986|consen 332 GLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE------ 404 (591)
T ss_pred ceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc------
Confidence 9999998888888889999999999997765 999999999999999999999999765443332222221100
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCCC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDPN 384 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~~ 384 (429)
....++..+|+++++|++.+|+.||++|+ ++.++.+||||+.+.+..
T Consensus 405 -------------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 405 -------------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred -------------------chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 01124456899999999999999999998 677999999999988854
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=338.54 Aligned_cols=285 Identities=33% Similarity=0.579 Sum_probs=222.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.+. |+||+++++++...........
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 6999999999999999999999999999999875432 23457999999995 6999999998865554444567
Q ss_pred EEEEeccchhHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPETVYRVAKHYSRA-SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+++++...+...... ...+++..++.++.||+.||.||| +.||+||||||+||+++.+...+||+|||++..
T Consensus 82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH-KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 899999998887776543322 356899999999999999999999 889999999999999998334899999999876
Q ss_pred cccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 244 LVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 244 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
..... ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+....+..+....+.+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T cd07837 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS 240 (295)
T ss_pred cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence 53321 12233568889999988765668999999999999999999999999988888888888877777665443221
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~ 378 (429)
.......++........ ...+.++..+.+||.+||..||.+|||+.+++.||||.
T Consensus 241 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 241 KLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 11111112221111111 11235789999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=351.26 Aligned_cols=248 Identities=27% Similarity=0.405 Sum_probs=199.3
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEe
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
+.||+|+||.||+|++..+|+.||+|++.... ....+|+++++.++||||+++++++ ....++++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999986532 2234688899999999999998887 33446899999
Q ss_pred ccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC-C
Q 014174 170 FVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-E 248 (429)
Q Consensus 170 ~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~-~ 248 (429)
|++++.+... ......+++..++.++.||+.||.|||+..||+||||||+|||++.++ .+||+|||+++..... .
T Consensus 76 ~~~~~~L~~~---l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~ 151 (325)
T cd05594 76 YANGGELFFH---LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGA 151 (325)
T ss_pred CCCCCcHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCc
Confidence 9986533221 223467999999999999999999999337999999999999999888 7999999998754322 2
Q ss_pred CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 014174 249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328 (429)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~-----------------~~ 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-----------------EI 213 (325)
T ss_pred ccccccCCcccCCHHHHccC-CCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC-----------------CC
Confidence 23345789999999998664 4899999999999999999999999877654444333221 00
Q ss_pred cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCC
Q 014174 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDP 383 (429)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~ 383 (429)
.++..+++++.+||++||+.||.+|+ ++.++++||||....+.
T Consensus 214 ------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 214 ------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred ------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 12345789999999999999999997 99999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=339.60 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=199.1
Q ss_pred EccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
||+|+||+||++.+..+++.||+|.+.... .....|+++++.++|+||+++++++ .....+++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 699999999999999999999999886432 2234689999999999999998887 3444588999999
Q ss_pred chh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCC-
Q 014174 172 PET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP- 249 (429)
Q Consensus 172 ~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~- 249 (429)
+++ |...+.........+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~ 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH-QRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence 864 43333332334467999999999999999999999 88999999999999999887 799999999976544322
Q ss_pred cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 014174 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329 (429)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
.....||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+.......
T Consensus 154 ~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 216 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND---------------- 216 (280)
T ss_pred ccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------
Confidence 2345689999999999764 48899999999999999999999997654332222222110000
Q ss_pred CCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCC
Q 014174 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDP 383 (429)
Q Consensus 330 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~ 383 (429)
...++..++..+.+|+.+||+.||++|+ |++++++||||..+.+.
T Consensus 217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 217 ---------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred ---------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 0012345799999999999999999999 88999999999886654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=350.80 Aligned_cols=253 Identities=28% Similarity=0.454 Sum_probs=220.0
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
++|.+++++|+|+||.+++++++..+..|++|.+.-. +.....|+.+++++.|||||.+++.|+ .+..++
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence 4799999999999999999999999999999988533 334567999999999999999999995 334469
Q ss_pred EEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+|||+||+|+ +.+.+.. .+...++++.+..|+.||+.|+.||| +.+|+|||||+.||++++++ .|||+|||+|+.
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~--~k~~~f~E~~i~~~~~Q~~~av~ylH-~~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~ 155 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKE--QKGVLFPEERILKWFVQILLAVNYLH-ENRVLHRDLKCANIFLTKDK-KVKLGDFGLAKI 155 (426)
T ss_pred EEEEeecCCCCHHHHHHH--HhhccccHHHHHHHHHHHHHHHHHHH-hhhhhcccchhhhhhccccC-ceeecchhhhhh
Confidence 9999999965 4444443 22577999999999999999999999 89999999999999999998 589999999999
Q ss_pred cccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 244 LVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 244 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
..... ...+..||++||+||++.+. .|+.++|||||||++|||++-+++|.+.+-.....+|.+....|
T Consensus 156 l~~~~~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P--------- 225 (426)
T KOG0589|consen 156 LNPEDSLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP--------- 225 (426)
T ss_pred cCCchhhhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC---------
Confidence 87776 56678999999999999774 59999999999999999999999999999888888888754332
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
++...+.+++.||+.||..+|..||++.++|.+|.....
T Consensus 226 -------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 226 -------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred -------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 334579999999999999999999999999999998743
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=345.03 Aligned_cols=245 Identities=30% Similarity=0.482 Sum_probs=196.2
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHH-cCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
++||+|+||.||+|++..+++.||+|++.... .....|..++.. .+||||+++++++ ....++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 46999999999999999999999999986532 122345566654 4899999999887 3344689999
Q ss_pred eccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||++++ |...+. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.....
T Consensus 76 e~~~gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH-~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~ 149 (316)
T cd05592 76 EYLNGGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLH-KKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNG 149 (316)
T ss_pred cCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCC
Confidence 999754 433332 2467999999999999999999999 88999999999999999888 7999999999765332
Q ss_pred C-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 E-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
. .....+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~-------------- 212 (316)
T cd05592 150 EGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND--R-------------- 212 (316)
T ss_pred CCccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--C--------------
Confidence 2 233457899999999997644 899999999999999999999999887765555443221 0
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-HHHhcCCCCcccCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-LEACIHPFFYELRD 382 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~-~ell~hp~f~~~~~ 382 (429)
..++..++.++.+||.+||..||.+|+++ .++++||||....+
T Consensus 213 -------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05592 213 -------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDW 256 (316)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCH
Confidence 01233478999999999999999999986 48999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=352.90 Aligned_cols=254 Identities=28% Similarity=0.432 Sum_probs=203.8
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.++..++|+||+++++.+ ....++
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~ 76 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL 76 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence 5999999999999999999999999999999986421 2345689999999999999999988 444568
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+++ +|.+.+. ....+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||++..
T Consensus 77 ~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH-~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~ 150 (360)
T cd05627 77 YLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIH-QLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTG 150 (360)
T ss_pred EEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEccCCCHHHEEECCCC-CEEEeeccCCcc
Confidence 999999985 4444443 2467999999999999999999999 89999999999999999888 799999999865
Q ss_pred cccCC------------------------------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHH
Q 014174 244 LVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAEL 287 (429)
Q Consensus 244 ~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 287 (429)
..... .....+||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyel 229 (360)
T cd05627 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-GYNKLCDWWSLGVIMYEM 229 (360)
T ss_pred cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-CCCCcceeccccceeeec
Confidence 42110 01234689999999998764 489999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-
Q 014174 288 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC- 366 (429)
Q Consensus 288 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~- 366 (429)
++|..||.+.+.......+..... ...+|. ...+++++++||.+|+. ||.+|+
T Consensus 230 ~tG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~~li~~l~~-~p~~R~~ 283 (360)
T cd05627 230 LIGYPPFCSETPQETYRKVMNWKE---------------TLVFPP----------EVPISEKAKDLILRFCT-DSENRIG 283 (360)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCC---------------ceecCC----------CCCCCHHHHHHHHHhcc-ChhhcCC
Confidence 999999988776665555443100 001111 01368999999999874 999998
Q ss_pred --CHHHHhcCCCCcccCCC
Q 014174 367 --TALEACIHPFFYELRDP 383 (429)
Q Consensus 367 --t~~ell~hp~f~~~~~~ 383 (429)
++.++++||||..+.+.
T Consensus 284 ~~~~~ei~~hp~f~~~~~~ 302 (360)
T cd05627 284 SNGVEEIKSHPFFEGVDWG 302 (360)
T ss_pred CCCHHHHhcCCCCCCCCHH
Confidence 47999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=344.54 Aligned_cols=315 Identities=37% Similarity=0.634 Sum_probs=244.5
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||.|+||.||+|++..++..||||.+.... ....+|+.+++.++|+||+++++++..........++
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4899999999999999999999899999999886432 3455799999999999999999988655433334678
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||+++++.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++....
T Consensus 81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH-~~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLH-SANVIHRDLKPSNILVNSNC-DLKICDFGLARGVD 154 (330)
T ss_pred EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence 9999999876665542 347999999999999999999999 88999999999999999887 79999999998765
Q ss_pred cCC----CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 246 KGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 246 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
... ......++..|+|||.+.+...++.++|+||||+++|+|++|.+||.+.+..+.+..++...+.+..+.+...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 234 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI 234 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence 543 2334567889999999977646899999999999999999999999999999999999998888887655422
Q ss_pred CcC-cccc--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCC
Q 014174 322 NPN-YTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFN 398 (429)
Q Consensus 322 ~~~-~~~~--~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~ 398 (429)
... ...+ ..+......+.. +...++.++.+||.+||+++|.+|||+.++++||||..+.++....+...+ ++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~----~~ 309 (330)
T cd07834 235 TSEKARNYLKSLPKKPKKPLSK-LFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPP----FD 309 (330)
T ss_pred cccchhhHHhhcccCCcchhHH-hcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCc----cc
Confidence 111 1111 011111112222 223478999999999999999999999999999999999887665444333 24
Q ss_pred CChhhhccCCHHHHHhhcH
Q 014174 399 FKPQELKGASKELLSKLIP 417 (429)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~ 417 (429)
+.+-+-+...++.++.++.
T Consensus 310 ~~~~~~~~~~~~~~~~~~~ 328 (330)
T cd07834 310 FDFFDDDELTEEELKELIY 328 (330)
T ss_pred ccccchhhcCHHHHhHHhh
Confidence 4333334444555555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=348.40 Aligned_cols=245 Identities=29% Similarity=0.456 Sum_probs=196.3
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecchh-------hhHHHHH-HHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQ-TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+.||+|+||+||+|++..+|+.||||++..... ...+|.. +++.++||||+++++++. .....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence 469999999999999999999999999864321 1123333 567899999999998883 334588999
Q ss_pred eccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+.++ |...+. ....+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~ 149 (323)
T cd05575 76 DYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLH-SLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH 149 (323)
T ss_pred cCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence 999864 333332 3467999999999999999999999 88999999999999999888 7999999998754322
Q ss_pred -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (323)
T cd05575 150 SKTTSTFCGTPEYLAPEVLRKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P------------- 212 (323)
T ss_pred CCccccccCChhhcChhhhcCC-CCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C-------------
Confidence 223345789999999998764 4899999999999999999999999887765554444321 0
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCCcccCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFYELRD 382 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~----~ell~hp~f~~~~~ 382 (429)
..++..++..+.+||++||+.||.+|+++ .++++||||..+.+
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~ 259 (323)
T cd05575 213 -------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINW 259 (323)
T ss_pred -------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 01223478999999999999999999998 69999999987655
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=349.83 Aligned_cols=256 Identities=28% Similarity=0.450 Sum_probs=204.9
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...+|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++||||+++++++ ...
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence 345799999999999999999999999999999988542 12345789999999999999999888 444
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
.++++||||+++ +|..++. ...+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDLkp~NIll~~~~-~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSG-HLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH-HCCEEeCCCCHHHEEECCCC-CEEEEeCCc
Confidence 568999999975 4544443 245899999999999999999999 89999999999999999888 799999999
Q ss_pred ceecccCCC--cccccccccccccccccCCC---CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 241 AKVLVKGEP--NISYICSRYYRAPELIFGAT---EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 241 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+........ .....||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---- 264 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN---- 264 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC----
Confidence 987643322 23457899999999986432 378899999999999999999999998776666555543211
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCCcccC
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFYELR 381 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--R~t~~ell~hp~f~~~~ 381 (429)
...++. ...++..+++||.+||..++.+ |+++.++++||||.+..
T Consensus 265 -----------~~~~~~----------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~ 311 (371)
T cd05622 265 -----------SLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 311 (371)
T ss_pred -----------cccCCC----------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCC
Confidence 011111 1247999999999999844443 78999999999997743
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=346.65 Aligned_cols=245 Identities=29% Similarity=0.474 Sum_probs=199.6
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
++||+|+||.||+|++..+++.||+|++.... .....|.+++..+ +||||+++++++. ....+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence 36999999999999999999999999986532 1233577888765 7999999999883 344588999
Q ss_pred eccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||++++ |...+. ....+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||++......
T Consensus 76 E~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~ 149 (321)
T cd05591 76 EYVNGGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLH-RHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILN 149 (321)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCC-CEEEeecccceecccC
Confidence 999864 433332 3467899999999999999999999 88999999999999999888 7999999998764322
Q ss_pred -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
.......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~----------------- 211 (321)
T cd05591 150 GVTTTTFCGTPDYIAPEILQEL-EYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD----------------- 211 (321)
T ss_pred CccccccccCccccCHHHHcCC-CCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 223445789999999998664 4899999999999999999999999988776666554431
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-------CHHHHhcCCCCcccCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-------TALEACIHPFFYELRD 382 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-------t~~ell~hp~f~~~~~ 382 (429)
.. .++..++.++.+||.+||..||.+|+ ++.++++||||..+.+
T Consensus 212 ~~------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~ 262 (321)
T cd05591 212 DV------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDW 262 (321)
T ss_pred CC------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCH
Confidence 00 12234689999999999999999999 9999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=334.04 Aligned_cols=276 Identities=40% Similarity=0.736 Sum_probs=224.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|+||.||+|.+..+|..||+|++.... ....+|+.+++.++|+||+++++++. ...+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence 4899999999999999999999999999999886432 34557999999999999999999884 344688
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+|+||+++++.+.+.. ....+++..++.++.||+.||.||| +.||+|+||||+||+++.++ .++|+|||++....
T Consensus 76 ~v~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~ 150 (286)
T cd07832 76 LVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMH-ANGIMHRDLKPANLLISADG-VLKIADFGLARLFS 150 (286)
T ss_pred EEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence 9999997777766543 2366999999999999999999999 88999999999999999887 79999999988764
Q ss_pred cCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 014174 246 KGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 322 (429)
Q Consensus 246 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 322 (429)
.... .....++..|+|||.+.+...++.++||||+||++|+|++|.++|.+.+....+..+....+.+....+....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 4331 2345678899999998766667899999999999999999999999888888888888888888776554322
Q ss_pred -cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCc
Q 014174 323 -PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378 (429)
Q Consensus 323 -~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~ 378 (429)
.++....++......+.. ..+..+.++.+||++||..||++|||+.++++||||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 231 LPDYNKITFPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cchhhcccCCCCCcchHHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 122222233222222222 2235679999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=345.07 Aligned_cols=246 Identities=26% Similarity=0.472 Sum_probs=195.1
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
++||+|+||.||+|++..+++.||+|++.+.. ....+|..+++.+ +||||+++++++ .....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 46999999999999999999999999987532 2244688888888 799999999988 3444689999
Q ss_pred eccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc-
Q 014174 169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK- 246 (429)
Q Consensus 169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~- 246 (429)
||++++ |...+. ..+.+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++....
T Consensus 76 e~~~~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~ 149 (329)
T cd05588 76 EFVSGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLH-ERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRP 149 (329)
T ss_pred eCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEECCCC-CEEECcCccccccccC
Confidence 999864 433332 3467999999999999999999999 89999999999999999887 799999999875322
Q ss_pred CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHH
Q 014174 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~ 318 (429)
........||+.|+|||++.+. .++.++|+|||||++|+|++|+.||..... .+.+.+....
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--------- 219 (329)
T cd05588 150 GDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE--------- 219 (329)
T ss_pred CCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence 2333456789999999999764 489999999999999999999999963211 1111111100
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCCCcccCC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT------ALEACIHPFFYELRD 382 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t------~~ell~hp~f~~~~~ 382 (429)
. ...++..++..+.+||++||+.||.+|+| +.++++||||..+.+
T Consensus 220 -------~------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~ 270 (329)
T cd05588 220 -------K------------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDW 270 (329)
T ss_pred -------C------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 0 00123457899999999999999999997 789999999987655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=344.92 Aligned_cols=245 Identities=29% Similarity=0.476 Sum_probs=198.8
Q ss_pred eEEccCCceEEEEEEEc---CCCcEEEEEEeecch--------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 97 RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+.||+|+||.||+|++. .+++.||+|++.... ....+|+.+++.++||||+++++++. ....++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence 68999999999999864 478899999886431 22346999999999999999999883 334588
Q ss_pred EEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+.++ |...+. ..+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus 77 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 150 (323)
T cd05584 77 LILEYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLH-QQGIIYRDLKPENILLDAQG-HVKLTDFGLCKES 150 (323)
T ss_pred EEEeCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-CEEEeeCcCCeec
Confidence 999999864 433332 3467889999999999999999999 89999999999999999888 7999999998754
Q ss_pred ccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 151 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~-------------- 215 (323)
T cd05584 151 IHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG-------------- 215 (323)
T ss_pred ccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--------------
Confidence 3322 23345789999999998764 4889999999999999999999999887765555444321
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRD 382 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~ 382 (429)
. ..++..+++.+.+||++||+.||++|+ ++.++++||||....+
T Consensus 216 ---~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 216 ---K------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred ---C------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 0 012345789999999999999999999 8999999999987544
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=343.24 Aligned_cols=257 Identities=27% Similarity=0.418 Sum_probs=204.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++.+.||+|+||.||++++..+++.||+|++.+. ...+.+|+.+++.++|+||+++++++ ....++
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL 76 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence 699999999999999999999999999999998642 12345788999999999999999988 344568
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+.+ +|...+.. ....+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~ 151 (331)
T cd05597 77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVH-QLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLR 151 (331)
T ss_pred EEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEECCCCHHHEEECCCC-CEEEEECCceee
Confidence 999999975 55554432 2457999999999999999999999 89999999999999999888 799999999876
Q ss_pred cccCCCc--ccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 244 LVKGEPN--ISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 244 ~~~~~~~--~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
....... ....||+.|+|||++.. ...++.++||||+||++|+|++|+.||.+.+..+....+.....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~------ 225 (331)
T cd05597 152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------ 225 (331)
T ss_pred cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC------
Confidence 5443322 23468999999999863 23478899999999999999999999988776655554433110
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCCcccCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFYELRD 382 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--R~t~~ell~hp~f~~~~~ 382 (429)
.+.++. ....++..+++||++||+.++.+ |+++.++++||||..+.+
T Consensus 226 ---------~~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~ 274 (331)
T cd05597 226 ---------HFQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDW 274 (331)
T ss_pred ---------cccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCH
Confidence 001111 11237899999999999765544 789999999999988655
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-44 Score=337.12 Aligned_cols=279 Identities=36% Similarity=0.601 Sum_probs=224.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.+|++.+.||.|+||.||+|.+..+++.+|+|.+.... ....+|+.+++.++||||+++++++.... ..+.
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence 46999999999999999999999999999999886432 12346999999999999999999875432 2458
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++|+||+++++..++.. ....+++..++.++.||+.||.||| +.||+|+||||+||+++.++ .+||+|||++...
T Consensus 82 ~lv~e~~~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH-~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~ 156 (293)
T cd07843 82 YMVMEYVEHDLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLH-DNWILHRDLKTSNLLLNNRG-ILKICDFGLAREY 156 (293)
T ss_pred EEEehhcCcCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCCHHHEEECCCC-cEEEeecCceeec
Confidence 89999999877776543 2246899999999999999999999 88999999999999999887 7999999999876
Q ss_pred ccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... .......++..|+|||.+.+...++.++|+||||+++|+|++|.+||...+....+.++....+.+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 544 2233456788899999987655578999999999999999999999999998888888988888887766543211
Q ss_pred --CcccccCCCcCCCCcccccCCC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 --NYTEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 --~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
..............+...++.. +++.+.+||++||+.||++|||+.|+|+||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 1111111111222223334444 68899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=326.12 Aligned_cols=259 Identities=25% Similarity=0.439 Sum_probs=209.7
Q ss_pred CccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceEeeecCC
Q 014174 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 87 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 158 (429)
.....+|.++++||+|+|.+|.+++.++|.+.||+|+++++- ...+.|-.++... +||++|.++.||
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf----- 320 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF----- 320 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----
Confidence 344568999999999999999999999999999999987642 2223455565554 799999999999
Q ss_pred CCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 159 KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
+.+..+++|.||++|+ +++.+.. ...+++++.++++..+|+.||.||| +.|||+||||.+|||+|..|| +||+|+
T Consensus 321 qtesrlffvieyv~gg--dlmfhmq-rqrklpeeharfys~ei~lal~flh-~rgiiyrdlkldnvlldaegh-ikltdy 395 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGG--DLMFHMQ-RQRKLPEEHARFYSAEICLALNFLH-ERGIIYRDLKLDNVLLDAEGH-IKLTDY 395 (593)
T ss_pred cccceEEEEEEEecCc--ceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHh-hcCeeeeeccccceEEccCCc-eeeccc
Confidence 6667799999999986 4444433 3578999999999999999999999 899999999999999999995 999999
Q ss_pred ccceeccc-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-------CChHHHHHHHHHHh
Q 014174 239 GSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG-------ESGVDQLVEIIKVL 310 (429)
Q Consensus 239 G~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~-------~~~~~~~~~i~~~~ 310 (429)
|+++.... +.....++||+.|+|||++.+.. |+..+|||+||++|+||+.|+.||.- .+..+.+.+++-.
T Consensus 396 gmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile- 473 (593)
T KOG0695|consen 396 GMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE- 473 (593)
T ss_pred chhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-
Confidence 99987654 44556789999999999998854 99999999999999999999999952 2222333332211
Q ss_pred CCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC------CHHHHhcCCCCcccCCCC
Q 014174 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC------TALEACIHPFFYELRDPN 384 (429)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~------t~~ell~hp~f~~~~~~~ 384 (429)
. +-.++..+|-.+..+++..|.+||.+|+ ...++..|+||+.+.|..
T Consensus 474 -------------------------k--qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~ 526 (593)
T KOG0695|consen 474 -------------------------K--QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL 526 (593)
T ss_pred -------------------------h--cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence 0 0123445788889999999999999997 467999999999887753
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=340.95 Aligned_cols=245 Identities=28% Similarity=0.490 Sum_probs=196.8
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHH-cCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+.||+|+||+||+|++..+++.||||++.... .....|..+++. ++||||+++++++. ...++++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence 46999999999999999999999999986542 223356777765 58999999999884 334588999
Q ss_pred eccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+++ +|...+. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++......
T Consensus 76 ey~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH-~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~ 149 (316)
T cd05619 76 EYLNGGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLH-SKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLG 149 (316)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCC
Confidence 99985 4444433 2457899999999999999999999 88999999999999999888 7999999998754322
Q ss_pred -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
.......||..|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....+... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~-------------- 212 (316)
T cd05619 150 DAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--N-------------- 212 (316)
T ss_pred CCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence 223345789999999998764 4899999999999999999999999887665544433221 0
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCCCcccCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL-EACIHPFFYELRD 382 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~-ell~hp~f~~~~~ 382 (429)
..++..++.++.+||.+||..||.+|+++. ++++||||..+.+
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~ 256 (316)
T cd05619 213 -------------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDW 256 (316)
T ss_pred -------------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCH
Confidence 011234688999999999999999999996 8999999988765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=345.74 Aligned_cols=254 Identities=27% Similarity=0.364 Sum_probs=199.1
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
...+|.+++.||+|+||.||+|++..+++.||||++.... ..+.+|+++++.++|+||+++++++ .....
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 146 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE 146 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence 3457999999999999999999999999999999985432 3345799999999999999999988 34445
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+++||||+.++.+.. .....+..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus 147 ~~lv~e~~~~~~L~~-------~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~ 217 (353)
T PLN00034 147 IQVLLEFMDGGSLEG-------THIADEQFLADVARQILSGIAYLH-RRHIVHRDIKPSNLLINSAK-NVKIADFGVSRI 217 (353)
T ss_pred EEEEEecCCCCcccc-------cccCCHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEcCCC-CEEEccccccee
Confidence 889999999764321 234577888899999999999999 88999999999999999887 799999999987
Q ss_pred cccCC-CcccccccccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 244 LVKGE-PNISYICSRYYRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 244 ~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
..... ......||..|+|||.+... ...+.++|||||||++|+|++|+.||......+....+......
T Consensus 218 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~------ 291 (353)
T PLN00034 218 LAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS------ 291 (353)
T ss_pred cccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc------
Confidence 64332 22345789999999987431 23456899999999999999999999743322211111111000
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
.....+..++.++++||.+||..||++|||+.|+++||||..-.
T Consensus 292 -------------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 292 -------------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred -------------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 00012234789999999999999999999999999999998743
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=332.31 Aligned_cols=275 Identities=37% Similarity=0.644 Sum_probs=217.6
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh-----hhHHHHHHHHHcC-CCCeeecceEeeecCCCCceEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
|++.+.||+|+||.||+|.+..++..||+|.+..... ...+|+.+++++. |+|++++++++... ...++++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 6789999999999999999999999999998864321 1235888888885 99999999988543 1135789
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
||||+++++++.+.. ....+++..++.++.||+.||.||| +.||+||||||+||+++. + .+||+|||++.....
T Consensus 78 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH-~~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~ 151 (282)
T cd07831 78 VFELMDMNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMH-RNGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS 151 (282)
T ss_pred EEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence 999999887776543 2356899999999999999999999 889999999999999998 6 799999999987655
Q ss_pred CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC-c
Q 014174 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-Y 325 (429)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~ 325 (429)
........++..|+|||.+.....++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+........... .
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 444445567899999998755555788999999999999999999999998888888888888887776543322211 1
Q ss_pred ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
..+.++......+ ..+...++.++.+||.+||.+||++|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 232 MNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1122222111111 11223578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=341.79 Aligned_cols=288 Identities=35% Similarity=0.650 Sum_probs=229.4
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.+|.+.+.||+|+||.||+|.+..+|..||+|++.... ....+|+.+++.++||||+++++++.... ....++
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence 46999999999999999999999999999999886432 23346999999999999999998775433 334568
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++||||+.+++...+. ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus 84 ~lv~e~~~~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLMESDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIH-SANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhhhhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence 8999999887665543 2456999999999999999999999 88999999999999999888 7999999999765
Q ss_pred ccCCC-----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 245 VKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 245 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
..... .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....|.|+...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 43221 1234678899999998665558999999999999999999999999998888888888888888776554
Q ss_pred hcCcCcccc---cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCC
Q 014174 320 CMNPNYTEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNAR 386 (429)
Q Consensus 320 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~ 386 (429)
......... .++......+.. +....+.++.++|++||+.+|.+|||+.+++.||||.....+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~ 306 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDE 306 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCccc
Confidence 322111000 111111112211 223468999999999999999999999999999999988877654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=338.55 Aligned_cols=281 Identities=37% Similarity=0.623 Sum_probs=215.8
Q ss_pred ceEEeeEEccCCceEEEEEEEcC--CCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLE--TGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 48999999999999999999988 89999999887632 3345799999999999999999988542 224
Q ss_pred EEEEEEeccchhHHHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC----CCCcEEEee
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRAS-QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP----HTHQVKLCD 237 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~----~~~~vkl~D 237 (429)
.+++||||+++++...+....... ..+++..++.++.||+.||.||| +.||+||||||+||+++. ++ .+||+|
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~h~dlkp~Nil~~~~~~~~~-~~kl~D 155 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH-SNWVLHRDLKPANILVMGEGPERG-VVKIGD 155 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH-hCCEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence 688999999988887765543333 37899999999999999999999 889999999999999998 76 799999
Q ss_pred cccceecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---------HHHH
Q 014174 238 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV---------DQLV 304 (429)
Q Consensus 238 fG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---------~~~~ 304 (429)
||++........ .....+|..|+|||.+.+...++.++|||||||++|+|++|++||.+.... ..+.
T Consensus 156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 999886543322 223467888999998877666899999999999999999999999865532 3556
Q ss_pred HHHHHhCCCCHHHHhhcC--cCccc----ccCCCcCCCCcccccC--CCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014174 305 EIIKVLGTPTREEIKCMN--PNYTE----FKFPQIKAHPWHKIFH--KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376 (429)
Q Consensus 305 ~i~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~--~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~ 376 (429)
.++..++.+....+.... +.+.. .....+........+. ...+..+.++|.+||..||++|||+.++++|||
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 666777766654432211 11111 0001111011111111 156889999999999999999999999999999
Q ss_pred C
Q 014174 377 F 377 (429)
Q Consensus 377 f 377 (429)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=353.04 Aligned_cols=275 Identities=25% Similarity=0.336 Sum_probs=205.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEe
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
...|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+++++.++|+|||++++++.. ....++||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEE
Confidence 4479999999999999999999999999999996432 234579999999999999999998743 334789999
Q ss_pred ccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCC
Q 014174 170 FVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249 (429)
Q Consensus 170 ~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~ 249 (429)
++.++++..+.. ....+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+++.......
T Consensus 241 ~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH-~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KYRSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIH-GEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWS 315 (461)
T ss_pred ccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCEEECcCCHHHEEECCCC-CEEEcccCCceecccccc
Confidence 999887776543 2346999999999999999999999 88999999999999999887 799999999986543221
Q ss_pred ---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCC-CCCC------hHHHHHHHHHHhCCCCHHH--
Q 014174 250 ---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLF-PGES------GVDQLVEIIKVLGTPTREE-- 317 (429)
Q Consensus 250 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~------~~~~~~~i~~~~~~~~~~~-- 317 (429)
.....||..|+|||++.+. .++.++|||||||+||+|++|..++ .... ...++.++++..+....+.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 1235689999999999765 4899999999999999999987554 3221 1234445554433221110
Q ss_pred ------HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 318 ------IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 318 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.............+......|... ..++.++.+||++||++||.+|||+.|+|+||||+.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000000000001111112222221 135778999999999999999999999999999964
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=333.08 Aligned_cols=275 Identities=36% Similarity=0.660 Sum_probs=217.5
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++++.||.|++|.||+|++..+|..||||.+..+. ....+|+++++.++||||+++++++. +....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence 4899999999999999999999999999999885432 23557999999999999999999873 344588
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||+.+++...+... ....+++..+..++.|++.||+||| +.|++|+||+|+||+++.++ .+||+|||++....
T Consensus 76 ~v~e~~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh-~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~ 151 (284)
T cd07860 76 LVFEFLHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFG 151 (284)
T ss_pred EEeeccccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence 99999988776655432 2356899999999999999999999 88999999999999999888 79999999987654
Q ss_pred cCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 014174 246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP- 323 (429)
Q Consensus 246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 323 (429)
.... .....++..|+|||.+.+...++.++|||||||++|+|+||+.||.+.+......++....+.+....+.....
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 3321 22335678899999887655578899999999999999999999999888888888888887776543321110
Q ss_pred -CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 -NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 -~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.+. ..++......... +...++++++++|.+||+.||.+|||+.++++||||
T Consensus 232 ~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYK-PSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHH-hhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 000 0122221111111 123478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=332.13 Aligned_cols=276 Identities=34% Similarity=0.634 Sum_probs=216.5
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+++++.++|+||+++++++ ....+.+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeEE
Confidence 47999999999999999999999899999999885432 2335799999999999999999987 3344688
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||+++++.+.+.. ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+++...
T Consensus 80 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH-~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~ 154 (291)
T cd07844 80 LVFEYLDTDLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCH-QRRVLHRDLKPQNLLISERG-ELKLADFGLARAKS 154 (291)
T ss_pred EEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecccCCHHHEEEcCCC-CEEECccccccccC
Confidence 9999999877765543 2346899999999999999999999 88999999999999999888 79999999986543
Q ss_pred cCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... ......++..|+|||.+.+...++.++||||+||++|+|++|..||.+.. ..+.+..+...++.+..+.+.....
T Consensus 155 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred CCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 221 11223467889999998765668899999999999999999999997765 5566677777777777665543322
Q ss_pred C--cccccCCCcCCCCcccccCCCCC--hhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 N--YTEFKFPQIKAHPWHKIFHKRMP--PEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 ~--~~~~~~~~~~~~~~~~~~~~~~s--~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
. +.....+..........+ ..++ .++.++|.+||+.||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 1 112222222111111111 1234 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=338.66 Aligned_cols=318 Identities=32% Similarity=0.540 Sum_probs=241.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC-CCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 163 (429)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++|+||+++++++..... .....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 46999999999999999999999999999999885421 224579999999999999999998754322 12234
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
.++|+||+..++.... ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||+++.
T Consensus 95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH-~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIH-SAGIIHRDLKPGNLAVNEDC-ELKILDFGLARH 166 (342)
T ss_pred EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEeeCCCCcC
Confidence 6799999987554432 246899999999999999999999 88999999999999999887 799999999876
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... ......++..|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..+....+.+....+.....
T Consensus 167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 432 223456788999999987655588999999999999999999999999888888888888877776655443321
Q ss_pred Cc-cc--ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCC
Q 014174 324 NY-TE--FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFK 400 (429)
Q Consensus 324 ~~-~~--~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 400 (429)
.. .. ...+......+... .+..+..+.+||++||+.||.+|||+.+++.||||..+++.... +. +.+++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~-~~----~~~~~~~ 318 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTL-FPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEE-TE----QQPYDDS 318 (342)
T ss_pred cchHHHHhhcCCcccchHHHH-hcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccccc-CC----CCcccch
Confidence 10 00 01122211222111 13468899999999999999999999999999999998864332 11 3335555
Q ss_pred hhhhccCCHHHHHhhcHHHHhhhCC
Q 014174 401 PQELKGASKELLSKLIPEHARKQCP 425 (429)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (429)
.... ....+.+...+..+..+.+|
T Consensus 319 ~~~~-~~~~~~~~~~~~~~~~~~~~ 342 (342)
T cd07879 319 LENE-KLSVDEWKKHIYKEVKSFSP 342 (342)
T ss_pred hhhh-hCCHHHHHHHhhhhhhccCC
Confidence 5433 44456677778777777665
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=334.81 Aligned_cols=256 Identities=26% Similarity=0.398 Sum_probs=202.5
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
|++.+.||+|+||.||++.+..+++.||+|.+.... ....+|+.+++.++|+||+.+++.+. ...+++
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEEE
Confidence 788899999999999999999999999999885431 22346999999999999999988873 334689
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+.+ +|...+.. .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++...
T Consensus 77 lv~e~~~g~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~ 152 (285)
T cd05630 77 LVLTLMNGGDLKFHIYH--MGEAGFEEGRAVFYAAEICCGLEDLH-QERIVYRDLKPENILLDDHG-HIRISDLGLAVHV 152 (285)
T ss_pred EEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCCCHHHEEECCCC-CEEEeeccceeec
Confidence 99999975 44444432 22346899999999999999999999 89999999999999999887 7999999998765
Q ss_pred ccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
..........||..|+|||.+.+. .++.++||||+||++|+|++|+.||..................
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------------ 219 (285)
T cd05630 153 PEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------------ 219 (285)
T ss_pred CCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------------
Confidence 444333445789999999999764 4899999999999999999999999765432111111110000
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCCC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRDP 383 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~~ 383 (429)
....++..+++++.+||++||+.||.+|+| +.++++||||.++...
T Consensus 220 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 220 -------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred -------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 000123357899999999999999999999 9999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=341.13 Aligned_cols=287 Identities=30% Similarity=0.511 Sum_probs=217.0
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCC-------
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK------- 159 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------- 159 (429)
.+|.+.+.||.|+||.||+|.+..+|..||+|.+.... ....+|+++++.++||||+++++++......
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 47999999999999999999999999999999885432 3345799999999999999998876433211
Q ss_pred --CceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEee
Q 014174 160 --DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD 237 (429)
Q Consensus 160 --~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~D 237 (429)
.....++||||+++++.+.+. ...+++..++.++.||+.||.||| +.||+||||||+||+++.++..+||+|
T Consensus 85 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH-~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIH-SANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEcCCCceEEECC
Confidence 123578999999987665543 256899999999999999999999 889999999999999986655799999
Q ss_pred cccceecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014174 238 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313 (429)
Q Consensus 238 fG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 313 (429)
||++........ .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+.......+......+
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999976532211 1223568889999987665568899999999999999999999999888777776666554443
Q ss_pred CHHHHhhcCcCcccccC--CCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 314 TREEIKCMNPNYTEFKF--PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
................. ......+.. .+.+.++.++.+||++||+.||.+|||+.++++||||..+..|.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~~ 310 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLR-DLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPF 310 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHH-HHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCCc
Confidence 33222211100000000 000011111 12235789999999999999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=356.95 Aligned_cols=262 Identities=25% Similarity=0.339 Sum_probs=211.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC---CC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---KD 160 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 160 (429)
..+|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.++..++|+||+++++.+..... ..
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 347999999999999999999999999999999885431 234578899999999999998877653322 22
Q ss_pred ceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
..++++||||++ ++|.+.+.........+++..+..++.|++.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH-~~~IiHrDLKP~NILl~~~~-~vkL~DFG 188 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH-SKHMIHRDIKSANILLCSNG-LVKLGDFG 188 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEeCCC-CEEEEecc
Confidence 235789999998 4666666554444567999999999999999999999 88999999999999999888 79999999
Q ss_pred cceecccC---CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 240 SAKVLVKG---EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 240 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~------ 261 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR------ 261 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC------
Confidence 99765432 122346789999999999764 48999999999999999999999998876655544433210
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
...++..+++++.+|+.+||..||.+|||+.++++|||+..+..
T Consensus 262 ----------------------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~ 305 (496)
T PTZ00283 262 ----------------------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS 305 (496)
T ss_pred ----------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence 00123457899999999999999999999999999999876443
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=333.26 Aligned_cols=282 Identities=37% Similarity=0.631 Sum_probs=221.5
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh---------hhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
+|.+.+.||+|+||.||+|.+..+++.||||.+..... ....|+++++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 48899999999999999999999999999999865421 23468999999999999999998843 44
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
+.++||||+.+++...+.. ....+++..+..++.||+.||.||| ++||+|+||||+||+++.++ .++|+|||++.
T Consensus 76 ~~~lv~e~~~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~ 150 (298)
T cd07841 76 NINLVFEFMETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLH-SNWILHRDLKPNNLLIASDG-VLKLADFGLAR 150 (298)
T ss_pred EEEEEEcccCCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCChhhEEEcCCC-CEEEccceeee
Confidence 6889999997777666543 1236999999999999999999999 88999999999999999887 79999999998
Q ss_pred ecccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 243 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
...... ......++..|+|||.+.+...++.++|+|||||++|+|++|.++|.+.+..+.+.++....+.+....+...
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence 765432 2223456788999999866566789999999999999999999999988887888888777777766554321
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
...-............. .......+..+.+||.+||.+||++|||+.++++||||.+...+.
T Consensus 231 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 231 TSLPDYVEFKPFPPTPL-KQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred ccccccccccccCCcch-hhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 11100001111111111 112245688999999999999999999999999999999866654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=333.30 Aligned_cols=282 Identities=35% Similarity=0.620 Sum_probs=220.9
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
++|++.+.||+|++|.||+|.+..+|+.||+|.+.... ....+|+++++.++|+||+++++++. ...+.
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence 46999999999999999999999999999999875321 23457999999999999999999884 33468
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++||||+++++...+.. .....+++..++.++.||+.||+||| +.||+||||+|+||+++.++..+||+|||++...
T Consensus 77 ~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~ 153 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYCH-SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF 153 (294)
T ss_pred EEEEecccccHHHHHHh--CCCCCcCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence 89999999877666543 12334688889999999999999999 8899999999999999865557999999999765
Q ss_pred ccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ......++..|+|||.+.+...++.++|||||||++|+|+||.+||...+..+.+.+++...+.+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 3322 123345688999999987655688999999999999999999999998888888888888888776655432110
Q ss_pred --CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 324 --NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 324 --~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
.+. ...+...... .......+++++.+++.+||+.+|++||++.++++||||.+++.
T Consensus 234 ~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 234 LPDYK-SAFPKWPPKD-LATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred chhhh-hhcccCCCCC-HHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 110 0111111110 11123457899999999999999999999999999999987653
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=329.62 Aligned_cols=276 Identities=35% Similarity=0.636 Sum_probs=213.4
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++|+||+++++++. ...+.+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~ 76 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKLH 76 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEEE
Confidence 6999999999999999999999999999999875432 23457999999999999999999884 334588
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||++++++..+. .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus 77 ~v~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~ql~~~l~~LH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 151 (286)
T cd07847 77 LVFEYCDHTVLNELE---KNPRGVPEHLIKKIIWQTLQAVNFCH-KHNCIHRDVKPENILITKQG-QIKLCDFGFARILT 151 (286)
T ss_pred EEEeccCccHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCChhhEEEcCCC-cEEECccccceecC
Confidence 999999987666443 23456899999999999999999999 89999999999999999888 79999999998765
Q ss_pred cCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc-
Q 014174 246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP- 323 (429)
Q Consensus 246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 323 (429)
... ......++..|+|||.+.+...++.++|+||||+++|+|++|.+||.+.+..+.+..+....+............
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred CCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 443 223445788899999987655688999999999999999999999998887777766666554433321111100
Q ss_pred -CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 -NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 -~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
-+.....+..............++..+.+||.+||..||++|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001111111100000001123468999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=330.36 Aligned_cols=252 Identities=35% Similarity=0.566 Sum_probs=203.5
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhh------hHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
|++++.||+|+||+||++++..+++.||+|++...... ..+|+.+++.++|+||+++++++.. ..+.++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 88999999999999999999999999999999765321 1248999999999999999998854 445889
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec-
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL- 244 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~- 244 (429)
||||+.+ ++.+.+. ....+++..+..++.||+.||.+|| +.||+|+||||+||+++.++ .++|+|||.+...
T Consensus 76 v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh-~~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLH-SKGIVHRDIKPENILLDENG-EVKLIDFGSSVKLS 149 (260)
T ss_dssp EEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHH-HTTEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred ccccccccccccccc----ccccccccccccccccccccccccc-cccccccccccccccccccc-cccccccccccccc
Confidence 9999998 6666665 3477899999999999999999999 78999999999999999877 7999999999764
Q ss_pred ccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
..........+|..|+|||++.....++.++|+||||+++|+|++|..||......+....+.+...........
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 224 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ----- 224 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence 223333456779999999998634568999999999999999999999998874444444433332211111100
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.....+..+.+||.+||+.||++|||+.++++||||
T Consensus 225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 000124899999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=323.48 Aligned_cols=284 Identities=31% Similarity=0.531 Sum_probs=231.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--h----hhhHHHHHHHHHcCCCCeeecceEeeecC---CCCc
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--K----RYKNRELQTMRLLDHPNVVSLKHCFFSTT---DKDE 161 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~ 161 (429)
+.|.-..+||+|.||.||+|+...+|+.||+|++..+ + ...-+|+++|..|+|+|++.++.++.... ....
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3588889999999999999999999999999976432 1 12248999999999999999988764333 2344
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
..+++||.+|..+|..++.. ...+++..+++.++.+++.||.|+| +..|+|||+|+.|+||+.++ .+||+|||++
T Consensus 97 ~t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iH-r~kilHRDmKaaNvLIt~dg-ilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIH-RNKILHRDMKAANVLITKDG-ILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHH-HhhHHhhcccHhhEEEcCCc-eEEeeccccc
Confidence 56889999999988877654 3467999999999999999999999 88999999999999999988 8999999999
Q ss_pred eecccCCC-----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 242 KVLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 242 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
+.+..... .+..+.|.+|++||.+.+...|+.+.|||+.||||.+|+||.+.+.++++.+++..|...+|..+.+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 77644322 2445679999999999999999999999999999999999999999999999999999999999988
Q ss_pred HHhhcC--cCcccccCCCcCCC---CcccccCC-CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 317 EIKCMN--PNYTEFKFPQIKAH---PWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 317 ~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~-~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.|..+. +-|..+..+..... .......+ .-.+++.+|+.+||.+||.+|+++.++|+|.||..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 886553 22333332322222 11111111 12568999999999999999999999999999965
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=343.69 Aligned_cols=245 Identities=29% Similarity=0.467 Sum_probs=199.8
Q ss_pred eEEccCCceEEEEEEEc---CCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
+.||+|+||.||++++. .+|+.||+|++.... ....+|+++++.++||||+++++++. .....++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence 57999999999999863 578999999986432 22346899999999999999999883 34458899
Q ss_pred Eeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||+.+ +|...+. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 77 LDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESID 150 (318)
T ss_pred EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCC
Confidence 999975 4444432 2467999999999999999999999 88999999999999999888 799999999976544
Q ss_pred C-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 014174 247 G-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325 (429)
Q Consensus 247 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 325 (429)
. .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....
T Consensus 151 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~--------------- 214 (318)
T cd05582 151 HEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK--------------- 214 (318)
T ss_pred CCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------------
Confidence 4 223456789999999998664 47899999999999999999999998877665555443310
Q ss_pred ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCC
Q 014174 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRD 382 (429)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~ 382 (429)
. .++..+++++.+||++||+.||.+||| +.++++||||..+.+
T Consensus 215 --~------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~ 262 (318)
T cd05582 215 --L------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDW 262 (318)
T ss_pred --C------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCH
Confidence 0 123347899999999999999999999 788999999987644
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=329.96 Aligned_cols=276 Identities=35% Similarity=0.646 Sum_probs=221.4
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
+|++.+.||.|++|.||+|++..+|..||||.+... .....+|+.+++.++|+||+++++++.. ....++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence 489999999999999999999999999999988643 2334579999999999999999998844 334789
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
||||+++++.+.+.... ....+++..+..++.||+.||.||| +.||+||||||+||++++++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~ 152 (284)
T cd07836 76 VFEYMDKDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCH-ENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI 152 (284)
T ss_pred EEecCCccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence 99999988777665422 2356899999999999999999999 88999999999999999887 799999999975533
Q ss_pred CC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 014174 247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325 (429)
Q Consensus 247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 325 (429)
.. ......++..|++||.+.+...++.++|+|||||++|+|++|..||.+.+..+...++....+.|....+..+. +.
T Consensus 153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 231 (284)
T cd07836 153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL 231 (284)
T ss_pred CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence 22 12234568889999998765667899999999999999999999999998888888888888888776654332 11
Q ss_pred ccc--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 326 TEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 326 ~~~--~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
..+ .++....... ..+.+.++..+.++|.+||+.||.+|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 232 PEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred chhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 111 1121111111 11223468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=340.31 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=204.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++.++||+|+||.||++++..+++.||+|++.+.. ....+|+.++..++|+||+++++++ .....+
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL 76 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence 6999999999999999999999999999999885421 2245688899999999999999888 334458
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+.+ +|.+.+.. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH-~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~ 151 (332)
T cd05623 77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVH-QLHYVHRDIKPDNILMDMNG-HIRLADFGSCLK 151 (332)
T ss_pred EEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHEEECCCC-CEEEeecchhee
Confidence 899999974 55554432 2457899999999999999999999 89999999999999999887 799999999876
Q ss_pred cccCCC--cccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 244 LVKGEP--NISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 244 ~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
...... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~------- 224 (332)
T cd05623 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK------- 224 (332)
T ss_pred cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-------
Confidence 533322 123568999999999852 3457889999999999999999999998877666655544310
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCCcccCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFYELRD 382 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--R~t~~ell~hp~f~~~~~ 382 (429)
....+|. ....++.++++||++||+.++.+ |+++.++++||||..+.+
T Consensus 225 --------~~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~ 274 (332)
T cd05623 225 --------ERFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW 274 (332)
T ss_pred --------ccccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence 0001111 11347899999999999765555 689999999999988654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=342.74 Aligned_cols=247 Identities=26% Similarity=0.466 Sum_probs=193.5
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+.||+|+||+||+|++..+++.||+|++.+.. ....+|+.++..+ +||||+++++++. ....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence 46999999999999999999999999987532 2234677777766 8999999999884 334588999
Q ss_pred eccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc-C
Q 014174 169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-G 247 (429)
Q Consensus 169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~-~ 247 (429)
||++++.+... ......+++..++.++.||+.||.||| ++||+||||||+||+++.++ .+||+|||+++.... .
T Consensus 76 E~~~~~~L~~~---~~~~~~l~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~ 150 (329)
T cd05618 76 EYVNGGDLMFH---MQRQRKLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG 150 (329)
T ss_pred eCCCCCCHHHH---HHHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCC
Confidence 99986533221 223467999999999999999999999 88999999999999999888 799999999875432 2
Q ss_pred CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCCCHHHHh
Q 014174 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG--------VDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~~ 319 (429)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ...+.+....
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------- 219 (329)
T cd05618 151 DTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------- 219 (329)
T ss_pred CccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc----------
Confidence 223456789999999999764 489999999999999999999999953111 1111111100
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCCCcccCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT------ALEACIHPFFYELRD 382 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t------~~ell~hp~f~~~~~ 382 (429)
. ...++..++..+.+||++||..||.+|+| +.++++||||....+
T Consensus 220 ------~------------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~ 270 (329)
T cd05618 220 ------K------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 270 (329)
T ss_pred ------C------------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCH
Confidence 0 01133457899999999999999999998 579999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=339.22 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=201.6
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 163 (429)
+|.+.+.||+|+||.||+|++..+|+.||+|++.+.. .....|..+++.+. |++|+++++++ .....
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 3788899999999999999999999999999886532 12345778888776 46777888877 33345
Q ss_pred EEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
+++||||++++ |...+ .....+++..+..++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++
T Consensus 76 ~~lv~Ey~~~g~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH-~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~ 149 (323)
T cd05615 76 LYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFFLH-RRGIIYRDLKLDNVMLDSEG-HIKIADFGMCK 149 (323)
T ss_pred EEEEEcCCCCCcHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCC-CEEEecccccc
Confidence 88999999854 44333 23467999999999999999999999 88999999999999999888 79999999987
Q ss_pred ecccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 243 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
...... ......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~----------- 217 (323)
T cd05615 150 EHMVDGVTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN----------- 217 (323)
T ss_pred ccCCCCccccCccCCccccCHHHHcCC-CCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 543222 22345689999999998664 48999999999999999999999998877666555544310
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRD 382 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~ 382 (429)
. .++..++.++.+|+.+||..||.+|++ ..++++||||..+.+
T Consensus 218 ------~------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~ 265 (323)
T cd05615 218 ------V------------SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDW 265 (323)
T ss_pred ------C------------CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence 0 123357899999999999999999997 579999999998765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=330.87 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=197.0
Q ss_pred EccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
||+|+||.||++++..+|+.||+|.+.... .....|+++++.++||||+++++++ ....++++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 699999999999999999999999885321 2234589999999999999998887 4445689999999
Q ss_pred chh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCc
Q 014174 172 PET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 250 (429)
Q Consensus 172 ~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~ 250 (429)
+++ +...+.. .....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++.........
T Consensus 76 ~g~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~ 151 (277)
T cd05607 76 NGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLH-SMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTI 151 (277)
T ss_pred CCCCHHHHHHh--ccccCCCHHHHHHHHHHHHHHHHHHH-HCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCcee
Confidence 854 4333322 22345889999999999999999999 89999999999999999887 7999999999876554444
Q ss_pred ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccC
Q 014174 251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330 (429)
Q Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
....||..|+|||++.+.. ++.++|+|||||++|+|++|..||...........+....-. .....
T Consensus 152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------~~~~~ 217 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE-------------DEVKF 217 (277)
T ss_pred eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc-------------ccccc
Confidence 4557899999999987655 899999999999999999999999765432221111111000 00000
Q ss_pred CCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCCcccCCCC
Q 014174 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFYELRDPN 384 (429)
Q Consensus 331 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~----~ell~hp~f~~~~~~~ 384 (429)
....++.++.+||++||+.||.+|||+ .++++||||..+.++.
T Consensus 218 -----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~ 264 (277)
T cd05607 218 -----------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPR 264 (277)
T ss_pred -----------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHH
Confidence 012478999999999999999999999 6788999998876643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=330.20 Aligned_cols=295 Identities=29% Similarity=0.531 Sum_probs=224.4
Q ss_pred CCccccEEEEeeCCCCCCCccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhh---hHHHHHHHHHcCC--
Q 014174 69 GTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY---KNRELQTMRLLDH-- 143 (429)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~h-- 143 (429)
.+..|+++..... ...++|.+++.+|+|.||.|..+.+..++..||||+++.-..+ ..-|+++|+++++
T Consensus 73 dD~dGH~v~~~gD------~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~D 146 (415)
T KOG0671|consen 73 DDKDGHYVYQVGD------ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESD 146 (415)
T ss_pred CCCCceEEEEecc------ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcC
Confidence 3445666655321 2356899999999999999999999999999999988654333 3458999999942
Q ss_pred CC----eeecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecC
Q 014174 144 PN----VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 219 (429)
Q Consensus 144 ~n----iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DL 219 (429)
|+ +|.+.++| .-..+.|||+|.++-++++.+.. +.-.+++..+++.+++|++.+++||| +.+++|.||
T Consensus 147 P~g~~rcv~m~~wF-----dyrghiCivfellG~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh-~~kl~HTDL 218 (415)
T KOG0671|consen 147 PNGKFRCVQMRDWF-----DYRGHICIVFELLGLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLH-DLKLTHTDL 218 (415)
T ss_pred CCCceEEEeeehhh-----hccCceEEEEeccChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHH-hcceeecCC
Confidence 22 56666666 56667999999999888887764 34567999999999999999999999 899999999
Q ss_pred CCCceEecC--------------------CCCcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHH
Q 014174 220 KPQNLLVNP--------------------HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWS 279 (429)
Q Consensus 220 kp~Nill~~--------------------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 279 (429)
||+|||+.+ +. .|+|+|||.|+.. .+.....+.|+.|+|||++.+-. ++.++||||
T Consensus 219 KPENILfvss~~~~~~~~k~~~~~~r~~ks~-~I~vIDFGsAtf~--~e~hs~iVsTRHYRAPEViLgLG-wS~pCDvWS 294 (415)
T KOG0671|consen 219 KPENILFVSSEYFKTYNPKKKVCFIRPLKST-AIKVIDFGSATFD--HEHHSTIVSTRHYRAPEVILGLG-WSQPCDVWS 294 (415)
T ss_pred ChheEEEeccceEEEeccCCccceeccCCCc-ceEEEecCCccee--ccCcceeeeccccCCchheeccC-cCCccCcee
Confidence 999999732 22 5899999999865 33345677899999999999854 999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc-CcCcc---cccCCCcC-----------CCCcccccC-
Q 014174 280 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-NPNYT---EFKFPQIK-----------AHPWHKIFH- 343 (429)
Q Consensus 280 lG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~-----------~~~~~~~~~- 343 (429)
+||||+|++||..+|+..++.+.+..+...+|..+...+... ...|- .+..+... ..++.....
T Consensus 295 iGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~ 374 (415)
T KOG0671|consen 295 IGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ 374 (415)
T ss_pred eeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc
Confidence 999999999999999999999999888888896665555433 11110 00000000 000110000
Q ss_pred -CCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 344 -KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 344 -~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
...-..+.|||++||.+||.+|+|+.|+|.||||+.+.
T Consensus 375 ~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 375 DDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred CcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 01123589999999999999999999999999998754
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.55 Aligned_cols=300 Identities=36% Similarity=0.593 Sum_probs=232.3
Q ss_pred ceEEeeEEccCCceEEEEEEEcCC--CcEEEEEEeecc------hhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCce
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLET--GETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 162 (429)
+|++.+.||+|+||.||+|++..+ +..||+|.+... .....+|+.+++.+ +|+||+++++++.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 489999999999999999999888 899999987542 12335699999999 5999999988754332 2233
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.++++++|++++|...+. ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++.
T Consensus 80 ~~~~~~e~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH-~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELMEADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIH-SANVLHRDLKPGNLLVNADC-ELKICDFGLAR 153 (332)
T ss_pred cEEEEEecccCCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence 477899999987776654 2467999999999999999999999 88999999999999999887 79999999997
Q ss_pred ecccCCC-----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 243 VLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 243 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
....... .....||..|+|||.+.+...++.++||||+||++|+|++|.+||.+.+....+..++..+|.+..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 6543221 22346789999999886655689999999999999999999999999888889999999999887765
Q ss_pred HhhcCcCcc-c--ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCC
Q 014174 318 IKCMNPNYT-E--FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFP 394 (429)
Q Consensus 318 ~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~ 394 (429)
+..+..... . ..........+.. .....+..+.+|+.+||+.||.+|||+.+++.||||++++++.....+ ..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~--~~~ 310 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVC--QKP 310 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccc--ccc
Confidence 543321100 0 0111111111111 123468899999999999999999999999999999999988666544 334
Q ss_pred CCCCCCh
Q 014174 395 PLFNFKP 401 (429)
Q Consensus 395 ~~~~~~~ 401 (429)
..+.|..
T Consensus 311 ~~~~~~~ 317 (332)
T cd07857 311 FDFSFES 317 (332)
T ss_pred ccCCccc
Confidence 4455543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=354.73 Aligned_cols=253 Identities=27% Similarity=0.351 Sum_probs=207.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCC-CcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLET-GETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ....+|+.+++.++|||||++++++.. ...+++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCEEEE
Confidence 499999999999999999998877 7889999764322 334579999999999999999998843 345889
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+++ +|.+.+.........+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~ 220 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH-SRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYS 220 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH-hCCEEECCcCHHhEEECCCC-cEEEEeCcCceecC
Confidence 9999974 565555444444567899999999999999999999 88999999999999999888 79999999998764
Q ss_pred cCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 246 KGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 246 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
.... ....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.....
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~----------- 288 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY----------- 288 (478)
T ss_pred CccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence 4321 2345689999999998664 589999999999999999999999988776555554433100
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
..++..++.++.+||.+||..||++|||+.+++.|||+..+
T Consensus 289 -----------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 289 -----------------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred -----------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 01223478999999999999999999999999999998653
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=337.52 Aligned_cols=314 Identities=32% Similarity=0.590 Sum_probs=237.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCC-CCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 162 (429)
.++|++.+.||+|+||.||+|++..++..||+|++... .....+|+.+++.++|+||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 34699999999999999999999999999999987542 1223469999999999999999887743322 2233
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
..++|+||+++++.+++.. ..+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++.
T Consensus 94 ~~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH-~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~ 166 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIH-SAGIIHRDLKPSNIAVNEDC-ELKILDFGLAR 166 (343)
T ss_pred cEEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-CEEEccccccc
Confidence 5789999998887776542 57999999999999999999999 88999999999999999887 79999999997
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
..... .....++..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.+....+....
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 65433 3345678899999998665568899999999999999999999999988888888888888777765544332
Q ss_pred cCccc-c--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCC
Q 014174 323 PNYTE-F--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNF 399 (429)
Q Consensus 323 ~~~~~-~--~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 399 (429)
..... + ..+......+.. ....++..+.+||++||..||.+|||+.++++||||.+...+.... .+++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~-----~~~~~~~ 318 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEP-----VAPPYDQ 318 (343)
T ss_pred chhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccc-----cccccCc
Confidence 11110 0 011111111111 1234689999999999999999999999999999999887765432 2333332
Q ss_pred ChhhhccCCHHHHHhhcHHH
Q 014174 400 KPQELKGASKELLSKLIPEH 419 (429)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~ 419 (429)
+... .......|+.++..+
T Consensus 319 ~~~~-~~~~~~~~~~~~~~~ 337 (343)
T cd07851 319 SFES-RDLTVDEWKELVYKE 337 (343)
T ss_pred chhh-hhcCHHHHHHHhHHH
Confidence 2211 133456666665544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=310.25 Aligned_cols=285 Identities=30% Similarity=0.588 Sum_probs=234.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeec-chhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceEEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.++|++.+++|+|-|+.||.|.+..+++.++||+++. ....+.||++||+.|. ||||++++++..++. +....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccCchhH
Confidence 4479999999999999999999999999999998865 3456789999999997 999999998775433 3346789
Q ss_pred EeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
+||++..-+..+ -..++...++.++.|++.||.||| ++||+|||+||.|++||.....++|+|+|+|..+..+
T Consensus 114 FE~v~n~Dfk~l------y~tl~d~dIryY~~elLkALdyCH-S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDFKQL------YPTLTDYDIRYYIYELLKALDYCH-SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccHHHH------hhhhchhhHHHHHHHHHHHHhHHH-hcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 999987533332 246888999999999999999999 8999999999999999988778999999999999888
Q ss_pred CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHh-----hc
Q 014174 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIK-----CM 321 (429)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~-----~~ 321 (429)
......+.+++|--||.+..-..|+.+-|+|||||+|..|+..+-| |.|.++.+++.+|.+++|+......- .+
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L 266 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL 266 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence 7777778899999999998888899999999999999999998765 57889999999999999975432211 13
Q ss_pred CcCcccccCCCcCCCCcccccCC----CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHK----RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNA 385 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~----~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~ 385 (429)
++++..+ .......+|...++. -+++++.|||.++|.+|-.+|+||.|++.||||..++....
T Consensus 267 dp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~ 333 (338)
T KOG0668|consen 267 DPQFEDI-LGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAES 333 (338)
T ss_pred ChhHhhH-hhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhh
Confidence 3444332 122334445444432 25699999999999999999999999999999988776543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=326.71 Aligned_cols=278 Identities=34% Similarity=0.599 Sum_probs=212.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+.+|++.+.||+|+||.||+|.+..+|..||+|.+.... ....+|+.+++.++|+||+++++++. ...+.
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeE
Confidence 357999999999999999999999999999999885432 23457999999999999999999873 33458
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++||||+.++++..+.. ....+++..++.++.||+.||.||| +.||+|+||||+||+++.++ .+||+|||+++..
T Consensus 79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~ 153 (291)
T cd07870 79 TFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIH-GQHILHRDLKPQNLLISYLG-ELKLADFGLARAK 153 (291)
T ss_pred EEEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChHHEEEcCCC-cEEEecccccccc
Confidence 89999999877665432 2356788899999999999999999 88999999999999999887 7999999998754
Q ss_pred ccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcC
Q 014174 245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
.... ......++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+. .+.+.++....+.|....+....
T Consensus 154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 3221 223345688999999987655678899999999999999999999976543 45566666667766655433221
Q ss_pred --cCcccccCCCcCCCCcccccC-CCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 323 --PNYTEFKFPQIKAHPWHKIFH-KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 323 --~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
+.+.....+............ -..+..+.+|+.+||..||++|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 111111111111111100000 0236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=338.80 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=204.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++.+.||+|+||.||++++..+++.||+|++.+.. ....+|..+++.++|+||+++++++ ....+.
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~ 76 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL 76 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence 6999999999999999999999999999999886421 2244688899999999999999988 444568
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+.+ +|...+.. ....+++..++.++.|++.||+||| ++||+||||||+|||++.++ .+||+|||++..
T Consensus 77 ~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH-~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~ 151 (331)
T cd05624 77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIH-QLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLK 151 (331)
T ss_pred EEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCchHHEEEcCCC-CEEEEeccceee
Confidence 999999975 45444432 2457899999999999999999999 89999999999999999888 799999999977
Q ss_pred cccCCCc--ccccccccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 244 LVKGEPN--ISYICSRYYRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 244 ~~~~~~~--~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
....... ....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...+..+....+.....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------ 225 (331)
T cd05624 152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE------ 225 (331)
T ss_pred ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC------
Confidence 6443222 234689999999988542 3478899999999999999999999988776655554433110
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCCcccCCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFYELRDP 383 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--R~t~~ell~hp~f~~~~~~ 383 (429)
...+|. ....++.++++||.+||+.++.+ |+++.++++||||....+.
T Consensus 226 ---------~~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 226 ---------RFQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred ---------cccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 001111 01236899999999999976655 5699999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=330.58 Aligned_cols=284 Identities=30% Similarity=0.491 Sum_probs=216.7
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC---C
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---K 159 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~ 159 (429)
..++|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+++++.++||||+++++++..... .
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3457999999999999999999999999999999885431 123469999999999999999998754332 2
Q ss_pred CceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
.....++||||+++++...+.. ....+++..++.++.||+.||.||| +.|++|+||||+||+++.++ .+||+|||
T Consensus 90 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH-~~~i~H~dl~p~nil~~~~~-~~kl~dfg 164 (310)
T cd07865 90 YKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIH-RNKILHRDMKAANILITKDG-ILKLADFG 164 (310)
T ss_pred CCceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEECCCC-cEEECcCC
Confidence 2345789999999877666543 2346899999999999999999999 88999999999999999887 79999999
Q ss_pred cceecccCCCc-----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 240 SAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 240 ~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
++......... ....++..|+|||.+.+...++.++|+||||+++|+|++|.+||.+.+.......+....+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99765433211 2345678899999887655578899999999999999999999998887777777777666555
Q ss_pred HHHHhhcC--cCcccccCCCcCCCCccccc-CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 315 REEIKCMN--PNYTEFKFPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 315 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.+.+.... ..+....++..........+ ....+..+.+||.+||..||.+|||+.++|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 44332211 00111112221111111111 11246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=328.70 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=205.9
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
|+..+.||+|+||+||+|.+..+++.||+|.+.... ....+|+++++.++|+||+.+++++ ......+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence 788899999999999999999999999999885431 2245699999999999999998887 3344688
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||+.++.+..... ......+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus 77 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~~ql~~~l~~lH-~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~ 153 (285)
T cd05632 77 LVLTIMNGGDLKFHIY-NMGNPGFEEERALFYAAEILCGLEDLH-RENTVYRDLKPENILLDDYG-HIRISDLGLAVKIP 153 (285)
T ss_pred EEEEeccCccHHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecCCCHHHEEECCCC-CEEEecCCcceecC
Confidence 9999998653332221 122346999999999999999999999 88999999999999999887 79999999997654
Q ss_pred cCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 014174 246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325 (429)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 325 (429)
.........|+..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.........+.......
T Consensus 154 ~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~------------ 220 (285)
T cd05632 154 EGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET------------ 220 (285)
T ss_pred CCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc------------
Confidence 44333456789999999998764 48999999999999999999999998766544443333211100
Q ss_pred ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCCC
Q 014174 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRDP 383 (429)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~~ 383 (429)
...++..++.++.+|+.+||..||.+||| +.++++||||......
T Consensus 221 -------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 221 -------------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred -------------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 00123457899999999999999999999 8899999999887543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=365.32 Aligned_cols=264 Identities=28% Similarity=0.396 Sum_probs=211.0
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
....+|++++.||+|+||+||+|++..++..||+|.+... ...+..|+.+++.|+|||||+++++|.... .
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~---~ 86 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA---N 86 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---C
Confidence 3445799999999999999999999999999999988532 233457999999999999999999886432 3
Q ss_pred eEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-------CeeeecCCCCceEecCCC---
Q 014174 162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI-------GVCHRDIKPQNLLVNPHT--- 230 (429)
Q Consensus 162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-------givH~DLkp~Nill~~~~--- 230 (429)
..++|||||++ ++|...+.........+++..++.|+.||+.||.||| +. +||||||||+||||+...
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH-s~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH-NLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-hcccccccCCceeccCcHHHeEeecCcccc
Confidence 35889999998 4676666654444567999999999999999999999 63 599999999999996421
Q ss_pred -------------CcEEEeecccceecccCCCcccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 014174 231 -------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPG 296 (429)
Q Consensus 231 -------------~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~ 296 (429)
..+||+|||++.............||+.|+|||++.+. ..++.++|||||||+||+|+||..||..
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 24899999999876544444456789999999998642 3478999999999999999999999987
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014174 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376 (429)
Q Consensus 297 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~ 376 (429)
.+....+...+... + .+ .....+.++.+||.+||..+|.+|||+.++|.|||
T Consensus 246 ~~~~~qli~~lk~~--p------------------~l--------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 246 ANNFSQLISELKRG--P------------------DL--------PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred CCcHHHHHHHHhcC--C------------------CC--------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 66555443333210 0 00 01235889999999999999999999999999999
Q ss_pred CcccCCC
Q 014174 377 FYELRDP 383 (429)
Q Consensus 377 f~~~~~~ 383 (429)
|..+..+
T Consensus 298 ik~i~~p 304 (1021)
T PTZ00266 298 IKNVGPP 304 (1021)
T ss_pred HhhcCCC
Confidence 9876654
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=342.78 Aligned_cols=244 Identities=27% Similarity=0.471 Sum_probs=194.4
Q ss_pred EccCCceEEEEEEEcCCCcEEEEEEeecchh-------hhHHHHHHHHHc---CCCCeeecceEeeecCCCCceEEEEEE
Q 014174 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
||+|+||+||+|++..+++.||+|++..... ....|..++..+ +||||++++.++ .....+++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 6999999999999999999999999864321 112355666555 699999999888 3344588999
Q ss_pred eccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+.++ |...+. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++......
T Consensus 76 e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH-~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~ 149 (330)
T cd05586 76 DYMSGGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLH-KYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTD 149 (330)
T ss_pred cCCCCChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCC
Confidence 999854 443332 3567999999999999999999999 88999999999999999888 7999999998764332
Q ss_pred -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
.......||..|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~----------------- 212 (330)
T cd05586 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG----------------- 212 (330)
T ss_pred CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 22335678999999999876666899999999999999999999999887665544443221
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC----CHHHHhcCCCCcccC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC----TALEACIHPFFYELR 381 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~----t~~ell~hp~f~~~~ 381 (429)
...++ ...+++++.+||++||..||.+|| ++.++++||||....
T Consensus 213 ~~~~~-----------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 213 KVRFP-----------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCC-----------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 01111 123689999999999999999998 799999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=340.23 Aligned_cols=245 Identities=26% Similarity=0.426 Sum_probs=196.0
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecchh-------hhHHH-HHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRE-LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E-~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+.||+|+||+||+|++..+++.||+|++..... ....| ..+++.++|+||+++++++. ....+++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence 369999999999999999999999999864321 11123 33567889999999998883 334588999
Q ss_pred eccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+.++ +...+. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.....
T Consensus 76 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH-~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~ 149 (325)
T cd05602 76 DYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLH-SLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH 149 (325)
T ss_pred eCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence 999864 433332 3467889999999999999999999 89999999999999999888 7999999998754322
Q ss_pred -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (325)
T cd05602 150 NGTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---P------------- 212 (325)
T ss_pred CCCcccccCCccccCHHHHcCC-CCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC---C-------------
Confidence 223456789999999999764 4899999999999999999999999887766655544331 0
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHH----HHhcCCCCcccCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL----EACIHPFFYELRD 382 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~----ell~hp~f~~~~~ 382 (429)
..+++.++..+.+||++||+.||.+|+++. ++++|+||..+.+
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 213 -------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred -------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 012235789999999999999999999876 8999999977554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=341.46 Aligned_cols=245 Identities=29% Similarity=0.466 Sum_probs=195.6
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHH-HHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQ-TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+.||+|+||+||+|++..+|+.||+|++.... ....+|.. +++.++||||+++++.+. .....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence 46999999999999999999999999986432 11223433 567799999999998883 334588999
Q ss_pred eccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc-
Q 014174 169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK- 246 (429)
Q Consensus 169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~- 246 (429)
||+.++ +...+ .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....
T Consensus 76 e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~al~~lH-~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~ 149 (325)
T cd05604 76 DFVNGGELFFHL----QRERSFPEPRARFYAAEIASALGYLH-SINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQ 149 (325)
T ss_pred cCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCC
Confidence 999865 33332 23567999999999999999999999 89999999999999999888 799999999875432
Q ss_pred CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+...
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~----------------- 211 (325)
T cd05604 150 SDTTTTFCGTPEYLAPEVIRKQ-PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK----------------- 211 (325)
T ss_pred CCCcccccCChhhCCHHHHcCC-CCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC-----------------
Confidence 2223456789999999998764 4889999999999999999999999887765555444321
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCCcccCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFYELRD 382 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~----~ell~hp~f~~~~~ 382 (429)
. ..+++..+..+.++|++||..||.+||++ .++++||||....+
T Consensus 212 ~------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 212 P------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred C------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 0 01223478999999999999999999976 59999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=337.36 Aligned_cols=281 Identities=33% Similarity=0.537 Sum_probs=230.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhh---HHHHHHHHHcC------CCCeeecceEeeecCCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLD------HPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~E~~~l~~l~------h~niv~~~~~~~~~~~~~ 160 (429)
..+|.+....|+|-||+|..|.+...|..||||++....-+. .+|++||+.|+ --|+++++..| ..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~h 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----KH 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----hh
Confidence 457999999999999999999999999999999997765333 47999999995 35789998888 55
Q ss_pred ceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
..++|||+|-+.-+|.++++.|.+. -.+....++.|+.|++.||..|. .+||+|.||||+||||+.....+||||||.
T Consensus 506 knHLClVFE~LslNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK-~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 506 KNHLCLVFEPLSLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLK-KCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred cceeEEEehhhhchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHH-hcCeeecccCccceEeccCcceeeeccCcc
Confidence 6679999999999999999988764 56899999999999999999999 999999999999999998888999999999
Q ss_pred ceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
|.....++ .+.+..+..|.|||++.|.. |++..|+||+||+||||.||+..|+|.++.+++...+.+.|..+...+..
T Consensus 584 A~~~~ene-itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK 661 (752)
T KOG0670|consen 584 ASFASENE-ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK 661 (752)
T ss_pred cccccccc-ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence 98876554 35778899999999999865 99999999999999999999999999999999999999999877765542
Q ss_pred cC-------c--CcccccCCCcCCC-------------CcccccC--CCCC-------hhHHHHHHhhcCcCCCCCCCHH
Q 014174 321 MN-------P--NYTEFKFPQIKAH-------------PWHKIFH--KRMP-------PEAVDLVSRLLQYSPNLRCTAL 369 (429)
Q Consensus 321 ~~-------~--~~~~~~~~~~~~~-------------~~~~~~~--~~~s-------~~l~~Li~~~L~~dP~~R~t~~ 369 (429)
-. . ||-......+... .+...+. +.++ ..+++||.+||..||++|.|+.
T Consensus 662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n 741 (752)
T KOG0670|consen 662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN 741 (752)
T ss_pred cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence 11 1 1111111111111 1111110 1122 3588999999999999999999
Q ss_pred HHhcCCCCcc
Q 014174 370 EACIHPFFYE 379 (429)
Q Consensus 370 ell~hp~f~~ 379 (429)
++|+||||..
T Consensus 742 qAL~HpFi~~ 751 (752)
T KOG0670|consen 742 QALKHPFITE 751 (752)
T ss_pred HHhcCCcccC
Confidence 9999999964
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=337.89 Aligned_cols=278 Identities=26% Similarity=0.407 Sum_probs=202.9
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
++|++.+.||+|+||.||++.+..++..+|+|.+.... ..+.+|+++++.++|+||+++++++.. ..+++
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 79 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS 79 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEEE
Confidence 57999999999999999999999999999999876432 335589999999999999999999854 33588
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+.+ +|.+.+.. ...+++..+..++.|++.||.|||+..+|+||||||+|||++.++ .+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~ 154 (333)
T cd06650 80 ICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL 154 (333)
T ss_pred EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhh
Confidence 99999975 55554432 456899999999999999999999435899999999999999888 7999999998765
Q ss_pred ccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCCHHHHhhcCc
Q 014174 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK-VLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~ 323 (429)
... ......||..|+|||.+.+. .++.++|+|||||++|+|++|+.||......+....... ..+.+..........
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred hhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 332 22345689999999998764 489999999999999999999999976654332211110 001110000000000
Q ss_pred C-------cccccCCC---------cCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 324 N-------YTEFKFPQ---------IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 324 ~-------~~~~~~~~---------~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
. +..-..+. +............++.++++||.+||++||++|||+.|+++||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 0 00000000 000000000012367899999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=337.04 Aligned_cols=247 Identities=25% Similarity=0.447 Sum_probs=195.5
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+.||+|+||+||+|++..+++.||+|++.... ....+|..++..+ +|+||+++++++. ....+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEE
Confidence 46999999999999999999999999997532 2234688888887 6999999999883 344589999
Q ss_pred eccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc-
Q 014174 169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK- 246 (429)
Q Consensus 169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~- 246 (429)
||++++ |...+. ..+.+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++....
T Consensus 76 e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~ 149 (327)
T cd05617 76 EYVNGGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLH-ERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGP 149 (327)
T ss_pred eCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCC
Confidence 999864 433332 2467999999999999999999999 88999999999999999888 699999999875332
Q ss_pred CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCCHHHHhh
Q 014174 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~ 320 (429)
.......+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... .+.+...... .
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~-------- 218 (327)
T cd05617 150 GDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K-------- 218 (327)
T ss_pred CCceecccCCcccCCHHHHCCC-CCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C--------
Confidence 2333456789999999998764 489999999999999999999999964221 1122211110 0
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC------HHHHhcCCCCcccCCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT------ALEACIHPFFYELRDP 383 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t------~~ell~hp~f~~~~~~ 383 (429)
. ..++..++..+.++|.+||..||.+|++ ..++++||||..+.+.
T Consensus 219 ------~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~ 269 (327)
T cd05617 219 ------P------------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWD 269 (327)
T ss_pred ------C------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHH
Confidence 0 0123457899999999999999999998 5799999999887653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=333.09 Aligned_cols=286 Identities=34% Similarity=0.580 Sum_probs=223.9
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC-CCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 163 (429)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++|+||+++++++..... .....
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 47999999999999999999999999999999886431 234469999999999999999988753321 22234
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
.+++++++++++...+. ...+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++..
T Consensus 97 ~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~ 169 (345)
T cd07877 97 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH 169 (345)
T ss_pred EEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCChHHEEEcCCC-CEEEeccccccc
Confidence 67899999887766543 246899999999999999999999 88999999999999999888 799999999876
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... ......++..|+|||.+.+...++.++|||||||++|+|++|+.||...+....+..+....+.+.......+..
T Consensus 170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (345)
T cd07877 170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247 (345)
T ss_pred ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence 432 233456788999999987655688999999999999999999999998888787888877777766655443322
Q ss_pred Cccc-c--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCC
Q 014174 324 NYTE-F--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNAR 386 (429)
Q Consensus 324 ~~~~-~--~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~ 386 (429)
.... + ..+.+....+... ....++++.+||.+||..||.+|+|+.++++||||.++..+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~ 312 (345)
T cd07877 248 ESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE 312 (345)
T ss_pred HhHHHHHHHhcccCCcchhhh-cCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCcc
Confidence 1100 0 0111111111111 12368899999999999999999999999999999988776644
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=336.69 Aligned_cols=298 Identities=36% Similarity=0.648 Sum_probs=231.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 162 (429)
.++|++.+.||+|+||.||+|.+..+|..+|+|++... .....+|+.+++.+ +|+||+++++++.. .+..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~~ 82 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---ENDK 82 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCCc
Confidence 45799999999999999999999989999999987432 12344699999999 99999999998743 2234
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
..++||||+++++...+.. ..+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++.
T Consensus 83 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH-~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~ 155 (337)
T cd07852 83 DIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIH-SGNVIHRDLKPSNILLNSDC-RVKLADFGLAR 155 (337)
T ss_pred eEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-cEEEeeccchh
Confidence 5789999999877665532 36888899999999999999999 88999999999999999888 79999999987
Q ss_pred ecccCC------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 243 VLVKGE------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 243 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
...... ......+|..|+|||.+.+...++.++|+||||+++|+|++|+.||.+....+...++....+.+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 654322 12234678899999988766668899999999999999999999999988888888888888877766
Q ss_pred HHhhcCcCcccccC---CCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCC
Q 014174 317 EIKCMNPNYTEFKF---PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPF 393 (429)
Q Consensus 317 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~ 393 (429)
.+..+......... +......... ..+.++.++.+||.+||+.||++|||+.++++||||..+..+........+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~ 314 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPI 314 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCc
Confidence 55443222111111 1111111111 2233789999999999999999999999999999999988776555444444
Q ss_pred CCCCC
Q 014174 394 PPLFN 398 (429)
Q Consensus 394 ~~~~~ 398 (429)
.++++
T Consensus 315 ~~~~~ 319 (337)
T cd07852 315 TIPLD 319 (337)
T ss_pred cCCcc
Confidence 44444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=332.62 Aligned_cols=315 Identities=33% Similarity=0.568 Sum_probs=235.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCC-Cce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 162 (429)
.++|++.+.||+|+||.||+|.+..+|..||+|++.... ....+|+.+++.++|+||+++++++...... ...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 346999999999999999999999999999999885421 2345799999999999999999987543221 123
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
..++||+|+++++...+. ...+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++.
T Consensus 94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH-~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~ 166 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIH-AAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR 166 (343)
T ss_pred eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence 468999999877665543 257999999999999999999999 88999999999999999887 79999999997
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
..... .....+++.|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+++..+.+..+....+.
T Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 167 QTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 65332 2345678899999998764558899999999999999999999999888877777777776666554433222
Q ss_pred cCcc-c--ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCC
Q 014174 323 PNYT-E--FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNF 399 (429)
Q Consensus 323 ~~~~-~--~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 399 (429)
.... . ...+......+ ..+...+++.+.++|.+||..||.+|||+.+++.||||...+.+.... ..+.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~-----~~~~~~~ 318 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDET-----EAPPYDD 318 (343)
T ss_pred chhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCccccc-----CCCCccc
Confidence 1100 0 01111111111 112345788999999999999999999999999999999987764431 1122333
Q ss_pred ChhhhccCCHHHHHhhcHHHH
Q 014174 400 KPQELKGASKELLSKLIPEHA 420 (429)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~ 420 (429)
.-... ....+.|.++..-++
T Consensus 319 ~~~~~-~~~~~~~~~~~~~~~ 338 (343)
T cd07880 319 SFDEV-DQSLEEWKRLTFTEI 338 (343)
T ss_pred cHHhh-ccchHHHHHHHHHHH
Confidence 22222 234556777755444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=338.12 Aligned_cols=245 Identities=29% Similarity=0.428 Sum_probs=194.5
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecchh-------hhHHHH-HHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNREL-QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
++||+|+||.||+|++..+++.||+|++.+... ...+|. .+++.++||||+++++++. .....++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence 469999999999999999999999999864321 122333 4678899999999998873 334588999
Q ss_pred eccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||++++ +...+ .....+++..++.++.||+.||.||| +.||+||||||+||+|+.++ .+||+|||+++.....
T Consensus 76 e~~~~~~L~~~l----~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~ 149 (321)
T cd05603 76 DYVNGGELFFHL----QRERCFLEPRARFYAAEVASAIGYLH-SLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEP 149 (321)
T ss_pred cCCCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCC
Confidence 999864 33322 23467899999999999999999999 88999999999999999888 7999999998754222
Q ss_pred -CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
.......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+... +
T Consensus 150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~------------- 212 (321)
T cd05603 150 EETTSTFCGTPEYLAPEVLRKE-PYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P------------- 212 (321)
T ss_pred CCccccccCCcccCCHHHhcCC-CCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C-------------
Confidence 223345789999999998664 4899999999999999999999999887655544433221 0
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCCcccCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFYELRD 382 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~----~ell~hp~f~~~~~ 382 (429)
..++...+..+.++|.+||+.||.+|+++ .++++||||..+.+
T Consensus 213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~ 259 (321)
T cd05603 213 -------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINW 259 (321)
T ss_pred -------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCH
Confidence 01233468899999999999999999976 49999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=324.92 Aligned_cols=274 Identities=35% Similarity=0.643 Sum_probs=216.4
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
|++.+.||.|++|.||+|.+..+|..||+|++..+. ....+|+++++.++|+|++++++++. ...+.++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence 678899999999999999999999999999886432 23457999999999999999999883 3456889
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
+|||+++++...+.... ...+++..+..++.|++.||.||| +.+++||||+|+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH-~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~ 151 (283)
T cd07835 76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCH-SHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV 151 (283)
T ss_pred EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence 99999887776654321 236899999999999999999999 88999999999999999877 799999999876533
Q ss_pred CC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc--
Q 014174 247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323 (429)
Q Consensus 247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 323 (429)
.. ......++..|+|||.+.+...++.++|+||||+++|+|++|.+||.+.+....+..+.+..+.+....+.....
T Consensus 152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 22 122335688899999887655578899999999999999999999999888888888888777776654422111
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
++.. .++....... ......++..+.++|.+||+.||.+|||+.++++||||
T Consensus 232 ~~~~-~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKP-TFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhh-hcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 1100 1111111111 11234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=321.78 Aligned_cols=247 Identities=28% Similarity=0.459 Sum_probs=200.5
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
+|.+.+.||+|++|.||+|.+..+++.||+|.+.... ....+|+++++.++||||+++++++. ...
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~ 77 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DDE 77 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cCC
Confidence 5999999999999999999999999999999875321 23457999999999999999999883 334
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++|+||+++ ++.+.+.. ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++
T Consensus 78 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nilv~~~~-~~~l~dfg~~ 151 (263)
T cd06625 78 TLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLH-SNMIVHRDIKGANILRDSAG-NVKLGDFGAS 151 (263)
T ss_pred eEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEeecccc
Confidence 68999999975 44444432 356899999999999999999999 88999999999999999887 7999999998
Q ss_pred eecccCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 242 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 242 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
+........ ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.......+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~------- 223 (263)
T cd06625 152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP------- 223 (263)
T ss_pred eeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC-------
Confidence 765332211 2345778899999997754 8999999999999999999999997765544433322110
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
....++..++..+.+||++||..+|.+|||+.++++||||
T Consensus 224 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 224 --------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0111334578999999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=324.84 Aligned_cols=276 Identities=38% Similarity=0.690 Sum_probs=220.3
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|+||.||+|.+..+++.||+|.+... .....+|+++++.++|+||+++++++.. ....+
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 76 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY 76 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence 699999999999999999999999999999987532 2345679999999999999999999854 33588
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||++++++..+. .....+++..+..++.||+.||.||| +.|++|+||+|+||+++.++ .+||+|||++....
T Consensus 77 iv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~ 151 (288)
T cd07833 77 LVFEYVERTLLELLE---ASPGGLPPDAVRSYIWQLLQAIAYCH-SHNIIHRDIKPENILVSESG-VLKLCDFGFARALR 151 (288)
T ss_pred EEEecCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence 999999987766543 23456899999999999999999999 88999999999999999887 79999999988765
Q ss_pred cCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC-
Q 014174 246 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN- 322 (429)
Q Consensus 246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~- 322 (429)
... ......++..|+|||.+.+...++.++|+||||+++|+|++|++||.+.+..+.+..+....+...........
T Consensus 152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence 443 23345678899999999776468999999999999999999999999888888777777776655544332221
Q ss_pred -cCcccccCCCcC-CCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 323 -PNYTEFKFPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 323 -~~~~~~~~~~~~-~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
..+....++... ...+...++..++.++.+||++||..+|++|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 111111222111 1112223444568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=325.97 Aligned_cols=276 Identities=37% Similarity=0.662 Sum_probs=214.5
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+++++.++|+||+++++++ ....+.+
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 76 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY 76 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence 5999999999999999999999899999999875322 2345799999999999999999988 4445688
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+|+||++++++..+.. ....+++..+..++.||+.||.||| +.||+|+||+|+||++++++ .++|+|||++....
T Consensus 77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~ 151 (286)
T cd07846 77 LVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCH-SHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLA 151 (286)
T ss_pred EEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence 9999999866554332 2345899999999999999999999 88999999999999999888 79999999987654
Q ss_pred cCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC--
Q 014174 246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN-- 322 (429)
Q Consensus 246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-- 322 (429)
.... .....++..|+|||.+.+...++.++||||||+++|+|++|++||...+..+....+....+...........
T Consensus 152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 3322 2335678899999998765567889999999999999999999998888777777777665543322111110
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
........+............+.++..+.+|+.+||..+|++|||+.++++||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0011112222211111111234678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=328.09 Aligned_cols=281 Identities=33% Similarity=0.595 Sum_probs=218.6
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC---CC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---KD 160 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 160 (429)
.++|++.++||.|+||.||+|.+..+++.||+|++.... ....+|+++++.++|+||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999999999999999885321 234579999999999999999988754432 23
Q ss_pred ceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
..++++|+||+.+++...+.. ....+++..++.++.||+.||.||| +.||+|+||||+||+++.++ .+||+|||+
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLH-ENHILHRDIKAANILIDNQG-ILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEECcCcc
Confidence 446789999999876665532 2457999999999999999999999 88999999999999999888 799999999
Q ss_pred ceecccCCC------------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014174 241 AKVLVKGEP------------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308 (429)
Q Consensus 241 a~~~~~~~~------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~ 308 (429)
+........ .....+++.|+|||.+.+...++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 876533221 12235678899999887655688999999999999999999999999888888888888
Q ss_pred HhCCCCHHHHhhcC--cCccc-ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 309 VLGTPTREEIKCMN--PNYTE-FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 309 ~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
..+.+....+.... +.... ....... ...... ...+++.+.+||.+||..||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYP-RTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCC-ccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 77776654433211 00000 0000000 011111 12356889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=308.84 Aligned_cols=267 Identities=26% Similarity=0.411 Sum_probs=215.9
Q ss_pred eCCCCCCCccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhh-----hHHHHHHH-HHcCCCCeeecceEe
Q 014174 80 IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-----KNRELQTM-RLLDHPNVVSLKHCF 153 (429)
Q Consensus 80 ~~~~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~E~~~l-~~l~h~niv~~~~~~ 153 (429)
+++........++.+++..||+|+-|+|++++.+.+|...|+|.+.+.... +...+.++ +..+.|+||+.+++|
T Consensus 81 i~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyF 160 (391)
T KOG0983|consen 81 IGGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYF 160 (391)
T ss_pred ecCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEE
Confidence 333445556677888899999999999999999999999999999654321 11233332 233589999999999
Q ss_pred eecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcE
Q 014174 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV 233 (429)
Q Consensus 154 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~v 233 (429)
+...+ +++.||.|..-...++.. ..+++++..+-.+...++.||.||..++||+|||+||+|||+|..| .+
T Consensus 161 i~n~d-----V~IcMelMs~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-ni 231 (391)
T KOG0983|consen 161 ITNTD-----VFICMELMSTCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NI 231 (391)
T ss_pred eeCch-----HHHHHHHHHHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CE
Confidence 77665 788999998665555543 2467999999999999999999998788999999999999999888 79
Q ss_pred EEeecccceecccCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHh
Q 014174 234 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGE-SGVDQLVEIIKVL 310 (429)
Q Consensus 234 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~i~~~~ 310 (429)
||||||++.++.+....+...|.+.|||||.+.. ...|+.++||||||++++||.||+.||.+. .+-+.+.++....
T Consensus 232 KlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e 311 (391)
T KOG0983|consen 232 KLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE 311 (391)
T ss_pred EeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC
Confidence 9999999999988888888889999999999843 346899999999999999999999999884 4456666665521
Q ss_pred CCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
. |. ++ ....+|+++++|+..||.+|+.+||.-.++|+|||+....
T Consensus 312 P-P~---------------L~----------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 312 P-PL---------------LP----------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred C-CC---------------CC----------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 1 11 00 1234799999999999999999999999999999987644
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=345.85 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=210.3
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-hh---hhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KR---YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.|.|+..||.|+||+||+|.++.++-..|.|++... .. ..--|++||..++||+||++++.|+..+. ++|+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lwil 107 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LWIL 107 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eEEE
Confidence 588999999999999999999999989999987432 22 22358999999999999999999866554 8999
Q ss_pred EeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc-
Q 014174 168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK- 246 (429)
Q Consensus 168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~- 246 (429)
.|||+|+-.+-+. ..-...+++..++.+++|+|.||.||| +.+|||||||..|||++-+| .|+|+|||.+.....
T Consensus 108 iEFC~GGAVDaim--lEL~r~LtE~QIqvvc~q~ldALn~LH-s~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIM--LELGRVLTEDQIQVVCYQVLDALNWLH-SQNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKST 183 (1187)
T ss_pred EeecCCchHhHHH--HHhccccchHHHHHHHHHHHHHHHHHh-hcchhhhhccccceEEEecC-cEeeecccccccchhH
Confidence 9999987555432 234678999999999999999999999 88999999999999999999 799999998754332
Q ss_pred CCCcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 247 GEPNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
.....++.||++|||||+..+ ...|++++||||||++|.+|..+.+|-...+.+..+.+|.+.- .|+
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSe-PPT-------- 254 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE-PPT-------- 254 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcC-CCc--------
Confidence 233457899999999999744 3469999999999999999999999998888877777766521 111
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
-.-|.+.+..+.|||.+||.+||..||++.++|+||||..
T Consensus 255 -----------------LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 255 -----------------LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred -----------------ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence 0123457889999999999999999999999999999975
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=331.34 Aligned_cols=277 Identities=35% Similarity=0.565 Sum_probs=218.0
Q ss_pred cceEE-eeEEccCCceEEEEEEEcCCCcEEEEEEeecchh------------------hhHHHHHHHHHcCCCCeeecce
Q 014174 91 ISYMA-ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR------------------YKNRELQTMRLLDHPNVVSLKH 151 (429)
Q Consensus 91 ~~y~i-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~~~~E~~~l~~l~h~niv~~~~ 151 (429)
++|.. .+.||+|+||+||+|.+..+++.||+|.+..... ...+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45764 5779999999999999999999999998854321 2357999999999999999999
Q ss_pred EeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC
Q 014174 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH 231 (429)
Q Consensus 152 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~ 231 (429)
++. ...+.++||||+.+++.+.+.. ...+++..+..++.|++.||.||| +.||+|+||||+||+++.++
T Consensus 88 ~~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH-~~~i~H~dl~~~nill~~~~- 156 (335)
T PTZ00024 88 VYV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLH-KWYFMHRDLSPANIFINSKG- 156 (335)
T ss_pred EEe-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeecccccHHHeEECCCC-
Confidence 884 3346889999999887776543 456899999999999999999999 89999999999999999887
Q ss_pred cEEEeecccceecccC---------------CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 014174 232 QVKLCDFGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296 (429)
Q Consensus 232 ~vkl~DfG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 296 (429)
.+||+|||++...... .......++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 7999999998765411 1112234578899999987766679999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcC--cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 297 ESGVDQLVEIIKVLGTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 297 ~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.+..+.+..+....+.+....+.... +.+..+. ........ ......+..+.+||.+||..+|++|||+.++|.|
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFT--PRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccC--cCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 99888888888888877665433211 0111100 00000111 1123468899999999999999999999999999
Q ss_pred CCCcccC
Q 014174 375 PFFYELR 381 (429)
Q Consensus 375 p~f~~~~ 381 (429)
|||....
T Consensus 314 ~~~~~~~ 320 (335)
T PTZ00024 314 EYFKSDP 320 (335)
T ss_pred cccCCCC
Confidence 9998643
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=324.51 Aligned_cols=256 Identities=28% Similarity=0.418 Sum_probs=201.7
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh-----hhHHHHHH-HHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNRELQT-MRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|+||.||+|++..+|+.||||++..... ....|+.+ ++.++||||+++++++.. ....+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~~ 76 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDVW 76 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcEE
Confidence 69999999999999999999999999999998865321 12235443 667799999999998843 33488
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-CeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+++++.+.+.........+++..+..++.||+.||.||| +. +++||||||+||+++.++ .+||+|||++...
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~ 154 (283)
T cd06617 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYL 154 (283)
T ss_pred EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCeecCCCCHHHEEECCCC-CEEEeeccccccc
Confidence 99999999887777654444567999999999999999999999 65 999999999999999888 7999999999866
Q ss_pred ccCCCcccccccccccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhh
Q 014174 245 VKGEPNISYICSRYYRAPELIFGA---TEYTTAIDIWSVGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
..........++..|+|||.+.+. ..++.++|+|||||++|+|++|+.||.... ..+.+..+.... .
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~------- 225 (283)
T cd06617 155 VDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--S------- 225 (283)
T ss_pred ccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--C-------
Confidence 443333335678889999988542 336889999999999999999999996432 223332222110 0
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
+.+ ....+|.++.+||.+||..+|.+|||+.++++||||....
T Consensus 226 ----------~~~--------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 226 ----------PQL--------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ----------CCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 000 0123689999999999999999999999999999998744
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=324.19 Aligned_cols=277 Identities=33% Similarity=0.599 Sum_probs=218.4
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
|.+.+.||+|+||.||+|.+..+++.+|+|.+.... ....+|+++++.++|+|++++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 678999999999999999999999999999987542 23457999999999999999999874331 245889
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|+||+++++...+.. ....+++..++.++.||+.||.||| +.|++|+||||+||+++.++ .+||+|||++.....
T Consensus 78 v~e~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH-~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~ 152 (287)
T cd07840 78 VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLH-SNGILHRDIKGSNILINNDG-VLKLADFGLARPYTK 152 (287)
T ss_pred EeccccccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence 999999877665543 2257899999999999999999999 88999999999999999888 799999999987654
Q ss_pred CC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 247 GE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 247 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
.. ......++..|+|||.+.+...++.++||||||+++|+|++|..||...+....+..+....+.+....+......
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 43 1233456888999998876556899999999999999999999999998888888888887777766554332111
Q ss_pred --cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 325 --YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 325 --~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.................+...++..+.++|++||..+|.+|||+.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00000000001111112222248999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=303.65 Aligned_cols=259 Identities=27% Similarity=0.381 Sum_probs=204.4
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
...+|+|.+.||+|||+.||++++..++..||+|++.... +...+|++..++++|||+++++++............
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 3458999999999999999999999999999999986433 444589999999999999999988765554566678
Q ss_pred EEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeeecCCCCceEecCCCCcEEEeecccc
Q 014174 165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g--ivH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
||+++|.. |++++.+......+..+++..+..|+.+|++||++|| ... ++||||||.|||+..++ .++|.|||.+
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH-~~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~ 176 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH-EKEPPYAHRDIKPANILLSDSG-LPVLMDLGSA 176 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh-ccCCcccccCCCcceeEecCCC-ceEEEeccCc
Confidence 89999987 6688888877777778999999999999999999999 777 99999999999999877 7999999998
Q ss_pred eecccCC----------CcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 014174 242 KVLVKGE----------PNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 309 (429)
Q Consensus 242 ~~~~~~~----------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~ 309 (429)
+...-.- ......||..|+|||.+.-. ...+.++|||||||+||+|+.|..||.. +.+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~~~ 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------IYQQ 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------Hhhc
Confidence 7642211 11234579999999988432 3468899999999999999999999942 1111
Q ss_pred hCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.|..... -+...+.+|. ...+|..+.+||+.||+.||.+||++.+++.+
T Consensus 248 GgSlaLA------v~n~q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 248 GGSLALA------VQNAQISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCeEEEe------eeccccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1111000 0001122222 12379999999999999999999999999864
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=324.44 Aligned_cols=274 Identities=40% Similarity=0.736 Sum_probs=220.9
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
|++.+.||.|++|.||+|.+..+++.+|+|.+.... ....+|+.+++.++|+||+++++++.. ....++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-----KGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-----CCCEEE
Confidence 677889999999999999999999999999885432 234579999999999999999998743 345889
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|+||+++++...+.. ....+++..+..++.||+.||.||| +.||+|+||||+||+++.++ .++|+|||.+.....
T Consensus 76 v~e~~~~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~ 150 (283)
T cd05118 76 VFEFMDTDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCH-SHGILHRDLKPENLLINTEG-VLKLADFGLARSFGS 150 (283)
T ss_pred EEeccCCCHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHH-HCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence 999999877766543 2357899999999999999999999 88999999999999999887 799999999977654
Q ss_pred CC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc--
Q 014174 247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-- 323 (429)
Q Consensus 247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~-- 323 (429)
.. ......++..|+|||.+.+...++.++|+||||+++|+|+||+.||.+.+..+.+..+...++.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 43 223355788899999987764689999999999999999999999999998888888888888877665544332
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
....+.++....... ....+.++.++.+||.+||..||.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 111122222111111 11234578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=327.95 Aligned_cols=259 Identities=29% Similarity=0.513 Sum_probs=209.2
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+++++.++|+||+++++++ ....+.
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 76 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL 76 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence 6999999999999999999999999999999886532 2345789999999999999999887 444568
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+.+ +|.+.+.. .....+++..++.++.||+.||.||| +.|++|+||||+||+++.++ .++|+|||++..
T Consensus 77 ~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~ 152 (316)
T cd05574 77 CLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLH-LLGIVYRDLKPENILLHESG-HIMLSDFDLSKQ 152 (316)
T ss_pred EEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHH-HCCeeccCCChHHeEEcCCC-CEEEeecchhhc
Confidence 899999975 55554432 22467899999999999999999999 88999999999999999887 799999999865
Q ss_pred cccCCC------------------------------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC
Q 014174 244 LVKGEP------------------------------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL 293 (429)
Q Consensus 244 ~~~~~~------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p 293 (429)
...... .....||..|+|||++.+. .++.++||||||+++|+|++|..|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCchHHHHHHHHHHHHHhhCCCC
Confidence 432211 1123578889999998764 489999999999999999999999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC----HH
Q 014174 294 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT----AL 369 (429)
Q Consensus 294 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t----~~ 369 (429)
|.+.+....+..+... ...++. ...++..+.++|.+||..||++||| +.
T Consensus 232 f~~~~~~~~~~~~~~~-----------------~~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 232 FKGSNRDETFSNILKK-----------------EVTFPG----------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCCCchHHHHHHHhcC-----------------CccCCC----------ccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 9887766555444321 000110 1126899999999999999999999 99
Q ss_pred HHhcCCCCcccCCCCCCC
Q 014174 370 EACIHPFFYELRDPNARL 387 (429)
Q Consensus 370 ell~hp~f~~~~~~~~~~ 387 (429)
++|+||||....++..+.
T Consensus 285 ~ll~~~~~~~~~~~~~~~ 302 (316)
T cd05574 285 EIKQHPFFRGVNWALIRH 302 (316)
T ss_pred HHHcCchhhcCChhhccc
Confidence 999999999988876665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=324.38 Aligned_cols=249 Identities=29% Similarity=0.481 Sum_probs=206.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++.+.||+|+||.||++.+..+++.||+|.+... .....+|+++++.++||||+++++++. .....
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 76 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSNL 76 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCeE
Confidence 699999999999999999999999999999988643 223457999999999999999999884 34458
Q ss_pred EEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||++ +++.+.+.. ...+++..+..++.||+.||.||| +.||+|+||+|.||+|+.++ .+||+|||++..
T Consensus 77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH-~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~ 150 (290)
T cd05580 77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLH-SLDIVYRDLKPENLLLDSDG-YIKITDFGFAKR 150 (290)
T ss_pred EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence 89999995 555554433 467999999999999999999999 89999999999999999888 799999999987
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... .....+++.|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+... .
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~----------- 214 (290)
T cd05580 151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K----------- 214 (290)
T ss_pred cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C-----------
Confidence 6444 3345678999999998664 4789999999999999999999999877644433333210 0
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDP 383 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~ 383 (429)
..++..++..+.++|++||..||.+|+ ++.++++||||..+.+.
T Consensus 215 ----------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 215 ----------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred ----------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 012334689999999999999999999 99999999999887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.71 Aligned_cols=262 Identities=25% Similarity=0.353 Sum_probs=206.9
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
..++|.+.+.||+|+||.||+|.+..+++.+|+|.+... .....+|+.+++.+ +|||++++++++...........
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 356799999999999999999999999999999988543 23445789999998 89999999998875543344567
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+++ ++.+.+.........+++..++.++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++..
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~ 177 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH-NNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQ 177 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEEcCCC-CEEEeecccchh
Confidence 899999975 555555443334567899999999999999999999 88999999999999999887 799999999876
Q ss_pred cccCCC-cccccccccccccccccCCC----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 244 LVKGEP-NISYICSRYYRAPELIFGAT----EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 244 ~~~~~~-~~~~~gt~~y~aPE~~~~~~----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
...... .....++..|+|||.+.... .++.++|||||||++|+|++|++||...+....+..+.+. .+
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~~----- 250 (291)
T cd06639 178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN--PP----- 250 (291)
T ss_pred cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC--CC-----
Confidence 543221 22346788899999875432 2678999999999999999999999876654444333221 00
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCc
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~ 378 (429)
+. ...+...+..+.+||.+||..+|++||++.++++||||+
T Consensus 251 ------------~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 251 ------------PT-------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred ------------CC-------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00 001223578899999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=315.31 Aligned_cols=283 Identities=33% Similarity=0.552 Sum_probs=229.9
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCC-CceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~ 163 (429)
.+|.-++.+|.|.- .|..|.+.-.++.||+|.+... .....+|..++..++|+||++++.+|...... ...-
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 36999999999998 8999999999999999987543 24456899999999999999999988533321 1123
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+|+|||++..++...+. -.+.-..+..+++|++.|++||| +.||+||||||+||++..++ .+||.|||+|+.
T Consensus 96 ~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lh-s~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLH-SAGIIHRDLKPSNIVVNSDC-TLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHH-hcceeecccCcccceecchh-heeeccchhhcc
Confidence 67899999998877765 24666788999999999999999 89999999999999999998 899999999987
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
....-..+.++.|++|+|||++.+.. +...+||||+||++.||++|+..|+|.+..++..++.+.+|.|....+..+.+
T Consensus 168 e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 168 EDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred cCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 66555667889999999999998866 99999999999999999999999999999999999999999999988766553
Q ss_pred Ccccc--cCCCcC---------CCCcccccC--CCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 324 NYTEF--KFPQIK---------AHPWHKIFH--KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 324 ~~~~~--~~~~~~---------~~~~~~~~~--~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
....+ ..|+.. ...|..... +.-+..+++|+.+||..||++|.++.++|+||||+-+.++
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~ 319 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDP 319 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccc
Confidence 22211 122221 122221111 1234568999999999999999999999999999854333
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=325.00 Aligned_cols=259 Identities=26% Similarity=0.431 Sum_probs=202.8
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
+|++++.||+|+||.||+|++..++..||+|.+.... ....+|+.+++.++|+||+++++++.. ..+.++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEEE
Confidence 5899999999999999999999999999999886431 234579999999999999999998843 445889
Q ss_pred EEeccchhHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~~l~-~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||++++.+ .++.. ......+++..+..++.||+.||.|||++.||+||||||+||+++.++ .+||+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 154 (286)
T cd06622 77 CMEYMDAGSLDKLYAG-GVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLV 154 (286)
T ss_pred EEeecCCCCHHHHHHh-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCccccc
Confidence 9999986443 33322 111347899999999999999999999446999999999999999877 79999999987653
Q ss_pred cCCCcccccccccccccccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 246 KGEPNISYICSRYYRAPELIFGAT-----EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
... .....++..|+|||.+.+.. .++.++|+|||||++|+|++|..||...........+.......
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------- 226 (286)
T cd06622 155 ASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD------- 226 (286)
T ss_pred CCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-------
Confidence 332 22345788899999885432 35789999999999999999999997654433332222211100
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
...++..++.++.+||.+||..+|.+||++.++++||||...+..
T Consensus 227 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 227 ------------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred ------------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 001233478999999999999999999999999999999887654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=326.26 Aligned_cols=283 Identities=37% Similarity=0.704 Sum_probs=223.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.++|++.+.||.|+||.||+|.+..+++.||+|++... .....+|+.+++.++||||++++++|.... ..
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----~~ 84 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL----ED 84 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC----Cc
Confidence 45799999999999999999999999999999987432 234457999999999999999999875322 24
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
.++|+||+++++...+. ...+++..+..++.||+.||.||| +.||+||||+|+||+++.++ .+||+|||++..
T Consensus 85 ~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH-~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~ 157 (328)
T cd07856 85 IYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVH-SAGVVHRDLKPSNILINENC-DLKICDFGLARI 157 (328)
T ss_pred EEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEeECCCC-CEEeCccccccc
Confidence 77999999887766543 256888999999999999999999 88999999999999999887 799999999875
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... ......++..|+|||.+.+...++.++|+|||||++|+|++|..||.+.........+.+.++.++.+.......
T Consensus 158 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (328)
T cd07856 158 QDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS 235 (328)
T ss_pred cCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 432 223456788899999886655689999999999999999999999998888777777888888887665543221
Q ss_pred Ccc-cc--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCC
Q 014174 324 NYT-EF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNAR 386 (429)
Q Consensus 324 ~~~-~~--~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~ 386 (429)
... .+ ..+.....+... ..+.++..+.++|++||+.+|++|||+.+++.||||...+.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~ 300 (328)
T cd07856 236 ENTLRFVQSLPKREPVPFSE-KFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE 300 (328)
T ss_pred hhhHHHHhhccccCCCcHHH-HcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence 100 00 001000111111 123478999999999999999999999999999999988887655
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=332.34 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=196.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 162 (429)
...|+++++||+||-+.||+|.. .+...||+|++... ......|+..|.+|+ |.+||.+|++- -.+.
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCc
Confidence 34699999999999999999985 34467777766432 233457999999995 89999999976 4456
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
++||||||-+.+|-.++... ...++..++++|+.|++.|+.++| +.||||.||||.|+|+- .| .+||+|||+|.
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH-~~gIVHSDLKPANFLlV-kG-~LKLIDFGIA~ 507 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIH-QHGIVHSDLKPANFLLV-KG-RLKLIDFGIAN 507 (677)
T ss_pred eEEEEeecccccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHH-HhceeecCCCcccEEEE-ee-eEEeeeechhc
Confidence 89999999998888877653 334554589999999999999999 99999999999999987 45 79999999998
Q ss_pred ecccCCC---cccccccccccccccccCCC----------CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 014174 243 VLVKGEP---NISYICSRYYRAPELIFGAT----------EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 309 (429)
Q Consensus 243 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~ 309 (429)
.+..... ..+.+||+.||+||.+.... ..++++||||||||||+|+.|+.||.... ..+.++ ..
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl-~a 584 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKL-HA 584 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHH-Hh
Confidence 7754432 24578999999999985321 25779999999999999999999995432 122222 22
Q ss_pred hCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
+-.|. .++.||.++. ..++.++++.||++||.+|||+.++|+|||+.-
T Consensus 585 I~~P~-----------~~Iefp~~~~-----------~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 585 ITDPN-----------HEIEFPDIPE-----------NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred hcCCC-----------ccccccCCCC-----------chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 22221 2334454322 234999999999999999999999999999965
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=338.13 Aligned_cols=259 Identities=27% Similarity=0.403 Sum_probs=218.9
Q ss_pred CCccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 86 QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 86 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
.....+.|.+.+.||+|.|++|.+|++..++..||||.+.+.. ....+|+++|+.|+|||||+++.+...
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t---- 126 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET---- 126 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee----
Confidence 3445567999999999999999999999999999999886542 234689999999999999999999844
Q ss_pred CceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
...+|+||||+.++ .+..|..+.+++.+.+++.++.|++.|++||| +++|||||||.+|||++.+. .+||+|||
T Consensus 127 -~~~lylV~eya~~g---e~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH-~k~ivHrdLk~eNilL~~~m-nikIaDfg 200 (596)
T KOG0586|consen 127 -EATLYLVMEYASGG---ELFDYLVKHGRMKEKEARAKFRQIVSAVEYCH-SKNIVHRDLKAENILLDENM-NIKIADFG 200 (596)
T ss_pred -cceeEEEEEeccCc---hhHHHHHhcccchhhhhhhhhHHHHHHHHHHh-hcceeccccchhhccccccc-ceeeeccc
Confidence 34499999999863 22234455788888999999999999999999 88999999999999999887 69999999
Q ss_pred cceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
++..+..+....+++|++.|.|||++.+..+.++.+|+||+|+++|.|+.|.+||.+.+-.+.-...+.
T Consensus 201 fS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~----------- 269 (596)
T KOG0586|consen 201 FSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLR----------- 269 (596)
T ss_pred cceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhee-----------
Confidence 999998888888999999999999999988889999999999999999999999987654332211111
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
..+. ++-.++.++.+||+++|..+|.+|++.++++.|.|.......
T Consensus 270 ------gk~r------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 270 ------GKYR------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ------eeec------------ccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 0111 233478999999999999999999999999999999876665
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=321.59 Aligned_cols=275 Identities=39% Similarity=0.697 Sum_probs=220.4
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
|++.+.||+|++|+||+|.+..+++.||||.+.... ....+|+..++.++ |+||+++++++.. ....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence 678899999999999999998899999999875432 12346889999999 9999999998844 345889
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
||||+++++.+.+... ....+++..+..++.|++.||.||| ++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh-~~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~ 151 (283)
T cd07830 76 VFEYMEGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIH-KHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS 151 (283)
T ss_pred EEecCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence 9999988877766432 1247899999999999999999999 88999999999999999887 799999999987755
Q ss_pred CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC--
Q 014174 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN-- 324 (429)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-- 324 (429)
........++..|+|||.+.....++.++|+||||+++++|++|.+||...+..+.+.++...++.+....+......
T Consensus 152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 544455678889999998866566889999999999999999999999999988888888888888776544322111
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.....++..........+ ...+.++.+||++||+.||++|||+.|++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLI-PNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred cccccccccccccHHHHc-ccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 111122222211111112 2347899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=339.68 Aligned_cols=251 Identities=30% Similarity=0.478 Sum_probs=213.4
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
|.-++.||+|+||.||-|++..+.+.||||++.-.. ..+-+|++.|+.++|||+|.+.+||....+ .+
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----aW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----AW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----HH
Confidence 777789999999999999999999999999985332 233479999999999999999999964443 78
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+|||||-|+-.+++.-. .+++-+.++..|+.+.+.||.||| +++.||||||..|||++..| .|||+|||.|....
T Consensus 103 LVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLH-S~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 103 LVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLH-SHNRIHRDIKAGNILLSEPG-LVKLADFGSASIMA 177 (948)
T ss_pred HHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHH-HhhHHhhhccccceEecCCC-eeeeccccchhhcC
Confidence 99999998777776643 367999999999999999999999 89999999999999999888 89999999997753
Q ss_pred cCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 246 KGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
+..+++|||+|||||++.. ...|+-++||||||++..+|...++|+-..+.+..+..|.+. ..|+
T Consensus 178 ---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQN-esPt--------- 244 (948)
T KOG0577|consen 178 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-ESPT--------- 244 (948)
T ss_pred ---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhc-CCCC---------
Confidence 3457899999999999843 346899999999999999999999999898888888887662 1111
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
... ...|..++.|+..||.+-|.+|||++++|+|+|...-|.+
T Consensus 245 ---------Lqs--------~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~ 287 (948)
T KOG0577|consen 245 ---------LQS--------NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPP 287 (948)
T ss_pred ---------CCC--------chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCc
Confidence 111 2358899999999999999999999999999999764443
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=322.81 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=203.9
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
+.|++++.||.|+||.||+|++..++..||+|.+.... ....+|+.+++.++|+||+++++++.. ....++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEE
Confidence 36999999999999999999999999999999886442 233468999999999999999998843 335889
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
||||++++.+.... ......+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~~--~~~~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~ 162 (292)
T cd06644 87 MIEFCPGGAVDAIM--LELDRGLTEPQIQVICRQMLEALQYLH-SMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVK 162 (292)
T ss_pred EEecCCCCcHHHHH--HhhcCCCCHHHHHHHHHHHHHHHHHHh-cCCeeecCCCcceEEEcCCC-CEEEccCccceeccc
Confidence 99999976544322 122456899999999999999999999 88999999999999999877 799999999875433
Q ss_pred CC-CcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 247 GE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 247 ~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.. ......++..|+|||.+.+ ...++.++|+|||||++|+|++|..||...+......++... .+
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~-------- 232 (292)
T cd06644 163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EP-------- 232 (292)
T ss_pred cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CC--------
Confidence 22 2234567889999998852 234678999999999999999999999776654433332211 00
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
+ ....+..++.++.+||.+||..||++||++.++++||||..+...
T Consensus 233 ---------~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 233 ---------P-------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred ---------c-------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 0 001123468899999999999999999999999999999876653
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=324.12 Aligned_cols=252 Identities=26% Similarity=0.456 Sum_probs=199.4
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
+|++.++||+|+||.||+|.+..++..||+|.+..+. ..+.+|+++++.++||||+++++++... .+.++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEEE
Confidence 5889999999999999999999999999999886432 2345799999999999999999988543 34789
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
||||++++.+... ..+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .++|+|||++.....
T Consensus 77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~ 147 (279)
T cd06619 77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLW-SLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN 147 (279)
T ss_pred EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHH-HCCEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence 9999998655432 35788999999999999999999 89999999999999999888 799999999976543
Q ss_pred CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCCHHHHhhcCc
Q 014174 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQL---VEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~ 323 (429)
. ......+|..|+|||.+.+. .++.++|+|||||++|+|++|..||......... ....+......
T Consensus 148 ~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------- 216 (279)
T cd06619 148 S-IAKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--------- 216 (279)
T ss_pred c-cccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---------
Confidence 3 23345789999999998764 4899999999999999999999999653221110 01111100000
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
.+ .......++++.+||.+||..||.+||++.++++||||.....
T Consensus 217 ------~~--------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 217 ------PP--------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred ------CC--------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence 00 0011236889999999999999999999999999999977643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=320.70 Aligned_cols=262 Identities=24% Similarity=0.340 Sum_probs=205.7
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceE
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 163 (429)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.+ +|+||+++++++.........+
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 34567999999999999999999999999999999875422 3455799999999 6999999999886554445567
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.++||||+++ +|.+.+.........+++..++.++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||++.
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~ 172 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH-VNKTIHRDVKGNNILLTTEG-GVKLVDFGVSA 172 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH-hCCccccCCCHHhEEECCCC-CEEEccCCcee
Confidence 8899999975 455555443334567899999999999999999999 88999999999999999888 69999999987
Q ss_pred ecccCC-CcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 243 VLVKGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 243 ~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
...... ......|+..|+|||.+.. ...++.++||||+||++|+|++|+.||...+....+..+... .
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~--~----- 245 (286)
T cd06638 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN--P----- 245 (286)
T ss_pred ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc--C-----
Confidence 654332 2233468899999998743 234788999999999999999999999765543332221110 0
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.+ ....+..++..+.+||.+||+.||++|||+.++++|+||
T Consensus 246 ------------~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 246 ------------PP-------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ------------CC-------cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00 001122357889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=340.02 Aligned_cols=249 Identities=29% Similarity=0.452 Sum_probs=203.2
Q ss_pred EEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEeccch
Q 014174 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE 173 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 173 (429)
+||+|.||+||-|+++.|....|||.+... ......|+.+-+.|+|.|||++++++ ..+.++-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence 799999999999999999999999988543 34456899999999999999999987 555578899999997
Q ss_pred hHHHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCc-
Q 014174 174 TVYRVAKHYSRASQRM--PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN- 250 (429)
Q Consensus 174 ~l~~~~~~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~- 250 (429)
+.++.+.. ..-+++ .+.++.++..||++||.||| ...|||||||-+||||+...+.+||+|||.+++...-.+.
T Consensus 657 GSLSsLLr--skWGPlKDNEstm~fYtkQILeGLkYLH-en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T 733 (1226)
T KOG4279|consen 657 GSLSSLLR--SKWGPLKDNESTMNFYTKQILEGLKYLH-ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT 733 (1226)
T ss_pred CcHHHHHH--hccCCCccchhHHHHHHHHHHHHhhhhh-hcceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence 65554433 223555 89999999999999999999 8899999999999999887779999999999887544433
Q ss_pred cccccccccccccccc-CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 014174 251 ISYICSRYYRAPELIF-GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329 (429)
Q Consensus 251 ~~~~gt~~y~aPE~~~-~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
..+.||..|||||++. |...|+.++|||||||++.||.||++||......+.. ++++
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkV-------------------- 791 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKV-------------------- 791 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhh--------------------
Confidence 4577999999999994 4467999999999999999999999999754433321 1111
Q ss_pred CCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 330 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
..++ ....+|..++.+++.||.+|+.+||.+||+|.++|..||++.-
T Consensus 792 -GmyK---vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 792 -GMYK---VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred -ccee---cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 0000 1122456689999999999999999999999999999999764
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=319.42 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=201.7
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHc-CCCCeeecceEeeecCCC-CceEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK-DELYL 164 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~-~~~~~ 164 (429)
.+.|++.+.||+|+||.||+|.+..+++.||+|.+... ......|+.+++.+ +|+||+++++++...... .....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 34699999999999999999999999999999988643 23456788999988 699999999988654322 23467
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+++ ++.+.+.. .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~~~~qi~~~l~~LH-~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~ 160 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKN--TKGNTLKEEWIAYICREILRGLSHLH-QHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEcCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCHHHEEECCCC-CEEEccCCCcee
Confidence 899999985 55554432 12356899999999999999999999 88999999999999999888 799999999876
Q ss_pred cccCC-CcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 244 LVKGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 244 ~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
..... ......|+..|+|||++.+ ...++.++|+||+||++|+|++|..||...........+...
T Consensus 161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~--------- 231 (272)
T cd06637 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN--------- 231 (272)
T ss_pred cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---------
Confidence 53322 2234567889999999853 234788999999999999999999999765433332221110
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.........++.++.+||.+||..||.+|||+.++++||||
T Consensus 232 ------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 232 ------------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ------------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00001122468899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=317.58 Aligned_cols=293 Identities=27% Similarity=0.429 Sum_probs=222.4
Q ss_pred CCCccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhH---HHHHHHHHcC--------CCCeeecceEe
Q 014174 85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLD--------HPNVVSLKHCF 153 (429)
Q Consensus 85 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~E~~~l~~l~--------h~niv~~~~~~ 153 (429)
|.....++|.+.++||.|.|++||+|.+..+.+.||+|+++....+.+ .|+++|++++ ..+||++++.|
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 345566799999999999999999999999999999999987654443 6999999883 34799999988
Q ss_pred eecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC----
Q 014174 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH---- 229 (429)
Q Consensus 154 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~---- 229 (429)
.... .+..++|+|+|+++.+|+.++.... .+.++...++.|++||+.||.|||.++||||.||||+|||+...
T Consensus 152 khsG-pNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~ 228 (590)
T KOG1290|consen 152 KHSG-PNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDP 228 (590)
T ss_pred eecC-CCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccch
Confidence 6554 6677899999999999999988644 46799999999999999999999999999999999999997210
Q ss_pred ------------------------C-------------------------------------------------------
Q 014174 230 ------------------------T------------------------------------------------------- 230 (429)
Q Consensus 230 ------------------------~------------------------------------------------------- 230 (429)
.
T Consensus 229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~ 308 (590)
T KOG1290|consen 229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR 308 (590)
T ss_pred hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence 0
Q ss_pred --------------------------------------------------------------------------------
Q 014174 231 -------------------------------------------------------------------------------- 230 (429)
Q Consensus 231 -------------------------------------------------------------------------------- 230 (429)
T Consensus 309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~ 388 (590)
T KOG1290|consen 309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE 388 (590)
T ss_pred CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence
Q ss_pred --CcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC------ChHHH
Q 014174 231 --HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE------SGVDQ 302 (429)
Q Consensus 231 --~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~------~~~~~ 302 (429)
-+|||+|||.|+.... ..+.-..|+.|+|||++.+.. |++.+||||++|+++||+||..+|... ...+.
T Consensus 389 ~di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDH 465 (590)
T KOG1290|consen 389 CDIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDH 465 (590)
T ss_pred cceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHH
Confidence 0133444444333211 112234578899999999865 999999999999999999999999643 35678
Q ss_pred HHHHHHHhCCCCHHHHhhcC-------cCcccccCCCcCCCCcccc------cCCCCChhHHHHHHhhcCcCCCCCCCHH
Q 014174 303 LVEIIKVLGTPTREEIKCMN-------PNYTEFKFPQIKAHPWHKI------FHKRMPPEAVDLVSRLLQYSPNLRCTAL 369 (429)
Q Consensus 303 ~~~i~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~------~~~~~s~~l~~Li~~~L~~dP~~R~t~~ 369 (429)
++.|++.+|..+......-. +.-.--.+...+..++..+ ++.....++.+||.-||+++|++|+||.
T Consensus 466 iA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~ 545 (590)
T KOG1290|consen 466 IALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAA 545 (590)
T ss_pred HHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHH
Confidence 99999999988776543211 1111111222222222222 1223345688999999999999999999
Q ss_pred HHhcCCCCcccCCC
Q 014174 370 EACIHPFFYELRDP 383 (429)
Q Consensus 370 ell~hp~f~~~~~~ 383 (429)
++|+|||+..+..+
T Consensus 546 ~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 546 QCLKHPWLNPVAGP 559 (590)
T ss_pred HHhcCccccCCCCC
Confidence 99999999887665
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=329.55 Aligned_cols=277 Identities=22% Similarity=0.336 Sum_probs=197.6
Q ss_pred EeeEEccC--CceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 95 AERVVGQG--SFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 95 i~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
++++||+| +|++||++.+..+|+.||+|++..+. ....+|+.+++.++||||+++++++... .+.++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence 46789999 78899999999999999999986432 3455799999999999999999988443 35889
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+++ ++.+++... ....+++..++.++.||+.||.||| ++||+||||||+|||++.++ .++++||+.+....
T Consensus 77 v~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH-~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~ 152 (327)
T cd08227 77 VTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIH-HMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMI 152 (327)
T ss_pred EEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCChhhEEEecCC-cEEEcccchhhccc
Confidence 9999985 454544321 2345899999999999999999999 88999999999999999887 79999998754332
Q ss_pred cCCC--------cccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC---
Q 014174 246 KGEP--------NISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP--- 313 (429)
Q Consensus 246 ~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~--- 313 (429)
.... .....++..|+|||++.+. ..++.++|||||||++|+|++|..||............... ..+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~ 231 (327)
T cd08227 153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG-TVPCLL 231 (327)
T ss_pred cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcC-Cccccc
Confidence 1111 1123456779999998653 35889999999999999999999999865544433322211 000
Q ss_pred -----CHHHHhhcCcC------cccc-c---CCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCc
Q 014174 314 -----TREEIKCMNPN------YTEF-K---FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378 (429)
Q Consensus 314 -----~~~~~~~~~~~------~~~~-~---~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~ 378 (429)
..+.+...... +... . ................+++.+.+||++||++||++|||+.++++||||.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~ 311 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 311 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence 00000000000 0000 0 0000000011112334688999999999999999999999999999998
Q ss_pred ccC
Q 014174 379 ELR 381 (429)
Q Consensus 379 ~~~ 381 (429)
++.
T Consensus 312 ~~~ 314 (327)
T cd08227 312 QIK 314 (327)
T ss_pred hcc
Confidence 754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=316.89 Aligned_cols=262 Identities=28% Similarity=0.419 Sum_probs=206.8
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHc-CCCCeeecceEeeecCC-CCce
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD-KDEL 162 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~~ 162 (429)
...++|++.+.||+|++|.||+|.+..+++.||+|++.... ..+.+|+.+++++ +|+||+++++++..... ....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 34568999999999999999999999899999999886542 3456799999998 79999999999875543 3455
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
++++||||+++ ++.+.+.........+++..++.++.|++.||.||| +.|++|+||+|+||+++.++ .+||+|||++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH-~~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~ 160 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH-ENKVIHRDIKGQNILLTKNA-EVKLVDFGVS 160 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCHHHEEEccCC-eEEECCCccc
Confidence 68899999996 454554433333567999999999999999999999 88999999999999999887 7999999998
Q ss_pred eecccCC-CcccccccccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 242 KVLVKGE-PNISYICSRYYRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 242 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
....... ......++..|+|||.+... ..++.++|||||||++|+|++|..||........+..+... +.
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~-- 235 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PP-- 235 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CC--
Confidence 7654322 22345678899999987432 34678899999999999999999999765544444333221 00
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
+.. ..+..++.++.+||++||..||++|||+.++++|||+
T Consensus 236 --------------~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 236 --------------PTL-------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred --------------CCC-------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 000 0112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=330.21 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=190.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeecCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 158 (429)
.++|++.++||+|+||.||+|.+. .++..||+|++.... ....+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~-- 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP-- 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC--
Confidence 357999999999999999999752 345789999886432 2345799999999 899999999977432
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhh-----------------------------------------------------
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSR----------------------------------------------------- 184 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------------------------------------- 184 (429)
...+++||||+++ +|.+.+.....
T Consensus 84 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 84 --NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 2247889999985 55444432110
Q ss_pred -----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCC---ccccccc
Q 014174 185 -----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICS 256 (429)
Q Consensus 185 -----~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt 256 (429)
....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....... .....++
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLA-SRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHH-HCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCC
Confidence 0234788889999999999999999 88999999999999999887 799999999976533221 1123456
Q ss_pred ccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCC
Q 014174 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA 335 (429)
Q Consensus 257 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (429)
..|+|||++.+. .++.++|||||||++|+|++ |..||.+......+....... .
T Consensus 240 ~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~----------------------- 294 (338)
T cd05102 240 LKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG-T----------------------- 294 (338)
T ss_pred ccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC-C-----------------------
Confidence 789999998764 48999999999999999997 999998765443333222210 0
Q ss_pred CCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 336 HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 336 ~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+...++.+.+|+.+||..||.+|||+.++++
T Consensus 295 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 295 ---RMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00112346889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=322.42 Aligned_cols=251 Identities=27% Similarity=0.396 Sum_probs=206.5
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEec
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF 170 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 170 (429)
|.++.+||+|+||.||+|.++.+|..+|||.+.-+ ...+-+|+.|+++++.|++|++|+.|+...+ ++|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehhh
Confidence 88889999999999999999999999999998654 4555689999999999999999999976665 9999999
Q ss_pred cchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC-C
Q 014174 171 VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-P 249 (429)
Q Consensus 171 ~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~-~ 249 (429)
|+.+....+... ..+.+++.++..+++..+.||+||| ...-||||||..|||++.+| ..||+|||.|..+.+.- .
T Consensus 110 CGAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH-~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 110 CGAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLH-DLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred cCCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHH-HHHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHHh
Confidence 995544433332 3578999999999999999999999 88889999999999999999 69999999997765432 2
Q ss_pred cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 014174 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329 (429)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
.....||+.|||||++.. ..|...+||||||++..||..|++||........+ +..-..|+
T Consensus 186 RNTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---FMIPT~PP--------------- 246 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---FMIPTKPP--------------- 246 (502)
T ss_pred hCccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCccccccccee---EeccCCCC---------------
Confidence 345689999999999965 45999999999999999999999999765433222 11111111
Q ss_pred CCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 330 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
..++ -+...|.++.||+++||.++|++|-|+.++++|||+++
T Consensus 247 ------PTF~--KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 247 ------PTFK--KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred ------CCCC--ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 1111 12346899999999999999999999999999999976
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=319.10 Aligned_cols=274 Identities=38% Similarity=0.685 Sum_probs=223.5
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
|++.+.||+|+||.||+|++..+++.||+|.+.... .....|+.+++.++|+|++++++++.. ..+.++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-----ERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-----CCceEE
Confidence 677889999999999999999999999999886532 233468999999999999999998843 345889
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|+||+++++.+.+... ...+++..+..++.|++.||.||| +.||+||||+|+||+++.++ .++|+|||++.....
T Consensus 76 v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~ 150 (282)
T cd07829 76 VFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCH-SHRILHRDLKPQNILINRDG-VLKLADFGLARAFGI 150 (282)
T ss_pred EecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence 9999998877766542 246999999999999999999999 88999999999999999887 799999999876543
Q ss_pred CC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC-
Q 014174 247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 324 (429)
Q Consensus 247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~- 324 (429)
.. ......++..|+|||.+.+...++.++|+|||||++|+|++|.+||.+.+....+..+....+.+....+......
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 32 2223455778999999876656899999999999999999999999999988899999998888888766544322
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
+....++..........++ .++..+.++|++||..||++||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1222334433333333332 358899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=320.95 Aligned_cols=282 Identities=31% Similarity=0.512 Sum_probs=218.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC-----
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD----- 158 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 158 (429)
..+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+++++.++||||+++++++....+
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 457999999999999999999999999999999886432 233579999999999999999988754331
Q ss_pred CCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 159 KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
....++++|+||+++++...+.. ....+++..++.++.||+.||.||| +.||+|+||||+||+++.++ .+||+||
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~i~H~dl~p~nili~~~~-~~kl~df 160 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCH-KKNFLHRDIKCSNILLNNKG-QIKLADF 160 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-cEEeCcc
Confidence 12236889999999877665543 2356899999999999999999999 88999999999999999887 7999999
Q ss_pred ccceecccCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 239 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 239 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
|++........ .....++..|+|||.+.+...++.++|||||||++|+|++|++||...+..+.+..+.+..+.+...
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99976644331 1223457789999988665557899999999999999999999999888888888888887777655
Q ss_pred HHhhcCc--CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 317 EIKCMNP--NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 317 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.+..... .+............+.. ....++..+.+||.+||..||.+|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 4432210 01000000000011111 123468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=345.50 Aligned_cols=248 Identities=26% Similarity=0.445 Sum_probs=199.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcC-CCCeeecce-EeeecCCCC-ceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKH-CFFSTTDKD-ELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~niv~~~~-~~~~~~~~~-~~~ 163 (429)
-+++|.++|.+|||+.||+|++...|..||+|++.... ....+|+++|+.|+ |+|||.+++ ......... ..-
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 36999999999999999999998888999999885432 34468999999997 999999999 443333333 345
Q ss_pred EEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeeecCCCCceEecCCCCcEEEeeccc
Q 014174 164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g--ivH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
+.|.||||. ++|.+.+..+.. .+|++.++.+|++|+|+|+.+|| ... |||||||-|||||+.++ ..||||||.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g-~~KLCDFGS 192 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADG-NYKLCDFGS 192 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCC-CEEeCcccc
Confidence 678999999 699998887554 45999999999999999999999 776 99999999999999988 699999999
Q ss_pred ceecccCCCc----------cccccccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014174 241 AKVLVKGEPN----------ISYICSRYYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308 (429)
Q Consensus 241 a~~~~~~~~~----------~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~ 308 (429)
|......... .....|+.|+|||++. .....+.++|||+|||+||-|+....||........+
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl----- 267 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL----- 267 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE-----
Confidence 8755433211 1234589999999972 3345899999999999999999999999654221111
Q ss_pred HhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
+ ..|.+|.. +.++..+.+||+.||+.||.+||++.+++.
T Consensus 268 -------------n---g~Y~~P~~----------p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 268 -------------N---GNYSFPPF----------PNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred -------------e---ccccCCCC----------ccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 1 22344442 347999999999999999999999999886
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=322.98 Aligned_cols=262 Identities=22% Similarity=0.345 Sum_probs=202.7
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|...+.||+|+||.||++.+..+++.||+|.+... .....+|+.++.++. |+||+++++++... ...+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcEE
Confidence 577788999999999999999999999999988643 223456888888886 99999999987542 3367
Q ss_pred EEEeccchhHHHHHHHh-hhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPETVYRVAKHY-SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~-~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++|||++.++..+.... ......+++..+..++.|++.||+|||++.||+||||||+||+++.++ .+||+|||++...
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 158 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL 158 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence 89999987665544322 223467999999999999999999999446999999999999999887 7999999999766
Q ss_pred ccCCCcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 245 VKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
..........++..|+|||.+.+. ..++.++||||+||++|+|++|+.||..... ....+.+.....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~--------- 227 (288)
T cd06616 159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGD--------- 227 (288)
T ss_pred ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCC---------
Confidence 544444445678899999998765 3588999999999999999999999975541 111111111000
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
.+.+ .......++.++.+||.+||..||++|||+.++++||||.....
T Consensus 228 -------~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~ 275 (288)
T cd06616 228 -------PPIL-----SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE 275 (288)
T ss_pred -------CCcC-----CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence 0000 00111347899999999999999999999999999999987553
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=310.94 Aligned_cols=249 Identities=28% Similarity=0.456 Sum_probs=200.5
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|++|.||++.+..+++.||+|.+.... ....+|+++++.++|+|++++++.+.. ...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 4999999999999999999999999999999885432 234578999999999999999877632 234578
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+++ ++.+.+.. .....+++..+..++.|++.||.+|| +.||+||||||+||+++.++ .++|+|||++...
T Consensus 77 lv~e~~~~~~l~~~l~~--~~~~~l~~~~~~~~~~~l~~~l~~lH-~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~ 152 (257)
T cd08223 77 IVMGFCEGGDLYHKLKE--QKGKLLPENQVVEWFVQIAMALQYLH-EKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVL 152 (257)
T ss_pred EEecccCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence 99999985 45444432 22356899999999999999999999 88999999999999999887 7999999999876
Q ss_pred ccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
..... .....+++.|+|||.+.+. .++.++|+|||||++++|++|+.||...+.......+....
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~------------- 218 (257)
T cd08223 153 ENQCDMASTLIGTPYYMSPELFSNK-PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK------------- 218 (257)
T ss_pred cccCCccccccCCcCccChhHhcCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-------------
Confidence 43322 2334678899999998664 48899999999999999999999998766544443332210
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.+ ..+..+++.+.+||.+||+.||++|||+.++++||||
T Consensus 219 ------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 219 ------LP---------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred ------CC---------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 0123478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=323.12 Aligned_cols=278 Identities=25% Similarity=0.387 Sum_probs=202.4
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
+|++.+.||+|+||.||++.+..++..||+|.+..+. ....+|+++++.++||||+++++++.. ..++++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEEE
Confidence 5999999999999999999999999999999886431 234579999999999999999999843 345889
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+++ +|.+.+.. ...+++..+..++.||+.||.|||+..+++||||||+|||++.++ .+||+|||++....
T Consensus 77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 151 (308)
T cd06615 77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI 151 (308)
T ss_pred EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccc
Confidence 9999985 55444432 467899999999999999999999436999999999999999887 79999999987653
Q ss_pred cCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 014174 246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325 (429)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 325 (429)
... .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+... .......................
T Consensus 152 ~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 152 DSM-ANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ccc-cccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccC
Confidence 322 2345678999999998654 48899999999999999999999997655322 22222111000000000000000
Q ss_pred ccccCCC----------cCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 326 TEFKFPQ----------IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 326 ~~~~~~~----------~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
.....+. .........-...++.++.+|+.+||..||++|||+.++++||||.....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 295 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAEL 295 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhccc
Confidence 0000000 00000000001136789999999999999999999999999999976543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=316.14 Aligned_cols=278 Identities=35% Similarity=0.608 Sum_probs=215.6
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHc---CCCCeeecceEeeecCCCCceE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 163 (429)
|++.+.||+|+||.||+|++..++..||+|.+.... ....+|+.+++.+ +|+|++++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678999999999999999998889999999886321 2234577777666 6999999999987655444456
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++++|||+++++.+.+.... ...+++..++.++.||+.||.||| +.|++|+||+|+||+++.++ .+||+|||++..
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH-~~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLH-SHRIVHRDLKPQNILVTSDG-QVKIADFGLARI 156 (287)
T ss_pred eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCChhhEEEccCC-CEEEeccCccee
Confidence 88999999987766654321 236899999999999999999999 88999999999999999887 799999999987
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
...........++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||.+.+..+.+.++....+.+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (287)
T cd07838 157 YSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV- 234 (287)
T ss_pred ccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc-
Confidence 65544444456788899999987644 8899999999999999999999999988888888887766655443221110
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
......++....... ....+.++..+.+||.+||+.||.+||++.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 000001111111111 11123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=313.68 Aligned_cols=255 Identities=27% Similarity=0.407 Sum_probs=202.3
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
+|++.+.||.|+||+||+|.+..++..+|+|++... .....+|+++++.++|+||+++++.+.. ....++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~i 76 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELWL 76 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEEE
Confidence 699999999999999999999889999999988543 2345679999999999999999988743 345789
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
|+|++.+ ++.+.+.. ......+++..++.++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++....
T Consensus 77 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~ql~~al~~lh-~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~ 153 (267)
T cd06610 77 VMPYLSGGSLLDIMKS-SYPRGGLDEAIIATVLKEVLKGLEYLH-SNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLA 153 (267)
T ss_pred EEeccCCCcHHHHHHH-hcccCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHhEEEcCCC-CEEEcccchHHHhc
Confidence 9999985 44444432 112356899999999999999999999 89999999999999999887 79999999987665
Q ss_pred cCCCc-----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 246 KGEPN-----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 246 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
..... ....++..|+|||.+.....++.++|+|||||++|+|++|..||...+....+.+.... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~------ 224 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DP------ 224 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CC------
Confidence 43322 23457889999999876546899999999999999999999999876654444333221 00
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.. .+.. .....+++.+.+|+.+||..||++|||+.++++||||
T Consensus 225 -----~~--~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 225 -----PS--LETG-------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -----CC--cCCc-------cccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 00 0000 0013478999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=329.23 Aligned_cols=242 Identities=26% Similarity=0.369 Sum_probs=198.8
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
.+++++.||+|-||.||+|.+..+ ..||+|.++.. ...+.+|+++|+.|+|+|||++++++.... -++|||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVt 280 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVT 280 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEE
Confidence 466678999999999999998432 48999988652 345568999999999999999999984322 388999
Q ss_pred eccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
|||. |+|++.+.. .....+.......++.|||+|++||. ++++|||||-..||||+.+. .+||+|||+|+...++
T Consensus 281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLe-s~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLE-SKNYIHRDLAARNILVDEDL-VVKISDFGLARLIGDD 356 (468)
T ss_pred EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHH-hCCccchhhhhhheeeccCc-eEEEcccccccccCCC
Confidence 9998 567776654 34677999999999999999999999 89999999999999999887 8999999999955444
Q ss_pred CCccccc--ccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 248 EPNISYI--CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 248 ~~~~~~~--gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
....... -..-|.|||.+.... ++.+||||||||+|+||+| |+.||.+.+..+.+..+.+...-
T Consensus 357 ~Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl------------ 423 (468)
T KOG0197|consen 357 EYTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL------------ 423 (468)
T ss_pred ceeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC------------
Confidence 3322211 145699999997644 9999999999999999998 89999999998888877654222
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell 372 (429)
|. |..+|+++.+++..||..+|++|||.+.+.
T Consensus 424 ------p~----------P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 424 ------PR----------PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ------CC----------CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 21 345899999999999999999999998664
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=332.24 Aligned_cols=238 Identities=26% Similarity=0.410 Sum_probs=200.3
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEeccc-hh
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ET 174 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 174 (429)
++-||.|+.|.||+++. .++.||||+++.- .+.+++-|+.|+|+||+.|.+++ ....++|||||||. |-
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~el---kETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVREL---KETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhh---hhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence 57899999999999986 6789999988443 34688999999999999999998 66667899999999 45
Q ss_pred HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCccccc
Q 014174 175 VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254 (429)
Q Consensus 175 l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~ 254 (429)
|+.+++ ..+.++......|..+|+.|++||| .+.|||||||.-||||+.+. .|||+|||.++...+.....+++
T Consensus 199 L~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH-~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFa 272 (904)
T KOG4721|consen 199 LYEVLK----AGRPITPSLLVDWSKGIAGGMNYLH-LHKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFA 272 (904)
T ss_pred HHHHHh----ccCccCHHHHHHHHHHhhhhhHHHH-HhhHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhh
Confidence 555554 4678899999999999999999999 89999999999999999887 89999999999887777778899
Q ss_pred ccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcC
Q 014174 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 334 (429)
Q Consensus 255 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (429)
||..|||||++... ..+.++|||||||+||||+||..||..-+....+. .. .
T Consensus 273 GTVaWMAPEvIrne-PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----GV-----------------------G 324 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNE-PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----GV-----------------------G 324 (904)
T ss_pred hhHhhhCHHHhhcC-CcccccceehhHHHHHHHHhcCCCccccchheeEE----ec-----------------------c
Confidence 99999999999764 49999999999999999999999997654322211 01 1
Q ss_pred CCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 335 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 335 ~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.+.+.-..+..+++.++-||++||+-.|..||++.++|.|=-+
T Consensus 325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 1222233456689999999999999999999999999998544
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=318.74 Aligned_cols=254 Identities=28% Similarity=0.430 Sum_probs=204.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.+|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++.. ....++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----CceEEE
Confidence 46999999999999999999999999999999885432 334579999999999999999998843 345889
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|+||+.++.+..... ...+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++.....
T Consensus 94 v~e~~~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH-~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~ 167 (296)
T cd06655 94 VMEYLAGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLH-ANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITP 167 (296)
T ss_pred EEEecCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEccCccchhccc
Confidence 999998654433221 246899999999999999999999 88999999999999999887 799999999876543
Q ss_pred CCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 014174 247 GEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325 (429)
Q Consensus 247 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 325 (429)
... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+.......+... +.+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~~----------- 234 (296)
T cd06655 168 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPE----------- 234 (296)
T ss_pred ccccCCCcCCCccccCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCcc-----------
Confidence 322 2234678899999998654 4889999999999999999999999887665544333221 0000
Q ss_pred ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
...+..+++.+.+||++||..||.+|||+.++++||||...+.
T Consensus 235 --------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 235 --------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred --------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 0012347899999999999999999999999999999986553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=319.66 Aligned_cols=255 Identities=27% Similarity=0.380 Sum_probs=202.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
++|++.+.||.|+||.||+|.+..++..||+|.+.... ....+|+++++.++|+||+++++.+.. ....++
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 79 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKLWI 79 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeEEE
Confidence 46999999999999999999998899999999886432 234479999999999999999998843 345889
Q ss_pred EEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||++++ +.+.+. .....+++..++.++.|++.||.||| +.||+|+||||+||+++.++ .++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~ 154 (280)
T cd06611 80 LIEFCDGGALDSIML---ELERGLTEPQIRYVCRQMLEALNFLH-SHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNK 154 (280)
T ss_pred EeeccCCCcHHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChhhEEECCCC-CEEEccCccchhhc
Confidence 99999874 433332 22356999999999999999999999 88999999999999999887 79999999986543
Q ss_pred cCC-CcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 246 KGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 246 ~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
... ......+|..|+|||.+.. ...++.++|+|||||++|+|++|+.||...+....+..+... .+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~------- 225 (280)
T cd06611 155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKS--EP------- 225 (280)
T ss_pred ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcC--CC-------
Confidence 322 2234567889999998742 234678999999999999999999999876654444333221 00
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
+. ...+..++.++.+||.+||..+|.+|||+.++++||||....
T Consensus 226 ----------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 226 ----------PT-------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred ----------CC-------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 00 001234688999999999999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=310.28 Aligned_cols=249 Identities=29% Similarity=0.451 Sum_probs=203.6
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|+||.||+|.+..+++.+|+|.+... .....+|+++++.++|+||+++++.+. .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence 489999999999999999999999999999988543 233457999999999999999998873 334588
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+++ ++.+.+.. .....+++..+..++.|++.||.||| ++||+|+||||+||+++.++..+||+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 76 IVMEYAPGGTLAEYIQK--RCNSLLDEDTILHFFVQILLALHHVH-TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred EEEecCCCCCHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 99999975 55555433 12345899999999999999999999 8899999999999999876657899999999877
Q ss_pred ccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
..........++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~------------- 218 (256)
T cd08220 153 SSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF------------- 218 (256)
T ss_pred CCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------
Confidence 555444456678899999998664 478899999999999999999999987665544433322100
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
..++..++.++.+++.+||..||.+|||+.++++||||
T Consensus 219 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 219 ---------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ---------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 01223478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=319.10 Aligned_cols=252 Identities=27% Similarity=0.406 Sum_probs=202.0
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.+|++.+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++.. ..+.++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEEE
Confidence 47999999999999999999999999999999886432 344578999999999999999998843 335889
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+.+ ++...+. ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus 95 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH-~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~ 167 (296)
T cd06654 95 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT 167 (296)
T ss_pred eecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEcCCC-CEEECccccchhcc
Confidence 9999985 4444432 245889999999999999999999 88999999999999999887 79999999987653
Q ss_pred cCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
.... .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.......+.. .+.+.
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~---------- 235 (296)
T cd06654 168 PEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPE---------- 235 (296)
T ss_pred ccccccCcccCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCCC----------
Confidence 3221 2234678899999988654 478999999999999999999999987665433322211 00000
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
...+..++..+.+||.+||..||.+|||+.++++||||...+
T Consensus 236 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 236 ---------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred ---------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 011234788999999999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=317.72 Aligned_cols=253 Identities=26% Similarity=0.368 Sum_probs=201.5
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
|++.+.||+|+||.||+|.+..++..+|+|.+.... ....+|+++++.++|+||+++++++.. ..+.++|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEEE
Confidence 788899999999999999999999999999885432 234468999999999999999998843 33578999
Q ss_pred eccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC
Q 014174 169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248 (429)
Q Consensus 169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~ 248 (429)
||++++.+..... .....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++.......
T Consensus 82 e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~qi~~~L~~LH-~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 82 EFCAGGAVDAVML--ELERPLTEPQIRVVCKQTLEALNYLH-ENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTI 157 (282)
T ss_pred EecCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCcccEEEccCC-CEEEccccccccccccc
Confidence 9998765443221 22457899999999999999999999 88999999999999999887 79999999987653322
Q ss_pred -CcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 249 -PNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 249 -~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
......++..|+|||.+.. ...++.++|+||+||++|+|++|.+||...+..+....+......
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~----------- 226 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP----------- 226 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCC-----------
Confidence 1233467889999998742 234678999999999999999999999877655554444331100
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
. ...+..++.++.+||.+||..||.+|||+.++++||||...
T Consensus 227 --------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 227 --------T-------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred --------C-------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 0 01123468899999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=307.01 Aligned_cols=260 Identities=27% Similarity=0.466 Sum_probs=201.5
Q ss_pred eEEe-eEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceEEEE
Q 014174 93 YMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 93 y~i~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
|++. +.||+|+|+.|--+....+|..||+|++.+. +....||++++..++ |+||+.++++| ++....|+
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYL 153 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYL 153 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEE
Confidence 4443 5899999999999999999999999998654 344568999999985 99999999999 55566889
Q ss_pred EEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC--cEEEeeccccee
Q 014174 167 VLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKV 243 (429)
Q Consensus 167 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~--~vkl~DfG~a~~ 243 (429)
|||-|.|+ ++..+ .....|++.++..+..+|+.||.||| .+||.||||||+|||-....+ -||||||.+..-
T Consensus 154 VfEKm~GGplLshI----~~~~~F~E~EAs~vvkdia~aLdFlH-~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHI----QKRKHFNEREASRVVKDIASALDFLH-TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred EEecccCchHHHHH----HHhhhccHHHHHHHHHHHHHHHHHHh-hcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 99999864 33333 33578999999999999999999999 899999999999999854332 699999998755
Q ss_pred cccCC--------Cccccccccccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH----------
Q 014174 244 LVKGE--------PNISYICSRYYRAPELIF----GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD---------- 301 (429)
Q Consensus 244 ~~~~~--------~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---------- 301 (429)
...+. ...+.+|+..|||||+.. ....|+.++|.||||+|+|.|+.|.+||.|.-..+
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 43222 223557888999999862 23468999999999999999999999998754321
Q ss_pred -HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 302 -QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 302 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
--..+++. |. -..|.||. ..| ..+|.+++|||+.+|..|+.+|.++.++++|||+...
T Consensus 309 ~CQ~~LFes--------IQ-----EGkYeFPd---kdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 309 VCQNKLFES--------IQ-----EGKYEFPD---KDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHHHHH--------Hh-----ccCCcCCh---hhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 11111111 00 02233332 122 3479999999999999999999999999999999887
Q ss_pred CCC
Q 014174 381 RDP 383 (429)
Q Consensus 381 ~~~ 383 (429)
+..
T Consensus 368 ~~e 370 (463)
T KOG0607|consen 368 APE 370 (463)
T ss_pred chh
Confidence 654
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=314.40 Aligned_cols=249 Identities=29% Similarity=0.452 Sum_probs=196.8
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
+|++.+.||+|+||.||+|.+..++..||+|.+... .....+|+.+++.++||||+++++++... ...
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 79 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AEK 79 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CCC
Confidence 699999999999999999999999999999987532 12345799999999999999999877432 234
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++++||+++ +|.+.+.. ...+++...+.++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++
T Consensus 80 ~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH-~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~ 153 (266)
T cd06651 80 TLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLH-SNMIVHRDIKGANILRDSAG-NVKLGDFGAS 153 (266)
T ss_pred EEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEECCCC-CEEEccCCCc
Confidence 57899999985 45444432 356899999999999999999999 89999999999999999887 7999999998
Q ss_pred eecccCC----CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 242 KVLVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 242 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
....... ......++..|+|||.+.+. .++.++|+||+||++|+|++|+.||...+.......+... +.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~~--- 226 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---PT--- 226 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---CC---
Confidence 7543211 11234578889999998764 4899999999999999999999999766544433322110 00
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCc
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~ 378 (429)
...++..+++.+.+|| +||..+|++|||+.++++||||.
T Consensus 227 ---------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ---------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ---------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0112234688899999 68889999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=314.67 Aligned_cols=252 Identities=26% Similarity=0.469 Sum_probs=199.6
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
+|+..+.||+|+||.||++.+..+++.||+|++.... ....+|+++++.++|+||+++++++ ...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 3888899999999999999999999999999886422 3345799999999999999999988 334
Q ss_pred eEEEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
...++|+||+.+. |.+.+. ....+++..+..++.||+.||.||| ++|++|+||||+||+++.++..+||+|||.
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH-~~~i~H~~i~~~nil~~~~~~~~~l~dfg~ 150 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLH-ENQIIHRDVKGANLLIDSTGQRLRIADFGA 150 (268)
T ss_pred CeEEEEEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence 4588999999864 444433 2457899999999999999999999 889999999999999987776799999999
Q ss_pred ceecccCCC-----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 241 AKVLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 241 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+........ .....+|..|+|||.+.+. .++.++|+||+||++|+|++|..||...+.......+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 226 (268)
T cd06630 151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA--- 226 (268)
T ss_pred ccccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---
Confidence 876643311 1234578889999998664 4889999999999999999999999755433332222221000
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCc
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~ 378 (429)
.....++..+++++.+++.+||..+|.+|||+.++++||||+
T Consensus 227 ---------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 ---------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ---------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 000112334789999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=343.57 Aligned_cols=278 Identities=22% Similarity=0.296 Sum_probs=196.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCC-cEEEEE------------------Eeecc---hhhhHHHHHHHHHcCCCCee
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETG-ETVAIK------------------KVLQD---KRYKNRELQTMRLLDHPNVV 147 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~-~~vaiK------------------~~~~~---~~~~~~E~~~l~~l~h~niv 147 (429)
..+|++++.||+|+||+||+|..+... ..+++| .+... ...+.+|+.+++.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 457999999999999999998764322 222222 11111 12345799999999999999
Q ss_pred ecceEeeecCCCCceEEEEEEeccchhHHHHHHHhh-hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe
Q 014174 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYS-RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV 226 (429)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill 226 (429)
++++++.. ..+.++|++++.++++..+.... ..........++.++.||+.||.||| ++||+||||||+|||+
T Consensus 227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH-~~gIiHrDLKP~NILl 300 (501)
T PHA03210 227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH-DKKLIHRDIKLENIFL 300 (501)
T ss_pred cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEE
Confidence 99998843 33478899999887777654311 11233456778889999999999999 8899999999999999
Q ss_pred cCCCCcEEEeecccceecccCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCC--CChHH
Q 014174 227 NPHTHQVKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL-FPG--ESGVD 301 (429)
Q Consensus 227 ~~~~~~vkl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~--~~~~~ 301 (429)
+.++ .+||+|||+++....... .....||..|+|||++.+. .++.++|||||||++|+|++|..+ |.. .....
T Consensus 301 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 301 NCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred CCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 9888 799999999987654332 2345789999999999764 489999999999999999998854 432 23345
Q ss_pred HHHHHHHHhCCCCHHH-------HhhcCcCcccccCCCcCCCCcccc-cCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 302 QLVEIIKVLGTPTREE-------IKCMNPNYTEFKFPQIKAHPWHKI-FHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 302 ~~~~i~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+.+++..++....+. +..+. ...+.... ...... -...++.++.++|.+||++||.+|||+.|+|+
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~----~~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYID----SAEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhh----hhhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 5555555544332211 00000 00000000 000000 11246788999999999999999999999999
Q ss_pred CCCCccc
Q 014174 374 HPFFYEL 380 (429)
Q Consensus 374 hp~f~~~ 380 (429)
||||...
T Consensus 454 hp~f~~~ 460 (501)
T PHA03210 454 LPLFSAE 460 (501)
T ss_pred ChhhhcC
Confidence 9999764
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=315.99 Aligned_cols=256 Identities=27% Similarity=0.397 Sum_probs=200.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHc-CCCCeeecceEeeecCC-CCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD-KDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~~~ 165 (429)
+.|++.+.||.|+||.||+|++..+++.||+|++.... .....|+.+++.+ +|+||+++++++..... ....+.+
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 46999999999999999999999999999999885442 3345688888888 79999999998864322 2345688
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++|||+++ ++.+++.. .....+++..+..++.||+.||.||| +.||+|+||||+||+++.++ .++|+|||++...
T Consensus 96 iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~al~~LH-~~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~ 171 (282)
T cd06636 96 LVMEFCGAGSVTDLVKN--TKGNALKEDWIAYICREILRGLAHLH-AHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL 171 (282)
T ss_pred EEEEeCCCCcHHHHHHH--ccCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEeeCcchhhh
Confidence 99999986 55555543 12355889999999999999999999 88999999999999999888 7999999998754
Q ss_pred ccC-CCcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 245 VKG-EPNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 245 ~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
... .......|+..|+|||.+.. ...++.++|+|||||++|+|++|..||...........+... .
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~------ 242 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P------ 242 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---C------
Confidence 322 12234568889999998753 234788999999999999999999999765443332221110 0
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
. .......++.++.+||++||..||.+|||+.++++||||
T Consensus 243 ----------~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 243 ----------P--------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ----------C--------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 0 001123468999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=329.60 Aligned_cols=246 Identities=30% Similarity=0.515 Sum_probs=208.3
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEec
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF 170 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 170 (429)
++||+|-||+||-|+++++|+.||||++.+. ......|+.||+.+.||.||.+.-.| +....+++|||-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~ervFVVMEK 644 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERVFVVMEK 644 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceEEEEehh
Confidence 6999999999999999999999999998543 34556899999999999999997666 333458899999
Q ss_pred cchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC--CcEEEeecccceecccCC
Q 014174 171 VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVLVKGE 248 (429)
Q Consensus 171 ~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~--~~vkl~DfG~a~~~~~~~ 248 (429)
+.|+.++.+... ..+++++...++++.||+.||.||| .++|+|+||||+|||+.+.. -++||||||.|+...+..
T Consensus 645 l~GDMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH-~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 645 LHGDMLEMILSS--EKGRLPERITKFLVTQILVALRYLH-FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hcchHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhh-hcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 999988877653 3578999999999999999999999 88999999999999996432 379999999999998888
Q ss_pred CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 014174 249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYTE 327 (429)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 327 (429)
...+.+||+.|+|||++.. +.|...-|+||.|+|+|.-+.|..||..... .++++.. .
T Consensus 722 FRrsVVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA--------------------a 780 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA--------------------A 780 (888)
T ss_pred hhhhhcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhhcc--------------------c
Confidence 8888999999999999976 5599999999999999999999999965432 2232211 1
Q ss_pred ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
+- ++..+|. .+++++.|||..+|+..-.+|.|....|.|||+++
T Consensus 781 FM---yPp~PW~-----eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 781 FM---YPPNPWS-----EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred cc---cCCCchh-----hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 11 1233443 47999999999999999999999999999999976
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=320.04 Aligned_cols=254 Identities=28% Similarity=0.409 Sum_probs=202.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++. ...+.++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEEE
Confidence 47999999999999999999999999999999885432 33457899999999999999999884 3445889
Q ss_pred EEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||++++ +...+. ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++....
T Consensus 94 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH-~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~ 166 (297)
T cd06656 94 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT 166 (297)
T ss_pred eecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEECcCccceEcc
Confidence 99999864 433332 246889999999999999999999 88999999999999999887 79999999987654
Q ss_pred cCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+.. .+.+.
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~---------- 234 (297)
T cd06656 167 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPE---------- 234 (297)
T ss_pred CCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCCC----------
Confidence 3322 223467889999999866 4488999999999999999999999976554322211110 00000
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
...+..++..+.+|+.+||..||.+|||+.++++||||...+..
T Consensus 235 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 235 ---------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred ---------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 01123468899999999999999999999999999999876643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=314.17 Aligned_cols=246 Identities=30% Similarity=0.501 Sum_probs=197.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------------hhhHHHHHHHHHcCCCCeeecceEeeecCC
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 158 (429)
+|.+.+.||.|+||.||+|.+..++..||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence 4788899999999999999998899999999875321 234578999999999999999998743
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEee
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD 237 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~D 237 (429)
..+.++||||+++ ++...+. ....+++..+..++.|++.||.||| +.|++||||+|+||+++.++ .++|+|
T Consensus 78 --~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH-~~~ivH~di~p~nil~~~~~-~~~l~d 149 (267)
T cd06628 78 --ADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLH-NRGIIHRDIKGANILVDNKG-GIKISD 149 (267)
T ss_pred --CCccEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHH-hcCcccccCCHHHEEEcCCC-CEEecc
Confidence 3457899999976 4444443 2467899999999999999999999 88999999999999999887 799999
Q ss_pred cccceecccCCC-------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014174 238 FGSAKVLVKGEP-------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310 (429)
Q Consensus 238 fG~a~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 310 (429)
||.++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+....+..+...
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~- 227 (267)
T cd06628 150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN- 227 (267)
T ss_pred cCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc-
Confidence 999877642211 1123578889999998664 4788999999999999999999999876554443332220
Q ss_pred CCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.. ..++..++..+.++|++||+.||.+||++.++++||||
T Consensus 228 ------------------~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 228 ------------------AS---------PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ------------------CC---------CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 00 01223478999999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=315.40 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=202.7
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
+|++.+.||.|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++.. ..++++
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~ 76 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKLWI 76 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeEEE
Confidence 6899999999999999999999999999999886432 234579999999999999999998743 346889
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
|+||+.+ ++.+.+.. ..+++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||+++...
T Consensus 77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~ 149 (274)
T cd06609 77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLH-EEGKIHRDIKAANILLSEEG-DVKLADFGVSGQLT 149 (274)
T ss_pred EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCC-CEEEcccccceeec
Confidence 9999986 44444332 37899999999999999999999 88999999999999999887 79999999998765
Q ss_pred cC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
.. .......++..|+|||.+.+.. ++.++|||||||++|+|+||..||...+.......+....
T Consensus 150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-------------- 214 (274)
T cd06609 150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN-------------- 214 (274)
T ss_pred ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--------------
Confidence 43 2233456788899999997654 8999999999999999999999997765443333222210
Q ss_pred cccccCCCcCCCCcccccCCC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~-~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
.+ .+... ++.++.+++.+||..+|++|||+.++++||||.+..
T Consensus 215 -----~~---------~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 215 -----PP---------SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred -----CC---------CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 00 01112 688999999999999999999999999999997643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=314.51 Aligned_cols=251 Identities=27% Similarity=0.377 Sum_probs=196.8
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.+|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++||||+++++++.. ....++
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~i 83 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLWI 83 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEEE
Confidence 3699999999999999999999999999999988643 2334579999999999999999998843 335789
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+++ +|.+.+. ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~ 157 (267)
T cd06646 84 CMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLH-SKGKMHRDIKGANILLTDNG-DVKLADFGVAAKIT 157 (267)
T ss_pred EEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEECCCC-CEEECcCccceeec
Confidence 9999986 4444443 2457899999999999999999999 88999999999999999887 69999999998664
Q ss_pred cCC-CcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 246 KGE-PNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 246 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
... ......++..|+|||.+.. ...++.++|+||+||++|+|++|..||...+.......+...
T Consensus 158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~------------- 224 (267)
T cd06646 158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS------------- 224 (267)
T ss_pred ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------------
Confidence 322 2234567889999998742 234678999999999999999999999654332221111110
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~ 376 (429)
.+..+.. .....++..+.+||++||..+|++|||+.++++|+|
T Consensus 225 ----~~~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 225 ----NFQPPKL-------KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ----CCCCCCC-------ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 0000000 011246889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=307.86 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=201.2
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|.+.+.||+|++|.||+|.+..+++.|++|.+... .....+|+++++.++||||+++++++. .....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence 488999999999999999999999999999987532 233446899999999999999999884 334688
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+.+ ++.+.+... ....+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .++|+|||++...
T Consensus 76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH-~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~ 151 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLH-SKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL 151 (256)
T ss_pred EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcceEEEeCCC-CEEEcccccceec
Confidence 99999974 555554432 2457899999999999999999999 88999999999999999887 7999999998876
Q ss_pred ccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
..... .....++..|+|||++.+. .++.++|+|||||++++|++|+.||...+.......+....
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 217 (256)
T cd08529 152 SDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV------------- 217 (256)
T ss_pred cCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 44332 2234678899999998764 48899999999999999999999998777544444332210
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.+ .++..++..+.++|.+||+.+|++||++.++++|||+
T Consensus 218 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 218 ------FP---------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------CC---------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00 1122468899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=311.53 Aligned_cols=247 Identities=28% Similarity=0.457 Sum_probs=196.6
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+.... ....+|+.+++.++|+||+++++++. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cC
Confidence 488899999999999999986 578999999875321 23457999999999999999999883 34
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
.+.++|+||+++ +|...+. ....+++..+..++.|++.||.||| +.||+|+||+|+||++++++ .++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~ 148 (265)
T cd06631 75 NTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLH-NNCVVHRDIKGNNVMLMPNG-IIKLIDFGC 148 (265)
T ss_pred CeEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcCHHhEEECCCC-eEEeccchh
Confidence 568899999986 4444332 2356899999999999999999999 88999999999999999887 799999999
Q ss_pred ceecccC-------CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014174 241 AKVLVKG-------EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313 (429)
Q Consensus 241 a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 313 (429)
+...... .......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+.......+....+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~- 226 (265)
T cd06631 149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL- 226 (265)
T ss_pred hHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-
Confidence 8754211 112234578899999998664 4889999999999999999999999776544433222221000
Q ss_pred CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
...++..++.++.+||++||..+|.+|||+.++++||||
T Consensus 227 -------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 -------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 011234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=311.03 Aligned_cols=250 Identities=28% Similarity=0.429 Sum_probs=200.9
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch--hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
++|++.+.||+|+||.||+|.+..++..||+|.+.... ....+|+++++.++|+||+++++++.. ..++++++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEEE
Confidence 46999999999999999999998889999999886543 445689999999999999999998843 34588999
Q ss_pred eccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||++++ +.+.+. .....+++..+..++.|++.||.||| +.||+|+||+|+||+++.++ .++|+|||++......
T Consensus 78 e~~~~~~L~~~l~---~~~~~l~~~~~~~~~~~l~~~l~~lh-~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 78 EYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLH-SNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDT 152 (256)
T ss_pred ecCCCCcHHHHHH---hCccCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcceEEECCCC-cEEEcccccchhcccC
Confidence 999864 444332 22467899999999999999999999 88999999999999999888 7999999998876443
Q ss_pred C-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 E-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
. ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+.......+... .
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~--------------~-- 215 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK--------------P-- 215 (256)
T ss_pred ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC--------------C--
Confidence 3 22334578889999998664 5899999999999999999999999765543322211110 0
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.+ ....+..++.++.++|.+||+.||++|||+.++|+||||
T Consensus 216 ---~~-------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 216 ---PP-------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ---CC-------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00 000123467899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=309.66 Aligned_cols=248 Identities=35% Similarity=0.538 Sum_probs=200.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
+|+..+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++. ...
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence 4788899999999999999998899999999875422 33457999999999999999998873 334
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++|+||+++ ++.+.+. ....+++..+..++.||+.||.||| +.||+|+||+|+||+++.++ .+||+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~ 149 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLH-DRNTVHRDIKGANILVDTNG-VVKLADFGMA 149 (258)
T ss_pred eEEEEEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEccCccc
Confidence 58899999985 4444433 2456899999999999999999999 88999999999999999887 7999999998
Q ss_pred eecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.............++..|+|||.+.....++.++|+|||||++|+|++|+.||...........+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~---------- 219 (258)
T cd06632 150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE---------- 219 (258)
T ss_pred eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc----------
Confidence 8765444334566788999999986543478999999999999999999999976654333333221100
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.+ .++..+++.+.+|+++||+.+|.+|||+.+++.|||+
T Consensus 220 --------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 220 --------LP---------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred --------CC---------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 00 1233478999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=307.61 Aligned_cols=253 Identities=26% Similarity=0.445 Sum_probs=203.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||.|+||.||+|.+..++..||+|.+... ......|+.+++.++|+||+++++++.. ......+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence 489999999999999999999999999999988532 1234468999999999999999887753 2334578
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH----cCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
++|||+++ ++.+.+.........+++..+..++.||+.||.||| .+.+|+|+||||+||+++.++ .+||+|||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g~ 156 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGL 156 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEecccc
Confidence 99999974 566666554444578999999999999999999999 134799999999999999887 799999999
Q ss_pred ceecccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 241 AKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 241 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
+........ .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------- 225 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG---------- 225 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC----------
Confidence 987654443 33456889999999986644 889999999999999999999999877643333222210
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.. ..++..++..+.+|+.+||..+|.+|||+.++++|||+
T Consensus 226 ---------~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 226 ---------KF---------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ---------CC---------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 00 01233578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=308.99 Aligned_cols=253 Identities=27% Similarity=0.387 Sum_probs=200.5
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.+|++.+.||.|+||.||+|.+..++..+|+|.+... .....+|+.+++.++||||+++++++.. ...+++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence 4699999999999999999999999999999988653 2345679999999999999999998843 345889
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
+|||++++.+..+.. .....+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .+||+|||++.....
T Consensus 78 ~~e~~~~~~l~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lh-~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~ 153 (262)
T cd06613 78 VMEYCGGGSLQDIYQ--VTRGPLSELQIAYVCRETLKGLAYLH-ETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTA 153 (262)
T ss_pred EEeCCCCCcHHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCChhhEEECCCC-CEEECccccchhhhh
Confidence 999999644433221 22367999999999999999999999 88999999999999999887 799999999876543
Q ss_pred CC-CcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 247 GE-PNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.. ......++..|+|||.+.+. ..++.++|+|||||++|+|++|..||...+.......+....-.+.
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~--------- 224 (262)
T cd06613 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP--------- 224 (262)
T ss_pred hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc---------
Confidence 22 22345678889999998654 2478899999999999999999999987765544433322100000
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~ 376 (429)
. .......+.++.+||++||..+|.+|||+.+++.|||
T Consensus 225 --------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 --------K-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred --------c-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 0 0011235788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=314.79 Aligned_cols=251 Identities=26% Similarity=0.387 Sum_probs=197.8
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
++|.+.+.||+|+||.||+|++..+++.||+|.+.... ....+|+.+++.++||||+++++++.. ..++++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEEE
Confidence 46999999999999999999999999999999886432 234579999999999999999998843 345889
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+++ +|.+++. ..+.+++..++.++.|++.||.||| +.||+|+||||+||+++.++ .+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~ 157 (267)
T cd06645 84 CMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLH-SKGKMHRDIKGANILLTDNG-HVKLADFGVSAQIT 157 (267)
T ss_pred EEeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEECcceeeeEcc
Confidence 9999985 5544443 2467999999999999999999999 88999999999999999887 79999999987654
Q ss_pred cCC-CcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 246 KGE-PNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 246 ~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
... ......|+..|+|||.+.. ...++.++|+|||||++|+|++|..||...............
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~------------- 224 (267)
T cd06645 158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS------------- 224 (267)
T ss_pred CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhcc-------------
Confidence 322 2234568999999998742 234788999999999999999999999765443332221110
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~ 376 (429)
+ ...+.. . ....++..+.+||.+||+.||++|||+.++++|||
T Consensus 225 -~---~~~~~~-----~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 225 -N---FQPPKL-----K--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -C---CCCCcc-----c--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 0 000000 0 01136788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=332.15 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=201.9
Q ss_pred EEeeEEccCCceEEEEEEEcCCCcEEEEEEee-----cc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVL-----QD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 94 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-----~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+...+||+|+|-+||+|.|..+|..||.-.++ +. ...+..|+.+|+.|+|+|||++|..|.+... .++.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---KTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---ceee
Confidence 34568999999999999999999999854332 22 2455679999999999999999999876443 5577
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+|+|.+.. +|.. |....++++...++.|++||++||.|||++ --|||||||.+||+|+.+.+.|||+|+|+|..
T Consensus 120 ~iTEL~TSGtLr~----Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 120 FITELFTSGTLRE----YRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeecccCCcHHH----HHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 89999985 4443 344567899999999999999999999942 25999999999999998888999999999987
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
..... ..+.+|||.|||||++. ..|+..+||||||++|+||+|+..||..-....++.+.+-. |..+...
T Consensus 196 ~r~s~-aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S-GiKP~sl------ 265 (632)
T KOG0584|consen 196 LRKSH-AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS-GIKPAAL------ 265 (632)
T ss_pred hhccc-cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc-CCCHHHh------
Confidence 65443 34589999999999985 56999999999999999999999999876666655543331 2222111
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
.+--.+++++||.+||.. .++|+|+.|+|+||||..-
T Consensus 266 -------------------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 266 -------------------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred -------------------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 111368999999999999 9999999999999999873
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=309.25 Aligned_cols=249 Identities=29% Similarity=0.456 Sum_probs=197.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
+|++.+.||+|+||.||++.+..++..||||.+... .....+|+.+++.++|+||+++++++... ...
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 79 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---MER 79 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CCc
Confidence 599999999999999999999999999999987532 12345699999999999999999987432 234
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++||||+++ +|.+.+. ....+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .++|+|||++
T Consensus 80 ~~~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~ 153 (265)
T cd06652 80 TLSIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLH-SNMIVHRDIKGANILRDSVG-NVKLGDFGAS 153 (265)
T ss_pred eEEEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEecCCC-CEEECcCccc
Confidence 57899999985 4544433 2356889999999999999999999 88999999999999999887 7999999998
Q ss_pred eecccCC----CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 242 KVLVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 242 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
....... ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||...+......++.. .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~--- 226 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QPT--- 226 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CCC---
Confidence 7643211 12234578899999998664 489999999999999999999999976654444332221 110
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCc
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~ 378 (429)
...++..++..+.++|++||. +|.+|||+.++++|||+.
T Consensus 227 ---------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 ---------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ---------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 011233468889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.53 Aligned_cols=245 Identities=29% Similarity=0.472 Sum_probs=197.4
Q ss_pred EccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
||.|+||.||+|++..++..||+|++.... ....+|+.+++.++|+||+++++.+. ...++++|+||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence 689999999999999999999999886432 33457999999999999999999874 334588999999
Q ss_pred ch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCc
Q 014174 172 PE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 250 (429)
Q Consensus 172 ~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~ 250 (429)
++ +|.+.+.. ...+++..+..++.||+.||.||| +.|++|+||||+||+++.++ .++|+|||++.........
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH-~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~ 149 (262)
T cd05572 76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLH-NRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKT 149 (262)
T ss_pred CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccccc
Confidence 75 55444432 356899999999999999999999 89999999999999999888 7999999999876554333
Q ss_pred ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 014174 251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES--GVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328 (429)
Q Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.... .......+.....
T Consensus 150 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------- 211 (262)
T cd05572 150 WTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG----------------- 211 (262)
T ss_pred ccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC-----------------
Confidence 445678899999998654 48899999999999999999999998765 3233322221000
Q ss_pred cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCC
Q 014174 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRD 382 (429)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~ 382 (429)
...++...++++.++|.+||..||.+|+| +.|+++||||.++.+
T Consensus 212 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 212 ----------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred ----------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 01122345889999999999999999999 999999999998765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=310.98 Aligned_cols=246 Identities=29% Similarity=0.455 Sum_probs=201.0
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|++.+.||.|+||.||+|.+..++..||+|.+.+.. ....+|+++++.++||||+++++++ ....+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 4899999999999999999999999999999886432 3345789999999999999999887 444568
Q ss_pred EEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++|+||+.++ |...+.. ...+++..+..++.||+.||.||| +.|++|+||+|+||+++.++ .++|+|||++..
T Consensus 76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh-~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~ 149 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLH-SKGIIHRDIKPDNILLDEQG-HVHITDFNIATK 149 (258)
T ss_pred EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeEEcCCC-CEEEeecccccc
Confidence 9999999864 3333322 357899999999999999999999 88999999999999999888 799999999877
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHhhc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV--DQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~ 321 (429)
...........++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.. ..+......
T Consensus 150 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 216 (258)
T cd05578 150 VTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------------ 216 (258)
T ss_pred cCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------------
Confidence 65443344566788999999986644 899999999999999999999999876642 222111110
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH--HHHhcCCCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA--LEACIHPFF 377 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~--~ell~hp~f 377 (429)
....++..++..+.++|++||..||.+|+++ .|+++||||
T Consensus 217 ----------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 217 ----------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ----------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 0111334578999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=317.41 Aligned_cols=255 Identities=29% Similarity=0.408 Sum_probs=202.6
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.|.....||+|+||.||++.+..++..||||.+... .....+|+.+++.++|+||+++++.+.. ..+.++|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-----GDELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-----CCeEEEE
Confidence 355567899999999999999999999999987543 2334579999999999999999998743 3458899
Q ss_pred EeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
|||++++.+..+.. ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++|+|||++......
T Consensus 98 ~e~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 98 MEFLEGGALTDIVT----HTRMNEEQIATVCLSVLRALSYLH-NQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKE 171 (292)
T ss_pred EeCCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccc
Confidence 99998754433321 346899999999999999999999 88999999999999999887 7999999998754322
Q ss_pred C-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 E-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
. ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+....+..+.......
T Consensus 172 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 237 (292)
T cd06658 172 VPKRKSLVGTPYWMAPEVISRL-PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR------------- 237 (292)
T ss_pred cccCceeecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-------------
Confidence 2 12345678899999998654 48899999999999999999999998766555443332211000
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
. .....++..+.+||.+||..||++|||+.++++||||.....|.
T Consensus 238 ---~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 238 ---V----------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred ---c----------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 0 01123688999999999999999999999999999998877664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=312.49 Aligned_cols=252 Identities=27% Similarity=0.381 Sum_probs=197.9
Q ss_pred EccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
||+|+||+||+|.+..+|+.||+|.+.... ....+|+++++.++||||+++++.+ ......|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 689999999999999999999999885421 2234699999999999999999887 3334588999999
Q ss_pred ch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCc
Q 014174 172 PE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 250 (429)
Q Consensus 172 ~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~ 250 (429)
++ +|...+... ....+++..+..++.|++.||.||| +.|++||||+|+||+++.++ .+||+|||++.........
T Consensus 76 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH-~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~ 151 (277)
T cd05577 76 NGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLH-QRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKI 151 (277)
T ss_pred CCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCcc
Confidence 85 444444321 2246899999999999999999999 88999999999999999888 7999999998765443333
Q ss_pred ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccC
Q 014174 251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330 (429)
Q Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
....++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||...........+....-
T Consensus 152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------- 211 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL------------------- 211 (277)
T ss_pred ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-------------------
Confidence 4456788899999987655 88999999999999999999999976554222111111000
Q ss_pred CCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCCCC
Q 014174 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDPNA 385 (429)
Q Consensus 331 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~~~ 385 (429)
.....++..+++.+.++|++||+.||.+|| ++.++++||||.++.+...
T Consensus 212 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~ 265 (277)
T cd05577 212 ------EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRL 265 (277)
T ss_pred ------cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhh
Confidence 000112334689999999999999999999 8999999999988776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=306.27 Aligned_cols=248 Identities=27% Similarity=0.455 Sum_probs=201.5
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|+||.||++++..+|+.||+|.+... .....+|+.+++.++|+||+++++++ ....+.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 489999999999999999999999999999988532 12455799999999999999999988 4445688
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+|+||+.+ ++.+.+.. .....+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||++...
T Consensus 76 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~ 151 (256)
T cd08218 76 IVMDYCEGGDLYKKINA--QRGVLFPEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVL 151 (256)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence 99999975 55554432 12346789999999999999999999 88999999999999999887 7999999999766
Q ss_pred ccCCCc-ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGEPN-ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
...... ....++..|+|||.+.+.. .+.++|+|||||++++|++|..||...+..+....+... ..
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~---------- 218 (256)
T cd08218 152 NSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SY---------- 218 (256)
T ss_pred CcchhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--CC----------
Confidence 443221 2345788899999986644 788999999999999999999999876655554443321 00
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
+ ..+..++.++.++|.+||..+|.+||++.++++||||
T Consensus 219 -------~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 219 -------P---------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -------C---------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0 1123468999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=312.23 Aligned_cols=240 Identities=17% Similarity=0.204 Sum_probs=191.4
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEe
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
..||+|++|.||+|.. +|+.||||.+.... ..+.+|+.++++++||||+++++++.... ....++++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5799999999999987 78999999886432 33458999999999999999999885422 22345789999
Q ss_pred ccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC
Q 014174 170 FVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248 (429)
Q Consensus 170 ~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~ 248 (429)
|++++ |.+.+. ..+.+++.....++.|++.||.|||+..+++||||||+|||++.++ .+||+|||+++.....
T Consensus 103 y~~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~- 176 (283)
T PHA02988 103 YCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSP- 176 (283)
T ss_pred eCCCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhccc-
Confidence 99965 444443 2467899999999999999999999435999999999999999888 7999999998765332
Q ss_pred CcccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 014174 249 PNISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327 (429)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 327 (429)
.....+|..|+|||++.+. ..++.++|||||||++|+|++|..||.+.+..+....+......+
T Consensus 177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 241 (283)
T PHA02988 177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL-------------- 241 (283)
T ss_pred -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence 2345678899999998652 458999999999999999999999998876655554443311100
Q ss_pred ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.++...++.+.+||.+||+.||++|||+.++++
T Consensus 242 -------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 242 -------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 122246899999999999999999999999985
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=310.73 Aligned_cols=265 Identities=25% Similarity=0.410 Sum_probs=201.3
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
+|+..+.||.|++|.||+|.+..+++.||+|.+.... ....+|+++++.++||||+++++++... ....+++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~l 78 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIGI 78 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEEE
Confidence 5899999999999999999999999999999886432 2345799999999999999999987542 2335789
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+++ +|.+++.........+++..+..++.||+.||.||| +.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH-~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~ 156 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH-SRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV 156 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence 9999975 555555444444567899999999999999999999 88999999999999999887 79999999987654
Q ss_pred cCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
.... ....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...... ...............
T Consensus 157 ~~~~-~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 225 (287)
T cd06621 157 NSLA-GTFTGTSFYMAPERIQGK-PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN--------- 225 (287)
T ss_pred cccc-ccccCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc---------
Confidence 3322 234568889999988654 4889999999999999999999999765220 000011111100000
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
+...... ......++.+.+||.+||..||++|||+.|+++||||....
T Consensus 226 ------~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 226 ------PELKDEP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred ------hhhccCC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 0000000 00012467899999999999999999999999999995533
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.84 Aligned_cols=250 Identities=28% Similarity=0.498 Sum_probs=199.8
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+++++.++||||+++++.+.. ....++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEE
Confidence 5888999999999999999999999999999886542 234578999999999999999998843 345889
Q ss_pred EEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 167 VLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 167 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
|+||++ ++|.+++.. ....+++..+..++.|++.||.||| + .|++|+||||+||+++.++ .++|+|||.+...
T Consensus 77 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~ 151 (265)
T cd06605 77 CMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLH-EKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQL 151 (265)
T ss_pred EEEecCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHc-CCCCeecCCCCHHHEEECCCC-CEEEeecccchhh
Confidence 999999 555555443 1267899999999999999999999 7 8999999999999999887 7999999998765
Q ss_pred ccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCCHHHHh
Q 014174 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG-----VDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~ 319 (429)
...... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+. .+.+..+.. .+
T Consensus 152 ~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~------ 220 (265)
T cd06605 152 VNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN---EP------ 220 (265)
T ss_pred HHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc---CC------
Confidence 433222 26678899999998664 589999999999999999999999965421 111111111 00
Q ss_pred hcCcCcccccCCCcCCCCcccccCC-CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
.+. .+. .++.++.+||.+||..||.+|||+.+++.||||+.+.
T Consensus 221 ----------~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 221 ----------PPR---------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred ----------CCC---------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 000 111 1688999999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=314.86 Aligned_cols=253 Identities=29% Similarity=0.491 Sum_probs=201.0
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+|.+.+.||+|+||.||++.+..+++.||+|.+.... ....+|+++++.++||||+++++.+ ....++
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence 5999999999999999999999999999999886432 2334789999999999999999887 344468
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+++ ++...+. ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||+++.
T Consensus 77 ~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~ 150 (305)
T cd05609 77 CMVMEYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLH-NYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKI 150 (305)
T ss_pred EEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCchHHEEECCCC-CEEEeeCCCccc
Confidence 999999986 4444443 2457899999999999999999999 88999999999999999887 799999999864
Q ss_pred cccCC----------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014174 244 LVKGE----------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307 (429)
Q Consensus 244 ~~~~~----------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~ 307 (429)
..... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||.+.+..+....+.
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred cCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 21110 00123567889999998664 48999999999999999999999998776554444333
Q ss_pred HHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCCcccCC
Q 014174 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACIHPFFYELRD 382 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t---~~ell~hp~f~~~~~ 382 (429)
... ...+. ....++.++.+||.+||..||++||| +.++|+||||...++
T Consensus 230 ~~~-----------------~~~~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 230 SDD-----------------IEWPE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred hcc-----------------cCCCC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 210 00000 01236899999999999999999998 799999999977554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=326.35 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=223.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..+..++..||-|+||.|=+++.......+|+|++++. .+....|-+||..++.|+||++|..| .+..
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccch
Confidence 34678889999999999999987666556999987643 23445689999999999999999998 7788
Q ss_pred EEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
|+|++||-|- |.+|.++. ..+.|.+.++++++..+++|++||| ++|||+|||||+|++++.+| -+||.|||+|
T Consensus 494 yvYmLmEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH-~k~iIYRDLKPENllLd~~G-y~KLVDFGFA 567 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLH-RKGIIYRDLKPENLLLDNRG-YLKLVDFGFA 567 (732)
T ss_pred hhhhhHHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHH-hcCceeccCChhheeeccCC-ceEEeehhhH
Confidence 8999999875 56666554 3688999999999999999999999 99999999999999999998 7999999999
Q ss_pred eecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
+....+...-++|||+.|.|||++... ..+.++|.||||+++|||++|.+||.+.+.+..+..|.+.+.
T Consensus 568 Kki~~g~KTwTFcGTpEYVAPEIILnK-GHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid---------- 636 (732)
T KOG0614|consen 568 KKIGSGRKTWTFCGTPEYVAPEIILNK-GHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID---------- 636 (732)
T ss_pred HHhccCCceeeecCCcccccchhhhcc-CcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh----------
Confidence 999999888899999999999999874 489999999999999999999999999999999998887531
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCCCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRDPN 384 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~~~ 384 (429)
.+. +|..++..+.+||+++...+|.+|+. +.+|-+|.||..+.|..
T Consensus 637 -----~i~------------~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweg 687 (732)
T KOG0614|consen 637 -----KIE------------FPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEG 687 (732)
T ss_pred -----hhh------------cccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhh
Confidence 111 34468899999999999999999995 88999999998877753
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=304.22 Aligned_cols=248 Identities=32% Similarity=0.480 Sum_probs=203.0
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||.|+||.||.+++..+++.+++|.+.... ....+|+.+++.++|+||+++++++.. ...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence 4999999999999999999999999999999875321 234579999999999999999999843 34588
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++|||+++ ++.+.+... ....+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .+||+|||++...
T Consensus 76 ~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~ 151 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIH-KAGILHRDIKTLNIFLTKAG-LIKLGDFGISKIL 151 (256)
T ss_pred EEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence 99999985 555554431 1356899999999999999999999 88999999999999999887 7999999999876
Q ss_pred ccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+... ...
T Consensus 152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~--------- 219 (256)
T cd08221 152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT--------- 219 (256)
T ss_pred ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------
Confidence 4433 223456789999999987644 788999999999999999999999877665555544321 000
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.....++.++.++|.+||..+|.+|||+.++++|||+
T Consensus 220 -----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 -----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0113468999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=311.70 Aligned_cols=248 Identities=25% Similarity=0.356 Sum_probs=189.4
Q ss_pred EEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHH---HcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMR---LLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.||+|+||.||++.+..+++.||+|.+.... ....+|..+++ ..+|+||+.+++.+.. ....++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence 4899999999999999999999999885432 11223443333 3479999999888743 3357899
Q ss_pred EeccchhHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~~l~-~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||+.++.+ ..+ .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++.....
T Consensus 76 ~e~~~~~~L~~~i----~~~~~l~~~~~~~i~~qi~~al~~lH-~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~ 149 (279)
T cd05633 76 LDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMH-NRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSK 149 (279)
T ss_pred EecCCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH-HCCcCCCCCCHHHEEECCCC-CEEEccCCcceeccc
Confidence 999986533 332 23467999999999999999999999 88999999999999999887 799999999875543
Q ss_pred CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
.. .....||..|+|||.+.....++.++|+||+||++|+|++|..||......... .+.....
T Consensus 150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~--------------- 212 (279)
T cd05633 150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL--------------- 212 (279)
T ss_pred cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh---------------
Confidence 32 234568999999998865455889999999999999999999999754322111 1111000
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDP 383 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~ 383 (429)
.....++..++.++.++|++||..||.+|+ |+.++++||||+.+...
T Consensus 213 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~ 264 (279)
T cd05633 213 ----------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQ 264 (279)
T ss_pred ----------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHh
Confidence 000112345789999999999999999999 69999999999886643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=307.86 Aligned_cols=252 Identities=31% Similarity=0.527 Sum_probs=197.2
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch--------------hhhHHHHHHHHHcCCCCeeecceEeeecC
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT 157 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 157 (429)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+.... ..+.+|+.+++.++|+|++++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--- 78 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--- 78 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence 5899999999999999999999899999999874311 13456899999999999999999873
Q ss_pred CCCceEEEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEe
Q 014174 158 DKDELYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~ 236 (429)
.....++||||++++ +.+.+. ....+++..++.++.||+.||.||| +.|++||||+|+||+++.++ .++|+
T Consensus 79 --~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~~~nil~~~~~-~~~l~ 150 (272)
T cd06629 79 --TEEYLSIFLEYVPGGSIGSCLR----TYGRFEEQLVRFFTEQVLEGLAYLH-SKGILHRDLKADNLLVDADG-ICKIS 150 (272)
T ss_pred --cCCceEEEEecCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHh-hCCeeecCCChhhEEEcCCC-eEEEe
Confidence 334578999999754 444333 2367899999999999999999999 88999999999999999887 79999
Q ss_pred ecccceecccCC---CcccccccccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014174 237 DFGSAKVLVKGE---PNISYICSRYYRAPELIFGAT-EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312 (429)
Q Consensus 237 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 312 (429)
|||++....... ......++..|+|||.+.... .++.++|+||||+++|+|++|..||...+....+..+....
T Consensus 151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-- 228 (272)
T cd06629 151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR-- 228 (272)
T ss_pred eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccc--
Confidence 999987653221 122345788899999986543 47889999999999999999999997555443332221100
Q ss_pred CCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
. .+ .+...+...++..+.+||.+||..+|.+|||+.++|+||||
T Consensus 229 -------------~---~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 229 -------------S---AP-----PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred -------------c---CC-----cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0 00 00111223468999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=304.45 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=200.4
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|.+.+.||+|+||.||+|.+..+|..||+|.+... .....+|+.+++.++|+||+++++++ ......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 489999999999999999999999999999988542 23445799999999999999999987 3444688
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+|+||+.+ ++.+.+.. .....+++..+..++.|++.||.||| +.+++|+||||+||+++.++..+||+|||.+...
T Consensus 76 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 76 IVMEYCDGGDLMKRINR--QRGVLFSEDQILSWFVQISLGLKHIH-DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred EEEecCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99999975 55444432 12335799999999999999999999 8899999999999999988656799999998766
Q ss_pred ccCCCc-ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGEPN-ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
...... ....|+..|+|||.+.+. .++.++|+||||+++++|++|..||...+..+....+....
T Consensus 153 ~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 218 (257)
T cd08225 153 NDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------- 218 (257)
T ss_pred cCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence 443222 234578889999988654 48899999999999999999999998766544443322110
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
. ..+...++.++.++|.+||..+|++|||+.++++||||
T Consensus 219 ------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ------F---------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ------C---------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0 01123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=304.36 Aligned_cols=250 Identities=33% Similarity=0.512 Sum_probs=203.2
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
+|++.+.||.|++|.||+|.+..+++.||+|++... .....+|+..++.++|+||+++++++.. ....++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-----EGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-----CCeEEE
Confidence 589999999999999999999999999999988654 2345679999999999999999998843 345889
Q ss_pred EEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 167 VLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 167 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
|+||++ ++|.+.+.. ...+++..+..++.|++.||.||| + .|++||||+|+||+++.++ .++|+|||.+...
T Consensus 77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh-~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~ 150 (264)
T cd06623 77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLH-TKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVL 150 (264)
T ss_pred EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHh-ccCCCccCCCCHHHEEECCCC-CEEEccCccceec
Confidence 999999 555555433 367899999999999999999999 7 9999999999999999887 7999999999876
Q ss_pred ccCCCcc-cccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHHHHhh
Q 014174 245 VKGEPNI-SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 245 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~~ 320 (429)
....... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... .+....+.. ..
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~------- 219 (264)
T cd06623 151 ENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GP------- 219 (264)
T ss_pred ccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CC-------
Confidence 5443332 45678899999998664 588999999999999999999999977642 222211111 00
Q ss_pred cCcCcccccCCCcCCCCcccccCCC-CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKR-MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
. ..++.. ++..+.++|.+||..+|++|||+.++++||||+...
T Consensus 220 ---------~---------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 220 ---------P---------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred ---------C---------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 0 011223 688999999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=313.69 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=201.8
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.|.+.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+++++.++||||+++++++... ...
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~~ 90 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HTA 90 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----CeE
Confidence 5999999999999999999999999999999885321 2345799999999999999999988543 347
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++|+||+.+++.+.+.. ....+++..+..++.||+.||.||| +.||+||||+|+||+++.++ .+||+|||++...
T Consensus 91 ~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH-~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~ 165 (307)
T cd06607 91 WLVMEYCLGSASDILEV---HKKPLQEVEIAAICHGALQGLAYLH-SHERIHRDIKAGNILLTEPG-TVKLADFGSASLV 165 (307)
T ss_pred EEEHHhhCCCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCcccEEECCCC-CEEEeecCcceec
Confidence 89999999887766543 2356899999999999999999999 88999999999999999888 7999999998764
Q ss_pred ccCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 245 VKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
... ....++..|+|||.+.+ ...++.++||||||+++|+|++|..||.+.+.......+... ..
T Consensus 166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~~---------- 231 (307)
T cd06607 166 SPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DS---------- 231 (307)
T ss_pred CCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-CC----------
Confidence 322 23467888999998742 244788999999999999999999999776654443322210 00
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
+.. ....++..+.+||.+||..||.+|||+.+++.||||..-.
T Consensus 232 --------~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 232 --------PTL--------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred --------CCC--------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 000 0123578899999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=322.71 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=190.6
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCC-----CcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeecCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 158 (429)
..+|.+.+.||+|+||.||+|++..+ +..||+|.+.... ....+|+.+++.+ +|+||+++++++.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~---- 112 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT---- 112 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec----
Confidence 44799999999999999999986543 3579999886432 2345799999999 8999999999884
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhh------------------------------------------------------
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYS------------------------------------------------------ 183 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~------------------------------------------------------ 183 (429)
....+++||||+.+ +|.+.+....
T Consensus 113 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 113 -HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred -CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 33458899999984 5544443211
Q ss_pred ------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCc-
Q 014174 184 ------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN- 250 (429)
Q Consensus 184 ------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~- 250 (429)
.....+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++........
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA-SKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH-HCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCccee
Confidence 01135788899999999999999999 88999999999999999777 7999999999765433221
Q ss_pred --ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 014174 251 --ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327 (429)
Q Consensus 251 --~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 327 (429)
....++..|+|||++.+. .++.++|||||||++|+|++ |..||........+........
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~---------------- 332 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY---------------- 332 (374)
T ss_pred eccCCCCccceeCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc----------------
Confidence 112345679999998654 48999999999999999997 9999987654443333322100
Q ss_pred ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..+++++.++|.+||+.||.+|||+.++++
T Consensus 333 -----------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 333 -----------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -----------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00112236899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=312.30 Aligned_cols=254 Identities=19% Similarity=0.254 Sum_probs=190.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcC----------------CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeec
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLE----------------TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL 149 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~ 149 (429)
++|++.++||+|+||.||+|.+.. ++..||+|.+.... ..+.+|+++++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 469999999999999999998532 34479999886532 234579999999999999999
Q ss_pred ceEeeecCCCCceEEEEEEeccch-hHHHHHHHhhh---------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 014174 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSR---------------ASQRMPLIYVKLYTYQICRALAYIHGGIG 213 (429)
Q Consensus 150 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~g 213 (429)
++++... ...++||||+.+ +|.+.+..... ....+++..+..++.||+.||.||| +.|
T Consensus 85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~ 158 (304)
T cd05096 85 LGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS-SLN 158 (304)
T ss_pred EEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH-HCC
Confidence 9988443 347899999975 55555533211 1134678889999999999999999 889
Q ss_pred eeeecCCCCceEecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-
Q 014174 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL- 289 (429)
Q Consensus 214 ivH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt- 289 (429)
|+||||||+|||++.++ .+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++
T Consensus 159 ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 159 FVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG-KFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred ccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC-CCCchhhhHHHHHHHHHHHHc
Confidence 99999999999999887 799999999976543321 1123347789999998664 48999999999999999987
Q ss_pred -CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH
Q 014174 290 -GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368 (429)
Q Consensus 290 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~ 368 (429)
+..||.+.+..+.+..+......... . .....+..++..+.+||.+||..||.+|||+
T Consensus 237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~-----------~----------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 295 (304)
T cd05096 237 CKEQPYGELTDEQVIENAGEFFRDQGR-----------Q----------VYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295 (304)
T ss_pred cCCCCCCcCCHHHHHHHHHHHhhhccc-----------c----------ccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence 56788776655544433322100000 0 0000123468899999999999999999999
Q ss_pred HHHhc
Q 014174 369 LEACI 373 (429)
Q Consensus 369 ~ell~ 373 (429)
.++.+
T Consensus 296 ~~i~~ 300 (304)
T cd05096 296 SDIHA 300 (304)
T ss_pred HHHHH
Confidence 99954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=314.15 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=201.9
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
|.....||+|+||.||+|.+..+++.||+|.+... .....+|+.+++.++||||+++++++.. ....++|+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEE
Confidence 44556899999999999999999999999988532 2334578999999999999999998843 34588999
Q ss_pred eccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC
Q 014174 169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248 (429)
Q Consensus 169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~ 248 (429)
||++++.+..+.. ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++.......
T Consensus 98 e~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH-~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 98 EFLQGGALTDIVS----QTRLNEEQIATVCESVLQALCYLH-SQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDV 171 (297)
T ss_pred ecCCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHeEEccCC-cEEEeechhHhhccccc
Confidence 9998654333221 256899999999999999999999 88999999999999999888 79999999986543322
Q ss_pred -CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 014174 249 -PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327 (429)
Q Consensus 249 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 327 (429)
......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...+..+.+..+... +.
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~------------- 234 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP------------- 234 (297)
T ss_pred ccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC-------------
Confidence 22345678999999998664 4899999999999999999999999876655544332210 00
Q ss_pred ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCC
Q 014174 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNA 385 (429)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~ 385 (429)
+. ......++..+.++|++||+.+|.+|||+.++++||||.+...+..
T Consensus 235 ---~~-------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~~~~ 282 (297)
T cd06659 235 ---PK-------LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPEC 282 (297)
T ss_pred ---CC-------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCCccc
Confidence 00 0011246889999999999999999999999999999987666544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=325.66 Aligned_cols=245 Identities=31% Similarity=0.445 Sum_probs=199.6
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
....|.+...+|.|+|+.|-.+.+..+++.+++|++.+......+|+.++... +||||+++.+.+ .+....++|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v 394 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV 394 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence 34579999999999999999999999999999999988766667788766655 799999999998 566668999
Q ss_pred EeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe-cCCCCcEEEeecccceeccc
Q 014174 168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill-~~~~~~vkl~DfG~a~~~~~ 246 (429)
||.+.+..+- .. .+. .+.....+..|++||+.|+.||| .+|+|||||||+|||+ ++.+ .++|+|||.++....
T Consensus 395 ~e~l~g~ell--~r-i~~-~~~~~~e~~~w~~~lv~Av~~LH-~~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 395 MELLDGGELL--RR-IRS-KPEFCSEASQWAAELVSAVDYLH-EQGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELER 468 (612)
T ss_pred ehhccccHHH--HH-HHh-cchhHHHHHHHHHHHHHHHHHHH-hcCeeecCCChhheeecCCCC-cEEEEEechhhhCch
Confidence 9999975322 22 222 23333778889999999999999 7999999999999999 4666 699999999987644
Q ss_pred CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
. ....+-|..|.|||++.. ..|+.++||||||++||+|++|+.||...... ..+...++.+..
T Consensus 469 ~--~~tp~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~~----------- 531 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPKF----------- 531 (612)
T ss_pred h--hcccchhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCcc-----------
Confidence 4 333456888999999974 55999999999999999999999999876555 223333332221
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
...+|.++++||++||+.||.+|+++.+++.||||
T Consensus 532 ----------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 ----------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ----------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 13489999999999999999999999999999999
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=303.64 Aligned_cols=283 Identities=34% Similarity=0.545 Sum_probs=221.8
Q ss_pred EEeeEEccCCceEEEEEEEcCCCcEEEEEEeec------chhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 94 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
+-.+.||-|+||.||.+.+..+|+.||+|++.. ......+|+++|..++|.|++..+++..-..-.--.-+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 334689999999999999999999999998843 23445689999999999999998876532211000014568
Q ss_pred EeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
+|.+..+|..++ -..+.++...++.+++||++||+||| +.||+||||||.|+|+++|. .+||||||+|+.....
T Consensus 136 TELmQSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLH-sA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d 209 (449)
T KOG0664|consen 136 TELMQSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLH-TANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHh-hcchhhccCCCccEEeccCc-eEEecccccccccchh
Confidence 888877665554 34678999999999999999999999 89999999999999999999 8999999999876543
Q ss_pred C--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 014174 248 E--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325 (429)
Q Consensus 248 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 325 (429)
+ ..+..+.|.+|+|||++.+...|+.++||||.|||+.||+..+..|...+..+++..|...+|.|+.+.++..-...
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 3 23445679999999999999999999999999999999999999999999999999999999999998775322111
Q ss_pred ccc--cCC-CcCCCCccccc--CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 326 TEF--KFP-QIKAHPWHKIF--HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 326 ~~~--~~~-~~~~~~~~~~~--~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
..- ..+ ..+..+..-.+ +..-..+..+++.++|.+||.+|.+..+++.|++..+.|-
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R~ 351 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGRL 351 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccce
Confidence 110 000 00000000111 1234567899999999999999999999999999977553
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=308.29 Aligned_cols=249 Identities=26% Similarity=0.357 Sum_probs=190.8
Q ss_pred EEccCCceEEEEEEEcCCCcEEEEEEeecchh-------hhHHHH---HHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNREL---QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.||+|+||.||+|.+..+++.||+|.+..... ....|. .+++...||||+++++++. .....++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCEEEEE
Confidence 48999999999999999999999998854311 112233 3344568999999988883 34458899
Q ss_pred EeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
|||+.++.+... ......+++..++.++.|++.||.||| +.+|+||||||+||+++.++ .+||+|||++......
T Consensus 76 ~e~~~g~~L~~~---l~~~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~ 150 (278)
T cd05606 76 LDLMNGGDLHYH---LSQHGVFSEAEMRFYAAEIILGLEHMH-NRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK 150 (278)
T ss_pred EecCCCCcHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCcc
Confidence 999986543322 223467999999999999999999999 88999999999999999887 7999999998765332
Q ss_pred CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 014174 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327 (429)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 327 (429)
. .....|+..|+|||.+.+...++.++||||+||++|+|++|+.||.................
T Consensus 151 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 213 (278)
T cd05606 151 K-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------------- 213 (278)
T ss_pred C-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc----------------
Confidence 2 23456899999999987555588999999999999999999999976532211110000000
Q ss_pred ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCC
Q 014174 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDP 383 (429)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~ 383 (429)
....++..++.++.++|.+||..+|.+|+ ++.++++||||....+.
T Consensus 214 ----------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 214 ----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred ----------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 00112334689999999999999999999 99999999999886643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=303.57 Aligned_cols=248 Identities=28% Similarity=0.463 Sum_probs=191.4
Q ss_pred EeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEec
Q 014174 95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF 170 (429)
Q Consensus 95 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 170 (429)
....||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++. ...+.++|+||
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 86 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----ENGFFKIFMEQ 86 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cCCEEEEEEec
Confidence 3458999999999999999999999999876432 34567999999999999999999873 33468899999
Q ss_pred cch-hHHHHHHHhhhcCCCC--CHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 171 VPE-TVYRVAKHYSRASQRM--PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 171 ~~~-~l~~~~~~~~~~~~~l--~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
+++ +|...+.. ....+ ++..+..++.||+.||.||| +.||+||||||+||+++.+...++|+|||++......
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 87 VPGGSLSALLRS---KWGPLKDNEQTIIFYTKQILEGLKYLH-DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred CCCCCHHHHHHH---hcccCCCcHHHHHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 985 55444432 12334 78888999999999999999 8899999999999999864447999999998765432
Q ss_pred CC-cccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 014174 248 EP-NISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325 (429)
Q Consensus 248 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 325 (429)
.. .....++..|+|||.+.+. ..++.++|+||+|+++|+|++|..||................
T Consensus 163 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~--------------- 227 (268)
T cd06624 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF--------------- 227 (268)
T ss_pred CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh---------------
Confidence 22 2234578899999988543 347889999999999999999999996543221111000000
Q ss_pred ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.....++..+++++.+|+++||..+|.+|||+.+++.||||
T Consensus 228 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 228 -----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00011234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=305.25 Aligned_cols=246 Identities=33% Similarity=0.503 Sum_probs=191.9
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecchh-------hhHHHHHH-HHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+.||.|+||.||+|.+..+|+.||+|.+..... ....|..+ ....+|+|++++++++. .....++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence 569999999999999999999999998864321 11233333 34558999999999883 334588999
Q ss_pred eccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+++ +|..++. ....+++..+..++.||+.||.||| +.|++||||+|+||+++.++ .+||+|||++.....
T Consensus 77 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~- 149 (260)
T cd05611 77 EYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLH-QRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE- 149 (260)
T ss_pred eccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEECCCC-cEEEeecccceeccc-
Confidence 99986 4444433 2457899999999999999999999 88999999999999999887 799999999876433
Q ss_pred CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 014174 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327 (429)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 327 (429)
.....++..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+.... ..
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------~~--- 211 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR------------IN--- 211 (260)
T ss_pred --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc------------cC---
Confidence 22345788899999987654 8999999999999999999999998776655443332210 00
Q ss_pred ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCCcccCC
Q 014174 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACIHPFFYELRD 382 (429)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t---~~ell~hp~f~~~~~ 382 (429)
+.......++.++.++|.+||+.||++||| +.|++.||||.+..+
T Consensus 212 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 212 ----------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred ----------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 011112247899999999999999999995 579999999987665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=311.31 Aligned_cols=258 Identities=25% Similarity=0.381 Sum_probs=199.5
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeecCCCCce
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 162 (429)
..++|++.+.||+|+||.||+|.+..++..||+|.+.... ....+|+.++... .|+||+++++++.. ..
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~ 87 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DS 87 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CC
Confidence 4457999999999999999999999889999999986432 1223466655555 59999999998843 34
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
..++||||+++.+..+.... ...+++..+..++.||+.||.|||+..||+||||+|+||+++.++ .+||+|||++.
T Consensus 88 ~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~ 163 (296)
T cd06618 88 DVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISG 163 (296)
T ss_pred eEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccch
Confidence 58899999988766655432 347899999999999999999999436999999999999999887 79999999987
Q ss_pred ecccCCCcccccccccccccccccCC---CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHH
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGA---TEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 318 (429)
............++..|+|||.+.+. ..++.++||||||+++|+|++|+.||...... +.+..+....
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-------- 235 (296)
T cd06618 164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE-------- 235 (296)
T ss_pred hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--------
Confidence 66444333344577889999998643 23788999999999999999999999654322 2222222110
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
.+... ....++.++.+||.+||..||.+|||+.++++||||...+
T Consensus 236 -----------~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 236 -----------PPSLP-------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred -----------CCCCC-------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 00000 0113688999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=310.63 Aligned_cols=260 Identities=28% Similarity=0.411 Sum_probs=199.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.+|++.+.||+|+||+||++.+..+|..||+|++.... ..+.+|+++++.++||||+++++++.. ...++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCEEE
Confidence 46999999999999999999999999999999875432 334579999999999999999998843 34588
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||++++.+... ....+.+++..+..++.|++.||.|||+..|++||||||+||+++.++ .++|+|||++....
T Consensus 80 lv~e~~~~~~L~~~---~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~ 155 (284)
T cd06620 80 MCMEFMDCGSLDRI---YKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELI 155 (284)
T ss_pred EEEecCCCCCHHHH---HHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchh
Confidence 99999986544322 122457899999999999999999999446999999999999999887 79999999986543
Q ss_pred cCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH----HHHHHHHhCCCCHHHHhhc
Q 014174 246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ----LVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~ 321 (429)
... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||........ ...+... +..+
T Consensus 156 ~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~ 225 (284)
T cd06620 156 NSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL--------LQQI 225 (284)
T ss_pred hhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH--------HHHH
Confidence 322 2245688999999998664 588999999999999999999999986543211 0001000 0000
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
... ..+.+ ....++.++.+||.+||..||.+|||+.|+++||||.+-.
T Consensus 226 ~~~----~~~~~--------~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 226 VQE----PPPRL--------PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hhc----cCCCC--------CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 000 00000 0012678899999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=301.07 Aligned_cols=250 Identities=30% Similarity=0.496 Sum_probs=203.3
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|.+.+.||+|+||.||++.+..++..||+|++... .....+|+++++.++|+|++++++.+.. ..+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence 489999999999999999999989999999988643 2334579999999999999999998843 34688
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+|+||+++ ++...+.........+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~ 153 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH-SRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVL 153 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH-hCCEecccCChHHeEEcCCC-cEEECCccceeec
Confidence 99999985 565555443323477999999999999999999999 88999999999999999877 7999999999776
Q ss_pred ccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ......+++.|+|||.+.+.. ++.++|+||+|+++++|++|..||...+............
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 219 (258)
T cd08215 154 SSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ------------- 219 (258)
T ss_pred ccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------
Confidence 4443 223356788999999886644 8899999999999999999999997766443333322110
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.+ .++..++..+.+++.+||..+|++|||+.++|+||||
T Consensus 220 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 ------YP---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred ------CC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 00 1223478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=313.10 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=198.8
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.|++.+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++. ...+.++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEE
Confidence 4788899999999999999999999999999876332 23467999999999999999999884 3345889
Q ss_pred EEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||++++ +.+.+. ...+++..++.++.||+.||.||| +.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 80 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH-~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~ 152 (277)
T cd06642 80 IMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLH-SERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT 152 (277)
T ss_pred EEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHh-cCCeeccCCChheEEEeCCC-CEEEcccccccccc
Confidence 99999864 333322 356899999999999999999999 88999999999999999887 79999999987654
Q ss_pred cCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
.... .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+...
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------------- 216 (277)
T cd06642 153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN--------------- 216 (277)
T ss_pred CcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---------------
Confidence 3322 1234578889999998664 4889999999999999999999999755433222211100
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
. ...+...++..+.++|.+||..+|++|||+.++++||||..+.
T Consensus 217 ----~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 217 ----S---------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred ----C---------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 0 0012234688999999999999999999999999999997755
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=308.40 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=199.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.|+..+.||.|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++.. ..+.++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCEEEE
Confidence 4888999999999999999999999999999886432 234579999999999999999998843 345899
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+++ ++.+.+. ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||++....
T Consensus 80 v~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh-~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~ 152 (277)
T cd06640 80 IMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLH-SEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT 152 (277)
T ss_pred EEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-hCCccCcCCChhhEEEcCCC-CEEEcccccceecc
Confidence 9999986 4444332 256899999999999999999999 88999999999999999887 79999999997664
Q ss_pred cCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
.... .....++..|+|||.+.+. ..+.++|+|||||++|+|++|..||...+.......+.. +.
T Consensus 153 ~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~------------ 217 (277)
T cd06640 153 DTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NN------------ 217 (277)
T ss_pred CCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CC------------
Confidence 4332 2234578889999998664 488999999999999999999999976654333222110 00
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
...+...++..+.+||.+||..+|.+|||+.++++||||....
T Consensus 218 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 218 --------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred --------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 0012234678899999999999999999999999999996543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=307.09 Aligned_cols=251 Identities=28% Similarity=0.472 Sum_probs=199.5
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcC---CCCeeecceEeeecCCCCceE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 163 (429)
.|++.+.||+|+||.||+|.+..+++.||+|.+... .....+|+.+++.++ |||++++++++. ...+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence 488899999999999999999999999999987543 233557889999986 999999999874 3345
Q ss_pred EEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.++||||+.++ |.+.+. ...+++..+..++.|++.||.||| +.||+|+||+|+||+++.++ .++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh-~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~ 149 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIH-KVGVIHRDIKAANILVTNTG-NVKLCDFGVAA 149 (277)
T ss_pred EEEEEecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcCHHHEEEcCCC-CEEEccCCcee
Confidence 88999999764 433332 247899999999999999999999 88999999999999999877 79999999998
Q ss_pred ecccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 243 VLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 243 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
....... .....|+..|+|||.+.+...++.++|+|||||++|+|++|..||.+.+.......+...
T Consensus 150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------ 217 (277)
T cd06917 150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------ 217 (277)
T ss_pred ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence 7654332 234468889999999876556789999999999999999999999765433222111000
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
..+.+ ....++.++.+++.+||..||.+|||+.++++||||++..
T Consensus 218 -------~~~~~--------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 218 -------KPPRL--------EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred -------CCCCC--------CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 00000 0112678999999999999999999999999999997644
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=304.73 Aligned_cols=246 Identities=20% Similarity=0.213 Sum_probs=191.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEc---CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..+|++.+.||+|+||.||+|.+. ..+..||+|.+.... ..+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----G 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----C
Confidence 346999999999999999999865 346789999886542 234579999999999999999998843 3
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
...++||||++++.+..... .....+++..+..++.||+.||+||| +.|++||||||+||+++.++ .+|++|||.+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~--~~~~~l~~~~~~~~~~~i~~al~~lH-~~~iiH~dikp~nili~~~~-~~~l~dfg~~ 154 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLR--KHEGQLVAGQLMGMLPGLASGMKYLS-EMGYVHKGLAAHKVLVNSDL-VCKISGFRRL 154 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeeccccHhhEEEcCCC-cEEECCCccc
Confidence 34889999999754443222 22357899999999999999999999 88999999999999999887 7999999987
Q ss_pred eecccCCCcc--cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 242 KVLVKGEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 242 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
.......... ...++..|+|||.+.+ ..++.++|||||||++|++++ |..||.+.+..+.+..+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~------- 226 (266)
T cd05064 155 QEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR------- 226 (266)
T ss_pred ccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC-------
Confidence 6542221111 2234578999999866 458999999999999999775 9999987766554443322100
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+..++..+.+++.+||+.+|.+|||+.++++
T Consensus 227 ---------------------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 227 ---------------------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 0112347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=303.80 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=190.0
Q ss_pred ceEEeeEE--ccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEEEE
Q 014174 92 SYMAERVV--GQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 92 ~y~i~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+|.+.+.+ |+|+||.||++.+..++..+|+|.+..... ...|+.....+ +|+||+++++++.. ....++||
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~-----~~~~~iv~ 88 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTT-----LKGHVLIM 88 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEec-----CCeeEEEE
Confidence 46666665 999999999999999999999998865421 12234333333 79999999998843 33588999
Q ss_pred eccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+++ +|.+.+.. ...+++..++.++.||+.||.||| +.|++||||||+||+++.++..++|+|||++......
T Consensus 89 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 163 (267)
T PHA03390 89 DYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP 163 (267)
T ss_pred EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence 99974 55555432 347999999999999999999999 8899999999999999987756999999998765332
Q ss_pred CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||........ ..........
T Consensus 164 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------- 225 (267)
T PHA03390 164 ---SCYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-------------- 225 (267)
T ss_pred ---ccCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc--------------
Confidence 234678899999999664 488999999999999999999999975543221 1111111000
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-HHHHhcCCCCc
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-ALEACIHPFFY 378 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-~~ell~hp~f~ 378 (429)
.....+.+++.+.+||.+||+.||.+|++ .+++|+||||.
T Consensus 226 ------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 226 ------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 00112247999999999999999999996 59999999996
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=309.07 Aligned_cols=254 Identities=28% Similarity=0.422 Sum_probs=201.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.++|.+.+.||+|+||.||++.+..++..||+|.+... .....+|+.+++.++||||+++++++... ...+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----CcEE
Confidence 45799999999999999999999889999999988533 23345788999999999999999988443 3478
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+|+||+.+ ++.+.+. ...+++..+..++.|++.||.||| +.|++|+||||+||+++.++ .++|+|||++...
T Consensus 93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH-~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~ 165 (293)
T cd06647 93 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI 165 (293)
T ss_pred EEEecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHH-hCCEeeccCCHHHEEEcCCC-CEEEccCcceecc
Confidence 99999985 4444332 245889999999999999999999 88999999999999999887 7999999988755
Q ss_pred ccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
..... .....+++.|+|||.+... .++.++|+|||||++|+|++|..||...+....+..+.. .+.+
T Consensus 166 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~---------- 233 (293)
T cd06647 166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP---------- 233 (293)
T ss_pred cccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC----------
Confidence 43322 2234678889999998664 488999999999999999999999977654333222111 0000
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
. ...+..++..+.+||++||..+|++||++.+++.||||...+.
T Consensus 234 --------~-------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 234 --------E-------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred --------C-------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 0 0012246788999999999999999999999999999987553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=308.81 Aligned_cols=247 Identities=29% Similarity=0.450 Sum_probs=200.6
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
|...+.||+|+||+||+|++..++..||+|.+.... ....+|+++++.++|+|++++++++.. ....+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEE
Confidence 677788999999999999999999999999885321 234578999999999999999998844 34578
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||+.+++...+.. ....+++..+..++.||+.||.||| +.||+|+||||+||+++.++ .+||+|||++....
T Consensus 98 lv~e~~~~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH-~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~ 172 (313)
T cd06633 98 LVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH-SHNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS 172 (313)
T ss_pred EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCChhhEEECCCC-CEEEeecCCCcccC
Confidence 9999999887766543 3456899999999999999999999 88999999999999999887 79999999986432
Q ss_pred cCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 246 KGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
......++..|+|||.+.. ...++.++|+|||||++|+|++|..||...+.......+... ..
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~-~~----------- 237 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-DS----------- 237 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc-CC-----------
Confidence 2234567889999999842 244788999999999999999999999877655555443321 00
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
+.. ....++..+.+|+.+||+.+|.+|||+.++++||||..
T Consensus 238 -------~~~--------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 238 -------PTL--------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred -------CCC--------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 000 11235788999999999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=301.34 Aligned_cols=245 Identities=27% Similarity=0.448 Sum_probs=197.6
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
+|++.+.||.|+||.||++.+..++..||+|.+... .....+|+.+++.++|+||+++++++. ...++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEE
Confidence 489999999999999999999999999999987532 233457899999999999999999883 3446899
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+++ ++...+.. .....+++..+..++.||+.||.||| +.||+|+||||+||+++.++ .++|+|||++....
T Consensus 76 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~ 151 (255)
T cd08219 76 VMEYCDGGDLMQKIKL--QRGKLFPEDTILQWFVQMCLGVQHIH-EKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT 151 (255)
T ss_pred EEeeCCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence 9999985 45454432 22456899999999999999999999 88999999999999999887 79999999997664
Q ss_pred cCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
.... .....++..|+|||++.+. .++.++|+||||+++|+|++|..||...+.......+....
T Consensus 152 ~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 216 (255)
T cd08219 152 SPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS-------------- 216 (255)
T ss_pred ccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC--------------
Confidence 3322 2345678899999998664 48999999999999999999999998766554444332210
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
. ..++..++..+.+||.+||..||.+|||+.++++-
T Consensus 217 -----~---------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 -----Y---------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----C---------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 01123468899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=319.71 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=190.9
Q ss_pred ccceEEeeEEccCCceEEEEEEE-----cCCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeecCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 158 (429)
..+|++.+.||+|+||+||+|.+ ..++..||+|++.... ....+|+.+++.+ +||||+++++++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~---- 109 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT---- 109 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec----
Confidence 34799999999999999999974 3456789999886432 2345799999999 8999999999883
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhh------------------------------------------------------
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYS------------------------------------------------------ 183 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~------------------------------------------------------ 183 (429)
.....++||||+++ +|.+.+....
T Consensus 110 -~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 110 -VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred -cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 33347899999984 5555443211
Q ss_pred -----------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 184 -----------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 184 -----------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
.....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~ 266 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA-SKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRN 266 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCchhhEEEECCC-cEEEecCccceeccC
Confidence 01125788899999999999999999 88999999999999999776 799999999986543
Q ss_pred CCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 247 GEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 247 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
.... ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||..........+.....
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~------------ 333 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG------------ 333 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCC-CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC------------
Confidence 3221 122345679999999764 48999999999999999998 889998765444433332210
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
+ ....+...+.++.+||.+||+.||++|||+.++++.
T Consensus 334 --~-------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 334 --Y-------------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred --c-------------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 000112357899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=317.02 Aligned_cols=278 Identities=22% Similarity=0.302 Sum_probs=196.5
Q ss_pred eEEccC--CceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQG--SFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
..||+| +||+||+|++..+|+.||+|++.... ....+|+.+++.++||||++++++|. ...+.++|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence 356666 99999999999999999999886432 33457888999999999999999984 334588999
Q ss_pred eccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+.+ ++..++.... ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++++||+.+......
T Consensus 79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH-~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~ 154 (328)
T cd08226 79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLH-QNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN 154 (328)
T ss_pred ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence 99985 5555544321 245899999999999999999999 88999999999999999887 7999999865433221
Q ss_pred CCc--------ccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH--
Q 014174 248 EPN--------ISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-- 316 (429)
Q Consensus 248 ~~~--------~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~-- 316 (429)
... ....++..|+|||++.+. ..++.++|||||||++|+|++|..||........+.............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd08226 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT 234 (328)
T ss_pred CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence 110 011235669999998653 347899999999999999999999998776655544433321110000
Q ss_pred -------HHhhcCcCcc----cccC-----CCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 317 -------EIKCMNPNYT----EFKF-----PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 317 -------~~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
.+......+. .... .......+.......+++.+.+||++||++||++|||+.++|+||||...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0000000000 0000 00000111112233467889999999999999999999999999999876
Q ss_pred CCC
Q 014174 381 RDP 383 (429)
Q Consensus 381 ~~~ 383 (429)
...
T Consensus 315 ~~~ 317 (328)
T cd08226 315 KEQ 317 (328)
T ss_pred HHh
Confidence 653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=302.34 Aligned_cols=249 Identities=29% Similarity=0.448 Sum_probs=196.1
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
++|++.+.||+|+||.||+|++..++..||||.+... .....+|+++++.++||||+++++++... ..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence 4699999999999999999999999999999977431 12345699999999999999999988543 34
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.++|+||+++ ++..++.........+++..+..++.||+.||.||| +.|++|+||||+||+++.++ .++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~ 154 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH-SRRVMHRDIKPANVFITATG-VVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh-hCCeeCCCCCHHHEEEcCCC-CEEECccccce
Confidence 7899999995 555555544444566899999999999999999999 88999999999999999887 79999999987
Q ss_pred ecccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhh
Q 014174 243 VLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 243 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 320 (429)
....... .....++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...... ..+.......+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 227 (267)
T cd08228 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------ 227 (267)
T ss_pred eccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence 6543322 1234578889999998664 4889999999999999999999999654321 22222222111111
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
......+..+.+||.+||+.+|++|||+.++++
T Consensus 228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 011235788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=300.79 Aligned_cols=248 Identities=27% Similarity=0.460 Sum_probs=197.5
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
+|++.+.||+|+||.||+|.+..+++.||+|.+... ...+.+|+++++.++|+||+++++++... ...
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~~ 79 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EEK 79 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CCC
Confidence 699999999999999999999999999999987422 12345799999999999999999987432 223
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++|+||+++ ++.+.+. ....+++..+..++.||+.||.||| +.|++|+||||+||+++.++ .++|+|||++
T Consensus 80 ~~~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH-~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~ 153 (264)
T cd06653 80 KLSIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLH-SNMIVHRDIKGANILRDSAG-NVKLGDFGAS 153 (264)
T ss_pred EEEEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCC-CEEECccccc
Confidence 57789999975 4444433 2356889999999999999999999 88999999999999999887 7999999999
Q ss_pred eecccC----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 242 KVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 242 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
+..... .......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||..........++.. .+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~--- 226 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT---QPT--- 226 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc---CCC---
Confidence 765321 111234678899999998764 488999999999999999999999987655444333221 111
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
...++..+++.+.++|++||. +|..|||+.++++|||.
T Consensus 227 ---------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 ---------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ---------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 112345678999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=301.59 Aligned_cols=250 Identities=30% Similarity=0.509 Sum_probs=196.6
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.++|+||+++++++. ....++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence 5899999999999999999998899999999886442 23457999999999999999998773 334588
Q ss_pred EEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+|+||+.++ +.+.+. ....+++..+..++.|++.||.||| +.||+|+||+|+||+++.++ .+||+|||++...
T Consensus 76 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh-~~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~ 149 (264)
T cd06626 76 IFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLH-SHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL 149 (264)
T ss_pred EEEecCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEccccccccc
Confidence 999999854 444332 2456889999999999999999999 88999999999999999877 7999999998776
Q ss_pred ccCCCcc-----cccccccccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 245 VKGEPNI-----SYICSRYYRAPELIFGAT--EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 245 ~~~~~~~-----~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
....... ...++..|+|||.+.+.. .++.++||||||+++|+|++|+.||...+........... +.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~---- 224 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHK---- 224 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCC----
Confidence 4432211 245678899999986533 3788999999999999999999999765433222211111 000
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
..+|. ...++..+.+||.+||+.+|.+|||+.+++.|||+
T Consensus 225 ----------~~~~~----------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 225 ----------PPIPD----------SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ----------CCCCc----------ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00111 12358899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=304.62 Aligned_cols=253 Identities=30% Similarity=0.466 Sum_probs=201.0
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
|...+.||+|++|.||++.+..+++.+|+|++.... ....+|+.+++.++|+||+++++++.. ..+.++|+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v~ 95 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVVM 95 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEEE
Confidence 555679999999999999999999999999875322 234578999999999999999998743 33478999
Q ss_pred eccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+.+ ++.+.+.. ..+++..+..++.|++.||.||| +.||+||||+|+||+++.++ .++|+|||.+......
T Consensus 96 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 96 EFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLH-AQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKE 168 (285)
T ss_pred eccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCChhhEEEcCCC-cEEEcccccchhhccC
Confidence 99975 44443322 56899999999999999999999 88999999999999999887 7999999987654332
Q ss_pred C-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 E-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
. ......|+..|+|||.+.+.. ++.++|+||+||++|+|++|..||...+.......+... ..+.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~------------ 234 (285)
T cd06648 169 VPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPK------------ 234 (285)
T ss_pred CcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCC------------
Confidence 2 122346788999999986644 889999999999999999999999876655444433321 0000
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
. .....++..+.+||++||..+|++|||+.++++||||...+++.
T Consensus 235 ------~-------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 279 (285)
T cd06648 235 ------L-------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPS 279 (285)
T ss_pred ------C-------cccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCcc
Confidence 0 00123688999999999999999999999999999999877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=304.45 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=199.0
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
|++.+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++|+||+++++++. ...+.++|
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv 80 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWII 80 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEEE
Confidence 888899999999999999998999999999875322 23457999999999999999999884 33458899
Q ss_pred Eeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||++++ +...+. ...+++..+..++.|++.||.||| +.|++|+||||+||+++.++ .++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~ 153 (277)
T cd06641 81 MEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLH-SEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTD 153 (277)
T ss_pred EEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHc-cCCeecCCCCHHhEEECCCC-CEEEeecccceeccc
Confidence 9999864 433332 256899999999999999999999 89999999999999999887 799999999876543
Q ss_pred CCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 014174 247 GEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325 (429)
Q Consensus 247 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 325 (429)
... .....++..|+|||.+.+. ..+.++|+|||||++|+|++|..||...........+... +.
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~------------- 218 (277)
T cd06641 154 TQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN-NP------------- 218 (277)
T ss_pred chhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC-CC-------------
Confidence 221 2234578889999998654 4788999999999999999999999765543333322110 00
Q ss_pred ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
..+...++.++.++|.+||..+|.+||++.++++||||.+..
T Consensus 219 --------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 219 --------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred --------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 012234688999999999999999999999999999998743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=305.78 Aligned_cols=248 Identities=22% Similarity=0.287 Sum_probs=195.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCC-----cEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETG-----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
.+|++.+.||+|+||.||+|.+...+ ..||+|.+.... ..+.+|+.+++.++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence 46999999999999999999876555 689999886432 23457999999999999999999873 3
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN 227 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~ 227 (429)
....+++|||+++ +|.+.+..... ....+++..+..++.|++.||.||| +.||+||||||+||+++
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH-~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS-SHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccccceEEEc
Confidence 3347899999984 55555543211 1146888999999999999999999 88999999999999999
Q ss_pred CCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014174 228 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL 303 (429)
Q Consensus 228 ~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~ 303 (429)
.++ .+||+|||++........ .....+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+..
T Consensus 159 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 159 EGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred CCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 887 799999999976533221 2234557889999988664 48999999999999999998 99999887665544
Q ss_pred HHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 304 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
..+..... ...+..++.++.+|+.+||+.||.+|||+.+++++
T Consensus 237 ~~i~~~~~----------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 237 EMIRSRQL----------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCc----------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43332100 01223578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=300.51 Aligned_cols=245 Identities=22% Similarity=0.326 Sum_probs=194.5
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.+|.+.+.||+|+||.||+|.+..+++.||+|.+..+. ....+|+++++.++|+||+++++++. ....+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEEE
Confidence 35999999999999999999999999999999886543 23457999999999999999999873 33347899
Q ss_pred Eeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||+++ ++.+.+.. .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~ 156 (263)
T cd05052 81 TEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTG 156 (263)
T ss_pred EEeCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccCcceEEEcCCC-cEEeCCCcccccccc
Confidence 999974 45444432 12346899999999999999999999 88999999999999999887 799999999977644
Q ss_pred CCCcc--cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 247 GEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
..... ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------------- 222 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY------------- 222 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence 32211 12235679999988654 48899999999999999998 999998766544433332110
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..++.++.+||.+||..||++|||+.++++
T Consensus 223 ---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 ---------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 01123457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=303.90 Aligned_cols=257 Identities=24% Similarity=0.309 Sum_probs=196.4
Q ss_pred cccceEEeeEEccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 158 (429)
...+|++.+.||+|+||.||+|.++. .+..||+|.+.... ....+|+.+++.++|+||+++++++..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 80 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK--- 80 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC---
Confidence 34579999999999999999997642 35589999875432 123468899999999999999998733
Q ss_pred CCceEEEEEEeccc-hhHHHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC
Q 014174 159 KDELYLNLVLEFVP-ETVYRVAKHYSR------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH 231 (429)
Q Consensus 159 ~~~~~~~lv~e~~~-~~l~~~~~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~ 231 (429)
....++||||++ ++|.+.+..... ....++...+..++.||+.||.||| ++||+||||||+||+++.++
T Consensus 81 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dikp~nili~~~~- 156 (288)
T cd05061 81 --GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN-AKKFVHRDLAARNCMVAHDF- 156 (288)
T ss_pred --CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcCCCCChheEEEcCCC-
Confidence 334789999997 566665543221 1234567788899999999999999 89999999999999999887
Q ss_pred cEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014174 232 QVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII 307 (429)
Q Consensus 232 ~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~ 307 (429)
.++|+|||+++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..+....+.
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 799999999876533221 1122346679999998664 48999999999999999998 789998766554433322
Q ss_pred HHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc------CCCCcccC
Q 014174 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI------HPFFYELR 381 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~------hp~f~~~~ 381 (429)
.. +.+ ..+...++.+.+++.+||+.||.+|||+.++++ ||||..+.
T Consensus 236 ~~-~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~ 287 (288)
T cd05061 236 DG-GYL---------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 287 (288)
T ss_pred cC-CCC---------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence 11 000 012245789999999999999999999999987 99998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=303.90 Aligned_cols=245 Identities=32% Similarity=0.586 Sum_probs=200.7
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 163 (429)
+|.+.+.||+|+||.||+|.+..++..||+|++... .....+|..+++.++ |+||+++++++ .....
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~ 76 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN 76 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence 699999999999999999999999999999988542 133457889999998 99999999987 34445
Q ss_pred EEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.++|||++. +++.+.+.. ...+++..+..++.|++.||.||| +.|++|+||||+||+++.++ .++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh-~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~ 150 (280)
T cd05581 77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLH-SKGIIHRDLKPENILLDKDM-HIKITDFGTAK 150 (280)
T ss_pred EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence 889999995 566555443 357999999999999999999999 89999999999999999888 79999999987
Q ss_pred ecccCCC---------------------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 014174 243 VLVKGEP---------------------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301 (429)
Q Consensus 243 ~~~~~~~---------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 301 (429)
....... .....++..|+|||.+... .++.++|+||||++++++++|+.||...+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 229 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC-CCChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 6543221 1223567889999988654 48889999999999999999999998776544
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCC
Q 014174 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFF 377 (429)
Q Consensus 302 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~----~ell~hp~f 377 (429)
.+..+... ...++..+++.+.+||.+||..||.+|||+ .++++||||
T Consensus 230 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 230 TFQKILKL-----------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHhc-----------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 44433321 011233568999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=296.18 Aligned_cols=248 Identities=29% Similarity=0.488 Sum_probs=200.4
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
+|.+.+.||+|++|.||++.+..++..+++|++.... ....+|+++++.++|+|++++++++... ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence 4889999999999999999998899999999886543 3456899999999999999999988433 447899
Q ss_pred Eeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
+||++ +++.+.+.. ....+++..+..++.|++.||.+|| +.|++||||+|+||+++.++ .++|+|||.+.....
T Consensus 76 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh-~~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~ 150 (253)
T cd05122 76 MEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLH-SNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSD 150 (253)
T ss_pred EecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhh-cCCEecCCCCHHHEEEccCC-eEEEeeccccccccc
Confidence 99999 455444432 2257899999999999999999999 89999999999999999877 799999999987655
Q ss_pred CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
........++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+....+..... ...+
T Consensus 151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~------------- 215 (253)
T cd05122 151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPP------------- 215 (253)
T ss_pred cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCC-------------
Confidence 43234556788999999986644 88999999999999999999999987654444333222 0000
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~ 376 (429)
... ....++..+.++|.+||..||++|||+.++++|||
T Consensus 216 -----~~~-------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 216 -----GLR-------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -----CcC-------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 000 01124789999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=319.28 Aligned_cols=255 Identities=28% Similarity=0.466 Sum_probs=200.7
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
-|..++.||-|+||.|.+++...|...||+|.+.+.. ...+.|..||..-+.+-||++|..| ++...+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCce
Confidence 4889999999999999999999999999999885432 2334689999999999999999888 455558
Q ss_pred EEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
|+||+|++|+ +..++- ..+-|+|..+++|+.++.+|+++.| +.|+|||||||+|||||.+|| |||+|||+|.-
T Consensus 705 YFVMdYIPGGDmMSLLI----rmgIFeE~LARFYIAEltcAiesVH-kmGFIHRDiKPDNILIDrdGH-IKLTDFGLCTG 778 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLI----RMGIFEEDLARFYIAELTCAIESVH-KMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTG 778 (1034)
T ss_pred EEEEeccCCccHHHHHH----HhccCHHHHHHHHHHHHHHHHHHHH-hccceecccCccceEEccCCc-eeeeecccccc
Confidence 9999999964 333332 2478999999999999999999999 999999999999999999995 99999999864
Q ss_pred c---------ccCC----------------------------------CcccccccccccccccccCCCCCCCchhHHHH
Q 014174 244 L---------VKGE----------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSV 280 (429)
Q Consensus 244 ~---------~~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 280 (429)
+ ..+. ...+.+||+.|+|||++.. ..|+..+||||.
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~ 857 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSV 857 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHh
Confidence 3 1000 0024568999999999965 559999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCc
Q 014174 281 GCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360 (429)
Q Consensus 281 G~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~ 360 (429)
|||||+|+.|++||-.....+.-.+++.. ..+ +.-.+..++|.++.+||.++++
T Consensus 858 gvil~em~~g~~pf~~~tp~~tq~kv~nw----------------~~~---------l~~~~~~~ls~e~~~li~kLc~- 911 (1034)
T KOG0608|consen 858 GVILYEMLVGQPPFLADTPGETQYKVINW----------------RNF---------LHIPYQGNLSKEALDLIQKLCC- 911 (1034)
T ss_pred hHHHHHHhhCCCCccCCCCCcceeeeeeh----------------hhc---------cccccccccCHHHHHHHHHHhc-
Confidence 99999999999999776654433332221 100 0111234689999999998755
Q ss_pred CCCCCC---CHHHHhcCCCCcccCCCC
Q 014174 361 SPNLRC---TALEACIHPFFYELRDPN 384 (429)
Q Consensus 361 dP~~R~---t~~ell~hp~f~~~~~~~ 384 (429)
+++.|+ .++++..||||+.+....
T Consensus 912 sad~RLGkng~d~vKaHpfFkgIDfss 938 (1034)
T KOG0608|consen 912 SADSRLGKNGADQVKAHPFFKGIDFSS 938 (1034)
T ss_pred ChhhhhcccchhhhhcCccccccchHh
Confidence 678888 467899999998765543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=310.80 Aligned_cols=277 Identities=23% Similarity=0.315 Sum_probs=194.1
Q ss_pred EEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 94 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.+.+.+|. +|.||++++..+++.||+|++... ...+.+|+.+++.++|+||+++++++.. ....+++
T Consensus 5 ~i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~~ 77 (314)
T cd08216 5 LIGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYVV 77 (314)
T ss_pred hhhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEEE
Confidence 34444444 455666666679999999998643 1345679999999999999999998843 3347899
Q ss_pred Eeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||++++ +.+++... ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||.+.....
T Consensus 78 ~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH-~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~ 153 (314)
T cd08216 78 SPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIH-SKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIK 153 (314)
T ss_pred EeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCcceEEEecCC-ceEEecCccceeecc
Confidence 9999854 44444322 2346899999999999999999999 88999999999999999887 799999999876533
Q ss_pred CCC--------cccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH-
Q 014174 247 GEP--------NISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE- 316 (429)
Q Consensus 247 ~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~- 316 (429)
... .....++..|+|||.+.+. ..++.++|+||+||++|+|++|..||........+..... +.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~~ 231 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPCLL 231 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCcccc
Confidence 221 1223457789999998653 3478899999999999999999999987655444322221 111000
Q ss_pred ---HHhhcCcCccc----ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 317 ---EIKCMNPNYTE----FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 317 ---~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
.......+... ...+. ............++.++.+|+.+||.+||++|||+.++|+||||..++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~ 305 (314)
T cd08216 232 DKSTYPLYEDSMSQSRSSNEHPN-NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRN 305 (314)
T ss_pred ccCchhhhcCCcCcccccccccc-hhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccc
Confidence 00000000000 00000 011111122334567899999999999999999999999999999877543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.32 Aligned_cols=256 Identities=28% Similarity=0.443 Sum_probs=206.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
+-+|.-...||.|.||.||.|.+..+|+..|+|-++-. .....+|..+|..++|||+|++|++=+....
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek----- 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK----- 1308 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-----
Confidence 34688888999999999999999999999999977422 2345689999999999999999998744333
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++|.||||.++.+..+.. .++..++...+.+..|++.|+.||| ++|||||||||.||+++.+| .+|++|||.|..
T Consensus 1309 v~IFMEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH-~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLH-EHGIVHRDIKPANILLDFNG-LIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHH-hcCceecCCCccceeeecCC-cEEeecccceeE
Confidence 788999999654443332 2455788888899999999999999 89999999999999999888 899999999987
Q ss_pred cccCC-----CcccccccccccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 244 LVKGE-----PNISYICSRYYRAPELIFGAT--EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 244 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
...+- ......||+.|||||++.+.. +...+.|||||||+..||+||+.||...+..-++.-.+...
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~g------ 1457 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAG------ 1457 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhcc------
Confidence 75542 123578999999999996643 46779999999999999999999998765443332222211
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
..|+ +|.++|++.++||.+||..||.+|.++.|+|.|-|=+..++
T Consensus 1458 ------------h~Pq---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1458 ------------HKPQ---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred ------------CCCC---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccccc
Confidence 1222 34568999999999999999999999999999998766554
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=295.56 Aligned_cols=250 Identities=34% Similarity=0.503 Sum_probs=200.8
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|++|.||+|.+..++..|++|++.... ....+|+.++++++|+||+++++++.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 4888999999999999999999899999999886543 34567999999999999999998884331 24578
Q ss_pred EEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+|+||++ +++.+.+.. ...+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh-~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~ 151 (260)
T cd06606 78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLH-SNGIVHRDIKGANILVDSDG-VVKLADFGCAKRL 151 (260)
T ss_pred EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence 9999996 455444432 347999999999999999999999 89999999999999999877 7999999999877
Q ss_pred ccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 245 VKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 245 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
..... .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+.... .......
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~---------- 218 (260)
T cd06606 152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGS---------- 218 (260)
T ss_pred ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccc----------
Confidence 65543 33456788999999986644 89999999999999999999999987652111 1111100
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
......++..++..+.+||.+||..||.+|||+.++++||||
T Consensus 219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 000111334568999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=300.93 Aligned_cols=244 Identities=32% Similarity=0.556 Sum_probs=195.9
Q ss_pred EccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
||.|+||.||+|++..+|+.||+|.+.... ....+|+++++.++|+||+++++++ ......++|+||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 689999999999999899999999886432 2345788999999999999998887 3445688999999
Q ss_pred ch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC--
Q 014174 172 PE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-- 248 (429)
Q Consensus 172 ~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~-- 248 (429)
.+ ++.+.+.. ...+++..+..++.||+.||.||| +.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH-~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~ 149 (265)
T cd05579 76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLH-SNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI 149 (265)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence 75 55555433 347899999999999999999999 88999999999999999888 79999999987654332
Q ss_pred -------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 249 -------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 249 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
......++..|+|||.+.... .+.++|+||||+++|+|++|..||...........+... .
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~--------- 217 (265)
T cd05579 150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--K--------- 217 (265)
T ss_pred ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C---------
Confidence 112345678899999986654 889999999999999999999999877655444333220 0
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH---HHHhcCCCCcccC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA---LEACIHPFFYELR 381 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~---~ell~hp~f~~~~ 381 (429)
...+. ...++..+.+|+.+||+.+|.+|||+ .++|+||||.++.
T Consensus 218 ------~~~~~----------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 218 ------IEWPE----------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred ------cCCCc----------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 00111 01248999999999999999999999 9999999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=306.16 Aligned_cols=255 Identities=30% Similarity=0.434 Sum_probs=201.2
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
|....+||+|+||.||++.+..+++.||||.+... .....+|+.+++.++|+||+++++++.. ..+.++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEE
Confidence 33446899999999999999999999999987432 2234578999999999999999998843 34588999
Q ss_pred eccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC
Q 014174 169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248 (429)
Q Consensus 169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~ 248 (429)
||++++.+..+.. ...+++..++.++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++.......
T Consensus 97 e~~~~~~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH-~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~ 170 (292)
T cd06657 97 EFLEGGALTDIVT----HTRMNEEQIAAVCLAVLKALSVLH-AQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEV 170 (292)
T ss_pred ecCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-CEEEcccccceeccccc
Confidence 9998754433221 346899999999999999999999 88999999999999999887 79999999987654322
Q ss_pred -CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 014174 249 -PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327 (429)
Q Consensus 249 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 327 (429)
......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+.... +. .
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~--~~---------~--- 235 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL--PP---------K--- 235 (292)
T ss_pred ccccccccCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC--Cc---------c---
Confidence 1233567889999998865 447899999999999999999999998766554443332211 00 0
Q ss_pred ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCC
Q 014174 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNA 385 (429)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~ 385 (429)
.. ....++..+.+++.+||..||.+||++.++++||||.....+..
T Consensus 236 --~~----------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~~ 281 (292)
T cd06657 236 --LK----------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSC 281 (292)
T ss_pred --cC----------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCcc
Confidence 00 01236889999999999999999999999999999988775543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=296.83 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=201.4
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|+||.||++++..+++.+|+|.+... .....+|+++++.++|+||+++++++.. ....+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence 489999999999999999999999999999988642 1233468899999999999999988843 34588
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+|+||+++ ++...+.........+++..+..++.|++.||.||| +.|++|+||+|+||+++.++ .+||+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh-~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~ 153 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH-EQKILHRDLKSANILLVAND-LVKIGDLGISKVL 153 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence 99999975 555555443333467899999999999999999999 88999999999999999877 7999999999776
Q ss_pred ccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.......+...
T Consensus 154 ~~~-~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 216 (256)
T cd08530 154 KKN-MAKTQIGTPHYMAPEVWKGR-PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG--------------- 216 (256)
T ss_pred ccC-CcccccCCccccCHHHHCCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------
Confidence 544 23345678899999998664 4888999999999999999999999877654433322211
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.++. ++..++.+++++|.+||..+|.+|||+.++++||++
T Consensus 217 ----~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 217 ----KYPP---------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ----CCCC---------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 0011 122468899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=304.40 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=199.5
Q ss_pred ceEEeeEEccCCceEEEEEEEc---CCCcEEEEEEeecch--------hhhHHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 92 SYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
+|++.+.||.|+||.||+|++. .+|..||+|++.... ....+|+.+++.+ +|+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4889999999999999999875 478999999886421 3345799999999 599999998887 3
Q ss_pred CceEEEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
...+.++|+||++++ +.+.+. ....+++..+..++.||+.||.||| +.|++||||||+|||++.++ .+||+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH-~~~i~H~dl~p~nil~~~~~-~~kl~df 149 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLH-KLGIIYRDIKLENILLDSNG-HVVLTDF 149 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeEECCCC-CEEEeeC
Confidence 444688999999854 444332 2456899999999999999999999 89999999999999999887 7999999
Q ss_pred ccceecccCC--CcccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 239 GSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 239 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
|++....... ......++..|+|||.+.+. ..++.++||||||+++|+|++|..||...........+.......
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (290)
T cd05613 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-- 227 (290)
T ss_pred ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence 9997654332 12245678899999998643 246789999999999999999999997543322222222210000
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCC
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDP 383 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~ 383 (429)
...++..+++.+.+|+++||..||.+|+ ++.++++||||....+.
T Consensus 228 -----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 277 (290)
T cd05613 228 -----------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWD 277 (290)
T ss_pred -----------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHH
Confidence 0012334789999999999999999997 89999999999887753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=307.78 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=190.6
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcE--EEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCc
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 161 (429)
.++|++.+.||+|+||.||+|.+..++.. +|+|.+... ...+.+|++++.++ +|+||+++++++ ...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~ 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence 45799999999999999999998877764 577766432 12345799999999 899999999988 334
Q ss_pred eEEEEEEeccc-hhHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC
Q 014174 162 LYLNLVLEFVP-ETVYRVAKHYS------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP 228 (429)
Q Consensus 162 ~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~ 228 (429)
.+.++||||++ +++.+.+.... .....+++..++.++.||+.||+||| +.||+||||||+|||++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGE 159 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH-hCCccccccchheEEecC
Confidence 45889999997 45555554321 11235889999999999999999999 899999999999999998
Q ss_pred CCCcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014174 229 HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII 307 (429)
Q Consensus 229 ~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~ 307 (429)
++ .+||+|||++.............++..|+|||.+.+. .++.++|||||||++|+|+| |..||.+.+..+....+.
T Consensus 160 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 160 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred CC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhcc-CCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 87 7999999998643222111222335679999988654 48899999999999999998 999997765544332221
Q ss_pred HHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.. .....+..+++++.+||.+||+.+|++|||+.+++++
T Consensus 238 ~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 238 QG----------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cC----------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 0000122368899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=334.56 Aligned_cols=142 Identities=25% Similarity=0.396 Sum_probs=122.1
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..+|+++++||+|+||+||+|.+..+++.||||++.... ..+.+|+.+++.++|+||++++.++. ...
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECC
Confidence 357999999999999999999999999999999986532 44567899999999999999988773 334
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
++|+||||+.+ +|..++.. .+.+++..++.++.||+.||.||| .+||+||||||+||||+.++ .+||+|||++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH-~~gIiHrDLKP~NILl~~~g-~vkL~DFGls 151 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLH-RHGIIHRDLKPDNMLISNEG-HIKLTDFGLS 151 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCccHHHEEEcCCC-CEEEEeCCCC
Confidence 68999999964 55555432 356899999999999999999999 88999999999999999888 7999999987
Q ss_pred e
Q 014174 242 K 242 (429)
Q Consensus 242 ~ 242 (429)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=297.18 Aligned_cols=243 Identities=21% Similarity=0.303 Sum_probs=191.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.+|++.+.||+|+||.||++.+. ++..+|+|.+... .....+|+.+++.++||||+++++++. .....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEE
Confidence 46999999999999999999874 4568999987543 234567999999999999999999873 33448899
Q ss_pred Eeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||+++ ++.+.+.. ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||.++....
T Consensus 78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~ 152 (256)
T cd05114 78 TEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLE-RNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHH-HCCccccccCcceEEEcCCC-eEEECCCCCccccCC
Confidence 999984 45444432 2346899999999999999999999 88999999999999999887 799999999876533
Q ss_pred CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+.+..+.....
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~------------ 219 (256)
T cd05114 153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR------------ 219 (256)
T ss_pred CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC------------
Confidence 2221 122345679999998654 48999999999999999999 8999987776555554433100
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
. ..+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 220 ----~------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 220 ----L------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred ----C------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 011235788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=312.27 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=190.8
Q ss_pred cceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
.+|++.+.||+|+||.||+|.+. .+++.||+|++.... ....+|+.+++.+ +|+||+++++++...
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~--- 83 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP--- 83 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC---
Confidence 47999999999999999999754 345789999886432 2334699999999 899999999877532
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhh------------------------------------------------------
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSR------------------------------------------------------ 184 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------ 184 (429)
...++++|||+++ ++.+.+.....
T Consensus 84 -~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 84 -GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred -CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 2357789999985 44444432110
Q ss_pred ---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCC---ccccccccc
Q 014174 185 ---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRY 258 (429)
Q Consensus 185 ---~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~ 258 (429)
....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++........ .....++..
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH-~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLA-SRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCcc
Confidence 1236889999999999999999999 88999999999999999887 799999999987533221 122345678
Q ss_pred ccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCC
Q 014174 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 337 (429)
Q Consensus 259 y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (429)
|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+.+...+...-
T Consensus 241 y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-------------------------- 293 (337)
T cd05054 241 WMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT-------------------------- 293 (337)
T ss_pred ccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC--------------------------
Confidence 9999998764 48999999999999999998 9999987544443333222100
Q ss_pred cccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 338 WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 338 ~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
....+...++++.+++.+||+.+|++|||+.++++|
T Consensus 294 -~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 294 -RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred -CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 001123468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=300.78 Aligned_cols=250 Identities=23% Similarity=0.290 Sum_probs=191.2
Q ss_pred cccceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 158 (429)
..++|++.+.||+|+||.||+|.+. .++..||+|.+.... ..+.+|+.+++.++|+||+++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 3457999999999999999999864 235689999875422 2244789999999999999999887
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSRA------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH 231 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~ 231 (429)
......++||||+++ +|.+.+...... ...+++..+..++.|++.||.||| +.|++||||||+||+++.++
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~vH~dlkp~Nil~~~~~- 156 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDF- 156 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCcchheEEEcCCC-
Confidence 333457899999985 555544331110 123577888999999999999999 88999999999999999887
Q ss_pred cEEEeecccceecccCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014174 232 QVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII 307 (429)
Q Consensus 232 ~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~ 307 (429)
.++|+|||+++........ ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcC-CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 7999999998755332211 122446789999998664 48999999999999999999 789998776554443332
Q ss_pred HHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.. +. + ..+...+..+.+++.+||+.||++|||+.+++++
T Consensus 236 ~~-~~------------------~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 EG-GL------------------L---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred cC-Cc------------------C---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 21 00 0 0123468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=306.87 Aligned_cols=249 Identities=28% Similarity=0.422 Sum_probs=201.8
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.|...+.||+|+||.||+|++..++..||+|.+.... ..+.+|+++++.++|+|++++++++... ...
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~ 100 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HTA 100 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----CeE
Confidence 3888999999999999999999999999999886321 2344689999999999999999988443 347
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++||||+.+++.+.+.. ....+++..+..++.||+.||.||| +.||+||||+|+||+++.++ .+||+|||++...
T Consensus 101 ~lv~e~~~g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH-~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~ 175 (317)
T cd06635 101 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLH-SHNMIHRDIKAGNILLTEPG-QVKLADFGSASIA 175 (317)
T ss_pred EEEEeCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcccEEECCCC-CEEEecCCCcccc
Confidence 89999999887765543 2456899999999999999999999 88999999999999999887 7999999998654
Q ss_pred ccCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 245 VKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
.. .....++..|+|||.+.. ...++.++|+|||||++|+|++|..||...+....+..+......+
T Consensus 176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 243 (317)
T cd06635 176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT--------- 243 (317)
T ss_pred CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------
Confidence 32 234567889999998742 2347889999999999999999999998766555554443311000
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
.....+++.+.+||.+||..+|.+|||+.++++|+|+...
T Consensus 244 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 244 ------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 0112367889999999999999999999999999999653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=334.91 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=191.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
++|++.++||+|+||.||+|.+..+|+.||+|++..+. ....+|+++++.++||||+++++++. ....
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence 47999999999999999999999999999999886431 23457999999999999999999873 3345
Q ss_pred EEEEEeccch-hHHHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEE
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSR-------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 235 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl 235 (429)
.++||||+++ +|.+.+..... ....++...+..++.||+.||.||| +.||+||||||+||+++.++ .+||
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH-s~GIIHRDLKPeNILLd~dg-~vKL 154 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH-SKGVLHRDLKPDNILLGLFG-EVVI 154 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH-HCCccccCCchheEEEcCCC-CEEE
Confidence 8899999985 55555543211 1234566778899999999999999 88999999999999999888 7999
Q ss_pred eecccceecccCC-------------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 014174 236 CDFGSAKVLVKGE-------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296 (429)
Q Consensus 236 ~DfG~a~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 296 (429)
+|||+++...... ......||+.|+|||.+.+. .++.++|||||||++|+|+||..||..
T Consensus 155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999998652110 01124689999999998764 489999999999999999999999976
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 297 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.+....... .....|. .. . -...+++.+.+++.+||..||++|++..+.+.+
T Consensus 234 ~~~~ki~~~--~~i~~P~--------------~~-----~-----p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 234 KKGRKISYR--DVILSPI--------------EV-----A-----PYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred cchhhhhhh--hhccChh--------------hc-----c-----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 543322211 1000000 00 0 012468999999999999999999987766654
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=306.35 Aligned_cols=252 Identities=27% Similarity=0.429 Sum_probs=202.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.|...+.||+|+||.||+|++..++..+|+|.+.... ....+|+++++.++|+|++++++++... ...
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 90 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA 90 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----Cee
Confidence 4888899999999999999999999999999885321 1234689999999999999999988543 347
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++||||+.+++...+.. ....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++...
T Consensus 91 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH-~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~ 165 (308)
T cd06634 91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM 165 (308)
T ss_pred EEEEEccCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHhEEECCCC-cEEECCcccceee
Confidence 89999999877665543 2356899999999999999999999 88999999999999999887 7999999998765
Q ss_pred ccCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 245 VKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
... ....++..|+|||.+.+ ...++.++|||||||++|+|++|..||...+.......+.... .
T Consensus 166 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~---------- 231 (308)
T cd06634 166 APA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-S---------- 231 (308)
T ss_pred cCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcC-C----------
Confidence 332 23467889999998742 2347889999999999999999999997765444443332210 0
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
+. .....++..+.+||++||..+|.+|||+.++++|||+...+.+
T Consensus 232 --------~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~ 276 (308)
T cd06634 232 --------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276 (308)
T ss_pred --------CC--------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCCh
Confidence 00 0112468889999999999999999999999999999885543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=299.08 Aligned_cols=249 Identities=23% Similarity=0.423 Sum_probs=196.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
+|.+.+.||+|+||.||++.+..++..+++|.++.. .....+|+.+++.++||||+++++++.. ..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-----RD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-----CC
Confidence 589999999999999999999888777777765421 1223468899999999999999988743 33
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
..++|+||+++ ++...+.........+++..+..++.|++.||.||| +.|++|+||||+||+++. + .+||+|||++
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~h~~l~~~nili~~-~-~~~l~d~g~~ 152 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-QRRILHRDLKAKNIFLKN-N-LLKIGDFGVS 152 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH-HcCccccCCChhheEeec-C-CEeecccCce
Confidence 47899999985 555555444444567999999999999999999999 889999999999999984 4 5999999998
Q ss_pred eecccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 242 KVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 242 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
........ .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~-------- 221 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG--P-------- 221 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC--C--------
Confidence 77644332 223457888999998865 44788999999999999999999999765544433332210 0
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.+ .++..++.++.++|.+||..||++||++.++++||||
T Consensus 222 ---------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 222 ---------TP---------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ---------CC---------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 00 1123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=302.22 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=193.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
.+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+++++.++|+||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 80 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG---- 80 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC----
Confidence 469999999999999999998743 46789999886432 3455799999999999999999988443
Q ss_pred ceEEEEEEeccch-hHHHHHHHhh----------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYS----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH 229 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~ 229 (429)
...++||||+++ +|.+.+.... .....+++..+..++.||+.||.||| +.|++||||||+||+++.+
T Consensus 81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 81 -DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA-SQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred -CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh-hCCeeccccccceEEEcCC
Confidence 458899999985 4444443321 12345788999999999999999999 8899999999999999988
Q ss_pred CCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014174 230 THQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVE 305 (429)
Q Consensus 230 ~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~ 305 (429)
+ .+||+|||++........ .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 159 ~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 159 L-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred C-eEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 7 799999999876533221 12334577899999987644 8999999999999999998 9999987766554443
Q ss_pred HHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 306 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
+... .. ...+..++..+.+|+++||+.||++|||+.|+++
T Consensus 237 ~~~~--~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 237 ITQG--RL--------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHcC--Cc--------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3211 00 0112346899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=298.76 Aligned_cols=251 Identities=21% Similarity=0.270 Sum_probs=192.3
Q ss_pred eEEeeEEccCCceEEEEEEEcCC---CcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC-CCce
Q 014174 93 YMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL 162 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 162 (429)
|.+.+.||+|+||.||+|....+ +..||+|.+..+. ....+|++.++.++|+||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999987643 4789999886432 234578999999999999999987754332 3344
Q ss_pred EEEEEEeccch-hHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYS--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
+.++|+||+.+ ++...+.... .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~dfg 158 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS-NRNFIHRDLAARNCMLREDM-TVCVADFG 158 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH-hCCeeccccchheEEECCCC-eEEECCcc
Confidence 57899999985 4444443221 12346899999999999999999999 88999999999999999887 79999999
Q ss_pred cceecccCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 240 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 240 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+++........ ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----- 232 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN----- 232 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 99876433221 11234667999998865 458999999999999999999 889998766544433322210
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
....+..++..+.+++.+||+.||++|||+.+++++
T Consensus 233 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 -----------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -----------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001123468999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=307.61 Aligned_cols=244 Identities=23% Similarity=0.364 Sum_probs=189.5
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcE----EEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGET----VAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
.+|++.+.||+|+||.||+|++..++.. ||+|.+.... ....+|+.+++.++||||+++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 3699999999999999999998766654 8999875332 2345689999999999999999987432
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
..++|++|+.+ ++.+.+.. ....+++..+..++.||+.||+||| +.||+||||||+|||++.++ .+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH-~~~iiH~dlkp~Nill~~~~-~~kl~DfG~ 155 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE-ERRLVHRDLAARNVLVKTPQ-HVKITDFGL 155 (316)
T ss_pred -CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHH-hcCeeccccchhheEecCCC-cEEEccccc
Confidence 14578999874 45554432 2346889999999999999999999 88999999999999999887 799999999
Q ss_pred ceecccCCCcc---cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 241 AKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 241 a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
++......... ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....+. ..+.....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~----- 228 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGE----- 228 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCC-----
Confidence 98765433221 12336679999998664 48999999999999999998 9999977654332 22222100
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
..+ .+...+.++.+++.+||..||.+|||+.+++.+
T Consensus 229 ------------~~~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 229 ------------RLP----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred ------------CCC----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000 112367889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=297.00 Aligned_cols=244 Identities=18% Similarity=0.269 Sum_probs=191.4
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.+|++.+.||+|+||.||++.+.. +..+|+|.+.... ....+|+.+++.++||||+++++++. .....++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEE
Confidence 469999999999999999998643 4569999886432 33467999999999999999999873 33347899
Q ss_pred Eeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||+.+ ++.+.+.. ....+++..+..++.||+.||.||| +.|++|+||||+||+++.++ .+||+|||+++....
T Consensus 78 ~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~ 152 (256)
T cd05113 78 TEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLE-SKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLD 152 (256)
T ss_pred EEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccCcceEEEcCCC-CEEECCCccceecCC
Confidence 999975 45444432 2346899999999999999999999 88999999999999999887 799999999876544
Q ss_pred CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 153 ~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------- 220 (256)
T cd05113 153 DEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL----------- 220 (256)
T ss_pred CceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----------
Confidence 3221 1223456799999986544 8899999999999999998 99999776654444433221000
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
..+...+..+.+++.+||..||.+|||+.+++++
T Consensus 221 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 -----------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 0112358899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=296.26 Aligned_cols=238 Identities=21% Similarity=0.308 Sum_probs=184.3
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
+.||+|+||.||+|.+..+++.||+|.+... .....+|+++++.++|+||+++++++. .....++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence 3689999999999999999999999987543 233567999999999999999999884 334588999999
Q ss_pred chh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCc
Q 014174 172 PET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 250 (429)
Q Consensus 172 ~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~ 250 (429)
.++ +.+.+. .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++.........
T Consensus 76 ~~~~L~~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~ 150 (252)
T cd05084 76 QGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLE-SKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA 150 (252)
T ss_pred cCCcHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccchheEEEcCCC-cEEECccccCccccccccc
Confidence 764 444332 22346899999999999999999999 88999999999999999887 7999999998764332111
Q ss_pred c---cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 251 I---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 251 ~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
. ...++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||...........+....
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~---------------- 213 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV---------------- 213 (252)
T ss_pred ccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----------------
Confidence 1 112245699999986644 8999999999999999998 889997655433322221100
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+...+..+.+|+.+||..||++|||+.++++
T Consensus 214 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 214 ------------RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ------------CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=293.75 Aligned_cols=246 Identities=35% Similarity=0.568 Sum_probs=200.7
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+|++.+.||+|++|.||++.+..+++.||+|.+.... ....+|+++++.++|+|++++++++.. ..+.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence 4889999999999999999999999999999886543 234579999999999999999988743 34588
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+++ ++.+.+.. ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++...
T Consensus 76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~ 149 (254)
T cd06627 76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLH-EQGVIHRDIKAANILTTKDG-VVKLADFGVATKL 149 (254)
T ss_pred EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHh-hCCcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence 99999986 44444332 367899999999999999999999 88999999999999999877 7999999999876
Q ss_pred ccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
..... .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+...........
T Consensus 150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 214 (254)
T cd06627 150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD-------------- 214 (254)
T ss_pred CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------
Confidence 54433 22346788899999986644 889999999999999999999999766544333332210
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
....++..++..+.+++.+||..+|++|||+.+++.||||
T Consensus 215 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 215 --------------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred --------------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0011234578999999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=300.89 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=192.3
Q ss_pred cceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
.+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ....+|+.+++.++|+||+++++++. ..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence 36999999999999999999853 345679999886432 23557999999999999999999884 33
Q ss_pred eEEEEEEeccc-hhHHHHHHHhh---------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC
Q 014174 162 LYLNLVLEFVP-ETVYRVAKHYS---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH 231 (429)
Q Consensus 162 ~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~ 231 (429)
.+.++||||++ ++|.+.+.... .....+++..+..++.||+.||.||| +.|++||||||+||+++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH-~~~i~H~dlkp~Nili~~~~- 157 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCLVGENL- 157 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccCcceEEEccCC-
Confidence 45889999998 45555544321 11235899999999999999999999 88999999999999999888
Q ss_pred cEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014174 232 QVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII 307 (429)
Q Consensus 232 ~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~ 307 (429)
.+||+|||++........ .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |.+||...+....+..+.
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~ 236 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 236 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 799999999976533221 122334678999999865 458999999999999999998 999998776555444433
Q ss_pred HHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
... . + ..+..++.++.+|+.+||+.||.+|||+.+++.
T Consensus 237 ~~~--~-----------------~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGR--V-----------------L---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCC--c-----------------C---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 210 0 0 011236889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=299.13 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=193.1
Q ss_pred ccceEEeeEEccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ..+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER--- 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC---
Confidence 3579999999999999999999977 77899999875332 2345689999999999999999987432
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC--CcE
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSR---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQV 233 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~--~~v 233 (429)
...++||||+. ++|.+.+..... ....+++..+..++.||+.||.||| +.+++||||||+||+++.++ ..+
T Consensus 82 --~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 82 --LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE-ENHFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred --CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccchheEEEeccCCCcce
Confidence 33679999996 466655543211 1235899999999999999999999 88999999999999998653 259
Q ss_pred EEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 014174 234 KLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKV 309 (429)
Q Consensus 234 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 309 (429)
||+|||+++....... ......+..|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+.......+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~ 237 (277)
T cd05036 159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237 (277)
T ss_pred EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 9999999986532221 11222356799999987644 8999999999999999997 99999876654433322210
Q ss_pred hCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.. ...+..++..+.+++.+||+.+|++|||+.++++|
T Consensus 238 -~~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 -GR---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred -Cc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 01223578999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=299.39 Aligned_cols=251 Identities=21% Similarity=0.267 Sum_probs=189.8
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCc--EEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCC-CCceE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY 163 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 163 (429)
+.+.+.||+|+||.||+|++..++. .||+|.+... .....+|+.+++.++|+||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467899999999999999877765 6899987532 2234568999999999999999987654322 22234
Q ss_pred EEEEEeccch-hHHHHHHHh--hhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 164 LNLVLEFVPE-TVYRVAKHY--SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
.+++|||+.+ ++...+... ......+++..+..++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~ 158 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS-SKSFIHRDLAARNCMLNENM-NVCVADFGL 158 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhheEEcCCC-CEEECCCCc
Confidence 6789999984 444433221 112345899999999999999999999 88999999999999999887 799999999
Q ss_pred ceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 241 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 241 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||.+....+....+... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~---- 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-NR---- 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CC----
Confidence 987643321 1122346789999998654 48999999999999999999 88999876554433322210 00
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...+..++..+.++|.+||+.||.+|||+.+++++
T Consensus 233 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 233 -----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01123468899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=303.42 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=190.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCc--EEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 162 (429)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. .....+|+.++.++ +||||+++++++. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence 369999999999999999999877765 4688877532 12345799999999 7999999999873 334
Q ss_pred EEEEEEeccc-hhHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC
Q 014174 163 YLNLVLEFVP-ETVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH 229 (429)
Q Consensus 163 ~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~ 229 (429)
..++|+||++ +++.+.+..... ....+++..++.++.||+.||+||| +.||+||||||+|||++.+
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH-~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS-EKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCcCCcceEEECCC
Confidence 5789999997 456555543110 1135889999999999999999999 8999999999999999988
Q ss_pred CCcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 014174 230 THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIK 308 (429)
Q Consensus 230 ~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~ 308 (429)
+ .+||+|||++..............+..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 156 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 156 L-ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS-VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred C-eEEECCcCCCccccceeccCCCCcCccccCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 7 7999999998643222111122235569999988654 48999999999999999997 9999987766554443322
Q ss_pred HhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.. ....+..++..+.+||.+||..+|.+|||+.++++.
T Consensus 234 ~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 234 GY----------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 001123478999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=299.54 Aligned_cols=248 Identities=20% Similarity=0.288 Sum_probs=191.8
Q ss_pred cceEEeeEEccCCceEEEEEEEc----CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
.+|++.+.||+|+||+||+|.+. .++..||+|.+.... ..+.+|+.+++.++||||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----E 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----C
Confidence 46999999999999999999853 456789999886422 335579999999999999999998743 3
Q ss_pred eEEEEEEeccch-hHHHHHHHhh-------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYS-------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN 227 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~-------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~ 227 (429)
...++||||+++ ++.+.+.... .....+++..+..++.|++.||.||| ++||+||||||+|||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~nili~ 158 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS-SHFFVHKDLAARNILIG 158 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-hcCeehhccccceEEEc
Confidence 347899999985 5544442211 01234788889999999999999999 88999999999999999
Q ss_pred CCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014174 228 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL 303 (429)
Q Consensus 228 ~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~ 303 (429)
.++ .+||+|||+++....... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+.....
T Consensus 159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 159 EQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred CCC-cEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 887 799999999976543321 1233456779999998664 48999999999999999998 99999876554433
Q ss_pred HHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 304 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
..+.... . ...+..+++.+.+++.+||+.||.+||++.+++++
T Consensus 237 ~~~~~~~-~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 237 EMVRKRQ-L---------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHcCC-c---------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3322210 0 01223478999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=299.40 Aligned_cols=249 Identities=31% Similarity=0.483 Sum_probs=195.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.+|++.+.||+|+||.||+|++..+++.||+|.+... .....+|+.+++.++|+||+++++++.. ..+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence 3689999999999999999999999999999987532 1234468999999999999999998843 335
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+++|||+.+ ++.+.+.........+++..+..++.||+.||.||| +.|++|+||||+||+++.++ .++|+|||++.
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~ 154 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATG-VVKLGDLGLGR 154 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-CEEECcchhhh
Confidence 7899999985 566655544444567899999999999999999999 88999999999999999887 79999999987
Q ss_pred ecccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhh
Q 014174 243 VLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 243 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~ 320 (429)
....... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 223 (267)
T cd08229 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC---------- 223 (267)
T ss_pred ccccCCcccccccCCcCccCHHHhcCC-CccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC----------
Confidence 6543322 2234678899999998664 4888999999999999999999999754322 1111111100
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
..+. ..+..++..+.+||.+||..||++|||+.++++
T Consensus 224 --------~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 224 --------DYPP--------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred --------CCCC--------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0010 011246889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=295.60 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=192.8
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..+|++.++||+|+||.||+|.+. ++..||+|.+.... ....+|+.+++.++|+||+++++++. .....++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l 78 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYI 78 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEE
Confidence 347999999999999999999864 56779999876432 34457999999999999999988873 3344789
Q ss_pred EEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+|||+. +++.+.+.. .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++....
T Consensus 79 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~~l~~~l~~LH-~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~ 154 (261)
T cd05072 79 ITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIE-RKNYIHRDLRAANVLVSESL-MCKIADFGLARVIE 154 (261)
T ss_pred EEecCCCCcHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhhEEecCCC-cEEECCCccceecC
Confidence 999997 466555533 23456888999999999999999999 88999999999999999887 79999999998764
Q ss_pred cCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 246 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 246 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
..... ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...........+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------- 222 (261)
T cd05072 155 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR----------- 222 (261)
T ss_pred CCceeccCCCccceecCCHHHhccC-CCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 33211 123346679999998654 48889999999999999998 9999987665544433322100
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
. .....++.++.+|+.+||..+|++|||+.++++
T Consensus 223 -------~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 -------M----------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -------C----------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 011246889999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=297.89 Aligned_cols=247 Identities=24% Similarity=0.302 Sum_probs=193.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCC-----CcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
++|++.+.||+|+||.||+|.+... +..||+|.+.... ....+|+.+++.++|+||+++++++. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~ 80 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----T 80 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----C
Confidence 4799999999999999999988643 3789999875432 23457899999999999999999884 3
Q ss_pred ceEEEEEEeccc-hhHHHHHHHhhh------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcE
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHYSR------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV 233 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~v 233 (429)
..+.++||||++ ++|...+..... ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~di~p~nill~~~~-~~ 158 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA-AKKFVHRDLAARNCMVAEDL-TV 158 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccChheEEEcCCC-CE
Confidence 345789999997 566555543221 1234788899999999999999999 89999999999999999888 79
Q ss_pred EEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHH
Q 014174 234 KLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKV 309 (429)
Q Consensus 234 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~ 309 (429)
||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~- 236 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID- 236 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-
Confidence 9999999876543321 1233457789999998654 48999999999999999998 9999987665444333221
Q ss_pred hCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+. ..++...+..+.+||.+||+.+|++|||+.++++
T Consensus 237 ~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 237 GGH---------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCC---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 0122346899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=294.19 Aligned_cols=250 Identities=31% Similarity=0.509 Sum_probs=195.5
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
++|++.+.||+|+||.||+|.+..+|+.||+|.+... .....+|+++++.++|+|++++++++.. ...
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence 4699999999999999999999999999999987531 2344579999999999999999998843 345
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.++||||+++ +|...+.........+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++.
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~ 154 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH-SKRIMHRDIKPANVFITATG-VVKLGDLGLGR 154 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH-hCCEecCCcChhhEEECCCC-cEEEeccceee
Confidence 7899999985 666665544344566899999999999999999999 88999999999999999888 79999999987
Q ss_pred ecccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 243 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
...... ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||...... .........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~---------- 221 (267)
T cd08224 155 FFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIE---------- 221 (267)
T ss_pred eccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhh----------
Confidence 654332 22345678889999998664 4889999999999999999999999654321 111111000
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+. .....++..+.++|.+||..+|++|||+.++++
T Consensus 222 -----~~~~~~--------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 222 -----KCDYPP--------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred -----cCCCCC--------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000000 001246789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=312.19 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=190.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCC-----CcEEEEEEeecch-----hhhHHHHHHHHHcC-CCCeeecceEeeecCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTD 158 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 158 (429)
..+|++.++||+|+||.||+|.+... +..||||++.... ....+|+++++.++ ||||+++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~----- 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC----- 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE-----
Confidence 45799999999999999999987433 3479999886432 23457999999996 99999999988
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhh-----------------------------------------------------
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSR----------------------------------------------------- 184 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------------------------------------- 184 (429)
.....+++|||||++ +|.+.+.....
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 334458899999984 55544432110
Q ss_pred ---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceE
Q 014174 185 ---------------------------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL 225 (429)
Q Consensus 185 ---------------------------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nil 225 (429)
....+++..+..++.||+.||.||| +.||+||||||+|||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivH~dikp~Nil 269 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA-SKNCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChHhEE
Confidence 1235788889999999999999999 889999999999999
Q ss_pred ecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 014174 226 VNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVD 301 (429)
Q Consensus 226 l~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~ 301 (429)
++.++ .+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.......
T Consensus 270 l~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 270 LAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDN-LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 99887 799999999986543322 1233457789999998764 48999999999999999997 999997654433
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 302 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+....... .. ...+..++.++.+|+.+||+.||++|||+.++.+
T Consensus 348 ~~~~~~~~~-----------------~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 348 TFYNKIKSG-----------------YR----------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHhcC-----------------CC----------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 333222210 00 0112346899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=292.67 Aligned_cols=238 Identities=35% Similarity=0.581 Sum_probs=194.9
Q ss_pred EccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
||.|+||.||++.+..+++.||+|.+.... .....|+.+++.++|+||+++++.+ ....+.++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 689999999999998889999999886532 2455789999999999999999887 4455689999999
Q ss_pred c-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC-CC
Q 014174 172 P-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EP 249 (429)
Q Consensus 172 ~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~-~~ 249 (429)
. +++.+.+.. ...+++..+..++.|++.||.||| +.+++|+||+|+||+++.++ .++|+|||++...... ..
T Consensus 76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh-~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~ 149 (250)
T cd05123 76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLH-SLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR 149 (250)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence 4 566555443 346899999999999999999999 89999999999999999887 7999999999776443 22
Q ss_pred cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 014174 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329 (429)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
.....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+.......+.. +
T Consensus 150 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~------------------ 208 (250)
T cd05123 150 TNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--D------------------ 208 (250)
T ss_pred ccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--C------------------
Confidence 33456788899999986643 78899999999999999999999977665333333222 0
Q ss_pred CCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH---HHHhcCCCC
Q 014174 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA---LEACIHPFF 377 (429)
Q Consensus 330 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~---~ell~hp~f 377 (429)
...++..++..+.++|++||..||++|||+ .++++||||
T Consensus 209 ---------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 209 ---------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 011233468999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=299.69 Aligned_cols=256 Identities=30% Similarity=0.439 Sum_probs=204.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
...|.+.+.||+|+||.||+|.+..++..||+|++.... ....+|+++++.++|+|++++++++... .+.++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEE
Confidence 345999999999999999999998889999999886543 3456799999999999999999988543 45889
Q ss_pred EEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
|+||++ ++|.+.+... ...+++..+..++.|++.||.||| +.||+|+||+|+||+++.++ .++|+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH-~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~ 167 (286)
T cd06614 93 VMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLH-SQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLT 167 (286)
T ss_pred EEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCChhhEEEcCCC-CEEECccchhhhhc
Confidence 999999 5666655431 137999999999999999999999 89999999999999999887 79999999886543
Q ss_pred cCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
.... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.......+... +.+.
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~---------- 235 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRK-DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP---------- 235 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC----------
Confidence 3221 1234567889999998664 4899999999999999999999999876655444333221 0000
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
......++..+.+||++||+.+|.+|||+.++++||||.....
T Consensus 236 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 236 ---------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred ---------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 0011236889999999999999999999999999999988443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=294.12 Aligned_cols=242 Identities=26% Similarity=0.377 Sum_probs=194.4
Q ss_pred eEEccCCceEEEEEEEcCC---CcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+.||+|+||.||+|.+... +..||+|.+.... ....+|+++++.++|+||+++++++.. ...+++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 4699999999999999866 8999999886542 344579999999999999999998843 44588999
Q ss_pred eccc-hhHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 169 EFVP-ETVYRVAKHYSRA-----SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 169 e~~~-~~l~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
||+. +++.+.+...... ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||.+.
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~di~p~nili~~~~-~~~l~dfg~~~ 153 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA-SKKFVHRDLAARNCLVGEDL-VVKISDFGLSR 153 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH-cCCcccCccCcceEEECCCC-cEEEccccccc
Confidence 9995 6666655442111 367999999999999999999999 89999999999999999887 79999999998
Q ss_pred ecccCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 243 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 243 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
...... ......++..|+|||.+... .++.++|||||||++|+|++ |..||...+..+....+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------- 223 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG--------- 223 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Confidence 765432 22344568889999988664 58999999999999999999 69999887655444433320
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.....+..++.++.+++.+||+.||.+|||+.+++++
T Consensus 224 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 224 -------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0011233468999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=301.76 Aligned_cols=247 Identities=20% Similarity=0.243 Sum_probs=192.0
Q ss_pred cceEEeeEEccCCceEEEEEEEcCC-----CcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
.+|++.+.||+|+||.||+|.+..+ +..||+|++.... ..+.+|+.+++.++||||+++++++. .
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~ 79 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----K 79 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----C
Confidence 4688999999999999999987543 5789999986432 23457889999999999999999873 3
Q ss_pred ceEEEEEEeccch-hHHHHHHHh------------hhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHY------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN 227 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~------------~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~ 227 (429)
....++++||+.+ ++...+... ......+++..+..++.|++.||.||| ++||+||||||+||+++
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH-~~gi~H~dlkp~Nil~~ 158 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS-SHHVVHKDLATRNVLVF 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-HcCccccccchhheEec
Confidence 3347889999984 444443211 011235888899999999999999999 88999999999999999
Q ss_pred CCCCcEEEeecccceecccCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014174 228 PHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL 303 (429)
Q Consensus 228 ~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~ 303 (429)
.++ .+||+|||+++........ ....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+..
T Consensus 159 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 159 DKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred CCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 877 7999999998765433221 2234467899999986644 8999999999999999998 88899877665554
Q ss_pred HHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 304 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
..+..... ..++..++.++.+|+.+||+.+|.+||++.+++.
T Consensus 237 ~~i~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 237 EMIRNRQV----------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 44333100 0123457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=298.59 Aligned_cols=257 Identities=26% Similarity=0.356 Sum_probs=188.2
Q ss_pred ce-EEeeEEccCCceEEEEEE----EcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 92 SY-MAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 92 ~y-~i~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
+| ++.+.||+|+||+||++. ...++..||+|.+.... ....+|+++++.++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GG 80 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CC
Confidence 45 999999999999998865 33578899999886432 3345799999999999999999876432 23
Q ss_pred eEEEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
.++++||||++++ +.+.+. ...+++..++.++.|++.||.||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~~l~dfg~ 153 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLH-SQHYIHRDLAARNVLLDNDR-LVKIGDFGL 153 (283)
T ss_pred ceEEEEecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccChheEEEcCCC-cEEEeeccc
Confidence 4578999999864 433332 246999999999999999999999 88999999999999999887 799999999
Q ss_pred ceecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH-hCCCCH
Q 014174 241 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV-LGTPTR 315 (429)
Q Consensus 241 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~-~~~~~~ 315 (429)
++....... .....++..|+|||.+.+. .++.++||||||+++|+|+||..||...... +...... .+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~ 230 (283)
T cd05080 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKEN-KFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTV 230 (283)
T ss_pred ccccCCcchhhccCCCCCCCceeeCHhHhccc-CCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccch
Confidence 986643322 1122346679999988654 4899999999999999999999998654321 1111110 000000
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
..+. ...........+..++..+.+++.+||+.||++|||+.++++
T Consensus 231 ~~~~------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 231 VRLI------------ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhh------------hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000 000000011123457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=300.25 Aligned_cols=254 Identities=19% Similarity=0.208 Sum_probs=186.1
Q ss_pred cceEEeeEEccCCceEEEEEEEcCC---CcEEEEEEeecchhhhH---------------HHHHHHHHcCCCCeeecceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQDKRYKN---------------RELQTMRLLDHPNVVSLKHC 152 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~---------------~E~~~l~~l~h~niv~~~~~ 152 (429)
.+|++.++||+|+||+||+|.+..+ +..+|+|.......... .+...+..++|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4799999999999999999998777 66788886533222111 12233455689999999987
Q ss_pred eeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCc
Q 014174 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ 232 (429)
Q Consensus 153 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~ 232 (429)
..... ....+.+++++++..++...+.. ....++..++.++.|++.||.||| +.+|+||||||+|||++.++ .
T Consensus 92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH-~~~iiHrDiKp~Nill~~~~-~ 164 (294)
T PHA02882 92 GSFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIH-EHGISHGDIKPENIMVDGNN-R 164 (294)
T ss_pred eeEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-c
Confidence 64433 22345678999887766555443 234678889999999999999999 88999999999999999887 7
Q ss_pred EEEeecccceecccCC--------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 014174 233 VKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304 (429)
Q Consensus 233 vkl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 304 (429)
++|+|||+|+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+........
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~-~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA-CVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999998764321 11234689999999998764 48999999999999999999999998774333222
Q ss_pred HHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 305 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+. +.+..+... .. ..+..+..+.++++.|+..+|++||+..++++
T Consensus 244 ~~~~~------~~~~~~~~~--~~-------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 244 HAAKC------DFIKRLHEG--KI-------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHhHH------HHHHHhhhh--hh-------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 21111 000000000 00 01235788999999999999999999999875
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=292.53 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=192.1
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.+|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+|+.+++.++|+||+++++++.. ....++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv 79 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-----EEPIYIV 79 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEec-----CCCeeee
Confidence 46999999999999999999864 45789999886532 345679999999999999999988733 3347899
Q ss_pred Eeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||+. +++.+.+... ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++.....
T Consensus 80 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~ 155 (261)
T cd05068 80 TELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLE-AQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKE 155 (261)
T ss_pred eecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCcceEEEcCCC-CEEECCcceEEEccC
Confidence 99995 5666555431 1346899999999999999999999 88999999999999999888 799999999987653
Q ss_pred CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... .....+..|+|||.+.+. .++.++|+||||+++|+|++ |+.||.+.+....+..+.....
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------ 222 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYN-RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------------ 222 (261)
T ss_pred CcccccCCCcCceeccCccccccC-CCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 3211 111224579999988654 48999999999999999999 9999987765554443322100
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+...+..+.+++.+||+.+|.+||++.++++
T Consensus 223 ----------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 223 ----------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ----------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0012346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=294.71 Aligned_cols=243 Identities=21% Similarity=0.301 Sum_probs=190.8
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+|++.+.||+|+||.||+|.+. ++..+|+|.+... .....+|+++++.++|+||+++++++ ....+.++||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEEE
Confidence 5899999999999999999875 5678999988643 23445799999999999999999887 3334578999
Q ss_pred eccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+++ ++.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+++.....
T Consensus 79 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 79 EYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLE-SNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDD 153 (256)
T ss_pred ecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-HCCcccccccHhhEEECCCC-cEEECCcccceecccc
Confidence 99975 45544432 2346899999999999999999999 88999999999999999888 7999999998765433
Q ss_pred CCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 248 EPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 248 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
... ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------- 219 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------- 219 (256)
T ss_pred cccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc-------------
Confidence 221 112234579999988764 48999999999999999999 8999987665544433322100
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...+...+..+.+++.+||..+|++|||+.++++.
T Consensus 220 ---------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 220 ---------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 01122368999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=322.08 Aligned_cols=285 Identities=20% Similarity=0.245 Sum_probs=183.1
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCC----CcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCC-CCceE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLET----GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY 163 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 163 (429)
..++|.+.+.||+|+||.||+|++..+ +..||+|++...........+.++...+.++..++..+..... .....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE 209 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence 456899999999999999999999888 9999999875432211111122223333444444333322111 33445
Q ss_pred EEEEEeccch-hHHHHHHHhhh----------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSR----------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV 226 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~----------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill 226 (429)
.++|+||+++ +|.+++..... .........+..++.||+.||.||| +.||+||||||+|||+
T Consensus 210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH-~~gIiHRDLKP~NILl 288 (566)
T PLN03225 210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH-STGIVHRDVKPQNIIF 288 (566)
T ss_pred eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH-HCCEEeCcCCHHHEEE
Confidence 7899999985 45454432100 0011223456789999999999999 8899999999999999
Q ss_pred cCCCCcEEEeecccceecccCC--CcccccccccccccccccCCC---------------------CCCCchhHHHHHHH
Q 014174 227 NPHTHQVKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT---------------------EYTTAIDIWSVGCV 283 (429)
Q Consensus 227 ~~~~~~vkl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~DiwslG~i 283 (429)
+.+...+||+|||+|+...... ......+|+.|+|||.+.... .++.++|||||||+
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi 368 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence 8644479999999997653322 223567899999999663211 23456799999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCC
Q 014174 284 LAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 363 (429)
Q Consensus 284 l~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~ 363 (429)
||+|+++..++ .+....+..++...+...........+.. .+... ....+....+..+.+||.+||++||+
T Consensus 369 L~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~~~----~~~~~---~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 369 FLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLVEPRA----SPDLR---RGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhhcccc----chhhh---hhhhhccccchHHHHHHHHHccCCcc
Confidence 99999976553 34444444444443333222111111110 00000 00000111345677999999999999
Q ss_pred CCCCHHHHhcCCCCcccCCC
Q 014174 364 LRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 364 ~R~t~~ell~hp~f~~~~~~ 383 (429)
+|||+.++|+||||......
T Consensus 440 kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 440 QRISAKAALAHPYFDREGLL 459 (566)
T ss_pred cCCCHHHHhCCcCcCCCCcc
Confidence 99999999999999875543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=295.12 Aligned_cols=245 Identities=22% Similarity=0.290 Sum_probs=191.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCC---CcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
++|++.+.||+|+||+||+|.+..+ ...||+|.+.... ....+|+.+++.++|+||+++++++. ...
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence 4699999999999999999998654 4579999875432 23346899999999999999999873 334
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
..++||||+.+ +|.+.+.. ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh-~~~i~H~di~p~nili~~~~-~~~l~dfg~~ 153 (266)
T cd05033 79 PVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLS-EMNYVHRDLAARNILVNSNL-VCKVSDFGLS 153 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCcceEEEcCCC-CEEECccchh
Confidence 47899999986 44444332 2347899999999999999999999 89999999999999999887 7999999999
Q ss_pred eecccCCCc-c--cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 242 KVLVKGEPN-I--SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 242 ~~~~~~~~~-~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
......... . ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||......+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~------ 226 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR------ 226 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC------
Confidence 876422211 1 12335679999998654 48999999999999999998 9999976655444333322100
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
. ..+...+..+.+|+.+||+.+|++||++.+++++
T Consensus 227 ------------~----------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 227 ------------L----------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ------------C----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0122468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=293.37 Aligned_cols=263 Identities=25% Similarity=0.356 Sum_probs=205.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh-----hhHHHHH-HHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNRELQ-TMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.+.+-+..||.|+||+|++..++.+|+..|+|+++.... .+..|.+ +++.-+.||||++|+..+...+ .
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-----c 138 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-----C 138 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-----e
Confidence 345666789999999999999999999999999965432 2223444 3445579999999999876555 8
Q ss_pred EEEEeccchhHHHHHHH-hhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPETVYRVAKH-YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+|.||+|+-++..+.+. |......+++..+-.|...++.||.||.....|||||+||+|||++..| .|||||||++..
T Consensus 139 WiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcGq 217 (361)
T KOG1006|consen 139 WICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICGQ 217 (361)
T ss_pred eeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchHh
Confidence 89999999776554443 3344578999999999999999999998788999999999999999988 799999999987
Q ss_pred cccCCCcccccccccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGAT-EYTTAIDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
..++-..+.-.|.+.|||||.+.... .|+.+||+||||++|||+.||..||.+-+. .+++..+. .|.|+.-.
T Consensus 218 Lv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv--~gdpp~l~---- 291 (361)
T KOG1006|consen 218 LVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV--IGDPPILL---- 291 (361)
T ss_pred HHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH--cCCCCeec----
Confidence 76665556667888899999996543 489999999999999999999999976332 23333322 23332110
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
... -.-+++..+..+|.-||.+|-+.||...+++++||++....
T Consensus 292 -------------~~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 292 -------------FDK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred -------------Ccc----cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 000 00136899999999999999999999999999999976544
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=299.58 Aligned_cols=250 Identities=22% Similarity=0.329 Sum_probs=193.4
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCC-----cEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeecC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETG-----ETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT 157 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 157 (429)
...+|++.+.||+|+||.||++.+...+ ..+|+|.+.... ....+|+.+++.+ +|+||+++++++.
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--- 86 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT--- 86 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc---
Confidence 3457999999999999999999876443 789999886432 2244789999999 8999999999873
Q ss_pred CCCceEEEEEEeccch-hHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCce
Q 014174 158 DKDELYLNLVLEFVPE-TVYRVAKHYS------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNL 224 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Ni 224 (429)
....++++|||+.+ ++...+.... .....+++..+..++.||+.||.||| +.||+||||||+||
T Consensus 87 --~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~ivH~dlkp~Ni 163 (293)
T cd05053 87 --QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA-SKKCIHRDLAARNV 163 (293)
T ss_pred --CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH-HCCccccccceeeE
Confidence 33347899999974 5555543211 23456899999999999999999999 88999999999999
Q ss_pred EecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 014174 225 LVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGV 300 (429)
Q Consensus 225 ll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~ 300 (429)
+++.++ .+||+|||+++....... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 164 l~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 164 LVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EEcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 999887 799999999987644321 112234567999998865 448999999999999999997 99999876655
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 301 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
+....+.... ....+...+..+.+|+.+||..||++|||+.+++++
T Consensus 242 ~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLKEGY----------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHHcCC----------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 4443322210 001123468899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=320.79 Aligned_cols=206 Identities=27% Similarity=0.393 Sum_probs=170.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecC-CCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTT-DKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~ 164 (429)
..|...+.||+|+||.||+++++.+|+.||||.++.. .+..-+|+++|++|+|+|||+++++-.... .-.....
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 3488889999999999999999999999999988653 233347999999999999999976532111 0002235
Q ss_pred EEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec--C-CCCcEEEeeccc
Q 014174 165 NLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN--P-HTHQVKLCDFGS 240 (429)
Q Consensus 165 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~--~-~~~~vkl~DfG~ 240 (429)
.+|||||.++ |...+. ...+...+++.+...++..++.||.||| ++||+||||||.||++- . ..+.-||+|||.
T Consensus 93 vlvmEyC~gGsL~~~L~-~PEN~~GLpE~e~l~lL~d~~~al~~Lr-En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLN-SPENAYGLPESEFLDLLSDLVSALRHLR-ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred eEEEeecCCCcHHHHhc-CcccccCCCHHHHHHHHHHHHHHHHHHH-HcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 6899999964 444444 3455678999999999999999999999 99999999999999873 2 223689999999
Q ss_pred ceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 298 (429)
|+...++....+.+||..|.+||++.....|+..+|.|||||++|+++||..||-...
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9999999999999999999999999755679999999999999999999999996543
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=297.82 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=192.4
Q ss_pred cceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
.+|.+.+.||+|+||.||+|++. .++..+++|.+.... ....+|+.+++.++|+||+++++++. ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence 46999999999999999999854 345679999876442 34567999999999999999999883 33
Q ss_pred eEEEEEEeccc-hhHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC
Q 014174 162 LYLNLVLEFVP-ETVYRVAKHYS------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP 228 (429)
Q Consensus 162 ~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~ 228 (429)
...++||||++ +++.+.+.... .....+++..++.++.||+.||.||| ++||+||||||+||+++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGA 158 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccCcceEEEcc
Confidence 45889999997 45555543321 11245899999999999999999999 889999999999999998
Q ss_pred CCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014174 229 HTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLV 304 (429)
Q Consensus 229 ~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~ 304 (429)
++ .++|+|||++........ .....++..|+|||.+.+. .++.++|||||||++|+|+| |..||...+..+...
T Consensus 159 ~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 236 (291)
T cd05094 159 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236 (291)
T ss_pred CC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 87 799999999976543221 2234457889999998764 48899999999999999999 999997766555433
Q ss_pred HHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 305 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+... . .+ ..+...+..+.+|+.+||+.||++|||+.++++
T Consensus 237 ~~~~~--~-----------------~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQG--R-----------------VL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCC--C-----------------CC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 32210 0 00 011236889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=295.54 Aligned_cols=244 Identities=21% Similarity=0.305 Sum_probs=189.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCc----EEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
..+|++.++||+|+||+||+|++..++. .||+|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence 3469999999999999999999877776 48999875432 2344688899999999999999877421
Q ss_pred ceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
..+++++|++ +++.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus 82 --~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH-~~~iiH~dlkp~Nil~~~~~-~~kL~dfG 154 (279)
T cd05109 82 --TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLE-EVRLVHRDLAARNVLVKSPN-HVKITDFG 154 (279)
T ss_pred --CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccccceEEEcCCC-cEEECCCC
Confidence 2567999998 455554432 2356899999999999999999999 88999999999999998877 69999999
Q ss_pred cceecccCCCcc---cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 240 SAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 240 ~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+++......... ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||.......... .......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~-- 230 (279)
T cd05109 155 LARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERL-- 230 (279)
T ss_pred ceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcC--
Confidence 998764332211 12335679999998664 48999999999999999998 899997655433322 22211000
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
..+...+.++.+++.+||..||++|||+.+++.
T Consensus 231 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 231 -------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 011246889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=298.08 Aligned_cols=254 Identities=18% Similarity=0.235 Sum_probs=192.8
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCC----------------cEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeec
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETG----------------ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL 149 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~ 149 (429)
.+|++++.||+|+||.||+|.+..++ ..||+|.+.... ....+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 47999999999999999999876544 468999886542 234579999999999999999
Q ss_pred ceEeeecCCCCceEEEEEEeccch-hHHHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCC
Q 014174 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSR-------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP 221 (429)
Q Consensus 150 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp 221 (429)
++++.. ..+.++||||+.+ ++...+..... ....+++..+..++.|++.||.||| +.||+||||||
T Consensus 85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH-~~~i~H~dlkp 158 (296)
T cd05051 85 LGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE-SLNFVHRDLAT 158 (296)
T ss_pred EEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH-HcCccccccch
Confidence 998743 3457899999974 55555443211 1126899999999999999999999 88999999999
Q ss_pred CceEecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 014174 222 QNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL--GQPLFPG 296 (429)
Q Consensus 222 ~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~ 296 (429)
+||+++.++ .++|+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||..
T Consensus 159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 159 RNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 999999887 799999999876543321 1233457789999998664 48999999999999999998 6788877
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 297 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+..+.+........... .......+..++.++.+|+.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 237 LTDQQVIENAGHFFRDDG---------------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred cChHHHHHHHHhcccccc---------------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 665554444332211000 00000112346789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=304.72 Aligned_cols=267 Identities=25% Similarity=0.395 Sum_probs=209.6
Q ss_pred CCCCCccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----------hhhHHHHHHHHHcCCCCeeecce
Q 014174 83 RNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKH 151 (429)
Q Consensus 83 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~ 151 (429)
....+....+|-++..||+|||+.||+|.+....+.||+|+-.-.+ ...-+|.+|-+.|+||.||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 3445566778999999999999999999999999999999763221 11227999999999999999999
Q ss_pred EeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCeeeecCCCCceEecCC-
Q 014174 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-GIGVCHRDIKPQNLLVNPH- 229 (429)
Q Consensus 152 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~givH~DLkp~Nill~~~- 229 (429)
+|....+ .+|.|+|||+|+-++ .|...++-+++.+++.|+.||+.||.||.. +-.|||-||||.|||+-..
T Consensus 535 yfslDtd----sFCTVLEYceGNDLD---FYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 535 YFSLDTD----SFCTVLEYCEGNDLD---FYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeeccc----cceeeeeecCCCchh---HHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence 9865443 378899999985444 445557889999999999999999999983 2369999999999998421
Q ss_pred -CCcEEEeecccceecccCCCc--------ccccccccccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 014174 230 -THQVKLCDFGSAKVLVKGEPN--------ISYICSRYYRAPELIFG---ATEYTTAIDIWSVGCVLAELLLGQPLFPGE 297 (429)
Q Consensus 230 -~~~vkl~DfG~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~~ 297 (429)
.+.|||+|||+++.+...... ....||.+|++||.+.- .+..+.++||||+|||+|.++.|+.||..+
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence 237999999999988654322 34568999999999843 345789999999999999999999999765
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 298 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
...+.+...-.. -+..++.||.- +-+++++++||++||++--++|....++-.||+|
T Consensus 688 qsQQdILqeNTI-------------lkAtEVqFP~K----------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyl 744 (775)
T KOG1151|consen 688 QSQQDILQENTI-------------LKATEVQFPPK----------PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYL 744 (775)
T ss_pred hhHHHHHhhhch-------------hcceeccCCCC----------CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccc
Confidence 444333221111 12234455442 3479999999999999999999999999999999
Q ss_pred cc
Q 014174 378 YE 379 (429)
Q Consensus 378 ~~ 379 (429)
..
T Consensus 745 lP 746 (775)
T KOG1151|consen 745 LP 746 (775)
T ss_pred cc
Confidence 65
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=310.35 Aligned_cols=247 Identities=19% Similarity=0.269 Sum_probs=190.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.+...+...||+|.||+||+|++.. .||||+++.+ .+.++.|+..+++-+|.||+-+.+++. ...+
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~-----~p~~ 462 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM-----NPPL 462 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc-----CCce
Confidence 3456788999999999999999843 5999998643 345678999999999999999999883 3333
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
.||+.+|+|+.+....+. ...+|.....+.|+.||++|+.||| .++|||||||..||++.+++ .|||+|||++..
T Consensus 463 -AIiTqwCeGsSLY~hlHv--~etkfdm~~~idIAqQiaqGM~YLH-AK~IIHrDLKSnNIFl~~~~-kVkIgDFGLatv 537 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHV--QETKFDMNTTIDIAQQIAQGMDYLH-AKNIIHRDLKSNNIFLHEDL-KVKIGDFGLATV 537 (678)
T ss_pred -eeeehhccCchhhhhccc--hhhhhhHHHHHHHHHHHHHhhhhhh-hhhhhhhhccccceEEccCC-cEEEecccceee
Confidence 799999997543322222 2367899999999999999999999 88999999999999999877 899999999865
Q ss_pred cccC---CCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 244 LVKG---EPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 244 ~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
-..- .......|...|||||++.- ...|++.+|||||||++|||+||..||...+..+.+..+=+..+.|.
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd---- 613 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPD---- 613 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCcc----
Confidence 4221 12223456778999999853 23589999999999999999999999985444443332221111111
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
......+.+.++++|+..||++++++||+..+||.
T Consensus 614 --------------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 --------------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred --------------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 11123456789999999999999999999998876
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=292.56 Aligned_cols=243 Identities=25% Similarity=0.328 Sum_probs=190.1
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
++|++.++||+|+||.||+|++..+ ..||+|.+.... ....+|+.+++.++|+||+++++.+. . .+.++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv 78 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EPIYIV 78 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CCcEEE
Confidence 4699999999999999999988655 469999886532 33567999999999999999987652 1 235799
Q ss_pred Eeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||+++ ++.+.+... ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~ 154 (262)
T cd05071 79 TEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENL-VCKVADFGLARLIED 154 (262)
T ss_pred EEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHH-HCCccccccCcccEEEcCCC-cEEeccCCceeeccc
Confidence 999985 555555321 2345789999999999999999999 88999999999999999887 799999999976644
Q ss_pred CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ....++..|+|||...+. .++.++|+|||||++|+|+| |..||.+.........+.....
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~------------ 221 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR------------ 221 (262)
T ss_pred cccccccCCcccceecCHhHhccC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC------------
Confidence 3321 123356679999988654 48999999999999999999 8899987665544433221100
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
. .....++..+.+|+.+||+.||++|||+.++++
T Consensus 222 ------~----------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 222 ------M----------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ------C----------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 0 012346889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=294.50 Aligned_cols=244 Identities=22% Similarity=0.319 Sum_probs=195.5
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.+|++.++||.|+||.||+|.+.. +..+|+|.+.... ....+|+.+++.++|+||+++++++. .....++
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l 79 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVYI 79 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeEE
Confidence 469999999999999999999877 8899999886443 34567999999999999999998873 3334789
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+++ +|.+.+... ....+++..+..++.||+.||.||| +.||+|+||||+||+++.++ .+||+|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~ 155 (261)
T cd05148 80 ITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLE-EQNSIHRDLAARNILVGEDL-VCKVADFGLARLIK 155 (261)
T ss_pred EEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccCcceEEEcCCc-eEEEccccchhhcC
Confidence 9999985 666655432 2456899999999999999999999 88999999999999999887 79999999997654
Q ss_pred cCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 246 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 246 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... .....++..|+|||.+... .++.++||||||+++|+|++ |+.||.+.+..+.+..+......
T Consensus 156 ~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------- 223 (261)
T cd05148 156 EDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM----------- 223 (261)
T ss_pred CccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC-----------
Confidence 3221 1123346779999998654 48899999999999999998 89999877765555444321100
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
..+..++..+.+++.+||+.||.+|||+.++++
T Consensus 224 -----------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 -----------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -----------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 112346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=289.60 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=190.8
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch--hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
.+|++.+.||+|+||.||++.. .|..||+|.+..+. ....+|+.+++.++|+|++++++++... ....++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEEE
Confidence 4699999999999999999976 57889999886543 2345799999999999999999876432 22478999
Q ss_pred eccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+++ ++.+.+.. .....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++......
T Consensus 80 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE-ANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeccccchheEEEcCCC-cEEecCCccceecccc
Confidence 99985 55555432 12335889999999999999999999 88999999999999999887 7999999998765332
Q ss_pred CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
. ....++..|+|||.+.+. .++.++|||||||++|+|++ |+.||...+..+....+.+..
T Consensus 156 ~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~---------------- 216 (256)
T cd05082 156 Q--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---------------- 216 (256)
T ss_pred C--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC----------------
Confidence 2 233446679999988654 48899999999999999997 999997665444333322110
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..+++.+.+++.+||..+|++|||+.++++
T Consensus 217 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 217 ------------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00122347899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=290.82 Aligned_cols=235 Identities=24% Similarity=0.318 Sum_probs=183.2
Q ss_pred EEccCCceEEEEEEE--cCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEe
Q 014174 98 VVGQGSFGIVFQAKC--LETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
.||+|+||.||+|.+ ..++..+|+|++.... ....+|+.+++.++|+||+++++++. .. ..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~-~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-----AE-SWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CC-CcEEEEe
Confidence 589999999999964 4677899999875432 23457899999999999999988762 22 2578999
Q ss_pred ccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC
Q 014174 170 FVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248 (429)
Q Consensus 170 ~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~ 248 (429)
|++++ +.+.+. ....+++..+..++.|++.||.||| ++||+||||||.||+++.++ .+||+|||++.......
T Consensus 76 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH-~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~ 149 (257)
T cd05116 76 LAELGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLE-ETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE 149 (257)
T ss_pred cCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence 99854 544443 2457899999999999999999999 88999999999999999887 79999999997664432
Q ss_pred Cc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 249 PN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 249 ~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.. ....++..|+|||.+.. ..++.++|+|||||++|+|++ |..||...+.......+.+..
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~------------- 215 (257)
T cd05116 150 NYYKAKTHGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE------------- 215 (257)
T ss_pred CeeeecCCCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence 21 12233578999998854 448889999999999999998 999998766544433332210
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...++..+++++.+||.+||+.||.+||++.+|..
T Consensus 216 ---------------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 216 ---------------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 00123357899999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=297.15 Aligned_cols=246 Identities=22% Similarity=0.347 Sum_probs=187.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... ....+|+.+++.++||||+++++++. ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence 47889999999999999998753 23568898875432 23457999999999999999999873 33
Q ss_pred eEEEEEEeccch-hHHHHHHHhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCC
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYS--------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIK 220 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~--------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLk 220 (429)
...++|+||+.+ ++.+.+.... .....+++..+..++.|++.||.||| +.||+|||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~ivH~dik 154 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA-EMKLVHRDLA 154 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH-HCCeehhhhh
Confidence 347889999984 4544443211 11245788999999999999999999 8999999999
Q ss_pred CCceEecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 014174 221 PQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPG 296 (429)
Q Consensus 221 p~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~ 296 (429)
|+|||++.++ .+||+|||+++....... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+
T Consensus 155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccC-CcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999877 799999999976533221 1222346789999988654 48999999999999999998 9999977
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 297 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.........+... +....+..++.++.+|+.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 233 IAPERLFNLLKTG----------------------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCHHHHHHHHhCC----------------------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 6544332221110 000112347899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=289.02 Aligned_cols=242 Identities=24% Similarity=0.362 Sum_probs=192.1
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh---hhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..+|++.+.||.|+||.||+|.. .|+.||+|.+..... ...+|+.+++.++|+||+++++++.. ....++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEE
Confidence 34699999999999999999987 588999999876543 44579999999999999999998743 334789
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+++ ++.+.+... ....+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .+||+|||.++...
T Consensus 78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~ 153 (256)
T cd05039 78 VTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLE-EKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEAS 153 (256)
T ss_pred EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-hCCccchhcccceEEEeCCC-CEEEcccccccccc
Confidence 9999984 665554431 1236899999999999999999999 88999999999999999887 79999999998763
Q ss_pred cCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
.... ....+..|+|||.+... .++.++|+||||+++|+|++ |..||...+..+....+...
T Consensus 154 ~~~~--~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd05039 154 QGQD--SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG--------------- 215 (256)
T ss_pred cccc--cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC---------------
Confidence 3222 23345679999998654 48899999999999999997 99999766544332222110
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
+ ....+..+++.+.++|++||..+|++|||+.++++
T Consensus 216 ~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 216 Y-------------RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred C-------------CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 00112346899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=297.01 Aligned_cols=248 Identities=23% Similarity=0.349 Sum_probs=192.0
Q ss_pred cccceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeecC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT 157 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 157 (429)
..++|.+.+.||+|+||.||+|.+. .++..||+|.+.... ....+|+.+++++ +|+||+++++++..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-- 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence 3457999999999999999999752 345689999886432 2345799999999 79999999998843
Q ss_pred CCCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEe
Q 014174 158 DKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~ 236 (429)
...+++||||+.+ +|.+.+.. .....+++..+..++.||+.||.||| +.||+|+||||+|||++.++ .++|+
T Consensus 111 ---~~~~~lv~e~~~~~~L~~~i~~--~~~~~l~~~~~~~i~~~i~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~~l~ 183 (302)
T cd05055 111 ---GGPILVITEYCCYGDLLNFLRR--KRESFLTLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNVLLTHGK-IVKIC 183 (302)
T ss_pred ---CCceEEEEEcCCCCcHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeehhhhccceEEEcCCC-eEEEC
Confidence 3348899999984 55554432 11234899999999999999999999 88999999999999999777 79999
Q ss_pred ecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 014174 237 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 312 (429)
Q Consensus 237 DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~ 312 (429)
|||+++....... .....++..|+|||.+.+.. ++.++||||+||++|+|++ |..||................ .
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~-~ 261 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG-Y 261 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC-C
Confidence 9999976543321 11234567899999986644 8999999999999999998 999998766554443332210 0
Q ss_pred CCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+...++.+.+|+.+||..+|++|||+.++++
T Consensus 262 --------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 262 --------------------------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred --------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00012346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=293.42 Aligned_cols=244 Identities=25% Similarity=0.331 Sum_probs=190.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCc---EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.+|++.+.||+|+||.||+|.+..++. .+|+|.+... .....+|+.+++.++||||+++++++. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence 479999999999999999999865543 7999987543 234457999999999999999999873 334
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
+.++||||+++ ++.+.+.. ....+++..+..++.|++.||.||| +.|++||||||+|||++.++ .++|+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~h~dlkp~nili~~~~-~~~l~dfg~~ 153 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILVNSNL-VCKVSDFGLS 153 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeehhhchhcEEECCCC-eEEeCCCCcc
Confidence 58899999985 44444432 2356899999999999999999999 89999999999999999887 7999999999
Q ss_pred eecccCCCcc----cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 242 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 242 ~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
.......... ...++..|+|||.+.+. .++.++|+|||||++|++++ |..||...+..+....+.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~----- 227 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR----- 227 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-----
Confidence 8764432211 11224679999998664 48999999999999999886 9999987665544433322100
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
. ..+..+++.+.+++.+||+.+|.+|||+.++++
T Consensus 228 -------------~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 228 -------------L----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred -------------C----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 0 011246889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=288.92 Aligned_cols=243 Identities=25% Similarity=0.326 Sum_probs=190.5
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
++|.+...||+|+||.||+|.+..+ ..+|+|.+.... ....+|+++++.++|+|++++++++. . ...++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v 78 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYIV 78 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEEE
Confidence 4699999999999999999987554 469999876432 23457999999999999999988762 1 136799
Q ss_pred Eeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||+.+ ++.+.+... ....+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~ 154 (260)
T cd05069 79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIE-RMNYIHRDLRAANILVGDNL-VCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence 999985 666655431 2345889999999999999999999 88999999999999999887 799999999976543
Q ss_pred CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+....+....+.... .
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~----------- 221 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY-R----------- 221 (260)
T ss_pred CcccccCCCccchhhCCHHHhccC-CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-----------
Confidence 3211 123356679999988654 48999999999999999999 899998766554443332210 0
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+...+..+.+|+++||..||++|||+.++++
T Consensus 222 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 222 ----------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ----------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0112346889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=298.50 Aligned_cols=247 Identities=21% Similarity=0.314 Sum_probs=189.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcC-------CCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeecC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTT 157 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 157 (429)
++|.+.+.||+|+||.||+|++.. +...+|+|.+..+. ....+|+++++.+ +|+||+++++++.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--- 94 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--- 94 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe---
Confidence 479999999999999999998643 23579999886432 2344689999999 7999999999883
Q ss_pred CCCceEEEEEEeccch-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCce
Q 014174 158 DKDELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNL 224 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Ni 224 (429)
.....++||||+++ +|.+.+..... ....+++..+..++.|++.||+||| +.|++||||||+||
T Consensus 95 --~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH-~~gi~H~dlkp~Ni 171 (307)
T cd05098 95 --QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNV 171 (307)
T ss_pred --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH-HCCcccccccHHhe
Confidence 33357899999984 66555543211 1235888999999999999999999 88999999999999
Q ss_pred EecCCCCcEEEeecccceecccCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 014174 225 LVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGV 300 (429)
Q Consensus 225 ll~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~ 300 (429)
+++.++ .+||+|||+++........ ....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.+..
T Consensus 172 ll~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 172 LVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred EEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 999887 7999999998765432211 112234679999998764 48999999999999999998 88999765543
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 301 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
+....+... . ....+..++.++.+||.+||..+|.+|||+.++++
T Consensus 250 ~~~~~~~~~-~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 250 ELFKLLKEG-H---------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred HHHHHHHcC-C---------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 333222110 0 00122346899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=296.65 Aligned_cols=256 Identities=30% Similarity=0.461 Sum_probs=196.6
Q ss_pred ceEEeeEEccCCceEEEEEEEc---CCCcEEEEEEeecch--------hhhHHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 92 SYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
+|++.+.||+|+||.||++++. .++..||+|.+.... ....+|+.+++.+ +|+||+++++++ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 3889999999999999999864 467899999886421 2344789999999 599999999887 3
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
.....++||||+.+ ++...+. ....+++..++.++.|++.||.||| +.|++||||||+||+++.++ .++|+||
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH-~~~~~H~dl~p~nil~~~~~-~~~l~df 149 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLH-QLGIIYRDIKLENILLDSEG-HVVLTDF 149 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHeEECCCC-CEEEEEC
Confidence 34458899999986 4443332 2456899999999999999999999 88999999999999999887 7999999
Q ss_pred ccceecccCCC--cccccccccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 239 GSAKVLVKGEP--NISYICSRYYRAPELIFGAT-EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 239 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
|++........ .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+..-
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---- 225 (288)
T cd05583 150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL---- 225 (288)
T ss_pred ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH----
Confidence 99876543322 12345788999999985532 367899999999999999999999965432222222111100
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC---HHHHhcCCCCcccCCC
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACIHPFFYELRDP 383 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t---~~ell~hp~f~~~~~~ 383 (429)
. .....+..++..+.++|.+||+.||++||| +.++|+||||+.+.++
T Consensus 226 ---~------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 226 ---K------------------SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred ---c------------------cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 0 000122346889999999999999999998 5678999999887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=291.07 Aligned_cols=228 Identities=27% Similarity=0.343 Sum_probs=180.7
Q ss_pred CCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEeccch-hHHHHHH
Q 014174 102 GSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAK 180 (429)
Q Consensus 102 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 180 (429)
|.||.||+|++..+++.||+|.+..... ..+|...+....||||+++++++. .....++||||+++ +|.+.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence 8899999999999999999999876543 345666666678999999999883 33458899999985 5555443
Q ss_pred HhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCccccccccccc
Q 014174 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 260 (429)
Q Consensus 181 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~ 260 (429)
. ...+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++++|||.+...... .....++..|+
T Consensus 78 ~----~~~l~~~~~~~~~~ql~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~ 149 (237)
T cd05576 78 K----FLNIPEECVKRWAAEMVVALDALH-REGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC 149 (237)
T ss_pred H----hcCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence 3 346899999999999999999999 88999999999999999888 6999999987655432 22344577799
Q ss_pred ccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCccc
Q 014174 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK 340 (429)
Q Consensus 261 aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (429)
|||.+.+. .++.++|+||+||++|+|++|..||...... +. ... ..
T Consensus 150 aPE~~~~~-~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------~~----~~~------------~~ 195 (237)
T cd05576 150 APEVGGIS-EETEACDWWSLGAILFELLTGKTLVECHPSG-----------------IN----THT------------TL 195 (237)
T ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------cc----ccc------------cc
Confidence 99988553 4789999999999999999999887432110 00 000 00
Q ss_pred ccCCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCC
Q 014174 341 IFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFF 377 (429)
Q Consensus 341 ~~~~~~s~~l~~Li~~~L~~dP~~R~t~-----~ell~hp~f 377 (429)
.++..+++.+.+||.+||+.||++|+|+ .++++||||
T Consensus 196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 196 NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 1234578999999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=291.22 Aligned_cols=244 Identities=22% Similarity=0.299 Sum_probs=190.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCc---EEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.+|+..+.||+|+||.||+|.+..++. .+|+|.+.... .....|+++++.++|+||+++++++. ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCC
Confidence 468999999999999999999876654 79999875432 23456899999999999999999883 333
Q ss_pred EEEEEEeccchhHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~~l~-~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
..++||||++++.+ ..+. .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~ 154 (268)
T cd05063 80 PAMIITEYMENGALDKYLR---DHDGEFSSYQLVGMLRGIAAGMKYLS-DMNYVHRDLAARNILVNSNL-ECKVSDFGLS 154 (268)
T ss_pred CcEEEEEcCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccccchhhEEEcCCC-cEEECCCccc
Confidence 47899999986433 3332 23457899999999999999999999 88999999999999999887 7999999998
Q ss_pred eecccCCCcc----cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 242 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 242 ~~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
.......... ....+..|+|||.+... .++.++|||||||++|+|++ |..||...+.......+......+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~--- 230 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP--- 230 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---
Confidence 7664332211 11224569999988654 48999999999999999997 999998766555444433211000
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.....+..+.+|+.+||+.+|++||++.++++
T Consensus 231 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 -------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11236889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=292.11 Aligned_cols=244 Identities=24% Similarity=0.328 Sum_probs=190.4
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCc---EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..|++.+.||+|+||.||+|.+..+++ .||||.+... ...+..|+.+++.++||||+++++++ ....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence 469999999999999999999887665 6999988643 12345799999999999999999887 3334
Q ss_pred EEEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
..++||||++++ +.+.+.. ..+.+++..++.++.|++.||.||| +.|++|+||||+||+++.++ .+||+|||++
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH-~~g~~H~dl~p~nili~~~~-~~kl~dfg~~ 153 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLS-EMNYVHRDLAARNILVNSNL-VCKVSDFGLS 153 (269)
T ss_pred ceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccChheEEEcCCC-cEEECCCccc
Confidence 478999999864 4443332 2456899999999999999999999 88999999999999999887 7999999998
Q ss_pred eecccCCCccc---cc---ccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 242 KVLVKGEPNIS---YI---CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 242 ~~~~~~~~~~~---~~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
........... .. .+..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~--- 229 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR--- 229 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccC-cccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc---
Confidence 76543322111 11 13579999998654 48999999999999999886 9999987665544443321100
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
. ..+..++..+.+++.+||..+|.+||++.+++.
T Consensus 230 ---------------~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 230 ---------------L----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ---------------C----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 012346889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=293.85 Aligned_cols=260 Identities=25% Similarity=0.364 Sum_probs=188.6
Q ss_pred cceEEeeEEccCCceEEEEEE----EcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.+|++.+.||+|+||.||++. +..++..||+|.+.... ..+.+|+++++.++||||+++++++.... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CC
Confidence 369999999999999999997 34678899999886432 23457999999999999999988765432 23
Q ss_pred EEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++||||++ ++|.+.+.. ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH-~~~i~H~dlkp~nili~~~~-~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLG-SKRYVHRDLATRNILVESEN-RVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCHhhEEECCCC-eEEECCCccc
Confidence 4789999997 455554432 2346899999999999999999999 88999999999999999887 7999999999
Q ss_pred eecccCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCCHH
Q 014174 242 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL-GTPTRE 316 (429)
Q Consensus 242 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~~ 316 (429)
......... ....++..|+|||.+.+. .++.++|||||||++|+|++|..++...... ....+.... +.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccC-CcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchH
Confidence 865433221 112234569999998664 4899999999999999999998776433211 110000000 000000
Q ss_pred HHh-hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 317 EIK-CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 317 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+. .+... .....+..++.++.+|+.+||..+|++|||+.++++
T Consensus 234 ~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 234 HLIELLKNN-------------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHHhcC-------------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 000 00000 001122457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=288.82 Aligned_cols=243 Identities=23% Similarity=0.311 Sum_probs=191.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.+|+++++||+|+||.||+|.. .+++.||+|.+.... ....+|+.+++.++|+||+++++++. . ...+++
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v 78 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-----Q-EPIYII 78 (260)
T ss_pred HHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-----c-CCcEEE
Confidence 4699999999999999999985 467889999886533 34567999999999999999988652 1 136799
Q ss_pred Eeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||+.+ ++.+.+.. .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH-~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~ 154 (260)
T cd05067 79 TEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIE-RKNYIHRDLRAANILVSETL-CCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHh-cCCeecccccHHhEEEcCCC-CEEEccCcceeecCC
Confidence 999974 55554432 22456899999999999999999999 89999999999999999887 799999999977643
Q ss_pred CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ....++..|+|||.+... .++.++||||||+++|+|++ |++||.+.+..+....+......
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------- 222 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM----------- 222 (260)
T ss_pred CCcccccCCcccccccCHHHhccC-CcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC-----------
Confidence 2221 123446789999988654 48899999999999999999 99999877655444333221000
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
..+...+.++.+++.+||..+|++|||+.++++
T Consensus 223 -----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 223 -----------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -----------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 012346889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=312.99 Aligned_cols=263 Identities=28% Similarity=0.405 Sum_probs=215.7
Q ss_pred CccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCce
Q 014174 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 87 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 162 (429)
+..++.|++.++||.|.||+||+++++.+|+..|+|+.... ...++.|.++|+.+ .|||++.+|++|+........
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 33455699999999999999999999999999999987543 45566788999887 599999999999876666667
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.++||||||++ +.-++.+... +.++.|.++..|++.++.||.+|| +..++|||+|-.|||++.++ .|||+|||++
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH-~nkviHRDikG~NiLLT~e~-~VKLvDFGvS 170 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLH-NNKVIHRDIKGQNVLLTENA-EVKLVDFGVS 170 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHh-hcceeeecccCceEEEeccC-cEEEeeeeee
Confidence 79999999995 5556666544 788999999999999999999999 88999999999999999999 6999999998
Q ss_pred eecccCC-CcccccccccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 242 KVLVKGE-PNISYICSRYYRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 242 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
....... ......||++|||||++.+. ..|+.++|+||||++..||.-|.+|+-.......+..|.. .|+..
T Consensus 171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPPk 247 (953)
T KOG0587|consen 171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPPK 247 (953)
T ss_pred eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCcc
Confidence 7664432 33467899999999999654 3467799999999999999999999977655444433221 12111
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
..-++..+..+.+||..||.+|-.+||+..++|+|||+.+
T Consensus 248 -----------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 248 -----------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred -----------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 1113456899999999999999999999999999999974
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=296.53 Aligned_cols=254 Identities=20% Similarity=0.262 Sum_probs=190.0
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCC--------------cEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETG--------------ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKH 151 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~ 151 (429)
.+|++.+.||+|+||.||+|++..++ ..||+|.+.... ....+|+++++.++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 46999999999999999999875432 358999886532 23457999999999999999999
Q ss_pred EeeecCCCCceEEEEEEeccch-hHHHHHHHhh--------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCC
Q 014174 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYS--------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQ 222 (429)
Q Consensus 152 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~ 222 (429)
++.. ....++||||+.+ ++.+.+.... .....+++..+..++.|++.||.||| +.|++||||||+
T Consensus 85 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-~~~i~H~dlkp~ 158 (295)
T cd05097 85 VCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA-SLNFVHRDLATR 158 (295)
T ss_pred EEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH-hcCeeccccChh
Confidence 8843 3347899999985 4544443211 01124688889999999999999999 889999999999
Q ss_pred ceEecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCC
Q 014174 223 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL--GQPLFPGE 297 (429)
Q Consensus 223 Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~~ 297 (429)
||+++.++ .+||+|||++........ .....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||...
T Consensus 159 Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 159 NCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999877 799999999876533221 11223467899999886644 8999999999999999998 66888776
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 298 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
+..+.+..+.+...... .... ...+...++.+.+|+.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~------------~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 237 SDEQVIENTGEFFRNQG------------RQIY---------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred ChHHHHHHHHHhhhhcc------------cccc---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 66555544333110000 0000 0012236889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=296.64 Aligned_cols=248 Identities=21% Similarity=0.313 Sum_probs=190.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcC-------CCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeec
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST 156 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 156 (429)
..+|.+.+.||+|+||.||+|++.. ....||+|.+.... ....+|+++++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-- 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence 3579999999999999999998642 34579999876432 2244789999999 6999999999883
Q ss_pred CCCCceEEEEEEeccch-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCc
Q 014174 157 TDKDELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223 (429)
Q Consensus 157 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~N 223 (429)
...++++||||+++ +|.+.+..... ....+++..+..++.||+.||.||| +.||+||||||+|
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH-~~gi~H~dlkp~N 164 (314)
T cd05099 89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE-SRRCIHRDLAARN 164 (314)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH-HCCeeecccccee
Confidence 33457899999984 55555543211 1245888999999999999999999 8899999999999
Q ss_pred eEecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 014174 224 LLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESG 299 (429)
Q Consensus 224 ill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~ 299 (429)
||++.++ .+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+...
T Consensus 165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 165 VLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999887 799999999976543211 1112234579999998664 48999999999999999999 8899977665
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 300 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+....+.... ....+..++.++.+|+.+||..||++|||+.++++
T Consensus 243 ~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 243 EELFKLLREGH----------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 44443332110 00112346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=289.32 Aligned_cols=243 Identities=23% Similarity=0.317 Sum_probs=190.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
++|++.+.||+|+||.||+|.+. ++..+|+|.+... .....+|+.+++.++|+|++++++++. . ...+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~~~lv 78 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-----E-EPIYIV 78 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-----C-CCcEEE
Confidence 46999999999999999999865 5667999988653 234568999999999999999988762 1 125799
Q ss_pred Eeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||+++ ++.+.+.. .....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .++|+|||++.....
T Consensus 79 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~al~~lH-~~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~ 154 (260)
T cd05070 79 TEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIE-RMNYIHRDLRSANILVGDGL-VCKIADFGLARLIED 154 (260)
T ss_pred EEecCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCccceEEEeCCc-eEEeCCceeeeeccC
Confidence 999975 55554432 12345899999999999999999999 88999999999999999887 799999999987644
Q ss_pred CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ....++..|+|||.+.+. .++.++|+||||+++|+|++ |.+||.+.+..+....+.....
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------ 221 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR------------ 221 (260)
T ss_pred cccccccCCCCCccccChHHHhcC-CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 3221 122345679999988654 48899999999999999999 8999987665554443322100
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+...+..+.+|+.+||..||.+|||+.++.+
T Consensus 222 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 222 ----------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred ----------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0112346889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=303.04 Aligned_cols=250 Identities=25% Similarity=0.340 Sum_probs=188.6
Q ss_pred cceEEeeEEccCCceEEEEEEE-----cCCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
++|++.+.||+|+||.||+|.+ ..+++.||||.+.... ....+|+.++..+ +|+||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--- 83 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--- 83 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC---
Confidence 4799999999999999999984 3467899999886432 2345799999999 689999999877432
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhh------------------------------------------------------
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSR------------------------------------------------------ 184 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------ 184 (429)
...+++||||+++ +|.+.+.....
T Consensus 84 -~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 84 -GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred -CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 2347789999985 44444432100
Q ss_pred ---------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCc---cc
Q 014174 185 ---------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN---IS 252 (429)
Q Consensus 185 ---------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~---~~ 252 (429)
....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++......... ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCC
Confidence 0124678888999999999999999 89999999999999999887 7999999998765332211 12
Q ss_pred ccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCC
Q 014174 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331 (429)
Q Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
..++..|+|||.+.+. .++.++|||||||++|+|++ |..||................. .
T Consensus 241 ~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------~---- 300 (343)
T cd05103 241 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---------------R---- 300 (343)
T ss_pred CCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC---------------C----
Confidence 2345679999998664 48999999999999999997 9999976544333322221100 0
Q ss_pred CcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 332 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...+...++++.+++.+||+.||.+|||+.++++|
T Consensus 301 --------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 301 --------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred --------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00112357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=328.29 Aligned_cols=258 Identities=29% Similarity=0.409 Sum_probs=194.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCC-----
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD----- 158 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 158 (429)
-..+|+.++.||+||||.||+|+++-+|+.||||++.-. ...+.+|++.|.+|+|||||+++..|+....
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 345788999999999999999999999999999998644 2345689999999999999998876532100
Q ss_pred --------------------------------------------------------------------------------
Q 014174 159 -------------------------------------------------------------------------------- 158 (429)
Q Consensus 159 -------------------------------------------------------------------------------- 158 (429)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred ---------------------CCc--------eEEEEEEeccchhHHHHHHHhhhcCCCC-CHHHHHHHHHHHHHHHHHH
Q 014174 159 ---------------------KDE--------LYLNLVLEFVPETVYRVAKHYSRASQRM-PLIYVKLYTYQICRALAYI 208 (429)
Q Consensus 159 ---------------------~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~l-~~~~~~~i~~qi~~aL~~L 208 (429)
..+ .++||=||||+..+++.+-.. +... ....++.+++||++||.|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~---N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR---NHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh---cccchhhHHHHHHHHHHHHHHHHH
Confidence 000 457899999998777655432 2222 4678899999999999999
Q ss_pred HcCCCeeeecCCCCceEecCCCCcEEEeecccceecc-------------------cCCCcccccccccccccccccCCC
Q 014174 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-------------------KGEPNISYICSRYYRAPELIFGAT 269 (429)
Q Consensus 209 H~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~ 269 (429)
| ++|||||||||.||++++++ .|||+|||+|+... .....++.+||.-|+|||++.+..
T Consensus 714 H-~~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 714 H-DQGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred H-hCceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 9 88999999999999999888 69999999998721 011345678999999999997665
Q ss_pred --CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCC
Q 014174 270 --EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMP 347 (429)
Q Consensus 270 --~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 347 (429)
.|+.++|||||||||+||+. ||.. .++-...+.. +..+ .+|.. ..+...--
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~-LR~g---------------~iP~~------~~f~~~~~ 844 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTN-LRKG---------------SIPEP------ADFFDPEH 844 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHh-cccC---------------CCCCC------cccccccc
Confidence 69999999999999999985 4532 2222221111 1111 11110 00111123
Q ss_pred hhHHHHHHhhcCcCCCCCCCHHHHhcCCCCc
Q 014174 348 PEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378 (429)
Q Consensus 348 ~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~ 378 (429)
+.-..+|+.||+.||++||||.|+|++.||-
T Consensus 845 ~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 845 PEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred hHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 5567899999999999999999999999996
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=287.05 Aligned_cols=244 Identities=21% Similarity=0.324 Sum_probs=191.1
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.+|++.+.||+|+||.||+|.+. ++..+|+|.+... .....+|+++++.++|||++++++++ ......++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEE
Confidence 36999999999999999999875 4678999988643 23456799999999999999999887 333457899
Q ss_pred EeccchhHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~~l~-~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||+.++.+ +.+. .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++.....
T Consensus 78 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~ 152 (256)
T cd05112 78 FEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEGMAYLE-SSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLD 152 (256)
T ss_pred EEcCCCCcHHHHHH---hCccCCCHHHHHHHHHHHHHHHHHHH-HCCccccccccceEEEcCCC-eEEECCCcceeeccc
Confidence 999986533 3322 22356889999999999999999999 88999999999999999877 799999999876543
Q ss_pred CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...........+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~aPe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~------------- 218 (256)
T cd05112 153 DQYTSSTGTKFPVKWSSPEVFSFS-KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF------------- 218 (256)
T ss_pred CcccccCCCccchhhcCHhHhccC-CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC-------------
Confidence 3211 122345679999988664 48899999999999999998 999998766544444332210
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
....+...+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 219 ---------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 219 ---------------RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 000112358899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=290.61 Aligned_cols=249 Identities=21% Similarity=0.375 Sum_probs=194.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcC-CCcEEEEEEeecch--------------hhhHHHHHHHH-HcCCCCeeecceEeee
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQDK--------------RYKNRELQTMR-LLDHPNVVSLKHCFFS 155 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--------------~~~~~E~~~l~-~l~h~niv~~~~~~~~ 155 (429)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... ....+|+.++. .++|+||+++++++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 38889999999999999999887 68899999874221 11234677665 479999999999883
Q ss_pred cCCCCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEE
Q 014174 156 TTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK 234 (429)
Q Consensus 156 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vk 234 (429)
...+.++||||+.+ ++.+.+.........+++..++.++.|++.||.|||+..|++|+||||+||+++.++ .+|
T Consensus 80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~ 154 (269)
T cd08528 80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVT 154 (269)
T ss_pred ----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEE
Confidence 34468899999975 555555443444567999999999999999999999436899999999999999887 799
Q ss_pred EeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 235 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 235 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
|+|||++.............++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+......+
T Consensus 155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 232 (269)
T cd08528 155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP- 232 (269)
T ss_pred EecccceeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-
Confidence 99999998765544444566788999999997644 8999999999999999999999997665544433332211000
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
......++.+.+||.+||+.||++|||+.|+..+
T Consensus 233 --------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 --------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred --------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0012368899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=293.23 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=190.6
Q ss_pred cceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
.+|++.++||+|+||.||+|... .++..+|+|.+... ...+.+|+++++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----G 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----C
Confidence 36889999999999999999743 35678999987543 2345679999999999999999988743 3
Q ss_pred eEEEEEEeccch-hHHHHHHHhhh-----------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSR-----------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH 229 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~ 229 (429)
...++||||+++ ++.+.+..... ....+++..+..++.||+.||.||| +.||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA-SLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH-HCCeecccccHhhEEEcCC
Confidence 347899999984 55555433211 1135889999999999999999999 8999999999999999987
Q ss_pred CCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014174 230 THQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVE 305 (429)
Q Consensus 230 ~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~ 305 (429)
+ .+||+|||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |.+||......+....
T Consensus 159 ~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 159 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred C-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 7 799999999976533221 1223346789999988664 48999999999999999998 9999977665554433
Q ss_pred HHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 306 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
+.... + ...+..+++.+.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~--~--------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGR--E--------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCc--c--------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 32210 0 0112346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=294.72 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=192.0
Q ss_pred cccceEEeeEEccCCceEEEEEEEc-------CCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeee
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCL-------ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS 155 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~ 155 (429)
...+|.+.+.||+|+||.||+|++. .++..||+|.+.... ....+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~- 91 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 91 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe-
Confidence 3457999999999999999999753 234579999875432 3345799999999 8999999999883
Q ss_pred cCCCCceEEEEEEeccch-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCC
Q 014174 156 TTDKDELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQ 222 (429)
Q Consensus 156 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~ 222 (429)
.....++||||+.+ +|.+.+..... ....+++..+..++.||+.||.||| +.||+||||||+
T Consensus 92 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH-~~givH~dlkp~ 166 (304)
T cd05101 92 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA-SQKCIHRDLAAR 166 (304)
T ss_pred ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH-HCCeeecccccc
Confidence 33457899999985 55555543211 1235788889999999999999999 889999999999
Q ss_pred ceEecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 014174 223 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGES 298 (429)
Q Consensus 223 Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~ 298 (429)
||+++.++ .+||+|||+++....... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||.+.+
T Consensus 167 Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 167 NVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred eEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999887 799999999987643221 1123346779999998664 48999999999999999998 788997765
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 299 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 299 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
..+....+.... ....+..++..+.+||.+||..+|.+|||+.++++.
T Consensus 245 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKEGH----------------------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHcCC----------------------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 544433322100 000123468999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=291.62 Aligned_cols=240 Identities=23% Similarity=0.328 Sum_probs=182.7
Q ss_pred EEccCCceEEEEEEEcCCCc--EEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEEEEe
Q 014174 98 VVGQGSFGIVFQAKCLETGE--TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
.||+|+||.||+|++..++. .+|+|.+... .....+|+++++.+ +||||+++++++. ...+.++|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~e 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAIE 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEEE
Confidence 68999999999999988776 4688877632 12345799999999 7999999999883 3345789999
Q ss_pred ccc-hhHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEe
Q 014174 170 FVP-ETVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236 (429)
Q Consensus 170 ~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~ 236 (429)
|++ ++|.+.+..... ....+++..+..++.|++.||+||| +.|++||||||+||+++.++ .+||+
T Consensus 77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH-~~~i~H~dikp~nili~~~~-~~kl~ 154 (270)
T cd05047 77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENY-VAKIA 154 (270)
T ss_pred eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccccceEEEcCCC-eEEEC
Confidence 997 456665543211 1235789999999999999999999 89999999999999999888 79999
Q ss_pred ecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 237 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
|||++..............+..|+|||.+.. ..++.++|+|||||++|+|++ |..||.+.+..+....+...
T Consensus 155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~------ 227 (270)
T cd05047 155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------ 227 (270)
T ss_pred CCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC------
Confidence 9999864322111112223567999998865 448999999999999999997 99999776554433332110
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
+ ....+..++.++.+|+.+||..||.+|||+.++++
T Consensus 228 ---------~-------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 ---------Y-------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred ---------C-------------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0 00012236789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=292.14 Aligned_cols=243 Identities=20% Similarity=0.298 Sum_probs=185.9
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCc----EEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
.+|++.+.||+|+||+||+|.+..++. .+++|.+.... .....|+.+++.++||||+++++++. ..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~~ 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----GA 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----CC
Confidence 469999999999999999999887776 47777764321 22345667888999999999998762 11
Q ss_pred eEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
..++++||+. +++.+.+.. ....+++..+..++.||+.||.||| +.|++||||||+||+++.++ .+||+|||+
T Consensus 82 -~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH-~~~iiH~dlkp~nili~~~~-~~kl~Dfg~ 155 (279)
T cd05111 82 -SLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLE-EHRMVHRNLAARNILLKSDS-IVQIADFGV 155 (279)
T ss_pred -ccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-HCCEeccccCcceEEEcCCC-cEEEcCCcc
Confidence 2567899987 555555432 2456899999999999999999999 88999999999999999887 799999999
Q ss_pred ceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 241 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 241 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+....... .+......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-~~~~~~~~~--- 230 (279)
T cd05111 156 ADLLYPDDKKYFYSEHKTPIKWMALESILFG-RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVP-DLLEKGERL--- 230 (279)
T ss_pred ceeccCCCcccccCCCCCcccccCHHHhccC-CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcC---
Confidence 986543321 1223456789999998664 48999999999999999998 99999876543322 222210000
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
. .+...+.++.+++.+||..||++|||+.|+++
T Consensus 231 ------------~------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 231 ------------A------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ------------C------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 11225678999999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=304.97 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=191.6
Q ss_pred cceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhhHHHHHHHHHcC-CCCeeecceEeeecCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 159 (429)
.+|.+.+.||+|+||.||+|++. .++..||+|++.... ....+|++++..+. ||||+++++++..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~---- 112 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK---- 112 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc----
Confidence 46889999999999999999864 345689999986542 23457999999997 9999999998843
Q ss_pred CceEEEEEEeccch-hHHHHHHHhh-------------------------------------------------------
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYS------------------------------------------------------- 183 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~------------------------------------------------------- 183 (429)
...+++||||+.+ +|.+.+....
T Consensus 113 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 113 -GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred -CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 3348899999984 5555553211
Q ss_pred ---------------------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCce
Q 014174 184 ---------------------------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNL 224 (429)
Q Consensus 184 ---------------------------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Ni 224 (429)
.....+++..+..++.||+.||.||| +.||+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrdlkp~Ni 270 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA-SKNCVHRDLAARNV 270 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh-cCCcCcccCCcceE
Confidence 01124677788899999999999999 88999999999999
Q ss_pred EecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 014174 225 LVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGV 300 (429)
Q Consensus 225 ll~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~ 300 (429)
|++.++ .+||+|||+++....... .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||......
T Consensus 271 Ll~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 271 LICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNN-LYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred EEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCC-CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 999877 799999999986533221 1234567889999998664 48999999999999999998 88999776554
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 301 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
+........ +. ....+..++.++.+|+.+||..+|.+||++.++++.
T Consensus 349 ~~~~~~~~~-~~--------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 349 EQFYNAIKR-GY--------------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHHc-CC--------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 443333221 00 001223468999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=287.23 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=193.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.++|++.+.||+|+||.||+|.+. ++..||+|.+... .....+|+.+++.++|+||+++++++. .....++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceEE
Confidence 457999999999999999999975 4578999988653 234567999999999999999998873 3334789
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+.+ ++.+.+.. .....+++..+..++.||+.||.||| +.||+|+||||+||+++.++ .+||+|||++....
T Consensus 79 v~e~~~~~~L~~~i~~--~~~~~~~~~~~~~~~~~i~~al~~lh-~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~ 154 (261)
T cd05034 79 VTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLE-SRNYIHRDLAARNILVGENL-VCKIADFGLARLIE 154 (261)
T ss_pred EEeccCCCCHHHHHhc--cccCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCcchheEEEcCCC-CEEECccccceecc
Confidence 9999975 55554432 12346899999999999999999999 88999999999999999887 79999999987764
Q ss_pred cCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 246 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 246 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
..... ....++..|+|||.+.+. .++.++|+||+|+++|+|++ |+.||.+.+....+..+.....
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~----------- 222 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYG-RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR----------- 222 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 32111 122345679999988754 48999999999999999998 9999987766555544432110
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+...+.++.+++.+||..+|.+|||+.++++
T Consensus 223 -----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 223 -----------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0112235789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=287.93 Aligned_cols=236 Identities=23% Similarity=0.289 Sum_probs=182.0
Q ss_pred EEccCCceEEEEEEEc--CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEec
Q 014174 98 VVGQGSFGIVFQAKCL--ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF 170 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 170 (429)
.||+|+||.||+|.+. .++..||+|++.... ....+|+.+++.++|+||+++++++. .. ..++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~~-~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----AE-ALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----CC-CeEEEEEe
Confidence 3899999999999765 445679999885432 23457999999999999999998762 21 36799999
Q ss_pred cchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCC
Q 014174 171 VPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249 (429)
Q Consensus 171 ~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~ 249 (429)
++++ |.+.+. .....+++..+..++.||+.||.||| ++|++||||||+||+++.++ .+||+|||++........
T Consensus 76 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~ 150 (257)
T cd05115 76 ASGGPLNKFLS---GKKDEITVSNVVELMHQVSMGMKYLE-GKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDS 150 (257)
T ss_pred CCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHH-hcCeeecccchheEEEcCCC-cEEeccCCccccccCCcc
Confidence 9854 443332 22457899999999999999999999 88999999999999999877 799999999976543321
Q ss_pred c----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 250 N----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 250 ~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
. ....++..|+|||.+... .++.++|||||||++|+|++ |..||......+....+.+. .+
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--~~----------- 216 (257)
T cd05115 151 YYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG--KR----------- 216 (257)
T ss_pred ceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC--CC-----------
Confidence 1 111235679999988654 48999999999999999996 99999876655443332221 00
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+...++++.++|.+||..||++||++.++.+
T Consensus 217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122346899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=303.61 Aligned_cols=262 Identities=26% Similarity=0.372 Sum_probs=189.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.+++|.-...||+|+||.||+|.. .+|..||||++.... ..+..|+.++.+++|||+|++++++..... ..
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~ 147 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR 147 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence 456788889999999999999986 445899999886432 347789999999999999999999954332 37
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--CeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI--GVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
+||+||+.. +|.+.+.. .... .++|.....|+.++++||+|||... .|||||||++|||+|.+. ..||+|||+|
T Consensus 148 ~LVYEym~nGsL~d~L~~-~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa 224 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHG-KKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLA 224 (361)
T ss_pred EEEEEccCCCCHHHHhCC-CCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCc
Confidence 799999995 55444432 2111 8899999999999999999999545 399999999999999888 7999999999
Q ss_pred eeccc-CCCcccc-cccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHH-HHhCCCCHH
Q 014174 242 KVLVK-GEPNISY-ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES--GVDQLVEII-KVLGTPTRE 316 (429)
Q Consensus 242 ~~~~~-~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~i~-~~~~~~~~~ 316 (429)
+.... ....... .||..|+|||.+.. ...+.++||||||++|+||+||+.+..... ....+.... ..+...
T Consensus 225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~--- 300 (361)
T KOG1187|consen 225 KLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG--- 300 (361)
T ss_pred ccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc---
Confidence 66543 2222222 78999999999966 448999999999999999999998776432 111122211 111110
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCC-CCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHK-RMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...++--|.+.. ..+.. ..-..+..+..+|+..+|.+||+..++++
T Consensus 301 -------~~~eiiD~~l~~----~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 301 -------KLREIVDPRLKE----GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -------chhheeCCCccC----CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111111111110 00100 01223667888999999999999999744
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=286.86 Aligned_cols=236 Identities=26% Similarity=0.358 Sum_probs=184.1
Q ss_pred eEEccCCceEEEEEEEcCCC---cEEEEEEeecchh-----hhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETG---ETVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
++||+|+||.||+|....++ ..||+|.+..... ...+|+.+++.++|+||+++++++. .. ..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~-~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----GE-PLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----CC-ceEEEE
Confidence 46999999999999876554 7899998864432 3457899999999999999998762 11 367899
Q ss_pred eccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+.+ ++.+.+.. ...+++..+..++.|++.||.||| ..|++|+||||+||+++.++ .+||+|||+++.....
T Consensus 75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh-~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~ 148 (257)
T cd05060 75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLE-SKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG 148 (257)
T ss_pred EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHh-hcCeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence 99975 55554432 347899999999999999999999 88999999999999999888 7999999999866443
Q ss_pred CCcc----cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 248 EPNI----SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 248 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
.... ...++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+....
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~------------ 215 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE------------ 215 (257)
T ss_pred CcccccccCccccccccCHHHhcCC-CCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC------------
Confidence 3211 11224579999988654 48999999999999999998 999998766544433322110
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..++..+.++|.+||..+|++|||+.++++
T Consensus 216 ----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 216 ----------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ----------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00112346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=291.19 Aligned_cols=242 Identities=26% Similarity=0.378 Sum_probs=186.1
Q ss_pred EEeeEEccCCceEEEEEEEc----CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 94 MAERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 94 ~i~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.+.+.||.|.||.||+|... ..+..|+||.++.. ...+.+|++.++.++||||+++++++..... .
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence 46789999999999999987 44678999999542 2345579999999999999999999863222 7
Q ss_pred EEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++|+||+. ++|.+.+... ....+++.....++.||+.||.||| +.+|+|+||+++||+++.++ .+||+|||++..
T Consensus 77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh-~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~ 152 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLH-SNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRP 152 (259)
T ss_dssp EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHH-HTTEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred ccccccccccccccccccc--ccccccccccccccccccccccccc-cccccccccccccccccccc-cccccccccccc
Confidence 78999998 5666666542 2467899999999999999999999 78999999999999999888 899999999987
Q ss_pred cccCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 244 LVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 244 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
....... ....+...|+|||.+.... ++.++||||||+++|||++ |+.||...+..+....+.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~--------- 222 (259)
T PF07714_consen 153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ--------- 222 (259)
T ss_dssp TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE---------
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---------
Confidence 6322211 2234567899999987654 8999999999999999999 789998876666555542210
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..++..+.++|.+||..||.+|||+.++++
T Consensus 223 -------------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 223 -------------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -------------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -------------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 01122357899999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=298.25 Aligned_cols=249 Identities=21% Similarity=0.312 Sum_probs=190.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCC-------CcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeec
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLET-------GETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST 156 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 156 (429)
..+|++.+.||+|+||.||+|++... +..||+|.+.... ....+|+++++.+ +|+||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--
Confidence 34699999999999999999986432 2368999876432 2345799999999 7999999999883
Q ss_pred CCCCceEEEEEEeccch-hHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCc
Q 014174 157 TDKDELYLNLVLEFVPE-TVYRVAKHYS------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223 (429)
Q Consensus 157 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~N 223 (429)
....+++++||+++ +|.+.+.... .....+++..+..++.||+.||.||| +.||+||||||+|
T Consensus 89 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH-~~givH~dlkp~N 164 (334)
T cd05100 89 ---QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA-SQKCIHRDLAARN 164 (334)
T ss_pred ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH-HCCeeccccccce
Confidence 33457899999985 5555554321 11235788889999999999999999 8899999999999
Q ss_pred eEecCCCCcEEEeecccceecccCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 014174 224 LLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESG 299 (429)
Q Consensus 224 ill~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~ 299 (429)
||++.++ .+||+|||+++........ ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+.
T Consensus 165 ill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 165 VLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999887 7999999999765432211 112235679999998664 48899999999999999998 8899987665
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 300 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.+....+.... ....+...+.++.+|+.+||..+|++|||+.+++++
T Consensus 243 ~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKEGH----------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 44433332110 001123468899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=289.93 Aligned_cols=249 Identities=19% Similarity=0.252 Sum_probs=191.8
Q ss_pred ccceEEeeEEccCCceEEEEEEEcC----CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLE----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
..+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---- 80 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED---- 80 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence 4579999999999999999999875 35789999876432 2345789999999999999999976532
Q ss_pred ceEEEEEEeccc-hhHHHHHHHhhhc----CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEE
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHYSRA----SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 235 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl 235 (429)
....+++++|++ +++...+...... ...+++..+..++.||+.||.||| +.+++||||||+||+++.++ .+||
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~i~H~di~p~nil~~~~~-~~kl 158 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-KRGVIHKDIAARNCVIDEEL-QVKI 158 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccCHhhEEEcCCC-cEEE
Confidence 223678999987 4555555432221 156899999999999999999999 88999999999999999887 7999
Q ss_pred eecccceecccCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 014174 236 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 311 (429)
Q Consensus 236 ~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 311 (429)
+|||+++.+...... ....++..|+|||.+.+. .++.++|||||||++|++++ |+.||...+..+....+...
T Consensus 159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-- 235 (280)
T cd05043 159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-- 235 (280)
T ss_pred CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC--
Confidence 999999765433211 123346679999998664 48999999999999999999 99999876554432222110
Q ss_pred CCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
... .....+++++.+++.+||..||++|||+.++++
T Consensus 236 ----------------~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 236 ----------------YRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ----------------CCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 011236889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=289.95 Aligned_cols=237 Identities=19% Similarity=0.203 Sum_probs=178.5
Q ss_pred eEEccCCceEEEEEEEcC------------CCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 97 RVVGQGSFGIVFQAKCLE------------TGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
+.||+|+||.||+|.... ....+|+|.+.... ..+.+|+.+++.++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~---- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD---- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 368999999999998532 22358888765432 2334678899999999999999987432
Q ss_pred ceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC------cEE
Q 014174 161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH------QVK 234 (429)
Q Consensus 161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~------~vk 234 (429)
...++||||++++.+..... .....+++.++..++.||+.||.||| +.||+||||||+|||++.++. .++
T Consensus 77 -~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 77 -VENIMVEEFVEFGPLDLFMH--RKSDVLTTPWKFKVAKQLASALSYLE-DKDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred -CCCEEEEecccCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHhh-hCCeECCCCCcccEEEecCCccCCCCceeE
Confidence 33679999999765544322 23456899999999999999999999 899999999999999976552 289
Q ss_pred EeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCC
Q 014174 235 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTP 313 (429)
Q Consensus 235 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~~~~ 313 (429)
++|||++...... ....++..|+|||.+.....++.++|||||||++|+|+ +|..||......+... ....
T Consensus 153 l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-~~~~---- 224 (262)
T cd05077 153 LSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEG---- 224 (262)
T ss_pred eCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-HHhc----
Confidence 9999998654322 23457888999998865566899999999999999998 5888887654322211 1000
Q ss_pred CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
. . ......+.++.+||.+||+.||.+||++.+|+++
T Consensus 225 ----------~-----~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 225 ----------Q-----C----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ----------C-----c----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 0 0011246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=292.39 Aligned_cols=236 Identities=19% Similarity=0.239 Sum_probs=180.3
Q ss_pred eEEccCCceEEEEEEEcCCCc-------EEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGE-------TVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+.||+|+||.||+|.+..++. .||+|.+.... ....+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-----ESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-----CcE
Confidence 368999999999999865544 38888775432 23456889999999999999999885433 367
Q ss_pred EEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCc-------EEEee
Q 014174 166 LVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-------VKLCD 237 (429)
Q Consensus 166 lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~-------vkl~D 237 (429)
+||||++++ |...+.. ....+++..+..++.||+.||.||| ++||+||||||+||+++.++.. ++++|
T Consensus 76 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 76 MVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLE-DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCccceEEEecccccccCCCceEEecc
Confidence 899999865 4444322 2346899999999999999999999 8999999999999999876532 79999
Q ss_pred cccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 238 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
||++...... ....++..|+|||.+.+...++.++|||||||++|+|++|. +||...+....... ...
T Consensus 152 ~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-~~~------- 220 (258)
T cd05078 152 PGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-YED------- 220 (258)
T ss_pred cccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-HHc-------
Confidence 9998655332 23457888999999976556899999999999999999984 66655443332211 110
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...++...+.++.+||.+||+.||.+|||+.++++.
T Consensus 221 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 221 ----------------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred ----------------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 001223356889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=294.55 Aligned_cols=254 Identities=19% Similarity=0.257 Sum_probs=189.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcC----------------CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeec
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLE----------------TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL 149 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~ 149 (429)
++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ....+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 369999999999999999986432 34579999886432 234579999999999999999
Q ss_pred ceEeeecCCCCceEEEEEEeccch-hHHHHHHHhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCC
Q 014174 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSR-------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP 221 (429)
Q Consensus 150 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp 221 (429)
++++... ...++||||+.+ ++.+.+..... ....+++..+..++.||+.||.||| +.||+||||||
T Consensus 85 ~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dlkp 158 (296)
T cd05095 85 LAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS-SLNFVHRDLAT 158 (296)
T ss_pred EEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH-HCCeecccCCh
Confidence 9988433 347899999974 56555543221 1134778899999999999999999 88999999999
Q ss_pred CceEecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCC
Q 014174 222 QNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL--GQPLFPG 296 (429)
Q Consensus 222 ~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~ 296 (429)
+|||++.++ .++|+|||+++....... .....++..|+|||...+. .++.++|+|||||++|+|++ |..||..
T Consensus 159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 159 RNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred heEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999877 799999999876533221 1122335679999987664 48999999999999999998 7789977
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 297 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+..+.+........ ........ ..+..+++.+.+|+.+||..||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~-----------~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LSDEQVIENTGEFFR-----------DQGRQVYL----------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cChHHHHHHHHHHHh-----------hccccccC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 665544433221100 00000000 012346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=289.27 Aligned_cols=249 Identities=22% Similarity=0.275 Sum_probs=191.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
.+|++.+.||+|+||.||+|+... +...||+|.+.... ....+|+++++.++|+||+++++++ ..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence 369999999999999999999754 34679999875432 2356799999999999999999887 33
Q ss_pred ceEEEEEEeccc-hhHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEE
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHYSRA-----SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK 234 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vk 234 (429)
..+.++||||++ ++|.+.+...... ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH-~~~i~H~dlkp~Nili~~~~-~~~ 157 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS-NARFVHRDLAARNCLVSSQR-EVK 157 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh-hcCcccCcCccceEEEeCCC-cEE
Confidence 445789999998 4555555432211 126899999999999999999999 88999999999999999887 799
Q ss_pred EeecccceecccCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 014174 235 LCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 311 (429)
Q Consensus 235 l~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 311 (429)
|+|||++....... ......++..|+|||.+.+.. ++.++||||||+++|+|++ |..||........+..+...
T Consensus 158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~-- 234 (275)
T cd05046 158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG-- 234 (275)
T ss_pred EcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence 99999986543221 112334577799999886544 7889999999999999998 88899765544433332210
Q ss_pred CCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
. +....+..++..+.+++.+||+.||.+|||+.+++++
T Consensus 235 ---------------~----------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 235 ---------------K----------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred ---------------C----------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0 0001123478999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=286.48 Aligned_cols=239 Identities=25% Similarity=0.339 Sum_probs=187.8
Q ss_pred eEEccCCceEEEEEEEcC-CCc--EEEEEEeecchh-----hhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLE-TGE--TVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+.||+|++|.||+|.+.. ++. .||||.+..... .+.+|+.+++.++|+||+++++.+.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 368999999999999865 333 699998865433 34579999999999999999988743 4578999
Q ss_pred eccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||++ ++|.+.+.... ...+++..+..++.|++.||.||| +.|++|+||||+||+++.++ .+||+|||++......
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 75 ELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLE-SKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN 150 (257)
T ss_pred EecCCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHH-hCCccccccCcccEEEecCC-EEEecccccccccccc
Confidence 9997 45555554321 146899999999999999999999 88999999999999999887 7999999999876442
Q ss_pred CC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 248 EP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 248 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
.. .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+......
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~---------- 219 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTR-TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER---------- 219 (257)
T ss_pred ccceecccCCCCCceecCHHHhccc-CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc----------
Confidence 21 1123456789999988654 48999999999999999998 99999877666554444321000
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+...+..+.+++.+||+.+|++|||+.++++
T Consensus 220 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 220 -----------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -----------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0012246889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=289.68 Aligned_cols=244 Identities=25% Similarity=0.333 Sum_probs=190.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCc----EEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
..+|++.+.||+|+||.||+|.+..+|+ .||+|...... ....+|+.+++.++|+||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS----- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 3579999999999999999999876665 58999876442 234579999999999999999998753
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
...++||||+.+ ++.+.+. .....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~i~H~di~p~nil~~~~~-~~kL~dfg 154 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVR---NHKDNIGSQYLLNWCVQIAKGMSYLE-EKRLVHRDLAARNVLVKTPQ-HVKITDFG 154 (279)
T ss_pred -CceEEEEecCCCCcHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHH-hCCEEecccCcceEEEcCCC-eEEECCCc
Confidence 237789999975 4444433 23456899999999999999999999 89999999999999999887 79999999
Q ss_pred cceecccCCCccc---ccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 240 SAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 240 ~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+++.......... ..++..|+|||.+.. ..++.++|+|||||++|++++ |..||.+....+....+... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~--- 229 (279)
T cd05057 155 LAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG-ER--- 229 (279)
T ss_pred ccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCC-CC---
Confidence 9987643332211 123567999998865 348899999999999999998 99999877654443333221 00
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
. ..+...+..+.+++.+||..||+.|||+.++++
T Consensus 230 ------------~------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 230 ------------L------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ------------C------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 012235788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=285.65 Aligned_cols=242 Identities=26% Similarity=0.377 Sum_probs=191.7
Q ss_pred EEeeEEccCCceEEEEEEEcCCC----cEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 94 MAERVVGQGSFGIVFQAKCLETG----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 94 ~i~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
++.+.||+|+||.||++.+..++ ..||+|.+.... .....|+.+++.++|+||+++++++... ...
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Cee
Confidence 46789999999999999998766 899999886443 2445799999999999999999988433 458
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+++|||+++ ++.+.+.... ...+++..+..++.|++.||.||| +.|++|+||||+||+++.++ .++|+|||++..
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh-~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~ 152 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLE-SKNFIHRDLAARNCLVGENL-VVKISDFGLSRD 152 (258)
T ss_pred EEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHh-cCCeeecccccceEEEccCC-eEEEcccCCcee
Confidence 899999975 5555443311 122899999999999999999999 88999999999999999887 799999999987
Q ss_pred cccCCCcc--cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 244 LVKGEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 244 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
........ ...++..|+|||.+.+ ..++.++|+||||+++|+|++ |.+||...+.......+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------- 222 (258)
T smart00219 153 LYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--------- 222 (258)
T ss_pred cccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---------
Confidence 65442221 1236788999998854 458999999999999999998 8899987665555444332100
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+...+.++.+++.+||..||++|||+.++++
T Consensus 223 -------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 223 -------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0112236899999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=291.09 Aligned_cols=236 Identities=19% Similarity=0.216 Sum_probs=178.5
Q ss_pred EEccCCceEEEEEEEcCC------------------------CcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeec
Q 014174 98 VVGQGSFGIVFQAKCLET------------------------GETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSL 149 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~ 149 (429)
.||+|+||.||+|....+ ...||+|.+.... ..+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 589999999999975322 2358888875432 233467889999999999999
Q ss_pred ceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC
Q 014174 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH 229 (429)
Q Consensus 150 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~ 229 (429)
++++... .+.++||||++++.+..+.. ...+.+++.++..++.||+.||.||| +.||+||||||+|||++..
T Consensus 82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRG-----SENIMVEEFVEHGPLDVCLR--KEKGRVPVAWKITVAQQLASALSYLE-DKNLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeC-----CceEEEEecCCCCcHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH-cCCccCCCCCcccEEEecc
Confidence 9988543 34789999999765443322 23467899999999999999999999 8899999999999999754
Q ss_pred C------CcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHH
Q 014174 230 T------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQ 302 (429)
Q Consensus 230 ~------~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~ 302 (429)
+ ..+|++|||++...... ....++..|+|||.+.+...++.++|||||||++|+|+ +|..||......+.
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred CcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3 14899999988654322 22356778999998866556899999999999999985 69999976654332
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 303 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 303 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.. ..... ..++...++.+.++|.+||+.+|++|||+.+++++
T Consensus 231 ~~-~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 231 ER-FYEKK-----------------------------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HH-HHHhc-----------------------------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 21 11100 00112246789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=284.41 Aligned_cols=237 Identities=23% Similarity=0.359 Sum_probs=183.9
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
++||+|+||.||+|.. .++..||+|.+.... ..+.+|+++++.++||||+++++++.. ....++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence 3689999999999985 468899999875432 234579999999999999999998743 33478999999
Q ss_pred chh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCc
Q 014174 172 PET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 250 (429)
Q Consensus 172 ~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~ 250 (429)
+++ +.+.+. .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++.........
T Consensus 75 ~~~~L~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~ 149 (250)
T cd05085 75 PGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLE-SKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYS 149 (250)
T ss_pred CCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccChheEEEcCCC-eEEECCCccceeccccccc
Confidence 854 433332 22356889999999999999999999 88999999999999999887 7999999998754332211
Q ss_pred c--cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 014174 251 I--SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327 (429)
Q Consensus 251 ~--~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 327 (429)
. ...++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+.........+....
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~----------------- 211 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY----------------- 211 (250)
T ss_pred cCCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence 1 12335679999998654 48899999999999999998 999998776544433322110
Q ss_pred ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..++..+.+|+.+||..+|++|||+.++++
T Consensus 212 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 212 -----------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00112346899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=291.54 Aligned_cols=247 Identities=24% Similarity=0.296 Sum_probs=190.9
Q ss_pred cceEEeeEEccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
++|++.+.||+|+||.||+|.+.. ++..||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~----- 79 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV----- 79 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----
Confidence 469999999999999999998743 67899999886432 335579999999999999999988733
Q ss_pred ceEEEEEEeccch-hHHHHHHHhh------------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCC
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYS------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP 221 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp 221 (429)
....++||||+++ ++.+.+.... .....+++..+..++.||+.||.||| +.|++||||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH-~~~i~H~dl~p 158 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS-ERKFVHRDLAT 158 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH-hCCeecccccH
Confidence 3347899999985 5555554211 11134788889999999999999999 88999999999
Q ss_pred CceEecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 014174 222 QNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGE 297 (429)
Q Consensus 222 ~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~ 297 (429)
+||+++.++ .++|+|||++........ .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||.+.
T Consensus 159 ~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 159 RNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred hheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999888 799999999876533221 1122345679999988654 48999999999999999997 88899776
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 298 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
+..+....+.... .. ..+..++.++.+||.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 237 AHEEVIYYVRDGN-------------------VL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CHHHHHHHHhcCC-------------------CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 6554443322110 00 012346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=284.18 Aligned_cols=237 Identities=24% Similarity=0.344 Sum_probs=184.3
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
++||.|+||.||+|.+.. ++.||+|.+.... ....+|+++++.++|+||+++++++.. ..+.++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-----KQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-----CCCeEEEEEcC
Confidence 368999999999999877 9999999876432 234579999999999999999998743 33478999999
Q ss_pred chh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCc
Q 014174 172 PET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 250 (429)
Q Consensus 172 ~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~ 250 (429)
.++ +.+.+. .....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++.........
T Consensus 75 ~~~~l~~~l~---~~~~~~~~~~~~~~~~~~~~~l~~lH-~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~ 149 (251)
T cd05041 75 PGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEYLE-SKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT 149 (251)
T ss_pred CCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-hCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce
Confidence 754 444332 22356889999999999999999999 88999999999999999887 7999999998765422211
Q ss_pred ---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 251 ---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 251 ---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...........+....
T Consensus 150 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~---------------- 212 (251)
T cd05041 150 VSDGLKQIPIKWTAPEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY---------------- 212 (251)
T ss_pred eccccCcceeccCChHhhccC-CCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC----------------
Confidence 112235569999988664 48999999999999999999 889997765433333221100
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..++.++.+++.+||..+|.+|||+.++++
T Consensus 213 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 213 ------------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred ------------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00112346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=290.93 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=187.5
Q ss_pred ceEEeeEEccCCceEEEEEEE----cCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 92 SYMAERVVGQGSFGIVFQAKC----LETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
-|++++.||+|+||.||+|+. ..++..||+|.+.... ....+|+.+++.++|+||+++++++... +..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence 489999999999999999974 4578899999885332 3445799999999999999998877432 223
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
+.++||||+++ +|...+. .....+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|||++
T Consensus 82 ~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~~i~~aL~~lH-~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLP---RNKNKINLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEH-QVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecccchheEEEcCCC-CEEECCCccc
Confidence 47899999975 4444432 22346899999999999999999999 88999999999999999887 7999999999
Q ss_pred eecccCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC---
Q 014174 242 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT--- 314 (429)
Q Consensus 242 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~--- 314 (429)
......... ....++..|+|||.+.+. .++.++|||||||++|+|+++..|+..... .. .+..+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~--~~---~~~~~~~~~~~ 230 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT--LF---LKMIGPTHGQM 230 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc--hh---hhhcccccccc
Confidence 866443221 123456779999998664 488999999999999999998866533211 00 01111000
Q ss_pred -H-HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 315 -R-EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 315 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
. ..+..+... .....+..++..+.+|+.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 231 TVTRLVRVLEEG-------------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred cHHHHHHHHHcC-------------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 000000000 001123457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=285.61 Aligned_cols=243 Identities=28% Similarity=0.373 Sum_probs=189.5
Q ss_pred cceEEeeEEccCCceEEEEEEEcCC---CcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.+|.+.+.||+|+||.||+|.+... ...||||...... ....+|+.+++.++|+||+++++++.. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~- 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----N- 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----C-
Confidence 3699999999999999999987544 3568999875432 234579999999999999999987632 1
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
..++||||+++ ++.+.+.. ....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~~H~dl~p~nili~~~~-~~~l~d~g~~ 154 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLE-SKRFVHRDIAARNVLVSSPD-CVKLGDFGLS 154 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccChheEEEecCC-CeEEccCcee
Confidence 25689999984 55554432 2346899999999999999999999 88999999999999999887 7999999999
Q ss_pred eecccCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 242 KVLVKGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 242 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
+........ ....++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-------- 225 (270)
T cd05056 155 RYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-------- 225 (270)
T ss_pred eecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 765443221 11223457999998865 448999999999999999996 999998877655544332210
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..++..+.++|.+||..+|.+|||+.+++.
T Consensus 226 --------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 226 --------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred --------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00122457899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=286.59 Aligned_cols=245 Identities=21% Similarity=0.289 Sum_probs=180.7
Q ss_pred EEccCCceEEEEEEEcC--CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEec
Q 014174 98 VVGQGSFGIVFQAKCLE--TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF 170 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 170 (429)
.||+|+||.||+|.... ....+|+|.+.... ....+|+.+++.++|+||+++++.+. .....++||||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e~ 76 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLEF 76 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEEe
Confidence 58999999999996532 34578888765332 23346899999999999999999874 33448899999
Q ss_pred cch-hHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC
Q 014174 171 VPE-TVYRVAKHYSR-ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248 (429)
Q Consensus 171 ~~~-~l~~~~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~ 248 (429)
+++ +|.+.+..... .....++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++.......
T Consensus 77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH-QADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPED 154 (269)
T ss_pred CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH-hcCEecccccHhheEecCCC-cEEEeccccccccccch
Confidence 985 55555543221 1233567888999999999999999 88999999999999999887 79999999986543221
Q ss_pred C---cccccccccccccccccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 249 P---NISYICSRYYRAPELIFG------ATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 249 ~---~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
. .....++..|+|||++.. ...++.++|||||||++|+|++ |..||......+.+..........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~----- 229 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIK----- 229 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCcc-----
Confidence 1 112334677999998743 2346889999999999999999 788998776655544443321100
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+ ...+...++..+.+++..|+ .||.+|||+.++++
T Consensus 230 -----------~~-------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 230 -----------LP-------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -----------CC-------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 00 01123357889999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=285.00 Aligned_cols=246 Identities=20% Similarity=0.230 Sum_probs=180.6
Q ss_pred eEEccCCceEEEEEEEc--CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEe
Q 014174 97 RVVGQGSFGIVFQAKCL--ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
+.||+|+||.||+|... .++..+|+|.+.... ....+|+.+++.++||||+++++++. .....++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence 36899999999999854 355789999875432 23456999999999999999999873 3344789999
Q ss_pred ccch-hHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 170 FVPE-TVYRVAKHYSR-ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 170 ~~~~-~l~~~~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
|+++ ++.+.+..... .....++..++.++.|++.||.||| +.|++||||||+||+++.++ .+||+|||+++.....
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-KNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE 153 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH-HCCEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence 9984 55555543221 1234567788899999999999999 88999999999999999887 7999999998754332
Q ss_pred CC---cccccccccccccccccCC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 248 EP---NISYICSRYYRAPELIFGA------TEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 248 ~~---~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
.. .....++..|+|||++.+. ..++.++|||||||++|+|++ |..||......+...........
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----- 228 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQL----- 228 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccC-----
Confidence 21 1123467789999988532 135789999999999999996 99999776554443322111000
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+..+ .+....+..+.+++++|+ .+|++|||+.+++.
T Consensus 229 ---------~~~~~---------~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 ---------KLPKP---------RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ---------CCCCC---------ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00000 112236788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=283.09 Aligned_cols=240 Identities=23% Similarity=0.342 Sum_probs=189.4
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
.+|++.+.||+|+||.||++.. +++.||+|.+... .....+|+.+++.++|||++++++++.. . ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~-~~~~v~ 77 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-----N-GLYIVM 77 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----C-CcEEEE
Confidence 4699999999999999999864 7889999988653 2344679999999999999999988732 1 157899
Q ss_pred eccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+.+ ++.+.+... ....+++..+..++.|++.||.||| +.|++||||||+||+++.++ .+||+|||++......
T Consensus 78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 78 ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLE-SKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG 153 (254)
T ss_pred ECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence 99984 666655432 2345889999999999999999999 89999999999999999887 7999999998764332
Q ss_pred CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
. .....+..|+|||.+.+. .++.++|+|||||++|+|++ |+.||...+..+....+.+..
T Consensus 154 ~--~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------------- 214 (254)
T cd05083 154 V--DNSKLPVKWTAPEALKHK-KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY---------------- 214 (254)
T ss_pred C--CCCCCCceecCHHHhccC-CcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC----------------
Confidence 1 223345679999988654 48899999999999999997 999998776544333222100
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..++..+.+|+++||+.+|.+|||+.+++.
T Consensus 215 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 ------------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ------------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00012346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=283.63 Aligned_cols=244 Identities=25% Similarity=0.350 Sum_probs=190.3
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ....+|+++++.++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI 77 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence 347999999999999999999854 55679999886533 334579999999999999999887732 23678
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+|||+++ ++.+.+.. .....+++..+..++.|++.||.||| +.|++|+||||+||+++.++ .+||+|||++....
T Consensus 78 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~ 153 (260)
T cd05073 78 ITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANILVSASL-VCKIADFGLARVIE 153 (260)
T ss_pred EEEeCCCCcHHHHHHh--CCccccCHHHHHHHHHHHHHHHHHHH-hCCccccccCcceEEEcCCC-cEEECCCcceeecc
Confidence 9999974 66555543 12356788889999999999999999 88999999999999999887 79999999997654
Q ss_pred cCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 246 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 246 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
..... ....++..|+|||.+... .++.++|+|||||++|+|++ |..||.+.+.......+....
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~------------ 220 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY------------ 220 (260)
T ss_pred CCCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC------------
Confidence 33221 122345679999998654 48889999999999999999 999998766544443332110
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.. ..+...+.++.+++.+||..+|++||++.++++
T Consensus 221 ------~~----------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 221 ------RM----------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ------CC----------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00 011346889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=291.46 Aligned_cols=244 Identities=22% Similarity=0.315 Sum_probs=188.0
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCc----EEEEEEeecchh-----hhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
.+|++.+.||+|+||.||+|.+..+|. .||+|.+..... ...+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~----- 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP----- 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence 468999999999999999999887776 478887764321 345788999999999999999987421
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
..++++||+++ ++.+.+.. ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH-~~~ivH~dikp~Nill~~~~-~~kL~Dfg~ 155 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLE-ERRLVHRDLAARNVLVKSPN-HVKITDFGL 155 (303)
T ss_pred -CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHh-hcCeeccccccceeeecCCC-ceEEccccc
Confidence 14579999984 45554432 2346889999999999999999999 88999999999999999877 799999999
Q ss_pred ceecccCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 241 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 241 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
++........ ....++..|+|||.+.+. .++.++|||||||++|+|++ |..||.+...... ..+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~---- 229 (303)
T cd05110 156 ARLLEGDEKEYNADGGKMPIKWMALECIHYR-KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGER---- 229 (303)
T ss_pred cccccCcccccccCCCccccccCCHHHhccC-CCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCC----
Confidence 9865433221 123346789999998654 48999999999999999997 8999977653332 222221000
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
. ..+...+..+.+++.+||..+|++||++.++++.
T Consensus 230 -------------~----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 230 -------------L----------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -------------C----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0112357889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=313.68 Aligned_cols=244 Identities=24% Similarity=0.341 Sum_probs=198.2
Q ss_pred ceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 92 SYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
+-+..+.||+|+||+||+|+.. .....||||.++.. ...++||++++..|+|||||++++++....
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~---- 562 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD---- 562 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC----
Confidence 5667789999999999999854 23468999988654 345679999999999999999999995433
Q ss_pred eEEEEEEeccc-hhHHHHHHHhhh------cC----CCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC
Q 014174 162 LYLNLVLEFVP-ETVYRVAKHYSR------AS----QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT 230 (429)
Q Consensus 162 ~~~~lv~e~~~-~~l~~~~~~~~~------~~----~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~ 230 (429)
-+|+|+|||. |+|.+.+..... .+ .+++..+...|+.||+.|+.||- ++.+|||||-..|+||..+.
T Consensus 563 -P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs-~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 563 -PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS-SHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred -eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCcccccchhhhhceeccce
Confidence 3889999998 666666543221 12 23888899999999999999999 88999999999999999887
Q ss_pred CcEEEeecccceecccCCCcc---cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 014174 231 HQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEI 306 (429)
Q Consensus 231 ~~vkl~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i 306 (429)
.|||+|||+++..-..+... ...-...|||||.+...+ ++.+|||||+||+|||+++ |..||.+.++.+.+..+
T Consensus 641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i 718 (774)
T KOG1026|consen 641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI 718 (774)
T ss_pred -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence 89999999998764433221 223366799999998755 9999999999999999997 89999999998888776
Q ss_pred HHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 014174 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~el 371 (429)
.+.. ... -+.+.|.++.+|+..||..+|.+||++.||
T Consensus 719 ~~g~----------------lL~------------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 719 RAGQ----------------LLS------------CPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HcCC----------------ccc------------CCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 6521 011 134689999999999999999999999987
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=283.61 Aligned_cols=239 Identities=22% Similarity=0.328 Sum_probs=178.5
Q ss_pred eEEccCCceEEEEEEEcC---CCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLE---TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+.||+|+||.||+|.+.. .+..||||.+... .....+|+.+++.++||||+++++++... ....++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence 368999999999998753 3457999987432 12344688999999999999999866432 22367899
Q ss_pred eccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+.+ ++...+.. .....++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.....
T Consensus 77 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 77 PYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLA-SKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDK 151 (262)
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccCcceEEEcCCC-cEEECCccccccccCC
Confidence 99985 44444432 2345677888889999999999999 88999999999999999887 7999999998765332
Q ss_pred CC-----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 248 EP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 248 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.. .....++..|+|||.+.+. .++.++|||||||++|+|++| .+||...+..+....+... .+
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~-------- 220 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR-------- 220 (262)
T ss_pred cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC--------
Confidence 11 1123346789999988654 489999999999999999994 6777665544333222110 00
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+..++..+.+++.+||..+|++||++.++++
T Consensus 221 ------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 221 ------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred ------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0011235789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=280.94 Aligned_cols=245 Identities=19% Similarity=0.254 Sum_probs=179.5
Q ss_pred EEccCCceEEEEEEEcCC--CcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEec
Q 014174 98 VVGQGSFGIVFQAKCLET--GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF 170 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 170 (429)
.||+|+||.||++....+ ...+++|.+.... ....+|+.+++.++||||+++++.+. .....++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence 589999999999975433 2356677665332 33457888999999999999999884 33457899999
Q ss_pred cch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC-
Q 014174 171 VPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE- 248 (429)
Q Consensus 171 ~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~- 248 (429)
+++ +|...+.........+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||++.......
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH-~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-KHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH-HCCeeccCCccceEEEcCCc-cEEecccccccccCcchh
Confidence 985 555555432222345677888899999999999999 88999999999999999888 69999999986432211
Q ss_pred --CcccccccccccccccccCC------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 249 --PNISYICSRYYRAPELIFGA------TEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 249 --~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
......++..|+|||++... ..++.++|||||||++|+|++ |..||...+..+.+..+......
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~------- 227 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQV------- 227 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhccc-------
Confidence 11234578889999987431 235789999999999999997 56788776665555444331100
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
. .+...+...+++.+.+++..|| .+|.+|||+.++++
T Consensus 228 -------~---------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 228 -------K---------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred -------c---------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0 0011122346889999999999 68999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=283.25 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=187.8
Q ss_pred eEEeeEEccCCceEEEEEEEcC---CCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc-e
Q 014174 93 YMAERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE-L 162 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~-~ 162 (429)
|++.+.||+|+||.||+|.+.. ++..||||++..+. ....+|+++++.++||||+++++++......+. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6778899999999999998653 57899999886432 234578999999999999999998765433222 2
Q ss_pred EEEEEEeccchh-HHHHHHHh--hhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 163 YLNLVLEFVPET-VYRVAKHY--SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 163 ~~~lv~e~~~~~-l~~~~~~~--~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
..+++++|+.++ +...+... ......+++..+..++.||+.||+||| +.||+||||||+||+++.++ .+||+|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~nili~~~~-~~kl~dfg 158 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS-SKNFIHRDLAARNCMLNENM-TVCVADFG 158 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeecccchhhEEEcCCC-CEEECccc
Confidence 346788998754 33333211 111235789999999999999999999 88999999999999999887 79999999
Q ss_pred cceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 240 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 240 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+++....... .....++..|++||.+... .++.++|||||||++|+|++ |.+||.+.+..+....+... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~---- 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADN-VYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-N---- 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcC-ccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-C----
Confidence 9986543221 1223345679999988654 48899999999999999999 88999776554333322211 0
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.. ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus 233 -----------~~------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 233 -----------RL------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred -----------cC------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 011236789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=283.80 Aligned_cols=242 Identities=22% Similarity=0.332 Sum_probs=184.5
Q ss_pred eEEccCCceEEEEEEEcCCC------cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 97 RVVGQGSFGIVFQAKCLETG------ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+.||+|+||.||+|++.... ..+|||.+... .....+|+.+++.++||||+++++++.. ....+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-----NEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-----CCCeE
Confidence 36899999999999976543 68999977543 2334579999999999999999998743 33478
Q ss_pred EEEeccc-hhHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC----CcEEEee
Q 014174 166 LVLEFVP-ETVYRVAKHYSR---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT----HQVKLCD 237 (429)
Q Consensus 166 lv~e~~~-~~l~~~~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~----~~vkl~D 237 (429)
+||||++ +++.+.+..... ....+++..+..++.||+.||.||| +.+++|+||||+||+++.++ ..++|+|
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE-QMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH-hCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 9999997 455555543221 2245788999999999999999999 88999999999999998654 2699999
Q ss_pred cccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014174 238 FGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP 313 (429)
Q Consensus 238 fG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 313 (429)
||++........ .....++..|+|||.+.+. .++.++|||||||++|+|++ |..||...+..+....+... .
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~-- 230 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDG-KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G-- 230 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccC-CcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C--
Confidence 999876533221 1123446789999998664 48999999999999999998 99999876654443332110 0
Q ss_pred CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..++..+.+||.+||..+|.+|||+.++++
T Consensus 231 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 -------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00112346889999999999999999999999865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=299.46 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=194.7
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCc---E-EEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGE---T-VAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
-.+.++||+|+||.||+|+.+..+. . ||+|..+.+. ..+-+|+++++.++|||||++||+.....
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~---- 234 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE---- 234 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC----
Confidence 3445899999999999999875432 3 8999886421 23347999999999999999999884433
Q ss_pred eEEEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
-+++|||+|.|+ |.+.+.. ....++..+...++.+.+.||+||| ++++|||||-..|+|++.++ .+||+|||+
T Consensus 235 -Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh-~k~~IHRDIAARNcL~~~~~-~vKISDFGL 308 (474)
T KOG0194|consen 235 -PLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLH-SKNCIHRDIAARNCLYSKKG-VVKISDFGL 308 (474)
T ss_pred -ccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHH-HCCCcchhHhHHHheecCCC-eEEeCcccc
Confidence 378999999974 4443332 2336999999999999999999999 89999999999999999877 689999999
Q ss_pred ceecccCCCcc-cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 241 AKVLVKGEPNI-SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 241 a~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
++....-.... ..--...|+|||.+... .|+.++|||||||++||+++ |..||.+....+....+....
T Consensus 309 s~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~-------- 379 (474)
T KOG0194|consen 309 SRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNG-------- 379 (474)
T ss_pred ccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcC--------
Confidence 87643111111 11235679999999765 59999999999999999998 889999998887777764411
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
++...+...+.++..++.+|+..||++|+|+.++.+ ++..+..
T Consensus 380 -------------------~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~--~l~~~~~ 422 (474)
T KOG0194|consen 380 -------------------YRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK--KLEALEK 422 (474)
T ss_pred -------------------ccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH--HHHHHHh
Confidence 111223356889999999999999999999999876 5555444
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=281.17 Aligned_cols=234 Identities=20% Similarity=0.196 Sum_probs=178.6
Q ss_pred eEEccCCceEEEEEEEcCCC----------cEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 97 RVVGQGSFGIVFQAKCLETG----------ETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
+.||+|+||.||+|.+..++ ..+++|.+.... ..+.+|+.+++.++|+||+++++++.. . .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-----~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-D-----E 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-C-----C
Confidence 36899999999999998776 358888765433 345578999999999999999998754 2 2
Q ss_pred EEEEEeccchhH-HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC------cEEEe
Q 014174 164 LNLVLEFVPETV-YRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH------QVKLC 236 (429)
Q Consensus 164 ~~lv~e~~~~~l-~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~------~vkl~ 236 (429)
.++||||++++. ...+.. ....+++..+..++.||+.||.||| +.||+||||||+||+++.++. .+||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH-~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLE-DKKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred cEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHh-hCCeecccCccceEEEecCccccCCceeEEeC
Confidence 578999998654 333322 1236899999999999999999999 899999999999999986651 49999
Q ss_pred ecccceecccCCCcccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 237 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
|||++..... .....++..|+|||.+.+. ..++.++|||||||++|+|++ |..||...+.......... .
T Consensus 151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~----~- 222 (259)
T cd05037 151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD----Q- 222 (259)
T ss_pred CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc----C-
Confidence 9999986543 2234466779999998765 358999999999999999999 5788866543222111110 0
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+......+.+||.+||..+|.+|||+.++++
T Consensus 223 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 -------------------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -------------------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0001112478999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=280.87 Aligned_cols=259 Identities=25% Similarity=0.348 Sum_probs=188.6
Q ss_pred ceEEeeEEccCCceEEEEEEEc----CCCcEEEEEEeecchh-----hhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 92 SYMAERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.|++.+.||+|+||.||+|... .++..||+|.+..... .+.+|+++++.++|+||+++++++.. ....
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~~ 81 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGGR 81 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCCC
Confidence 5888999999999999999864 3478999998865433 45679999999999999999887743 2234
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
+.++||||+++ ++.+.+.. ....+++..+..++.|++.||.||| +.||+|+||||+||+++.++ .++|+|||++
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH-~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~ 156 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLG-SQRYIHRDLAARNILVESED-LVKISDFGLA 156 (284)
T ss_pred ceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHhEEEcCCC-CEEEcccccc
Confidence 57899999975 55554432 2235899999999999999999999 88999999999999999887 7999999999
Q ss_pred eecccCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCCHH
Q 014174 242 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK-VLGTPTRE 316 (429)
Q Consensus 242 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~-~~~~~~~~ 316 (429)
......... ....++..|+|||.+.+. .++.++|||||||++|+|++|..||......... +.. ..+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~ 233 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR--MIGIAQGQMIVT 233 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhcc--ccccccccccHH
Confidence 876532211 122345669999988664 4889999999999999999999998653321100 000 00000000
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+.....+.. ....+...+.++.+|+.+||..+|.+|||+.++++
T Consensus 234 ~~~~~~~~~~------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 234 RLLELLKEGE------------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHHcCC------------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000000 00012235789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=310.31 Aligned_cols=247 Identities=20% Similarity=0.326 Sum_probs=196.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCc-----EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGE-----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
..-++.+.||+|+||.||.|....... .||||.+.+. ...+-+|..+|+.++|||||+++++.+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~-- 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP-- 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC--
Confidence 457788999999999999998764333 4999988654 3344579999999999999999999976333
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEe
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSR---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~ 236 (429)
.+|++|||.+ +|+..+..-.. ....++......++.||++|++||+ ++++|||||...|+||+... .|||+
T Consensus 770 ---~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe-~~~fvHRDLAaRNCLL~~~r-~VKIa 844 (1025)
T KOG1095|consen 770 ---PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE-SKHFVHRDLAARNCLLDERR-VVKIA 844 (1025)
T ss_pred ---cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH-hCCCcCcchhhhheeecccC-cEEEc
Confidence 6789999985 55555443210 1456899999999999999999999 89999999999999999887 89999
Q ss_pred ecccceecccCCCccc---ccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 014174 237 DFGSAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGT 312 (429)
Q Consensus 237 DfG~a~~~~~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~ 312 (429)
|||+|+.....+.... ..-...|||||.+.. ..++.++|||||||++||++| |..||.+.++.+.+......-
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-- 921 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-- 921 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--
Confidence 9999995433322111 122457999999976 449999999999999999998 889999988877776554421
Q ss_pred CCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
+-..+..++..+.++|..||+.+|++||+...|++
T Consensus 922 --------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 --------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred --------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 01124568999999999999999999999999887
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=283.07 Aligned_cols=282 Identities=29% Similarity=0.463 Sum_probs=211.9
Q ss_pred cccceEEeeEEccCCceEEEEEEEcC---CCcEEEEEEee--cchhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCce
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLE---TGETVAIKKVL--QDKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 162 (429)
....|.++++||.|.|++||++.+.. ..+.||+|.+. .....+..|+++|..+. +.||+++.+++ ..+.
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccCC
Confidence 34469999999999999999999887 78899999885 34566778999999985 89999999988 5555
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+++|+||++..-...+. ..++...++.+++.++.||.++| ..|||||||||.|+|.+.....-.|+|||+|.
T Consensus 109 ~v~ivlp~~~H~~f~~l~------~~l~~~~i~~Yl~~ll~Al~~~h-~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLY------RSLSLAEIRWYLRNLLKALAHLH-KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eeEEEecccCccCHHHHH------hcCCHHHHHHHHHHHHHHhhhhh-ccCccccCCCccccccccccCCceEEechhHH
Confidence 689999999975433332 34778999999999999999999 89999999999999999877788899999986
Q ss_pred ecccC---------------------------------------------CCcccccccccccccccccCCCCCCCchhH
Q 014174 243 VLVKG---------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAIDI 277 (429)
Q Consensus 243 ~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 277 (429)
..... ....+..||+.|+|||++......++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 21000 000134589999999999888888999999
Q ss_pred HHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHhhcC------------------cCcccccCCCcCC---
Q 014174 278 WSVGCVLAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEIKCMN------------------PNYTEFKFPQIKA--- 335 (429)
Q Consensus 278 wslG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~--- 335 (429)
||.|+|+..+++++.||- ..+....+.++...+|.........+. .+|..+....+..
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 999999999999998874 455556666666555543222211111 1111111011111
Q ss_pred -CCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 336 -HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 336 -~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
..+........+..+.+|+.+||..||.+|+|++++|+||||.+...
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~ 389 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADR 389 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhh
Confidence 01222223345678999999999999999999999999999986443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=292.73 Aligned_cols=274 Identities=22% Similarity=0.273 Sum_probs=181.3
Q ss_pred ccccceEEeeEEccCCceEEEEEEEc----------------CCCcEEEEEEeecchh------------------hhHH
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCL----------------ETGETVAIKKVLQDKR------------------YKNR 133 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~------------------~~~~ 133 (429)
...++|.+.++||+|+||+||+|... ..++.||||++..... ....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 34568999999999999999999752 3456799999854321 1123
Q ss_pred HHHHHHHcCCCCe-----eecceEeeecCC---CCceEEEEEEeccch-hHHHHHHHhh-----------h---------
Q 014174 134 ELQTMRLLDHPNV-----VSLKHCFFSTTD---KDELYLNLVLEFVPE-TVYRVAKHYS-----------R--------- 184 (429)
Q Consensus 134 E~~~l~~l~h~ni-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~~~~~~-----------~--------- 184 (429)
|+.++.+++|.++ +++++++..... ......++|+||+++ +|.+.+.... .
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 6666777766654 566666543211 112346799999985 4444443210 0
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCccc--cccccccccc
Q 014174 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--YICSRYYRAP 262 (429)
Q Consensus 185 ~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~--~~gt~~y~aP 262 (429)
....+++..++.++.|++.||.||| +.+|+||||||+|||++.++ .+||+|||++........... ..+|+.|+||
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH-~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLH-RIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1123467788999999999999999 88999999999999999887 799999999976543322222 2347899999
Q ss_pred ccccCCCC-------------------C--CCchhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 263 ELIFGATE-------------------Y--TTAIDIWSVGCVLAELLLGQP-LFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 263 E~~~~~~~-------------------~--~~~~DiwslG~il~~lltg~~-pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
|.+..... + ....||||+||++|+|++|.. ||.+....... .+... .....|..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~---~~~~~-~~~~~~r~ 455 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE---LRQYD-NDLNRWRM 455 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH---Hhhcc-chHHHHHh
Confidence 98753211 1 234799999999999999985 77542211110 00000 00001110
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCC---CCCCCHHHHhcCCCCcc
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP---NLRCTALEACIHPFFYE 379 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP---~~R~t~~ell~hp~f~~ 379 (429)
. ....+........++.++||+.+||..+| .+|+|+.|+|+||||..
T Consensus 456 ~------------~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 456 Y------------KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred h------------cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 0 00011111223468999999999999876 68999999999999953
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=304.09 Aligned_cols=250 Identities=30% Similarity=0.470 Sum_probs=190.6
Q ss_pred eEEeeEEccCCceE-EEEEEEcCCCcEEEEEEeecchh-hhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEEEEe
Q 014174 93 YMAERVVGQGSFGI-VFQAKCLETGETVAIKKVLQDKR-YKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 93 y~i~~~lg~G~~g~-V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
|.-.+++|.|+-|+ ||+|.. .|+.||+|++..+.. ...+|+..|+.- +|||||++|+.- .+..+.||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence 44457889999986 699976 789999999876654 778999999988 599999986543 67778999999
Q ss_pred ccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC---CC-CcEEEeecccceecc
Q 014174 170 FVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HT-HQVKLCDFGSAKVLV 245 (429)
Q Consensus 170 ~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~---~~-~~vkl~DfG~a~~~~ 245 (429)
.|..+|.+++...............+.++.|++.||++|| +.+||||||||.||||+. ++ -+++|+|||+|+...
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH-sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH-SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH-hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 9999998888763111111122456788899999999999 899999999999999976 23 379999999999886
Q ss_pred cCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 246 KGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 246 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
.+... ....||-.|+|||++.... -+.++|||||||++|+.++| ..||...-. .-..|..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~--R~~NIl~------------ 727 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--RQANILT------------ 727 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHH--hhhhhhc------------
Confidence 55432 3456899999999997654 57799999999999999986 799954321 1112221
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.++.-+.+ .+....++.+||.+||.++|..||+|.++|.||||-.
T Consensus 728 --~~~~L~~L------------~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 728 --GNYTLVHL------------EPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred --Cccceeee------------ccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 11111111 1111228999999999999999999999999999955
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=253.22 Aligned_cols=216 Identities=23% Similarity=0.422 Sum_probs=177.7
Q ss_pred CccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHH-HcCCCCeeecceEeeecCCCC
Q 014174 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMR-LLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 87 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~ 160 (429)
....+....+..||+|+||.|-+.++..+|...|+|.+.... ...-+|+.+.. ...+|++|.+|+.++...+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd-- 119 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD-- 119 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc--
Confidence 344455667789999999999999999999999999985432 22224555443 3469999999998865555
Q ss_pred ceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
++|.||.|..++..+..+....++.+++..+-+++..++.||.|||++..++|||+||+||||+.+| ++||||||+
T Consensus 120 ---vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGI 195 (282)
T KOG0984|consen 120 ---VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGI 195 (282)
T ss_pred ---EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEccccc
Confidence 8999999999888888887888899999999999999999999999888999999999999999998 799999999
Q ss_pred ceecccCCCcccccccccccccccccC---CCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHH
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFG---ATEYTTAIDIWSVGCVLAELLLGQPLFPG-ESGVDQLVEIIK 308 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~~~~~~i~~ 308 (429)
+....++-..+...|...|||||.+.. ...|+.++||||||+++.||.+++.||.. .+.-+++.++.+
T Consensus 196 sG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 196 SGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred ceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 988766655554567777999999843 34689999999999999999999999964 455566665554
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=284.47 Aligned_cols=239 Identities=31% Similarity=0.463 Sum_probs=189.2
Q ss_pred eEEeeEEccCCceEEEEEEEcCC--Cc--EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLET--GE--TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~--~~--~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
-.+.++||.|-||.||.|....- |+ .||||..+.+ .+.+-.|..+++.++|||||++++++....
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P------ 464 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP------ 464 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc------
Confidence 44457999999999999986532 33 5889987653 344457999999999999999999984322
Q ss_pred EEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
++||||+++ |.|...+ .+....++......+++||+.||.||| +..+|||||-..||||.+.. .|||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yL---q~nk~sL~l~tL~ly~~Qi~talaYLe-SkrfVHRDIAaRNiLVsSp~-CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYL---QQNKDSLPLRTLTLYCYQICTALAYLE-SKRFVHRDIAARNILVSSPQ-CVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHH---HhccccchHHHHHHHHHHHHHHHHHHH-hhchhhhhhhhhheeecCcc-eeeecccchhh
Confidence 789999998 4444433 345677999999999999999999999 88999999999999999887 79999999999
Q ss_pred ecccCCCcccccc--cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 243 VLVKGEPNISYIC--SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 243 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
.+.+........| ..-|||||.+.- ..++.++|+|.|||+|||++. |..||.+-.+.+.+..+.+.-
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe--------- 609 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE--------- 609 (974)
T ss_pred hccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC---------
Confidence 8866654443333 455999999843 559999999999999999885 999998866555443332211
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~el 371 (429)
+...|+++|+.+..|+.+||+++|.+||+..++
T Consensus 610 -------------------RlP~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 610 -------------------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred -------------------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 112456789999999999999999999987764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=263.69 Aligned_cols=238 Identities=38% Similarity=0.624 Sum_probs=190.6
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEeccch-hHH
Q 014174 103 SFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVY 176 (429)
Q Consensus 103 ~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 176 (429)
+||.||+|.+..+|+.+|+|++... .....+|++.++.++|+||+++++++... ...++++||+++ ++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHH
Confidence 5899999999889999999988643 34556899999999999999999988432 457899999997 666
Q ss_pred HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCccccccc
Q 014174 177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256 (429)
Q Consensus 177 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt 256 (429)
..+.. ...++...+..++.+++.++.+|| +.|++|+||+|.||+++.++ .++|+|||.+.............++
T Consensus 76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~ 149 (244)
T smart00220 76 DLLKK----RGRLSEDEARFYARQILSALEYLH-SNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT 149 (244)
T ss_pred HHHHh----ccCCCHHHHHHHHHHHHHHHHHHH-HcCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence 55443 233899999999999999999999 88999999999999999887 7999999999877655444556778
Q ss_pred ccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCC
Q 014174 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH 336 (429)
Q Consensus 257 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (429)
..|++||.+.+ ..++.++|+||||+++++|++|..||....................
T Consensus 150 ~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---------------------- 206 (244)
T smart00220 150 PEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF---------------------- 206 (244)
T ss_pred cCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC----------------------
Confidence 89999999865 3478899999999999999999999977433333332222100000
Q ss_pred CcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 337 PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 337 ~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
......++.++.+++.+||..+|++||++.++++||||
T Consensus 207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 00001167899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=282.48 Aligned_cols=250 Identities=23% Similarity=0.332 Sum_probs=201.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCC-C--cEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLET-G--ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
++..+.++||+|.||.|++|.+... | -.||||.+..+. ..+.+|+.+|.+|+|+|++++|++..+..
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp----- 184 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP----- 184 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch-----
Confidence 4566778999999999999998743 3 368999886543 34568999999999999999999875421
Q ss_pred EEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
+.+|||+++ |+|++.+.. .....|.......|+.||+.|+.||. .+++|||||-..|+|+-+.. .|||+|||+.
T Consensus 185 -~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLe-skrlvHRDLAARNlllaspr-tVKI~DFGLm 259 (1039)
T KOG0199|consen 185 -AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLE-SKRLVHRDLAARNLLLASPR-TVKICDFGLM 259 (1039)
T ss_pred -hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhhhheecccc-eeeeecccce
Confidence 558999998 566665544 23567889999999999999999999 88999999999999998766 8999999999
Q ss_pred eecccCCCcccccc----cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 242 KVLVKGEPNISYIC----SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 242 ~~~~~~~~~~~~~g----t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
+.+..++....... ...|+|||.+.... ++.++|+|++||++|||+| |.-||.|....+.+.++-+.-.
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er----- 333 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER----- 333 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-----
Confidence 99877766542222 44599999997654 9999999999999999998 7899999988887776643110
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.. =++.++.++.+++.+||+.+|.+|||+..|...-+..+
T Consensus 334 -----------Lp------------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 334 -----------LP------------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred -----------CC------------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 00 12457999999999999999999999999876545443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=287.34 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=204.3
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCC---cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...-.|.++||.|.||.|++|+.+..| ..||||.++.. +..+..|+.||-+++||||+++.++. ...
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tks 702 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TKS 702 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ecC
Confidence 345788999999999999999988766 46999998643 34445799999999999999999987 333
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.-+.||+|||+.+.++.... ...+.|+..+..-+++.|+.|++||- ++|+|||||-..||||+++- .+|++|||++
T Consensus 703 ~PvMIiTEyMENGsLDsFLR--~~DGqftviQLVgMLrGIAsGMkYLs-dm~YVHRDLAARNILVNsnL-vCKVsDFGLS 778 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLR--QNDGQFTVIQLVGMLRGIASGMKYLS-DMNYVHRDLAARNILVNSNL-VCKVSDFGLS 778 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHh--hcCCceEeehHHHHHHHHHHHhHHHh-hcCchhhhhhhhheeeccce-EEEeccccce
Confidence 44779999999554443322 34577999999999999999999999 99999999999999999998 8999999999
Q ss_pred eecccCC-Ccccccc---cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 242 KVLVKGE-PNISYIC---SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 242 ~~~~~~~-~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
+...++. ...+..| ...|.|||.+.-+ .++.++|+||+|++|||.++ |..||-..++.+.+..|.+..+.|+
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp-- 855 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP-- 855 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC--
Confidence 9875554 2222232 4679999999654 49999999999999999775 9999999999999999888655554
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
|.++|..+..|+..||++|-.+||+..+|+.
T Consensus 856 --------------------------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 856 --------------------------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred --------------------------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 2357999999999999999999999999877
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=274.45 Aligned_cols=241 Identities=22% Similarity=0.359 Sum_probs=195.8
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+....++||.|-||.||.+.+++-...||+|.++.+. ..+..|..+|+.++|||+|++++++ ..+.-+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC-----T~EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----THEPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh-----ccCCCeEEEE
Confidence 4556789999999999999999989999999987653 4556799999999999999999998 4444478999
Q ss_pred eccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
|||. |+|++.+.... ...++.-....++.||..|+.||. .+++|||||-..|+||..+. .||++|||+++.+...
T Consensus 343 EfM~yGNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLE-kknFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtgD 418 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENH-IVKVADFGLSRLMTGD 418 (1157)
T ss_pred ecccCccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHH-Hhhhhhhhhhhhhccccccc-eEEeeccchhhhhcCC
Confidence 9987 78888776533 245777778889999999999999 88999999999999999775 8999999999987543
Q ss_pred CCcccccc---cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 248 EPNISYIC---SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 248 ~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
. .+...| ..-|.|||.+.-. .++.++|||+|||+|||+.| |..||++-+..+.+..+.+.
T Consensus 419 T-YTAHAGAKFPIKWTAPEsLAyN-tFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkg-------------- 482 (1157)
T KOG4278|consen 419 T-YTAHAGAKFPIKWTAPESLAYN-TFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKG-------------- 482 (1157)
T ss_pred c-eecccCccCcccccCccccccc-ccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcc--------------
Confidence 2 222233 4559999988543 48999999999999999998 88999998766655444331
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~el 371 (429)
|.+ .-+..+++.+.+|++.||+++|.+||+..|+
T Consensus 483 ----yRM----------~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 483 ----YRM----------DGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred ----ccc----------cCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 111 1134689999999999999999999999876
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=271.95 Aligned_cols=251 Identities=20% Similarity=0.280 Sum_probs=193.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
....+.++||+|-||.|.++.- ..+.+||+|.++.+ ...+.+|+++|.+|+|||||.+++++..... +|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----ic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hH
Confidence 3688899999999999999984 45799999998654 2455689999999999999999999865443 78
Q ss_pred EEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+|+||+. |+|...+..... ..+.-.....++.||+.|++||. +.++|||||.+.|+|++.++ .+||+|||+++..
T Consensus 612 mI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLe-s~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~l 687 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLE-SLNFVHRDLATRNCLVDGEF-TIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHH-hhchhhccccccceeecCcc-cEEecCccccccc
Confidence 9999998 555444433211 11233445569999999999999 99999999999999999998 6999999999866
Q ss_pred ccCCCcc---cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 245 VKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL--GQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 245 ~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
-.++... ..+-...|||+|.+.-.+ ++.++|+|+||++|||+++ ...||......+.....-..+..+....+.
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 4443321 223367899999997655 9999999999999999864 779998777766665544433322221110
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.-|.-++..+.+||.+||..|-.+|||.+++-.
T Consensus 767 ---------------------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 767 ---------------------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ---------------------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 113347889999999999999999999999844
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=304.92 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=182.0
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
.|...++||+|+||.||+|++..++..||+|.+.........|++++++++|||||++++++... ...++||||+
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~ 765 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYI 765 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCC
Confidence 46677899999999999999989999999999876555556789999999999999999998543 3378999999
Q ss_pred ch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc--CCCeeeecCCCCceEecCCCCcEEEeecccceecccCC
Q 014174 172 PE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG--GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248 (429)
Q Consensus 172 ~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~ 248 (429)
++ ++.+.+. .+++..+..++.||+.||+|||. +.+|+||||||+||+++.++ ..++. ||........
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-eccccccccC-
Confidence 85 4444432 37899999999999999999993 34899999999999999776 56665 6655433211
Q ss_pred CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 014174 249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYTE 327 (429)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 327 (429)
....+|..|+|||++.+. .++.++|||||||++|||+||+.||..... ...+....+...... ....
T Consensus 836 --~~~~~t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 903 (968)
T PLN00113 836 --TKCFISSAYVAPETRETK-DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC---------HLDM 903 (968)
T ss_pred --CCccccccccCcccccCC-CCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc---------chhh
Confidence 233678999999998764 489999999999999999999999953221 111111111100000 0000
Q ss_pred ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
+..+.+... .........++.+++.+||+.||++|||+.++++.
T Consensus 904 ~~~~~~~~~---~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 904 WIDPSIRGD---VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred eeCccccCC---CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000111000 00011123467899999999999999999999874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=258.58 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=185.6
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-hhhhHHHHHHHHH--cCCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..+-++.+.||+|.||.||+|++ .|+.||||++... ...-.||.+|.+. |+|+||+.+++.-...+ .....++|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQLwL 286 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQLWL 286 (513)
T ss_pred hheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEEEEE
Confidence 35789999999999999999998 7899999999654 3445678888764 69999999988654433 45567999
Q ss_pred EEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-------CCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 167 VLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-------GIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 167 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-------~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
|++|.+ |+|++.+.. ..++...+.++++.++.||+|||. +-.|.|||||..||||.+++ .+-|+|+
T Consensus 287 vTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADL 360 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADL 360 (513)
T ss_pred eeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeec
Confidence 999998 677776653 678999999999999999999993 33599999999999999998 7999999
Q ss_pred ccceecccCC-----CcccccccccccccccccCCCCC-----CCchhHHHHHHHHHHHHhC----------CCCCCCCC
Q 014174 239 GSAKVLVKGE-----PNISYICSRYYRAPELIFGATEY-----TTAIDIWSVGCVLAELLLG----------QPLFPGES 298 (429)
Q Consensus 239 G~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~lltg----------~~pf~~~~ 298 (429)
|+|....... .....+||..|||||++...... -..+||||||.++||++.. ++||.+--
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 9997765432 23457899999999999553321 1268999999999999852 46775421
Q ss_pred ----hHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 299 ----GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 299 ----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
..+.+.+++-. -.+.......|.. ...-..+-.|++.||..||.-|.||.-+.+
T Consensus 441 p~DPs~eeMrkVVCv------------------~~~RP~ipnrW~s---~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCV------------------QKLRPNIPNRWKS---DPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCHHHHhcceee------------------cccCCCCCccccc---CHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 11222111110 0000001111111 011234668899999999999999987754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=267.95 Aligned_cols=198 Identities=28% Similarity=0.410 Sum_probs=170.9
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhh------------hHHHHHHHHHcC---CCCeeecceEe
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY------------KNRELQTMRLLD---HPNVVSLKHCF 153 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------~~~E~~~l~~l~---h~niv~~~~~~ 153 (429)
...+|..++.+|.|+||.|++|.++++...|+||.+.+++-. ...|+.||..|+ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 345799999999999999999999999999999988765422 225999999997 99999999999
Q ss_pred eecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcE
Q 014174 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV 233 (429)
Q Consensus 154 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~v 233 (429)
++..|+||+||-.+.+ .++... ......+++.++..|+.||+.|+++|| +.||||||||-+||.++++| .+
T Consensus 639 -----Eddd~yyl~te~hg~g-IDLFd~-IE~kp~m~E~eAk~IFkQV~agi~hlh-~~~ivhrdikdenvivd~~g-~~ 709 (772)
T KOG1152|consen 639 -----EDDDYYYLETEVHGEG-IDLFDF-IEFKPRMDEPEAKLIFKQVVAGIKHLH-DQGIVHRDIKDENVIVDSNG-FV 709 (772)
T ss_pred -----ecCCeeEEEecCCCCC-cchhhh-hhccCccchHHHHHHHHHHHhcccccc-ccCceecccccccEEEecCC-eE
Confidence 7777899999998754 233322 333678999999999999999999999 88999999999999999999 79
Q ss_pred EEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 014174 234 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296 (429)
Q Consensus 234 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 296 (429)
||+|||.|.... +.+...+.||..|.|||++.+..+.+..-|||+||++||.++....||..
T Consensus 710 klidfgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 710 KLIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EEeeccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999987554 34455789999999999998888789999999999999999999999863
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=259.61 Aligned_cols=271 Identities=25% Similarity=0.310 Sum_probs=193.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-hhhhHHHHHHHHH--cCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
....+.++||+|.||.||+|+. +++.||||++... +.....|-+|++. ++|+||++++..-.... ....-++||
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccceeEE
Confidence 3467788999999999999986 6799999999643 4555667777765 58999999977543322 223457799
Q ss_pred Eeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC--------CCeeeecCCCCceEecCCCCcEEEeec
Q 014174 168 LEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG--------IGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 168 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--------~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
++|.+ |+|.+.++. ..+++.....++..+++||+|||.. ..|+|||||..||||.++. +..|+||
T Consensus 287 t~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDF 360 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADF 360 (534)
T ss_pred eeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeecc
Confidence 99998 666666653 5699999999999999999999942 3699999999999999998 7999999
Q ss_pred ccceecccCCC---cccccccccccccccccCCCCCC-----CchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHH
Q 014174 239 GSAKVLVKGEP---NISYICSRYYRAPELIFGATEYT-----TAIDIWSVGCVLAELLLGQPLFP-GESGVDQLVEIIKV 309 (429)
Q Consensus 239 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~lltg~~pf~-~~~~~~~~~~i~~~ 309 (429)
|+|..+..+.. ....+||..|||||++.+...+. .+.||||+|.+||||++...-+. +.-..-++---.++
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 99988765433 34578999999999998766555 36899999999999998764442 22222222222233
Q ss_pred hCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHH------HHhcCCC
Q 014174 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL------EACIHPF 376 (429)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~------ell~hp~ 376 (429)
...|+.+.+....-. ....|.++. .|... .....+.+.+..||..||+-|+|+. ..+.|+|
T Consensus 441 G~hPt~e~mq~~VV~--kK~RP~~p~-~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVR--KKQRPKIPD-AWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred cCCCCHHHHHHHHHh--hccCCCChh-hhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 334555544332100 011222211 11110 1345689999999999999999986 3455555
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=275.40 Aligned_cols=255 Identities=25% Similarity=0.352 Sum_probs=206.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.+|.++.++|+|.||.||+++++.+++..|+|+++-+ ...++.|+-+++..+|||||.+++.+..... +++
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-----lwi 89 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-----LWI 89 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----cEE
Confidence 3699999999999999999999999999999999754 3455679999999999999999999855443 899
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
+||||+++.+..+. ...+.+++..+..++++.+.||+||| +.|=+|||||-.|||++..| .+|++|||.+..+..
T Consensus 90 cMEycgggslQdiy---~~TgplselqiayvcRetl~gl~ylh-s~gk~hRdiKGanilltd~g-DvklaDfgvsaqita 164 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLH-SQGKIHRDIKGANILLTDEG-DVKLADFGVSAQITA 164 (829)
T ss_pred EEEecCCCccccee---eecccchhHHHHHHHhhhhccchhhh-cCCcccccccccceeecccC-ceeecccCchhhhhh
Confidence 99999987665443 34688999999999999999999999 88999999999999999888 699999999865533
Q ss_pred C-CCccccccccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 247 G-EPNISYICSRYYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
. ....++.||++|||||+.. ....|...+|||++|+...|+---++|-...-....+..+-+-
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS-------------- 230 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS-------------- 230 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc--------------
Confidence 2 2345789999999999862 2345899999999999999998888776555544444433332
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
+|...... -....++.+-+|++.+|.++|.+|||++.+|.|||...
T Consensus 231 ~~qpp~lk----------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 231 GFQPPTLK----------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred CCCCCccc----------CCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 11111111 11346888999999999999999999999999999743
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=265.83 Aligned_cols=251 Identities=25% Similarity=0.407 Sum_probs=189.8
Q ss_pred ceEEeeEEccCCceEEEEEEEc---C----CCcEEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceEeeecCC
Q 014174 92 SYMAERVVGQGSFGIVFQAKCL---E----TGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~---~----~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 158 (429)
+..+.+.||+|.||.|++|.-. . ....||+|..+.. ...+..|+++|+.+ .|+||+.+++++..
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~--- 373 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ--- 373 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc---
Confidence 3456679999999999999743 1 1457999987543 34455799999988 59999999998843
Q ss_pred CCceEEEEEEeccc-hhHHHHHHHhh---h-c------C--CCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceE
Q 014174 159 KDELYLNLVLEFVP-ETVYRVAKHYS---R-A------S--QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL 225 (429)
Q Consensus 159 ~~~~~~~lv~e~~~-~~l~~~~~~~~---~-~------~--~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nil 225 (429)
...+++|+||+. |+|+..+.... . . . ..++......++.||+.|++||+ +..+|||||-..|||
T Consensus 374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~-~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA-SVPCVHRDLAARNVL 450 (609)
T ss_pred --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh-hCCccchhhhhhhEE
Confidence 445889999998 66666665432 0 0 0 13889999999999999999999 889999999999999
Q ss_pred ecCCCCcEEEeecccceecccCCCccc--ccc--cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 014174 226 VNPHTHQVKLCDFGSAKVLVKGEPNIS--YIC--SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGV 300 (429)
Q Consensus 226 l~~~~~~vkl~DfG~a~~~~~~~~~~~--~~g--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~ 300 (429)
|..+. .+||+|||+|+...+...... ..+ ...|||||.+.. ..|+.++||||+|++|||+++ |..||++-...
T Consensus 451 i~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 451 ITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred ecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99876 899999999986544433221 112 344999999977 559999999999999999998 88999885423
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 301 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
..+.+..+. |... .-|..+++++.++++.||..+|++||+..++.+ +|..
T Consensus 529 ~~l~~~l~~-G~r~--------------------------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~ 578 (609)
T KOG0200|consen 529 EELLEFLKE-GNRM--------------------------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFEK 578 (609)
T ss_pred HHHHHHHhc-CCCC--------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHHH
Confidence 333322221 1110 113457899999999999999999999998876 4543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=260.49 Aligned_cols=241 Identities=26% Similarity=0.352 Sum_probs=190.3
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCc----EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.+..++||+|+||+||+|.+...|+ +||||++... ...+-+|+-+|.+|+|||++++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 4556799999999999999876665 5788877533 234457899999999999999999884322
Q ss_pred EEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
+-||++|++ |.|++.++. ....+.......|.+||++||.||| .+++|||||-..||||.+-. .+||+|||+|+
T Consensus 772 ~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe-~qrlVHrdLaaRNVLVksP~-hvkitdfgla~ 846 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLE-EQRLVHRDLAARNVLVKSPN-HVKITDFGLAK 846 (1177)
T ss_pred HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHH-hcchhhhhhhhhheeecCCC-eEEEEecchhh
Confidence 668999999 555555543 4567889999999999999999999 88999999999999999877 59999999999
Q ss_pred ecccCCCcccccc---cccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 243 VLVKGEPNISYIC---SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 243 ~~~~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
............+ .+-|||-|.+... .|+.++||||+||++||++| |..|+.+....+.-..+.+.
T Consensus 847 ll~~d~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g--------- 916 (1177)
T KOG1025|consen 847 LLAPDEKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG--------- 916 (1177)
T ss_pred ccCcccccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc---------
Confidence 8766555443332 4569999988664 49999999999999999998 89999887654443322221
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
..... |+..+-++..++.+||..|+..||++.++-.
T Consensus 917 -------eRLsq------------PpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 917 -------ERLSQ------------PPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -------ccCCC------------CCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 01111 2347889999999999999999999988754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=235.69 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=183.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
+.|.|.+.||+|.||.+.+|+++.++..+++|.+.... ..+.+|..---.| -|.||+.-|++-+... .++++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~----d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS----DAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcC----ceEEE
Confidence 46999999999999999999999999999999886543 3344565544444 4899999887765433 36778
Q ss_pred EEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe-cCCCCcEEEeecccceec
Q 014174 167 VLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 167 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill-~~~~~~vkl~DfG~a~~~ 244 (429)
++||++ |+|.+-+ . ...+.+...+.++.|++.||.||| ++++||||||.+|||| +.+..+|||||||+.+..
T Consensus 100 ~qE~aP~gdL~snv---~--~~GigE~~~K~v~~ql~SAi~fMH-sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNV---E--AAGIGEANTKKVFAQLLSAIEFMH-SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eeccCccchhhhhc---C--cccccHHHHHHHHHHHHHHHHHhh-ccchhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999 4443322 2 356889999999999999999999 8999999999999998 555568999999998654
Q ss_pred ccCCCcccccccccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHh
Q 014174 245 VKGEPNISYICSRYYRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIK 319 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~ 319 (429)
+..-. ..-.+..|.+||..... -...+.+|+|.||+++|.++||.+||......+. +.+.++..+..+.
T Consensus 174 g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~---- 247 (378)
T KOG1345|consen 174 GTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP---- 247 (378)
T ss_pred Cceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc----
Confidence 32211 11225569999987432 1246789999999999999999999985443322 2333333222111
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCC---CCHHHHhcCCCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR---CTALEACIHPFF 377 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R---~t~~ell~hp~f 377 (429)
.++.+ | ..+++.+..+.++-|..++++| -++..-...-|.
T Consensus 248 ~~P~~-----------------F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 248 ALPKK-----------------F-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred cCchh-----------------h-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 00011 1 2378999999999999999999 455555555564
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-29 Score=222.81 Aligned_cols=207 Identities=35% Similarity=0.578 Sum_probs=173.5
Q ss_pred EccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEeccc-
Q 014174 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP- 172 (429)
Q Consensus 99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~- 172 (429)
||+|++|.||++.+..+++.+++|++.... ....+|++.++.++|++|+++++++.. ....++++|+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence 689999999999998889999999987654 346789999999999999999988843 345889999999
Q ss_pred hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC-CCCcEEEeecccceecccCC-Cc
Q 014174 173 ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVLVKGE-PN 250 (429)
Q Consensus 173 ~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~-~~~~vkl~DfG~a~~~~~~~-~~ 250 (429)
+++...+... ...++...+..++.+++.+|.+|| +.|++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus 76 ~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh-~~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~ 150 (215)
T cd00180 76 GSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLH-SNGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL 150 (215)
T ss_pred CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence 5655554431 146899999999999999999999 889999999999999997 56 79999999998764432 12
Q ss_pred ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccC
Q 014174 251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330 (429)
Q Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
....+...|++||.+......+.++|+|++|+++++|
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 3345678899999886643578999999999999999
Q ss_pred CCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 014174 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375 (429)
Q Consensus 331 ~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp 375 (429)
..+.+++.+||..||++||++.++++|+
T Consensus 188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1267899999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=276.73 Aligned_cols=207 Identities=18% Similarity=0.174 Sum_probs=145.7
Q ss_pred HcCC-CCeeecceEeeecCC--CCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeee
Q 014174 140 LLDH-PNVVSLKHCFFSTTD--KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 216 (429)
Q Consensus 140 ~l~h-~niv~~~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH 216 (429)
.++| .||+++++.|-.... .....+++++|+++++|...+.. ....+++.+++.++.||+.||.||| ++||+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH-~~gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAH-SQGIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHH-hCCeee
Confidence 4455 577777776522221 11234667899999988877653 2356999999999999999999999 899999
Q ss_pred ecCCCCceEecCCC------------------CcEEEeecccceecccCC-----------------Ccccccccccccc
Q 014174 217 RDIKPQNLLVNPHT------------------HQVKLCDFGSAKVLVKGE-----------------PNISYICSRYYRA 261 (429)
Q Consensus 217 ~DLkp~Nill~~~~------------------~~vkl~DfG~a~~~~~~~-----------------~~~~~~gt~~y~a 261 (429)
|||||+||||+..+ ..+||+|||+++...... ......||++|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 99999999996433 146666777665321100 0012357889999
Q ss_pred cccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccc
Q 014174 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 341 (429)
Q Consensus 262 PE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (429)
||++.+.. ++.++|||||||+||||++|.+|+.... ..+..+... ..+. .
T Consensus 184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~-~~~~-~------------------------- 233 (793)
T PLN00181 184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR-VLPP-Q------------------------- 233 (793)
T ss_pred hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh-hcCh-h-------------------------
Confidence 99987654 8999999999999999999988875321 111111110 0000 0
Q ss_pred cCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 342 FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 342 ~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
. ....+...+++.+||..||.+|||+.++|+||||.+.+
T Consensus 234 ~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~ 272 (793)
T PLN00181 234 I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR 272 (793)
T ss_pred h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence 0 00145577899999999999999999999999998754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=222.02 Aligned_cols=197 Identities=34% Similarity=0.586 Sum_probs=163.6
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
|.+.+.||.|++|.||++.+..+++.+|+|.+... .....+|++.++.++|+|++++++++... ...+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence 56788999999999999999888999999998653 34556799999999999999999887432 347899
Q ss_pred Eeccch-hHHHHHHHhhhcCCC-CCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 168 LEFVPE-TVYRVAKHYSRASQR-MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 168 ~e~~~~-~l~~~~~~~~~~~~~-l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+|++++ ++.+.+.. ... +++..+..++.+++.+|.+|| +.+++|+||+|.||+++.++ .++|+|||.+....
T Consensus 76 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lh-~~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~ 149 (225)
T smart00221 76 MEYCEGGDLFDYLRK----KGGKLSEEEARFYLRQILEALEYLH-SLGIVHRDLKPENILLGMDG-LVKLADFGLARFIH 149 (225)
T ss_pred EeccCCCCHHHHHHh----cccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEeeCceeeEec
Confidence 999997 66555543 223 889999999999999999999 88999999999999999887 79999999998775
Q ss_pred cCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC-CChH
Q 014174 246 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG-ESGV 300 (429)
Q Consensus 246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~ 300 (429)
... ......++..|++||.+.....++.++|+|+||+++++|++|+.||.. .+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~ 207 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT 207 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence 543 334456788899999884334577899999999999999999999977 4444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-28 Score=216.62 Aligned_cols=203 Identities=23% Similarity=0.329 Sum_probs=172.5
Q ss_pred CCccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeec--chhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCce
Q 014174 86 QPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 86 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 162 (429)
....+..|+|.++||+|+||..|.+.+.-+++.||||.... +......|.+..+.|. .++|..+|.+. ....
T Consensus 23 ~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~ 97 (449)
T KOG1165|consen 23 VLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGK 97 (449)
T ss_pred ceEecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccc
Confidence 33445589999999999999999999999999999997643 3345567999999986 68888876554 5556
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec----CCCCcEEEeec
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN----PHTHQVKLCDF 238 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~----~~~~~vkl~Df 238 (429)
|-.||+|+++.+|.+++.. ++++|+..++..++.|++.-++|+| .+.+|+|||||+|+||. .+.+.|.|+||
T Consensus 98 ~NiLVidLLGPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH-~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 98 YNILVIDLLGPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVH-EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred hhhhhhhhhCcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHH-hcceeecccCccceeecCCCCCCCceEEEEec
Confidence 6779999999988887765 4678999999999999999999999 89999999999999994 33447999999
Q ss_pred ccceecccCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 014174 239 GSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298 (429)
Q Consensus 239 G~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 298 (429)
|+|+.+.+... ..+..||..||+-..+.+.+ .+.+.|+-|||-++++.+-|..||.|..
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 99998866543 34667999999999999866 8999999999999999999999998744
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=211.63 Aligned_cols=207 Identities=25% Similarity=0.325 Sum_probs=170.7
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch--hhhHHHHHHHHHcCC-CCeeecceEeeecCCCCceEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.+++|+++++||+|+||.+|+|....+|+.||||+.++.. .....|.++.+.|++ ..|..+.+++ .+..|-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccce
Confidence 3457999999999999999999999999999999886553 344579999999975 4566665555 5556778
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC--CCCcEEEeeccccee
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKV 243 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~--~~~~vkl~DfG~a~~ 243 (429)
+||+.++.+|.+++... ...++..++..++-|++.-++|+| .+++|||||||+|+|..- ..+.+.|+|||+|+.
T Consensus 88 lVMdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH-~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVH-LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eeeeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHH-hhccccccCCccceeeccccccceEEEEeccchhh
Confidence 99999999888877653 467999999999999999999999 899999999999999743 334799999999988
Q ss_pred cccCC--------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014174 244 LVKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVE 305 (429)
Q Consensus 244 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~ 305 (429)
+.+.. ......||..|.+-..+.+.. .+.+.|+-|+|.+|.++.-|..||.+.......++
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK 232 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK 232 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHH
Confidence 75433 234567899999998887654 78999999999999999999999998665544433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=209.59 Aligned_cols=166 Identities=21% Similarity=0.197 Sum_probs=123.3
Q ss_pred hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCcccc
Q 014174 174 TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253 (429)
Q Consensus 174 ~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~ 253 (429)
+|.+.+.. ....+++..++.++.||+.||.||| +.+ ||+|||++.++ .+|+ ||+++..... ..
T Consensus 2 sL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH-~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~~ 64 (176)
T smart00750 2 SLADILEV---RGRPLNEEEIWAVCLQCLRALRELH-RQA------KSGNILLTWDG-LLKL--DGSVAFKTPE----QS 64 (176)
T ss_pred cHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH-hcC------CcccEeEcCcc-ceee--ccceEeeccc----cC
Confidence 45555543 2456999999999999999999999 666 99999999888 6888 9999875432 23
Q ss_pred cccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhcCcCcccccCCC
Q 014174 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 332 (429)
Q Consensus 254 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (429)
.||+.|+|||++.+. .++.++|||||||++|+|+||+.||....... .+..+........ +.
T Consensus 65 ~g~~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------~~ 127 (176)
T smart00750 65 RVDPYFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD----------------PR 127 (176)
T ss_pred CCcccccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC----------------cc
Confidence 678999999999764 48999999999999999999999997654332 2222222110000 00
Q ss_pred cCCCCcccccCCCCCh--hHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 333 IKAHPWHKIFHKRMPP--EAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 333 ~~~~~~~~~~~~~~s~--~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.......++. ++.++|.+||..||.+|||+.++++|+|+..
T Consensus 128 ------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 128 ------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0000011233 6999999999999999999999999999853
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-26 Score=219.54 Aligned_cols=251 Identities=20% Similarity=0.204 Sum_probs=190.8
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCC-cEEEEEEeecch----hhhHHHHHHHHHcCC----CCeeecceEeeecCCCCce
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQDK----RYKNRELQTMRLLDH----PNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 162 (429)
+|.+.+.||+|+||.||+|.+..++ ..+|+|...... .....|..++..+.. .++..+++.+. ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 6999999999999999999987774 689999876532 146679999999873 57777776652 2455
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC----CcEEEeec
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT----HQVKLCDF 238 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~----~~vkl~Df 238 (429)
+.++||+.++.+|.++..... .+.++..++..++.|++.+|.+|| +.|++||||||+|+++.... +.+.|.||
T Consensus 95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH-~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLH-SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHH-hcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 688999999999988776543 578999999999999999999999 89999999999999997543 47999999
Q ss_pred ccce--ecccCC--------C-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 014174 239 GSAK--VLVKGE--------P-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307 (429)
Q Consensus 239 G~a~--~~~~~~--------~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~ 307 (429)
|+|+ ...... . ...+.||..|+++.++.+.. .+++.|+||++.++.+|+.|..||.+........+..
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 9998 321111 1 22456999999999997754 8999999999999999999999997765433332222
Q ss_pred HHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
+...... ... +....+.++..+...+-..+...+|....+...
T Consensus 251 ~~~~~~~---------------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPRKLL---------------TDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhhhhc---------------ccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 2110000 000 112245677888887777888899987766553
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=250.02 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=191.9
Q ss_pred EEeeEEccCCceEEEEEEEcCCCcEEEEEEeec----chhh------hHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ----DKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 94 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~------~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
....++|.|++|.|+.+......+.++.|.+.. .... ...|+.+-..+.|+|++.....+..... +
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~----~ 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG----I 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc----c
Confidence 456789999999999998877777777775431 1110 2235556667899999877665533222 2
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
. -+||||+.+|+.++.. ...+...++..++.|++.|++||| ..||.|||||++|++++.++ .+||+|||.+..
T Consensus 397 ~-~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h-~~GiahrdlK~enll~~~~g-~lki~Dfg~~~v 469 (601)
T KOG0590|consen 397 L-QSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLH-SMGLAHRDLKLENLLVTENG-ILKIIDFGAASV 469 (601)
T ss_pred h-hhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHH-hcCceeccCccccEEEecCC-ceEEeecCccee
Confidence 2 2499999977776653 247899999999999999999999 89999999999999999888 899999999877
Q ss_pred cccCCC-----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 244 LVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 244 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
...... ....+|+..|+|||++.+........||||.|++++.|++|+.||......+....-..
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~---------- 539 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN---------- 539 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc----------
Confidence 654332 24567899999999998877667789999999999999999999976543332210000
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
....... ..-...+...++...+.+|.+||++||.+|.|+.+|++.+||+++...
T Consensus 540 -----~~~~~~~-----~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 540 -----YSDQRNI-----FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred -----ccccccc-----ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 0000000 000011223478889999999999999999999999999999987654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-28 Score=236.09 Aligned_cols=237 Identities=30% Similarity=0.431 Sum_probs=189.7
Q ss_pred EEccCCceEEEEEEE---cCCCcEEEEEEeecc------hhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceEEEEE
Q 014174 98 VVGQGSFGIVFQAKC---LETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
++|.|+||.|++++- ...|..||+|+.++. ......|..++..++ ||++|++..+| +....++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence 379999999998763 245778999977532 122235778888887 99999998888 444447889
Q ss_pred EeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
+++..++ ++... ......+.+...+.+...++.|++++| +.||+|||+|++||+++.+|| +++.|||+++.....
T Consensus 76 ld~~rgg--~lft~-l~~~~~f~~~~~~~~~aelaLald~lh-~l~iiyrd~k~enilld~~Gh-i~~tdfglske~v~~ 150 (612)
T KOG0603|consen 76 LDFLRGG--DLFTR-LSKEVMFDELDVAFYLAELALALDHLH-KLGIAYRDYKLENVLLLLEGH-IKLTDFGLSKEAVKE 150 (612)
T ss_pred hhhcccc--hhhhc-cccCCchHHHHHHHHHHHHHHHHhhcc-hhHHHHhcccccceeecccCc-cccCCchhhhHhHhh
Confidence 9999874 22222 233566888899999999999999999 999999999999999999995 999999999887655
Q ss_pred CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccc
Q 014174 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327 (429)
Q Consensus 248 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 327 (429)
... |||..|||||++. ....++|+||+|+++++|+||..||.+ +.+..|.+..
T Consensus 151 ~~~---cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~----------------- 203 (612)
T KOG0603|consen 151 KIA---CGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAE----------------- 203 (612)
T ss_pred hhc---ccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhc-----------------
Confidence 443 8999999999996 378899999999999999999999987 4455554420
Q ss_pred ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCCcccCCC
Q 014174 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFYELRDP 383 (429)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~-----~ell~hp~f~~~~~~ 383 (429)
..++..++..+++++..++..+|..|.-. .|+++|+||..+.+.
T Consensus 204 ------------~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 204 ------------LEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred ------------cCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 11234578999999999999999999854 699999999998876
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=210.46 Aligned_cols=248 Identities=19% Similarity=0.242 Sum_probs=184.1
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCC-----cEEEEEEeecchhhhH-----HHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETG-----ETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~-----~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
.++++...+-+|.||.||.|.++..+ +.|-+|.++.....++ .|-..+..+.|||+..+.++.....+
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~-- 361 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA-- 361 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC--
Confidence 36778888999999999999765332 3455676655443332 46667777899999999888765332
Q ss_pred ceEEEEEEeccc-hhHHHHHHHhh----hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEE
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHYS----RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 235 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl 235 (429)
..++++.+++ ++|...+.... ...+.++-.+...++.|++.|+.||| ++||||.||-..|++|+..- ++||
T Consensus 362 --~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh-~~~ViHkDiAaRNCvIdd~L-qVkl 437 (563)
T KOG1024|consen 362 --TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH-NHGVIHKDIAARNCVIDDQL-QVKL 437 (563)
T ss_pred --cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH-hcCcccchhhhhcceehhhe-eEEe
Confidence 3566788887 44444433111 12244666777889999999999999 89999999999999999776 8999
Q ss_pred eecccceecccCCCcc---cccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 014174 236 CDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 311 (429)
Q Consensus 236 ~DfG~a~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 311 (429)
+|=.+++..-..+... +......||+||.+.. ..|+.++|+||||++||||+| |+.|+..-+..++..-+.+..
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy- 515 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY- 515 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc-
Confidence 9999988765443221 1112456999999976 459999999999999999998 899998877766654444321
Q ss_pred CCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+. -|-++|+++..++.-||+.+|++||+.+++..
T Consensus 516 -----------------Rla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 516 -----------------RLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred -----------------eec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 111 12358999999999999999999999998754
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-23 Score=200.75 Aligned_cols=258 Identities=34% Similarity=0.473 Sum_probs=195.6
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCC-CeeecceEeeecCCCCceEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHP-NVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 164 (429)
|.+.+.||.|+||.||++.+. ..+|+|.+... ...+.+|+.++..+.|+ +++++++++. .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence 788999999999999999986 78899988543 23355788999999988 7999999882 22236
Q ss_pred EEEEeccchhHHHHHHHhhhcC---CCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 165 NLVLEFVPETVYRVAKHYSRAS---QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
+++++++.+..+... .... ..++...+..++.|++.++.|+| +.|++|||+||+||+++..+..++++|||.+
T Consensus 74 ~~~~~~~~~~~l~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H-~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~ 149 (384)
T COG0515 74 YLVMEYVDGGSLEDL---LKKIGRKGPLSESEALFILAQILSALEYLH-SKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149 (384)
T ss_pred EEEEecCCCCcHHHH---HHhcccccCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeeecCCCCeEEEeccCcc
Confidence 789999996544422 1222 27999999999999999999999 8899999999999999977645999999999
Q ss_pred eecccCC-------CcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHH
Q 014174 242 KVLVKGE-------PNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKV 309 (429)
Q Consensus 242 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~i~~~ 309 (429)
+...... ......||..|+|||.+.+. ..++...|+||+|++++++++|..||..... .......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 229 (384)
T COG0515 150 KLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229 (384)
T ss_pred eecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh
Confidence 8654433 23566789999999999763 4689999999999999999999999877664 3333333333
Q ss_pred hCCC-CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 310 LGTP-TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 310 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
...+ ... .. ...........+.+++.+++..+|..|.+..+...++|......
T Consensus 230 ~~~~~~~~--------------~~------~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~ 283 (384)
T COG0515 230 LPTPSLAS--------------PL------SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL 283 (384)
T ss_pred cCCccccc--------------cc------CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence 2222 000 00 00000112367899999999999999999999999877755444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-26 Score=230.21 Aligned_cols=224 Identities=29% Similarity=0.481 Sum_probs=166.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEe
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
-.+|..++.|..|+||.||+++++.+.+.+|+| ++++.-.... ++.....|++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn---ilt~a~npfvv---------------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN---ILTFAGNPFVV---------------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc---cccccCCccee----------------------
Confidence 347999999999999999999999999999995 5554332221 22222233222
Q ss_pred ccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC-
Q 014174 170 FVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE- 248 (429)
Q Consensus 170 ~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~- 248 (429)
|+-..+++ .-+.++.. ++.|++||| +.||+|||+||+|.+|+.-| .+|++|||+.+......
T Consensus 136 ---gDc~tllk----~~g~lPvd--------mvla~Eylh-~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLK----NIGPLPVD--------MVLAVEYLH-SYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcc----cCCCCcch--------hhHHhHhhc-cCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhcc
Confidence 11112222 12344443 378999999 99999999999999999888 59999999987542211
Q ss_pred ---------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014174 249 ---------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313 (429)
Q Consensus 249 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 313 (429)
.....+||+.|+|||++.- ..|+..+|||++|+|+|+.+.|..||.+++..+.+...+....
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i-- 275 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI-- 275 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc--
Confidence 1124578999999999965 4599999999999999999999999999988887766654211
Q ss_pred CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC---CHHHHhcCCCCcccCCC
Q 014174 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC---TALEACIHPFFYELRDP 383 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~---t~~ell~hp~f~~~~~~ 383 (429)
..|. . ...++++++++|.++|..+|..|. .+.++.+|+||+.+.+.
T Consensus 276 ---------------~wpE--------~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 276 ---------------EWPE--------E-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred ---------------cccc--------c-CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 1111 0 123689999999999999999997 56789999999998876
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=211.06 Aligned_cols=160 Identities=20% Similarity=0.279 Sum_probs=122.1
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcC-CCcEEEEEEeecc---------hhhhHHHHHHHHHcCCCCeeecceEeeecC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTT 157 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 157 (429)
...++|.+.++||+|+||+||+|++.. ++..||||++... ...+.+|+++|+.++|+|++..+..+ .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence 345579999999999999999999876 6788899986422 23456899999999999998532211 1
Q ss_pred CCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecC-CCCceEecCCCCcEEEe
Q 014174 158 DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI-KPQNLLVNPHTHQVKLC 236 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DL-kp~Nill~~~~~~vkl~ 236 (429)
..++||||+++..+... . ... ...++.|++.||.||| +.||+|||| ||+|||++.++ .+||+
T Consensus 92 -----~~~LVmE~~~G~~L~~~----~---~~~---~~~~~~~i~~aL~~lH-~~gIiHrDL~KP~NILv~~~~-~ikLi 154 (365)
T PRK09188 92 -----KDGLVRGWTEGVPLHLA----R---PHG---DPAWFRSAHRALRDLH-RAGITHNDLAKPQNWLMGPDG-EAAVI 154 (365)
T ss_pred -----CcEEEEEccCCCCHHHh----C---ccc---hHHHHHHHHHHHHHHH-HCCCeeCCCCCcceEEEcCCC-CEEEE
Confidence 25799999987644421 1 111 1467889999999999 899999999 99999998777 79999
Q ss_pred ecccceecccCCCc---------ccccccccccccccccC
Q 014174 237 DFGSAKVLVKGEPN---------ISYICSRYYRAPELIFG 267 (429)
Q Consensus 237 DfG~a~~~~~~~~~---------~~~~gt~~y~aPE~~~~ 267 (429)
|||+|+........ ....++..|+|||.+..
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999876543211 23456788999998854
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-24 Score=194.81 Aligned_cols=205 Identities=22% Similarity=0.314 Sum_probs=148.5
Q ss_pred CCCCeeecceEeeecCC----------------------CCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHH
Q 014174 142 DHPNVVSLKHCFFSTTD----------------------KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199 (429)
Q Consensus 142 ~h~niv~~~~~~~~~~~----------------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~ 199 (429)
+|||||++...|.+... .....+|+||-.++.+|..++.. +..+....+.++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence 69999999887753310 23345889999999988877653 5677888899999
Q ss_pred HHHHHHHHHHcCCCeeeecCCCCceEe--cCCC-CcEEEeecccceecccC-------CCcccccccccccccccccCCC
Q 014174 200 QICRALAYIHGGIGVCHRDIKPQNLLV--NPHT-HQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPELIFGAT 269 (429)
Q Consensus 200 qi~~aL~~LH~~~givH~DLkp~Nill--~~~~-~~vkl~DfG~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~ 269 (429)
|+++|+.||| ++||.|||||.+|||| +.++ -.+.|+|||+|-....- .......|...-||||+....+
T Consensus 349 QlLEav~hL~-~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 349 QLLEAVTHLH-KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHH-HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999 9999999999999998 3222 26889999998543221 1122345677789999874432
Q ss_pred CC-----CCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCC
Q 014174 270 EY-----TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK 344 (429)
Q Consensus 270 ~~-----~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (429)
.. -.++|.|+.|.+.||+++...||.+......- .++|.+-++|. ++.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~------------------~r~Yqe~qLPa---------lp~ 480 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD------------------TRTYQESQLPA---------LPS 480 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheec------------------hhhhhhhhCCC---------Ccc
Confidence 11 23789999999999999999999873321110 12233333443 455
Q ss_pred CCChhHHHHHHhhcCcCCCCCCCHH---HHhcCCCCcc
Q 014174 345 RMPPEAVDLVSRLLQYSPNLRCTAL---EACIHPFFYE 379 (429)
Q Consensus 345 ~~s~~l~~Li~~~L~~dP~~R~t~~---ell~hp~f~~ 379 (429)
.+++.+++|+..+|+.||++|+++. .+|+-..|..
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~ 518 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRM 518 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcC
Confidence 6899999999999999999999864 5665444433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=188.86 Aligned_cols=237 Identities=26% Similarity=0.323 Sum_probs=144.0
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhH-------HHHHHHHHcC----------CCCeeecceEee
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLD----------HPNVVSLKHCFF 154 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~E~~~l~~l~----------h~niv~~~~~~~ 154 (429)
.+...+.||.|+++.||.|.+..||+.+|+|++........ +|.-....+. |-.++--++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 36778899999999999999999999999998854332221 2221111111 111111112111
Q ss_pred ec--------CCCCceE----EEEEEeccchhHHHHHHHhhhcCCC---CCHHHHHHHHHHHHHHHHHHHcCCCeeeecC
Q 014174 155 ST--------TDKDELY----LNLVLEFVPETVYRVAKHYSRASQR---MPLIYVKLYTYQICRALAYIHGGIGVCHRDI 219 (429)
Q Consensus 155 ~~--------~~~~~~~----~~lv~e~~~~~l~~~~~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~givH~DL 219 (429)
.. ......+ .+++|+-+.++|..++......... +.......+..|+++.+++|| +.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh-~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH-SYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH-HTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh-hcceEeccc
Confidence 11 1011111 3678888888887766543332222 222233455689999999999 889999999
Q ss_pred CCCceEecCCCCcEEEeecccceecccCCCcccccccccccccccccCC-------CCCCCchhHHHHHHHHHHHHhCCC
Q 014174 220 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTTAIDIWSVGCVLAELLLGQP 292 (429)
Q Consensus 220 kp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~lltg~~ 292 (429)
||+|++++.+| .++|+||+.....+..... ...+..|.+||..... ..++.+.|.|+||+++|.|.+|+.
T Consensus 172 ~~~nfll~~~G-~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 172 KPENFLLDQDG-GVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp SGGGEEE-TTS--EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred ceeeEEEcCCC-CEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999998 7999999988765433221 3345779999976432 236889999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCC
Q 014174 293 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR 365 (429)
Q Consensus 293 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R 365 (429)
||........... .+.. - .++|+.+++||+++|.+||.+|
T Consensus 249 Pf~~~~~~~~~~~-------------------------------~f~~-C-~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW-------------------------------DFSR-C-RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG-------------------------------GGTT-S-S---HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc-------------------------------cchh-c-CCcCHHHHHHHHHHccCCcccC
Confidence 9975432110000 0000 1 1579999999999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-23 Score=213.63 Aligned_cols=241 Identities=29% Similarity=0.408 Sum_probs=172.4
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhH---HHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKN---RELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~---~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.|...+.||++.|=+|.+|++. .| .|+||++.+.. +... +|++ ...+++||.+.+.-.. .....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 5888899999999999999873 34 49999886543 1111 3444 5667999999986543 23334
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
-|||-+|+..+|++.+.. ...+...+.+.|+.|++.||..+| ..||+|||||.+||||++=. .+.|+||..=+.
T Consensus 96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH-~~gVcHGDIKsENILiTSWN-W~~LtDFAsFKP 169 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCH-KLGVCHGDIKSENILITSWN-WLYLTDFASFKP 169 (1431)
T ss_pred HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHH-HcCccccccccceEEEeeec-hhhhhcccccCC
Confidence 567899999988887654 345778888999999999999999 89999999999999999765 799999987554
Q ss_pred cccCC----Ccccccc----cccccccccccCC----------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014174 244 LVKGE----PNISYIC----SRYYRAPELIFGA----------TEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLV 304 (429)
Q Consensus 244 ~~~~~----~~~~~~g----t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~ 304 (429)
.--.+ ..+-++- -.+|+|||.+... ...+++-||||+||+++||++ |++||. ..++.
T Consensus 170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~ 245 (1431)
T KOG1240|consen 170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLL 245 (1431)
T ss_pred ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHH
Confidence 32111 1111222 2359999988541 125778999999999999987 799994 22222
Q ss_pred HHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 305 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.....- .-..+.. +.+--+..++.||..|++.||++|.+|++.|+-
T Consensus 246 aYr~~~-~~~~e~~-----------------------Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 246 AYRSGN-ADDPEQL-----------------------LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hHhccC-ccCHHHH-----------------------HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 222110 1111111 111135679999999999999999999999985
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=178.79 Aligned_cols=135 Identities=16% Similarity=0.237 Sum_probs=103.5
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeecchh------------------------------hhHHHHHHHHHcCCCC
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR------------------------------YKNRELQTMRLLDHPN 145 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l~~l~h~n 145 (429)
...||+|+||.||+|.+. +|+.||||+++.... ...+|++++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999986 899999999864311 1124889999998877
Q ss_pred eeecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HcCCCeeeecCCCCce
Q 014174 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI-HGGIGVCHRDIKPQNL 224 (429)
Q Consensus 146 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~givH~DLkp~Ni 224 (429)
+....... .. . .+|||||++++.+.... .....+++..+..++.|++.+|.+| | +.||+||||||+||
T Consensus 81 v~~p~~~~--~~-~----~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H-~~giiHrDlkP~NI 149 (190)
T cd05147 81 IPCPEPIL--LK-S----HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQ-DCRLVHADLSEYNL 149 (190)
T ss_pred CCCCcEEE--ec-C----CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHE
Confidence 64332221 11 1 26899999975332111 1235789999999999999999999 7 78999999999999
Q ss_pred EecCCCCcEEEeecccceec
Q 014174 225 LVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 225 ll~~~~~~vkl~DfG~a~~~ 244 (429)
|++ ++ .++|+|||+|...
T Consensus 150 li~-~~-~v~LiDFG~a~~~ 167 (190)
T cd05147 150 LYH-DG-KLYIIDVSQSVEH 167 (190)
T ss_pred EEE-CC-cEEEEEccccccC
Confidence 998 45 6999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.3e-22 Score=171.91 Aligned_cols=183 Identities=16% Similarity=0.114 Sum_probs=133.6
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh--------hhHHHHHHHHHcC-CCCeeecceEeeecCCCCceE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR--------YKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 163 (429)
..+...|++|+||+|+++.. .+..++.+.+..... .+.+|+++|++|. |+++++++++. .
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~---- 72 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G---- 72 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----
Confidence 34567899999999998865 778888887754432 3568999999995 47788887641 1
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecC-CCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI-KPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DL-kp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+++|+|+.|..+... .+.. ...++.|++.+|.++| +.||+|||| ||+|||++.++ .++|+|||+|.
T Consensus 73 ~~lvmeyI~G~~L~~~---------~~~~-~~~~~~qi~~~L~~lH-~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~ 140 (218)
T PRK12274 73 RHLDRSYLAGAAMYQR---------PPRG-DLAYFRAARRLLQQLH-RCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAV 140 (218)
T ss_pred EEEEEeeecCccHHhh---------hhhh-hHHHHHHHHHHHHHHH-HCcCccCCCCCcceEEEcCCC-CEEEEECCCce
Confidence 5789999987644311 1111 1346789999999999 899999999 79999999887 69999999998
Q ss_pred ecccCCCcc--------------cccccccccccccccCCCCCC-CchhHHHHHHHHHHHHhCCCCCCCCC
Q 014174 243 VLVKGEPNI--------------SYICSRYYRAPELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGES 298 (429)
Q Consensus 243 ~~~~~~~~~--------------~~~gt~~y~aPE~~~~~~~~~-~~~DiwslG~il~~lltg~~pf~~~~ 298 (429)
......... -...++.|++|+...-....+ .+.++++.|+.+|.++|+..++-+++
T Consensus 141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 654333210 012367788887653222233 56799999999999999998875543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.5e-22 Score=177.64 Aligned_cols=171 Identities=11% Similarity=0.118 Sum_probs=125.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hh---------hHHHHHHHHHcCCCCeeecceEeeec
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RY---------KNRELQTMRLLDHPNVVSLKHCFFST 156 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~---------~~~E~~~l~~l~h~niv~~~~~~~~~ 156 (429)
.++|+++++||.|+||.||++.. ++..+|||.+.... .. ..+|+..+.+++|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 45799999999999999999765 56789999885321 11 45788899999999999998876543
Q ss_pred CCC---CceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcE
Q 014174 157 TDK---DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV 233 (429)
Q Consensus 157 ~~~---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~v 233 (429)
... -....++||||++|..+... ..+++ ....+++.+|..|| +.|++|||+||+||++++++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~-------~~~~~----~~~~~i~~~l~~lH-~~gi~H~Dikp~Nili~~~g--i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDM-------PEISE----DVKAKIKASIESLH-QHGMVSGDPHKGNFIVSKNG--L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHh-------hhccH----HHHHHHHHHHHHHH-HcCCccCCCChHHEEEeCCC--E
Confidence 211 12246789999997533222 12333 24569999999999 89999999999999999766 9
Q ss_pred EEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHH
Q 014174 234 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL 288 (429)
Q Consensus 234 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 288 (429)
+|+|||............. .+.. ..++.++|+||||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~d~-----------~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAKDR-----------IDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhHHH-----------HHHH-hHhcccccccceeEeehHHH
Confidence 9999998865422211100 1223 33668999999999987664
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=171.50 Aligned_cols=135 Identities=18% Similarity=0.212 Sum_probs=104.8
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeecchh------------------------------hhHHHHHHHHHcCCCC
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR------------------------------YKNRELQTMRLLDHPN 145 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~E~~~l~~l~h~n 145 (429)
...||+|++|.||+|.+. +|+.||||++..... ...+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999986 899999998864310 1246888899999998
Q ss_pred eeecceEeeecCCCCceEEEEEEeccchhH-HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeeecCCCCc
Q 014174 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETV-YRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQN 223 (429)
Q Consensus 146 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l-~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~givH~DLkp~N 223 (429)
+.....+.. . . .++||||+++.. ..... ....++...+..++.|++.+|.+|| + .||+||||||+|
T Consensus 81 i~~p~~~~~--~-~----~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH-~~~givHrDlkP~N 148 (190)
T cd05145 81 VPVPEPILL--K-K----NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLY-QEAGLVHGDLSEYN 148 (190)
T ss_pred CCCceEEEe--c-C----CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHH-HhCCEecCCCChhh
Confidence 754433221 1 1 368999999752 22111 1246788899999999999999999 6 899999999999
Q ss_pred eEecCCCCcEEEeecccceecc
Q 014174 224 LLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 224 ill~~~~~~vkl~DfG~a~~~~ 245 (429)
|+++ ++ .++|+|||+|....
T Consensus 149 Ill~-~~-~~~liDFG~a~~~~ 168 (190)
T cd05145 149 ILYH-DG-KPYIIDVSQAVELD 168 (190)
T ss_pred EEEE-CC-CEEEEEcccceecC
Confidence 9998 56 79999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.5e-20 Score=191.42 Aligned_cols=195 Identities=23% Similarity=0.366 Sum_probs=147.4
Q ss_pred CCCccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh-hhHHHHHHHHHcC---CCCeeecceEeeecCCCC
Q 014174 85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-YKNRELQTMRLLD---HPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 85 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~ 160 (429)
.....+..|.|.+.||+|+||+||+|.... |+.||+|+-+.... .+.-=.+++.+|+ -+-|+.+..++...+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~-- 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA-- 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc--
Confidence 334556789999999999999999999766 99999997754321 1111223444454 2334444444433222
Q ss_pred ceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec------CCCCcE
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN------PHTHQV 233 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~------~~~~~v 233 (429)
-++|+||.+ |+|++++. ..+.+++..+..+..|++.-+++|| .++|||+||||+|+||. .+...+
T Consensus 769 ---S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH-~~~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 769 ---SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLH-AMGIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred ---ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHH-hcceecccCCcceeEeecccCCCCcccce
Confidence 357999998 77777765 4678999999999999999999999 89999999999999983 222259
Q ss_pred EEeecccceeccc---CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCC
Q 014174 234 KLCDFGSAKVLVK---GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ 291 (429)
Q Consensus 234 kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~ 291 (429)
+|+|||.+.-+.- +......++|-.+-.+|+..|.. +++.+|.|.|+.+++.|+.|+
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHH
Confidence 9999999865532 22334556688899999997755 999999999999999999997
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.4e-19 Score=159.53 Aligned_cols=133 Identities=20% Similarity=0.237 Sum_probs=100.0
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHc-----CCCCeeecceEeeecCCCCceE-EE
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLL-----DHPNVVSLKHCFFSTTDKDELY-LN 165 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~-~~ 165 (429)
.+.||+|+||.||. +..++.. +||++... .....+|+.+++.+ +||||+++++++.... +..+ +.
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEEE
Confidence 46899999999995 6667666 69987643 34567899999999 6799999999885432 2234 34
Q ss_pred EEEeccc---hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH-HHHHcCCCeeeecCCCCceEecCCC---CcEEEeec
Q 014174 166 LVLEFVP---ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL-AYIHGGIGVCHRDIKPQNLLVNPHT---HQVKLCDF 238 (429)
Q Consensus 166 lv~e~~~---~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~givH~DLkp~Nill~~~~---~~vkl~Df 238 (429)
+|+||++ ++|.+.+.. ..+++. ..++.|++.++ +||| +.+|+||||||+|||++..+ ..++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh-~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLL-DNRIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHH-HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 7899955 577666643 346555 35678888888 9999 89999999999999997422 26999995
Q ss_pred ccc
Q 014174 239 GSA 241 (429)
Q Consensus 239 G~a 241 (429)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.6e-19 Score=164.48 Aligned_cols=140 Identities=16% Similarity=0.153 Sum_probs=105.3
Q ss_pred ceEEeeEEccCCceEEEEEE-EcCCCcEEEEEEeecch----------------------------hhhHHHHHHHHHcC
Q 014174 92 SYMAERVVGQGSFGIVFQAK-CLETGETVAIKKVLQDK----------------------------RYKNRELQTMRLLD 142 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~----------------------------~~~~~E~~~l~~l~ 142 (429)
-|.+.+.||+|+||.||+|. +..+|+.||+|++.... ....+|+.+++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 67799999999886431 11347999999997
Q ss_pred CCCeeecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC-eeeecCCC
Q 014174 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG-VCHRDIKP 221 (429)
Q Consensus 143 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g-ivH~DLkp 221 (429)
+.+ +.+...+.. . . .++||||+++..+.... .....+....+..++.||+.+|.+|| +.| |+||||||
T Consensus 109 ~~~-i~~p~~~~~-~-~----~~lV~E~~~g~~L~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH-~~g~iiH~Dikp 177 (237)
T smart00090 109 EAG-VPVPKPIAW-R-R----NVLVMEFIGGDGLPAPR---LKDVEPEEEEEFELYDDILEEMRKLY-KEGELVHGDLSE 177 (237)
T ss_pred hcC-CCCCeeeEe-c-C----ceEEEEEecCCcccccc---cccCCcchHHHHHHHHHHHHHHHHHH-hcCCEEeCCCCh
Confidence 532 222222211 1 1 36899999985432211 11244566677899999999999999 889 99999999
Q ss_pred CceEecCCCCcEEEeecccceec
Q 014174 222 QNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 222 ~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||+++ ++ .++|+|||.|...
T Consensus 178 ~NIli~-~~-~i~LiDFg~a~~~ 198 (237)
T smart00090 178 YNILVH-DG-KVVIIDVSQSVEL 198 (237)
T ss_pred hhEEEE-CC-CEEEEEChhhhcc
Confidence 999999 55 7999999998653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.8e-20 Score=161.85 Aligned_cols=241 Identities=17% Similarity=0.236 Sum_probs=174.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeec------chhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
..+..+..+|.+...|..|++++ .|..++.|++.- ..+.++.|.-.|+.+.||||+.+++.+-. ...
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-----ppn 261 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-----PPN 261 (448)
T ss_pred hhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-----CCC
Confidence 34566778899999999999998 455566675532 23455678899999999999999998843 344
Q ss_pred EEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeee-cCCCCceEecCCCCcEEEeecccc
Q 014174 164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR-DIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~-DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
+.++..||+ ++|+.++.. ..+--..-.++..++.+|++|+.|||+-..++-| -|....++||.+- +.+|+ .+-+
T Consensus 262 lv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-taris-mad~ 337 (448)
T KOG0195|consen 262 LVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARIS-MADT 337 (448)
T ss_pred ceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhhee-cccc
Confidence 889999999 777777653 2233456678889999999999999943334433 6888889998776 55543 1111
Q ss_pred eecccCCCcccccccccccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
++. -........+.||+||.+...+. .-.++|+|||.+++|||.|...||..-+..+.-.++.-
T Consensus 338 kfs---fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial----------- 403 (448)
T KOG0195|consen 338 KFS---FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL----------- 403 (448)
T ss_pred eee---eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-----------
Confidence 111 11123344788999999965432 23479999999999999999999987776554433321
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHH
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~el 371 (429)
.-++..+++.++.....|+.-|+..||.+||....+
T Consensus 404 ----------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 404 ----------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred ----------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 122344677899999999999999999999987654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.9e-20 Score=174.96 Aligned_cols=180 Identities=29% Similarity=0.467 Sum_probs=132.8
Q ss_pred ceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
..|++|.|++|....+..+....+....-+......++.|+..|+.| +|.+|||+||.||+...+. .+||.|||+
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~-q~kIgDFgl 402 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDD-QLKIGDFGL 402 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccch-hhhhhhhhh
Confidence 34689999999976555554444455667888899999999999999 5999999999999998777 799999999
Q ss_pred ceecccCC-------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCC
Q 014174 241 AKVLVKGE-------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGT 312 (429)
Q Consensus 241 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~ 312 (429)
........ ..+...||..||+||.+.+.. |+.++||||||++|+|++.- ...|.. ...+..+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~------ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFER---IATLTDI------ 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhh------
Confidence 88776555 445678999999999998755 99999999999999999972 211210 0000000
Q ss_pred CCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
....|...+..+ -+.-.+|+.+||...|.+||++.+.--|+|.
T Consensus 473 ---------------------r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 ---------------------RDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ---------------------hcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 011111011111 2445689999999999999988888777775
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=163.70 Aligned_cols=205 Identities=24% Similarity=0.354 Sum_probs=147.6
Q ss_pred HHHcCCCCeeecceEeeecCCCCceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeee
Q 014174 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCH 216 (429)
Q Consensus 138 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH 216 (429)
|+.+.|.|+.++++..+... ..++|.+||. |++.+.+.. ....+++.....++++|+.||.|||++....|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~-----~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP-----EMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCC-----ceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence 45789999999999986653 3788999998 666666544 35678888889999999999999996555599
Q ss_pred ecCCCCceEecCCCCcEEEeecccceecccC---CCcccccccccccccccccCCCC------CCCchhHHHHHHHHHHH
Q 014174 217 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATE------YTTAIDIWSVGCVLAEL 287 (429)
Q Consensus 217 ~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~~l 287 (429)
+.|+..|++++... .+||+|||+....... .......-...|.|||.+..... .+.+.|+||+|++++|+
T Consensus 73 g~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 73 GALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 99999999999887 8999999998765321 11111222445999999866321 36679999999999999
Q ss_pred HhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCC
Q 014174 288 LLGQPLFPGESGVD----QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 363 (429)
Q Consensus 288 ltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~ 363 (429)
++...||....... .+..+.+ .+. ....|.+... ..+.+++..++++||..+|.
T Consensus 152 ~~r~~~~~~~~~~~~~~eii~~~~~-~~~--------------~~~rP~i~~~-------~e~~~~l~~l~~~cw~e~P~ 209 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDPDEIILRVKK-GGS--------------NPFRPSIELL-------NELPPELLLLVARCWEEIPE 209 (484)
T ss_pred HhccCccccccccCChHHHHHHHHh-cCC--------------CCcCcchhhh-------hhcchHHHHHHHHhcccChh
Confidence 99999997633222 2222222 111 0111111100 03566899999999999999
Q ss_pred CCCCHHHHhc
Q 014174 364 LRCTALEACI 373 (429)
Q Consensus 364 ~R~t~~ell~ 373 (429)
+||++..+-.
T Consensus 210 ~rPs~~~i~~ 219 (484)
T KOG1023|consen 210 KRPSIEQIRS 219 (484)
T ss_pred hCccHHHHHh
Confidence 9999998743
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3e-19 Score=182.18 Aligned_cols=257 Identities=24% Similarity=0.313 Sum_probs=191.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcC-CCcEEEEEEeecch------hhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 163 (429)
.|.+.+.||+|+|+.|-++.... +...+|.|.+.... .....|..+-+.++ |.|++++++.. ....+
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~~ 95 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPRS 95 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCcc
Confidence 58999999999999999887643 44567777664321 12234777777777 99999998877 44445
Q ss_pred EEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+++++|..++ +..... .......+...+..++.|+..++.|+|...++.|||+||+|.+++..+..+++.|||+|.
T Consensus 96 ~~~~~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccccCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 77899997754 222221 111226777888999999999999999667999999999999999776359999999998
Q ss_pred eccc-CCC---cccccc-cccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 243 VLVK-GEP---NISYIC-SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 243 ~~~~-~~~---~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
.+.. ... ....+| ++.|+|||...+....+...|+||.|+++..+++|..|+...........
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~------------ 241 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS------------ 241 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce------------
Confidence 7765 222 234567 99999999998766678999999999999999999999975543221100
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.+.... ..........++..+.+++.+++..+|..|.+..++..+||+..
T Consensus 242 -----------~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 242 -----------SWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----------eecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 000000 11111223457899999999999999999999999999999987
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=148.17 Aligned_cols=131 Identities=17% Similarity=0.163 Sum_probs=99.8
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch--------------------------hhhHHHHHHHHHcCCCC-
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------------------------RYKNRELQTMRLLDHPN- 145 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~E~~~l~~l~h~n- 145 (429)
|.+.+.||+|+||.||++.. .+|+.||||++.... ....+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 88889999999999999986 479999999865321 11346788888887774
Q ss_pred -eeecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCce
Q 014174 146 -VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNL 224 (429)
Q Consensus 146 -iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Ni 224 (429)
++..++. . ..++||||+++..+..+.. ......++.+++.++.++| +.||+||||||+||
T Consensus 96 ~v~~~~~~----~-----~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh-~~gi~H~Dl~p~Ni 156 (198)
T cd05144 96 PVPKPIDW----N-----RHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAY-KHGIIHGDLSEFNI 156 (198)
T ss_pred CCCceeec----C-----CceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHH-HCCCCcCCCCcccE
Confidence 3333221 1 2478999999854332210 1345678899999999999 88999999999999
Q ss_pred EecCCCCcEEEeecccceec
Q 014174 225 LVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 225 ll~~~~~~vkl~DfG~a~~~ 244 (429)
+++.++ .++|+|||.+...
T Consensus 157 ll~~~~-~~~liDfg~~~~~ 175 (198)
T cd05144 157 LVDDDE-KIYIIDWPQMVST 175 (198)
T ss_pred EEcCCC-cEEEEECCccccC
Confidence 999877 7999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.3e-17 Score=145.57 Aligned_cols=129 Identities=18% Similarity=0.314 Sum_probs=99.5
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch------------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+.||+|++|.||+|.+ .|..+++|+..... ....+|+.++..+.|+++.....++.... ..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence 5799999999999987 77889999754321 12346889999999998876655543322 25
Q ss_pred EEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||++|. +.+.+.. . .. ....++.+++.+|.+|| +.|++|||++|.|||++ ++ .++|+|||++..
T Consensus 75 ~lv~e~~~G~~L~~~~~~----~---~~-~~~~i~~~i~~~l~~lH-~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~ 143 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS----N---GM-EELELSREIGRLVGKLH-SAGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF 143 (211)
T ss_pred EEEEEEeCCcCHHHHHHh----c---cH-HHHHHHHHHHHHHHHHH-hCCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence 6899999864 4333321 1 11 77889999999999999 89999999999999999 55 699999999865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=140.93 Aligned_cols=127 Identities=17% Similarity=0.282 Sum_probs=93.2
Q ss_pred EEccCCceEEEEEEEcCCCcEEEEEEeecch------------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.||+|+||.||++.. +|..+++|...... ....+|+++++.+.|+++....-++.... ..+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence 379999999999984 67889999754321 22346999999998887544433332222 246
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||++|..+..... .... .++.|++.+|.+|| +.|++|+|++|.||+++ ++ .++++|||++...
T Consensus 74 lv~e~~~g~~l~~~~~---~~~~-------~~~~~i~~~l~~lH-~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~~ 139 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIE---EGND-------ELLREIGRLVGKLH-KAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKYS 139 (199)
T ss_pred EEEEEECCccHHHHHh---hcHH-------HHHHHHHHHHHHHH-HCCeecCCCCcceEEEE-CC-cEEEEECCCCcCC
Confidence 8999998643332211 1110 77889999999999 89999999999999999 55 7999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.3e-16 Score=139.11 Aligned_cols=132 Identities=21% Similarity=0.181 Sum_probs=91.9
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhh----------------------------HHHHHHHHHcCCCC--
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK----------------------------NRELQTMRLLDHPN-- 145 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------~~E~~~l~~l~h~n-- 145 (429)
.+.||+|+||+||+|.+. +|+.||||++....... ..|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999976 89999999876432110 23444444444332
Q ss_pred eeecceEeeecCCCCceEEEEEEeccchhHH--HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeeecCCCC
Q 014174 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVY--RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQ 222 (429)
Q Consensus 146 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~--~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~givH~DLkp~ 222 (429)
+.+.+.+. ..++||||++++.. ..+.... .. ..++.++.+++.++.++| . .||+||||||+
T Consensus 81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh-~~~~ivH~Dl~p~ 144 (187)
T cd05119 81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLY-REAGLVHGDLSEY 144 (187)
T ss_pred CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHh-hccCcCcCCCChh
Confidence 23332211 14789999997211 1111110 11 567889999999999999 6 99999999999
Q ss_pred ceEecCCCCcEEEeecccceeccc
Q 014174 223 NLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 223 Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
||+++ ++ .++|+|||.+.....
T Consensus 145 Nili~-~~-~~~liDfg~a~~~~~ 166 (187)
T cd05119 145 NILVD-DG-KVYIIDVPQAVEIDH 166 (187)
T ss_pred hEEEE-CC-cEEEEECcccccccC
Confidence 99999 65 799999999976533
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.5e-16 Score=161.12 Aligned_cols=132 Identities=17% Similarity=0.249 Sum_probs=97.6
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------------hhhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
.|...+.||+|+||+||++.+. +..+++|+.... .....+|+++++.++|++++..+.+.....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-- 409 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE-- 409 (535)
T ss_pred ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--
Confidence 4567889999999999999874 334444432111 123457999999999999887655443322
Q ss_pred CceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
..++||||+++..+..... ....++.|++.+|.+|| +.||+||||||+|||++ ++ .++|+|||
T Consensus 410 ---~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH-~~giiHrDlkp~NILl~-~~-~~~liDFG 472 (535)
T PRK09605 410 ---EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLH-KAGIVHGDLTTSNFIVR-DD-RLYLIDFG 472 (535)
T ss_pred ---CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHH-hCCCccCCCChHHEEEE-CC-cEEEEeCc
Confidence 2568999998643332111 34678899999999999 89999999999999994 55 69999999
Q ss_pred cceec
Q 014174 240 SAKVL 244 (429)
Q Consensus 240 ~a~~~ 244 (429)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 99753
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.2e-15 Score=135.77 Aligned_cols=133 Identities=17% Similarity=0.230 Sum_probs=96.1
Q ss_pred eEEc-cCCceEEEEEEEcCCCcEEEEEEeecc-----------------hhhhHHHHHHHHHcCCCCe--eecceEeeec
Q 014174 97 RVVG-QGSFGIVFQAKCLETGETVAIKKVLQD-----------------KRYKNRELQTMRLLDHPNV--VSLKHCFFST 156 (429)
Q Consensus 97 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~ 156 (429)
..|| .|+.|+||.+.. .+..+++|.+... .....+|++++..|+|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 888899999876 4788999977421 1223569999999998885 5555543322
Q ss_pred CCCCceEEEEEEeccch--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEE
Q 014174 157 TDKDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK 234 (429)
Q Consensus 157 ~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vk 234 (429)
. ......++|||++++ ++...+. ...+++.. +.||+.+|.+|| +.||+||||||.|||++.++ .++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~~----~~~i~~~l~~lH-~~GI~HrDlkp~NILv~~~~-~v~ 182 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQ-----EAPLSEEQ----WQAIGQLIARFH-DAGVYHADLNAHNILLDPDG-KFW 182 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHh-----cCCCCHHH----HHHHHHHHHHHH-HCCCCCCCCCchhEEEcCCC-CEE
Confidence 1 111123589999986 4444432 23455543 568999999999 89999999999999999877 799
Q ss_pred Eeeccccee
Q 014174 235 LCDFGSAKV 243 (429)
Q Consensus 235 l~DfG~a~~ 243 (429)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.1e-15 Score=127.45 Aligned_cols=130 Identities=18% Similarity=0.233 Sum_probs=101.9
Q ss_pred EeeEEccCCceEEEEEEEcCCCcEEEEEEeecch--hhhHHHHHHHHHcCC--CCeeecceEeeecCCCCceEEEEEEec
Q 014174 95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDH--PNVVSLKHCFFSTTDKDELYLNLVLEF 170 (429)
Q Consensus 95 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~ 170 (429)
+++.||+|.++.||++... +..+++|...... ....+|+.+++.++| .++++++..+. .....+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEEEe
Confidence 4578999999999999973 4789999886654 356789999999976 47888766552 22347789999
Q ss_pred cchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 171 VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG---IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 171 ~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+.+..... ++......++.+++.+|.+|| . .+++|+||+|.||+++..+ .++++|||.+..
T Consensus 75 ~~g~~~~~----------~~~~~~~~~~~~~~~~l~~lh-~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDE----------VSEEEKEDIAEQLAELLAKLH-QLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY 138 (155)
T ss_pred cCCeeccc----------CCHHHHHHHHHHHHHHHHHHh-CCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence 98743221 145566778899999999999 5 3799999999999999765 799999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.2e-15 Score=145.58 Aligned_cols=250 Identities=25% Similarity=0.270 Sum_probs=190.3
Q ss_pred cccceEEeeEEcc--CCceEEEEEEE--cCCCcEEEEEEeec------chhhhHHHHHHHHHc-CCCCeeecceEeeecC
Q 014174 89 QTISYMAERVVGQ--GSFGIVFQAKC--LETGETVAIKKVLQ------DKRYKNRELQTMRLL-DHPNVVSLKHCFFSTT 157 (429)
Q Consensus 89 ~~~~y~i~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~------~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 157 (429)
....+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+. ......+|+...+.+ .|+|.++.+..+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~---- 187 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW---- 187 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc----
Confidence 3346778889999 99999999998 88999999996321 222334577666666 489999977766
Q ss_pred CCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHH----HHHHHHcCCCeeeecCCCCceEecCCCCcE
Q 014174 158 DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR----ALAYIHGGIGVCHRDIKPQNLLVNPHTHQV 233 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~givH~DLkp~Nill~~~~~~v 233 (429)
.+...+++-+|+|+..+...... ....++...++..+.+... ||.++| +.+|+|-|+||+||++..+....
T Consensus 188 -e~~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~h-s~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 188 -EGSGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLH-SNNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred -ccCCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccC-CCcccccccchhheeccccccee
Confidence 55556889999999766554432 3455888999999999999 999999 88999999999999999883479
Q ss_pred EEeecccceecccCCCccc------ccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC--ChHHHHHH
Q 014174 234 KLCDFGSAKVLVKGEPNIS------YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE--SGVDQLVE 305 (429)
Q Consensus 234 kl~DfG~a~~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~--~~~~~~~~ 305 (429)
+++|||+...+..+..... ..+..-|++||...+ -++...|++++|.++.+-.+|..+.... +...++..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 9999999988766543222 246677999998854 4799999999999999999988666433 22111111
Q ss_pred HHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 306 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
..+...+-...+.++...+..|+..+|-.|+++..+++|+++..
T Consensus 341 ------------------------------~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 341 ------------------------------GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ------------------------------ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 01111222345778888999999999999999999999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.2e-15 Score=154.81 Aligned_cols=268 Identities=25% Similarity=0.276 Sum_probs=190.0
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..+.+.+.+-+-+|+++.++.+.-..+|...++|+..... +...++-.++-...+|.++.....+ ...
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r 876 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR 876 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence 4456888889999999999999988888777877553321 1112233333334456666553332 222
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
.-.++|++|+++ ++...+. ..+..+.+.++.+...+..++++|| ...+.|+|++|.|+++..++ ..+++|||.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~----~~~~~saepaRs~i~~~vqs~e~L~-s~~r~h~~~~p~~~l~~~~g-h~~l~~~~t 950 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLH----NSGCLSAEPARSPILERVQSLESLH-SSLRKHRDLKPDSLLIAYDG-HRPLTDFGT 950 (1205)
T ss_pred CCcchhhHHhccCCchhhhh----cCCCcccccccchhHHHHhhhhccc-cchhhcccccccchhhcccC-CcccCcccc
Confidence 236789999974 3333332 3456777888889999999999999 66699999999999999888 599999984
Q ss_pred ceeccc---------------------C-----------CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHH
Q 014174 241 AKVLVK---------------------G-----------EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL 288 (429)
Q Consensus 241 a~~~~~---------------------~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll 288 (429)
.....- . .......+|+.|.+||.+.+.. .+..+|+|++|+++++.+
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhh
Confidence 322110 0 0112346789999999998755 888999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH
Q 014174 289 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368 (429)
Q Consensus 289 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~ 368 (429)
+|.+||......+....+.... .+|.. -+...+.++++++.++|..+|.+|..+
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~~-------------------------~~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRD-------------------------IPWPE-GPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred cCCCCCCCcchhhhhhccccCC-------------------------CCCCC-CccccChhhhhhhhhhhccCchhccCc
Confidence 9999998877665554443310 00100 112368999999999999999999998
Q ss_pred H---HHhcCCCCcccCCCCCCCCCCCCCC
Q 014174 369 L---EACIHPFFYELRDPNARLPNGRPFP 394 (429)
Q Consensus 369 ~---ell~hp~f~~~~~~~~~~~~~~~~~ 394 (429)
. ++-.||||....+......+-.+.|
T Consensus 1084 ~~~~e~k~~~~~~~~~~~~l~~q~~~~~p 1112 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWENLALQKAEFVP 1112 (1205)
T ss_pred ccccccccCCccCCCCccccccccCccCC
Confidence 8 9999999999888665443333333
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.2e-14 Score=129.17 Aligned_cols=241 Identities=18% Similarity=0.217 Sum_probs=156.1
Q ss_pred EEEEEEEcCCCcEEEEEEee----c----chhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEeccc-hhHH
Q 014174 106 IVFQAKCLETGETVAIKKVL----Q----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVY 176 (429)
Q Consensus 106 ~V~~~~~~~~~~~vaiK~~~----~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 176 (429)
.||++-+...|..|+--.+. + .....+.-+.-|-.+-|.|||+++.++.+....+.....+++||+. +++.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 35666666666555433221 1 1111111233455667999999998876655545666778999998 5666
Q ss_pred HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--CeeeecCCCCceEecCCCCcEEEeeccccee--c---ccCCC
Q 014174 177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI--GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV--L---VKGEP 249 (429)
Q Consensus 177 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--givH~DLkp~Nill~~~~~~vkl~DfG~a~~--~---~~~~~ 249 (429)
..++....+...+.....++|+-||+.||.||| +. -|+|+++..+-|++..++ -|||.--.-... . .....
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~PpiihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~E 238 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPPIIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAE 238 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCccccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhh
Confidence 666666666778999999999999999999999 44 599999999999999887 577642111100 0 00011
Q ss_pred cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHHhhcCcCcccc
Q 014174 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328 (429)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 328 (429)
.....+-++|.|||.=.. ...+.++|||++|+...+|..|..--. +.+....-..+...
T Consensus 239 k~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~------------------- 298 (458)
T KOG1266|consen 239 KSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV------------------- 298 (458)
T ss_pred hhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh-------------------
Confidence 112334667899986532 346778999999999999998874321 11110000000000
Q ss_pred cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
+-.--...-++++.+||.-.|+.||++.+++.||...++.
T Consensus 299 -------------i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 299 -------------IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred -------------eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 0000122346789999999999999999999999987644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.4e-12 Score=129.32 Aligned_cols=180 Identities=23% Similarity=0.275 Sum_probs=127.2
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
|.+ ...+-++.+..--|..+.++..|.+...+... ....+-++.|+.++||||+++++++ +....+|||+
T Consensus 15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvT 88 (690)
T KOG1243|consen 15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVT 88 (690)
T ss_pred ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEe
Confidence 555 33344444422235556778888888775443 3345778899999999999999988 4444688999
Q ss_pred eccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC
Q 014174 169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248 (429)
Q Consensus 169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~ 248 (429)
|.+.. +-..++. +....+...++||+.||.|||.+++++|++|.-+.|+|+..| ..||++|.++.......
T Consensus 89 ErV~P-l~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~ 159 (690)
T KOG1243|consen 89 ERVRP-LETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFN 159 (690)
T ss_pred ecccc-HHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCC
Confidence 99863 2222322 336677778899999999999789999999999999999998 69999999886543322
Q ss_pred C-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC
Q 014174 249 P-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG 290 (429)
Q Consensus 249 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg 290 (429)
. .....---.|..|+.+.. -+-..|.|.|||++++++.|
T Consensus 160 ~~~~~~~~~~s~~~P~~~~~---s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 160 APAKSLYLIESFDDPEEIDP---SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccccchhhhcccChhhcCc---cccchhhhhHHHHHHHHhCc
Confidence 1 111111223667765522 22467999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.9e-13 Score=134.12 Aligned_cols=251 Identities=22% Similarity=0.190 Sum_probs=176.4
Q ss_pred ccccceEEeeEEccCCceEEEEEEEc-CCCcEEEEEEeecchhhh------HHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCL-ETGETVAIKKVLQDKRYK------NRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~------~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
....+|..+..||.|.|+.|+.+... .++..|++|...+..... -.|+-+...+ .|.++++++..|.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~- 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ- 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-
Confidence 34567999999999999999987755 788999999775443222 2455555555 58899988777643222
Q ss_pred CceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
.++-.|||.+....+.. .....+.+...+.+..|++.|+.++| ++.++|+|+||+||++..++...++.|||
T Consensus 341 ----~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~-s~~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 341 ----GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIH-SKLFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred ----ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhcccccc-chhhhcccccccceeeccchhhhhccccc
Confidence 55788999765544433 22355778888899999999999999 99999999999999998764579999999
Q ss_pred cceecccCCCccccccccccc-ccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 240 SAKVLVKGEPNISYICSRYYR-APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
++..+.-. ......+..+. ..|++.....+..+.|++|||..+.+.++|...-........ ++..
T Consensus 413 ~~t~~~~~--~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i~~~--------- 478 (524)
T KOG0601|consen 413 CWTRLAFS--SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---IRSG--------- 478 (524)
T ss_pred ccccccee--cccccccccccccchhhccccccccccccccccccccccccCcccCccccccee---eecc---------
Confidence 98652111 11222233344 356665656688899999999999999999843322111000 0000
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
..+ .......++..+...++..++..|+.+.++..|+=|....
T Consensus 479 ----------~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 479 ----------DTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred ----------ccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence 000 0112347788999999999999999999999998776543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.4e-12 Score=126.64 Aligned_cols=137 Identities=20% Similarity=0.248 Sum_probs=87.4
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch-hhh-------------------------------------------H
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYK-------------------------------------------N 132 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~-------------------------------------------~ 132 (429)
+.||.|++|.||+|+. .+|+.||||+..... ..+ .
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999985 579999999874321 011 1
Q ss_pred HHHHHHHHc----CCCCeeecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHH-HHHH
Q 014174 133 RELQTMRLL----DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR-ALAY 207 (429)
Q Consensus 133 ~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~-aL~~ 207 (429)
+|.+.+.++ +|.+-+.+-.++....+ ..++||||++|..+........ .... ...++.+++. .+..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~----~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~q 272 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTS----ERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLNQ 272 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcC----CceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHHH
Confidence 233333333 23333333333322221 2468999998754332222111 1122 2345555555 4678
Q ss_pred HHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 208 LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+| ..|++|+|+||.||+++.++ .++++|||++....
T Consensus 273 l~-~~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~ 308 (437)
T TIGR01982 273 VL-RDGFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS 308 (437)
T ss_pred HH-hCCceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence 89 88999999999999999887 79999999997764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.9e-13 Score=132.40 Aligned_cols=142 Identities=18% Similarity=0.216 Sum_probs=89.0
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhh--------------------------------------h--
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY--------------------------------------K-- 131 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------~-- 131 (429)
.|.. +.||+|++|.||+|+.+.+|+.||||+....... .
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 7899999999999999888999999988643100 0
Q ss_pred ----HHHHHHHHHc----CCCCeeecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcC---CCCCHHHHHHHHHH
Q 014174 132 ----NRELQTMRLL----DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRAS---QRMPLIYVKLYTYQ 200 (429)
Q Consensus 132 ----~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~---~~l~~~~~~~i~~q 200 (429)
.+|...+.++ .+.+.+.+-.++...++ ..++||||+.|.-...+......+ ..+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st----~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS----ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCC----CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 1122222222 23333443343432221 246899999975443222211111 12444455555556
Q ss_pred HHHHHHHHHcCCCeeeecCCCCceEecCCC---CcEEEeecccceeccc
Q 014174 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHT---HQVKLCDFGSAKVLVK 246 (429)
Q Consensus 201 i~~aL~~LH~~~givH~DLkp~Nill~~~~---~~vkl~DfG~a~~~~~ 246 (429)
++ ..|++|+|+||.||+++.++ ..++++|||++.....
T Consensus 276 if--------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 VF--------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HH--------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 54 35999999999999998765 2699999999987643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=3.4e-12 Score=110.45 Aligned_cols=125 Identities=15% Similarity=0.191 Sum_probs=90.2
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCee-ecceEeeecCCCCceEEEEEEecc
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVV-SLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
++.|+.|.++.||+++. .+..|++|...... ....+|+.+++.+.+.+++ +++.+. ... .++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence 35789999999999986 47889999875543 3356899999998765544 343322 111 35799999
Q ss_pred chhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC-----eeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 172 PETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG-----VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 172 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g-----ivH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++...... . .....++.+++.+|..|| ..+ ++|+|++|.||+++ ++ .++++|||.+..
T Consensus 74 ~G~~l~~~--------~---~~~~~~~~~l~~~l~~LH-~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~~ 136 (170)
T cd05151 74 EGSELLTE--------D---FSDPENLEKIAKLLKKLH-SSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAGM 136 (170)
T ss_pred CCCccccc--------c---ccCHHHHHHHHHHHHHHh-CCCCCCceeecCCCCcCcEEEE-CC-eEEEEecccccC
Confidence 98532210 0 112345679999999999 666 49999999999999 45 699999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.5e-12 Score=110.42 Aligned_cols=133 Identities=17% Similarity=0.180 Sum_probs=93.8
Q ss_pred eEEccCCceEEEEEEEcC------CCcEEEEEEeecc--------------hh------------hh----HHHHHHHHH
Q 014174 97 RVVGQGSFGIVFQAKCLE------TGETVAIKKVLQD--------------KR------------YK----NRELQTMRL 140 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~--------------~~------------~~----~~E~~~l~~ 140 (429)
..||.|--+.||.|.... .+..+|||+.+.. .+ .. ++|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 3578999976311 00 11 268888888
Q ss_pred cCC--CCeeecceEeeecCCCCceEEEEEEeccchhHH--HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH-HcCCCee
Q 014174 141 LDH--PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVY--RVAKHYSRASQRMPLIYVKLYTYQICRALAYI-HGGIGVC 215 (429)
Q Consensus 141 l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~--~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~giv 215 (429)
+.. -++...+.+. . .+|||||++++.+ ..+. ...++...+..+..+++.+|..| | +.|||
T Consensus 83 l~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H-~~glV 147 (197)
T cd05146 83 MQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYK-ECNLV 147 (197)
T ss_pred HHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHH-hCCee
Confidence 853 3444554321 1 4689999986411 1111 12355566777889999999999 8 88999
Q ss_pred eecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 216 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 216 H~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|+||++.||+++. + .+.|+|||.+....+
T Consensus 148 HGDLs~~NIL~~~-~-~v~iIDF~qav~~~h 176 (197)
T cd05146 148 HADLSEYNMLWHD-G-KVWFIDVSQSVEPTH 176 (197)
T ss_pred cCCCCHHHEEEEC-C-cEEEEECCCceeCCC
Confidence 9999999999974 4 599999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.6e-12 Score=129.33 Aligned_cols=185 Identities=23% Similarity=0.302 Sum_probs=128.3
Q ss_pred HHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCC--------cccc--cccccccccccccCCCC
Q 014174 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--------NISY--ICSRYYRAPELIFGATE 270 (429)
Q Consensus 201 i~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~--------~~~~--~gt~~y~aPE~~~~~~~ 270 (429)
+..||.|+|.+.++||++|.|++|.++.++ .+||+.|+.+.....+.. .... .-...|.|||.+.+ ..
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-TT 185 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-cc
Confidence 348999999888999999999999999888 799999998865433111 1111 12456999999976 45
Q ss_pred CCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChh
Q 014174 271 YTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPE 349 (429)
Q Consensus 271 ~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 349 (429)
.+.++|++|+||++|.+. .|+..+................ .--...+..+++++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~-------------------------~~~~~~~s~~~p~e 240 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL-------------------------NAGAFGYSNNLPSE 240 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc-------------------------ccccccccccCcHH
Confidence 889999999999999999 5666565443322221111100 00011123568999
Q ss_pred HHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCChhhhccCCHHHHHhhcHH
Q 014174 350 AVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPE 418 (429)
Q Consensus 350 l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (429)
+++=|.++|..++.-||++.+++..|||.+.+-...++ ...+..+++.|-.. ..+.+.+++|+
T Consensus 241 l~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~aLrf-----LD~l~~kdn~qKs~-Flk~Ls~~ip~ 303 (700)
T KOG2137|consen 241 LRESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKALRF-----LDDLPQKDNSQKSS-FLKGLSKLIPT 303 (700)
T ss_pred HHHHHHHHhcCCcccCcchhhhhcccccCCchhhhhhh-----cccccccCcHHHHH-HHHHHHHhhcc
Confidence 99999999999999999999999999998866554443 33344456655433 33446665443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.1e-10 Score=109.58 Aligned_cols=214 Identities=20% Similarity=0.260 Sum_probs=150.4
Q ss_pred ceEEEEEEEcCCCcEEEEEEeecchh----hhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEeccch--hHHH
Q 014174 104 FGIVFQAKCLETGETVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE--TVYR 177 (429)
Q Consensus 104 ~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~ 177 (429)
-.+.|++....+|..|++|++..++. ....-+++++++.|.|+|++.++|.... -+...+++|++|.++ +|++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHHH
Confidence 35779999999999999999943322 2234688999999999999999987333 455568899999984 4444
Q ss_pred HHHHh-----------hhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 178 VAKHY-----------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 178 ~~~~~-----------~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
+...- ...+...++..+|.++.|+..||.++| +.|..-+-|.|.+||++.+. +++|+..|.......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH-ssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH-SSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH-hcCceeecccHhHeEeeCcc-eEEEecccceeeecC
Confidence 32210 112345789999999999999999999 78999999999999999776 799988877655433
Q ss_pred CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHH-HHHHHHHhCCCCHHHHhhcCcC
Q 014174 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL-FPGESGVDQ-LVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
... +.+.+ -.+-|.=.||.+++.|.||..- +......+. +..|
T Consensus 446 d~~-------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------------ 490 (655)
T KOG3741|consen 446 DPT-------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------------ 490 (655)
T ss_pred CCC-------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------------
Confidence 320 11211 2356899999999999999621 111111111 1111
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
....+.+++++|.-+..-++++ -++.+++.|
T Consensus 491 ------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 ------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1236788888888888888876 566666653
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=8e-10 Score=93.35 Aligned_cols=140 Identities=19% Similarity=0.246 Sum_probs=94.8
Q ss_pred EeeEEccCCceEEEEEEEcCCCcEEEEEEee-cc-----------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 95 AERVVGQGSFGIVFQAKCLETGETVAIKKVL-QD-----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 95 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~-----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
....|-+|+-+.|+++.+ .|+.+.||.-. +. +....+|+++|.++.--.|.--.-+|.+...
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~---- 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG---- 84 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC----
Confidence 456888999999999986 88998888432 11 2223468888888753333221112322222
Q ss_pred EEEEEEeccch--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcE--EEeec
Q 014174 163 YLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV--KLCDF 238 (429)
Q Consensus 163 ~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~v--kl~Df 238 (429)
-+|+|||++| ++.+.+.... .......-...++.+|-..+.-|| ..+|+|+||..+||++.+++..+ .++||
T Consensus 85 -~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH-~ndiiHGDLTTSNill~~~~~~~~~~lIdf 160 (229)
T KOG3087|consen 85 -GQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLH-DNDIIHGDLTTSNILLRSDGNQITPILIDF 160 (229)
T ss_pred -CeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhh-hCCeecccccccceEEecCCCcCceEEEee
Confidence 4579999997 4444433321 122223333678888999999999 88999999999999998777654 89999
Q ss_pred ccceec
Q 014174 239 GSAKVL 244 (429)
Q Consensus 239 G~a~~~ 244 (429)
|++...
T Consensus 161 gls~~s 166 (229)
T KOG3087|consen 161 GLSSVS 166 (229)
T ss_pred cchhcc
Confidence 998654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=6.5e-10 Score=94.31 Aligned_cols=128 Identities=16% Similarity=0.276 Sum_probs=84.0
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecc------------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
..+++|+-+.++.+.+ -|..+++|.-... .....+|++++..+.--.|..-+=+++.... .
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-----~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-----G 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----C
Confidence 3578999999999966 4555777743211 1222368888888754333222222222222 4
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
.|+|||++|.++.... ... . ..++..+-.-+.-|| ..||+|+||.++||++... .+.++|||++...
T Consensus 75 ~I~me~I~G~~lkd~l---~~~---~----~~~~r~vG~~vg~lH-~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~s 141 (204)
T COG3642 75 LIVMEYIEGELLKDAL---EEA---R----PDLLREVGRLVGKLH-KAGIVHGDLTTSNIILSGG--RIYFIDFGLGEFS 141 (204)
T ss_pred EEEEEEeCChhHHHHH---Hhc---c----hHHHHHHHHHHHHHH-hcCeecCCCccceEEEeCC--cEEEEECCccccc
Confidence 5899999986555221 111 2 334556666677799 8999999999999999854 4999999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.1e-09 Score=95.64 Aligned_cols=122 Identities=22% Similarity=0.277 Sum_probs=77.4
Q ss_pred EEEEEEEcCCCcEEEEEEeecc------------------------------hhhhHHHHHHHHHcCCC--CeeecceEe
Q 014174 106 IVFQAKCLETGETVAIKKVLQD------------------------------KRYKNRELQTMRLLDHP--NVVSLKHCF 153 (429)
Q Consensus 106 ~V~~~~~~~~~~~vaiK~~~~~------------------------------~~~~~~E~~~l~~l~h~--niv~~~~~~ 153 (429)
.||.|.. ..|..+|+|+.+.. .....+|.+.|.++..- ++.+.+.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4888885 56789999976321 01123699999999765 455554432
Q ss_pred eecCCCCceEEEEEEeccc--hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHH-HHcCCCeeeecCCCCceEecCCC
Q 014174 154 FSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY-IHGGIGVCHRDIKPQNLLVNPHT 230 (429)
Q Consensus 154 ~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~givH~DLkp~Nill~~~~ 230 (429)
. .+|||||++ |..+..+.. ..++......++.+++..+.. +| +.||+|+||.+.||+++.+
T Consensus 80 -----~----~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~-~~givHGDLs~~NIlv~~~- 143 (188)
T PF01163_consen 80 -----R----NVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLH-KAGIVHGDLSEYNILVDDG- 143 (188)
T ss_dssp -----T----TEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHH-CTTEEESS-STTSEEEETT-
T ss_pred -----C----CEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHH-hcCceecCCChhhEEeecc-
Confidence 2 358999999 543333332 112234456677788885555 57 8999999999999999965
Q ss_pred CcEEEeecccceecc
Q 014174 231 HQVKLCDFGSAKVLV 245 (429)
Q Consensus 231 ~~vkl~DfG~a~~~~ 245 (429)
.+.|+|||.+....
T Consensus 144 -~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 144 -KVYIIDFGQAVDSS 157 (188)
T ss_dssp -CEEE--GTTEEETT
T ss_pred -eEEEEecCcceecC
Confidence 59999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.7e-09 Score=96.40 Aligned_cols=140 Identities=18% Similarity=0.186 Sum_probs=92.3
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCC--eeecceEeeecCCCCceEEEEEEe
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
+.|+.|..+.||++... +|..+++|..... .....+|.++++.+.+.+ +.+++.+.... ......++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEE
Confidence 57899999999999863 3689999987543 235578999999997643 45555443211 11123568999
Q ss_pred ccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc---------------------------------------
Q 014174 170 FVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG--------------------------------------- 210 (429)
Q Consensus 170 ~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------------------------------------- 210 (429)
|++|..+.... . ...++......++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~---~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 81 RVDGRVLRDRL---L-RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred EeCCEecCCCC---C-CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99874222110 0 0234555555566666666666661
Q ss_pred ----------------CCCeeeecCCCCceEecCC-CCcEEEeeccccee
Q 014174 211 ----------------GIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKV 243 (429)
Q Consensus 211 ----------------~~givH~DLkp~Nill~~~-~~~vkl~DfG~a~~ 243 (429)
...++|+|++|.||+++.+ ...+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1357999999999999873 22689999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.7e-08 Score=93.48 Aligned_cols=133 Identities=11% Similarity=0.102 Sum_probs=87.2
Q ss_pred EEEEEEEcCCCcEEEEEEeecch---------------hhhHHHHHHHHHcCCCCee--ecceEeeecCCCCceEEEEEE
Q 014174 106 IVFQAKCLETGETVAIKKVLQDK---------------RYKNRELQTMRLLDHPNVV--SLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 106 ~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~h~niv--~~~~~~~~~~~~~~~~~~lv~ 168 (429)
.|+++.. .|+.|.||...... ....+|.+.+..|..-+|. ..+.++....+.....-++||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555543 56677777553211 1356888888887543332 223333222212122356899
Q ss_pred eccch--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC------CCcEEEeeccc
Q 014174 169 EFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH------THQVKLCDFGS 240 (429)
Q Consensus 169 e~~~~--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~------~~~vkl~DfG~ 240 (429)
|++++ ++.+++.... ....+......++.+++..+.-|| ..||+|+||++.|||++.+ ...+.|+||+.
T Consensus 115 e~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH-~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r 191 (268)
T PRK15123 115 EDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMH-AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR 191 (268)
T ss_pred eeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHH-HCcCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence 99997 4555543221 234566778899999999999999 8999999999999999751 23799999998
Q ss_pred cee
Q 014174 241 AKV 243 (429)
Q Consensus 241 a~~ 243 (429)
+..
T Consensus 192 ~~~ 194 (268)
T PRK15123 192 AQI 194 (268)
T ss_pred ccc
Confidence 753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.3e-08 Score=91.63 Aligned_cols=133 Identities=18% Similarity=0.154 Sum_probs=94.3
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--------------------------hhhhHHHHHHHHHcCCC-
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--------------------------KRYKNRELQTMRLLDHP- 144 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------------------~~~~~~E~~~l~~l~h~- 144 (429)
-+.+...||-|--|.||.|.+ ..|..+|||.-+-. ....++|.++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G 170 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG 170 (304)
T ss_pred HHhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence 367778999999999999996 47899999954210 12234799999998654
Q ss_pred -CeeecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCc
Q 014174 145 -NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223 (429)
Q Consensus 145 -niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~N 223 (429)
.+.+.++ ....++|||+++|..+.- -++.......++..|+.-+..+- ..||||+||.+-|
T Consensus 171 ~~VP~P~~---------~nRHaVvMe~ieG~eL~~--------~r~~~en~~~il~~il~~~~~~~-~~GiVHGDlSefN 232 (304)
T COG0478 171 VKVPKPIA---------WNRHAVVMEYIEGVELYR--------LRLDVENPDEILDKILEEVRKAY-RRGIVHGDLSEFN 232 (304)
T ss_pred CCCCCccc---------cccceeeeehcccceeec--------ccCcccCHHHHHHHHHHHHHHHH-HcCccccCCchhe
Confidence 5555432 223568999999843221 12234445555666666666665 6799999999999
Q ss_pred eEecCCCCcEEEeecccceec
Q 014174 224 LLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 224 ill~~~~~~vkl~DfG~a~~~ 244 (429)
|+++.+| .+.++||--+...
T Consensus 233 IlV~~dg-~~~vIDwPQ~v~~ 252 (304)
T COG0478 233 ILVTEDG-DIVVIDWPQAVPI 252 (304)
T ss_pred EEEecCC-CEEEEeCcccccC
Confidence 9999998 6999999876543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.5e-07 Score=86.81 Aligned_cols=260 Identities=16% Similarity=0.188 Sum_probs=146.5
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeecchh-hhHHHHHHHHHc-CCCCeeecceEe----eecCCCCceEEEEEEe
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-YKNRELQTMRLL-DHPNVVSLKHCF----FSTTDKDELYLNLVLE 169 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l-~h~niv~~~~~~----~~~~~~~~~~~~lv~e 169 (429)
.+.||+|+-+.+|-.-.. + ..+.|+.....- ....-+..|... .||-+-.-+ .+ .... ......-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rv-aWPqa~L~G~-~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRV-AWPQATLHGG-RRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh--h-chhheeecCCCchHHHHHHHHhccCCCCcchhhhh-cccHHHhhCC-CccceeEEecc
Confidence 467999999999876432 2 234566643321 111222222222 354332200 01 0111 11222556777
Q ss_pred ccchh--HHHHHH--HhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 170 FVPET--VYRVAK--HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 170 ~~~~~--l~~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
.+.+- ...+.. +..+......+..+...++.++.+..-|| ..|.+-+|+.++|+|++.++ .|.|.|=..-....
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH-~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~~ 168 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH-EHGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQINA 168 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH-hcCCcccccCccceeeecCc-eEEEEcccceeecc
Confidence 77642 111111 11223345788899999999999999999 88999999999999999887 78888744333333
Q ss_pred cCCCccccccccccccccccc----CCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 246 KGEPNISYICSRYYRAPELIF----GATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
++......+|...|.+||.-. ..-..+...|.|.||+++++++.| +.||.|-.... ..+.|.+..|..
T Consensus 169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~-------~ap~p~E~~Ia~ 241 (637)
T COG4248 169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS-------DAPNPLETDIAH 241 (637)
T ss_pred CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccC-------CCCCcchhhhhc
Confidence 333334456788999999642 112356789999999999999987 89998632100 000111111111
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCc--CCCCCCCHHH
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY--SPNLRCTALE 370 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~--dP~~R~t~~e 370 (429)
-.--|..-..+.....+... -..-+++++..|..+|+.. ++.-|||++-
T Consensus 242 g~f~ya~~~~~g~~p~P~~~-P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSI-PLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ceeeechhccCCCCCCCCCC-ChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 00000000111111111000 1124789999999999985 3678998863
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=7.4e-07 Score=78.74 Aligned_cols=138 Identities=14% Similarity=0.176 Sum_probs=86.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhh-------------HHHHHHHHHcCCCCeeec---ceEe
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMRLLDHPNVVSL---KHCF 153 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------~~E~~~l~~l~h~niv~~---~~~~ 153 (429)
.++|.+.+++-......|.+..- +|..+++|......... .+++..+..+....+..+ +-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 34699999999888888887764 78999999775442221 123333334432222222 1111
Q ss_pred eecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcE
Q 014174 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV 233 (429)
Q Consensus 154 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~v 233 (429)
.-....-....+++|||++|--+... ..+++ .+...|..++.-|| +.|++|+|..|.|++++.++ +
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~-------~~i~e----~~~~ki~~~ikqlH-~~G~~HGD~hpgNFlv~~~~--i 173 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDI-------EDIDE----DLAEKIVEAIKQLH-KHGFYHGDPHPGNFLVSNNG--I 173 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccc-------hhcCH----HHHHHHHHHHHHHH-HcCCccCCCCcCcEEEECCc--E
Confidence 11111112235689999998422211 11232 23456778899999 89999999999999999554 9
Q ss_pred EEeeccccee
Q 014174 234 KLCDFGSAKV 243 (429)
Q Consensus 234 kl~DfG~a~~ 243 (429)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999986543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.1e-07 Score=80.17 Aligned_cols=109 Identities=17% Similarity=0.260 Sum_probs=75.4
Q ss_pred hhHHHHHHHHHcCCCCe--eecceEeeecCCCCceEEEEEEeccch--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Q 014174 130 YKNRELQTMRLLDHPNV--VSLKHCFFSTTDKDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205 (429)
Q Consensus 130 ~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 205 (429)
...+|...+..|..-.| ...+.+........ ..-++|+|++++ ++...+.. ....+......++.++...+
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~-~~s~lite~l~~~~~L~~~~~~----~~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGG-YRSYLITEALPGAQDLRDLLQQ----WEQLDPSQRRELLRALARLI 131 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCc-eeEEEEEEeCCCcccHHHHHHh----hcccchhhHHHHHHHHHHHH
Confidence 34578887777753333 33333333322222 345789999986 34444432 12266677888999999999
Q ss_pred HHHHcCCCeeeecCCCCceEecCCC--CcEEEeecccceec
Q 014174 206 AYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVL 244 (429)
Q Consensus 206 ~~LH~~~givH~DLkp~Nill~~~~--~~vkl~DfG~a~~~ 244 (429)
.-|| ..||+|+|+++.|||++.++ ..+.++||+.++..
T Consensus 132 ~~lH-~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLH-DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHH-HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999 89999999999999998664 25899999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.60 E-value=5.4e-07 Score=80.49 Aligned_cols=133 Identities=17% Similarity=0.163 Sum_probs=90.3
Q ss_pred EEccCCceEEEEEEEcCCCcEEEEEEeecchhh----------------------------hHHHHHHHHHcCCC--Cee
Q 014174 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY----------------------------KNRELQTMRLLDHP--NVV 147 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------------~~~E~~~l~~l~h~--niv 147 (429)
.|..|--+.||+|.. .++..+|+|+++..... ..+|+.-|+++... .+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 678888889999984 56899999988532111 12477777776433 233
Q ss_pred ecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec
Q 014174 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN 227 (429)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~ 227 (429)
+-+.+. . ..|||||++... . ..-.-..-.+...++..+..++++.+.-|-...|+||+||+.-|||+.
T Consensus 134 ~Pi~~~-----~----nVLvMEfIg~~g-~--pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 134 EPIAFR-----N----NVLVMEFIGDDG-L--PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred Cceeec-----C----CeEEEEeccCCC-C--CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 333333 1 358999998531 0 000001223344467888889999999887458999999999999999
Q ss_pred CCCCcEEEeecccceecc
Q 014174 228 PHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 228 ~~~~~vkl~DfG~a~~~~ 245 (429)
++ .+.|+|||-|....
T Consensus 202 -~~-~p~iID~~QaV~~~ 217 (268)
T COG1718 202 -DG-EPYIIDVSQAVTID 217 (268)
T ss_pred -CC-eEEEEECccccccC
Confidence 55 69999999986654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.3e-06 Score=75.36 Aligned_cols=138 Identities=12% Similarity=0.084 Sum_probs=94.7
Q ss_pred ccCCceEEEEEEEcCCCcEEEEEEeec----------chhhhHHHHHHHHHcCCCC--eeecceEeeecCCCCceEEEEE
Q 014174 100 GQGSFGIVFQAKCLETGETVAIKKVLQ----------DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 100 g~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv 167 (429)
|+||-+.|+.... .|..|-+|+-.. ....+.+|+..|+.|..-+ +.+.. ++-.........-+||
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 6788888988765 445677885531 1234568999998885433 44443 2222222334456789
Q ss_pred Eeccc--hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC-cEEEeeccccee
Q 014174 168 LEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKV 243 (429)
Q Consensus 168 ~e~~~--~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~-~vkl~DfG~a~~ 243 (429)
+|-++ .+|...+... ...+.+......++.+++.++.-|| +.|+.|+|+-+.||+++.++. .++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH-~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMH-SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99888 4554444321 1234577777899999999999999 899999999999999986652 399999987654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.2e-08 Score=101.02 Aligned_cols=245 Identities=18% Similarity=0.162 Sum_probs=162.5
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCC-eeecceEeeecCCCCceEEEEEEec
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPN-VVSLKHCFFSTTDKDELYLNLVLEF 170 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~lv~e~ 170 (429)
-|...+-+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+ +.+.+..+++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCcccccccC-----Ccccccchhhhh
Confidence 4666678899999999999987766555 6766554 44456899999999999 44433322 667788999999
Q ss_pred cchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCc
Q 014174 171 VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 250 (429)
Q Consensus 171 ~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~ 250 (429)
++++-.... ......-.+.......+.+.-.++|++|| +.-=+|+| ||+..+. ..|..||+....+......
T Consensus 316 ~s~~rs~~~-~~~~se~~~~~~~~~~~~r~et~~l~~l~-~~~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~ 387 (829)
T KOG0576|consen 316 CSTGRSSAL-EMTVSEIALEQYQFAYPLRKETRPLAELH-SSYKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKP 387 (829)
T ss_pred hcCCccccc-cCChhhHhhhhhhhhhhhhhhcccccccc-cccccCcc----ccccccc--ccccccccCCcccCccccc
Confidence 986510100 00001112233334455566678999999 54458888 8888754 5899999998877666556
Q ss_pred ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccC
Q 014174 251 ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330 (429)
Q Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 330 (429)
....+|+.++|||+..... +....|.|++|.-..+|.-|-+|-...-. . ....|..+ ..
T Consensus 388 ~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~P~~--~----~~~~g~~p--------------~s 446 (829)
T KOG0576|consen 388 RTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSSPPA--V----LPMIGNGP--------------NS 446 (829)
T ss_pred ccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCCCcc--c----cCCCCCCC--------------Cc
Confidence 6778999999999886644 88899999999887788877766543110 0 00000000 00
Q ss_pred CCcCC-CCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 331 PQIKA-HPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 331 ~~~~~-~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
+.... ..|... .-.++-..|+...|..|++..+++.|.+|..
T Consensus 447 ~~L~~~~aw~~~-------~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 447 PMLTDKSAWSPV-------FHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred cccchhhhcCcc-------cccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 11000 111111 1125778899999999999999999999965
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.3e-07 Score=95.34 Aligned_cols=203 Identities=21% Similarity=0.310 Sum_probs=135.0
Q ss_pred HHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc
Q 014174 132 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210 (429)
Q Consensus 132 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 210 (429)
+.|++.+..+.|+|++.++.+.......+ ..+.+..++|.. .+...+. ..+..+...++.+..++++||.|+|
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h- 303 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLH- 303 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHH-
Confidence 45777888899999999877664433222 112223345543 2222222 3467899999999999999999999
Q ss_pred CCCeeeecCCCC---ceEecCCCCcEEEe--ecccceecccCCCcccccccccccccccccCCC-CCCCchhHHHHHHHH
Q 014174 211 GIGVCHRDIKPQ---NLLVNPHTHQVKLC--DFGSAKVLVKGEPNISYICSRYYRAPELIFGAT-EYTTAIDIWSVGCVL 284 (429)
Q Consensus 211 ~~givH~DLkp~---Nill~~~~~~vkl~--DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il 284 (429)
+....|.-|... +..++..+ .+.++ ||+..+.............+.-+.++|...... ......|+|.+|..+
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred HhccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 655555544444 33445555 46666 999888877666665666677788888775432 123347999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC
Q 014174 285 AELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364 (429)
Q Consensus 285 ~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~ 364 (429)
..+..|..+-.... .....+ +........+++.+|+.-++++
T Consensus 383 ~~~~~~~~i~~~~~---~~~~~l-----------------------------------~~~~~~~~~d~~~~~~~~~~~~ 424 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSA---VPVSLL-----------------------------------DVLSTSELLDALPKCLDEDSEE 424 (1351)
T ss_pred hhhhhcCccccccc---chhhhh-----------------------------------ccccchhhhhhhhhhcchhhhh
Confidence 99998874321110 000000 0011126889999999999999
Q ss_pred CCCHHHHhcCCCCcc
Q 014174 365 RCTALEACIHPFFYE 379 (429)
Q Consensus 365 R~t~~ell~hp~f~~ 379 (429)
|+++.+++.|||...
T Consensus 425 Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 425 RLSALELLTHPFLRF 439 (1351)
T ss_pred ccchhhhhhchhccc
Confidence 999999999999854
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.3e-06 Score=85.87 Aligned_cols=139 Identities=19% Similarity=0.197 Sum_probs=82.2
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecchhh-h-------------------------------------------H
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-K-------------------------------------------N 132 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~-------------------------------------------~ 132 (429)
+.|+.++-|.||+|+. .+|+.||||+....-.. + .
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 4789999999999996 45999999987432100 0 0
Q ss_pred HHHHHHHHc----CCCCeeecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 014174 133 RELQTMRLL----DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208 (429)
Q Consensus 133 ~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 208 (429)
+|..-+.++ ....-+.+-.++...++. -.++|||++|.-...+..... ..++...+...+.+++--.-+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f~~q~~- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAFLRQLL- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHHHHHHH-
Confidence 233333333 222223333444332221 458999999743333322111 334433333322222221112
Q ss_pred HcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 209 H~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
..|+.|.|.+|.||+++.++ .+.+.|||+.....+
T Consensus 283 --~dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 --RDGFFHADPHPGNILVRSDG-RIVLLDFGIVGRLDP 317 (517)
T ss_pred --hcCccccCCCccceEEecCC-cEEEEcCcceecCCH
Confidence 24999999999999999998 799999999876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.4e-06 Score=74.73 Aligned_cols=75 Identities=19% Similarity=0.176 Sum_probs=50.0
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCC--eeecceEeeecCCCCceEEEEEEecc
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
++.|+.|..+.||++.... ..+++|..... .....+|..+++.+.... +.+++..... .......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~--~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTS--DEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEE--TEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeeccc--ccccccceEEEEEe
Confidence 4679999999999998643 59999987654 345567888888885433 3455442211 12233467899998
Q ss_pred chh
Q 014174 172 PET 174 (429)
Q Consensus 172 ~~~ 174 (429)
++.
T Consensus 78 ~g~ 80 (239)
T PF01636_consen 78 PGR 80 (239)
T ss_dssp SSE
T ss_pred ccc
Confidence 864
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=5.9e-06 Score=69.94 Aligned_cols=129 Identities=19% Similarity=0.276 Sum_probs=84.5
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEec
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEF 170 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 170 (429)
-++.+.||+|.+|.||++.+ .|..+|+|+-..+ +.....|.++|..++-.++-.=+..+ . . .++.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y-g---~----~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY-G---E----DFIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe-c---h----hhhhhhh
Confidence 44567899999999999997 6778999976544 45567899999999876664422111 1 1 2357999
Q ss_pred cchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCC--CceEecCCCCcEEEeecccceec
Q 014174 171 VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP--QNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 171 ~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp--~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+.|--+..+.. ..... -...++.+---|- ..||-|+.|.- .||++. ++ .+.|+||..|+.-
T Consensus 94 i~G~~L~~~~~------~~~rk----~l~~vlE~a~~LD-~~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At~k 156 (201)
T COG2112 94 IDGRPLGKLEI------GGDRK----HLLRVLEKAYKLD-RLGIEHGELSRPWKNVLVN-DR-DVYIIDFDSATFK 156 (201)
T ss_pred hcCcchhhhhh------cccHH----HHHHHHHHHHHHH-HhccchhhhcCCceeEEec-CC-cEEEEEccchhhc
Confidence 99832221111 01222 2334555533455 77999998864 456665 44 6999999999743
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.8e-05 Score=70.45 Aligned_cols=69 Identities=17% Similarity=0.157 Sum_probs=45.7
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCe--eecceEeeecCCCCceEEEEEEeccc
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNV--VSLKHCFFSTTDKDELYLNLVLEFVP 172 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~ 172 (429)
..||+|..+.||+. .|..+++|..... .....+|.++++.+..-.+ .+.+++. .......+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence 57899999999984 2556888977542 2345789999988864333 3444433 12222567999998
Q ss_pred hh
Q 014174 173 ET 174 (429)
Q Consensus 173 ~~ 174 (429)
|.
T Consensus 78 G~ 79 (226)
T TIGR02172 78 GK 79 (226)
T ss_pred Cc
Confidence 73
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.3e-05 Score=67.59 Aligned_cols=126 Identities=27% Similarity=0.359 Sum_probs=87.9
Q ss_pred cceEEeeEEccCCc-eEEEEEEEcCCCcEEEEEEeec--------------c-----------hhhhHHHHHHHHHc---
Q 014174 91 ISYMAERVVGQGSF-GIVFQAKCLETGETVAIKKVLQ--------------D-----------KRYKNRELQTMRLL--- 141 (429)
Q Consensus 91 ~~y~i~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~--------------~-----------~~~~~~E~~~l~~l--- 141 (429)
.+++.++.||.|.- |.||+++. .|+.||+|.+.. . ...+..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 36889999999999 99999987 788999998421 0 01123466655555
Q ss_pred CCCCe--eecceEeeecCC-------------CCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Q 014174 142 DHPNV--VSLKHCFFSTTD-------------KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206 (429)
Q Consensus 142 ~h~ni--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~ 206 (429)
.+.++ |+++++.....+ .......||.||+.... .+... -+.+|.+-|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~----~~~~~~~dl~ 178 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIR----DIPQMLRDLK 178 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchh----HHHHHHHHHH
Confidence 55666 888887754421 11223467888876531 12222 2457888889
Q ss_pred HHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 207 ~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+| +.||+-+|+++.|.. + -||+|||.+
T Consensus 179 ~~~-k~gI~~~Dv~~~ny~---~---G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILH-KLGIVPRDVKPRNYR---G---GKLVDFSSS 206 (207)
T ss_pred HHH-HCCeeeccCcccccc---C---CEEEecccC
Confidence 999 999999999999987 3 379999864
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.93 E-value=8.8e-05 Score=74.52 Aligned_cols=139 Identities=18% Similarity=0.207 Sum_probs=82.3
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecchhhh-----------------------------------------HHHH
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-----------------------------------------NREL 135 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------------------------------------~~E~ 135 (429)
+.||.-+.|.||+|+.+ +|+.||||+-+..-+.. .+|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 67999999999999965 49999999653221000 0122
Q ss_pred H----HHHHcCCCC---eeecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q 014174 136 Q----TMRLLDHPN---VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208 (429)
Q Consensus 136 ~----~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 208 (429)
+ +.+.+.|-+ -|.+-.++....+ .-.|+||||+|.-.+.+.... ...++...+..-+.++..-+-+-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl~~i~--~~gi~~~~i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDLDAID--KRGISPHDILNKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCHHHHH--HcCCCHHHHHHHHHHHHHHHHHh
Confidence 2 122234444 1223233332221 246899999974333333222 23455554444333333322222
Q ss_pred HcCCCeeeecCCCCceEecC---CCCcEEEeecccceecc
Q 014174 209 HGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 209 H~~~givH~DLkp~Nill~~---~~~~vkl~DfG~a~~~~ 245 (429)
.|++|+|=+|-||++.+ .+..+.+.|||+.....
T Consensus 320 ---~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 ---TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ---cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 38999999999999984 24489999999987653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00011 Score=79.37 Aligned_cols=77 Identities=17% Similarity=0.179 Sum_probs=49.9
Q ss_pred eeEEccCCceEEEEEEEcCCC--cEEEEEEeec-----chhhhHHHHHHHHHcC-CCCe--eecceEeeecCCCCceEEE
Q 014174 96 ERVVGQGSFGIVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTMRLLD-HPNV--VSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~-----~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~ 165 (429)
++.++.|.++.+|+......+ ..+++|+... ......+|+++++.+. |.++ .+++.++... ......|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCCce
Confidence 467899999999998764332 4678886533 2235678999999995 6664 4554433211 1112356
Q ss_pred EEEeccchh
Q 014174 166 LVLEFVPET 174 (429)
Q Consensus 166 lv~e~~~~~ 174 (429)
+||||++|.
T Consensus 121 lVME~v~G~ 129 (822)
T PLN02876 121 YIMEYLEGR 129 (822)
T ss_pred EEEEecCCc
Confidence 899999864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00017 Score=66.17 Aligned_cols=69 Identities=17% Similarity=0.122 Sum_probs=42.3
Q ss_pred EccCCc-eEEEEEEEcCCCcEEEEEEeecc-hhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceEEEEEEeccchh
Q 014174 99 VGQGSF-GIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVLEFVPET 174 (429)
Q Consensus 99 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~ 174 (429)
|..|.. +.||++.. .+..+.+|+.... .....+|+++++.+. +--+.+++++... ....++||++++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSD-----DGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEec-----CCccEEEEEeeCCc
Confidence 344444 78899964 3467888876442 134567999988884 3234455544421 12356799999864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00015 Score=68.40 Aligned_cols=139 Identities=16% Similarity=0.196 Sum_probs=95.2
Q ss_pred EEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------------------------------hhhHHHHHHHHHcCC
Q 014174 94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------------------------RYKNRELQTMRLLDH 143 (429)
Q Consensus 94 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~~l~~l~h 143 (429)
.|..+|..|--+.||.|. ..+|..+|||+++.+. ...+.|++-|++|+.
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 344578888889999998 4678889999774220 112358888888876
Q ss_pred CCeeecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCc
Q 014174 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223 (429)
Q Consensus 144 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~N 223 (429)
..|.----+. ..+ ..|||+|++..-+- .-.-....++...+..+-.|++.-+.-|-..++.||.||.--|
T Consensus 226 aGIP~PePIl-Lk~------hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN 295 (520)
T KOG2270|consen 226 AGIPCPEPIL-LKN------HVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN 295 (520)
T ss_pred cCCCCCCcee-eec------ceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence 5543211111 111 35899999853221 1111235577778888888888888888658899999999999
Q ss_pred eEecCCCCcEEEeecccceecc
Q 014174 224 LLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 224 ill~~~~~~vkl~DfG~a~~~~ 245 (429)
+|+. +| .+.|+|.+-+....
T Consensus 296 ~Lyh-dG-~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 296 LLYH-DG-KLYIIDVSQSVEHD 315 (520)
T ss_pred heEE-CC-EEEEEEccccccCC
Confidence 9998 45 69999998775543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.0013 Score=64.37 Aligned_cols=70 Identities=21% Similarity=0.327 Sum_probs=46.8
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeec-----------chhhhHHHHHHHHHcC---CCCeeecceEeeecCCCCce
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQ-----------DKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~ 162 (429)
+.||.|.+..||++.+...++.|+||.-.. .......|.+.|+.+. -.++.+++++. ...
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~~~- 105 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----EEL- 105 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CCC-
Confidence 578999999999999854336899997431 1223346788887763 34566676542 211
Q ss_pred EEEEEEeccch
Q 014174 163 YLNLVLEFVPE 173 (429)
Q Consensus 163 ~~~lv~e~~~~ 173 (429)
.++|||++++
T Consensus 106 -~~lVME~L~~ 115 (401)
T PRK09550 106 -AVTVMEDLSD 115 (401)
T ss_pred -CEEEEecCCC
Confidence 4589999874
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.64 E-value=7.3e-05 Score=73.32 Aligned_cols=171 Identities=20% Similarity=0.258 Sum_probs=110.4
Q ss_pred HHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 014174 133 RELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212 (429)
Q Consensus 133 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 212 (429)
.-..+++.+.|+|...++++-.. . .....+|+|+++.++.+.+... .+-.. ++. -|
T Consensus 31 gr~~~lktl~~~~l~~yl~~~r~---~-~~r~IVV~e~~~~Sled~~~~~-----~l~~~-------s~~-----~~--- 86 (725)
T KOG1093|consen 31 GRFQYLKSLQHDNLCQYLDFSRG---K-HERVIVVMEHYTMSLEDILKTG-----NLKDE-------SLL-----AH--- 86 (725)
T ss_pred hhhHHHHhhcCccceeeEeeecC---c-cceEEEEehhhccchHHHHHhc-----ccchh-------hhc-----cc---
Confidence 35677888999999998775422 2 2237789999999888876531 11110 111 12
Q ss_pred CeeeecCCCCceEecCCCCcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 014174 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQP 292 (429)
Q Consensus 213 givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~ 292 (429)
|+.|- + .++++| .++ |. | | ...++++||||+|.++.++..|..
T Consensus 87 ~~~~~------------~-~~~~td-~~~--------------t~-~--~------~~~~pKsdVwsl~~i~~el~L~~~ 129 (725)
T KOG1093|consen 87 GVLHL------------N-IIYITD-HFL--------------TK-Y--P------SPIGPKSDVWSLGFIILELYLGIS 129 (725)
T ss_pred cccee------------h-hhhccc-ccc--------------cc-C--C------CCCCcchhhhhHHHHHHHHHHhhH
Confidence 33321 1 345555 110 00 1 1 112359999999999999999999
Q ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 014174 293 LFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372 (429)
Q Consensus 293 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell 372 (429)
.+......+.+..+.+..-.+.......+.. .+...++..+..++.+|+-..|..||...++.
T Consensus 130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~-----------------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 130 LEAELTESEYLEILLKYYTDDQELLSTAMEH-----------------LIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HHHHHHHHHHHHHHHHhccCchhHHHHHHHH-----------------HHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 9988887777777776554443322211100 11123567788999999999999999999999
Q ss_pred cCCCCcccC
Q 014174 373 IHPFFYELR 381 (429)
Q Consensus 373 ~hp~f~~~~ 381 (429)
+++-|.++.
T Consensus 193 k~~i~~ev~ 201 (725)
T KOG1093|consen 193 KRCSFTEVY 201 (725)
T ss_pred cCccHHHHH
Confidence 999998763
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00066 Score=59.88 Aligned_cols=130 Identities=19% Similarity=0.313 Sum_probs=81.7
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecch--------------------hhhHHHHHHHHHcC------CCCeeecc
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------------------RYKNRELQTMRLLD------HPNVVSLK 150 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------~~~~~E~~~l~~l~------h~niv~~~ 150 (429)
..||+|+.-.||.-- .+....||+..... ....+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 579999999999764 34557888876544 33446777666665 78899999
Q ss_pred eEeeecCCCCceEEEEEEeccc---hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec
Q 014174 151 HCFFSTTDKDELYLNLVLEFVP---ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN 227 (429)
Q Consensus 151 ~~~~~~~~~~~~~~~lv~e~~~---~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~ 227 (429)
+...+... .-+|+|.+. |.....+..+.. ...++. .....+.+ -..||- +.+|+.+||+|.||++.
T Consensus 84 G~veT~~G-----~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~~~L~~---f~~~l~-~~~Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLG-----LGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELRQALDE---FKRYLL-DHHIVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCc-----eEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHHHHHHH---HHHHHH-HcCCeecCCCcccEEEE
Confidence 87743333 566777764 222222222222 345665 33333333 344555 67899999999999995
Q ss_pred CC--CC-cEEEee-ccc
Q 014174 228 PH--TH-QVKLCD-FGS 240 (429)
Q Consensus 228 ~~--~~-~vkl~D-fG~ 240 (429)
.. +. .+.|+| ||.
T Consensus 153 ~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ecCCCceEEEEEeCCCC
Confidence 32 22 577777 454
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0006 Score=62.18 Aligned_cols=32 Identities=34% Similarity=0.403 Sum_probs=25.7
Q ss_pred CCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 211 ~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
..+++|+|+.+.||+++.++ ..-|+||+.|..
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~~ 194 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGR-LSAVIDFGCLGV 194 (235)
T ss_pred CceEEeCCCCCCcEEEECCC-EEEEEeCcccCc
Confidence 34699999999999998554 457999998743
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00023 Score=62.41 Aligned_cols=102 Identities=22% Similarity=0.178 Sum_probs=75.0
Q ss_pred HHHHHHHHHcCC-CCeeecceEeeecCCCCceEEEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 014174 132 NRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209 (429)
Q Consensus 132 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 209 (429)
..|.-+++.+.+ +++++++|.+ . -++|.||.+.+ ++... .....-...++.....++.+++..+.+|+
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~ 76 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELD 76 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHh
Confidence 358888999976 6899998877 2 24689999853 32110 00001134689999999999999999998
Q ss_pred cC--CCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 210 GG--IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 210 ~~--~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
.+ ..+.-.|++++|+-++.++ .+|++|...+...
T Consensus 77 ~~~~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~ 112 (188)
T PF12260_consen 77 HGPLGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE 112 (188)
T ss_pred cCCCCcEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence 31 2477789999999999887 7999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0014 Score=59.75 Aligned_cols=69 Identities=20% Similarity=0.314 Sum_probs=44.1
Q ss_pred eeEEccCCceEEEEEEEcC-CCcEEEEEEeecch---hhhHHHHHHHHHcCCCCe-eecceEeeecCCCCceEEEEEEec
Q 014174 96 ERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQDK---RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNLVLEF 170 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 170 (429)
++.|..|-...+|++.... .+..|++|+..... ....+|+.+++.+...++ +++++.+ .+ .+||||
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~ 73 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF 73 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence 3567888888999997533 35789999765432 223478999998854343 3333322 11 269999
Q ss_pred cch
Q 014174 171 VPE 173 (429)
Q Consensus 171 ~~~ 173 (429)
++|
T Consensus 74 i~G 76 (235)
T cd05157 74 IPG 76 (235)
T ss_pred eCC
Confidence 875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.52 E-value=5.8e-05 Score=82.33 Aligned_cols=215 Identities=16% Similarity=-0.013 Sum_probs=136.6
Q ss_pred HHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 014174 134 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212 (429)
Q Consensus 134 E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 212 (429)
|...++...|+++...+.-... ....-.+.+++|+. |.+++.+.........+...-+.....+.+.+..-+|+..
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 4445566789988876543321 22222456888887 5566665554444444544444444444477777777433
Q ss_pred C----eeeecCCCCceEecCCCCcEEEeecccceeccc-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHH
Q 014174 213 G----VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAEL 287 (429)
Q Consensus 213 g----ivH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 287 (429)
+ .+|++||+-|.+|..+. .+|+.++|+.+...+ ........|++.|++|++... ..++.++|+|..|+.+|..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHH
Confidence 3 68999999999999876 799999999983222 222334567889999997744 4578889999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC
Q 014174 288 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367 (429)
Q Consensus 288 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t 367 (429)
..|..+|. ..++.+++. .-.+-.....+ ...|.++-.....+|-+.-..||.
T Consensus 1434 s~~n~~fi-----~flq~~Lkg-----------iidn~tf~sIe------------~l~pgdaNve~~~~Ll~K~~~rp~ 1485 (2724)
T KOG1826|consen 1434 SDGNAYFI-----FFLQPALKG-----------IIDNHTFFSIE------------KLKPGDANVEALHRLLWKYMERPG 1485 (2724)
T ss_pred hcccHHHH-----HHHHHHHcC-----------ccccccccccc------------ccCCCcccHHHHHHHHHHhhhcch
Confidence 99987772 222222221 11111111111 123455555556666666778999
Q ss_pred HHHHhcCCCCcccC
Q 014174 368 ALEACIHPFFYELR 381 (429)
Q Consensus 368 ~~ell~hp~f~~~~ 381 (429)
-...+.-+.|...+
T Consensus 1486 q~isls~d~~a~~~ 1499 (2724)
T KOG1826|consen 1486 QYISLSRDHFAVGL 1499 (2724)
T ss_pred hhhhcccccccccc
Confidence 99999988886543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00049 Score=63.66 Aligned_cols=132 Identities=19% Similarity=0.220 Sum_probs=73.4
Q ss_pred EccCCceEEEEEEEcCCCcEEEEEEeecchh----hhHHHHHHHHHcCCCCee-ecceEeeecCCCCceEEEEEEeccch
Q 014174 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKR----YKNRELQTMRLLDHPNVV-SLKHCFFSTTDKDELYLNLVLEFVPE 173 (429)
Q Consensus 99 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~~~ 173 (429)
+..|-.+.+|++. .++..+++|....... ...+|.++++.+....++ +++... . -++|+||++|
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G 72 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG 72 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence 4567778899886 3677888997543322 246799999988654332 332221 1 1478999886
Q ss_pred hHHH------------HHHHhh--h----cCCCCCHH-HHHHHHHHH---------HHHHHHHHc-------CCCeeeec
Q 014174 174 TVYR------------VAKHYS--R----ASQRMPLI-YVKLYTYQI---------CRALAYIHG-------GIGVCHRD 218 (429)
Q Consensus 174 ~l~~------------~~~~~~--~----~~~~l~~~-~~~~i~~qi---------~~aL~~LH~-------~~givH~D 218 (429)
.... +..... . ....++.. .+..+..++ ...+..+-. ...++|+|
T Consensus 73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D 152 (256)
T TIGR02721 73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD 152 (256)
T ss_pred cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence 3221 111000 0 01111211 112222121 111222210 12589999
Q ss_pred CCCCceEecCCCCcEEEeeccccee
Q 014174 219 IKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 219 Lkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+.|.||+++.++ +.|+||..|..
T Consensus 153 l~~~Nil~~~~~--~~lIDwE~a~~ 175 (256)
T TIGR02721 153 VHAYNLVVTPQG--LKLIDWEYASD 175 (256)
T ss_pred CCcCcEEEeCCC--CEEEeccccCc
Confidence 999999999765 78999998864
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0029 Score=59.84 Aligned_cols=74 Identities=7% Similarity=-0.003 Sum_probs=49.5
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeec--chhhhHHHHHHHHHcCC---CCeeecceEeeecCCCCceEEEEEEec
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLDH---PNVVSLKHCFFSTTDKDELYLNLVLEF 170 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~lv~e~ 170 (429)
.+.||.|..+.||.... ++..+.+|..+. .......|...|+.|.. -.+.++++++.... .....++|||+
T Consensus 19 ~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEEEec
Confidence 46799999999999964 233577787544 23577889999998853 24566665543211 11235789999
Q ss_pred cch
Q 014174 171 VPE 173 (429)
Q Consensus 171 ~~~ 173 (429)
+++
T Consensus 95 i~G 97 (297)
T PRK10593 95 LRG 97 (297)
T ss_pred cCC
Confidence 885
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.002 Score=61.28 Aligned_cols=144 Identities=14% Similarity=0.036 Sum_probs=77.3
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCC--eeecceEeeec-CCCCceEEEEEEec
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPN--VVSLKHCFFST-TDKDELYLNLVLEF 170 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~~~lv~e~ 170 (429)
++.++.|....+|++.. ++..+++|+.... ......|.+++..|.... +.+++...... ........+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 45677887789999864 3446888977543 344556778887774322 33332211000 00112345789999
Q ss_pred cchhHH------------HHHHHhhhcCCCC--------C-HHHHH--------------HHHHHHHHHHHHHH------
Q 014174 171 VPETVY------------RVAKHYSRASQRM--------P-LIYVK--------------LYTYQICRALAYIH------ 209 (429)
Q Consensus 171 ~~~~l~------------~~~~~~~~~~~~l--------~-~~~~~--------------~i~~qi~~aL~~LH------ 209 (429)
++|... ..+...-.....+ . ..+.. .....+...++++.
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 875210 0111000000000 0 00000 00112233455553
Q ss_pred cCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 210 ~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
...+++|+|+.+.||+++.++ .+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDS-VKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCc-eEEEeeccccc
Confidence 136899999999999999776 57899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0053 Score=58.72 Aligned_cols=30 Identities=30% Similarity=0.302 Sum_probs=25.4
Q ss_pred CCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 212 ~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.|++|+|+.|.||+++.+. ..-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR-LSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCc-eEEEEeccccc
Confidence 4899999999999998554 45799999874
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0025 Score=60.22 Aligned_cols=144 Identities=13% Similarity=0.018 Sum_probs=77.2
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeec-chhhhHHHHHHHHHcCCCC--eeecceEeeec-CCCCceEEEEEEecc
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYKNRELQTMRLLDHPN--VVSLKHCFFST-TDKDELYLNLVLEFV 171 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~~~lv~e~~ 171 (429)
.+.|..|....+|++.. .+..+++|+... .......|++++..+.+.+ +.+++...... ........++|++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 45677788789999864 445799998763 3344567888888885433 33332210000 000112346799998
Q ss_pred chhHHH------------H---HHHhhhc-CCC----CCHHHHHH------------HHHHHHHHHHHHHc------CCC
Q 014174 172 PETVYR------------V---AKHYSRA-SQR----MPLIYVKL------------YTYQICRALAYIHG------GIG 213 (429)
Q Consensus 172 ~~~l~~------------~---~~~~~~~-~~~----l~~~~~~~------------i~~qi~~aL~~LH~------~~g 213 (429)
+|.... . +...... ... ....+... ....+..++.++.. ..+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 752210 0 0100000 000 00010000 11112233444431 247
Q ss_pred eeeecCCCCceEecCCCCcEEEeecccce
Q 014174 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 214 ivH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
++|+|+.|.||+++.++ .+.|+||+.+.
T Consensus 177 l~HgD~~~~Nil~~~~~-~~~iIDfe~a~ 204 (296)
T cd05153 177 VIHADLFRDNVLFDGDE-LSGVIDFYFAC 204 (296)
T ss_pred CCccCcCcccEEEeCCc-eEEEeehhhhc
Confidence 99999999999999765 56899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.00028 Score=65.65 Aligned_cols=132 Identities=16% Similarity=0.155 Sum_probs=85.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeec----------ch----------------hhhHHHHHHHHHcC-CC
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ----------DK----------------RYKNRELQTMRLLD-HP 144 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~----------------~~~~~E~~~l~~l~-h~ 144 (429)
-|.+.+.||-|--+.||.+-+ ..|...++|.-.- .+ -...+|+..|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 377889999999999999986 5688899984311 11 11235888888774 32
Q ss_pred C-eeecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCc
Q 014174 145 N-VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223 (429)
Q Consensus 145 n-iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~N 223 (429)
+ +.+.+++ ...|+|||++.+--+....+ -.. +..+...+..-+.-|- .+|+||+|+.-=|
T Consensus 172 fpVPkpiD~---------~RH~Vvmelv~g~Pl~~v~~------v~d---~~~ly~~lm~~Iv~la-~~GlIHgDFNEFN 232 (465)
T KOG2268|consen 172 FPVPKPIDH---------NRHCVVMELVDGYPLRQVRH------VED---PPTLYDDLMGLIVRLA-NHGLIHGDFNEFN 232 (465)
T ss_pred CCCCCcccc---------cceeeHHHhhcccceeeeee------cCC---hHHHHHHHHHHHHHHH-HcCceecccchhe
Confidence 2 2333222 23678999988732221111 112 2233344555555666 7899999999999
Q ss_pred eEecCCCCcEEEeecccceec
Q 014174 224 LLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 224 ill~~~~~~vkl~DfG~a~~~ 244 (429)
|+|+.++ .++++||--+...
T Consensus 233 imv~dd~-~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 233 IMVKDDD-KIVVIDFPQMVST 252 (465)
T ss_pred eEEecCC-CEEEeechHhhcc
Confidence 9999777 6999999865443
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0094 Score=57.25 Aligned_cols=69 Identities=22% Similarity=0.216 Sum_probs=43.2
Q ss_pred EEccCCceEEEEEEEcCCCcEEEEEEeecc-----------hhhhHHHHHHHHHcC--CC-CeeecceEeeecCCCCceE
Q 014174 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD-----------KRYKNRELQTMRLLD--HP-NVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~~~~ 163 (429)
.||.|....||++.+...++.|+||.-... ......|.+.|+... -| ++.++|++- ...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D------~e~- 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD------TEM- 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc------ccc-
Confidence 479999999999997544468999965211 122235777777663 23 455555432 111
Q ss_pred EEEEEeccch
Q 014174 164 LNLVLEFVPE 173 (429)
Q Consensus 164 ~~lv~e~~~~ 173 (429)
..+|||+++.
T Consensus 75 ~~~vMEdL~~ 84 (370)
T TIGR01767 75 AVTVMEDLSH 84 (370)
T ss_pred ceehHhhCcc
Confidence 3479999863
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.016 Score=54.89 Aligned_cols=30 Identities=30% Similarity=0.542 Sum_probs=26.1
Q ss_pred CCeeeecCCCCceEecCC----CCcEEEeecccce
Q 014174 212 IGVCHRDIKPQNLLVNPH----THQVKLCDFGSAK 242 (429)
Q Consensus 212 ~givH~DLkp~Nill~~~----~~~vkl~DfG~a~ 242 (429)
.+++|+|+.+.||+++.+ + .+.++||..|.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~-~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETK-KLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCC-cEEEEeeCCCC
Confidence 468999999999999874 5 69999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0086 Score=58.23 Aligned_cols=71 Identities=17% Similarity=0.175 Sum_probs=45.6
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeec----------chhhhHHHHHHHHHcC--CC-CeeecceEeeecCCCCce
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ----------DKRYKNRELQTMRLLD--HP-NVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~~~ 162 (429)
.+.||.|.-..||++.+...++.|+||.-.. .......|.+.|+.+. -| ++.++|++- ...
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D------~e~ 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD------SVM 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC------cHH
Confidence 5678999999999999844467899996521 1122345888887763 23 455565432 112
Q ss_pred EEEEEEeccch
Q 014174 163 YLNLVLEFVPE 173 (429)
Q Consensus 163 ~~~lv~e~~~~ 173 (429)
..+|||+++.
T Consensus 108 -~~~vMEdL~~ 117 (409)
T PRK12396 108 -NCCVMEDLSD 117 (409)
T ss_pred -hhHHHHhCcc
Confidence 3479999863
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.021 Score=54.31 Aligned_cols=29 Identities=31% Similarity=0.600 Sum_probs=25.1
Q ss_pred CCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 212 ~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+++|+|+.+.||+++. + .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence 58999999999999986 4 58899999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.021 Score=54.92 Aligned_cols=30 Identities=23% Similarity=0.411 Sum_probs=25.7
Q ss_pred eeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 214 ivH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++|.||.+.|||++.+++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999975544799999998854
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.014 Score=54.56 Aligned_cols=31 Identities=29% Similarity=0.531 Sum_probs=25.8
Q ss_pred CeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 213 givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
.++|+|++|.||+++.++...-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999996453467999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.026 Score=54.61 Aligned_cols=32 Identities=28% Similarity=0.670 Sum_probs=26.7
Q ss_pred CCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 212 ~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
..++|+|+++.||+++.+...+.++||..|..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 36899999999999986433799999998754
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.026 Score=53.43 Aligned_cols=31 Identities=26% Similarity=0.463 Sum_probs=27.6
Q ss_pred CeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 213 givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
.++|+|+.+.||+|+.++ .+=++||+++...
T Consensus 199 ~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGR-PTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCC-eeEEEeccccccC
Confidence 599999999999999887 5889999998764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.011 Score=56.22 Aligned_cols=76 Identities=17% Similarity=0.235 Sum_probs=59.6
Q ss_pred CCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 159 KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
.+..|.|++|++.++.+... .....+++..++.+.+.-+.-+...-..-||||..+||||+ +| .|-|+||
T Consensus 296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf 365 (488)
T COG5072 296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF 365 (488)
T ss_pred CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence 45678999999988754331 23456777788888777777776556789999999999999 77 7999999
Q ss_pred ccceec
Q 014174 239 GSAKVL 244 (429)
Q Consensus 239 G~a~~~ 244 (429)
-+++..
T Consensus 366 klsRl~ 371 (488)
T COG5072 366 KLSRLS 371 (488)
T ss_pred eeeecc
Confidence 999854
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.053 Score=53.14 Aligned_cols=69 Identities=17% Similarity=0.242 Sum_probs=44.9
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeec-----------chhhhHHHHHHHHHcC---CCCeeecceEeeecCCCCc
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ-----------DKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~ 161 (429)
.+.||.|....||++.+ .+..|+||+-.. .......|.+.|+.+. ..++.+++++. .+.
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed~ 109 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RTM 109 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CCC
Confidence 56789999999999986 355799996541 1222234666666653 24667776654 221
Q ss_pred eEEEEEEeccch
Q 014174 162 LYLNLVLEFVPE 173 (429)
Q Consensus 162 ~~~~lv~e~~~~ 173 (429)
-+++||++++
T Consensus 110 --~vlvME~L~~ 119 (418)
T PLN02756 110 --ALIGMRYLEP 119 (418)
T ss_pred --CEEEEeecCC
Confidence 3578999965
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.082 Score=50.31 Aligned_cols=31 Identities=13% Similarity=0.186 Sum_probs=27.1
Q ss_pred CCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 212 ~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
.+++|+|+.+.|||++.++ .+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETR-GGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence 4799999999999998777 689999998753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.43 E-value=0.28 Score=48.08 Aligned_cols=29 Identities=28% Similarity=0.382 Sum_probs=24.4
Q ss_pred CCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 212 ~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
...+|.||-+.||+.+.+ .+.++||-.|.
T Consensus 227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecCC--CEEEEEecccc
Confidence 468999999999998754 49999998774
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=93.43 E-value=0.7 Score=43.37 Aligned_cols=71 Identities=17% Similarity=0.152 Sum_probs=43.0
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeecc-hhhhHHHHHHHHHcC---CCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
.+.++.|....+|+.. .+++.+.+|+-... ...+..|.+-|+.|. --.+.+++.+...... -++||||+
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-----~fLlle~l 94 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-----AFLLLEFL 94 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-----CEEEEE--
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-----ceEEEEee
Confidence 4678889999999987 57889999977633 456678998888883 3345566665433222 36899998
Q ss_pred ch
Q 014174 172 PE 173 (429)
Q Consensus 172 ~~ 173 (429)
+.
T Consensus 95 ~~ 96 (288)
T PF03881_consen 95 EM 96 (288)
T ss_dssp --
T ss_pred cC
Confidence 63
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.30 E-value=0.088 Score=49.80 Aligned_cols=54 Identities=28% Similarity=0.354 Sum_probs=34.1
Q ss_pred HHHHHHHHHHHHHHHH---HHHcCCCeeeecCCCCceEecCCCC-----------------cEEEeecccceec
Q 014174 191 LIYVKLYTYQICRALA---YIHGGIGVCHRDIKPQNLLVNPHTH-----------------QVKLCDFGSAKVL 244 (429)
Q Consensus 191 ~~~~~~i~~qi~~aL~---~LH~~~givH~DLkp~Nill~~~~~-----------------~vkl~DfG~a~~~ 244 (429)
.+-++.++.||+.-.- -|-+..+++|-||||+||||-+... .++|.||.+++..
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3456777888754331 1212347999999999999843221 3567777776543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.39 E-value=0.1 Score=45.42 Aligned_cols=30 Identities=23% Similarity=0.265 Sum_probs=25.4
Q ss_pred CeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 213 givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
-.+|+|+.|.||+++.++ ++|+||+.|...
T Consensus 78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~g 107 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG--LRLIDWEYAGDG 107 (188)
T ss_pred eeecCCCCCccEEEECCC--EEEEeCCcccCC
Confidence 469999999999998654 889999998653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=92.18 E-value=0.028 Score=55.59 Aligned_cols=70 Identities=20% Similarity=0.474 Sum_probs=55.4
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT 157 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 157 (429)
...+++....++|.|+||+|+.+.+..++..+|||.+.... ....+|..-+..+.|++++++.+.|....
T Consensus 46 r~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~ 120 (516)
T KOG1033|consen 46 REANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYERP 120 (516)
T ss_pred hhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecCC
Confidence 34456888899999999999999998888899999885332 22235777788899999999988886543
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.61 E-value=0.3 Score=45.37 Aligned_cols=49 Identities=27% Similarity=0.416 Sum_probs=35.8
Q ss_pred HHHHHHHHHHHHHHHHcC-CCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 194 VKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 194 ~~~i~~qi~~aL~~LH~~-~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
.+..+..+-.++.-.+.. .-++|+|+.|+|++.++.+ .++|+||..|..
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~ 183 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence 333444555555555522 3589999999999999766 699999988764
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=91.34 E-value=0.24 Score=46.69 Aligned_cols=75 Identities=16% Similarity=0.095 Sum_probs=55.9
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
..+||-|++..-.- .-.-+...++..+.+..-.|+..++.-|-..+-+||.||.--|+|.... .+.++|..-+..
T Consensus 358 hvLVMsFiGd~~~a---APkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~~g--Kvw~IDVsQsve 432 (531)
T KOG2269|consen 358 HVLVMSFIGDQGLA---APKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWTPG--KVWVIDVSQSVE 432 (531)
T ss_pred ceEEEEeecCCCCC---CccccccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheecCC--ceEEEechhccC
Confidence 34799998742111 1111235688888888889999999988558899999999999999854 599999876644
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=91.21 E-value=0.22 Score=44.34 Aligned_cols=31 Identities=42% Similarity=0.741 Sum_probs=20.6
Q ss_pred CCeeeecCCCCceEe-cCCCCcEEEeeccccee
Q 014174 212 IGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 212 ~givH~DLkp~Nill-~~~~~~vkl~DfG~a~~ 243 (429)
..++|+||.+.|||+ +.++ .++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~-~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDG-EVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSS-CEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCC-eEEEecHHHHhh
Confidence 368999999999999 5455 799999998865
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.14 E-value=0.35 Score=46.31 Aligned_cols=141 Identities=16% Similarity=0.192 Sum_probs=74.4
Q ss_pred EEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCC------eeecceEeeecCCCCceEEEEEEe
Q 014174 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPN------VVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
.|.+ .-..||++.. .+..+++|+.... ...+..|...++.|.-.. +...-+-....-... .+.+-+++
T Consensus 33 ~l~s-~eN~~f~~~~--~~g~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~-~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQT--EDGRYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG-PRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEe--cCCCeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC-ceeEEEEE
Confidence 3444 4557888875 3334499988664 344556778887773222 222212111111111 35677889
Q ss_pred ccchhHHHH------HHHhh-------hcCC-----------CCCHH----HH---------HHHHHHHHHHHHHHHc--
Q 014174 170 FVPETVYRV------AKHYS-------RASQ-----------RMPLI----YV---------KLYTYQICRALAYIHG-- 210 (429)
Q Consensus 170 ~~~~~l~~~------~~~~~-------~~~~-----------~l~~~----~~---------~~i~~qi~~aL~~LH~-- 210 (429)
|++|..... +.... .... ...+. .. .....++...+..+..
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 988644431 00000 0000 11111 00 0122344444554441
Q ss_pred -----CCC--eeeecCCCCceEecCCCCcEEEeecccce
Q 014174 211 -----GIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 211 -----~~g--ivH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
..+ +||+|+.|.||+++.+...+.++|||-|.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 224 99999999999999765238899999874
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 429 | ||||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-143 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-143 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-143 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-143 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-143 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-142 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-142 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-142 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-142 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-141 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-141 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-141 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-141 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-140 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-140 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-140 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-140 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-139 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-139 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-139 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-137 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-133 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-92 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-87 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-46 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-45 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-45 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-45 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-45 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-45 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-45 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-44 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-44 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-44 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-44 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-44 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-44 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-44 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-44 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-44 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-44 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-44 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-44 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-44 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-44 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-44 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-44 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-44 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-44 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-44 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-44 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-44 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-44 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-44 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-44 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-44 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-44 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-44 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-44 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-44 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-44 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-44 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-44 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-44 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-44 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-44 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-44 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-44 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-44 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-44 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-44 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-44 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-44 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-44 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-43 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-43 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-43 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-43 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-43 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-43 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-43 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-43 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-43 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-43 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-43 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-43 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-43 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-43 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-43 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-43 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-42 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-42 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-42 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-42 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-41 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-41 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-41 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-40 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-40 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 6e-40 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-40 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-40 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-40 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-40 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-39 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-39 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-39 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-39 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-39 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-39 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-39 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-39 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-39 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-39 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-39 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-39 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-38 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-38 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-38 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-38 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-38 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-38 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-38 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-38 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-38 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-38 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-38 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-38 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-38 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-38 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-38 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-38 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-38 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-38 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-38 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-38 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-38 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-38 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-38 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-38 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-38 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-38 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-38 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-38 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-38 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-38 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-38 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-38 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-38 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-38 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-38 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-38 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-38 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-38 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-38 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-38 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-38 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-38 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-38 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-37 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-37 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-37 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-37 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-37 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-37 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-37 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-34 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-34 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-34 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-34 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-33 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-33 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-33 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-32 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-32 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-32 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-32 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-32 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-32 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-32 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-32 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-32 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-32 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-32 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-32 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-31 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-31 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-31 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-31 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-31 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-31 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-31 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-31 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-31 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-31 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-31 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-31 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-31 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-31 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-31 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-31 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-31 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-30 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-30 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-30 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-30 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-30 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-30 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-30 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-30 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-30 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-30 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-30 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-30 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-30 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 3e-30 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-30 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-30 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-30 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-30 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-30 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-30 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-30 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-30 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 9e-30 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-30 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 9e-30 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-30 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-29 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-29 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-29 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-29 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-29 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-29 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-29 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-28 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-28 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-28 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-28 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-28 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-28 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-28 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-28 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-27 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-27 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-27 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-26 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-26 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-26 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-26 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-24 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-24 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-24 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-24 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-24 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-24 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-24 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-24 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-24 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-24 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-24 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-23 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-23 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-23 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-23 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-23 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-23 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-23 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-23 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-23 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-23 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-23 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-23 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-23 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-23 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-23 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-21 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-20 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-20 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-20 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 9e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-19 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-19 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-19 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-19 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-19 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-19 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-19 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-19 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-19 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 8e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-18 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-18 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-18 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-18 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-18 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-18 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-18 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-18 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-18 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-17 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-17 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-17 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-17 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-17 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-17 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-17 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-17 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-17 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-17 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-17 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-17 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-17 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-17 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-17 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-17 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-17 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-17 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-17 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-17 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-17 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-17 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-17 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-17 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-17 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-17 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-17 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-17 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-16 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-16 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-16 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-16 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 5e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-16 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-16 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-16 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-16 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-16 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-16 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-16 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-16 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-16 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-15 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-15 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-15 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-15 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-15 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-15 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-15 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-15 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-15 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-15 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-15 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-15 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-15 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-15 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-15 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-15 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-14 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-14 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-14 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-14 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-14 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-14 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-14 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-14 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-14 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-14 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-14 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-14 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-14 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-13 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-13 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-13 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-12 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-12 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-11 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-11 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 8e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 9e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-08 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-08 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 8e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 8e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 9e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-07 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 8e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 8e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 9e-04 |
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 635 bits (1641), Expect = 0.0
Identities = 244/398 (61%), Positives = 299/398 (75%), Gaps = 17/398 (4%)
Query: 29 KPDDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPK 88
+ ++ + P MK+ D +G++ ++ T G+
Sbjct: 6 RTTSFAESCKPVQQPSAFGSMKVSR------------DKDGSKVTTVVATP--GQGPDRP 51
Query: 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS 148
Q +SY +V+G GSFG+V+QAK ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V
Sbjct: 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVR 111
Query: 149 LKHCFFSTTDK-DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
L++ F+S+ +K DE+YLNLVL++VPETVYRVA+HYSRA Q +P+IYVKLY YQ+ R+LAY
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
IH G+CHRDIKPQNLL++P T +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFG
Sbjct: 172 IHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 230
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
AT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPTRE+I+ MNPNYTE
Sbjct: 231 ATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 290
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARL 387
FKFPQIKAHPW K+F R PPEA+ L SRLL+Y+P R T LEAC H FF ELRDPN +L
Sbjct: 291 FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 350
Query: 388 PNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
PNGR P LFNF QEL ++ L + LIP HAR Q
Sbjct: 351 PNGRDTPALFNFTTQELS-SNPPLATILIPPHARIQAA 387
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 627 bits (1620), Expect = 0.0
Identities = 225/373 (60%), Positives = 286/373 (76%), Gaps = 5/373 (1%)
Query: 57 EKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG 116
+ ++ I V G+ G+ ++ I+Y +V+G GSFG+VFQAK +E+
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESD 65
Query: 117 ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEFVPETV 175
E VAIKKVLQDKR+KNRELQ MR++ HPNVV LK F+S DK DE++LNLVLE+VPETV
Sbjct: 66 E-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124
Query: 176 YRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 235
YR ++HY++ Q MP++ +KLY YQ+ R+LAYIH IG+CHRDIKPQNLL++P + +KL
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKL 183
Query: 236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFP 295
DFGSAK+L+ GEPN+SYICSRYYRAPELIFGAT YTT IDIWS GCV+AEL+ GQPLFP
Sbjct: 184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243
Query: 296 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVS 355
GESG+DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+ HP+ K+F R PP+A+DL+S
Sbjct: 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLIS 303
Query: 356 RLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKL 415
RLL+Y+P+ R TA+EA HPFF ELR AR+PNGR PPLFN+ +EL +L+S+L
Sbjct: 304 RLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELS-VRPDLISRL 362
Query: 416 IPEHARKQCPFLG 428
+P+HA + G
Sbjct: 363 VPQHAEAELLSRG 375
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 601 bits (1552), Expect = 0.0
Identities = 160/358 (44%), Positives = 229/358 (63%), Gaps = 12/358 (3%)
Query: 73 GHIIVTTIGGRNGQP--KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY 130
G ++ + K+ + ER+ GQG+FG V K TG +VAIKKV+QD R+
Sbjct: 3 GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62
Query: 131 KNRELQTMRLL---DHPNVVSLKHCFFSTT--DKDELYLNLVLEFVPETVYRVAKHYSRA 185
+NRELQ M+ L HPN+V L+ F++ D+ ++YLN+V+E+VP+T++R ++Y R
Sbjct: 63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122
Query: 186 SQRMPLIYVKLYTYQICRALAYIH-GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
P I +K++ +Q+ R++ +H + VCHRDIKP N+LVN +KLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182
Query: 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
EPN++YICSRYYRAPELIFG YTTA+DIWSVGC+ AE++LG+P+F G++ QL
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHK---RMPPEAVDLVSRLLQYS 361
EI++VLG P+RE ++ +NP++T+ K PW +F + EA DL+S LLQY
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302
Query: 362 PNLRCTALEACIHPFFYELRDPNARLPNGRPFPP-LFNFKPQELKGASKELLSKLIPE 418
P R EA HP+F EL DP +LPN + P LF F P E++ S+ +KL+ +
Sbjct: 303 PEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 584 bits (1507), Expect = 0.0
Identities = 165/382 (43%), Positives = 242/382 (63%), Gaps = 43/382 (11%)
Query: 85 GQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP 144
G + Y + +G GSFGIV + +E+G+ A+KKVLQD RYKNREL M++LDH
Sbjct: 1 GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60
Query: 145 NVVSLKHCFFSTTDK---------------------------------DELYLNLVLEFV 171
N++ L F++T D+ YLN+++E+V
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 172 PETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH 231
P+T+++V K + R+ + +P+ + +Y YQ+ RA+ +IH +G+CHRDIKPQNLLVN +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDN 179
Query: 232 QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ 291
+KLCDFGSAK L+ EP+++YICSR+YRAPEL+ GATEYT +ID+WS+GCV EL+LG+
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
Query: 292 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAV 351
PLF GE+ +DQLV II+++GTPT+E++ MNP+YTE +FP +KA W KI + P A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299
Query: 352 DLVSRLLQYSPNLRCTALEACIHPFFYELRDP-------NARLPNG--RPFPPLFNFKPQ 402
DL+ ++L+Y P+LR EA HPFF LR+ N+ P+G + P LFNF P
Sbjct: 300 DLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPY 359
Query: 403 ELKGASKELLSKLIPEHARKQC 424
EL +L++++P++
Sbjct: 360 ELSIIPGNVLNRILPKNFSPNY 381
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 7e-99
Identities = 103/312 (33%), Positives = 160/312 (51%), Gaps = 22/312 (7%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
+G+GS+G+VF+ + +TG+ VAIKK L+ + RE++ ++ L HPN+V+L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
F K L+L V E+ TV Y + +P VK T+Q +A+ + H
Sbjct: 71 F---RRKRRLHL--VFEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 271
HRD+KP+N+L+ H+ +KLCDFG A++L + + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK 329
+D+W++GCV AELL G PL+PG+S VDQL I K LG + N ++ K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240
Query: 330 FPQIK-AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLP 388
P + P F + A+ L+ L P R T + HP+F +R+ L
Sbjct: 241 IPDPEDMEPLELKF-PNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE-DLA 298
Query: 389 NGRPFPPLFNFK 400
P +
Sbjct: 299 KEHDKPAENLYF 310
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 1e-96
Identities = 99/295 (33%), Positives = 154/295 (52%), Gaps = 21/295 (7%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
VG+GS+G+V + + +TG VAIKK L+ K RE++ ++ L H N+V+L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
K YL V EFV T+ + + + V+ Y +QI + + H
Sbjct: 93 C---KKKKRWYL--VFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH- 143
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 271
+ HRDIKP+N+LV+ + VKLCDFG A+ L GE + +R+YRAPEL+ G +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--EIKCMNPNYTEFK 329
A+D+W++GC++ E+ +G+PLFPG+S +DQL I+ LG E+ NP + +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262
Query: 330 FPQIKAH-PWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383
P+IK P + + ++ +DL + L P+ R E H FF
Sbjct: 263 LPEIKEREPLERRY-PKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFA 316
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 4e-96
Identities = 90/315 (28%), Positives = 151/315 (47%), Gaps = 34/315 (10%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQD----KR-YKNRELQTMRLLDHPNV 146
YM + +G G G+VF A + + VAIKK+ L D K RE++ +R LDH N+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70
Query: 147 VSLKHCF-----------FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVK 195
V + S T+ + +Y+ V E++ + V + + + +
Sbjct: 71 VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLE-----QGPLLEEHAR 123
Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--- 252
L+ YQ+ R L YIH V HRD+KP NL +N +K+ DFG A+++ +
Sbjct: 124 LFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182
Query: 253 -YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
+ +++YR+P L+ YT AID+W+ GC+ AE+L G+ LF G ++Q+ I++ +
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242
Query: 312 TPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 369
E+ + + + P ++ + EAVD + ++L +SP R TA
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTAE 301
Query: 370 EACIHPFFYELRDPN 384
EA HP+ P
Sbjct: 302 EALSHPYMSIYSFPM 316
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 287 bits (736), Expect = 9e-95
Identities = 90/303 (29%), Positives = 149/303 (49%), Gaps = 23/303 (7%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMR-LLDHPNVVSL 149
Y R +G+G + VF+A + E V +K + ++ K+ K RE++ + L PN+++L
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+ V E V T ++ + Y Q + ++ Y Y+I +AL Y H
Sbjct: 97 ADIVKDPVSRTPAL---VFEHVNNTDFK--QLY----QTLTDYDIRFYMYEILKALDYCH 147
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
G+ HRD+KP N++++ +++L D+G A+ G+ + SRY++ PEL+
Sbjct: 148 SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 270 EYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEI--KCMNPNYT 326
Y ++D+WS+GC+LA ++ +P F G DQLV I KVLGT + K
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266
Query: 327 EFK--FPQIKAHPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
F + W + H + PEA+D + +LL+Y R TA EA HP+FY +
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326
Query: 381 RDP 383
Sbjct: 327 VKD 329
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 286 bits (735), Expect = 1e-94
Identities = 101/329 (30%), Positives = 172/329 (52%), Gaps = 36/329 (10%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLD 142
+Y+ +G+G++ V++ K T VA+K++ R ++ RE+ ++ L
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
H N+V+L + L L V E++ + ++ + + VKL+ +Q+
Sbjct: 59 HANIVTLHDII---HTEKSLTL--VFEYLD---KDLKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYY 259
R LAY H V HRD+KPQNLL+N ++KL DFG A+ K P +Y + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEVVTLWY 166
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE--- 316
R P+++ G+T+Y+T ID+W VGC+ E+ G+PLFPG + +QL I ++LGTPT E
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226
Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
I + + +P+ +A R+ + DL+++LLQ+ R +A +A HPF
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHA-PRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 377 FYELRDPNARLPNGRPFPPLFNFKPQELK 405
F L + +LP+ +F K +L+
Sbjct: 285 FLSLGERIHKLPD---TTSIFALKEIQLQ 310
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 1e-94
Identities = 95/347 (27%), Positives = 158/347 (45%), Gaps = 40/347 (11%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------------RELQT 137
Y +R + GS+G V G VAIK+V RE++
Sbjct: 24 YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 138 MRLLDHPNVVSLKHCF--FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPL--IY 193
+ HPN++ L+ F F +LYL V E + + +V QR+ + +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIH-----DQRIVISPQH 135
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
++ + Y I L +H GV HRD+ P N+L+ + + +CDF A+ Y
Sbjct: 136 IQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
+ R+YRAPEL+ +T +D+WS GCV+AE+ + LF G + +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 314 TREEIKCM-NP---NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 369
E++ +P +Y + A W + P A+DL++++L+++P R +
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRISTE 312
Query: 370 EACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
+A HP+F L DP L G F+F + K+
Sbjct: 313 QALRHPYFESLFDPL-DLTEGLSER--FHFDESVT---DVYDMHKIF 353
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 286 bits (733), Expect = 6e-94
Identities = 109/349 (31%), Positives = 185/349 (53%), Gaps = 39/349 (11%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-----LQD-KR-YKNRELQTMRLLDHPN 145
+ + ++G+G++G+V A TGE VAIKK+ R RE++ ++ H N
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70
Query: 146 VVSLKHCFFSTTDKD--ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
++++ + + ++ E+Y+ + E + ++RV +Q + +++ + YQ R
Sbjct: 71 IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLR 123
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----------- 252
A+ +HG V HRD+KP NLL+N +K+CDFG A+++ + + S
Sbjct: 124 AVKVLHGS-NVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
++ +R+YRAPE++ + +Y+ A+D+WS GC+LAEL L +P+FPG QL+ I ++GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 313 PTREEI--KCMNPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368
P + +P E+ P A P K+F + + P+ +DL+ R+L + P R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITA 300
Query: 369 LEACIHPFFYELRDPNARLPNGRPFPPL-FNFKPQELKGASKELLSKLI 416
EA HP+ DPN P G P PP F F + + + L KLI
Sbjct: 301 KEALEHPYLQTYHDPN-DEPEGEPIPPSFFEFD-HYKEALTTKDLKKLI 347
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 2e-93
Identities = 110/342 (32%), Positives = 163/342 (47%), Gaps = 33/342 (9%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 149
+G+G F V++A+ T + VAIKK+ R + RE++ ++ L HPN++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
F K + L V +F+ + + K S + ++K Y + L Y+H
Sbjct: 78 LDAF---GHKSNISL--VFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH 129
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 266
+ HRD+KP NLL++ +KL DFG AK G PN +Y + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---KCMNP 323
GA Y +D+W+VGC+LAELLL P PG+S +DQL I + LGTPT EE C P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383
+Y F P H IF + +DL+ L ++P R TA +A +F P
Sbjct: 245 DYVT--FKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR--P 299
Query: 384 NARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
P P +E + + K + P
Sbjct: 300 GPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLP 341
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 281 bits (720), Expect = 7e-92
Identities = 107/340 (31%), Positives = 179/340 (52%), Gaps = 33/340 (9%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQD----KR-YKNRELQTMRLLDHPN 145
Y +G+G++G+V A VAIKK+ + +R RE++ + H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86
Query: 146 VVSLKHCFF--STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
++ + + ++Y+ V + + +Y++ K +Q + ++ + YQI R
Sbjct: 87 IIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLK-----TQHLSNDHICYFLYQILR 139
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYY 259
L YIH V HRD+KP NLL+N T +K+CDFG A+V + Y+ +R+Y
Sbjct: 140 GLKYIHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
RAPE++ + YT +IDIWSVGC+LAE+L +P+FPG+ +DQL I+ +LG+P++E++
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257
Query: 320 CM-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
C+ N + P PW+++F +A+DL+ ++L ++P+ R +A HP+
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316
Query: 377 FYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
+ DP+ P F F EL KE L +LI
Sbjct: 317 LEQYYDPS-DEP---IAEAPFKF-DMELDDLPKEKLKELI 351
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 279 bits (716), Expect = 9e-92
Identities = 90/313 (28%), Positives = 157/313 (50%), Gaps = 41/313 (13%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
+G+G++G V++A T ETVAIK++ + + RE+ ++ L H N++ LK
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
L+L + E+ + K Y + + + +K + YQ+ + + H
Sbjct: 102 I---HHNHRLHL--IFEYAENDL----KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR- 151
Query: 213 GVCHRDIKPQNLLVNPHTH----QVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 265
HRD+KPQNLL++ +K+ DFG A+ G P + I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMN 322
G+ Y+T++DIWS+ C+ AE+L+ PLFPG+S +DQL +I +VLG P + +
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382
P++ + FP+ + ++ + E +DL++ +L+ P R +A A HP+F
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN-- 325
Query: 383 PNARLPNGRPFPP 395
F P
Sbjct: 326 ---------DFDP 329
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 3e-91
Identities = 102/294 (34%), Positives = 164/294 (55%), Gaps = 27/294 (9%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
VG+G++G+V++AK G VA+K++ D + RE+ ++ L HPN+VSL
Sbjct: 29 VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
+ L L V EF+ + K + +K+Y YQ+ R +A+ H
Sbjct: 88 I---HSERCLTL--VFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH- 138
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
+ HRD+KPQNLL+N +KL DFG A+ G P SY + + +YRAP+++ G+
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 326
+Y+T++DIWS+GC+ AE++ G+PLFPG + DQL +I +LGTP +++ + P +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
+ F + PW I E +DL+S +L + PN R +A +A HP+F +L
Sbjct: 255 QRTFQVFEKKPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 1e-90
Identities = 102/337 (30%), Positives = 167/337 (49%), Gaps = 32/337 (9%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
Y + VG G++G V A TG VAIKK+ + REL+ ++ + H NV
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 147 VSLKHCFF---STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
+ L F + D + YL V+ F+ + ++ K +++ ++ YQ+ +
Sbjct: 87 IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 262
L YIH G+ HRD+KP NL VN +K+ DFG A+ + ++ Y+ +R+YRAP
Sbjct: 140 GLRYIHAA-GIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGYVVTRWYRAP 194
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 321
E+I YT +DIWSVGC++AE++ G+ LF G +DQL EI+KV GTP E ++ +
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254
Query: 322 NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379
+ + P+++ + I P AV+L+ ++L R TA EA HP+F
Sbjct: 255 SDEAKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313
Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
L D P + + F + + + ++
Sbjct: 314 LHDTEDE-PQVQKYDDSF-----DDVDRTLDEWKRVT 344
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 5e-90
Identities = 94/318 (29%), Positives = 159/318 (50%), Gaps = 37/318 (11%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 149
+G G++ V++ TG VA+K+V + + RE+ M+ L H N+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRAS--QRMPLIYVKLYTYQICRALAY 207
+++L L V EF+ + + + + + + L VK + +Q+ + LA+
Sbjct: 69 YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 264
H + HRD+KPQNLL+N Q+KL DFG A+ G P ++ + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 321
+ G+ Y+T+IDIWS GC+LAE++ G+PLFPG + +QL I ++GTP + +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239
Query: 322 NPNYTEFKFPQIKAHPWHKIFHK----RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
P Y Q ++ + +D + LLQ +P++R +A +A HP+F
Sbjct: 240 -PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297
Query: 378 YELRDPNARLPNGRPFPP 395
E A + R
Sbjct: 298 AEYYHH-ASMGGSRSHHH 314
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 273 bits (700), Expect = 6e-90
Identities = 101/294 (34%), Positives = 157/294 (53%), Gaps = 28/294 (9%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
+G+G++G+V++A+ GET A+KK+ +K + RE+ ++ L H N+V L
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
K L L V E + + K + + K + Q+ +AY H
Sbjct: 69 I---HTKKRLVL--VFEHLD---QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
V HRD+KPQNLL+N ++K+ DFG A+ G P Y I + +YRAP+++ G+
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 326
+Y+T IDIWSVGC+ AE++ G PLFPG S DQL+ I ++LGTP + + + P Y
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY- 234
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
+ F + PW K + +DL+S++L+ PN R TA +A H +F E
Sbjct: 235 DPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 7e-90
Identities = 104/337 (30%), Positives = 170/337 (50%), Gaps = 32/337 (9%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
Y++ VG G++G V A +GE VAIKK+ + REL ++ + H NV
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 147 VSLKHCFFSTTDKD---ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
+ L F + + YL V+ F+ + ++ + ++ YQ+ +
Sbjct: 86 IGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMG------LKFSEEKIQYLVYQMLK 137
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 262
L YIH GV HRD+KP NL VN +K+ DFG A+ + ++ Y+ +R+YRAP
Sbjct: 138 GLKYIHSA-GVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGYVVTRWYRAP 192
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM- 321
E+I Y +DIWSVGC++AE+L G+ LF G+ +DQL +I+KV G P E ++ +
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252
Query: 322 NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379
+ + PQ + ++F R P+A DL+ ++L+ + R TA +A HPFF
Sbjct: 253 DKAAKSYIQSLPQTPRKDFTQLF-PRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEP 311
Query: 380 LRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
RDP +PF + + ++L + + + I
Sbjct: 312 FRDPEEETEAQQPFD--DSLEHEKL---TVDEWKQHI 343
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 1e-88
Identities = 105/339 (30%), Positives = 170/339 (50%), Gaps = 36/339 (10%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 144
Y VG G++G V A +TG VA+KK+ + KR Y REL+ ++ + H
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88
Query: 145 NVVSLKHCFFSTTDKD---ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
NV+ L F + ++YL V + + + K Q++ +V+ YQI
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVK-----CQKLTDDHVQFLIYQI 141
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYR 260
R L YIH + HRD+KP NL VN ++K+ DFG A+ ++ Y+ +R+YR
Sbjct: 142 LRGLKYIHSA-DIIHRDLKPSNLAVN-EDCELKILDFGLARHT---ADEMTGYVATRWYR 196
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
APE++ Y +DIWSVGC++AELL G+ LFPG +DQL I++++GTP E +K
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256
Query: 321 M-NPNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ + + + Q+ + +F P AVDL+ ++L + R TA +A H +F
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 315
Query: 378 YELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
+ DP+ P P+ + + ++L + L
Sbjct: 316 AQYHDPDDE-PVADPYD--QSLESRDL---LIDEWKSLT 348
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 4e-88
Identities = 100/298 (33%), Positives = 155/298 (52%), Gaps = 28/298 (9%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 152
+G+G++G VF+AK ET E VA+K+V D + RE+ ++ L H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
+L L V EF + K++ + + VK + +Q+ + L + H
Sbjct: 70 L---HSDKKLTL--VFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 269
V HRD+KPQNLL+N ++KL +FG A+ G P Y + + +YR P+++FGA
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 270 EYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCMNPNY 325
Y+T+ID+WS GC+ AEL G+PLFPG DQL I ++LGTPT E + + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383
+ + ++ DL+ LL+ +P R +A EA HP+F + P
Sbjct: 237 KPYPMYPAT-TSLVNVV-PKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 271 bits (694), Expect = 1e-87
Identities = 102/369 (27%), Positives = 180/369 (48%), Gaps = 61/369 (16%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL---QD----KR-YKNRELQTMRLL-DH 143
Y + +G+G++GIV+++ TGE VA+KK+ Q+ +R + RE+ + L H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
N+V+L + + D+D +YL V +++ ++ V + + + ++ + YQ+ +
Sbjct: 69 ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----------- 252
+ Y+H G G+ HRD+KP N+L+N H VK+ DFG ++ V +
Sbjct: 121 VIKYLHSG-GLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178
Query: 253 -----------YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
Y+ +R+YRAPE++ G+T+YT ID+WS+GC+L E+L G+P+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238
Query: 302 QLVEIIKVLGTPTREEIKCM-NPNYTEF--KFPQIKAHPWHKIFHKRMP----------- 347
QL II V+ P+ E+++ + +P +
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298
Query: 348 ----PEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQE 403
EA+DL+ +LLQ++PN R +A +A HPF +PN N +
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKH 358
Query: 404 LKGASKELL 412
+ L+
Sbjct: 359 SIDDYRNLV 367
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 5e-87
Identities = 101/350 (28%), Positives = 164/350 (46%), Gaps = 45/350 (12%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQD----KR-YKNRELQTMRLLDHP 144
Y + +G G+ GIV A VAIKK+ Q+ KR Y REL M+ ++H
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84
Query: 145 NVVSLKHCFFSTTDKD---ELYLNLVLEFVPETVYRVAKHYSRASQRMPL--IYVKLYTY 199
N++ L + F + ++Y+ V+E + + +V +M L + Y
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVI--------QMELDHERMSYLLY 134
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
Q+ + ++H G+ HRD+KP N++V +K+ DFG A+ Y+ +RYY
Sbjct: 135 QMLCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 192
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
RAPE+I G Y +DIWSVGC++ E++ G LFPG +DQ ++I+ LGTP E +K
Sbjct: 193 RAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251
Query: 320 CMNPNYTEF--KFPQIKAHPWHKIFHKRMP-----------PEAVDLVSRLLQYSPNLRC 366
+ P + P+ + + K+F + +A DL+S++L + R
Sbjct: 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311
Query: 367 TALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
+ EA HP+ DP+ P P +E + E +LI
Sbjct: 312 SVDEALQHPYINVWYDPS-EAEAPPPKIPDKQLDEREH---TIEEWKELI 357
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 8e-87
Identities = 109/392 (27%), Positives = 161/392 (41%), Gaps = 83/392 (21%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 144
Y ++G GS+G V +A VAIKK+L+ KR RE+ + L+H
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112
Query: 145 NVVSLKHCFF--STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
+VV + DELY +VLE ++ R + +++K Y +
Sbjct: 113 HVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKLF----RTPVYLTELHIKTLLYNLL 166
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------- 252
+ Y+H G+ HRD+KP N LVN VK+CDFG A+ + E S
Sbjct: 167 VGVKYVHSA-GILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 253 ------------------YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL----- 289
++ +R+YRAPELI YT AID+WS+GC+ AELL
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 290 ------GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCM-N 322
PLFPG S DQL I +LGTP+ E+I+ +
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344
Query: 323 PNYTEF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
+ + FP+ + + F +A+ L+ R+L ++PN R T E HPFF E+
Sbjct: 345 EDAKRYIRIFPKREGTDLAERF-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403
Query: 381 RDPNARLPNGRPFPPLFNFKPQELKGASKELL 412
R FN + +
Sbjct: 404 RIAEVETNATEKVRLPFNDWMNMDEPQLRYAF 435
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 2e-86
Identities = 85/304 (27%), Positives = 141/304 (46%), Gaps = 32/304 (10%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RE---LQTMRLLDHPNV 146
+G G++G V++A+ +G VA+K V RE L+ + +HPNV
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
V L ++ E+ + LV E V + + +P +K Q R L
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLD--KAPPPGLPAETIKDLMRQFLRGLD 134
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 263
++H + HRD+KP+N+LV VKL DFG A++ ++ + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVVVTLWYRAPE 189
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
++ +T Y T +D+WSVGC+ AE+ +PLF G S DQL +I ++G P ++ P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244
Query: 324 NYTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
FP P + M L+ +L ++P+ R +A A H + ++
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVV-PEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303
Query: 381 RDPN 384
+ N
Sbjct: 304 -EGN 306
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 3e-86
Identities = 92/343 (26%), Positives = 149/343 (43%), Gaps = 37/343 (10%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK-- 150
+GQG+FG VF+A+ +TG+ VA+KKVL + + RE++ ++LL H NVV+L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 151 -HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
S ++ + + LV +F + +A S + L +K + L YIH
Sbjct: 85 CRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV--LVKGEPNISY---ICSRYYRAPEL 264
+ HRD+K N+L+ +KL DFG A+ L K Y + + +YR PEL
Sbjct: 142 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 199
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE---EIKCM 321
+ G +Y ID+W GC++AE+ P+ G + QL I ++ G+ T E +
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259
Query: 322 NPNYTEFKFPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
Y + + + + P A+DL+ +LL P R + +A H FF+
Sbjct: 260 -ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318
Query: 381 RDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQ 423
P P + E L+ P
Sbjct: 319 -----------PMPSDLKGMLSTHLTSMFEYLAP--PRRKHHH 348
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 8e-86
Identities = 97/314 (30%), Positives = 151/314 (48%), Gaps = 33/314 (10%)
Query: 99 VGQGSFGIVFQAK-CLETGETVAIKKVLQDKRYKN-------RE---LQTMRLLDHPNVV 147
+G+G++G VF+A+ G VA+K+V + RE L+ + +HPNVV
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
L + E L LV E V + + +P +K +Q+ R L +
Sbjct: 78 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDF 135
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 264
+H V HRD+KPQN+LV + Q+KL DFG A++ ++ + + +YRAPE+
Sbjct: 136 LHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-MALTSVVVTLWYRAPEV 190
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
+ ++ Y T +D+WSVGC+ AE+ +PLF G S VDQL +I+ V+G P E+ P
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR 245
Query: 325 YTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381
F A P K + DL+ + L ++P R +A A HP+F +L
Sbjct: 246 DVALPRQAFHSKSAQPIEKFV-TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304
Query: 382 DPNARLPNGRPFPP 395
L + PP
Sbjct: 305 RCKENLDS--HLPP 316
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 2e-85
Identities = 94/331 (28%), Positives = 156/331 (47%), Gaps = 38/331 (11%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 144
Y + +G G+ GIV A VAIKK+ + KR Y REL M+ ++H
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121
Query: 145 NVVSLKHCFFSTTDKD---ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
N++SL + F + ++YL V+E + + +V + + + YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQ------MELDHERMSYLLYQM 173
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
+ ++H G+ HRD+KP N++V +K+ DFG A+ Y+ +RYYRA
Sbjct: 174 LCGIKHLHSA-GIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
PE+I G Y +DIWSVGC++ E++ + LFPG +DQ ++I+ LGTP E +K +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290
Query: 322 NPNYTEF--KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTA 368
P + P+ + K+F +K +A DL+S++L P R +
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350
Query: 369 LEACIHPFFYELRDPNARLP-NGRPFPPLFN 398
+A HP+ DP + + +
Sbjct: 351 DDALQHPYINVWYDPAEVEAPPPQIYDKQLD 381
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 265 bits (680), Expect = 5e-85
Identities = 101/388 (26%), Positives = 162/388 (41%), Gaps = 79/388 (20%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQD-KR-YKNRELQTMRLLDHP 144
Y+ + ++G+GS+G V+ A T + VAIKKV L D KR RE+ + L
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85
Query: 145 NVVSLKHCFF--STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
++ L DELY+ VLE + ++ + + ++K Y +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLF----KTPIFLTEEHIKTILYNLL 139
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------- 252
+IH G+ HRD+KP N L+N VK+CDFG A+ + +
Sbjct: 140 LGENFIHES-GIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 253 -------------YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-------- 291
++ +R+YRAPELI YT +IDIWS GC+ AELL
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 292 ---PLFPGESG-----------------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF-- 328
PLFPG S DQL I ++GTPT +++K + P ++
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLP 388
FP K + + + + ++L+ +L+++PN R T +A HP+ ++R
Sbjct: 318 LFPHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLE-- 374
Query: 389 NGRPFPPLFNFKPQELKGASKELLSKLI 416
+ S+ L +
Sbjct: 375 --NFSTKKIILPFDDWMVLSETQLRYIF 400
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 249 bits (638), Expect = 3e-79
Identities = 96/361 (26%), Positives = 163/361 (45%), Gaps = 53/361 (14%)
Query: 99 VGQGSFGIVFQAKCLE--TGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 154
VG+G++G V++AK + + A+K++ + RE+ +R L HPNV+SL+ F
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHY-----SRASQRMPLIYVKLYTYQICRALAYIH 209
S D+ + L+ ++ ++ + K + ++ ++P VK YQI + Y+H
Sbjct: 89 SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 210 GGIGVCHRDIKPQNLLVN---PHTHQVKLCDFGSAKVLVKGEPNISY------ICSRYYR 260
V HRD+KP N+LV P +VK+ D G A++ P + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES---------GVDQLVEIIKVLG 311
APEL+ GA YT AIDIW++GC+ AELL +P+F DQL I V+G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262
Query: 312 TPTRE---------EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP 362
P + E + ++ + + + + +A L+ +LL P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322
Query: 363 NLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARK 422
R T+ +A P+F E P P F ++ +E L++ P+
Sbjct: 323 IKRITSEQAMQDPYFLED-----------PLPTSDVFAGCQIPYPKREFLTEEEPDDKGD 371
Query: 423 Q 423
+
Sbjct: 372 K 372
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 213 bits (543), Expect = 9e-65
Identities = 95/381 (24%), Positives = 162/381 (42%), Gaps = 69/381 (18%)
Query: 43 PEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTT---IGGRNGQPKQTISYMAERVV 99
EI + + ++ + G + G + + R Y +V+
Sbjct: 55 YPEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYR---------YEVLKVI 105
Query: 100 GQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLL------DHPNVVSLK 150
G+GSFG V +A + + VA+K V +KR+ E++ + L + NV+ +
Sbjct: 106 GKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165
Query: 151 HCFFSTTDKDELYLN---LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
F + N + E + +Y + K Q L V+ + + I + L
Sbjct: 166 ENF--------TFRNHICMTFELLSMNLYELIK--KNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 208 IHGGIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
+H + H D+KP+N LL +K+ DFGS+ + +YI SR+YRAPE+I
Sbjct: 216 LHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFYRAPEVIL 272
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK------- 319
GA Y ID+WS+GC+LAELL G PL PGE DQL +I++LG P+++ +
Sbjct: 273 GA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331
Query: 320 ----CMNPNYTEFKF---------------PQIKAHPWHKIFHKRMPPEA----VDLVSR 356
P Y +++ P + + + +D + +
Sbjct: 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQ 391
Query: 357 LLQYSPNLRCTALEACIHPFF 377
L++ P +R T +A HP+
Sbjct: 392 CLEWDPAVRMTPGQALRHPWL 412
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 7e-64
Identities = 83/340 (24%), Positives = 139/340 (40%), Gaps = 44/340 (12%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLL-----DHP 144
Y+ R +G G F V+ AK + VA+K V DK Y E++ ++ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 145 NVVSLKHC-----FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
+ + H F+ + +++ +V E + E + + K Y + +PLIYVK +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-----VKLCDFGSAKVLVKGEPNISYI 254
Q+ L Y+H G+ H DIKP+N+L+ +K+ D G+A E + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIK 308
+R YR+PE++ GA + DIWS C++ EL+ G LF + G D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255
Query: 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP--------------EAVDLV 354
+LG ++ F + K+ + E D +
Sbjct: 256 LLGELPSYLLR-NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 314
Query: 355 SRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFP 394
S +LQ P R A HP+ + R
Sbjct: 315 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELY 354
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-63
Identities = 101/382 (26%), Positives = 159/382 (41%), Gaps = 74/382 (19%)
Query: 53 GERVEKEMEATVVDGNGTETGHIIVT---TIGGRNGQPKQTISYMAERVVGQGSFGIVFQ 109
K+ DG + IV R Y + ++G+GSFG V +
Sbjct: 22 SMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDR---------YEIDSLIGKGSFGQVVK 72
Query: 110 AKCLETGETVAIKKVLQDKRYKN---RELQTMRLL------DHPNVVSLKHCFFSTTDKD 160
A E VAIK + K + N E++ + L+ +V LK F
Sbjct: 73 AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM------ 126
Query: 161 ELYLN---LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCH 216
+ N LV E + +Y + ++ + + + L + + Q+C AL ++ + + H
Sbjct: 127 --FRNHLCLVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATPELSIIH 182
Query: 217 RDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI 275
D+KP+N LL NP +K+ DFGS+ G+ YI SR+YR+PE++ G Y AI
Sbjct: 183 CDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGM-PYDLAI 239
Query: 276 DIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-----------CMNPN 324
D+WS+GC+L E+ G+PLF G + VDQ+ +I++VLG P + +
Sbjct: 240 DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGT 299
Query: 325 YTEFKFPQIKAH---PWHKIFH-----KRMPPEA----------------VDLVSRLLQY 360
+ K K P + H + P DL+ R+L Y
Sbjct: 300 WNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359
Query: 361 SPNLRCTALEACIHPFFYELRD 382
P R A H FF + D
Sbjct: 360 DPKTRIQPYYALQHSFFKKTAD 381
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-61
Identities = 80/362 (22%), Positives = 141/362 (38%), Gaps = 78/362 (21%)
Query: 71 ETGHIIV---TTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD 127
E H + ++ R +G G+FG V + ++ + A+K V
Sbjct: 21 EIVHFSWKKGMLLNNA---------FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI 71
Query: 128 KRYKN---RELQTMRLL-----DHPNVVSLKHCFFSTTDKDELYLN---LVLEFVPETVY 176
K+Y E ++ + ++ N+V F +Y + L+ E + ++Y
Sbjct: 72 KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF--------MYYDHMCLIFEPLGPSLY 123
Query: 177 RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN-LLVNPHTH---- 231
+ + + +KLY +I +AL Y+ + + H D+KP+N LL +P+
Sbjct: 124 EIITRNNY--NGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLI 180
Query: 232 -------------------QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 272
+KL DFG A K + + S I +R YRAPE+I +
Sbjct: 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWD 237
Query: 273 TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI---------KCMNP 323
+ D+WS GCVLAEL G LF ++ L + ++ + + K +N
Sbjct: 238 VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK 297
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEA--------VDLVSRLLQYSPNLRCTALEACIHP 375
+ + +P+ + K+ P D + +LQ P LR + E H
Sbjct: 298 DELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHK 357
Query: 376 FF 377
F
Sbjct: 358 FL 359
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 9e-61
Identities = 83/361 (22%), Positives = 141/361 (39%), Gaps = 72/361 (19%)
Query: 72 TGHIIVTT---IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQD 127
+ H+I + + R Y +G+G+FG V + + G VA+K V
Sbjct: 1 SMHLICQSGDVLSAR---------YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV 51
Query: 128 KRYKN---RELQTMRLL------DHPNVVSLKHCFFSTTDKDELYLN---LVLEFVPETV 175
RY E+Q + L V + F + +V E + +
Sbjct: 52 DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE--------HHGHICIVFELLGLST 103
Query: 176 YRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN-------- 227
Y K L +++ YQIC+++ ++H + H D+KP+N+L
Sbjct: 104 YDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAY 160
Query: 228 ----------PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDI 277
+K+ DFGSA E + + + +R+YRAPE+I ++ D+
Sbjct: 161 NPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDV 217
Query: 278 WSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK---------CMNPNYTEF 328
WS+GC+L E LG +FP + L + ++LG + I+ ++ E
Sbjct: 218 WSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEH 277
Query: 329 KFPQIKAHPWHKIFHKRMPPE------AVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382
K + M + DL+ ++L+Y P R T EA HPFF L+
Sbjct: 278 SSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
Query: 383 P 383
Sbjct: 338 S 338
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-60
Identities = 81/371 (21%), Positives = 138/371 (37%), Gaps = 72/371 (19%)
Query: 71 ETGHIIVT---TIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQ 126
+ GH++ + R Y +G+G+FG V + G VA+K +
Sbjct: 5 KEGHLVCRIGDWLQER---------YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN 55
Query: 127 DKRYKN---RELQTMRLL------DHPNVVSLKHCFFSTTDKDELYLN---LVLEFVPET 174
+Y+ E+ ++ + + V + F + + E + +
Sbjct: 56 VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF--------NFHGHMCIAFELLGKN 107
Query: 175 VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN------- 227
+ K + Q PL +V+ YQ+C AL ++H + H D+KP+N+L
Sbjct: 108 TFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETL 164
Query: 228 -----------PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAID 276
+++ DFGSA E + + + +R+YR PE+I + D
Sbjct: 165 YNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILE-LGWAQPCD 221
Query: 277 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM---------NPNYTE 327
+WS+GC+L E G LF + LV + K+LG I + E
Sbjct: 222 VWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDE 281
Query: 328 FKFPQIKAHPWHKIFHKRMPPEA------VDLVSRLLQYSPNLRCTALEACIHPFFYELR 381
K M ++ DL+ R+L++ P R T EA +HPFF L
Sbjct: 282 NSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341
Query: 382 DPNARLPNGRP 392
R
Sbjct: 342 PEERSFHTSRN 352
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 5e-59
Identities = 67/301 (22%), Positives = 105/301 (34%), Gaps = 65/301 (21%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLL----DHP 144
S+ +G GS+G VF+ + E G A+K+ + + + R+L + HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
V L+ + + LY L E + + +H +P V Y A
Sbjct: 118 CCVRLEQAWE---EGGILY--LQTELCGPS---LQQHCEAWGASLPEAQVWGYLRDTLLA 169
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
LA++H G+ H D+KP N+ + P KL DFG L Y APEL
Sbjct: 170 LAHLH-SQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
+ Y TA D++S+G + E+ L G
Sbjct: 228 L--QGSYGTAADVFSLGLTILEVACNMELPHG---------------------------- 257
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPP--------EAVDLVSRLLQYSPNLRCTALEACIHPF 376
W ++ +PP E ++ +L+ P LR TA P
Sbjct: 258 ----------GEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307
Query: 377 F 377
Sbjct: 308 L 308
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 5e-57
Identities = 70/326 (21%), Positives = 112/326 (34%), Gaps = 56/326 (17%)
Query: 77 VTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKN 132
+ I ++ Y+ + +G+G F V + L G A+K++L QD+
Sbjct: 23 MVIIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ 74
Query: 133 RELQTMRLLDHPNVVSLKHCFF-STTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMP 190
RE RL +HPN++ L K E + L+L F T++ + +
Sbjct: 75 READMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLT 132
Query: 191 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--- 247
+ ICR L IH G HRD+KP N+L+ Q L D GS
Sbjct: 133 EDQILWLLLGICRGLEAIH-AKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEG 190
Query: 248 -------EPNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
+ + C+ YRAPEL D+WS+GCVL ++ G+ +
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250
Query: 299 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLL 358
V + V + PQ R L++ ++
Sbjct: 251 QKGDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMM 284
Query: 359 QYSPNLRCTALEACIHPFFYELRDPN 384
P+ R + P
Sbjct: 285 TVDPHQRPHIPLLLSQLEALQPPAPG 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 190 bits (483), Expect = 1e-56
Identities = 47/350 (13%), Positives = 92/350 (26%), Gaps = 65/350 (18%)
Query: 83 RNGQPKQTIS--------YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK--- 131
S + G +VF + +E E A+K
Sbjct: 46 PQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE 105
Query: 132 ----NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN---------------------L 166
+ L + + D + + L
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165
Query: 167 VLEFVP---ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223
++ E ++ ++ + + T Q+ R A + G+ H P N
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ-SKGLVHGHFTPDN 224
Query: 224 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTAIDIWSVGC 282
L + P + L D + + G + Y E + +T A++ W +G
Sbjct: 225 LFIMPDGR-LMLGDVSALWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 283 VLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF 342
+ + F + + L P +
Sbjct: 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD--------------------SLAFGS 321
Query: 343 HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD-PNARLPNGR 391
+P L+ R L + R LEA P F +L++ ++ L G+
Sbjct: 322 CTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLSTGQ 371
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-56
Identities = 70/356 (19%), Positives = 125/356 (35%), Gaps = 68/356 (19%)
Query: 56 VEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLET 115
+ + GTE + ++ GR Y + +G G VFQ E
Sbjct: 1 MHHHHHHSSGVDLGTENLYFQSMSVKGRI--------YSILKQIGSGGSSKVFQVLN-EK 51
Query: 116 GETVAIKKV----LQDKRYKN--RELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLV 167
+ AIK V ++ + E+ + L + ++ L + Y+ +V
Sbjct: 52 KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----ITDQYIYMV 106
Query: 168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN 227
+E + K + + K Y + A+ IH G+ H D+KP N L+
Sbjct: 107 MECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLI- 160
Query: 228 PHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGA----------TEYTTA 274
+KL DFG A + ++ S + + Y PE I ++ +
Sbjct: 161 -VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPK 219
Query: 275 IDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 334
D+WS+GC+L + G+ F + I ++PN+ E +FP I
Sbjct: 220 SDVWSLGCILYYMTYGKTPFQQIINQISKLHAI-------------IDPNH-EIEFPDI- 264
Query: 335 AHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNG 390
+ D++ L+ P R + E HP+ P ++ G
Sbjct: 265 -----------PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 309
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 4e-56
Identities = 69/353 (19%), Positives = 121/353 (34%), Gaps = 69/353 (19%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN- 145
Y + +G G VFQ E + AIK V ++ E+ + L +
Sbjct: 58 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 146 -VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
++ L + Y+ +V+E + K + + K Y + A
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 167
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRA 261
+ IH G+ H D+KP N L+ +KL DFG A + ++ S + + Y
Sbjct: 168 VHTIHQ-HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 262 PELIFGA----------TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
PE I ++ + D+WS+GC+L + G+ F + I
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 280
Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
++PN+ E +FP I + D++ L+ P R + E
Sbjct: 281 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 318
Query: 372 CIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
HP+ P + +E+K +L+ P K
Sbjct: 319 LAHPYVQ---------IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAA 362
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 5e-56
Identities = 69/353 (19%), Positives = 121/353 (34%), Gaps = 69/353 (19%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN- 145
Y + +G G VFQ E + AIK V ++ E+ + L +
Sbjct: 11 YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 146 -VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
++ L + Y+ +V+E + K + + K Y + A
Sbjct: 70 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRA 261
+ IH G+ H D+KP N L+ +KL DFG A + ++ S + + Y
Sbjct: 121 VHTIHQ-HGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 262 PELIFG----------ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
PE I ++ + D+WS+GC+L + G+ F + I
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 233
Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
++PN+ E +FP I + D++ L+ P R + E
Sbjct: 234 ---------IDPNH-EIEFPDI------------PEKDLQDVLKCCLKRDPKQRISIPEL 271
Query: 372 CIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQC 424
HP+ P + +E+K +L+ P K
Sbjct: 272 LAHPYVQ---------IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAA 315
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 9e-55
Identities = 66/301 (21%), Positives = 120/301 (39%), Gaps = 51/301 (16%)
Query: 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVS 148
IS+ + V+G G+ G + + + VA+K++L + + +RE+Q +R D HPNV+
Sbjct: 24 ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
KD + + +E T+ V + P+ ++ Q LA+
Sbjct: 83 YFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133
Query: 208 IHGGIGVCHRDIKPQNLLVNPH----THQVKLCDFGSAKVLVKGEPNISY---IC-SRYY 259
+H + + HRD+KP N+L++ + + DFG K L G + S + + +
Sbjct: 134 LHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 260 RAPELIFGATE--YTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 316
APE++ + T +DI+S GCV ++ G F G +
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQR 236
Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
+ + P A +L+ +++ P R +A HPF
Sbjct: 237 QANILLGAC-SLDCLH----PEKHE-----DVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 377 F 377
F
Sbjct: 287 F 287
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-54
Identities = 73/297 (24%), Positives = 117/297 (39%), Gaps = 45/297 (15%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
Y +G GS+G + + G+ + K++ +K+ E+ +R L HPN+
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
V D+ L +V+E+ + V ++ Q + +V Q+ AL
Sbjct: 68 VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 206 AYIH----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYR 260
H GG V HRD+KP N+ ++ VKL DFG A++L + YY
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
+PE + Y DIWS+GC+L EL P F S +L I+
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
E KF +I R E ++++R+L R + E +P
Sbjct: 230 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-53
Identities = 57/304 (18%), Positives = 112/304 (36%), Gaps = 27/304 (8%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 147
++ ++GQG+ VF+ + +TG+ AIK L+ + RE + ++ L+H N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
L TT L ++EF P + + + +P + + +
Sbjct: 71 KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGM 125
Query: 206 AYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
++ G+ HR+IKP N++ KL DFG+A+ L E +S + Y P
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 263 ELIFGAT-------EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK--VLGTP 313
++ A +Y +D+WS+G G F G + E++ + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
+ + P + + +++ +L+ +
Sbjct: 245 SGAISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
Query: 374 HPFF 377
Sbjct: 303 ETSD 306
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-53
Identities = 77/306 (25%), Positives = 126/306 (41%), Gaps = 54/306 (17%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
V+G+G++GIV+ + L +AIK++ +D RY E+ + L H N+V
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83
Query: 153 FFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
+ + + ++ + +E VP + R + I YT QI L Y+
Sbjct: 84 -YLGSFSENGFIKIFMEQVPGGSLSALLR--SKWGPLKDNEQTI--GFYTKQILEGLKYL 138
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFG 267
H + HRDIK N+L+N ++ +K+ DFG++K L P ++ + Y APE+I
Sbjct: 139 HDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 268 ATE-YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
Y A DIWS+GC + E+ G+P F +L E +
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM---------------- 235
Query: 327 EFKFPQIKAHPWHKIFHKRMP----PEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382
FK K HP +P EA + + + P+ R A + + F
Sbjct: 236 -FKVGMFKVHP-------EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287
Query: 383 PNARLP 388
P
Sbjct: 288 KKKTQP 293
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 6e-53
Identities = 76/314 (24%), Positives = 131/314 (41%), Gaps = 60/314 (19%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMR-LLDHPNVVSLK 150
++E+++G GS G V + G VA+K++L D E++ + DHPNV+
Sbjct: 17 VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY- 74
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVY-RVAKH--YSRASQRMPLIYVKLYTYQICRALAY 207
+C + LY+ LE + V + QI +A+
Sbjct: 75 YCSET--TDRFLYI--ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGE----PNI 251
+H + + HRD+KPQN+LV+ + ++ + DFG K L G+ N+
Sbjct: 131 LHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 252 SYIC-SRYYRAPELIFGATE------YTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQL 303
+ + +RAPEL+ + T +IDI+S+GCV +L G+ F + +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRE 247
Query: 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN 363
II+ F ++K + EA DL+S+++ + P
Sbjct: 248 SNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLISQMIDHDPL 285
Query: 364 LRCTALEACIHPFF 377
R TA++ HP F
Sbjct: 286 KRPTAMKVLRHPLF 299
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-52
Identities = 82/332 (24%), Positives = 126/332 (37%), Gaps = 66/332 (19%)
Query: 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKN---RELQTMR 139
P+ Y+ R +G+G F F+ +T E A K +L + E+ R
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYT 198
L H +VV F D D +++ VLE ++ + + + + Y
Sbjct: 71 SLAHQHVVGFHGFF---EDNDFVFV--VLELCRRRSLL----ELHKRRKALTEPEARYYL 121
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE--------P 249
QI Y+H V HRD+K NL +N +VK+ DFG + KV GE P
Sbjct: 122 RQIVLGCQYLHR-NRVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 179
Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 309
N Y APE++ ++ +D+WS+GC++ LL+G+P F + + I K
Sbjct: 180 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 230
Query: 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 369
E+ P + P A L+ ++LQ P R T
Sbjct: 231 -----------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTIN 261
Query: 370 EACIHPFFYELRDPNARLPNGRPFPPLFNFKP 401
E FF P PP F+ P
Sbjct: 262 ELLNDEFFTSGYIPARLPITCLTIPPRFSIAP 293
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-52
Identities = 85/346 (24%), Positives = 134/346 (38%), Gaps = 66/346 (19%)
Query: 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKN---RELQTMR 139
P+ Y+ R +G+G F F+ +T E A K +L + E+ R
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYT 198
L H +VV F D D +++ VLE ++ + + + + Y
Sbjct: 97 SLAHQHVVGFHGFF---EDNDFVFV--VLELCRRRSLL----ELHKRRKALTEPEARYYL 147
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE--------P 249
QI Y+H V HRD+K NL +N +VK+ DFG + KV GE P
Sbjct: 148 RQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGTP 205
Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 309
N Y APE++ ++ +D+WS+GC++ LL+G+P F + + I K
Sbjct: 206 N--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 256
Query: 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 369
E+ P + P A L+ ++LQ P R T
Sbjct: 257 -----------------EYSIP-----KH-------INPVAASLIQKMLQTDPTARPTIN 287
Query: 370 EACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKL 415
E FF P PP F+ P L ++++ L+ L
Sbjct: 288 ELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVL 333
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 6e-52
Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 52/297 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 146
Y + +G G++G V + T AIK + E+ ++LLDHPN+
Sbjct: 39 YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYTYQIC 202
+ L F +D+ LV+E E + ++ + Q+
Sbjct: 99 MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEV-------DAAVIIKQVL 146
Query: 203 RALAYIHGGIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYR 260
+ Y+H + HRD+KP+N LL + +K+ DFG + V + + + YY
Sbjct: 147 SGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYI 205
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
APE++ +Y D+WS+G +L LL G P F G++ DQ EI+ +++
Sbjct: 206 APEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEK 251
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ W + A DL+ ++LQ+ R +A +A HP+
Sbjct: 252 GKYTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 8e-52
Identities = 78/302 (25%), Positives = 123/302 (40%), Gaps = 60/302 (19%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPN 145
+ E+ +G+G F V++A CL G VA+KKV + + +E+ ++ L+HPN
Sbjct: 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
V+ F + +EL +VLE + R+ KH+ + + +P V Y Q+C A
Sbjct: 94 VIKYYASFI---EDNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNISYIC 255
L ++H V HRDIKP N+ + T VKL D G + + G P
Sbjct: 149 LEHMHSR-RVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTP------ 200
Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPT 314
YY +PE I Y DIWS+GC+L E+ Q F G+ + L + I+
Sbjct: 201 --YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------ 251
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
+ +P + + E LV+ + P R
Sbjct: 252 ------------QCDYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291
Query: 375 PF 376
Sbjct: 292 AK 293
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 8e-52
Identities = 65/313 (20%), Positives = 112/313 (35%), Gaps = 61/313 (19%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 149
+ V+GQG+FG V +A+ AIKK+ + + E+ + L+H VV
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 150 KHCFFSTTDKDEL--------YLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTY 199
+ + + L + +E+ + + +
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR---- 123
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-- 257
QI AL+YIH G+ HRD+KP N+ ++ + VK+ DFG AK + + +
Sbjct: 124 QILEALSYIHSQ-GIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 258 -------------YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
Y A E++ G Y ID++S+G + E++ P G V
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RV 235
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
I+K L + +FP P F ++ L+ + PN
Sbjct: 236 NILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNK 274
Query: 365 RCTALEACIHPFF 377
R A +
Sbjct: 275 RPGARTLLNSGWL 287
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 9e-52
Identities = 79/298 (26%), Positives = 131/298 (43%), Gaps = 53/298 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHPN 145
Y +RV+G+GSFG V K TG+ A+K + ++ K K RE+Q ++ LDHPN
Sbjct: 28 YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYTYQI 201
++ L F +D+ Y LV E E + +S Q+
Sbjct: 88 IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEV-------DAARIIRQV 135
Query: 202 CRALAYIHGGIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYY 259
+ Y+H + HRD+KP+N LL + +++ DFG + + I + YY
Sbjct: 136 LSGITYMH-KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY 194
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
APE++ G Y D+WS G +L LL G P F G + + +I+ ++++
Sbjct: 195 IAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVE 240
Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ W K+ A DL+ ++L Y P++R +A +A H +
Sbjct: 241 KGKYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISARDALDHEWI 285
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 74/309 (23%), Positives = 128/309 (41%), Gaps = 52/309 (16%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 146
Y ++G+GSFG V + K T + A+K + +D RE++ ++ LDHPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYTYQIC 202
+ L +D +V E E + K +S Q+
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 203 RALAYIHGGIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYR 260
+ Y+H + HRD+KP+N LL + +K+ DFG + + I + YY
Sbjct: 132 SGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
APE++ G Y D+WS G +L LL G P F G++ + +I+ + ++
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVET 236
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
+ W I +A DL+ ++L + P+LR TA + HP+ +
Sbjct: 237 GKYAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
Query: 381 RDPNARLPN 389
+ +
Sbjct: 284 SSETPTISD 292
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 4e-51
Identities = 60/295 (20%), Positives = 101/295 (34%), Gaps = 46/295 (15%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 152
+ ++G G FG VF+AK G+T IK+V + RE++ + LDH N+V C
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRV----------AKHYSRASQRMPLIYVKLYTYQIC 202
+ E + ++ R +++ + QI
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
+ + YIH + +RD+KP N+ + T QVK+ DFG L + Y +P
Sbjct: 133 KGVDYIH-SKKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSP 190
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
E I +Y +D++++G +LAELL ++
Sbjct: 191 EQISS-QDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRD-------------- 233
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
I + L+ +LL P R E
Sbjct: 234 -----------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-51
Identities = 73/311 (23%), Positives = 135/311 (43%), Gaps = 66/311 (21%)
Query: 85 GQPKQTIS-YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQ 136
+ I + ++G+GSF V++A+ + TG VAIK + + YK E++
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 137 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVK 195
L HP+++ L + F D + +Y LVLE + R K+ + +
Sbjct: 64 IHCQLKHPSILELYNYF---EDSNYVY--LVLEMCHNGEMNRYLKNRVK---PFSENEAR 115
Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE------ 248
+ +QI + Y+H G+ HRD+ NLL+ + +K+ DFG + ++ + E
Sbjct: 116 HFMHQIITGMLYLH-SHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTLC 173
Query: 249 --PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 306
PN Y +PE+ + + D+WS+GC+ LL+G+P F ++ + L ++
Sbjct: 174 GTPN--------YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV 224
Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC 366
+ +++ P + + EA DL+ +LL+ +P R
Sbjct: 225 VLA-----------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADRL 255
Query: 367 TALEACIHPFF 377
+ HPF
Sbjct: 256 SLSSVLDHPFM 266
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 6e-51
Identities = 64/317 (20%), Positives = 116/317 (36%), Gaps = 48/317 (15%)
Query: 71 ETGHIIVTTIGGRNGQPKQTIS-YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDK 128
G ++ + + + ++ + + VG+GSFG V + K +TG A+KKV L+
Sbjct: 37 NEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV- 95
Query: 129 RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQ 187
++ EL L P +V L ++ ++N+ +E + ++ ++ K
Sbjct: 96 -FRVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQMGC--- 146
Query: 188 RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247
+P Y Q L Y+H + H D+K N+L++ + LCDFG A L
Sbjct: 147 -LPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204
Query: 248 EPNISYICSR------YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
S + + APE++ G +DIWS C++ +L G +
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263
Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 361
++I P +I P + L+
Sbjct: 264 LCLKIAS-EPPPI----------------REIPPS---------CAPLTAQAIQEGLRKE 297
Query: 362 PNLRCTALEACIHPFFY 378
P R +A+E
Sbjct: 298 PVHRASAMELRRKVGKA 314
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-50
Identities = 79/296 (26%), Positives = 127/296 (42%), Gaps = 64/296 (21%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 149
R +G+G FG V+ A+ ++ +A+K ++ + RE++ L HPN++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
F D +Y L+LE+ P TVYR + + Y ++ AL+Y
Sbjct: 75 YGYFH---DATRVY--LILEYAPLGTVYR----ELQKLSKFDEQRTATYITELANALSYC 125
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-------GEPNISYICSRYYRA 261
H V HRDIKP+NLL+ +K+ DFG + G + Y
Sbjct: 126 H-SKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YLP 175
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
PE+I G + +D+WS+G + E L+G+P F + + I +V
Sbjct: 176 PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 222
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
EF FP + + A DL+SRLL+++P+ R E HP+
Sbjct: 223 -----EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-50
Identities = 79/308 (25%), Positives = 125/308 (40%), Gaps = 63/308 (20%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------------REL 135
Y R +G G++G V K AIK + + + K E+
Sbjct: 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 136 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPL 191
++ LDHPN++ L F +D+ Y LV EF E ++ +
Sbjct: 98 SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDEC------ 146
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEP 249
QI + Y+H + HRDIKP+N LL N ++ +K+ DFG + K
Sbjct: 147 -DAANIMKQILSGICYLH-KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 309
+ + YY APE++ +Y D+WS G ++ LL G P F G++ DQ +II
Sbjct: 205 LRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII-- 256
Query: 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 369
++++ + + W I EA +L+ +L Y N RCTA
Sbjct: 257 ------KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTAE 297
Query: 370 EACIHPFF 377
EA +
Sbjct: 298 EALNSRWI 305
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 2e-50
Identities = 61/297 (20%), Positives = 116/297 (39%), Gaps = 56/297 (18%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 151
+G+GSF V++ ET VA ++ K K+ E + ++ L HPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
+ ST + + LV E + T+ K + + M + ++ + QI + L ++H
Sbjct: 93 SWESTVKGKK-CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 147
Query: 211 -GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAP 262
+ HRD+K N+ + T VK+ D G A + V G P + AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAP 199
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
E+ +Y ++D+++ G + E+ + + Q+
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------------------- 238
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379
++ P F K PE +++ ++ + + R + + H FF E
Sbjct: 239 -----YRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-50
Identities = 72/313 (23%), Positives = 122/313 (38%), Gaps = 47/313 (15%)
Query: 74 HIIVTTIGGRNGQPKQTIS-YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQ 126
H G Q++ Y+ + +G+GSFG K E G IK++ +
Sbjct: 6 HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65
Query: 127 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRA 185
++ RE+ + + HPN+V + F + LY +V+++ +++ ++
Sbjct: 66 EREESRREVAVLANMKHPNIVQYRESFE---ENGSLY--IVMDYCEGGDLFKRIN--AQK 118
Query: 186 SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245
+ + QIC AL ++H + HRDIK QN+ + V+L DFG A+VL
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKD-GTVQLGDFGIARVLN 176
Query: 246 KGEPNISYIC-SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304
+ YY +PE+ Y DIW++GCVL EL + F S + LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
I ++ +Y + LVS+L + +P
Sbjct: 235 LKII------SGSFPPVSLHY---------------------SYDLRSLVSQLFKRNPRD 267
Query: 365 RCTALEACIHPFF 377
R + F
Sbjct: 268 RPSVNSILEKGFI 280
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-50
Identities = 57/295 (19%), Positives = 112/295 (37%), Gaps = 27/295 (9%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 147
++ ++GQG+ VF+ + +TG+ AIK L+ + RE + ++ L+H N+V
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
L TT L ++EF P + + + + +P + + +
Sbjct: 71 KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGM 125
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
++ G+ HR+IKP N++ KL DFG+A+ L E +S + Y P
Sbjct: 126 NHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
Query: 263 ELIFGAT-------EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK--VLGTP 313
++ A +Y +D+WS+G G F G + E++ + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244
Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368
+ + P + + +++ +L+
Sbjct: 245 SGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 6e-50
Identities = 58/309 (18%), Positives = 120/309 (38%), Gaps = 47/309 (15%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN----------------REL 135
R + QG F + + + + A+K + + + + EL
Sbjct: 37 RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 136 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-----ETVYRVAKHYSRASQRMP 190
Q + + + ++ + T+ DE+Y+ + E++ + + +P
Sbjct: 95 QIITDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 191 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 250
+ +K + + +YIH +CHRD+KP N+L++ + VKL DFG ++ +V +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKK-- 206
Query: 251 ISYIC-SRYYRAPELIFGATEY-TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
I + + PE + Y +DIWS+G L + F + + +L I+
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266
Query: 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368
+ I+ P F + + + E +D + L+ +P R T+
Sbjct: 267 ------TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317
Query: 369 LEACIHPFF 377
+A H +
Sbjct: 318 EDALKHEWL 326
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 3e-49
Identities = 84/348 (24%), Positives = 136/348 (39%), Gaps = 84/348 (24%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL---------QDKRYKNRELQTMRLLDH 143
Y + +GQGS+G+V A +T AIK + +D E++ M+ L H
Sbjct: 28 YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKL----- 196
PN+ L + +DE Y+ LV+E + ++ ++ + + VK
Sbjct: 88 PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 197 ------------------------------YTYQICRALAYIHGGIGVCHRDIKPQN-LL 225
QI AL Y+H G+CHRDIKP+N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN-QGICHRDIKPENFLF 201
Query: 226 VNPHTHQVKLCDFGSAKVLVKGEPNISYIC-----SRYYRAPELIFGATE-YTTAIDIWS 279
+ ++KL DFG +K K Y + Y+ APE++ E Y D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261
Query: 280 VGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 339
G +L LL+G FPG + D + +++ + F ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301
Query: 340 KIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARL 387
+ P A DL+S LL + + R A+ A HP+ + D ++
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKM 344
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 3e-49
Identities = 81/321 (25%), Positives = 126/321 (39%), Gaps = 44/321 (13%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNRELQTMRLLDHPNVVS 148
Y +G G+FG+V + TG K DK E+ M L HP +++
Sbjct: 53 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
L F DK E+ L +LEF+ E R+A + S+ V Y Q C L
Sbjct: 113 LHDAF---EDKYEMVL--ILEFLSGGELFDRIAAEDYKMSEA----EVINYMRQACEGLK 163
Query: 207 YIHGGIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
++H + H DIKP+N++ VK+ DFG A L E + + APE I
Sbjct: 164 HMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
D+W++G + LL G F GE ++ L + +
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC---------------- 265
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF-YELRDPN 384
+++F + + PEA D + LLQ P R T +A HP+ + +
Sbjct: 266 -DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 316
Query: 385 ARLPNGRPFPPLFNFKPQELK 405
+R+P+ R K +
Sbjct: 317 SRIPSSRYNKIRQKIKEKYAD 337
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-49
Identities = 78/345 (22%), Positives = 125/345 (36%), Gaps = 67/345 (19%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMR-LLDHPNVV 147
RV+ +G F V++A+ + +G A+K++L + R +E+ M+ L HPN+V
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 148 SLKHCFF-----STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
S T + E L+ E + K + + V YQ C
Sbjct: 90 QFCSAASIGKEESDTGQAEFL--LLTELCKGQLVEFLKK-MESRGPLSCDTVLKIFYQTC 146
Query: 203 RALAYIHG-GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------------E 248
RA+ ++H + HRD+K +NLL++ +KLCDFGSA + E
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 249 PNISYICSRYYRAPELI--FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 306
I+ + YR PE+I + DIW++GC+L L Q F + + I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRI 261
Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC 366
+ ++ P H L+ +LQ +P R
Sbjct: 262 VNG-----------------KYSIPP----------HDTQYTVFHSLIRAMLQVNPEERL 294
Query: 367 TALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKEL 411
+ E A N P P+ Q S L
Sbjct: 295 SIAEVVHQLQEI------AAARNVNPKSPITELLEQNGGYGSATL 333
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 6e-49
Identities = 83/305 (27%), Positives = 129/305 (42%), Gaps = 52/305 (17%)
Query: 85 GQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNRELQTM 138
G K I+ Y E +G+GS+G V A T A K ++D +E++ M
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYV 194
+ LDHPN++ L F +D + LV+E E RV + +
Sbjct: 61 KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRES-------DA 108
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNIS 252
+ A+AY H + V HRD+KP+N L + +KL DFG A G+ +
Sbjct: 109 ARIMKDVLSAVAYCH-KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT 167
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
+ + YY +P+++ G Y D WS G ++ LL G P F + + +++I +
Sbjct: 168 KVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG--- 222
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
F FP W + P+A L+ RLL SP R T+L+A
Sbjct: 223 --------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITSLQAL 260
Query: 373 IHPFF 377
H +F
Sbjct: 261 EHEWF 265
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 6e-49
Identities = 76/290 (26%), Positives = 127/290 (43%), Gaps = 44/290 (15%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVA---IKKVLQDKRYKNRELQTMRLLDHPNVVSL 149
YM +G+G FGIV + + +T +K D+ +E+ + + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
F +EL ++ EF+ + R+ ++R + Y +Q+C AL +
Sbjct: 67 HESF---ESMEELV--MIFEFISGLDIFERINTSAFELNERE----IVSYVHQVCEALQF 117
Query: 208 IHGGIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
+H + H DI+P+N++ + +K+ +FG A+ L G+ + + Y APE +
Sbjct: 118 LH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPE-V 174
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
+TA D+WS+G ++ LL G F E+ +Q +II E I +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQ--QII--------ENIMNAEYTF 222
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375
E F +I EA+D V RLL R TA EA HP
Sbjct: 223 DEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTASEALQHP 259
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 6e-49
Identities = 86/354 (24%), Positives = 150/354 (42%), Gaps = 64/354 (18%)
Query: 51 IKGERVEKEMEATVVDGN----GTETGHIIVTTIGGRNGQPKQTIS----YMAERVVGQG 102
+ E V K + + + + V + Q + Y+ + +G G
Sbjct: 87 VNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSG 146
Query: 103 SFGIVFQAKCLETGETVAIKKVLQDKRYKN------------RELQTMRLLDHPNVVSLK 150
+ G V A +T + VAI+ + + K E++ ++ L+HP ++ +K
Sbjct: 147 ACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
+ F D ++ Y+ VLE + E +V + +R+ KLY YQ+ A+ Y+
Sbjct: 207 NFF----DAEDYYI--VLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYL 255
Query: 209 HGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
H G+ HRD+KP+N+L++ +K+ DFG +K+L + + +C + Y APE++
Sbjct: 256 HE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVL 313
Query: 266 FGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
Y A+D WS+G +L L G P F L + I G
Sbjct: 314 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG------------ 360
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
++ F W ++ +A+DLV +LL P R T EA HP+
Sbjct: 361 ---KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEALRHPWL 403
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-48
Identities = 52/322 (16%), Positives = 95/322 (29%), Gaps = 90/322 (27%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLL----DHPN 145
+ +G G FG VF+ G AIK+ L + L+ + H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
VV + + D + + E+ ++ R +K Q+ R
Sbjct: 73 VVRYFSAWA---EDDHMLI--QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPH------------------THQVKLCDFGSAKVL-- 244
L YIH + + H DIKP N+ ++ K+ D G +
Sbjct: 128 LRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 245 ---VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
+G+ + A E++ + DI+++ + +PL
Sbjct: 187 PQVEEGDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN----- 233
Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPP-------EAVDLV 354
WH+I R+P E +L+
Sbjct: 234 ---------------------------------GDQWHEIRQGRLPRIPQVLSQEFTELL 260
Query: 355 SRLLQYSPNLRCTALEACIHPF 376
++ P R +A+ H
Sbjct: 261 KVMIHPDPERRPSAMALVKHSV 282
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-48
Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 66/297 (22%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 149
R +G+G FG V+ A+ + +A+K ++ ++ RE++ L HPN++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
+ F D+ +Y L+LEF P E + KH R + ++ AL Y
Sbjct: 80 YNYFH---DRKRIY--LMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHY 129
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-------GEPNISYICSRYYR 260
H V HRDIKP+NLL+ +K+ DFG + G + Y
Sbjct: 130 CH-ERKVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGTLD--------YL 179
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
PE+I G + +D+W G + E L+G P F S + I+ V
Sbjct: 180 PPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------- 227
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ KFP P+ + + DL+S+LL+Y P R HP+
Sbjct: 228 ------DLKFP-----PF-------LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV 266
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-48
Identities = 66/318 (20%), Positives = 118/318 (37%), Gaps = 60/318 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNVV 147
+ + +G+G FG+VF+AK AIK++ + RE++ + L+HP +V
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 148 SLKHCFF-------STTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTY 199
+ + ++YL + ++ E + +
Sbjct: 67 RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHIFL 125
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-- 257
QI A+ ++H G+ HRD+KP N+ VK+ DFG + + E + +
Sbjct: 126 QIAEAVEFLH-SKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 258 -----------YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 306
Y +PE I G Y+ +DI+S+G +L ELL P F + + +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239
Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC 366
++ KFP + + P +V +L SP R
Sbjct: 240 VR------------------NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERP 272
Query: 367 TALEACIHPFFYELRDPN 384
A+ + F +L P
Sbjct: 273 EAINIIENAVFEDLDFPG 290
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-48
Identities = 82/356 (23%), Positives = 140/356 (39%), Gaps = 43/356 (12%)
Query: 27 PAKPDDDDDAMPVDKLPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQ 86
P +P ++ ++ +G+ V + + N
Sbjct: 93 PCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH 152
Query: 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLD 142
Y +G G+FG+V + TG A K V DK +E+QTM +L
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
HP +V+L F D +E+ + + EF+ E +VA +++ S+ + Y++ Q
Sbjct: 213 HPTLVNLHDAF---EDDNEMVM--IYEFMSGGELFEKVADEHNKMSEDEAVEYMR----Q 263
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
+C+ L ++H H D+KP+N++ ++++KL DFG L + + +
Sbjct: 264 VCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEF 322
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
APE+ G D+WSVG + LL G F GE+ + T +K
Sbjct: 323 AAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------------TLRNVK 369
Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375
+ N + F I + D + +LL PN R T +A HP
Sbjct: 370 SCDWNMDDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTIHQALEHP 412
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-48
Identities = 76/321 (23%), Positives = 125/321 (38%), Gaps = 58/321 (18%)
Query: 74 HIIVTTIGGRNGQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQ 126
H + G N + TI ++ +R +G G+FG V + +G IK +
Sbjct: 3 HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62
Query: 127 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--------ETVYRV 178
E++ ++ LDHPN++ + F +D + +V+E +
Sbjct: 63 PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117
Query: 179 AKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLC 236
K S YV Q+ ALAY H V H+D+KP+N+L + +K+
Sbjct: 118 GKALSEG-------YVAELMKQMMNALAYFH-SQHVVHKDLKPENILFQDTSPHSPIKII 169
Query: 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
DFG A++ E + + + Y APE+ + T DIWS G V+ LL G F G
Sbjct: 170 DFGLAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTG 227
Query: 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 356
S + + E + + P+AVDL+ +
Sbjct: 228 TSLEEVQQKATYK-----------------EPNYAV---ECRP------LTPQAVDLLKQ 261
Query: 357 LLQYSPNLRCTALEACIHPFF 377
+L P R +A + H +F
Sbjct: 262 MLTKDPERRPSAAQVLHHEWF 282
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 3e-48
Identities = 77/296 (26%), Positives = 129/296 (43%), Gaps = 56/296 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----RELQTMRLLDHPNVVS 148
++ V+G G+F VF K TG+ A+K + + +++ E+ ++ + H N+V+
Sbjct: 11 FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYR-VAK-HYS--RASQRMPLIYVKLYTYQIC 202
L+ + Y LV++ V E R + + Y+ AS Q+
Sbjct: 71 LEDIY---ESTTHYY--LVMQLVSGGELFDRILERGVYTEKDASL---------VIQQVL 116
Query: 203 RALAYIHGGIGVCHRDIKPQNLLV-NPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYY 259
A+ Y+H G+ HRD+KP+NLL P + ++ + DFG +K+ G +S C + Y
Sbjct: 117 SAVKYLH-ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGY 173
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
APE + Y+ A+D WS+G + LL G P F E+ +I +
Sbjct: 174 VAPE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG---------- 222
Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375
++F + W I A D + LL+ PN R T +A HP
Sbjct: 223 -------YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTCEKALSHP 263
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 7e-48
Identities = 83/347 (23%), Positives = 144/347 (41%), Gaps = 64/347 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKN--------RELQTMRL 140
Y+ + +G G+ G V A +T + VAIK + + E++ ++
Sbjct: 12 YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKL 196
L+HP ++ +K+ F D ++ Y+ VLE + E +V A+ + L
Sbjct: 72 LNHPCIIKIKNFF----DAEDYYI--VLELMEGGELFDKVVGNKRLKEATCK-------L 118
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYI 254
Y YQ+ A+ Y+H G+ HRD+KP+N+L++ +K+ DFG +K+L + + +
Sbjct: 119 YFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTL 176
Query: 255 C-SRYYRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311
C + Y APE++ Y A+D WS+G +L L G P F L + I G
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG 235
Query: 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA 371
++ F W ++ +A+DLV +LL P R T EA
Sbjct: 236 ---------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTTEEA 272
Query: 372 CIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPE 418
HP+ + + N + ++ S+ P
Sbjct: 273 LRHPWLQD----EDMKRKFQDLLSEENESTALPQVLAQPSTSRKRPR 315
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 9e-48
Identities = 70/326 (21%), Positives = 122/326 (37%), Gaps = 59/326 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 142
Y +G G F +V + + TG A K + + RE+ ++ +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYT 198
HPNV++L + +K ++ L +LE V E +A+ + +
Sbjct: 73 HPNVITLHEVY---ENKTDVIL--ILELVAGGELFDFLAEKESLTEEE-------ATEFL 120
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC 255
QI + Y+H + + H D+KP+N+++ N ++K+ DFG A + G I
Sbjct: 121 KQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIF 178
Query: 256 -SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
+ + APE I D+WS+G + LL G F G++ + L + V
Sbjct: 179 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV----- 232
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
++F + A D + RLL P R T ++ H
Sbjct: 233 ------------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTIQDSLQH 272
Query: 375 PFFYELRDPNARLPNGRPFPPLFNFK 400
P+ +D L + FK
Sbjct: 273 PWIKP-KDTQQALSRKASAVNMEKFK 297
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 9e-48
Identities = 77/318 (24%), Positives = 126/318 (39%), Gaps = 21/318 (6%)
Query: 81 GGRNGQPKQTI--SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----R 133
GGR+ + + +G G FG V + +TGE VAIK+ Q+ KN
Sbjct: 2 GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN-LVLEFVP--ETVYRVAKHYSRASQRMP 190
E+Q M+ L+HPNVVS + L L +E+ + + + +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLK 119
Query: 191 LIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGE 248
++ I AL Y+H + HRD+KP+N+++ P + K+ D G AK L +GE
Sbjct: 120 EGPIRTLLSDISSALRYLH-ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178
Query: 249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308
++ + Y APEL+ +YT +D WS G + E + G F Q ++
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237
Query: 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368
+ E I + KF + P H + + +L + R T
Sbjct: 238 ---EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG--KLERWLQCMLMWHQRQRGTD 292
Query: 369 LEACIHPFFYELRDPNAR 386
+ F L +
Sbjct: 293 PQNPNVGCFQALDSILSL 310
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 1e-47
Identities = 74/297 (24%), Positives = 122/297 (41%), Gaps = 52/297 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
Y ++G+GSFG V + K T + A+K + + RE++ ++ LDHPN+
Sbjct: 24 YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYTYQIC 202
+ L +D +V E E + K +S Q+
Sbjct: 84 MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-------DAARIIKQVF 131
Query: 203 RALAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 260
+ Y+H + HRD+KP+N+L+ +K+ DFG + + I + YY
Sbjct: 132 SGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
APE++ G Y D+WS G +L LL G P F G++ D L +
Sbjct: 191 APEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------ 236
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
++ F W I +A DL+ ++L + P+LR TA + HP+
Sbjct: 237 -----GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-47
Identities = 73/312 (23%), Positives = 118/312 (37%), Gaps = 58/312 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 142
Y +G G F IV + + TG+ A K + + RE+ +R +
Sbjct: 7 YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYT 198
HPN+++L F +K ++ L +LE V E +A+ + +
Sbjct: 67 HPNIITLHDIF---ENKTDVVL--ILELVSGGELFDFLAEKESLTEDE-------ATQFL 114
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC 255
QI + Y+H + H D+KP+N+++ N ++KL DFG A + G I
Sbjct: 115 KQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172
Query: 256 -SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
+ + APE I D+WS+G + LL G F GE+ + L I V
Sbjct: 173 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV----- 226
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
+ F + A D + RLL P R T ++ H
Sbjct: 227 ------------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTIAQSLEH 266
Query: 375 PFFYELRDPNAR 386
+ +R N R
Sbjct: 267 SWIKAIRRRNVR 278
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 4e-47
Identities = 73/326 (22%), Positives = 117/326 (35%), Gaps = 59/326 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 142
Y +G G F IV + + TG A K + + RE+ +R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYT 198
H NV++L + ++ ++ L +LE V E +A+ S +
Sbjct: 74 HHNVITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC 255
QI + Y+H + H D+KP+N+++ N +KL DFG A + G I
Sbjct: 122 KQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 256 -SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
+ + APE I D+WS+G + LL G F G++ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV----- 233
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
+ F + A D + +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 375 PFFYELRDPNARLPNGRPFPPLFNFK 400
P+ D + L NF+
Sbjct: 274 PWITP-VDNQQAMVRRESVVNLENFR 298
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-47
Identities = 74/326 (22%), Positives = 119/326 (36%), Gaps = 59/326 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 142
Y +G G F IV + + TG A K + + RE+ +R +
Sbjct: 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYSRASQRMPLIYVKLYT 198
HPN+++L + ++ ++ L +LE V E +A+ S +
Sbjct: 74 HPNIITLHDVY---ENRTDVVL--ILELVSGGELFDFLAQKESLSEEE-------ATSFI 121
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC 255
QI + Y+H + H D+KP+N+++ N +KL DFG A + G I
Sbjct: 122 KQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIF 179
Query: 256 -SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
+ + APE I D+WS+G + LL G F G++ + L I V
Sbjct: 180 GTPEFVAPE-IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV----- 233
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
+ F + + A D + +LL R T EA H
Sbjct: 234 ------------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTIQEALRH 273
Query: 375 PFFYELRDPNARLPNGRPFPPLFNFK 400
P+ D + L NFK
Sbjct: 274 PWITP-VDTQQAMVRRESVVNLENFK 298
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-47
Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 51/297 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 151
Y + +G GS+ + + T A+K + + KR E++ + R HPN+++LK
Sbjct: 24 YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83
Query: 152 CFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYS--RASQRMPLIYVKLYTYQICRAL 205
+ D Y+ +V E + E + ++ + +S AS + + I + +
Sbjct: 84 VY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL---------FTITKTV 129
Query: 206 AYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 261
Y+H GV HRD+KP N+L + + +++CDFG AK L + C + + A
Sbjct: 130 EYLH-AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIKC 320
PE + Y A DIWS+G +L +L G F + ++ G
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG--------- 238
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+F W+ + A DLVS++L P+ R TA HP+
Sbjct: 239 ------KFSLS---GGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 9e-47
Identities = 88/305 (28%), Positives = 132/305 (43%), Gaps = 54/305 (17%)
Query: 84 NGQPKQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMR 139
+G + +S + E +G+G+ IV++ K T + A+K + + K E+ +
Sbjct: 44 DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYR-VAK-HYS--RASQRMPLIY 193
L HPN++ LK F E+ L VLE V E R V K +YS A+
Sbjct: 104 RLSHPNIIKLKEIF---ETPTEISL--VLELVTGGELFDRIVEKGYYSERDAAD------ 152
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNI 251
QI A+AY+H G+ HRD+KP+NLL P +K+ DFG +K++ +
Sbjct: 153 ---AVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-M 207
Query: 252 SYIC-SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310
+C + Y APE I Y +D+WSVG + LL G F E G + I
Sbjct: 208 KTVCGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL-- 264
Query: 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 370
C E+ F + W ++ A DLV +L+ P R T +
Sbjct: 265 --------NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTTFQ 302
Query: 371 ACIHP 375
A HP
Sbjct: 303 ALQHP 307
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 164 bits (415), Expect = 1e-46
Identities = 69/400 (17%), Positives = 123/400 (30%), Gaps = 101/400 (25%)
Query: 42 LPEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAE----- 96
+ E N + R E + D +V+T GQP + S + E
Sbjct: 24 IEELFNRIPQANVRTTSEYMQSAADS--------LVSTSLWNTGQPFRVESELGERPRTL 75
Query: 97 ---RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLL----- 141
V+GQ +A ETGE+ + +R + E+ +RLL
Sbjct: 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 142 --------------------DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKH 181
++ ++ +L ++ +T V
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 182 YSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241
+S + + T Q+ R LA +H G+ H ++P +++++ V L F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLVHTYLRPVDIVLDQRGG-VFLTGFEHL 253
Query: 242 KVLVKGEPNISYICSRYYRAPELI----------FGATEYTTAIDIWSVGCVLAELLLGQ 291
V+ + SR + PEL T T + D W++G V+ +
Sbjct: 254 ---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 292 PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFH--KRMPPE 349
++ + IF K +P
Sbjct: 311 LPITKDAALG-----------------------------------GSEWIFRSCKNIPQP 335
Query: 350 AVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP-NARLP 388
L+ L+Y R L+A P + +LR +A LP
Sbjct: 336 VRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-46
Identities = 68/292 (23%), Positives = 122/292 (41%), Gaps = 48/292 (16%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFF 154
++V+G G G V + TG+ A+K +L D +E+ + P++V + +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDSPKARQEVDHHWQASGGPHIVCILD-VY 91
Query: 155 STTDKDELYLNLVLEFVP------ETVYRVAKHYS--RASQRMPLIYVKLYTYQICRALA 206
+ L +++E + R + ++ A++ M I A+
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM---------RDIGTAIQ 142
Query: 207 YIHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 263
++H + HRD+KP+NLL + +KL DFG AK + + C + YY APE
Sbjct: 143 FLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE 199
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
+ G +Y + D+WS+G ++ LL G P F +G + + I+
Sbjct: 200 -VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--------RIRLG-- 248
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375
++ FP W ++ +A L+ LL+ P R T + HP
Sbjct: 249 ---QYGFP---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTITQFMNHP 289
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-46
Identities = 83/336 (24%), Positives = 136/336 (40%), Gaps = 50/336 (14%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 151
+ +V+G G G V Q T E A+ K+LQD RE++ R P++V +
Sbjct: 64 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRI-V 121
Query: 152 CFFSTTDKDELYLNLVLEFVP------ETVYRVAKHYS--RASQRMPLIYVKLYTYQICR 203
+ L +V+E + R + ++ AS+ M I
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM---------KSIGE 172
Query: 204 ALAYIHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
A+ Y+H I + HRD+KP+NLL + + +KL DFG AK + + YY A
Sbjct: 173 AIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
PE + G +Y + D+WS+G ++ LL G P F G+ + I+
Sbjct: 232 PE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-- 280
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381
+++FP W ++ E L+ LL+ P R T E HP+ +
Sbjct: 281 ---MGQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329
Query: 382 D-PNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
P L R + +++K +E+ S L
Sbjct: 330 KVPQTPLHTSRVL-KEDKERWEDVK---EEMTSALA 361
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-46
Identities = 78/300 (26%), Positives = 123/300 (41%), Gaps = 56/300 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
Y +G+G+F +V + + G+ A + K RE + RLL HPN+
Sbjct: 13 YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYS--RASQRMPLIYVKLYTYQ 200
V L +++ Y L+ + V E + +YS AS Q
Sbjct: 73 VRLHDSI---SEEGHHY--LIFDLVTGGELFEDIVAREYYSEADASH---------CIQQ 118
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SR 257
I A+ + H +GV HR++KP+NLL + VKL DFG A + + +
Sbjct: 119 ILEAVLHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
Y +PE + Y +D+W+ G +L LL+G P F E +I
Sbjct: 178 GYLSPE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA--------- 227
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ FP + W + PEA DL++++L +P+ R TA EA HP+
Sbjct: 228 --------GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITAAEALKHPWI 271
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 8e-46
Identities = 80/300 (26%), Positives = 120/300 (40%), Gaps = 57/300 (19%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
Y + +G+G+F +V + TG A K + K RE + R L HPN+
Sbjct: 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYR-VAK-HYS--RASQRMPLIYVKLYTYQ 200
V L ++ YL V + V E VA+ YS AS + Q
Sbjct: 68 VRLHDSI---QEESFHYL--VFDLVTGGELFEDIVAREFYSEADASHCI---------QQ 113
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SR 257
I ++AY H G+ HR++KP+NLL+ VKL DFG A + E +
Sbjct: 114 ILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTP 171
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
Y +PE + Y+ +DIW+ G +L LL+G P F E +I
Sbjct: 172 GYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG-------- 222
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ +P + W + PEA L+ +L +P R TA +A P+
Sbjct: 223 ---------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 265
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 8e-46
Identities = 74/303 (24%), Positives = 128/303 (42%), Gaps = 43/303 (14%)
Query: 80 IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNREL 135
+ + G + ++G G FG V + + TG +A K + ++DK E+
Sbjct: 78 VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137
Query: 136 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIY 193
M LDH N++ L F K+++ LV+E+V E R+ ++ +++
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIV--LVMEYVDGGELFDRIIDESYNLTELDTILF 192
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNIS 252
+K QIC + ++H + + H D+KP+N+L VN Q+K+ DFG A+ E
Sbjct: 193 MK----QICEGIRHMH-QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
+ + APE + + D+WSVG + LL G F G++ + L I+
Sbjct: 248 NFGTPEFLAPE-VVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC--- 303
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
+ + I EA + +S+LL + R +A EA
Sbjct: 304 --------------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISASEAL 341
Query: 373 IHP 375
HP
Sbjct: 342 KHP 344
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 9e-46
Identities = 80/299 (26%), Positives = 120/299 (40%), Gaps = 55/299 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
Y + +G+G+F +V + TG A K + K RE + R L HPN+
Sbjct: 31 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYR-VAK-HYS--RASQRMPLIYVKLYTYQ 200
V L ++ YL V + V E VA+ YS AS Q
Sbjct: 91 VRLHDSI---QEESFHYL--VFDLVTGGELFEDIVAREFYSEADASH---------CIQQ 136
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 258
I ++AY H G+ HR++KP+NLL+ VKL DFG A + E + +
Sbjct: 137 ILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG 195
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
Y +PE + Y+ +DIW+ G +L LL+G P F E +I
Sbjct: 196 YLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG--------- 245
Query: 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ +P + W + PEA L+ +L +P R TA +A P+
Sbjct: 246 --------AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITADQALKVPWI 288
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 86/334 (25%), Positives = 125/334 (37%), Gaps = 57/334 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDH 143
Y V+G+G F +V + ETG+ A+K V K + RE +L H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIY----VKLY 197
P++V L + + L +V EF+ + + + K Y Y
Sbjct: 86 PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFV-----YSEAVASHY 135
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQN-LLVNPH-THQVKLCDFGSAKVLVKGEPNISYIC 255
QI AL Y H + HRD+KP LL + + VKL FG A L +
Sbjct: 136 MRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 256 -SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
+ ++ APE + Y +D+W G +L LL G F G ++L E I
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII------ 245
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
++K W I A DLV R+L P R T EA H
Sbjct: 246 ----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITVYEALNH 287
Query: 375 PFFYELRDPNARLPNGRPFPPLFNFKPQ-ELKGA 407
P+ E ++ L F + +LKGA
Sbjct: 288 PWLKERDRYAYKIHLPETVEQLRKFNARRKLKGA 321
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 74/296 (25%), Positives = 134/296 (45%), Gaps = 45/296 (15%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-NRELQTMRLLD-HPNVVSLK 150
+ ++ +G+GSF I + ++ + A+K + + +E+ ++L + HPN+V L
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYR-VAK-HYS--RASQRMPLIYVKLYTYQICRA 204
F D+L+ LV+E + E R K H+S AS M ++ A
Sbjct: 73 EVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM---------RKLVSA 118
Query: 205 LAYIHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 261
++++H +GV HRD+KP+NLL + + + ++K+ DFG A++ + C + +Y A
Sbjct: 119 VSHMH-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAA 177
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
PE + Y + D+WS+G +L +L GQ F ++++ ++IK
Sbjct: 178 PE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG 231
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+F F W + EA DL+ LL PN R + +
Sbjct: 232 -----DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWL 274
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 6e-45
Identities = 65/384 (16%), Positives = 117/384 (30%), Gaps = 90/384 (23%)
Query: 76 IVTTIGGRNGQPKQTISYMAER--------VVGQGSFGIVFQAKCLETGETVAIKKVLQD 127
+V+T GQP + S + ER V+GQ +A ETGE+ +
Sbjct: 55 LVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 114
Query: 128 KRYKN-------RELQTMRLL-------------------------DHPNVVSLKHCFFS 155
+R + E+ +RLL ++ ++
Sbjct: 115 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 174
Query: 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 215
+L ++ +T V +S + + T Q+ R LA +H G+
Sbjct: 175 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLV 233
Query: 216 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY----YRAPELIFGA--- 268
H ++P +++++ V L F G +S I + A ++
Sbjct: 234 HTYLRPVDIVLDQRGG-VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHH 290
Query: 269 -TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
T T A D W++G + + ++ +
Sbjct: 291 PTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS------------------------ 326
Query: 328 FKFPQIKAHPWHKIFH--KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD-PN 384
IF K +P L+ L+Y R L+A P + +LR +
Sbjct: 327 -----------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 375
Query: 385 ARLPNGRPFPPLFNFKPQELKGAS 408
A LP + G S
Sbjct: 376 AALPLYQTDGEPTREGGAPPSGTS 399
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-44
Identities = 68/311 (21%), Positives = 118/311 (37%), Gaps = 56/311 (18%)
Query: 94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 146
+ + +G+G F +V Q TG+ A K + + +R ++ E+ + L P V
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP------ETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
++L + + E+ L +LE+ + +A+ S V Q
Sbjct: 92 INLHEVY---ENTSEIIL--ILEYAAGGEIFSLCLPELAEMVSEN-------DVIRLIKQ 139
Query: 201 ICRALAYIHGGIGVCHRDIKPQN-LLVNPH-THQVKLCDFGSAKVLVKGEPNISYIC-SR 257
I + Y+H + H D+KPQN LL + + +K+ DFG ++ + + I +
Sbjct: 140 ILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTP 197
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
Y APE I TTA D+W++G + LL F GE + + I +V
Sbjct: 198 EYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-------- 248
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ + + A D + LL +P R TA H +
Sbjct: 249 ---------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291
Query: 378 YELRDPNARLP 388
+ N P
Sbjct: 292 QQWDFENLFHP 302
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-43
Identities = 73/311 (23%), Positives = 125/311 (40%), Gaps = 68/311 (21%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK------------KVLQDKRYK-NRELQTMR 139
Y + ++G+G +V + T + A+K + +Q+ R +E+ +R
Sbjct: 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 140 LLD-HPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYS--RASQRMPLI 192
+ HPN++ LK + + + LV + + E + + S + M
Sbjct: 79 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM--- 130
Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
+ + +H + + HRD+KP+N+L++ + +KL DFG + L GE +
Sbjct: 131 ------RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK-LR 181
Query: 253 YIC-SRYYRAPELIFGATE-----YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 306
+C + Y APE+I + Y +D+WS G ++ LL G P F + L I
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241
Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC 366
+ ++F + W DLVSR L P R
Sbjct: 242 MSG-----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRY 276
Query: 367 TALEACIHPFF 377
TA EA HPFF
Sbjct: 277 TAEEALAHPFF 287
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-43
Identities = 79/310 (25%), Positives = 127/310 (40%), Gaps = 56/310 (18%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIK----KVLQDKRYKNRELQTM-RLLDHPNVVSLK 150
E V+G+G+ V L T + A+K + + RE++ + + H NV+ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 151 HCFFSTTDKDELYLNLVLEFVP--ETVYRVAK--HYS--RASQRMPLIYVKLYTYQICRA 204
F ++E LV E + + + K H++ AS + + A
Sbjct: 78 EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV---------QDVASA 123
Query: 205 LAYIHGGIGVCHRDIKPQNLL-VNP-HTHQVKLCDFGSAKVLVKGE-------PNISYIC 255
L ++H G+ HRD+KP+N+L +P VK+CDF + P + C
Sbjct: 124 LDFLH-NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 256 -SRYYRAPELI----FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310
S Y APE++ A+ Y D+WS+G +L LL G P F G G D + +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 311 GTPTR---EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
E I+ +++FP W I A DL+S+LL R +
Sbjct: 243 PACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRLS 289
Query: 368 ALEACIHPFF 377
A + HP+
Sbjct: 290 AAQVLQHPWV 299
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-42
Identities = 68/314 (21%), Positives = 122/314 (38%), Gaps = 39/314 (12%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQTMRLLDHPNVVSLKHC 152
+G G+ G+VF+ +G +A K + ++ RELQ + + P +V
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 153 FFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
F+S + +++ +E + + V + A R+P + + + + L Y+
Sbjct: 100 FYSDGE-----ISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVSIAVIKGLTYL 147
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
+ HRD+KP N+LVN ++KLCDFG + L+ N S++ +R Y +PE + G
Sbjct: 148 REKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGT 205
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
Y+ DIWS+G L E+ +G+ P + + + E
Sbjct: 206 H-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 329 KFPQIKAHPWHKIF---------------HKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
+ + P IF E D V++ L +P R + +
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
Query: 374 HPFFYELRDPNARL 387
H F
Sbjct: 325 HAFIKRSDAEEVDF 338
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 4e-42
Identities = 73/310 (23%), Positives = 127/310 (40%), Gaps = 67/310 (21%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------------RELQTMRL 140
Y + V+G+G +V + TG A+K + + RE +R
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 141 L-DHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYR-VAK-HYS--RASQRMPLIY 193
+ HP++++L + ++L V + + E K S M
Sbjct: 156 VAGHPHIITLIDSY---ESSSFMFL--VFDLMRKGELFDYLTEKVALSEKETRSIM---- 206
Query: 194 VKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
+ A++++H + HRD+KP+N+L++ + Q++L DFG + L GE +
Sbjct: 207 -----RSLLEAVSFLHA-NNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LRE 258
Query: 254 IC-SRYYRAPELIFGATE-----YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
+C + Y APE++ + + Y +D+W+ G +L LL G P F + L I+
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318
Query: 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
+ +++F + W DL+SRLLQ P R T
Sbjct: 319 EG-----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLT 353
Query: 368 ALEACIHPFF 377
A +A HPFF
Sbjct: 354 AEQALQHPFF 363
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-42
Identities = 81/305 (26%), Positives = 125/305 (40%), Gaps = 72/305 (23%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 149
+++G+GSF V A+ L T AIK ++++ Y RE M LDHP V L
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
F D ++LY L + E + Y R + YT +I AL Y
Sbjct: 96 YFTF---QDDEKLY--FGLSYAKNGELLK-----YIRKIGSFDETCTRFYTAEIVSALEY 145
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------YICSRY 258
+H G G+ HRD+KP+N+L+N H +++ DFG+AKVL Y+
Sbjct: 146 LH-GKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV---- 199
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
+PEL+ + D+W++GC++ +L+ G P F + + + I
Sbjct: 200 --SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKII---------- 245
Query: 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP------NLRCTALEAC 372
E+ FP ++ P+A DLV +LL
Sbjct: 246 ------KLEYDFP------------EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287
Query: 373 IHPFF 377
HPFF
Sbjct: 288 AHPFF 292
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-41
Identities = 76/324 (23%), Positives = 127/324 (39%), Gaps = 59/324 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN---RELQTMRLLDHP 144
Y+ ++G+GS+G V + ET A+K K+ + + +E+Q +R L H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
NV+ L ++ + +Y +V+E+ E + V + R P+ Y Q
Sbjct: 67 NVIQLVDVLYNEEKQK-MY--MVMEYCVCGMQEMLDSVPEK------RFPVCQAHGYFCQ 117
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SR 257
+ L Y+H G+ H+DIKP NLL+ +K+ G A+ L + S
Sbjct: 118 LIDGLEYLH-SQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 258 YYRAPELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
++ PE+ G ++ +DIWS G L + G F G++ I L E
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKL----FE 223
Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
I + P P DL+ +L+Y P R + + H +
Sbjct: 224 NIG-----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266
Query: 377 FYELRDPNARLPNGRPFPPLFNFK 400
F + P P PP + K
Sbjct: 267 FRKKHPPAEAPV---PIPPSPDTK 287
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 70/294 (23%), Positives = 112/294 (38%), Gaps = 66/294 (22%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 151
+ +V+G G G V Q T E A+ K+LQD RE++ R P++V +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 152 CFFSTTDKDELYLNLVLEFVP------ETVYRVAKHYS--RASQRMPLIYVKLYTYQICR 203
+ L +V+E + R + ++ AS+ M I
Sbjct: 79 -VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM---------KSIGE 128
Query: 204 ALAYIHGGIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
A+ Y+H I + HRD+KP+NLL + + +KL DFG AK
Sbjct: 129 AIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE-------------- 173
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
+Y + D+WS+G ++ LL G P F G+ + I+
Sbjct: 174 --------KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------TRIR-- 215
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375
+++FP W ++ E L+ LL+ P R T E HP
Sbjct: 216 ---MGQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTITEFMNHP 258
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-41
Identities = 83/363 (22%), Positives = 141/363 (38%), Gaps = 71/363 (19%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 149
+V+G+G+FG V K + A+K ++L+ E + D + +L
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
+ F D + LY LV+++ + + S+ R+P + Y ++ A+
Sbjct: 140 HYAF---QDDNNLY--LVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-YRAPELI 265
+H + HRDIKP N+L++ + H ++L DFGS L++ S Y +PE++
Sbjct: 191 VH-QLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 266 ----FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
G Y D WS+G + E+L G+ F ES + + I M
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------M 294
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPN-LRCT-ALEACIHPFFYE 379
N F+FP + A DL+ RL+ + L + HPFF
Sbjct: 295 NHK-ERFQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344
Query: 380 -----LRDPNARLPNGRPFPP-------LFNFKPQELKGASKE-LLSKLIPEHARKQCPF 426
+R+ A P+ P NF + + E + + PF
Sbjct: 345 IDWDNIRNCEA------PYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPF 398
Query: 427 LGF 429
+GF
Sbjct: 399 VGF 401
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 8e-41
Identities = 71/294 (24%), Positives = 118/294 (40%), Gaps = 46/294 (15%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 147
Y + +G G+FG+ + T E VA+K + + RE+ R L HPN+V
Sbjct: 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
K + T L +++E+ E R+ R + + Q+ +
Sbjct: 80 RFKEVILTPTH---LA--IIMEYASGGELYERICNA-----GRFSEDEARFFFQQLLSGV 129
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 264
+Y H + +CHRD+K +N L++ ++K+CDFG +K V S + + Y APE+
Sbjct: 130 SYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188
Query: 265 IFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
+ EY D+WS G L +L+G F T + I +
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV-- 237
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
++ P R+ PE L+SR+ P R + E H +F
Sbjct: 238 ---KYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 8e-41
Identities = 88/377 (23%), Positives = 138/377 (36%), Gaps = 92/377 (24%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKK-----VLQDKR--YKNRELQTMRLLDHPNVVSL 149
+V+G+G+F V K +TG+ A+K +L+ E + D + L
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
F D++ LYL V+E+ + + S+ +R+P + Y +I A+
Sbjct: 127 HFAF---QDENYLYL--VMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--------YICSRYY 259
+H +G HRDIKP N+L++ H ++L DFGS L S Y+
Sbjct: 178 VHR-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230
Query: 260 RAPELI------FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
+PE++ G Y D W++G E+ GQ F +S + I
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------ 282
Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR---CTALE 370
++ P + +P EA D + RLL P R A +
Sbjct: 283 -------VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGD 324
Query: 371 ACIHPFFYE-----LRDPNARLPNGRPFPPLF-------NF------KPQELKGASKELL 412
HPFF+ LRD PF P F NF + G + L
Sbjct: 325 FRTHPFFFGLDWDGLRDSVP------PFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLS 378
Query: 413 SKLIPEHARKQCPFLGF 429
PF+G+
Sbjct: 379 DIREGAPLGVHLPFVGY 395
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-41
Identities = 71/320 (22%), Positives = 121/320 (37%), Gaps = 73/320 (22%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--------------- 132
Y + +G+GS+G+V A A+K K+++ +
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 133 ----------RELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAK 180
+E+ ++ LDHPNVV L ++D LY+ V E V V V
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFELVNQGP-VMEVPT 130
Query: 181 HYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240
+ + + Y + + + Y+H + HRDIKP NLLV +K+ DFG
Sbjct: 131 L-----KPLSEDQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVG-EDGHIKIADFGV 183
Query: 241 AKVLVKGEPNISYIC-SRYYRAPELIFGAT-EYT-TAIDIWSVGCVLAELLLGQPLFPGE 297
+ + +S + + APE + ++ A+D+W++G L + GQ F E
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
+ L IK +FP + + DL++R+
Sbjct: 244 R-IMCLHSKIK----------------SQALEFPD----------QPDIAEDLKDLITRM 276
Query: 358 LQYSPNLRCTALEACIHPFF 377
L +P R E +HP+
Sbjct: 277 LDKNPESRIVVPEIKLHPWV 296
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-40
Identities = 73/295 (24%), Positives = 131/295 (44%), Gaps = 54/295 (18%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 149
R +G+GSFG V + +T + A+K K ++ R +ELQ M+ L+HP +V+L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
+ F D+++++ +V++ + + Y H + + VKL+ ++ AL Y
Sbjct: 81 WYSF---QDEEDMF--MVVDLLLGGDLRY----HLQQ-NVHFKEETVKLFICELVMALDY 130
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF- 266
+ + HRD+KP N+L++ H H V + DF A +L + + ++ Y APE+
Sbjct: 131 LQ-NQRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 267 -GATEYTTAIDIWSVGCVLAELLLGQPLFPGESG--VDQLVEIIKVLGTPTREEIKCMNP 323
Y+ A+D WS+G ELL G+ + S ++V +
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------------- 233
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-HPFF 377
T +P E V L+ +LL+ +P+ R + L P+
Sbjct: 234 -TTVVTYPS------------AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-40
Identities = 82/361 (22%), Positives = 139/361 (38%), Gaps = 74/361 (20%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRE-----------LQTMRLLDHPN 145
R++G+G FG V+ + +TG+ A+K L KR K ++ L + D P
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
+V + + F D+L +L+ + + Y +++H ++ Y +I
Sbjct: 254 IVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 303
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263
L ++H V +RD+KP N+L++ H H V++ D G A K +P+ + + + Y APE
Sbjct: 304 GLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
++ Y ++ D +S+GC+L +LL G F D + EI
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI----- 402
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR--CT---ALEACIHPFFY 378
PE L+ LLQ N R C A E PFF
Sbjct: 403 ------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF- 453
Query: 379 ELRDPN-ARLPNGRPFPPLFNFKPQELKGASKELL---------SKLIPEHARKQCPFLG 428
R + + + PP P + + + +K I Q +
Sbjct: 454 --RSLDWQMVFLQKYPPP---LIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRN 508
Query: 429 F 429
F
Sbjct: 509 F 509
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 72/289 (24%), Positives = 125/289 (43%), Gaps = 41/289 (14%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQ-TMRLLDHPNVVSLKH 151
+G+G++G+V + + + +G+ +A+K++ + + K +L +MR +D P V+
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
F D + + +E + ++ + K Q +P + I +AL ++H
Sbjct: 74 ALFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG---A 268
+ V HRD+KP N+L+N QVK+CDFG + LV + Y APE I
Sbjct: 129 LSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQ 187
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
Y+ DIWS+G + EL + + + Q ++ + V
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS--------------- 231
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
PQ+ A + E VD S+ L+ + R T E HPFF
Sbjct: 232 --PQLPADKF--------SAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 71/296 (23%), Positives = 123/296 (41%), Gaps = 50/296 (16%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
+ + +G+G++G V A T E VA+K V + +E+ ++L+H NVV
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
Y L LE+ E R+ MP + + +Q+ +
Sbjct: 69 KFYGHRREGNI---QY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 262
Y+H GIG+ HRDIKP+NLL++ +K+ DFG A V ++ +C + Y AP
Sbjct: 119 VYLH-GIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 263 ELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
EL+ E+ +D+WS G VL +L G+ + DQ + + ++
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
PW K + + L+ ++L +P+ R T + ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-39
Identities = 91/323 (28%), Positives = 139/323 (43%), Gaps = 61/323 (18%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 148
RV+G+G FG V + TG+ A K L+ KR K R E Q + ++ VVS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACK-KLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRM-PLIYVKLYTYQICRAL 205
L + + + KD L L VL + + + H Q P Y +IC L
Sbjct: 249 LAYAYET---KDALCL--VLTLMNGGDLKF----HIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
+H + +RD+KP+N+L++ H H +++ D G A + +G+ + + Y APE++
Sbjct: 300 EDLHR-ERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
YT + D W++GC+L E++ GQ F REE+
Sbjct: 358 KN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRK------------KKIKREEV------- 397
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFYEL 380
+K P + + +R P+A L S+LL P R +A E HP F
Sbjct: 398 ----ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF--- 448
Query: 381 RDPN-ARLPNGRPFPPLFNFKPQ 402
+ N RL G PP FKP
Sbjct: 449 KKLNFKRLGAGMLEPP---FKPD 468
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 7e-39
Identities = 94/382 (24%), Positives = 160/382 (41%), Gaps = 72/382 (18%)
Query: 43 PEEINEMKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTIS---YMAERVV 99
E ++ + ++K+ A + +G+ + + + +PK ++ + +++
Sbjct: 97 EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLL 156
Query: 100 GQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNVVSL 149
G+G+FG V K TG A+K ++ NR LQ R HP + +L
Sbjct: 157 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTAL 213
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
K+ F T D+ L V+E+ E + H SR + + Y +I AL Y
Sbjct: 214 KYSF-QTHDR--LCF--VMEYANGGELFF----HLSR-ERVFSEDRARFYGAEIVSALDY 263
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 266
+H V +RD+K +NL+++ H +K+ DFG K +K + C + Y APE++
Sbjct: 264 LHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 322
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
+Y A+D W +G V+ E++ G+ F + ++L E+I
Sbjct: 323 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL----------------ME 364
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFYELR 381
E +FP + + PEA L+S LL+ P R A E H FF
Sbjct: 365 EIRFP------------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF---A 409
Query: 382 DPN-ARLPNGRPFPPLFNFKPQ 402
+ + PP FKPQ
Sbjct: 410 GIVWQHVYEKKLSPP---FKPQ 428
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-39
Identities = 71/296 (23%), Positives = 123/296 (41%), Gaps = 50/296 (16%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
+ + +G+G++G V A T E VA+K V + +E+ ++L+H NVV
Sbjct: 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
Y L LE+ E R+ MP + + +Q+ +
Sbjct: 69 KFYGHRREGNI---QY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 262
Y+H GIG+ HRDIKP+NLL++ +K+ DFG A V ++ +C + Y AP
Sbjct: 119 VYLH-GIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 263 ELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
EL+ E+ +D+WS G VL +L G+ + DQ + + ++
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
PW K + + L+ ++L +P+ R T + ++
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARITIPDIKKDRWY 265
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 76/323 (23%), Positives = 126/323 (39%), Gaps = 58/323 (17%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 148
RV+G+G FG VF + TG+ A K L KR K R E + + + +VS
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACK-KLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
L + F + K +L L V+ + + Y + + YT QI L
Sbjct: 250 LAYAFET---KTDLCL--VMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLE 303
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 265
++H + +RD+KP+N+L++ + V++ D G A L G+ + + APEL+
Sbjct: 304 HLHQ-RNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
G EY ++D +++G L E++ + F +E+
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPFRARG------------EKVENKEL------- 401
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFYEL 380
++ + + P + D LLQ P R + HP F
Sbjct: 402 ----KQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF--- 452
Query: 381 RDPN-ARLPNGRPFPPLFNFKPQ 402
RD + +L G PP F P
Sbjct: 453 RDISWRQLEAGMLTPP---FVPD 472
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 142 bits (358), Expect = 1e-38
Identities = 37/309 (11%), Positives = 91/309 (29%), Gaps = 64/309 (20%)
Query: 92 SYMAERVVGQGSFGIVFQAKC-----LETGETVAIK----KVLQDKRYKNRELQTMRLLD 142
++G+G+F V++A + + +K + + ++ ++
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
+ ++ L V E + + + + + MP V + +
Sbjct: 126 QHMFMKFYSAHL---FQNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ----------VKLCDFGSA---KVLVKG 247
+ + +H + H DIKP N ++ + + L D G + K+ KG
Sbjct: 181 MLYMIEQVHD-CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 248 EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
+ + ++ E++ + ID + V + +L G + G
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG-------- 290
Query: 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
+ + + W++ FH +L
Sbjct: 291 ------GECKPEGLFRRL-------PHLDMWNEFFHV------------MLNIPDCHHLP 325
Query: 368 ALEACIHPF 376
+L+
Sbjct: 326 SLDLLRQKL 334
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-38
Identities = 77/318 (24%), Positives = 132/318 (41%), Gaps = 57/318 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 144
Y + +G+G+F V A+ + TG VAIK + DK N RE++ M++L+HP
Sbjct: 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
N+V L + L L++E+ E + H RM + QI
Sbjct: 75 NIVKLFEVIETEKT-----LYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIV 124
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 261
A+ Y H + HRD+K +NLL++ +K+ DFG + G + C + Y A
Sbjct: 125 SAVQYCH-QKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAA 181
Query: 262 PELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
PEL G +Y +D+WS+G +L L+ G F G++ + +L E +
Sbjct: 182 PELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL------------ 227
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
+++ P + M + +L+ R L +P R T + +
Sbjct: 228 ----RGKYRIP-----FY-------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271
Query: 381 RDPNARLPNGRPFPPLFN 398
+ + P P + +
Sbjct: 272 HEEDELKPFVEPELDISD 289
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-38
Identities = 66/321 (20%), Positives = 117/321 (36%), Gaps = 67/321 (20%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN-----RELQTMRLLD 142
Y ++G G FG V+ + VAIK ++ N E+ ++ +
Sbjct: 45 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104
Query: 143 H--PNVVSLKHCFFSTTDKDELYLNLVLEFVP---ETVYRVAKHYSRASQRMPLIYVKLY 197
V+ L +F D L +LE + + + + + +
Sbjct: 105 SGFSGVIRLLD-WFER--PDSFVL--ILERPEPVQDLFDFITER-----GALQEELARSF 154
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 256
+Q+ A+ + H GV HRDIK +N+L++ + ++KL DFGS +L + +
Sbjct: 155 FWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGT 211
Query: 257 RYYRAPELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315
R Y PE I Y + +WS+G +L +++ G F + EII+
Sbjct: 212 RVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------- 257
Query: 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375
+ F +R+ E L+ L P+ R T E HP
Sbjct: 258 ----------GQVFFR------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHP 295
Query: 376 FFYELRDPNARLP-NGRPFPP 395
+ ++ P + P
Sbjct: 296 WMQDVLLPQETAEIHLHSLSP 316
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-38
Identities = 80/307 (26%), Positives = 129/307 (42%), Gaps = 52/307 (16%)
Query: 81 GGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------R 133
G ++ + Y+ +G G+FG V + TG VA+K + + K R
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 134 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPL 191
E+Q ++L HP+++ L + TD + +V+E+V E + KH R+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTD---FF--MVMEYVSGGELFDYICKH-----GRVEE 110
Query: 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 251
+ + QI A+ Y H V HRD+KP+N+L++ H K+ DFG + ++ GE +
Sbjct: 111 MEARRLFQQILSAVDYCH-RHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167
Query: 252 SYIC-SRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310
C S Y APE+I G +DIWS G +L LL G F E + L
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTL 219
Query: 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 370
++I+ F P + + L+ +LQ P R T +
Sbjct: 220 ----FKKIR-----GGVFYIP-----EY-------LNRSVATLLMHMLQVDPLKRATIKD 258
Query: 371 ACIHPFF 377
H +F
Sbjct: 259 IREHEWF 265
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-38
Identities = 64/355 (18%), Positives = 120/355 (33%), Gaps = 103/355 (29%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
+ + +G+G FG+VF+AK AIK++ R RE++ + L+HP +V
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 148 SLKHCF----------------------------------------------------FS 155
+ +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 215
++YL + ++ + + + + + QI A+ ++H G+
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH-SKGLM 186
Query: 216 HRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------------VKGEPNISYICSRYYRAP 262
HRD+KP N+ VK+ DFG + + + ++ Y +P
Sbjct: 187 HRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
E I G Y+ +DI+S+G +L ELL F + +++ ++
Sbjct: 246 EQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR-------------- 287
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
KFP +F ++ P E +V +L SP R A + + F
Sbjct: 288 ----NLKFP--------LLFTQKYPQEH-MMVQDMLSPSPTERPEATDIIENAIF 329
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 83/322 (25%), Positives = 137/322 (42%), Gaps = 64/322 (19%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 149
+++G+G+FG V + TG A+K ++ + E + ++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
K+ F T D+ L V+E+ E + H SR + + Y +I AL Y
Sbjct: 71 KYAF-QTHDR--LCF--VMEYANGGELFF----HLSR-ERVFTEERARFYGAEIVSALEY 120
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIF 266
+H V +RDIK +NL+++ H +K+ DFG K + + C Y APE++
Sbjct: 121 LHS-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
+Y A+D W +G V+ E++ G+ F + ++L E+I
Sbjct: 179 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL----------------ME 220
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFYELR 381
E +FP + + PEA L++ LL+ P R A E H FF
Sbjct: 221 EIRFP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF---L 265
Query: 382 DPN-ARLPNGRPFPPLFNFKPQ 402
N + + PP FKPQ
Sbjct: 266 SINWQDVVQKKLLPP---FKPQ 284
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-37
Identities = 74/324 (22%), Positives = 118/324 (36%), Gaps = 70/324 (21%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN-----RELQTMRLLD 142
Y ++G+G FG VF L VAIK +VL + E+ + +
Sbjct: 33 YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 143 ----HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETV----YRVAKHYSRASQRMPLIYV 194
HP V+ L +F T ++ L VLE Y K +
Sbjct: 93 AGGGHPGVIRL-LDWFET--QEGFML--VLERPLPAQDLFDYITEK------GPLGEGPS 141
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
+ + Q+ A+ + H GV HRDIK +N+L++ KL DFGS +L +
Sbjct: 142 RCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDF 198
Query: 255 C-SRYYRAPELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
+R Y PE I +Y +WS+G +L +++ G F + EI++
Sbjct: 199 DGTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA--- 248
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
E FP + P+ L+ R L P+ R + E
Sbjct: 249 --------------ELHFP------------AHVSPDCCALIRRCLAPKPSSRPSLEEIL 282
Query: 373 IHPFFYELRDPNARLPNGRPFPPL 396
+ P+ + P+ PL
Sbjct: 283 LDPWMQTPAEDVPLNPSKGGPAPL 306
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 91/367 (24%), Positives = 139/367 (37%), Gaps = 83/367 (22%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 149
+V+G+G+FG V + T + A+K ++++ + E M + P VV L
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
+ F +D+ YL +V+E++P + V S +P + + YT ++ AL
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGDLVN----LMSN--YDVPEKWARFYTAEVVLALDA 183
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--------YICSRYY 259
IH +G HRD+KP N+L++ H +KL DFG+ + K YI
Sbjct: 184 IH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236
Query: 260 RAPELIF---GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316
+PE++ G Y D WSVG L E+L+G F +S LV
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYS-------- 283
Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT---ALEACI 373
K MN FP + EA +L+ L +R E
Sbjct: 284 --KIMNHK-NSLTFP----------DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKR 329
Query: 374 HPFFYEL--RDPNAR--LPNGRPFPPLF-------NFKPQELKGASKELLSKLIPEHARK 422
H FF R + P P NF E +E +
Sbjct: 330 HLFFKNDQWAWETLRDTVA---PVVPDLSSDIDTSNFDDLEED-KGEEETFPIPKAFVGN 385
Query: 423 QCPFLGF 429
Q PF+GF
Sbjct: 386 QLPFVGF 392
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 75/294 (25%), Positives = 128/294 (43%), Gaps = 51/294 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPN 145
Y+ +G+GSFG V A +T + VA+K + + + RE+ ++LL HP+
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
++ L + TD + +V+E+ E + + +RM + + QI A
Sbjct: 71 IIKLYDVITTPTD---IV--MVIEYAGGELFDYIVEK-----KRMTEDEGRRFFQQIICA 120
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 263
+ Y H + HRD+KP+NLL++ + VK+ DFG + ++ G + C S Y APE
Sbjct: 121 IEYCH-RHKIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPE 177
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
+I G +D+WS G VL +L+G+ F E + L + +
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN--------------- 221
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ P + + P A L+ R++ P R T E P+F
Sbjct: 222 -SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 72/292 (24%), Positives = 119/292 (40%), Gaps = 43/292 (14%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKH 151
+G+G++G V + +G+ +A+K++ + +K K +L MR D P +V
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 152 CFFSTTDKDELYLNLVLEFVP---ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
F D + +E + + Y+ YS +P + T +AL ++
Sbjct: 89 ALFREGD-----CWICMELMSTSFDKFYK--YVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
+ + HRDIKP N+L++ + +KLCDFG + LV R Y APE I +
Sbjct: 142 KENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 269 TE---YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
Y D+WS+G L EL G+ +P + V + + V G P
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP------------ 247
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
PQ+ + F P ++ V+ L + R E HPF
Sbjct: 248 -----PQLSNSEERE-F----SPSFINFVNLCLTKDESKRPKYKELLKHPFI 289
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 67/301 (22%), Positives = 111/301 (36%), Gaps = 46/301 (15%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKH 151
+G G+ G V++ + +TG +A+K++ + K +L ++ D P +V
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
F + TD + + +E + K R +P + T I +AL Y+
Sbjct: 92 TFITNTD-----VFIAMELMGTCA---EKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI----FG 267
GV HRD+KP N+L++ Q+KLCDFG + LV + Y APE I
Sbjct: 144 HGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEIKCMNPNYT 326
+Y D+WS+G L EL GQ + + L ++++ P
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--EEP------------- 247
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNAR 386
P + H + V L R + H F
Sbjct: 248 ----PLLPG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVD 296
Query: 387 L 387
+
Sbjct: 297 V 297
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 67/303 (22%), Positives = 115/303 (37%), Gaps = 68/303 (22%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN-------RELQTMRL 140
Y +G G+FG V+ A E + V +K KVL+D ++ E+ +
Sbjct: 26 YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 141 LDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETV----YRVAKHYSRASQRMPLIYVKL 196
++H N++ + F ++ LV+E + + R+
Sbjct: 86 VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLDLFAFIDRH------PRLDEPLASY 134
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC- 255
Q+ A+ Y+ + HRDIK +N+++ +KL DFGSA L +G+ C
Sbjct: 135 IFRQLVSAVGYLRLK-DIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCG 191
Query: 256 SRYYRAPELIFGATEYT-TAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
+ Y APE++ G Y +++WS+G L L+ + F +L E ++
Sbjct: 192 TIEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------ 238
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
P + E + LVS LLQ P R T +
Sbjct: 239 -----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTTLEKLVTD 275
Query: 375 PFF 377
P+
Sbjct: 276 PWV 278
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-36
Identities = 84/324 (25%), Positives = 137/324 (42%), Gaps = 66/324 (20%)
Query: 97 RVVGQGSFGIVFQAK---CLETGETVAIKKVLQDKRYKNRELQTM---RLL---DHPNVV 147
+V+GQGSFG VF K + + A+K + + ++T +L +HP +V
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
L + F T K LYL +L+F+ + R++K VK Y ++ AL
Sbjct: 90 KLHYAF-QTEGK--LYL--ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALAL 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 264
++H +G+ +RD+KP+N+L++ H +KL DFG +K + E C + Y APE+
Sbjct: 140 DHLHS-LGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
+ +T + D WS G ++ E+L G F G+ + + +I
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMIL---------------- 239
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFYE 379
+ PQ + PEA L+ L + +P R E H FF
Sbjct: 240 KAKLGMPQ------------FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF-- 285
Query: 380 LRDPN-ARLPNGRPFPPLFNFKPQ 402
+ +L PP FKP
Sbjct: 286 -STIDWNKLYRREIHPP---FKPA 305
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 74/301 (24%), Positives = 124/301 (41%), Gaps = 70/301 (23%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 149
+ +G GSFG V K E+G A+K KV++ K + E + ++ ++ P +V L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
+ F KD L +V+E+V E + R R + + Y QI Y
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFS-----HLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYYRA 261
+H + + +RD+KP+NLL++ + +++ DFG AK + G P A
Sbjct: 157 LH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------ALA 206
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
PE+I Y A+D W++G ++ E+ G P F + Q+ E I +
Sbjct: 207 PEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI----------VSG- 253
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP-----NLRCTALEACIHPF 376
+ +FP + DL+ LLQ NL+ + H +
Sbjct: 254 -----KVRFP------------SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
Query: 377 F 377
F
Sbjct: 297 F 297
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-35
Identities = 85/323 (26%), Positives = 127/323 (39%), Gaps = 66/323 (20%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQ-DKRYKNRELQ-TM-------RLLDHPNVV 147
+V+G+GSFG V A+ A+ KVLQ K +E + M + + HP +V
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAV-KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
L F T DK LY VL+++ E Y H R + + Y +I AL
Sbjct: 103 GLHFS-FQTADK--LY--FVLDYINGGELFY----HLQR-ERCFLEPRARFYAAEIASAL 152
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 264
Y+H + + +RD+KP+N+L++ H + L DFG K ++ S C Y APE+
Sbjct: 153 GYLH-SLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
+ Y +D W +G VL E+L G P F + ++ + I
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL---------------- 252
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR----CTALEACIHPFFYEL 380
+ + A L+ LLQ R +E H FF
Sbjct: 253 NKPLQLK------------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF--- 297
Query: 381 RDPN-ARLPNGRPFPPLFNFKPQ 402
N L N + PP F P
Sbjct: 298 SLINWDDLINKKITPP---FNPN 317
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 88/327 (26%), Positives = 139/327 (42%), Gaps = 70/327 (21%)
Query: 97 RVVGQGSFGIVFQAKCL---ETGETVAIK---KVLQDKRYKNRELQTM---RLL---DHP 144
RV+G+G +G VFQ + + TG+ A+K K + + K+ T +L HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA-HTKAERNILEEVKHP 81
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
+V L + F T K LYL +LE++ E ++ + Y +I
Sbjct: 82 FIVDLIYAF-QTGGK--LYL--ILEYLSGGELFMQLER-----EGIFMEDTACFYLAEIS 131
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRA 261
AL ++H G+ +RD+KP+N+++N H VKL DFG K + C Y A
Sbjct: 132 MALGHLHQ-KGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
PE++ + + A+D WS+G ++ ++L G P F GE+ + ++ I
Sbjct: 190 PEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKIL------------- 234
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPF 376
+ P + EA DL+ +LL+ + R A E HPF
Sbjct: 235 ---KCKLNLP------------PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279
Query: 377 FYELRDPN-ARLPNGRPFPPLFNFKPQ 402
F R N L + PP FKP
Sbjct: 280 F---RHINWEELLARKVEPP---FKPL 300
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-35
Identities = 78/327 (23%), Positives = 135/327 (41%), Gaps = 77/327 (23%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 149
R +G GSFG V + G A+K V++ K + N E + ++ HP ++ +
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 150 KHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
F +D + ++++++ E + R SQR P K Y ++C AL Y
Sbjct: 72 WGTF-----QDAQQIFMIMDYIEGGELFSLL-----RKSQRFPNPVAKFYAAEVCLALEY 121
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYYRA 261
+H + +RD+KP+N+L++ + H +K+ DFG AK + G P+ Y A
Sbjct: 122 LH-SKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------YIA 171
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
PE++ Y +ID WS G ++ E+L G F + + E I
Sbjct: 172 PEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKIL------------- 216
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP-----NLRCTALEACIHPF 376
E +FP + DL+SRL+ NL+ + HP+
Sbjct: 217 ---NAELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261
Query: 377 FYELRDPN-ARLPNGRPFPPLFNFKPQ 402
F ++ +L + P ++P
Sbjct: 262 F---KEVVWEKLLSRNIETP---YEPP 282
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-35
Identities = 88/326 (26%), Positives = 141/326 (43%), Gaps = 70/326 (21%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 146
RV+G+GSFG V A+ ETG+ A+K +LQD + R L R +HP +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 86
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
L C F T D+ L+ V+EFV + ++ H + S+R + Y +I A
Sbjct: 87 TQLFCC-FQTPDR--LF--FVMEFVNGGDLMF----HIQK-SRRFDEARARFYAAEIISA 136
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 263
L ++H G+ +RD+K N+L++ H KL DFG K + + C Y APE
Sbjct: 137 LMFLH-DKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
++ Y A+D W++G +L E+L G F E+ D L E I
Sbjct: 195 ILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAIL--------------- 237
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR------CTALEACIHPFF 377
E +P + +A ++ + +P +R HPFF
Sbjct: 238 -NDEVVYP------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
Query: 378 YELRDPN-ARLPNGRPFPPLFNFKPQ 402
++ + A+L + + PP F+P+
Sbjct: 285 ---KEIDWAQLNHRQIEPP---FRPR 304
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 79/363 (21%), Positives = 135/363 (37%), Gaps = 84/363 (23%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLL-----DHP 144
Y R +G G F V+ + ++ + VA+K V + Y E++ ++ + + P
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 145 N---VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
N VV L F + ++ +V E + + + + Q +PL VK Q+
Sbjct: 99 NREMVVQLLDDFKISGVNGT-HICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLV----------------------------------- 226
+ L Y+H + H DIKP+N+L+
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 227 -------------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 273
N +VK+ D G+A + + I +R YR+ E++ G+ Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272
Query: 274 AIDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIKVLGTPTREEI-------KC 320
DIWS C+ EL G LF SG D + II++LG R+ I +
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMP------PEAVDLVSRLLQYSPNLRCTALEACIH 374
++K ++ ++ D + +L+ P R TA E H
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
Query: 375 PFF 377
P+
Sbjct: 393 PWL 395
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 82/325 (25%), Positives = 127/325 (39%), Gaps = 69/325 (21%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 146
V+G+GSFG V ++ T E A+K V+QD + R L P +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 83
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
L C F T D+ LY V+E+V + +Y + + R + Y +I
Sbjct: 84 TQLHSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIG 133
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 263
L ++ G+ +RD+K N++++ H +K+ DFG K + C Y APE
Sbjct: 134 LFFLQ-SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
+I Y ++D W+ G +L E+L GQ F GE D+L + I
Sbjct: 192 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM--------------- 234
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFY 378
+P K M EAV + L+ P R + H FF
Sbjct: 235 -EHNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF- 280
Query: 379 ELRDPN-ARLPNGRPFPPLFNFKPQ 402
R + +L PP +KP+
Sbjct: 281 --RYIDWEKLERKEIQPP---YKPK 300
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 78/295 (26%), Positives = 123/295 (41%), Gaps = 52/295 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPN 145
Y+ +G G+FG V K TG VA+K K+ RE+Q ++L HP+
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
++ L + +D ++ +V+E+V E + K+ R+ + QI
Sbjct: 78 IIKLYQVISTPSD---IF--MVMEYVSGGELFDYICKN-----GRLDEKESRRLFQQILS 127
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAP 262
+ Y H V HRD+KP+N+L++ H K+ DFG + ++ GE + C S Y AP
Sbjct: 128 GVDYCH-RHMVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-LRTSCGSPNYAAP 184
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
E+I G +DIWS G +L LL G F + V L + I
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC-------------- 229
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
F P + + P + L+ +LQ P R T + H +F
Sbjct: 230 --DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-35
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 18/215 (8%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 153
E VVG+G+FG+V +AK + VAIK++ + K EL+ + ++HPN+V L
Sbjct: 13 EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69
Query: 154 FSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-- 210
+ + LV+E+ ++Y V H + + + Q + +AY+H
Sbjct: 70 --CLNP----VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
+ HRD+KP NLL+ +K+CDFG+A + S + APE+ G +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG-SN 179
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVE 305
Y+ D++S G +L E++ + F G +
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM 214
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-35
Identities = 83/323 (25%), Positives = 138/323 (42%), Gaps = 69/323 (21%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 144
+++G+GSFG VF A+ +T + AIK VL D + TM R+L +HP
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLAWEHP 78
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
+ + F T + L+ V+E++ + +Y + + L Y +I
Sbjct: 79 FLTHMFCTF-QTKEN--LFF--VMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEII 128
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRA 261
L ++H G+ +RD+K N+L++ H +K+ DFG K + G+ + C Y A
Sbjct: 129 LGLQFLHS-KGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIA 186
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
PE++ G +Y ++D WS G +L E+L+GQ F G+ ++L I+
Sbjct: 187 PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR------------- 231
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA-CIHPFFYEL 380
+P + + EA DL+ +L P R HP F
Sbjct: 232 ---MDNPFYP------------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF--- 273
Query: 381 RDPN-ARLPNGRPFPPLFNFKPQ 402
R+ N L PP F+P+
Sbjct: 274 REINWEELERKEIDPP---FRPK 293
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 8e-35
Identities = 62/320 (19%), Positives = 113/320 (35%), Gaps = 44/320 (13%)
Query: 93 YMAERVVGQG--SFGIVFQAKCLETGETVAIKKV----LQDKRYKN--RELQTMRLLDHP 144
Y V+G+G V A+ TGE V ++++ ++ EL +L +HP
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
N+V + F + +EL+ +V F+ + + + M + + + +
Sbjct: 87 NIVPYRATFIA---DNELW--VVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLK 139
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--------KVLVKGEPNISYIC 255
AL YIH +G HR +K ++L++ +V L S + V + +
Sbjct: 140 ALDYIH-HMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 256 SRYYRAPELIF-GATEYTTAIDIWSVGCVLAELLLGQP----------LF-------PGE 297
+ +PE++ Y DI+SVG EL G L P
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257
Query: 298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRL 357
+ + ++ + T +H+ P V +
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317
Query: 358 LQYSPNLRCTALEACIHPFF 377
LQ +P+ R +A H FF
Sbjct: 318 LQRNPDARPSASTLLNHSFF 337
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-35
Identities = 76/303 (25%), Positives = 119/303 (39%), Gaps = 46/303 (15%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
Y + V+G G+ +V A C E VAIK++ +K + +E+Q M HPN+V
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 148 SLKHCFFSTTDKDELYLNLVLEF-----VPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
S F KDEL+ LV++ V + + + S + + ++
Sbjct: 77 SYYTSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSR---- 257
L Y+H G HRD+K N+L+ V++ DFG SA + G+ + R
Sbjct: 132 EGLEYLH-KNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFV 187
Query: 258 ---YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
+ APE++ Y DIWS G EL G + + L+ ++
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ------ 241
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
N P ++ K K+ ++S LQ P R TA E H
Sbjct: 242 -------ND------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288
Query: 375 PFF 377
FF
Sbjct: 289 KFF 291
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 85/329 (25%), Positives = 145/329 (44%), Gaps = 66/329 (20%)
Query: 97 RVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDKRYKNREL--QTM---RLL----DHP 144
+V+G G++G VF + + +TG+ A+K + + + + T ++L P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
+V+L + F + +L+L +L+++ E +++ +R V++Y +I
Sbjct: 120 FLVTLHYAF---QTETKLHL--ILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIV 169
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-IC-SRYYR 260
AL ++H +G+ +RDIK +N+L++ + H V L DFG +K V E +Y C + Y
Sbjct: 170 LALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 261 APELIFGATE-YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
AP+++ G + A+D WS+G ++ ELL G F + + EI I
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--------RRIL 279
Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIH 374
+E +PQ M A DL+ RLL P R A E H
Sbjct: 280 -----KSEPPYPQ------------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322
Query: 375 PFFYELRDPN-ARLPNGRPFPPLFNFKPQ 402
FF + N L + P FKP
Sbjct: 323 LFF---QKINWDDLAAKKVPAP---FKPV 345
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-33
Identities = 73/328 (22%), Positives = 136/328 (41%), Gaps = 65/328 (19%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 144
RV+G+GS+ V + +T A+K V D+ + +HP
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID----WVQTEKHVFEQASNHP 70
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
+V L C F T + L+ V+E+V + ++ + + +++P + + Y+ +I
Sbjct: 71 FLVGLHSC-FQTESR--LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEIS 120
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 261
AL Y+H G+ +RD+K N+L++ H +KL D+G K ++ S C + Y A
Sbjct: 121 LALNYLH-ERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
PE++ G +Y ++D W++G ++ E++ G+ F D + T + +
Sbjct: 179 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 227
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR------CTALEACIHP 375
F I + + +A ++ L P R + HP
Sbjct: 228 --------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277
Query: 376 FFYELRDPN-ARLPNGRPFPPLFNFKPQ 402
FF R+ + + + PP FKP
Sbjct: 278 FF---RNVDWDMMEQKQVVPP---FKPN 299
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-33
Identities = 73/328 (22%), Positives = 136/328 (41%), Gaps = 65/328 (19%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 144
RV+G+GS+ V + +T A++ V D+ + +HP
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDID----WVQTEKHVFEQASNHP 113
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
+V L C F T + L+ V+E+V + ++ + + +++P + + Y+ +I
Sbjct: 114 FLVGLHSC-FQTESR--LF--FVIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEIS 163
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 261
AL Y+H G+ +RD+K N+L++ H +KL D+G K ++ S C + Y A
Sbjct: 164 LALNYLH-ERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
PE++ G +Y ++D W++G ++ E++ G+ F D + T + +
Sbjct: 222 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 270
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR--CTALEACI----HP 375
F I + + +A ++ L P R C HP
Sbjct: 271 --------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320
Query: 376 FFYELRDPN-ARLPNGRPFPPLFNFKPQ 402
FF R+ + + + PP FKP
Sbjct: 321 FF---RNVDWDMMEQKQVVPP---FKPN 342
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 49/224 (21%), Positives = 85/224 (37%), Gaps = 30/224 (13%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHP 144
E+ +G+G FG+V + + ++ VAIK ++ RE+ M L+HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
N+V L + +V+EFVP +Y + + I
Sbjct: 84 NIVKLYGL---MHNP----PRMVMEFVPCGDLYHR---LLDKAHPIKWSVKLRLMLDIAL 133
Query: 204 ALAYIHG-GIGVCHRDIKPQNLLVNPHTHQ----VKLCDFGSAKVLVKGEPNISYICSRY 258
+ Y+ + HRD++ N+ + K+ DFG ++ + +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191
Query: 259 YRAPELIFGATE-YTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301
+ APE I E YT D +S +L +L G+ F S
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 82/325 (25%), Positives = 128/325 (39%), Gaps = 69/325 (21%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 146
V+G+GSFG V ++ T E A+K V+QD + R L P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 404
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
L CF T D+ LY V+E+V + +Y + + R + Y +I
Sbjct: 405 TQLHSCF-QTMDR--LYF--VMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIG 454
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 263
L ++ G+ +RD+K N++++ H +K+ DFG K + C + Y APE
Sbjct: 455 LFFLQS-KGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
+I Y ++D W+ G +L E+L GQ F GE D+L + I
Sbjct: 513 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIM--------------- 555
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFY 378
+P K M EAV + L+ P R + H FF
Sbjct: 556 -EHNVAYP------------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF- 601
Query: 379 ELRDPN-ARLPNGRPFPPLFNFKPQ 402
R + +L PP +KP+
Sbjct: 602 --RYIDWEKLERKEIQPP---YKPK 621
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 49/294 (16%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
+ R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ L HPN
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+ + C+ LV+E+ + + + + + + + + T+ + L
Sbjct: 116 TIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
AY+H + HRD+K N+L++ VKL DFGSA ++ S++ + Y+ APE+I
Sbjct: 168 AYLH-SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222
Query: 266 FGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
E Y +D+WS+G EL +P + + L I +
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------NES 270
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
P +++ W + F + V LQ P R T+ H F
Sbjct: 271 -------PALQSGHWSEYFR--------NFVDSCLQKIPQDRPTSEVLLKHRFV 309
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 67/305 (21%), Positives = 113/305 (37%), Gaps = 54/305 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
+ +G+GSFG VF+ T + VAIK + ++ +E+ + D P V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
+ T L +++E++ + + + +I +
Sbjct: 84 KYYGSYLKDTK-----LWIIMEYLGGGSALDLLE--------PGPLDETQIATILREILK 130
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAP 262
L Y+H HRDIK N+L++ +VKL DFG + ++ +++ + ++ AP
Sbjct: 131 GLDYLHS-EKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 188
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
E+I + Y + DIWS+G EL G+P + L I K PT E
Sbjct: 189 EVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN-NPPTLEG----- 241
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382
+ K + V L P+ R TA E H F
Sbjct: 242 --------------NYSKPLK--------EFVEACLNKEPSFRPTAKELLKHKFILRNAK 279
Query: 383 PNARL 387
+ L
Sbjct: 280 KTSYL 284
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 75/300 (25%), Positives = 125/300 (41%), Gaps = 47/300 (15%)
Query: 84 NGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMR 139
G PK+ Y +GQG+ G V+ A + TG+ VAI+++ K E+ MR
Sbjct: 15 VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYT 198
+PN+V+ + DEL++ V+E++ ++ V M +
Sbjct: 73 ENKNPNIVNYLDSYLV---GDELWV--VMEYLAGGSLTDVVTE-----TCMDEGQIAAVC 122
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSR 257
+ +AL ++H V HRDIK N+L+ VKL DFG + + + + +
Sbjct: 123 RECLQALEFLHSN-QVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
Y+ APE++ Y +DIWS+G + E++ G+P + E+ + L I GTP +
Sbjct: 181 YWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTPELQN 238
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
IF D ++R L+ R +A E H F
Sbjct: 239 -----------------PEKLSAIFR--------DFLNRCLEMDVEKRGSAKELLQHQFL 273
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 149
+ +G GSFG V +A+ G VA+K +++ + RE+ M+ L HPN+V
Sbjct: 42 KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99
Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
+ T L +V E++ ++YR+ H S A +++ Y + + + Y+
Sbjct: 100 MG---AVTQPPNLS--IVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYL 153
Query: 209 HG-GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIF 266
H + HR++K NLLV+ + VK+CDFG +++ + S + + APE++
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
D++S G +L EL Q +
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-31
Identities = 60/220 (27%), Positives = 102/220 (46%), Gaps = 34/220 (15%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHPNVV 147
E ++G G FG V++A + G+ VA+K D +E + +L HPN++
Sbjct: 12 EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 148 SLK-HCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+L+ C + L L V+EF + RV +R+P + + QI R +
Sbjct: 70 ALRGVC----LKEPNLCL--VMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGM 118
Query: 206 AYIH--GGIGVCHRDIKPQNLLVN-------PHTHQVKLCDFGSAKVLVKGEPNISYICS 256
Y+H + + HRD+K N+L+ +K+ DFG A+ + +S +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGA 177
Query: 257 RYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
+ APE+I + ++ D+WS G +L ELL G+ F G
Sbjct: 178 YAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 75/291 (25%), Positives = 126/291 (43%), Gaps = 45/291 (15%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 148
+ +G+GS GIV A+ +G VA+K + Q + E+ MR H NVV
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
+ + +EL++ ++EF+ + + R+ + + +ALAY
Sbjct: 107 MYKSYLV---GEELWV--LMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAY 156
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 266
+H GV HRDIK ++L+ +VKL DFG A++ S + + Y+ APE+I
Sbjct: 157 LHAQ-GVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
+ Y T +DIWS+G ++ E++ G+P + +S V + + P +
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS-PPPKLKN--------- 263
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+H + D + R+L P R TA E HPF
Sbjct: 264 --------SHKVSPVLR--------DFLERMLVRDPQERATAQELLDHPFL 298
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 9e-31
Identities = 73/292 (25%), Positives = 117/292 (40%), Gaps = 47/292 (16%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 150
+ +G+GS+G V++A ETG+ VAIK+V + + +E+ M+ D P+VV
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 151 HCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
+F TD L +V+E+ + R+ + + + + L
Sbjct: 91 GSYFKNTD-----LWIVMEYCGAGSVSDIIRLRN------KTLTEDEIATILQSTLKGLE 139
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI 265
Y+H HRDIK N+L+N KL DFG + ++ + I + ++ APE+I
Sbjct: 140 YLHFM-RKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
Y DIWS+G E+ G+P + + + I PT +
Sbjct: 198 QEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN-PPPTFRK-------- 247
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
W F D V + L SP R TA + HPF
Sbjct: 248 ---------PELWSDNFT--------DFVKQCLVKSPEQRATATQLLQHPFV 282
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 57/236 (24%), Positives = 100/236 (42%), Gaps = 46/236 (19%)
Query: 78 TTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQD-------KR 129
+ G+ Y + + G G ++ A G V +K L
Sbjct: 76 DIVAGQ---------YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAM 125
Query: 130 YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN-LVLEFVP-ETVYRVAKHYSRASQ 187
E Q + + HP++V + F TD+ + +V+E+V +++ R Q
Sbjct: 126 AM-AERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------Q 177
Query: 188 RMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL--- 244
++P+ Y +I AL+Y+H IG+ + D+KP+N+++ Q+KL D G+ +
Sbjct: 178 KLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF 234
Query: 245 --VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
+ G P ++APE++ T A DI++VG LA L L P G
Sbjct: 235 GYLYGTP--------GFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-30
Identities = 69/310 (22%), Positives = 123/310 (39%), Gaps = 48/310 (15%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMR-LLDHPNVVS 148
+ +VG G++G V++ + ++TG+ AIK + ++ +E+ ++ H N+ +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 149 LKHCFF-STTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
F + L LV+EF + + K + ++ +I R
Sbjct: 86 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-----GNTLKEEWIAYICREILR 140
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAP 262
L+++H V HRDIK QN+L+ +VKL DFG SA++ ++I + Y+ AP
Sbjct: 141 GLSHLHQH-KVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 263 ELI----FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
E+I Y D+WS+G E+ G P + L I +
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---------- 248
Query: 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378
NP P++K+ W K F + L + + R + HPF
Sbjct: 249 ---NP------APRLKSKKWSKKFQ--------SFIESCLVKNHSQRPATEQLMKHPFIR 291
Query: 379 ELRDPNARLP 388
+ +
Sbjct: 292 DQPNERQVRI 301
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-30
Identities = 72/306 (23%), Positives = 122/306 (39%), Gaps = 52/306 (16%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 148
+ +G G+FG V++AK ETG A K + ++ E++ + DHP +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP----ETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
L ++ L +++EF P + + + +++ Q+ A
Sbjct: 81 LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR------GLTEPQIQVVCRQMLEA 129
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPE 263
L ++H + HRD+K N+L+ ++L DFG SAK L + S+I + Y+ APE
Sbjct: 130 LNFLHSK-RIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPE 187
Query: 264 LIFGAT----EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319
++ T Y DIWS+G L E+ +P + + L++I K PT
Sbjct: 188 VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-DPPTLLT-- 244
Query: 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379
W F D + L +P R +A + HPF
Sbjct: 245 ---------------PSKWSVEFR--------DFLKIALDKNPETRPSAAQLLEHPFVSS 281
Query: 380 LRDPNA 385
+ A
Sbjct: 282 ITSNKA 287
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-30
Identities = 68/241 (28%), Positives = 108/241 (44%), Gaps = 39/241 (16%)
Query: 74 HIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------ 127
H+I I R Y +G G V+ A+ VAIK +
Sbjct: 3 HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52
Query: 128 ---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYS 183
KR++ RE+ L H N+VS+ + D YL V+E++ T+ Y
Sbjct: 53 ETLKRFE-REVHNSSQLSHQNIVSM---IDVDEEDDCYYL--VMEYIEGPTL----SEYI 102
Query: 184 RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243
+ + + +T QI + + H + + HRDIKPQN+L++ +K+ DFG AK
Sbjct: 103 ESHGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDS-NKTLKIFDFGIAKA 160
Query: 244 LVKGEPNISY----ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG 299
L E +++ + + Y +PE G DI+S+G VL E+L+G+P F GE+
Sbjct: 161 L--SETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETA 217
Query: 300 V 300
V
Sbjct: 218 V 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-30
Identities = 57/219 (26%), Positives = 90/219 (41%), Gaps = 28/219 (12%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYK---NRELQTMRLLDHP 144
Y R+VG+G G V++A+ VA+K ++ D ++ RE +T L P
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
+VV + +LY+ + + R + QI
Sbjct: 95 HVVPI---HDFGEIDGQLYV--DMRLINGVD----LAAMLRRQGPLAPPRAVAIVRQIGS 145
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYY 259
AL H G HRD+KP+N+LV+ L DFG A + + + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201
Query: 260 RAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298
APE + T DI+++ CVL E L G P + G+
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ 239
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 31/221 (14%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQ--DKRYKN--RELQTMRLLDHPNVVSLKH 151
V+G+G FG + ETGE + +K++++ ++ + +E++ MR L+HPNV+
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72
Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
L + E++ T+ + K + P + I +AY+H
Sbjct: 73 -IGVLYKDKRLN--FITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH- 125
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------------- 257
+ + HRD+ N LV V + DFG A+++V + + S
Sbjct: 126 SMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 258 --YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
Y+ APE+I G Y +D++S G VL E++ P
Sbjct: 185 NPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 37/239 (15%)
Query: 78 TTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-----QDKRYKN 132
+ + R Y ++G G V A+ L VA+K VL +D +
Sbjct: 8 SHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYL 57
Query: 133 R---ELQTMRLLDHPNVVSLKHCFF---STTDKDELYLNLVLEFVP-ETVYRVAKHYSRA 185
R E Q L+HP +V++ + +V+E+V T+ +
Sbjct: 58 RFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTL----RDIVHT 109
Query: 186 SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245
M C+AL + H G+ HRD+KP N++++ T+ VK+ DFG A+ +
Sbjct: 110 EGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISA-TNAVKVMDFGIARAIA 167
Query: 246 KGEPNISY----ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300
+++ I + Y +PE G + D++S+GCVL E+L G+P F G+S V
Sbjct: 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPV 225
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 46/215 (21%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 151
+ +G+G +G V+ K GE VA+K ++ RE + L+ H N++ +
Sbjct: 42 VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
T +LYL + ++ ++Y K + ++ M +KL Y L ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSM----LKL-AYSSVSGLCHLHT 152
Query: 211 GI-------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----RY 258
I + HRD+K +N+LV + + D G A + + + +
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 259 YRAPELIFGAT-----EYTTAIDIWSVGCVLAELL 288
Y PE++ + + D++S G +L E+
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 47/215 (21%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 151
VG+G +G V++ GE VA+K +D++ RE L +L H N++ +
Sbjct: 13 LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70
Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
S +L+L + + ++Y + + + +++ I LA++H
Sbjct: 71 DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSC----LRI-VLSIASGLAHLHI 123
Query: 211 GI-------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----RY 258
I + HRD+K +N+LV + + D G A + + + + +
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 259 YRAPELI-----FGATEYTTAIDIWSVGCVLAELL 288
Y APE++ + +DIW+ G VL E+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 50/224 (22%), Positives = 96/224 (42%), Gaps = 26/224 (11%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 149
+ +G GSFG V++ K VA+K + E+ +R H N++
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84
Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
F + +L + V ++ ++Y + + + + Q R + Y+
Sbjct: 85 ---FMGYSTAPQLAI--VTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 265
H + HRD+K N+ ++ + VK+ DFG A + + + S + APE+I
Sbjct: 137 HA-KSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 266 FGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
Y+ D+++ G VL EL+ GQ + + DQ++E++
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 28/211 (13%), Positives = 74/211 (35%), Gaps = 22/211 (10%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 149
+ + G +++ + G + +K + R N E +R+ HPNV+ +
Sbjct: 15 LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 150 KHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
+ L+ ++P ++Y V + + + + + R +A++
Sbjct: 73 LGA---CQSPPAPHPTLITHWMPYGSLYNVL--HEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 209 HG-GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
H + + ++++++ ++ + + + APE +
Sbjct: 128 HTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSP----GRMYAPAWVAPEALQK 182
Query: 268 --ATEYTTAIDIWSVGCVLAELLLGQPLFPG 296
+ D+WS +L EL+ + F
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFAD 213
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 49/215 (22%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 151
+ +G+G FG V++ K GE VA+K +++R RE + +L H N++ +
Sbjct: 47 QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH- 209
+L+L V ++ +++ Y+ + M +KL LA++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGM----IKL-ALSTASGLAHLHM 157
Query: 210 ------GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----RY 258
G + HRD+K +N+LV + + D G A I + +
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 259 YRAPELIFGAT-----EYTTAIDIWSVGCVLAELL 288
Y APE++ + E DI+++G V E+
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 57/254 (22%), Positives = 104/254 (40%), Gaps = 37/254 (14%)
Query: 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNV 146
++ V +G FG V++A+ E VA+K QDK+ E + ++ + H N+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80
Query: 147 VS-LKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
+ + T+ +L+L + F + ++ K + + + + R
Sbjct: 81 LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNEL----CHIA-ETMARG 133
Query: 205 LAYIHGGI---------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 255
LAY+H I + HRDIK +N+L+ + + DFG A E S
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF---EAGKSAGD 189
Query: 256 SRY------YRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVE 305
+ Y APE++ GA + ID++++G VL EL G L
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 306 IIKVLGTPTREEIK 319
++ P+ E+++
Sbjct: 250 EEEIGQHPSLEDMQ 263
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-27
Identities = 43/225 (19%), Positives = 86/225 (38%), Gaps = 41/225 (18%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 149
++G+G FG V+ + VAI+ + ++ ++ RE+ R H NVV
Sbjct: 38 GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 150 K-HCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
C L + + T+Y V + A + + + +I + + Y
Sbjct: 95 MGAC----MSPPHLAI--ITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--------Y 259
+H G+ H+D+K +N+ + V + DFG + G + +
Sbjct: 146 LHA-KGILHKDLKSKNVFYDNGK--VVITDFGLFSI--SGVLQAGRREDKLRIQNGWLCH 200
Query: 260 RAPELIFGATE--------YTTAIDIWSVGCVLAELLLGQPLFPG 296
APE+I + ++ D++++G + EL + F
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 57/303 (18%), Positives = 113/303 (37%), Gaps = 42/303 (13%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKNRELQTMRL--LDHPNVVSLKHC 152
++G+G +G V++ VA+K +++ E R+ ++H N+
Sbjct: 18 LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 153 FFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
T + LV+E+ P ++ + ++ + + + R LAY+H
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-----AHSVTRGLAYLHTE 130
Query: 212 I--------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY----- 258
+ + HRD+ +N+LV + DFG + L
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 259 ----YRAPELIFGA------TEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVD-QLVEI 306
Y APE++ GA +D++++G + E+ + LFPGES + Q+
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC 366
+V PT E+++ + E + P+ W + + + + R
Sbjct: 250 TEVGNHPTFEDMQVL--VSREKQRPKFPEA-WKE--NSLAVRSLKETIEDCWDQDAEARL 304
Query: 367 TAL 369
TA
Sbjct: 305 TAQ 307
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-22
Identities = 65/233 (27%), Positives = 100/233 (42%), Gaps = 40/233 (17%)
Query: 96 ERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
R +G+G FG V TGE VA+K + D ++ +E+ +R L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
+ K C D L LV+E+VP + Y + L + L+ QIC +A
Sbjct: 96 IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLP-RHSIGLAQLLLFAQQICEGMA 148
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
Y+H HRD+ +N+L++ + VK+ DFG AK + +G YYR
Sbjct: 149 YLH-AQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDGD 198
Query: 261 ------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEI 306
APE + + A D+WS G L ELL + +L+ I
Sbjct: 199 SPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 52/238 (21%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
+V+G G+FG V++ + GE VAIK++ + K E M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 147 VSLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRA 204
L C + L+ + +P + Y R + + Y+ + QI +
Sbjct: 80 CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 205 LAYI--HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 260
+ Y+ + HRD+ +N+LV VK+ DFG AK+L E Y
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177
Query: 261 ---------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
A E ++ YT D+WS G + EL+ G + G + ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 3e-21
Identities = 35/267 (13%), Positives = 55/267 (20%), Gaps = 60/267 (22%)
Query: 55 RVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLE 114
R + D G GR Y G +QA
Sbjct: 7 REPDRESSAPPDDVQLVPGA---RIANGR---------YRLLIFHGGVPPLQFWQALDTA 54
Query: 115 TGETVAIKKVL----QDKRYKNR---ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167
VA+ V + +D P V + + + V
Sbjct: 55 LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV---LDVVHTRAGGLV--V 109
Query: 168 LEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV 226
E++ ++ VA + + A H GV P + V
Sbjct: 110 AEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRV 162
Query: 227 NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAE 286
+ V L DI +G L
Sbjct: 163 SI-DGDVVLAYPA-------------------TMPDA--------NPQDDIRGIGASLYA 194
Query: 287 LLLGQPLFPGESGVDQLVEIIKVLGTP 313
LL+ + P L +
Sbjct: 195 LLVNRWPLPEAGVRSGLAPAERDTAGQ 221
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 7e-21
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 40/215 (18%)
Query: 96 ERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
+ +G+G+FG V + TGE VA+KK LQ ++ RE++ ++ L H N+
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
V K L L++E++P Y + Y + + R+ I + YT QIC+ +
Sbjct: 74 VKYKGV---CYSAGRRNLKLIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 127
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
Y+ HRD+ +N+LV + ++VK+ DFG KVL + + +++
Sbjct: 128 EYLG-TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKE--------FFKVKEPG 177
Query: 261 -------APELIFGATEYTTAIDIWSVGCVLAELL 288
APE + ++++ A D+WS G VL EL
Sbjct: 178 ESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 40/215 (18%)
Query: 96 ERVVGQGSFGIVFQAKCL----ETGETVAIK--KVLQDKRYKN--RELQTMRLLDHPNVV 147
+ +G+G+FG V + TGE VA+K + ++ ++ RE++ ++ L H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 148 SLKHCFFSTTDKDE-LYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
K + L L++E++P Y + Y + + R+ I + YT QIC+ +
Sbjct: 106 KYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
Y+ HRD+ +N+LV ++VK+ DFG KVL + + YY+
Sbjct: 159 EYLG-TKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKEPG 208
Query: 261 -------APELIFGATEYTTAIDIWSVGCVLAELL 288
APE + ++++ A D+WS G VL EL
Sbjct: 209 ESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 49/230 (21%), Positives = 92/230 (40%), Gaps = 43/230 (18%)
Query: 94 MAERVVGQGSFGIVFQAKCLETGET--VAIKKV---LQDKRYKN---RELQTMRLLDHPN 145
+ ++ +G G+FG V + VA+K + D K+ E M+ LD+P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+V + + + LV+E Y + ++ + + +Q+ +
Sbjct: 80 IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
Y+ HRD+ +N+L+ H K+ DFG +K L E YY+
Sbjct: 131 KYL-EESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQTHG 180
Query: 261 -------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
APE + + ++++ D+WS G ++ E GQ + G G +
Sbjct: 181 KWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 40/233 (17%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
R++G+G FG V +A+ + VA+K + D + RE M+ DHP+V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 147 VSLKH-CFFSTTDKDELYLNLVLEFVPE---TVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
L S ++L F+ + +A +PL + + I
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 260
+ Y+ HRD+ +N ++ V + DFG ++ + G+ YYR
Sbjct: 148 CGMEYL-SSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGD---------YYRQG 196
Query: 261 ----------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
A E L YT D+W+ G + E++ GQ + G +
Sbjct: 197 CASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 39/215 (18%)
Query: 96 ERVVGQGSFGIVFQAKCL----ETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
R +G+G FG V + TGE VA+K + + + +E++ +R L H N+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRAS-QRMPLIYVKLYTYQICRAL 205
V K T+ + L++EF+P K Y + ++ L Y QIC+ +
Sbjct: 86 VKYKGI---CTEDGGNGIKLIMEFLP---SGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
Y+ HRD+ +N+LV HQVK+ DFG K + + YY
Sbjct: 140 DYLG-SRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVKDDR 189
Query: 261 -------APELIFGATEYTTAIDIWSVGCVLAELL 288
APE + + + A D+WS G L ELL
Sbjct: 190 DSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 27/218 (12%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
+ +G G +G V++ + TVA+K + +D +E M+ + HPN+V L
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHG 210
T + Y ++ EF+ Y Y R R + V L QI A+ Y+
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 335
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 264
HR++ +N LV H VK+ DFG ++++ Y + APE
Sbjct: 336 KKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 390
Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
+ ++ D+W+ G +L E+ G +PG
Sbjct: 391 LAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 33/213 (15%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 153
+ +G+G FG V G VA+K + D + E M L H N+V L
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHGG 211
+K LY +V E++ Y R+ R L L ++ +C A+ Y+ G
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EG 307
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE-L 264
HRD+ +N+LV+ + K+ DFG K + APE L
Sbjct: 308 NNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 358
Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
+++T D+WS G +L E+ G+ +P
Sbjct: 359 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 8e-20
Identities = 49/235 (20%), Positives = 84/235 (35%), Gaps = 45/235 (19%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
+++G+G FG V + + VA+K + D + E M+ HPNV
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRAS----QRMPLIYVKL--YTYQ 200
+ L + + ++L F+ Y Y S + L +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMK---YGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 260
I + Y+ HRD+ +N ++ V + DFG +K + G+ YYR
Sbjct: 156 IALGMEYL-SNRNFLHRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD---------YYR 204
Query: 261 ------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
A E L YT+ D+W+ G + E+ G +PG +
Sbjct: 205 QGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 40/215 (18%)
Query: 96 ERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
+G+G+FG V + TG VA+K LQ RE+Q ++ L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
V + + L LV+E++P + + + + R+ + LY+ QIC+ +
Sbjct: 87 VKYRGV-SYGPGRQSLR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
Y+ HRD+ +N+LV VK+ DFG AK+L + YY
Sbjct: 141 EYLG-SRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVREPG 190
Query: 261 -------APELIFGATEYTTAIDIWSVGCVLAELL 288
APE + ++ D+WS G VL EL
Sbjct: 191 QSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
+ +G G +G V++ + TVA+K + +D +E M+ + HPN+V L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHG 210
T + Y ++ EF+ Y Y R R + V L QI A+ Y+
Sbjct: 78 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-E 128
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE- 263
HRD+ +N LV + H VK+ DFG ++++ Y + APE
Sbjct: 129 KKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 183
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
L + +++ D+W+ G +L E+ G +PG
Sbjct: 184 LAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-19
Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 33/218 (15%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 153
+ +G+G FG V G VA+K + D + E M L H N+V L
Sbjct: 26 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHGG 211
+K LY +V E++ Y R+ R L L ++ +C A+ Y+ G
Sbjct: 83 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-G 135
Query: 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE-L 264
HRD+ +N+LV+ + K+ DFG K + APE L
Sbjct: 136 NNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 186
Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
+++T D+WS G +L E+ G+ +P D
Sbjct: 187 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 31/224 (13%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
E +GQG FG V+ T VAIK + +E Q M+ L H +V L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHG 210
++ ++ +Y +V E++ + + L +L QI +AY+
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-E 297
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 264
+ HRD++ N+LV + K+ DFG A+++ E Y + + APE
Sbjct: 298 RMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 352
Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
+T D+WS G +L EL G+ +PG + VE
Sbjct: 353 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-19
Identities = 57/252 (22%), Positives = 94/252 (37%), Gaps = 56/252 (22%)
Query: 96 ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTM-RLLDHP 144
+ +G G+FG V +A + TVA+K + L ++ EL+ + L +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYSRASQRMPL 191
N+V+L T ++ E+ + + L
Sbjct: 88 NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 192 IYVKLYT--YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249
L + YQ+ + +A++ HRD+ +N+L+ K+CDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDS- 199
Query: 250 NISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
Y APE IF YT D+WS G L EL LG +PG
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 297 ESGVDQLVEIIK 308
+ ++IK
Sbjct: 251 MPVDSKFYKMIK 262
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 3e-19
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 31/224 (13%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
E +GQG FG V+ T VAIK + +E Q M+ L H +V L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHG 210
++ ++ +Y +V E++ + + L +L QI +AY+
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-E 380
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 264
+ HRD++ N+LV + K+ DFG A+++ E Y + + APE
Sbjct: 381 RMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 435
Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
+T D+WS G +L EL G+ +PG + VE
Sbjct: 436 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 53/228 (23%), Positives = 84/228 (36%), Gaps = 45/228 (19%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 150
+G+G+FG VF + VA+K + + E + ++ HPN+V L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177
Query: 151 H--CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL-YTYQICRALAY 207
C T K +Y +V+E V + R + L + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------- 260
+ HRD+ +N LV + +K+ DFG ++ G Y
Sbjct: 229 LE-SKCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGLRQV 277
Query: 261 -----APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
APE L +G Y++ D+WS G +L E LG +P S
Sbjct: 278 PVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-19
Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 43/230 (18%)
Query: 94 MAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
+A+ +G G+FG V Q + VAIK + Q + E Q M LD+P +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
V L + L LV+E + + +P+ V +Q+ +
Sbjct: 73 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
Y+ HRD+ +N+L+ + H K+ DFG +K L + YY
Sbjct: 124 KYL-EEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARSAG 173
Query: 261 -------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
APE + F ++++ D+WS G + E L GQ + G +
Sbjct: 174 KWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-19
Identities = 58/237 (24%), Positives = 95/237 (40%), Gaps = 50/237 (21%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
+V+G G+FG V++ + GE VAIK++ + K E M +D+P+V
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 147 VSLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRA 204
L C + L+ + +P + Y R + + Y+ + QI +
Sbjct: 80 CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 205 LAYI--HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 260
+ Y+ + HRD+ +N+LV VK+ DFG AK+L E Y
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177
Query: 261 ---------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
A E I YT D+WS G + EL+ G + G + ++E
Sbjct: 178 GGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 57/230 (24%), Positives = 96/230 (41%), Gaps = 43/230 (18%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
E+ +G G FG V+ A + VA+K + E M+ L H +V L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHG 210
K+ +Y ++ EF+ + ++ + KL ++ QI +A+I
Sbjct: 252 VT----KEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-E 301
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 260
HRD++ N+LV+ K+ DFG A+V+ E Y
Sbjct: 302 QRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPIKW 351
Query: 261 -APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
APE + FG +T D+WS G +L E++ G+ +PG S + + +E
Sbjct: 352 TAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 9e-19
Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 45/231 (19%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 147
V+G+G FG V+ L+ A+K + D + E M+ HPNV+
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL-YTYQICRALA 206
SL + +VL ++ + +++ R P + + + Q+ + +
Sbjct: 90 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
Y+ HRD+ +N +++ VK+ DFG A+ + E YY
Sbjct: 143 YLA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSVHNKTG 191
Query: 261 --------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
A E L ++TT D+WS G +L EL+ G P +P + D
Sbjct: 192 AKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 9e-19
Identities = 46/233 (19%), Positives = 79/233 (33%), Gaps = 46/233 (19%)
Query: 96 ERVVGQGSFGIVFQAKCLETGET-------VAIKKVLQDKRYKN----RELQTMRLLDHP 144
+GQG+F +F+ E G+ V +K + + R + M L H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 145 NVVSLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL-YTYQIC 202
++V C DE L V EFV + Y + ++ I KL Q+
Sbjct: 73 HLVLNYGVC----VCGDENIL--VQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-------VKLCDFGSAKVLVKGEPNISYIC 255
A+ ++ + H ++ +N+L+ + +KL D G + ++ +
Sbjct: 124 AAMHFLEE-NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 256 SRYYR------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
+ PE I A D WS G L E+ G
Sbjct: 176 --ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 43/230 (18%)
Query: 94 MAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
+A+ +G G+FG V Q + VAIK + Q + E Q M LD+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
V L + L LV+E + + +P+ V +Q+ +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
Y+ HR++ +N+L+ + H K+ DFG +K L + YY
Sbjct: 450 KYL-EEKNFVHRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARSAG 499
Query: 261 -------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
APE + F ++++ D+WS G + E L GQ + G +
Sbjct: 500 KWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 51/229 (22%), Positives = 91/229 (39%), Gaps = 34/229 (14%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
+V+G G FG V + + GE V IK + ++ + + LDH ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
V L L LV +++P + R + + + + QI + +
Sbjct: 78 VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
Y+ G+ HR++ +N+L+ QV++ DFG A +L + + +
Sbjct: 129 YYLE-EHGMVHRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---KQLLYSEAKTPIKW 183
Query: 261 -APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
A E I YT D+WS G + EL+ G + G + L+E
Sbjct: 184 MALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 51/243 (20%)
Query: 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTM 138
P + + ++RV+G+G FG+V+ + ++ + AIK + + + RE M
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 139 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMP----LIYV 194
R L+HPNV++L + L ++L ++ + + R+ QR P LI
Sbjct: 77 RGLNHPNVLALIGI---MLPPEGLPH-VLLPYMC---HGDLLQFIRSPQRNPTVKDLIS- 128
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
+ Q+ R + Y+ HRD+ +N +++ + VK+ DFG A+ ++ E
Sbjct: 129 --FGLQVARGMEYLA-EQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDRE------ 178
Query: 255 CSRYYR--------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGES 298
YY A E L +TT D+WS G +L ELL G P +
Sbjct: 179 ---YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRHID 233
Query: 299 GVD 301
D
Sbjct: 234 PFD 236
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 55/243 (22%), Positives = 98/243 (40%), Gaps = 50/243 (20%)
Query: 97 RVVGQGSFGIVFQAKCLETGE-----TVAIKKV-----LQDKRYKNRELQTMRLLDHPNV 146
R +GQGSFG+V++ + VAIK V ++++ E M+ + +V
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPE----TVYRVAKH-YSRASQRMPLIYVKL--YTY 199
V L + +++E + + R + + P K+
Sbjct: 91 VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 259
+I +AY++ HRD+ +N +V VK+ DFG + + + + YY
Sbjct: 146 EIADGMAYLN-ANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETD---------YY 194
Query: 260 R------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVE 305
R +PE L G +TT D+WS G VL E+ L + + G S +Q++
Sbjct: 195 RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLR 251
Query: 306 IIK 308
+
Sbjct: 252 FVM 254
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 60/249 (24%), Positives = 101/249 (40%), Gaps = 53/249 (21%)
Query: 97 RVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLD-HPN 145
+ +G+G+FG V +A T TVA+K + + R EL+ + + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYSRASQRMPLI 192
VV+L T L +++EF E V + L
Sbjct: 93 VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 193 YVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
++ Y++Q+ + + ++ HRD+ +N+L++ + VK+CDFG A+ + K
Sbjct: 149 HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDP---- 202
Query: 253 YICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESG 299
Y APE IF YT D+WS G +L E+ LG +PG
Sbjct: 203 -----DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 300 VDQLVEIIK 308
++ +K
Sbjct: 257 DEEFCRRLK 265
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 54/230 (23%), Positives = 94/230 (40%), Gaps = 43/230 (18%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
+G G FG V+ VA+K + Q + E M+ L H +V L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIHG 210
++ ++ +Y ++ E++ + + + L KL QI +A+I
Sbjct: 74 -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-E 126
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 260
HRD++ N+LV+ K+ DFG A+++ E Y
Sbjct: 127 ERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPIKW 176
Query: 261 -APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESG--VDQLVE 305
APE + +G +T D+WS G +L E++ G+ +PG + V Q +E
Sbjct: 177 TAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 6e-18
Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 55/224 (24%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT----MRLLDHPNVVSL-K 150
+ ++G G FG V++ L G VA+K+ + E +T + HP++VSL
Sbjct: 44 KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 151 HCFFSTTDKDELYLNLVLEFVP-----ETVYRVAKHYSRAS--QRMPLIYVKLYTYQIC- 202
C +++E+ L+ +++ +Y S QR+ +IC
Sbjct: 103 FC----DERNEMI--LIYKYMENGNLKRHLYGSDLPTMSMSWEQRL----------EICI 146
Query: 203 ---RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY- 258
R L Y+H + HRD+K N+L++ + K+ DFG +K + + +++ +
Sbjct: 147 GAARGLHYLHTR-AIIHRDVKSINILLDENFV-PKITDFGISKKGTELDQ--THLSTVVK 202
Query: 259 ----YRAPELIFGATEY------TTAIDIWSVGCVLAELLLGQP 292
Y P EY T D++S G VL E+L +
Sbjct: 203 GTLGYIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 52/231 (22%), Positives = 92/231 (39%), Gaps = 45/231 (19%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 147
V+G+G FG V+ L+ A+K + D + E M+ HPNV+
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMP----LIYVKLYTYQICR 203
SL + +VL ++ + +++ R P LI + Q+ +
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIG---FGLQVAK 203
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 260
+ ++ HRD+ +N +++ VK+ DFG A+ + E + +
Sbjct: 204 GMKFLA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNKTG 255
Query: 261 --------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
A E L ++TT D+WS G +L EL+ G P +P + D
Sbjct: 256 AKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 7e-18
Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 48/230 (20%)
Query: 96 ERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
R++G+G FG V++ VA+K +D N+ E M+ LDHP++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
L +++ + +++E P Y HY ++ + ++ + LY+ QIC+A+A
Sbjct: 77 KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 207 YI--HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 260
Y+ + HRDI +N+LV VKL DFG ++ + + YY+
Sbjct: 128 YLESINCV---HRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKASVT 174
Query: 261 -------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
+PE + F +TTA D+W + E+L G+ F D
Sbjct: 175 RLPIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 54/258 (20%), Positives = 100/258 (38%), Gaps = 64/258 (24%)
Query: 96 ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
+ +G+G FG V +A TVA+K + + R E ++ ++HP+
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVP-------------------ETVYRVAKHYSRAS 186
V+ L + L L++E+ +
Sbjct: 88 VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 187 QRMPLIYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
L L + +QI + + Y+ + + HRD+ +N+LV ++K+ DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL-AEMKLVHRDLAARNILVAEG-RKMKISDFGLSRDV 200
Query: 245 VKGEPNISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LG- 290
+ + Y A E +F YTT D+WS G +L E++ LG
Sbjct: 201 YEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250
Query: 291 QPLFPGESGVDQLVEIIK 308
P +PG ++L ++K
Sbjct: 251 NP-YPGIP-PERLFNLLK 266
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 51/225 (22%), Positives = 94/225 (41%), Gaps = 43/225 (19%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 151
+ +G G FG+V K VA+K + + ++ +E QTM L HP +V
Sbjct: 13 LKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL--YTYQICRALAYIH 209
C + + +Y +V E++ +Y R S L +L Y +C +A++
Sbjct: 72 C----SKEYPIY--IVTEYIS---NGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMAFL- 120
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--------- 260
HRD+ +N LV+ VK+ DFG + ++ + Y
Sbjct: 121 ESHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPVK 170
Query: 261 --APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
APE + +Y++ D+W+ G ++ E+ LG+ + + +
Sbjct: 171 WSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE 213
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 51/224 (22%), Positives = 89/224 (39%), Gaps = 41/224 (18%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 151
+ +G G FG+V L + VAIK + + + E + M L HP +V L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY-TYQICRALAYIHG 210
C ++ + LV EF+ + Y R + + L +C +AY+
Sbjct: 72 C----LEQAPIC--LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-E 121
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 260
V HRD+ +N LV + +K+ DFG + ++ + Y
Sbjct: 122 EACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPVKW 171
Query: 261 -APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
+PE F Y++ D+WS G ++ E+ G+ + S +
Sbjct: 172 ASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 82.6 bits (203), Expect = 1e-17
Identities = 49/338 (14%), Positives = 97/338 (28%), Gaps = 86/338 (25%)
Query: 99 VGQGSFGIVFQAKCLETGETVAIKKV-LQDKRYKN-----------RELQTMRLL----- 141
+G+G FG VFQ VAIK + ++ N E+ + L
Sbjct: 28 IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85
Query: 142 ----DHPNVVSLKHCFF---------------------------STTDKDELYLNLVLEF 170
+ L D+L++ L EF
Sbjct: 86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145
Query: 171 VPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT 230
+ ++ S + K +Q+ +LA + HRD+ N+L+ +
Sbjct: 146 GGIDLEQMRTKLSSLAT------AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTS 199
Query: 231 HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG 290
KL + K L +YT + V ++ +
Sbjct: 200 L-KKLHYTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMD 245
Query: 291 QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP-------NYTEFKFPQIKAHPWHKIF- 342
+ LF G+ D +I +++ +P +Y K +
Sbjct: 246 EDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTP 303
Query: 343 -HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379
K++ + + +L +S +A + ++
Sbjct: 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 51/230 (22%), Positives = 88/230 (38%), Gaps = 45/230 (19%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
E+++G G G V + G+ VAIK + + R E M DHPN++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 148 SLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL-YTYQICRAL 205
L+ T +V E++ + R I + + +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
Y+ +G HRD+ +N+LV+ + K+ DFG ++VL
Sbjct: 165 RYL-SDLGYVHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP--------DAAYTTTGG 214
Query: 261 -------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
APE + F +++A D+WS G V+ E+L G+ + + D
Sbjct: 215 KIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 58/259 (22%), Positives = 101/259 (38%), Gaps = 59/259 (22%)
Query: 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGE-----TVAIKKV----LQDKRYKNRELQT 137
++ I R +G+G+FG VF A+C VA+K + L ++ RE +
Sbjct: 13 KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-----------ETVYRVAKHYSRAS 186
+ L H ++V D D L +V E++ +
Sbjct: 71 LTNLQHEHIVKFYGV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 187 QRMPLIYVKLY--TYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
+ L ++ QI + Y+ HRD+ +N LV + VK+ DFG ++ +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYL-ASQHFVHRDLATRNCLVGAN-LLVKIGDFGMSRDV 183
Query: 245 VKGEPNISYICSRYYR------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LG 290
+ YYR PE +++ ++TT D+WS G +L E+ G
Sbjct: 184 YSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYG 232
Query: 291 -QPLFPGESGVDQLVEIIK 308
QP + S +++E I
Sbjct: 233 KQP-WFQLS-NTEVIECIT 249
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 55/229 (24%), Positives = 93/229 (40%), Gaps = 43/229 (18%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
++VVG G FG V + + +VAIK + K R E M DHPN++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 148 SLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRAL 205
L+ T + +V E++ + R + +I + I +
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 260
Y+ +G HRD+ +N+L+N + K+ DFG +VL Y
Sbjct: 161 KYL-SDMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDP-------EAAYTTRGGK 211
Query: 261 ------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
+PE + + ++T+A D+WS G VL E++ G+ + S D
Sbjct: 212 IPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 61/228 (26%), Positives = 95/228 (41%), Gaps = 44/228 (19%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
R +G+G FG V Q + VAIK R E TMR DHP++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
L ++ ++ +++E + + + + + L + LY YQ+ ALA
Sbjct: 80 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
Y+ HRDI +N+LV+ + VKL DFG ++ + YY+
Sbjct: 131 YLE-SKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKGKL 179
Query: 261 -----APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
APE + F +T+A D+W G + E+L G F G D
Sbjct: 180 PIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 60/258 (23%), Positives = 96/258 (37%), Gaps = 63/258 (24%)
Query: 96 ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTM-RLLDHP 144
+V+G G+FG V A VA+K + ++ EL+ M +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP------------------ETVYRVAKHYSRAS 186
N+V+L T +Y L+ E+ E Y K
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 187 QRMPLIYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
L + L + YQ+ + + ++ HRD+ +N+LV VK+CDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL-EFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDI 222
Query: 245 VKGEPNISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAEL--LLG 290
+ Y APE +F YT D+WS G +L E+ L
Sbjct: 223 MSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272
Query: 291 QPLFPGESGVDQLVEIIK 308
P +PG ++I+
Sbjct: 273 NP-YPGIPVDANFYKLIQ 289
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 46/234 (19%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 147
R +G+G FG V Q + VAIK R E TMR DHP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRALA 206
L ++ ++ +++E + + + + + L + LY YQ+ ALA
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 260
Y+ HRDI +N+LV+ + VKL DFG ++ + YY+
Sbjct: 506 YLE-SKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKGKL 554
Query: 261 -----APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESG--VDQLVE 305
APE + F +T+A D+W G + E+L G F G V +E
Sbjct: 555 PIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 56/249 (22%), Positives = 97/249 (38%), Gaps = 56/249 (22%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE-----TVAIKKV----LQDKRYKNRELQTMRLLDHPNV 146
+ +G+G+FG VF A+C VA+K + ++ RE + + +L H ++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP----------ETVYRVAKHYSRASQRMPLIYVKL 196
V T+ L +V E++ PL +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 197 --YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
Q+ + Y+ G+ HRD+ +N LV VK+ DFG ++ + +
Sbjct: 161 LAVASQVAAGMVYL-AGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD------ 212
Query: 255 CSRYYR------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LG-QPLFPGESG 299
YYR PE +++ ++TT D+WS G VL E+ G QP + S
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP-WYQLS- 265
Query: 300 VDQLVEIIK 308
+ ++ I
Sbjct: 266 NTEAIDCIT 274
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 6e-17
Identities = 57/239 (23%), Positives = 91/239 (38%), Gaps = 52/239 (21%)
Query: 96 ERVVGQGSFGIVFQAKC-LETGET--VAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
+G GSFG+V + + +G+T VA+K + D + RE+ M LDH N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRA 204
++ L + + +V E P R Q L + Y Q+
Sbjct: 83 LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133
Query: 205 LAYI--HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 260
+ Y+ I HRD+ +NLL+ VK+ DFG + L + + +Y
Sbjct: 134 MGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVMQ 181
Query: 261 ----------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD--QLVE 305
APE L ++ A D W G L E+ GQ + G +G ++
Sbjct: 182 EHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 57/252 (22%), Positives = 105/252 (41%), Gaps = 57/252 (22%)
Query: 96 ERVVGQGSFGIVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 142
+ +G+G FG V A+ + + TVA+K + +D E++ M +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-----------TVYRVAKHYSRASQRMPL 191
H N+++L T LY +++E+ + + +
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 192 IYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249
+ L TYQ+ R + Y+ HRD+ +N+LV + + +K+ DFG A+ + +
Sbjct: 201 TFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 257
Query: 250 NISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
YY+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 258 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308
Query: 297 ESGVDQLVEIIK 308
V++L +++K
Sbjct: 309 IP-VEELFKLLK 319
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 61/268 (22%), Positives = 105/268 (39%), Gaps = 68/268 (25%)
Query: 87 PKQTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQ 136
P+ I Y+ R +G+G+FG VFQA+ E VA+K + + RE
Sbjct: 45 PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 137 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYS 183
M D+PN+V L + L+ E++ P TV ++
Sbjct: 103 LMAEFDNPNIVKLLGV---CAVGKPMC--LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 184 RASQRMPLIYVKLYT--------YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 235
R+ + Q+ +AY+ HRD+ +N LV + VK+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYL-SERKFVHRDLATRNCLVGEN-MVVKI 215
Query: 236 CDFGSAKVLVKGEPNISYICSRYYR------------APE-LIFGATEYTTAIDIWSVGC 282
DFG ++ + + YY+ PE + + YTT D+W+ G
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264
Query: 283 VLAELL-LG-QPLFPGESGVDQLVEIIK 308
VL E+ G QP + G + ++++ ++
Sbjct: 265 VLWEIFSYGLQP-YYGMA-HEEVIYYVR 290
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-17
Identities = 47/223 (21%), Positives = 88/223 (39%), Gaps = 43/223 (19%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 149
Y R +G+GSFG++F+ L + VAIK + E +T +LL + ++
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+ ++ L+ LV++ + ++ + R + + V + Q+ + IH
Sbjct: 72 YYF-----GQEGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIH 123
Query: 210 GGIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YR 260
+ +RDIKP N L+ + + + + + DFG K Y YR
Sbjct: 124 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK---------FYRDPVTKQHIPYR 173
Query: 261 APELIFGATEYTTAI------------DIWSVGCVLAELLLGQ 291
+ + G Y +I D+ ++G V L G
Sbjct: 174 EKKNLSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 9e-17
Identities = 57/252 (22%), Positives = 101/252 (40%), Gaps = 57/252 (22%)
Query: 96 ERVVGQGSFGIVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 142
+ +G+G+FG V A+ + VA+K + +D E++ M +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVP-----------ETVYRVAKHYSRASQRMPL 191
H N+++L T LY +++E+ + + L
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 192 IYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249
L YQ+ R + Y+ HRD+ +N+LV + +K+ DFG A+ + +
Sbjct: 189 SSKDLVSCAYQVARGMEYL-ASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHID- 245
Query: 250 NISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
YY+ APE +F YT D+WS G +L E+ LG +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 297 ESGVDQLVEIIK 308
V++L +++K
Sbjct: 297 VP-VEELFKLLK 307
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 48/230 (20%), Positives = 89/230 (38%), Gaps = 44/230 (19%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 146
++V+G G FG V++ + VAIK + K R E M H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 147 VSLKH-CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQ-RMPLIYVKLYTYQICRA 204
+ L+ + + ++ E++ + R ++ + I
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 260
+ Y+ + HRD+ +N+LVN + K+ DFG ++VL Y
Sbjct: 160 MKYLA-NMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDP-------EATYTTSGG 210
Query: 261 -------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
APE + + +T+A D+WS G V+ E++ G+ + S +
Sbjct: 211 KIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 49/224 (21%), Positives = 91/224 (40%), Gaps = 41/224 (18%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 151
+ +G G FG+V K VAIK + + ++ E + M L H +V L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY-TYQICRALAYIHG 210
C T + ++ ++ E++ +Y R + L +C A+ Y+
Sbjct: 88 C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-E 137
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 260
HRD+ +N LVN VK+ DFG ++ ++ E Y
Sbjct: 138 SKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSKFPVRW 187
Query: 261 -APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
PE L++ ++++ DIW+ G ++ E+ LG+ + + +
Sbjct: 188 SPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 56/251 (22%), Positives = 90/251 (35%), Gaps = 58/251 (23%)
Query: 96 ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
+G+ FG V++ E + VAIK + + E L HPN
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVP-----------ETVYRVAKHYSRASQRMPLIYV 194
VV L T L ++ + V + + L
Sbjct: 74 VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 195 KL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 252
QI + Y+ V H+D+ +N+LV VK+ D G + + +
Sbjct: 129 DFVHLVAQIAAGMEYL-SSHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYAAD---- 182
Query: 253 YICSRYYR------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LG-QPLFPGE 297
YY+ APE +++G +++ DIWS G VL E+ G QP + G
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP-YCGY 234
Query: 298 SGVDQLVEIIK 308
S +VE+I+
Sbjct: 235 S-NQDVVEMIR 244
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 55/248 (22%), Positives = 95/248 (38%), Gaps = 52/248 (20%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE-----TVAIKKV-----LQDKRYKNRELQTM-RLLDHP 144
+ +G G+FG V +A G+ VA+K + +K EL+ M L H
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP---------ETVYRVAKHYSRASQRMPLIYVK 195
N+V+L T + ++ E+ + + A
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 196 L--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253
L ++ Q+ + +A++ HRD+ +N+L+ H K+ DFG A+ ++
Sbjct: 166 LLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDS----- 218
Query: 254 ICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGV 300
Y APE IF YT D+WS G +L E+ LG +PG
Sbjct: 219 ----NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273
Query: 301 DQLVEIIK 308
+ +++K
Sbjct: 274 SKFYKLVK 281
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 57/252 (22%), Positives = 106/252 (42%), Gaps = 57/252 (22%)
Query: 96 ERVVGQGSFGIVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 142
+ +G+G+FG V A+ + + TVA+K + +D E++ M +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPE-----------TVYRVAKHYSRASQRMPL 191
H N+++L T LY +++E+ + + +
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 192 IYVKL--YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249
+ L TYQ+ R + Y+ HRD+ +N+LV + + +K+ DFG A+ + +
Sbjct: 155 TFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 211
Query: 250 NISYICSRYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
YY+ APE +F YT D+WS G ++ E+ LG +PG
Sbjct: 212 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262
Query: 297 ESGVDQLVEIIK 308
V++L +++K
Sbjct: 263 IP-VEELFKLLK 273
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 54/245 (22%), Positives = 92/245 (37%), Gaps = 52/245 (21%)
Query: 96 ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
R +G G+FG V++ + + VA+K + QD+ E + +H N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKL--YTY 199
+V + + ++LE + + R + R SQ L + L
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLR--ETRPRPSQPSSLAMLDLLHVAR 188
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSR 257
I Y+ HRDI +N L+ K+ DFG A+ + +
Sbjct: 189 DIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG--------- 238
Query: 258 YYR------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQL 303
YYR PE + G +T+ D WS G +L E+ LG +P +S ++
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 295
Query: 304 VEIIK 308
+E +
Sbjct: 296 LEFVT 300
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 53/245 (21%), Positives = 92/245 (37%), Gaps = 52/245 (21%)
Query: 96 ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
R +G G+FG V++ + + VA+K + QD+ E + +H N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE----TVYRVAKHYSRASQRMPLIYVKL--YTY 199
+V + + +++E + + R + R SQ L + L
Sbjct: 95 IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLR--ETRPRPSQPSSLAMLDLLHVAR 147
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSR 257
I Y+ HRDI +N L+ K+ DFG A+ + +
Sbjct: 148 DIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--------- 197
Query: 258 YYR------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQL 303
YYR PE + G +T+ D WS G +L E+ LG +P +S ++
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-NQEV 254
Query: 304 VEIIK 308
+E +
Sbjct: 255 LEFVT 259
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 36/215 (16%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 150
+ ++G+G FG V++ + L G VA+K++ +++ E++ + + H N++ L+
Sbjct: 35 KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKH-YSRASQRMPLIYVKLYTYQIC----RAL 205
T + L LV ++ VA R + PL + K +I R L
Sbjct: 94 GF--CMTPTERL---LVYPYMANG--SVASCLRERPESQPPLDWPK--RQRIALGSARGL 144
Query: 206 AYIHGGIGVC--HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY----- 258
AY+H HRD+K N+L++ + + DFG AK++ + +++ +
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDTHVTTAVRGTIG 200
Query: 259 YRAPE-LIFG-ATEYTTAIDIWSVGCVLAELLLGQ 291
+ APE L G ++E T D++ G +L EL+ GQ
Sbjct: 201 HIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 46/223 (20%), Positives = 81/223 (36%), Gaps = 43/223 (19%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIK--KVLQDKRYKNRELQTMRLLDH-PNVVSL 149
+ + +G G+FG + K L T E VAIK + + E + + L + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+ Y +VLE + ++ + R L V + Q+ + Y+H
Sbjct: 71 YYF-----GPCGKYNAMVLELLGPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVH 122
Query: 210 GGIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YR 260
+ +RD+KP+N L+ N + + DF AK YI YR
Sbjct: 123 -SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE---------YIDPETKKHIPYR 172
Query: 261 APELIFGATEYTTAI------------DIWSVGCVLAELLLGQ 291
+ + G Y +I D+ ++G + L G
Sbjct: 173 EHKSLTGTARY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 7e-15
Identities = 50/221 (22%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLL-DHPNVVSL 149
+ R +G GSFG ++ ++T E VAIK ++ E + R+L + ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+ + Y LV++ + + + ++ S+++ L V + Q+ + ++H
Sbjct: 69 RWF-----GVEGDYNVLVMDLLGPS---LEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 210 GGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 262
HRDIKP N L+ +QV + DFG AK Y + YR
Sbjct: 121 -SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---------KYRDTSTHQHIPYREN 170
Query: 263 ELIFGATEYTTAI------------DIWSVGCVLAELLLGQ 291
+ + G Y ++ D+ S+G VL L G
Sbjct: 171 KNLTGTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 54/221 (24%), Positives = 88/221 (39%), Gaps = 41/221 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 149
Y R +G GSFG ++ + GE VAIK ++ E + +++ + ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+ C + Y +V+E + ++ + SR + L V L Q+ + YIH
Sbjct: 71 RWC-----GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIH 122
Query: 210 GGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 262
HRD+KP N L+ + V + DFG AK Y +R YR
Sbjct: 123 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK---------KYRDARTHQHIPYREN 172
Query: 263 ELIFGATEYTTAI------------DIWSVGCVLAELLLGQ 291
+ + G Y +I D+ S+G VL LG
Sbjct: 173 KNLTGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-14
Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 44/217 (20%)
Query: 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK----NRELQT----MRLLDHPNVVSL 149
+G+G FG+V++ + TVA+KK+ ++ M H N+V L
Sbjct: 38 KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 150 K-HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC----RA 204
+D D+L LV ++P + S PL + +I
Sbjct: 96 LGFS----SDGDDLC--LVYVYMPNG--SLLDRLSCLDGTPPLSWHM--RCKIAQGAANG 145
Query: 205 LAYIHGGIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAKVLVKGEPNISYICSR--- 257
+ ++H HRDIK N+L+ K+ DFG A+ K + + SR
Sbjct: 146 INFLHEN-HHIHRDIKSANILLDEAFTA-----KISDFGLARASEKFA--QTVMTSRIVG 197
Query: 258 -Y-YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQP 292
Y APE + G E T DI+S G VL E++ G P
Sbjct: 198 TTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 56/236 (23%), Positives = 94/236 (39%), Gaps = 56/236 (23%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE--TVAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 147
+ V+G+G+FG V +A+ + G AIK++ D R EL+ + +L HPN++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP-----------ETVYRVAKHYSRASQRMPLIYVKL 196
+L + LY L +E+ P + S L +L
Sbjct: 90 NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 197 --YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
+ + R + Y+ HRD+ +N+LV + + K+ DFG ++
Sbjct: 145 LHFAADVARGMDYL-SQKQFIHRDLAARNILVGEN-YVAKIADFGLSRG----------- 191
Query: 255 CSRYYR------------APE-LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPG 296
Y A E L + YTT D+WS G +L E++ LG + G
Sbjct: 192 -QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 7e-14
Identities = 43/250 (17%), Positives = 82/250 (32%), Gaps = 49/250 (19%)
Query: 72 TGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK 131
G ++ G + ++ + +G G FG+++ A E A V + +
Sbjct: 27 EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77
Query: 132 N---RELQTMRLLDHPNVVSLK--------------HCFFSTTDKDELYLNLVLEFVPET 174
EL+ + + + + + T K Y +V+E +
Sbjct: 78 GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137
Query: 175 VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTHQV 233
+ + S + V ++ L YIH H DIK NLL+ + QV
Sbjct: 138 L----QKISGQNGTFKKSTVLQLGIRMLDVLEYIH-ENEYVHGDIKAANLLLGYKNPDQV 192
Query: 234 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI------------DIWSVG 281
L D+G + + Y + G E+ T++ D+ +G
Sbjct: 193 YLADYGLSYRYCPNGNHKQYQ----ENPRKGHNGTIEF-TSLDAHKGVALSRRSDVEILG 247
Query: 282 CVLAELLLGQ 291
+ L G+
Sbjct: 248 YCMLRWLCGK 257
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 40/252 (15%), Positives = 82/252 (32%), Gaps = 50/252 (19%)
Query: 72 TGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETG--------ETVAIKK 123
TG ++ G + + + + + GI+++A T + ++K
Sbjct: 32 TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82
Query: 124 VLQDKRYKNRELQTMRLLDHPNVVSLK-----------HCFFSTTDKDELYLNLVLEFVP 172
+D R N + R V K C +D+ LVL +
Sbjct: 83 DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141
Query: 173 ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTH 231
++ + + V ++ AL ++H H ++ +N+ V+P
Sbjct: 142 RSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFVDPEDQS 198
Query: 232 QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI------------DIWS 279
QV L +G A +++Y G E+ ++ D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY---VEGSRSPHE-GDLEF-ISMDLHKGCGPSRRSDLQS 253
Query: 280 VGCVLAELLLGQ 291
+G + + L G
Sbjct: 254 LGYCMLKWLYGF 265
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 50/275 (18%), Positives = 87/275 (31%), Gaps = 50/275 (18%)
Query: 49 MKIKGERVEKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERVVGQGSFGIVF 108
M++K + ++ A G II + +GQG FG ++
Sbjct: 2 MRVKAAQAGRQSSAKRHLAEQFAVGEIITDMAAAA---------WKVGLPIGQGGFGCIY 52
Query: 109 QA-----KCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK------------- 150
A + + + +K D EL+ + P +
Sbjct: 53 LADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112
Query: 151 -HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+ Y ++++ + K Y ++R V + +I L YIH
Sbjct: 113 YWGSGLHDKNGKSYRFMIMDRFGSDL---QKIYEANAKRFSRKTVLQLSLRILDILEYIH 169
Query: 210 GGIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
H DIK NLL+N + QV L D+G A + +Y G
Sbjct: 170 E-HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYA----ADPKRCHDGT 224
Query: 269 TEYTTAI------------DIWSVGCVLAELLLGQ 291
E+ T+I D+ +G + + L G
Sbjct: 225 IEF-TSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 34/125 (27%), Positives = 57/125 (45%), Gaps = 25/125 (20%)
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 256
Y++Q+ + + ++ HRD+ +N+L++ + VK+CDFG A+ + K
Sbjct: 198 YSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP-------- 247
Query: 257 RYYR------------APELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQL 303
Y APE IF YT D+WS G +L E+ LG +PG ++
Sbjct: 248 -DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305
Query: 304 VEIIK 308
+K
Sbjct: 306 CRRLK 310
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 23/88 (26%), Positives = 38/88 (43%), Gaps = 15/88 (17%)
Query: 96 ERVVGQGSFGIVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLD-HP 144
+ +G+G+FG V +A T TVA+K + + R EL+ + + H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP 172
NVV+L T L +++EF
Sbjct: 87 NVVNLLGA--CTKPGGPLM--VIVEFCK 110
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 2e-08
Identities = 55/377 (14%), Positives = 96/377 (25%), Gaps = 122/377 (32%)
Query: 122 KKVLQDKRYK------NRELQTMRLLD-------------------------------HP 144
K +L + + T+RL
Sbjct: 43 KSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ 102
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYS--RASQRM-PLIYVKLY---- 197
S+ + +D LY N F V R+ + +A + P V +
Sbjct: 103 RQPSMMTRMYIEQ-RDRLY-NDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG 160
Query: 198 ------TYQICRALAYIH---GGI-----GVCHRD---IKPQNLLVNPHTHQVKLCDFGS 240
+C + I C+ ++ L+ +Q+ ++ S
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL----YQID-PNWTS 215
Query: 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI----DIWSVGCVLAELLLGQPLFPG 296
NI + + Y + ++ + A F
Sbjct: 216 ---RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNA--------FNL 264
Query: 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRM---PPEAVDL 353
K+L T TR T+F H + H M P E L
Sbjct: 265 SC---------KILLT-TR------FKQVTDFLSAATTTHI--SLDHHSMTLTPDEVKSL 306
Query: 354 VSRLLQYSPNLRCTAL--EAC-IHPFFY-----ELRDPNARLPNGRPFPPLFNFKPQELK 405
+ + L + R L E +P +RD A N + + +L
Sbjct: 307 LLKYL----DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWK------HVNCDKLT 356
Query: 406 GASKELLSKLIPEHARK 422
+ L+ L P RK
Sbjct: 357 TIIESSLNVLEPAEYRK 373
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 9e-04
Identities = 57/396 (14%), Positives = 103/396 (26%), Gaps = 122/396 (30%)
Query: 95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVV---SLKH 151
A+ V+ G G G+T V + + + + +LK+
Sbjct: 150 AKNVLIDGVLGS---------GKTWVALDVCLSYKVQCK---------MDFKIFWLNLKN 191
Query: 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG 211
C S E+ L+ + P R + H S R+ I +L R L
Sbjct: 192 C-NSPETVLEMLQKLLYQIDPNWTSR-SDHSSNIKLRIHSIQAEL------RRL------ 237
Query: 212 IGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLV--KGEPNISYICSRYYRAPEL 264
+ + LLV N + K+L+ + + ++ + L
Sbjct: 238 --LKSKP-YENCLLVLLNVQNAKA--WNAFNLSC-KILLTTRFKQVTDFLSAATTTHISL 291
Query: 265 IFGATEYTT--AIDIWS--VGCVLAEL----LLGQPL-----------FPG------ESG 299
+ T + + C +L L P
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351
Query: 300 VDQLVEIIKVLGTPTREEIKCMNPN-----YTEFK-FP---QIKAHP----WHKIFHKRM 346
D+L II+ + + P + FP I W +
Sbjct: 352 CDKLTTIIES-------SLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFD-----V 399
Query: 347 PPEAV-DLVSRLLQYS-----PN------------LRCTAL-EACIHPFFYELRDPNARL 387
V +V++L +YS P L+ E +H + +
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTF 459
Query: 388 PNGRPFPP-----LFNFKPQELKGASKELLSKLIPE 418
+ PP ++ LK L
Sbjct: 460 DSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRM 495
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 429 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.07 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.98 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.63 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.53 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.24 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.22 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.18 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.08 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.06 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.57 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.52 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.37 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.32 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.2 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.18 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.13 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.06 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.06 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.98 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.91 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.83 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.57 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.25 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.62 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-63 Score=459.81 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=202.8
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.++|++.+.||+|+||+||+|++..+|+.||||++.+. ...+.+|+++++.++|||||+++++|. +..
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECC
Confidence 46799999999999999999999999999999998643 234568999999999999999999984 444
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+|+|||||+|+|++.+.. .+.+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+
T Consensus 87 ~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH-~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~ 160 (275)
T 3hyh_A 87 EIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCH-RHKIVHRDLKPENLLLDEHL-NVKIADFGLSN 160 (275)
T ss_dssp EEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCTTTEEECTTC-CEEECCSSCC-
T ss_pred EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCChHHeEECCCC-CEEEeecCCCe
Confidence 6899999999988887654 467999999999999999999999 88999999999999999888 79999999998
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
.........+.+||+.|||||++.+...++.++|||||||++|+|+||+.||.+.+..+.+..+....
T Consensus 161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~------------ 228 (275)
T 3hyh_A 161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV------------ 228 (275)
T ss_dssp --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------
T ss_pred ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC------------
Confidence 87666666678999999999999877656789999999999999999999999887766666554420
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
+ .++..+|+++++||++||+.||++|||+.|+|+||||+.
T Consensus 229 -----~------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 229 -----Y------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----C------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----C------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 1 123457999999999999999999999999999999963
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-62 Score=478.04 Aligned_cols=319 Identities=33% Similarity=0.597 Sum_probs=253.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC-CCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 163 (429)
++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+++|+.|+|||||++++++..... .....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 47999999999999999999999999999999996432 234579999999999999999998754321 23346
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+|||||||+++|...+. ..+.+++..++.|++||+.||.||| ++|||||||||+|||++.++ .+||+|||+|+.
T Consensus 134 ~~ivmE~~~g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH-~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMH-SAQVIHRDLKPSNLLVNENC-ELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCSEEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred EEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCcCcCCCcCccccccCCCC-CEEEeecceeee
Confidence 88999999998877664 3578999999999999999999999 88999999999999999888 799999999986
Q ss_pred cccC-----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 244 LVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 244 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
.... ......+||+.|||||++.+...++.++||||+||++|+|++|++||.+.+..+++..|+...|.|+...+
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~ 287 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI 287 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 5332 23456789999999999988777899999999999999999999999999999999999999999987655
Q ss_pred hhcCcCccc---ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCC
Q 014174 319 KCMNPNYTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPP 395 (429)
Q Consensus 319 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~ 395 (429)
......... ..++.....+|...+ +.+++++++||++||++||.+|+|+.|+|+||||.++.++...+. ..+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~----~~~ 362 (398)
T 4b99_A 288 QAVGAERVRAYIQSLPPRQPVPWETVY-PGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPD----CAP 362 (398)
T ss_dssp C-----CHHHHHHSSCCCCCCCHHHHS-TTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCC----CSS
T ss_pred hhhhhhhhhhhhhcCCCcCCCCHHHhC-CCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccC----CCC
Confidence 433211110 123333333443333 458999999999999999999999999999999999988765432 233
Q ss_pred CCCCChhhhccCCHHHHHhhcHHHHh
Q 014174 396 LFNFKPQELKGASKELLSKLIPEHAR 421 (429)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (429)
+++++. +....+.+.+.+++.++..
T Consensus 363 ~~~~~~-~~~~~~~~~~k~~i~~ei~ 387 (398)
T 4b99_A 363 PFDFAF-DREALTRERIKEAIVAEIE 387 (398)
T ss_dssp CCCCHH-HHSCCCHHHHHHHHHHHHH
T ss_pred CCCCcc-chhhcCHHHHHHHHHHHHH
Confidence 455533 3344556666666655543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-62 Score=462.05 Aligned_cols=254 Identities=32% Similarity=0.542 Sum_probs=219.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.+|+++++||+|+||+||+|+++.+|+.||||++.+. .....+|+++|+.|+|||||+++++| .+..+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 4699999999999999999999999999999999643 23456899999999999999999998 44456
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
+|||||||++ +|.+.+.. .+.+++..++.|+.||+.||+||| ++||+||||||+||||+.++ .+||+|||+|+
T Consensus 107 ~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH-~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~ 180 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLH-GKGIIHRDLKPENILLNEDM-HIQITDFGTAK 180 (311)
T ss_dssp EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCHHHeEEcCCC-CEEEEEcCCce
Confidence 8999999985 66666543 467999999999999999999999 88999999999999999888 69999999999
Q ss_pred ecccCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 243 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 243 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
...... ...+.+||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+..+.+.++.+.
T Consensus 181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~---------- 249 (311)
T 4aw0_A 181 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL---------- 249 (311)
T ss_dssp ECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT----------
T ss_pred ecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------
Confidence 864332 23467899999999999764 4899999999999999999999999998888777777652
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHH------HhcCCCCcccCCCCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE------ACIHPFFYELRDPNA 385 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~e------ll~hp~f~~~~~~~~ 385 (429)
.+. ++..+|+++++||++||++||++|+|+.| +++||||+.+.|...
T Consensus 250 -------~~~------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 250 -------EYD------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp -------CCC------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred -------CCC------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 111 23458999999999999999999999987 689999999887654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-61 Score=461.43 Aligned_cols=254 Identities=30% Similarity=0.436 Sum_probs=215.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..|++.++||+|+||+||+|+++.+|+.||||++... ...+.+|+++|+.++|||||+++++|... ..+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEE
Confidence 3599999999999999999999999999999998543 34567899999999999999999999543 35899
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
|||||++ +|.+++.. ..+++..++.|+.||+.||.||| ++|||||||||+||||+.++ .+||+|||+|+...
T Consensus 149 vmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~ 221 (346)
T 4fih_A 149 VMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLH-AQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS 221 (346)
T ss_dssp EECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCHHHEEECCCC-CEEEecCcCceecC
Confidence 9999986 55554432 57999999999999999999999 88999999999999999988 79999999998775
Q ss_pred cC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
.. ......+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+...... .
T Consensus 222 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~---------- 289 (346)
T 4fih_A 222 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-R---------- 289 (346)
T ss_dssp SSSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-C----------
T ss_pred CCCCcccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-C----------
Confidence 44 334567899999999998664 5999999999999999999999999998887777766542100 0
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
. .....+|+++++||.+||++||++|||+.|+|+||||.+...+
T Consensus 290 -----~----------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 290 -----L----------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp -----C----------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred -----C----------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 0 0123479999999999999999999999999999999875543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-60 Score=463.55 Aligned_cols=254 Identities=30% Similarity=0.432 Sum_probs=216.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..|+++++||+|+||+||+|+++.+|+.||||++... ...+.+|+.+|+.++|||||+++++|... ..+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEEE
Confidence 4699999999999999999999999999999998643 34567899999999999999999999543 35899
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
|||||++ +|.+++. ...+++..++.|+.||+.||.||| ++|||||||||+||||+.++ .+||+|||+|+...
T Consensus 226 VmEy~~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH-~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~ 298 (423)
T 4fie_A 226 VMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLH-AQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS 298 (423)
T ss_dssp EEECCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSTTTEEECTTC-CEEECCCTTCEECC
T ss_pred EEeCCCCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHH-HCCeecccCCHHHEEEcCCC-CEEEecCccceECC
Confidence 9999986 5555443 256999999999999999999999 88999999999999999988 69999999998775
Q ss_pred cC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
.. ......+||+.|||||++.+. .|+.++|||||||++|+|++|++||.+.+..+.+..+..... +.
T Consensus 299 ~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~---------- 366 (423)
T 4fie_A 299 KEVPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PR---------- 366 (423)
T ss_dssp SSCCCBCCCEECTTTCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CC----------
T ss_pred CCCccccccccCcCcCCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CC----------
Confidence 44 344567899999999999664 599999999999999999999999999888777776654210 00
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
......+|+++++||.+||+.||++|+|+.|+|+||||.+...+
T Consensus 367 ---------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 367 ---------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp ---------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred ---------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 01123579999999999999999999999999999999875443
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-61 Score=460.38 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=209.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+++|+.|+|||||+++++|.. ...
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NGS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CCE
Confidence 45899999999999999999999999999999998643 2345689999999999999999999843 345
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
+|||||||++ +|.+.+.. +....+++..++.|+.||+.||.||| ++|||||||||+||||+.++ .+||+|||+|+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~ 173 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLTKDG-TVQLGDFGIAR 173 (350)
T ss_dssp EEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHH-HTTCEETTCCGGGEEECTTC-CEEECSTTEES
T ss_pred EEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCCHHHEEECCCC-CEEEcccccce
Confidence 8999999984 67676643 23456899999999999999999999 88999999999999999988 79999999998
Q ss_pred ecccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 243 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
...... .....+||+.|||||++.+. .|+.++|||||||+||+|+||++||.+.+..+.+.++....
T Consensus 174 ~~~~~~~~~~~~~GT~~YmAPE~l~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~----------- 241 (350)
T 4b9d_A 174 VLNSTVELARACIGTPYYLSPEICENK-PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS----------- 241 (350)
T ss_dssp CCCHHHHHHHHHHSCCTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-----------
T ss_pred eecCCcccccccCCCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-----------
Confidence 764432 23456799999999999764 59999999999999999999999999988888777776521
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
++ .++..+|+++++||.+||+.||++|||+.|+|+||||.+
T Consensus 242 --------~~---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 242 --------FP---------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp --------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred --------CC---------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 11 123457999999999999999999999999999999965
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-60 Score=463.60 Aligned_cols=332 Identities=49% Similarity=0.968 Sum_probs=288.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCC----------
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD---------- 158 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---------- 158 (429)
...+|++.+.||+|+||+||+|++..+|+.||||++..+.....+|+++++.++||||++++++|.....
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~ 84 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC------------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCccccccccccc
Confidence 3457999999999999999999999999999999998887777899999999999999999999876443
Q ss_pred -----------------------CCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCee
Q 014174 159 -----------------------KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVC 215 (429)
Q Consensus 159 -----------------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~giv 215 (429)
....++++||||+++++.+.+..+......+++..++.++.||+.||.||| +.||+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~gi~ 163 (383)
T 3eb0_A 85 DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGIC 163 (383)
T ss_dssp -------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-TTTEE
T ss_pred ccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCcCc
Confidence 345578899999999998888877777788999999999999999999999 89999
Q ss_pred eecCCCCceEecCCCCcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 014174 216 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFP 295 (429)
Q Consensus 216 H~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~ 295 (429)
||||||+|||++.+.+.+||+|||+|+............||+.|+|||++.+...++.++||||+||++|+|++|+.||.
T Consensus 164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 243 (383)
T 3eb0_A 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243 (383)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence 99999999999854348999999999987766666778899999999998876668999999999999999999999999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 014174 296 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375 (429)
Q Consensus 296 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp 375 (429)
+.+..+.+..+.+.+|.|+.+.+..+++++..+.++.+....|...++..+++++.+||++||++||.+|||+.|+|+||
T Consensus 244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (383)
T 3eb0_A 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHP 323 (383)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccCC-------CCCCCCCC--CCCCCCCCCChhhhccCCHHHHHhhcHHHHh
Q 014174 376 FFYELRD-------PNARLPNG--RPFPPLFNFKPQELKGASKELLSKLIPEHAR 421 (429)
Q Consensus 376 ~f~~~~~-------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (429)
||.++++ +....++. .+.|.+++|++.|+.....+++.+++|+..+
T Consensus 324 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 378 (383)
T 3eb0_A 324 FFDHLRNSYESEVKNNSNFPHGVNQNIPQLFNFSPYELSIIPGNVLNRILPKNFS 378 (383)
T ss_dssp GGHHHHHC------------------CCCCSCCCHHHHHHSCHHHHHHHSCC---
T ss_pred HHHHHHhhccccccccccCCCcccCCCCCCCCCCHHHHhcCCHHHHhhcCchhhc
Confidence 9998766 34444555 6778999999999998888999999887543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-60 Score=441.00 Aligned_cols=251 Identities=23% Similarity=0.342 Sum_probs=206.6
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
|++.++||+|+||+||+|.+..++..||+|++.... ..+.+|+++++.|+|||||+++++|.... ....+++|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l 106 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence 478889999999999999999999999999986432 34568999999999999999999886533 33456889
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeeecCCCCceEecC-CCCcEEEeecccce
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNP-HTHQVKLCDFGSAK 242 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g--ivH~DLkp~Nill~~-~~~~vkl~DfG~a~ 242 (429)
|||||++ +|.+.+.. .+.+++..++.|+.||+.||+||| ++| ||||||||+||||+. ++ .+||+|||+|+
T Consensus 107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH-~~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~ 180 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-TSSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCCEEecccChhheeEECCCC-CEEEEeCcCCE
Confidence 9999985 66665543 467999999999999999999999 778 999999999999985 55 79999999997
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
... .......+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+.+....+.........|
T Consensus 181 ~~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~--------- 248 (290)
T 3fpq_A 181 LKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--------- 248 (290)
T ss_dssp GCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC---------
T ss_pred eCC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC---------
Confidence 543 334456789999999998864 49999999999999999999999998776655554433211000
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
..++...++++++||.+||+.||++|||+.|+|+||||++
T Consensus 249 -----------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 249 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -----------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 1123347899999999999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-59 Score=463.40 Aligned_cols=331 Identities=71% Similarity=1.208 Sum_probs=295.5
Q ss_pred CccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCC-CCceEEE
Q 014174 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELYLN 165 (429)
Q Consensus 87 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~ 165 (429)
.....+|++.+.||+|+||.||+|++..+|+.||||++..+.....+|+++++.++||||++++++|..... .+..+++
T Consensus 50 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp CCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred CcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 344557999999999999999999999999999999998877777789999999999999999998875433 4566788
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||+++++...+..+......+++..++.++.||+.||.||| +.||+||||||+||||+.++..+||+|||+++...
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 99999999988888877777788999999999999999999999 89999999999999999776579999999999876
Q ss_pred cCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 014174 246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325 (429)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 325 (429)
.........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++.++++.+|.|..+.+..+++++
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 66666677899999999999776669999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCChhhhc
Q 014174 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELK 405 (429)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (429)
..+.++.+...+|...++..+++++.+||++||.+||.+|||+.|+|+||||.+++++....++....+.+++|+..++.
T Consensus 289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (420)
T 1j1b_A 289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELS 368 (420)
T ss_dssp CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHT
T ss_pred hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCCCCCCCccCCCCHHHhc
Confidence 99999999999999999999999999999999999999999999999999999999998888888888999999988775
Q ss_pred cCCHHHHHhhcHHH
Q 014174 406 GASKELLSKLIPEH 419 (429)
Q Consensus 406 ~~~~~~~~~~~~~~ 419 (429)
. ...+...++|+.
T Consensus 369 ~-~~~~~~~~~~~~ 381 (420)
T 1j1b_A 369 S-NPPLATILIPPH 381 (420)
T ss_dssp T-CGGGHHHHSCTT
T ss_pred c-ChhHHHhhCCHh
Confidence 4 333344444443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-60 Score=450.93 Aligned_cols=257 Identities=25% Similarity=0.340 Sum_probs=214.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEEe
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
...|++.++||+|+||+||+|+++.+|+.||||++..+.. ..+|+.+++.++|||||+++++|.. ..++|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-~~~E~~il~~l~HpnIV~l~~~~~~-----~~~~~ivmE 130 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-RVEELVACAGLSSPRIVPLYGAVRE-----GPWVNIFME 130 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CTHHHHTTTTCCCTTBCCEEEEEEE-----TTEEEEEEC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-HHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEEEe
Confidence 3469999999999999999999999999999999976543 3579999999999999999999843 345899999
Q ss_pred ccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC
Q 014174 170 FVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248 (429)
Q Consensus 170 ~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~ 248 (429)
||++ +|.+++.. .+.+++..++.|+.||+.||.||| ++|||||||||+||||+.++..+||+|||+|+......
T Consensus 131 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9985 66666643 467999999999999999999999 89999999999999999887569999999998765432
Q ss_pred C------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 249 P------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 249 ~------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
. ....+||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+..+.+..+... .+.
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~-------- 274 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGK-PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP-------- 274 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG--------
T ss_pred cccceecCCccccCccccCHHHHCCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC--------
Confidence 1 1235799999999999774 4999999999999999999999999887766665555441 000
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHH-------------hcCCCCcccCCCC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA-------------CIHPFFYELRDPN 384 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~el-------------l~hp~f~~~~~~~ 384 (429)
...+++.+|+++.+||.+||++||.+|||+.|+ |+|||+.+.+.|.
T Consensus 275 ----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr 333 (336)
T 4g3f_A 275 ----------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR 333 (336)
T ss_dssp ----------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred ----------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence 012345689999999999999999999999997 6799999887764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-60 Score=447.02 Aligned_cols=252 Identities=28% Similarity=0.434 Sum_probs=208.7
Q ss_pred cceEEeeEEccCCceEEEEEEEc---CCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
.+|++++.||+|+||+||+|++. .+++.||||++.+. .....+|+++|+.++|||||+++++|.. .
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence 57999999999999999999974 46889999998543 2345679999999999999999999844 3
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
..+|+|||||++ +|.+.+.. .+.+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH-~~~IiHRDlKp~NILl~~~g-~vKl~DFGl 172 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEG-HIKLTDFGL 172 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCCGGGEEECTTS-CEEEESSEE
T ss_pred CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHHHeEEcCCC-CEEeccccc
Confidence 458999999984 66666543 467999999999999999999999 88999999999999999988 699999999
Q ss_pred ceecccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 241 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 241 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
|+..... ....+.+||+.|||||++.+. .|+.++|||||||++|+|+||++||.+.+..+.+..+.+..
T Consensus 173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------- 242 (304)
T 3ubd_A 173 SKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--------- 242 (304)
T ss_dssp EEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred ceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC---------
Confidence 9875443 334567899999999999764 49999999999999999999999999988888777776521
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRDP 383 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~~ 383 (429)
+ .++..+|+++++||++||++||++||| ++|+++||||+.+.+.
T Consensus 243 --------~------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~ 291 (304)
T 3ubd_A 243 --------L------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWN 291 (304)
T ss_dssp --------C------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred --------C------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHH
Confidence 1 123458999999999999999999998 5799999999987653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-59 Score=456.75 Aligned_cols=328 Identities=67% Similarity=1.175 Sum_probs=296.5
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCC-CCceEEEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELYLNLV 167 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv 167 (429)
...+|++.++||+|+||+||+|++..++. ||+|++........+|+++++.++||||+++++++..... ....++++|
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 34579999999999999999999877765 9999888777777789999999999999999999876554 556778899
Q ss_pred EeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec-CCCCcEEEeecccceeccc
Q 014174 168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN-PHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~-~~~~~vkl~DfG~a~~~~~ 246 (429)
|||++++++..+..+......+++..++.++.||+.||.||| +.||+||||||+||||+ .++ .+||+|||+|+....
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~~~~ 194 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIA 194 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCT
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCCCHHHEEEcCCCC-cEEEeeCCCcccccC
Confidence 999999988887776666788999999999999999999999 88999999999999999 565 899999999998776
Q ss_pred CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 247 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.+|.|..+.+..+++++.
T Consensus 195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 274 (394)
T 4e7w_A 195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM 274 (394)
T ss_dssp TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence 66667788999999999997766799999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCChhhhcc
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKG 406 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (429)
...++.+....+...++..+++++.+||.+||++||.+|||+.|+++||||.+++++....++....|++++|+..++..
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (394)
T 4e7w_A 275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSV 354 (394)
T ss_dssp SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTTSSCCCCSCCCCHHHHHT
T ss_pred hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCCCCCCCCcCCCCHHHhhc
Confidence 99999999999998899999999999999999999999999999999999999999988888889999999999887755
Q ss_pred CCHHHHHhhcHHHH
Q 014174 407 ASKELLSKLIPEHA 420 (429)
Q Consensus 407 ~~~~~~~~~~~~~~ 420 (429)
..+++.+++|...
T Consensus 355 -~~~~~~~~~~~~~ 367 (394)
T 4e7w_A 355 -RPDLISRLVPQHA 367 (394)
T ss_dssp -CGGGHHHHSCGGG
T ss_pred -CHHHHHhhccHhh
Confidence 4477777777655
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-58 Score=443.54 Aligned_cols=280 Identities=27% Similarity=0.446 Sum_probs=215.4
Q ss_pred cccceEEeeEEccCCceEEEEEEEc---CCCcEEEEEEeecch--hhhHHHHHHHHHc-CCCCeeecceEeeecCCCCce
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 162 (429)
..++|++.+.||+|+||+||+|+++ .+++.||||.+.... ....+|+++|+.+ +|||||+++++|.. ..
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-----~~ 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK-----ND 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-----TT
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE-----CC
Confidence 3457999999999999999999875 467899999886543 3456899999998 69999999999843 34
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
++|+|||||++ +|.+.+ +.+++.+++.++.||+.||+||| ++||+||||||+|||++.+.+.+||+|||+|
T Consensus 94 ~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH-~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIH-QFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 58999999985 555543 35999999999999999999999 8999999999999999877448999999999
Q ss_pred eecccCC-----------------------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 014174 242 KVLVKGE-----------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQP 292 (429)
Q Consensus 242 ~~~~~~~-----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~ 292 (429)
+...... ...+.+||+.|+|||++.+...|+.++||||+||++|+|+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 8653321 12345799999999999887779999999999999999999999
Q ss_pred CC-CCCChHHHHHHHHHHhCCCCHHHHhhcCcCc---------------------ccccCCCc----CCCCcccccCCCC
Q 014174 293 LF-PGESGVDQLVEIIKVLGTPTREEIKCMNPNY---------------------TEFKFPQI----KAHPWHKIFHKRM 346 (429)
Q Consensus 293 pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~----~~~~~~~~~~~~~ 346 (429)
|| .+.+..+++..|...+|.+............ .....|.. ............+
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 98 4567778899999988865443322110000 00001110 0001111123468
Q ss_pred ChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 347 PPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 347 s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
|++++|||++||++||++|+|+.|+|+||||+++.
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999999999999998763
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-57 Score=427.68 Aligned_cols=260 Identities=24% Similarity=0.397 Sum_probs=192.1
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCC-------
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD------- 158 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 158 (429)
.+|++++.||+|+||+||+|+++.+|+.||||++.... ..+.+|+++|+.|+|||||+++++|...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46999999999999999999999999999999986432 334589999999999999999999875543
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEee
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD 237 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~D 237 (429)
....++|+|||||++ +|.+.+... ......++..++.++.||+.||+||| ++||+||||||+||||+.++ .+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~al~ylH-~~~IiHRDlKp~NILl~~~~-~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDD-VVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTC-CSGGGSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhc-CCCChhHHHHHHHHHHHHHHHHHHHH-HCcCccccCcHHHeEECCCC-cEEEcc
Confidence 234568999999985 555555431 11223456778899999999999999 88999999999999999888 799999
Q ss_pred cccceecccCCC-------------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 014174 238 FGSAKVLVKGEP-------------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV 304 (429)
Q Consensus 238 fG~a~~~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~ 304 (429)
||+|+....... ....+||+.|||||++.+. .|+.++|||||||++|+|++ ||.+. .+...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~ 235 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFELLY---PFSTQ--MERVR 235 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCC-CCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHH
Confidence 999987654321 2345799999999999764 59999999999999999996 77543 22222
Q ss_pred HHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 305 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
.+...........+ ...++.+.+||++||+.||.+|||+.|+|+||||.++.+|.
T Consensus 236 ~~~~~~~~~~p~~~-------------------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p~ 290 (299)
T 4g31_A 236 TLTDVRNLKFPPLF-------------------------TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290 (299)
T ss_dssp HHHHHHTTCCCHHH-------------------------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC----
T ss_pred HHHHHhcCCCCCCC-------------------------cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCCC
Confidence 22222111111110 12467889999999999999999999999999999887654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-56 Score=454.28 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=210.5
Q ss_pred CccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHH---HHHHHHcCCCCeeecceEeeec
Q 014174 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRE---LQTMRLLDHPNVVSLKHCFFST 156 (429)
Q Consensus 87 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E---~~~l~~l~h~niv~~~~~~~~~ 156 (429)
+...++|+++++||+|+||+||+|+++.+|+.||||++.+.. ....+| +.+++.++|||||+++++|
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f--- 261 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF--- 261 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE---
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE---
Confidence 445678999999999999999999999999999999996432 122233 4556667899999999999
Q ss_pred CCCCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEE
Q 014174 157 TDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 235 (429)
Q Consensus 157 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl 235 (429)
.+..++|||||||+| +|...+.. .+.+++..++.|+.||+.||.||| ++|||||||||+||||+.+| .+||
T Consensus 262 --~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH-~~gIiHRDLKPeNILld~~G-~vKL 333 (689)
T 3v5w_A 262 --HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMH-NRFVVYRDLKPANILLDEHG-HVRI 333 (689)
T ss_dssp --ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCSGGGEEECTTS-CEEE
T ss_pred --EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCchHHeEEeCCC-CEEe
Confidence 445569999999985 66665543 467999999999999999999999 89999999999999999998 6999
Q ss_pred eecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCC
Q 014174 236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD---QLVEIIKVLGT 312 (429)
Q Consensus 236 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~~i~~~~~~ 312 (429)
+|||+|+...... ..+.+||+.|||||++.....|+.++|||||||++|+|++|.+||.+.+..+ ....+...
T Consensus 334 ~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~--- 409 (689)
T 3v5w_A 334 SDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--- 409 (689)
T ss_dssp CCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC---
T ss_pred cccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC---
Confidence 9999998765443 3567899999999999755569999999999999999999999997643322 22222210
Q ss_pred CCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCCC
Q 014174 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRDP 383 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~~ 383 (429)
. ..++..+|+++++||.+||+.||.+|++ +.|+++||||+.+.|.
T Consensus 410 --------------~------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~ 459 (689)
T 3v5w_A 410 --------------A------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 459 (689)
T ss_dssp --------------C------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred --------------C------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence 0 1134468999999999999999999998 7999999999988764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-56 Score=452.60 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=221.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.++|++++.||+|+||+||+|+++.+|+.||||++... .....+|+++|+.|+|||||+++++| .....++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence 46899999999999999999999999999999998653 23456899999999999999999998 4445689
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC-CCcEEEeeccccee
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKV 243 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~-~~~vkl~DfG~a~~ 243 (429)
||||||++ +|++.+. .....+++..++.++.||+.||.||| ++||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus 231 iv~E~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH-~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 231 MIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp EEEECCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred EEEeecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 99999985 5555442 33467999999999999999999999 8899999999999999854 23799999999998
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
..........+||+.|||||++.+. .|+.++|||||||+||+|++|.+||.+.+..+.+..+........
T Consensus 307 ~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~--------- 376 (573)
T 3uto_A 307 LDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD--------- 376 (573)
T ss_dssp CCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC---------
T ss_pred ccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC---------
Confidence 8776666778899999999999774 489999999999999999999999999988888777765321111
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
......+|+++++||++||++||.+|||+.|+|+||||....++.
T Consensus 377 ----------------~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 377 ----------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp ----------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred ----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 112235799999999999999999999999999999999877664
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-53 Score=425.85 Aligned_cols=325 Identities=32% Similarity=0.516 Sum_probs=241.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.++|++++.||+|+||+||+|++..+|+.||||++... .....+|+++|+.++||||+++++++..........
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 45799999999999999999999999999999998643 233457999999999999999999986554444456
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+|+||||+++++...+.. ...+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+|+.
T Consensus 132 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH-~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVH-SAGILHRDLKPANCLVNQDC-SVKVCDFGLART 205 (458)
T ss_dssp EEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred EEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHH-hCCcCCCCCChhhEEECCCC-CEeecccccchh
Confidence 889999999988776643 467999999999999999999999 88999999999999999888 799999999987
Q ss_pred cccCC----------------------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh------
Q 014174 244 LVKGE----------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL------ 289 (429)
Q Consensus 244 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt------ 289 (429)
..... .....+||+.|+|||++.....++.++|||||||++|+|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 64221 22446789999999987666679999999999999999999
Q ss_pred -----CCCCCCCCC--------------------hHHHHHHHHHHhCCCCHHHHhhcCcCccc---ccCCCcCCCCcccc
Q 014174 290 -----GQPLFPGES--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTE---FKFPQIKAHPWHKI 341 (429)
Q Consensus 290 -----g~~pf~~~~--------------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 341 (429)
|+++|.+.+ ..+++..++..+|.|..+.+..+...... ..++......+...
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 788887755 36788899999999998877654321100 01222222223322
Q ss_pred cCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCChhhhccCCHHHHHhhcHHHHh
Q 014174 342 FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 421 (429)
Q Consensus 342 ~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (429)
+ +.+++++.+||++||.+||.+|||+.|+|+||||.+++++........+...+++ +......+.+...+.+++.
T Consensus 366 ~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~----~~~~~~~~~~~~~~~~e~~ 440 (458)
T 3rp9_A 366 F-PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN----DWMNMDEPQLRYAFVKEIQ 440 (458)
T ss_dssp S-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC----TTSCCCHHHHHHHHHHHHT
T ss_pred C-CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc----ccccCCHHHHHHHHHHHHH
Confidence 2 3579999999999999999999999999999999999887655433333322222 2234556667777777776
Q ss_pred hhCC
Q 014174 422 KQCP 425 (429)
Q Consensus 422 ~~~~ 425 (429)
.-.|
T Consensus 441 ~~~~ 444 (458)
T 3rp9_A 441 RYHP 444 (458)
T ss_dssp TTCT
T ss_pred HhCc
Confidence 5544
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=405.72 Aligned_cols=253 Identities=22% Similarity=0.322 Sum_probs=204.6
Q ss_pred cceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
.+|.+.+.||+|+||+||+|++. .++..||||++... ...+.+|+++|++++|||||++++++...
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~----- 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG----- 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence 47999999999999999999875 35789999998643 23456899999999999999999998433
Q ss_pred eEEEEEEeccc-hhHHHHHHHhh---------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC
Q 014174 162 LYLNLVLEFVP-ETVYRVAKHYS---------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH 231 (429)
Q Consensus 162 ~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~ 231 (429)
..++||||||+ |+|.+.+.... .....+++..+..++.||+.||.||| +++||||||||+||||+.++
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHRDlKp~NILl~~~~- 165 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCLVGENL- 165 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCccCHhhEEECCCC-
Confidence 34889999998 56766665421 12357999999999999999999999 88999999999999999888
Q ss_pred cEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014174 232 QVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII 307 (429)
Q Consensus 232 ~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~ 307 (429)
.+||+|||+|+....... .....||+.|||||++.+. .|+.++|||||||++|||+| |+.||.+.+..+.+..+.
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 244 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT 244 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 799999999986544322 1234689999999999765 49999999999999999998 899999988777766655
Q ss_pred HHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
+.. . ...+..+|+++.+||.+||+.||++|||+.+++ +|+.++.
T Consensus 245 ~~~--~--------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~~ 288 (299)
T 4asz_A 245 QGR--V--------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNLA 288 (299)
T ss_dssp HTC--C--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHHH
T ss_pred cCC--C--------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHHH
Confidence 421 0 012345899999999999999999999999994 5776543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=406.64 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=196.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
..+|.+.++||+|+||+||+|++. .++..||||++... ...+.+|+++|+.++|||||++++++..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~----- 114 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE----- 114 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence 347999999999999999999865 36889999998643 2345689999999999999999999843
Q ss_pred ceEEEEEEeccc-hhHHHHHHHhh-----------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHYS-----------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP 228 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~ 228 (429)
...++||||||+ |+|.+++.... .....+++..+..|+.||+.||.||| +++||||||||+||||+.
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEET
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh-cCCeecccccHhhEEECC
Confidence 334889999998 46666654321 12356999999999999999999999 889999999999999998
Q ss_pred CCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHH
Q 014174 229 HTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLV 304 (429)
Q Consensus 229 ~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~ 304 (429)
++ .+||+|||+|+....... .....||+.|||||++.+. .++.++|||||||+||||+| |+.||.+.+..+.+.
T Consensus 194 ~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 194 GL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp TT-EEEECCCC----------------CCCCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCC-CCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 88 799999999987644322 2345789999999999764 49999999999999999999 899999988777766
Q ss_pred HHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 305 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+.+.. . ...+..+++++.+||.+||+.||++|||+.|+++
T Consensus 272 ~i~~g~--~--------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 272 CITQGR--E--------------------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HHHHTC--C--------------------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred HHHcCC--C--------------------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 655421 0 0123458999999999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=417.23 Aligned_cols=325 Identities=30% Similarity=0.486 Sum_probs=250.1
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.++|++.+.||+|+||.||+|++..+|+.||||++... .....+|+++++.++||||+++++++..........
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 45799999999999999999999999999999998643 234458999999999999999999886543333345
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+|+||||++++|...+.. ...+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+|+.
T Consensus 105 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH-~~givHrDlkp~NILl~~~~-~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIH-ESGIIHRDLKPANCLLNQDC-SVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCCCCCCCHHHeEECCCC-CEEEccCCCccc
Confidence 889999999988877643 467999999999999999999999 88999999999999999888 799999999987
Q ss_pred cccCC-----------------------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-----------
Q 014174 244 LVKGE-----------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL----------- 289 (429)
Q Consensus 244 ~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt----------- 289 (429)
..... .....+||+.|+|||++.....++.++|||||||++|+|++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 64332 12567889999999987666679999999999999999998
Q ss_pred CCCCCCCCC-----------------hHHHHHHHHHHhCCCCHHHHhhcCcCcc-cc--cCCCcCCCCcccccCCCCChh
Q 014174 290 GQPLFPGES-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYT-EF--KFPQIKAHPWHKIFHKRMPPE 349 (429)
Q Consensus 290 g~~pf~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~s~~ 349 (429)
|.++|.+.+ ..+++..++..+|.|+.+.+........ .+ ..+......+...+ +.++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~ 337 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDD 337 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCHH
Confidence 556666654 3678899999999999988765432110 00 11221122222222 358999
Q ss_pred HHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCChhhhccCCHHHHHhhcHHHHhhhCC
Q 014174 350 AVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425 (429)
Q Consensus 350 l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (429)
+.+||++||++||.+|||+.|+|+||||.+++++........+...+ |+. ....+.+.+..++.+++..-.|
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~e~~~~~~ 409 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILP--FDD--WMVLSETQLRYIFLKEVQSFHP 409 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCS--SCT--TCCCCHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCC--hhh--cccCCHHHHHHHHHHHHHHhCc
Confidence 99999999999999999999999999999999886654333333322 221 2345667777777777776655
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-53 Score=414.63 Aligned_cols=318 Identities=31% Similarity=0.561 Sum_probs=237.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 162 (429)
..+|++++.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+. ||||+++++++.... ..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~---~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN---DR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---SS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---CC
Confidence 35799999999999999999999999999999988532 223447999999997 999999999885432 23
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+|+||||+++++...+.. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+|+
T Consensus 85 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~ 157 (388)
T 3oz6_A 85 DVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLH-SGGLLHRDMKPSNILLNAEC-HVKVADFGLSR 157 (388)
T ss_dssp CEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred EEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-hCCEEeCCCCHHHeEEcCCC-CEEecCCcccc
Confidence 4789999999988777653 57999999999999999999999 88999999999999999888 79999999998
Q ss_pred ecccC----------------------CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 014174 243 VLVKG----------------------EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300 (429)
Q Consensus 243 ~~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~ 300 (429)
..... ......+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65321 11234678999999999987667999999999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCcccccC------CCcCCCCcccc------------cCCCCChhHHHHHHhhcCcCC
Q 014174 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKF------PQIKAHPWHKI------------FHKRMPPEAVDLVSRLLQYSP 362 (429)
Q Consensus 301 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~------------~~~~~s~~l~~Li~~~L~~dP 362 (429)
+++..+...++.|..+.+..+...+..... .......+... ....+++++.+||++||++||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 999999999999998877654332211000 00000011111 122578999999999999999
Q ss_pred CCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCChhhhccCCHHHHHhhcHHHHh
Q 014174 363 NLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 421 (429)
Q Consensus 363 ~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (429)
.+|||+.|+|+||||..+.++............++. +....+.+.+..++.+++.
T Consensus 318 ~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 372 (388)
T 3oz6_A 318 NKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN----DNVKHSIDDYRNLVYSEIS 372 (388)
T ss_dssp GGSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC----------CCHHHHHHHHHHHHH
T ss_pred ccCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCcc----ccccCCHHHHHHHHHHHHH
Confidence 999999999999999999887765444443333222 2223445555555555543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=425.54 Aligned_cols=318 Identities=30% Similarity=0.514 Sum_probs=238.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCC-CCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 162 (429)
.++|++++.||+|+||+||+|++..+|+.||||++... .....+|+.+++.++||||+++++++..... ....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 45799999999999999999999999999999998643 2334579999999999999999999864432 2334
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+++||||+++++...+. ..+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+|+
T Consensus 141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH-~~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCCCCC-
T ss_pred eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChHhEEEeCCC-CEEEEEEEeee
Confidence 678999999998776552 35999999999999999999999 88999999999999999888 79999999998
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
...........+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+++..+++.+|.|..+.+..+.
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 213 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred ecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 87666566678899999999999775 59999999999999999999999999999999999999999999988776544
Q ss_pred cCcccc--cCCCcCCCCcccccCCC-----------CChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCC
Q 014174 323 PNYTEF--KFPQIKAHPWHKIFHKR-----------MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPN 389 (429)
Q Consensus 323 ~~~~~~--~~~~~~~~~~~~~~~~~-----------~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~ 389 (429)
.....+ ..+......+...++.. .++++++||++||.+||.+|||+.|+|+||||..+.++....
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~-- 369 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-- 369 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHS--
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCccccc--
Confidence 322211 11111222222222211 156799999999999999999999999999999877754321
Q ss_pred CCCCCCCCCCChhhhccCCHHHHHhhcHHHH
Q 014174 390 GRPFPPLFNFKPQELKGASKELLSKLIPEHA 420 (429)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (429)
.+.+..++++..+ .....+.+..++.+++
T Consensus 370 -~~~~~~~~~~~~~-~~~~~~~~~~~~~~e~ 398 (464)
T 3ttj_A 370 -APPPQIYDKQLDE-REHTIEEWKELIYKEV 398 (464)
T ss_dssp -CCC------------CCCHHHHHHHHHHHH
T ss_pred -CCCCccCCcchhh-ccCCHHHHHHHHHHHH
Confidence 1122223333222 2234455655555544
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=402.07 Aligned_cols=247 Identities=22% Similarity=0.301 Sum_probs=193.8
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
..++++.++||+|+||+||+|++. ..||||+++.. ...+.+|++++++++|||||++++++.. + .
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~--~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----D--N 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----C--e
Confidence 346899999999999999999853 35999988532 2345689999999999999999997621 1 2
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
++||||||++ +|.+.+.. ....+++..+..|+.||+.||+||| +++||||||||+||||+.++ .+||+|||+|+
T Consensus 106 ~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH-~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~ 180 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLH-AKNIIHRDMKSNNIFLHEGL-TVKIGDFGLAT 180 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCCSSSEEEETTE-EEEECCCSSCB
T ss_pred EEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCccCCccCHHHEEECCCC-cEEEeeccCce
Confidence 6789999985 55555432 3467999999999999999999999 88999999999999999888 79999999998
Q ss_pred ecccCC---CcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 243 VLVKGE---PNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 243 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
...... .....+||+.|||||++.+. ..|+.++|||||||+||||+||+.||.+.+....+..+......
T Consensus 181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~----- 255 (307)
T 3omv_A 181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYA----- 255 (307)
T ss_dssp C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCC-----
T ss_pred ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCC-----
Confidence 654322 23456899999999998643 34899999999999999999999999987776666555442111
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.|.. ..++..+++++.+||.+||+.||++|||+.++++
T Consensus 256 ------------~p~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 256 ------------SPDL------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp ------------CCCS------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred ------------CCCc------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1110 1133468999999999999999999999997654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=407.38 Aligned_cols=323 Identities=46% Similarity=0.869 Sum_probs=260.8
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhh---hHHHHHHHHHcCCCCeeecceEeeecCC--CCceEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY---KNRELQTMRLLDHPNVVSLKHCFFSTTD--KDELYL 164 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~~~~~ 164 (429)
.++|++.+.||+|+||.||+|++..+|+.||||++..+... ..++++.++.++||||+++++++..... ....++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 45799999999999999999999999999999988665433 3356677788899999999999876443 445678
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCeeeecCCCCceEecC-CCCcEEEeecccce
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-GIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAK 242 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~givH~DLkp~Nill~~-~~~~vkl~DfG~a~ 242 (429)
++||||+++++...+..+......+++..++.++.||+.||.|||. +.||+||||||+||||+. ++ .+||+|||+++
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~-~~kl~Dfg~a~ 180 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAK 180 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT-EEEECCCTTCB
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC-cEEEeeCCCce
Confidence 8999999999888777766667889999999999999999999993 469999999999999997 55 89999999998
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+.+..+.+..+.+..+.
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3e3p_A 181 KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLN 260 (360)
T ss_dssp CCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred ecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcc
Confidence 87666666677889999999999776668999999999999999999999999999999999999999999999888877
Q ss_pred cCcccccCCCcCCCCcccccCC---CCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCC-CCCC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHK---RMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFP-PLFN 398 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~---~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~-~~~~ 398 (429)
+..............|...++. ..++++.+||.+||+.||.+|||+.|+|+||||.++.++....++....+ .++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~ 340 (360)
T 3e3p_A 261 PSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFR 340 (360)
T ss_dssp TTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCTTSCCCCGGGGC
T ss_pred cchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCCCCCCCCcHHHH
Confidence 6666555554444444444332 36789999999999999999999999999999999999887777766665 5577
Q ss_pred CChhhhccCCHHHHH
Q 014174 399 FKPQELKGASKELLS 413 (429)
Q Consensus 399 ~~~~~~~~~~~~~~~ 413 (429)
+.+++.....++...
T Consensus 341 ~~~~~~~~~~~~~~~ 355 (360)
T 3e3p_A 341 FLPNEIEVMSEAQKA 355 (360)
T ss_dssp CCHHHHHHSCHHHHH
T ss_pred cCchHHHHHHHHHhh
Confidence 777777666655443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=401.57 Aligned_cols=249 Identities=21% Similarity=0.245 Sum_probs=202.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
..++++.++||+|+||+||+|+.. .+++.||||+++.. ...+.+|+.++++++|||||++++++...
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--- 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD--- 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC---
Confidence 346899999999999999999863 46789999998543 24566899999999999999999998433
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYS------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV 226 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill 226 (429)
..++||||||+ |+|.+.+.... .....+++..+..++.||+.||.||| +++||||||||+||||
T Consensus 102 --~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 --QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS-SHHVVHKDLATRNVLV 178 (308)
T ss_dssp --SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEE
T ss_pred --CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH-hCCCCCCCccccceEE
Confidence 33789999998 56666664321 11346899999999999999999999 8899999999999999
Q ss_pred cCCCCcEEEeecccceecccCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 014174 227 NPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQ 302 (429)
Q Consensus 227 ~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~ 302 (429)
+.++ .+||+|||+|+...... ......||+.|||||++.+. .|+.++|||||||+||||+| |..||.+.+..+.
T Consensus 179 ~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 179 YDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp CGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9888 79999999998764332 23446789999999999765 49999999999999999998 8999999887766
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 303 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 303 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
+..+..... ...+..+|+++.+|+.+||+.||++|||+.||+++
T Consensus 257 ~~~i~~~~~----------------------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRNRQV----------------------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCC----------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 655443110 01234589999999999999999999999999874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=393.89 Aligned_cols=282 Identities=34% Similarity=0.536 Sum_probs=229.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.+|++++.||+|+||+||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence 47999999999999999999999999999999986432 334579999999999999999999843 3358
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++||||+++++...+.. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus 77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH-~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLLINRNG-ELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEeecccceec
Confidence 89999999988776543 3467999999999999999999999 88999999999999999888 7999999999876
Q ss_pred ccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
.... ......||+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+....+.+....+..+.
T Consensus 152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence 4332 234557899999999997766689999999999999999987766 67778888889999999988776554432
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
........+............+.+++++++||++||+.||++|||+.|+|+||||.++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p 291 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence 211111222222222223344568999999999999999999999999999999987653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=401.59 Aligned_cols=319 Identities=32% Similarity=0.541 Sum_probs=243.5
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCC-CCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 163 (429)
.+|++.+.||+|+||.||+|.+..+|+.||||++... .....+|+++++.++||||+++++++..... .....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 4799999999999999999999999999999998542 1234579999999999999999999854322 11234
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+++||||++++|..++.. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus 105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ 177 (367)
T ss_dssp CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCccccCcCHHHEEEcCCC-CEEEEeeecccc
Confidence 679999998888776653 57999999999999999999999 88999999999999999888 799999999987
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+.+..|.|+.+.+..+..
T Consensus 178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 543 344567899999999998756699999999999999999999999999999999999999999999887765432
Q ss_pred Cccc---ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCC
Q 014174 324 NYTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFK 400 (429)
Q Consensus 324 ~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 400 (429)
.... ...+......+... ...+++++.+||.+||..||.+|||+.++|+||||.++.++...... ..++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~-----~~~~~~ 329 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASI-LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV-----QKYDDS 329 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGT-CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CC-----CCCCCC
T ss_pred HHHHHHHHhCCCCCCCCHHHH-CCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCC-----CCCCCC
Confidence 1110 02233333333332 34579999999999999999999999999999999999887654221 124443
Q ss_pred hhhhccCCHHHHHhhcHHHHhhhCC
Q 014174 401 PQELKGASKELLSKLIPEHARKQCP 425 (429)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (429)
-++. ....+.|.+++.++...-.|
T Consensus 330 ~~~~-~~~~~~~~~~~~~~~~~~~~ 353 (367)
T 1cm8_A 330 FDDV-DRTLDEWKRVTYKEVLSFKP 353 (367)
T ss_dssp ------CCHHHHHHHHHHHHHTCCC
T ss_pred hhhh-cCCHHHHHHHHHHHHHHhcc
Confidence 3332 44566778877777655443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=393.95 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=218.7
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++. ..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~ 86 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TE 86 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----EC
Confidence 34567999999999999999999999999999999986532 23457999999999999999999883 34
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
..+++||||+++ ++.+.+.. .+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~NIll~~~~-~~kl~DFG~ 160 (328)
T 3fe3_A 87 KTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCH-QKRIVHRDLKAENLLLDADM-NIKIADFGF 160 (328)
T ss_dssp SEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECSTTC
T ss_pred CEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCEeccCCCHHHEEEcCCC-CEEEeeccC
Confidence 458899999974 66665543 367999999999999999999999 88999999999999999888 799999999
Q ss_pred ceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+............+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~---------- 230 (328)
T 3fe3_A 161 SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK---------- 230 (328)
T ss_dssp CGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred ceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 9877666666677899999999999876655689999999999999999999999888776666555420
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNA 385 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~ 385 (429)
+. ++..+++++.+||++||..||.+|||+.++++||||........
T Consensus 231 -------~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~ 276 (328)
T 3fe3_A 231 -------YR------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDE 276 (328)
T ss_dssp -------CC------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTCC
T ss_pred -------CC------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcccc
Confidence 11 22347999999999999999999999999999999987665443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=398.36 Aligned_cols=323 Identities=32% Similarity=0.594 Sum_probs=255.8
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.++|++++.||+|+||.||+|++..++..||||++.... ....+|+++++.++||||+++++++...........
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 347999999999999999999999999999999986432 334579999999999999999999865544444568
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++||||+++++...+.. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++...
T Consensus 106 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCChHhEEECCCC-CEEEEeCcceEec
Confidence 89999999988887653 56999999999999999999999 88999999999999999888 7999999999876
Q ss_pred ccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 245 VKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 245 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
..... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+...++.+..+.+..
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 258 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 258 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 43322 23457899999999987666689999999999999999999999999999999999999999999887754
Q ss_pred cCcCc-c--cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCC
Q 014174 321 MNPNY-T--EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLF 397 (429)
Q Consensus 321 ~~~~~-~--~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~ 397 (429)
..... . ....+......+.. +...+++++.+||.+||++||.+|||+.++|+||||.+...+...... ..++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~----~~~~ 333 (364)
T 3qyz_A 259 IINLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA----EAPF 333 (364)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCC----SSCC
T ss_pred hhhhhHHHHHHhcCCccCCCHHH-hCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCC----CCcC
Confidence 32110 0 01122222222222 234579999999999999999999999999999999998766544222 2234
Q ss_pred CCChhhhccCCHHHHHhhcHHHHhhhCC
Q 014174 398 NFKPQELKGASKELLSKLIPEHARKQCP 425 (429)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (429)
.++. +......+.+..++.++...-.|
T Consensus 334 ~~~~-~~~~~~~~~~~~~~~~e~~~~~~ 360 (364)
T 3qyz_A 334 KFDM-ELDDLPKEKLKELIFEETARFQP 360 (364)
T ss_dssp CCC------CCHHHHHHHHHHHTGGGCC
T ss_pred Cccc-ccccCCHHHHHHHHHHHHHHhhh
Confidence 4432 45567788888888887766554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=401.96 Aligned_cols=250 Identities=24% Similarity=0.343 Sum_probs=202.4
Q ss_pred cceEEeeEEccCCceEEEEEEEcCC-----CcEEEEEEeecc-----hhhhHHHHHHHHHcCC-CCeeecceEeeecCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQD-----KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTDK 159 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~ 159 (429)
++|++.+.||+|+||+||+|++..+ ++.||||.+... ...+.+|+++|+.++| ||||++++++....
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~-- 141 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-- 141 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT--
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC--
Confidence 4799999999999999999997654 368999988643 2345579999999976 89999999874322
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV 226 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill 226 (429)
..++||||||+ |+|.+.+..... ....+++..+..++.||+.||.||| +++||||||||+|||+
T Consensus 142 --~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH-~~~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 --GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILL 218 (353)
T ss_dssp --SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEE
T ss_pred --CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh-hCCeecCccCccceee
Confidence 23789999998 566666654322 1345899999999999999999999 8899999999999999
Q ss_pred cCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 014174 227 NPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQ 302 (429)
Q Consensus 227 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~ 302 (429)
+.++ .+||+|||+|+....... .....||+.|||||++.+. .|+.++|||||||+||||+| |+.||.+.+..+.
T Consensus 219 ~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~ 296 (353)
T 4ase_A 219 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 296 (353)
T ss_dssp CGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred CCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9888 799999999987654432 2345789999999999775 49999999999999999998 9999998776555
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 303 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 303 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
+..++.....+ ..+..+++++.+||.+||+.||++|||+.++++|
T Consensus 297 ~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 297 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 55444321111 1234579999999999999999999999999987
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=392.10 Aligned_cols=281 Identities=35% Similarity=0.648 Sum_probs=227.1
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..++|++++.||+|+||+||+|++. +|+.||+|++.... ....+|+++++.++||||+++++++ ....
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 92 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSER 92 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSS
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCC
Confidence 3457999999999999999999984 58999999886432 3345899999999999999999998 3444
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+++||||+++++...+.. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++
T Consensus 93 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~ 167 (311)
T 3niz_A 93 CLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCH-QHRILHRDLKPQNLLINSDG-ALKLADFGLAR 167 (311)
T ss_dssp CEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred EEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCchHhEEECCCC-CEEEccCcCce
Confidence 5889999999988776653 3456999999999999999999999 88999999999999999888 79999999998
Q ss_pred ecccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 243 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
...... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV 247 (311)
T ss_dssp ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence 764332 2344578999999999977666899999999999999999999999999999999999999988876544332
Q ss_pred CcC--cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 322 NPN--YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 322 ~~~--~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
... +....+.......+.. +.+.+++++.+||++||++||.+|||+.|+|+||||+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred hccchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 210 1111111222222222 3345789999999999999999999999999999998865
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=400.68 Aligned_cols=319 Identities=31% Similarity=0.535 Sum_probs=238.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCC-CCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 163 (429)
.+|++++.||+|+||.||+|.+..+|+.||||++... .....+|+++++.++||||+++++++..... .....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 4799999999999999999999999999999998543 2334579999999999999999998854321 11234
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+++|+|+++++|..++.. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus 109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH-~~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~ 181 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH 181 (367)
T ss_dssp CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence 678999999887776542 57999999999999999999999 88999999999999999888 799999999986
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+++..+.+.+|.|..+.+..+..
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 533 234568899999999997756689999999999999999999999999999999999999999999887765432
Q ss_pred Ccc-cc--cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCC
Q 014174 324 NYT-EF--KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFK 400 (429)
Q Consensus 324 ~~~-~~--~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 400 (429)
... .+ ..+......+...+ ...++++.+||++||++||.+|||+.++|+||||.++.++.... ...+++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~-----~~~~~~~~ 333 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP-----VADPYDQS 333 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCC-----CCCCCCGG
T ss_pred HHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCC-----CCCCCCcc
Confidence 211 00 12222223333222 35789999999999999999999999999999999988876542 22234432
Q ss_pred hhhhccCCHHHHHhhcHHHHhhhCC
Q 014174 401 PQELKGASKELLSKLIPEHARKQCP 425 (429)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (429)
. +......+.|..++.++..+-.|
T Consensus 334 ~-~~~~~~~~~~~~~~~~e~~~~~~ 357 (367)
T 2fst_X 334 L-ESRDLLIDEWKSLTYDEVISFVP 357 (367)
T ss_dssp G-SSCCCCHHHHHHHHHHHHHHCCC
T ss_pred h-hhccCCHHHHHHHHHHHHHHhcc
Confidence 2 22355677888888888776544
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=387.78 Aligned_cols=284 Identities=30% Similarity=0.516 Sum_probs=229.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---------hhhHHHHHHHHHcC---CCCeeecceEeeecC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLD---HPNVVSLKHCFFSTT 157 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 157 (429)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 457999999999999999999999999999999986322 23457887777664 999999999987766
Q ss_pred CCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEee
Q 014174 158 DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD 237 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~D 237 (429)
.....++++||||+++++.+.+... ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~Nil~~~~~-~~kl~D 163 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENILVTSGG-TVKLAD 163 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCTTTEEECTTS-CEEECS
T ss_pred CCCceeEEEEehhhhcCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEcCCC-CEEEee
Confidence 5556678999999999888876542 2234999999999999999999999 88999999999999999888 799999
Q ss_pred cccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 238 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
||+++............||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+.+..+....+.+....
T Consensus 164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (308)
T 3g33_A 164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242 (308)
T ss_dssp CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 99998776665666778999999999997654 89999999999999999999999999999999999999988887654
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
+..... .....++....... ..+.+.+++++.+||.+||++||.+|||+.|+|+||||.+.
T Consensus 243 ~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 243 WPRDVS-LPRGAFPPRGPRPV-QSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SCSSCS-SCGGGSCCCCCCCH-HHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ccchhh-ccccccCCCCCCcH-HHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 432111 01111111111111 12345689999999999999999999999999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=390.64 Aligned_cols=288 Identities=32% Similarity=0.547 Sum_probs=218.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.+|++++.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .....++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~ 79 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT 79 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence 46999999999999999999999999999999986432 3456899999999999999999998 4444688
Q ss_pred EEEeccchhHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 166 LVLEFVPETVYRVAKHYSR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+||||++++|.+.+..... ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus 80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH-~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH-ENKILHRDLKPQNLLINKRG-QLKLGDFGLARA 157 (317)
T ss_dssp EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence 9999999988887765332 2246899999999999999999999 88999999999999999888 799999999987
Q ss_pred cccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 244 LVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 244 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
..... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+....
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 64332 23456789999999999775668999999999999999999999999999999999999988887765443321
Q ss_pred c--CcccccCCCcCCCCc----ccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCC
Q 014174 323 P--NYTEFKFPQIKAHPW----HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNAR 386 (429)
Q Consensus 323 ~--~~~~~~~~~~~~~~~----~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~ 386 (429)
. .+.. ..+......+ .......++.++.+||.+||+.||++|||+.++|+||||.+..+....
T Consensus 238 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~ 306 (317)
T 2pmi_A 238 KLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHASM 306 (317)
T ss_dssp GCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC----
T ss_pred hhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchhhc
Confidence 1 1100 0111111111 112234678999999999999999999999999999999998876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=384.40 Aligned_cols=276 Identities=35% Similarity=0.643 Sum_probs=220.9
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
++|++++.||+|+||+||+|++ .+|+.||+|++.... ....+|+.+++.++||||+++++++... ..+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeE
Confidence 4799999999999999999998 678999999985432 3345899999999999999999998433 348
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++||||+++++...+.. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus 76 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREG-ELKIADFGLARAF 150 (288)
T ss_dssp EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred EEEEEecCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-CEEEeECcccccc
Confidence 89999999988776653 2467999999999999999999999 88999999999999999888 7999999999765
Q ss_pred ccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+.....
T Consensus 151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence 432 2233457899999999997666689999999999999999999999999999999999998888776544332110
Q ss_pred --CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 324 --NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 324 --~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.+. ..++.....++. .+...+++++.+||++||+.||++|||+.++|+||||.+
T Consensus 231 ~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 231 LPKYD-PNFTVYEPLPWE-SFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp STTCC-TTCCCCCCCCGG-GTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccc-cccccccCccHH-HHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 000 011111111221 233568999999999999999999999999999999976
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=392.86 Aligned_cols=290 Identities=33% Similarity=0.613 Sum_probs=230.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh-----hhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
++|++++.||+|+||+||+|++..+++.||+|++..... ...+|+++++.++||||+++++++.. ....+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence 479999999999999999999999999999998864322 22369999999999999999998843 33488
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||+++++...+.. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...
T Consensus 77 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCH-RQKVLHRDLKPQNLLINERG-ELKLADFGLARAKS 151 (324)
T ss_dssp EEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred EEecccccCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence 9999999988877654 3456999999999999999999999 88999999999999999888 79999999997654
Q ss_pred cCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+......
T Consensus 152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 332 2334578999999999977666899999999999999999999999999999999999999998877655432211
Q ss_pred --cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCC
Q 014174 325 --YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGR 391 (429)
Q Consensus 325 --~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~ 391 (429)
+..+.++......+. .....+++++.+||.+||++||.+|||+.|+|+||||.++.......+...
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~ 299 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALL-SHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTT 299 (324)
T ss_dssp HHHHHTCCCCCCCCCHH-HHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTS
T ss_pred hhhcccccccccchhhh-hhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCC
Confidence 112222322222221 123467999999999999999999999999999999999887655544433
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=388.53 Aligned_cols=252 Identities=26% Similarity=0.416 Sum_probs=212.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.++|++++.||+|+||+||+|++..+|+.||||++.+. .....+|+.+++.++||||+++++++. ...
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCC
Confidence 45799999999999999999999999999999998653 233457999999999999999999884 344
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++||||+++ +|...+.. .+.+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||++
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a 152 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDG-HIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCcCCHHHEEECCCC-CEEEeeccch
Confidence 58899999986 55444432 467999999999999999999999 88999999999999999888 6999999999
Q ss_pred eeccc-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 242 KVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 242 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----------- 220 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----------- 220 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred hhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-----------
Confidence 86433 3344567899999999999764 4899999999999999999999999988776666555441
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRD 382 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~ 382 (429)
.. .++..+++++.+||.+||+.||.+|| ++.++++||||..+.+
T Consensus 221 ------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~ 269 (337)
T 1o6l_A 221 ------EI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp ------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ------CC------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCH
Confidence 01 12345799999999999999999999 9999999999988665
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=391.31 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=216.3
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----------hhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
.++|.+.+.||+|+||.||+|++..+|+.||+|++.... ..+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~----- 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE----- 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-----
Confidence 457999999999999999999999999999999986532 34568999999999999999999983
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC---cEEE
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKL 235 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~---~vkl 235 (429)
....+++||||+. ++|.+.+. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++. .+||
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDlkp~NIll~~~~~~~~~vkl 160 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKL 160 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred eCCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEeCCCCCccCEEE
Confidence 3445889999996 56655543 3467999999999999999999999 889999999999999987653 5999
Q ss_pred eecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 236 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+|||+++...........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 161 ~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 239 (361)
T 2yab_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239 (361)
T ss_dssp CCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred EecCCceEcCCCCccccCCCCccEECchHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 999999887666556677899999999998664 4899999999999999999999999998877777666543221111
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
. +...+++++++||++||..||.+|||+.++|+||||....
T Consensus 240 ~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 240 E-------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp H-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred h-------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 1 1234799999999999999999999999999999998643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-51 Score=390.88 Aligned_cols=284 Identities=30% Similarity=0.567 Sum_probs=226.7
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...++|++.+.||+|+||+||+|++..+++.||||++.... ....+|+.+++.++||||+++++++.. .
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----N 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----T
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----C
Confidence 44568999999999999999999999999999999986432 234579999999999999999999844 3
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC----CcEEEee
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT----HQVKLCD 237 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~----~~vkl~D 237 (429)
..+++||||+++++.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ ..+||+|
T Consensus 106 ~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 106 HRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCH-SRRCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp TEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred CEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCEECCCCCHHHEEEecCCCCccceEEECc
Confidence 35889999999988777654 456999999999999999999999 88999999999999995332 2599999
Q ss_pred cccceecccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 238 FGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 238 fG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
||+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+...
T Consensus 181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 9999766433 223445779999999999776668999999999999999999999999999999999999998888765
Q ss_pred HHhhcC--cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 317 EIKCMN--PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 317 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
.+.... +.+ ...++......+...+...+++++.+||.+||++||.+|||+.|+|+||||....+
T Consensus 261 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 261 TWPGVTALPDW-KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TSTTGGGSTTC-CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhh-hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 443221 111 11333444444444555568999999999999999999999999999999987653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=396.41 Aligned_cols=319 Identities=29% Similarity=0.498 Sum_probs=232.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC-CCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 162 (429)
.++|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++..... ....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 357999999999999999999999999999999986431 234579999999999999999998854331 2233
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+++||||+++++.+.+. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++
T Consensus 104 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECCCCC--
T ss_pred ceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHH-HCCeecccCCHHHEEEcCCC-CEEEEEeeccc
Confidence 678999999998877653 45899999999999999999999 88999999999999999888 79999999998
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+..+.
T Consensus 176 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 176 TAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred ccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 76555445567889999999999764 48999999999999999999999999999999999999999988877665443
Q ss_pred cCcccc--cCCCcCCCCcccccC-----------CCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCC
Q 014174 323 PNYTEF--KFPQIKAHPWHKIFH-----------KRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPN 389 (429)
Q Consensus 323 ~~~~~~--~~~~~~~~~~~~~~~-----------~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~ 389 (429)
+....+ ..+......+...++ ...+.++++||++||+.||.+|||+.|+|+||||..+.++.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~- 333 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA- 333 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTC-
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCC-
Confidence 221111 111111111111111 112578999999999999999999999999999988766532211
Q ss_pred CCCCCCCCCCChhhhccCCHHHHHhhcHHHHh
Q 014174 390 GRPFPPLFNFKPQELKGASKELLSKLIPEHAR 421 (429)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (429)
+.|.....+. +......+.|+.+++++..
T Consensus 334 --~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 362 (371)
T 2xrw_A 334 --PPPKIPDKQL-DEREHTIEEWKELIYKEVM 362 (371)
T ss_dssp --CCCCCCTTTT-CCCCCCHHHHHHHHHHHHH
T ss_pred --CCCCCCChhh-ccccCcHHHHHHHHHHHHH
Confidence 1111122222 1223455668887777654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=393.49 Aligned_cols=254 Identities=29% Similarity=0.472 Sum_probs=209.3
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
...++|+++++||+|+||+||+|++..+|+.||||++.+.. ....+|..+++.+ +||||+++++++ .
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~ 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----Q 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----E
Confidence 34467999999999999999999999999999999987532 2345788999988 799999999998 3
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
....+++||||+.+ +|...+.. ...+++..++.++.||+.||.||| ++||+||||||+||||+.++ .+||+||
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NILl~~~g-~ikL~DF 168 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLH-DKGIIYRDLKLDNVLLDHEG-HCKLADF 168 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCHHHEEECCCC-CEEEccc
Confidence 44458999999985 55554433 467999999999999999999999 88999999999999999888 6999999
Q ss_pred ccceeccc-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 239 GSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 239 G~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
|+|+.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 169 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------- 239 (353)
T 3txo_A 169 GMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-------- 239 (353)
T ss_dssp TTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--------
T ss_pred cceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--------
Confidence 99986433 2334466899999999999764 4899999999999999999999999998888777776652
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCCcccCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHPFFYELRD 382 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~------~ell~hp~f~~~~~ 382 (429)
.. .++..+++++.+||++||+.||.+|+++ .++++||||.++.+
T Consensus 240 ---------~~------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w 289 (353)
T 3txo_A 240 ---------EV------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDW 289 (353)
T ss_dssp ---------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCH
T ss_pred ---------CC------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCH
Confidence 11 1233479999999999999999999999 89999999998765
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=391.34 Aligned_cols=319 Identities=33% Similarity=0.567 Sum_probs=248.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCC-CceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~ 163 (429)
.+|.+.+.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++...... ....
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 4799999999999999999999999999999998653 13345799999999999999999998544321 1122
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
.++||||+++++...+ ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus 122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~ 193 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDC-ELKILDFGLARH 193 (371)
T ss_dssp CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECSTTCC--
T ss_pred EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCcCHHHeEECCCC-CEEEEecCcccc
Confidence 4789999998776644 345999999999999999999999 88999999999999999888 799999999986
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+..+..
T Consensus 194 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 194 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred ccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 533 234567899999999997756689999999999999999999999999999999999999999998876654432
Q ss_pred Ccccc---cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCC
Q 014174 324 NYTEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFK 400 (429)
Q Consensus 324 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 400 (429)
..... ..+......+. .+...+++++.+||++||++||.+|||+.++|+||||..++.+.......+++....
T Consensus 272 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~~~~~~~--- 347 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQPFDDSL--- 347 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSCCCCTT---
T ss_pred hhhhhhhhccCCCcchhHH-HhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcccccccccCcCcch---
Confidence 21110 11111111111 123457999999999999999999999999999999999888766544444443222
Q ss_pred hhhhccCCHHHHHhhcHHHHhhhCC
Q 014174 401 PQELKGASKELLSKLIPEHARKQCP 425 (429)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (429)
+......+.+.+.+.++..+-.|
T Consensus 348 --~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 348 --EHEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp --SSCCCCHHHHHHHHHHHHHHCCC
T ss_pred --hhcccchHHHHHHHHHHHHhccc
Confidence 22345556678888877766554
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=400.59 Aligned_cols=263 Identities=25% Similarity=0.396 Sum_probs=218.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..+|+++++||+|+||+||+|++..+++.||+|++.+. .....+|..+++.++||||++++++|. ...
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~-----~~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ-----DDN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE-----CSS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCC
Confidence 45799999999999999999999999999999998642 223568999999999999999999883 444
Q ss_pred EEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++||||+. ++|...+.. ....+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||+|
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH-~~giiHrDLKp~NILl~~~g-~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVH-QLHYVHRDIKPDNILMDMNG-HIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHH-hCCeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence 5899999996 466555543 2467999999999999999999999 88999999999999999888 6999999999
Q ss_pred eecccCCCc--cccccccccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 242 KVLVKGEPN--ISYICSRYYRAPELIF----GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 242 ~~~~~~~~~--~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+........ ...+||+.|+|||++. +...++.++|||||||++|+|++|+.||.+.+..+...+++....
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---- 298 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE---- 298 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc----
Confidence 876544332 3467999999999986 234589999999999999999999999999888888777764211
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCCcccCCCCCC
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFYELRDPNAR 386 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--R~t~~ell~hp~f~~~~~~~~~ 386 (429)
.+.+|. ....+++++++||++||+.+|++ |+++.|+++||||..+.|...+
T Consensus 299 -----------~~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~ 351 (437)
T 4aw2_A 299 -----------RFQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIR 351 (437)
T ss_dssp -----------HCCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGG
T ss_pred -----------cccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHh
Confidence 011111 11347999999999999999988 9999999999999998876543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=388.67 Aligned_cols=285 Identities=34% Similarity=0.572 Sum_probs=227.3
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---------hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++. .
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~ 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----H 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----C
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe-----e
Confidence 457999999999999999999999999999999885321 23457999999999999999999984 3
Q ss_pred ceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
....++||||+++++...+.. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~ 158 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH-QHWILHRDLKPNNLLLDENG-VLKLADFGL 158 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECCCGG
T ss_pred CCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHH-HCCEECCCCCHHHEEEcCCC-CEEEEeccc
Confidence 334789999999987765532 3456899999999999999999999 88999999999999999888 799999999
Q ss_pred ceecccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 241 AKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 241 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
++...... ......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.+.
T Consensus 159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 98764332 33456789999999999766668999999999999999999999999999999999999998888766554
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNA 385 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~ 385 (429)
..........+......++.. +...+++++.+||++||..||.+|||+.|+|+||||.+...+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred hhccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 322211111111111112111 23467899999999999999999999999999999988666543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=377.34 Aligned_cols=284 Identities=35% Similarity=0.610 Sum_probs=222.0
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
++|++++.||+|+||+||+|++..+|+.||+|++.... ....+|+++++.++||||+++++++.. ....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence 47999999999999999999999999999999885432 234579999999999999999999843 3348
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++||||++++++..+. .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus 78 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 78 HLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCH-KHNCIHRDVKPENILITKHS-VIKLCDFGFARLL 152 (311)
T ss_dssp EEEEECCSEEHHHHHH---HTSSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEeCCCchHHHHH---hhhcCCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence 8999999987655443 23467999999999999999999999 88999999999999999888 7999999999876
Q ss_pred ccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc--
Q 014174 245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 321 (429)
Q Consensus 245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 321 (429)
.... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+....+.+..+..........
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 5332 2345678999999999987666899999999999999999999999999999998888888887665443321
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
...+.....+............+.++.++.+||.+||+.||.+|||+.++|+||||.++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 111122222222111111112245899999999999999999999999999999999987754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=384.97 Aligned_cols=321 Identities=32% Similarity=0.602 Sum_probs=244.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+++++.++||||+++++++...........
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 457999999999999999999999999999999986432 233479999999999999999998754433334568
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++||||+++++.+.+.. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++...
T Consensus 90 ~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH-~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLH-GSNVIHRDLKPSNLLINSNC-DLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEEcCCC-cEEEEeccccccc
Confidence 89999999988776653 57999999999999999999999 88999999999999999888 7999999999876
Q ss_pred ccCCC-----------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014174 245 VKGEP-----------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313 (429)
Q Consensus 245 ~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 313 (429)
..... .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 43211 1234689999999998765668999999999999999999999999999988888888888877
Q ss_pred CHHHHh-hcCcC-ccc--ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCC
Q 014174 314 TREEIK-CMNPN-YTE--FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPN 389 (429)
Q Consensus 314 ~~~~~~-~~~~~-~~~--~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~ 389 (429)
...... +.... ... ...+......+. .....+++++.+||.+||..||++|||+.++|+||||....++.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~- 320 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPE- 320 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCC-
T ss_pred chhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccc-
Confidence 532111 00000 000 011111111111 123468999999999999999999999999999999999888765533
Q ss_pred CCCCC-CCCCCChhhhccCCHHHHHhhcHHHH
Q 014174 390 GRPFP-PLFNFKPQELKGASKELLSKLIPEHA 420 (429)
Q Consensus 390 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (429)
..+.| ..++++. .......+.+.+++.+++
T Consensus 321 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 351 (353)
T 2b9h_A 321 GEPIPPSFFEFDH-YKEALTTKDLKKLIWNEI 351 (353)
T ss_dssp CCCCCGGGGGGGC-CSSCCCHHHHHHHHHHHH
T ss_pred cCCCCcceeeecc-hhhcCCHHHHHHHHHHHh
Confidence 33333 3333322 222345666777776654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=391.11 Aligned_cols=255 Identities=25% Similarity=0.446 Sum_probs=208.5
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
....+|+++++||+|+||+||+|++..+++.||+|++.+.. ....+|..+++.+ +||||++++++|.
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~----- 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ----- 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----
Confidence 44568999999999999999999999999999999987542 2345788898877 8999999999983
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
....+++||||+++ +|...+.. ...+++..++.++.||+.||.||| ++||+||||||+||||+.++ .+||+||
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDLKp~NILl~~~g-~ikL~DF 197 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDSEG-HIKLTDY 197 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCEEeccCCHHHEEECCCC-CEEEeec
Confidence 44468999999986 55444432 467999999999999999999999 88999999999999999988 6999999
Q ss_pred ccceecc-cCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH--------HHH-HHHHH
Q 014174 239 GSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV--------DQL-VEIIK 308 (429)
Q Consensus 239 G~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--------~~~-~~i~~ 308 (429)
|+|+... ........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... +.+ ..+..
T Consensus 198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 276 (396)
T 4dc2_A 198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 276 (396)
T ss_dssp TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred ceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence 9998633 33445567899999999999764 5899999999999999999999999653221 111 11211
Q ss_pred HhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCCcccCC
Q 014174 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHPFFYELRD 382 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~------~ell~hp~f~~~~~ 382 (429)
. . ..++..+++++++||++||+.||.+|+++ .++++||||..+.+
T Consensus 277 ~-----------------~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 277 K-----------------Q------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp C-----------------C------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred c-----------------c------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 0 0 11334589999999999999999999985 79999999998765
Q ss_pred C
Q 014174 383 P 383 (429)
Q Consensus 383 ~ 383 (429)
.
T Consensus 328 ~ 328 (396)
T 4dc2_A 328 D 328 (396)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=387.01 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=211.9
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
...++|++++.||+|+||.||+|++..+++.||+|++.... ....+|+++++.++||||++++++|. .
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~ 86 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----D 86 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence 44568999999999999999999999999999999986432 34457999999999999999999884 3
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
...+++||||+.+ +|...+. ....+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIll~~~g-~vkL~DFG 160 (384)
T 4fr4_A 87 EEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQ-NQRIIHRDMKPDNILLDEHG-HVHITDFN 160 (384)
T ss_dssp SSEEEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCcHHHeEECCCC-CEEEeccc
Confidence 4458899999975 4444443 3567999999999999999999999 88999999999999999888 69999999
Q ss_pred cceecccCCCcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCCH
Q 014174 240 SAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD--QLVEIIKVLGTPTR 315 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~i~~~~~~~~~ 315 (429)
+++...........+||+.|+|||++.+. ..++.++|||||||++|+|++|..||...+... .+.......
T Consensus 161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~----- 235 (384)
T 4fr4_A 161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT----- 235 (384)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-----
T ss_pred eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-----
Confidence 99987666666778899999999998642 348899999999999999999999997543322 221111110
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-HHHHhcCCCCcccCC
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-ALEACIHPFFYELRD 382 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-~~ell~hp~f~~~~~ 382 (429)
...++..+++++.+||.+||+.||.+||+ +.++++||||..+.+
T Consensus 236 -----------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 236 -----------------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp -----------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred -----------------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 01123457999999999999999999998 899999999988765
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=387.37 Aligned_cols=252 Identities=27% Similarity=0.439 Sum_probs=211.5
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
...++|++.+.||+|+||+||+|++..+++.||+|++... .....+|+.+++.++||||+++++++..
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----- 80 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT----- 80 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-----
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----
Confidence 3456899999999999999999999999999999998643 2345689999999999999999999843
Q ss_pred ceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
...+++||||+++++++.+.. .+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus 81 ~~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH-~~givH~Dlkp~NIll~~~~-~~kl~DFG~ 154 (336)
T 3h4j_B 81 PTDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCH-RHKIVHRDLKPENLLLDDNL-NVKIADFGL 154 (336)
T ss_dssp SSEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HHTCCCCCCSTTTEEECTTC-CEEECCSSC
T ss_pred CCEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCchhhEEEcCCC-CEEEEEecc
Confidence 345889999999988877654 367999999999999999999999 88999999999999999888 799999999
Q ss_pred ceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+............+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.......
T Consensus 155 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------- 217 (336)
T 3h4j_B 155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------- 217 (336)
T ss_dssp TBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------------
T ss_pred ceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------------
Confidence 987766655567789999999999977654588999999999999999999999754321110
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
..+.. ....++..+++++.+||++||..||.+|||+.|+++||||..
T Consensus 218 ----------~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 218 ----------KKVNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp ----------CCCCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred ----------HHHHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 00000 011234568999999999999999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=382.87 Aligned_cols=289 Identities=29% Similarity=0.557 Sum_probs=228.0
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---------------hhhHHHHHHHHHcCCCCeeecceEeee
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------------RYKNRELQTMRLLDHPNVVSLKHCFFS 155 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~E~~~l~~l~h~niv~~~~~~~~ 155 (429)
++|++.+.||+|+||.||+|.+.. |..||||++.... ....+|+++++.++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 469999999999999999999754 8999999885321 345689999999999999999999877
Q ss_pred cCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEE
Q 014174 156 TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 235 (429)
Q Consensus 156 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl 235 (429)
.......++++||||+++++...+.. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~NIl~~~~~-~~kl 175 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLH-EAGVVHRDLHPGNILLADNN-DITI 175 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEE
T ss_pred ccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-HCcCEecCCChHHEEEcCCC-CEEE
Confidence 66566667899999999988877653 3457999999999999999999999 88999999999999999888 7999
Q ss_pred eecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 236 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 255 (362)
T 3pg1_A 176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255 (362)
T ss_dssp CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 99999986655555566788999999999877566899999999999999999999999999999999999999999887
Q ss_pred HHHhhcCcC-ccc---ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCC
Q 014174 316 EEIKCMNPN-YTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNAR 386 (429)
Q Consensus 316 ~~~~~~~~~-~~~---~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~ 386 (429)
+.+...... ... ..........+. ......++.+.+||.+||+.||.+|||+.++|+||||..+..+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~ 329 (362)
T 3pg1_A 256 EDVVMFSSPSARDYLRNSLSNVPARAWT-AVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDL 329 (362)
T ss_dssp HHHHHTSCHHHHHHTTTCCCCCCCCCHH-HHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGG
T ss_pred HHhhhccchhhhHHHHhhcccCChhhHH-hhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccc
Confidence 655432211 000 011111122222 2334578999999999999999999999999999999998776543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=378.59 Aligned_cols=251 Identities=26% Similarity=0.461 Sum_probs=214.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..+|++.+.||+|+||+||+|++..+|+.||+|++.+. .....+|..+++.++||||+++++++. ...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCC
Confidence 45799999999999999999999999999999998653 233457999999999999999999883 444
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++||||+.+ +|...+.. ...+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a 153 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLH-SKDIIYRDLKPENILLDKNG-HIKITDFGFA 153 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChheEEEcCCC-CEEEeecCcc
Confidence 68899999985 66665543 467999999999999999999999 89999999999999999888 6999999999
Q ss_pred eecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
+.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 154 ~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------- 219 (318)
T 1fot_A 154 KYVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE----------- 219 (318)
T ss_dssp EECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------
T ss_pred eecCC--ccccccCCccccCHhHhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 87533 23456899999999998764 48999999999999999999999999888777766665420
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDP 383 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~ 383 (429)
. .++..+++++.+||++||..||.+|+ ++.++++||||..+.+.
T Consensus 220 ------~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 220 ------L------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp ------C------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred ------C------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 1 12345799999999999999999999 99999999999886653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=383.73 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=215.6
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++.. ...+++
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEE
Confidence 357999999999999999999999999999999886442 344689999999999999999999844 335889
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC--CCCcEEEeeccccee
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKV 243 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~--~~~~vkl~DfG~a~~ 243 (429)
||||+++ +|.+.+. .....+++..++.++.||+.||.||| +.||+||||||+|||++. ++ .+||+|||++..
T Consensus 79 v~e~~~g~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH-~~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~ 153 (321)
T 1tki_A 79 IFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLH-SHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQ 153 (321)
T ss_dssp EECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSCC-CEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeE
Confidence 9999986 5555442 23357999999999999999999999 889999999999999986 45 799999999988
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
...........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+...........+
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----- 227 (321)
T 1tki_A 154 LKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF----- 227 (321)
T ss_dssp CCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH-----
T ss_pred CCCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh-----
Confidence 7666555667899999999999764 4799999999999999999999999998887777777664322222211
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
..++.++.+||.+||..||.+|||+.|+|+||||.+.
T Consensus 228 --------------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 228 --------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp --------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred --------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 2479999999999999999999999999999999764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=394.29 Aligned_cols=281 Identities=31% Similarity=0.542 Sum_probs=228.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHc------CCCCeeecceEeeecCCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL------DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~ 159 (429)
...+|++++.||+|+||+||+|.+..+++.||||++.... ....+|+++++.+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~--- 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR--- 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET---
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC---
Confidence 3457999999999999999999999999999999997653 3345688888887 577999999988443
Q ss_pred CceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC-cEEEeec
Q 014174 160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-QVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~-~vkl~Df 238 (429)
..+++||||+++++.+.+... ....+++..++.++.||+.||.||| +.||+||||||+||||+.++. .+||+||
T Consensus 172 --~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 --NHICMTFELLSMNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALH-KNRIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp --TEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHH-HHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred --CeEEEEEeccCCCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeEEccCCCcceEEeec
Confidence 458899999999988877652 2345999999999999999999999 889999999999999998772 2999999
Q ss_pred ccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 239 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 239 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
|+++.... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+++.++.|....+
T Consensus 247 G~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~ 323 (429)
T 3kvw_A 247 GSSCYEHQ--RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL 323 (429)
T ss_dssp TTCEETTC--CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccceecCC--cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 99976533 334568899999999997754 899999999999999999999999999999999999999999998766
Q ss_pred hhcCcCcccc---cCC---------------------------CcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH
Q 014174 319 KCMNPNYTEF---KFP---------------------------QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368 (429)
Q Consensus 319 ~~~~~~~~~~---~~~---------------------------~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~ 368 (429)
.........+ ..+ ......|...+....++++.+||++||++||++|||+
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta 403 (429)
T 3kvw_A 324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP 403 (429)
T ss_dssp HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence 5432110000 000 0112233334445568899999999999999999999
Q ss_pred HHHhcCCCCccc
Q 014174 369 LEACIHPFFYEL 380 (429)
Q Consensus 369 ~ell~hp~f~~~ 380 (429)
.|+|+||||++.
T Consensus 404 ~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 404 GQALRHPWLRRR 415 (429)
T ss_dssp HHHHTSTTTC--
T ss_pred HHHhCChhhccC
Confidence 999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=385.41 Aligned_cols=266 Identities=19% Similarity=0.211 Sum_probs=186.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh-h--hHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-Y--KNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~--~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.+|.+.++||+|+||+||+|++ +|+.||||++..... . .++|+..+..++|||||++++++.... .....++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence 3699999999999999999987 689999999865432 2 234555667889999999999886543 233457899
Q ss_pred Eeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--------CeeeecCCCCceEecCCCCcEEEeec
Q 014174 168 LEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI--------GVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 168 ~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
||||+ |+|.+.+.. ..+++..+..++.|++.||.||| +. +||||||||+||||+.++ .+||+||
T Consensus 80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH-~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DF 152 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLH-MEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADL 152 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHH-CCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH-HhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeC
Confidence 99998 566665543 56999999999999999999999 55 899999999999999988 7999999
Q ss_pred ccceecccCCCc-----ccccccccccccccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014174 239 GSAKVLVKGEPN-----ISYICSRYYRAPELIFGAT-----EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308 (429)
Q Consensus 239 G~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~ 308 (429)
|+|+........ ...+||+.|||||++.+.. .++.++|||||||+||||+||.+||......+......
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~- 231 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL- 231 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc-
Confidence 999876544322 2357999999999996542 25678999999999999999988774322110000000
Q ss_pred HhCCCCHHHHhh-cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 309 VLGTPTREEIKC-MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 309 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
....+..+.+.. .... ...|.++.. ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~---~~rp~~p~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 232 VPSDPSVEEMRKVVCEQ---KLRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCSSCCHHHHHHHHTTS---CCCCCCCGG----GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccccchHHHHHHHHhcc---cCCCCCCcc----ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 000000000000 0000 000111000 0011134578899999999999999999999863
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=392.64 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=215.4
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...+|+++++||+|+||+||+|++..+++.||+|++.+. .....+|+.+++.++||||++++++| ...
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence 345799999999999999999999999999999998642 23356899999999999999999998 444
Q ss_pred eEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
.++++||||++ ++|..++.. ..+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH-~~givHrDLKp~NILl~~~g-~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIH-SMGFIHRDVKPDNMLLDKSG-HLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCCHHHeeECCCC-CEEEeccce
Confidence 56899999996 466555532 46999999999999999999999 88999999999999999888 699999999
Q ss_pred ceecccCCC--cccccccccccccccccCCCC---CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 241 AKVLVKGEP--NISYICSRYYRAPELIFGATE---YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 241 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
|+....... ....+||+.|+|||++.+... ++.++|||||||++|+|++|+.||.+.+......++.....
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---- 290 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN---- 290 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc----
Confidence 987654432 235689999999999975432 77899999999999999999999999888877777765310
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCC--CCCHHHHhcCCCCcccCCC
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL--RCTALEACIHPFFYELRDP 383 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~--R~t~~ell~hp~f~~~~~~ 383 (429)
.+.+|. ...+++++++||++||+.+|.+ |+++.|+++||||+.+.+.
T Consensus 291 -----------~~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 291 -----------SLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp -----------HCCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred -----------cccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 011111 1247999999999999999988 9999999999999987664
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=384.16 Aligned_cols=253 Identities=26% Similarity=0.471 Sum_probs=212.4
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceEeeecCCCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 160 (429)
...+|++.+.||+|+||+||+|++..+|+.||||++.+.. ....+|..+++.+ +||||+++++++. .
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~-----~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----T 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----C
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE-----e
Confidence 3457999999999999999999999999999999996532 2345688888876 9999999999883 3
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
...+++||||+++ +|...+.. ...+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~vkL~DFG 163 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLH-SKGIVYRDLKLDNILLDKDG-HIKIADFG 163 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCChhhEEECCCC-CEEEeECh
Confidence 4458999999975 66555543 367999999999999999999999 88999999999999999888 69999999
Q ss_pred cceecccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 240 SAKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 240 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
+++..... ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-------- 234 (345)
T 1xjd_A 164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN-------- 234 (345)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred hhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------
Confidence 99864332 334567899999999999764 48999999999999999999999999888776666654410
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCCCcccCC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL-EACIHPFFYELRD 382 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~-ell~hp~f~~~~~ 382 (429)
..++..+++++.+||.+||..||++|||+. ++++||||..+.+
T Consensus 235 ---------------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 235 ---------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred ---------------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 012335799999999999999999999998 9999999998765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=377.22 Aligned_cols=256 Identities=23% Similarity=0.381 Sum_probs=214.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----------hhhhHHHHHHHHHcCCCCeeecceEeeecCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 158 (429)
..++|.+.+.||+|+||.||+|++..+|+.||+|++... ...+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---- 84 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE---- 84 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence 345799999999999999999999999999999998643 234568999999999999999999884
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC---cEE
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVK 234 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~---~vk 234 (429)
....+++||||+.+ +|.+.+. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++. .+|
T Consensus 85 -~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~NIll~~~~~~~~~~k 158 (326)
T 2y0a_A 85 -NKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIK 158 (326)
T ss_dssp -CSSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESCSSSSSCCEE
T ss_pred -eCCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHH-HCCeEcCCCCHHHEEEecCCCCCCCEE
Confidence 34458899999974 6655543 3467999999999999999999999 889999999999999987652 599
Q ss_pred EeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 235 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 235 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
|+|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (326)
T 2y0a_A 159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237 (326)
T ss_dssp ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred EEECCCCeECCCCCccccccCCcCcCCceeecCC-CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence 9999999887655555567899999999998654 489999999999999999999999998887777666554322111
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
.. ....++..+.+||++||..||.+|||+.++|+||||...
T Consensus 238 ~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 238 DE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp HH-------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred cc-------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 11 123478999999999999999999999999999999753
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=388.59 Aligned_cols=263 Identities=28% Similarity=0.455 Sum_probs=216.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..++|+++++||+|+||+||+|+++.+|+.||||++.+. .....+|..++..++||||++++++| .+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence 345799999999999999999999999999999998642 23356799999999999999999988 444
Q ss_pred eEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
.++|+||||+. ++|...+.. ....+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH-~~giiHrDLKp~NILld~~g-~vkL~DFGl 208 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVH-RLGYVHRDIKPDNILLDRCG-HIRLADFGS 208 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred CEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecccCHHHeeecCCC-CEEEeechh
Confidence 56899999996 566666543 2357999999999999999999999 88999999999999999888 699999999
Q ss_pred ceecccCCC--cccccccccccccccccC------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014174 241 AKVLVKGEP--NISYICSRYYRAPELIFG------ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312 (429)
Q Consensus 241 a~~~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 312 (429)
|+....... ....+||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+.+..+...++.....
T Consensus 209 a~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~- 287 (412)
T 2vd5_A 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKE- 287 (412)
T ss_dssp CEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-
T ss_pred heeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-
Confidence 987654433 234579999999999862 24589999999999999999999999999888777777654210
Q ss_pred CCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCC---CCHHHHhcCCCCcccCCCCCC
Q 014174 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR---CTALEACIHPFFYELRDPNAR 386 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R---~t~~ell~hp~f~~~~~~~~~ 386 (429)
...+|. +...+|+++++||++||+ +|.+| +++.|+++||||..+.|...+
T Consensus 288 --------------~~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 288 --------------HLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR 340 (412)
T ss_dssp --------------HCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred --------------CcCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 001111 123579999999999999 99998 499999999999998886554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=380.23 Aligned_cols=254 Identities=25% Similarity=0.450 Sum_probs=207.3
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
....+|++++.||+|+||.||+|++..+++.||||++.+.. ....+|..+++.+ +||||+++++++.
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~----- 80 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ----- 80 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----
Confidence 44568999999999999999999999999999999997542 2345789999887 8999999999983
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
....+++||||+++ +|...+.. ...+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+||
T Consensus 81 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~~kL~DF 154 (345)
T 3a8x_A 81 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLH-ERGIIYRDLKLDNVLLDSEG-HIKLTDY 154 (345)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCG
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCHHHEEECCCC-CEEEEec
Confidence 34468999999975 55555433 367999999999999999999999 88999999999999999888 6999999
Q ss_pred ccceeccc-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh--------HH-HHHHHHH
Q 014174 239 GSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG--------VD-QLVEIIK 308 (429)
Q Consensus 239 G~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~-~~~~i~~ 308 (429)
|+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||..... .. ....+..
T Consensus 155 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~ 233 (345)
T 3a8x_A 155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 233 (345)
T ss_dssp GGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred cccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence 99986432 3334566899999999999764 489999999999999999999999975321 11 1111111
Q ss_pred HhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH------HHHhcCCCCcccCC
Q 014174 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHPFFYELRD 382 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~------~ell~hp~f~~~~~ 382 (429)
. . ..++..++.++.+||++||+.||.+||++ .++++||||..+.+
T Consensus 234 ~-----------------~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 234 K-----------------Q------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp C-----------------C------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred C-----------------C------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 0 0 01334579999999999999999999995 89999999988765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=372.80 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=210.8
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
..+|++.+.||+|+||+||+|.+..+|+.||+|++... .....+|+.+++.++||||+++++++... ..++
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence 34799999999999999999999999999999998543 33456899999999999999999988543 3478
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+.+ +|.+.+.. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++...
T Consensus 94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI 166 (297)
T ss_dssp EEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCHHHEEECCCC-CEEEeeCCCceec
Confidence 99999964 55555432 46999999999999999999999 88999999999999999888 7999999999876
Q ss_pred ccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+.... .+.
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-~~~--------- 235 (297)
T 3fxz_A 167 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPE--------- 235 (297)
T ss_dssp CSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCC---------
T ss_pred CCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCC---------
Confidence 5433 23456789999999999765 48999999999999999999999999887776665554421 110
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
...+..++..+.+||.+||+.||.+|||+.++++||||....
T Consensus 236 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 236 ----------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp ----------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ----------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 001234789999999999999999999999999999997643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=381.75 Aligned_cols=259 Identities=29% Similarity=0.381 Sum_probs=210.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
.++|++.+.||+|+||+||+|.+..+|+.||||++... .....+|+.+++.++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----- 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----- 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----
Confidence 35799999999999999999999999999999998532 2445689999999999999999998844
Q ss_pred ceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC--cEEEee
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCD 237 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~--~vkl~D 237 (429)
...+++||||++ ++|...+.........+++..++.++.||+.||.||| ++||+||||||+|||++.++. .+||+|
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-DNNIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCChHHeEEecCCCCCcEEEec
Confidence 335889999998 5665655554444556999999999999999999999 889999999999999986542 499999
Q ss_pred cccceecccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 238 FGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 238 fG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.. ......+..........
T Consensus 177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR 254 (351)
T ss_dssp CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred CcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence 999987655432 3456789999999999764 48999999999999999999999998743 33333333321111111
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
. ...+++++.+||.+||..||++|||+.++|+||||.+..
T Consensus 255 ~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 255 Q-------------------------WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp H-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred c-------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 1 124789999999999999999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=380.92 Aligned_cols=290 Identities=29% Similarity=0.479 Sum_probs=226.5
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC---C
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---K 159 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~ 159 (429)
..++|++++.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++..... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4568999999999999999999999999999999885432 234579999999999999999998865431 1
Q ss_pred CceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
....+++||||+++++...+.. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg 169 (351)
T 3mi9_A 95 CKGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIH-RNKILHRDMKAANVLITRDG-VLKLADFG 169 (351)
T ss_dssp --CEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred CCceEEEEEeccCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCHHHEEEcCCC-CEEEccch
Confidence 1345789999999988776653 2356999999999999999999999 88999999999999999888 79999999
Q ss_pred cceecccC-----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 240 SAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 240 ~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
+++..... .......||+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+....+..+....+.+.
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99876422 2224457899999999997766689999999999999999999999999999999999998888776
Q ss_pred HHHHhhcCcC--cccccCCCcCCCCccccc-CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 315 REEIKCMNPN--YTEFKFPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 315 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
.+.+...... +................+ ....++.+.+||.+||++||.+|||+.|+|+||||.....+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 5543322110 001111100000000000 00137789999999999999999999999999999865444
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=380.21 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=214.1
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
...++|++++.||+|+||.||+|++..+|+.||||++.+.. ....+|+++++.++||||+++++++. .
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----D 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----c
Confidence 34568999999999999999999999999999999986432 23457999999999999999999883 3
Q ss_pred ceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
...+++||||++ ++|...+.. .+.+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~g-~~kL~DFg 186 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQG-YIQVTDFG 186 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCccceEEECCCC-CEEEcccc
Confidence 446889999997 466665543 357999999999999999999999 88999999999999999888 69999999
Q ss_pred cceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
+++..... ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 187 ~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------- 254 (350)
T 1rdq_E 187 FAKRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--------- 254 (350)
T ss_dssp TCEECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred cceeccCC--cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC---------
Confidence 99876432 3456899999999999764 48999999999999999999999999888777666665420
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRD 382 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~ 382 (429)
. .++..+++++.+||.+||+.||.+||+ +.++++||||..+.+
T Consensus 255 --------~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w 302 (350)
T 1rdq_E 255 --------V------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp --------C------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred --------C------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence 0 123457999999999999999999998 999999999987654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=391.32 Aligned_cols=289 Identities=30% Similarity=0.527 Sum_probs=212.4
Q ss_pred ceEE-eeEEccCCceEEEEEEEc--CCCcEEEEEEeecch--hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMA-ERVVGQGSFGIVFQAKCL--ETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.|.+ .++||+|+||+||+|++. .+++.||||++.... ....+|+.+++.++||||+++++++.... ...+++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~~~l 97 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWL 97 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCeEEE
Confidence 4777 458999999999999965 578999999986542 34568999999999999999999986532 345889
Q ss_pred EEeccchhHHHHHHHhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe----cCCCCcEEEee
Q 014174 167 VLEFVPETVYRVAKHYSRA-----SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV----NPHTHQVKLCD 237 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill----~~~~~~vkl~D 237 (429)
||||++++++..+...... ...+++..++.++.||+.||.||| +.||+||||||+|||| +.++ .+||+|
T Consensus 98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH-~~~ivH~Dlkp~NIll~~~~~~~~-~~kl~D 175 (405)
T 3rgf_A 98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMGEGPERG-RVKIAD 175 (405)
T ss_dssp EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECCSSTTTT-CEEECC
T ss_pred EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH-hCCEeCCCcCHHHeEEecCCCCCC-cEEEEE
Confidence 9999999988877653321 235999999999999999999999 8899999999999999 5555 799999
Q ss_pred cccceecccC----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---------HHHHH
Q 014174 238 FGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG---------VDQLV 304 (429)
Q Consensus 238 fG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~ 304 (429)
||+|+..... .......||+.|+|||++.+...++.++|||||||++|+|++|++||.+... .+++.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~ 255 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD 255 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence 9999876432 2234567899999999997766689999999999999999999999987654 47888
Q ss_pred HHHHHhCCCCHHHHhhcCcCcc------cc---cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 014174 305 EIIKVLGTPTREEIKCMNPNYT------EF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375 (429)
Q Consensus 305 ~i~~~~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp 375 (429)
.++..+|.|....+..+...-. .+ .+.......+........++.+.+||++||++||.+|||+.|+|+||
T Consensus 256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp 335 (405)
T 3rgf_A 256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDP 335 (405)
T ss_dssp HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 9999999888765543211000 00 00000000001111223478999999999999999999999999999
Q ss_pred CCcccCCCCC
Q 014174 376 FFYELRDPNA 385 (429)
Q Consensus 376 ~f~~~~~~~~ 385 (429)
||.+...+..
T Consensus 336 ~f~~~~~~~~ 345 (405)
T 3rgf_A 336 YFLEDPLPTS 345 (405)
T ss_dssp GGTSSSCCCS
T ss_pred hhccCCCCcc
Confidence 9988666543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=384.68 Aligned_cols=261 Identities=25% Similarity=0.439 Sum_probs=197.4
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
...++|++++.||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++.. ...+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~~ 91 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHL 91 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEee-----CCEE
Confidence 34568999999999999999999999999999999986543 445689999999999999999999843 3458
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC-cEEEeecccce
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAK 242 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~-~vkl~DfG~a~ 242 (429)
++||||+.+ +|...+.. .+.+++..++.++.||+.||.||| ++||+||||||+|||++.++. .+||+|||+++
T Consensus 92 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH-~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 92 AIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 899999974 66555543 357999999999999999999999 889999999999999986652 49999999998
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~---------- 236 (361)
T 3uc3_A 167 SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILS---------- 236 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHT----------
T ss_pred cccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhc----------
Confidence 6554545556789999999999977664455599999999999999999999875543333332221100
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
..+.++. ...+++++.+||++||..||.+|||+.++++||||....
T Consensus 237 ---~~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~ 282 (361)
T 3uc3_A 237 ---VKYSIPD----------DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL 282 (361)
T ss_dssp ---TCCCCCT----------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred ---CCCCCCC----------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence 0001111 124789999999999999999999999999999996643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=382.30 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=212.8
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceEeeecCCCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 160 (429)
...+|++++.||+|+||+||+|++..+|+.||||++.+.. ....+|..++..+ +||||+++++++ ..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 3457999999999999999999999999999999986532 2345688888887 799999999988 34
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
...+|+||||+++ +|...+.. .+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIll~~~g-~vkL~DFG 166 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQ-SKGIIYRDLKLDNVMLDSEG-HIKIADFG 166 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCEEeccCCHHHEEEcCCC-cEEEEeCC
Confidence 4468999999975 66555543 357999999999999999999999 88999999999999999888 69999999
Q ss_pred cceeccc-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 240 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 240 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--------- 236 (353)
T 2i0e_A 167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--------- 236 (353)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC---------
T ss_pred cccccccCCcccccccCCccccChhhhcCC-CcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC---------
Confidence 9986432 3334567899999999999764 4899999999999999999999999988877777666552
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDP 383 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~ 383 (429)
.. .++..+++++.+||++||..||.+|| ++.++++||||..+.+.
T Consensus 237 --------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 237 --------NV------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp --------CC------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred --------CC------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 01 12345799999999999999999999 46999999999887653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=385.73 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=208.4
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh-------hhHHHHHH-HHHcCCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~ 159 (429)
....+|++++.||+|+||+||+|++..+++.||||++.+... ...+|..+ ++.++||||++++++|.
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~----- 109 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ----- 109 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----
Confidence 345689999999999999999999999999999999865431 12234444 46689999999999883
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
....+|+||||+++ +|...+.. ...+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+||
T Consensus 110 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~givHrDlkp~NIll~~~g-~ikL~DF 183 (373)
T 2r5t_A 110 TADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLH-SLNIVYRDLKPENILLDSQG-HIVLTDF 183 (373)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCC
T ss_pred eCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCHHHEEECCCC-CEEEeeC
Confidence 34468999999985 55555433 467999999999999999999999 88999999999999999988 6999999
Q ss_pred ccceeccc-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 239 GSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 239 G~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
|+++.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 184 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-------- 254 (373)
T 2r5t_A 184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ-PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-------- 254 (373)
T ss_dssp CBCGGGBCCCCCCCSBSCCCCCCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--------
T ss_pred ccccccccCCCccccccCCccccCHHHhCCC-CCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--------
Confidence 99986433 3344567899999999999764 4899999999999999999999999988877777666542
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH----HHHhcCCCCcccCCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA----LEACIHPFFYELRDP 383 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~----~ell~hp~f~~~~~~ 383 (429)
.. .++..++.++++||++||+.||.+|+++ .++++||||..+.+.
T Consensus 255 ---------~~------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 255 ---------PL------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp ---------CC------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred ---------cc------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 00 1234579999999999999999999987 699999999887653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=383.70 Aligned_cols=255 Identities=29% Similarity=0.429 Sum_probs=212.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 457999999999999999999999999999999986532 34457999999999999999999883 4445
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC--CcEEEeeccc
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGS 240 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~--~~vkl~DfG~ 240 (429)
.++||||+.+ +|.+.+. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ ..+||+|||+
T Consensus 103 ~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 8899999986 5555443 2467999999999999999999999 88999999999999998653 2599999999
Q ss_pred ceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+.............||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+......
T Consensus 178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~-------- 248 (362)
T 2bdw_A 178 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD-------- 248 (362)
T ss_dssp CBCCTTCCSCCCSCSCTTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------
T ss_pred ceEecCCcccccCCCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC--------
Confidence 9887665555567899999999999664 4899999999999999999999999988777666665542111
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
++. . ....+++++.+||.+||..||.+|||+.++|+||||...
T Consensus 249 ---------~~~---~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 249 ---------YPS---P-----EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ---------CCT---T-----GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ---------CCc---c-----cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 110 0 112478999999999999999999999999999999753
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=380.20 Aligned_cols=319 Identities=33% Similarity=0.562 Sum_probs=244.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCC-CceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~ 163 (429)
.+|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++...... ....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 46999999999999999999999999999999986432 2345799999999999999999988543221 1123
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
.++||||+++++...+ ...+++..++.++.||+.||.||| ++||+||||||+||+++.++ .+||+|||+++.
T Consensus 104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH-~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDC-ELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence 5789999998765543 245999999999999999999999 88999999999999999888 799999999976
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... .....+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..|.+..+.+..+..
T Consensus 176 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 176 ADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred CCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 5332 34567899999999987756689999999999999999999999999999999999999999988776654432
Q ss_pred Ccccc---cCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCC
Q 014174 324 NYTEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFK 400 (429)
Q Consensus 324 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 400 (429)
..... ..+......+. .+...+++++.+||.+||+.||++|||+.++|+||||..++.+........+ ++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~----~~~~ 328 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQP----FDDS 328 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSSC----CCCT
T ss_pred HHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCCC----Cccc
Confidence 21100 11111111111 1234579999999999999999999999999999999998877554333222 2222
Q ss_pred hhhhccCCHHHHHhhcHHHHhhhCC
Q 014174 401 PQELKGASKELLSKLIPEHARKQCP 425 (429)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (429)
. +....+.+.|.+.+.++...-.|
T Consensus 329 ~-~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 329 L-EHEKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp T-TTCCCCHHHHHHHHHHHHHTCCC
T ss_pred h-hhccCCHHHHHHHHHHHHHhhcc
Confidence 2 22345566778777777665444
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=390.32 Aligned_cols=255 Identities=28% Similarity=0.394 Sum_probs=210.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++ .....
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCE
Confidence 457999999999999999999999999999999986532 3356899999999999999999988 34446
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC--CCcEEEeeccc
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH--THQVKLCDFGS 240 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~--~~~vkl~DfG~ 240 (429)
.++||||+.+ +|.+.+.. ...+++..+..++.||+.||.||| +.||+||||||+|||++.+ ...+||+|||+
T Consensus 85 ~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH-~~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 8899999985 55555543 467999999999999999999999 8899999999999999842 23799999999
Q ss_pred ceecccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 241 AKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 241 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
+........ .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+........
T Consensus 160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~----- 233 (444)
T 3soa_A 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP----- 233 (444)
T ss_dssp CBCCCTTCCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-----
T ss_pred eEEecCCCceeecccCCcccCCHHHhcCC-CCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC-----
Confidence 977654332 3456899999999999664 489999999999999999999999998887777766655321111
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
. .....+++++.+||.+||+.||.+|||+.++|+||||...
T Consensus 234 ------------~--------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 234 ------------S--------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp ------------T--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred ------------c--------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 0 0113479999999999999999999999999999999753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=372.81 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=205.1
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------------------------------hhhHHHHHH
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------------------------RYKNRELQT 137 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~E~~~ 137 (429)
...++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 44568999999999999999999999999999999986432 335679999
Q ss_pred HHHcCCCCeeecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeee
Q 014174 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 217 (429)
Q Consensus 138 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~ 217 (429)
++.++||||+++++++... ....+++||||++++.+..+ .....+++..++.++.||+.||.||| +.||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~ 161 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEV----PTLKPLSEDQARFYFQDLIKGIEYLH-YQKIIHR 161 (298)
T ss_dssp HHTCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCS----SCSSCCCHHHHHHHHHHHHHHHHHHH-HTTEECC
T ss_pred HHhCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecc
Confidence 9999999999999988542 23468899999986432211 22467999999999999999999999 8899999
Q ss_pred cCCCCceEecCCCCcEEEeecccceecccCCC-cccccccccccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCCC
Q 014174 218 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLF 294 (429)
Q Consensus 218 DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~~pf 294 (429)
||||+|||++.++ .+||+|||+++....... .....||+.|+|||++.+... ++.++|||||||++|+|++|+.||
T Consensus 162 Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 162 DIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999999999888 799999999987654332 234678999999999865432 377899999999999999999999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 295 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 295 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.+.+.......+.... ..++ ....+++++.+||.+||+.||++|||+.++++|
T Consensus 241 ~~~~~~~~~~~~~~~~-----------------~~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 241 MDERIMCLHSKIKSQA-----------------LEFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CCSSHHHHHHHHHHCC-----------------CCCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCccHHHHHHHHhccc-----------------CCCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 8876655444433310 0111 113478999999999999999999999999999
Q ss_pred CCCc
Q 014174 375 PFFY 378 (429)
Q Consensus 375 p~f~ 378 (429)
|||.
T Consensus 294 p~~~ 297 (298)
T 2zv2_A 294 PWVT 297 (298)
T ss_dssp HHHH
T ss_pred cccc
Confidence 9995
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=369.67 Aligned_cols=290 Identities=33% Similarity=0.534 Sum_probs=233.2
Q ss_pred ccccceEEeeEEccCCceEEEEEEEc-CCCcEEEEEEeecch------hhhHHHHHHHHHc---CCCCeeecceEeeecC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCL-ETGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTT 157 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~------~~~~~E~~~l~~l---~h~niv~~~~~~~~~~ 157 (429)
...++|++.+.||+|+||.||+|++. .+|+.||+|++.... ....+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 34568999999999999999999995 678999999885432 2345788877776 8999999999886544
Q ss_pred CCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEee
Q 014174 158 DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD 237 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~D 237 (429)
.......++||||+++++.+.+... ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH-~~gi~H~dlkp~Nili~~~~-~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTSSG-QIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECS
T ss_pred cCCCceEEEEEecCCCCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCHHHeEEcCCC-CEEEec
Confidence 4456678999999999888877642 2345999999999999999999999 88999999999999999888 799999
Q ss_pred cccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 238 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
||+++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred CcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence 9999876544444556789999999999764 489999999999999999999999999999999999999888887665
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
+....... ...+..... .....+...++..+.+||.+||..||.+|||+.++++||||.++....
T Consensus 243 ~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 243 WPRDVALP-RQAFHSKSA-QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp SCTTCSSC-GGGSCCCCC-CCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred Cccccccc-hhhhcccCc-chhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 43211100 001111111 112234456899999999999999999999999999999999887654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=376.25 Aligned_cols=277 Identities=26% Similarity=0.436 Sum_probs=220.6
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcC-----CCCeeecceEeeecCCCCc
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-----HPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----h~niv~~~~~~~~~~~~~~ 161 (429)
.++|+++++||+|+||+||+|++..+++.||||++.... ....+|+.+++.+. ||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~----- 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY----- 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-----
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-----
Confidence 357999999999999999999999999999999986533 33457999999986 99999999988543
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC-------------
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP------------- 228 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~------------- 228 (429)
..+++||||++++|.+.+... ....+++..++.++.||+.||.||| +.||+||||||+|||++.
T Consensus 109 ~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 109 DHMCLIFEPLGPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLR-KMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp TEEEEEECCCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred CeeEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCcccEEEccccccccccchhcc
Confidence 358899999988888877642 2346999999999999999999999 889999999999999975
Q ss_pred ------------CCCcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 014174 229 ------------HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPG 296 (429)
Q Consensus 229 ------------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 296 (429)
++ .+||+|||+++.... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+
T Consensus 186 ~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 186 TDGKKIQIYRTKST-GIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNL-GWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp TTCCEEEEEEESCC-CEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccCCC-CEEEEeccCceecCC--CCcCccCcccccCcHHHcCC-CCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 44 799999999986533 23456789999999999765 489999999999999999999999999
Q ss_pred CChHHHHHHHHHHhCCCCHHHHhhcCcCcc-cc--------cCCCcCCC--------CcccccCCCCChhHHHHHHhhcC
Q 014174 297 ESGVDQLVEIIKVLGTPTREEIKCMNPNYT-EF--------KFPQIKAH--------PWHKIFHKRMPPEAVDLVSRLLQ 359 (429)
Q Consensus 297 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~--------~~~~~~~~--------~~~~~~~~~~s~~l~~Li~~~L~ 359 (429)
.+..+.+..+....+.++...+........ .+ ..+..... .....+....++.+.+||.+||+
T Consensus 262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 341 (360)
T 3llt_A 262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ 341 (360)
T ss_dssp SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence 999999988888888777665543221110 00 00000000 00000111235788899999999
Q ss_pred cCCCCCCCHHHHhcCCCCc
Q 014174 360 YSPNLRCTALEACIHPFFY 378 (429)
Q Consensus 360 ~dP~~R~t~~ell~hp~f~ 378 (429)
+||.+|||+.|+|+||||+
T Consensus 342 ~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 342 IDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SSGGGSCCHHHHTTSGGGC
T ss_pred CChhhCCCHHHHhcCcccC
Confidence 9999999999999999995
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=375.86 Aligned_cols=282 Identities=33% Similarity=0.589 Sum_probs=227.4
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++.. .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~ 96 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-----K 96 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----C
Confidence 34568999999999999999999999999999999885432 223479999999999999999999843 3
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
...++||||++++++..+.. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~ 171 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCH-SHNIIHRDIKPENILVSQSG-VVKLCDFGFA 171 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred CEEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH-HCCEEccCcChheEEEcCCC-cEEEEeCCCc
Confidence 45889999999876665432 3467999999999999999999999 88999999999999999888 7999999999
Q ss_pred eecccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 242 KVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 242 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
....... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.........
T Consensus 172 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 172 RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred eeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 7654332 234457899999999997765689999999999999999999999999999999999998888776654332
Q ss_pred --cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 321 --MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 321 --~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
..+.+.....+.+..........+.+++.+.+||.+||+.||.+|||+.|+|+||||..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 22333344444444433333344568999999999999999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=365.07 Aligned_cols=256 Identities=29% Similarity=0.438 Sum_probs=206.5
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
..++|.+.+.||+|+||.||+|++..++..||+|++.... ....+|+++++.++||||+++++++. ....
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~ 94 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHN 94 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCe
Confidence 4467999999999999999999999999999999986543 44568999999999999999999883 3445
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec---CCCCcEEEeecc
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN---PHTHQVKLCDFG 239 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~---~~~~~vkl~DfG 239 (429)
.++||||+++ +|.+.+.........+++..++.++.||+.||.||| +.||+||||||+||+++ .++ .+||+|||
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg 172 (285)
T 3is5_A 95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH-SQHVVHKDLKPENILFQDTSPHS-PIKIIDFG 172 (285)
T ss_dssp EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEESSSSTTC-CEEECCCC
T ss_pred EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH-hCCEEECCCCHHHEEEecCCCCC-CEEEEeee
Confidence 8899999985 777777655555678999999999999999999999 88999999999999994 344 79999999
Q ss_pred cceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-------- 242 (285)
T 3is5_A 173 LAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP-------- 242 (285)
T ss_dssp CCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--------
T ss_pred cceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc--------
Confidence 9987665555566778999999998853 489999999999999999999999988776555444332100
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.+ + .....+++++.+||.+||+.||++|||+.|+|+||||++
T Consensus 243 ----~~-----~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 243 ----NY-----A---------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ----CC-----C---------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ----cc-----c---------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 00 0 011236899999999999999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=378.11 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=208.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
.++|++.+.||+|+||+||+|.+..+|+.||||++.+......+|++++..+ +||||+++++++ .+..++++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEEE
Confidence 4579999999999999999999999999999999988777777899999888 799999999998 4445689999
Q ss_pred eccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC---cEEEeecccceec
Q 014174 169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKLCDFGSAKVL 244 (429)
Q Consensus 169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~---~vkl~DfG~a~~~ 244 (429)
||+.+ +|.+.+.. .+.+++..++.++.||+.||.||| +.||+||||||+|||+..+.+ .+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH-~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLH-AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 99975 56555432 467999999999999999999999 889999999999999854321 4999999999876
Q ss_pred ccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHHhCCCCHHHHhh
Q 014174 245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE---SGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
.... .....+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+. +..+.+..+...
T Consensus 171 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~----------- 238 (342)
T 2qr7_A 171 RAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG----------- 238 (342)
T ss_dssp BCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC-----------
T ss_pred cCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC-----------
Confidence 5432 33456789999999998654 3889999999999999999999999763 222333333221
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
.+.+ ...++..+++++.+||++||..||.+|||+.++++||||.++.
T Consensus 239 ------~~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 239 ------KFSL--------SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp ------CCCC--------CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred ------Cccc--------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 0000 0112245799999999999999999999999999999997654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=372.94 Aligned_cols=256 Identities=26% Similarity=0.349 Sum_probs=206.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.++|++.+.||+|+||+||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++. .....
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence 457999999999999999999999999999999885432 44568999999999999999999883 34458
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+++ +|.+.+ .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~aL~~LH-~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~ 154 (323)
T 3tki_A 81 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERD-NLKISDFGLATV 154 (323)
T ss_dssp EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHH----hhcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccccchHHEEEeCCC-CEEEEEeeccce
Confidence 899999976 444432 33467999999999999999999999 88999999999999999888 799999999986
Q ss_pred cccCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 244 LVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 244 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
..... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+...............
T Consensus 155 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------- 227 (323)
T 3tki_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------- 227 (323)
T ss_dssp CEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT-------
T ss_pred eccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc-------
Confidence 54332 23356789999999999776655889999999999999999999998765543322222110000
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
. . ....+++.+.+||.+||..||.+|||+.|+++||||.....
T Consensus 228 ---------~-----~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 228 ---------L-----N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp ---------S-----T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred ---------C-----C-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 0 0 01247899999999999999999999999999999986443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=380.80 Aligned_cols=257 Identities=27% Similarity=0.404 Sum_probs=212.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.++|++.+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+++.++||||+++++++. ....++
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence 45799999999999999999999999999999998653 234568999999999999999999984 344588
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC-CCcEEEeeccccee
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKV 243 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~-~~~vkl~DfG~a~~ 243 (429)
+||||+.+ +|.+.+. .....+++..++.++.||+.||.||| +.||+||||||+|||++.+ ...+||+|||+++.
T Consensus 125 lv~E~~~gg~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 125 LILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp EEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 99999975 5544332 23357999999999999999999999 8899999999999999743 23699999999988
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
...........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+......
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~----------- 268 (387)
T 1kob_A 201 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE----------- 268 (387)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----------
T ss_pred cCCCcceeeeccCCCccCchhccCC-CCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 7665555566899999999999764 4899999999999999999999999988877766665542110
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
++ ......+++++.+||++||+.||.+|||+.++|+||||....
T Consensus 269 ------~~--------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 269 ------FD--------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp ------CC--------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ------CC--------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 00 111235799999999999999999999999999999997643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=382.65 Aligned_cols=288 Identities=22% Similarity=0.318 Sum_probs=209.5
Q ss_pred CccccceEEeeEEccC--CceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC
Q 014174 87 PKQTISYMAERVVGQG--SFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 87 ~~~~~~y~i~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 158 (429)
....++|+++++||+| +||+||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 98 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-- 98 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC--
Confidence 3456689999999999 99999999999999999999996542 3445799999999999999999998543
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEee
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD 237 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~D 237 (429)
..+++||||+.+ ++.+++... ....+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|
T Consensus 99 ---~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~NIll~~~~-~~kl~d 171 (389)
T 3gni_B 99 ---NELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIH-HMGYVHRSVKASHILISVDG-KVYLSG 171 (389)
T ss_dssp ---TEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECC
T ss_pred ---CEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEcCCC-CEEEcc
Confidence 348899999984 555555432 2356999999999999999999999 88999999999999999888 799999
Q ss_pred cccceecccCC--------CcccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014174 238 FGSAKVLVKGE--------PNISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308 (429)
Q Consensus 238 fG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~ 308 (429)
||.+....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 99986543221 12234789999999999763 4589999999999999999999999988776665544332
Q ss_pred HhCC--------CCHHHHhhcCc-----Cccc-----ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHH
Q 014174 309 VLGT--------PTREEIKCMNP-----NYTE-----FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 370 (429)
Q Consensus 309 ~~~~--------~~~~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~e 370 (429)
..-. +.......... .... ...+. ........++..+++++.+||++||++||++|||+.|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 330 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS-NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330 (389)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred CCCCccccccccccccccccccccccccccccccccCccccc-cCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence 1100 00000000000 0000 00000 0001112244568999999999999999999999999
Q ss_pred HhcCCCCcccCCCC
Q 014174 371 ACIHPFFYELRDPN 384 (429)
Q Consensus 371 ll~hp~f~~~~~~~ 384 (429)
+|+||||.++....
T Consensus 331 ll~hp~f~~~~~~~ 344 (389)
T 3gni_B 331 LLNHSFFKQIKRRA 344 (389)
T ss_dssp HTTSGGGGGC---C
T ss_pred HhcCHHHHHHhhcc
Confidence 99999999887643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=374.49 Aligned_cols=282 Identities=30% Similarity=0.547 Sum_probs=218.8
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-hhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceEEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
++|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++ ||||+++++++... ...+.++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceEEEE
Confidence 4799999999999999999999999999999998643 455678999999997 99999999988542 234578999
Q ss_pred eccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC
Q 014174 169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248 (429)
Q Consensus 169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~ 248 (429)
||+.++.+..+. ..+++..++.++.||+.||.||| +.||+||||||+|||++.++..+||+|||+++......
T Consensus 113 e~~~~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 113 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp ECCCCCCHHHHG------GGCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred eccCchhHHHHH------HhCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 999865433221 34899999999999999999999 88999999999999999777579999999998876666
Q ss_pred CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCHHHH-hhcCcCcc
Q 014174 249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFP-GESGVDQLVEIIKVLGTPTREEI-KCMNPNYT 326 (429)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~-~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~ 326 (429)
......+|+.|+|||++.+...++.++|||||||++|+|++|+.||. +.+..+.+..+....+.+..... ........
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 55667889999999999775668999999999999999999999984 45566667776666654332211 11110000
Q ss_pred cc---cCCCcCCCCcccc----cCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 327 EF---KFPQIKAHPWHKI----FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 327 ~~---~~~~~~~~~~~~~----~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
.. .........|... ....+++++.+||.+||++||.+|||+.|+|+||||..+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 00 0000111111111 12237999999999999999999999999999999988664
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=362.20 Aligned_cols=261 Identities=27% Similarity=0.393 Sum_probs=215.8
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++. ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence 457999999999999999999999999999999986542 33457999999999999999999883 3445
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC--cEEEeeccc
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGS 240 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~--~vkl~DfG~ 240 (429)
.++||||+.+ ++...+.. ...+++..+..++.||+.||.||| +.||+||||||+||+++.++. .+||+|||+
T Consensus 80 ~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 7899999985 55454433 367999999999999999999999 889999999999999976542 499999999
Q ss_pred ceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+.............||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+.......+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------ 227 (284)
T 3kk8_A 155 AIEVNDSEAWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP------ 227 (284)
T ss_dssp CEECCSSCBCCCSCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC------
T ss_pred eEEcccCccccCCCCCcCCcCchhhcCC-CCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCC------
Confidence 9887666555667899999999999764 489999999999999999999999988877766665554211111
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNAR 386 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~ 386 (429)
. .....+++++.+||.+||+.||++|||+.++|+||||.+.+.....
T Consensus 228 -----------~--------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 228 -----------S--------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274 (284)
T ss_dssp -----------T--------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred -----------c--------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence 0 0113478999999999999999999999999999999886654433
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=391.19 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=214.7
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
...++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~----- 87 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST----- 87 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----
Confidence 34567999999999999999999999999999999986432 345689999999999999999998843
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
...+++||||+++ +|.+.+ ...+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDLkp~NIll~~~~-~vkL~DFG 161 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCH-RHMVVHRDLKPENVLLDAHM-NAKIADFG 161 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHT----TSSSSCCHHHHHHHHHHHHHHHHHHH-TTTEECSCCSGGGEEECTTC-CEEECCCS
T ss_pred CCEEEEEEeCCCCCcHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCCcccccHHHEEEecCC-CeEEEecc
Confidence 3458899999964 555543 23567999999999999999999999 89999999999999999888 79999999
Q ss_pred cceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
++............+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~--------- 232 (476)
T 2y94_A 162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI--------- 232 (476)
T ss_dssp SCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC---------
T ss_pred chhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC---------
Confidence 99987666555677899999999999876555789999999999999999999999887766665554311
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
+ ..+..+++++.+||++||..||.+|||+.++++||||...
T Consensus 233 --------~------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 --------F------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --------C------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --------c------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0 1123478999999999999999999999999999999763
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=371.46 Aligned_cols=254 Identities=28% Similarity=0.449 Sum_probs=205.4
Q ss_pred ccccceEEeeEEccCCceEEEEEEEc---CCCcEEEEEEeecch--------hhhHHHHHHHHHcCCCCeeecceEeeec
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFST 156 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 156 (429)
....+|++.+.||+|+||.||+|++. .+|+.||+|++.+.. ....+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT- 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc-
Confidence 34467999999999999999999985 689999999986431 234579999999999999999998843
Q ss_pred CCCCceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEE
Q 014174 157 TDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 235 (429)
Q Consensus 157 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl 235 (429)
...+++||||+. ++|...+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||
T Consensus 93 ----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH-~~~ivH~Dlkp~Nill~~~~-~~kl 162 (327)
T 3a62_A 93 ----GGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLH-QKGIIYRDLKPENIMLNHQG-HVKL 162 (327)
T ss_dssp ----SSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCTTTEEECTTS-CEEE
T ss_pred ----CCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-hCCEEcccCCHHHeEECCCC-cEEE
Confidence 334889999997 455555443 357999999999999999999999 88999999999999999888 7999
Q ss_pred eecccceecccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 236 CDFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 236 ~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
+|||+++..... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..+....
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---- 237 (327)
T 3a62_A 163 TDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK---- 237 (327)
T ss_dssp CCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC----
T ss_pred EeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC----
Confidence 999999764332 223456789999999999764 48999999999999999999999999888777766665521
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCC
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRD 382 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~ 382 (429)
. .++..+++++.+||.+||..||.+|| ++.++++||||..+.+
T Consensus 238 -------------~------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~ 285 (327)
T 3a62_A 238 -------------L------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINW 285 (327)
T ss_dssp -------------C------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCH
T ss_pred -------------C------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCH
Confidence 0 12335799999999999999999999 8999999999988655
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=367.71 Aligned_cols=256 Identities=25% Similarity=0.359 Sum_probs=214.6
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----------hhhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
.++|++.+.||+|+||.||+|++..+|+.||+|++... .....+|+.+++.++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----- 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence 45799999999999999999999999999999998643 234568999999999999999999884
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC---cEEE
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKL 235 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~---~vkl 235 (429)
.....++||||+. ++|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+||+++.++. .+||
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH-~~~ivH~dikp~NIl~~~~~~~~~~~kl 160 (321)
T 2a2a_A 86 NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKL 160 (321)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred cCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCChHHEEEecCCCCcCCEEE
Confidence 3445889999996 466665542 467899999999999999999999 889999999999999987763 5999
Q ss_pred eecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 236 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+|||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 239 (321)
T 2a2a_A 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE 239 (321)
T ss_dssp CCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred ccCccceecCccccccccCCCCCccCcccccCC-CCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh
Confidence 999999887665555667799999999998664 4899999999999999999999999988777666655442211111
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
.+...++..+.+||.+||..||.+|||+.++++||||....
T Consensus 240 -------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 240 -------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp -------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred -------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 11234789999999999999999999999999999997654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=369.47 Aligned_cols=288 Identities=29% Similarity=0.481 Sum_probs=219.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecC---------
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTT--------- 157 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------- 157 (429)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+++++.++||||+++++++....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 47999999999999999999999999999999886432 33457999999999999999998874321
Q ss_pred CCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEee
Q 014174 158 DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD 237 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~D 237 (429)
.......++||||+++++.+.+. .+.+++..++.++.||+.||.||| +.||+||||||+||+++.++..+||+|
T Consensus 91 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 91 LTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 12335678999999988777653 367999999999999999999999 889999999999999985544899999
Q ss_pred cccceecccC----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014174 238 FGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313 (429)
Q Consensus 238 fG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 313 (429)
||+++..... .......+|..|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999865432 122345678999999998765668999999999999999999999999999888888888877766
Q ss_pred CHHHHhhcCcCcccccCCCc-CCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 314 TREEIKCMNPNYTEFKFPQI-KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
..+....+......+..... ........+...++.++.+||++||+.||.+|||+.++|+||||.....|.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 65544332211110000000 000011123346899999999999999999999999999999999877664
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=390.37 Aligned_cols=255 Identities=26% Similarity=0.393 Sum_probs=207.2
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
...++|+++++||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~---- 220 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH---- 220 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET----
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC----
Confidence 34568999999999999999999999999999999986432 2234688889999999999999988443
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeeecCCCCceEecCCCCcEEEeec
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
..+++||||+++ +|...+.. ...+++..++.++.||+.||.||| + .||+||||||+||||+.++ .+||+||
T Consensus 221 -~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~~giiHrDlkp~NIll~~~~-~~kl~DF 293 (446)
T 4ejn_A 221 -DRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLH-SEKNVVYRDLKLENLMLDKDG-HIKITDF 293 (446)
T ss_dssp -TEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH-HHTCCCCCCCCGGGEEECSSS-CEEECCC
T ss_pred -CEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHh-hcCCEEECCCCHHHEEECCCC-CEEEccC
Confidence 348899999986 45444432 467999999999999999999999 6 8999999999999999888 7999999
Q ss_pred ccceeccc-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 239 GSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 239 G~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
|+|+.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+....
T Consensus 294 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~------- 365 (446)
T 4ejn_A 294 GLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE------- 365 (446)
T ss_dssp CCCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-------
T ss_pred CCceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-------
Confidence 99976433 2334457899999999999764 48999999999999999999999999887776666554410
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDP 383 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~ 383 (429)
. .++..+++++.+||.+||+.||.+|| |+.++++||||..+.+.
T Consensus 366 ----------~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 366 ----------I------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp ----------C------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred ----------C------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 1 12345799999999999999999999 99999999999987653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=363.46 Aligned_cols=258 Identities=26% Similarity=0.388 Sum_probs=197.7
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh------hhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..++|++.+.||+|+||+||+|++..+|+.||+|++..... ...++...++.++||||+++++++... .
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----G 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----C
Confidence 45689999999999999999999999999999999864321 122344457778999999999988543 3
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-CeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
..++||||+++++.+.+.........+++..++.++.||+.||.||| +. ||+||||||+||+++.++ .+||+|||++
T Consensus 80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~ 157 (290)
T 3fme_A 80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALG-QVKMCDFGIS 157 (290)
T ss_dssp SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HHSCCCCCCCSGGGCEECTTC-CEEBCCC---
T ss_pred CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh-hcCCeecCCCCHHHEEECCCC-CEEEeecCCc
Confidence 37899999999888887776666788999999999999999999999 76 999999999999999888 7999999999
Q ss_pred eecccCCCcccccccccccccccc---cCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHH
Q 014174 242 KVLVKGEPNISYICSRYYRAPELI---FGATEYTTAIDIWSVGCVLAELLLGQPLFPGES-GVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~ 317 (429)
+............||+.|+|||++ .....++.++|||||||++|+|++|+.||.... ....+....... .+
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~---- 232 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-SP---- 232 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-CC----
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-CC----
Confidence 877655555556789999999997 234558899999999999999999999998643 333333333210 00
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
. .....+++++.+||.+||+.||++|||+.++++||||...
T Consensus 233 --------------~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 233 --------------Q--------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp --------------C--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred --------------C--------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 0 0113478999999999999999999999999999999763
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=389.52 Aligned_cols=257 Identities=28% Similarity=0.454 Sum_probs=214.5
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----------------hhhHHHHHHHHHcCCCCeeecce
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----------------RYKNRELQTMRLLDHPNVVSLKH 151 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------------~~~~~E~~~l~~l~h~niv~~~~ 151 (429)
...+|+++++||+|+||+||+|++..++..||+|++.... ....+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3457999999999999999999999999999999986432 33457999999999999999999
Q ss_pred EeeecCCCCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC
Q 014174 152 CFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT 230 (429)
Q Consensus 152 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~ 230 (429)
++ ....++++|||||++ +|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++.++
T Consensus 114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~ 183 (504)
T 3q5i_A 114 VF-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLH-KHNIVHRDIKPENILLENKN 183 (504)
T ss_dssp EE-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESSTT
T ss_pred EE-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeCCCcHHHEEEecCC
Confidence 98 344568899999975 56555543 367999999999999999999999 88999999999999998765
Q ss_pred C--cEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014174 231 H--QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308 (429)
Q Consensus 231 ~--~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~ 308 (429)
. .+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus 184 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 3 599999999988766655667789999999999853 489999999999999999999999999888777777665
Q ss_pred HhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
......... ...+++++++||++||++||.+|||+.++|+||||.....
T Consensus 262 ~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 262 GKYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 322222111 1347999999999999999999999999999999987554
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=377.24 Aligned_cols=283 Identities=28% Similarity=0.406 Sum_probs=221.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcC--------CCCeeecceEeeecCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD--------HPNVVSLKHCFFSTTD 158 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~~ 158 (429)
.++|++.++||+|+||+||+|++..+++.||||++.... ....+|+++++.++ |+||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~- 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG- 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence 457999999999999999999999999999999997543 34457999999885 788999999885432
Q ss_pred CCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-CeeeecCCCCceEecCCC-------
Q 014174 159 KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHT------- 230 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-givH~DLkp~Nill~~~~------- 230 (429)
....++++||||++++++..+... ....+++..++.++.||+.||.||| ++ ||+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH-~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLH-TKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHH-HTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHH-HhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 245578999999999888876542 2356999999999999999999999 76 999999999999998664
Q ss_pred -----------------------------------------CcEEEeecccceecccCCCcccccccccccccccccCCC
Q 014174 231 -----------------------------------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269 (429)
Q Consensus 231 -----------------------------------------~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 269 (429)
..+||+|||++...... .....||+.|+|||++.+..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC
Confidence 16999999999876433 34567899999999998754
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhhcCcCccccc----CCCcCC-CCc
Q 014174 270 EYTTAIDIWSVGCVLAELLLGQPLFPGES------GVDQLVEIIKVLGTPTREEIKCMNPNYTEFK----FPQIKA-HPW 338 (429)
Q Consensus 270 ~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-~~~ 338 (429)
++.++|||||||++|+|++|+.||.+.+ ....+..+.+..|.++...+.........+. ...+.. .++
T Consensus 270 -~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 270 -YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp -CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred -CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 8999999999999999999999998755 4567788888888887766543211100000 000000 000
Q ss_pred --------ccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 339 --------HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 339 --------~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
...++...+..+.+||.+||+.||++|||+.|+|+||||.+
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 00012234567899999999999999999999999999963
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=367.82 Aligned_cols=247 Identities=28% Similarity=0.375 Sum_probs=196.8
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh------hhHHHHHHHHH-cCCCCeeecceEeeecCCCCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR------YKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
++|++.++||+|+||+||+|++..+|+.||||++..... ....|+..+.. .+|+||+++++++.. ...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CCE
Confidence 579999999999999999999999999999998854321 11234444444 489999999999843 345
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+++||||+++++...+... ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus 132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~ 206 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLH-SQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECGGG-CEEECCCTTCEE
T ss_pred EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEECCCC-CEEEccceeeee
Confidence 8899999999888766542 457999999999999999999999 88999999999999999888 799999999988
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
...........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...... +.. +..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~~~--~~~---------- 269 (311)
T 3p1a_A 207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---LRQ--GYL---------- 269 (311)
T ss_dssp CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---HTT--TCC----------
T ss_pred cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---Hhc--cCC----------
Confidence 765555556678999999999865 489999999999999999999776654322111 111 000
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
...++..+++++.+||.+||+.||++|||+.++|+||||++
T Consensus 270 ---------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 270 ---------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ---------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ---------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 11123457999999999999999999999999999999975
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=358.90 Aligned_cols=255 Identities=30% Similarity=0.446 Sum_probs=214.8
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.++|++.+.||+|+||.||+|.+..++..||+|++... .....+|+++++.++||||+++++++. .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence 45799999999999999999999999999999998643 345568999999999999999999884 344588
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe---cCCCCcEEEeecccc
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSA 241 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill---~~~~~~vkl~DfG~a 241 (429)
+||||+++ ++.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+||++ +.++ .+||+|||++
T Consensus 83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~ 156 (277)
T 3f3z_A 83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCH-KLNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLA 156 (277)
T ss_dssp EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCCCHHHEEEecCCCCC-cEEEEecccc
Confidence 99999975 55554433 466999999999999999999999 8899999999999999 6566 7999999999
Q ss_pred eecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+...........+
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 231 (277)
T 3f3z_A 157 ARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW--- 231 (277)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH---
T ss_pred eeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh---
Confidence 88766665566789999999999854 3899999999999999999999999988877777666553322222211
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
..+++.+.+||.+||+.||.+|||+.++|+||||.+...
T Consensus 232 ----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 232 ----------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp ----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred ----------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 246899999999999999999999999999999976443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=404.76 Aligned_cols=255 Identities=26% Similarity=0.402 Sum_probs=214.4
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
....+|+++++||+|+||+||+|++..+++.||||++.+.. .....|..++..+ +||||++++++| .
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~ 412 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----Q 412 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----B
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----E
Confidence 34568999999999999999999999999999999986532 2344688888877 799999999988 4
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
....+|+||||+++ +|...+.. .+.+++..++.|+.||+.||.||| +.||+||||||+||||+.++ .+||+||
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~gIiHrDLKp~NILl~~~g-~ikL~DF 486 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQ-SKGIIYRDLKLDNVMLDSEG-HIKIADF 486 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTSEECCCCCSTTEEECSSS-CEEECCC
T ss_pred eCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeEeccCChhhEEEcCCC-cEEEeec
Confidence 44568999999985 55555443 367999999999999999999999 88999999999999999988 6999999
Q ss_pred ccceeccc-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 239 GSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 239 G~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
|+|+.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus 487 Gla~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-------- 557 (674)
T 3pfq_A 487 GMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-------- 557 (674)
T ss_dssp TTCEECCCTTCCBCCCCSCSSSCCHHHHTCC-CBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS--------
T ss_pred ceeeccccCCcccccccCCCcccCHhhhcCC-CCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--------
Confidence 99986433 3344567899999999999664 5899999999999999999999999998887777766541
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH-----HHHhcCCCCcccCCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA-----LEACIHPFFYELRDP 383 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~-----~ell~hp~f~~~~~~ 383 (429)
.. .++..+++++.+||++||+.||.+|+++ .++++||||..+.+.
T Consensus 558 ---------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~ 607 (674)
T 3pfq_A 558 ---------NV------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 607 (674)
T ss_dssp ---------CC------------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHH
T ss_pred ---------CC------------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHH
Confidence 01 1334589999999999999999999997 999999999987764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=395.46 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=212.1
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
...++|++.++||+|+||.||+|++..+|+.||+|++.+. .....+|+.+++.++||||+++++++. .
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----T 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----e
Confidence 4456899999999999999999999999999999998643 223457999999999999999999883 3
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
...+++||||+++ +|...+.. .....+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+||+|||
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~--~~~~~l~e~~~~~i~~qIl~aL~yLH-~~gIvHrDLKPeNILld~~g-~vKL~DFG 331 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYH--MGQAGFPEARAVFYAAEICCGLEDLH-RERIVYRDLKPENILLDDHG-HIRISDLG 331 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHS--SSSCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEEcCCCCcHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeccCCchheEEEeCCC-CeEEEecc
Confidence 4468999999974 55554433 12345999999999999999999999 88999999999999999888 69999999
Q ss_pred cceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCCHH
Q 014174 240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~~~~ 316 (429)
+++...........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+. ...+.......
T Consensus 332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------ 404 (576)
T 2acx_A 332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------ 404 (576)
T ss_dssp TCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC------
T ss_pred cceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc------
Confidence 99887666555667899999999999764 489999999999999999999999987543 22222222110
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRD 382 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~ 382 (429)
...++..+++++.+||++||+.||.+|| ++.|+++||||..+.+
T Consensus 405 ----------------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w 453 (576)
T 2acx_A 405 ----------------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453 (576)
T ss_dssp ----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred ----------------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence 0112345799999999999999999999 8999999999998765
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=389.32 Aligned_cols=257 Identities=27% Similarity=0.443 Sum_probs=212.1
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
...+|+++++||+|+||+||+|++..+++.||||++... .....+|+++++.++||||+++++++. ...
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~ 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSS 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCC
Confidence 346899999999999999999999999999999998532 334568999999999999999999883 344
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC--CcEEEeecc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFG 239 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~--~~vkl~DfG 239 (429)
.+++||||+.+ +|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++..+ ..+||+|||
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence 58899999975 55555433 367999999999999999999999 88999999999999995432 269999999
Q ss_pred cceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
+++............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 170 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~---- 243 (486)
T 3mwu_A 170 LSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL---- 243 (486)
T ss_dssp CTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCS----
T ss_pred cCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----
Confidence 9987766555566789999999999865 3899999999999999999999999998887777666553111110
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
+ ....+|+++++||++||+.||.+|||+.++|+||||.....
T Consensus 244 -----------~----------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 244 -----------P----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp -----------G----------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred -----------c----------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 0 11247999999999999999999999999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=389.50 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=211.6
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
....+|.+.++||+|+||+||+|++..+|+.||||++.+.. ....+|+++++.++||||++++++|. .
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----T 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----e
Confidence 34568999999999999999999999999999999986432 23457999999999999999999883 3
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
...+|+||||+++ +|...+.........+++..++.++.||+.||.||| ++||+||||||+||||+.++ .+||+|||
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH-~~gIvHrDLKP~NILl~~~g-~vkL~DFG 334 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDG-NVRISDLG 334 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH-HcCCcccCCChHHEEEeCCC-CEEEeecc
Confidence 4458999999985 555555443333457999999999999999999999 88999999999999999988 69999999
Q ss_pred cceecccCCCc-ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHHhCCCC
Q 014174 240 SAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG----VDQLVEIIKVLGTPT 314 (429)
Q Consensus 240 ~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~i~~~~~~~~ 314 (429)
+++........ ...+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+. ......+...
T Consensus 335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~----- 408 (543)
T 3c4z_A 335 LAVELKAGQTKTKGYAGTPGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ----- 408 (543)
T ss_dssp TCEECCTTCCCBCCCCSCTTTSCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-----
T ss_pred eeeeccCCCcccccccCCccccChhhhcCC-CCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-----
Confidence 99876554432 345899999999999764 589999999999999999999999987542 2222222221
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCC
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRD 382 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~ 382 (429)
. ..++..+++++.+||++||+.||.+||+ +.++++||||..+.+
T Consensus 409 ------------~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w 457 (543)
T 3c4z_A 409 ------------A------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW 457 (543)
T ss_dssp ------------C------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred ------------c------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence 0 0123458999999999999999999996 589999999998665
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=370.04 Aligned_cols=256 Identities=29% Similarity=0.416 Sum_probs=194.5
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..++|++.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.++||||+++++++. .....++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEEE
Confidence 445799999999999999999999999999999998754 334567999999999999999999984 3345889
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC---CCCcEEEeecccce
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAK 242 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~---~~~~vkl~DfG~a~ 242 (429)
||||+.+ +|.+.+. ....+++..++.++.||+.||.||| +.||+||||||+|||++. ++ .+||+|||+++
T Consensus 126 v~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~ 199 (349)
T 2w4o_A 126 VLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLH-ENGIVHRDLKPENLLYATPAPDA-PLKIADFGLSK 199 (349)
T ss_dssp EECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEESSSSTTC-CEEECCCC---
T ss_pred EEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeEecCCCcccEEEecCCCCC-CEEEccCcccc
Confidence 9999975 5555443 3467999999999999999999999 889999999999999975 55 79999999998
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCHHHHhhc
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLV-EIIKVLGTPTREEIKCM 321 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~-~i~~~~~~~~~~~~~~~ 321 (429)
............||+.|+|||++.+. .++.++|||||||++|+|++|..||........+. .+.....
T Consensus 200 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~---------- 268 (349)
T 2w4o_A 200 IVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY---------- 268 (349)
T ss_dssp -------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC----------
T ss_pred ccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC----------
Confidence 76555444567789999999999764 48999999999999999999999998766655332 2222100
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
.. .......++.++.+||++||+.||++|||+.++|+||||....
T Consensus 269 -------~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 269 -------YF--------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp -------CC--------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred -------cc--------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 00 0112235799999999999999999999999999999997644
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=378.95 Aligned_cols=254 Identities=27% Similarity=0.399 Sum_probs=206.4
Q ss_pred ceEE--eeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 92 SYMA--ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 92 ~y~i--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.|.+ .+.||+|+||.||+|++..+|+.||+|++... ...+.+|+++++.++||||+++++++. ....++
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~ 162 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIV 162 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEE
Confidence 3555 67899999999999999999999999998753 344568999999999999999999884 334588
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe--cCCCCcEEEeecccce
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAK 242 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill--~~~~~~vkl~DfG~a~ 242 (429)
+||||+++ +|.+.+.. ....+++..++.++.||+.||.||| +.||+||||||+|||+ +.++ .+||+|||+++
T Consensus 163 lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~ 237 (373)
T 2x4f_A 163 LVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMH-QMYILHLDLKPENILCVNRDAK-QIKIIDFGLAR 237 (373)
T ss_dssp EEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEEETTTT-EEEECCCSSCE
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccccCCHHHEEEecCCCC-cEEEEeCCCce
Confidence 99999975 55555532 2346899999999999999999999 8899999999999999 4444 79999999999
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 238 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~------- 309 (373)
T 2x4f_A 238 RYKPREKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED------- 309 (373)
T ss_dssp ECCTTCBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCS-------
T ss_pred ecCCccccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCCh-------
Confidence 87666555567799999999998654 4899999999999999999999999998888777777653211110
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
.....+++++++||.+||+.||.+|||+.++|+||||.+..
T Consensus 310 ------------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 310 ------------------EEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp ------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred ------------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 01134799999999999999999999999999999998754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=360.42 Aligned_cols=271 Identities=28% Similarity=0.417 Sum_probs=220.6
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...+|.+.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++||||+++++++. ..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~ 87 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DN 87 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cC
Confidence 345799999999999999999999999999999998653 233457999999999999999999883 34
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
...++||||+++ ++.+.+.. ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~ 161 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLH-RNRVIHRDLKLGNLFLNEDL-EVKIGDFGL 161 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTT
T ss_pred CEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChHhEEEcCCC-CEEEEeccC
Confidence 458899999984 55554432 367999999999999999999999 88999999999999999888 799999999
Q ss_pred ceecccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 241 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 241 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
+...... .......||+.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------- 230 (294)
T 2rku_A 162 ATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN---------- 230 (294)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHTTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----------
T ss_pred ceecccCccccccccCCCCcCCcchhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc----------
Confidence 9876433 233446789999999998664 4899999999999999999999999887765554443321
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNF 399 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 399 (429)
.. .++..+++.+.+||.+||..||++|||+.++++||||.+...+..........|+.+.+
T Consensus 231 -------~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (294)
T 2rku_A 231 -------EY------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSI 291 (294)
T ss_dssp -------CC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCS
T ss_pred -------cC------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCCCCccCCCCCCCccc
Confidence 00 12335789999999999999999999999999999999877766555555555555555
Q ss_pred C
Q 014174 400 K 400 (429)
Q Consensus 400 ~ 400 (429)
.
T Consensus 292 ~ 292 (294)
T 2rku_A 292 A 292 (294)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=390.46 Aligned_cols=257 Identities=31% Similarity=0.505 Sum_probs=215.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..++|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.++||||+++++++ ...
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 98 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDK 98 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence 345799999999999999999999999999999998543 23456899999999999999999998 344
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec---CCCCcEEEee
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN---PHTHQVKLCD 237 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~---~~~~~vkl~D 237 (429)
.++++||||+.+ +|.+.+. ....+++..++.++.||+.||.||| ++||+||||||+|||++ .++ .+||+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~~-~~kl~D 172 (484)
T 3nyv_A 99 GYFYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMH-KNKIVHRDLKPENLLLESKSKDA-NIRIID 172 (484)
T ss_dssp SEEEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESSSSTTC-CEEECC
T ss_pred CEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeCCCCHHHEEEecCCCCC-cEEEEe
Confidence 568899999975 5555443 2467999999999999999999999 88999999999999994 445 799999
Q ss_pred cccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 238 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
||+++............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+........
T Consensus 173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~--- 247 (484)
T 3nyv_A 173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE--- 247 (484)
T ss_dssp TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC---
T ss_pred eeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence 999987766666667789999999999865 489999999999999999999999999888777776655211111
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
.+ ....+++++++||++||++||.+|||+.++|+||||......
T Consensus 248 ------------~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~ 291 (484)
T 3nyv_A 248 ------------LP----------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE 291 (484)
T ss_dssp ------------SG----------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred ------------Cc----------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence 00 112479999999999999999999999999999999876553
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=366.57 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=198.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCC------
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD------ 158 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 158 (429)
.++|++.+.||+|+||.||+|++..+|+.||||++... .....+|+++++.++||||+++++++.....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 35799999999999999999999999999999998632 2345689999999999999999998865432
Q ss_pred ----------------------------------------------CCceEEEEEEeccch-hHHHHHHHhhhcCCCCCH
Q 014174 159 ----------------------------------------------KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPL 191 (429)
Q Consensus 159 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~ 191 (429)
....++++|||||.+ +|.+.+... ......++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRR-CSLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTC-CSGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcc-cCccchhh
Confidence 223458899999986 555555432 22234566
Q ss_pred HHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC-------------Cccccccccc
Q 014174 192 IYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-------------PNISYICSRY 258 (429)
Q Consensus 192 ~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~-------------~~~~~~gt~~ 258 (429)
..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++...... ......||+.
T Consensus 164 ~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHH-hCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 778999999999999999 88999999999999999888 79999999998765432 2234568999
Q ss_pred ccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCc
Q 014174 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW 338 (429)
Q Consensus 259 y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (429)
|+|||++.+. .++.++|||||||++|+|++|..|+. .....+...........
T Consensus 242 y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~~~~~~~--------------------- 294 (332)
T 3qd2_B 242 YMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRNLKFPLL--------------------- 294 (332)
T ss_dssp GSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHTTCCCHH---------------------
T ss_pred ccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhccCCCcc---------------------
Confidence 9999999764 48999999999999999999876652 11111111111110000
Q ss_pred ccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 339 HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 339 ~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
....++++.+||.+||+.||.+|||+.++|+||||.++
T Consensus 295 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 295 ----FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp ----HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred ----cccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 01247888999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=369.31 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=211.4
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------------hhhHHHHHHHHHc-CCCCeeecceEeeecC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLL-DHPNVVSLKHCFFSTT 157 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 157 (429)
++|.+.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.+ +||||+++++++.
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--- 170 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE--- 170 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence 57999999999999999999999999999999886432 2345799999999 7999999999883
Q ss_pred CCCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEe
Q 014174 158 DKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~ 236 (429)
.....++||||+.+ +|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+
T Consensus 171 --~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH-~~gi~H~Dlkp~NIl~~~~~-~ikl~ 242 (365)
T 2y7j_A 171 --SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLH-ANNIVHRDLKPENILLDDNM-QIRLS 242 (365)
T ss_dssp --BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEEC
T ss_pred --eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEECCCC-CEEEE
Confidence 34458899999986 56555542 357999999999999999999999 88999999999999999888 79999
Q ss_pred ecccceecccCCCcccccccccccccccccCC-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 014174 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA-----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG 311 (429)
Q Consensus 237 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~ 311 (429)
|||++.............||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+.+....+..+.....
T Consensus 243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 322 (365)
T 2y7j_A 243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY 322 (365)
T ss_dssp CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999887666555667899999999998532 3478899999999999999999999988777666666554322
Q ss_pred CCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
...... ...++..+.+||.+||+.||.+|||+.++|+||||.+
T Consensus 323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 221111 1246899999999999999999999999999999963
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=372.01 Aligned_cols=281 Identities=31% Similarity=0.557 Sum_probs=218.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcC-CC-----CeeecceEeeecCCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-HP-----NVVSLKHCFFSTTDKD 160 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~~~~~ 160 (429)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+|+++++.++ |+ +|+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~---- 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR---- 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET----
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC----
Confidence 468999999999999999999999999999999997553 23446888888885 44 488888888543
Q ss_pred ceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCeeeecCCCCceEecC--CCCcEEEee
Q 014174 161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-GIGVCHRDIKPQNLLVNP--HTHQVKLCD 237 (429)
Q Consensus 161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~givH~DLkp~Nill~~--~~~~vkl~D 237 (429)
..+++||||++++|.+.+.... ...+++..++.++.||+.||.|||+ +.||+||||||+||||+. ++ .+||+|
T Consensus 129 -~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~D 204 (382)
T 2vx3_A 129 -NHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVD 204 (382)
T ss_dssp -TEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECC
T ss_pred -CceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEe
Confidence 3588999999999888776532 2569999999999999999999994 469999999999999953 44 799999
Q ss_pred cccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 238 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
||+++.... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+.+..+.++...
T Consensus 205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp CTTCEETTC--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccCceeccc--ccccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 999987643 33456789999999999775 489999999999999999999999999999999999999999888766
Q ss_pred HhhcCcC---ccc-----cc----------CCCcCCCCcccccCC-----------------CCChhHHHHHHhhcCcCC
Q 014174 318 IKCMNPN---YTE-----FK----------FPQIKAHPWHKIFHK-----------------RMPPEAVDLVSRLLQYSP 362 (429)
Q Consensus 318 ~~~~~~~---~~~-----~~----------~~~~~~~~~~~~~~~-----------------~~s~~l~~Li~~~L~~dP 362 (429)
+...... +.. +. +.......+...+.. ..++++++||++||++||
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 361 (382)
T 2vx3_A 282 LDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361 (382)
T ss_dssp HTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCT
T ss_pred HHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCCh
Confidence 5432110 000 00 000000000000000 001478999999999999
Q ss_pred CCCCCHHHHhcCCCCcccC
Q 014174 363 NLRCTALEACIHPFFYELR 381 (429)
Q Consensus 363 ~~R~t~~ell~hp~f~~~~ 381 (429)
++|||+.|+|+||||.+..
T Consensus 362 ~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 362 KTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp TTSCCHHHHTTSGGGCC--
T ss_pred hhCCCHHHHhcCcccccCC
Confidence 9999999999999998754
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=368.30 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=210.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
..|.+.+.||+|+||+||+|++..+|+.||||++.... ..+.+|+++++.++||||+++++++... ..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence 35999999999999999999999999999999986431 2345799999999999999999998543 34
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
.++||||+.+++.+.+.. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++..
T Consensus 129 ~~lv~e~~~g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~ 203 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLSEPG-LVKLGDFGSASI 203 (348)
T ss_dssp EEEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred EEEEEecCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHEEECCCC-CEEEeeccCcee
Confidence 889999999988776643 2467999999999999999999999 88999999999999999888 799999999976
Q ss_pred cccCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+....+..+.... .
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-~--------- 270 (348)
T 1u5q_A 204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-S--------- 270 (348)
T ss_dssp SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-C---------
T ss_pred cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-C---------
Confidence 533 235678999999999853 3458999999999999999999999998887766665554421 0
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
+. .....+++.+.+||.+||+.||++|||+.++++||||...+
T Consensus 271 ---------~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 271 ---------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp ---------CC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred ---------CC--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 00 01234689999999999999999999999999999997643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=387.77 Aligned_cols=255 Identities=28% Similarity=0.443 Sum_probs=210.6
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
..+|++++.||+|+||+||+|++..++..||+|++... .....+|+.+++.++||||+++++++. ....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence 34799999999999999999999999999999998643 234568999999999999999999983 3445
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC--CcEEEeeccc
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGS 240 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~--~~vkl~DfG~ 240 (429)
+++|||||.+ +|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++..+ ..+||+|||+
T Consensus 111 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLH-KHNIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 8899999985 55554433 367999999999999999999999 88999999999999997643 2599999999
Q ss_pred ceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+............+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.........
T Consensus 186 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~----- 258 (494)
T 3lij_A 186 SAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS----- 258 (494)
T ss_dssp CEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS-----
T ss_pred CeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-----
Confidence 988766665667789999999998853 4899999999999999999999999998887777766553211111
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
.....+++.+++||++||+.||.+|||+.++|+||||.+..
T Consensus 259 --------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 259 --------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp --------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred --------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 11134799999999999999999999999999999998753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=368.69 Aligned_cols=244 Identities=24% Similarity=0.389 Sum_probs=205.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------------hhhHHHHHHHHHcCCCCeeecceEeeecC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT 157 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 157 (429)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~---- 98 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF---- 98 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence 357999999999999999999999999999999986542 2345799999999999999999988
Q ss_pred CCCceEEEEEEeccch--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEE
Q 014174 158 DKDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 235 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl 235 (429)
.....+++||||+.+ ++...+. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||
T Consensus 99 -~~~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~-~~kL 171 (335)
T 3dls_A 99 -ENQGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLR-LKDIIHRDIKDENIVIAEDF-TIKL 171 (335)
T ss_dssp -ECSSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEE
T ss_pred -eeCCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCeEEeccCHHHEEEcCCC-cEEE
Confidence 344468899999864 5555443 3467999999999999999999999 88999999999999999887 7999
Q ss_pred eecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 236 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+|||++.............||+.|+|||++.+...++.++|||||||++|+|++|..||......
T Consensus 172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------- 236 (335)
T 3dls_A 172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------- 236 (335)
T ss_dssp CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------
T ss_pred eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------
Confidence 99999988766666667789999999999977664588999999999999999999999642110
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.. . ....+..+++++.+||.+||..||.+|||+.++++||||.+
T Consensus 237 --~~------~------------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 237 --VE------A------------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp --TT------T------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred --Hh------h------------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 00 0 00112347999999999999999999999999999999976
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=375.12 Aligned_cols=260 Identities=27% Similarity=0.396 Sum_probs=198.9
Q ss_pred cccceEEe-eEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHH-HHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 89 QTISYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 89 ~~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..++|.+. ++||+|+||+||+|.+..+|+.||||++... ....+|+.++ +..+||||++++++|.... .+..++++
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~l 136 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 136 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEEE
Confidence 44578887 7999999999999999999999999998654 3456788887 4558999999999875422 23556899
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC---CCCcEEEeecccce
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAK 242 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~---~~~~vkl~DfG~a~ 242 (429)
||||+.+ +|.+.+.. .....+++..++.++.||+.||.||| +.||+||||||+|||++. ++ .+||+|||+++
T Consensus 137 v~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~ 212 (400)
T 1nxk_A 137 VMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAK 212 (400)
T ss_dssp EEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSTTC-CEEECCCTTCE
T ss_pred EEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCcCcceEEEecCCCCc-cEEEEeccccc
Confidence 9999975 66666543 12346999999999999999999999 889999999999999987 45 79999999998
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHH
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD----QLVEIIKVLGTPTREEI 318 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~ 318 (429)
...........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+... ....+...
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~--------- 282 (400)
T 1nxk_A 213 ETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG--------- 282 (400)
T ss_dssp ECC-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT---------
T ss_pred ccCCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC---------
Confidence 7765555556788999999999865 458999999999999999999999997754322 11222110
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
.+.++. .....++.++.+||++||..||.+|||+.++++||||...
T Consensus 283 --------~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 283 --------QYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp --------CCCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred --------cccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 011111 0113479999999999999999999999999999999763
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=371.50 Aligned_cols=263 Identities=30% Similarity=0.457 Sum_probs=208.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---------hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
..+|++.+.||+|+||.||+|.+..++..||+|++.... ....+|+++++.++||||+++++++. .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~ 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE-----D 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc-----c
Confidence 457999999999999999999999999999999986432 34557999999999999999999983 3
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhc------------------------------------CCCCCHHHHHHHHHHHHH
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRA------------------------------------SQRMPLIYVKLYTYQICR 203 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~------------------------------------~~~l~~~~~~~i~~qi~~ 203 (429)
....++||||+++ +|.+.+..+... ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 4468899999974 555444211000 112467788899999999
Q ss_pred HHHHHHcCCCeeeecCCCCceEecCCCC-cEEEeecccceecccCCC-----cccccccccccccccccCC-CCCCCchh
Q 014174 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGA-TEYTTAID 276 (429)
Q Consensus 204 aL~~LH~~~givH~DLkp~Nill~~~~~-~vkl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~D 276 (429)
||.||| +.||+||||||+|||++.++. .+||+|||++........ .....||+.|+|||++.+. ..++.++|
T Consensus 180 ~l~~LH-~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 180 ALHYLH-NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHH-HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHH-HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 889999999999999986542 699999999987643221 2356789999999998642 45899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHh
Q 014174 277 IWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSR 356 (429)
Q Consensus 277 iwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~ 356 (429)
||||||++|+|++|+.||.+.+..+....+......... .....+++++.+||.+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~li~~ 313 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN-------------------------PNYNVLSPLARDLLSN 313 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS-------------------------GGGGGSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC-------------------------cccccCCHHHHHHHHH
Confidence 999999999999999999998887777666552111110 0112368999999999
Q ss_pred hcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 357 LLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 357 ~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
||+.||.+|||+.++|+||||.++.+.
T Consensus 314 ~l~~~p~~Rps~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 314 LLNRNVDERFDAMRALQHPWISQFSDK 340 (345)
T ss_dssp HSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred HcCCChhHCCCHHHHhcChhhccChHh
Confidence 999999999999999999999987654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=356.72 Aligned_cols=258 Identities=25% Similarity=0.391 Sum_probs=209.9
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
++|++.+.||+|+||.||+|++..+|+.||+|++... ...+.+|+.+++.++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN----- 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-----
Confidence 4799999999999999999999999999999988643 2345689999999999999999998843
Q ss_pred ceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC---cEEEe
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKLC 236 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~---~vkl~ 236 (429)
....++||||++ ++|.+.+.. ...+++..+..++.||+.||.||| +.||+||||||+||+++.++. .+||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLH-SKRIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCChHHEEEecCCCCCCceEEE
Confidence 345889999996 566665543 357999999999999999999999 889999999999999986652 59999
Q ss_pred ecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 237 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
|||++.............||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+.+..+.........
T Consensus 155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 232 (283)
T 3bhy_A 155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE- 232 (283)
T ss_dssp CCTTCEECC--------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH-
T ss_pred ecccceeccCCCcccccCCCcCccCcceecCC-CCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc-
Confidence 99999877655555566789999999998654 4899999999999999999999999988776665554432111111
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
.....++..+.+||.+||..||++|||+.++++||||..++...
T Consensus 233 ------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 233 ------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp ------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred ------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 11234789999999999999999999999999999998876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=364.97 Aligned_cols=271 Identities=28% Similarity=0.418 Sum_probs=219.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..+|.+.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++||||+++++++. ...
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence 45799999999999999999999999999999998653 234457999999999999999999884 344
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++||||+.+ ++.+.+.. ...+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~ 188 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLH-RNRVIHRDLKLGNLFLNEDL-EVKIGDFGLA 188 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTC-CEEECCCTTC
T ss_pred eEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCEecCCCchhEEEcCCC-CEEEeeccCc
Confidence 68899999985 55554432 367999999999999999999999 88999999999999999888 7999999999
Q ss_pred eecccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 242 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 242 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+....
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------- 257 (335)
T 2owb_A 189 TKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE---------- 257 (335)
T ss_dssp EECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC----------
T ss_pred eecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC----------
Confidence 876433 233456789999999999764 48999999999999999999999998877666554443310
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFK 400 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 400 (429)
+ .++..+++.+.+||.+||..||++|||+.++++||||.....+..........++.+...
T Consensus 258 -------~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (335)
T 2owb_A 258 -------Y------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIA 318 (335)
T ss_dssp -------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSCCCGGGGTSCCCCCSS
T ss_pred -------C------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccccCCcccccCCCccccC
Confidence 0 122357899999999999999999999999999999988766554433333344444443
Q ss_pred h
Q 014174 401 P 401 (429)
Q Consensus 401 ~ 401 (429)
|
T Consensus 319 ~ 319 (335)
T 2owb_A 319 P 319 (335)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=365.26 Aligned_cols=255 Identities=27% Similarity=0.447 Sum_probs=185.4
Q ss_pred cceEEe---eEEccCCceEEEEEEEcCCCcEEEEEEeecch-hhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAE---RVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.+|.+. +.||+|+||.||+|.+..+|+.||||++.... ....+|+.+++.+. ||||+++++++. .....+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEE
Confidence 357775 78999999999999999999999999997643 45568999999997 999999999983 444588
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC--cEEEeecccce
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAK 242 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~--~vkl~DfG~a~ 242 (429)
+||||+++ +|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++.++. .+||+|||+++
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMH-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 99999975 66665543 467999999999999999999999 889999999999999976542 69999999998
Q ss_pred ecccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHHHhCCCC
Q 014174 243 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-------DQLVEIIKVLGTPT 314 (429)
Q Consensus 243 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-------~~~~~i~~~~~~~~ 314 (429)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.. +.+..+....
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~---- 232 (325)
T 3kn6_A 158 LKPPDNQPLKTPCFTLHYAAPELLNQN-GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD---- 232 (325)
T ss_dssp ECCC----------------------C-CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC----
T ss_pred ecCCCCCcccccCCCcCccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC----
Confidence 654432 23456789999999998664 4899999999999999999999999865432 1222211100
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
+. +.......+++++++||.+||..||.+|||+.++++||||.+..
T Consensus 233 -------------~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 233 -------------FS--------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp -------------CC--------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred -------------CC--------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 00 00011124799999999999999999999999999999998644
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=354.45 Aligned_cols=253 Identities=29% Similarity=0.451 Sum_probs=208.2
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
...++|++.+.||+|+||.||+|++..++..||+|++... .....+|+.+++.++||||+++++++. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----D 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----c
Confidence 3456899999999999999999999999999999998543 233557999999999999999999884 3
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
....++||||+++ ++.+.+.. ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH-~~~i~H~dlkp~Nili~~~~-~~~l~Dfg 154 (279)
T 3fdn_A 81 ATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCH-SKRVIHRDIKPENLLLGSAG-ELKIADFG 154 (279)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-TTTCEECCCCGGGEEECTTS-CEEECSCC
T ss_pred CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCEecccCChHhEEEcCCC-CEEEEecc
Confidence 3458899999985 55555543 356999999999999999999999 89999999999999999888 79999999
Q ss_pred cceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
++...... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.+..+....+....
T Consensus 155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 223 (279)
T 3fdn_A 155 WSVHAPSS-RRTDLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE--------- 223 (279)
T ss_dssp EESCC---------CCCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------
T ss_pred ccccCCcc-cccccCCCCCccCHhHhccC-CCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC---------
Confidence 98654332 23456789999999998764 48999999999999999999999999887766665554421
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
..++..+++.+.+||.+||..||.+|||+.++++||||.....
T Consensus 224 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 224 --------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred --------------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 0122347899999999999999999999999999999987543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=367.50 Aligned_cols=290 Identities=29% Similarity=0.473 Sum_probs=222.0
Q ss_pred CccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcC-----------CCCeeecceE
Q 014174 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKHC 152 (429)
Q Consensus 87 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~niv~~~~~ 152 (429)
+...++|++.+.||+|+||+||+|++..+++.||||++..+. ....+|+.+++.++ |+||++++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 344568999999999999999999999999999999987543 34457899988886 8999999998
Q ss_pred eeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-CeeeecCCCCceEecCCC-
Q 014174 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHT- 230 (429)
Q Consensus 153 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-givH~DLkp~Nill~~~~- 230 (429)
+.... ....++++||||++++|.+.+.... ...+++..++.++.||+.||.||| +. ||+||||||+||||+.++
T Consensus 95 ~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH-~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 95 FNHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHH-HTTCEECSCCSGGGEEEEEEET
T ss_pred hhccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHH-hcCCEEecCCChHHeEEeccCC
Confidence 86543 3445788999999988888776532 356999999999999999999999 76 999999999999995322
Q ss_pred ----CcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------hH
Q 014174 231 ----HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES------GV 300 (429)
Q Consensus 231 ----~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~ 300 (429)
..+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+ ..
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 26999999999876433 34457899999999997754 8999999999999999999999998654 45
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCcccc-------cCCCcCCCCc------ccccCCCCChhHHHHHHhhcCcCCCCCCC
Q 014174 301 DQLVEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKAHPW------HKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367 (429)
Q Consensus 301 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~------~~~~~~~~s~~l~~Li~~~L~~dP~~R~t 367 (429)
..+..+...+|.++...+.........+ .......... ...++..++.++.+||++||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 6777888888887765543211000000 0000000000 00122345678999999999999999999
Q ss_pred HHHHhcCCCCcccCCC
Q 014174 368 ALEACIHPFFYELRDP 383 (429)
Q Consensus 368 ~~ell~hp~f~~~~~~ 383 (429)
+.|+|+||||.+....
T Consensus 328 ~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 328 AGGLVNHPWLKDTLGM 343 (373)
T ss_dssp HHHHHTCGGGTTCTTC
T ss_pred HHHHhhChhhhcccCc
Confidence 9999999999886554
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=355.45 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=213.2
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------------hhhHHHHHHHHHcC-CCCeeecceEee
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------------RYKNRELQTMRLLD-HPNVVSLKHCFF 154 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~niv~~~~~~~ 154 (429)
...+|++.+.||+|+||.||+|.+..+|+.||||++.... ....+|+++++.+. ||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~- 93 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY- 93 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence 3457999999999999999999999999999999986431 23347999999995 99999999988
Q ss_pred ecCCCCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcE
Q 014174 155 STTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV 233 (429)
Q Consensus 155 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~v 233 (429)
......++||||+++ +|.+.+.. ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+
T Consensus 94 ----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~ 163 (298)
T 1phk_A 94 ----ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENILLDDDM-NI 163 (298)
T ss_dssp ----ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CE
T ss_pred ----ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCcceEEEcCCC-cE
Confidence 334568899999984 66665543 357999999999999999999999 88999999999999999888 79
Q ss_pred EEeecccceecccCCCccccccccccccccccc-----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014174 234 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308 (429)
Q Consensus 234 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~ 308 (429)
||+|||++.............+|+.|+|||++. ....++.++||||||+++|+|++|..||.+.+.......+..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 164 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243 (298)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence 999999998876665556677899999999885 234578999999999999999999999988777666555544
Q ss_pred HhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
...... . .....++..+.+||.+||..||.+|||+.++++||||.+....
T Consensus 244 ~~~~~~-----------------~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 244 GNYQFG-----------------S--------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp TCCCCC-----------------T--------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred CCcccC-----------------c--------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 211100 0 0112468999999999999999999999999999999876554
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=360.57 Aligned_cols=252 Identities=29% Similarity=0.440 Sum_probs=207.4
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.|...+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.... ..++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE-----ELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-----EEEEE
Confidence 4888899999999999999999999999999986432 33558999999999999999999885433 48899
Q ss_pred Eeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||++++ |.+.+. ...+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++.....
T Consensus 121 ~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~ 193 (321)
T 2c30_A 121 MEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLH-AQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISK 193 (321)
T ss_dssp ECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEECCCC-cEEEeeeeeeeeccc
Confidence 9999864 444332 357999999999999999999999 88999999999999999888 799999999987654
Q ss_pred CC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 014174 247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325 (429)
Q Consensus 247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 325 (429)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.... .+
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~------------ 259 (321)
T 2c30_A 194 DVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PP------------ 259 (321)
T ss_dssp SSCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS-CC------------
T ss_pred CccccccccCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CC------------
Confidence 32 23456789999999999664 48999999999999999999999998877766655444311 00
Q ss_pred ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
.. .....+++.+.+||.+||+.||++|||+.++++||||.+...
T Consensus 260 ------~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 260 ------KL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGL 303 (321)
T ss_dssp ------CC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCC
T ss_pred ------Cc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCC
Confidence 00 011236899999999999999999999999999999986543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=377.76 Aligned_cols=255 Identities=29% Similarity=0.455 Sum_probs=197.1
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------------hhhHHHHHHHHHcCCCCeeecceEeeecC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT 157 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 157 (429)
.++|.+.+.||+|+||+||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 457999999999999999999999999999999986532 23468999999999999999999862
Q ss_pred CCCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC--cEE
Q 014174 158 DKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVK 234 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~--~vk 234 (429)
... .++||||+.+ +|.+. ......+++..++.++.||+.||.||| ++||+||||||+|||++.++. .+|
T Consensus 211 --~~~-~~lv~e~~~~g~L~~~----l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 --AED-YYIVLELMEGGELFDK----VVGNKRLKEATCKLYFYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp --SSE-EEEEEECCTTCBGGGG----TSSSCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred --cCc-eEEEEEcCCCCcHHHH----HhccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCChHhEEEecCCCcceEE
Confidence 222 5799999986 44332 234577999999999999999999999 889999999999999975432 599
Q ss_pred EeecccceecccCCCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014174 235 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312 (429)
Q Consensus 235 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 312 (429)
|+|||+++............||+.|+|||++.+ ...++.++|||||||++|+|++|..||.+......+.........
T Consensus 283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 999999988765555556789999999999853 345788999999999999999999999876544333332221111
Q ss_pred CCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.. .......+++.+.+||.+||+.||.+|||+.++|+||||.+
T Consensus 363 ~~------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 363 NF------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp CC------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CC------------------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 00 00112347999999999999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=364.19 Aligned_cols=261 Identities=23% Similarity=0.334 Sum_probs=208.9
Q ss_pred ccceEEe-eEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCc
Q 014174 90 TISYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 90 ~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 161 (429)
.++|.+. +.||+|+||.||+|++..+++.||+|++... .....+|+.+++.+. ||||+++++++. ..
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~-----~~ 101 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE-----NT 101 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE-----eC
Confidence 3468888 8999999999999999999999999988643 234567999999995 699999999983 34
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC---CCCcEEEee
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCD 237 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~---~~~~vkl~D 237 (429)
...++||||+.+ +|.+.+.. .....+++..++.++.||+.||.||| +.||+||||||+|||++. ++ .+||+|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH-~~givH~Dikp~NIl~~~~~~~~-~~kL~D 177 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLH-QNNIVHLDLKPQNILLSSIYPLG-DIKIVD 177 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEESCBTTBC-CEEECC
T ss_pred CeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHH-HCCeecCcCChHHEEEecCCCCC-cEEEee
Confidence 458899999986 44443311 22467999999999999999999999 889999999999999987 55 799999
Q ss_pred cccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 238 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
||+++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.........
T Consensus 178 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~-- 254 (327)
T 3lm5_A 178 FGMSRKIGHACELREIMGTPEYLAPEILNYD-PITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE-- 254 (327)
T ss_dssp GGGCEEC---------CCCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred CccccccCCccccccccCCcCccCCeeecCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc--
Confidence 9999887665555567899999999998664 4899999999999999999999999988877776666553211111
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNA 385 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~ 385 (429)
.....+++.+.+||.+||+.||.+|||+.++|+||||+.+.+...
T Consensus 255 -----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 255 -----------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp -----------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred -----------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 112347899999999999999999999999999999998776544
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-47 Score=358.93 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=211.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch--------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence 357999999999999999999999999999999986432 3456899999999999999999987532 22
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
...++||||+.+++.+.+... ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH-~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~ 156 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLH-SQGIVHKDIKPGNLLLTTGG-TLKISALGVA 156 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred CeEEEEehhccCCHHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCcccEEEcCCC-cEEeeccccc
Confidence 347899999998877766543 2467999999999999999999999 88999999999999999887 7999999999
Q ss_pred eecccCC---CcccccccccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 242 KVLVKGE---PNISYICSRYYRAPELIFGAT-EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 242 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
....... ......||+.|+|||++.+.. .++.++|||||||++|+|++|..||.+.+.......+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~------- 229 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS------- 229 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-------
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-------
Confidence 8764322 223456899999999986533 24779999999999999999999998877665555443310
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
+ .++..+++.+.+||.+||..||.+|||+.++++||||.+...+.
T Consensus 230 ----------~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 230 ----------Y------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp ----------C------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred ----------C------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 0 12335789999999999999999999999999999998876654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=352.29 Aligned_cols=252 Identities=27% Similarity=0.441 Sum_probs=210.8
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
...++|++.+.||+|+||.||+|++..++..||+|++... .....+|+++++.++||||+++++++. .
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 85 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----D 85 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----c
Confidence 3456899999999999999999999999999999998543 234568999999999999999999884 3
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
....++||||+++ +|.+.+.. ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg 159 (284)
T 2vgo_A 86 RKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCH-ERKVIHRDIKPENLLMGYKG-ELKIADFG 159 (284)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCSGGGEEECTTC-CEEECCCT
T ss_pred CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCHHHEEEcCCC-CEEEeccc
Confidence 3458899999975 66665543 356999999999999999999999 89999999999999999888 79999999
Q ss_pred cceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
++...... ......||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+...
T Consensus 160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---------- 227 (284)
T 2vgo_A 160 WSVHAPSL-RRRTMCGTLDYLPPEMIEGK-THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV---------- 227 (284)
T ss_dssp TCEECSSS-CBCCCCSCGGGCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----------
T ss_pred ccccCccc-ccccccCCCCcCCHHHhccC-CCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc----------
Confidence 98765432 23456789999999998764 4899999999999999999999999887766655444321
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
. ..++..++.++.+||.+||..||.+|||+.++++||||....
T Consensus 228 -------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 228 -------D------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp -------C------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred -------c------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 0 012345789999999999999999999999999999998644
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=354.91 Aligned_cols=253 Identities=27% Similarity=0.448 Sum_probs=185.0
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++. ..
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cC
Confidence 3457999999999999999999999999999999986432 34567999999999999999999883 34
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
...++||||+++ ++.+.+.. ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nili~~~~-~~kl~dfg~ 158 (278)
T 3cok_A 84 NYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLH-SHGILHRDLTLSNLLLTRNM-NIKIADFGL 158 (278)
T ss_dssp SEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSSCCGGGEEECTTC-CEEECCCTT
T ss_pred CeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHEEEcCCC-CEEEEeecc
Confidence 468899999975 55554432 3467999999999999999999999 88999999999999999888 799999999
Q ss_pred ceecccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 241 AKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 241 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
+....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----------- 226 (278)
T 3cok_A 159 ATQLKMPHEKHYTLCGTPNYISPEIATRS-AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL----------- 226 (278)
T ss_dssp CEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS-----------
T ss_pred eeeccCCCCcceeccCCCCcCCcchhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh-----------
Confidence 98764322 23345789999999998664 488999999999999999999999976554332211100
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
.. ..++..++.++.+||.+||..||++|||+.++++||||.+..
T Consensus 227 ------~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 227 ------AD------------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp ------SC------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred ------cc------------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 00 112345789999999999999999999999999999997643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=353.14 Aligned_cols=252 Identities=28% Similarity=0.418 Sum_probs=201.8
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+|+.+++.++||||+++++++.. .
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-----P 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----S
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----C
Confidence 4457999999999999999999999999999999986432 244579999999999999999998843 3
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
...++||||+.+ +|.+.+.. ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~ 157 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCH-RHMVVHRDLKPENVLLDAHM-NAKIADFGL 157 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HHCSSCCCCCGGGEEECTTS-CEEECCCCG
T ss_pred CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCChhhEEECCCC-CEEEeeccc
Confidence 458899999974 66666543 356999999999999999999999 88999999999999999888 799999999
Q ss_pred ceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+.............+|+.|+|||.+.+....+.++||||||+++|+|++|..||...+.......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 227 (276)
T 2h6d_A 158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV---------- 227 (276)
T ss_dssp GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc----------
Confidence 9876555444556789999999999775545789999999999999999999998876655554443310
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
. .++..++..+.+||.+||+.||.+|||+.++++||||.+.
T Consensus 228 -------~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 228 -------F------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -------C------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -------c------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 0 1223478999999999999999999999999999999763
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=350.24 Aligned_cols=253 Identities=23% Similarity=0.332 Sum_probs=205.9
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
..|++.+.||+|+||.||+|.+..++..||+|.+.... ....+|+.+++.++||||+++++++.... .+..++
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence 35999999999999999999999999999999886432 33457999999999999999999876543 345668
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeeecCCCCceEec-CCCCcEEEeeccc
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVN-PHTHQVKLCDFGS 240 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g--ivH~DLkp~Nill~-~~~~~vkl~DfG~ 240 (429)
++||||+++ +|.+.+.. ...+++..++.++.||+.||.||| +.| |+||||||+|||++ .++ .+||+|||+
T Consensus 105 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~~~i~H~dikp~Nil~~~~~~-~~kl~Dfg~ 178 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGL 178 (290)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-TSSSCCCCSCCCGGGEEESSTTS-CEEECCTTG
T ss_pred EEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHH-cCCCCEEECCCCHHHEEEECCCC-CEEEeeCCC
Confidence 899999975 66665543 367999999999999999999999 788 99999999999998 555 799999999
Q ss_pred ceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||..................
T Consensus 179 ~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------- 247 (290)
T 1t4h_A 179 ATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-------- 247 (290)
T ss_dssp GGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--------
T ss_pred cccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--------
Confidence 965433 23345678999999998864 4899999999999999999999999876655554433221100
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
...++...++++.+||.+||..||.+|||+.++++||||.+
T Consensus 248 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 248 ------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 01122346889999999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=359.12 Aligned_cols=259 Identities=26% Similarity=0.383 Sum_probs=196.9
Q ss_pred cccceEEe-eEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCce
Q 014174 89 QTISYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 89 ~~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 162 (429)
..+.|++. +.||+|+||+||+|++..+++.||||++... .....+|+.+++++ +||||+++++++.. ..
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~ 84 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----ED 84 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CC
Confidence 34579995 7899999999999999999999999998654 23456899999885 79999999999854 33
Q ss_pred EEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC--cEEEeecc
Q 014174 163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFG 239 (429)
Q Consensus 163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~--~vkl~DfG 239 (429)
.+++||||+. ++|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++.++. .+||+|||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLH-NKGIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 5889999997 566665543 357999999999999999999999 889999999999999987662 39999999
Q ss_pred cceecccCC--------CcccccccccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-------
Q 014174 240 SAKVLVKGE--------PNISYICSRYYRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGV------- 300 (429)
Q Consensus 240 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~------- 300 (429)
++....... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 987653221 12234689999999998541 23788999999999999999999999875421
Q ss_pred --------HHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 014174 301 --------DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372 (429)
Q Consensus 301 --------~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell 372 (429)
.....+.... +.++ ......+++++++||++||+.||.+|||+.|+|
T Consensus 240 ~~~~~~~~~~~~~i~~~~-----------------~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 294 (316)
T 2ac3_A 240 EACPACQNMLFESIQEGK-----------------YEFP--------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVL 294 (316)
T ss_dssp -CCHHHHHHHHHHHHHCC-----------------CCCC--------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred ccchhHHHHHHHHHhccC-----------------cccC--------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence 1111221110 0000 001124789999999999999999999999999
Q ss_pred cCCCCcccCC
Q 014174 373 IHPFFYELRD 382 (429)
Q Consensus 373 ~hp~f~~~~~ 382 (429)
+||||.....
T Consensus 295 ~hp~~~~~~~ 304 (316)
T 2ac3_A 295 QHPWVQGCAP 304 (316)
T ss_dssp HSTTCC----
T ss_pred cChhhcCCCC
Confidence 9999987654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=365.30 Aligned_cols=277 Identities=20% Similarity=0.302 Sum_probs=207.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+|+++++.++||||+++++++.... ..+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceE
Confidence 457999999999999999999999999999999986432 33458999999999999999999875432 2357
Q ss_pred EEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe----cCCCCcEEEeecc
Q 014174 165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV----NPHTHQVKLCDFG 239 (429)
Q Consensus 165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill----~~~~~~vkl~DfG 239 (429)
++||||++ ++|.+.+... .....+++..++.++.||+.||.||| +.||+||||||+|||+ +.++ .+||+|||
T Consensus 85 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg 161 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG 161 (319)
T ss_dssp EEEEECCTTCBHHHHHHSG-GGTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEECTTSCE-EEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHh-ccccCCCHHHHHHHHHHHHHHHHHHH-HCCEecCCCCHHHEEEeccCCCCc-eEEEccCC
Confidence 89999997 5666665542 22344999999999999999999999 8899999999999999 6665 79999999
Q ss_pred cceecccCCCcccccccccccccccccC-------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHH
Q 014174 240 SAKVLVKGEPNISYICSRYYRAPELIFG-------ATEYTTAIDIWSVGCVLAELLLGQPLFPGESG----VDQLVEIIK 308 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~i~~ 308 (429)
+++............||+.|+|||++.. ...++.++|||||||++|+|++|+.||..... .+.+..+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 9998766666666789999999998852 24589999999999999999999999975433 333333333
Q ss_pred HhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014174 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~ 376 (429)
.........+...... .+... ...+....+...++..+.+||++||+.||++|||+.|+|+||-
T Consensus 242 ~~p~~~~~~~~~~~~~--~~~~~--~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 242 GKPSGAISGVQKAENG--PIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HCCTTCCEEEECSTTC--CEEEE--SSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCCcccchhhhcccCC--ccccC--ccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 2111100000000000 00000 0000011122345678999999999999999999999999984
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=370.59 Aligned_cols=265 Identities=15% Similarity=0.141 Sum_probs=190.4
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHc--CCCCeeecceEe-------e
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL--DHPNVVSLKHCF-------F 154 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l--~h~niv~~~~~~-------~ 154 (429)
.+|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.| +||||++++..+ .
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 35999999999999999999999999999999997632 2234675545555 699988865333 2
Q ss_pred ecCC------------CCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHH------HHHHHHHHHHHHHHHcCCCeee
Q 014174 155 STTD------------KDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYV------KLYTYQICRALAYIHGGIGVCH 216 (429)
Q Consensus 155 ~~~~------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~------~~i~~qi~~aL~~LH~~~givH 216 (429)
.... .....+++||||++++|.+.+.... ..+++... ..++.||+.||.||| ++||+|
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH-~~~ivH 217 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQ-SKGLVH 217 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHH-HTTEEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHH-HCCCcc
Confidence 2111 0114578999999999988887642 23444444 567799999999999 889999
Q ss_pred ecCCCCceEecCCCCcEEEeecccceecccCCCcccccccccccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 014174 217 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTAIDIWSVGCVLAELLLGQPLFP 295 (429)
Q Consensus 217 ~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~ 295 (429)
|||||+||||+.++ .+||+|||+|+.... ......+|+.|+|||++.+ ...++.++|||||||++|+|++|+.||.
T Consensus 218 rDikp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 218 GHFTPDNLFIMPDG-RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TTCSGGGEEECTTS-CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CcCCHHHEEECCCC-CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999888 799999999986532 2225667899999999964 1358999999999999999999999997
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 014174 296 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375 (429)
Q Consensus 296 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp 375 (429)
+..... ...+............+.......+++.+.+||.+||+.||++|||+.++|+||
T Consensus 295 ~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp 354 (371)
T 3q60_A 295 LVTPGI--------------------KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354 (371)
T ss_dssp BCCTTC--------------------TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSH
T ss_pred CcCccc--------------------ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCH
Confidence 653210 001111111111111222222346899999999999999999999999999999
Q ss_pred CCcccCC
Q 014174 376 FFYELRD 382 (429)
Q Consensus 376 ~f~~~~~ 382 (429)
||.++.+
T Consensus 355 ~f~~~~~ 361 (371)
T 3q60_A 355 EFLQLQN 361 (371)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9987654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=352.78 Aligned_cols=253 Identities=19% Similarity=0.254 Sum_probs=202.9
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHc-CCCCeeecceEeeecCCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 160 (429)
...++|++.+.||+|+||+||+|++..+++.||+|++... .....+|+.++..+ +||||+++++++...
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~---- 83 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED---- 83 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET----
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC----
Confidence 3456899999999999999999999999999999998643 23344688888888 999999999988443
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC---------
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--------- 230 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~--------- 230 (429)
...++||||+++ +|.+.+.........+++..++.++.||+.||.||| ++||+||||||+|||++.++
T Consensus 84 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 84 -DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp -TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEC------------
T ss_pred -CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH-hCCEeecCCCHHHEEEcCCCCCccccccc
Confidence 358899999975 888877665555577999999999999999999999 88999999999999998432
Q ss_pred ---------CcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 014174 231 ---------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD 301 (429)
Q Consensus 231 ---------~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 301 (429)
..+||+|||++....... ...||+.|+|||++.+...++.++|||||||++|+|++|.+++.....
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-- 236 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-- 236 (289)
T ss_dssp --------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred ccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence 269999999998764432 345899999999997765577899999999999999999987754422
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 302 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
...+... .. ..++..+++++.+||.+||..||++|||+.++++||||.+.
T Consensus 237 -~~~~~~~-------------------~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 237 -WHEIRQG-------------------RL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp -HHHHHTT-------------------CC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred -HHHHHcC-------------------CC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 1111110 00 11334579999999999999999999999999999999763
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=359.29 Aligned_cols=281 Identities=27% Similarity=0.486 Sum_probs=219.8
Q ss_pred ccceEEeeEEccCCceEEEEEEE-cCCCcEEEEEEeecch---hhhHHHHHHHHHcCCC------CeeecceEeeecCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKC-LETGETVAIKKVLQDK---RYKNRELQTMRLLDHP------NVVSLKHCFFSTTDK 159 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~~ 159 (429)
.++|++.+.||+|+||.||+|.+ ..+++.||+|++.... ....+|+.+++.++|+ +++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~---- 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH---- 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE----
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc----
Confidence 35799999999999999999998 5688999999986543 3455799999988665 48999988843
Q ss_pred CceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC-----------
Q 014174 160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP----------- 228 (429)
Q Consensus 160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~----------- 228 (429)
..+.++||||+++++.+.+... ....+++..++.++.||+.||.||| ++||+||||||+|||++.
T Consensus 89 -~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 89 -HGHICIVFELLGLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLH-SNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred -CCcEEEEEcCCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 3358899999998888877542 2246899999999999999999999 889999999999999986
Q ss_pred --------CCCcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 014174 229 --------HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300 (429)
Q Consensus 229 --------~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~ 300 (429)
++ .+||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..
T Consensus 165 ~~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 165 KRDERTLINP-DIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp -CEEEEESCC-CEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccccCC-CceEeeCcccccCcc--ccccccCCccccChHHhhCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 44 699999999986533 23456789999999999764 4899999999999999999999999999988
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCcc-c---ccCCCcC---------CCCccc--ccCCCCChhHHHHHHhhcCcCCCCC
Q 014174 301 DQLVEIIKVLGTPTREEIKCMNPNYT-E---FKFPQIK---------AHPWHK--IFHKRMPPEAVDLVSRLLQYSPNLR 365 (429)
Q Consensus 301 ~~~~~i~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~---------~~~~~~--~~~~~~s~~l~~Li~~~L~~dP~~R 365 (429)
+.+..+....+..+...+........ . ....... ...+.. ......++++.+||.+||..||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 88888888888777665543221100 0 0000000 000000 0112235789999999999999999
Q ss_pred CCHHHHhcCCCCcccCC
Q 014174 366 CTALEACIHPFFYELRD 382 (429)
Q Consensus 366 ~t~~ell~hp~f~~~~~ 382 (429)
||+.|+++||||..++.
T Consensus 321 pt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 321 ITLREALKHPFFDLLKK 337 (339)
T ss_dssp CCHHHHTTSGGGGGGGC
T ss_pred cCHHHHhcCHHHHHHhc
Confidence 99999999999998764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=366.50 Aligned_cols=253 Identities=24% Similarity=0.333 Sum_probs=198.8
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcC--CCCeeecceEeeecCCCCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~ 162 (429)
.+|++.+.||+|+||+||+|.+.. ++.||||++.... ....+|+.+++.++ ||||+++++++.. ..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----DQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----CC
Confidence 469999999999999999999754 8999999986432 33458999999997 5999999998843 33
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
++++|||+.+++|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++ ++ .+||+|||+++
T Consensus 130 ~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH-~~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~ 202 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIV-DG-MLKLIDFGIAN 202 (390)
T ss_dssp EEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHH-TTTCCCCCCCGGGEEES-SS-CEEECCCSSSC
T ss_pred EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCCHHHEEEE-CC-eEEEEecCccc
Confidence 5889999888888777654 457899999999999999999999 89999999999999996 45 69999999998
Q ss_pred ecccCCC---cccccccccccccccccCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHH
Q 014174 243 VLVKGEP---NISYICSRYYRAPELIFGA----------TEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIK 308 (429)
Q Consensus 243 ~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~ 308 (429)
....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...... ..+..+..
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 7644322 2356799999999998641 35889999999999999999999999765432 22222221
Q ss_pred HhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
. . . ...++...+.++.+||.+||..||.+|||+.++|+||||.....+
T Consensus 283 ~--------------~-~------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~ 330 (390)
T 2zmd_A 283 P--------------N-H------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330 (390)
T ss_dssp T--------------T-S------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred c--------------c-c------------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence 0 0 0 011223357899999999999999999999999999999865443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=361.18 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=199.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCC--CCeeecceEeeecCCCCc
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDH--PNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~ 161 (429)
..+|++.+.||+|+||.||+|.+ .+++.||||++.... ....+|+.+++.++| +||+++++++. ..
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence 45799999999999999999987 568999999986432 334579999999987 99999999884 34
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.++++|||+.+++|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++ ++ .+||+|||++
T Consensus 82 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH-~~~iiHrDikp~NIll~-~~-~~kl~DFG~a 154 (343)
T 3dbq_A 82 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIV-DG-MLKLIDFGIA 154 (343)
T ss_dssp SEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEE-TT-EEEECCCSSS
T ss_pred CEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCcceEEEE-CC-cEEEeecccc
Confidence 46889999888888877654 467999999999999999999999 88999999999999997 55 7999999999
Q ss_pred eecccCCC---cccccccccccccccccC----------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Q 014174 242 KVLVKGEP---NISYICSRYYRAPELIFG----------ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEII 307 (429)
Q Consensus 242 ~~~~~~~~---~~~~~gt~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~ 307 (429)
+....... .....||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...... ..+..+.
T Consensus 155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 87644322 235678999999999853 245888999999999999999999999764432 2222211
Q ss_pred HHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
.. .....++...+.++.+||.+||..||.+|||+.++|+||||.....
T Consensus 235 ~~---------------------------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 235 DP---------------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp CT---------------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred cC---------------------------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 10 0011123346789999999999999999999999999999976443
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=359.33 Aligned_cols=254 Identities=30% Similarity=0.469 Sum_probs=202.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------------hhhHHHHHHHHHcCCCCeeecceEeeecCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 158 (429)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+++++.++||||+++++++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 86 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--- 86 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC---
Confidence 47999999999999999999999999999999885432 235689999999999999999998732
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC--cEEE
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKL 235 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~--~vkl 235 (429)
.. .++||||+.+ +|.+.+. ....+++..++.++.||+.||.||| ++||+||||||+|||++.++. .+||
T Consensus 87 --~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 87 --ED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp --SS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred --Cc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHHHEEEecCCCCCeEEE
Confidence 11 6789999975 5555443 3467999999999999999999999 889999999999999986552 4999
Q ss_pred eecccceecccCCCccccccccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014174 236 CDFGSAKVLVKGEPNISYICSRYYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313 (429)
Q Consensus 236 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 313 (429)
+|||++.............||+.|+|||++. +...++.++|||||||++|+|++|..||........+..........
T Consensus 159 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (322)
T 2ycf_A 159 TDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238 (322)
T ss_dssp CCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC
T ss_pred ccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc
Confidence 9999998765443334567899999999974 33458899999999999999999999997655433332222211100
Q ss_pred CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
. .......++..+.+||.+||..||.+|||+.++|+||||.+
T Consensus 239 ~------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 239 F------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp C------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred c------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 0 00112347899999999999999999999999999999976
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=354.13 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=209.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.++|.+.+.||+|+||.||+|++..+|+.||+|++.... ....+|+.+++.++||||+++++++. .....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence 347999999999999999999999999999999986542 34568999999999999999999884 334588
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe---cCCCCcEEEeecccc
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSA 241 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill---~~~~~~vkl~DfG~a 241 (429)
+||||+++ +|.+.+.. ...+++..+..++.||+.||.||| +.||+||||||+||++ +.++ .+||+|||++
T Consensus 83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~ 156 (304)
T 2jam_A 83 LVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLH-ENGIVHRDLKPENLLYLTPEENS-KIMITDFGLS 156 (304)
T ss_dssp EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTT
T ss_pred EEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCHHHEEEecCCCCC-CEEEccCCcc
Confidence 99999974 66665543 357999999999999999999999 8899999999999999 5555 7999999999
Q ss_pred eecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
...... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+......
T Consensus 157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~--------- 225 (304)
T 2jam_A 157 KMEQNG-IMSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE--------- 225 (304)
T ss_dssp CCCCCB-TTHHHHSCCCBCCTTTBSSC-SCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC---------
T ss_pred eecCCC-ccccccCCCCccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 764332 23445689999999998764 4899999999999999999999999888776666555442110
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
+...+...+++++.+||.+||..||++|||+.++++||||....
T Consensus 226 ----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 226 ----------------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp ----------------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ----------------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 01112245799999999999999999999999999999997643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=349.24 Aligned_cols=255 Identities=26% Similarity=0.345 Sum_probs=204.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+|+.+++.++||||+++++++.. ....
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 80 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ 80 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEE
Confidence 357999999999999999999999999999999986432 345689999999999999999998843 3357
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+++ +|.+.+ .....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~ 154 (276)
T 2yex_A 81 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERD-NLKISDFGLATV 154 (276)
T ss_dssp EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHH----hhccCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCChHHEEEccCC-CEEEeeCCCccc
Confidence 899999985 544432 33457999999999999999999999 88999999999999999888 799999999986
Q ss_pred cccCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 244 LVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 244 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
..... ......||+.|+|||++.+...++.++|||||||++|+|++|..||.+................
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 226 (276)
T 2yex_A 155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------- 226 (276)
T ss_dssp CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT--------
T ss_pred cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc--------
Confidence 54332 2334578999999999976554578999999999999999999999876543222211110000
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
..+ ....+++.+.+||.+||..||.+|||+.++++||||.+..
T Consensus 227 --------~~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 227 --------YLN----------PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp --------TST----------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred --------ccC----------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 000 0124789999999999999999999999999999997643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=367.02 Aligned_cols=260 Identities=28% Similarity=0.445 Sum_probs=204.9
Q ss_pred CccccceEEeeEEccCCceEEEEEEEc---CCCcEEEEEEeecc--------hhhhHHHHHHHHHc-CCCCeeecceEee
Q 014174 87 PKQTISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQD--------KRYKNRELQTMRLL-DHPNVVSLKHCFF 154 (429)
Q Consensus 87 ~~~~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l-~h~niv~~~~~~~ 154 (429)
.....+|++.+.||+|+||.||+|++. .+++.||||++... .....+|+.+++.+ +||||+++++++.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 345578999999999999999999984 58999999988532 23345799999999 6999999999884
Q ss_pred ecCCCCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcE
Q 014174 155 STTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQV 233 (429)
Q Consensus 155 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~v 233 (429)
. ...+++||||+++ +|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+||||+.++ .+
T Consensus 130 ~-----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~ 198 (355)
T 1vzo_A 130 T-----ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLH-KLGIIYRDIKLENILLDSNG-HV 198 (355)
T ss_dssp E-----TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CE
T ss_pred e-----CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-cE
Confidence 3 3358899999985 66665543 357999999999999999999999 88999999999999999888 79
Q ss_pred EEeecccceecccCC--CcccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014174 234 KLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310 (429)
Q Consensus 234 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 310 (429)
||+|||+++...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+....
T Consensus 199 kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 278 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 278 (355)
T ss_dssp EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHH
Confidence 999999998654322 22345789999999999753 347899999999999999999999997543322222221110
Q ss_pred CCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCC
Q 014174 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRD 382 (429)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~ 382 (429)
.. . ...++..++..+.+||.+||..||.+|| |+.++++||||..+.+
T Consensus 279 --------~~--------~---------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~ 330 (355)
T 1vzo_A 279 --------LK--------S---------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 330 (355)
T ss_dssp --------HH--------C---------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred --------hc--------c---------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCCh
Confidence 00 0 0112345789999999999999999999 9999999999988765
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=359.94 Aligned_cols=281 Identities=26% Similarity=0.461 Sum_probs=219.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCC-cEEEEEEeecch---hhhHHHHHHHHHcCCCC------eeecceEeeecCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETG-ETVAIKKVLQDK---RYKNRELQTMRLLDHPN------VVSLKHCFFSTTDK 159 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~---~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~~ 159 (429)
.++|++.+.||+|+||+||+|.+..++ ..||+|++.... ....+|+.+++.++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~---- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF---- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE----
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee----
Confidence 357999999999999999999998777 689999986542 34457999999987665 8888887743
Q ss_pred CceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe-------------
Q 014174 160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV------------- 226 (429)
Q Consensus 160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill------------- 226 (429)
....++||||+++++++.+... ....+++..++.++.||+.||.||| ++||+||||||+|||+
T Consensus 94 -~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH-~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 94 -HGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLH-ENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp -TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred -CCeEEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEEecccccccccccc
Confidence 3358899999999888876542 2356999999999999999999999 8899999999999999
Q ss_pred ------cCCCCcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH
Q 014174 227 ------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV 300 (429)
Q Consensus 227 ------~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~ 300 (429)
+.++ .+||+|||+++.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..
T Consensus 170 ~~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 170 SCEEKSVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCCEEEESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 4455 799999999986533 23456789999999999764 4899999999999999999999999999988
Q ss_pred HHHHHHHHHhCCCCHHHHhhcCcCcccc----cCCCcC---------CCCccc--ccCCCCChhHHHHHHhhcCcCCCCC
Q 014174 301 DQLVEIIKVLGTPTREEIKCMNPNYTEF----KFPQIK---------AHPWHK--IFHKRMPPEAVDLVSRLLQYSPNLR 365 (429)
Q Consensus 301 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------~~~~~~--~~~~~~s~~l~~Li~~~L~~dP~~R 365 (429)
+.+..+.+..+.++...+.........+ ..+... ...+.. ......+.++.+||.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 8888888888887776554322110000 000000 000000 0011234689999999999999999
Q ss_pred CCHHHHhcCCCCcccCC
Q 014174 366 CTALEACIHPFFYELRD 382 (429)
Q Consensus 366 ~t~~ell~hp~f~~~~~ 382 (429)
||+.++|+||||.++..
T Consensus 326 pt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 326 ITLAEALLHPFFAGLTP 342 (355)
T ss_dssp CCHHHHTTSGGGGGCCH
T ss_pred cCHHHHhcChhhcCCCh
Confidence 99999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=359.26 Aligned_cols=261 Identities=25% Similarity=0.359 Sum_probs=207.2
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++||||+++++++.... ...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 88 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 88 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCC
Confidence 3457999999999999999999999999999999986542 23457888999999999999999886544 233
Q ss_pred eEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
.+.++||||++ ++|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~ 162 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMISATN-AVKVMDFGI 162 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEETTS-CEEECCCSC
T ss_pred cccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCCcCCCCHHHEEEcCCC-CEEEeeccC
Confidence 45689999997 566665543 357999999999999999999999 88999999999999999888 799999999
Q ss_pred ceecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 241 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 241 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.......+......+..
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~- 240 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS- 240 (311)
T ss_dssp C------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHH-
T ss_pred cccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcc-
Confidence 986543321 2335689999999999765 4899999999999999999999999988877666555543211111
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
.....++.++.+||.+||+.||.+||++.+++.|+|+.....
T Consensus 241 ------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 241 ------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ------------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ------------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 112347999999999999999999999999999999976554
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=379.24 Aligned_cols=255 Identities=18% Similarity=0.207 Sum_probs=193.8
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHH---HHHHcCCCCeeecc-------eE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQ---TMRLLDHPNVVSLK-------HC 152 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~---~l~~l~h~niv~~~-------~~ 152 (429)
..+|++.+.||+|+||+||+|++..+|+.||||++... ...+.+|+. +++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 45799999999999999999999999999999998632 234457884 45556899999998 44
Q ss_pred eeecC---------CCCce---EEEEEEeccchhHHHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeee
Q 014174 153 FFSTT---------DKDEL---YLNLVLEFVPETVYRVAKHYSRA---SQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 217 (429)
Q Consensus 153 ~~~~~---------~~~~~---~~~lv~e~~~~~l~~~~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~ 217 (429)
+.... +.... ..++||||++++|.+.+...... ...+++..+..++.||+.||.||| ++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH-HTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH-hCCeecC
Confidence 32221 11111 26799999999888887653221 112334788889999999999999 8899999
Q ss_pred cCCCCceEecCCCCcEEEeecccceecccCCCcccccccccccccccccCC----------CCCCCchhHHHHHHHHHHH
Q 014174 218 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA----------TEYTTAIDIWSVGCVLAEL 287 (429)
Q Consensus 218 DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~l 287 (429)
||||+||||+.++ .+||+|||+++... .......| +.|+|||++.+. ..++.++|||||||++|+|
T Consensus 231 Dikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 231 YLRPVDIVLDQRG-GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCCGGGEEECTTC-CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCC-CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 9999999999888 79999999998642 23345566 999999999765 2489999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC
Q 014174 288 LLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367 (429)
Q Consensus 288 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t 367 (429)
++|+.||.+.+.......+ ......+++++.+||.+||+.||.+|||
T Consensus 307 ltg~~Pf~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rpt 353 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWI---------------------------------FRSCKNIPQPVRALLEGFLRYPKEDRLL 353 (377)
T ss_dssp HHSSCCC------CCSGGG---------------------------------GSSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred HHCCCCCcccccccchhhh---------------------------------hhhccCCCHHHHHHHHHHcCCCchhCCC
Confidence 9999999654321111000 0011357999999999999999999999
Q ss_pred HHHHhcCCCCcccCC
Q 014174 368 ALEACIHPFFYELRD 382 (429)
Q Consensus 368 ~~ell~hp~f~~~~~ 382 (429)
+.++++||||.+++.
T Consensus 354 ~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 354 PLQAMETPEYEQLRT 368 (377)
T ss_dssp HHHHHTSHHHHHHHH
T ss_pred HHHHhhChHHHHHHH
Confidence 999999999987653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=346.79 Aligned_cols=259 Identities=26% Similarity=0.383 Sum_probs=211.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..++|++.+.||+|+||.||+|++..+|+.||+|.+... .....+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 80 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNT 80 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGT
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCc
Confidence 456899999999999999999999999999999998643 23345799999999999999999987543 233
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC-----eeeecCCCCceEecCCCCcEEEe
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG-----VCHRDIKPQNLLVNPHTHQVKLC 236 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g-----ivH~DLkp~Nill~~~~~~vkl~ 236 (429)
.+++||||+++ +|.+.+.........+++..++.++.||+.||.||| +.| |+||||||+||+++.++ .+||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~ 158 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH-RRSDGGHTVLHRDLKPANVFLDGKQ-NVKLG 158 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HHC------CCCCCSGGGEEECSSS-CEEEC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh-cccCCCCeeEEeccchhhEEEcCCC-CEEEe
Confidence 58899999975 777777665555567999999999999999999999 778 99999999999999888 79999
Q ss_pred ecccceecccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 237 DFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 237 DfG~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
|||++........ .....||+.|+|||++.+. .++.++||||||+++|+|++|..||...+..+....+....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~----- 232 (279)
T 2w5a_A 159 DFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK----- 232 (279)
T ss_dssp CCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----
T ss_pred cCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcc-----
Confidence 9999976543322 2245689999999999764 48999999999999999999999998877655554444310
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
.+ .++..++.++.+||.+||..||.+|||+.++++|+|+.+-.
T Consensus 233 --------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 233 --------------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp --------------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred --------------cc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 00 12335789999999999999999999999999999997633
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=350.32 Aligned_cols=256 Identities=27% Similarity=0.457 Sum_probs=210.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.++|++.+.||+|+||.||+|++..+++.||+|++... .....+|+++++.++||||+++++++. ....
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence 34799999999999999999999999999999998543 234568999999999999999999884 3345
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC--cEEEeeccc
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGS 240 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~--~vkl~DfG~ 240 (429)
.++||||+.+ ++.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+||+++.++. .+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 8899999974 55554433 357999999999999999999999 889999999999999976432 699999999
Q ss_pred ceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+.............+|+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 241 (287)
T 2wei_A 171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF------- 241 (287)
T ss_dssp GGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC-------
T ss_pred ceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence 987655555555678999999999865 38999999999999999999999999887766655544421000
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
..+ ....+++++.+||++||..||.+|||+.++|+||||.+...
T Consensus 242 --------~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 242 --------DLP----------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp --------CSG----------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred --------Cch----------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 000 11347899999999999999999999999999999987654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=350.03 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=205.1
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHc-CCCCeeecceEeeecCCC-CceE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK-DELY 163 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~-~~~~ 163 (429)
..++|++.+.||+|+||.||+|++..+|+.||||++... .....+|+.+++.+ +||||+++++++...... ....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 455799999999999999999999999999999998643 34556899999999 799999999998754321 1346
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
+++||||+++ +|.+++... ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++.
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~ 177 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLH-QHKVIHRDIKGQNVLLTENA-EVKLVDFGVSA 177 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEECTTC-CEEECCCTTTC
T ss_pred EEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCcHHHEEEcCCC-CEEEeeCcCce
Confidence 8899999986 776666542 2357999999999999999999999 88999999999999999888 79999999987
Q ss_pred ecccCC-CcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 243 VLVKGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 243 ~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
...... ......||+.|+|||++.. ...++.++|||||||++|+|++|..||.+.+....+..+.... .
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~----- 251 (326)
T 2x7f_A 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-A----- 251 (326)
T ss_dssp -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-C-----
T ss_pred ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc-c-----
Confidence 654332 2234578999999999862 2458899999999999999999999998877665554433210 0
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
+ ......++..+.+||.+||..||.+|||+.++++||||.+.
T Consensus 252 -------------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 252 -------------P--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp -------------C--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred -------------c--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 0 01123478999999999999999999999999999999763
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=356.31 Aligned_cols=267 Identities=23% Similarity=0.373 Sum_probs=185.9
Q ss_pred ccccceEEee-EEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 88 KQTISYMAER-VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 88 ~~~~~y~i~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
...++|.+.+ +||+|+||+||+|++..+|+.||||++........+....++.++||||+++++++.... ....++++
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l 103 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRCLLI 103 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCceEEE
Confidence 4556899965 699999999999999999999999999776655555556678889999999999885433 33556889
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC--CcEEEeeccccee
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKV 243 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~--~~vkl~DfG~a~~ 243 (429)
||||+.+ +|.+.+.. .....+++..++.++.||+.||.||| +.||+||||||+|||++.++ ..+||+|||+++.
T Consensus 104 v~e~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~~LH-~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 104 IMECMEGGELFSRIQE--RGDQAFTEREAAEIMRDIGTAIQFLH-SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEECCTTEEHHHHHHT--C-CCCCBHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEeccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 9999986 66666653 22357999999999999999999999 88999999999999997533 2599999999986
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+...............
T Consensus 181 ~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------ 246 (336)
T 3fhr_A 181 TTQN-ALQTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR------------ 246 (336)
T ss_dssp C-----------------------C-HHHHHHHHHHHHHHHHHHHHSSCCC-----------------------------
T ss_pred cccc-ccccCCCCcCccChhhhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh------------
Confidence 5433 23356789999999998654 488999999999999999999999976554332211111000
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
...+.++ ......+++++.+||.+||+.||.+|||+.++|+||||.+..
T Consensus 247 -~~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 247 -LGQYGFP--------NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp -----CCC--------TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred -ccccccC--------chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 0000000 011235799999999999999999999999999999998643
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=349.22 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=204.7
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
...+|++++.||+|+||.||+|++..+++.||+|++... .....+|+++++.++||||+++++++... ...
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 91 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GKL 91 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----CeE
Confidence 345799999999999999999999999999999988543 23445799999999999999999988543 347
Q ss_pred EEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||++++ +...+.. ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++..
T Consensus 92 ~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 92 WIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAK 166 (302)
T ss_dssp EEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEECTTS-CEEECCCHHHHH
T ss_pred EEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCHHHEEECCCC-CEEEEECCCCcc
Confidence 8999999864 4333322 2467999999999999999999999 88999999999999999888 799999998754
Q ss_pred cccC-CCccccccccccccccccc----CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 244 LVKG-EPNISYICSRYYRAPELIF----GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 244 ~~~~-~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
.... .......||+.|+|||++. ....++.++|||||||++|+|++|..||...+.......+..... +
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~----- 240 (302)
T 2j7t_A 167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-P----- 240 (302)
T ss_dssp HHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C-----
T ss_pred ccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-c-----
Confidence 3221 1223457899999999884 334588999999999999999999999998877666555443210 0
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
. ...+..++..+.+||.+||..||.+|||+.++++||||..+..
T Consensus 241 -------------~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 241 -------------T-------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp -------------C-------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred -------------c-------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 0 0112346899999999999999999999999999999987553
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=354.26 Aligned_cols=269 Identities=26% Similarity=0.389 Sum_probs=191.1
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
..++|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++.... .
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 87 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-----E 87 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----C
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----C
Confidence 345799999999999999999999889999999987543 233457888999999999999999885433 3
Q ss_pred EEEEEeccc-hhHHHHHHHhhh----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 164 LNLVLEFVP-ETVYRVAKHYSR----ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 164 ~~lv~e~~~-~~l~~~~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
.++||||++ ++|.+.+..... ....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+||
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~df 165 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-KNGQIHRDVKAGNILLGEDG-SVQIADF 165 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEECTTC-CEEECCC
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCCCCChhhEEEcCCC-CEEEEec
Confidence 789999996 466666654322 2456899999999999999999999 88999999999999999888 7999999
Q ss_pred ccceecccCC------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Q 014174 239 GSAKVLVKGE------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312 (429)
Q Consensus 239 G~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~ 312 (429)
|++....... ......||+.|+|||++.+...++.++|||||||++|+|++|..||................
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-- 243 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND-- 243 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS--
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC--
Confidence 9987653321 12345689999999998654458999999999999999999999998876655443332210
Q ss_pred CCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
+. ..............++.++.+||.+||+.||.+|||+.++++||||.+.+..
T Consensus 244 ~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 244 PP-----------------SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297 (303)
T ss_dssp CC-----------------CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred CC-----------------ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence 00 0000001112234578999999999999999999999999999999876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=348.88 Aligned_cols=253 Identities=22% Similarity=0.339 Sum_probs=194.8
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
....+|++.+.||+|+||+||+|++ +|..||+|++.... ....+|+++++.++||||+++++++.. .
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 106 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-----P 106 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----T
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----C
Confidence 4456899999999999999999987 68899999986432 234579999999999999999998843 3
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeeecCCCCceEecCCCCcEEEeec
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g--ivH~DLkp~Nill~~~~~~vkl~Df 238 (429)
..+++||||+.+ +|.+.+.... ....+++..+..++.||+.||.||| +.| |+||||||+|||++.++ .+||+||
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH-~~~~~ivH~Dikp~NIll~~~~-~~kL~Df 183 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKY-TVKVCDF 183 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHH-TSSSCCCCTTCCGGGEEECTTC-CEEECCC
T ss_pred CceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCEECCCCChhhEEEeCCC-cEEECCC
Confidence 347899999985 6666554311 1224899999999999999999999 889 99999999999999887 7999999
Q ss_pred ccceecccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 239 GSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 239 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
|+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------ 256 (309)
T 3p86_A 184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK------ 256 (309)
T ss_dssp C-----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC------
T ss_pred CCCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------
Confidence 9997654332 23356789999999999764 489999999999999999999999988876665554432110
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCCCc
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI--HPFFY 378 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~--hp~f~ 378 (429)
...++..+++++.+||.+||+.||.+|||+.++++ ++++.
T Consensus 257 ---------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 257 ---------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp ---------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred ---------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 01133458999999999999999999999999988 44443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=361.51 Aligned_cols=281 Identities=24% Similarity=0.397 Sum_probs=206.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.++|++.+.||+|+||.||+|++..++..||+|++... .....+|+.+++.++||||+++++++... ...
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CEE
Confidence 45799999999999999999999999999999998654 23345799999999999999999988543 348
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
++||||+++ +|.+.+.. ...+++..+..++.||+.||.||| + .||+||||||+|||++.++ .+||+|||++.
T Consensus 107 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh-~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~ 180 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSG 180 (360)
T ss_dssp EEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HHHCCCCSCCSGGGEEECTTC-CEEECCCCCCH
T ss_pred EEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-HhCCEEcCCccHHHEEECCCC-CEEEEECCCCc
Confidence 899999975 66666543 357999999999999999999999 6 4999999999999999888 79999999987
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-CCCCHHHHh--
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL-GTPTREEIK-- 319 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~-- 319 (429)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+.... +........
T Consensus 181 ~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 181 QLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp HHHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred ccccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 65332 23356789999999999764 48999999999999999999999998876554432221110 000000000
Q ss_pred hcCcCcccccCCC------------cCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 320 CMNPNYTEFKFPQ------------IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 320 ~~~~~~~~~~~~~------------~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
........+.... +............++.++.+||++||+.||++|||+.++|+||||......
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 0000000000000 000000111123478999999999999999999999999999999875543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=348.31 Aligned_cols=254 Identities=28% Similarity=0.398 Sum_probs=204.8
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch--hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
.+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+.+++.++||||+++++++... ...++||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~ 103 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDLWIVM 103 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEEEEe
Confidence 36999999999999999999999999999999986543 4456899999999999999999988543 3478999
Q ss_pred eccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
||+++ +|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLH-FMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhh
Confidence 99986 56555532 3467999999999999999999999 88999999999999999888 7999999999876543
Q ss_pred C-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcc
Q 014174 248 E-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326 (429)
Q Consensus 248 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 326 (429)
. ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.......+.... .+
T Consensus 179 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~------------- 243 (314)
T 3com_A 179 MAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PP------------- 243 (314)
T ss_dssp BSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CC-------------
T ss_pred ccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-Cc-------------
Confidence 2 23345789999999998664 48999999999999999999999998877655544332210 00
Q ss_pred cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
. ...+..++..+.+||.+||..||.+|||+.++++||||....
T Consensus 244 -----~-------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 244 -----T-------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp -----C-------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred -----c-------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 0 001223689999999999999999999999999999998644
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=345.84 Aligned_cols=249 Identities=26% Similarity=0.381 Sum_probs=207.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
..|++.+.||+|+||.||+|++..+++.||||++... .....+|+.+++.++||||+++++++... ...+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 96 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLW 96 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEE
Confidence 3699999999999999999999999999999998643 24456899999999999999999988543 3488
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+++ ++.+.+. ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus 97 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLH-SEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQL 169 (303)
T ss_dssp EEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCChheEEECCCC-CEEEeecccceec
Confidence 99999986 5544432 367999999999999999999999 88999999999999999888 7999999999876
Q ss_pred ccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...........+... .
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~----------- 235 (303)
T 3a7i_A 170 TDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--N----------- 235 (303)
T ss_dssp BTTBCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--C-----------
T ss_pred CccccccCccCCCcCccCHHHHhcC-CCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--C-----------
Confidence 5433 23345789999999999664 4889999999999999999999999887665554443321 0
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
...++..++..+.+||.+||..||.+|||+.++++||||..-
T Consensus 236 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 236 ---------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ---------------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ---------------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 001234578999999999999999999999999999999753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=346.78 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=202.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.++|++.+.||+|+||.||+|++..++..||+|.+... .....+|+.+++.++||||+++++++ ....
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence 45799999999999999999999999999999988432 13345799999999999999999988 3444
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
..++||||+++ +|.+.+.. .+.+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~ 158 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAH-DMRIVHRDIKPQNILIDSNK-TLKIFDFGIA 158 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCCSSS
T ss_pred eEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCCHHHEEECCCC-CEEEEeCCCc
Confidence 58899999975 66665543 357999999999999999999999 88999999999999999888 7999999999
Q ss_pred eecccCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 242 KVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 242 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+........... ..+.
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~-~~~~----- 231 (294)
T 4eqm_A 159 KALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD-SVPN----- 231 (294)
T ss_dssp TTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS-CCCC-----
T ss_pred cccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc-cCCC-----
Confidence 7654332 22345689999999999774 4899999999999999999999999988766554443321 0111
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
....++..+++.+.++|.+||..||.+||+..+.+.+.|..-+..
T Consensus 232 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 232 ------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp ------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred ------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 111233458999999999999999999997777777777654443
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=353.20 Aligned_cols=272 Identities=20% Similarity=0.323 Sum_probs=205.9
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---------------------hhhHHHHHHHHHcCCCCee
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------------------RYKNRELQTMRLLDHPNVV 147 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~E~~~l~~l~h~niv 147 (429)
..++|++.+.||+|+||.||+|.+ +|+.||+|++.... ....+|+.+++.++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 345799999999999999999998 89999999986432 4567899999999999999
Q ss_pred ecceEeeecCCCCceEEEEEEeccch-hHHHHHHHh--hhc--CCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeeecCCC
Q 014174 148 SLKHCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHY--SRA--SQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKP 221 (429)
Q Consensus 148 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~-~givH~DLkp 221 (429)
++++++.. ....++||||+++ +|.+.+... ... ...+++..++.++.||+.||.||| + .||+||||||
T Consensus 107 ~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~~i~H~dl~p 180 (348)
T 2pml_X 107 TCEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH-NEKNICHRDVKP 180 (348)
T ss_dssp CCSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH-HTSCEECCCCCG
T ss_pred eEEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh-ccCCEeecCCCh
Confidence 99999843 3458899999986 544431100 111 467999999999999999999999 6 8999999999
Q ss_pred CceEecCCCCcEEEeecccceecccCCCcccccccccccccccccCCCCCCC-chhHHHHHHHHHHHHhCCCCCCCCCh-
Q 014174 222 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT-AIDIWSVGCVLAELLLGQPLFPGESG- 299 (429)
Q Consensus 222 ~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwslG~il~~lltg~~pf~~~~~- 299 (429)
+||+++.++ .+||+|||++...... ......||+.|+|||++.+...++. ++|||||||++|+|++|..||...+.
T Consensus 181 ~Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 181 SNILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp GGEEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred HhEEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999999888 7999999999876443 3345678999999999976534555 99999999999999999999988766
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 300 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.+....+.......+ .....+..+.. . .........+++++.+||.+||+.||.+|||+.++++||||.+
T Consensus 259 ~~~~~~i~~~~~~~~--------~~~~~~~~~~~-~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 259 VELFNNIRTKNIEYP--------LDRNHFLYPLT-N-KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp HHHHHHHTSCCCCCC--------CSSSSSTTTTC-C---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHhccCcCCc--------cchhhhhcccc-c-cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 333333322100000 00000000000 0 0001122458999999999999999999999999999999976
Q ss_pred c
Q 014174 380 L 380 (429)
Q Consensus 380 ~ 380 (429)
.
T Consensus 329 ~ 329 (348)
T 2pml_X 329 T 329 (348)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=349.58 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=203.9
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----------hhhHHHHHHHHHcC--CCCeeecceEeeec
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFST 156 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~niv~~~~~~~~~ 156 (429)
..++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+.+++.++ |+||+++++++.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~-- 118 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE-- 118 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe--
Confidence 3457999999999999999999999999999999986542 23457999999996 599999999884
Q ss_pred CCCCceEEEEEEeccc--hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEE
Q 014174 157 TDKDELYLNLVLEFVP--ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVK 234 (429)
Q Consensus 157 ~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vk 234 (429)
.....++|||++. ++|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++.+...+|
T Consensus 119 ---~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 119 ---RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp ---CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTTEEE
T ss_pred ---cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-HCCcEeCCCCHHHEEEeCCCCCEE
Confidence 3345789999997 567666543 367999999999999999999999 889999999999999984333899
Q ss_pred EeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 235 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 235 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
|+|||++...... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||...+. +.. +.
T Consensus 191 L~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~--~~-- 259 (320)
T 3a99_A 191 LIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR--GQ-- 259 (320)
T ss_dssp ECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH--CC--
T ss_pred EeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc--cc--
Confidence 9999999876543 234567899999999987655457899999999999999999999965321 111 00
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
..++..+++++.+||.+||..||.+|||+.++++||||.+...
T Consensus 260 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 260 -------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp -------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred -------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 0123457999999999999999999999999999999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=343.10 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=198.9
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
|.....||+|+||.||+|++..++..||+|.+.... ....+|+.+++.++||||+++++++.. ....++||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~ 98 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFM 98 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEE
Confidence 444458999999999999999999999999886542 345689999999999999999998843 33588999
Q ss_pred eccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC-CCCcEEEeecccceeccc
Q 014174 169 EFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 169 e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~-~~~~vkl~DfG~a~~~~~ 246 (429)
||++ ++|.+.+.. ......+++..++.++.||+.||.||| +.||+||||||+||+++. ++ .+||+|||++.....
T Consensus 99 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dl~p~Nil~~~~~~-~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 99 EQVPGGSLSALLRS-KWGPLKDNEQTIGFYTKQILEGLKYLH-DNQIVHRDIKGDNVLINTYSG-VLKISDFGTSKRLAG 175 (295)
T ss_dssp ECCSEEEHHHHHHH-TTCCCTTCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTC-CEEECCTTTCEESCC
T ss_pred EeCCCCCHHHHHHh-hccCCCccHHHHHHHHHHHHHHHHHHH-hCCEEccCCChhhEEEECCCC-CEEEeecccccccCC
Confidence 9996 566565543 222345678999999999999999999 889999999999999987 55 799999999987644
Q ss_pred CCC-cccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 247 GEP-NISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 247 ~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
... .....||+.|+|||++.+. ..++.++||||||+++|+|++|+.||..................
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------ 243 (295)
T 2clq_A 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV------------ 243 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCC------------
T ss_pred CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccc------------
Confidence 322 2345789999999998643 23789999999999999999999999765433322111111000
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
...++..+++++.+||.+||..||++|||+.++|+||||.....
T Consensus 244 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 244 --------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp --------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred --------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 01123457999999999999999999999999999999986554
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=349.81 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=185.4
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh-----hhHHHHH-HHHHcCCCCeeecceEeeecCCCCce
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-----YKNRELQ-TMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+|+. +++.++||||+++++++.. ..
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~ 94 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EG 94 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SS
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CC
Confidence 34579999999999999999999999999999999865421 1223444 6677899999999998843 33
Q ss_pred EEEEEEeccchhHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHcCC-CeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 163 YLNLVLEFVPETVYRVAKHYSR-ASQRMPLIYVKLYTYQICRALAYIHGGI-GVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~-givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
..++||||+++++.+.+..... ....+++..+..++.|++.||.||| +. ||+||||||+|||++.++ .+||+|||+
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~ 172 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK-ENLKIIHRDIKPSNILLDRSG-NIKLCDFGI 172 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH-HHHSCCCSCCCGGGEEEETTT-EEEECCCSS
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh-ccCCEeECCCCHHHEEEcCCC-CEEEccCCC
Confidence 5889999999988777664322 2567999999999999999999999 77 999999999999999888 799999999
Q ss_pred ceecccCCCccccccccccccccccc---CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIF---GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
++............||+.|+|||++. ....++.++|||||||++|+|++|+.||.+.+..... +..
T Consensus 173 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~--------- 241 (327)
T 3aln_A 173 SGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--LTQ--------- 241 (327)
T ss_dssp SCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CC---------
T ss_pred ceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--HHH---------
Confidence 98765554444557899999999983 2344889999999999999999999999764321110 000
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
. .....+. +.......+++.+.+||.+||..||.+|||+.++++||||....
T Consensus 242 ---~----~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 242 ---V----VKGDPPQ-----LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp ---C----CCSCCCC-----CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ---H----hcCCCCC-----CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 0 0000001 11112245799999999999999999999999999999997654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=342.75 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=197.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCC--------
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-------- 158 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------- 158 (429)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 357999999999999999999999999999999986543 334579999999999999999998765321
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEee
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD 237 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~D 237 (429)
......++||||+++ +|.+.+.. ....+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dlkp~Nil~~~~~-~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIH-SQGIIHRDLKPMNIFIDESR-NVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHH-hCCeecccCCHHhEEEcCCC-CEEEee
Confidence 235678899999975 77666653 2346788999999999999999999 88999999999999999888 799999
Q ss_pred cccceecccC---------------CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 014174 238 FGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ 302 (429)
Q Consensus 238 fG~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~ 302 (429)
||++...... .......||+.|+|||++.+...++.++|||||||++|+|++ ||........
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 9999765321 122345689999999999765568999999999999999998 5543222222
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 303 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 303 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
........ ... +...+....+..+.+||++||+.||.+|||+.++++||||..
T Consensus 237 ~~~~~~~~----------------~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 237 ILKKLRSV----------------SIE--------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp HHHHHHST----------------TCC--------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred HHHhcccc----------------ccc--------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 11111100 000 111233456788999999999999999999999999999964
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=346.82 Aligned_cols=259 Identities=24% Similarity=0.349 Sum_probs=189.6
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh------hhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...++|++.+.||+|+||.||+|++..+|+.||||++..... ...++..+++.++||||+++++++.. .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~ 96 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----N 96 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----C
Confidence 345689999999999999999999999999999999865421 12234456788899999999998843 3
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG-IGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
...++||||+++.+..+... ....+++..++.++.||+.||.||| + .||+||||||+||+++.++ .+||+|||+
T Consensus 97 ~~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~ 171 (318)
T 2dyl_A 97 TDVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLK-EKHGVIHRDVKPSNILLDERG-QIKLCDFGI 171 (318)
T ss_dssp SEEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH-HHHCCCCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred CcEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH-hhCCEEeCCCCHHHEEECCCC-CEEEEECCC
Confidence 45889999997655544432 2467999999999999999999999 6 4999999999999999888 799999999
Q ss_pred ceecccCCCcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCH
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTR 315 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~i~~~~~~~~~ 315 (429)
+.............+|+.|+|||++.. ...++.++|||||||++|+|++|+.||..... .+.+..+.... +.
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~- 248 (318)
T 2dyl_A 172 SGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--PP- 248 (318)
T ss_dssp C--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--CC-
T ss_pred chhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--CC-
Confidence 987655554555678999999999852 34578999999999999999999999987443 33333333310 00
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
..+ ....+++++.+||.+||..||.+|||+.++++||||.+...
T Consensus 249 -------------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 249 -------------LLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp -------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred -------------CCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 000 11247899999999999999999999999999999986543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=347.43 Aligned_cols=248 Identities=19% Similarity=0.207 Sum_probs=200.1
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..+|++.+.||+|+||.||+|++..+|+.||||++... .....+|+++++.+ +||||+++++++.. ..+.++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEE
Confidence 45799999999999999999999999999999988643 34567899999999 99999999998844 335889
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCc-----EEEeecccc
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ-----VKLCDFGSA 241 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~-----vkl~DfG~a 241 (429)
||||++++|.+++... ...+++..+..++.||+.||.||| +.||+||||||+|||++.++ . +||+|||++
T Consensus 83 v~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH-~~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 83 VLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVH-SKNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALA 157 (330)
T ss_dssp EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTC
T ss_pred EEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCHHHeeeccCC-CCCCceEEEEEcccc
Confidence 9999988888877542 467999999999999999999999 88999999999999998776 4 999999999
Q ss_pred eecccCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Q 014174 242 KVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV---DQLVEIIKVL 310 (429)
Q Consensus 242 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~i~~~~ 310 (429)
+....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.. +.+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 236 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGK-EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK 236 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCC-CCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence 87654332 2356789999999999764 4899999999999999999999999875432 2333332211
Q ss_pred CCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.....+. .....+ ++.+||.+||..||.+||++.++++
T Consensus 237 ~~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 237 RATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1111110 111234 9999999999999999999988776
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=344.36 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=201.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.++|++.+.||+|+||+||+|.+..+++.||+|.+... ...+.+|+++++.++||||+++++++... ...+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----CeeE
Confidence 45799999999999999999999999999999988542 23455899999999999999999998543 3488
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+.+ +|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLH-SMNIIHRDLNSHNCLVRENK-NVVVADFGLARLM 158 (310)
T ss_dssp EEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCCcCeEEECCCC-CEEEeecccceec
Confidence 99999976 66665543 2467999999999999999999999 88999999999999999888 7999999999876
Q ss_pred ccCCCc---------------ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 014174 245 VKGEPN---------------ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 309 (429)
Q Consensus 245 ~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~ 309 (429)
...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~------ 231 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD------ 231 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT------
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH------
Confidence 433221 14578999999999976 45899999999999999999999998653211000
Q ss_pred hCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
.............+..+++.+.+||.+||+.||++|||+.++++ |+..++.
T Consensus 232 --------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~ 282 (310)
T 3s95_A 232 --------------------FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRM 282 (310)
T ss_dssp --------------------SSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred --------------------HhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence 00000000011123467899999999999999999999999988 7766553
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=336.95 Aligned_cols=250 Identities=19% Similarity=0.215 Sum_probs=202.7
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.++|++.+.||+|+||.||+|++..+|+.||+|++... .....+|+.+++.+ +|+|++++++++. .....++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCceeEE
Confidence 44799999999999999999999999999999988643 34567899999999 7999999998873 3345889
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC----cEEEeecccce
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH----QVKLCDFGSAK 242 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~----~vkl~DfG~a~ 242 (429)
||||++++|.+.+... ...+++..+..++.||+.||.||| ++||+||||||+|||++.++. .+||+|||+++
T Consensus 84 v~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 84 VIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH-EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 9999988888877542 356999999999999999999999 899999999999999986652 39999999998
Q ss_pred ecccCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhC
Q 014174 243 VLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES---GVDQLVEIIKVLG 311 (429)
Q Consensus 243 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~i~~~~~ 311 (429)
....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+ ....+..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 7654322 2345789999999998764 48999999999999999999999998743 3333333333211
Q ss_pred CCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+... .+...+++++.+||.+||+.||++|||+.++++
T Consensus 239 ~~~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 239 STPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HSCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CccHH------------------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 11111 112347999999999999999999999999877
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=349.65 Aligned_cols=250 Identities=21% Similarity=0.320 Sum_probs=200.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEc-------CCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeee
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCL-------ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS 155 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~ 155 (429)
..++|++.+.||+|+||.||+|++. .++..||+|++.... ....+|+.+++.+ +||||+++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4568999999999999999999875 345689999986532 2345799999999 89999999998843
Q ss_pred cCCCCceEEEEEEeccch-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCC
Q 014174 156 TTDKDELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQ 222 (429)
Q Consensus 156 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~ 222 (429)
...+++||||+.+ +|.+.+..... ....+++..+..++.||+.||.||| ++||+||||||+
T Consensus 159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~ 232 (370)
T 2psq_A 159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA-SQKCIHRDLAAR 232 (370)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGG
T ss_pred -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCeeccccchh
Confidence 3347899999985 67666654221 1245899999999999999999999 889999999999
Q ss_pred ceEecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCC
Q 014174 223 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGES 298 (429)
Q Consensus 223 Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~ 298 (429)
||||+.++ .+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+
T Consensus 233 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 233 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999888 799999999987644322 2334567899999999764 48999999999999999999 999998876
Q ss_pred hHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 299 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 299 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
..+....+.... ....+..++.++.+||.+||..||.+|||+.+++++
T Consensus 311 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKEGH----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHTTC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 655544332210 011234578999999999999999999999999873
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=353.33 Aligned_cols=257 Identities=18% Similarity=0.207 Sum_probs=204.0
Q ss_pred ccccceEEeeEEccCCceEEEEEE-----EcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAK-----CLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTT 157 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 157 (429)
....+|++.+.||+|+||.||+|+ +..++..||||++... .....+|+.+++.++||||+++++++..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-- 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-- 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence 344689999999999999999999 4457789999998542 2234579999999999999999998843
Q ss_pred CCCceEEEEEEeccc-hhHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC--
Q 014174 158 DKDELYLNLVLEFVP-ETVYRVAKHYSR---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-- 231 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~-- 231 (429)
....++||||+. ++|.+.+..... ....+++..+..++.||+.||.||| +.||+||||||+||||+.++.
T Consensus 146 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 146 ---SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESCSSTTC
T ss_pred ---CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChhhEEEecCCCCc
Confidence 333689999996 477776655321 1245899999999999999999999 889999999999999985442
Q ss_pred cEEEeecccceecccC---CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014174 232 QVKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII 307 (429)
Q Consensus 232 ~vkl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~ 307 (429)
.+||+|||+++..... .......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 222 ~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp CEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred eEEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 5999999999755322 223345678999999998764 48999999999999999998 999999887766655544
Q ss_pred HHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.... ...+..++..+.+||.+||+.||.+|||+.++++|.++..
T Consensus 301 ~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 SGGR----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCC----------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 3110 0122357899999999999999999999999999988743
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=344.48 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=199.1
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCc---EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
...++|++.+.||+|+||.||+|++..++. .||||++... ...+.+|+.+++.++||||+++++++ .
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 120 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----T 120 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 345689999999999999999999986655 5999998653 23345799999999999999999988 3
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
.....++||||+++ +|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~Df 195 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLS-DLGYVHRDLAARNVLVDSNL-VCKVSDF 195 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCC
T ss_pred eCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCcceEEECCCC-CEEECCC
Confidence 34457899999975 66665532 2457999999999999999999999 88999999999999999888 7999999
Q ss_pred ccceecccCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014174 239 GSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP 313 (429)
Q Consensus 239 G~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 313 (429)
|+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~- 273 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL- 273 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-
Confidence 999876543221 223457789999999764 48999999999999999999 99999888776666554432110
Q ss_pred CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
..+..+++.+.+||.+||..||.+|||+.++++
T Consensus 274 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 274 ---------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 123357999999999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=347.28 Aligned_cols=268 Identities=22% Similarity=0.257 Sum_probs=197.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..+|++.++||+|+||+||+|++ +++.||||++.... ....+|+.+++.++||||+++++++.... .....+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEEE
Confidence 45799999999999999999987 48999999986543 22345888899999999999999886544 22345789
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC----------CeeeecCCCCceEecCCCCcEEE
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI----------GVCHRDIKPQNLLVNPHTHQVKL 235 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~----------givH~DLkp~Nill~~~~~~vkl 235 (429)
||||+++ +|.+.+.. ..+++..++.++.||+.||.||| +. ||+||||||+|||++.++ .+||
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH-~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLH-EDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHT-CCEEEETTEEECEEECSCCSGGGEEECTTC-CEEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH-hhccccccccCCCEEeCCCChHhEEECCCC-eEEE
Confidence 9999975 66666543 56999999999999999999999 88 999999999999999887 7999
Q ss_pred eecccceecccCCC---cccccccccccccccccCC----CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 014174 236 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGA----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIK 308 (429)
Q Consensus 236 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~ 308 (429)
+|||+++....... .....||+.|+|||++.+. ..++.++|||||||++|+|+||+.||.+............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999987654332 2345789999999998763 2345688999999999999999999987544322222222
Q ss_pred HhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+....+...... ....+.... .+ -....++++.+||.+||+.||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~--~~~~~~~~~-~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVH--KKKRPVLRD-YW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HCSSCCHHHHHHHHTT--SCCCCCCCG-GG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccCCchhhhhhhhhc--ccCCCCccc-cc---cccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2233333322211000 000000000 00 00123456999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=334.38 Aligned_cols=246 Identities=20% Similarity=0.319 Sum_probs=200.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
...+|++.+.||+|+||.||+|++. ++..||+|++... .....+|+++++.++||||+++++++. .....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~ 81 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPIC 81 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceE
Confidence 3457999999999999999999986 5778999998654 344568999999999999999999884 333478
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+++ ++.+.+.. ....+++..+..++.|++.||.||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV 156 (269)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHH-hCCeecCCcchheEEEcCCC-CEEeccccccccc
Confidence 99999986 55555432 3456999999999999999999999 88999999999999999887 7999999999765
Q ss_pred ccCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 245 VKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 245 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.... ......+|+.|+|||.+.+. .++.++||||||+++|+|++ |..||.+.+..+....+.....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~---------- 225 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR---------- 225 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC----------
T ss_pred cccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCcc----------
Confidence 3321 12234567889999998664 48999999999999999999 9999988777666555433110
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...+...++.+.+||.+||+.||.+|||+.++++|
T Consensus 226 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 226 ------------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 01223468999999999999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=339.25 Aligned_cols=254 Identities=24% Similarity=0.320 Sum_probs=196.1
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcC--CCCeeecceEeeecCCCCc
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~ 161 (429)
..+|++.+.||+|+||.||+|.+. +++.||+|++.... ....+|+.+++.++ |+||+++++++. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~ 100 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD 100 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----CS
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----cC
Confidence 346999999999999999999974 58999999986432 33457999999997 599999999884 33
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+.++|||+.+++|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++. + .+||+|||++
T Consensus 101 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~ 173 (313)
T 3cek_A 101 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-G-MLKLIDFGIA 173 (313)
T ss_dssp SEEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEET-T-EEEECCCSSS
T ss_pred CEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCcccEEEEC-C-eEEEeecccc
Confidence 45889999888888877654 467899999999999999999999 889999999999999974 5 7999999999
Q ss_pred eecccCCC---cccccccccccccccccCC----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Q 014174 242 KVLVKGEP---NISYICSRYYRAPELIFGA----------TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD-QLVEII 307 (429)
Q Consensus 242 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~i~ 307 (429)
........ .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||....... .+..+.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence 87644322 2345689999999998641 357889999999999999999999997654322 222111
Q ss_pred HHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
.. . ....++...+.++.+||.+||..||.+|||+.++++||||.....+
T Consensus 254 ~~--------------~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 254 DP--------------N-------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp CT--------------T-------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred hc--------------c-------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 10 0 0011223458899999999999999999999999999999864433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=339.21 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=208.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecC-----------C
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT-----------D 158 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----------~ 158 (429)
..+|++.+.||+|+||.||+|++..+++.||+|++........+|+++++.++||||+++++++.... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~ 89 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSR 89 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------C
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccc
Confidence 35799999999999999999999999999999999887778889999999999999999999874311 1
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEee
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD 237 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~D 237 (429)
.....+++||||+++ +|.+.+... ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~D 165 (284)
T 2a19_B 90 SKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIH-SKKLINRDLKPSNIFLVDTK-QVKIGD 165 (284)
T ss_dssp CEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECC
T ss_pred cCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCCHHHEEEcCCC-CEEECc
Confidence 224558899999996 777766542 2467999999999999999999999 88999999999999999887 799999
Q ss_pred cccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 238 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 238 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
||++.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.... .....+..
T Consensus 166 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~--------- 233 (284)
T 2a19_B 166 FGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD--------- 233 (284)
T ss_dssp CTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT---------
T ss_pred chhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc---------
Confidence 9999887665555566789999999999764 48999999999999999999998874211 11111100
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
..++..++..+.+||.+||..||.+|||+.++++|.+...
T Consensus 234 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 234 ----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 0122347899999999999999999999999999988754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=342.55 Aligned_cols=262 Identities=20% Similarity=0.264 Sum_probs=188.1
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCc---EEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
..++|++.+.||+|+||.||+|++..++. .||+|++... .....+|+++++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34579999999999999999999877765 8999988643 23455899999999999999999988654332
Q ss_pred Cc-eEEEEEEeccch-hHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEE
Q 014174 160 DE-LYLNLVLEFVPE-TVYRVAKHYSR--ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 235 (429)
Q Consensus 160 ~~-~~~~lv~e~~~~-~l~~~~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl 235 (429)
+. ...++||||+.+ +|...+..... ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~ivH~Dikp~NIli~~~~-~~kl 178 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS-SRNFIHRDLAARNCMLAEDM-TVCV 178 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTS-CEEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH-cCCcccCCCCcceEEEcCCC-CEEE
Confidence 11 224789999986 66665543221 2236899999999999999999999 88999999999999999887 7999
Q ss_pred eecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 014174 236 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 311 (429)
Q Consensus 236 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 311 (429)
+|||+++....... .....+|+.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 257 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence 99999987644322 2234567889999998764 48999999999999999999 9999988777666554433110
Q ss_pred CCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-------HHHHhcCCCCcccC
Q 014174 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-------ALEACIHPFFYELR 381 (429)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-------~~ell~hp~f~~~~ 381 (429)
...+..+++++.+||.+||+.||.+||| +.++++|||+....
T Consensus 258 ----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 258 ----------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp ----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred ----------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 0122457899999999999999999999 78899999997644
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=333.32 Aligned_cols=247 Identities=22% Similarity=0.338 Sum_probs=196.7
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----------hhhHHHHHHHHHcCCCCeeecceEeeec
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFST 156 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 156 (429)
...++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--- 92 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--- 92 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE---
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee---
Confidence 34568999999999999999999999999999999885321 3456899999999999999999987
Q ss_pred CCCCceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeeecCCCCceEecCCCC--
Q 014174 157 TDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTH-- 231 (429)
Q Consensus 157 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g--ivH~DLkp~Nill~~~~~-- 231 (429)
.... ++||||+. +++.+.+. .....+++..+..++.|++.||.||| +.| |+||||||+|||++.++.
T Consensus 93 --~~~~--~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~~ivH~dikp~Nil~~~~~~~~ 164 (287)
T 4f0f_A 93 --HNPP--RMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENA 164 (287)
T ss_dssp --TTTT--EEEEECCTTCBHHHHHH---CTTSCCCHHHHHHHHHHHHHHHHHHH-TSSSCCBCSCCSGGGEEESCCCTTC
T ss_pred --cCCC--eEEEEecCCCCHHHHHh---cccCCccHHHHHHHHHHHHHHHHHHH-hCCCCeecCCCCcceEEEeccCCCC
Confidence 3332 47999998 55555443 23467999999999999999999999 889 999999999999987662
Q ss_pred --cEEEeecccceecccCCCcccccccccccccccccC-CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHH
Q 014174 232 --QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQL-VEII 307 (429)
Q Consensus 232 --~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-~~i~ 307 (429)
.+||+|||+++.... ......||+.|+|||++.+ ...++.++|||||||++|+|++|+.||...+..... ....
T Consensus 165 ~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 165 PVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp SCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred ceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 299999999975432 3345678999999999843 234688999999999999999999999876543331 1111
Q ss_pred HHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+ ....++..+++++.+||.+||+.||.+|||+.++++
T Consensus 243 ~~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 243 REEG--------------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHSC--------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccC--------------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1111 111233457999999999999999999999999986
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=346.47 Aligned_cols=258 Identities=17% Similarity=0.152 Sum_probs=197.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCC-----CcEEEEEEeecchhhhHHHHH---------------HHHHcCCCCeeec
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLET-----GETVAIKKVLQDKRYKNRELQ---------------TMRLLDHPNVVSL 149 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~E~~---------------~l~~l~h~niv~~ 149 (429)
.++|++.+.||+|+||.||+|.+..+ ++.||||++........+|++ .++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34799999999999999999998764 588999998766544444444 4445679999999
Q ss_pred ceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec--
Q 014174 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN-- 227 (429)
Q Consensus 150 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~-- 227 (429)
++++.... .+..+.++||||++++|.+++.. ....+++..++.++.||+.||.||| +.||+||||||+|||++
T Consensus 114 ~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH-~~~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIH-EHEYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEE-TTEEEEEEEEECEEEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEESS
T ss_pred Eeeeeecc-CCcceEEEEEeCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-HCCeEEecCCHHHEEEecC
Confidence 99886543 34567899999998887777654 3467999999999999999999999 88999999999999998
Q ss_pred CCCCcEEEeecccceecccCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 014174 228 PHTHQVKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG 299 (429)
Q Consensus 228 ~~~~~vkl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 299 (429)
.++ .+||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.+...
T Consensus 189 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 189 NPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp CTT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 666 799999999987643321 13345899999999997654 89999999999999999999999986443
Q ss_pred HHHHHHHHHHhCCCCH-HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 300 VDQLVEIIKVLGTPTR-EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 300 ~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.............+.. ..+... + ....++.++.+||.+||..||.+|||+.++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~--------~-----------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 267 DPKYVRDSKIRYRENIASLMDKC--------F-----------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp CHHHHHHHHHHHHHCHHHHHHHH--------S-----------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CHHHHHHHHHHhhhhHHHHHHHh--------c-----------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 3333222221111111 111000 0 01347999999999999999999999999876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=359.38 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=190.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-hhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEEEEe
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVLE 169 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 169 (429)
+|.+.++||+|+||+|+. ....+|+.||||++... .....+|+++++.+ +|||||++++++. ...++++|||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~~lv~E 98 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEK-----DRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTEEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCEEEEEEE
Confidence 699999999999999764 34568999999998654 34467899999999 7999999998873 3345889999
Q ss_pred ccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC---C-CcEEEeecccceecc
Q 014174 170 FVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH---T-HQVKLCDFGSAKVLV 245 (429)
Q Consensus 170 ~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~---~-~~vkl~DfG~a~~~~ 245 (429)
||+++|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+||||+.+ + ..+||+|||+|+...
T Consensus 99 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCAATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLH-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCSEEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHH-HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCCCCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHH-HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 999988877653 2334556667889999999999999 8899999999999999532 2 158899999998765
Q ss_pred cCC----CcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 246 KGE----PNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 246 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
... ......||+.|+|||++.+ ...++.++|||||||++|+|++ |..||........ ..+ .+...
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-~~~---~~~~~---- 246 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-NIL---LGACS---- 246 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-HHH---TTCCC----
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-HHH---hccCC----
Confidence 432 2334678999999999864 2446889999999999999999 8999965443222 111 11100
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
..... .....+..+.+||.+||+.||.+|||+.++++||||..+.
T Consensus 247 -----------~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~ 291 (432)
T 3p23_A 247 -----------LDCLH-------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLE 291 (432)
T ss_dssp -----------CTTSC-------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred -----------ccccC-------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence 00000 0112356789999999999999999999999999997643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=347.01 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=200.4
Q ss_pred ccceEEeeEEccCCceEEEEEE-----EcCCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeecCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAK-----CLETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 158 (429)
.++|++.+.||+|+||.||+|+ +..+++.||||++.... ....+|+++++.+ +||||+++++++....
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~- 99 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 99 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC-
Confidence 4579999999999999999998 55677899999986532 2356799999999 7899999999885322
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhhc----------------------------------------------------
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSRA---------------------------------------------------- 185 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~---------------------------------------------------- 185 (429)
..+++||||+.+ +|.+.+......
T Consensus 100 ---~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 100 ---GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp ---SCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred ---CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 236789999985 666666543210
Q ss_pred ----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCC---ccc
Q 014174 186 ----------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NIS 252 (429)
Q Consensus 186 ----------~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~ 252 (429)
...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+++....... ...
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH-~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~ 254 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD 254 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHH-HCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccc
Confidence 122899999999999999999999 88999999999999999887 799999999986643322 234
Q ss_pred ccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCC
Q 014174 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331 (429)
Q Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (429)
..||+.|+|||++.+. .++.++|||||||++|+|+| |..||.+......+.........+
T Consensus 255 ~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------ 315 (359)
T 3vhe_A 255 ARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------------------ 315 (359)
T ss_dssp CEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC------------------
T ss_pred cCCCceeEChhhhcCC-CCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC------------------
Confidence 5678899999998764 48999999999999999998 999998877655555444421111
Q ss_pred CcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 332 ~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 316 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 316 ---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1223478999999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=341.91 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=186.4
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcC-CCCeeecceEeeecCC---CCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTD---KDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~---~~~~ 162 (429)
.+|++.++||+|+||.||+|++..+++.||+|++.... ....+|+.+++.+. ||||+++++++..... ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47999999999999999999999999999999885432 33457999999996 9999999998864332 4456
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeeecCCCCceEecCCCCcEEEeeccc
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g--ivH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
.+++||||++++|.+.+.... ....+++..++.++.||+.||.||| +.| |+||||||+|||++.++ .+||+|||+
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~ 184 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQG-TIKLCDFGS 184 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHH-TSSSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred eEEEEEEecCCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence 688999999999888776533 3467999999999999999999999 888 99999999999999888 799999999
Q ss_pred ceecccCCCc-------------cccccccccccccccc--CCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 014174 241 AKVLVKGEPN-------------ISYICSRYYRAPELIF--GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVE 305 (429)
Q Consensus 241 a~~~~~~~~~-------------~~~~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~ 305 (429)
++........ ....||+.|+|||++. ....++.++|||||||++|+|++|..||...........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 9876443221 1445899999999983 234578899999999999999999999965433221110
Q ss_pred HHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014174 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376 (429)
Q Consensus 306 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~ 376 (429)
. +. .......+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 265 ~---------------------~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 K---------------------YS----------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----------------------CC----------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred c---------------------cc----------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0 00 0112346788999999999999999999999999744
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=330.15 Aligned_cols=246 Identities=19% Similarity=0.284 Sum_probs=200.1
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
...+|++.+.||+|+||.||+|.+. ++..||+|++... .....+|+.+++.++||||+++++++ ......+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence 4457999999999999999999875 5678999998654 34456899999999999999999988 3334488
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+++ ++.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus 80 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLE-SHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYV 154 (268)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHH-HTTEEESSCSGGGEEECTTC-CEEECCTTCEEEC
T ss_pred EEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCcCcceEEECCCC-CEEEccCccceec
Confidence 99999975 56665543 2346999999999999999999999 88999999999999999888 7999999999876
Q ss_pred ccCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 245 VKGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 245 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
...... ....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+.......+.....
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---------- 223 (268)
T 3sxs_A 155 LDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR---------- 223 (268)
T ss_dssp CTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----------
T ss_pred chhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC----------
Confidence 444321 2334577899999987644 8999999999999999999 9999988777666554433110
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...+...++.+.+||.+||+.||.+|||+.++++|
T Consensus 224 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 224 ------------------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123468999999999999999999999999984
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=330.41 Aligned_cols=243 Identities=26% Similarity=0.406 Sum_probs=187.8
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..+|++.+.||+|+||.||+|.+ +|..||+|++... .....+|+++++.++||||+++++++. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC
T ss_pred hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cC
Confidence 45799999999999999999997 5889999987543 134557999999999999999999883 33
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC---eeeecCCCCceEecC--------CC
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG---VCHRDIKPQNLLVNP--------HT 230 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g---ivH~DLkp~Nill~~--------~~ 230 (429)
...++||||++++.+..+. ....+++..++.++.||+.||.||| +.| |+||||||+||+++. ++
T Consensus 79 ~~~~lv~e~~~~~~L~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH-~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLH-DEAIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp --CEEEEECCTTEEHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHH-HSSSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred CceEEEEEcCCCCCHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceeecCCchHHEEEecccccccccCc
Confidence 4578999999754433222 2467999999999999999999999 778 999999999999985 44
Q ss_pred CcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014174 231 HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310 (429)
Q Consensus 231 ~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 310 (429)
.+||+|||++....... .....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+.......+....
T Consensus 154 -~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (271)
T 3dtc_A 154 -ILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK 230 (271)
T ss_dssp -CEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred -ceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence 79999999998654433 2356789999999998764 48999999999999999999999998877655544433210
Q ss_pred CCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
....++..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 231 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 231 ---------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ---------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 0111234578999999999999999999999999874
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=358.94 Aligned_cols=273 Identities=22% Similarity=0.333 Sum_probs=201.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.++|++.++||+|+||+||+|++..+|+.||||++.... ....+|+++++.++||||+++++++.... ..+.
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence 457999999999999999999999999999999986432 33458999999999999999999875432 2347
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe----cCCCCcEEEeecc
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV----NPHTHQVKLCDFG 239 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill----~~~~~~vkl~DfG 239 (429)
++||||+.+ +|.+.+... .....+++..++.++.||+.||.||| +.||+||||||+|||+ +.++ .+||+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG 161 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG 161 (396)
T ss_dssp EEEECCCTTEEHHHHTTSG-GGTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEEEECTTSCE-EEEECCGG
T ss_pred EEEEecCCCCCHHHHHHhh-hcccCCCHHHHHHHHHHHHHHHHHHH-HCCEEECCcCHHHEEEeecCCCce-eEEEecCC
Confidence 899999974 665555432 22344999999999999999999999 8899999999999999 6555 79999999
Q ss_pred cceecccCCCcccccccccccccccccCC-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHH
Q 014174 240 SAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTTAIDIWSVGCVLAELLLGQPLFPGES----GVDQLVEIIK 308 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~i~~ 308 (429)
+++............||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.... ..+.+..+..
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 99887655555567799999999988541 346789999999999999999999996532 2334444333
Q ss_pred HhCCCCHHHHhhcCc-CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 309 VLGTPTREEIKCMNP-NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
+.|.. .+..... ....+.... ..+....+...++..+.+||++||+.||++|+|+.++++
T Consensus 242 --~~p~~-~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 242 --GKPSG-AISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp --SCCTT-CCEEEECSTTCCEEEES--SCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred --CCCcc-cchhheeccCCCcccCc--cCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 22211 1100000 000000000 000011122335567899999999999999999999754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=344.33 Aligned_cols=251 Identities=20% Similarity=0.302 Sum_probs=201.9
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCC-------CcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEee
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLET-------GETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF 154 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~ 154 (429)
...++|++.+.||+|+||.||+|++..+ +..||+|++.... ....+|+++++.+ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 3456899999999999999999997543 3579999986542 3345799999999 9999999999884
Q ss_pred ecCCCCceEEEEEEeccch-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCC
Q 014174 155 STTDKDELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP 221 (429)
Q Consensus 155 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp 221 (429)
. ...+++||||+.+ +|.+.+..... ....+++..++.++.||+.||.||| +.||+||||||
T Consensus 146 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp 219 (382)
T 3tt0_A 146 Q-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAA 219 (382)
T ss_dssp S-----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCG
T ss_pred c-----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH-hCCEecCCCCc
Confidence 3 3347899999975 77776654321 1245999999999999999999999 88999999999
Q ss_pred CceEecCCCCcEEEeecccceecccCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 014174 222 QNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGE 297 (429)
Q Consensus 222 ~Nill~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~ 297 (429)
+||||+.++ .+||+|||+++...... ......+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.
T Consensus 220 ~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 220 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp GGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999888 79999999998664432 22344568899999999764 48999999999999999999 99999887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 298 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
+..+....+.... ....+..+++++.+||.+||+.||++|||+.+++++
T Consensus 298 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 298 PVEELFKLLKEGH----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHTTC----------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCC----------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7665544433210 001224579999999999999999999999999984
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=340.70 Aligned_cols=245 Identities=27% Similarity=0.425 Sum_probs=196.1
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----------hhhHHHHHHHHHc----CCCCeeecceEeeec
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLL----DHPNVVSLKHCFFST 156 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l----~h~niv~~~~~~~~~ 156 (429)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.+ +|+||+++++++..
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~- 109 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET- 109 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec-
Confidence 46999999999999999999999999999999985432 2234699999999 89999999998843
Q ss_pred CCCCceEEEEEEec-cc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec-CCCCcE
Q 014174 157 TDKDELYLNLVLEF-VP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN-PHTHQV 233 (429)
Q Consensus 157 ~~~~~~~~~lv~e~-~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~-~~~~~v 233 (429)
....++|||+ +. ++|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+||+++ .++ .+
T Consensus 110 ----~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~-~~ 179 (312)
T 2iwi_A 110 ----QEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCH-SRGVVHRDIKDENILIDLRRG-CA 179 (312)
T ss_dssp -------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HHTEECCCCSGGGEEEETTTT-EE
T ss_pred ----CCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecCCChhhEEEeCCCC-eE
Confidence 3347789998 44 566666543 356999999999999999999999 88999999999999998 555 89
Q ss_pred EEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014174 234 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313 (429)
Q Consensus 234 kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 313 (429)
||+|||++...... ......||..|+|||++.+....+.++|||||||++|+|++|+.||.... .+...
T Consensus 180 kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~---- 248 (312)
T 2iwi_A 180 KLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA---- 248 (312)
T ss_dssp EECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT----
T ss_pred EEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh----
Confidence 99999999876543 33456789999999998765544668999999999999999999996431 11110
Q ss_pred CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
. ..++..++..+.+||.+||+.||++|||+.++++||||.....
T Consensus 249 -------------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 249 -------------E------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp -------------C------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred -------------c------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 0 0123457999999999999999999999999999999987554
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=343.32 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=202.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
.++|++.+.||+|+||.||+|++. .+++.||+|++.... ....+|+.+++.++||||+++++++..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 121 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV---- 121 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc----
Confidence 457999999999999999999987 455899999986542 345679999999999999999998843
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeec
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSR--------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 218 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~D 218 (429)
....++||||+.+ +|.+.+..... ....+++..++.++.||+.||.||| ++||+|||
T Consensus 122 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-~~~ivH~D 199 (343)
T 1luf_A 122 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRD 199 (343)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSC
T ss_pred -CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecCC
Confidence 3347899999985 77776654221 1257999999999999999999999 88999999
Q ss_pred CCCCceEecCCCCcEEEeecccceecccCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 014174 219 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLF 294 (429)
Q Consensus 219 Lkp~Nill~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf 294 (429)
|||+|||++.++ .+||+|||+++...... ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||
T Consensus 200 lkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 200 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999999888 79999999997653321 223456788999999987644 8999999999999999999 99999
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 295 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 295 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.+.+..+....+.... . ..++..+++++.+||.+||+.||.+|||+.++++
T Consensus 278 ~~~~~~~~~~~~~~~~-------------------~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~- 328 (343)
T 1luf_A 278 YGMAHEEVIYYVRDGN-------------------I---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR- 328 (343)
T ss_dssp TTSCHHHHHHHHHTTC-------------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH-
T ss_pred CCCChHHHHHHHhCCC-------------------c---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH-
Confidence 8877666554443210 0 0123457899999999999999999999999987
Q ss_pred CCCccc
Q 014174 375 PFFYEL 380 (429)
Q Consensus 375 p~f~~~ 380 (429)
+|.++
T Consensus 329 -~L~~~ 333 (343)
T 1luf_A 329 -ILQRM 333 (343)
T ss_dssp -HHHHT
T ss_pred -HHHHH
Confidence 44443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=330.49 Aligned_cols=254 Identities=22% Similarity=0.250 Sum_probs=201.8
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.++|++.+.||+|+||.||+|++..+|+.||+|++... .....+|+.+++.++|++++..+..+... ..+.++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCC----CCceEEE
Confidence 45799999999999999999999999999999988643 34567899999999999887776655432 2357899
Q ss_pred EeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec---CCCCcEEEeecccceec
Q 014174 168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN---PHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~---~~~~~vkl~DfG~a~~~ 244 (429)
|||++++|.+.+.. ....+++..+..++.||+.||.||| ++||+||||||+|||++ .++ .+||+|||++...
T Consensus 84 ~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 84 MELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY 158 (296)
T ss_dssp EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred EEecCCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHH-hCCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCcccc
Confidence 99998888877653 2457999999999999999999999 88999999999999994 555 7999999999876
Q ss_pred ccCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCC
Q 014174 245 VKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG---VDQLVEIIKVLGTP 313 (429)
Q Consensus 245 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~i~~~~~~~ 313 (429)
..... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+. ...+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 54432 23557899999999997644 89999999999999999999999986432 22233322211111
Q ss_pred CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
... .+...+++++.+||.+||+.||.+|||+.++++ .|.+
T Consensus 238 ~~~------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~l~~ 277 (296)
T 3uzp_A 238 PIE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ--LFRN 277 (296)
T ss_dssp CHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH--HHHH
T ss_pred chH------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH--HHHH
Confidence 110 112357899999999999999999999999887 4444
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=353.96 Aligned_cols=258 Identities=28% Similarity=0.427 Sum_probs=189.4
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-hhhHHHHHHHHHc-CCCCeeecceEeeecCCCCceEEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
+.|.+.+.||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +||||+++++++ ....++++||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEE
Confidence 357788999999999998754 5689999999986543 3456899999876 899999999887 3445689999
Q ss_pred eccchhHHHHHHHhhhcCCC---CCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC------------CcE
Q 014174 169 EFVPETVYRVAKHYSRASQR---MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT------------HQV 233 (429)
Q Consensus 169 e~~~~~l~~~~~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~------------~~v 233 (429)
|||+++|.+.+......... .++..+..++.||+.||.||| +.||+||||||+|||++.++ ..+
T Consensus 89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH-HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 99999888877643221111 133345779999999999999 88999999999999997532 269
Q ss_pred EEeecccceecccCCC-----cccccccccccccccccC------CCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 014174 234 KLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFG------ATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVD 301 (429)
Q Consensus 234 kl~DfG~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~------~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~ 301 (429)
||+|||+++....... .....||+.|+|||++.+ ...++.++|||||||++|+|+| |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 9999999987654322 224578999999999865 2458999999999999999999 999997654332
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 302 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
..+.... +..+... ......+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 248 --~~i~~~~-----------------~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 248 --SNIIRGI-----------------FSLDEMK-----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp --HHHHHTC-----------------CCCCCCT-----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred --HHHhcCC-----------------CCccccc-----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 1222210 0011100 0001124688999999999999999999999999999964
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=331.38 Aligned_cols=247 Identities=19% Similarity=0.265 Sum_probs=198.1
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
....+|++.+.||+|+||.||+|.+. ++..||+|++... .....+|+++++.++||||+++++++. .....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 94 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPI 94 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCe
Confidence 44568999999999999999999875 6778999998654 344568999999999999999999883 33447
Q ss_pred EEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+. ++|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+++.
T Consensus 95 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~ 169 (283)
T 3gen_A 95 FIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRY 169 (283)
T ss_dssp EEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCSGGGEEECTTS-CEEECSTTGGGG
T ss_pred EEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHH-HCCccCCCCccceEEEcCCC-CEEEcccccccc
Confidence 89999997 456555543 2356999999999999999999999 88999999999999999888 799999999976
Q ss_pred cccCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 244 LVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 244 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
..... ......+|+.|+|||++.+. .++.++||||||+++|+|++ |+.||...+..+....+.....
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~--------- 239 (283)
T 3gen_A 170 VLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--------- 239 (283)
T ss_dssp BCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC---------
T ss_pred ccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC---------
Confidence 53321 12234467889999999764 48999999999999999998 9999988877666655443211
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...+...++.+.+||.+||+.||.+|||+.++++|
T Consensus 240 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 240 -------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 01123468999999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=334.74 Aligned_cols=250 Identities=22% Similarity=0.247 Sum_probs=198.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.++|++.+.||+|+||.||+|++..+++.||+|++... .....+|+.+++.++|++++..+..+... ..+.++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCC----CCceEEE
Confidence 45799999999999999999999999999999986543 34567899999999999888877666432 2357899
Q ss_pred EeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe---cCCCCcEEEeecccceec
Q 014174 168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill---~~~~~~vkl~DfG~a~~~ 244 (429)
|||++++|.+++.. ....+++..+..++.||+.||.||| +.||+||||||+|||+ +.++ .+||+|||+++..
T Consensus 84 ~e~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 84 MELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY 158 (296)
T ss_dssp EECCCCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred EEccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCCHHHeeeeccCCCC-eEEEecCccceec
Confidence 99998888877653 2457999999999999999999999 8899999999999999 6666 7999999999876
Q ss_pred ccCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCC
Q 014174 245 VKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV---DQLVEIIKVLGTP 313 (429)
Q Consensus 245 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~~ 313 (429)
..... .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.. ..+..+.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 54422 23457899999999997654 899999999999999999999999864432 2222222211001
Q ss_pred CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
+.. .+...+++++.+||.+||+.||++|||+.++++
T Consensus 238 ~~~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 238 PIE------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp CHH------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hhh------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 110 112357899999999999999999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=348.43 Aligned_cols=247 Identities=20% Similarity=0.276 Sum_probs=199.5
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
....+|.+.+.||+|+||.||+|++..+++.||||++.... ..+.+|+++++.++||||+++++++.. ..
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 185 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-----KQ 185 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-----CC
Confidence 34568999999999999999999999999999999886432 234579999999999999999998843 33
Q ss_pred EEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++||||++ ++|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||++
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s 260 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLE-SKCCIHRDLAARNCLVTEKN-VLKISDFGMS 260 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCGGGC
T ss_pred CcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCcCCcccCHHHEEEcCCC-cEEECcCCCc
Confidence 4789999997 566665543 2346899999999999999999999 88999999999999999888 7999999999
Q ss_pred eecccCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 242 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 242 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
+........ ....++..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~------- 332 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG------- 332 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-------
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------
Confidence 865332111 122357789999998764 48999999999999999998 999998877655443332210
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..+++++.+||.+||+.||++|||+.++++
T Consensus 333 ---------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 333 ---------------------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00123457899999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=336.81 Aligned_cols=250 Identities=20% Similarity=0.328 Sum_probs=199.7
Q ss_pred cccceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 158 (429)
...+|++.+.||+|+||.||+|.+. .++..||+|++.... ....+|+++++.++||||+++++++..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--- 97 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ--- 97 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec---
Confidence 3457999999999999999999973 456899999986532 334579999999999999999998843
Q ss_pred CCceEEEEEEeccc-hhHHHHHHHhhh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeee
Q 014174 159 KDELYLNLVLEFVP-ETVYRVAKHYSR--------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 217 (429)
Q Consensus 159 ~~~~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~ 217 (429)
....++||||+. ++|.+.+..... ....+++..++.++.||+.||.||| ++||+||
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~ivH~ 174 (314)
T 2ivs_A 98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA-EMKLVHR 174 (314)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH-HTTEECC
T ss_pred --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH-HCCCccc
Confidence 334789999998 577666654322 1234899999999999999999999 8899999
Q ss_pred cCCCCceEecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 014174 218 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPL 293 (429)
Q Consensus 218 DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~p 293 (429)
||||+||+++.++ .+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..|
T Consensus 175 dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 252 (314)
T 2ivs_A 175 DLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP 252 (314)
T ss_dssp CCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCC-CcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999887 799999999987644332 2234567889999999764 48999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 294 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 294 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
|.+.+.......+.... ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~ 304 (314)
T 2ivs_A 253 YPGIPPERLFNLLKTGH----------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK 304 (314)
T ss_dssp STTCCGGGHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHhhcCC----------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 98876655443332210 00123457999999999999999999999999987
Q ss_pred C
Q 014174 374 H 374 (429)
Q Consensus 374 h 374 (429)
+
T Consensus 305 ~ 305 (314)
T 2ivs_A 305 D 305 (314)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=334.31 Aligned_cols=250 Identities=23% Similarity=0.325 Sum_probs=201.0
Q ss_pred ccceEEeeEEccCCceEEEEEEE-----cCCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeecCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 158 (429)
.++|++.+.||+|+||.||+|++ ..+++.||+|++.... ....+|+.+++.+ +||||+++++++..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--- 98 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--- 98 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec---
Confidence 35799999999999999999985 4577899999986442 3455899999999 99999999998843
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCc
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSR--------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~N 223 (429)
....++||||+++ +|.+.+..... ....+++..+..++.||+.||.||| +.||+||||||+|
T Consensus 99 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~N 175 (313)
T 1t46_A 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARN 175 (313)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGG
T ss_pred --CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-HCCeecCCCccce
Confidence 3347899999975 77776654321 1235899999999999999999999 8899999999999
Q ss_pred eEecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 014174 224 LLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESG 299 (429)
Q Consensus 224 ill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~ 299 (429)
|+++.++ .+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|+| |..||.+...
T Consensus 176 il~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred EEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999887 799999999987654432 1234567889999998764 48999999999999999999 9999988776
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 300 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
............. ...+..++..+.+||.+||..||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 254 DSKFYKMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SHHHHHHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHhccCCC---------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 5555544432110 01123578999999999999999999999999873
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=334.49 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=193.7
Q ss_pred ccccceEEeeEEccCCceEEEEEE----EcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
....+|++++.||+|+||+||+|+ +..+++.||+|++.... ..+.+|+++++.++||||+++++++....
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 84 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-- 84 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH--
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--
Confidence 345689999999999999999998 56789999999986543 34568999999999999999999875422
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
...+++||||+++ +|.+.+... ...+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus 85 -~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dikp~Nil~~~~~-~~kl~Df 158 (295)
T 3ugc_A 85 -RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG-TKRYIHRDLATRNILVENEN-RVKIGDF 158 (295)
T ss_dssp -HTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECCC
T ss_pred -CCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHh-cCCcccCCCCHhhEEEcCCC-eEEEccC
Confidence 1236789999964 666665442 345999999999999999999999 88999999999999999887 7999999
Q ss_pred ccceecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 239 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 239 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
|++........ .....+|..|+|||.+.+. .++.++|||||||++|+|+||..||...... . ....+...
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~---~~~~~~~~ 232 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE--F---MRMIGNDK 232 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--H---HHHHCTTC
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH--H---HhhhcCcc
Confidence 99987644321 2234567789999999764 4899999999999999999999998643211 1 11111110
Q ss_pred H-H-----HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 315 R-E-----EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 315 ~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
. . ....+.. ......+..+++++.+||.+||+.||++|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 233 QGQMIVFHLIELLKN-------------NGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp CTHHHHHHHHHHHHT-------------TCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccchhHHHHHHHHhc-------------cCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 0 0000000 0011123467999999999999999999999999976
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=338.75 Aligned_cols=252 Identities=21% Similarity=0.285 Sum_probs=200.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceEeeecC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTT 157 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 157 (429)
...+|++.+.||+|+||.||+|++. .++..||+|++... .....+|+.+++.+ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--
Confidence 3457999999999999999999973 45678999998643 23456899999999 89999999998843
Q ss_pred CCCceEEEEEEeccch-hHHHHHHHhhhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeee
Q 014174 158 DKDELYLNLVLEFVPE-TVYRVAKHYSRA-------------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 217 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~ 217 (429)
....++||||+++ +|.+.+...... ...+++..+..++.||+.||.||| +.||+||
T Consensus 121 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivH~ 196 (344)
T 1rjb_A 121 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHR 196 (344)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH-HTTEEET
T ss_pred ---CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCcccC
Confidence 3347899999975 777766542210 134899999999999999999999 8899999
Q ss_pred cCCCCceEecCCCCcEEEeecccceecccCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCC
Q 014174 218 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPL 293 (429)
Q Consensus 218 DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~p 293 (429)
||||+|||++.++ .+||+|||++......... ....+|+.|+|||++.+. .++.++|||||||++|+|+| |..|
T Consensus 197 Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p 274 (344)
T 1rjb_A 197 DLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNP 274 (344)
T ss_dssp TCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred CCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHHHHHHHHHHcCCCCC
Confidence 9999999999887 7999999999876544322 234568889999998764 48999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 294 FPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 294 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
|.+......+..+..... ....+..+++++.+||.+||..||.+|||+.++++
T Consensus 275 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 327 (344)
T 1rjb_A 275 YPGIPVDANFYKLIQNGF---------------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327 (344)
T ss_dssp STTCCCSHHHHHHHHTTC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCcHHHHHHHHhcCC---------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 988776555544443210 00122347899999999999999999999999998
Q ss_pred CC
Q 014174 374 HP 375 (429)
Q Consensus 374 hp 375 (429)
|-
T Consensus 328 ~l 329 (344)
T 1rjb_A 328 FL 329 (344)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=339.70 Aligned_cols=251 Identities=22% Similarity=0.294 Sum_probs=200.5
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEE--EEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETV--AIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
...++|++.+.||+|+||.||+|++..++..+ |+|.+... .....+|+++++.+ +||||+++++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~---- 97 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH---- 97 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE----
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee----
Confidence 44568999999999999999999998888865 99988642 23456799999999 89999999998843
Q ss_pred CceEEEEEEeccch-hHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYS------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV 226 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill 226 (429)
...+++||||+++ +|.+.+.... .....+++..++.++.||+.||.||| +.||+||||||+|||+
T Consensus 98 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 98 -RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILV 175 (327)
T ss_dssp -TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEE
T ss_pred -CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCccceEEE
Confidence 3358899999975 7777665422 12357999999999999999999999 8899999999999999
Q ss_pred cCCCCcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 014174 227 NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVE 305 (429)
Q Consensus 227 ~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~ 305 (429)
+.++ .+||+|||+++............+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....
T Consensus 176 ~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~ 253 (327)
T 1fvr_A 176 GENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253 (327)
T ss_dssp CGGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred cCCC-eEEEcccCcCccccccccccCCCCCccccChhhhccc-cCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence 9887 7999999999754433333445668889999998654 48999999999999999998 9999988776554433
Q ss_pred HHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 306 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
+.... ....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 254 ~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 254 LPQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GGGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhcCC----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 22110 001223578999999999999999999999999884
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=339.83 Aligned_cols=246 Identities=22% Similarity=0.293 Sum_probs=194.5
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcE----EEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGET----VAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
...+|++.+.||+|+||+||+|++..++.. ||+|.+... .....+|+.+++.++||||+++++++.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----- 85 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP----- 85 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence 345799999999999999999999888876 677766432 133457999999999999999999772
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
+ ...++||||+. ++|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus 86 ~-~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dikp~Nil~~~~~-~~kl~Df 159 (325)
T 3kex_A 86 G-SSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLE-EHGMVHRNLAARNVLLKSPS-QVQVADF 159 (325)
T ss_dssp B-SSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHH-HTTCCCSCCSSTTEEESSSS-CEEECSC
T ss_pred C-CccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHH-hCCCCCCccchheEEECCCC-eEEECCC
Confidence 1 12678999998 466555532 2357899999999999999999999 88999999999999999888 7999999
Q ss_pred ccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 239 GSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 239 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
|+++....... .....+|..|+|||++.+.. ++.++|||||||++|+|+| |..||.+.+..+....+....
T Consensus 160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---- 234 (325)
T 3kex_A 160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---- 234 (325)
T ss_dssp SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC----
T ss_pred CcccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----
Confidence 99987644332 23445678999999997644 8999999999999999999 999998876655444333210
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
....+..++.++.+||.+||..||.+|||+.++++|
T Consensus 235 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 235 ------------------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ------------------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ------------------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001123467889999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=341.48 Aligned_cols=267 Identities=19% Similarity=0.261 Sum_probs=200.1
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
..++|++.+.||+|+||.||+|++ .+|+.||||++.... ....+|+++++.++||||+++++++.. ...
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~ 101 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT-----PTE 101 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC-----SSC
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec-----CCc
Confidence 345799999999999999999984 568999999886432 245689999999999999999999843 333
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---CeeeecCCCCceEecCCCCcEEEeecc
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI---GVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
.++||||+.+ +|.+.+.........+++..+..++.||+.||.||| +. ||+||||||+|||++.++ .+||+|||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg 179 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH-DHCDPKIIHRDVKAANILLDEEF-EAVVGDFG 179 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH-HSSSSCEECCCCSGGGEEECTTC-CEEECCCS
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCchhhEEECCCC-CEEeccCc
Confidence 6799999975 676766654444556999999999999999999999 77 999999999999999887 79999999
Q ss_pred cceecccCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----hHHHHHHHHHHhCCC
Q 014174 240 SAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES----GVDQLVEIIKVLGTP 313 (429)
Q Consensus 240 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~i~~~~~~~ 313 (429)
++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... ..........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----- 253 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK----- 253 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT-----
T ss_pred cccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH-----
Confidence 9987643322 23445899999999986644 8999999999999999999999995210 0000001000
Q ss_pred CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCc
Q 014174 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~ 378 (429)
...................+....+..+.+|+.+||+.||.+|||+.++++|-.-.
T Consensus 254 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 254 ---------GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp ---------TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred ---------HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 00001111111111111222233457899999999999999999999999976543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=337.29 Aligned_cols=260 Identities=24% Similarity=0.376 Sum_probs=200.3
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.++|++.+.||+|+||.||+|++..+|+.||+|++... .....+|+.+++.++||||+++++++.... ......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence 34799999999999999999999999999999988543 234558999999999999999999886432 2345678
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+.+ +|.+.+.........+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~ 184 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-AKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQA 184 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTS-CEEECCCSSCEES
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEcCCC-CEEEEecCcchhc
Confidence 99999986 777777665555678999999999999999999999 88999999999999999888 7999999998765
Q ss_pred ccCCC----------cccccccccccccccccCCC--CCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhC
Q 014174 245 VKGEP----------NISYICSRYYRAPELIFGAT--EYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLG 311 (429)
Q Consensus 245 ~~~~~----------~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~ 311 (429)
..... .....||+.|+|||++.+.. .++.++|||||||++|+|++|+.||...... .........
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-- 262 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-- 262 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC--
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc--
Confidence 32111 12345699999999986533 2688999999999999999999999431100 000000000
Q ss_pred CCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
....+ ....++.++.+||.+||+.||.+|||+.+++++ +..+.
T Consensus 263 ---------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~ 305 (317)
T 2buj_A 263 ---------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ--LEALQ 305 (317)
T ss_dssp ---------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHTC
T ss_pred ---------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH--hhhcC
Confidence 00011 123478999999999999999999999999984 44443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=338.27 Aligned_cols=257 Identities=15% Similarity=0.129 Sum_probs=191.6
Q ss_pred ccceEEeeEEccCCceEEEEEEEcC---CCcEEEEEEeecchhh---------------hHHHHHHHHHcCCCCeeecce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQDKRY---------------KNRELQTMRLLDHPNVVSLKH 151 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---------------~~~E~~~l~~l~h~niv~~~~ 151 (429)
.++|++.+.||+|+||.||+|++.. ++..||+|++...... ..+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3579999999999999999999987 7889999998654322 225667778889999999999
Q ss_pred EeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC-
Q 014174 152 CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT- 230 (429)
Q Consensus 152 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~- 230 (429)
++.... .+..+.++||||++++|.+.+.. ...+++..++.++.||+.||.||| +.||+||||||+|||++.++
T Consensus 116 ~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIH-ENEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEESSST
T ss_pred cccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCcCHHHEEEccCCC
Confidence 886533 33557899999997777665432 347999999999999999999999 88999999999999998654
Q ss_pred CcEEEeecccceecccCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHH
Q 014174 231 HQVKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES-GVD 301 (429)
Q Consensus 231 ~~vkl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~ 301 (429)
..+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.. ...
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 2699999999987643211 1345789999999999764 48999999999999999999999996532 222
Q ss_pred HHHHHH-HHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 302 QLVEII-KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 302 ~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...... .............. -...++.++.+||.+||..||++|||+.++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 269 AVQTAKTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 222222 21111111111100 01147899999999999999999999999987
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=330.94 Aligned_cols=248 Identities=21% Similarity=0.319 Sum_probs=203.2
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
....+|++.+.||+|+||.||+|.+..++..||+|++..+. ....+|+.+++.++||||+++++++. .....
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCE
Confidence 34567999999999999999999999999999999987553 34558999999999999999999883 33347
Q ss_pred EEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+. ++|.+.+... ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++..
T Consensus 85 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENH-LVKVADFGLSRL 160 (288)
T ss_dssp EEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHH-HHTCCCSCCSGGGEEECGGG-CEEECCCCGGGT
T ss_pred EEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHH-HCCccCCCCCcceEEEcCCC-CEEEccCcccee
Confidence 89999998 5666666432 2356999999999999999999999 88999999999999999887 799999999986
Q ss_pred cccCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 244 LVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 244 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
...... .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||.+.+.......+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~---------- 229 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------- 229 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------
T ss_pred ccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC----------
Confidence 644332 1234567889999999764 48999999999999999999 999998876655444333210
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 230 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 230 ------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 01123457899999999999999999999999976
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=332.13 Aligned_cols=256 Identities=19% Similarity=0.257 Sum_probs=193.0
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcC---CCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 158 (429)
....+|.+.+.||+|+||.||+|.+.. ++..||+|++.... ....+|+.+++.++||||+++++++.....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 344579999999999999999998765 55689999886431 334579999999999999999999876554
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhh--hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEE
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYS--RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 235 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl 235 (429)
......++||||+.+ +|...+.... .....+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dikp~NIli~~~~-~~kl 188 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS-NRNFLHRDLAARNCMLRDDM-TVCV 188 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH-TTTCCCCCCSGGGEEECTTS-CEEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCcceEEEcCCC-cEEE
Confidence 434456899999985 6655553321 23467999999999999999999999 88999999999999999887 7999
Q ss_pred eecccceecccCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhC
Q 014174 236 CDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLG 311 (429)
Q Consensus 236 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~ 311 (429)
+|||++....... ......+++.|+|||.+.+. .++.++|||||||++|+|++ |..||.+.+.......+....
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~- 266 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH- 266 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCC-CccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-
Confidence 9999997664332 12234568889999999764 48999999999999999999 899998877665554443310
Q ss_pred CCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
....+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 267 ---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 267 ---------------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp ---------------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 011234578999999999999999999999999873
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=338.52 Aligned_cols=246 Identities=23% Similarity=0.330 Sum_probs=190.9
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEE----EEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETV----AIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
...+|++.+.||+|+||+||+|++..+++.+ |+|.+... ...+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence 3457999999999999999999998887754 77766422 23456799999999999999999988532
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
. .++|++|+. +++.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus 90 --~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivH~Dikp~NIll~~~~-~~kl~Df 161 (327)
T 3poz_A 90 --T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQ-HVKITDF 161 (327)
T ss_dssp --S-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEETT-EEEECCT
T ss_pred --C-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHh-hCCeeCCCCChheEEECCCC-CEEEccC
Confidence 1 557888887 455555433 3467999999999999999999999 88999999999999999888 7999999
Q ss_pred ccceecccCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 239 GSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 239 G~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
|+++........ ....+|..|+|||.+.+. .++.++|||||||++|+|+| |+.||.+.+..+....+.....
T Consensus 162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--- 237 (327)
T 3poz_A 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--- 237 (327)
T ss_dssp THHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---
T ss_pred cceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC---
Confidence 999876443322 233457889999999764 48999999999999999999 9999988766554333322100
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...+..++.++.+|+.+||+.||.+|||+.+++++
T Consensus 238 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 238 -------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -------------------------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -------------------------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 01123468999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=335.43 Aligned_cols=260 Identities=23% Similarity=0.272 Sum_probs=206.5
Q ss_pred ccccceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT 157 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 157 (429)
...++|++.+.||+|+||.||+|.+. .++..||+|.+.... ....+|+.+++.++||||+++++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-- 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-- 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS--
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc--
Confidence 34457999999999999999999876 457899999986432 234579999999999999999998833
Q ss_pred CCCceEEEEEEeccch-hHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC
Q 014174 158 DKDELYLNLVLEFVPE-TVYRVAKHYSRA------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT 230 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~ 230 (429)
....++||||+.+ +|.+.+...... ...+++..+..++.||+.||.||| ++||+||||||+||+++.++
T Consensus 100 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 100 ---GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCSGGGEEECTTC
T ss_pred ---CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH-HCCCccCCCccceEEEcCCC
Confidence 3347899999975 777766543221 246799999999999999999999 88999999999999999887
Q ss_pred CcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 014174 231 HQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEI 306 (429)
Q Consensus 231 ~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i 306 (429)
.+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 176 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 253 (322)
T 1p4o_A 176 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 253 (322)
T ss_dssp -CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred -eEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence 799999999976543321 1234568889999998764 48999999999999999999 89999887766555444
Q ss_pred HHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC------CCCccc
Q 014174 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH------PFFYEL 380 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h------p~f~~~ 380 (429)
.... . ...+..++..+.+||.+||..||.+|||+.++++| |+|.++
T Consensus 254 ~~~~-------------------~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~ 305 (322)
T 1p4o_A 254 MEGG-------------------L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305 (322)
T ss_dssp HTTC-------------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHH
T ss_pred HcCC-------------------c---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccc
Confidence 3210 0 01223578999999999999999999999999986 777665
Q ss_pred CCC
Q 014174 381 RDP 383 (429)
Q Consensus 381 ~~~ 383 (429)
...
T Consensus 306 ~~~ 308 (322)
T 1p4o_A 306 SFY 308 (322)
T ss_dssp CST
T ss_pred ccc
Confidence 443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=331.38 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=193.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-hhhHHHHHHHHH--cCCCCeeecceEeeecCCCCceEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
..++|++.+.||+|+||+||+|++ +|+.||||++.... ....+|.+++.. ++||||+++++++.... .....++
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~ 82 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLW 82 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeE
Confidence 345799999999999999999987 78999999986543 333467777776 79999999999876543 3445688
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-------CCCeeeecCCCCceEecCCCCcEEEee
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-------GIGVCHRDIKPQNLLVNPHTHQVKLCD 237 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-------~~givH~DLkp~Nill~~~~~~vkl~D 237 (429)
+||||+++ +|.+.+. ...+++..+..++.||+.||.|||. +.||+||||||+|||++.++ .+||+|
T Consensus 83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECC
T ss_pred EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEEee
Confidence 99999985 6666552 3579999999999999999999993 46999999999999999888 799999
Q ss_pred cccceecccCCCc-----ccccccccccccccccCCC-----CCCCchhHHHHHHHHHHHHhC----------CCCCCCC
Q 014174 238 FGSAKVLVKGEPN-----ISYICSRYYRAPELIFGAT-----EYTTAIDIWSVGCVLAELLLG----------QPLFPGE 297 (429)
Q Consensus 238 fG~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg----------~~pf~~~ 297 (429)
||+++........ ....||+.|+|||++.+.. .++.++|||||||++|+|+|| ..||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 9999876544322 2347899999999997643 234689999999999999999 8888653
Q ss_pred Ch----HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 298 SG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 298 ~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.. ...+.......+ ..+.+. ...+....++++.+||.+||+.||.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQ-----------------QRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHHHHTTSC-----------------CCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhHHHhccC-----------------CCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22 122222211100 000000 01112235678999999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=329.58 Aligned_cols=246 Identities=27% Similarity=0.362 Sum_probs=187.9
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCC---CcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
...++|++.+.||+|+||.||+|.+..+ +..||+|.+... .....+|+.+++.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---- 87 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---- 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc----
Confidence 4456899999999999999999998654 457999987543 2334579999999999999999998721
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
. ..++||||+++ +|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus 88 -~-~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~Df 160 (281)
T 1mp8_A 88 -N-PVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSND-CVKLGDF 160 (281)
T ss_dssp -S-SCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECC-
T ss_pred -C-ccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-hCCeecccccHHHEEECCCC-CEEECcc
Confidence 1 25789999985 66665543 2346999999999999999999999 88999999999999999887 7999999
Q ss_pred ccceecccCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 239 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 239 G~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
|+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~----- 234 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE----- 234 (281)
T ss_dssp ------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-----
T ss_pred ccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-----
Confidence 99987644332 1233457889999998654 48999999999999999997 999998877665554443210
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...++..+++.+.+||.+||..||.+|||+.++++
T Consensus 235 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 235 -----------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp -----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00123457999999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=331.70 Aligned_cols=247 Identities=25% Similarity=0.318 Sum_probs=189.1
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+|+.+++.++||||+++++++.. .
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence 3467999999999999999999999999999999986432 334579999999999999999998854 3
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
...++||||+++ +|.+.+.. ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~ 180 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAH-AAGATHRDVKPENILVSADD-FAYLVDFGI 180 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECSCCC
T ss_pred CeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HCcCCcCCCChHHEEEcCCC-CEEEecCcc
Confidence 358899999985 66665543 357999999999999999999999 88999999999999999887 799999999
Q ss_pred ceecccCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 241 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 241 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
+....... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||.+.+.. .+....... .+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~~----- 252 (309)
T 2h34_A 181 ASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQA-IP----- 252 (309)
T ss_dssp ----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSC-CC-----
T ss_pred CccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccC-CC-----
Confidence 97654432 22345789999999998764 4899999999999999999999999876543 222222210 00
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-CHHHHhc
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-TALEACI 373 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-t~~ell~ 373 (429)
....++..+++++.+||.+||..||++|| |+.++++
T Consensus 253 -------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 253 -------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 01123346899999999999999999999 7777665
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=332.15 Aligned_cols=252 Identities=19% Similarity=0.224 Sum_probs=196.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCC-------cEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETG-------ETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTT 157 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 157 (429)
...+|++.+.||+|+||+||+|++..++ ..||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~- 84 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG- 84 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT-
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC-
Confidence 3457999999999999999999998877 479999885432 3445799999999999999999988432
Q ss_pred CCCceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCc----
Q 014174 158 DKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ---- 232 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~---- 232 (429)
...++||||+. ++|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++..
T Consensus 85 ----~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dlkp~NIll~~~~~~~~~~ 156 (289)
T 4fvq_A 85 ----DENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLE-ENTLIHGNVCAKNILLIREEDRKTGN 156 (289)
T ss_dssp ----TCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEEEECCBGGGTB
T ss_pred ----CCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHh-hCCeECCCcCcceEEEecCCcccccc
Confidence 33678999998 577666653 2334999999999999999999999 8899999999999999877621
Q ss_pred ---EEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHH
Q 014174 233 ---VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIK 308 (429)
Q Consensus 233 ---vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~ 308 (429)
+||+|||++..... .....+|+.|+|||++.+...++.++|||||||++|+|++|. +||...+..... ....
T Consensus 157 ~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~ 232 (289)
T 4fvq_A 157 PPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYE 232 (289)
T ss_dssp CCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHH
T ss_pred cceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhh
Confidence 99999999865422 234567899999999977456899999999999999999955 555544433322 2222
Q ss_pred HhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
.. ..++...++++.+||.+||+.||.+|||+.++++ .+.++-.|.
T Consensus 233 ~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~l~~l~~p~ 277 (289)
T 4fvq_A 233 DR-----------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIR--DLNSLFTPD 277 (289)
T ss_dssp TT-----------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHH--HHHTCC---
T ss_pred cc-----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH--HHHHhcCCC
Confidence 10 0122345788999999999999999999999998 455555543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=334.68 Aligned_cols=249 Identities=23% Similarity=0.322 Sum_probs=200.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCc-----EEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceEeeecCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGE-----TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 158 (429)
..+|++.+.||+|+||.||+|.+..++. .||+|.+... .....+|+.+++.+ +||||+++++++..
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--- 121 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH--- 121 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec---
Confidence 4579999999999999999999877664 7999988654 23455899999999 89999999998843
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhh----------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSR----------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN 227 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~ 227 (429)
...+++||||+++ +|.+.+..... ....+++..+..++.||+.||.||| +.||+||||||+|||++
T Consensus 122 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 --GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLT 198 (333)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGCEEE
T ss_pred --CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh-cCCcccCCcccceEEEC
Confidence 3347899999975 77776654322 1356899999999999999999999 88999999999999999
Q ss_pred CCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 014174 228 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQL 303 (429)
Q Consensus 228 ~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~ 303 (429)
.++ .+||+|||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|+| |..||.+.......
T Consensus 199 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 199 NGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp GGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred CCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 887 799999999986644332 1234567889999998764 48999999999999999998 99999887665555
Q ss_pred HHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 304 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
..+...... ...+...++.+.+||.+||+.||.+|||+.++++
T Consensus 277 ~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 277 YKLVKDGYQ---------------------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCC---------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 544442110 0112346899999999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=329.90 Aligned_cols=251 Identities=30% Similarity=0.473 Sum_probs=189.8
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..++|++.+.||+|+||.||+|.+..+|+.||+|++... .....+|+.+++.++||||+++++++...
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 104 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED----- 104 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----
Confidence 345799999999999999999999999999999998642 23345799999999999999999988543
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
...++||||+.+ +|.+.+.........+++..++.++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~ 182 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATG-VVKLGDLGL 182 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCC--
T ss_pred CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh-hCCeeCCCCcHHHEEEcCCC-CEEEEeccc
Confidence 348899999986 777777665555678999999999999999999999 88999999999999999888 799999999
Q ss_pred ceecccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHH
Q 014174 241 AKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV-DQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 241 a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 318 (429)
+........ .....||+.|+|||++.+. .++.++||||||+++|+|++|..||.+.... ..+........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------- 254 (310)
T 2wqm_A 183 GRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD------- 254 (310)
T ss_dssp ----------------CCSSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC-------
T ss_pred eeeecCCCccccccCCCeeEeChHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc-------
Confidence 876543322 2345689999999998764 4899999999999999999999999764321 22222111110
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
++. .....+++++.+||.+||..||.+|||+.++++
T Consensus 255 -----------~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 255 -----------YPP--------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp -----------SCC--------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------CCC--------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 110 011347899999999999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=329.55 Aligned_cols=245 Identities=27% Similarity=0.397 Sum_probs=186.7
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch--hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
...+|++.+.||+|+||.||+|++ +++.||+|++.... ..+.+|+++++.++||||+++++++. +. .++
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEE
Confidence 345799999999999999999987 57899999986543 34568999999999999999998763 22 568
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG---IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
||||+++ +|.+.+... .....+++..+..++.||+.||.||| + +||+||||||+|||++.++..+||+|||++.
T Consensus 77 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH-~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~ 154 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLH-SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154 (307)
T ss_dssp EEECCTTCBHHHHHHCS-SSEECCCHHHHHHHHHHHHHHHHHHH-TCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--
T ss_pred EEEcCCCCCHHHHHhcc-CCCCccCHHHHHHHHHHHHHHHHHHH-hCCCCCeecCCCChhHEEEeCCCCEEEEccccccc
Confidence 9999975 666655431 11235788999999999999999999 6 7999999999999999887558999999997
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
..... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||................+.
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---------- 221 (307)
T 2eva_A 155 DIQTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT---------- 221 (307)
T ss_dssp ------------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC----------
T ss_pred ccccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC----------
Confidence 65332 2345689999999999764 5899999999999999999999999764332211111110000
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+...++..+.+||.+||+.||.+|||+.++++
T Consensus 222 ----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 222 ----------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ----------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00122457899999999999999999999999988
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=341.96 Aligned_cols=267 Identities=20% Similarity=0.219 Sum_probs=197.8
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
...++|++.+.||+|+||.||+|++ .+|+.||+|++.... ....+|+.+++.++||||+++++++.. ...
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~ 109 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNE 109 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-----TTC
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-----CCe
Confidence 3456899999999999999999995 478999999876432 345689999999999999999998843 334
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.++||||+.+ +|.+.+.........+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~ 187 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINILLDENF-VPKITDFGISK 187 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCSTTEEECTTC-CEEECCCTTCE
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc-CCCeecCCCCHHHEEECCCC-CEEEeeccccc
Confidence 7899999985 554443322222346899999999999999999999 88999999999999999888 79999999998
Q ss_pred ecccCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 243 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 243 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+........ ....
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~~~- 260 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VESH- 260 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HHHH-
T ss_pred ccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hhcc-
Confidence 653322 223456899999999987644 899999999999999999999999764432211000000 0000
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp 375 (429)
... .+...........++...+..+.+|+.+||+.||++|||+.++++|-
T Consensus 261 -~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 261 -NNG-----QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp -TTT-----CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -ccc-----cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 000 01111111112222334567899999999999999999999998754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=331.80 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=198.7
Q ss_pred ccccceEEeeEEccCCceEEEEEEEc-------CCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEee
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCL-------ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF 154 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~ 154 (429)
...++|++.+.||+|+||.||+|++. .++..||+|++.... ....+|+++++.+ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34468999999999999999999975 457789999986532 2345799999999 8999999999884
Q ss_pred ecCCCCceEEEEEEeccch-hHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCC
Q 014174 155 STTDKDELYLNLVLEFVPE-TVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKP 221 (429)
Q Consensus 155 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp 221 (429)
. ...+++||||+.+ +|.+.+..... ....+++..+..++.||+.||.||| +.||+||||||
T Consensus 112 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp 185 (334)
T 2pvf_A 112 Q-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA-SQKCIHRDLAA 185 (334)
T ss_dssp S-----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSG
T ss_pred c-----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCcc
Confidence 3 3347899999975 77666654221 1234899999999999999999999 88999999999
Q ss_pred CceEecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 014174 222 QNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGE 297 (429)
Q Consensus 222 ~Nill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~ 297 (429)
+||+++.++ .+||+|||+++....... .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.
T Consensus 186 ~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 186 RNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999888 799999999987654322 22345678899999987644 8999999999999999999 99999887
Q ss_pred ChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 298 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 298 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
+..+....+..... ...+..++.++.+||.+||..||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 264 PVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 76655544433110 01223578999999999999999999999999873
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=334.97 Aligned_cols=244 Identities=23% Similarity=0.331 Sum_probs=189.1
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEE----EEEEeec-----chhhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETV----AIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
..+|++++.||+|+||.||+|++..+++.| |+|.+.. ......+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence 457999999999999999999998888765 5565532 224456799999999999999999988532
Q ss_pred ceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
. .++|++|+. +++.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus 90 -~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~-~~kL~DfG 162 (327)
T 3lzb_A 90 -T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFG 162 (327)
T ss_dssp -S-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred -C-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHh-hCCCcCCCCCHHHEEEcCCC-CEEEccCc
Confidence 1 567888887 456555543 3467999999999999999999999 88999999999999999887 79999999
Q ss_pred cceecccCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 240 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 240 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~---- 237 (327)
T 3lzb_A 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER---- 237 (327)
T ss_dssp C----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC----
T ss_pred ceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC----
Confidence 99876443222 233457789999999764 48999999999999999999 9999988766554443332110
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+..++.++.+||.+||..||.+|||+.++++
T Consensus 238 ------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 238 ------------------------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0122347899999999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=331.75 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=199.0
Q ss_pred ccceEEeeEEccCCceEEEEEEE-----cCCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeecCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 158 (429)
.++|++.+.||+|+||.||+|++ ..+++.||+|++.... ....+|+.+++.+ +||||+++++++...
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-- 103 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP-- 103 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence 34799999999999999999985 3567899999986532 2345799999999 689999999987432
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceE
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSRA------------SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL 225 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nil 225 (429)
...+++||||+.+ +|.+.+...... ...+++..+..++.||+.||.||| +.||+||||||+||+
T Consensus 104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~i~H~dikp~Nil 180 (316)
T 2xir_A 104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNIL 180 (316)
T ss_dssp --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEE
T ss_pred --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH-hCCcccccCccceEE
Confidence 2346789999985 666666542211 123899999999999999999999 889999999999999
Q ss_pred ecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 014174 226 VNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVD 301 (429)
Q Consensus 226 l~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~ 301 (429)
++.++ .+||+|||+++....... .....+|+.|+|||++.+. .++.++|||||||++|+|+| |..||.+.....
T Consensus 181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 99887 799999999986644332 1234568899999998764 48999999999999999998 999998876555
Q ss_pred HHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 302 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.+.........+ ..+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus 259 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 259 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 444433321100 1223478999999999999999999999999885
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=321.80 Aligned_cols=246 Identities=14% Similarity=0.215 Sum_probs=197.6
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
....+|++.+.||+|+||.||+|++ ++..||+|++.... ....+|+.+++.++||||+++++++.... .
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 81 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---A 81 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---S
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---C
Confidence 3456899999999999999999998 58899999986432 33557999999999999999999884431 2
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeeecCCCCceEecCCCCcEEEeec
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g--ivH~DLkp~Nill~~~~~~vkl~Df 238 (429)
...++||||+++ +|.+.+.. .....+++..+..++.||+.||.||| +.| |+||||||+||+++.++ .++|+||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~~~i~H~dikp~Nil~~~~~-~~~l~~~ 157 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRHALNSRSVMIDEDM-TARISMA 157 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHT-TSSSCCTTCCCSGGGEEECTTS-CEEEEGG
T ss_pred CCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHh-cCCCceecCCCccceEEEcCCc-ceeEEec
Confidence 347799999985 77666643 12235899999999999999999999 889 99999999999999887 6999999
Q ss_pred ccceecccCCCcccccccccccccccccCCCC--CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 239 GSAKVLVKGEPNISYICSRYYRAPELIFGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 239 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
|++.... .....||+.|+|||++.+... ++.++|||||||++|+|++|+.||.+.+..+....+......
T Consensus 158 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~---- 229 (271)
T 3kmu_A 158 DVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR---- 229 (271)
T ss_dssp GSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCC----
T ss_pred cceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCC----
Confidence 8875432 234568999999999976432 233799999999999999999999888776665554432111
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
..++..+++++.+||.+||+.||++|||+.++++
T Consensus 230 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 -----------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp -----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1123457999999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=326.23 Aligned_cols=249 Identities=21% Similarity=0.285 Sum_probs=186.2
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...++|++.+.||+|+||.||+|++. ..||+|++.... ..+.+|+.+++.++||||++++++.. .
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~- 91 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-----A- 91 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-----C-
Confidence 34457999999999999999999853 359999885432 33567999999999999999988541 1
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
...++||||+.+ +|.+.+. .....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH-~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~ 166 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH-AKSIIHRDLKSNNIFLHEDN-TVKIGDFGL 166 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEETTT-EEEECCCC-
T ss_pred CccEEEEEecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCccceEEECCCC-CEEEcccee
Confidence 126789999985 4444432 23467999999999999999999999 88999999999999999887 799999999
Q ss_pred ceecccC---CCcccccccccccccccccC--CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 241 AKVLVKG---EPNISYICSRYYRAPELIFG--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 241 a~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+...... .......||+.|+|||++.. ...++.++|||||||++|+|++|+.||.+....+.+.........+.
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~- 245 (289)
T 3og7_A 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP- 245 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC-
T ss_pred ccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc-
Confidence 9765432 22234568999999999852 34478899999999999999999999988777666655554321111
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+...+++.+.+||.+||..||.+|||+.++++
T Consensus 246 ----------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 ----------------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp ----------------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 001123457899999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=322.82 Aligned_cols=245 Identities=20% Similarity=0.309 Sum_probs=198.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..+|++.+.||+|+||.||+|.+. ++..||+|++.... ....+|+++++.++||||+++++++.. ....++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 80 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICL 80 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSCEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCCeEE
Confidence 457999999999999999999985 67889999987542 445689999999999999999998843 334789
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+++ +|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 81 VTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL 155 (267)
T ss_dssp EECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred EEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCchheEEECCCC-CEEEcccccccccc
Confidence 9999975 66665543 2356899999999999999999999 88999999999999999887 79999999997653
Q ss_pred cCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 246 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
... ......+|..|+|||++.+. .++.++||||||+++|+|++ |..||.+.+..+....+.....
T Consensus 156 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~----------- 223 (267)
T 3t9t_A 156 DDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------- 223 (267)
T ss_dssp CHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------
T ss_pred cccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCc-----------
Confidence 221 12234567889999998754 48999999999999999999 8999988776665554433100
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...+...+..+.+||.+||..||.+|||+.+++++
T Consensus 224 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 224 -----------------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 01123468999999999999999999999999873
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=325.08 Aligned_cols=248 Identities=27% Similarity=0.351 Sum_probs=195.5
Q ss_pred CccccceEEeeEEccCCceEEEEEEEcC---CCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCC
Q 014174 87 PKQTISYMAERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 87 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 158 (429)
.....+|++.+.||+|+||.||+|++.. ++..||+|.+... .....+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--- 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---
Confidence 3445689999999999999999998654 3456999988654 2344579999999999999999998732
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEee
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCD 237 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~D 237 (429)
.. .++||||+.+ +|.+.+.. ....+++..+..++.||+.||.||| ++||+||||||+||+++.++ .+||+|
T Consensus 85 --~~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~kl~D 156 (281)
T 3cc6_A 85 --EP-TWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLE-SINCVHRDIAVRNILVASPE-CVKLGD 156 (281)
T ss_dssp --SS-CEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEEEETT-EEEECC
T ss_pred --CC-CEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHH-HCCcccCCCccceEEECCCC-cEEeCc
Confidence 11 4689999984 56555543 2456999999999999999999999 88999999999999999887 799999
Q ss_pred cccceecccCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 238 FGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 238 fG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
||++........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||...+..+....+......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~-- 233 (281)
T 3cc6_A 157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFR-RFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL-- 233 (281)
T ss_dssp CCGGGCC---------CCCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC--
T ss_pred cCCCcccccccccccccCCCCcceeCchhhccC-CCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC--
Confidence 999976644322 2234567889999998654 48999999999999999998 99999877665555444331100
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
..+..+++.+.+||.+||..||.+|||+.+++++
T Consensus 234 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 234 --------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 1123478999999999999999999999999874
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=342.99 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=197.7
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch--hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
....+|++.+.||+|+||.||+|.+ +|+.||||++.... ..+.+|+++++.++||||+++++++.... ..++
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~~ 263 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLY 263 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----CceE
Confidence 3456899999999999999999987 47899999997543 44568999999999999999999875432 2378
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+.+ +|.+.+... ....+++..+..++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++..
T Consensus 264 iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA 339 (450)
T ss_dssp EEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCHhhEEECCCC-CEEEeeCCCcccc
Confidence 99999975 776666542 2234799999999999999999999 88999999999999999888 7999999999865
Q ss_pred ccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ....+|..|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+....
T Consensus 340 ~~~~--~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~------------- 403 (450)
T 1k9a_A 340 SSTQ--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY------------- 403 (450)
T ss_dssp C--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTC-------------
T ss_pred cccc--cCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 3322 233568889999999764 48999999999999999998 999998876655554433210
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 404 ---------------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 404 ---------------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01123457999999999999999999999999875
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=334.06 Aligned_cols=257 Identities=18% Similarity=0.208 Sum_probs=198.6
Q ss_pred ccccceEEeeEEccCCceEEEEEE-----EcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAK-----CLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTT 157 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 157 (429)
....+|++.+.||+|+||.||+|+ +..++..||+|.+... .....+|+.+++.++||||+++++++..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-- 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC--
Confidence 345689999999999999999999 5567889999998533 2334579999999999999999998843
Q ss_pred CCCceEEEEEEeccc-hhHHHHHHHhhh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC--C
Q 014174 158 DKDELYLNLVLEFVP-ETVYRVAKHYSR---ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--H 231 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~--~ 231 (429)
....++||||++ ++|.+.+..... ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .
T Consensus 105 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH-~~~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 105 ---SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESCSSTTC
T ss_pred ---CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh-hCCeecCcCCHhHEEEecCCCcc
Confidence 334689999995 577776654321 1145899999999999999999999 88999999999999998433 2
Q ss_pred cEEEeecccceecccCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 014174 232 QVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEII 307 (429)
Q Consensus 232 ~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~ 307 (429)
.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++|+|+| |..||.+.+..+....+.
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 259 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259 (327)
T ss_dssp CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred eEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh
Confidence 69999999987553322 22345678899999998764 48999999999999999998 999998877655544433
Q ss_pred HHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
... . ...+..++..+.+||.+||..||.+|||+.++++|.|+..
T Consensus 260 ~~~-~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 260 SGG-R---------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TTC-C---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC-C---------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 210 0 0122357899999999999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=333.55 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=198.7
Q ss_pred ccccceEEeeEEccCCceEEEEEE----EcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
....+|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+|+++++.++||||+++++++.. .
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---P 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---S
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---C
Confidence 344689999999999999999999 56789999999986542 335689999999999999999998754 2
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
....+++||||++ ++|.+.+... ...+++..++.++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH-~~~ivH~Dikp~NIl~~~~~-~~kl~Df 171 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEA-HVKIADF 171 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECCG
T ss_pred CCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCChhhEEECCCC-CEEEccc
Confidence 3445889999996 5666655432 346999999999999999999999 88999999999999999888 7999999
Q ss_pred ccceecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 239 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 239 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
|++........ .....+|..|+|||++.+.. ++.++|||||||++|+|++|..||.......... .......+.
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~ 249 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPA 249 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-ccccccccc
Confidence 99987644332 22345788899999987644 7999999999999999999999996533221100 000000000
Q ss_pred HHHH-hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 315 REEI-KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 315 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+ ...... .....+..+++++.+||.+||..||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 250 LSRLLELLEEG-------------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhhcc-------------cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0000 000000 011123457999999999999999999999999965
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=352.97 Aligned_cols=254 Identities=20% Similarity=0.218 Sum_probs=191.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCC-CCeeecc---------eE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDH-PNVVSLK---------HC 152 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h-~niv~~~---------~~ 152 (429)
...|++.+.||+|+||+||+|++..+|+.||||++... ...+.+|+.+++.++| .|...+. +.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34699999999999999999999999999999988632 2334589999998877 3221111 11
Q ss_pred e------------eecCCCCceEEEEEEeccchhHHHHHHHhh---hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeee
Q 014174 153 F------------FSTTDKDELYLNLVLEFVPETVYRVAKHYS---RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHR 217 (429)
Q Consensus 153 ~------------~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~ 217 (429)
. ..........++++|+++.++|.+++.... .....+++..+..++.||+.||.||| ++||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH-HTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccC
Confidence 1 100001122367899999988888775432 22345778888999999999999999 8899999
Q ss_pred cCCCCceEecCCCCcEEEeecccceecccCCCccccccccccccccccc---------CCCCCCCchhHHHHHHHHHHHH
Q 014174 218 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF---------GATEYTTAIDIWSVGCVLAELL 288 (429)
Q Consensus 218 DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~ll 288 (429)
||||+||||+.++ .+||+|||+++..... ....+| +.|+|||++. ....++.++|||||||++|+|+
T Consensus 236 DiKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 236 YLRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred CcccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999988 6999999999875433 344566 9999999983 3334788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCH
Q 014174 289 LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA 368 (429)
Q Consensus 289 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~ 368 (429)
+|+.||.+.+.......+ +. -...+++++.+||.+||+.||.+|||+
T Consensus 312 tg~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~ 358 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLP 358 (413)
T ss_dssp HSSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HCCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCH
Confidence 999999765421111000 00 012478999999999999999999999
Q ss_pred HHHhcCCCCcccC
Q 014174 369 LEACIHPFFYELR 381 (429)
Q Consensus 369 ~ell~hp~f~~~~ 381 (429)
.++++||||.++.
T Consensus 359 ~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 359 LQAMETPEYEQLR 371 (413)
T ss_dssp HHHTTSHHHHHHH
T ss_pred HHHHhCHHHHHHH
Confidence 9999999997753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=369.25 Aligned_cols=285 Identities=25% Similarity=0.322 Sum_probs=205.9
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCC-CCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 163 (429)
.++|++.+.||+|+||.||+|.+..+|+.||||++... .....+|+++++.++||||+++++++..... .....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 35799999999999999999999999999999988643 2334579999999999999999887643111 12345
Q ss_pred EEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC--cEEEeeccc
Q 014174 164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGS 240 (429)
Q Consensus 164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~--~vkl~DfG~ 240 (429)
.++||||++ ++|.+.+... .....+++..++.++.||+.||.||| +.||+||||||+||+++.++. .+||+|||+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLH-s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLH-ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHH-HTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHH-HCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 678999996 4666655432 22346999999999999999999999 889999999999999986653 489999999
Q ss_pred ceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+.............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+........... .......+..
T Consensus 171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i---~~~~~~~~~~ 246 (676)
T 3qa8_A 171 AKELDQGELCTEFVGTLQYLAPELLEQK-KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV---REKSNEHIVV 246 (676)
T ss_dssp CCBTTSCCCCCCCCSCCTTCSSCSSCCS-CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTC---C------CCS
T ss_pred ccccccccccccccCCcccCChHHhccC-CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhh---hcccchhhhh
Confidence 9887666656667899999999998764 58999999999999999999999997754332211100 0000000000
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
.......+.++. ..+....+...+++.+.+||.+||.+||++|||+.++++||||..+.+
T Consensus 247 ~~~l~g~~~~~~--~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 247 YDDLTGAVKFSS--VLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp CCCCSSSCCCCS--SSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hhhhcccccccc--ccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 000001111111 011112233446789999999999999999999999999999987555
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=326.70 Aligned_cols=261 Identities=23% Similarity=0.349 Sum_probs=195.1
Q ss_pred ccceEEeeEEccCCceEEEEEE----EcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
...|++.+.||+|+||.||+|+ +..+++.||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--- 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---
Confidence 3469999999999999999999 56789999999986432 44568999999999999999999885432
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
...+++||||+++ +|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg 171 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEH-QVKIGDFG 171 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred CceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhh-cCCcccCCCchheEEEcCCC-CEEECccc
Confidence 2347899999975 66665533 2456999999999999999999999 88999999999999999887 79999999
Q ss_pred cceecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 240 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 240 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
++........ .....+|..|+|||++.+.. ++.++|||||||++|+|++|..|+.... . ......+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~--~---~~~~~~~~~~~ 245 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPM--A---LFLKMIGPTHG 245 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHH--H---HHHHHHCSCCG
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchh--h---HHhhccCCccc
Confidence 9987654432 22445788899999987644 8899999999999999999998864221 1 11111111110
Q ss_pred H-HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 316 E-EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 316 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
. ......... ........+..+++++.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 246 QMTVTRLVNTL---------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp GGHHHHHHHHH---------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccCHHHHHHHH---------hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0 000000000 000011133468999999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=323.32 Aligned_cols=243 Identities=22% Similarity=0.275 Sum_probs=194.5
Q ss_pred ccceEEee-EEccCCceEEEEEEE--cCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 90 TISYMAER-VVGQGSFGIVFQAKC--LETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 90 ~~~y~i~~-~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
..+|.+.+ .||+|+||.||+|.+ ..+++.||+|++... .....+|+++++.++||||+++++++ ...
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~--- 90 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE--- 90 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS---
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC---
Confidence 34799998 999999999999954 567889999998643 23456799999999999999999987 221
Q ss_pred ceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
..++||||+. ++|.+.+.. ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||
T Consensus 91 --~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg 162 (291)
T 1xbb_A 91 --SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQH-YAKISDFG 162 (291)
T ss_dssp --SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred --CcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHH-hCCeEcCCCCcceEEEeCCC-cEEEccCC
Confidence 2679999998 456555543 466999999999999999999999 88999999999999999887 79999999
Q ss_pred cceecccCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 240 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 240 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
++......... ....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---- 237 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---- 237 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----
Confidence 99876544321 1234568899999986644 7899999999999999999 999998877655444332210
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...++..+++.+.+||.+||+.||.+|||+.++++
T Consensus 238 ------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 ------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00123457999999999999999999999999876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=322.90 Aligned_cols=247 Identities=25% Similarity=0.278 Sum_probs=197.9
Q ss_pred ccceEEee-EEccCCceEEEEEEEc--CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 90 TISYMAER-VVGQGSFGIVFQAKCL--ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 90 ~~~y~i~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
.++|.+.+ .||+|+||.||+|.+. .++..||+|++... .....+|+++++.++||||+++++++. ..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~---- 82 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AE---- 82 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS----
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CC----
Confidence 45688877 9999999999999864 46788999998653 233457999999999999999999872 21
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
..++||||+++ +|.+.+. .....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 83 -~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~qi~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~ 156 (287)
T 1u59_A 83 -ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRH-YAKISDFGL 156 (287)
T ss_dssp -SEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred -CcEEEEEeCCCCCHHHHHH---hCCccCCHHHHHHHHHHHHHHHHHHH-HCCEeeCCCchheEEEcCCC-CEEECcccc
Confidence 26799999986 5555442 23466999999999999999999999 88999999999999999887 799999999
Q ss_pred ceecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 241 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 241 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+........ .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~----- 230 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK----- 230 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-----
T ss_pred eeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-----
Confidence 987644322 1233457889999998654 48999999999999999998 999998877665554433210
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~ 376 (429)
...++..+++++.+||.+||..||.+|||+.++++|.+
T Consensus 231 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 231 -----------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp -----------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -----------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 01123457999999999999999999999999998654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=337.57 Aligned_cols=254 Identities=14% Similarity=0.119 Sum_probs=196.1
Q ss_pred cceEEeeEEccCCceEEEEEEEcCC--------CcEEEEEEeecchhhhHHHHHHHHHcCCCCeeec-------------
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLET--------GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL------------- 149 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~------------- 149 (429)
++|++.+.||+|+||.||+|++..+ ++.||+|++... ....+|+++++.++||||+++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~ 120 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP 120 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence 4799999999999999999999874 889999998765 456789999999999999984
Q ss_pred --ceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec
Q 014174 150 --KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN 227 (429)
Q Consensus 150 --~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~ 227 (429)
++++.. ...+.++||||++++|.+.+... ....+++..+..++.||+.||.||| +.||+||||||+|||++
T Consensus 121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLH-ENEYVHGNVTAENIFVD 193 (352)
T ss_dssp CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCCGGGEEEE
T ss_pred chhhcccc----CCcEEEEEecCCCcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCCHHHEEEc
Confidence 444432 23468899999988888877642 1367999999999999999999999 88999999999999999
Q ss_pred CCCC-cEEEeecccceecccCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 014174 228 PHTH-QVKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES 298 (429)
Q Consensus 228 ~~~~-~vkl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 298 (429)
.++. .+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+..
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 7651 699999999976543221 1334789999999999764 48999999999999999999999998754
Q ss_pred -hHHHHHHHHHHh-CCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 299 -GVDQLVEIIKVL-GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 299 -~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+....... ..+. .+... ......+++++.+||.+||..||++|||+.++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~-----------------~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDKPG-----------------PFVGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TCHHHHHHHHHHHHHSCC-----------------CEECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCHHHHHHHHHhccCChh-----------------hhhhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 333333222211 1100 00000 0001246899999999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=351.05 Aligned_cols=247 Identities=21% Similarity=0.317 Sum_probs=201.6
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
...+|++.+.||+|+||.||+|.+..++..||||.+... ...+.+|+.+++.++||||+++++++.. ...++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-----~~~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-----EPPFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEec-----CCcEE
Confidence 345799999999999999999999988999999998654 3445689999999999999999998843 33478
Q ss_pred EEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+. ++|.+.+... ....+++..+..++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+++..
T Consensus 293 lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~ 368 (495)
T 1opk_A 293 IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRNLAARNCLVGENH-LVKVADFGLSRLM 368 (495)
T ss_dssp EEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECGGG-CEEECCTTCEECC
T ss_pred EEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCChhhEEECCCC-cEEEeecccceec
Confidence 9999998 5676666532 2356899999999999999999999 88999999999999999887 7999999999876
Q ss_pred ccCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 245 VKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 245 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
..... .....+|..|+|||++.+. .++.++|||||||++|+|+| |..||.+.+..+....+....
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~----------- 436 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----------- 436 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----------
T ss_pred cCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 43321 1233457789999998764 48999999999999999999 999998877655444332210
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 437 -----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 437 -----------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 01123457899999999999999999999999976
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=326.41 Aligned_cols=245 Identities=26% Similarity=0.372 Sum_probs=187.7
Q ss_pred ccccceEEe-eEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHH-HHcCCCCeeecceEeeecCCCCceEEE
Q 014174 88 KQTISYMAE-RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 88 ~~~~~y~i~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
...++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.++||||+++++++.... ....+++
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~ 91 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL 91 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-HHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEE
Confidence 345678888 7899999999999999999999999988654 3456788887 6679999999999885422 2355688
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC---CCCcEEEeecccc
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSA 241 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~---~~~~vkl~DfG~a 241 (429)
+||||+++ +|.+.+.. .....+++..++.++.||+.||.||| +.||+||||||+|||++. ++ .+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNA-ILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCHHHEEEecCCCCC-cEEEeccccc
Confidence 99999975 77776654 22346999999999999999999999 889999999999999997 55 7999999998
Q ss_pred eecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.... ...++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~-------------- 211 (299)
T 3m2w_A 168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------------- 211 (299)
T ss_dssp EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC--------------
T ss_pred cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH--------------
Confidence 6532 1236789999999999999999999997654322110000
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
...... ...+.......+++++.+||.+||+.||.+|||+.++++||||.+..
T Consensus 212 ----~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 212 ----TRIRMG---QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp ----CSSCTT---CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ----HHHhhc---cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 000000 00011111145799999999999999999999999999999998654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=340.27 Aligned_cols=246 Identities=23% Similarity=0.307 Sum_probs=186.9
Q ss_pred cccceEEeeEEccCCceEEEEEEEc---CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
...+|.+.+.||+|+||.||+|++. .++..||||++... ...+.+|+.+++.++||||+++++++..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----- 117 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK----- 117 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----
Confidence 3457999999999999999999876 46778999998643 2345579999999999999999998843
Q ss_pred ceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
....++||||++ ++|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg 192 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLS-DMGYVHRDLAARNILINSNL-VCKVSDFG 192 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred CCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeCCCCCcceEEEcCCC-CEEECcCc
Confidence 334789999996 566665542 2457999999999999999999999 88999999999999999888 79999999
Q ss_pred cceecccCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 240 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 240 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
+++........ ....+|..|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~--- 268 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR--- 268 (373)
T ss_dssp ---------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE---
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 99876443211 122346789999999764 48999999999999999998 9999988776655544332110
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+..++..+.+||.+||+.||.+|||+.++++
T Consensus 269 -------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 269 -------------------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -------------------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0112347899999999999999999999998876
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=343.08 Aligned_cols=251 Identities=22% Similarity=0.242 Sum_probs=198.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..++|++.++||+|+||.||+|++..+++.||||++... .....+|+++++.++|++.+..+..+.. ...+.++
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEEE
Confidence 345799999999999999999999999999999987543 3456789999999998665555444432 2335789
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe---cCCCCcEEEeeccccee
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill---~~~~~~vkl~DfG~a~~ 243 (429)
||||++++|.+++.. ....+++..++.++.||+.||.||| ++||+||||||+|||| +.++ .+||+|||+++.
T Consensus 81 vme~~g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH-~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~ 155 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKK 155 (483)
T ss_dssp EEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEE
T ss_pred EEECCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHH-HCCEeecccCcceEEEecCCCCC-eEEEEeCCccee
Confidence 999998888887754 2467999999999999999999999 8899999999999999 4566 799999999987
Q ss_pred cccCCCc--------ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCC
Q 014174 244 LVKGEPN--------ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGV---DQLVEIIKVLGT 312 (429)
Q Consensus 244 ~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~i~~~~~~ 312 (429)
....... ....||+.|+|||++.+. .++.++|||||||+||+|++|+.||.+.... +.+..+....-.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA 234 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc
Confidence 6544321 256789999999999765 4899999999999999999999999875432 233333221111
Q ss_pred CCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+ .+...++.++.+||.+||..||.+||++.+|++
T Consensus 235 ~~~~------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 235 TSIE------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp SCHH------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccHH------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1111 112347899999999999999999999987665
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=334.54 Aligned_cols=278 Identities=21% Similarity=0.282 Sum_probs=193.3
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh-hhHHHHHH--HHHcCCCCeeecceEeeecCCCCceEE
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-YKNRELQT--MRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
...++|++.+.||+|+||.||+|++ +++.||||++..... ....|.++ +..++||||+++++.+......+...+
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 3456899999999999999999986 789999999865432 22334444 445899999999987765555666678
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---------CeeeecCCCCceEecCCCCcEE
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI---------GVCHRDIKPQNLLVNPHTHQVK 234 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---------givH~DLkp~Nill~~~~~~vk 234 (429)
++||||+++ +|.+.+.. ...++..+..++.||+.||.||| +. ||+||||||+||||+.++ .+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH-~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLH-TELPRGDHYKPAISHRDLNSRNVLVKNDG-TCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHH-CCBCCGGGCBCCEECSSCSGGGEEECTTS-CEE
T ss_pred EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHH-hhhccccccccceeecccccceEEEcCCC-cEE
Confidence 899999965 66666543 45689999999999999999999 88 999999999999999887 799
Q ss_pred EeecccceecccCC---------CcccccccccccccccccCC------CCCCCchhHHHHHHHHHHHHhCCCCCC-CCC
Q 014174 235 LCDFGSAKVLVKGE---------PNISYICSRYYRAPELIFGA------TEYTTAIDIWSVGCVLAELLLGQPLFP-GES 298 (429)
Q Consensus 235 l~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~------~~~~~~~DiwslG~il~~lltg~~pf~-~~~ 298 (429)
|+|||+++...... ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||. +..
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998764321 12245689999999998652 235678999999999999999976653 322
Q ss_pred hHHHHHHHH-HHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc----
Q 014174 299 GVDQLVEII-KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI---- 373 (429)
Q Consensus 299 ~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~---- 373 (429)
......... .....+....+...... ....+.+... + .....+++++.+||.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ 315 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSR--EKQRPKFPEA-W--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE 315 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTT--SCCCCCCCTT-C--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcc--cccCCCCCcc-c--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence 111111111 11122222222111000 0000110000 0 001123457999999999999999999999954
Q ss_pred --CCCCcc
Q 014174 374 --HPFFYE 379 (429)
Q Consensus 374 --hp~f~~ 379 (429)
++|-++
T Consensus 316 ll~~~~~~ 323 (336)
T 3g2f_A 316 LMMIWERN 323 (336)
T ss_dssp HHHCCCC-
T ss_pred HHHHHHhc
Confidence 566544
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=329.26 Aligned_cols=247 Identities=20% Similarity=0.272 Sum_probs=191.6
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCC----cEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETG----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
...+|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+|+.+++.++||||+++++++.
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----- 116 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS----- 116 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----
Confidence 3457999999999999999999986553 459999986432 23457999999999999999999883
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
.....++||||+++ +|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~Dikp~NIl~~~~~-~~kl~Df 191 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA-NMNYVHRDLAARNILVNSNL-VCKVSDF 191 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred cCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChheEEECCCC-cEEECCC
Confidence 33448899999986 66555543 3467999999999999999999999 88999999999999999887 7999999
Q ss_pred ccceecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014174 239 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP 313 (429)
Q Consensus 239 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 313 (429)
|+++....... .....+|..|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+....+.....
T Consensus 192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~-- 268 (333)
T 1mqb_A 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR-- 268 (333)
T ss_dssp CC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC--
T ss_pred CcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCc--
Confidence 99987644321 1123457789999999764 48999999999999999999 9999988776655544432110
Q ss_pred CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...+..++..+.+||.+||..||.+|||+.+++++
T Consensus 269 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 269 --------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp --------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 01123478999999999999999999999998873
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=321.88 Aligned_cols=246 Identities=22% Similarity=0.323 Sum_probs=192.1
Q ss_pred CccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch--hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 87 PKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 87 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.....+|++.+.||+|+||.||+|++ +|+.||+|++.... ....+|+.+++.++||||+++++++... ....
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~ 90 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGL 90 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CC
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCce
Confidence 34456899999999999999999987 58899999986543 3456799999999999999999986432 2246
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||+++ +|.+.+.... ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~ 166 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKE 166 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTS-CEEECCCCC---
T ss_pred EEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCcceEEEeCCC-cEEEeecccccc
Confidence 799999986 7777665422 234889999999999999999999 88999999999999999887 799999999876
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
.... .....+|+.|+|||++.+. .++.++||||||+++|+|++ |..||...+..+....+...
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~------------- 230 (278)
T 1byg_A 167 ASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG------------- 230 (278)
T ss_dssp -----------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-------------
T ss_pred cccc--ccCCCccccccCHHHhCCC-CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-------------
Confidence 5432 2234568889999998764 48999999999999999998 99999877655444332211
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 231 ---------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 231 ---------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 001123457999999999999999999999999876
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=329.91 Aligned_cols=253 Identities=20% Similarity=0.282 Sum_probs=187.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh-hhHHHHHHHHHc--CCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR-YKNRELQTMRLL--DHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.++|++.+.||+|+||.||+|++ +++.||||++..... ...+|.+++..+ +||||+++++++.... .....+++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l 112 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYL 112 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEE
T ss_pred ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEE
Confidence 35799999999999999999987 489999999865432 233555665544 8999999999886543 22246889
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--------CeeeecCCCCceEecCCCCcEEEee
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI--------GVCHRDIKPQNLLVNPHTHQVKLCD 237 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--------givH~DLkp~Nill~~~~~~vkl~D 237 (429)
||||+.+ +|.+.+.. ..+++..+..++.|++.||.||| +. ||+||||||+|||++.++ .+||+|
T Consensus 113 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH-~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~D 185 (337)
T 3mdy_A 113 ITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLH-TEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIAD 185 (337)
T ss_dssp EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHH-SCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECC
T ss_pred EEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH-HhhhhhccCCCEEecccchHHEEECCCC-CEEEEe
Confidence 9999975 77666643 46999999999999999999999 77 999999999999999888 799999
Q ss_pred cccceecccCCCc-----ccccccccccccccccCCCCCCC------chhHHHHHHHHHHHHhC----------CCCCCC
Q 014174 238 FGSAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTT------AIDIWSVGCVLAELLLG----------QPLFPG 296 (429)
Q Consensus 238 fG~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~------~~DiwslG~il~~lltg----------~~pf~~ 296 (429)
||++......... ....||+.|+|||++.+.. .+. ++|||||||++|+|+|| ..||..
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 9999766443322 2457899999999997644 344 39999999999999999 666654
Q ss_pred CCh----HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHh
Q 014174 297 ESG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372 (429)
Q Consensus 297 ~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell 372 (429)
... ............. .+... .......+++++.+||.+||+.||.+|||+.+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~-----------------~~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKKL-----------------RPSFP----NRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSCC-----------------CCCCC----GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hcCCCCchhhhHHHHhhhcc-----------------Ccccc----ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 321 1111111110000 00000 0001123567899999999999999999999998
Q ss_pred cC
Q 014174 373 IH 374 (429)
Q Consensus 373 ~h 374 (429)
+|
T Consensus 324 ~~ 325 (337)
T 3mdy_A 324 KT 325 (337)
T ss_dssp HH
T ss_pred HH
Confidence 74
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=342.60 Aligned_cols=245 Identities=24% Similarity=0.339 Sum_probs=198.7
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
...+|++.+.||+|+||.||+|.+. ++..||||++... ...+.+|+++++.++||||+++++++. . ..++
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-----~-~~~~ 258 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIY 258 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S-SSCE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-----C-CccE
Confidence 4468999999999999999999975 4678999998753 344568999999999999999998873 1 1267
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+.+ +|.+.+.... ...+++..+..++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+++..
T Consensus 259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH-~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANILVSASL-VCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSSCSGGGEEECTTC-CEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCCHHHEEECCCC-cEEEeeCCCceEc
Confidence 89999974 6766665321 246889999999999999999999 88999999999999999887 7999999999865
Q ss_pred ccCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 245 VKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 245 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.... ......+|..|+|||++... .++.++|||||||++|+|+| |+.||.+.+..+....+......
T Consensus 335 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~--------- 404 (454)
T 1qcf_A 335 EDNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM--------- 404 (454)
T ss_dssp CCHHHHTTCSSSSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---------
T ss_pred CCCceeccCCCcccccccCHHHhccC-CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence 3321 11233457789999999754 48999999999999999999 99999988877666555442110
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
..+..+++++.+||.+||..||++|||+.++++
T Consensus 405 -------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 405 -------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 112357899999999999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=322.48 Aligned_cols=246 Identities=21% Similarity=0.316 Sum_probs=192.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCC---cEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETG---ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..+|++.+.||+|+||.||+|++..++ ..||+|.+.... ....+|+.+++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----C
Confidence 346999999999999999999975443 468999886432 3345799999999999999999986432 2
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
...++||||+++ +|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||+
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~ 174 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLA-SKKFVHRDLAARNCMLDEKF-TVKVADFGL 174 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTC-CEEECSCGG
T ss_pred CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCchheEEECCCC-CEEECcccc
Confidence 346789999986 66665532 3466899999999999999999999 88999999999999999887 799999999
Q ss_pred ceecccCC-----CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 241 AKVLVKGE-----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 241 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
++...... ......+|+.|+|||.+.+. .++.++|||||||++|+|++ |.+||.+.+..+....+.....
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~--- 250 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--- 250 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC---
T ss_pred cccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC---
Confidence 97654322 12344568889999999764 48999999999999999999 6677877665554444332110
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+..+++.+.+||.+||..||.+|||+.++++
T Consensus 251 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 251 -------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0122347899999999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=317.74 Aligned_cols=245 Identities=22% Similarity=0.294 Sum_probs=196.8
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
...+|++.+.||+|+||.||+|.+. ++..||+|.+... .....+|+++++.++||||+++++++.. . ..+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~-~~~ 83 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----E-PIY 83 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S-SCE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-----C-CcE
Confidence 3457999999999999999999964 5678999998653 3445689999999999999999988731 1 267
Q ss_pred EEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+. ++|.+.+... ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++...
T Consensus 84 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH-~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTL-SCKIADFGLARLI 159 (279)
T ss_dssp EEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeccCCCHhhEEEcCCC-CEEECCCcccccc
Confidence 8999996 4665554321 1236999999999999999999999 88999999999999999887 7999999999876
Q ss_pred ccCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 245 VKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 245 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
..... .....+|..|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+....
T Consensus 160 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~----------- 227 (279)
T 1qpc_A 160 EDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY----------- 227 (279)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------
T ss_pred cCcccccccCCCCccCccChhhhccC-CCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc-----------
Confidence 54322 1234467789999998654 48899999999999999999 999998877666554443210
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..++.++.+||.+||..||++|||+.++++
T Consensus 228 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 228 -----------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 01122357899999999999999999999999876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=327.73 Aligned_cols=253 Identities=23% Similarity=0.296 Sum_probs=193.0
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
|...+.||+|+||.||+|.+ ++..||+|++... .....+|+.+++.++||||+++++++.. ....
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD-----GDDL 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSC
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEec-----CCce
Confidence 55668999999999999986 6889999988542 2345689999999999999999998843 3347
Q ss_pred EEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++||||++ ++|.+.+.. ......+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++..
T Consensus 106 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l~~lH-~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~ 182 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAF-TAKISDFGLARA 182 (307)
T ss_dssp EEEEECCTTCBHHHHHHT-GGGCCCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHh-ccCCCCCCHHHHHHHHHHHHHHHHHHh-cCCeecCCCCHHHEEEcCCC-cEEEeecccccc
Confidence 89999996 566665543 233467999999999999999999999 88999999999999999887 799999999987
Q ss_pred cccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC--CCHHHH
Q 014174 244 LVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT--PTREEI 318 (429)
Q Consensus 244 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~--~~~~~~ 318 (429)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||........+..+...... .....+
T Consensus 183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (307)
T 2nru_A 183 SEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY 260 (307)
T ss_dssp CCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHH
T ss_pred cccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhh
Confidence 644322 223568999999998864 3789999999999999999999999876544333332222111 111100
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
+ .+.. ...+...+..+.+|+.+||..||.+|||+.++++
T Consensus 261 --~--------~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 261 --I--------DKKM------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp --S--------CSSC------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --c--------cccc------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 0000 0011224578999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=319.94 Aligned_cols=245 Identities=21% Similarity=0.310 Sum_probs=191.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCc---EEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..|.+.++||+|+||+||+|.+..++. .||+|.+.... ....+|+.+++.++||||+++++++.... .
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~ 96 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----G 96 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----S
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----C
Confidence 358889999999999999999765554 79999886432 33457999999999999999999885332 2
Q ss_pred EEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
..++||||+. +++.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH-~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~ 171 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLA-EQKFVHRDLAARNCMLDESF-TVKVADFGLA 171 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTC-CEEECCTTSS
T ss_pred CcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCcceEEEcCCC-cEEeCcCCCc
Confidence 2468999986 566555532 3467899999999999999999999 88999999999999999888 7999999999
Q ss_pred eecccC-----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCH
Q 014174 242 KVLVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 242 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+..... .......+|+.|+|||.+.+. .++.++|||||||++|+|++|. +||...+..+....+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---- 246 (298)
T 3pls_A 172 RDILDREYYSVQQHRHARLPVKWTALESLQTY-RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR---- 246 (298)
T ss_dssp CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC----
T ss_pred ccccCCcccccccCcCCCCCccccChhhhccC-CCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC----
Confidence 755332 122345678899999999664 4899999999999999999955 55655554444333322110
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+..+++.+.+||.+||+.||.+|||+.++++
T Consensus 247 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 247 ------------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0122347899999999999999999999999887
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=333.83 Aligned_cols=247 Identities=16% Similarity=0.182 Sum_probs=191.2
Q ss_pred cccceEEeeEEccCCceEEEEE-----EEcCCCcEEEEEEeecc-hhhhHHHHHHHHHcC---CCCeeecceEeeecCCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQA-----KCLETGETVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~ 159 (429)
...+|++.+.||+|+||+||+| .+..+++.||+|++... .....+|+++++.++ |+||+++++++....
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~-- 140 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN-- 140 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS--
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC--
Confidence 3457999999999999999999 46778999999998654 344567888888887 999999999885433
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC---------
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSR-ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP--------- 228 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~--------- 228 (429)
..++||||++ ++|.+.+..... ....+++..++.++.||+.||.||| ++||+||||||+||||+.
T Consensus 141 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH-~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 141 ---GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH-DCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp ---CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCSGGGEEECGGGTCC----
T ss_pred ---CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh-hCCeecCCCCHHHEEecccccCccccc
Confidence 3789999997 577777665433 3467999999999999999999999 899999999999999987
Q ss_pred --CCCcEEEeecccceeccc---CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 014174 229 --HTHQVKLCDFGSAKVLVK---GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQL 303 (429)
Q Consensus 229 --~~~~vkl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~ 303 (429)
++ .+||+|||+|+.... .......+||+.|+|||++.+.. ++.++|||||||++|+|+||+.||......
T Consensus 217 ~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~--- 291 (365)
T 3e7e_A 217 DLSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGG--- 291 (365)
T ss_dssp --CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETT---
T ss_pred cccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCC---
Confidence 66 799999999976542 22234567899999999997754 899999999999999999999999543210
Q ss_pred HHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCC
Q 014174 304 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376 (429)
Q Consensus 304 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~ 376 (429)
.+........ ...++.+.+++.+||+.+|.+|++..+.+.+.+
T Consensus 292 -----------------------~~~~~~~~~~-------~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 292 -----------------------ECKPEGLFRR-------LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp -----------------------EEEECSCCTT-------CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred -----------------------ceeechhccc-------cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 0000000000 013678899999999999999977665555443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=340.26 Aligned_cols=245 Identities=24% Similarity=0.313 Sum_probs=194.2
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
...+|++.+.||+|+||.||+|.+.. +..||||++... ...+.+|+++++.++||||+++++++.. ..++
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~ 254 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 254 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence 34679999999999999999999864 467999998653 2445689999999999999999998732 1267
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+.+ +|.+.+... ....+++..+..++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++..
T Consensus 255 iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH-~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENL-VCKVADFGLARLI 330 (452)
T ss_dssp EEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCCCTTC--
T ss_pred EEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCChhhEEECCCC-CEEECCCccceec
Confidence 89999975 666665431 2356899999999999999999999 88999999999999999887 7999999999876
Q ss_pred ccCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 245 VKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 245 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
..... .....+|..|+|||++.+. .++.++|||||||++|+|++ |+.||.+....+.+..+.....
T Consensus 331 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---------- 399 (452)
T 1fmk_A 331 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---------- 399 (452)
T ss_dssp ------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred CCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence 43321 1234457889999998764 48999999999999999999 9999998877666554432110
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+..+++.+.+||.+||..||++|||+.++++
T Consensus 400 ------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 400 ------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0123457899999999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=324.45 Aligned_cols=253 Identities=25% Similarity=0.345 Sum_probs=191.0
Q ss_pred eEEeeEEccCCceEEEEEEE----cCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 93 YMAERVVGQGSFGIVFQAKC----LETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
|++++.||+|+||+||++.. ..+++.||||++.... ....+|+++++.++||||+++++++... +...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence 49999999999999988753 4578999999987542 3356899999999999999999988653 2345
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
+++||||+++ +|.+.+. ...+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+|||++.
T Consensus 110 ~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH-~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLH-AQHYIHRDLAARNVLLDNDR-LVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHH-hCCccCCCCchheEEEcCCC-CEEECCccccc
Confidence 7899999985 5555442 245999999999999999999999 88999999999999999887 79999999998
Q ss_pred ecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH--
Q 014174 243 VLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE-- 316 (429)
Q Consensus 243 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~-- 316 (429)
....... .....+|..|+|||++.+.. ++.++|||||||++|+|++|..||........ ...+.....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~~~~~ 256 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-----ELIGIAQGQMT 256 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHHCSCCHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhh-----hhhcccccchh
Confidence 7754432 22345788899999997644 88999999999999999999999965322110 000110000
Q ss_pred --HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 317 --EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 317 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+.... ........+..+++++.+||++||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 257 VLRLTELL------------ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHH------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHH------------hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 000000 000011123457999999999999999999999999985
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=334.46 Aligned_cols=246 Identities=21% Similarity=0.311 Sum_probs=185.6
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCC---cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...|.+.+.||+|+||.||+|.+..++ ..||+|.+... ...+.+|+.+++.++||||+++++++... .
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~ 163 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E 163 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----S
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----C
Confidence 346999999999999999999876433 46899988542 23345799999999999999999976432 2
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
...++||||+.+ +|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+|||+
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~-~~kL~DFG~ 238 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLA-SKKFVHRDLAARNCMLDEKF-TVKVADFGL 238 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCC--
T ss_pred CCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHH-HCCEecCccchheEEECCCC-CEEEeeccc
Confidence 236789999985 66665532 3456899999999999999999999 88999999999999999888 799999999
Q ss_pred ceecccCCC-----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 241 AKVLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 241 a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
++....... .....+|+.|+|||++.+. .++.++|||||||++|+|+| |.+||.+.+..+....+... .
T Consensus 239 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~--~-- 313 (373)
T 3c1x_A 239 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--R-- 313 (373)
T ss_dssp -------------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT--C--
T ss_pred cccccccccccccccCCCCCcccccChHHhcCC-CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC--C--
Confidence 986543321 1234567889999998764 48999999999999999999 77888776654444333221 0
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..++..+.+||.+||..||.+|||+.++++
T Consensus 314 ------------------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 314 ------------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp ------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00112357899999999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=321.54 Aligned_cols=251 Identities=24% Similarity=0.339 Sum_probs=191.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEcC-CCc--EEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLE-TGE--TVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
..+|++.+.||+|+||.||+|++.. ++. .||+|++... .....+|+++++.++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 4579999999999999999998643 333 6899987543 23345799999999999999999988432
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
. .++||||+. +++.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+||
T Consensus 94 --~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH-~~~i~H~dikp~Nili~~~~-~~kl~Df 165 (291)
T 1u46_A 94 --P-MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLE-SKRFIHRDLAARNLLLATRD-LVKIGDF 165 (291)
T ss_dssp --S-CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEEETT-EEEECCC
T ss_pred --C-ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHH-hCCcccCCCchheEEEcCCC-CEEEccc
Confidence 1 568999998 466665543 2356899999999999999999999 88999999999999999887 7999999
Q ss_pred ccceecccCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCC
Q 014174 239 GSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTP 313 (429)
Q Consensus 239 G~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~ 313 (429)
|++......... ....+|..|+|||++.+. .++.++||||||+++|+|++ |+.||.+.+..+.+..+......
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~- 243 (291)
T 1u46_A 166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER- 243 (291)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC-
T ss_pred cccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC-
Confidence 999876543321 234567789999998764 47899999999999999999 99999888776655544331100
Q ss_pred CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
...+..++.++.+||.+||..||.+|||+.++++ ++.+..
T Consensus 244 --------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~~~ 283 (291)
T 1u46_A 244 --------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLEAQ 283 (291)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHC
T ss_pred --------------------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHHhC
Confidence 0112357899999999999999999999999998 554433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=321.82 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=195.5
Q ss_pred ccccceEEeeEEccCCceEEEEEE----EcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
....+|++++.||+|+||.||+|+ +..+|+.||+|++.... ....+|+++++.++||||+++++++....
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 115 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG-- 115 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC--
Confidence 345579999999999999999998 46789999999986532 34568999999999999999999875422
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
...+++||||+++ +|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+||+++.++ .+||+||
T Consensus 116 -~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH-~~~ivH~dikp~NIli~~~~-~~kL~Df 189 (326)
T 2w1i_A 116 -RRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLG-TKRYIHRDLATRNILVENEN-RVKIGDF 189 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEEETT-EEEECCC
T ss_pred -CCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHH-hCCEeccCCCcceEEEcCCC-cEEEecC
Confidence 2246789999975 66666543 2356999999999999999999999 88999999999999999887 7999999
Q ss_pred ccceecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 239 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 239 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
|++........ .....+|..|+|||++.+.. ++.++|||||||++|+|+||..||..... . .....+...
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~--~---~~~~~~~~~ 263 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA--E---FMRMIGNDK 263 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHH--H---HHHHHCTTC
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHH--H---HHHhhcccc
Confidence 99987654432 12345677899999987644 88999999999999999999998854211 1 111111111
Q ss_pred H-H----HH-hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 315 R-E----EI-KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 315 ~-~----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
. . .+ ..+... .....+..+++++.+||.+||..||++|||+.++++
T Consensus 264 ~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 264 QGQMIVFHLIELLKNN-------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CTHHHHHHHHHHHHTT-------------CCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred chhhhHHHHHHHhhcC-------------CCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0 00 000000 001123457999999999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=343.74 Aligned_cols=244 Identities=25% Similarity=0.320 Sum_probs=197.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..+|++.+.||+|+||.||+|.+.. +..||||++.... ..+.+|+++++.++|+||+++++++.. ..+++
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~l 338 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI 338 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccceE
Confidence 4579999999999999999999854 4679999987532 455689999999999999999998732 12678
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+.+ +|.+.+... ....+++..+..++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+++...
T Consensus 339 v~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH-~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENL-VCKVADFGLARLIE 414 (535)
T ss_dssp EECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCTTSTTTCC
T ss_pred eeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeCCCCCHhhEEEcCCC-cEEEcccccceecC
Confidence 9999975 666665432 2356899999999999999999999 88999999999999999887 79999999997653
Q ss_pred cCC--CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 246 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 246 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
... ......+|..|+|||++... .++.++|||||||+||+|++ |+.||.+....+.+..+.....
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----------- 482 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------- 482 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC-----------
T ss_pred CCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----------
Confidence 221 11233457889999998764 48999999999999999999 9999998877666554432110
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+..++..+.+||.+||..||++|||+.++++
T Consensus 483 -----------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 483 -----------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0123457899999999999999999999999987
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=322.63 Aligned_cols=254 Identities=20% Similarity=0.227 Sum_probs=192.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-hhhHHHHHHHHH--cCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
++|++.+.||+|+||.||+|++ +|+.||||++.... ....+|.++++. ++||||+++++++.... .....+++|
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv 118 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 118 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence 4799999999999999999997 68999999986543 344578888887 79999999999885443 122357899
Q ss_pred Eeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-------CCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-------GIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-------~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
|||+++ +|.+.+.. ..+++..+..++.||+.||.|||. +.||+||||||+||||+.++ .+||+|||
T Consensus 119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg 192 (342)
T 1b6c_B 119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG 192 (342)
T ss_dssp ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEECCCT
T ss_pred EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEEEECC
Confidence 999986 77666643 469999999999999999999994 46999999999999999888 79999999
Q ss_pred cceecccCCC-----cccccccccccccccccCCCC-----CCCchhHHHHHHHHHHHHhC----------CCCCCCCCh
Q 014174 240 SAKVLVKGEP-----NISYICSRYYRAPELIFGATE-----YTTAIDIWSVGCVLAELLLG----------QPLFPGESG 299 (429)
Q Consensus 240 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~lltg----------~~pf~~~~~ 299 (429)
++........ .....||+.|+|||++.+... ++.++|||||||++|+|+|| ..||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 9987655432 234578999999999866432 23689999999999999999 778865422
Q ss_pred ----HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 300 ----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 300 ----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...+......... .+.+.. .......+..+.+||.+||+.||++|||+.++++|
T Consensus 273 ~~~~~~~~~~~~~~~~~-----------------~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKL-----------------RPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp SSCCHHHHHHHHTTSCC-----------------CCCCCG----GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcccHHHHHHHHHHHHh-----------------CCCCcc----cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 1222221110000 000000 00111245689999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=346.39 Aligned_cols=240 Identities=23% Similarity=0.281 Sum_probs=190.4
Q ss_pred eEEe-eEEccCCceEEEEEEE--cCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 93 YMAE-RVVGQGSFGIVFQAKC--LETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 93 y~i~-~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
+.+. +.||+|+||.||+|.+ ..+++.||||+++... ..+.+|+++++.++|||||++++++.. ..
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~- 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ES- 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----SS-
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CC-
Confidence 4443 4899999999999954 4567899999986532 345689999999999999999998731 11
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.++||||+.+ +|.+.+. ....+++..+..++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+++
T Consensus 444 ~~lv~E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH-~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~ 517 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQH-YAKISDFGLSK 517 (635)
T ss_dssp EEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECCTTHHH
T ss_pred EEEEEEccCCCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHH-HCCEeCCCCChHhEEEeCCC-CEEEEEcCCcc
Confidence 6799999985 5555553 3467999999999999999999999 88999999999999999887 79999999998
Q ss_pred ecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 243 VLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 243 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
....... .....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------ 590 (635)
T 4fl3_A 518 ALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------ 590 (635)
T ss_dssp HTTC-------------CGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------
T ss_pred ccccCccccccccCCCCceeeeChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence 7644322 2233457889999999664 48999999999999999998 9999998887665554433110
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+..+++++.+||.+||..||++|||+.++++
T Consensus 591 ----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 591 ----------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 0123457999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=346.14 Aligned_cols=243 Identities=25% Similarity=0.284 Sum_probs=191.2
Q ss_pred cceEEee-EEccCCceEEEEEEEc--CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 91 ISYMAER-VVGQGSFGIVFQAKCL--ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.++.+.+ .||+|+||.||+|.+. .++..||||++... ...+.+|+++++.++|||||++++++.. .
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~----- 408 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E----- 408 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S-----
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C-----
Confidence 3566666 8999999999999875 35667999998653 2445689999999999999999998742 1
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++||||+.+ +|.+.+. .....+++..+..++.||+.||.||| ++||+||||||+||||+.++ .+||+|||++
T Consensus 409 ~~~lv~E~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~iiHrDlkp~NILl~~~~-~vkL~DFGla 483 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRNLAARNVLLVNRH-YAKISDFGLS 483 (613)
T ss_dssp SEEEEEECCTTCBHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECCCSTT
T ss_pred CeEEEEEeCCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHH-HCCEEcCcCCHHHEEEcCCC-cEEEeeccCc
Confidence 27899999986 4544442 23466999999999999999999999 88999999999999999887 7999999999
Q ss_pred eecccCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 242 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 242 ~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
+........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |+.||.+.+..+....+....
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~-~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~------ 556 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------ 556 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC------
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC------
Confidence 865433221 122346789999999764 48999999999999999998 999999888776655543310
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...++..+++++.+||.+||..||.+|||+.++++
T Consensus 557 ----------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 557 ----------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp ----------------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred ----------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01123457999999999999999999999998754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=339.07 Aligned_cols=249 Identities=18% Similarity=0.182 Sum_probs=184.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------------hhhHHHHHHHHHcC---------CCCeee
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLD---------HPNVVS 148 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~---------h~niv~ 148 (429)
.++|++.+.||+|+||+||+|++ +|+.||||++.... ....+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 35799999999999999999998 78999999987542 44568999999886 667666
Q ss_pred cceEeeecC-------------------------CCCceEEEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHH
Q 014174 149 LKHCFFSTT-------------------------DKDELYLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQIC 202 (429)
Q Consensus 149 ~~~~~~~~~-------------------------~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~ 202 (429)
+.+++.... ......+++||||+.++ +++.+. ...+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence 665543211 01134588999999753 444331 25689999999999999
Q ss_pred HHHHHHHcCCCeeeecCCCCceEecCCC-------------------CcEEEeecccceecccCCCcccccccccccccc
Q 014174 203 RALAYIHGGIGVCHRDIKPQNLLVNPHT-------------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 263 (429)
Q Consensus 203 ~aL~~LH~~~givH~DLkp~Nill~~~~-------------------~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE 263 (429)
.||.|||+++||+||||||+||||+.++ ..+||+|||+|+..... ...||+.|+|||
T Consensus 172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE 247 (336)
T 2vuw_A 172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSG
T ss_pred HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChh
Confidence 9999999446999999999999998764 16999999999876432 457899999999
Q ss_pred cccCCCCCCCchhHHHHHHH-HHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccc
Q 014174 264 LIFGATEYTTAIDIWSVGCV-LAELLLGQPLFPGESGVDQL-VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI 341 (429)
Q Consensus 264 ~~~~~~~~~~~~DiwslG~i-l~~lltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (429)
++.+.. +.++||||+|++ .+++++|..||.+......+ ..+...... +. .....
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~~----~~~~~ 303 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF------------------KT----KCNTP 303 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC------------------SS----CCCSH
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc------------------Cc----ccchh
Confidence 997643 889999998777 77888999999432111111 122211000 00 00001
Q ss_pred cCCCCChhHHHHHHhhcCcCCCCCCCHHHHh-cCCCCc
Q 014174 342 FHKRMPPEAVDLVSRLLQYSPNLRCTALEAC-IHPFFY 378 (429)
Q Consensus 342 ~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell-~hp~f~ 378 (429)
+...+++++++||++||++| |+.|+| +||||+
T Consensus 304 ~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 304 AMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 12236889999999999987 999999 999995
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=319.03 Aligned_cols=253 Identities=19% Similarity=0.261 Sum_probs=193.6
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...++|++.+.||+|+||.||+|++.. .||+|++... .....+|+.+++.++||||+++++++...
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 101 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP----- 101 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-----
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----
Confidence 344579999999999999999999743 4999988542 23345799999999999999999988543
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
..+++||||+.+ +|.+.+. .....+++..+..++.||+.||.||| +.||+||||||+||+++ ++ .+||+|||+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~al~~lH-~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~ 175 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLH-AKGILHKDLKSKNVFYD-NG-KVVITDFGL 175 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTT---SSCCCCCSHHHHHHHHHHHHHHHHHH-HTTCCCCCCCSTTEEEC----CCEECCCSC
T ss_pred CceEEEeecccCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCChhhEEEe-CC-CEEEeecCC
Confidence 337899999974 5555442 22346999999999999999999999 88999999999999998 55 799999999
Q ss_pred ceeccc------CCCcccccccccccccccccC--------CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 014174 241 AKVLVK------GEPNISYICSRYYRAPELIFG--------ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEI 306 (429)
Q Consensus 241 a~~~~~------~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i 306 (429)
++.... ........||+.|+|||++.+ ...++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 865432 122234468999999999864 234788999999999999999999999887766555443
Q ss_pred HHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
.... . +. .....++.++.+||.+||..||.+|||+.++++ .+.++...
T Consensus 256 ~~~~-~------------------~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~ 303 (319)
T 2y4i_B 256 GTGM-K------------------PN--------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKR 303 (319)
T ss_dssp HTTC-C------------------CC--------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC---
T ss_pred ccCC-C------------------CC--------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHh
Confidence 3210 0 00 011246889999999999999999999999988 66555543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=342.38 Aligned_cols=246 Identities=27% Similarity=0.359 Sum_probs=196.3
Q ss_pred ccccceEEeeEEccCCceEEEEEEEcCC---CcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 88 KQTISYMAERVVGQGSFGIVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 88 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
....+|++.+.||+|+||.||+|.+..+ +..||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---- 462 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---- 462 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 3456899999999999999999998654 4679999876432 344579999999999999999998721
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
+ ..++||||++ ++|.+.+.. ....+++..+..++.||+.||.||| +.||+||||||+|||++.++ .+||+||
T Consensus 463 ~--~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDikp~NILl~~~~-~vkL~DF 535 (656)
T 2j0j_A 463 N--PVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSND-CVKLGDF 535 (656)
T ss_dssp S--SCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECCC
T ss_pred C--ceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHH-hCCccccccchHhEEEeCCC-CEEEEec
Confidence 1 2678999998 466555542 2346899999999999999999999 88999999999999999887 7999999
Q ss_pred ccceecccCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 239 GSAKVLVKGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 239 G~a~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
|+++........ ....+|+.|+|||++.+. .++.++|||||||++|+|++ |..||.+.+..+.+..+.....
T Consensus 536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~---- 610 (656)
T 2j0j_A 536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---- 610 (656)
T ss_dssp CCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCC----
T ss_pred CCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCC----
Confidence 999876443221 233457889999999764 58999999999999999997 9999998887766655544210
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
..++..+++.+.+||.+||..||.+|||+.++++
T Consensus 611 ------------------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 611 ------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0123457899999999999999999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=350.03 Aligned_cols=243 Identities=25% Similarity=0.338 Sum_probs=195.4
Q ss_pred ccceEEeeEEccCCceEEEEEEEcC-CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLE-TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.++|++.+.||+|+||.||+|.+.. +|+.||||++.... ....+|+++++.++||||+++++++......+..+
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4689999999999999999999976 78999999885432 23457999999999999999999987765545556
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
.|+||||++++.+.... ...+++..+..++.||+.||.||| ++||+||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~-----~~~l~~~~~~~~~~qi~~aL~~lH-~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLH-SIGLVYNDLKPENIMLTEE--QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECSS--CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHH-HCCCeecccChHHeEEeCC--cEEEEecccchh
Confidence 78999999864333221 237999999999999999999999 8899999999999999864 699999999987
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.... +.+.
T Consensus 231 ~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~--------- 286 (681)
T 2pzi_A 231 INSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPE--------- 286 (681)
T ss_dssp TTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCT---------
T ss_pred cccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc----------cccc---------
Confidence 6443 456789999999998653 588999999999999999999888642110 0000
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
.. .....++.+.+||.+||..||.+||+..+++.|+|+.-+
T Consensus 287 ------------~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 287 ------------DD----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ------------TC----HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------------cc----cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00 001136789999999999999999999999999998653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=300.76 Aligned_cols=227 Identities=15% Similarity=0.064 Sum_probs=176.0
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..++|++.+.||+|+||.||+|++..+|+.||||++.... ....+|+.+++.++||||+++++++.. .
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~ 103 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----R 103 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----C
Confidence 3467999999999999999999999999999999986542 345679999999999999999998854 3
Q ss_pred eEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
...|+||||+++ +|.+++. .......+..++.||+.||.||| ++||+||||||+|||++.++ .+||+++|
T Consensus 104 ~~~~lv~e~~~g~~L~~~l~------~~~~~~~~~~i~~ql~~aL~~lH-~~givH~Dikp~NIll~~~g-~~kl~~~~- 174 (286)
T 3uqc_A 104 AGGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAH-RAGVALSIDHPSRVRVSIDG-DVVLAYPA- 174 (286)
T ss_dssp TEEEEEEECCCEEEHHHHHT------TCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCSGGGEEEETTS-CEEECSCC-
T ss_pred CcEEEEEEecCCCCHHHHHh------cCCChHHHHHHHHHHHHHHHHHH-HCCCccCCCCcccEEEcCCC-CEEEEecc-
Confidence 348899999975 5555442 12456678889999999999999 88999999999999999888 79998543
Q ss_pred ceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 241 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 241 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
|++ .++.++|||||||++|+|+||+.||.+.+....+..
T Consensus 175 ------------------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--------------- 213 (286)
T 3uqc_A 175 ------------------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--------------- 213 (286)
T ss_dssp ------------------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---------------
T ss_pred ------------------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---------------
Confidence 333 278899999999999999999999987543211000
Q ss_pred cCcCcccccCCCc-CCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 321 MNPNYTEFKFPQI-KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 321 ~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
..... ........+...+++++.+||.+||+.||.+| |+.++++ .+.+..
T Consensus 214 --------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~--~L~~~~ 264 (286)
T 3uqc_A 214 --------AERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN--LMQQAT 264 (286)
T ss_dssp --------CCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH--HHHHHH
T ss_pred --------HHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH--HHHHHh
Confidence 00000 00011112345689999999999999999999 9999988 455443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=278.66 Aligned_cols=179 Identities=17% Similarity=0.072 Sum_probs=123.0
Q ss_pred EEccCCceEEEEEEEcCCCcEEEEEEeecc--------------hhhhHHHHHHHHHc-CCCCeeecceEeeecCCCCce
Q 014174 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD--------------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 162 (429)
..+.|++|.+..++....|+.||+|++.++ ...+.+|+++|+++ .|+||+++++++ ++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 456778888888887788999999998643 12355799999999 699999999998 5555
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+||||||++| +|.+.+. ..+.+++. .|+.||+.||.||| ++|||||||||+||||+.++ .+||+|||+|
T Consensus 316 ~~yLVMEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH-~~GIIHRDIKPeNILL~~dg-~vKL~DFGlA 386 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALE-KQGFWHDDVRPWNVMVDARQ-HARLIDFGSI 386 (569)
T ss_dssp EEEEEEECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHH-HTTCEESCCCGGGEEECTTS-CEEECCCTTE
T ss_pred EEEEEEecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHH-HCCceeccCchHhEEECCCC-CEEEeecccC
Confidence 68999999996 5555443 34667654 57899999999999 89999999999999999988 7999999999
Q ss_pred eecccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 014174 242 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQP 292 (429)
Q Consensus 242 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~ 292 (429)
+..... ....+.+||+.|||||++.+. +...+|+||+|++++.|.++..
T Consensus 387 r~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 387 VTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred eeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhccccc
Confidence 876543 334567899999999999653 6778999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-27 Score=240.03 Aligned_cols=178 Identities=15% Similarity=0.222 Sum_probs=132.2
Q ss_pred EEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 94 MAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 94 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
...+.||+|+||.||+|. ..+..+|+|...... ..+.+|+++++.++||||+++..++.....
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--- 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN--- 413 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT---
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc---
Confidence 445689999999999994 467899999764321 224689999999999999955444443222
Q ss_pred eEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
.++||||++ ++|.+.+.. +..++.||+.||.||| ++||+||||||+|||++. .+||+|||+
T Consensus 414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH-~~gIiHrDiKp~NILl~~---~~kL~DFGl 475 (540)
T 3en9_A 414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLH-KNDVIHNDLTTSNFIFDK---DLYIIDFGL 475 (540)
T ss_dssp --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHH-HTTEECTTCCTTSEEESS---SEEECCCTT
T ss_pred --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHH-HCcCccCCCCHHHEEECC---eEEEEECcc
Confidence 478999997 555554321 5688999999999999 889999999999999996 699999999
Q ss_pred ceecccCCC--------cccccccccccccccccCC-CCCCCchhHHHHHHHHHHHHhCCCCC
Q 014174 241 AKVLVKGEP--------NISYICSRYYRAPELIFGA-TEYTTAIDIWSVGCVLAELLLGQPLF 294 (429)
Q Consensus 241 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf 294 (429)
|+....... .....||+.|||||++... ..|+..+|+||..+-..+.+.++.+|
T Consensus 476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 988754322 1356789999999998541 23777899999999999988887666
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-24 Score=201.72 Aligned_cols=138 Identities=17% Similarity=0.188 Sum_probs=108.9
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----------------------hhhhHHHHHHHHHcCCCCeeecc
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------------------KRYKNRELQTMRLLDHPNVVSLK 150 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------------~~~~~~E~~~l~~l~h~niv~~~ 150 (429)
|.+.+.||+|+||.||+|.+ .+|+.||||.+... .....+|+.+++.++ | ++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 55669999999999999999 88999999988532 123458999999999 5 6776
Q ss_pred eEeeecCCCCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC
Q 014174 151 HCFFSTTDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH 229 (429)
Q Consensus 151 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~ 229 (429)
+++.. ...++||||+++ +|.+ + .......++.||+.||.||| +.||+||||||+|||++ +
T Consensus 168 ~~~~~------~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH-~~giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 168 KVYAW------EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFY-HRGIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp CEEEE------ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEEE-T
T ss_pred eEEec------cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHH-HCCCEeCCCCHHHEEEE-C
Confidence 65522 125789999986 4433 1 11335579999999999999 89999999999999999 7
Q ss_pred CCcEEEeecccceecccCCCccccccccccccccccc
Q 014174 230 THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266 (429)
Q Consensus 230 ~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~ 266 (429)
+ .+||+|||+|+. +..++|||.+.
T Consensus 229 ~-~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 229 E-GIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp T-EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred C-cEEEEECCCCeE------------CCCCCHHHHHH
Confidence 7 799999999964 34478888773
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3.7e-21 Score=177.35 Aligned_cols=134 Identities=18% Similarity=0.234 Sum_probs=102.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcE--EEEEEeecch----------------------------hhhHHHHHHHHHc
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQDK----------------------------RYKNRELQTMRLL 141 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~----------------------------~~~~~E~~~l~~l 141 (429)
-|.+.+.||+|+||.||+|.+..+|+. ||||++.... ....+|+.+++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 388999999999999999998788999 9999864321 1346799999999
Q ss_pred CCCCe--eecceEeeecCCCCceEEEEEEeccch------hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 014174 142 DHPNV--VSLKHCFFSTTDKDELYLNLVLEFVPE------TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213 (429)
Q Consensus 142 ~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g 213 (429)
.|+++ +.++.+ . ..++||||+++ .+.+... ..++..+..++.||+.||.|||.+.|
T Consensus 128 ~~~~i~~p~~~~~----~-----~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~g 191 (258)
T 1zth_A 128 KEAGVSVPQPYTY----M-----KNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQEAE 191 (258)
T ss_dssp HHTTCCCCCEEEE----E-----TTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred HhCCCCCCeEEEc----C-----CCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHHCC
Confidence 88864 222221 1 14689999953 3333211 12355678899999999999995579
Q ss_pred eeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 214 ivH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
|+||||||+|||++. .++|+|||+|...
T Consensus 192 ivHrDlkp~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 192 LVHADLSEYNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp EECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred EEeCCCCHHHEEEcC---cEEEEECcccccC
Confidence 999999999999986 5999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-18 Score=166.68 Aligned_cols=136 Identities=13% Similarity=0.124 Sum_probs=93.4
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh--------------------------hhHHHHHHHHHcCCCC
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR--------------------------YKNRELQTMRLLDHPN 145 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~E~~~l~~l~h~n 145 (429)
-|++..+||.|+||.||+|.+ .+|+.||||+++.... ...+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 399999999999999999997 5799999998742110 0113455555553333
Q ss_pred eeecceEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceE
Q 014174 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLL 225 (429)
Q Consensus 146 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nil 225 (429)
+.- ...+.. . . .+|||||++|..+.. ......+..++.||+.+|.+|| ++|||||||||.|||
T Consensus 175 v~v-p~p~~~-~-~----~~LVME~i~G~~L~~---------l~~~~~~~~l~~qll~~l~~lH-~~gIVHrDLKp~NIL 237 (397)
T 4gyi_A 175 FPV-PEPIAQ-S-R----HTIVMSLVDALPMRQ---------VSSVPDPASLYADLIALILRLA-KHGLIHGDFNEFNIL 237 (397)
T ss_dssp CSC-CCEEEE-E-T----TEEEEECCSCEEGGG---------CCCCSCHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEE
T ss_pred CCC-Ceeeec-c-C----ceEEEEecCCccHhh---------hcccHHHHHHHHHHHHHHHHHH-HCCCcCCCCCHHHEE
Confidence 211 111111 1 1 258999998753221 1122345678899999999999 889999999999999
Q ss_pred ecCCCC---------cEEEeecccceecc
Q 014174 226 VNPHTH---------QVKLCDFGSAKVLV 245 (429)
Q Consensus 226 l~~~~~---------~vkl~DfG~a~~~~ 245 (429)
++.++. .+.|+||+-+....
T Consensus 238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 238 IREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred EeCCCCcccccccccceEEEEeCCcccCC
Confidence 986652 28899999876543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=6.5e-12 Score=115.44 Aligned_cols=136 Identities=15% Similarity=0.111 Sum_probs=101.2
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeec----chhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQ----DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.|++...++.|+.+.||++.. .+..+++|+... ......+|+.+++.+. +..+.++++++.. ....++
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~l 87 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWSNL 87 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCceEE
Confidence 588999999999999999974 468999998863 3345778999999985 5667777776632 234779
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcC-----------------------------------
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGG----------------------------------- 211 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~----------------------------------- 211 (429)
||||++|..+... . .+......++.++..+|..||+-
T Consensus 88 v~e~i~G~~l~~~--~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 88 LMSEADGVLCSEE--Y------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHH--C------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEecCCeehhhc--c------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999998543321 1 11222346778999999999930
Q ss_pred -----------------------CCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 212 -----------------------IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 212 -----------------------~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
..++|+|++|.||+++.++ .+.|+||+.+..
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~~ 213 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSGR 213 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhccc
Confidence 4589999999999998543 567999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=2.1e-10 Score=104.78 Aligned_cols=133 Identities=17% Similarity=0.108 Sum_probs=90.7
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-hhhhHHHHHHHHHcCCCC--eeecceEeeecCCCCceEEEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
.|.+....+.|..+.||++.. .+|..+++|+.... .....+|+.+++.+.+.+ +.+++.+... ....++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCCEEEE
Confidence 466655445677799999964 56788999987543 244568999999986544 4456665532 12367899
Q ss_pred eccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC-----------------------------------
Q 014174 169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG----------------------------------- 213 (429)
Q Consensus 169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g----------------------------------- 213 (429)
||++|..+. . .... ...++.++...|..|| +..
T Consensus 95 e~i~G~~l~-~-------~~~~---~~~~~~~l~~~l~~lh-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 95 GEVPGQDLL-S-------SHLA---PAEKVSIMADAMRRLH-TLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp ECCSSEETT-T-------SCCC---HHHHHHHHHHHHHHHT-TSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EecCCcccC-c-------CcCC---HhHHHHHHHHHHHHHh-CCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 999875332 1 0111 1245667777777777 432
Q ss_pred -----------------------eeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 214 -----------------------VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 214 -----------------------ivH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++|+|++|.||+++.++ .+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhccc
Confidence 99999999999998654 567999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.07 E-value=3.7e-10 Score=108.64 Aligned_cols=140 Identities=16% Similarity=0.152 Sum_probs=99.2
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEee--cc-----hhhhHHHHHHHHHcCC--CCeeecceEeeecCCCCceEEEE
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVL--QD-----KRYKNRELQTMRLLDH--PNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~-----~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~l 166 (429)
++.|+.|.++.||++.. .+..+++|+.. .. .....+|..+++.|.. ..+.+++.++.... .....++
T Consensus 43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~~ 118 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAFY 118 (359)
T ss_dssp EEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCEE
T ss_pred EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeEE
Confidence 46789999999999975 35688899765 22 3456789999999974 44667766553221 1123568
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc------------------------------------
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG------------------------------------ 210 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~------------------------------------ 210 (429)
||||++|..+.. .....++......++.++..+|..||+
T Consensus 119 vme~v~G~~l~~-----~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 119 IMEFVSGRVLWD-----QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EEECCCCBCCCC-----TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEEecCCeecCC-----CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999999743210 112346788888899999999999994
Q ss_pred ---------------------CCCeeeecCCCCceEecCCCC-cEEEeecccceec
Q 014174 211 ---------------------GIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVL 244 (429)
Q Consensus 211 ---------------------~~givH~DLkp~Nill~~~~~-~vkl~DfG~a~~~ 244 (429)
..+++|+|+++.||+++.++. .+.|+||+.+...
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 146999999999999987652 4689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.98 E-value=2.5e-10 Score=107.22 Aligned_cols=186 Identities=12% Similarity=0.116 Sum_probs=110.5
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcC-CCCe--eecceEeeecCCCCceEEEEEEecc
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLD-HPNV--VSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
+.++.|....||++. ..+++|+.... .....+|.++++.+. +..+ .+++... .........|+||+++
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceEEEccc
Confidence 458999999999874 46899976543 345678999999884 3322 2232221 1111112346799999
Q ss_pred chhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-----------------------------------------
Q 014174 172 PETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG----------------------------------------- 210 (429)
Q Consensus 172 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~----------------------------------------- 210 (429)
+|..+.... ...++......++.|+...|..||+
T Consensus 99 ~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLL-----LNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHH-----HHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCccc-----cccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 974322111 0235666666677777777777762
Q ss_pred ----------------CCCeeeecCCCCceEecCC-CCcEEEeecccceecccCCCccccccccccccccccc------C
Q 014174 211 ----------------GIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF------G 267 (429)
Q Consensus 211 ----------------~~givH~DLkp~Nill~~~-~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~------~ 267 (429)
...++|+|++|.||+++.+ +..+.|+||+.+.................-..|+... +
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 0247999999999999974 4368899999987642211100000000001222110 0
Q ss_pred C-------CCCCCchhHHHHHHHHHHHHhCCCCC
Q 014174 268 A-------TEYTTAIDIWSVGCVLAELLLGQPLF 294 (429)
Q Consensus 268 ~-------~~~~~~~DiwslG~il~~lltg~~pf 294 (429)
. .......+.|++|.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0 00122368999999999999998766
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=8.6e-07 Score=83.06 Aligned_cols=134 Identities=15% Similarity=0.091 Sum_probs=80.4
Q ss_pred eEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCC---eeecceEeeecCCCCceEEEEEEecc
Q 014174 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPN---VVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
+.++.|....||++ |..+++|+.... .....+|.++|+.|.+.. +.+++.+.. . .....++||+++
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~--~--~~g~~~~v~e~i 95 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK--R--SDGNPFVGYRKV 95 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE--C--TTSCEEEEEECC
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc--c--CCCceEEEEecc
Confidence 45788999999988 567899975432 234568999999997532 334433332 1 122356899999
Q ss_pred chhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 014174 172 PETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH------------------------------------------ 209 (429)
Q Consensus 172 ~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH------------------------------------------ 209 (429)
+|........ ..++......++.++...|..||
T Consensus 96 ~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 96 QGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp CSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 8643221100 11222222222222222222222
Q ss_pred -----------------cCCCeeeecCCCCceEecC---CCCcEEEeecccceec
Q 014174 210 -----------------GGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVL 244 (429)
Q Consensus 210 -----------------~~~givH~DLkp~Nill~~---~~~~vkl~DfG~a~~~ 244 (429)
....++|+|++|.||+++. ++..+.|+||+.+...
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1335799999999999987 3534689999988764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=9.3e-06 Score=74.26 Aligned_cols=126 Identities=13% Similarity=0.067 Sum_probs=77.9
Q ss_pred eEEEEEEEcCCCcEEEEEEeecc-hhhhHHHHHHHHHcCC-CCeeecceEeeecCCCCceEEEEEEeccchhHHHHHHHh
Q 014174 105 GIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHY 182 (429)
Q Consensus 105 g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~ 182 (429)
+.||+......+..+++|+-... .....+|..+|+.+.. --+.+++.+.... ...++|||+++|.........
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~l~G~~~~~~~~~ 113 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTAIPGKTAFQVLEE 113 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECCCSEEHHHHHHH
T ss_pred CeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEeeCCccccccccC
Confidence 47999887777788999977543 2345689999998852 1244555544322 236789999986432211110
Q ss_pred hhcCCCCCHHHHHHHHHHHHHHHHHHHc--------------------------------------------------C-
Q 014174 183 SRASQRMPLIYVKLYTYQICRALAYIHG--------------------------------------------------G- 211 (429)
Q Consensus 183 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------------------------------------------------~- 211 (429)
.......+..++...|.-||+ .
T Consensus 114 -------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 186 (272)
T 4gkh_A 114 -------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKL 186 (272)
T ss_dssp -------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTT
T ss_pred -------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhc
Confidence 011122333444444444441 0
Q ss_pred ------CCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 212 ------IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 212 ------~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
..++|+|+.+.||+++.++ .+-|+||+.+..
T Consensus 187 ~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~ 223 (272)
T 4gkh_A 187 LPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGI 223 (272)
T ss_dssp CCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred ccccCCcEEEcCCCCCCeEEEECCe-EEEEEECccccc
Confidence 1379999999999999655 567999998854
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.18 E-value=8.5e-06 Score=77.13 Aligned_cols=32 Identities=22% Similarity=0.438 Sum_probs=27.5
Q ss_pred CCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 211 ~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
..+++|+|+++.||+++.++ .+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENE-QIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGG-CEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCC-cEEEEehhhccc
Confidence 46899999999999997666 699999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=8.7e-06 Score=77.76 Aligned_cols=77 Identities=9% Similarity=0.063 Sum_probs=48.9
Q ss_pred EeeEE-ccCCceEEEEEEEc--C----CCcEEEEEEeecch-------hhhHHHHHHHHHcCC---CCeeecceEeeecC
Q 014174 95 AERVV-GQGSFGIVFQAKCL--E----TGETVAIKKVLQDK-------RYKNRELQTMRLLDH---PNVVSLKHCFFSTT 157 (429)
Q Consensus 95 i~~~l-g~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h---~niv~~~~~~~~~~ 157 (429)
..+.| +.|....+|++... . ++..+++|+..... ....+|+.+++.|.. -.+.+++.+....
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~- 102 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG- 102 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS-
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC-
Confidence 34678 88989999998753 0 26789999765432 346789999988843 2455565544221
Q ss_pred CCCceEEEEEEeccch
Q 014174 158 DKDELYLNLVLEFVPE 173 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~ 173 (429)
......++|||+++|
T Consensus 103 -~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 103 -DVLGTPFFLMDYVEG 117 (357)
T ss_dssp -TTTSSCEEEEECCCC
T ss_pred -CccCCceEEEEecCC
Confidence 101224579999975
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=2.1e-05 Score=76.36 Aligned_cols=71 Identities=17% Similarity=0.176 Sum_probs=44.5
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----------hhhhHHHHHHHHHcCC--CC-eeecceEeeecCCCCc
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----------KRYKNRELQTMRLLDH--PN-VVSLKHCFFSTTDKDE 161 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~h--~n-iv~~~~~~~~~~~~~~ 161 (429)
.+.||.|..+.||++....+++.|++|..... ......|.++++.+.. +. +.+++.+ . ...
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d---~~~ 109 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM 109 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c---CCc
Confidence 45789999999999976556789999975321 1223578889888742 33 3344432 1 111
Q ss_pred eEEEEEEeccch
Q 014174 162 LYLNLVLEFVPE 173 (429)
Q Consensus 162 ~~~~lv~e~~~~ 173 (429)
.++|||++++
T Consensus 110 --~~lvmE~l~g 119 (397)
T 2olc_A 110 --AVTVMEDLSH 119 (397)
T ss_dssp --TEEEECCCTT
T ss_pred --cEEEEEeCCC
Confidence 3579999975
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00036 Score=64.74 Aligned_cols=65 Identities=14% Similarity=0.089 Sum_probs=40.9
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCe-eecceEeeecCCCCceEEEEEEecc
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
++.|+.|....+|++ ..+++|+..... ....+|..+++.+....+ .+++... .... ++|++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~~--~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PATG--VMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTTC--CEEEECC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCCC--EEEEeec
Confidence 578889999999999 568889775432 223578888887753333 3444322 2112 3689999
Q ss_pred -ch
Q 014174 172 -PE 173 (429)
Q Consensus 172 -~~ 173 (429)
++
T Consensus 90 ~~g 92 (301)
T 3dxq_A 90 AGA 92 (301)
T ss_dssp TTC
T ss_pred CCC
Confidence 54
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.52 E-value=0.0015 Score=56.88 Aligned_cols=101 Identities=17% Similarity=0.085 Sum_probs=64.5
Q ss_pred hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCcccc
Q 014174 174 TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 253 (429)
Q Consensus 174 ~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~ 253 (429)
+|.+++..+ +.++++++++.+++|.+.+|.-+-.+..-..+=+.|..|++..+| .|.+.+ +.+.
T Consensus 34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------
Confidence 566766654 578999999999999999988762122222344557889999888 576553 1110
Q ss_pred cccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCC
Q 014174 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQP 292 (429)
Q Consensus 254 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~ 292 (429)
.....+.|||... ...+.+.=|+|||+++|.-+--..
T Consensus 98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL 134 (229)
T 2yle_A 98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGL 134 (229)
T ss_dssp ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCC
Confidence 1122367888763 346788899999999999986543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00089 Score=65.30 Aligned_cols=78 Identities=12% Similarity=-0.050 Sum_probs=47.7
Q ss_pred CCCeeeecCCCCceEecCCCCcEEEeecccceecccCCCcccccc--cccccccccccCCCC--CCCchhHHHHHHHHHH
Q 014174 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATE--YTTAIDIWSVGCVLAE 286 (429)
Q Consensus 211 ~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ 286 (429)
...++|+|++|.|||++.++ ++|+||+.+.............+ ...|.+|+....... .....++.++...++.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 66899999999999998654 99999999876422211111111 234666665431110 1123445577777777
Q ss_pred HHhC
Q 014174 287 LLLG 290 (429)
Q Consensus 287 lltg 290 (429)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.0026 Score=58.49 Aligned_cols=70 Identities=16% Similarity=0.152 Sum_probs=48.4
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCC---CeeecceEeeecCCCCceEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHP---NVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~ 165 (429)
..-++.+|.|..+.||++.. .+|+.|.+|+.... ...+.+|...|+.|... .+.++++.. . -+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-----~----~~ 86 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-----D----RT 86 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE-----T----TE
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc-----C----ce
Confidence 44567899999999999984 67899999976433 23467899999988532 233333321 1 24
Q ss_pred EEEeccc
Q 014174 166 LVLEFVP 172 (429)
Q Consensus 166 lv~e~~~ 172 (429)
+||||+.
T Consensus 87 lv~e~l~ 93 (288)
T 3f7w_A 87 LAMEWVD 93 (288)
T ss_dssp EEEECCC
T ss_pred EEEEeec
Confidence 6899886
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0018 Score=60.39 Aligned_cols=143 Identities=14% Similarity=0.059 Sum_probs=74.9
Q ss_pred EeeEEccCCceEEEEEEEcCCCcEEEEEEeec--chhhhHHHHHHHHHcCCCC--eeecceEeeecCCC----CceEEEE
Q 014174 95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDK----DELYLNL 166 (429)
Q Consensus 95 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~----~~~~~~l 166 (429)
-.+.|+.|....+|++... +..+++|+... .......|..+++.|.... +.+++.. ..+. .....++
T Consensus 26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~---~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR---KDGELLGELSGRPAA 100 (322)
T ss_dssp EEEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB---TTCCSCEEETTEEEE
T ss_pred EeeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC---CCCCEEEEECCEEEE
Confidence 3467888888999999752 33688998865 3445667888888774322 2333211 0000 0123567
Q ss_pred EEeccchhH------------HHH---HHHhhhc-CCC----CCHHHHHH---------------HHHHHHHHHHHHHc-
Q 014174 167 VLEFVPETV------------YRV---AKHYSRA-SQR----MPLIYVKL---------------YTYQICRALAYIHG- 210 (429)
Q Consensus 167 v~e~~~~~l------------~~~---~~~~~~~-~~~----l~~~~~~~---------------i~~qi~~aL~~LH~- 210 (429)
++++++|.. ... +...... ... ........ +...+...+..+..
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 999987521 001 1111000 000 01100000 00113334444431
Q ss_pred -----CCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 211 -----GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 211 -----~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
..+++|+|+++.|||++.++ .+.|+||+.+..
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~ 217 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN 217 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred CcccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence 24799999999999998654 457999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0062 Score=59.92 Aligned_cols=70 Identities=16% Similarity=0.219 Sum_probs=45.6
Q ss_pred EeeEEccCCceEEEEEEEcCCCcEEEEEEeecchh---hhHHHHHHHHHcCCCCe-eecceEeeecCCCCceEEEEEEec
Q 014174 95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNLVLEF 170 (429)
Q Consensus 95 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 170 (429)
-++.|+.|....+|++.....+..+++|+...... ...+|..+++.|...++ .++++++ .+ .+|+||
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~ 182 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF 182 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence 34578889999999998744457899997743221 22589999999975555 4555554 22 148999
Q ss_pred cch
Q 014174 171 VPE 173 (429)
Q Consensus 171 ~~~ 173 (429)
++|
T Consensus 183 I~G 185 (458)
T 2qg7_A 183 MDG 185 (458)
T ss_dssp CCS
T ss_pred eCC
Confidence 874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0032 Score=58.71 Aligned_cols=71 Identities=18% Similarity=0.076 Sum_probs=50.6
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeecc-hhhhHHHHHHHHHcC---CCCeeecceEeeecCCCCceEEEEEEecc
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDELYLNLVLEFV 171 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 171 (429)
.+.|+.|....+|++.. ++..+++|+.... ...+.+|...|+.|. ...+.+++..... ....++|||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEEEec
Confidence 46789999999999974 5678999977544 345678999888884 2456666655422 23467899999
Q ss_pred ch
Q 014174 172 PE 173 (429)
Q Consensus 172 ~~ 173 (429)
++
T Consensus 114 ~G 115 (312)
T 3jr1_A 114 NK 115 (312)
T ss_dssp CC
T ss_pred cC
Confidence 75
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0019 Score=61.65 Aligned_cols=68 Identities=12% Similarity=0.140 Sum_probs=40.2
Q ss_pred eEEccCCceEEEEEEEcC--------CCcEEEEEEeecchh---hhHHHHHHHHHcCCCCe-eecceEeeecCCCCceEE
Q 014174 97 RVVGQGSFGIVFQAKCLE--------TGETVAIKKVLQDKR---YKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~---~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~ 164 (429)
+.|+.|....+|++.... .+..+++|+...... ....|..+++.+...++ .++++.+ .+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~~---- 109 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----NG---- 109 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----CC----
Confidence 467788888999997642 136889997654322 23578888888853343 3555433 11
Q ss_pred EEEEeccch
Q 014174 165 NLVLEFVPE 173 (429)
Q Consensus 165 ~lv~e~~~~ 173 (429)
++||+|++|
T Consensus 110 ~~v~e~i~G 118 (369)
T 3c5i_A 110 GRIEEWLYG 118 (369)
T ss_dssp EEEEECCCS
T ss_pred cEEEEEecC
Confidence 368999875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0038 Score=61.02 Aligned_cols=69 Identities=16% Similarity=0.232 Sum_probs=46.1
Q ss_pred eeEEccCCceEEEEEEEcC-------CCcEEEEEEeec-ch-hhhHHHHHHHHHcCCCCe-eecceEeeecCCCCceEEE
Q 014174 96 ERVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQ-DK-RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~-~~-~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~ 165 (429)
++.|+.|....||++.... .+..+++|+... .. ....+|..+++.|...++ .++++.+ .+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----C
Confidence 4578888899999998642 257899998744 22 344479998888854334 4555544 22 1
Q ss_pred EEEeccch
Q 014174 166 LVLEFVPE 173 (429)
Q Consensus 166 lv~e~~~~ 173 (429)
+|++|++|
T Consensus 149 ~v~e~l~G 156 (429)
T 1nw1_A 149 RLEEYIPS 156 (429)
T ss_dssp EEECCCCE
T ss_pred EEEEEeCC
Confidence 68898874
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0043 Score=58.22 Aligned_cols=34 Identities=38% Similarity=0.493 Sum_probs=27.8
Q ss_pred CCCeeeecCCCCceEecCC---CCcEEEeecccceec
Q 014174 211 GIGVCHRDIKPQNLLVNPH---THQVKLCDFGSAKVL 244 (429)
Q Consensus 211 ~~givH~DLkp~Nill~~~---~~~vkl~DfG~a~~~ 244 (429)
...++|+|+.+.||+++.+ ...+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4579999999999999864 126899999998653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.0075 Score=56.33 Aligned_cols=72 Identities=14% Similarity=0.001 Sum_probs=43.1
Q ss_pred EEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCC--eeecceEeeecCC--CCceEEEEEEec
Q 014174 98 VVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTD--KDELYLNLVLEF 170 (429)
Q Consensus 98 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~--~~~~~~~lv~e~ 170 (429)
.|+ |....||++.. .+|+.+++|..... ......|..+++.|.... +++++.. .... ......++||++
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence 456 77788998863 35668999988632 345567888888774322 3444332 0000 012245679999
Q ss_pred cch
Q 014174 171 VPE 173 (429)
Q Consensus 171 ~~~ 173 (429)
++|
T Consensus 109 i~G 111 (328)
T 1zyl_A 109 VGG 111 (328)
T ss_dssp CCC
T ss_pred cCC
Confidence 875
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0069 Score=58.03 Aligned_cols=138 Identities=16% Similarity=0.220 Sum_probs=75.1
Q ss_pred eEEccCCceEEEEEEEcC-------CCcEEEEEEeec---chhhhHHHHHHHHHcCCCC-eeecceEeeecCCCCceEEE
Q 014174 97 RVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQ---DKRYKNRELQTMRLLDHPN-VVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~---~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~ 165 (429)
+.|..|....+|++.... ++..|++|+.-. ......+|.++++.|...+ ..++++++ .+.
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~g---- 126 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PEG---- 126 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TTE----
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CCc----
Confidence 456667777888887532 357899997633 2233457999998885322 24555544 221
Q ss_pred EEEeccchhHH------------HHHHHhh---hc----CCCCC--HHHHHHHHHHHHH-------------------HH
Q 014174 166 LVLEFVPETVY------------RVAKHYS---RA----SQRMP--LIYVKLYTYQICR-------------------AL 205 (429)
Q Consensus 166 lv~e~~~~~l~------------~~~~~~~---~~----~~~l~--~~~~~~i~~qi~~-------------------aL 205 (429)
+||||++|..+ .+..... .. ..... +..+..+..++-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 68999875211 1111100 00 11111 3445555544322 12
Q ss_pred HHHH-------cCCCeeeecCCCCceEecCC---CCcEEEeeccccee
Q 014174 206 AYIH-------GGIGVCHRDIKPQNLLVNPH---THQVKLCDFGSAKV 243 (429)
Q Consensus 206 ~~LH-------~~~givH~DLkp~Nill~~~---~~~vkl~DfG~a~~ 243 (429)
..|. ....++|+|+.+.||+++.+ ...+.|+||..|..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2222 12369999999999999876 12699999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0042 Score=58.64 Aligned_cols=32 Identities=25% Similarity=0.496 Sum_probs=27.3
Q ss_pred CCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 212 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 212 ~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
..++|+|+.+.||+++.++ .+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEE-SIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGG-CEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCC-eEEEEECCCCeeC
Confidence 4699999999999998666 6999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.62 E-value=0.11 Score=50.42 Aligned_cols=68 Identities=15% Similarity=0.198 Sum_probs=42.7
Q ss_pred eEEccCCceEEEEEEEcC-------CCcEEEEEEeecch---hhhHHHHHHHHHcCCCCe-eecceEeeecCCCCceEEE
Q 014174 97 RVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQDK---RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~ 165 (429)
+.|..|....+|++.... .+..|++|+..... -...+|..+++.+...++ .++++.+ .+ +
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~~----~ 146 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----PE----G 146 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----TT----E
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----CC----C
Confidence 456667778888887642 15789999764322 223579999988853333 3444433 21 4
Q ss_pred EEEeccch
Q 014174 166 LVLEFVPE 173 (429)
Q Consensus 166 lv~e~~~~ 173 (429)
+|++|++|
T Consensus 147 ~I~efI~G 154 (424)
T 3mes_A 147 RIEEFIDG 154 (424)
T ss_dssp EEEECCCS
T ss_pred EEEEEeCC
Confidence 68999875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 429 | ||||
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-126 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-73 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-70 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-69 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-66 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-65 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-65 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-65 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-65 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-65 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-64 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-62 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-62 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-61 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-59 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-59 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-58 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-57 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-56 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-52 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-51 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-51 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-50 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-49 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-47 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-45 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-41 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-41 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-39 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-37 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-37 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-37 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-34 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-33 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-33 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-32 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-31 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-19 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 367 bits (944), Expect = e-126
Identities = 240/347 (69%), Positives = 285/347 (82%), Gaps = 4/347 (1%)
Query: 76 IVTTIGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNREL 135
+V T G +P Q +SY +V+G GSFG+V+QAK ++GE VAIKKVLQDKR+KNREL
Sbjct: 6 VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 136 QTMRLLDHPNVVSLKHCFFST-TDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYV 194
Q MR LDH N+V L++ F+S+ KDE+YLNLVL++VPETVYRVA+HYSRA Q +P+IYV
Sbjct: 65 QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
KLY YQ+ R+LAYIH G+CHRDIKPQNLL++P T +KLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
CSRYYRAPELIFGAT+YT++ID+WS GCVLAELLLGQP+FPG+SGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
RE+I+ MNPNYTEFKFPQIKAHPW K+F R PPEA+ L SRLL+Y+P R T LEAC H
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303
Query: 375 PFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHAR 421
FF ELRDPN +LPNGR P LFNF QEL ++ L + LIP HAR
Sbjct: 304 SFFDELRDPNVKLPNGRDTPALFNFTTQELS-SNPPLATILIPPHAR 349
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (587), Expect = 6e-73
Identities = 107/345 (31%), Positives = 176/345 (51%), Gaps = 25/345 (7%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV--LQDKRYKN---RELQTMRLLDHPNVV 147
Y +G+G++G+V A VAIKK+ + + Y RE++ + H N++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
+ + T + + LV + +Y++ K Q + ++ + YQI R L Y
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYYRAPE 263
IH V HRD+KP NLL+N T +K+CDFG A+V + Y+ +R+YRAPE
Sbjct: 125 IHSA-NVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM-- 321
++ + YT +IDIWSVGC+LAE+L +P+FPG+ +DQL I+ +LG+P++E++ C+
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 322 -NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
P PW+++F +A+DL+ ++L ++P+ R +A HP+ +
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
Query: 381 RDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLIPEHARKQCP 425
D P+ P EL KE L +LI E + P
Sbjct: 302 YD-----PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQP 341
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 4e-70
Identities = 70/305 (22%), Positives = 122/305 (40%), Gaps = 31/305 (10%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
+ +G G+ G+VF+ +G +A K + + + RELQ + + P +V
Sbjct: 8 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
F E+ + +E + + + R+P + + + + L Y
Sbjct: 68 GFYGAF---YSDGEISI--CMEHMDGGSLD---QVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
+ + HRD+KP N+LVN +KLCDFG + L+ N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESG-VDQLVEIIKVLGTPTREEIKCMNPNYT 326
T Y+ DIWS+G L E+ +G+ P +L+ +V G + P
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 327 EFKF--------------PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
+ I P K+ E D V++ L +P R +
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLM 296
Query: 373 IHPFF 377
+H F
Sbjct: 297 VHAFI 301
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 8e-69
Identities = 99/304 (32%), Positives = 149/304 (49%), Gaps = 23/304 (7%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVV 147
+G+G F V++A+ T + VAIKK+ R + RE++ ++ L HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
L F K + L V +F+ + S + ++K Y + L Y
Sbjct: 64 GLLDAF---GHKSNISL--VFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEY 115
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 266
+H + HRD+KP NLL++ + +KL DFG AK ++ +R+YRAPEL+F
Sbjct: 116 LHQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
GA Y +D+W+VGC+LAELLL P PG+S +DQL I + LGTPT E+ M
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP--N 384
F P H IF + +DL+ L ++P R TA +A +F P
Sbjct: 234 YVTFKSFPGIPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
Query: 385 ARLP 388
+LP
Sbjct: 293 CQLP 296
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 6e-66
Identities = 85/309 (27%), Positives = 144/309 (46%), Gaps = 22/309 (7%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
Y +GQG+FG VF+A+ +TG+ VA+KKVL + + RE++ ++LL H NV
Sbjct: 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 147 VSLKHCFFSTT---DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
V+L + ++ + + LV +F + S + L +K +
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQMLLN 128
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-----SYICSRY 258
L YIH + HRD+K N+L+ +KL DFG A+ + + + + + +
Sbjct: 129 GLYYIHR-NKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
YR PEL+ G +Y ID+W GC++AE+ P+ G + QL I ++ G+ T E
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 319 KCMNPNYTEFKFPQIKAHP---WHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375
++ K +K ++ P A+DL+ +LL P R + +A H
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306
Query: 376 FFYELRDPN 384
FF+ P+
Sbjct: 307 FFWSDPMPS 315
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 210 bits (535), Expect = 2e-65
Identities = 91/300 (30%), Positives = 149/300 (49%), Gaps = 21/300 (7%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-NRELQTM-RLLDHPNVVSLK 150
Y R +G+G + VF+A + E V +K + K+ K RE++ + L PN+++L
Sbjct: 37 YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96
Query: 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG 210
D LV E V T ++ + Q + ++ Y Y+I +AL Y H
Sbjct: 97 DIV---KDPVSRTPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS 147
Query: 211 GIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 270
+G+ HRD+KP N++++ +++L D+G A+ G+ + SRY++ PEL+
Sbjct: 148 -MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206
Query: 271 YTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
Y ++D+WS+GC+LA ++ + P F G DQLV I KVLGT + + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 330 FPQI----KAHPWHKIFHKR----MPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381
F I W + H + PEA+D + +LL+Y R TA EA HP+FY +
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 210 bits (536), Expect = 4e-65
Identities = 73/309 (23%), Positives = 124/309 (40%), Gaps = 41/309 (13%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 148
Y +G G+FG+V + TG A K V+ DK +E+QTM +L HP +V+
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
L F D +E+ + + EF+ + + + +M Y Q+C+ L ++
Sbjct: 88 LHDAF---EDDNEMVM--IYEFMSGG--ELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 209 HGGIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
H H D+KP+N++ ++++KL DFG L + + + APE+ G
Sbjct: 141 HEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
D+WSVG + LL G F GE+ + L +
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---------- 248
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP--NA 385
+ + D + +LL PN R T +A HP+ P ++
Sbjct: 249 ---------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
Query: 386 RLPNGRPFP 394
++P+ R
Sbjct: 294 QIPSSRYTK 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 4e-65
Identities = 109/335 (32%), Positives = 168/335 (50%), Gaps = 25/335 (7%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
Y + VG G++G V A TG VAIKK+ + + + REL+ ++ + H NV
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 147 VSLKHCFFS-TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+ L F T D LV+ F+ + ++ KH +++ ++ YQ+ + L
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
YIH G+ HRD+KP NL VN K+ DFG A+ Y+ +R+YRAPE+I
Sbjct: 135 RYIHA-AGIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
YT +DIWSVGC++AE++ G+ LF G +DQL EI+KV GTP E ++ + +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 326 TEF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382
+ P+++ + I P AV+L+ ++L R TA EA HP+F L D
Sbjct: 251 AKNYMKGLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309
Query: 383 PNARLPNGRPFPPLF---NFKPQELKGAS-KELLS 413
P + + F + E K + KE+LS
Sbjct: 310 TE-DEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLS 343
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 5e-65
Identities = 103/307 (33%), Positives = 164/307 (53%), Gaps = 21/307 (6%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
+ +G+G++G+V++A+ TGE VA+KK+ D + RE+ ++ L+HPN+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
V L E L LV EF+ + + + + +PLI K Y +Q+ + LA
Sbjct: 64 VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLI--KSYLFQLLQGLA 116
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 265
+ H V HRD+KPQNLL+N +KL DFG A+ V + + +YRAPE++
Sbjct: 117 FCHSHR-VLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK-CMNPN 324
G Y+TA+DIWS+GC+ AE++ + LFPG+S +DQL I + LGTP +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384
+ FP+ + K+ + + L+S++L Y PN R +A A HPFF ++ P
Sbjct: 235 DYKPSFPKWARQDFSKVV-PPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP- 292
Query: 385 ARLPNGR 391
+P+ R
Sbjct: 293 --VPHLR 297
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 7e-65
Identities = 100/335 (29%), Positives = 158/335 (47%), Gaps = 24/335 (7%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 146
Y VG G++G V A +TG VA+KK+ + + REL+ ++ + H NV
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
+ L F +E ++ + + Q++ +V+ YQI R L
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADL----NNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 266
YIH + HRD+KP NL VN K+ DFG A+ + Y+ +R+YRAPE++
Sbjct: 136 YIHSA-DIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191
Query: 267 GATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
Y +DIWSVGC++AELL G+ LFPG +DQL I++++GTP E +K ++
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251
Query: 327 EF---KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383
Q+ + +F P AVDL+ ++L + R TA +A H +F + DP
Sbjct: 252 RNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 384 NARLPNGRPFPPLFNFKPQELKGASKELLSKLIPE 418
+ P P+ F E + + L +
Sbjct: 311 D-DEPVADPYDQSF-----ESRDLLIDEWKSLTYD 339
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 5e-64
Identities = 97/299 (32%), Positives = 149/299 (49%), Gaps = 17/299 (5%)
Query: 93 YMAERVVGQGSFGIVFQAKCLET-GETVAIKKVLQDKRYKN------RELQTMRLL---D 142
Y +G+G++G VF+A+ L+ G VA+K+V + RE+ +R L +
Sbjct: 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
HPNVV L + E L LV E V + + +P +K +Q+
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY--LDKVPEPGVPTETIKDMMFQLL 126
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
R L ++H V HRD+KPQN+LV + Q+KL DFG A++ S + + +YRAP
Sbjct: 127 RGLDFLHS-HRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
E++ + Y T +D+WSVGC+ AE+ +PLF G S VDQL +I+ V+G P E+ +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RD 242
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381
F A P K + DL+ + L ++P R +A A HP+F +L
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 1e-62
Identities = 97/299 (32%), Positives = 150/299 (50%), Gaps = 18/299 (6%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
Y +G+G++G VF+AK ET E VA+K+V D + RE+ ++ L H N+
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
V L + L LV EF + + + + + VK + +Q+ + L
Sbjct: 64 VRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLG 115
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 265
+ H V HRD+KPQNLL+N + KL +FG A+ + + + + +YR P+++
Sbjct: 116 FCHS-RNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 266 FGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
FGA Y+T+ID+WS GC+ AEL +PLFPG DQL I ++LGTPT E+ M
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383
+P A ++ DL+ LL+ +P R +A EA HP+F + P
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 202 bits (515), Expect = 5e-62
Identities = 80/341 (23%), Positives = 128/341 (37%), Gaps = 42/341 (12%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 148
Y +G G+FG+V + TG K + DK E+ M L HP +++
Sbjct: 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
L F DK E+ L +LEF+ + + +M V Y Q C L ++
Sbjct: 91 LHDAF---EDKYEMVL--ILEFLSGG--ELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 209 HGGIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 267
H + H DIKP+N++ VK+ DFG A L E + + APE++
Sbjct: 144 HE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
D+W++G + LL G F GE ++ L + + +
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF--------- 252
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY-ELRDPNAR 386
+ PEA D + LLQ P R T +A HP+ + + +R
Sbjct: 253 ----------------SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
Query: 387 LPNGRPFPPLFNFKPQELKGASKELLSKLIPEHA--RKQCP 425
+P+ R K + + + I + RK P
Sbjct: 297 IPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRP 337
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 197 bits (501), Expect = 7e-61
Identities = 94/293 (32%), Positives = 153/293 (52%), Gaps = 20/293 (6%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
Y +G+G++G+V++A+ GET A+KK+ +K + RE+ ++ L H N+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
V L + L LV E + + + + + + K + Q+ +A
Sbjct: 63 VKLYDVIH-----TKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 265
Y H V HRD+KPQNLL+N ++K+ DFG A+ + I + +YRAP+++
Sbjct: 115 YCHD-RRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN- 324
G+ +Y+T IDIWSVGC+ AE++ G PLFPG S DQL+ I ++LGTP + +
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ F + PW K + +DL+S++L+ PN R TA +A H +F
Sbjct: 233 KYDPNFTVYEPLPWESFL-KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-60
Identities = 73/332 (21%), Positives = 130/332 (39%), Gaps = 31/332 (9%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFF 154
+V+G G G V Q T E A+ K+LQD RE++ R P++V + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75
Query: 155 STTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
+ + L +V+E + ++ + R Q I A+ Y+H I
Sbjct: 76 NLYAGRK-CLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLH-SIN 131
Query: 214 VCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 271
+ HRD+KP+NLL +KL DFG AK + + YY APE++ +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
+ D+WS+G ++ LL G P F G+ + + +++FP
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------QYEFP 237
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGR 391
+ + E L+ LL+ P R T E HP+ + +
Sbjct: 238 NPE--------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
Query: 392 PFPPLFNFKPQELKGASKELLSKLIPEHARKQ 423
+ +++K L+ + ++ + +
Sbjct: 290 RVLKEDKERWEDVKEEMTSALATMRVDYEQIK 321
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-60
Identities = 69/293 (23%), Positives = 114/293 (38%), Gaps = 44/293 (15%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
+ + +G+G++G V A T E VA+K V + +E+ ++L+H NVV
Sbjct: 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
L LE+ MP + + +Q+ + Y
Sbjct: 67 KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPEL 264
+HG IG+ HRDIKP+NLL++ + +K+ DFG A V + Y APEL
Sbjct: 119 LHG-IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 265 IFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
+ + +D+WS G VL +L G+ + S Q K T
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL---------- 226
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+PW KI + L+ ++L +P+ R T + ++
Sbjct: 227 -----------NPWKKI-----DSAPLALLHKILVENPSARITIPDIKKDRWY 263
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 7e-60
Identities = 57/289 (19%), Positives = 117/289 (40%), Gaps = 40/289 (13%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 149
+ +G+GSF V++ ET VA ++ K K+ E + ++ L HPN+V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+ + +T K + + LV E + + Y + + M + ++ + QI + L ++H
Sbjct: 74 -YDSWESTVKGKKCIVLVTELMTSGTLK---TYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 210 -GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
+ HRD+K N+ + T VK+ D G A L + + I + + APE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
+Y ++D+++ G + E+ + + Q+
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---------------------- 224
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ + F K PE +++ ++ + + R + + H FF
Sbjct: 225 ----VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-59
Identities = 64/294 (21%), Positives = 115/294 (39%), Gaps = 44/294 (14%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 148
+ +G G+FG V++A+ ET A K + ++ E+ + DHPN+V
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
L F ++ L++ ++EF + + +++ Q AL Y+
Sbjct: 74 LLDAF---YYENNLWI--LIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFG 267
H + HRD+K N+L +KL DFG + + + S+I + Y+ APE++
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184
Query: 268 AT----EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
T Y D+WS+G L E+ +P + + L++I
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
K+ P R D + + L+ + + R T + HPF
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (495), Expect = 1e-59
Identities = 73/331 (22%), Positives = 131/331 (39%), Gaps = 49/331 (14%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
+ R +G GSFG V+ A+ + E VAIKK+ + N +E++ ++ L HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+ + C+ + + LV+E+ + + + + + + + + T+ + L
Sbjct: 77 TIQYRGCY---LREHTAW--LVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 128
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
AY+H + HRD+K N+L++ VKL DFGSA ++ P S++ + Y+ APE+I
Sbjct: 129 AYLH-SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183
Query: 266 FGATE--YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
E Y +D+WS+G EL +P + + L I +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383
+ + + V LQ P R T+ H F R P
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 276
Query: 384 NARLPNGRPFPPLFNFKPQELKGASKELLSK 414
+ + K++L +
Sbjct: 277 TVIMDLIQRTKDAVRELDNLQYRKMKKILFQ 307
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-59
Identities = 71/296 (23%), Positives = 119/296 (40%), Gaps = 45/296 (15%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 146
Y +G GS+G + + G+ + K++ +K+ E+ +R L HPN+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
V T+ L +V+E+ + V ++ Q + +V Q+ AL
Sbjct: 66 VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 206 AYIH----GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYR 260
H GG V HRD+KP N+ ++ + VKL DFG A++L +++ + YY
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
+PE + Y DIWS+GC+L EL P F S + +I
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------- 227
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
E KF +I E ++++R+L R + E +P
Sbjct: 228 ------EGKFRRIPYR---------YSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-59
Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 48/292 (16%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
+ R +G+G FG V+ A+ ++ +A+K + + + K RE++ L HPN
Sbjct: 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
++ L F D +YL +LE+ P + + Y ++ AL
Sbjct: 68 ILRLYGYF---HDATRVYL--ILEYAPLGTVY---RELQKLSKFDEQRTATYITELANAL 119
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
+Y H V HRDIKP+NLL+ +K+ DFG + + + Y PE+I
Sbjct: 120 SYCHSK-RVIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMI 176
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
G + +D+WS+G + E L+G+P F + + I +V
Sbjct: 177 EG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV---------------- 219
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
EF FP + A DL+SRLL+++P+ R E HP+
Sbjct: 220 -EFTFP------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 3e-59
Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 38/289 (13%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDHPNVVSL 149
YM +G+G FGIV + + +T K V D+ +E+ + + H N++ L
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
F + L ++ EF+ + + + ++ + + Y +Q+C AL ++H
Sbjct: 67 HESF-----ESMEELVMIFEFISGL--DIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 210 GGIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 268
+ H DI+P+N++ + +K+ +FG A+ L G+ + Y APE+
Sbjct: 120 S-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH- 177
Query: 269 TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 328
+TA D+WS+G ++ LL G F E+ + I+ T E
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF---------- 227
Query: 329 KFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
K + EA+D V RLL R TA EA HP+
Sbjct: 228 ---------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 3e-58
Identities = 97/344 (28%), Positives = 164/344 (47%), Gaps = 33/344 (9%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 146
Y + +G G+ GIV A VAIKK+ + + + REL M+ ++H N+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 147 VSLKHCFFS-TTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+SL + F T ++ + LV+E + + +V + + + YQ+ +
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGI 132
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
++H G+ HRD+KP N++V K+ DFG A+ Y+ +RYYRAPE+I
Sbjct: 133 KHLHS-AGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
G Y +DIWSVGC++ E++ + LFPG +DQ ++I+ LGTP E +K + P
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 326 TEF--KFPQIKAHPWHKIF-----------HKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
+ P+ + K+F +K +A DL+S++L P R + +A
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 373 IHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASKELLSKLI 416
HP+ DP P P +++ + E + + E +LI
Sbjct: 310 QHPYINVWYDPAEVEA---PPPQIYDKQLDERE-HTIEEWKELI 349
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 192 bits (489), Expect = 4e-58
Identities = 94/357 (26%), Positives = 155/357 (43%), Gaps = 53/357 (14%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 149
Y+ R +G G F V+ AK + VA+K V DK Y E++ ++ ++ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 150 KH----------CFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTY 199
F+ + +++ +V E + E + + K Y + +PLIYVK +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGIPLIYVKQISK 132
Query: 200 QICRALAYIHGGIGVCHRDIKPQNLLVNPHTH-----QVKLCDFGSAKVLVKGEPNISYI 254
Q+ L Y+H G+ H DIKP+N+L+ Q+K+ D G+A E + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESG------VDQLVEIIK 308
+R YR+PE++ GA + DIWS C++ EL+ G LF + G D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 309 VLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHKI------FHKRMPPEAVDLVS 355
+LG ++ T F ++K P + F K E D +S
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309
Query: 356 RLLQYSPNLRCTALEACIHPFFY------ELRDPNARL-PNGRPFPPLFNFKPQELK 405
+LQ P R A HP+ E+R P+ L +G P F +E++
Sbjct: 310 PMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGWF----EEVR 362
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 4e-57
Identities = 72/290 (24%), Positives = 119/290 (41%), Gaps = 43/290 (14%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 148
Y +GQG+ G V+ A + TG+ VAI+++ K E+ MR +PN+V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
+ DEL++ V E + + M + + +AL ++
Sbjct: 82 YLDSY---LVGDELWV------VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 267
H V HRDIK N+L+ VKL DFG + + S + + Y+ APE++
Sbjct: 133 HS-NQVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190
Query: 268 ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTE 327
Y +DIWS+G + E++ G+P + E+ + L I GTP E
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP-------------E 235
Query: 328 FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377
+ P +++ D ++R L R +A E H F
Sbjct: 236 LQNP------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 186 bits (473), Expect = 2e-56
Identities = 70/322 (21%), Positives = 118/322 (36%), Gaps = 42/322 (13%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
Y V+G G+F V A+ T + VAIK + + E+ + + HPN+V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
+L + LYL +++ V +Q+ A+ Y
Sbjct: 71 ALDDIY---ESGGHLYL--IMQLVSGGELF---DRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
+H + HRD+KP+NLL ++ + DFG +K+ G + + Y APE++
Sbjct: 123 LHDLG-IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
Y+ A+D WS+G + LL G P F E+ +I+K
Sbjct: 182 AQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP--------- 231
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNA 385
+ + A D + L++ P R T +A HP+ +
Sbjct: 232 ----------------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275
Query: 386 RLPNGRPFPPLFNFKPQELKGA 407
+ NF + K A
Sbjct: 276 NIHQSVSEQIKKNFAKSKWKQA 297
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 183 bits (465), Expect = 2e-55
Identities = 71/304 (23%), Positives = 120/304 (39%), Gaps = 54/304 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-------------LQDKRYKNRELQTMR 139
Y + ++G+G +V + T + A+K + + + +E+ +R
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 140 LL-DHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYT 198
+ HPN++ LK + + + LV + + + Y + +
Sbjct: 65 KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELF---DYLTEKVTLSEKETRKIM 116
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 258
+ + +H + + HRD+KP+N+L++ + +KL DFG + L GE +
Sbjct: 117 RALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174
Query: 259 YRAPELIFGATE-----YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
Y APE+I + Y +D+WS G ++ LL G P F + L I
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
M+ NY +F P+ DLVSR L P R TA EA
Sbjct: 228 -------MSGNY-QFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
Query: 374 HPFF 377
HPFF
Sbjct: 270 HPFF 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 6e-55
Identities = 91/329 (27%), Positives = 138/329 (41%), Gaps = 61/329 (18%)
Query: 86 QPKQTI--SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYK-------NRELQ 136
QP++ + +++G+GSF V A+ L T AIK + + K RE
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 137 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKL 196
M LDHP V L F D ++LY L + Y R +
Sbjct: 61 VMSRLDHPFFVKLYFTF---QDDEKLYF--GLSYAKNGELL---KYIRKIGSFDETCTRF 112
Query: 197 YTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SY 253
YT +I AL Y+HG G+ HRD+KP+N+L+N H +++ DFG+AKVL S+
Sbjct: 113 YTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSF 170
Query: 254 ICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313
+ + Y +PEL+ + D+W++GC++ +L+ G P F + +IIK+
Sbjct: 171 VGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---- 225
Query: 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373
E+ FP+ + P+A DLV +LL R E
Sbjct: 226 -------------EYDFPE------------KFFPKARDLVEKLLVLDATKRLGCEEMEG 260
Query: 374 ------HPFFYELRDPNARLPNGRPFPPL 396
HPFF + L P P L
Sbjct: 261 YGPLKAHPFFESVT--WENLHQQTP-PKL 286
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 3e-52
Identities = 80/357 (22%), Positives = 143/357 (40%), Gaps = 62/357 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQT--------MRLLDHP 144
++ +++G+GSFG VF A+ +T + AIK + +D + +++ +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
+ + F + + L V+E++ ++ ++ + L Y +I
Sbjct: 64 FLTHMFCTF-----QTKENLFFVMEYLNGGDLM---YHIQSCHKFDLSRATFYAAEIILG 115
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 263
L ++H G+ +RD+K N+L++ H K+ DFG K + G+ + C + Y APE
Sbjct: 116 LQFLHS-KGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173
Query: 264 LIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
++ G +Y ++D WS G +L E+L+GQ F G+ + I+ NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI-HPFFYELRD 382
Y + + EA DL+ +L P R HP F E+
Sbjct: 221 FYPRW-----------------LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN- 262
Query: 383 PNARLPNGR---PFPP-------LFNFKPQELKGASKELLSKLIPEHARKQCPFLGF 429
L PF P NF + L + + ++ Q F F
Sbjct: 263 -WEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNF 318
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-51
Identities = 66/303 (21%), Positives = 113/303 (37%), Gaps = 56/303 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD 142
Y ++G G FG V+ + VAIK V +D+ E+ ++ +
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 143 --HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
V+ L F D L +LE + + + + +Q
Sbjct: 66 SGFSGVIRLLDWFE---RPDSFVL--ILERPEPVQDL--FDFITERGALQEELARSFFWQ 118
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 260
+ A+ + H GV HRDIK +N+L++ + ++KL DFGS L+K + +R Y
Sbjct: 119 VLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176
Query: 261 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320
PE I + + +WS+G +L +++ G F + EII+
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------ 218
Query: 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380
F +R+ E L+ L P+ R T E HP+ ++
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
Query: 381 RDP 383
P
Sbjct: 262 LLP 264
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 1e-51
Identities = 65/324 (20%), Positives = 123/324 (37%), Gaps = 51/324 (15%)
Query: 88 KQTIS--YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN----------REL 135
++ + Y +G G F +V + + TG A K + + + + RE+
Sbjct: 5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64
Query: 136 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVK 195
++ + HPNV++L + +K ++ L +LE V + + +
Sbjct: 65 SILKEIQHPNVITLHEVY---ENKTDVIL--ILELVAGGELF---DFLAEKESLTEEEAT 116
Query: 196 LYTYQICRALAYIHGGIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNIS 252
+ QI + Y+H + + H D+KP+N+++ N ++K+ DFG A + G +
Sbjct: 117 EFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175
Query: 253 YICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGT 312
+ + APE++ D+WS+G + LL G F G++ + L + V
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234
Query: 313 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEAC 372
E + A D + RLL P R T ++
Sbjct: 235 FEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269
Query: 373 IHPFFYELRDPNARLPNGRPFPPL 396
HP+ +D L + P
Sbjct: 270 QHPWIKP-KDTQQALSSAWSHPQF 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 172 bits (436), Expect = 3e-50
Identities = 77/359 (21%), Positives = 133/359 (37%), Gaps = 62/359 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD 142
+ R++G+G FG V+ + +TG+ A+K + + + + L + D
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
P +V + + F D+L +L+ + ++ ++ Y +I
Sbjct: 66 CPFIVCMSYAF---HTPDKLSF--ILDLMNGGDLH---YHLSQHGVFSEADMRFYAAEII 117
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 262
L ++H V +RD+KP N+L++ H H V++ D G A K +P+ S + Y AP
Sbjct: 118 LGLEHMHN-RFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
E++ Y ++ D +S+GC+L +LL G F D+ L
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------- 227
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFF 377
PE L+ LLQ N R A E PFF
Sbjct: 228 -------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268
Query: 378 YELRDPNARLPNGRPFPPLFNFKPQELKGAS-------KELLSKLIPEHARKQCPFLGF 429
R + ++ + +PP E+ A E +K I Q + F
Sbjct: 269 ---RSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNF 324
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (428), Expect = 1e-49
Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 54/297 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPN 145
+ R +G GSFG V + G A+K + L+ + N E + ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
++ + F +D + ++++++ R SQR P K Y ++C AL
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELF---SLLRKSQRFPNPVAKFYAAEVCLAL 117
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 265
Y+H + +RD+KP+N+L++ + H +K+ DFG AK + + + + Y APE++
Sbjct: 118 EYLH-SKDIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173
Query: 266 FGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325
Y +ID WS G ++ E+L G F + + +I+
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215
Query: 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFF 377
E +FP + DL+SRL+ + R + HP+F
Sbjct: 216 AELRFP------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (420), Expect = 6e-49
Identities = 64/295 (21%), Positives = 109/295 (36%), Gaps = 43/295 (14%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 145
Y ++G G V A+ L VA+K + D RE Q L+HP
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRAL 205
+V++ + +V+E+V R M C+AL
Sbjct: 69 IVAV-YDTGEAETPAGPLPYIVMEYVDGVTLR---DIVHTEGPMTPKRAIEVIADACQAL 124
Query: 206 AYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYYRA 261
+ H G+ HRD+KP N++++ + VK+ DFG A+ + ++ + I + Y +
Sbjct: 125 NFSHQ-NGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 262 PELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
PE G D++S+GCVL E+L G+P F G+S V + ++ P
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
H+ + + +V + L +P R
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-47
Identities = 69/318 (21%), Positives = 119/318 (37%), Gaps = 56/318 (17%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
+++G+G+FG V + TG A+K + ++ E + ++ HP + +L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
K+ F D L + + + + Y +I AL Y+H
Sbjct: 71 KYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
V +RDIK +NL+++ H +K+ DFG K + + C +
Sbjct: 123 S-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
+Y A+D W +G V+ E++ G+ F + I+ E +
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-----------------EEIR 223
Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEACIHPFFYELRDPN 384
FP + + PEA L++ LL+ P R A E H FF +
Sbjct: 224 FP------------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN--W 269
Query: 385 ARLPNGRPFPPLFNFKPQ 402
+ + PP FKPQ
Sbjct: 270 QDVVQKKLLPP---FKPQ 284
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-47
Identities = 54/290 (18%), Positives = 104/290 (35%), Gaps = 47/290 (16%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 149
+ +G GSFG V++ K VA+K + E+ +R H N++
Sbjct: 13 GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
L +V ++ + + H + +I + Q + + Y+H
Sbjct: 70 MGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 266
+ HRD+K N+ ++ VK+ DFG A V + + + S + APE+I
Sbjct: 122 AK-SIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 267 G--ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324
Y+ D+++ G VL EL+ GQ + + DQ++ ++
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG---------------- 223
Query: 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
+ P + P L++ L+ + R +
Sbjct: 224 -RGYLSPDLSKVR------SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 3e-45
Identities = 57/313 (18%), Positives = 105/313 (33%), Gaps = 54/313 (17%)
Query: 80 IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQT 137
+G R Y R +G GSFG ++ + GE VAIK ++ E +
Sbjct: 5 VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
+++ + + D Y +V+E + ++ ++ S++ L V L
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGD----YNVMVMELLGPSLED---LFNFCSRKFSLKTVLLL 108
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---- 251
Q+ + YIH HRD+KP N L+ + V + DFG AK +
Sbjct: 109 ADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 252 ----SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEII 307
+ + Y + G E + D+ S+G VL LG + G + +
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 226
Query: 308 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT 367
++ I+ + Y P E ++ + +
Sbjct: 227 RISEKKMSTPIEVLCKGY---------------------PSEFATYLNFCRSLRFDDKPD 265
Query: 368 A---LEACIHPFF 377
+ + F
Sbjct: 266 YSYLRQLFRNLFH 278
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (381), Expect = 2e-43
Identities = 56/281 (19%), Positives = 102/281 (36%), Gaps = 43/281 (15%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 154
+ +G+G FG V G VA+K + D + E M L H N+V L
Sbjct: 13 QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGV 214
+++ L +V E++ + SR + + ++ +C A+ Y+ G
Sbjct: 71 ----EEKGGLYIVTEYMAKGSLV-DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNF 124
Query: 215 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 274
HRD+ +N+LV+ K+ DFG K + + APE + +++T
Sbjct: 125 VHRDLAARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFSTK 180
Query: 275 IDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 333
D+WS G +L E+ G+ +P D + + K +K
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------------GYKMD-- 220
Query: 334 KAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
PP +++ +R + L+
Sbjct: 221 --------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 150 bits (380), Expect = 6e-43
Identities = 50/280 (17%), Positives = 101/280 (36%), Gaps = 33/280 (11%)
Query: 80 IGGRNGQPKQTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN--RELQT 137
+G Y R +G+GSFG++F+ L + VAIK + E +T
Sbjct: 3 VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53
Query: 138 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLY 197
+LL + + F + L+ LV++ + ++ + R + + V +
Sbjct: 54 YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLEDLLDLCGR---KFSVKTVAMA 106
Query: 198 TYQICRALAYIHGGIGVCHRDIKPQNLLVN----PHTHQVKLCDFGSAKVLVKGEPNI-- 251
Q+ + IH + +RDIKP N L+ + + + + DFG K
Sbjct: 107 AKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165
Query: 252 ------SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVE 305
+ + Y + G E + D+ ++G V L G + G +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224
Query: 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKR 345
++ ++ + + E +F + + + F
Sbjct: 225 YERIGEKKQSTPLRELCAGFPE-EFYKYMHYARNLAFDAT 263
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (374), Expect = 1e-41
Identities = 64/319 (20%), Positives = 118/319 (36%), Gaps = 61/319 (19%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 149
+ +G GSFG V K E+G A+K + + K K E + ++ ++ P +V L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
+ F ++ + + + + R R + + Y QI Y+H
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLH 158
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 269
+ + +RD+KP+NLL++ + +++ DFG AK + + APE+I
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213
Query: 270 EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
Y A+D W++G ++ E+ G P F + + +I
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250
Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP-----NLRCTALEACIHPFFYELRDPN 384
F + DL+ LLQ NL+ + H +F +
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF---ATTD 301
Query: 385 -ARLPNGRPFPPLFNFKPQ 402
+ + P F P+
Sbjct: 302 WIAIYQRKVEAP---FIPK 317
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-41
Identities = 78/330 (23%), Positives = 135/330 (40%), Gaps = 60/330 (18%)
Query: 93 YMAERVVGQGSFGIVFQAKCL---ETGETVAIKKV--------LQDKRYKNRELQTMRLL 141
+ +V+G G++G VF + + +TG+ A+K + + + E Q + +
Sbjct: 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85
Query: 142 DH-PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQ 200
P +V+L + F + +L+L L E +++ R V++Y +
Sbjct: 86 RQSPFLVTLHYAF---QTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGE 137
Query: 201 ICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC---SR 257
I AL ++H +G+ +RDIK +N+L++ + H V L DFG +K V E +Y
Sbjct: 138 IVLALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317
Y + G + + A+D WS+G ++ ELL G F + + EI +
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--------- 246
Query: 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR-----CTALEAC 372
+ + P + + M A DL+ RLL P R A E
Sbjct: 247 ------RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290
Query: 373 IHPFFYELRDPNARLPNGRPFPPLFNFKPQ 402
H FF ++ L + P FKP
Sbjct: 291 EHLFFQKINW--DDLAAKKVPAP---FKPV 315
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 3e-40
Identities = 55/293 (18%), Positives = 104/293 (35%), Gaps = 47/293 (16%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 149
+G G FG V+ VA+K + Q + E M+ L H +V L
Sbjct: 15 LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 150 KHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIH 209
++ +Y+ + E++ + + ++ + + QI +A+I
Sbjct: 74 YAVV----TQEPIYI--ITEYMENGSLVDFLK-TPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 210 GGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFG 267
HRD++ N+LV+ K+ DFG A+++ E + APE I
Sbjct: 127 ER-NYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184
Query: 268 ATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYT 326
+T D+WS G +L E++ G+ +PG + + + + +
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------------ 225
Query: 327 EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE--ACIHPFF 377
+ + P E L+ + P R T + + FF
Sbjct: 226 ----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 2e-39
Identities = 56/300 (18%), Positives = 112/300 (37%), Gaps = 37/300 (12%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVVS 148
+ + + +G+G FG V++ K GE VA+K + ++ E+ +L H N++
Sbjct: 4 TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 149 LKHCFFSTTDKDELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
+ + L LV ++ +++ Y+ + M + LA+
Sbjct: 62 F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA-----LSTASGLAH 115
Query: 208 IHGGI-------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----YIC 255
+H I + HRD+K +N+LV + D G A I +
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 256 SRYYRAPELIFGA-----TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310
++ Y APE++ + E DI+++G V E+ + G QL V
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 370
P+ EE++ + +++ + ++ ++ + R TAL
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR 287
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-39
Identities = 65/290 (22%), Positives = 108/290 (37%), Gaps = 47/290 (16%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
E +GQG FG V+ T VAIK + +E Q M+ L H +V L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
++ +Y+ V E++ + + + L + QI +AY+ +
Sbjct: 81 V----SEEPIYI--VTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYVER-M 132
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATE 270
HRD++ N+LV + K+ DFG A+++ E + APE
Sbjct: 133 NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190
Query: 271 YTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329
+T D+WS G +L EL G+ +PG + L ++ + P E
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC----------- 239
Query: 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA--LEACIHPFF 377
P DL+ + + P R T L+A + +F
Sbjct: 240 -----------------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-39
Identities = 48/283 (16%), Positives = 94/283 (33%), Gaps = 43/283 (15%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 153
+ +G G FG+V + VAIK + + + E + M L HP +V L
Sbjct: 11 QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
++ + L V EF+ + + +C +AY+
Sbjct: 70 ---LEQAPICL--VFEFMEHGCLS--DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-C 121
Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATEY 271
V HRD+ +N LV + +K+ DFG + ++ + S + +PE+ + Y
Sbjct: 122 VIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179
Query: 272 TTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 331
++ D+WS G ++ E+ + ++VE I
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216
Query: 332 QIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
+ + +++ + P R
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 2e-38
Identities = 64/309 (20%), Positives = 112/309 (36%), Gaps = 54/309 (17%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGET---VAIKKVL-----QDKRYKNRELQTMRLLDH 143
E+V+G G FG V G+ VAIK + + +R E M DH
Sbjct: 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86
Query: 144 PNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICR 203
PNV+ L+ T + ++ EF+ + + +I + I
Sbjct: 87 PNVIHLEGVV---TKSTPVM--IITEFMENGSLD--SFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 204 ALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------ 257
+ Y+ + HRD+ +N+LVN + K+ DFG ++ L + +Y +
Sbjct: 140 GMKYLA-DMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 258 YYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTRE 316
+ APE I ++T+A D+WS G V+ E++ G+ + + D + I + P
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM 256
Query: 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPF 376
+ P L+ Q N R +
Sbjct: 257 DC----------------------------PSALHQLMLDCWQKDRNHRPKFGQIVNT-L 287
Query: 377 FYELRDPNA 385
+R+PN+
Sbjct: 288 DKMIRNPNS 296
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-38
Identities = 58/299 (19%), Positives = 102/299 (34%), Gaps = 53/299 (17%)
Query: 97 RVVGQGSFGIVFQAKCLET---GETVAIKKVLQDKRYKN-------RELQTMRLLDHPNV 146
+G GSFG+V + + +VA+K + D + RE+ M LDH N+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALA 206
+ L + + +V E P + L + Y Q+ +
Sbjct: 74 IRLYGVVLTP------PMKMVTELAPLGSLL--DRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 207 YIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 263
Y+ HRD+ +NLL+ VK+ DFG + L + + + + +
Sbjct: 126 YLES-KRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
++ A D W G L E+ GQ + G +G L +I K R E
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPE----- 238
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381
P + +++ + + P R T + + F E +
Sbjct: 239 ----------------------DCPQDIYNVMVQCWAHKPEDRPTFVA--LRDFLLEAQ 273
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-38
Identities = 61/314 (19%), Positives = 107/314 (34%), Gaps = 70/314 (22%)
Query: 96 ERVVGQGSFGIVFQAKCLETGET-----VAIKKVLQDKRYKN-----RELQTM-RLLDHP 144
+V+G G+FG V A +T VA+K + + EL+ M +L H
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP--------------------ETVYRVAKHYSR 184
N+V+L T +Y L+ E+ E +
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 185 ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244
+ + + YQ+ + + ++ HRD+ +N+LV VK+CDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRDLAARNVLVTHGKV-VKICDFGLARDI 214
Query: 245 VKGEPNISYICSR---YYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGV 300
+ + +R + APE +F YT D+WS G +L E+ LG +PG
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 301 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQY 360
++I+ N + P E ++ +
Sbjct: 274 ANFYKLIQ---------------NGFKMDQP------------FYATEEIYIIMQSCWAF 306
Query: 361 SPNLRCTALEACIH 374
R +
Sbjct: 307 DSRKRPSFPNLTSF 320
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 9e-38
Identities = 50/284 (17%), Positives = 102/284 (35%), Gaps = 45/284 (15%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 153
+ +G G FG+V K VAIK + + ++ E + M L H +V L
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 154 FSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG 213
T + ++ ++ E++ + + R + +C A+ Y+
Sbjct: 69 ---TKQRPIF--IITEYMANG--CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQ 120
Query: 214 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--YICSRYYRAPELIFGATEY 271
HRD+ +N LVN VK+ DFG ++ ++ E S + PE++ +++
Sbjct: 121 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178
Query: 272 TTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
++ DIW+ G ++ E+ LG+ + + + I + L
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------------RLYR 222
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
P + + ++ + R T +
Sbjct: 223 PHL------------ASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-37
Identities = 67/312 (21%), Positives = 111/312 (35%), Gaps = 53/312 (16%)
Query: 97 RVVGQGSFGIVFQAKCLETGET----VAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
+V+G G+FG V++ + GE VAIK++ + K E M +D+P+V
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
L ++T + L+ + +P + + + Y+ + QI + + Y
Sbjct: 75 RLLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---YYRAPEL 264
+ + HRD+ +N+LV H VK+ DFG AK+L E + + A E
Sbjct: 127 LE-DRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
I YT D+WS G + EL+ G + G EI +L R
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSILEKGERLPQ----- 234
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383
+ ++ + + R E I F RDP
Sbjct: 235 -------------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE-FSKMARDP 274
Query: 384 NARLPNGRPFPP 395
L
Sbjct: 275 QRYLVIQGDERM 286
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (340), Expect = 3e-37
Identities = 53/280 (18%), Positives = 107/280 (38%), Gaps = 41/280 (14%)
Query: 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 152
+ +G G +G V++ + TVA+K + +D +E M+ + HPN+V L
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 153 FFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGI 212
T + Y+ EF+ Q + + + QI A+ Y+
Sbjct: 82 C---TREPPFYIIT--EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEK-K 134
Query: 213 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR--YYRAPELIFGATE 270
HRD+ +N LV + H VK+ DFG ++++ + APE + +
Sbjct: 135 NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192
Query: 271 YTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 330
++ D+W+ G +L E+ + Q+ E+++ +++
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRM 235
Query: 331 PQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 370
+ P + +L+ Q++P+ R + E
Sbjct: 236 E----------RPEGCPEKVYELMRACWQWNPSDRPSFAE 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-37
Identities = 56/302 (18%), Positives = 108/302 (35%), Gaps = 55/302 (18%)
Query: 96 ERVVGQGSFGIVFQAKC--LETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 147
++ +G G+FG V + + +TVA+K + + E M+ LD+P +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
+ + + L V+E Y + ++ + + +Q+ + Y
Sbjct: 72 RMIGIC----EAESWML--VMEMAELGPLN---KYLQQNRHVKDKNIIELVHQVSMGMKY 122
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPE 263
+ HRD+ +N+L+ H K+ DFG +K L E + APE
Sbjct: 123 LEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 264 LIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322
I ++++ D+WS G ++ E GQ + G G + + K
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------- 230
Query: 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA--LEACIHPFFYEL 380
P E DL++ Y R +E + ++Y++
Sbjct: 231 -------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271
Query: 381 RD 382
+
Sbjct: 272 VN 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 8e-37
Identities = 63/297 (21%), Positives = 104/297 (35%), Gaps = 54/297 (18%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE--TVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVS 148
+ +G G+FG V Q + VAIK + Q + RE Q M LD+P +V
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 149 LKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYI 208
L L LV+E + K + +P+ V +Q+ + Y+
Sbjct: 74 LIGVC------QAEALMLVMEMAGGGP--LHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 209 HGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAPEL 264
HRD+ +N+L+ + K+ DFG +K L + + + + APE
Sbjct: 126 EE-KNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183
Query: 265 IFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323
I ++++ D+WS G + E L GQ + G + + I + E
Sbjct: 184 INF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC----- 237
Query: 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI---HPFF 377
PPE L+S Y R L ++
Sbjct: 238 -----------------------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 7e-36
Identities = 54/304 (17%), Positives = 108/304 (35%), Gaps = 57/304 (18%)
Query: 96 ERVVGQGSFGIVFQAKCLE---TGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 147
V+G+G FG V+ L+ A+K + + E M+ HPNV+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAY 207
SL + E +VL ++ R + + + + Q+ + + +
Sbjct: 92 SLLGICL----RSEGSPLVVLPYMKHGDLR--NFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 208 IHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 262
+ HRD+ +N +++ VK+ DFG A+ + E + + + + A
Sbjct: 146 LA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
E + ++TT D+WS G +L EL+ G P +P + D V +++
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 249
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------LEACIHP 375
+ + P +++ + +R + + A
Sbjct: 250 ---------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
Query: 376 FFYE 379
F E
Sbjct: 295 FIGE 298
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-35
Identities = 61/305 (20%), Positives = 106/305 (34%), Gaps = 65/305 (21%)
Query: 96 ERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDKRYKN-----RELQTM-RLLDHP 144
+ +G G+FG V +A + TVA+K + EL+ + L +H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVP---------------ETVYRVAKHYSRASQRM 189
N+V+L T + + E+ +
Sbjct: 88 NIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 190 PLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249
L + ++YQ+ + +A++ HRD+ +N+L+ K+CDFG A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSN 200
Query: 250 NISYICSR---YYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVE 305
+ +R + APE IF YT D+WS G L EL LG +PG + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 306 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLR 365
+IK + + + P E D++ P R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
Query: 366 CTALE 370
T +
Sbjct: 293 PTFKQ 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-34
Identities = 69/293 (23%), Positives = 103/293 (35%), Gaps = 50/293 (17%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGET---VAIKKVLQDKRYKN-----RELQTMRLLDHP 144
R +G+G FG V Q + VAIK +E TMR DHP
Sbjct: 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68
Query: 145 NVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRA 204
++V L E + +++E R + L + LY YQ+ A
Sbjct: 69 HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120
Query: 205 LAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAP 262
LAY+ HRDI +N+LV+ + VKL DFG ++ + + + AP
Sbjct: 121 LAYLES-KRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 263 ELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321
E I +T+A D+W G + E+L+ G F G D + I P
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC--- 234
Query: 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
PP L+++ Y P+ R E
Sbjct: 235 -------------------------PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (318), Expect = 5e-34
Identities = 61/309 (19%), Positives = 103/309 (33%), Gaps = 71/309 (22%)
Query: 97 RVVGQGSFGIVFQAKC-----LETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 146
R +G+G+FG VFQA+ E VA+K + ++ RE M D+PN+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 147 VSLKHCFFSTTDKDELYLNLVLEFVP---------------------ETVYRVAKHYSRA 185
V + L + E++ + A+ S
Sbjct: 79 V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 186 SQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245
+ Q+ +AY+ HRD+ +N LV + VK+ DFG ++ +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDLATRNCLVGENMV-VKIADFGLSRNIY 191
Query: 246 KGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVD 301
+ + + PE IF YTT D+W+ G VL E+ G + G + +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 302 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYS 361
+ + I A P + P E +L+
Sbjct: 251 VIYYVRD----------------------GNILACP------ENCPLELYNLMRLCWSKL 282
Query: 362 PNLRCTALE 370
P R +
Sbjct: 283 PADRPSFCS 291
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-33
Identities = 51/292 (17%), Positives = 95/292 (32%), Gaps = 50/292 (17%)
Query: 92 SYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLD 142
++V+G G FG V++ + VAIK + K E M
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 143 HPNVVSLKHCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQIC 202
H N++ L+ + ++ E++ K ++ + I
Sbjct: 68 HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120
Query: 203 RALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC----SRY 258
+ Y+ + HRD+ +N+LVN + K+ DFG ++VL
Sbjct: 121 AGMKYLA-NMNYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 259 YRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318
+ APE I ++T+A D+WS G V+ E++ E ++++ I
Sbjct: 179 WTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227
Query: 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 370
+ P L+ + Q R +
Sbjct: 228 -----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-33
Identities = 56/300 (18%), Positives = 105/300 (35%), Gaps = 56/300 (18%)
Query: 96 ERVVGQGSFGIVFQAKCLETGE--TVAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 147
+ V+G+G+FG V +A+ + G AIK++ D R EL+ + +L HPN++
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 148 SLKHCFFSTTDKDELYLNLVLEFVP-------------ETVYRVAKHYSRASQRMPLIYV 194
+L YL L +E+ P + + + +
Sbjct: 75 NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 195 KLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 254
+ + R + Y+ HRD+ +N+LV + + K+ DFG ++
Sbjct: 130 LHFAADVARGMDYLSQ-KQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGR 187
Query: 255 CSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPT 314
+ A E + + YTT D+WS G +L E++ +L E +
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374
+ P E DL+ + + P R + + +
Sbjct: 241 ---------QGYRLEKP------------LNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 4e-32
Identities = 62/310 (20%), Positives = 108/310 (34%), Gaps = 62/310 (20%)
Query: 93 YMAERVVGQGSFGIVFQAKC-----LETGETVAIKKVLQD------KRYKNRELQTMRLL 141
+ +G+G+FG V +A T TVA+K + + + + + +
Sbjct: 15 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74
Query: 142 DHPNVVSLKHCFFSTTDKDELYLNLVLEFVP-------------ETVYRVAKHYSRASQR 188
H NVV+L L +++EF E V
Sbjct: 75 HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 189 MPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248
+ L ++ Y++Q+ + + ++ HRD+ +N+L++ VK+CDFG A+ + K
Sbjct: 131 LTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDP 188
Query: 249 PNI---SYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLV 304
+ + APE IF YT D+WS G +L E+ +PG ++
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 305 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNL 364
+K T + P PE + P+
Sbjct: 248 RRLK---------------EGTRMRAPDY------------TTPEMYQTMLDCWHGEPSQ 280
Query: 365 RCTALEACIH 374
R T E H
Sbjct: 281 RPTFSELVEH 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-31
Identities = 60/309 (19%), Positives = 112/309 (36%), Gaps = 66/309 (21%)
Query: 93 YMAERVVGQGSFGIVFQAKCLETGE-------TVAIKKVLQDKRYKN-----RELQTM-R 139
+ + +G+G+FG V A+ + + VA+K + D K+ E++ M
Sbjct: 15 LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74
Query: 140 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEFV-------------PETVYRVAKHYSRAS 186
+ H N+++L T LY+ ++E+ P +
Sbjct: 75 IGKHKNIINLLGAC---TQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 187 QRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246
+++ + YQ+ R + Y+ HRD+ +N+LV K+ DFG A+ +
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187
Query: 247 GEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQ 302
+ + + APE +F YT D+WS G +L E+ LG +PG V++
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEE 245
Query: 303 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSP 362
L +++K P E ++ P
Sbjct: 246 LFKLLK---------------EGHRMDKP------------SNCTNELYMMMRDCWHAVP 278
Query: 363 NLRCTALEA 371
+ R T +
Sbjct: 279 SQRPTFKQL 287
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-29
Identities = 59/312 (18%), Positives = 109/312 (34%), Gaps = 63/312 (20%)
Query: 96 ERVVGQGSFGIVFQAKC-----LETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 145
R +GQGSFG+V++ E VAIK V ++++ E M+ + +
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84
Query: 146 VVSLKHCFFSTTDKDELYLNLVLEFVPE-------TVYRVAKHYSRASQRMPLIYVKLYT 198
VV + + ++E + R A + L +
Sbjct: 85 VV---RLLGVVSQGQPTLV--IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 199 YQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--- 255
+I +AY++ HRD+ +N +V VK+ DFG + + + +
Sbjct: 140 GEIADGMAYLNA-NKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 256 SRYYRAPELIFGATEYTTAIDIWSVGCVLAELL-LGQPLFPGESGVDQLVEIIKVLGTPT 314
+ +PE + +TT D+WS G VL E+ L + + G S L +++
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250
Query: 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTA------ 368
P +L+ QY+P +R +
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
Query: 369 LEACIHPFFYEL 380
++ + P F E+
Sbjct: 289 IKEEMEPGFREV 300
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.9 bits (204), Expect = 3e-19
Identities = 29/205 (14%), Positives = 58/205 (28%), Gaps = 34/205 (16%)
Query: 97 RVVGQGSFGIVFQAKCLETGETVAIKKV--------------LQDKRYKNRELQTMRLLD 142
+++G+G VF E +K + + +
Sbjct: 6 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 143 HPNVVSLKHCFFSTT-DKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQI 201
+ L+ + + ++E ++ R+ + I
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAV--LMEL----------IDAKELYRVRVENPDEVLDMI 112
Query: 202 CRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 261
+A + + H D+ N+LV + + DF + + GE I R R
Sbjct: 113 LEEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRN 167
Query: 262 PELIFGATEYTTAIDIWSVGCVLAE 286
F Y T DI S + +
Sbjct: 168 IITYFS-RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 429 | |||
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.24 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.75 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.72 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.76 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.41 |
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-64 Score=484.92 Aligned_cols=326 Identities=71% Similarity=1.219 Sum_probs=291.1
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceEeeecCC-CCceEEEEEEe
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELYLNLVLE 169 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~e 169 (429)
.+|+.+++||+|+||+||+|++..+|+.||||++..+.....+|+++|+.++||||++++++|..... .+..++++|||
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E 99 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence 36999999999999999999999999999999998887777899999999999999999999876543 45678899999
Q ss_pred ccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCCC
Q 014174 170 FVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 249 (429)
Q Consensus 170 ~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~~ 249 (429)
||++++...+..+......+++..++.++.||+.||+||| ++||+||||||+|||++.++..+||+|||+++.......
T Consensus 100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH-~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~ 178 (350)
T d1q5ka_ 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 178 (350)
T ss_dssp CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH-hcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence 9999888887777777788999999999999999999999 899999999999999998876799999999998877666
Q ss_pred cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCccccc
Q 014174 250 NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 329 (429)
Q Consensus 250 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 329 (429)
.....||+.|+|||.+.+...++.++||||+||++|+|++|+.||.+.+..+.+..+.+.+|.+..+.+......+....
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~ 258 (350)
T d1q5ka_ 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258 (350)
T ss_dssp CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence 67788999999999988777799999999999999999999999999999999999999999999999999888888888
Q ss_pred CCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCChhhhccCCH
Q 014174 330 FPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFKPQELKGASK 409 (429)
Q Consensus 330 ~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (429)
++......+.......+++++.+||++||.+||++|||+.|+|+||||.+++++....++.+..+...+++.+|+....
T Consensus 259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~- 337 (350)
T d1q5ka_ 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNP- 337 (350)
T ss_dssp CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTTSCCCCCCCCCCHHHHTTCG-
T ss_pred ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCCCCCCCccCCCCHhhccCCc-
Confidence 8888888888888888999999999999999999999999999999999999999888999988999999988876543
Q ss_pred HHHHhhcHH
Q 014174 410 ELLSKLIPE 418 (429)
Q Consensus 410 ~~~~~~~~~ 418 (429)
++...++|+
T Consensus 338 ~~~~~~~p~ 346 (350)
T d1q5ka_ 338 PLATILIPP 346 (350)
T ss_dssp GGHHHHSCT
T ss_pred cccccCCCc
Confidence 445555554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-59 Score=432.04 Aligned_cols=248 Identities=31% Similarity=0.492 Sum_probs=211.7
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+. .....+|+++++.++|||||++++++. +..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECC
Confidence 45799999999999999999999999999999998642 233457999999999999999999984 444
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++|||||++ +|.+.+.. ...+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH-~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a 153 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCH-SKRVIHRDIKPENLLLGSAG-ELKIADFGWS 153 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEECCCCSC
T ss_pred EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH-HCCeeeeeeccccceecCCC-CEeeccccee
Confidence 58899999985 55555543 467999999999999999999999 88999999999999999888 7999999999
Q ss_pred eecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
+..... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.
T Consensus 154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------ 219 (263)
T d2j4za1 154 VHAPSS-RRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 219 (263)
T ss_dssp SCCCCC-CCEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred eecCCC-cccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence 865443 34467899999999999774 4899999999999999999999999988877766655431
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.+ .++..+|+++++||.+||+.||++|||+.|+|+||||.+
T Consensus 220 -----~~------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 -----EF------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----CC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----CC------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 01 123457999999999999999999999999999999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=434.60 Aligned_cols=253 Identities=26% Similarity=0.341 Sum_probs=208.1
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.++|++++.||+|+||+||+|+++.+|+.||||++... ...+.+|+++++.++|||||++++++.. ...+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ccee
Confidence 45799999999999999999999999999999998643 2345689999999999999999999854 3358
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++|||||++ +|.+.+ .....+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+.
T Consensus 79 ~ivmEy~~gg~L~~~l----~~~~~l~e~~~~~i~~qi~~al~ylH-~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~ 152 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLH-GIGITHRDIKPENLLLDERD-NLKISDFGLATV 152 (271)
T ss_dssp EEEEECCTTEEGGGGS----BTTTBCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred EEEEeccCCCcHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCccCcccHHHEEECCCC-CEEEccchhhee
Confidence 899999985 554433 34567999999999999999999999 88999999999999999888 799999999987
Q ss_pred cccCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 244 LVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 244 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
..... .....+||+.|||||++.+...++.++|||||||++|+|+||++||...+...............
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~------- 225 (271)
T d1nvra_ 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------- 225 (271)
T ss_dssp CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-------
T ss_pred eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Confidence 64432 23456899999999999876656788999999999999999999998765443333322211000
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
. .....+|+++.+||++||+.||++|||+.|+|+||||++
T Consensus 226 --------------~-----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 --------------L-----NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp --------------S-----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred --------------C-----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0 011347999999999999999999999999999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-59 Score=438.79 Aligned_cols=278 Identities=34% Similarity=0.579 Sum_probs=227.7
Q ss_pred EeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 95 AERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 95 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.+++||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++|||||++++++. ...+++
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-----~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----HKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-----cCCcee
Confidence 4679999999999999999999999999885331 23558999999999999999999984 334488
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+||||+.++++..+. .....+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 77 ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH-~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~ 151 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH-QHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFG 151 (299)
T ss_dssp EEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred ehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhh-ccceecccCCcceEEecCCC-ccccccCccccccC
Confidence 999999987655443 34567999999999999999999999 89999999999999999888 79999999998765
Q ss_pred cCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
... .....+||+.|+|||++.+...++.++|||||||++|+|+||.+||.+.+..+.+.++.+..|.|..+.+......
T Consensus 152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence 433 3345678999999999977677899999999999999999999999999999999999999999887665433322
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
.....+......++.. +.+.+++++++||++||++||++|||+.|+|+||||++...|
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p 289 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 289 (299)
T ss_dssp TTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred chhhhhccCCCCChHH-hcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence 2222222222222222 234579999999999999999999999999999999875544
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-59 Score=435.71 Aligned_cols=249 Identities=27% Similarity=0.395 Sum_probs=211.2
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
+|++.+.||+|+||+||+|++..+|+.||||++... .....+|+++++.++|||||+++++|... .++++|
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~iv 95 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWVV 95 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEEE
Confidence 699999999999999999999999999999998643 23456899999999999999999998543 358899
Q ss_pred Eeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
||||+++ |..++. ...+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 96 mEy~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH-~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 96 MEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH-SNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP 168 (293)
T ss_dssp EECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCS
T ss_pred EEecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCcHHHeEECCCC-cEeeccchhheeecc
Confidence 9999864 444332 257999999999999999999999 88999999999999999888 799999999987654
Q ss_pred CC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcCc
Q 014174 247 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPNY 325 (429)
Q Consensus 247 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 325 (429)
.. .....+||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+.... .+.
T Consensus 169 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~-~~~----------- 235 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPE----------- 235 (293)
T ss_dssp TTCCBCCCCSCGGGCCHHHHSSS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC-SCC-----------
T ss_pred ccccccccccCCCccChhhhcCC-CCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCC-----------
Confidence 33 34566799999999999764 48999999999999999999999999888777776665431 110
Q ss_pred ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 326 TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
...+..+|+++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 236 --------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 236 --------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp --------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred --------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 0122357999999999999999999999999999999964
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-59 Score=433.38 Aligned_cols=255 Identities=32% Similarity=0.531 Sum_probs=213.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
++|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|+++++.++|||||+++++|. +...
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECCE
Confidence 4799999999999999999999999999999998643 134568999999999999999999983 4455
Q ss_pred EEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
+|+|||||++ +|.+.+.. .+.+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|+
T Consensus 83 ~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH-~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~ 156 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLH-GKGIIHRDLKPENILLNEDM-HIQITDFGTAK 156 (288)
T ss_dssp EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred EEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhc-cccEEcCcCCccccccCCCc-eEEecccccce
Confidence 8999999985 55555443 467999999999999999999999 88999999999999999888 69999999998
Q ss_pred ecccCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 243 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 243 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
...... .....+||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+.++.+.
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~---------- 225 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 225 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT----------
T ss_pred ecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC----------
Confidence 764332 23456799999999999775 4899999999999999999999999988877776665431
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHH------HhcCCCCcccCCCCCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE------ACIHPFFYELRDPNAR 386 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~e------ll~hp~f~~~~~~~~~ 386 (429)
.+ .++..+++++++||++||+.||++|||+.| +++||||..+.+....
T Consensus 226 -------~~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~ 279 (288)
T d1uu3a_ 226 -------EY------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 279 (288)
T ss_dssp -------CC------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred -------CC------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhh
Confidence 01 123458999999999999999999999987 6899999998765433
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-58 Score=431.90 Aligned_cols=283 Identities=35% Similarity=0.634 Sum_probs=231.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
++|++++.||+|+||+||+|++..+|+.||||++... .....+|+++++.++|||||+++++|... ..+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cce
Confidence 4799999999999999999999999999999998543 23445899999999999999999999543 348
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
|+||||++++++..+.. .....+++..++.++.||+.||+||| ++|||||||||+|||++.++ .+||+|||+|+..
T Consensus 77 ~iv~e~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH-~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF 152 (298)
T ss_dssp EEEEECCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHH
T ss_pred eEEEeecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhh-cCCEEccccCchheeecccC-cceeccCCcceec
Confidence 99999999887776543 33567999999999999999999999 88999999999999999888 7999999999876
Q ss_pred ccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... .......||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+....+.....
T Consensus 153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 543 2344567899999999987777679999999999999999999999999999999999999888877654432211
Q ss_pred Ccc-cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 324 NYT-EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 324 ~~~-~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
... ....+......+.. ....+++++.+||++||.+||++|||+.|+|+||||+++..|
T Consensus 233 ~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp STTCCTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 100 01111211222111 234688999999999999999999999999999999988765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-58 Score=426.86 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=202.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
++|++++.||+|+||+||+|+++.+|+.||+|.+.... ..+.+|+++++.++|||||++++++... ....+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCEE
Confidence 57999999999999999999999999999999985432 2345799999999999999999988542 22347
Q ss_pred EEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC-----eeeecCCCCceEecCCCCcEEEeec
Q 014174 165 NLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG-----VCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 165 ~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g-----ivH~DLkp~Nill~~~~~~vkl~Df 238 (429)
++|||||+ ++|.+++.........+++..++.++.||+.||.||| +.| |+||||||+||||+.++ .+||+||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH-~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DF 158 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH-RRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF 158 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH-HHCC---------CCGGGEEECTTS-CEEECCH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH-HhcCCCCCEEeCcCchhhcCcCCCC-cEEEeec
Confidence 89999998 5777777665556678999999999999999999999 555 99999999999999888 7999999
Q ss_pred ccceecccCC-CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 239 GSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 239 G~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
|+|+...... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+....+....
T Consensus 159 G~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~------- 230 (269)
T d2java1 159 GLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK------- 230 (269)
T ss_dssp HHHHHC-----------CCCSCCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-------
T ss_pred cceeecccCCCccccCCCCcccCCHHHHcCC-CCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC-------
Confidence 9998765433 23457889999999999664 48999999999999999999999999888776666654420
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFF 377 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f 377 (429)
.+ .++..+|+++.+||++||+.||++|||+.|+|+|||+
T Consensus 231 ------------~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 231 ------------FR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp ------------CC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------------CC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 00 1234579999999999999999999999999999996
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-57 Score=429.06 Aligned_cols=286 Identities=34% Similarity=0.542 Sum_probs=235.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCC-CcEEEEEEeecc------hhhhHHHHHHHHHc---CCCCeeecceEeeecCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLET-GETVAIKKVLQD------KRYKNRELQTMRLL---DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~------~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~ 159 (429)
.++|++++.||+|+||+||+|++..+ ++.||||++... .....+|+.+++.| +||||++++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 45799999999999999999999765 677999998542 22345788887766 799999999998766656
Q ss_pred CceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 160 DELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 160 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
...+++++|||++++++..... .....+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH-~~~ivHrDiKp~NILi~~~~-~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLH-SHRVVHRDLKPQNILVTSSG-QIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHH-hCCEEecCCCccEEEEcCCC-Ceeecchh
Confidence 6778999999999877665443 34567999999999999999999999 88999999999999999888 79999999
Q ss_pred cceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 014174 240 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 319 (429)
Q Consensus 240 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 319 (429)
+++............||+.|+|||++.+. .|+.++||||+||++|+|++|++||.+.+..+.+..+.+..+.+....+.
T Consensus 162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~-~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 162 LARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp SCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhhcccccCCCcccChhhcCcchhcCC-CCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 99877666566678899999999999764 49999999999999999999999999999999999999999998876554
Q ss_pred hcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 320 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
....... ..+...... ....+...+++.+.+||++||++||++|||+.|+|+||||+++..
T Consensus 241 ~~~~~~~-~~~~~~~~~-~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 241 RDVALPR-QAFHSKSAQ-PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp TTCSSCG-GGSCCCCCC-CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccchh-hhhcccccc-chhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 3211111 111111111 122345678999999999999999999999999999999998764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6e-58 Score=439.13 Aligned_cols=259 Identities=26% Similarity=0.394 Sum_probs=219.3
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.++|++++.||+|+||+||+|++..+|+.||||++.... ..+.+|+++|+.++|||||++++++.. ...++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence 457999999999999999999999999999999986542 344689999999999999999999854 34588
Q ss_pred EEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC--CCCcEEEeecccce
Q 014174 166 LVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAK 242 (429)
Q Consensus 166 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~--~~~~vkl~DfG~a~ 242 (429)
+|||||++ +|.+.+. ...+.+++..++.++.||+.||.||| ++|||||||||+|||++. ++ .+||+|||+|+
T Consensus 100 ivmE~~~gg~L~~~l~---~~~~~l~e~~~~~i~~qi~~aL~ylH-~~~iiHrDiKp~NIll~~~~~~-~vkL~DFG~a~ 174 (350)
T d1koaa2 100 MIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTA 174 (350)
T ss_dssp EEECCCCSCBHHHHHT---CTTSCBCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSTTSC-CEEECCCTTCE
T ss_pred EEEEcCCCCCHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHH-hcCCeeeeechhHeeeccCCCC-eEEEeecchhe
Confidence 99999985 5555442 23467999999999999999999999 889999999999999964 34 79999999999
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
............||+.|||||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.........
T Consensus 175 ~~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~------- 246 (350)
T d1koaa2 175 HLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD------- 246 (350)
T ss_dssp ECCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCC-------
T ss_pred ecccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-------
Confidence 87766666678899999999999775 4899999999999999999999999998888887777653221111
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPN 384 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~ 384 (429)
.....+|+++++||++||++||++|||+.|+|+||||.....+.
T Consensus 247 ------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~~ 290 (350)
T d1koaa2 247 ------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 290 (350)
T ss_dssp ------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCCS
T ss_pred ------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCCC
Confidence 11234799999999999999999999999999999998876653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-58 Score=432.20 Aligned_cols=252 Identities=26% Similarity=0.419 Sum_probs=198.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
+.|++.+.||+|+||+||+|+++.+|+.||||++.... ....+|+++++.++|||||++++++ .+..+++
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~~ 83 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHLY 83 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence 45999999999999999999999999999999986432 2345799999999999999999998 4445689
Q ss_pred EEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecC---CCCcEEEeecccc
Q 014174 166 LVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSA 241 (429)
Q Consensus 166 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~---~~~~vkl~DfG~a 241 (429)
+|||||+ ++|.+.+.. .+.+++..++.++.||+.||.||| ++||+||||||+|||+.. ++ .+||+|||+|
T Consensus 84 lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH-~~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a 157 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLH-DLGIVHRDLKPENLLYYSLDEDS-KIMISDFGLS 157 (307)
T ss_dssp EEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEESSSSTTC-CEEECCC---
T ss_pred EEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhh-hceeeeEEecccceeecccCCCc-eEEEecccee
Confidence 9999998 566666543 567999999999999999999999 889999999999999953 45 7999999999
Q ss_pred eecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
+...........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.+....+
T Consensus 158 ~~~~~~~~~~~~~GT~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-------- 228 (307)
T d1a06a_ 158 KMEDPGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF-------- 228 (307)
T ss_dssp ---------------CTTSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC--------
T ss_pred EEccCCCeeeeeeeCccccCcHHHcCC-CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC--------
Confidence 877666666677899999999999764 48999999999999999999999999888777666655421110
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
.......+|+++++||.+||++||++|||+.|+|+||||..
T Consensus 229 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 229 -----------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp -----------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred -----------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 11123458999999999999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-58 Score=428.66 Aligned_cols=252 Identities=26% Similarity=0.376 Sum_probs=209.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.|++++.||+|+||+||+|++..+|+.||||++... .....+|+++++.++|||||++++++... ..+++|
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~lv 87 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWIL 87 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEEEE
Confidence 599999999999999999999999999999998643 24456899999999999999999998543 348899
Q ss_pred Eeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
||||+++ |..++.. ..+.+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+|+....
T Consensus 88 mEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH-~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 88 IEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLH-DNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTR 162 (288)
T ss_dssp EECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHH
T ss_pred EecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH-HCCEEEeecChhheeECCCC-CEEEEechhhhccCC
Confidence 9999864 4443332 3467999999999999999999999 88999999999999999888 799999999976543
Q ss_pred CC-CcccccccccccccccccC----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 247 GE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 247 ~~-~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
.. ......||+.|+|||++.. ...|+.++|||||||++|+|+||+.||.+.+..+.+.++.... +
T Consensus 163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~-------- 232 (288)
T d2jfla1 163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE--P-------- 232 (288)
T ss_dssp HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--C--------
T ss_pred CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--C--------
Confidence 22 2235678999999999842 3457899999999999999999999999988877776665521 0
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
+. ...+..+|+++++||++||+.||++|||+.|+|+||||..
T Consensus 233 ---------~~-------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 233 ---------PT-------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ---------CC-------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ---------CC-------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 00 0112357999999999999999999999999999999963
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-57 Score=432.61 Aligned_cols=252 Identities=26% Similarity=0.418 Sum_probs=215.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+|+.++||||++++++| .+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence 45799999999999999999999999999999998643 23345799999999999999999999 4455
Q ss_pred EEEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
++|+|||||+++ |...+. ..+.+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|
T Consensus 79 ~~~iv~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH-~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a 152 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDKDG-HIKITDFGLC 152 (337)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred ccccceeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhh-hcCccccccCHHHeEecCCC-CEEEeecccc
Confidence 689999999964 444433 3567999999999999999999999 88999999999999999988 6999999999
Q ss_pred eeccc-CCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 242 KVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 242 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+.... .......+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.+.+..+....+...
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~----------- 220 (337)
T d1o6la_ 153 KEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME----------- 220 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC-----------
Confidence 87644 3344567899999999999775 4899999999999999999999999998877766665541
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRD 382 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~ 382 (429)
.+ .++..+|+++++||++||++||.+|+ ++.++++||||.++.+
T Consensus 221 ------~~------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 221 ------EI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp ------CC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred ------CC------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCH
Confidence 11 13346899999999999999999999 4999999999987643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-57 Score=419.25 Aligned_cols=250 Identities=23% Similarity=0.347 Sum_probs=205.0
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
|++.++||+|+||+||+|++..++..||+|.+.... ..+.+|+++++.++|||||++++++.... .+...+++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence 478889999999999999999999999999986432 33468999999999999999999886543 33456889
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCC--eeeecCCCCceEecC-CCCcEEEeecccce
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIG--VCHRDIKPQNLLVNP-HTHQVKLCDFGSAK 242 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~g--ivH~DLkp~Nill~~-~~~~vkl~DfG~a~ 242 (429)
|||||++ +|.+.+.. ...+++..++.++.||+.||+||| ++| |+||||||+||||+. ++ .+||+|||+|+
T Consensus 90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH-~~~~~IiHrDiKp~NILl~~~~~-~~Kl~DFGla~ 163 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT 163 (270)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-TSSSCCCCSCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHH-HCCCCEEeCCcChhhceeeCCCC-CEEEeecCcce
Confidence 9999986 55555443 467999999999999999999999 777 999999999999975 55 79999999997
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
... .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+.+.+.. +.++
T Consensus 164 ~~~-~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~-------- 231 (270)
T d1t4ha_ 164 LKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP-------- 231 (270)
T ss_dssp GCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC--------
T ss_pred ecc-CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCC--------
Confidence 543 333456789999999999864 4899999999999999999999999876655554433321 1000
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~ 378 (429)
..++...++++.+||.+||+.||++|||+.|+|+||||+
T Consensus 232 -----------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 -----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -----------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -----------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 112335789999999999999999999999999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-57 Score=437.69 Aligned_cols=254 Identities=27% Similarity=0.389 Sum_probs=216.1
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
++|++++.||+|+||+||+|++..+|+.||||++.... ..+.+|+++|+.++|||||+++++|. ....+++
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence 46999999999999999999999999999999986542 34457999999999999999999984 4455889
Q ss_pred EEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec--CCCCcEEEeeccccee
Q 014174 167 VLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN--PHTHQVKLCDFGSAKV 243 (429)
Q Consensus 167 v~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~--~~~~~vkl~DfG~a~~ 243 (429)
|||||+++ |.+.+ .....++++.+++.++.||+.||.||| ++||+||||||+||||+ .++ .+||+|||+|+.
T Consensus 104 vmE~~~gg~L~~~~---~~~~~~l~e~~~~~i~~qi~~aL~ylH-~~~iiHRDiKp~NILl~~~~~~-~vkL~DFGla~~ 178 (352)
T d1koba_ 104 ILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATK 178 (352)
T ss_dssp EEECCCCCBHHHHT---TCTTCCBCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSTTCC-CEEECCCTTCEE
T ss_pred EEEcCCCChHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCeeecccccccccccccCCC-eEEEeeccccee
Confidence 99999864 43332 333457999999999999999999999 89999999999999997 345 799999999998
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
...........||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+......+.
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~--------- 248 (352)
T d1koba_ 179 LNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD--------- 248 (352)
T ss_dssp CCTTSCEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred cCCCCceeeccCcccccCHHHHcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence 8776666678899999999999764 589999999999999999999999999888888777765321111
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
......+|+++.+||++||++||.+|||+.|+|+||||+..
T Consensus 249 ----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 249 ----------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ----------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11224589999999999999999999999999999999764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-57 Score=424.42 Aligned_cols=257 Identities=23% Similarity=0.375 Sum_probs=216.7
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----------hhhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
.++|++++.||+|+||+||+|+++.+|+.||||++.+. ...+.+|+.+|+.++|||||+++++|.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~----- 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----- 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence 34699999999999999999999999999999998542 234568999999999999999999984
Q ss_pred CceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC---cEEE
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH---QVKL 235 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~---~vkl 235 (429)
+...+++|||||++ +|.+.+.. .+.+++..++.++.||+.||+||| +.||+||||||+|||++.++. .+||
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH-~~~ivHrDiKp~Nill~~~~~~~~~vkl 158 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKI 158 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred ECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhh-hcceeecccccceEEEecCCCcccceEe
Confidence 44568999999985 66665543 367999999999999999999999 889999999999999987653 4999
Q ss_pred eecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 236 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
+|||+|+............||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.+..+........
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~- 236 (293)
T d1jksa_ 159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE- 236 (293)
T ss_dssp CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC-
T ss_pred cchhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-
Confidence 999999987766666677899999999999764 589999999999999999999999999888777776655321111
Q ss_pred HHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 316 EEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
..++..+|+++++||++||+.||++|||+.|+|+||||+...+
T Consensus 237 ------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 237 ------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp ------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred ------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence 1123457999999999999999999999999999999986543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-57 Score=428.22 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=210.1
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.|++++.||+|+||+||+|++..+|+.||||++.... ..+.+|+++++.++|||||++++++... ..+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CEE
Confidence 5999999999999999999999999999999986432 2345799999999999999999998543 348
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++|||||.++++..... ....+++..++.++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+|+..
T Consensus 91 ~iv~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH-~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH-SHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIM 165 (309)
T ss_dssp EEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSS
T ss_pred EEEEEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHH-hCCEeccCCCcceEEECCCC-CEEEeeccccccc
Confidence 89999999876654332 3467999999999999999999999 88999999999999999888 7999999999865
Q ss_pred ccCCCcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 245 VKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
.. .....||+.|||||++.+. ..|+.++|||||||++|+|++|..||.+.+..+.+..+.....
T Consensus 166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~----------- 231 (309)
T d1u5ra_ 166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES----------- 231 (309)
T ss_dssp SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-----------
T ss_pred CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC-----------
Confidence 33 3456899999999998642 3488999999999999999999999998887777766654210
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
+. ..+..+|+++.+||.+||+.||.+|||+.|+|+||||..
T Consensus 232 --------~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 232 --------PA--------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp --------CC--------CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred --------CC--------CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 00 112347999999999999999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=430.28 Aligned_cols=319 Identities=31% Similarity=0.538 Sum_probs=244.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC-CCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 162 (429)
..+|++++.||+|+||+||+|.+..+|+.||||++.... ....+|+++|+.++|||||+++++|..... ....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 347999999999999999999999999999999986432 234579999999999999999999865432 2334
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
.+|+||||++.++..+... ..+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+|+
T Consensus 97 ~~~lv~e~~~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH-~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDC-ELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred eEEEEEecccccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHH-hCCCcccccCcchhhccccc-cccccccccee
Confidence 5789999998777666543 67999999999999999999999 88999999999999999888 79999999998
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
.... ......||+.|+|||++.+...++.++||||+||++|+|++|++||.+.+....+..+....+.++.+.+....
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 170 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 7643 34567899999999999877778999999999999999999999999999999999999999999887765443
Q ss_pred cCccc---ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCC
Q 014174 323 PNYTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNF 399 (429)
Q Consensus 323 ~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~ 399 (429)
..... ...+......+.. ....+++++.+||++||.+||.+|||+.|+|+||||+.+.++... +..+ -++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~-~~~~----~~~~ 321 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDE-PQVQ----KYDD 321 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-------CCC----CCCC
T ss_pred chhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCcccc-ccCC----CCCC
Confidence 21111 1223333333332 234689999999999999999999999999999999998866443 2212 1223
Q ss_pred ChhhhccCCHHHHHhhcHHHHhhhC
Q 014174 400 KPQELKGASKELLSKLIPEHARKQC 424 (429)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (429)
+..+. ....+.+++++.+++.+--
T Consensus 322 ~~~~~-~~~~~e~k~~~~~e~~~~~ 345 (346)
T d1cm8a_ 322 SFDDV-DRTLDEWKRVTYKEVLSFK 345 (346)
T ss_dssp C------CCHHHHHHHHHHHHHTCC
T ss_pred chhhh-hcCHHHHHHHHHHHhhcCC
Confidence 22222 3456778888887776543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-57 Score=427.52 Aligned_cols=252 Identities=26% Similarity=0.437 Sum_probs=214.8
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
..+|++++.||+|+||+||+|+++.+|+.||||++.+. .....+|+.+++.++|||||++++++. ...
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSS
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCC
Confidence 35799999999999999999999999999999998643 234568999999999999999999984 444
Q ss_pred EEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 163 YLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 163 ~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
++++|||||.++.+..+ ......+++..++.++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+|+
T Consensus 78 ~~~ivmE~~~gg~l~~~---~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~ 152 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSL---LRKSQRFPNPVAKFYAAEVCLALEYLH-SKDIIYRDLKPENILLDKNG-HIKITDFGFAK 152 (316)
T ss_dssp EEEEEECCCCSCBHHHH---HHHTSSCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECTTS-CEEECCCSSCE
T ss_pred eeeeEeeecCCcccccc---ccccccccccHHHHHHHHHHHhhhhhc-cCcEEccccCchheeEcCCC-CEEEecCccce
Confidence 68999999987543322 233577899999999999999999999 89999999999999999888 79999999998
Q ss_pred ecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 243 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 243 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
.... .....+||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+.++....
T Consensus 153 ~~~~--~~~~~~Gt~~Y~APE~l~~~-~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------ 217 (316)
T d1fota_ 153 YVPD--VTYTLCGTPDYIAPEVVSTK-PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------ 217 (316)
T ss_dssp ECSS--CBCCCCSCTTTCCHHHHTTC-CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC------------
T ss_pred Eecc--ccccccCcccccCHHHHcCC-CCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC------------
Confidence 7643 33467899999999999764 48999999999999999999999999988877777766521
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCCC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRDP 383 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~~ 383 (429)
. .++..+++++.+||++||..||.+|+ |++++++||||+++.+.
T Consensus 218 -----~------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 218 -----L------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp -----C------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred -----C------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 0 12345899999999999999999996 99999999999987553
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-58 Score=434.93 Aligned_cols=280 Identities=25% Similarity=0.419 Sum_probs=206.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
.++|++++.||+|+||+||+|++..+|+.||+|++..+ .....+|+.+|+.++|||||+++++|. ....+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence 45799999999999999999999999999999998643 233458999999999999999999994 33458
Q ss_pred EEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 165 NLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 165 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
++|||||.+ +|..++.. .+.+++..++.++.||+.||.|||+++||+||||||+||||+.++ .+||+|||+|+.
T Consensus 80 ~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~ 154 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ 154 (322)
T ss_dssp EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccc
Confidence 899999995 55555543 467999999999999999999999335999999999999999888 799999999987
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHHHHhhcC
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQ-LVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~~ 322 (429)
.... ...+.+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||.+.+..+. ...+....+.+.........
T Consensus 155 ~~~~-~~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 155 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HHHH-TC---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred cCCC-ccccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 6443 23467899999999999875 499999999999999999999999987664432 22222222221111000000
Q ss_pred c--Ccccc---cCCC---------cCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 323 P--NYTEF---KFPQ---------IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 323 ~--~~~~~---~~~~---------~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
. ..... ..+. +............+|.++++||.+||++||.+|||+.|+|+||||++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 0 00000 0000 0000000111123689999999999999999999999999999997644
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.7e-56 Score=414.38 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=215.8
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------------hhhHHHHHHHHHcC-CCCeeecceEeeec
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------------RYKNRELQTMRLLD-HPNVVSLKHCFFST 156 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 156 (429)
++|++.+.||+|+||+||+|++..+|+.||||++.+.. ....+|+.+++.++ ||||+++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 47999999999999999999999999999999986432 13457999999997 99999999998
Q ss_pred CCCCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEE
Q 014174 157 TDKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKL 235 (429)
Q Consensus 157 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl 235 (429)
.+..++|||||||++ +|.+.+.. .+.+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH-~~~ivHrDlkp~Nill~~~~-~~kl 151 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENILLDDDM-NIKL 151 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTC-CEEE
T ss_pred --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-HcCCcccccccceEEEcCCC-CeEE
Confidence 444568999999974 77666643 467999999999999999999999 88999999999999999888 7999
Q ss_pred eecccceecccCCCcccccccccccccccccC-----CCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Q 014174 236 CDFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVL 310 (429)
Q Consensus 236 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~ 310 (429)
+|||+|+............||+.|+|||.+.+ ...++.++||||+||++|+|++|+.||.+.+.......+....
T Consensus 152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~ 231 (277)
T d1phka_ 152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN 231 (277)
T ss_dssp CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence 99999998776666667789999999999853 3347889999999999999999999999988877776666531
Q ss_pred CCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCccc
Q 014174 311 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYEL 380 (429)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~ 380 (429)
..+. .....++|+++++||.+||+.||++|||+.|+|+||||++.
T Consensus 232 ~~~~-------------------------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 232 YQFG-------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp CCCC-------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCCC-------------------------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 1110 01123489999999999999999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=423.93 Aligned_cols=323 Identities=33% Similarity=0.585 Sum_probs=250.0
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
.+|++++.||+|+||+||+|++..+|+.||||++.... ....+|+.+|+.++||||+++++++.........+++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 47999999999999999999999999999999986432 2345799999999999999999998765555555677
Q ss_pred EEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 166 LVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 166 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
+++++++++|.+++.. ..+++..++.++.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+...
T Consensus 88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH-~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHH-HCCCcCCCCCcceEEECCCC-CEEEcccCceeecc
Confidence 8888888888887753 57999999999999999999999 88999999999999999888 79999999998764
Q ss_pred cCC----CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 246 KGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 246 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
... .....+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+.........+.+........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 332 2345678999999999876667899999999999999999999999999998898888888888876654322
Q ss_pred CcC-c--ccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCC
Q 014174 322 NPN-Y--TEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFN 398 (429)
Q Consensus 322 ~~~-~--~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~ 398 (429)
... . .....+.....++.. ....+++++++||.+||++||.+|||+.|+|+||||.+...+...... ...++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~----~~~~~ 315 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIA----EAPFK 315 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCC----SSCC-
T ss_pred hhhhhhcccccCCccCCCCHHH-hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccc----cCccC
Confidence 110 0 001222222223322 234579999999999999999999999999999999988776544222 22344
Q ss_pred CChhhhccCCHHHHHhhcHHHHhhhCCC
Q 014174 399 FKPQELKGASKELLSKLIPEHARKQCPF 426 (429)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (429)
++ .+......+.+.+++.++..+..|.
T Consensus 316 ~~-~~~~~~~~~~l~~l~~~e~~~~~~~ 342 (345)
T d1pmea_ 316 FD-MELDDLPKEKLKELIFEETARFQPG 342 (345)
T ss_dssp --------CCHHHHHHHHHHHSGGGSTT
T ss_pred CC-hhhhhCCHHHHHHHHHHHHHhcCCC
Confidence 43 4555667788888888888877763
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-56 Score=418.29 Aligned_cols=277 Identities=34% Similarity=0.600 Sum_probs=224.0
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
++|+++++||+|+||+||+|++. +|+.||||++... ...+.+|+.+|+.++|||||++++++.... ..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----ce
Confidence 47999999999999999999985 7899999998543 234558999999999999999999995433 48
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+++|||+.++++..+. ...+.+++..++.++.||+.||+||| +.|||||||||+|||++.++ .+||+|||+|...
T Consensus 76 ~i~~e~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREG-ELKIADFGLARAF 150 (286)
T ss_dssp EEEEECCSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred eEEEEeehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhc-cCcEEecCCCCceeeEcCCC-CEEecccccceec
Confidence 8999999988766554 34578999999999999999999999 88999999999999999988 7999999999876
Q ss_pred ccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 245 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 245 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
..... .....+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+.++....+.+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence 44332 34556899999999998777789999999999999999999999999999999999999998887665433221
Q ss_pred Ccc-cccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 324 NYT-EFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 324 ~~~-~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
... ..........+ ...+...+++++.+||++||++||++|||+.|+|+||||++
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLP-WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp STTCCTTCCCCCCCC-GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhcccccccccCcc-hhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 110 00111111111 22344568999999999999999999999999999999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-56 Score=426.47 Aligned_cols=250 Identities=25% Similarity=0.399 Sum_probs=213.1
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+|+++|+.++|||||++++++. ...
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----ccc
Confidence 468999999999999999999999999999999986432 23457999999999999999999984 444
Q ss_pred EEEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++||||+.++ +...+. ..+.+++..++.++.||+.||.||| ++|||||||||+||||+.++ .+||+|||+|
T Consensus 115 ~~~~v~e~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH-~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a 188 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQG-YIQVTDFGFA 188 (350)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred ccccccccccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHH-hCCEecCcCCHHHcccCCCC-CEEeeeceee
Confidence 588999999864 444433 2467999999999999999999999 88999999999999999888 7999999999
Q ss_pred eecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 242 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 242 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
+..... .....||+.|||||++.+. .++.++|||||||++|+|+||+.||.+.+....+..+.....
T Consensus 189 ~~~~~~--~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------- 255 (350)
T d1rdqe_ 189 KRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---------- 255 (350)
T ss_dssp EECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred eecccc--cccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC----------
Confidence 876433 3457899999999999774 489999999999999999999999999887777776655210
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCC
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRD 382 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~ 382 (429)
.++..+++++.+||++||.+||.+|+ |+.++++||||+...+
T Consensus 256 -------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 256 -------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp -------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred -------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCH
Confidence 12345899999999999999999995 9999999999987654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=424.32 Aligned_cols=255 Identities=27% Similarity=0.418 Sum_probs=217.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.++|++++.||+|+||+||+|+++.+|+.||||++.... ....+|+++|+.++|||||+++++|.. ...+|+
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEEE
Confidence 357999999999999999999999999999999997543 335689999999999999999999844 345899
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC-CcEEEeecccceec
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT-HQVKLCDFGSAKVL 244 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~-~~vkl~DfG~a~~~ 244 (429)
|||||++ +|.+.+. .....+++.+++.++.||+.||.||| ++||+||||||+|||++.++ ..+||+|||+++..
T Consensus 79 vmE~~~gg~L~~~i~---~~~~~l~e~~~~~i~~qi~~al~yLH-~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 79 IFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp EECCCCCCBHHHHHT---SSSCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-HcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999985 5655443 23347999999999999999999999 88999999999999997543 37999999999887
Q ss_pred ccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 245 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 245 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
..........+|+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+...
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~~~-~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------- 226 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------- 226 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH-------
T ss_pred ccCCcccccccccccccchhccCC-CCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh-------
Confidence 666656677889999999998764 489999999999999999999999999988888888776432222221
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
...+|+++++||++||..||.+|||+.|+|+||||.+
T Consensus 227 ------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 227 ------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 2347999999999999999999999999999999965
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.9e-56 Score=428.35 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=207.1
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHH---HHHHHHHcCCCCeeecceEeeecCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNR---ELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
.++|+++++||+|+||+||+|++..+|+.||||++.+.. ....+ |+++++.++|||||+++++|.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~----- 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH----- 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----
Confidence 457999999999999999999999999999999986432 11223 356666778999999999984
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeec
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDF 238 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~Df 238 (429)
....+|+|||||+ ++|...+.. ...+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+||
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH-~~~iiHrDlKP~NILl~~~g-~iKl~DF 151 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMH-NRFVVYRDLKPANILLDEHG-HVRISDL 151 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECSSS-CEEECCC
T ss_pred ECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHH-HCCccceeeccceeEEcCCC-cEEEeee
Confidence 3345889999998 556555543 467899999999999999999999 89999999999999999888 7999999
Q ss_pred ccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 239 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 239 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
|+|+...... .....||+.|+|||++.....++.++|||||||++|+|+||+.||.+.+..+...........
T Consensus 152 Gla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------ 224 (364)
T d1omwa3 152 GLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------ 224 (364)
T ss_dssp TTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC------
T ss_pred ceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------
Confidence 9998765443 345689999999999976666899999999999999999999999876543332211111000
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCC-----HHHHhcCCCCcccCC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCT-----ALEACIHPFFYELRD 382 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t-----~~ell~hp~f~~~~~ 382 (429)
...++..+|+++++||.+||++||++||| ++|+++||||+.+.+
T Consensus 225 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 225 --------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 11133468999999999999999999999 799999999988654
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=417.95 Aligned_cols=251 Identities=27% Similarity=0.487 Sum_probs=210.4
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHH-HHcCCCCeeecceEeeecCCCCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTM-RLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
++|+++++||+|+||+||+|+++.+|+.||||++.++. ....+|..++ +.++|||||++++++ ....
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 47999999999999999999999999999999996432 2233566655 468999999999998 4444
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+|+|||||++ +|...+. ....+++..++.++.||+.||+||| ++||+||||||+|||++.++ .+||+|||+|
T Consensus 77 ~~yivmEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH-~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a 150 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLH-SKGIVYRDLKLDNILLDKDG-HIKIADFGMC 150 (320)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHH-HTTCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred ceeEEEeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccCcccceeecCCC-ceeccccchh
Confidence 58999999986 5555543 3467999999999999999999999 88999999999999999888 7999999999
Q ss_pred eecccC-CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Q 014174 242 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 320 (429)
Q Consensus 242 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 320 (429)
+..... .......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.+.+..+.+..+... .+
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~------- 220 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP------- 220 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred hhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence 866443 334456899999999999775 4899999999999999999999999998877776666541 11
Q ss_pred cCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHH-HHhcCCCCcccCC
Q 014174 321 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL-EACIHPFFYELRD 382 (429)
Q Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~-ell~hp~f~~~~~ 382 (429)
.+++.+|+++.+||++||+.||.+|||+. ++++||||+++.+
T Consensus 221 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~ 263 (320)
T d1xjda_ 221 --------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 263 (320)
T ss_dssp --------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred --------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCH
Confidence 12345899999999999999999999996 8999999988654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-56 Score=412.99 Aligned_cols=245 Identities=26% Similarity=0.395 Sum_probs=203.8
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----------hhhHHHHHHHHHcC--CCCeeecceEeeecCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTD 158 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 158 (429)
++|++.+.||+|+||+||+|++..+|+.||||++.+.. ....+|+.+++.++ |||||++++++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~---- 79 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE---- 79 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE----
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe----
Confidence 47999999999999999999999999999999986432 22458999999997 899999999984
Q ss_pred CCceEEEEEEeccch--hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEe
Q 014174 159 KDELYLNLVLEFVPE--TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~ 236 (429)
....+++||||+.+ ++...+.. ...+++.+++.++.||+.||+||| ++||+||||||+|||++.+...+||+
T Consensus 80 -~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH-~~~iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 80 -RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp -CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred -eCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH-HCCCccccCcccceEEecCCCeEEEC
Confidence 33458899999964 44444432 467999999999999999999999 88999999999999998665589999
Q ss_pred ecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 237 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 237 DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
|||+|+..... ......||+.|+|||++.+...++.++|||||||++|+|+||+.||.+.+ .+.+.
T Consensus 154 DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~------- 219 (273)
T d1xwsa_ 154 DFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG------- 219 (273)
T ss_dssp CCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-------
T ss_pred ccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc-------
Confidence 99999875433 34567899999999999776656788999999999999999999997532 11110
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELR 381 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~ 381 (429)
. ..++..+|+++++||++||++||++|||+.|+|+||||+++.
T Consensus 220 ----------~------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 220 ----------Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ----------C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ----------c------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 0 013346899999999999999999999999999999998754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-55 Score=418.75 Aligned_cols=281 Identities=30% Similarity=0.542 Sum_probs=223.7
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc-hhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceEEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
++|+++++||+|+||+||+|++..+|+.||||++... .....+|+.+|+.++ ||||++++++|... ...++++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCceeEEE
Confidence 4799999999999999999999999999999998754 345668999999996 99999999988543 233578999
Q ss_pred eccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccCC
Q 014174 169 EFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 248 (429)
Q Consensus 169 e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~~ 248 (429)
|||+++.+.. ..+.+++..++.++.||+.||.||| ++||+||||||+||||+.+++.+||+|||+|+......
T Consensus 112 e~~~~~~L~~------~~~~l~e~~i~~i~~qil~aL~~LH-~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQ------LYQTLTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGG------TTTSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHH------HhcCCCHHHHHHHHHHHHHHHHHHh-hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999754321 1357999999999999999999999 89999999999999999777679999999999877666
Q ss_pred CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHHhCCCCHHHHhhcCc----
Q 014174 249 PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGE-SGVDQLVEIIKVLGTPTREEIKCMNP---- 323 (429)
Q Consensus 249 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~---- 323 (429)
......+|+.|+|||.+.+...++.++||||+||++|+|++|+.||... +..++...+...+|.+....+.....
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 6677889999999999987777899999999999999999999999654 45566677777777654433322111
Q ss_pred -CcccccCCCcCCCCccc----ccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCC
Q 014174 324 -NYTEFKFPQIKAHPWHK----IFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRD 382 (429)
Q Consensus 324 -~~~~~~~~~~~~~~~~~----~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~ 382 (429)
.+... ........+.. .....+++++++||++||++||.+|||+.|+|+||||+.+.+
T Consensus 265 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 265 PRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp GGGGGT-CCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred cccchh-cccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 11100 00011111111 112347899999999999999999999999999999988764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=422.69 Aligned_cols=316 Identities=30% Similarity=0.509 Sum_probs=232.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC-CCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 163 (429)
.+|+++++||+|+||+||+|++..+|+.||||++.... ....+|+.+++.++|||||+++++|..... ....+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 47999999999999999999999999999999996432 234589999999999999999999864332 34567
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+|+|||||.++++..+ ...+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+|++|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH-~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCCCC---
T ss_pred eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhh-hcccccccCCcccccccccc-ceeeechhhhhc
Confidence 8999999999877654 356999999999999999999999 88999999999999999988 699999999988
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
...........+|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+....+..+....+.+..+.+.....
T Consensus 169 ~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 7766666777899999999999774 589999999999999999999999999999999999999999888877755433
Q ss_pred Ccccc--cCCCcCCCCcccc-----------cCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCC
Q 014174 324 NYTEF--KFPQIKAHPWHKI-----------FHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNG 390 (429)
Q Consensus 324 ~~~~~--~~~~~~~~~~~~~-----------~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~ 390 (429)
....+ ..+......+... .....++++++||++||.+||++||||+|+|+||||++..++....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~--- 324 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE--- 324 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHT---
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCccccc---
Confidence 22111 0011111111111 1112467899999999999999999999999999999876643221
Q ss_pred CCCCCCCCCChhhhccCCHHHHHhhcHHH
Q 014174 391 RPFPPLFNFKPQELKGASKELLSKLIPEH 419 (429)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (429)
.+.|.+++.+.++ ...+.+.|+.++-.+
T Consensus 325 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 352 (355)
T d2b1pa1 325 APPPQIYDKQLDE-REHTIEEWKELIYKE 352 (355)
T ss_dssp CCCC-------CC-CCCCHHHHHHHHHHH
T ss_pred CCCCCCCCcchhh-hhcCHHHHHHHHHHH
Confidence 1112333433333 355666687766544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=406.82 Aligned_cols=283 Identities=34% Similarity=0.544 Sum_probs=229.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
++|+++++||+|+||+||+|++..+|+.||||+++... ....+|+.+++.++||||+++++++. .....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence 47999999999999999999999999999999986432 33458999999999999999999884 34458
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++|++++.++.+..+. ...+.+++..++.++.|++.||+||| ++||+||||||+|||++.++ .+||+|||.|+..
T Consensus 77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH-~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~ 151 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLLINRNG-ELKLANFGLARAF 151 (292)
T ss_dssp EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhh-cCCEeeecccCcccccccCC-ceeeeecchhhcc
Confidence 8999999987655443 34678999999999999999999999 88999999999999999887 7999999999887
Q ss_pred ccCCC-cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 245 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 245 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
..... .....+++.|+|||++.+...++.++||||+||++|+|++|+.| |.+.+..+.+..+....+.+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence 55433 33456688999999987766689999999999999999999977 56667777788888888877765543322
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCC
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDP 383 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~ 383 (429)
........+..............+++.+.+||++||++||.+|||+.|+|+||||+++.+|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~ 292 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence 2211222222222233333456789999999999999999999999999999999987764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=417.65 Aligned_cols=319 Identities=31% Similarity=0.523 Sum_probs=246.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC-CCceE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY 163 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 163 (429)
++|+++++||+|+||+||+|++..+|+.||||++.+.. ....+|+++|+.++|||||++++++..... .+..+
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 47999999999999999999999999999999986432 234589999999999999999998864432 23334
Q ss_pred EEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccccee
Q 014174 164 LNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 243 (429)
Q Consensus 164 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~ 243 (429)
+++++++++++|.+++. .+++++..++.++.||+.||+||| ++||+||||||+|||++.++ .+|++|||++..
T Consensus 98 ~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH-~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~ 170 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH 170 (348)
T ss_dssp CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTC-CEEECCC----C
T ss_pred EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHH-hCCCcccccCCccccccccc-cccccccchhcc
Confidence 55666666677766553 357999999999999999999999 88999999999999999888 799999999976
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... ......||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......+....+.+..+.......
T Consensus 171 ~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 248 (348)
T d2gfsa1 171 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248 (348)
T ss_dssp CTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred cCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence 532 334567899999999987777789999999999999999999999999999999999999998888766543321
Q ss_pred Cccc---ccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcccCCCCCCCCCCCCCCCCCCCC
Q 014174 324 NYTE---FKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYELRDPNARLPNGRPFPPLFNFK 400 (429)
Q Consensus 324 ~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~ 400 (429)
.... ...+......+... ...+++++++||++||++||++|||+.|+|+||||+++.++... +...+++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~-----~~~~~~~~~ 322 (348)
T d2gfsa1 249 ESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDE-----PVADPYDQS 322 (348)
T ss_dssp HHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSC-----CCCCCCCCG
T ss_pred hhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccC-----CCCCCCCCc
Confidence 1110 01222222222222 24579999999999999999999999999999999998876544 233344443
Q ss_pred hhhhccCCHHHHHhhcHHHHhhhCC
Q 014174 401 PQELKGASKELLSKLIPEHARKQCP 425 (429)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (429)
. +......+.++.++.++.-+-.|
T Consensus 323 ~-~~~~~~~~~~k~~~~~e~~~~~p 346 (348)
T d2gfsa1 323 F-ESRDLLIDEWKSLTYDEVISFVP 346 (348)
T ss_dssp G-GGCCCCHHHHHHHHHHHHHTCCC
T ss_pred c-cchhcCHHHHHHHHHHHhhccCC
Confidence 3 34456667677777776655443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-55 Score=420.53 Aligned_cols=264 Identities=26% Similarity=0.376 Sum_probs=208.9
Q ss_pred cccceEEee-EEccCCceEEEEEEEcCCCcEEEEEEeecchhhhHHHHHHHHH-cCCCCeeecceEeeecCCCCceEEEE
Q 014174 89 QTISYMAER-VVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 89 ~~~~y~i~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..++|.++. .||+|+||+||+|++..+|+.||||++... ....+|+.++.+ ++|||||+++++|.... ....++|+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~i 86 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-PKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI 86 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-HHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEE
Confidence 346799875 699999999999999999999999998654 456689998655 58999999999885432 33567899
Q ss_pred EEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC--CcEEEeeccccee
Q 014174 167 VLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKV 243 (429)
Q Consensus 167 v~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~--~~vkl~DfG~a~~ 243 (429)
|||||+ |+|.+.+.. +....+++.+++.++.||+.||.||| ++||+||||||+|||++.+. ..+||+|||+|+.
T Consensus 87 vmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH-~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 87 VMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHH-HcCCccccccccccccccccccccccccccceeee
Confidence 999998 577776643 22357999999999999999999999 88999999999999998532 2699999999998
Q ss_pred cccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 244 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 244 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
...........||+.|+|||++.+. .|+.++|||||||++|+|+||++||.+.+.......+.....
T Consensus 164 ~~~~~~~~~~~gt~~y~aPE~~~~~-~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~------------ 230 (335)
T d2ozaa1 164 TTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR------------ 230 (335)
T ss_dssp CCCCCCCCCCSCCCSSCCCCCCCGG-GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC------------
T ss_pred ccCCCccccccCCcccCCcHHHcCC-CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHh------------
Confidence 7776666778899999999998764 489999999999999999999999987665444433322110
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
...+.+|. .....+|+++.+||++||++||++|||+.|+|+||||.+
T Consensus 231 -~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 231 -MGQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp -SCSSSCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred -cCCCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 01111111 111247999999999999999999999999999999965
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=410.56 Aligned_cols=285 Identities=28% Similarity=0.471 Sum_probs=221.6
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceEeeecCC---CC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---KD 160 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 160 (429)
.++|++++.||+|+||+||+|++..+|+.||||++..+. ....+|+++|+.++||||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 568999999999999999999999999999999885432 234589999999999999999998854321 22
Q ss_pred ceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 161 ELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 161 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
...+++||||+.++++.... .....+++..++.++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH-~~~ivHrDlKp~NILl~~~~-~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIH-RNKILHRDMKAANVLITRDG-VLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhc-cCCEEecCcCchheeecCCC-cEEeeecce
Confidence 34578999999987766443 34567999999999999999999999 88999999999999999988 799999999
Q ss_pred ceecccC-----CCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Q 014174 241 AKVLVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTR 315 (429)
Q Consensus 241 a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~ 315 (429)
++..... ......+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+....+..+.+..+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9765432 12234578999999999987777999999999999999999999999999999999999999888776
Q ss_pred HHHhhcCcCcc--cccCCCcCCCCccccc-CCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 316 EEIKCMNPNYT--EFKFPQIKAHPWHKIF-HKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 316 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
+.+......-. .+.............+ ....++++++||.+||++||++|||+.|+|+||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 54432221110 0111110011110000 0124778999999999999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.4e-53 Score=391.88 Aligned_cols=256 Identities=25% Similarity=0.372 Sum_probs=201.8
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.++|++.+.||+|+||+||+|++..+|+.||||++..+. ..+.+|+++++.++|||||++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 357999999999999999999999999999999986432 23457999999999999999999886544 3445
Q ss_pred EEEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
++|+|||||+++ |...+. ..+.+++.+++.++.||+.||.||| ++||+||||||+|||++.++ .++|+|||.+
T Consensus 85 ~~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH-~~~iiHrDiKP~NIll~~~~-~~~l~d~~~~ 158 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSH-QNGIIHRDVKPANIMISATN-AVKVMDFGIA 158 (277)
T ss_dssp EEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEETTS-CEEECCCTTC
T ss_pred eEEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHH-hCCccCccccCcccccCccc-cceeehhhhh
Confidence 678999999964 443332 3467999999999999999999999 88999999999999999888 7999999998
Q ss_pred eecccCC----CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 242 KVLVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 242 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
....... .....+||+.|+|||++.+. .++.++|||||||++|+|+||++||.+.+..+.+.++......+.
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~--- 234 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--- 234 (277)
T ss_dssp EECC----------------TTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG---
T ss_pred hhhccccccccccccccCcccccCHHHHcCC-CCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC---
Confidence 7654332 23456789999999999764 489999999999999999999999999888777766655211111
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCc
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFY 378 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~ 378 (429)
......+|+++.+||++||++||.+||+..+.|.|+|++
T Consensus 235 ----------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 235 ----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ----------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 112345899999999999999999999555555666653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-52 Score=390.05 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=202.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
..+|++.+.||+|+||+||+|++..+|+.||||++..+ ...+.+|+++++.++|||||++++++... ..+++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeC-----CeeEE
Confidence 34799999999999999999999999999999998654 34456899999999999999999998433 33789
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
|||||++ ++...+.. .....+++..+..++.||+.||+||| ++||+||||||+||||+.++ .+||+|||+|+...
T Consensus 91 v~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH-~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHH-HCCcccCccccCeEEECCCC-cEEEccccceeecC
Confidence 9999985 55555433 23467899999999999999999999 88999999999999999888 79999999998764
Q ss_pred cCCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 246 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 246 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
..... ....||+.|+|||++.+. .++.++|||||||++|+|++|..||........+.++....
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~------------- 232 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD------------- 232 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-------------
T ss_pred CCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcC-------------
Confidence 43322 234578899999998765 48999999999999999999776655444444444433310
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCCCCcc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHPFFYE 379 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp~f~~ 379 (429)
....++..+|+++.+||.+||+.||++|||+.++++ +|..
T Consensus 233 --------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~ 272 (287)
T d1opja_ 233 --------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFET 272 (287)
T ss_dssp --------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred --------------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHH
Confidence 011133468999999999999999999999999976 4543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=385.73 Aligned_cols=248 Identities=21% Similarity=0.277 Sum_probs=195.6
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY 163 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 163 (429)
.++|++.+.||+|+||+||+|+. +..||||++... ...+.+|+.++++++|||||++++++.. . .
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-----~-~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-----P-Q 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S-S
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-----c-E
Confidence 35799999999999999999985 346999998532 2345579999999999999999987521 1 2
Q ss_pred EEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccce
Q 014174 164 LNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 242 (429)
Q Consensus 164 ~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~ 242 (429)
+++|||||+ ++|.+.+.. ....+++..+..++.||+.||+||| ++|||||||||+||||+.++ .+||+|||+|+
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH-~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~ 152 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH-AKSIIHRDLKSNNIFLHEDL-TVKIGDFGLAT 152 (276)
T ss_dssp CEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEETTS-SEEECCCCCSC
T ss_pred EEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHh-cCCEeccccCHHHEEEcCCC-CEEEcccccee
Confidence 678999998 466555532 3467999999999999999999999 88999999999999999888 79999999997
Q ss_pred ecccCC---CcccccccccccccccccCC--CCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Q 014174 243 VLVKGE---PNISYICSRYYRAPELIFGA--TEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREE 317 (429)
Q Consensus 243 ~~~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 317 (429)
...... ......||+.|||||++.+. ..++.++|||||||++|||+||+.||.+.+....+.........++
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p--- 229 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP--- 229 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC---
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---
Confidence 764332 22356789999999998643 3478999999999999999999999998877766655544311111
Q ss_pred HhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 318 IKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
....++..+++++.+||.+||+.||++|||+.+++++
T Consensus 230 --------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 230 --------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp --------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0112334679999999999999999999999999886
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-52 Score=393.25 Aligned_cols=249 Identities=21% Similarity=0.299 Sum_probs=201.0
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCc-----EEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGE-----TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
++|++.++||+|+||+||+|++..+++ .||+|.+... ...+.+|+.+++.+ +|||||++++++..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~---- 112 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL---- 112 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee----
Confidence 479999999999999999999876554 6999988543 23445799999988 89999999999843
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecC
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSR-------------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDI 219 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DL 219 (429)
...+++|||||+ |+|.+.+..... ....+++..++.++.||+.||+||| ++|||||||
T Consensus 113 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH-~~~IiHRDl 190 (325)
T d1rjba_ 113 -SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDL 190 (325)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH-HTTEEETTC
T ss_pred -CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccC
Confidence 334789999998 466666543211 1245899999999999999999999 889999999
Q ss_pred CCCceEecCCCCcEEEeecccceecccCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCC
Q 014174 220 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFP 295 (429)
Q Consensus 220 kp~Nill~~~~~~vkl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~ 295 (429)
||+|||++.++ .+||+|||+|+........ ....||+.|||||++.+. .++.++|||||||++|||+| |.+||.
T Consensus 191 Kp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 191 AARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp SGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred chhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999888 7999999999876554432 245679999999998764 48999999999999999998 899999
Q ss_pred CCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 296 GESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 296 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
+.+..+.+.++...... ...+..+|+++.+||.+||+.||++|||+.||++|
T Consensus 269 ~~~~~~~~~~~~~~~~~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFK---------------------------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp TCCCSHHHHHHHHTTCC---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCC---------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 87777766666542111 11234579999999999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=381.22 Aligned_cols=244 Identities=20% Similarity=0.312 Sum_probs=189.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.+|++.+.||+|+||+||+|++. ++..||||++... ...+.+|+++++.++|||||++++++.... .+++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEEE
Confidence 36999999999999999999975 5678999998653 344568999999999999999999985433 37899
Q ss_pred Eeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||+++ +|.+.+. .....+++..+..++.||+.||.||| +++|+||||||+||||+.++ .+||+|||+++....
T Consensus 79 ~E~~~~g~L~~~l~---~~~~~~~~~~~~~i~~qia~gl~~lH-~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLE-EACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD 153 (263)
T ss_dssp EECCTTCBHHHHHH---TTTTCCCHHHHHHHHHHHHHHHHHHH-HTTCCCTTCSGGGEEECGGG-CEEECSCC-------
T ss_pred EEecCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHhhh-ccceeecccchhheeecCCC-CeEecccchheeccC
Confidence 999985 4444443 23466899999999999999999999 88999999999999999888 799999999987654
Q ss_pred CCCc--ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 247 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
.... ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||...+..+.+..+.....
T Consensus 154 ~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------------ 220 (263)
T d1sm2a_ 154 DQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------ 220 (263)
T ss_dssp -----------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC------------
T ss_pred CCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC------------
Confidence 4322 235689999999999765 49999999999999999999 5677766666555555443210
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...+...++++.+||.+||+.||++|||+.++++|
T Consensus 221 ----------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 221 ----------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 01223478999999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-51 Score=387.77 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=188.0
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCc---EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.+|++.++||+|+||+||+|++..+++ .||||.+... ...+.+|+++|++++|||||++++++... .
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-----T 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----S
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----C
Confidence 469999999999999999999887765 5889987543 23456899999999999999999998433 3
Q ss_pred EEEEEEeccchhHH-HHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPETVY-RVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~~l~-~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++|||||+++.+ .++. ...+.+++..+..++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+|
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~---~~~~~l~~~~~~~i~~qia~gl~yLH-~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla 175 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLA-DMNYVHRDLAARNILVNSNL-VCKVSDFGLS 175 (299)
T ss_dssp SCEEEEECCTTEEHHHHHH---TTTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCC---
T ss_pred EEEEEEEecCCCcceeeec---cccCCCCHHHHHHHHHHHHHHHHHHh-hCCCccCccccceEEECCCC-cEEECCcccc
Confidence 37899999996544 4332 23457999999999999999999999 88999999999999999888 7999999999
Q ss_pred eecccCCCc------ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 242 KVLVKGEPN------ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 242 ~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
+........ ....||+.|+|||.+.+. .++.++|||||||++|||+| |+.||.+.+..+.+..+.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~--- 251 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYR--- 251 (299)
T ss_dssp --------------------CGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC---
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcC-CCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---
Confidence 876443221 224568899999999764 48999999999999999998 8999998887666655443110
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...+..+++++.+||.+||+.||++|||+.+++++
T Consensus 252 -------------------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 252 -------------------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 01234579999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=382.60 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=199.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.+|++.+.||+|+||+||+|++. ++..||||++... ...+.+|++++++++|||||++++++.. . .+++|
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~-~~~iv 85 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----E-PIYII 85 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S-SCEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-----C-CeEEE
Confidence 47999999999999999999974 6788999998654 3445689999999999999999997632 1 15789
Q ss_pred Eeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||++++ |.+.+.. .....+++..+..++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+|+....
T Consensus 86 ~Ey~~~g~L~~~~~~--~~~~~l~~~~~~~i~~qi~~gl~~lH-~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 86 TEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIE-ERNYIHRDLRAANILVSDTL-SCKIADFGLARLIED 161 (272)
T ss_dssp EECCTTCBHHHHTTS--HHHHTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCccchhheeeeccc-ceeeccccceEEccC
Confidence 9999864 4443322 22346999999999999999999999 88999999999999999888 799999999987754
Q ss_pred CCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 247 GEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... .....||+.|+|||++.+.. ++.++|||||||++|||+|| .+||...+..+.+..+....
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~------------- 227 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------- 227 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-------------
T ss_pred CccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC-------------
Confidence 432 23456789999999997644 89999999999999999995 55566555555544443210
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCCCcc
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI--HPFFYE 379 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~--hp~f~~ 379 (429)
....+..+++++.+||.+||+.||++|||+.++++ |+||..
T Consensus 228 ---------------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 228 ---------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 01123457999999999999999999999999998 788853
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=377.78 Aligned_cols=244 Identities=19% Similarity=0.266 Sum_probs=201.9
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.+|+++++||+|+||+||+|++ .++..||||+++.. ...+.+|++++++++||||+++++++... ..+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEEE
Confidence 4699999999999999999997 47889999998753 34556899999999999999999988433 338899
Q ss_pred Eeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceeccc
Q 014174 168 LEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 246 (429)
Q Consensus 168 ~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~ 246 (429)
|||+.++ +...+. .....+++..+..++.||+.||.||| ++||+||||||+|||++.++ .+||+|||+++....
T Consensus 78 ~Ey~~~g~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~~LH-~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 78 TEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD 152 (258)
T ss_dssp EECCTTEEHHHHHH---SGGGCCCHHHHHHHHHHHHHHHHHHH-HTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSS
T ss_pred EEccCCCcHHHhhh---ccccCCcHHHHHHHHHHHHHHHHHHh-hcCcccccccceeEEEcCCC-cEEECcchhheeccC
Confidence 9999854 444332 23467899999999999999999999 88999999999999999888 799999999986644
Q ss_pred CCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCc
Q 014174 247 GEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNP 323 (429)
Q Consensus 247 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 323 (429)
... .....||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+....+.+...
T Consensus 153 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~------------ 219 (258)
T d1k2pa_ 153 DEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR------------ 219 (258)
T ss_dssp SSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC------------
T ss_pred CCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCC------------
Confidence 332 23456899999999997644 8999999999999999998 8999998887766655543210
Q ss_pred CcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 324 NYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...+...++++.+||++||+.||++|||+.++++|
T Consensus 220 ----------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 220 ----------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 11234578999999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-51 Score=382.35 Aligned_cols=249 Identities=24% Similarity=0.293 Sum_probs=200.2
Q ss_pred cceEEeeE-EccCCceEEEEEEEcC--CCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 91 ISYMAERV-VGQGSFGIVFQAKCLE--TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
++|.+.+. ||+|+||+||+|.++. ++..||||++... ...+.+|+++|+.++|||||++++++.. .
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~----- 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E----- 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-----
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C-----
Confidence 46888885 9999999999998754 4557999998643 2334579999999999999999998732 1
Q ss_pred EEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++|||||++ +|.+.+. .....+++..+..++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+|
T Consensus 82 ~~~lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH-~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla 156 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRH-YAKISDFGLS 156 (285)
T ss_dssp SEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHH-HTTEECCCCSGGGEEEEETT-EEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHH-hCCeecCcCchhheeeccCC-ceeeccchhh
Confidence 16799999996 4444332 23467999999999999999999999 88999999999999999888 7999999999
Q ss_pred eecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 242 KVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 242 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
+....... .....||+.|+|||++.+. .++.++|||||||++|||+| |+.||.+.+..+....+.+. .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~--~---- 229 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG--K---- 229 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT--C----
T ss_pred hcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--C----
Confidence 87654332 2234678999999999765 48999999999999999998 99999988776665554331 0
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHH---hcCCCCcc
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA---CIHPFFYE 379 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~el---l~hp~f~~ 379 (429)
...+++.+|+++.+||.+||+.||++|||+.++ |+|+|+.-
T Consensus 230 ----------------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 230 ----------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp ----------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 011334689999999999999999999999877 67888743
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=391.65 Aligned_cols=257 Identities=28% Similarity=0.454 Sum_probs=206.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEc---CCCcEEEEEEeecc--------hhhhHHHHHHHHHcCC-CCeeecceEeeecC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCL---ETGETVAIKKVLQD--------KRYKNRELQTMRLLDH-PNVVSLKHCFFSTT 157 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~ 157 (429)
.++|++++.||+|+||+||+|++. .+|+.||||++.+. .....+|++++++++| |||+++++++..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-- 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 100 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence 467999999999999999999874 47899999988532 2344579999999987 799999998843
Q ss_pred CCCceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEe
Q 014174 158 DKDELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLC 236 (429)
Q Consensus 158 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~ 236 (429)
...+++||||+.+ +|...+.. .+.+++..++.++.||+.||.||| ++||+||||||+|||++.++ .+||+
T Consensus 101 ---~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH-~~~ivHrDiKp~Nill~~~~-~vkL~ 171 (322)
T d1vzoa_ 101 ---ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLH-KLGIIYRDIKLENILLDSNG-HVVLT 171 (322)
T ss_dssp ---TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHH-HTTCCCCCCCGGGEEECTTS-CEEES
T ss_pred ---CCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhh-cCCEEeccCCccceeecCCC-CEEEe
Confidence 3358899999985 55554433 467899999999999999999999 88999999999999999888 79999
Q ss_pred ecccceecccCC--CcccccccccccccccccCCC-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Q 014174 237 DFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT-EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTP 313 (429)
Q Consensus 237 DfG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~~~ 313 (429)
|||+|+...... ......||+.|+|||.+.+.. .++.++|||||||+||+|++|+.||.+.+..+....+.+.....
T Consensus 172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251 (322)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence 999998764332 234567899999999996543 46889999999999999999999998876555444443321000
Q ss_pred CHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCC-----CHHHHhcCCCCcccCC
Q 014174 314 TREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRC-----TALEACIHPFFYELRD 382 (429)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~-----t~~ell~hp~f~~~~~ 382 (429)
...++..+|+++++||++||.+||.+|| |++|+++||||+++.+
T Consensus 252 -------------------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 252 -------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp -------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred -------------------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 0112345899999999999999999999 5899999999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-51 Score=379.90 Aligned_cols=241 Identities=22% Similarity=0.287 Sum_probs=192.3
Q ss_pred eEEccCCceEEEEEEEc--CCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEEE
Q 014174 97 RVVGQGSFGIVFQAKCL--ETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL 168 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 168 (429)
++||+|+||+||+|.+. .+++.||||++..+ ...+.+|++++++++|||||++++++.. .. .++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----~~-~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ES-WMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----SS-EEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----CC-EEEEE
Confidence 47999999999999864 45678999998543 2345689999999999999999998732 11 56899
Q ss_pred eccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecccC
Q 014174 169 EFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 247 (429)
Q Consensus 169 e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~~~ 247 (429)
|||++ +|.+.+. ....+++..+..++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+|+.....
T Consensus 87 E~~~~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH-~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 87 EMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRAD 160 (277)
T ss_dssp ECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTT
T ss_pred EcCCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHH-hCCcccCCCcchhhcccccC-cccccchhhhhhcccc
Confidence 99985 5555443 3567999999999999999999999 88999999999999999888 7999999999876543
Q ss_pred CCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcC
Q 014174 248 EPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMN 322 (429)
Q Consensus 248 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 322 (429)
... ....||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+....+.+. .
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~--~---------- 227 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG--E---------- 227 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT--C----------
T ss_pred ccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC--C----------
Confidence 322 2346789999999997644 8999999999999999998 89999988766555444321 0
Q ss_pred cCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHH---hcCCCCc
Q 014174 323 PNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEA---CIHPFFY 378 (429)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~el---l~hp~f~ 378 (429)
...++..+|+++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 228 ----------------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 228 ----------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----------------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 011234589999999999999999999999988 5666653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-50 Score=373.79 Aligned_cols=252 Identities=25% Similarity=0.315 Sum_probs=195.8
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 165 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 165 (429)
...+|++.+.||+|+||+||+|++..+ ..||||++.... ..+.+|+.++++++|||||++++++.. .. ++
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-----~~-~~ 87 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-----EP-IY 87 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SS-CE
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-----CC-eE
Confidence 345899999999999999999998654 679999986543 456689999999999999999998731 11 56
Q ss_pred EEEeccchhH-HHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 166 LVLEFVPETV-YRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 166 lv~e~~~~~l-~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
+||||+.++. ...+.. .....+++..+..++.||+.||+||| +.||+||||||+||||+.++ .+||+|||+|+..
T Consensus 88 lv~Ey~~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH-~~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~ 163 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE-RMNYVHRDLRAANILVGENL-VCKVADFGLARLI 163 (285)
T ss_dssp EEECCCTTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECGGG-CEEECCCCTTC--
T ss_pred EEEEecCCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHh-hhheecccccceEEEECCCC-cEEEcccchhhhc
Confidence 8999999653 333322 23457999999999999999999999 88999999999999999888 7999999999876
Q ss_pred ccCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCHHHHhhc
Q 014174 245 VKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEIIKVLGTPTREEIKCM 321 (429)
Q Consensus 245 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 321 (429)
..... .....||+.|+|||.+... .++.++|||||||++|||+||. +||.+....+.+..+.....
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~---------- 232 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR---------- 232 (285)
T ss_dssp ------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred cCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC----------
Confidence 43332 2345689999999999764 4899999999999999999965 45555555445444432110
Q ss_pred CcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc--CCCCccc
Q 014174 322 NPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI--HPFFYEL 380 (429)
Q Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~--hp~f~~~ 380 (429)
..++..+++++.+||.+||+.||++|||+.++++ |+||...
T Consensus 233 ------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 233 ------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ------------------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1123457999999999999999999999999988 8899764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-50 Score=372.80 Aligned_cols=245 Identities=20% Similarity=0.246 Sum_probs=186.8
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCC----cEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETG----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
..|++.++||+|+||+||+|.+..++ ..||||++.... ..+.+|+++++.++|||||++++++...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~----- 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY----- 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-----
Confidence 36999999999999999999987654 479999985432 2345899999999999999999988433
Q ss_pred eEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 162 LYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 162 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
...++||||+.++++.... ......+++..+..++.||+.||+||| +++|+||||||+||||+.++ .+||+|||+|
T Consensus 82 ~~~~~v~e~~~~~~l~~~~--~~~~~~~~~~~~~~i~~~i~~gl~~lH-~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla 157 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLA-NMNYVHRDLAARNILVNSNL-VCKVSDFGLS 157 (283)
T ss_dssp SSEEEEEECCTTEEHHHHH--HHTTTCSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEECTTC-CEEECCCCC-
T ss_pred CceEEEEEecccCcchhhh--hcccccccHHHHHHHHHHHHHhhhhcc-ccccccCccccceEEECCCC-eEEEcccchh
Confidence 3378999999876444322 233467999999999999999999999 88999999999999999888 7999999999
Q ss_pred eecccCCC----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCC-CCCCChHHHHHHHHHHhCCCCHH
Q 014174 242 KVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPL-FPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 242 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|..| |.+.+..+.+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~-~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~------ 230 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF------ 230 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccC-CCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC------
Confidence 87644322 2234678999999999764 599999999999999999996555 54444444433332210
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
....+..++..+.+||.+||..||++|||+.++++
T Consensus 231 ----------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 231 ----------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ----------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 11123457899999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=374.25 Aligned_cols=244 Identities=27% Similarity=0.358 Sum_probs=188.3
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCC---cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCce
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL 162 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 162 (429)
.+|++.+.||+|+||+||+|++..++ ..||||.+... ...+.+|+.+++.++|||||++++++.. .
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------~ 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------N 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------S
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------C
Confidence 47999999999999999999987543 56899987532 2334579999999999999999998731 1
Q ss_pred EEEEEEeccchh-HHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccc
Q 014174 163 YLNLVLEFVPET-VYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 241 (429)
Q Consensus 163 ~~~lv~e~~~~~-l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a 241 (429)
.+++||||++++ +...+. .....+++..++.++.||+.||.||| ++||+||||||+||+++.++ .+||+|||+|
T Consensus 81 ~~~iv~E~~~~g~l~~~~~---~~~~~l~~~~~~~~~~qi~~gl~ylH-~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a 155 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSND-CVKLGDFGLS 155 (273)
T ss_dssp SCEEEEECCTTEEHHHHHH---HTTTTSCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEEEETT-EEEECC----
T ss_pred eEEEEEEeccCCcHHhhhh---ccCCCCCHHHHHHHHHHHHHHhhhhc-ccCeeccccchhheeecCCC-cEEEccchhh
Confidence 367899999855 433332 33467999999999999999999999 88999999999999999888 7999999999
Q ss_pred eecccCCC--cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHH
Q 014174 242 KVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEI 318 (429)
Q Consensus 242 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 318 (429)
+....... .....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-------- 226 (273)
T d1mp8a_ 156 RYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------- 226 (273)
T ss_dssp ---------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------
T ss_pred eeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 87643322 2345678999999999764 48999999999999999998 899999888777665554310
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
...+++.+|+++.+||.+||+.||++|||+.++++|
T Consensus 227 --------------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 227 --------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011345689999999999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=377.57 Aligned_cols=245 Identities=23% Similarity=0.325 Sum_probs=193.5
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCc----EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCc
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGE----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 161 (429)
.+|+++++||+|+||+||+|++..+|+ .||+|.+... ...+.+|+++++.++|||||++++++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 369999999999999999999988876 5788877432 23456899999999999999999988532
Q ss_pred eEEEEEEeccc-hhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeeccc
Q 014174 162 LYLNLVLEFVP-ETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 240 (429)
Q Consensus 162 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~ 240 (429)
. .+++++|+. +++.+.+. .....+++..++.++.||+.||.||| ++||+||||||+||||+.++ .+||+|||+
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~gl~yLH-~~~iiHrDlKp~NIll~~~~-~~kl~DFGl 157 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQ-HVKITDFGL 157 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHH---HTSSSCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEEEETT-EEEECCCSH
T ss_pred C-eeEEEEeccCCccccccc---ccccCCCHHHHHHHHHHHHHHHHHHH-HcCcccCcchhhcceeCCCC-CeEeecccc
Confidence 1 345666665 55655443 34577999999999999999999999 88999999999999999888 799999999
Q ss_pred ceecccCCCc---ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 014174 241 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTRE 316 (429)
Q Consensus 241 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~ 316 (429)
|+........ ....||+.|+|||++.+. .++.++|||||||++|||+| |.+||.+.+..+....+.... .+
T Consensus 158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-~~--- 232 (317)
T d1xkka_ 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RL--- 232 (317)
T ss_dssp HHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC-CC---
T ss_pred ceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-CC---
Confidence 9876543322 234579999999999775 48999999999999999998 789998877665544443311 00
Q ss_pred HHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcCC
Q 014174 317 EIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIHP 375 (429)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~hp 375 (429)
..+..+++++.+||.+||..||.+|||+.++++|.
T Consensus 233 ------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 233 ------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp ------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 12345789999999999999999999999999883
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=370.58 Aligned_cols=250 Identities=24% Similarity=0.331 Sum_probs=188.6
Q ss_pred cceEEeeEEccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeecCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 159 (429)
++|++.+.||+|+||+||+|++.. +++.||||++.... ....+|..++.++ .|+||+.+++++....
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-- 90 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG-- 90 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT--
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC--
Confidence 479999999999999999999754 45689999886432 2233566666666 6889999988764322
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhhh------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEe
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYSR------------ASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLV 226 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill 226 (429)
..+++|||||+ ++|.+.+..... ....+++..+..++.||+.||.||| ++||+||||||+||||
T Consensus 91 --~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH-~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 --GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILL 167 (299)
T ss_dssp --SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCCGGGEEE
T ss_pred --CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH-hCCCcCCcCCccceeE
Confidence 23778999998 566666544221 1345899999999999999999999 8899999999999999
Q ss_pred cCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHH
Q 014174 227 NPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQ 302 (429)
Q Consensus 227 ~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~ 302 (429)
+.++ .+||+|||+|+....... .....||+.|+|||++.+. .++.++|||||||++|||+|| .+||.+.+..+.
T Consensus 168 ~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 168 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp CGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred CCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9888 799999999986544322 2345789999999999774 489999999999999999986 578887776666
Q ss_pred HHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 303 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 303 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
+..+......+ .++..+++++.+||.+||+.||++|||+.|+++|
T Consensus 246 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 246 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55544421111 1234579999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=364.78 Aligned_cols=245 Identities=22% Similarity=0.327 Sum_probs=193.3
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEE
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
...+|++.++||+|+||.||+|++ +|..||||+++.+ .+.+.+|++++++++||||+++++++.... ..+++
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~l 78 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGLYI 78 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecC----CcEEE
Confidence 445799999999999999999998 5789999999654 345668999999999999999999875322 22689
Q ss_pred EEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceecc
Q 014174 167 VLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 245 (429)
Q Consensus 167 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~~ 245 (429)
||||+++ +|.+.+... ....+++..+..++.||+.||.||| +.+|+||||||+|||++.++ .+||+|||+++...
T Consensus 79 v~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH-~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS 154 (262)
T ss_dssp EECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTS-CEEECCCCC-----
T ss_pred EEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccc-cCceeccccchHhheecCCC-CEeecccccceecC
Confidence 9999974 566655432 2245899999999999999999999 88999999999999999988 79999999998654
Q ss_pred cCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhcCcC
Q 014174 246 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPTREEIKCMNPN 324 (429)
Q Consensus 246 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 324 (429)
.. .....+|..|+|||.+.+. .++.++|||||||++|||+| |++||...+..+....+.+.
T Consensus 155 ~~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~--------------- 216 (262)
T d1byga_ 155 ST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------- 216 (262)
T ss_dssp ---------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---------------
T ss_pred CC--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------------
Confidence 33 2345678899999999765 48999999999999999998 78889877766655444221
Q ss_pred cccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 325 YTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
....++..+++++.+||++||..||.+|||+.+++++
T Consensus 217 -------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 217 -------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp -------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0112344678999999999999999999999999873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=366.56 Aligned_cols=244 Identities=24% Similarity=0.323 Sum_probs=189.5
Q ss_pred cceEEeeEEccCCceEEEEEEEcC-CC--cEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceEeeecCCCC
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLE-TG--ETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 160 (429)
.+|++.+.||+|+||.||+|+... ++ ..||||++..+ ...+.+|+++++.++|||||++++++..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~----- 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----- 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence 469999999999999999998653 33 36899987542 1344689999999999999999998842
Q ss_pred ceEEEEEEeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 161 ELYLNLVLEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 161 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
. .+++||||+++ ++.+.+.. ....+++..+..++.||+.||.||| ++||+||||||+||||+.++ .+||+|||
T Consensus 83 ~-~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH-~~~iiHrDikp~NIll~~~~-~vkl~DfG 156 (273)
T d1u46a_ 83 P-PMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLE-SKRFIHRDLAARNLLLATRD-LVKIGDFG 156 (273)
T ss_dssp S-SCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred c-chheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhh-hCCEeeeeecHHHhcccccc-ceeeccch
Confidence 1 25689999985 44443332 2456999999999999999999999 88999999999999999888 89999999
Q ss_pred cceecccCCCc----ccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCC
Q 014174 240 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESGVDQLVEIIKVLGTPT 314 (429)
Q Consensus 240 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~i~~~~~~~~ 314 (429)
+++........ ....||..|+|||++.+. .++.++|||||||++|||+| |..||.+.+..+.+..+.+....
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~-- 233 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER-- 233 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC--
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCC-CCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC--
Confidence 99876544332 234568899999999764 48999999999999999998 89999998888777665542100
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+..+|+++.+||.+||..||++|||+.++++
T Consensus 234 -------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 234 -------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1123457999999999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.8e-48 Score=375.18 Aligned_cols=288 Identities=29% Similarity=0.463 Sum_probs=211.5
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch---hhhHHHHHHHHHcC-----------CCCeeecceEee
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKHCFF 154 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 154 (429)
..++|+++++||+|+||+||+|++..+|+.||||+++++. ....+|+++++.++ |+||+++++++.
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 3457999999999999999999999999999999997653 33457898888875 578999998875
Q ss_pred ecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCC---
Q 014174 155 STTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTH--- 231 (429)
Q Consensus 155 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~--- 231 (429)
... ....+.+++++++.++...... ......+++..++.++.||+.||.|||+..||+||||||+||||+.++.
T Consensus 91 ~~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 91 HKG-PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEE-TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred ecc-ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 432 2223333344444444333332 3445789999999999999999999995489999999999999976552
Q ss_pred --cEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------hHHHH
Q 014174 232 --QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGES------GVDQL 303 (429)
Q Consensus 232 --~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~ 303 (429)
.+|++|||.+..... ......||+.|+|||++.+. .++.++||||+||++++|++|+.||...+ ..+.+
T Consensus 168 ~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred cceeeEeeccccccccc--ccccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 499999999986543 33456799999999999764 48999999999999999999999997543 34566
Q ss_pred HHHHHHhCCCCHHHHhhcCcCcccc-------cCCCcCCCCc------ccccCCCCChhHHHHHHhhcCcCCCCCCCHHH
Q 014174 304 VEIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKAHPW------HKIFHKRMPPEAVDLVSRLLQYSPNLRCTALE 370 (429)
Q Consensus 304 ~~i~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~------~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~e 370 (429)
...+..+|.++...+.........+ .........+ ...+....++++.+||.+||++||.+|||+.|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 7778888888776553321110000 1111111111 11112235678999999999999999999999
Q ss_pred HhcCCCCcccCC
Q 014174 371 ACIHPFFYELRD 382 (429)
Q Consensus 371 ll~hp~f~~~~~ 382 (429)
+|+||||++.-.
T Consensus 325 ~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 325 LVNHPWLKDTLG 336 (362)
T ss_dssp HHTCGGGTTCTT
T ss_pred HhcCcccCCCCC
Confidence 999999986543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-49 Score=370.28 Aligned_cols=250 Identities=21% Similarity=0.283 Sum_probs=200.8
Q ss_pred cccceEEeeEEccCCceEEEEEEEcCCCcE--EEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceEeeecCCCC
Q 014174 89 QTISYMAERVVGQGSFGIVFQAKCLETGET--VAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD 160 (429)
Q Consensus 89 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~-----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 160 (429)
..++|++.++||+|+||+||+|+++.+|.. ||||.+... ...+.+|+++|+++ +|||||++++++...
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~---- 83 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR---- 83 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET----
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC----
Confidence 345899999999999999999999888874 677876432 23456899999998 799999999998543
Q ss_pred ceEEEEEEeccc-hhHHHHHHHh------------hhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEec
Q 014174 161 ELYLNLVLEFVP-ETVYRVAKHY------------SRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVN 227 (429)
Q Consensus 161 ~~~~~lv~e~~~-~~l~~~~~~~------------~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~ 227 (429)
..+++||||++ |+|.+.+... ......+++..+..++.||+.||.||| +.||+||||||+|||++
T Consensus 84 -~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH-~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 84 -GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVG 161 (309)
T ss_dssp -TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH-HTTEECSCCSGGGEEEC
T ss_pred -CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh-cCCccccccccceEEEc
Confidence 34889999999 5666655432 123467999999999999999999999 88999999999999999
Q ss_pred CCCCcEEEeecccceecccCCCcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHH
Q 014174 228 PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLFPGESGVDQLVEI 306 (429)
Q Consensus 228 ~~~~~vkl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~i 306 (429)
.++ .+||+|||+|+............||..|+|||.+.+.. ++.++|||||||++|+|++|. +||.+.+..+.+..+
T Consensus 162 ~~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 162 ENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp GGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred CCC-ceEEccccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 888 79999999998765555545567899999999997654 899999999999999999965 678777766655443
Q ss_pred HHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 307 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
.+.. ...++..+++++.+||.+||+.||++|||+.++++|
T Consensus 240 ~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 240 PQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp GGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcC----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2210 011234579999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-48 Score=367.13 Aligned_cols=248 Identities=23% Similarity=0.288 Sum_probs=198.2
Q ss_pred ccceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
.++|++.+.||+|+||+||+|++. .+++.||||++... ...+.+|+++++.++||||+++++++...
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--- 88 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG--- 88 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC---
Confidence 346999999999999999999975 35678999998643 23456899999999999999999988443
Q ss_pred CceEEEEEEeccc-hhHHHHHHHhh--------------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeec
Q 014174 160 DELYLNLVLEFVP-ETVYRVAKHYS--------------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRD 218 (429)
Q Consensus 160 ~~~~~~lv~e~~~-~~l~~~~~~~~--------------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~D 218 (429)
..+++||||+. ++|.+.+.... .....+++..+..++.||+.||+||| ++||||||
T Consensus 89 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH-~~~ivHrD 165 (301)
T d1lufa_ 89 --KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRD 165 (301)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSC
T ss_pred --CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc-cCCeEeeE
Confidence 33778999998 45666554211 11345899999999999999999999 88999999
Q ss_pred CCCCceEecCCCCcEEEeecccceecccCC---CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCC-CCC
Q 014174 219 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQ-PLF 294 (429)
Q Consensus 219 Lkp~Nill~~~~~~vkl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf 294 (429)
|||+||||+.++ .+||+|||+|+...... ......||+.|+|||.+.+. .++.++|||||||++|||++|. +||
T Consensus 166 lKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 166 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC-CCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999888 79999999998654332 22345678999999999764 4999999999999999999985 788
Q ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 295 PGESGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 295 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+.+..+.+..+.... . ..++..+++++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~e~~~~v~~~~-------------------~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 244 YGMAHEEVIYYVRDGN-------------------I---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TTSCHHHHHHHHHTTC-------------------C---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCC-------------------C---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8887777666544310 0 0123468999999999999999999999999965
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-48 Score=364.62 Aligned_cols=257 Identities=21% Similarity=0.255 Sum_probs=199.5
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
+++|++++.||+|+||+||+|++..+|+.||||++..+ .....+|+++++.++|+|++..+..+... ....++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEEE
Confidence 34799999999999999999999999999999987643 34567899999999988776665544332 2347899
Q ss_pred EeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC--CCcEEEeecccceecc
Q 014174 168 LEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH--THQVKLCDFGSAKVLV 245 (429)
Q Consensus 168 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~--~~~vkl~DfG~a~~~~ 245 (429)
|||+++++...+.. ....+++..+..++.|++.||+||| ++||+||||||+|||++.. ...+||+|||+|+...
T Consensus 82 me~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH-~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 82 MELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp EECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EEEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHH-HCCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 99999887765543 3567999999999999999999999 8899999999999998642 2369999999998875
Q ss_pred cCCC--------cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC---CCC
Q 014174 246 KGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLG---TPT 314 (429)
Q Consensus 246 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~~~---~~~ 314 (429)
.... .....||+.|+|||++.+. .++.++|||||||++|+|+||+.||...........+.+... .++
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence 4322 2345789999999999764 489999999999999999999999987665544433322110 000
Q ss_pred HHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHH---HHhcCCCCcc
Q 014174 315 REEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL---EACIHPFFYE 379 (429)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~---ell~hp~f~~ 379 (429)
. ..+...+|+++.+||.+||+.||++||++. ++|+|+|...
T Consensus 237 ~------------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 237 I------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp H------------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred h------------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 0 112345799999999999999999999987 5577877643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=363.24 Aligned_cols=248 Identities=21% Similarity=0.311 Sum_probs=192.6
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCC-------cEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeec
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETG-------ETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST 156 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 156 (429)
.++|++.+.||+|+||.||+|+...++ ..||||++..+. ....+|...+.++ +|||||++++++..
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~- 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence 458999999999999999999976554 379999886543 2334677888777 79999999999843
Q ss_pred CCCCceEEEEEEeccch-hHHHHHHHhh------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCc
Q 014174 157 TDKDELYLNLVLEFVPE-TVYRVAKHYS------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223 (429)
Q Consensus 157 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~N 223 (429)
...+++|||||.+ ++...+.... .....+++.++..++.||+.||+||| +.|||||||||+|
T Consensus 91 ----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH-~~~ivHrDiKp~N 165 (299)
T d1fgka_ 91 ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARN 165 (299)
T ss_dssp ----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGG
T ss_pred ----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh-hCCEEeeeecccc
Confidence 3347899999985 5555554321 12356899999999999999999999 8899999999999
Q ss_pred eEecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 014174 224 LLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESG 299 (429)
Q Consensus 224 ill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~ 299 (429)
||++.++ .+||+|||+++....... .....+|+.|+|||.+.+. .|+.++|||||||++|+|++ |.+||.+.+.
T Consensus 166 iLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~-~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 166 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp EEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCC-CCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 9999888 799999999987654432 2345789999999999764 59999999999999999998 7899987776
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 300 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+....+... .. ..++..+++++.+||.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~i~~~-~~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 244 EELFKLLKEG-HR---------------------------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHTT-CC---------------------------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcC-CC---------------------------CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 5544433221 00 1123457999999999999999999999999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-48 Score=362.88 Aligned_cols=254 Identities=23% Similarity=0.268 Sum_probs=203.0
Q ss_pred ccceEEeeEEccCCceEEEEEEEcC-----CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceEeeecCCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK 159 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 159 (429)
.++|++.+.||+|+||+||+|.+.. ++..||||++.... ..+.+|+++++.++|||||++++++...
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--- 95 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG--- 95 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS---
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC---
Confidence 3579999999999999999998752 35789999986432 2345899999999999999999988432
Q ss_pred CceEEEEEEeccch-hHHHHHHHhh------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCc
Q 014174 160 DELYLNLVLEFVPE-TVYRVAKHYS------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQ 232 (429)
Q Consensus 160 ~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~ 232 (429)
...++||||+.+ ++..++.... .....+++..+..++.|++.||.||| +++|+||||||+||||+.++ .
T Consensus 96 --~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH-~~~ivHrDlk~~NiLld~~~-~ 171 (308)
T d1p4oa_ 96 --QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDF-T 171 (308)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH-HTTCBCSCCSGGGEEECTTC-C
T ss_pred --CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh-hCCeeeceEcCCceeecCCc-e
Confidence 237899999984 5555444321 11245789999999999999999999 88999999999999999888 7
Q ss_pred EEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHH
Q 014174 233 VKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLG-QPLFPGESGVDQLVEIIK 308 (429)
Q Consensus 233 vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~i~~ 308 (429)
+||+|||+|+....... .....||+.|+|||.+.+. .++.++|||||||++|||+|| .+||.+.+..+.+..+.+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999999986644332 2334679999999999764 489999999999999999998 588888877776665543
Q ss_pred HhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc------CCCCcc
Q 014174 309 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI------HPFFYE 379 (429)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~------hp~f~~ 379 (429)
.. ....+..+++.+.+||.+||+.||++|||+.++++ +|+|.+
T Consensus 251 ~~----------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 251 GG----------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp TC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred CC----------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 11 01123457899999999999999999999999998 666654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=359.84 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=199.6
Q ss_pred ccceEEeeEEccCCceEEEEEEEc-----CCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceEeeecCC
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD 158 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 158 (429)
.++|++.++||+|+||.||+|++. .+++.||||++.... ..+.+|+.+++.+ +|||||++++++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~--- 98 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI--- 98 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee---
Confidence 357999999999999999999863 467799999986532 2345799999999 69999999999843
Q ss_pred CCceEEEEEEeccch-hHHHHHHHhh--------------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCc
Q 014174 159 KDELYLNLVLEFVPE-TVYRVAKHYS--------------RASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQN 223 (429)
Q Consensus 159 ~~~~~~~lv~e~~~~-~l~~~~~~~~--------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~N 223 (429)
...+++|||||++ ++...+.... .....+++..+..++.||+.||+||| ++||+||||||+|
T Consensus 99 --~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH-~~~ivHrDLKp~N 175 (311)
T d1t46a_ 99 --GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARN 175 (311)
T ss_dssp --SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGG
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH-hCCeeeccccccc
Confidence 3347899999985 5555544321 12346899999999999999999999 8899999999999
Q ss_pred eEecCCCCcEEEeecccceecccCCC---cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 014174 224 LLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLL-GQPLFPGESG 299 (429)
Q Consensus 224 ill~~~~~~vkl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~ 299 (429)
||++.++ .+||+|||+++....... .....||+.|+|||.+.+. .++.++|||||||++|+|+| |.+||.+.+.
T Consensus 176 Il~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 176 ILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp EEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCC-CCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 9999888 799999999987654432 2345789999999999764 48999999999999999998 6777877777
Q ss_pred HHHHHHHHHHhCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 300 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 300 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+.+.++...... ...+..+++++.+||.+||+.||.+|||+.++++
T Consensus 254 ~~~~~~~i~~~~~---------------------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 254 DSKFYKMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SHHHHHHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCCC---------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6666666543111 1123457899999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.1e-47 Score=356.73 Aligned_cols=250 Identities=19% Similarity=0.215 Sum_probs=199.7
Q ss_pred ccceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcCC-CCeeecceEeeecCCCCceEEEE
Q 014174 90 TISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 90 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.++|+++++||+|+||+||+|++..+|+.||||++... .....+|+++++.++| +|++.+++++.. ....++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec-----CCccEE
Confidence 45799999999999999999999999999999988543 3446789999999976 899999888743 345789
Q ss_pred EEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCC----CCcEEEeecccce
Q 014174 167 VLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPH----THQVKLCDFGSAK 242 (429)
Q Consensus 167 v~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~----~~~vkl~DfG~a~ 242 (429)
||||+++++...+.. ....+++..+..++.|++.||+||| ++||+||||||+|||++.+ .+.+||+|||+|+
T Consensus 79 vme~~~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH-~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 79 VIDLLGPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIH-EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHH-TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEecCCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHH-HCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 999999988776654 3457999999999999999999999 8999999999999999642 2369999999998
Q ss_pred ecccCC--------CcccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhC
Q 014174 243 VLVKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVD---QLVEIIKVLG 311 (429)
Q Consensus 243 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~~i~~~~~ 311 (429)
...... ......||+.|||||++.+. .++.++|||||||++|+|+||..||.+..... ....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCC-CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence 764332 22345799999999999764 49999999999999999999999998654432 2222222111
Q ss_pred CCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 312 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
.+... .+.+++|+++.+++..|+..+|++||+...+.+
T Consensus 234 ~~~~~------------------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 234 STPLR------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HSCHH------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CCChH------------------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11111 123457999999999999999999999877654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-47 Score=355.70 Aligned_cols=245 Identities=20% Similarity=0.259 Sum_probs=188.2
Q ss_pred eEEeeEEccCCceEEEEEEEcCCC---cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceEeeecCCCCceEE
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL 164 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 164 (429)
+...++||+|+||+||+|++..++ ..||||++... ...+.+|++++++++|||||++++++.... ...
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~ 104 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSP 104 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----Cce
Confidence 334678999999999999986643 36899988532 234568999999999999999999875432 247
Q ss_pred EEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCCCcEEEeecccceec
Q 014174 165 NLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 244 (429)
Q Consensus 165 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~~~vkl~DfG~a~~~ 244 (429)
++|||||+++.+..+.. .....+++..+..++.|++.||.||| +.+|+||||||+||||+.++ .+||+|||+++..
T Consensus 105 ~lv~E~~~~g~l~~~~~--~~~~~~~~~~~~~i~~qia~gL~~lH-~~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIR--NETHNPTVKDLIGFGLQVAKGMKFLA-SKKFVHRDLAARNCMLDEKF-TVKVADFGLARDM 180 (311)
T ss_dssp EEEEECCTTCBHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHH-HTTCCCSCCSGGGEEECTTC-CEEECSSGGGCCT
T ss_pred EEEEEEeecCchhhhhc--cccccchHHHHHHHHHHHHHhhhhhc-ccCcccCCccHHhEeECCCC-CEEEecccchhhc
Confidence 89999999654443322 23456788899999999999999999 88999999999999999887 7999999999876
Q ss_pred ccCCC-----cccccccccccccccccCCCCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHH
Q 014174 245 VKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQL-VEIIKVLGTPTREEI 318 (429)
Q Consensus 245 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-~~i~~~~~~~~~~~~ 318 (429)
..... .....||..|+|||.+.+. .++.++|||||||++|||+||..||........+ ..+.. |.
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~--g~------ 251 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--GR------ 251 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHT--TC------
T ss_pred cccccccceecccccccccccChHHHhcC-CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--CC------
Confidence 44322 2234679999999998764 4899999999999999999988777654332222 22211 00
Q ss_pred hhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhcC
Q 014174 319 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACIH 374 (429)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~h 374 (429)
....+..+++++.+||.+||..||++|||+.|+++|
T Consensus 252 --------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 252 --------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011234578999999999999999999999999997
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=353.31 Aligned_cols=267 Identities=19% Similarity=0.196 Sum_probs=187.2
Q ss_pred cceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecchhh-h--HHHHHHHHHcCCCCeeecceEeeecCCCCceEEEEE
Q 014174 91 ISYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDKRY-K--NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 167 (429)
Q Consensus 91 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~--~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 167 (429)
.+|.+.+.||+|+||.||+|+. +|+.||||++..+... . +.|+..+..++|||||++++++.... .....+++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence 3699999999999999999986 7899999998654322 2 23444556789999999999987654 344568899
Q ss_pred Eeccch-hHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHc-------CCCeeeecCCCCceEecCCCCcEEEeecc
Q 014174 168 LEFVPE-TVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHG-------GIGVCHRDIKPQNLLVNPHTHQVKLCDFG 239 (429)
Q Consensus 168 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-------~~givH~DLkp~Nill~~~~~~vkl~DfG 239 (429)
||||++ +|...+.. ..+++.....++.|++.||.|||+ ++||+||||||+||||+.++ .+||+|||
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFG 153 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecC
Confidence 999985 66665543 469999999999999999999993 25999999999999999888 79999999
Q ss_pred cceecccCCC-----cccccccccccccccccCCC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Q 014174 240 SAKVLVKGEP-----NISYICSRYYRAPELIFGAT-----EYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKV 309 (429)
Q Consensus 240 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~i~~~ 309 (429)
+++....... .....||+.|+|||++.+.. .++.++|||||||+||||+||..||............ ..
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~-~~ 232 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-LV 232 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-TS
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh-cc
Confidence 9987755432 23457899999999986532 1466899999999999999999887532211100000 00
Q ss_pred hCCCCHHHHhhcCcCcccccCCCcCCCCcccccCCCCChhHHHHHHhhcCcCCCCCCCHHHHhc
Q 014174 310 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALEACI 373 (429)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~Li~~~L~~dP~~R~t~~ell~ 373 (429)
...+....+..... .....|.+.. ..........+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~--~~~~~p~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 233 PSDPSVEEMRKVVC--EQKLRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CSSCCHHHHHHHHT--TSCCCCCCCG----GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cccchHHHHHHHHh--ccccCCCCCc----ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 00011111100000 0000011000 0001123356899999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.1e-25 Score=196.18 Aligned_cols=165 Identities=16% Similarity=0.122 Sum_probs=118.7
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecch----------------------hhhHHHHHHHHHcCCCCeeecc
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQDK----------------------RYKNRELQTMRLLDHPNVVSLK 150 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~E~~~l~~l~h~niv~~~ 150 (429)
|.+.++||+|+||+||+|++ .+|+.||||++.... ....+|...+..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 57889999999999999997 478999999764210 1123578888999999998876
Q ss_pred eEeeecCCCCceEEEEEEeccchhHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCeeeecCCCCceEecCCC
Q 014174 151 HCFFSTTDKDELYLNLVLEFVPETVYRVAKHYSRASQRMPLIYVKLYTYQICRALAYIHGGIGVCHRDIKPQNLLVNPHT 230 (429)
Q Consensus 151 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~givH~DLkp~Nill~~~~ 230 (429)
++. . .+++|||+++... ..++...+..++.|++.||.||| ++||+||||||+|||++.+
T Consensus 81 ~~~-----~----~~lvme~~~~~~~----------~~l~~~~~~~i~~ql~~~l~~lH-~~giiHrDiKP~NILv~~~- 139 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKEL----------YRVRVENPDEVLDMILEEVAKFY-HRGIVHGDLSQYNVLVSEE- 139 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEG----------GGCCCSCHHHHHHHHHHHHHHHH-HTTEECSCCSTTSEEEETT-
T ss_pred Eec-----C----CEEEEEeeccccc----------cchhhHHHHHHHHHHHHHHHHHh-hCCEEEccCChhheeeeCC-
Confidence 543 2 2589999987421 23556667889999999999999 8899999999999999954
Q ss_pred CcEEEeecccceecccCCCcccccc-cccccccccccCCCCCCCchhHHHHHHHH
Q 014174 231 HQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYTTAIDIWSVGCVL 284 (429)
Q Consensus 231 ~~vkl~DfG~a~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il 284 (429)
.++|+|||+|.....+.... +.. +... -.+.+ . ..|+.++|+||+.--+
T Consensus 140 -~~~liDFG~a~~~~~~~~~~-~l~rd~~~-~~~~f-~-r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 140 -GIWIIDFPQSVEVGEEGWRE-ILERDVRN-IITYF-S-RTYRTEKDINSAIDRI 189 (191)
T ss_dssp -EEEECCCTTCEETTSTTHHH-HHHHHHHH-HHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred -CEEEEECCCcccCCCCCcHH-HHHHHHHH-HHHHH-c-CCCCCcccHHHHHHHH
Confidence 49999999997754332211 000 0000 01112 2 3478899999987544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.24 E-value=1.8e-06 Score=76.45 Aligned_cols=77 Identities=17% Similarity=0.101 Sum_probs=49.9
Q ss_pred ceEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc----hhhhHHHHHHHHHcC-CCCeeecceEeeecCCCCceEEEE
Q 014174 92 SYMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 92 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 166 (429)
.|++++..+.++.+.||++. .++..+++|+.... .....+|...++.+. +--+.+++.+.. .....++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-----~~~~~~l 87 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDGWSNL 87 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe-----cCCceEE
Confidence 47777766666667999886 36677888977543 234568888888774 222345544442 2234678
Q ss_pred EEeccchhH
Q 014174 167 VLEFVPETV 175 (429)
Q Consensus 167 v~e~~~~~l 175 (429)
||++++|..
T Consensus 88 v~~~l~G~~ 96 (263)
T d1j7la_ 88 LMSEADGVL 96 (263)
T ss_dssp EEECCSSEE
T ss_pred EEEeccccc
Confidence 999998743
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.75 E-value=6.9e-05 Score=65.44 Aligned_cols=68 Identities=16% Similarity=0.104 Sum_probs=43.2
Q ss_pred ccCC-ceEEEEEEEcCCCcEEEEEEeecch-hhhHHHHHHHHHcCCCC--eeecceEeeecCCCCceEEEEEEeccch
Q 014174 100 GQGS-FGIVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVLEFVPE 173 (429)
Q Consensus 100 g~G~-~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~ 173 (429)
..|. -+.||++.. .++..+++|...... ....+|...++.+.... +.+++.+... ....++||++++|
T Consensus 19 ~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 19 TIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLGEVPG 90 (255)
T ss_dssp SCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEECCSS
T ss_pred CCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEEEeeec
Confidence 3443 468899874 556778899765443 34567999888875433 3445544322 2236789999974
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.72 E-value=0.00018 Score=67.29 Aligned_cols=71 Identities=17% Similarity=0.118 Sum_probs=43.3
Q ss_pred eeEEccCCceEEEEEEEcCCCcEEEEEEeecc-----------hhhhHHHHHHHHHcC-C--CCeeecceEeeecCCCCc
Q 014174 96 ERVVGQGSFGIVFQAKCLETGETVAIKKVLQD-----------KRYKNRELQTMRLLD-H--PNVVSLKHCFFSTTDKDE 161 (429)
Q Consensus 96 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~~ 161 (429)
.+.||.|....||++.+..+++.|++|.-... .....+|.+.|+.+. + ..+.+++.+. ...
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-----~~~ 105 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-----TEM 105 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-----TTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-----CCC
Confidence 34689999999999998777889999965321 122346888887763 2 2344554322 222
Q ss_pred eEEEEEEeccch
Q 014174 162 LYLNLVLEFVPE 173 (429)
Q Consensus 162 ~~~~lv~e~~~~ 173 (429)
.++|||++++
T Consensus 106 --~~lvmE~L~~ 115 (392)
T d2pula1 106 --AVTVMEDLSH 115 (392)
T ss_dssp --TEEEECCCTT
T ss_pred --CEEEEeccCC
Confidence 2479999864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.76 E-value=0.004 Score=56.13 Aligned_cols=38 Identities=18% Similarity=-0.013 Sum_probs=28.5
Q ss_pred ceEEEEEEEcCCCcEEEEEEeecc---hhhhHHHHHHHHHcC
Q 014174 104 FGIVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLD 142 (429)
Q Consensus 104 ~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~E~~~l~~l~ 142 (429)
--.||++.. .+|..|++|+.... ...+..|...+..|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~ 75 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLV 75 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHH
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHH
Confidence 358999984 67889999987653 345667888888774
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.71 E-value=0.0068 Score=56.11 Aligned_cols=68 Identities=16% Similarity=0.238 Sum_probs=44.4
Q ss_pred eEEccCCceEEEEEEEcC-------CCcEEEEEEeecch--hhhHHHHHHHHHcCCCCe-eecceEeeecCCCCceEEEE
Q 014174 97 RVVGQGSFGIVFQAKCLE-------TGETVAIKKVLQDK--RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNL 166 (429)
Q Consensus 97 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~--~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~l 166 (429)
+.|+.|.--.+|++.... ..+.|.+++.-... ....+|..+++.+.-.++ .++++++ .+ .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----ce
Confidence 568888888999998643 34567888764322 234578889888853344 4666655 22 35
Q ss_pred EEeccch
Q 014174 167 VLEFVPE 173 (429)
Q Consensus 167 v~e~~~~ 173 (429)
|+||++|
T Consensus 119 I~efi~g 125 (395)
T d1nw1a_ 119 LEEYIPS 125 (395)
T ss_dssp EECCCCE
T ss_pred EEEEecc
Confidence 8888874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.41 E-value=0.015 Score=51.75 Aligned_cols=48 Identities=15% Similarity=0.059 Sum_probs=30.6
Q ss_pred eEEeeEEccCCceEEEEEEEcCCCcEEEEEEeecc--hhhhHHHHHHHHHcC
Q 014174 93 YMAERVVGQGSFGIVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLD 142 (429)
Q Consensus 93 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~E~~~l~~l~ 142 (429)
..-.+.|..|.--+.|++.. ++..|++|++... ......|++++..|.
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t--~~g~yVLri~~~~~~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHT--TKDPLILTLYEKRVEKNDLPFFLGLMQHLA 69 (316)
T ss_dssp EEEEEEECC---EEEEEEEE--SSCCEEEEEECC---CCHHHHHHHHHHHHH
T ss_pred ceEeecCCCCcccCeEEEEE--CCCcEEEEEcCCCCCHHHHHHHHHHHHhhh
Confidence 44446677888888999975 3345999988543 344567888888774
|